PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhang, HR; Wang, XD; Yang, X; Chen, D; Hao, J; Cao, R; Wu, XZ				Zhang, H-R; Wang, X-D; Yang, X.; Chen, D.; Hao, J.; Cao, R.; Wu, X-Z			An FGFR inhibitor converts the tumor promoting effect of TGF-beta by the induction of fibroblast-associated genes of hepatoma cells	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; HEPATOCELLULAR-CARCINOMA; CANCER; PROGRESSION; EXPRESSION; ACTIVATION; AZD4547	Tumors consistently mimic wound-generating chronic inflammation; however, why they do not heal like wounds with fibrotic scars remains unknown. The components of the tumor microenvironment, such as transforming growth factor beta (TGF-beta) and fibroblast growth factors (FGFs), may account for this phenomenon. Tumor formation involves continuous activation of the FGF pathway, whereas the repair of tissue injury is a self-limiting process accompanied with controlled activation of the FGF pathway. In the tumor microenvironment TGF-beta increases the secretion of FGFs, further promoting the malignant biological properties of tumors. However, during wound healing, sufficient TGF-beta together with moderate FGFs lead to matrix deposition and the formation of fibrotic scars. In the present study, TGF-beta 1 combined with AZD4547, an FGF receptor (FGFR) inhibitor, transformed hepatoma cells into less malignant fibroblast-like cells with respect to morphology, physiological properties, and gene expression profiles. In vivo experiments showed that TGF-beta 1 combined with AZD4547 not only inhibited tumor growth but also promoted tumor parenchyma fibrosis. Our results indicate that FGFR inhibitor treatment converts the effect of TGF-beta on the hepatocellular carcinoma cells from tumor promotion into tumor inhibition by enhancing the induction effect of TGF-beta on some fibroblast-associated genes. Converting human liver cancer cells into less malignant fibroblast-like cells and inducing tumor parenchyma cell fibrosis provides an alternative strategy for limiting tumor progression.	[Zhang, H-R; Yang, X.; Hao, J.; Cao, R.; Wu, X-Z] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Zhang, H-R; Yang, X.; Hao, J.; Cao, R.; Wu, X-Z] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Zhang, H-R; Yang, X.; Hao, J.; Cao, R.; Wu, X-Z] Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China; [Wang, X-D] Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China; [Chen, D.] Tianjin Med Univ, Sch Basic Med Sci, Dept Pharmacol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Wu, XZ (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Zhong Shan Men Inpatient Dept, Huan Hu Xi Rd, Tianjin 300060, Peoples R China.	wuxiongzhi@163.com	Wu, Xiong-Zhi/P-4045-2019		National Natural Science Foundation of China [81473441]; Program for New Century Excellent Talents in University [NCET-11-1068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (81473441) and the Program for New Century Excellent Talents in University (NO. NCET-11-1068).	Abolhassani A, 2014, J CANCER, V5, P537, DOI 10.7150/jca.7797; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Chang JJ, 2015, ONCOTARGET, V6, P2009, DOI 10.18632/oncotarget.2987; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; El-Assal ON, 2001, CLIN CANCER RES, V7, P1299; Gaarenstroom T, 2014, SEMIN CELL DEV BIOL, V32, P107, DOI 10.1016/j.semcdb.2014.01.009; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Gupta EK, 2014, CANCER GROWTH METAST, V7, P1, DOI 10.4137/CGM.S14205; Islam SS, 2014, J CELL COMMUN SIGNAL, V8, P39, DOI 10.1007/s12079-013-0216-4; Jia LZ, 2012, CANCER LETT, V326, P176, DOI 10.1016/j.canlet.2012.08.004; Jiang WN, 2010, INT J MOL MED, V26, P571, DOI 10.3892/ijmm_00000501; Kajdaniuk D, 2013, ENDOKRYNOL POL, V64, P384, DOI 10.5603/EP.2013.0022; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Krisanaprakornkit S, 2013, ARCH ORAL BIOL, V58, P82, DOI 10.1016/j.archoralbio.2012.06.011; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Miyazono K, 2012, UPSALA J MED SCI, V117, P143, DOI 10.3109/03009734.2011.638729; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Sandhu DS, 2014, HEPATOLOGY, V59, P1166, DOI 10.1002/hep.26679; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schulte J, 2012, HISTOCHEM CELL BIOL, V138, P847, DOI 10.1007/s00418-012-0998-0; Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769; Seol Ho Jun, 2012, Genes Cancer, V3, P535, DOI 10.1177/1947601912473603; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Spyrou GE, 2002, BRIT J PLAST SURG, V55, P275, DOI 10.1054/bjps.2002.3831; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Vasdev Nandini, 2003, Indian J Pathol Microbiol, V46, P625	30	6	6	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 6	2017	36	27					3831	3841		10.1038/onc.2016.512	http://dx.doi.org/10.1038/onc.2016.512			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EZ6SM	28263980				2022-12-26	WOS:000404848200004
J	Gonzalez, AE; Munoz, VC; Cavieres, VA; Bustamante, HA; Cornejo, VH; Januario, YC; Gonzalez, I; Hetz, C; daSilva, LL; Rojas-Fernandez, A; Hay, RT; Mardones, GA; Burgos, PV				Gonzalez, Alexis E.; Munoz, Vanessa C.; Cavieres, Viviana A.; Bustamante, Hianara A.; Cornejo, Victor-Hugo; Januario, Yunan C.; Gonzalez, Ibeth; Hetz, Claudio; daSilva, Luis L.; Rojas-Fernandez, Alejandro; Hay, Ronald T.; Mardones, Gonzalo A.; Burgos, Patricia V.			Autophagosomes cooperate in the degradation of intracellular C-terminal fragments of the amyloid precursor protein via the MVB/lysosomal pathway	FASEB JOURNAL			English	Article						Alzheimer disease; APP; C99; multivesicular bodies; amphisome; proteostasis	TRANS-GOLGI NETWORK; ALZHEIMERS-DISEASE; A-BETA; MULTIVESICULAR BODIES; ENDOCYTIC PATHWAY; NEURODEGENERATIVE DISEASE; ENDOPLASMIC-RETICULUM; COGNITIVE DEFICITS; EARLY ENDOSOMES; DOWN-SYNDROME	Brain regions affected by Alzheimer disease (AD) displaywell-recognized early neuropathologic features in the endolysosomal and autophagy systems of neurons, including enlargement of endosomal compartments, progressive accumulation of autophagic vacuoles, and lysosomal dysfunction. Although the primary causes of these disturbances are still under investigation, a growing body of evidence suggests that the amyloid precursor protein (APP) intracellular C-terminal fragment beta (C99), generated by cleavage of APP by beta-site APP cleaving enzyme 1 (BACE-1), is the primary cause of the endosome enlargement inADand the earliest initiator of synaptic plasticity and long-termmemory impairment. The aim of the present study was to evaluate the possible relationship between the endolysosomal degradation pathway and autophagy on the proteolytic processing and turnover of C99. We found that pharmacologic treatments that either inhibit autophagosome formation or block the fusion of autophagosomes to endolysosomal compartments caused an increase in C99 levels. We also found that inhibition of autophagosome formation by depletion of Atg5 led to higher levels of C99 and to its massive accumulation in the lumen of enlarged perinuclear, lysosomal-associated membrane protein 1 (LAMP1)-positive organelles. In contrast, activation of autophagosome formation, either by starvation or by inhibition of the mammalian target of rapamycin, enhanced lysosomal clearance of C99. Altogether, our results indicate that autophagosomes are key organelles to help avoid C99 accumulation preventing its deleterious effects.	[Gonzalez, Alexis E.; Munoz, Vanessa C.; Cavieres, Viviana A.; Bustamante, Hianara A.; Gonzalez, Ibeth; Mardones, Gonzalo A.; Burgos, Patricia V.] Univ Austral Chile, Sch Med, Dept Physiol, Valdivia, Chile; [Rojas-Fernandez, Alejandro; Mardones, Gonzalo A.; Burgos, Patricia V.] Univ Austral Chile, Ctr Interdisciplinary Studies Nervous Syst CISNe, Valdivia, Chile; [Cornejo, Victor-Hugo; Hetz, Claudio] Univ Chile, Biomed Neurosci Inst, Fac Med, Santiago, Chile; [Cornejo, Victor-Hugo; Hetz, Claudio] Ctr Gerosci Brain Hlth & Metab, Santiago, Chile; [Januario, Yunan C.; daSilva, Luis L.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol, Ribeirao Preto, Brazil; [Hetz, Claudio] Buck Inst Res Aging, Novato, CA USA; [Hetz, Claudio] Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Rojas-Fernandez, Alejandro; Hay, Ronald T.] Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee, Scotland	Universidad Austral de Chile; Universidad Austral de Chile; Universidad de Chile; Universidade de Sao Paulo; Buck Institute for Research on Aging; Harvard University; Harvard T.H. Chan School of Public Health; University of Dundee	Burgos, PV (corresponding author), Univ Austral Chile, Sch Med, Dept Physiol, Lab Cell & Mol Biol, Valdivia 5110566, Chile.	patricia.burgos@uach.cl	Cornejo, Victor Hugo/ABD-8410-2021; Fernandez, Alejandro Rojas/K-3291-2014; LP daSilva, Luis/A-9949-2010; daSilva, Luis LP/AAD-5657-2019; Hay, Ronald/S-3233-2019; Hetz, Claudio/ABD-7514-2021	Fernandez, Alejandro Rojas/0000-0002-6004-5425; LP daSilva, Luis/0000-0003-3558-0087; daSilva, Luis LP/0000-0003-3558-0087; Hay, Ronald/0000-0001-7113-9024; 	National Fund for Scientific and Technological Development (FONDECYT) [1130929, 1130710, 1140549]; International Cooperation Program (PCI) of the National Commission for Scientific and Technological Research (CONICYT; Grant ECOS/CONICYT) [C14B03]; International Cooperation Program (PCI) of the National Commission for Scientific and Technological Research (CONICYT; Grant Fondo Newton-Picarte CONICYT) [DPI20140068]; International Cooperation Program (PCI) of the National Commission for Scientific and Technological Research (CONICYT; Grant Fondo CONICYT Chile-Brazil) [441921/2016-7]; Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (FONDAP) [15150012]; Millennium Institute [P09-015-F]; Office of Naval Research-Global (ONR-G) [N62909-16-1-2003]; Sao Paulo Research Foundation (FAPESP) [2014/25812-0]; Direccion de Investigacion y Desarrollo-Universidad Austral de Chile (DID-UACh) [D-2013-07, D-2015-02]; Programa de Mejoramiento de la Calidad y la Equidad de la Educacion (MECESUP) [AUS 1203]; CONICYT [201110746, 21151194, 21130315]; Coordination for the Improvement of Higher Education Personnel (CAPES) fellowship from the Brazilian Ministry of Education; Medical Research Council (MRC) Next Generation Optical Microscopy award [MR/K015869/1]; Medical Research Council [MR/K015869/1] Funding Source: researchfish; MRC [MR/K015869/1] Funding Source: UKRI	National Fund for Scientific and Technological Development (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); International Cooperation Program (PCI) of the National Commission for Scientific and Technological Research (CONICYT; Grant ECOS/CONICYT); International Cooperation Program (PCI) of the National Commission for Scientific and Technological Research (CONICYT; Grant Fondo Newton-Picarte CONICYT); International Cooperation Program (PCI) of the National Commission for Scientific and Technological Research (CONICYT; Grant Fondo CONICYT Chile-Brazil); Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (FONDAP)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Millennium Institute(Takeda Pharmaceutical Company Ltd); Office of Naval Research-Global (ONR-G)(Office of Naval Research); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Direccion de Investigacion y Desarrollo-Universidad Austral de Chile (DID-UACh); Programa de Mejoramiento de la Calidad y la Equidad de la Educacion (MECESUP); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Coordination for the Improvement of Higher Education Personnel (CAPES) fellowship from the Brazilian Ministry of Education(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Medical Research Council (MRC) Next Generation Optical Microscopy award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the National Fund for Scientific and Technological Development (FONDECYT; Grants 1130929 to P.V.B., 1130710 to G.A.M., and 1140549 to C.H.); International Cooperation Program (PCI) of the National Commission for Scientific and Technological Research (CONICYT; Grants ECOS/CONICYT C14B03 to P.V.B., Fondo Newton-Picarte CONICYT DPI20140068 to P.V.B., and Fondo CONICYT Chile-Brazil 441921/2016-7 to C.H.); Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (FONDAP; Program 15150012 to C.H.); Millennium Institute (Grant P09-015-F to C.H.); Office of Naval Research-Global (ONR-G; N62909-16-1-2003 to C.H.); Sao Paulo Research Foundation (FAPESP; 2014/25812-0 to L.L.D.); Direccion de Investigacion y Desarrollo-Universidad Austral de Chile (DID-UACh; Grant D-2013-07 to A.E.G. and D-2015-02 to H.A.B.); and Programa de Mejoramiento de la Calidad y la Equidad de la Educacion (MECESUP; AUS 1203). A.E.G., V.A.C., and H.A.B. were supported by CONICYT fellowships 201110746, 21151194, and 21130315, respectively. Y.C.J. was supported by a Coordination for the Improvement of Higher Education Personnel (CAPES) fellowship from the Brazilian Ministry of Education. The use of the OMX microscope was funded by a Medical Research Council (MRC) Next Generation Optical Microscopy award (MR/K015869/1).	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bago R., MOL CANC THER; Bellettato CM, 2010, J INHERIT METAB DIS, V33, P347, DOI 10.1007/s10545-010-9075-9; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Bustamante HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083096; Cataldo AM, 1996, J NEUROSCI, V16, P186; Cavieres VA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136313; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Edgar JR, 2015, J CELL SCI, V128, P2520, DOI 10.1242/jcs.170233; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hattersley N, 2011, MOL BIOL CELL, V22, P78, DOI 10.1091/mbc.E10-06-0504; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Jiang Yanfang, 2010, Mediators Inflamm, V2010, P143026, DOI 10.1155/2010/143026; Jiang Y, 2016, NEUROBIOL AGING, V39, P90, DOI 10.1016/j.neurobiolaging.2015.11.013; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim S, 2016, MOL PSYCHIATR, V21, P707, DOI 10.1038/mp.2015.97; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lamb CA, 2013, BIOESSAYS, V35, P34, DOI 10.1002/bies.201200130; Lanz TA, 2003, J PHARMACOL EXP THER, V305, P864, DOI 10.1124/jpet.102.048280; Lauritzen I, 2016, ACTA NEUROPATHOL, V132, P257, DOI 10.1007/s00401-016-1577-6; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MANDERS EMM, 1992, J CELL SCI, V103, P857; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Morel E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3250; Murrow L, 2015, NAT CELL BIOL, V17, P300, DOI 10.1038/ncb3112; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Ohm TG, 2003, PHARMACOPSYCHIATRY, V36, pS120; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Peng JY, 2014, SCI CHINA LIFE SCI, V57, P59, DOI 10.1007/s11427-013-4588-8; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Prabhu Y, 2012, MOL BIOL CELL, V23, P2339, DOI 10.1091/mbc.E11-11-0944; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Repnik U, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008755; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Rusten TE, 2010, NAT CELL BIOL, V12, P207, DOI 10.1038/ncb0310-207; Rusten TE, 2009, J CELL SCI, V122, P2179, DOI 10.1242/jcs.050021; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schwake M, 2013, TRAFFIC, V14, P739, DOI 10.1111/tra.12056; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; SIMAN R, 1993, J BIOL CHEM, V268, P16602; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Tenorio MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154719; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tian Y, 2011, FASEB J, V25, P1934, DOI 10.1096/fj.10-175158; Toh W. H., TRAFFIC; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Walczak M, 2013, AUTOPHAGY, V9, P424, DOI 10.4161/auto.22931; Wolfe DM, 2013, EUR J NEUROSCI, V37, P1949, DOI 10.1111/ejn.12169; Wong YC, 2015, J CELL SCI, V128, P1259, DOI 10.1242/jcs.161216; Xiao QL, 2015, J NEUROSCI, V35, P12137, DOI 10.1523/JNEUROSCI.0705-15.2015; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Xu W, 2016, J CLIN INVEST, V126, P1815, DOI 10.1172/JCI82409; Yi J, 1999, CELL RES, V9, P243, DOI 10.1038/sj.cr.7290023; Yuyama K, 2006, FEBS LETT, V580, P6972, DOI 10.1016/j.febslet.2006.11.072	75	29	29	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2446	2459		10.1096/fj.201600713R	http://dx.doi.org/10.1096/fj.201600713R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28254759	Green Submitted			2022-12-26	WOS:000401553400020
J	Bayles, BR; Thomas, SM; Simmons, GS; Grafton-Cardwell, EE; Daugherty, MP				Bayles, Brett R.; Thomas, Shyam M.; Simmons, Gregory S.; Grafton-Cardwell, Elizabeth E.; Daugherty, Mathew P.			Spatiotemporal dynamics of the Southern California Asian citrus psyllid (Diaphorina citri) invasion	PLOS ONE			English	Article							SPATIAL ASSOCIATION; HEMIPTERA PSYLLIDAE; DISEASE; SPREAD; TEMPERATURE; HOMOPTERA; MANAGEMENT; DISPERSAL; DISTANCE; ECOLOGY	Biological invasions are governed by spatial processes that tend to be distributed in non-ran-dom ways across landscapes. Characterizing the spatial and temporal heterogeneities of the introduction, establishment, and spread of non-native insect species is a key aspect of effectively managing their geographic expansion. The Asian citrus psyllid (Diaphorina citri), a vector of the bacterium associated with huanglongbing (HLB), poses a serious threat to commercial and residential citrus trees. In 2008, D. citri first began expanding northward from Mexico into parts of Southern California. Using georeferenced D. citri occurrence data from 2008-2014, we sought to better understand the extent of the geographic expansion of this invasive vector species. Our objectives were to: 1) describe the spatial and temporal distribution of D. citri in Southern California, 2) identify the locations of statistically significant D. citri hotspots, and 3) quantify the dynamics of anisotropic spread. We found clear evi-dence that the spatial and temporal distribution of D. citri in Southern California is non-ran-dom. Further, we identified the existence of statistically significant hotspots of D. citri occurrence and described the anisotropic dispersion across the Southern California land-scape. For example, the dominant hotspot surrounding Los Angeles showed rapid and strongly asymmetric spread to the south and east. Our study demonstrates the feasibility of quantitative invasive insect risk assessment with the application of a spatial epidemiology framework.	[Bayles, Brett R.; Thomas, Shyam M.; Grafton-Cardwell, Elizabeth E.; Daugherty, Mathew P.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Bayles, Brett R.] Dominican Univ Calif, Sch Hlth & Nat Sci, San Rafael, CA 94901 USA; [Simmons, Gregory S.] US Anim & Plant Hlth Inspect Serv, USDA, Salinas, CA USA	University of California System; University of California Riverside; United States Department of Agriculture (USDA)	Bayles, BR (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.; Bayles, BR (corresponding author), Dominican Univ Calif, Sch Hlth & Nat Sci, San Rafael, CA 94901 USA.	brett.bayles@dominican.edu	Bayles, Brett/AAA-2751-2020; Thomas, Shyam/AAN-4043-2020	Bayles, Brett/0000-0002-3474-4353; 	USDA-APHIS-PPQ; NIFA-AFRI grant [2012-01803]	USDA-APHIS-PPQ(United States Department of Agriculture (USDA)); NIFA-AFRI grant	This work was supported by funding from USDA-APHIS-PPQ and NIFA-AFRI grant #2012-01803 to M.P.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to R. Johnson and R. Dunn for providing the D. citri geodatabase, T. Galindo, M. Luque-Williams, D. Tanoue, and R. Broadway for ACP trapping summary statistics, and J. Morse and R. Stouthamer for helpful discussion. This work was supported by funding from USDA-APHIS-PPQ and NIFA-AFRI grant #2012-01803 to Mathew P Daugherty.	Alston KP, 2006, BIOL CONSERV, V132, P183, DOI 10.1016/j.biocon.2006.03.023; Anderson K, 2010, PHILOS T R SOC B, V365, P3007, DOI 10.1098/rstb.2010.0131; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Arakawa Kenryo, 2007, Research Bulletin of the Plant Protection Service Japan, V43, P23; Beloti VH, 2013, FLA ENTOMOL, V96, P173, DOI 10.1653/024.096.0123; Boina DR, 2009, ENVIRON ENTOMOL, V38, P1250, DOI 10.1603/022.038.0436; Bove JM, 2006, J PLANT PATHOL, V88, P7; Boyd IL, 2013, SCIENCE, V342, P823, DOI 10.1126/science.1235773; Chiyaka C, 2012, P NATL ACAD SCI USA, V109, P12213, DOI 10.1073/pnas.1208326109; Coletta HD, 2014, PHYTOPATHOLOGY, V104, P416, DOI 10.1094/PHYTO-06-13-0157-R; Dagulo L, 2010, J FOOD SCI, V75, pC199, DOI 10.1111/j.1750-3841.2009.01495.x; Daugherty M, 2013, CAPCA ADVISER MAGAZI, V16, P14; ESRI, 2011, ARCG1S DESKT REL 10; Gavier-Pizarro GI, 2010, ECOL APPL, V20, P1913, DOI 10.1890/09-2168.1; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gottwald T., 2014, J CITRUS PATHOL, V1, P121; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Halbert S.E., 2012, FLORIDA ENTOMOLOGIST, V95, P620; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Halbert SE, 2010, FLA ENTOMOL, V93, P33, DOI 10.1653/024.093.0104; Hall DG, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.8301; Hoddle M.S., 2012, CAPCA ADVISER, V15, P18; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kaplan H, 2014, BIOL INVASIONS, V16, P691, DOI 10.1007/s10530-013-0611-z; Kistner EJ, 2016, ANN ENTOMOL SOC AM; Kistner EJ, 2016, J ECON ENTOMOL, V109, P1047, DOI 10.1093/jee/tow021; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lee JA, 2015, P NATL ACAD SCI USA, V112, P7605, DOI 10.1073/pnas.1508253112; Lefever DW, 1926, AM J SOCIOL, V32, P88, DOI 10.1086/214027; Lewis-Rosenblum H, 2015, J ECON ENTOMOL, V108, P3, DOI 10.1093/jee/tou008; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Liu YH, 2000, ANN APPL BIOL, V137, P201, DOI 10.1111/j.1744-7348.2000.tb00060.x; MA, 2005, ECOSYSTEMS HUMAN WEL; Martini X, 2014, ANN ENTOMOL SOC AM, V107, P842, DOI 10.1603/AN14028; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Morin RS, 2009, BIOL INVASIONS, V11, P2341, DOI 10.1007/s10530-008-9420-1; Nakata T, 2006, APPL ENTOMOL ZOOL, V41, P383, DOI 10.1303/aez.2006.383; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Pereira-Peixoto MH, 2014, J INSECT CONSERV, V18, P815, DOI 10.1007/s10841-014-9688-7; Poland TM, 2006, J FOREST, V104, P118; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Qureshi JA, 2009, J ECON ENTOMOL, V102, P247, DOI 10.1603/029.102.0134; Richards TJ, 2014, AM J AGR ECON, V96, P615, DOI 10.1093/ajae/aat099; Rigot T, 2014, ECOGRAPHY, V37, P648, DOI 10.1111/j.1600-0587.2013.00447.x; Saumel I, 2010, LANDSCAPE URBAN PLAN, V94, P244, DOI 10.1016/j.landurbplan.2009.10.009; Sakamaki Y., 2005, KURCPI OCCASIONAL PA, V42, P121; Setamou M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131917; Shaver GR, 2005, Ecosystem Function in Heterogeneous Landscapes, P443, DOI 10.1007/0-387-24091-8_22; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Spreen TH, 2014, HORTSCIENCE, V49, P1052, DOI 10.21273/HORTSCI.49.8.1052; Thomas SM, USING REGUL IN PRESS; Tsai JH, 2002, FLA ENTOMOL, V85, P446, DOI 10.1653/0015-4040(2002)085[0446:SAOTAC]2.0.CO;2; Vinatier F, 2011, METHODS ECOL EVOL, V2, P11, DOI 10.1111/j.2041-210X.2010.00059.x; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494	58	37	39	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173226	10.1371/journal.pone.0173226	http://dx.doi.org/10.1371/journal.pone.0173226			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278188	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900055
J	Tran, HT; Liong, S; Lim, R; Barker, G; Lappas, M				Tran, Ha T.; Liong, Stella; Lim, Ratana; Barker, Gillian; Lappas, Martha			Resveratrol ameliorates the chemical and microbial induction of inflammation and insulin resistance in human placenta, adipose tissue and skeletal muscle	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; NECROSIS-FACTOR-ALPHA; PREEXISTING MATERNAL OBESITY; PROINFLAMMATORY CYTOKINES; METABOLIC ENDOTOXEMIA; RECEPTOR SUBSTRATE-1; FETAL MEMBRANES; DOWN-REGULATION; PREGNANT-WOMEN; KAPPA-B	Gestational diabetes mellitus (GDM), which complicates up to 20% of all pregnancies, is associated with low-grade maternal inflammation and peripheral insulin resistance. Sterile inflammation and infection are key mediators of this inflammation and peripheral insulin resistance. Resveratrol, a stilbene-type phytophenol, has been implicated to exert beneficial properties including potent anti-inflammatory and antidiabetic effects in non-pregnant humans and experimental animal models of GDM. However, studies showing the effects of resveratrol on inflammation and insulin resistance associated with GDM in human tissues have been limited. In this study, human placenta, adipose (omental and subcutaneous) tissue and skeletal muscle were stimulated with pro-inflammatory cytokines TNF-alpha and IL-1 beta, the bacterial product lipopolysaccharide (LPS) and the synthetic viral dsRNA analogue polyinosinic:polycytidylic acid (poly(I:C)) to induce a GDM-like model. Treatment with resveratrol significantly reduced the expression and secretion of pro-inflammatory cytokines IL-6, IL 1 alpha, IL-1 beta and pro-inflammatory chemokines IL-8 and MCP-1 in human placenta and omental and subcutaneous adipose tissue. Resveratrol also significantly restored the defects in the insulin signalling pathway and glucose uptake induced by TNF-alpha, LPS and poly(I:C). Collectively, these findings suggest that resveratrol reduces inflammation and insulin resistance induced by chemical and microbial products. Resveratrol may be a useful preventative therapeutic for pregnancies complicated by inflammation and insulin resistance, like GDM.	[Tran, Ha T.; Liong, Stella; Lim, Ratana; Barker, Gillian; Lappas, Martha] Univ Melbourne, Dept Obstet & Gynaecol, Obstet Nutr & Endocrinol Grp, Heidelberg, Vic, Australia; [Tran, Ha T.; Liong, Stella; Lim, Ratana; Barker, Gillian; Lappas, Martha] Mercy Hosp Women, Mercy Perinatal Res Ctr, Heidelberg, Vic, Australia	University of Melbourne	Lappas, M (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Obstet Nutr & Endocrinol Grp, Heidelberg, Vic, Australia.; Lappas, M (corresponding author), Mercy Hosp Women, Mercy Perinatal Res Ctr, Heidelberg, Vic, Australia.	mlappas@unimelb.edu.au	Liong, Stella/AAQ-5308-2021	Liong, Stella/0000-0001-6131-858X	Career Development Fellowship from the National Health and Medical Research Council (NHMRC) [1047025]; Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Research Foundation; University of Melbourne; Endocrine Society of Australia (ESA); Norman Beischer Medical Research Foundation; Diabetes Australia; Austin Medical Research Foundation; Rebecca L Cooper Medical Research Foundation	Career Development Fellowship from the National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Research Foundation; University of Melbourne(University of Melbourne); Endocrine Society of Australia (ESA); Norman Beischer Medical Research Foundation; Diabetes Australia; Austin Medical Research Foundation; Rebecca L Cooper Medical Research Foundation	Associate Professor Martha Lappas is supported by a Career Development Fellowship from the National Health and Medical Research Council (NHMRC; grant no. 1047025). Dr. Stella Liong is a recipient of the Glyn White Research Fellowship by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Research Foundation, the Early Career Researcher Fellowship by The University of Melbourne, and the Postdoctoral Award by the Endocrine Society of Australia (ESA). Funding for this study was provided by grants from the Norman Beischer Medical Research Foundation, Diabetes Australia, Rebecca L Cooper Medical Research Foundation and Austin Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ategbo JM, 2006, J CLIN ENDOCR METAB, V91, P4137, DOI 10.1210/jc.2006-0980; Barbour LA, 2006, REDUCED IRS 1 INCREA; Bari MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101327; Basu S, 2011, OBESITY, V19, P476, DOI 10.1038/oby.2010.215; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bhatt JK, 2012, NUTR RES, V32, P537, DOI 10.1016/j.nutres.2012.06.003; Boyadzhieva M, 2013, J ENDOCRINOL INVEST, V36, P944, DOI 10.3275/8968; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Catalano P, 2015, INT J OBESITY, V39, P642, DOI 10.1038/ijo.2015.15; CATALANO PM, 1991, AM J OBSTET GYNECOL, V165, P1667, DOI 10.1016/0002-9378(91)90012-G; Catalano PM, 2003, AM J OBSTET GYNECOL, V189, P1698, DOI 10.1016/S0002-9378(03)00828-7; Colomiere M, 2009, EUR J ENDOCRINOL, V160, P567, DOI 10.1530/EJE-09-0031; Coustan DR, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.04.006; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Dhurandhar NV, 1997, OBES RES, V5, P464, DOI 10.1002/j.1550-8528.1997.tb00672.x; Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Friedman JE, 2008, DIABETES, V57, P606, DOI 10.2337/db07-1356; Friedman JE, 1999, DIABETES, V48, P1807, DOI 10.2337/diabetes.48.9.1807; Gao XL, 2008, CHINESE MED J-PEKING, V121, P701, DOI 10.1097/00029330-200804020-00008; Ghanim H, 2010, J CLIN ENDOCR METAB, V95, pE1, DOI 10.1210/jc.2010-0482; Hauguel-de Mouzon S, 2006, PLACENTA, V27, P794, DOI 10.1016/j.placenta.2005.08.009; Hawkesworth S, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.24; Hornstra G, EUROPEAN JOURNAL OF, V61, P57; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jones HN, 2009, AM J PHYSIOL-CELL PH, V297, pC1228, DOI 10.1152/ajpcell.00195.2009; Kaaja Risto, 2008, Rev Diabet Stud, V5, P194, DOI 10.1900/RDS.2008.5.194; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Kim S, 2011, BIOCHEM PHARMACOL, V81, P1343, DOI 10.1016/j.bcp.2011.03.012; Kinalski M, 2005, HORM METAB RES, V37, P450, DOI 10.1055/s-2005-870238; Klein K, 2008, PRENATAL DIAG, V28, P845, DOI 10.1002/pd.2064; Koga K, 2009, AM J REPROD IMMUNOL, V61, P196, DOI 10.1111/j.1600-0897.2008.00682.x; Kuzmicki M, 2013, EUR J ENDOCRINOL, V168, P419, DOI 10.1530/EJE-12-0654; Lager S, 2011, PLACENTA, V32, P121, DOI 10.1016/j.placenta.2010.10.012; Langer O, 2005, AM J OBSTET GYNECOL, V192, P989, DOI 10.1016/j.ajog.2004.11.039; Lappas M, 2005, J ENDOCRINOL, V186, P457, DOI 10.1677/joe.1.06227; Lappas M, 2004, J CLIN ENDOCR METAB, V89, P5627, DOI 10.1210/jc.2003-032097; Lappas M, 2014, PLACENTA, V35, P866, DOI 10.1016/j.placenta.2014.08.089; Lappas M, 2005, ENDOCRINOLOGY, V146, P3334, DOI 10.1210/en.2005-0406; Lappas M, 2014, J ENDOCRINOL, V222, P99, DOI 10.1530/JOE-14-0179; Lappas M, 2014, METABOLISM, V63, P860, DOI 10.1016/j.metabol.2014.03.007; Lappas M, 2014, METABOLISM, V63, P250, DOI 10.1016/j.metabol.2013.10.001; Lappas M, 2014, MOL CELL ENDOCRINOL, V382, P74, DOI 10.1016/j.mce.2013.09.011; Lappas M, 2011, BIOL REPROD, V84, P167, DOI 10.1095/biolreprod.110.086983; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Lim R, 2015, AM J REPROD IMMUNOL, V73, P66, DOI 10.1111/aji.12334; Lim R, 2013, MOL HUM REPROD, V19, P451, DOI 10.1093/molehr/gat015; Liong S., 2015, J PHYSL BIOCH, P1; Liong S, 2016, MOL CELL ENDOCRINOL, V425, P11, DOI 10.1016/j.mce.2016.02.016; Liong S, 2015, AM J REPROD IMMUNOL, V74, P62, DOI 10.1111/aji.12366; Liong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122633; Lou YQ, 2014, DIABETES RES CLIN PR, V104, P136, DOI 10.1016/j.diabres.2014.01.014; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Movahed A, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/851267; Mrizak I, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-93; O'Tierney-Ginn P, 2015, PLACENTA, V36, P903, DOI 10.1016/j.placenta.2015.06.002; Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975; Radaelli T, 2003, DIABETES, V52, P2951, DOI 10.2337/diabetes.52.12.2951; Roberts VHJ, 2014, FASEB J, V28, P2466, DOI 10.1096/fj.13-245472; Shao JH, 2002, DIABETES, V51, P19, DOI 10.2337/diabetes.51.1.19; Shintani Y, 2004, GASTROENTEROLOGY, V126, P840, DOI 10.1053/j.gastro.2003.11.056; SOBEL DO, 1992, DIABETES, V41, P515, DOI 10.2337/diabetes.41.4.515; Szkudelska K, 2010, EUR J PHARMACOL, V635, P1, DOI 10.1016/j.ejphar.2010.02.054; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Wolf M, 2004, DIABETES CARE, V27, P21, DOI 10.2337/diacare.27.1.21; Xiong X, 2001, INT J GYNECOL OBSTET, V75, P221, DOI 10.1016/S0020-7292(01)00496-9; Xiong X, 2009, J PERIODONTOL, V80, P1742, DOI 10.1902/jop.2009.090250; Yao LQ, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0114-0; Yoshino J, 2012, CELL METAB, V16, P658, DOI 10.1016/j.cmet.2012.09.015	71	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173373	10.1371/journal.pone.0173373	http://dx.doi.org/10.1371/journal.pone.0173373			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278187	Green Published, gold, Green Submitted			2022-12-26	WOS:000396087900080
J	Abramovitch, JB; Lopata, AL; O'Hehir, RE; Rolland, JM				Abramovitch, Jodie B.; Lopata, Andreas L.; O'Hehir, Robyn E.; Rolland, Jennifer M.			Effect of thermal processing on T cell reactivity of shellfish allergens - Discordance with IgE reactivity	PLOS ONE			English	Article							BLACK TIGER PRAWN; MASS-SPECTROMETRY; PENAEUS-MONODON; FOOD ALLERGY; TROPOMYOSIN; CHILDREN; EXPRESSION; PROTEINS; IMMUNOTHERAPY; KINASE	Crustacean allergy is a major cause of food-induced anaphylaxis. We showed previously that heating increases IgE reactivity of crustacean allergens. Here we investigate the effects of thermal processing of crustacean extracts on cellular immune reactivity. Raw and cooked black tiger prawn, banana prawn, mud crab and blue swimmer crab extracts were prepared and IgE reactivity assessed by ELISA. Mass spectrometry revealed a mix of several allergens in the raw mud crab extract but predominant heat-stable tropomyosin in the cooked extract. PBMC from crustacean-allergic and non-atopic control subjects were cultured with the crab and prawn extracts and proliferation of lymphocyte subsets was analysed by CFSE labelling and flow cytometry. Effector responses were assessed by intracellular IL-4 and IFN-gamma, and regulatory T (CD4(+)CD25(+)CD127(lo)Foxp3(+)) cell proportions in cultures were also compared by flow cytometry. For each crustacean species, the cooked extract had greater IgE reactivity than the raw (mud crab p<0.05, other species p<0.01). In contrast, there was a trend for lower PBMC proliferative responses to cooked compared with raw extracts. In crustacean-stimulated PBMC cultures, dividing CD4(+) and CD56(+) lymphocytes showed higher IL-4(+)/IFN-gamma(+) ratios for crustacean-allergic subjects than for non-atopics (p<0.01), but there was no significant difference between raw and cooked extracts. The percentage IL-4(+) of dividing CD4(+) cells correlated with total and allergen-specific IgE levels (prawns p<0.01, crabs p<0.05). Regulatory T cell proportions were lower in cultures stimulated with cooked compared with raw extracts (mud crab p<0.001, banana prawn p<0.05). In conclusion, cooking did not substantially alter overall T cell proliferative or cytokine reactivity of crustacean extracts, but decreased induction of Tregs. In contrast, IgE reactivity of cooked extracts was increased markedly. These novel findings have important implications for improved diagnostics, managing crustacean allergy and development of future therapeutics. Assessment of individual allergen T cell reactivity is required.	[Abramovitch, Jodie B.; O'Hehir, Robyn E.; Rolland, Jennifer M.] Monash Univ, Dept Pathol & Immunol, Melbourne, Vic, Australia; [Abramovitch, Jodie B.; O'Hehir, Robyn E.; Rolland, Jennifer M.] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia; [Abramovitch, Jodie B.; O'Hehir, Robyn E.; Rolland, Jennifer M.] Monash Univ, Melbourne, Vic, Australia; [Lopata, Andreas L.] James Cook Univ, Dept Mol & Cell Biol, Townsville, Qld, Australia	Monash University; Florey Institute of Neuroscience & Mental Health; Monash University; James Cook University	Rolland, JM (corresponding author), Monash Univ, Dept Pathol & Immunol, Melbourne, Vic, Australia.	jennifer.rolland@monash.edu	Lopata, Andreas L/O-2143-2017; O'Hehir, Robyn E/H-3627-2011	Lopata, Andreas L/0000-0002-2940-9235; O'Hehir, Robyn E/0000-0002-3489-7595	Alfred Research Trusts; Australian Research Council	Alfred Research Trusts; Australian Research Council(Australian Research Council)	ROH received funding for this project from the Alfred Research Trusts and the Australian Research Council. AL is supported by an Australian Research Council Future Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067487; Aktas E, 2005, CLIN EXP IMMUNOL, V140, P301, DOI 10.1111/j.1365-2249.2005.02777.x; Barnes PJ, 2011, IMMUNOL REV, V242, P31, DOI 10.1111/j.1600-065X.2011.01020.x; Bullens DMA, 2005, CLIN EXP ALLERGY, V35, P1535, DOI 10.1111/j.1365-2222.2005.02352.x; Crack LR, 2011, CLIN EXP ALLERGY, V41, P1555, DOI 10.1111/j.1365-2222.2011.03819.x; Deniz G, 2011, EXPERT OPIN BIOL TH, V11, P833, DOI 10.1517/14712598.2011.572549; Eusebius NP, 2002, INT ARCH ALLERGY IMM, V127, P234, DOI 10.1159/000053868; Flinterman AE, 2010, CLIN EXP ALLERGY, V40, P590, DOI 10.1111/j.1365-2222.2009.03431.x; Gabrielsson S, 2001, CLIN EXP IMMUNOL, V126, P390, DOI 10.1046/j.1365-2249.2001.01703.x; Gamez C, 2015, FOOD CHEM, V173, P475, DOI 10.1016/j.foodchem.2014.10.063; Hilmenyuk T, 2010, IMMUNOLOGY, V129, P437, DOI 10.1111/j.1365-2567.2009.03199.x; Ilchmann A, 2010, J ALLERGY CLIN IMMUN, V125, P175, DOI 10.1016/j.jaci.2009.08.013; Kamath SD, 2014, MOL NUTR FOOD RES, V58, P1144, DOI 10.1002/mnfr.201300584; Kamath SD, 2013, FOOD CHEM, V141, P4031, DOI 10.1016/j.foodchem.2013.06.105; Karlsson MR, 2004, J EXP MED, V199, P1679, DOI 10.1084/jem.20032121; Koeberl M, 2014, J IMMUNOL METHODS, V415, P6, DOI 10.1016/j.jim.2014.10.008; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Liu GM, 2010, J FOOD SCI, V75, pT1, DOI 10.1111/j.1750-3841.2009.01391.x; Lopata AL, 2010, CLIN EXP ALLERGY, V40, P850, DOI 10.1111/j.1365-2222.2010.03513.x; Maleki SJ, 2000, J ALLERGY CLIN IMMUN, V106, P763, DOI 10.1067/mai.2000.109620; Mills ENC, 2009, MOL NUTR FOOD RES, V53, P963, DOI 10.1002/mnfr.200800236; Moldaver D, 2011, ALLERGY, V66, P784, DOI 10.1111/j.1398-9995.2011.02610.x; Nowak-Wegrzyn A, 2009, CURR OPIN ALLERGY CL, V9, P234, DOI 10.1097/ACI.0b013e32832b88e7; O'Hehir RE, 2009, AM J RESP CRIT CARE, V180, P936, DOI 10.1164/rccm.200905-0686OC; Palomares O, 2014, GENES IMMUN, V15, P511, DOI 10.1038/gene.2014.45; Pedrosa M, 2015, CLIN REV ALLERG IMMU, V49, P203, DOI 10.1007/s12016-014-8429-8; Prickett SR, 2015, CLIN EXP ALLERGY, V45, P1015, DOI 10.1111/cea.12554; Rahman AMA, 2011, J PROTEOMICS, V74, P231, DOI 10.1016/j.jprot.2010.10.010; Rahman AMA, 2010, RAPID COMMUN MASS SP, V24, P2462, DOI 10.1002/rcm.4664; Ravkov EV, 2013, HUM IMMUNOL, V74, P1542, DOI 10.1016/j.humimm.2013.08.276; Renand A, 2014, J ALLERGY CLIN IMMUN, V134, P1456, DOI 10.1016/j.jaci.2014.07.048; Rolland JM, 2010, CURR OPIN ALLERGY CL, V10, P559, DOI 10.1097/ACI.0b013e32833ff2b2; Rolland JM, 2009, PHARMACOL THERAPEUT, V121, P273, DOI 10.1016/j.pharmthera.2008.11.007; Sampath V, 2017, ANN ALLERG ASTHMA IM, V118, P21, DOI 10.1016/j.anai.2016.10.017; Schouten B, 2012, INT ARCH ALLERGY IMM, V159, P51, DOI 10.1159/000335242; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Smith M, 2008, J ALLERGY CLIN IMMUN, V121, P1460, DOI 10.1016/j.jaci.2008.03.025; Stelmaszczyk-Emmel A, 2013, INT ARCH ALLERGY IMM, V162, P16, DOI 10.1159/000350769; Stock P, 2008, CURR ALLERGY ASTHM R, V8, P165, DOI 10.1007/s11882-008-0027-5; Untersmayr E, 2006, PHARMACOL THERAPEUT, V112, P787, DOI 10.1016/j.pharmthera.2006.06.004; Verhoeckx KCM, 2015, FOOD CHEM TOXICOL, V80, P223, DOI 10.1016/j.fct.2015.03.005; Wang SP, 2012, HUM IMMUNOL, V73, P426, DOI 10.1016/j.humimm.2011.12.019; Yu HL, 2013, J SCI FOOD AGR, V93, P245, DOI 10.1002/jsfa.5748	44	15	17	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173549	10.1371/journal.pone.0173549	http://dx.doi.org/10.1371/journal.pone.0173549			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273149	Green Accepted, gold, Green Published			2022-12-26	WOS:000396073700016
J	Puhakka, N; Bot, AM; Vuokila, N; Debski, KJ; Lukasiuk, K; Pitkanen, A				Puhakka, Noora; Bot, Anna Maria; Vuokila, Niina; Debski, Konrad Jozef; Lukasiuk, Katarzyna; Pitkanen, Asla			Chronically dysregulated NOTCH1 interactome in the dentate gyrus after traumatic brain injury	PLOS ONE			English	Article							MICRORNA EXPRESSION; HIPPOCAMPUS; EPILEPSY; MODELS; CELLS; EPILEPTOGENESIS; EPIDEMIOLOGY; ACTIVATION; BIOMARKERS; PROFILES	Traumatic brain injury (TBI) can result in several dentate gyrus-regulated disabilities. Almost nothing is known about the chronic molecular changes after TBI, and their potential as treatment targets. We hypothesized that chronic transcriptional alterations after TBI are under microRNA (miRNA) control. Expression of miRNAs and their targets in the dentate gyrus was analyzed using microarrays at 3 months after experimental TBI. Of 305 miRNAs present on the miRNA-array, 12 were downregulated (p<0.05). In parallel, 75 of their target genes were upregulated (p<0.05). A bioinformatics analysis of miRNA targets highlighted the dysregulation of the transcription factor NOTCH1 and 39 of its target genes (NOTCH1 interactome). Validation assays confirmed downregulation of miR-139-5p, upregulation of Notch1 and its activated protein, and positive enrichment of NOTCH1 target gene expression. These findings demonstrate that miRNA-based transcriptional regulation can be present at chronic time points after TBI, and highlight the NOTCH1 interactome as one of the mechanisms behind the dentate gyrus pathology-related morbidities.	[Puhakka, Noora; Vuokila, Niina; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, Kuopio, Finland; [Bot, Anna Maria; Debski, Konrad Jozef; Lukasiuk, Katarzyna] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland	University of Eastern Finland; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, Kuopio, Finland.	asla.pitkanen@uef.fi		Lukasiuk, Katarzyna/0000-0002-1582-0920; Debski, Konrad/0000-0001-5949-9211	Academy of Finland; FP7-HEALTH project [602102]; National Research Centre [2011/01/M/NZ3/02139]; Ministry of Science and Education [DNP/N119/ESF-EuroEPINOMICS/2012]	Academy of Finland(Academy of Finland); FP7-HEALTH project; National Research Centre(National Research Centre (NRC)); Ministry of Science and Education	This study was supported by the Academy of Finland http://www.aka.fi/en (AP) and FP7-HEALTH project 602102 https://ec.europa.eu/research/fp7/index_en.cfm (EPITARGET), National Research Centre grant 2011/01/M/NZ3/02139 (KL), and Ministry of Science and Education grant DNP/N119/ESF-EuroEPINOMICS/2012.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Balaraman S, 2012, ALCOHOL CLIN EXP RES, V36, P1669, DOI 10.1111/j.1530-0277.2012.01793.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barth JMI, 2014, MIOMED RES; Bekris LM, 2015, NEURODEGENER DIS MAN, V5, P61, DOI [10.2217/nmt.14.52, 10.2217/NMT.14.52]; Boese AS, 2016, MOL CELL NEUROSCI, V71, P13, DOI 10.1016/j.mcn.2015.12.001; Bot AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076051; Brai E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00447; Brennan GP, 2016, CELL REP, V14, P2402, DOI 10.1016/j.celrep.2016.02.042; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Debski KJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep25668; Deprez F, 2011, NEUROBIOL DIS, V44, P174, DOI 10.1016/j.nbd.2011.06.011; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Fernandez-Espejo D, 2013, NAT REV NEUROSCI, V14, P801, DOI 10.1038/nrn3608; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gorter JA, 2014, NEUROBIOL DIS, V62, P508, DOI 10.1016/j.nbd.2013.10.026; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Grasso M, 2014, MOLECULES, V19, P6891, DOI 10.3390/molecules19056891; Guo YJ, 2009, PROG NEURO-PSYCHOPH, V33, P688, DOI 10.1016/j.pnpbp.2009.03.022; He M, 2012, NEURON, V73, P35, DOI 10.1016/j.neuron.2011.11.010; Hook G, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00178; Hu K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-115; Huang Yen-Hua, 2014, Biomed Res Int, V2014, P195162, DOI 10.1155/2014/195162; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Jovicic A, 2013, J NEUROSCI, V33, P5127, DOI 10.1523/JNEUROSCI.0600-12.2013; Kan AA, 2012, CELL MOL LIFE SCI, V69, P3127, DOI 10.1007/s00018-012-0992-7; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; LEWIS DA, 1986, J COMP NEUROL, V248, P1, DOI 10.1002/cne.902480102; Li MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04734; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Liu L, 2014, ADV DIFFER EQU, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0103948; Liu X, 2015, PLOS ONE; Liu XZ, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201300053; Liu Zhong, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P1, DOI 10.3724/SP.J.1011.2012.00001; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu J, 2013, P NATL ACAD SCI USA, V110, P10747, DOI 10.1073/pnas.1308950110; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKiernan RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035921; Mi L, 2015, J CELL BIOCHEM, V116, P1195, DOI 10.1002/jcb.25065; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Naghavian R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124555; Nagy Gergely, 2002, Pathology and Oncology Research, V8, P115; Niessen K, 2011, BLOOD, V118, P1989, DOI 10.1182/blood-2010-11-319129; Patino GA, 2011, J NEUROSCI, V31, P14577, DOI 10.1523/JNEUROSCI.0361-11.2011; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peng WJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0034-0; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Qu Y, 2014, NEUROBIOL DIS, V63, P184, DOI 10.1016/j.nbd.2013.11.023; R Core Team, 2012, LANG ENV STAT COMP; Rao P, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00039; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Risbud RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053464; Roncon P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14143; Roopra A, 2012, EPILEPSIA, V53, P2, DOI 10.1111/epi.12030; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sha LZ, 2014, MOL NEUROBIOL, V49, P633, DOI 10.1007/s12035-013-8545-0; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimada IS, 2011, STROKE, V42, P3231, DOI 10.1161/STROKEAHA.111.623280; Sibbe M, 2012, EUR J NEUROSCI, V36, P3643, DOI 10.1111/j.1460-9568.2012.08279.x; Song MX, 2014, PROTEIN CELL, V5, P851, DOI 10.1007/s13238-014-0093-5; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanase C, 2015, FUTURE ONCOL, V11, P511, DOI 10.2217/fon.14.238; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Tu J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/368082; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Wang J, 2014, EXP THER MED, V8, P1671, DOI 10.3892/etm.2014.2014; Wang S., 2010, SIGN SYST EL ISSSE 2, V1, P1, DOI DOI 10.1097/FBP.0B013E328334B677; Wang Y, 2012, EXP BIOL MED, V237, P1424, DOI 10.1258/ebm.2012.012123; Zattoni M, 2011, J NEUROSCI, V31, P4037, DOI 10.1523/JNEUROSCI.6210-10.2011; Zhang LJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-124; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang Z, 2015, BRAIN RES BULL, V113, P8, DOI 10.1016/j.brainresbull.2015.02.003	85	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172521	10.1371/journal.pone.0172521	http://dx.doi.org/10.1371/journal.pone.0172521			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273100	Green Published, Green Submitted, gold			2022-12-26	WOS:000396073700077
J	Riad, FS; Razak, E; Saba, S; Shalaby, A; Nemec, J				Riad, Fady S.; Razak, Eathar; Saba, Samir; Shalaby, Alaa; Nemec, Jan			Recent heart rate history affects QT interval duration in atrial fibrillation	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; RATE DEPENDENCE; MORTALITY; TORSADE; DYNAMICS; FORMULAS; POINTES	QT interval prolongation is associated with a risk of polymorphic ventricular tachycardia. QT interval shortens with increasing heart rate and correction for this effect is necessary for meaningful QT interval assessment. We aim to improve current methods of correcting the QT interval during atrial fibrillation (AF). Digitized Holter recordings were analyzed from patients with AF. Models of QT interval dependence on RR intervals were tested by sorting the beats into 20 bins based on corrected RR interval and assessing ST-T variability within the bins. Signal-averaging within bins was performed to determine QT/RR dependence. Data from 30 patients (29 men, 69.3 7.3 years) were evaluated. QT behavior in AF is well described by a linear function (slope-0.19) of steady-state corrected RR interval. Corrected RR is calculated as a combination of an exponential weight function with time-constant of 2 minutes and a smaller "immediate response" component (weight- 0.18). This model performs significantly (p<0.0001) better than models based on instantaneous RR interval only including Bazett and Fridericia. It also outperforms models based on shorter time-constants and other previously proposed models. This model may improve detection of repolarization delay in AF. QT response to heart rate changes in AF is similar to previously published QT dynamics during atrial pacing and in sinus rhythm.	[Riad, Fady S.] Univ Pittsburgh, Med Ctr, Dept Internal Med, Pittsburgh, PA USA; [Razak, Eathar; Shalaby, Alaa] VA Pittsburgh Healthcare Syst, Dept Cardiol, Pittsburgh, PA USA; [Saba, Samir; Nemec, Jan] Univ Pittsburgh, Med Ctr, Inst Heart & Vasc, Pittsburgh, PA 15260 USA; [Razak, Eathar] CHI Franciscan Hlth, Franciscan Heart & Vasc Associates St Joseph, Tacoma, WA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Nemec, J (corresponding author), Univ Pittsburgh, Med Ctr, Inst Heart & Vasc, Pittsburgh, PA 15260 USA.	limidus@hotmail.com		Riad, Fady/0000-0001-7874-2328				Aytemir K, 1999, PACE, V22, P1397, DOI 10.1111/j.1540-8159.1999.tb00635.x; Batchvarov VN, 2002, AM J PHYSIOL-HEART C, V282, pH2356, DOI 10.1152/ajpheart.00860.2001; Choy AMJ, 1999, J AM COLL CARDIOL, V34, P396, DOI 10.1016/S0735-1097(99)00226-0; Darbar D, 2007, J CARDIOVASC ELECTR, V18, P636, DOI 10.1111/j.1540-8167.2007.00817.x; EHLERT FA, 1992, AM J CARDIOL, V70, P332, DOI 10.1016/0002-9149(92)90614-5; Eisner DA, 2009, EXP PHYSIOL, V94, P520, DOI 10.1113/expphysiol.2008.044008; Fujiki A, 2011, J CARDIOL, V57, P269, DOI 10.1016/j.jjcc.2011.01.013; Fujiki A, 2011, CIRC J, V75, P274, DOI 10.1253/circj.CJ-10-0654; Gilmour RF, 1997, J AM COLL CARDIOL, V30, P209, DOI 10.1016/S0735-1097(97)00105-8; KAY GN, 1983, J AM COLL CARDIOL, V2, P806; Larroude CE, 2006, HEART RHYTHM, V3, P660, DOI 10.1016/j.hrthm.2006.02.021; LAU CP, 1988, CARDIOVASC RES, V22, P67, DOI 10.1093/cvr/22.1.67; Lin JF, 2015, INT J MED SCI, V12, P968, DOI 10.7150/ijms.13121; Luo S, 2004, J ELECTROCARDIOL, V37, P81, DOI 10.1016/j.jelectrocard.2004.08.030; Malik M, 1996, PACE, V19, P490, DOI 10.1111/j.1540-8159.1996.tb06521.x; Medenwald D, 2016, EUR J PREV CARDIOL, V23, P428, DOI 10.1177/2047487315587271; Musat DL, 2013, AM J CARDIOL, V112, P1379, DOI 10.1016/j.amjcard.2013.06.027; Nemec J, 2004, J CARDIOVASC ELECTR, V15, P550, DOI 10.1046/j.1540-8167.2004.03096.x; Noseworthy PA, 2012, ANN NONINVAS ELECTRO, V17, P340, DOI 10.1111/j.1542-474X.2012.00535.x; Pickham D, 2012, J ELECTROCARDIOL, V45, P556, DOI 10.1016/j.jelectrocard.2012.08.052; Razak E, 2011, ANN NONINVAS ELECTRO, V16, P148, DOI 10.1111/j.1542-474X.2011.00420.x; Roden DM, 2007, EUROPACE, V9, P1, DOI 10.1093/europace/eum165; Seethala S, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002395; Seethala S, 2011, HEART RHYTHM, V8, P263, DOI 10.1016/j.hrthm.2010.10.012; Tolkacheva EG, 2006, BIOPHYS J, V91, P2735, DOI 10.1529/biophysj.106.083865; Viswanathan PC, 1999, CIRCULATION, V99, P2466, DOI 10.1161/01.CIR.99.18.2466; Williams ES, 2012, AM HEART J, V164, P434, DOI 10.1016/j.ahj.2012.05.024; Yamaguchi Y, 2015, PACE, V38, P1418, DOI 10.1111/pace.12746; Zhang YY, 2011, ARCH INTERN MED, V171, P1727, DOI 10.1001/archinternmed.2011.433	29	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172962	10.1371/journal.pone.0172962	http://dx.doi.org/10.1371/journal.pone.0172962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273109	Green Submitted, Green Published, gold			2022-12-26	WOS:000396073700033
J	Rubio, CA				Rubio, Carlos A.			Corrupted colonic crypt fission in carcinogen-treated rats	PLOS ONE			English	Article							LYMPHOID-TISSUE; TUMORS; CANCER; FOCI	Background The colonic crypts in rats reproduce themselves by symmetric fission at the base of the crypts, and proceeding upwards, generate two separate identical crypts. Recently we reported corrupted colonic crypt fission (CCCF) in rats with colonic carcinoma. Here we investigated whether CCCF also occurred in the colonic mucosa without carcinoma in carcinogen-treated rats. Methods Filed Swiss-roll sections from 35 male rats (25 treated with 1,2-dimethyhydrazine (DMH) suspended in EDTA solution, and 10 EDTA-treated) were reviewed. CCCF were regarded those with either asymmetric basal fission, asymmetric lateral sprouting/lateral fission, basal dilatations, or spatial aberrations of the normal (vertical) axis. Results 202 CCCF (38%) were recorded amongst 533 crypts with fission in DMH-treated rats, and only one CCCF (0.1%) was found amongst 571 crypts with fission in EDTA-treated rats (p<0.05). The basal aspect of four adenomas included in Swiss roll sections exhibited CCCF lined either with indigenous (non-dysplastic) epithelium or with dysplastic epithelium. Conclusion It was demonstrated that CCCF without dysplasia develop in carcinogen-treated SD rats. As judged by the figures presented, the possibility that the epithelium in those corrupted crypts was successively replaced by top-down growing dysplastic cells, could not be totally rejected. This is the first report showing that non-dysplastic CCCF may antedate the very early stages of colonic carcinogenesis in SD rats.	[Rubio, Carlos A.] Karolinska Inst, Dept Pathol, Stockholm, Sweden; [Rubio, Carlos A.] Univ Hosp, Stockholm, Sweden	Karolinska Institutet	Rubio, CA (corresponding author), Karolinska Inst, Dept Pathol, Stockholm, Sweden.; Rubio, CA (corresponding author), Univ Hosp, Stockholm, Sweden.	Carlos.Rubio@ki.se			Karolinska University Hospital Research and Development Fund [77147]	Karolinska University Hospital Research and Development Fund	This study was supported by The Karolinska University Hospital Research and Development Fund No. 77147. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRD RP, 1989, CANCER SURV, V8, P189; Boman BM, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00244; DEASY JM, 1983, J SURG ONCOL, V24, P36, DOI 10.1002/jso.2930240109; DRUCKREY H, 1967, NATURWISSENSCHAFTEN, V54, P285, DOI 10.1007/BF00620890; Femia AP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-194; Ghirardi M, 1999, EUR SURG RES, V31, P272, DOI 10.1159/000008703; Jang HR, 2005, J NUTR, V135, p2967S, DOI 10.1093/jn/135.12.2967S; LAQUEUR GL, 1965, VIRCHOWS ARCH A, V340, P151, DOI 10.1007/BF00958669; LAQUEUR GL, 1963, J NATL CANCER I, V31, P919; MARTIN MS, 1986, INT J CANCER, V38, P75, DOI 10.1002/ijc.2910380113; Nascimbeni R, 1999, AM J SURG PATHOL, V23, P1256, DOI 10.1097/00000478-199910000-00011; Ochiai M, 2014, CANCER SCI, V105, P943, DOI 10.1111/cas.12446; Rubio CA, 1998, APOPTOSIS, V3, P35, DOI 10.1023/A:1009607102797; RUBIO CA, 1989, DIS COLON RECTUM, V32, P488, DOI 10.1007/BF02554503; RUBIO CA, 1980, J NATL CANCER I, V64, P569; RUBIO CA, 1986, AM J PATHOL, V123, P161; RUBIO CA, 1991, APMIS, V99, P993, DOI 10.1111/j.1699-0463.1991.tb01290.x; Rubio CA, 2011, STEM CELL REGENERATI, P279; Rubio CA, 2016, J CLIN PATHOL; Rubio CA, 2017, ANTICANCER RES, V37, P15, DOI 10.21873/anticanres.11284; Rubio CA, 2016, ANTICANCER RES, V36, P5385, DOI 10.21873/anticanres.11113; SHETYE JD, 1990, CANCER RES, V50, P6358; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; STCLAIR WH, 1985, CELL TISSUE KINET, V18, P255; Tan CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078519	25	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172824	10.1371/journal.pone.0172824	http://dx.doi.org/10.1371/journal.pone.0172824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273142	Green Published, Green Submitted, gold			2022-12-26	WOS:000396073700031
J	Akpaka, PE; Kissoon, S; Wilson, C; Jayaratne, P; Smith, A; Golding, GR				Akpaka, Patrick Eberechi; Kissoon, Shivnarine; Wilson, Clyde; Jayaratne, Padman; Smith, Ashley; Golding, George R.			Molecular characterization of vancomycin-resistant Enterococcus faecium isolates from Bermuda	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; EPIDEMIOLOGY; DETERMINANTS; ESP; PCR	Molecular characteristics of vancomycin resistant enterococci isolates from Bermuda Island is currently unknown. This study was conducted to investigate phenotypic and genotypic characteristics of VRE isolates from Bermuda Island using the chromogenic agar, E-tests, polymerase chain reaction (PCR), pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). Eighteen E. faecium isolates were completely analyzed and were all resistant to vancomycin, susceptible to linezolid and quinupristin/dalfopristin, positive for vanA and esp genes. The MLST analysis confirmed most isolates were of the sequence types linked to clonal complex 17 (CC17) that is widely associated with outbreaks in hospitals. Infection control measures, antibiotic stewardship, and surveillance activities will continue to be a priority in hospital on the Island.	[Akpaka, Patrick Eberechi; Kissoon, Shivnarine] Univ West Indies, Dept Paraclin Sci, St Augustine, Trinidad Tobago; [Wilson, Clyde] King Edward VII Mem Hosp, Dept Pathol & Microbiol, Hamilton, Bermuda; [Jayaratne, Padman] McMaster Univ, Dept Pathol Sci, Hamilton, ON, Canada; [Smith, Ashley] King Edward VII Mem Hosp, Dept Pharm, Hamilton, Bermuda; [Golding, George R.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	University West Indies Mona Jamaica; University West Indies Saint Augustine; McMaster University; Public Health Agency of Canada	Wilson, C (corresponding author), King Edward VII Mem Hosp, Dept Pathol & Microbiol, Hamilton, Bermuda.	clyde.wilson@bermudahospitals.bm	Smith, Ashley/GZB-0298-2022		University of the West Indies, St. Augustine Campus, Trinidad and Tobago	University of the West Indies, St. Augustine Campus, Trinidad and Tobago	The funds were provided by the University of the West Indies, St. Augustine Campus, Trinidad and Tobago. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpaka PE, 2016, ADV MED; BANNERMAN TL, 1995, J CLIN MICROBIOL, V33, P551, DOI 10.1128/JCM.33.3.551-555.1995; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P322; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; Chuang YC, 2010, J CLIN MICROBIOL, V48, P2897, DOI 10.1128/JCM.00136-10; Clinical and Laboratory Standards Institute, 2015, M100S25 CLSI; Corso AC, 2007, INT J INFECT DIS, V11, P69, DOI 10.1016/j.ijid.2006.02.003; Deshpande LM, 2007, DIAGN MICR INFEC DIS, V58, P163, DOI 10.1016/j.diagmicrobio.2006.12.022; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Healy M, 2005, J CLIN MICROBIOL, V43, P199, DOI 10.1128/JCM.43.1.199-207.2005; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Homan WL, 2002, J CLIN MICROBIOL, V40, P1963, DOI 10.1128/JCM.40.6.1963-1971.2002; Jayaratne P, 1999, J CLIN MICROBIOL, V37, P2090, DOI 10.1128/JCM.37.6.2090-2092.1999; Kissoon S, 2015, BRIT MICROBIOLOGY RE, V9, P1; Ko KS, 2005, J CLIN MICROBIOL, V43, P2303, DOI 10.1128/JCM.43.5.2303-2306.2005; Leavis H, 2004, J BACTERIOL, V186, P672, DOI 10.1128/JB.186.3.672-682.2004; McCracken M, 2013, J ANTIMICROB CHEMOTH; MURRAY BE, 1990, J CLIN MICROBIOL, V28, P2059, DOI 10.1128/JCM.28.9.2059-2063.1990; MURRAY BE, 1991, J CLIN MICROBIOL, V29, P418; NNIS System, 2001, AM J INFECT CONTROL, V29, P404, DOI 10.1067/mic.2001.119952; Panesso D, 2010, J CLIN MICROBIOL, V48, P1562, DOI 10.1128/JCM.02526-09; Smith S, 1999, J CLIN MICROBIOL, V37, P1231, DOI 10.1128/JCM.37.4.1231-1232.1999; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Turabelidze D, 2000, J CLIN MICROBIOL, V38, P4242, DOI 10.1128/JCM.38.11.4242-4245.2000; UTTLEY AHC, 1988, LANCET, V1, P57; Vankerckhoven V, 2004, J CLIN MICROBIOL, V42, P4473, DOI 10.1128/JCM.42.10.4473-4479.2004; Vergis EN, 2001, ANN INTERN MED, V135, P484, DOI 10.7326/0003-4819-135-7-200110020-00007; Willems RJL, 2005, EMERG INFECT DIS, V11, P821, DOI 10.3201/1106.041204	28	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0171317	10.1371/journal.pone.0171317	http://dx.doi.org/10.1371/journal.pone.0171317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267763	gold, Green Published, Green Submitted			2022-12-26	WOS:000396060600058
J	Koenen, A; Babendreyer, A; Schumacher, J; Pasqualon, T; Schwarz, N; Seifert, A; Deupi, X; Ludwig, A; Dreymueller, D				Koenen, Andrea; Babendreyer, Aaron; Schumacher, Julian; Pasqualon, Tobias; Schwarz, Nicole; Seifert, Anke; Deupi, Xavier; Ludwig, Andreas; Dreymueller, Daniela			The DRF motif of CXCR6 as chemokine receptor adaptation to adhesion	PLOS ONE			English	Article							LIGAND CXCL16; TNF-ALPHA; T-CELLS; INFLAMMATION; INTERNALIZATION; MIGRATION; SYSTEM; ATHEROSCLEROSIS; PROLIFERATION; ACCUMULATION	The CXC-chemokine receptor 6 (CXCR6) is a class A GTP-binding protein-coupled receptor (GPCRs) that mediates adhesion of leukocytes by interacting with the transmembrane cell surface-expressed chemokine ligand 16 (CXCL16), and also regulates leukocyte migration by interacting with the soluble shed variant of CXCL16. In contrast to virtually all other chemokine receptors with chemotactic activity, CXCR6 carries a DRF motif instead of the typical DRY motif as a key element in receptor activation and G protein coupling. In this work, modeling analyses revealed that the phenylalanine F-3.51 in CXCR6 might have impact on intramolecular interactions including hydrogen bonds by this possibly changing receptor function. Initial investigations with embryonic kidney HEK293 cells and further studies with monocytic THP-1 cells showed that mutation of DRF into DRY does not influence ligand binding, receptor internalization, receptor recycling, and protein kinase B (AKT) signaling. Adhesion was slightly decreased in a time-dependent manner. However, CXCL16-induced calcium signaling and migration were increased. Vice versa, when the DRY motif of the related receptor CX(3)CR1 was mutated into DRF the migratory response towards CX(3)CL1 was diminished, indicating that the presence of a DRF motif generally impairs chemotaxis in chemokine receptors. Transmembrane and soluble CXCL16 play divergent roles in homeostasis, inflammation, and cancer, which can be beneficial or detrimental. Therefore, the DRF motif of CXCR6 may display a receptor adaptation allowing adhesion and cell retention by transmembrane CXCL16 but reducing the chemotactic response to soluble CXCL16. This adaptation may avoid permanent or uncontrolled recruitment of inflammatory cells as well as cancer metastasis.	[Koenen, Andrea; Babendreyer, Aaron; Schumacher, Julian; Pasqualon, Tobias; Seifert, Anke; Ludwig, Andreas; Dreymueller, Daniela] Rhein Westfal TH Aachen, Fac Med, Inst Pharmacol & Toxicol, Aachen, Germany; [Schwarz, Nicole] Rhein Westfal TH Aachen, Fac Med, Inst Mol & Cellular Anat, Aachen, Germany; [Deupi, Xavier] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; [Deupi, Xavier] Paul Scherrer Inst, Condensed Matter Theory Grp, Villigen, Switzerland	RWTH Aachen University; RWTH Aachen University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Dreymueller, D (corresponding author), Rhein Westfal TH Aachen, Fac Med, Inst Pharmacol & Toxicol, Aachen, Germany.	daniela.dreymueller@rwth-aachen.de	Dreymueller, Daniela/B-9590-2016; Schwarz, Nicole/ABC-8096-2020; Deupi, Xavier/B-2424-2009; Yildiz, Daniela/AAP-9473-2020; Ludwig, Andreas/I-5685-2012	Dreymueller, Daniela/0000-0002-9702-8581; Deupi, Xavier/0000-0003-4572-9316; Yildiz, Daniela/0000-0002-9702-8581; Ludwig, Andreas/0000-0001-8536-4986; Babendreyer, Aaron/0000-0001-7207-8139; Schwarz, Nicole/0000-0001-7888-6970	START (RWTH Aachen, Germany); DFG grant [Lu869/4-1-2]; Swiss National Science Foundation [146520]; COST Action [CM1207]	START (RWTH Aachen, Germany); DFG grant(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); COST Action(European Cooperation in Science and Technology (COST))	This work was supported in part by START (RWTH Aachen, Germany (D.D.)), by the DFG grant Lu869/4-1-2 (AL), and by the Swiss National Science Foundation grant 146520 (X.D.). This work was also supported by COST Action CM1207 (GLISTEN) (X.D.). Molecular dynamics simulations were run at the Swiss National Supercomputing Centre (CSCS).	Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; Andrzejewski MG, 2010, BIOCHEM BIOPH RES CO, V395, P178, DOI 10.1016/j.bbrc.2010.03.139; Berchiche YA, 2007, J BIOL CHEM, V282, P5111, DOI 10.1074/jbc.C600270200; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Borst O, 2012, AM J PHYSIOL-CELL PH, V302, pC644, DOI 10.1152/ajpcell.00340.2011; Burger M, 1999, J IMMUNOL, V163, P2017; Chandrasekar B, 2004, J BIOL CHEM, V279, P3188, DOI 10.1074/jbc.M311660200; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Dawaliby R, 2016, NAT CHEM BIOL, V12, P35, DOI [10.1038/NCHEMBIO.1960, 10.1038/nchembio.1960]; Day C, 2009, EXP LUNG RES, V35, P272, DOI 10.1080/01902140802635517; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dreymueller D, 2016, J CELL MOL MED, V20, P104, DOI 10.1111/jcmm.12708; Fang YY, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/478641; Galkina E, 2007, CIRCULATION, V116, P1801, DOI 10.1161/CIRCULATIONAHA.106.678474; Germanov E, 2008, J IMMUNOL, V181, P81, DOI 10.4049/jimmunol.181.1.81; Han XB, 2015, FEBS OPEN BIO, V5, P182, DOI 10.1016/j.fob.2015.03.001; Hase K, 2006, J IMMUNOL, V176, P43, DOI 10.4049/jimmunol.176.1.43; Hattermann K, 2008, MOL CELL NEUROSCI, V39, P133, DOI 10.1016/j.mcn.2008.03.009; Hattermann K, 2016, ELIFE, V5, DOI 10.7554/eLife.10820; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Heydtmann M, 2005, J IMMUNOL, V174, P1055, DOI 10.4049/jimmunol.174.2.1055; Hofnagel O, 2011, ATHEROSCLEROSIS, V217, P371, DOI 10.1016/j.atherosclerosis.2011.04.021; Hu WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099056; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Isberg V, 2016, NUCLEIC ACIDS RES, V44, pD356, DOI 10.1093/nar/gkv1178; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Jensen ASM, 2012, ADV VIROL, V2012, DOI 10.1155/2012/231813; Kee JY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-949; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; Latta M, 2007, IMMUNOLOGY, V121, P555, DOI 10.1111/j.1365-2567.2007.02603.x; Lehrke M, 2007, J AM COLL CARDIOL, V49, P442, DOI 10.1016/j.jacc.2006.09.034; Leschner J, 2013, J PHARMACOL EXP THER, V344, P85, DOI 10.1124/jpet.112.199190; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Matsumura S, 2008, J IMMUNOL, V181, P3099, DOI 10.4049/jimmunol.181.5.3099; Meijer J, 2008, CANCER RES, V68, P4701, DOI 10.1158/0008-5472.CAN-08-0482; Morgan AJ, 2005, CLIN EXP ALLERGY, V35, P1572, DOI 10.1111/j.1365-2222.2005.02383.x; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; Nomiyama H, 2015, J LEUKOCYTE BIOL, V97, P39, DOI 10.1189/jlb.2RU0614-290R; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Petit SJ, 2011, ARTERIOSCL THROM VAS, V31, P914, DOI 10.1161/ATVBAHA.110.220558; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reig G, 2014, DEVELOPMENT, V141, P1999, DOI 10.1242/dev.101451; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Schramme A, 2008, BIOCHEM BIOPH RES CO, V370, P311, DOI 10.1016/j.bbrc.2008.03.088; Schwarz N, 2010, CELL MOL LIFE SCI, V67, P4233, DOI 10.1007/s00018-010-0433-4; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh SP, 2015, MOL PHARMACOL, V88, P894, DOI 10.1124/mol.115.099960; Speyer CL, 2011, J INVEST SURG, V24, P18, DOI 10.3109/08941939.2010.521232; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Tsai FC, 2014, NAT CELL BIOL, V16, P133, DOI 10.1038/ncb2906; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wang J, 2014, DEVELOPMENT, V141, P4199, DOI 10.1242/dev.101071; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Wehr A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112327; Wehr A, 2013, J IMMUNOL, V190, P5226, DOI 10.4049/jimmunol.1202909; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Xia YF, 2014, KIDNEY INT, V86, P327, DOI 10.1038/ki.2014.64; Yamauchi R, 2004, ARTERIOSCL THROM VAS, V24, P282, DOI 10.1161/01.ATV.0000114565.42679.c6; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhao LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087786	67	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173486	10.1371/journal.pone.0173486	http://dx.doi.org/10.1371/journal.pone.0173486			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267793	Green Published, Green Submitted, gold			2022-12-26	WOS:000396060600036
J	Mousavi, M; Yap, HJ; Musa, SN; Tahriri, F; Dawal, SZM				Mousavi, Maryam; Yap, Hwa Jen; Musa, Siti Nurmaya; Tahriri, Farzad; Dawal, Siti Zawiah Md			Multi-objective AGV scheduling in an FMS using a hybrid of genetic algorithm and particle swarm optimization	PLOS ONE			English	Article							AUTOMATED GUIDED VEHICLES; MANUFACTURING SYSTEM; SEARCH; PATH	Flexible manufacturing system (FMS) enhances the firm's flexibility and responsiveness to the ever-changing customer demand by providing a fast product diversification capability. Performance of an FMS is highly dependent upon the accuracy of scheduling policy for the components of the system, such as automated guided vehicles (AGVs). An AGV as a mobile robot provides remarkable industrial capabilities for material and goods transportation within a manufacturing facility or a warehouse. Allocating AGVs to tasks, while considering the cost and time of operations, defines the AGV scheduling process. Multi-objective scheduling of AGVs, unlike single objective practices, is a complex and combinatorial process. In the main draw of the research, a mathematical model was developed and integrated with evolutionary algorithms (genetic algorithm (GA), particle swarm optimization (PSO), and hybrid GA-PSO) to optimize the task scheduling of AGVs with the objectives of minimizing makespan and number of AGVs while considering the AGVs' battery charge. Assessment of the numerical examples' scheduling before and after the optimization proved the applicability of all the three algorithms in decreasing the makespan and AGV numbers. The hybrid GA-PSO produced the optimum result and outperformed the other two algorithms, in which the mean of AGVs operation efficiency was found to be 69.4, 74, and 79.8 percent in PSO, GA, and hybrid GA-PSO, respectively. Evaluation and validation of the model was performed by simulation via Flexsim software.	[Mousavi, Maryam; Yap, Hwa Jen; Musa, Siti Nurmaya; Tahriri, Farzad; Dawal, Siti Zawiah Md] Univ Malaya, Dept Mech Engn, Fac Engn, Ctr Product Design & Mfg, Kuala Lumpur, Malaysia	Universiti Malaya	Yap, HJ (corresponding author), Univ Malaya, Dept Mech Engn, Fac Engn, Ctr Product Design & Mfg, Kuala Lumpur, Malaysia.	hjyap737@um.edu.my	Musa, S. Nurmaya/AAZ-8487-2020; MUSA, S. NURMAYA/B-9803-2010; DAWAL, SITI ZAWIAH MD/B-9816-2010; YAP, HWA JEN/C-1065-2010; Mousavi, maryam/AAE-8757-2020; tahriri, farzad/K-3692-2013	Musa, S. Nurmaya/0000-0002-5165-4106; MUSA, S. NURMAYA/0000-0002-5165-4106; DAWAL, SITI ZAWIAH MD/0000-0003-0496-5128; YAP, HWA JEN/0000-0001-7637-9297; Mousavi, maryam/0000-0003-2317-3409; tahriri, farzad/0000-0002-8929-0707	University of Malaya's under UMRG Top Down Programme [RP027-14AET]; Ministry of Higher Education of Malaysia under High Impact Research [UM.C/HIR/MOHE/ENG/35, D000035-16001]	University of Malaya's under UMRG Top Down Programme; Ministry of Higher Education of Malaysia under High Impact Research	The authors would like to acknowledge University of Malaya's financial support of this project under UMRG Top Down Programme (Grant No. RP027-14AET). The authors would also like to acknowledge the Ministry of Higher Education of Malaysia for the facility support under High Impact Research Grant UM.C/HIR/MOHE/ENG/35 (D000035-16001).	Aized T, 2009, COMPUT IND ENG, V57, P822, DOI 10.1016/j.cie.2009.02.009; Anwar MF, 1998, INT J PROD RES, V36, P653, DOI 10.1080/002075498193624; Azimi P, 2011, MODELLING SIMULATION, V2011, P2; Beheshti Z., 2013, INT J ADV SOFT COMPU, V5, P1; Blazewicz J., 1991, International Journal of Flexible Manufacturing Systems, V4, P5, DOI 10.1007/BF01325094; Cai QX, 2014, INT J SMART SENS INT, V7, P1613; Chelouah R, 2003, EUR J OPER RES, V148, P335, DOI 10.1016/S0377-2217(02)00401-0; Chudasama C, 2011, INT C COMP COMM NETW; Du WB, 2015, APPL MATH COMPUT, V268, P832, DOI 10.1016/j.amc.2015.06.062; Eichfelder G, 2008, VECTOR OPTIM, P1, DOI 10.1007/978-3-540-79159-1; Elsayed SM, 2014, ENG APPL ARTIF INTEL, V27, P57, DOI 10.1016/j.engappai.2013.09.013; Fan SKS, 2007, EUR J OPER RES, V181, P527, DOI 10.1016/j.ejor.2006.06.034; Fauadi MHFBM, 2010, P INT MULTICONFERENC; Fazlollahtabar H, 2014, J MANUF SCI PROD, V14, P87, DOI 10.1515/jmsp-2013-0026; Gao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09295; Ghane-Kanafi A, 2015, APPL MATH MODEL, V39, P7483, DOI 10.1016/j.apm.2015.03.022; Giagkiozis I, 2015, INFORM SCIENCES, V293, P338, DOI 10.1016/j.ins.2014.08.071; Holland J.H., 1975, ADAPTATION NATURAL A; Hsiao-Fan Wang, 2014, International Journal of Modelling in Operations Management, V4, P35, DOI 10.1504/IJMOM.2014.063585; Huang D, 2013, 6 INT C ADV INF TECH; Inc. EA, 2006, BATT CHARG SYST AUT; INSTITUUT AK, 2015, GEN TECHN DESCR AGV; Jamrus T, 2013, 14TH ASIA PACIFIC IN; Joshi Gopesh, 2014, INT J ADV RES COMPUT, V4, P802; Kao YT, 2008, APPL SOFT COMPUT, V8, P849, DOI 10.1016/j.asoc.2007.07.002; Kapianogiu v, 2014, 4 IAJC ISAM JOINT IN; Kato F, 2010, P SICE ANN C 2010; Kaveh A, 2010, IRAN J SCI TECHNOL B, V34, P15; Kawakami T., 2012, DESIGN INNOVATIVE VA, P403; Kennedy J., 1995, P ICNN 95 INT C NEUR, P1942; Kennedy J, 2002, EV COMP 2002 CEC 02; Kumar MVS, 2011, INT J ADV MANUF TECH, V53, P339, DOI 10.1007/s00170-010-2820-2; Kuo IH, 2009, EXPERT SYST APPL, V36, P7027, DOI 10.1016/j.eswa.2008.08.054; Li XD, 2012, IEEE T EVOLUT COMPUT, V16, P210, DOI 10.1109/TEVC.2011.2112662; Liou CD, 2013, INT J SYST SCI, V44, P77, DOI 10.1080/00207721.2011.581396; Mehta M. H., 2012, INT J ADV COMPUTER R, V2, P300; Nageswararao M, 2014, INROADS AN INT J JAI, V3, P62; Natarajan A.M., 2009, INT J OPEN PROBLEMS, V2, P597; Nearchou AC, 2004, INT J PROD ECON, V88, P191, DOI 10.1016/S0925-5273(03)00184-1; Novas JM, 2014, EXPERT SYST APPL, V41, P2286, DOI 10.1016/j.eswa.2013.09.026; Oliveira MM, 2011, IEEE INT CONF ROBOT; Pan XY, 2013, APPL MECH MATER, V411-414, P2351, DOI 10.4028/www.scientific.net/AMM.411-414.2351; Pareto V, 1961, CORSO EC POLITICA; Rashmi M, 2014, INT J LATEST TRENDS, V4, P177; Reddy BSP, 2011, INT J SIMUL MODEL, V10, P78, DOI 10.2507/IJSIMM10(2)3.176; Ren NF, 2013, APPL MECH MATER, V300-301, P55, DOI 10.4028/www.scientific.net/AMM.300-301.55; SABUNCUOGLU I, 1992, INT J PROD RES, V30, P1059, DOI 10.1080/00207549208942943; Saidi-Mehrabad M, 2015, COMPUT IND ENG, V86, P2, DOI 10.1016/j.cie.2015.01.003; Song ML, 2014, APPL MECH MAT; Spears W.M., 1991, STUDY CROSSOVER OPER; Suzuki T, 2014, ASME 2014 INT DES EN; Tang JC, 2010, LECT NOTES COMPUT SC, V6145, P566, DOI 10.1007/978-3-642-13495-1_69; Tasgetiren MF, 2004, EVOLUTIONARY COMPUTA; Thakur M, 2014, APPL MATH COMPUT, V235, P292, DOI 10.1016/j.amc.2014.02.093; Udhayakumar P, 2010, INT J SIMUL MODEL, V9, P28, DOI 10.2507/IJSIMM09(1)3.139; Vasava AS, 2014, INT J INNOVATIVE RES, V1, P262; Ventura JA, 2015, INT J PROD ECON, V170, P850, DOI 10.1016/j.ijpe.2015.03.007; Wang JB, 2014, ADV MAT RES, V926-930, P1562, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/AMR.926-930.1562; Wang L, 2010, EL CIRC SYST ICECS 2; Wu CH, 2010, LECT NOTES COMPUT SC, V6024, P302; Xia WJ, 2006, INT J ADV MANUF TECH, V29, P360, DOI 10.1007/s00170-005-2513-4; Xia WJ, 2005, COMPUT IND ENG, V48, P409, DOI 10.1016/j.cie.2005.01.018; Zeng CK, 2014, APPL SOFT COMPUT, V24, P1033, DOI 10.1016/j.asoc.2014.08.028; Zheng K, 2013, PROD ENG-RES DEV, V7, P433, DOI 10.1007/s11740-013-0456-4	64	48	59	13	192	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0169817	10.1371/journal.pone.0169817	http://dx.doi.org/10.1371/journal.pone.0169817			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28263994	Green Submitted, Green Published, gold			2022-12-26	WOS:000396054300002
J	Zhou, J; Fang, L; Liao, JX; Li, L; Yao, WX; Xiong, ZJ; Zhou, X				Zhou, Jin; Fang, Li; Liao, Jiaxu; Li, Lin; Yao, Wenxiu; Xiong, Zhujuan; Zhou, Xiang			Investigation of the anti-cancer effect of quercetin on HepG2 cells in vivo	PLOS ONE			English	Article							OVEREXPRESSION; RECEPTOR; PROLIFERATION	Quercetin, a natural polyphenolic flavonoid compound, can inhibit the growth of several malignant cancers. However, the mechanism still remains unclear. Our previous findings have suggested that quercetin can significantly inhibit HepG2 cell proliferation and induce cell apoptosis in vitro. It can also affect cell cycle distribution and significantly decrease cyclin D1 expression. In this study, we investigated the anti-cancer effect of quercetin on HepG2 tumor-bearing nude mice and its effect on cyclin D1 expression in the tumor tissue. First, the nude murine tumor model was established by subcutaneous inoculation of HepG2 cells, then quercetin was administered intraperitoneally, and the mice injected with saline solution were used as controls. The daily behavior of the tumor-bearing mice was observed and differences in tumor growth and survival rate were monitored. The expression of cyclin D1 in isolated tumor sections was evaluated by immunohistochemistry. We found that HepG2 tumor became palpable in the mice one-week post-inoculation. Tumors in the control group grew rapidly and the daily behavior of the mice changed significantly, including listlessness, poor feeding and ataxia. The mice in quercetin-treated group showed delayed tumor growth, no significant changes in daily behavior, and the survival rate was significantly improved. Finally, we observed increased tumor necrosis and a lighter cyclin D1 staining with reduced staining areas. Our findings thus suggest that quercetin can significantly inhibit HepG2 cell proliferation, and this effect may be achieved through the regulation of cyclin D1 expression.	[Zhou, Jin; Yao, Wenxiu; Xiong, Zhujuan; Zhou, Xiang] Univ Elect Sci & Technol China, Sch Med, Dept Chemotherapy, Sichuan Canc Ctr, Chengdu, Sichuan, Peoples R China; [Fang, Li] Chengdu Med Coll, Affiliated Hosp 1, Dept Gastroenterol, Chengdu, Sichuan, Peoples R China; [Liao, Jiaxu] Sixth Hosp, Dept Radiol, Chengdu, Sichuan, Peoples R China; [Li, Lin] Second Hosp, Dept Nucl Med, Chengdu, Sichuan, Peoples R China	University of Electronic Science & Technology of China; Chengdu Medical College	Zhou, J (corresponding author), Univ Elect Sci & Technol China, Sch Med, Dept Chemotherapy, Sichuan Canc Ctr, Chengdu, Sichuan, Peoples R China.	zhoujt521@163.com			Basic Research Programs of Sichuan Province [2016JY0115, 2011JYZ034, 120035]	Basic Research Programs of Sichuan Province	This work was supported by Basic Research Programs of Sichuan Province (nos. 2016JY0115, 2011JYZ034 and 120035).	Adnane J, 1999, ONCOGENE, V18, P239, DOI 10.1038/sj.onc.1202297; Borska S, 2012, FOOD CHEM TOXICOL, V50, P3375, DOI 10.1016/j.fct.2012.06.035; Cantor JP, 2007, INT J CANCER, V120, P24, DOI 10.1002/ijc.22073; Chan ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054255; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; de Boer VCJ, 2005, J NUTR, V135, P1718, DOI 10.1093/jn/135.7.1718; Hwang SJ, 2015, ONCOTARGET, V6, P20434, DOI 10.18632/oncotarget.3886; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jing S, 2008, INT J HYPERTHER, V24, P151, DOI 10.1080/02656730701843109; Kahraman A, 2012, MOL BIOL REP, V39, P2789, DOI 10.1007/s11033-011-1037-2; Kenny FS, 1999, CLIN CANCER RES, V5, P2069; Kim MK, 2015, FITOTERAPIA, V101, P162, DOI 10.1016/j.fitote.2015.01.010; Luk'ianova L D, 2007, Vestn Ross Akad Med Nauk, P55; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Lutz JA, 2014, FITOTERAPIA, V98, P11, DOI 10.1016/j.fitote.2014.06.012; Mahmoud MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063784; Miranda-Carboni GA, 2008, GENE DEV, V22, P3121, DOI 10.1101/gad.1692808; Noel EE, 2010, AM J PATHOL, V176, P2607, DOI 10.2353/ajpath.2010.090780; Pereira RA, 2014, BRAZ J MED BIOL RES, V47, P515, DOI 10.1590/1414-431X20143240; Pratheeshkumar P, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047516, 10.1371/journal.pone.0052279]; Ravishankar D, 2015, EUR J MED CHEM, V97, P259, DOI 10.1016/j.ejmech.2015.04.056; Refolo MG, 2015, J CELL PHYSIOL, V230, P2973, DOI 10.1002/jcp.25026; Shimura T, 2010, ONCOGENE, V29, P4826, DOI 10.1038/onc.2010.238; Tao SF, 2015, MOL CELL BIOCHEM, V402, P93, DOI 10.1007/s11010-014-2317-7; Yuan Huiqing, 2010, Mol Cell Biochem, V339, P253, DOI 10.1007/s11010-010-0388-7; Zhang Y, 2012, MOL BIOL REP, V39, P7785, DOI 10.1007/s11033-012-1621-0; Zhou J, 2016, ONCOL LETT, V12, P516, DOI 10.3892/ol.2016.4639; Zhou J, 2009, OMICS, V13, P93, DOI 10.1089/omi.2008.0075	28	44	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172838	10.1371/journal.pone.0172838	http://dx.doi.org/10.1371/journal.pone.0172838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264020	gold, Green Published, Green Submitted			2022-12-26	WOS:000396054300020
J	Chowanski, S; Lubawy, J; Paluch-Lubawa, E; Spochacz, M; Rosinski, G; Slocinska, M				Chowanski, Szymon; Lubawy, Jan; Paluch-Lubawa, Ewelina; Spochacz, Marta; Rosinski, Grzegorz; Slocinska, Malgorzata			The physiological role of fat body and muscle tissues in response to cold stress in the tropical cockroach Gromphadorhina coquereliana	PLOS ONE			English	Article							HARDY GALL INSECTS; MEGAPHORURA-ARCTICA TULLBERG; SHOCK-PROTEIN TRANSCRIPT; FREEZE-TOLERANT INSECT; EUROSTA-SOLIDAGINIS; FLESH FLY; DROSOPHILA-MELANOGASTER; CRYOPROTECTIVE DEHYDRATION; SARCOPHAGA-CRASSIPALPIS; TERRESTRIAL ARTHROPODS	Protective mechanisms against cold stress are well studied in terrestrial and polar insects; however, little is known about these mechanisms in tropical insects. In our study, we tested if a tropical cockroach Gromphadorhina coquereliana, possesses any protective mechanisms against cold stress. Based on the results of earlier studies, we examined how shortterm (3 h) cold (4 degrees C) influences biochemical parameters, mitochondrial respiration activity, and the level of HSPs and aquaporins expression in the fat body and leg muscles of G. coquereliana. Following cold exposure, we found that the level of carbohydrates, lipids and proteins did not change significantly. Nevertheless, we observed significant changes in mitochondrial respiration activity. The oxygen consumption of resting (state 4) and phosphorylating (state 3) mitochondria was altered following cold exposure. The increase in respiratory rate in state 4 respiration was observed in both tissues. In state 3, oxygen consumption by mitochondria in fat body was significantly lower compared to control insects, whereas there were no changes observed for mitochondria in muscle tissue. Moreover, there were cold-induced changes in UCP protein activity, but the changes in activity differed in fat body and in muscles. Additionally, we detected changes in the level of HSP70 and aquaporins expression. Insects treated with cold had significantly higher levels of HSP70 in fat body and muscles. On the other hand, there were lower levels of aquaporins in both tissues following exposure to cold. These results suggest that fat body play an important role in protecting tropical insects from cold stress.	[Chowanski, Szymon; Lubawy, Jan; Spochacz, Marta; Rosinski, Grzegorz; Slocinska, Malgorzata] Adam Mickiewicz Univ, Dept Anim Physiol & Dev, Fac Biol, Poznan, Poland; [Paluch-Lubawa, Ewelina] Adam Mickiewicz Univ, Dept Plant Physiol, Fac Biol, Poznan, Poland	Adam Mickiewicz University; Adam Mickiewicz University	Chowanski, S; Lubawy, J; Slocinska, M (corresponding author), Adam Mickiewicz Univ, Dept Anim Physiol & Dev, Fac Biol, Poznan, Poland.	szyymon@amu.edu.pl; j.lubawy@amu.edu.pl; slocina@amu.edu.pl	Lubawy, Jan/AAD-4259-2019; Chowanski, Szymon/J-5465-2015	Lubawy, Jan/0000-0003-4030-3471; Chowanski, Szymon/0000-0002-5667-1781; Slocinska, Malgorzata/0000-0002-6367-5123; Paluch-Lubawa, Ewelina/0000-0003-4456-0758; Spochacz, Marta/0000-0003-3944-519X	Leading National Research Centre [KNOW-87/2016]	Leading National Research Centre	The funder (Leading National Research Centre "RNA Research Center in Poznah") had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The founder gave only the money for proofreading (to improve English style of manuscript). The funds were given to Szymon Chowanski. Grant number KNOW-87/2016. The funder is a part of our Faculty. It requires the information about given help in manuscript. There was no additional external funding received for this study.; The article was partially supported by Leading National Research Centre "RNA Research Center in Poznan" (supported author: SC; grant number KNOW-87/2016). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The founder supported only the proofreading (to improve English style of manuscript). The funds were given to Szymon Chowanski. The funder is a part of our Faculty. There was no additional external funding received for this study. Web site of National Research Centre "RNA Research Center in Poznan: http://know-rna.amu.edu.pl/en/	Airaksinen S, 2003, COMP BIOCHEM PHYS B, V136, P275, DOI 10.1016/S1096-4959(03)00205-7; Alves-Bezerra M, 2014, INSECT BIOCHEM MOLEC, V50, P24, DOI 10.1016/j.ibmb.2014.03.011; [Anonymous], 2010, LOW TEMPERATURE BIOL; Bale JS, 1996, EUR J ENTOMOL, V93, P369; Benoit JB, 2009, MED VET ENTOMOL, V23, P418, DOI 10.1111/j.1365-2915.2009.00832.x; Campbell EM, 2008, J COMP PHYSIOL B, V178, P935, DOI 10.1007/s00360-008-0288-2; Chowanski S, 2015, COMP BIOCHEM PHYS A, V183, P57, DOI 10.1016/j.cbpa.2015.01.007; Clark MS, 2008, J COMP PHYSIOL B, V178, P917, DOI 10.1007/s00360-008-0286-4; Clark MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-328; Cohen E, 2012, ORNITHOL HERPETOL S, VS1, P1, DOI DOI 10.4172/2161-0983.S1-001; Colinet H, 2011, COMP BIOCHEM PHYS A, V160, P63, DOI 10.1016/j.cbpa.2011.05.003; Colinet H, 2017, INSECT BIOCHEM MOLEC, V80, P52, DOI 10.1016/j.ibmb.2016.11.007; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; Da-Re C, 2014, EMBO REP, V15, P586, DOI 10.1002/embr.201337972; Davies PL, 2002, PHILOS T R SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; Doucet D, 2009, CELL MOL LIFE SCI, V66, P1404, DOI 10.1007/s00018-009-8320-6; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Duman JG, 2004, J INSECT PHYSIOL, V50, P259, DOI 10.1016/j.jinsphys.2003.12.003; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foster Nicola L., 2015, Communicative & Integrative Biology, V8, pe1040954, DOI 10.1080/19420889.2015.1040954; Garcia-Garcia E, 2009, DEV COMP IMMUNOL, V33, P728, DOI 10.1016/j.dci.2008.12.006; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hayward SAL, 2004, J EXP BIOL, V207, P963, DOI 10.1242/jeb.00842; Izumi Y, 2006, J INSECT PHYSIOL, V52, P215, DOI 10.1016/j.jinsphys.2005.11.001; Joanisse DR, 1996, PHYSIOL ZOOL, V69, P1079, DOI 10.1086/physzool.69.5.30164247; JOANISSE DR, 1994, INSECT BIOCHEM MOLEC, V24, P145, DOI 10.1016/0965-1748(94)90080-9; JOANISSE DR, 1995, ARCH INSECT BIOCHEM, V28, P339, DOI 10.1002/arch.940280404; Kayukawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008277; Khani A, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.8301; KUKAL O, 1989, J COMP PHYSIOL B, V158, P661, DOI 10.1007/BF00693004; Lalouette L, 2011, COMP BIOCHEM PHYS A, V158, P229, DOI 10.1016/j.cbpa.2010.11.007; Lee R., 1991, INSECTS LOW TEMPERAT; Levin DB, 2003, INSECT MOL BIOL, V12, P281, DOI 10.1046/j.1365-2583.2003.00413.x; Levis NA, 2012, J EXP BIOL, V215, P3768, DOI 10.1242/jeb.076885; Lyytinen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031446; McMullen DC, 2008, J INSECT PHYSIOL, V54, P1023, DOI 10.1016/j.jinsphys.2008.04.001; Michaud MR, 2007, MOL PHYSL INSECT LOW; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; Philip BN, 2008, J EXP BIOL, V211, P1114, DOI 10.1242/jeb.016758; Philip BN, 2011, J EXP BIOL, V214, P848, DOI 10.1242/jeb.051276; Qin W, 2007, INSECT MOL BIOL, V16, P423, DOI 10.1111/j.1365-2583.2007.00743.x; Rinehart JP, 2000, INSECT MOL BIOL, V9, P641, DOI 10.1046/j.1365-2583.2000.00230.x; Rozsypal J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061745; Singh A., 2013, J BIOCH RES, V1, P26; Slocinska M, 2016, PROTEIN PEPTIDE LETT, V23, P63, DOI 10.2174/0929866523666151106121943; Slocinska M, 2013, COMP BIOCHEM PHYS A, V166, P52, DOI 10.1016/j.cbpa.2013.05.009; Slocinska M, 2011, J BIOENERG BIOMEMBR, V43, P717, DOI 10.1007/s10863-011-9385-0; Sluse FE, 2006, BBA-BIOENERGETICS, V1757, P480, DOI 10.1016/j.bbabio.2006.02.004; Somme L, 1999, EUR J ENTOMOL, V96, P1; STOREY JM, 1985, J COMP PHYSIOL B, V155, P333, DOI 10.1007/BF00687475; Storey KB, 2013, COMPR PHYSIOL, V3, P1283, DOI 10.1002/cphy.c130007; Strok NE, 2003, ENCY INSECTS, P85; Sujak P, 1984, OXIDATIVE METABOLISM; Tamang AM, 2017, COMP BIOCHEM PHYS A, V203, P304, DOI 10.1016/j.cbpa.2016.10.011; Teets NM, 2012, PHYSIOL GENOMICS, V44, P764, DOI 10.1152/physiolgenomics.00042.2012; Thorne MAS, 2011, INSECT MOL BIOL, V20, P303, DOI 10.1111/j.1365-2583.2010.01062.x; Tomkowiak E, 2009, POSTEPY BIOL KOMORKI, V36, P203; Urbanski A., 2016, INSECT SCI; Urbanski A, 2014, J INSECT PHYSIOL, V60, P98, DOI 10.1016/j.jinsphys.2013.11.009; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Walters KR, 2009, J BIOL CHEM, V284, P16822, DOI 10.1074/jbc.M109.013870; Wharton DA, 2009, J INSECT PHYSIOL, V55, P27, DOI 10.1016/j.jinsphys.2008.09.007; WheaterSpark, 2015, HIST WEATH 2014 ANT; Yi SX, 2011, J INSECT PHYSIOL, V57, P1096, DOI 10.1016/j.jinsphys.2011.02.006; Yi W, 2013, SLEEP, V36, P1809, DOI 10.5665/sleep.3206; Yocum GD, 2001, J INSECT PHYSIOL, V47, P1139, DOI 10.1016/S0022-1910(01)00095-6; Yocum GD, 1998, INSECT BIOCHEM MOLEC, V28, P677, DOI 10.1016/S0965-1748(98)00046-0; Zachariassen KE, 2000, CRYOBIOLOGY, V41, P257, DOI 10.1006/cryo.2000.2289; Zelenina M, 2004, J BIOL CHEM, V279, P51939, DOI 10.1074/jbc.M407645200; Zhang GJ, 2011, J INSECT PHYSIOL, V57, P1115, DOI 10.1016/j.jinsphys.2011.02.016; Zhou XR, 2015, CRYOLETTERS, V36, P270	73	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173100	10.1371/journal.pone.0173100	http://dx.doi.org/10.1371/journal.pone.0173100			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253309	Green Submitted, Green Published, gold			2022-12-26	WOS:000396011300074
J	Furusawa, T; Naka, I; Yamauchi, T; Natsuhara, K; Eddie, R; Kimura, R; Nakazawa, M; Ishida, T; Ohtsuka, R; Ohashi, J				Furusawa, Takuro; Naka, Izumi; Yamauchi, Taro; Natsuhara, Kazumi; Eddie, Ricky; Kimura, Ryosuke; Nakazawa, Minato; Ishida, Takafumi; Ohtsuka, Ryutaro; Ohashi, Jun			Polymorphisms associated with a tropical climate and root crop diet induce susceptibility to metabolic and cardiovascular diseases in Solomon Islands	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; FADS GENE-CLUSTER; DIABETES-MELLITUS; POPULATION HISTORY; ALLELE FREQUENCY; PATHWAY GENES; HAN CHINESE; VARIANTS; KCNQ1; ADAPTATIONS	The people of the Solomon Islands represent an Austronesian (AN)-speaking population's adaptation to a humid tropical environment and subsistence of tuberous crops. Genome-wide association studies (GWASs) of other populations (e.g. the Human Genome Diversity Project [HGDP]) have suggested the existence of genotypes adaptive to ecoregion, diet, and subsistence, and that those genotypes are also associated with metabolic and cardiovascular diseases. Recently, the incidence of non-communicable diseases has been increasing in the Solomon Islands. In the present study, we explored the association of genotypes adaptive to a tropical environment and tuberous crop diet with metabolic and cardiovascular conditions in rural and urban AN-speaking Melanesian and Micronesian populations of the Solomon Islands. A total of 561 participants were genotyped for single nucleotide polymorphisms (SNPs) potentially associated with a tropical environment (rs174570 and rs2237892) and a tuberous crop diet (rs162036, rs185819, and rs2722425). The results showed that the allele frequencies of the Solomon Islands populations adopted patterns similar to those in populations from other hot, tropical areas with a tuberous crop diet in previous studies. Furthermore, rs162036, rs185819, rs2237892, and rs2722425 were all strongly associated with one or more metabolic and cardiovascular conditions. The derived allele of rs2722425 (i.e. rs2722425-G) was significantly associated with an elevated LDL level (P = 0.000264) even after the significance level was adjusted for multiple testing (i.e., alpha = 0.0005). Our results suggest that the inhabitants of the Solomon Islands exhibit the effects of the tropical environment and tuberous crop diet on their allele frequencies, and that their susceptibility to metabolic and cardiovascular diseases is therefore considered to be associated with their environment and diet.	[Furusawa, Takuro] Kyoto Univ, Grad Sch Asian & African Area Studies, Kyoto, Japan; [Naka, Izumi; Ishida, Takafumi; Ohashi, Jun] Univ Tokyo, Grad Sch Sci, Tokyo, Japan; [Yamauchi, Taro] Hokkaido Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido 060, Japan; [Natsuhara, Kazumi] Japanese Red Cross Akita Coll Nursing, Akita, Japan; [Eddie, Ricky] Minist Hlth & Med Serv, Natl Gizo Hosp, Gizo, Solomon Islands; [Kimura, Ryosuke] Univ Ryukyus, Grad Sch Med, Okinawa, Japan; [Nakazawa, Minato] Kobe Univ, Grad Sch Hlth Sci, Dept Int Hlth, Kobe, Hyogo, Japan; [Ohtsuka, Ryutaro] Japan Wildlife Res Ctr, Tokyo, Japan	Kyoto University; University of Tokyo; Hokkaido University; University of the Ryukyus; Kobe University	Ohashi, J (corresponding author), Kyoto Univ, Grad Sch Asian & African Area Studies, Kyoto, Japan.	furusawa@asafas.kyoto-u.ac.jp; juno-tky@umin.ac.jp		Furusawa, Takuro/0000-0001-7772-3053	Japan Society for the Promotion of Science, Japan [25291103, 14255008, 15H05123]; Grants-in-Aid for Scientific Research [16H05828, 15H05123] Funding Source: KAKEN	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported by the KAKENHI Grant-in-Aid for Scientific Research (Project Number: 25291103 (JO), Project Number: 14255008 (RO), and Project Number: 15H05123 (TF)) of the Japan Society for the Promotion of Science, Japan. http://www.jsps.go.jp/english/e-grants/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, WHO TECHN REP SER; Aslibekyan S., 2012, Frontiers in Genetics, V3, P72, DOI 10.3389/fgene.2012.00072; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bellwood P., 1995, AUSTRONESIAN PREHIST; Bokor S, 2011, INT J PEDIATR OBES, V6, pE336, DOI 10.3109/17477166.2010.500386; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Chen Z, 2010, MOL BIOL REP, V37, P207, DOI 10.1007/s11033-009-9597-0; Ding KY, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-55; Duan QH, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/347675; EASON RJ, 1987, MED J AUSTRALIA, V146, P465, DOI 10.5694/j.1326-5377.1987.tb120359.x; Furusawa T, 2016, ETHNOBIOLOGY, P1, DOI 10.1007/978-981-287-904-2; Furusawa T, 2011, NZ MED J, V366, P234; Furusawa T, 2013, J HUM GENET, V58, P142, DOI 10.1038/jhg.2012.147; Furusawa T, 2011, AM J HUM BIOL, V23, P435, DOI 10.1002/ajhb.21124; Furusawa T, 2010, HUM GENET, V127, P287, DOI 10.1007/s00439-009-0768-9; Glaser C, 2011, MATERN CHILD NUTR, V7, P27, DOI 10.1111/j.1740-8709.2011.00319.x; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Hancock AM, 2010, PHILOS T R SOC B, V365, P2459, DOI 10.1098/rstb.2010.0032; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; Hu C, 2009, DIABETOLOGIA, V52, P1322, DOI 10.1007/s00125-009-1335-6; Huang T, 2014, J NUTRIGENET NUTRIGE, V7, P63, DOI 10.1159/000365007; InterAct Consortium, 2016, DIABETOLOGIA, V59, P2613, DOI 10.1007/s00125-016-4090-5; Kenny EE, 2012, SCIENCE, V336, P554, DOI 10.1126/science.1217849; Kumar J, 2009, CIRC-CARDIOVASC GENE, V2, P599, DOI 10.1161/CIRCGENETICS.108.841411; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lee YH, 2012, MOL BIOL REP, V39, P10627, DOI 10.1007/s11033-012-1952-x; Lipson M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5689; Malerba G, 2008, LIPIDS, V43, P289, DOI 10.1007/s11745-008-3158-5; Mao HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045882; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Nakajima T, 2004, AM J HUM GENET, V74, P898, DOI 10.1086/420793; NEEL JV, 1962, AM J HUM GENET, V14, P353; Ohashi J, 2007, J HUM GENET, V52, P1031, DOI 10.1007/s10038-007-0198-2; Saif-Ali R, 2011, INT J MOL SCI, V12, P5705, DOI 10.3390/ijms12095705; Shin HD, 2010, J CLIN ENDOCR METAB, V95, P445, DOI 10.1210/jc.2009-1393; Soares PA, 2016, HUM GENET, V135, P309, DOI 10.1007/s00439-015-1620-z; Sone Y, 2013, J NUTR SCI VITAMINOL, V59, P325, DOI 10.3177/jnsv.59.325; Sovio U, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000409; Sun Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031093; Tan JT, 2009, DIABETES, V58, P1445, DOI 10.2337/db08-1138; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Weedon MN, 2008, TRENDS GENET, V24, P595, DOI 10.1016/j.tig.2008.09.006; Wu M., 2010, STUDIES COLL MATH, V13, P13; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082; Yu W, 2012, DIABETOLOGIA, V55, P2655, DOI 10.1007/s00125-012-2636-8	50	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172676	10.1371/journal.pone.0172676	http://dx.doi.org/10.1371/journal.pone.0172676			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253292	Green Published, gold, Green Submitted			2022-12-26	WOS:000396011300026
J	Kong, WY; Zhu, XP; Han, XJ; Nuo, M; Wang, H				Kong, Wuyi; Zhu, Xiao Ping; Han, Xiu Juan; Nuo, Mu; Wang, Hong			Epithelial stem cells are formed by small-particles released from particle-producing cells	PLOS ONE			English	Article							NICHE; SKIN; POPULATIONS; HOMEOSTASIS; FOLLICLE	Recent spatiotemporal report demonstrated that epidermal stem cells have equal potential to divide or differentiate, with no asymmetric cell division observed. Therefore, how epithelial stem cells maintain lifelong stem-cell support still needs to be elucidated. In mouse blood and bone marrow, we found a group of large cells stained strongly for eosin and containing coiled-tubing-like structures. Many were tightly attached to each other to form large cellular clumps. After sectioning, these large cell-clumps were composed of not cells but numerous small particles, however with few small "naked" nuclei. The small particles were about 2 to 3 mu m in diameter and stained dense red for eosin, so they may be rich in proteins. Besides the clumps composed of small particles, we identified clumps formed by fusion of the small particles and clumps of newly formed nucleated cells. These observations suggest that these small particles further fused and underwent cellularization. E-cadherin was expressed in particle-fusion areas, some "naked" nuclei and the newly formed nucleated cells, which suggests that these particles can form epithelial cells via fusion and nuclear remodeling. In addition, we observed similar-particle fusion before epithelial cellularization in mouse kidney ducts after kidney ischemia, which suggests that these particles can be released in the blood and carried to the target tissues for epithelial-cell regeneration. Oct4 and E-cadherin expressed in the cytoplasmic areas in cells that were rich in protein and mainly located in the center of the cellular clumps, suggesting that these newly formed cells have become tissue-specific epithelial stem cells. Our data provide evidence that these large particle-producing cells are the origin of epithelial stem cells. The epithelial stem cells are newly formed by particle fusion.	[Kong, Wuyi; Zhu, Xiao Ping; Han, Xiu Juan; Nuo, Mu; Wang, Hong] Beijing Khasar Med Technol Co Ltd, Beijing, Peoples R China		Kong, WY (corresponding author), Beijing Khasar Med Technol Co Ltd, Beijing, Peoples R China.	wuyikong@yahoo.com			Department of Technology, Inner Mongolia government, China for research and development	Department of Technology, Inner Mongolia government, China for research and development	Beijing Khasar Medical Technology Co. Ltd is a commercial affiliation that was funded by the Department of Technology, Inner Mongolia government, China for research and development. Both the government and the commercial affiliation did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The government funding provided financial support in the form of research materials and equipment. The commercial affiliation provided support in the form of salaries for authors XZ, XH, MN, and HW.	Al-Awqati Q, 2006, STEM CELL REV, V2, P181, DOI 10.1007/s12015-006-0046-3; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Berika M, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00033; Donne ML, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0082-9; FORBES DJ, 1983, CELL, V34, P13, DOI 10.1016/0092-8674(83)90132-0; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Fuchs E, 2013, EMBO REP, V14, P39, DOI 10.1038/embor.2012.197; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Kong WY, 2008, EXP CELL RES, V314, P1529, DOI 10.1016/j.yexcr.2008.01.022; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Rompolas P, 2016, SCIENCE, V352, P1471, DOI 10.1126/science.aaf7012; Shizuru JA, 2005, ANNU REV MED, V56, P509, DOI 10.1146/annurev.med.54.101601.152334; Sipos F, 2012, WORLD J GASTROENTERO, V18, P295, DOI 10.3748/wjg.v18.i4.295; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Volckaert T, 2011, J CLIN INVEST, V121, P4409, DOI 10.1172/JCI58097; Wagers AJ, 2002, GENE THER, V9, P606, DOI 10.1038/sj.gt.3301717; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1	20	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173072	10.1371/journal.pone.0173072	http://dx.doi.org/10.1371/journal.pone.0173072			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253358	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300068
J	Palmer, CL; Thomer, AK; Baker, KS; Wickett, KM; Hendrix, CL; Rodman, A; Sigler, S; Fouke, BW				Palmer, Carole L.; Thomer, Andrea K.; Baker, Karen S.; Wickett, Karen M.; Hendrix, Christie L.; Rodman, Ann; Sigler, Stacey; Fouke, Bruce W.			Site-based data curation based on hot spring geobiology	PLOS ONE			English	Article							NATURAL-RESOURCE MANAGEMENT	Site-Based Data Curation (SBDC) is an approach to managing research data that prioritizes sharing and reuse of data collected at scientifically significant sites. The SBDC framework is based on geobiology research at natural hot spring sites in Yellowstone National Park as an exemplar case of high value field data in contemporary, cross-disciplinary earth systems science. Through stakeholder analysis and investigation of data artifacts, we determined that meaningful and valid reuse of digital hot spring data requires systematic documentation of sampling processes and particular contextual information about the site of data collection. We propose a Minimum Information Framework for recording the necessary metadata on sampling locations, with anchor measurements and description of the hot spring vent distinct from the outflow system, and multi-scale field photography to capture vital information about hot spring structures. The SBDC framework can serve as a global model for the collection and description of hot spring systems field data that can be readily adapted for application to the curation of data from other kinds scientifically significant sites.	[Palmer, Carole L.] Univ Washington, Informat Sch, Seattle, WA 98195 USA; [Thomer, Andrea K.; Baker, Karen S.] Univ Illinois, Sch Informat Sci, Champaign, IL 61820 USA; [Wickett, Karen M.] Univ Texas Austin, Sch Informat, Austin, TX 78712 USA; [Hendrix, Christie L.; Rodman, Ann; Sigler, Stacey] Yellowstone Natl Pk, Yellowstone Ctr Resources, Yellowstone Natl Pk, WY USA; [Fouke, Bruce W.] Univ Illinois, Dept Geol, Urbana, IL USA; [Fouke, Bruce W.] Univ Illinois, Dept Microbiol, Urbana, IL USA; Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL USA; [Fouke, Bruce W.] Univ Illinois, Inst Genom Biol 2613, Roy J Carver Biotechnol Ctr, Urbana, IL USA; [Fouke, Bruce W.] Montana State Univ, Thermal Biol Inst, Bozeman, MT 59717 USA	University of Washington; University of Washington Seattle; University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; University of Texas Austin; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Montana State University System; Montana State University Bozeman	Thomer, AK (corresponding author), Univ Illinois, Sch Informat Sci, Champaign, IL 61820 USA.	thomer2@illinois.edu		Thomer, Andrea/0000-0001-6238-3498; Wickett, Karen/0000-0002-3625-1253	Institute of Museum and Library Services National Leadership [LG-06-120706-12]	Institute of Museum and Library Services National Leadership	This work was funded by Institute of Museum and Library Services (https://www.imls gov/) National Leadership grant number LG-06-120706-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouron, 2010, GEOB CURR TECHN RES; [Anonymous], MAND CUR RESP RES PE; [Anonymous], WELC SESAH SYST EART; ASM, 2001, GEOB EXPL INT BIOSPH; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Chao TC, 2014, P AM SOC INFO SCI TE, V51, P1; Chao TC, 2015, J ASSOC INF SCI TECH, V66, P616, DOI 10.1002/asi.23184; Committee on Strategy and Budget Task Force on Data Policies, 2011, NAT SCI FDN TASK FOR; Cragin M.H., 2011, P 11 ANN INT ACM IEE, P441, DOI DOI 10.1145/1998076.1998175; Cragin MH, 2010, PHILOS T R SOC A, V368, P4023, DOI 10.1098/rsta.2010.0165; Cragin Melissa H., 2007, AM LIB ASS C SCI TEC; Curry E, 2010, LINKING ENTERPRISE DATA, P25, DOI 10.1007/978-1-4419-7665-9_2; Fegraus E.H., 2005, B ECOLOGICAL SOC AM, V86, P158, DOI DOI 10.1890/0012-9623(2005)86[158:MTVOED]2.0.CO;2; Fouke BW, 2011, SEDIMENTOLOGY, V58, P170, DOI 10.1111/j.1365-3091.2010.01209.x; Gordon SC, 2014, P ASIST ANNU MEET, V51, P1; Grimble R, 1997, AGR SYST, V55, P173, DOI 10.1016/S0308-521X(97)00006-1; Hey T., 2009, 4 PARADIGM DATA INTE; Howe D, 2008, NATURE, V455, P47, DOI 10.1038/455047a; Kandianis MT, 2008, GEOL SOC AM BULL, V120, P442, DOI 10.1130/B26188.1; Karasti H., 2006, Computer Supported Cooperative Work: The Journal of Collaborative Computing, V15, P321, DOI 10.1007/s10606-006-9023-2; Karasti H., 2008, INT J DIGITAL CURATI, V2, P42, DOI DOI 10.2218/IJDC.V3I2.57; Mayernik Matthew S., 2011, P 2011 ICONFERENCE, P417, DOI DOI 10.1145/1940761.1940818; Mayernik MS, 2008, PROCEEDINGS OF THE 2; National Research Council, 2015, PREP WORKF DIG CUR; National Science and Technology Council, HARN POW DIG DAT SCI; National Science Board, 2005, LONG LIV DIG DAT COL; Palmer CL, 2013, P ASIST 2013, V2013, P1; Palmer CL, 2011, P AM SOC INF SCI TEC; Reed MS, 2009, J ENVIRON MANAGE, V90, P1933, DOI 10.1016/j.jenvman.2009.01.001; Sackman H., 1974, DELPHI ASSESSMENT; Taylor CF, 2008, NAT BIOTECHNOL, V26, P889, DOI 10.1038/nbt.1411; Tenopir C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134826; Thomer AK, 2014, WORKSH APR 16 17; Turner MG, 2003, FRONT ECOL ENVIRON, V1, P351, DOI 10.2307/3868187; Walls RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089606; Wright RG, 1999, ECOL APPL, V9, P30, DOI 10.2307/2641165; Yarmey L, 2013, INT J DIGITAL CURATI, V8, P157, DOI DOI 10.2218/IJDC.V8I1.252	37	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172090	10.1371/journal.pone.0172090	http://dx.doi.org/10.1371/journal.pone.0172090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253269	Green Published, gold, Green Submitted			2022-12-26	WOS:000396011300013
J	Sletner, L; Jenum, AK; Yajnik, CS; Morkrid, K; Nakstad, B; Rognerud-Jensen, OH; Birkeland, KI; Vangen, S				Sletner, Line; Jenum, Anne Karen; Yajnik, Chittaranjan S.; Morkrid, Kjersti; Nakstad, Britt; Rognerud-Jensen, Odd Harald; Birkeland, Kare I.; Vangen, Siri			Fetal growth trajectories in pregnancies of European and South Asian mothers with and without gestational diabetes, a population-based cohort study	PLOS ONE			English	Article							ETHNIC-DIFFERENCES; BIRTH-WEIGHT; RISK; TYPE-1; MODEL; SIZE	Objective Our aim was to examine the impact of gestational diabetes (GDM), from before the GDM-diagnosis is made, on fetal growth trajectories, and to compare it in Europeans and South Asians; two ethnic groups with dissimilar fetal growth patterns. Methods We studied European (n = 349) and South Asian (n = 184) pregnant women, from the population-based STORK-Groruddalen cohort in Oslo, Norway. Mothers were enrolled in early pregnancy, screened for GDM in gestational week 28 +/- 2, and classified as "non-GDM", "mild GDM" or "moderate/severe GDM". We measured fetal head circumference, abdominal circumference and femur length by ultrasound, and estimated fetal weight in gestational week 24, 32 and 37, and performed corresponding measurements at birth. Results In non-GDM pregnancies, South Asian fetuses (n = 156) had a slower growth from gestational week 24, compared with Europeans (n = 310). More than two thirds of the European mothers later diagnosed with GDM were overweight or obese in early pregnancy, while this was not observed in South Asians. Fetuses of GDM mothers tended to be smaller than fetuses of non-GDM mothers in week 24, but thereafter grew faster until birth. This pattern was especially pronounced in fetuses of South Asian mothers with moderate/severe GDM. In week 24 these fetuses had a -0.95 SD (95% CI: -1.53, -0.36) lower estimated fetal weight than their non-GDM counterparts. In contrast, at birth they were 0.45 SD (0.09, 0.81) larger. Conclusions Offspring of GDM mothers were smaller in mid pregnancy, but subsequently grew faster until birth, compared with offspring of non-GDM mothers. This pattern was most prominent in South Asian mothers with moderate to severe GDM. However, the most remarkable characteristic of these fetuses was not a large size at birth, but the small size in mid pregnancy, before the GDM diagnosis was set.	[Sletner, Line; Nakstad, Britt] Akershus Univ Hosp, Dept Pediat & Adolescents Med, Lorenskog, Norway; [Jenum, Anne Karen] Univ Oslo, Inst Hlth & Soc, Dept Gen Practice, Oslo, Norway; [Yajnik, Chittaranjan S.] King Edward Mem Hosp Res Ctr, Diabet Unit, Pune, Maharashtra, India; [Morkrid, Kjersti] Norwegian Inst Publ Hlth, Dept Int Publ Hlth, Oslo, Norway; [Nakstad, Britt] Univ Oslo, Inst Clin Med, Campus Ahus, Lorenskog, Norway; [Rognerud-Jensen, Odd Harald] Oslo & Akershus Univ Coll Appl Sci, Fac Hlth, Oslo, Norway; [Birkeland, Kare I.] Oslo Univ Hosp, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway; [Birkeland, Kare I.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Vangen, Siri] Oslo Univ Hosp, Dept Woman & Child Hlth, Norwegian Natl Advisory Unit Womens Hlth, Oslo, Norway	University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo; Oslo Metropolitan University (OsloMet); University of Oslo; University of Oslo; University of Oslo	Sletner, L (corresponding author), Akershus Univ Hosp, Dept Pediat & Adolescents Med, Lorenskog, Norway.	line.sletner@medisin.uio.no	Birkeland, Kåre I/E-9750-2010		South-Eastern Norway Regional Health Authority [2016126]	South-Eastern Norway Regional Health Authority	The South-Eastern Norway Regional Health Authority has funded the post-doc fellowship for L.S (Grant number 2016126), http://www.helse-sorost.no/omoss_/english. The funder had no role in study design, data collection	Bhopal R, 2004, J EPIDEMIOL COMMUN H, V58, P441, DOI 10.1136/jech.2003.013466; Bhopal RS, 2013, DIABETIC MED, V30, P35, DOI 10.1111/dme.12016; COMBS CA, 1993, OBSTET GYNECOL, V82, P365; Drooger JC, 2005, ULTRASOUND OBST GYN, V26, P115, DOI 10.1002/uog.1962; Farrar D, 2015, LANCET DIABETEENDO; Gangestad SW, 2012, BIOL REV, V87, P856, DOI 10.1111/j.1469-185X.2012.00226.x; Hammoud NM, 2013, ULTRASOUND OBST GYN, V41, P390, DOI 10.1002/uog.11221; Jenum AK, 2012, EUR J ENDOCRINOL, V166, P317, DOI 10.1530/EJE-11-0866; Jenum AK, 2010, SCAND J PUBLIC HEALT, V38, P60, DOI 10.1177/1403494810378921; Jenum Anne Karen, 2013, Food Nutr Res, V57, DOI 10.3402/fnr.v57i0.18889; Johnsen SL, 2006, ACTA OBSTET GYN SCAN, V85, P286, DOI 10.1080/00016340600569133; Johnsen SL, 2006, EUR J OBSTET GYN R B, V127, P172, DOI 10.1016/j.ejogrb.2005.10.004; Kuc S, 2011, BJOG-INT J OBSTET GY, V118, P748, DOI 10.1111/j.1471-0528.2011.02904.x; Lear SA, 2009, J CLIN ENDOCR METAB, V94, P4696, DOI 10.1210/jc.2009-1030; Leary S, 2006, ACTA OBSTET GYN SCAN, V85, P1066, DOI 10.1080/00016340600697306; Makgoba M, 2012, BJOG-INT J OBSTET GY, V119, P1091, DOI 10.1111/j.1471-0528.2012.03388.x; Maso G, 2014, SCI WORLD J, DOI 10.1155/2014/474809; MULDER EJH, 1991, EARLY HUM DEV, V25, P91, DOI 10.1016/0378-3782(91)90188-9; Sattar N, 2015, LANCET DIABETES ENDO, V3, P1004, DOI 10.1016/S2213-8587(15)00326-5; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Sletner L, 2015, EARLY HUM DEV, V91, P547, DOI 10.1016/j.earlhumdev.2015.07.002; Sletner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073058; Sommer C, 2015, EUR J ENDOCRINOL, V172, P649, DOI 10.1530/EJE-15-0060; Sovio U, 2016, DIABETES CARE; Tomar AS, 2015, CURR OBES REP, V4, P418, DOI 10.1007/s13679-015-0175-6; Tran AT, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-145; Wells JCK, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00145; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Xiang AH, 2015, DIABETOLOGIA, V58, P272, DOI 10.1007/s00125-014-3420-8	29	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172946	10.1371/journal.pone.0172946	http://dx.doi.org/10.1371/journal.pone.0172946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253366	Green Submitted, Green Published, gold			2022-12-26	WOS:000396011300050
J	Li, YJ; Yang, H; Ni, W; Gu, YX				Li, Yanjiang; Yang, Heng; Ni, Wei; Gu, Yuxiang			Effects of deferoxamine on blood-brain barrier disruption after subarachnoid hemorrhage	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; INTRACEREBRAL HEMORRHAGE; FREE-RADICALS; INJURY; IRON; EDEMA; RATS; PROTEINS; DAMAGE; PERMEABILITY	Blood brain barrier (BBB) disruption is a key mechanism of subarachnoid hemorrhage (SAH)-induced brain injury. This study examined the mechanism of iron-induced BBB disruption after SAH and investigated the potential therapeutic effect of iron chelation on SAH. Male adult Sprague-Dawley rats had an endovascular perforation of left internal carotid artery bifurcation or sham operation. The rats were treated with deferoxamine (DFX) or vehicle (100mg/kg) for a maximum of 7 days. Brain edema, BBB leakage, behavioral and cognitive impairment were examined. In SAH rat, the peak time of brain edema and BBB impairment in the cortex was at day 3 after SAH. SAH resulted in a significant increase in ferritin expression in the cortex. The ferritin positive cells were colocalized with endothelial cells, pericytes, astrocytes, microglia and neurons. Compared with vehicle, DFX caused less ferritin upregulation, brain water content, BBB impairment, behavioral and cognitive deficits in SAH rats. The results suggest iron overload could be a therapeutic target for SAH induced BBB damage.	[Li, Yanjiang; Yang, Heng; Ni, Wei; Gu, Yuxiang] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China	Fudan University	Ni, W; Gu, YX (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China.	hsniwei@fudan.edu.cn; Guyuxiang1972@126.com	gu, yu/GSD-4507-2022		National Natural Science Foundation of China (NSFC) [81500987]; Science and Technology Commission of Shanghai Municipality(STCSM) [15140902300]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(STCSM)(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by grants 81500987 from the National Natural Science Foundation of China (NSFC) and grants 15140902300 from Science and Technology Commission of Shanghai Municipality(STCSM), http://www.nsfc.gov.cn.	Bederson JB, 1995, STROKE, V26, P91; BRALET J, 1992, BIOCHEM PHARMACOL, V43, P979, DOI 10.1016/0006-2952(92)90602-F; Burdo JR, 2004, J CEREBR BLOOD F MET, V24, P67, DOI 10.1097/01.WCB.0000095800.98378.03; Cao SL, 2016, NEUROSCI LETT, V621, P88, DOI 10.1016/j.neulet.2016.04.018; Chi OZ, 2008, NEUROL RES, V30, P288, DOI 10.1179/016164107X230135; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Dang BQ, 2015, CRIT CARE MED, V43, pE369, DOI 10.1097/CCM.0000000000001146; Engelhardt S, 2014, J CELL PHYSIOL, V229, P1096, DOI 10.1002/jcp.24544; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fraser PA, 2011, FREE RADICAL BIO MED, V51, P967, DOI 10.1016/j.freeradbiomed.2011.06.003; Fujii M, 2013, TRANSL STROKE RES, V4, P432, DOI 10.1007/s12975-013-0257-2; Fujimura M, 1999, BRAIN RES, V842, P92, DOI 10.1016/S0006-8993(99)01843-0; Gao C, 2014, J CEREBR BLOOD F MET, V34, P1070, DOI 10.1038/jcbfm.2014.56; Guo C, 2016, EXP NEUROL, V280, P13, DOI 10.1016/j.expneurol.2016.03.016; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Huang FP, 2002, J NEUROSURG, V96, P287, DOI 10.3171/jns.2002.96.2.0287; Imaizumi S, 1996, NEUROCHEM INT, V29, P205, DOI 10.1016/0197-0186(95)00120-4; Jia W, 2014, MOL MED REP, V9, P779, DOI 10.3892/mmr.2013.1875; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Keep RF, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-18; Lee JY, 2010, J CEREBR BLOOD F MET, V30, P1793, DOI 10.1038/jcbfm.2010.137; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; Ni W, 2015, J CEREBR BLOOD F MET, V35, P1454, DOI 10.1038/jcbfm.2015.52; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Paul T, 2000, ARCH BIOCHEM BIOPHYS, V382, P253, DOI 10.1006/abbi.2000.2027; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Scholler K, 2007, BRAIN RES, V1142, P237, DOI 10.1016/j.brainres.2007.01.034; Sehba FA, 2006, NEUROL RES, V28, P381, DOI 10.1179/016164106X114991; Tso MK, 2014, TRANSL STROKE RES, V5, P174, DOI 10.1007/s12975-014-0323-4; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Won SM, 2011, EXP MOL MED, V43, P121, DOI 10.3858/emm.2011.43.2.020; Wu JM, 2003, STROKE, V34, P2964, DOI 10.1161/01.STR.0000103140.52838.45; Zhou Y, 2014, PROG NEUROBIOL, V115, P25, DOI 10.1016/j.pneurobio.2013.11.003; ZUCCARELLO M, 1993, J NEUROTRAUM, V10, P397, DOI 10.1089/neu.1993.10.397	34	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172784	10.1371/journal.pone.0172784	http://dx.doi.org/10.1371/journal.pone.0172784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249040	Green Published, gold, Green Submitted			2022-12-26	WOS:000395983500057
J	Islam, MA; Grosse-Brinkhaus, C; Proll, MJ; Uddin, MJ; Rony, SA; Tesfaye, D; Tholen, E; Hoelker, M; Schellander, K; Neuhoff, C				Islam, Md. Aminul; Grosse-Brinkhaus, Christine; Proell, Maren Julia; Uddin, Muhammad Jasim; Rony, Sharmin Aqter; Tesfaye, Dawit; Tholen, Ernst; Hoelker, Michael; Schellander, Karl; Neuhoff, Christiane			PBMC transcriptome profiles identifies potential candidate genes and functional networks controlling the innate and the adaptive immune response to PRRSV vaccine in Pietrain pig	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; BLOOD MONONUCLEAR-CELLS; INFECTION; EXPRESSION; RECOGNITION; PROTECTION; RECEPTORS; CYTOKINES; EFFICACY; SWINE	The porcine reproductive and respiratory syndrome (PRRS) is a devastating viral disease affecting swine production, health and welfare throughout the world. A synergistic action of the innate and the adaptive immune system of the host is essential for mounting a durable protective immunity through vaccination. Therefore, the current study aimed to investigate the transcriptome profiles of peripheral blood mononuclear cells (PBMCs) to characterize the innate and the adaptive immune response to PRRS Virus (PRRSV) vaccination in Pie-train pigs. The Affymetrix gene chip porcine gene 1.0 ST array was used for the transcriptome profiling of PBMCs collected at immediately before (D0), at one (D1) and 28 days (D28) post PRRSV vaccination with three biological replications. With FDR < 0.05 and log2 fold change +/- 1.5 as cutoff criteria, 295 and 115 transcripts were found to be differentially expressed in PBMCs during the stage of innate and adaptive response, respectively. The microarray expression results were technically validated by qRT-PCR. The gene ontology terms such as viral life cycle, regulation of lymphocyte activation, cytokine activity and inflammatory response were enriched during the innate immunity; cytolysis, T cell mediated cytotoxicity, immunoglobulin production were enriched during adaptive immunity to PRRSV vaccination. Significant enrichment of cytokine-cytokine receptor interaction, signaling by interleukins, signaling by the B cell receptor (BCR), viral mRNA translation, IFN-gamma pathway and AP-1 transcription factor network pathways were indicating the involvement of altered genes in the antiviral defense. Network analysis revealed that four network modules were functionally involved with the transcriptional network of innate immunity, and five modules were linked to adaptive immunity in PBMCs. The innate immune transcriptional network was found to be regulated by LCK, STAT3, ATP5B, UBB and RSP17. While TGF beta 1, IL7R, RAD21, SP1 and GZMB are likely to be predictive for the adaptive immune transcriptional response to PRRSV vaccine in PBMCs. Results of the current immunogenomics study advances our understanding of PRRS in term of host-vaccine interaction, and thereby contribute to design a rationale for disease control strategy.	[Islam, Md. Aminul; Grosse-Brinkhaus, Christine; Proell, Maren Julia; Rony, Sharmin Aqter; Tesfaye, Dawit; Tholen, Ernst; Hoelker, Michael; Schellander, Karl; Neuhoff, Christiane] Univ Bonn, Inst Anim Sci, Dept Anim Breeding & Husb, Endenicher Allee 15, D-53115 Bonn, Germany; [Islam, Md. Aminul; Uddin, Muhammad Jasim] Bangladesh Agr Univ, Fac Vet Sci, Dept Med, Mymensingh 2202, Bangladesh; [Uddin, Muhammad Jasim] Univ Queensland, Sch Vet Sci, Gatton, Qld 4343, Australia; [Hoelker, Michael; Schellander, Karl] Univ Bonn, Fac Agr, Teaching & Res Stn Frankenfrost, Konigswinter, Germany	University of Bonn; Bangladesh Agricultural University (BAU); University of Queensland; University of Bonn	Neuhoff, C (corresponding author), Univ Bonn, Inst Anim Sci, Dept Anim Breeding & Husb, Endenicher Allee 15, D-53115 Bonn, Germany.	cneu@itw.uni-bonn.de	Große-Brinkhaus, Christine/AAF-6712-2020; Islam, Aminul/AAE-9484-2019; Uddin, Muhammad Jasim/P-8497-2019; Uddin, Muhammad Jasim/N-3866-2013	Große-Brinkhaus, Christine/0000-0002-6190-4463; Islam, Aminul/0000-0003-1979-9652; Uddin, Muhammad Jasim/0000-0002-6732-5534; Uddin, Dr. Md. Jashim/0000-0002-3243-3455	State of North Rhine Westphalia of Germany [17-02.04.01-4/15]	State of North Rhine Westphalia of Germany	This work was financially supported by the State of North Rhine Westphalia of Germany with the program "Umweltvertragliche and Standortgerechte Landwirtschaft (USL)" with the grant nr. 17-02.04.01-4/15. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Aasted B, 2002, CLIN DIAGN LAB IMMUN, V9, P1229, DOI 10.1128/CDLI.9.6.1229-1234.2002; Adler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058306; Ait-Ali T, 2011, IMMUNOGENETICS, V63, P437, DOI 10.1007/s00251-011-0518-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; [Anonymous], 2001, NUCLEIC ACIDS RES, V29, DOI [10.1093/nar/29.9.e45, DOI 10.1093/NAR/29.9.E45]; Badaoui B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091918; Badaoui B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-220; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Breuer K, 2013, NUCLEIC ACIDS RES, V41, P24, DOI DOI 10.1093/NARL0KS1147; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; COLLINS JE, 1992, J VET DIAGN INVEST, V4, P117, DOI 10.1177/104063879200400201; Corzo CA, 2010, VIRUS RES, V154, P185, DOI 10.1016/j.virusres.2010.08.016; Garcia-Nicolas O, 2014, VET IMMUNOL IMMUNOP, V160, P26, DOI 10.1016/j.vetimm.2014.03.008; Gardy JL, 2009, TRENDS IMMUNOL, V30, P249, DOI 10.1016/j.it.2009.03.009; Genini S, 2008, J GEN VIROL, V89, P2550, DOI 10.1099/vir.0.2008/003244-0; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glass Elizabeth J., 2012, Frontiers in Genetics, V3, P263, DOI 10.3389/fgene.2012.00263; Goldman FD, 1998, J CLIN INVEST, V102, P421, DOI 10.1172/JCI3205; Islam MS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3249-2; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Kohane IS, 2012, BIOINFORMATICS, V28, P538, DOI 10.1093/bioinformatics/btr713; Li J, 2010, VIRUS RES, V148, P60, DOI 10.1016/j.virusres.2009.12.004; [李杏春 Li Xingchun], 2014, [生物技术通报, Biotechnology Bulletin], P26; Li Y, 2014, BIOMASS BIOENERG, V71, P162, DOI 10.1016/j.biombioe.2014.10.010; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Lockhart Stephen, 2003, Expert Rev Vaccines, V2, P633, DOI 10.1586/14760584.2.5.633; Loemba HD, 1996, ARCH VIROL, V141, P751, DOI 10.1007/BF01718333; Lopez OJ, 2004, VET IMMUNOL IMMUNOP, V102, P155, DOI 10.1016/j.vetimm.2004.09.005; Loving CL, 2015, VET IMMUNOL IMMUNOP, V167, P1, DOI 10.1016/j.vetimm.2015.07.003; Martelli P, 2007, VACCINE, V25, P3400, DOI 10.1016/j.vaccine.2006.12.050; Martelli P, 2009, VACCINE, V27, P3788, DOI 10.1016/j.vaccine.2009.03.028; Meier WA, 2003, VIROLOGY, V309, P18, DOI 10.1016/S0042-6822(03)00009-6; Miller LC, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-208; Motulsky HJ, 2007, PRISM 5 STAT GUIDE, V31, P39; Nielsen J, 1997, VET MICROBIOL, V55, P289, DOI 10.1016/S0378-1135(96)01334-X; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Renukaradhya GJ, 2010, VIRAL IMMUNOL, V23, P457, DOI 10.1089/vim.2010.0051; Rowland Raymond R. R., 2012, Frontiers in Genetics, V3, P260, DOI 10.3389/fgene.2012.00260; Rozen S, 2000, Methods Mol Biol, V132, P365; Schroyen M, 2015, MAMM GENOME, V26, P1, DOI 10.1007/s00335-014-9549-4; Shimizu M, 1996, VET IMMUNOL IMMUNOP, V50, P19, DOI 10.1016/0165-2427(95)05494-4; Shoemaker JE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-460; Silva-Campa E, 2012, VIROLOGY, V430, P73, DOI 10.1016/j.virol.2012.04.009; Silva-Campa E, 2010, VIROLOGY, V396, P264, DOI 10.1016/j.virol.2009.10.024; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Trus I, 2014, VACCINE, V32, P2995, DOI 10.1016/j.vaccine.2014.03.077; Uddin MJ, 2012, VET IMMUNOL IMMUNOP, V147, P211, DOI 10.1016/j.vetimm.2012.04.020; Van Breedam W, 2010, J GEN VIROL, V91, P1659, DOI 10.1099/vir.0.020503-0; Van Gucht S, 2005, VIRAL IMMUNOL, V18, P116; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Wang IM, 2012, MICROB BIOTECHNOL, V5, P177, DOI 10.1111/j.1751-7915.2011.00317.x; Weesendorp E, 2013, VET MICROBIOL, V163, P1, DOI 10.1016/j.vetmic.2012.09.013; Wilkie B, 1999, VET IMMUNOL IMMUNOP, V72, P231, DOI 10.1016/S0165-2427(99)00136-1; Wysocki M, 2012, ANIM GENET, V43, P328, DOI 10.1111/j.1365-2052.2011.02251.x; Xia J, 2014, NUCLEIC ACIDS RES, V42, P26, DOI DOI 10.1093/NALL0KU443; Xiao SQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-544; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Xu DQ, 2012, VIRUS RES, V169, P264, DOI 10.1016/j.virusres.2012.07.002; Yoon KJ, 1996, VIRAL IMMUNOL, V9, P51, DOI 10.1089/vim.1996.9.51; Zhang HM, 2012, VET MICROBIOL, V159, P494, DOI 10.1016/j.vetmic.2012.04.025; Zhou P, 2011, INT J BIOL SCI, V7, P947, DOI 10.7150/ijbs.7.947; Zhuge ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029320	67	10	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0171828	10.1371/journal.pone.0171828	http://dx.doi.org/10.1371/journal.pone.0171828			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278192	Green Published, gold, Green Submitted			2022-12-26	WOS:000396087900111
J	Cienfuegos, PJ; Shoemaker, A; Grange, RW; Abaid, N; Leonessa, A				Cienfuegos, Paola Jaramillo; Shoemaker, Adam; Grange, Robert W.; Abaid, Nicole; Leonessa, Alexander			Classical and adaptive control of ex vivo skeletal muscle contractions using Functional Electrical Stimulation (FES)	PLOS ONE			English	Article							NEURAL-NETWORK; MODEL; FREQUENCY; PATTERNS; FATIGUE	Functional Electrical Stimulation is a promising approach to treat patients by stimulating the peripheral nerves and their corresponding motor neurons using electrical current. This technique helps maintain muscle mass and promote blood flow in the absence of a functioning nervous system. The goal of this work is to control muscle contractions from FES via three different algorithms and assess the most appropriate controller providing effective stimulation of the muscle. An open-loop system and a closed-loop system with three types of model-free feedback controllers were assessed for tracking control of skeletal muscle contractions: a Proportional-Integral (PI) controller, a Model Reference Adaptive Control algorithm, and an Adaptive Augmented PI system. Furthermore, a mathematical model of a muscle-mass-spring system was implemented in simulation to test the open-loop case and closed-loop controllers. These simulations were carried out and then validated through experiments ex vivo. The experiments included muscle contractions following four distinct trajectories: a step, sine, ramp, and square wave. Overall, the closed-loop controllers followed the stimulation trajectories set for all the simulated and tested muscles. When comparing the experimental outcomes of each controller, we concluded that the Adaptive Augmented PI algorithm provided the best closed-loop performance for speed of convergence and disturbance rejection.	[Cienfuegos, Paola Jaramillo] US Naval Acad, Dept Weap & Syst Engn, Annapolis, MD 21402 USA; [Shoemaker, Adam; Leonessa, Alexander] Virginia Polytech Inst & State Univ, Dept Mech Engn, Blacksburg, VA 24061 USA; [Grange, Robert W.] Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA; [Abaid, Nicole] Virginia Polytech Inst & State Univ, Dept Biomed Engn & Mech, Foods, Blacksburg, VA 24061 USA	United States Department of Defense; United States Navy; United States Naval Academy; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Cienfuegos, PJ (corresponding author), US Naval Acad, Dept Weap & Syst Engn, Annapolis, MD 21402 USA.	paola.jaramillo.co@usna.edu			National Science Foundation Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET); Collaborative Research: Adaptive Control and Functional Electrical Stimulation for the Control and Understanding of Muscle Dynamics [0828114]; CAREER: Functional Electrical Stimulation to Aid Phonation in the Presence of Unilateral Vocal Fold Paralysis [1055315]; National Science Foundation [0828114, 1055315]; Directorate For Engineering [1055315] Funding Source: National Science Foundation	National Science Foundation Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)(National Science Foundation (NSF)); Collaborative Research: Adaptive Control and Functional Electrical Stimulation for the Control and Understanding of Muscle Dynamics; CAREER: Functional Electrical Stimulation to Aid Phonation in the Presence of Unilateral Vocal Fold Paralysis; National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research work was funded by the National Science Foundation Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET). Funds were awarded for the proposal No. 0828114 titled "Collaborative Research: Adaptive Control and Functional Electrical Stimulation for the Control and Understanding of Muscle Dynamics" and the proposal No. 1055315 titled "CAREER: Functional Electrical Stimulation to Aid Phonation in the Presence of Unilateral Vocal Fold Paralysis". The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Many thanks to the National Science Foundation for funding this study (Grant Funding No. 0828114 and No. 1055315). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Alexander Leonessa is the senior author and PI of the Center for Dynamic Systems Modeling and Control. This material is based upon work supported by (while serving at) the National Science Foundation.	ALAMOOD WS, 1987, J PHYSIOL-LONDON, V392, P377, DOI 10.1113/jphysiol.1987.sp016786; Asadi AR, 2012, IEEE T NEUR SYS REH, V20, P499, DOI 10.1109/TNSRE.2012.2197828; Brend O, 2015, IEEE T CONTR SYST T, V23, P1901, DOI 10.1109/TCST.2015.2394508; Chang G C, 1997, IEEE Trans Rehabil Eng, V5, P2, DOI 10.1109/86.559344; CHIZECK HJ, 1991, IEEE T BIO-MED ENG, V38, P1224, DOI 10.1109/10.137288; Coste C. Azevedo, 2015, IFAC - Papers Online, V48, P333, DOI 10.1016/j.ifacol.2015.10.161; D'Souza A., 1988, DESIGN OF CONTROL SY; Dennis RG, 2003, MED ENG PHYS, V25, P239, DOI 10.1016/S1350-4533(02)00193-5; Dow DE, 2004, MUSCLE NERVE, V30, P77, DOI 10.1002/mus.20054; EKEN T, 1988, J PHYSIOL-LONDON, V402, P651, DOI 10.1113/jphysiol.1988.sp017227; Grange RW, 2002, AM J PHYSIOL-CELL PH, V283, pC1090, DOI 10.1152/ajpcell.00450.2001; Gregory CM, 2005, PHYS THER, V85, P358, DOI 10.1093/ptj/85.4.358; GUNDERSEN K, 1992, ACTA PHYSIOL SCAND, V145, P49, DOI 10.1111/j.1748-1716.1992.tb09335.x; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hunt KJ, 2001, CONTROL ENG PRACT, V9, P313, DOI 10.1016/S0967-0661(00)00126-X; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Ianno M., 2002, ANN C INT FUNCT EL S; IOANNOU PA, 1996, ROBUST ADAPTIVE CONT; Jaramillo P., 2012, INT C NEUROREHABILIT; John CT, 2013, COMPUT METHOD BIOMEC, V16, P451, DOI 10.1080/10255842.2011.627560; Khalil H. K., 2002, NONLINEAR SYSTEM; Kralj A.R., 1989, FUNCTIONAL ELECT STI, DOI DOI 10.1201/9780203755402; Krsti M., 1995, NONLINEAR ADAPTIVE C; Li Z, 2014, IEEE COMPUT INTELL M, V9, P38, DOI 10.1109/MCI.2014.2307224; Lynch C. L., 2005, 10 ANN C INT FES SOC; Lynch CL, 2008, IEEE CONTR SYST MAG, V28, P40, DOI 10.1109/MCS.2007.914689; Lynch CL, 2012, IEEE T NEUR SYS REH, V20, P539, DOI 10.1109/TNSRE.2012.2185065; Maffiuletti NA, 2010, EUR J APPL PHYSIOL, V110, P223, DOI 10.1007/s00421-010-1502-y; Narendra K. S., 2012, STABLEADAPTIVESYSTEM; Narendra KS, 1989, STABLE ADAPTIVE SYST; Popovic DB, 2014, J ELECTROMYOGR KINES, V24, P795, DOI 10.1016/j.jelekin.2014.09.008; Riener R, 1996, J BIOMECH, V29, P1157, DOI 10.1016/0021-9290(96)00012-7; Riess J, 2000, IEEE T REHABIL ENG, V8, P42, DOI 10.1109/86.830948; Rouhani E., 2014, 2014 IEEE 19 INT FUN, P1; Sayenko DG, 2014, EUR J APPL PHYSIOL, V114, P793, DOI 10.1007/s00421-013-2807-4; Sheffler LR, 2007, MUSCLE NERVE, V35, P562, DOI 10.1002/mus.20758; Tamura Y, 2002, J BIOMECH, V35, P1273, DOI 10.1016/S0021-9290(02)00082-9; Thelen DG, 2003, J BIOMECH ENG-T ASME, V125, P70, DOI 10.1115/1.1531112; Watanabe T., 2002, P 7 IFESS, P265; WESTGAARD RH, 1988, J NEUROSCI, V8, P4415; Williams H. Bruce, 1996, Microsurgery, V17, P589, DOI 10.1002/(SICI)1098-2752(1996)17:11<589::AID-MICR5>3.0.CO;2-K; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Zhang DG, 2004, P ANN INT IEEE EMBS, V26, P4877; Zhang DG, 2004, IEEE IJCNN, P1245	46	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172761	10.1371/journal.pone.0172761	http://dx.doi.org/10.1371/journal.pone.0172761			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273101	gold, Green Published, Green Submitted			2022-12-26	WOS:000396073700029
J	Clemensson, EKH; Clemensson, LE; Fabry, B; Riess, O; Nguyen, HP				Clemensson, Erik Karl Hakan; Clemensson, Laura Emily; Fabry, Benedikt; Riess, Olaf; Huu Phuc Nguyen			Further investigation of phenotypes and confounding factors of progressive ratio performance and feeding behavior in the BACHD rat model of Huntington disease	PLOS ONE			English	Article							MONOSODIUM GLUTAMATE; COGNITIVE IMPAIRMENT; ENERGY-BALANCE; LEPTIN; NUCLEUS; MOTOR; FOOD; MOTIVATION; OBESITY; LESIONS	Huntington disease is an inherited neurodegenerative disorder characterized by motor, cognitive, psychiatric and metabolic symptoms. We recently published a study describing that the BACHD rat model of HD shows an obesity phenotype, which might affect their motivation to perform food-based behavioral tests. Further, we argued that using a food restriction protocol based on matching BACHD and wild type rats' food consumption rates might resolve these motivational differences. In the current study, we followed up on these ideas in a longitudinal study of the rats' performance in a progressive ratio test. We also investigated the phenotype of reduced food consumption rate, which is typically seen in food-restricted BACHD rats, in greater detail. In line with our previous study, the BACHD rats were less motivated to perform the progressive ratio test compared to their wild type littermates, although the phenotype was no longer present when the rats' food consumption rates had been matched. However, video analysis of food consumption tests suggested that the reduced consumption rate found in the BACHD rats was not entirely based on differences in hunger, but likely involved motoric impairments. Thus, restriction protocols based on food consumption rates are not appropriate when working with BACHD rats. As an alternative, we suggest that studies where BACHD rats are used should investigate how the readouts of interest are affected by motivational differences, and use appropriate control tests to avoid misleading results. In addition, we show that BACHD rats display distinct behavioral changes in their progressive ratio performance, which might be indicative of striatal dysfunction.	[Clemensson, Erik Karl Hakan; Clemensson, Laura Emily; Riess, Olaf; Huu Phuc Nguyen] Inst Med Genet & Appl Genom, Tubingen, Tuebingen, Germany; [Clemensson, Erik Karl Hakan; Clemensson, Laura Emily; Riess, Olaf; Huu Phuc Nguyen] Ctr Rare Dis, Tubingen, Tuebingen, Germany; [Clemensson, Laura Emily; Fabry, Benedikt] QPS Austria, Grambach, Austria		Nguyen, HP (corresponding author), Inst Med Genet & Appl Genom, Tubingen, Tuebingen, Germany.; Nguyen, HP (corresponding author), Ctr Rare Dis, Tubingen, Tuebingen, Germany.	Hoa.nguyen@med.uni-tuebingen.de	Nguyen, Huu Phuc/HDO-3462-2022	Nguyen, Huu Phuc/0000-0001-6139-788X; Clemensson, Erik/0000-0002-5158-6924	EU 7th Framework program [324495]	EU 7th Framework program(European Commission)	HPN, LEC, and BF were supported by EU 7th Framework program (FP7/2012), project "SWITCH-HD," under grant agreement no. 324495. LEC and BF are employees of QPS Austria, but their salaries for this study were provided by the above-mentioned grant. QPS Austria had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada YK, 2013, PLOS ONE; Adam OR, 2008, NEUROTHERAPEUTICS, V5, P181, DOI 10.1016/j.nurt.2008.01.008; Alhadeff AL, 2014, AM J PHYSIOL-REG I, V307, pR1338, DOI 10.1152/ajpregu.00329.2014; Balthasar N, 2003, ENDOCRINOLOGY, V144, P2728, DOI 10.1210/en.2003-0006; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Baudic S, 2006, DEMENT GERIATR COGN, V21, P316, DOI 10.1159/000091523; Berryman DE, 2010, J GERONTOL A-BIOL, V65, P31, DOI 10.1093/gerona/glp175; Berryman DE, 2004, GROWTH HORM IGF RES, V14, P309, DOI 10.1016/j.ghir.2004.02.005; BERTHERAT J, 1992, NEUROENDOCRINOLOGY, V56, P25, DOI 10.1159/000126204; BESSER GM, 1974, J CLIN PATHOL, V27, P173, DOI 10.1136/jcp.27.3.173; BLOCH B, 1984, NATURE, V307, P272, DOI 10.1038/307272a0; Bradbury MJ, 2005, J PHARMACOL EXP THER, V313, P395, DOI 10.1124/jpet.104.076406; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; Brooks SP, 2015, CURR TOP BEHAV NEURO, V22, P101, DOI 10.1007/7854_2013_256; Carreira JC, 2015, CURR TOP BEHAV NEURO, V22, P135, DOI 10.1007/7854_2013_245; Chang RB, 2015, DRUG DES DEV THER, V9, P2179, DOI 10.2147/DDDT.S58470; Chen W, 2013, N-S ARCH PHARMACOL, V386, P721, DOI 10.1007/s00210-013-0875-y; Clemens LE, 2015, BRAIN, V138, P3632, DOI 10.1093/brain/awv290; Davis JF, 2011, BIOL PSYCHIAT, V69, P668, DOI 10.1016/j.biopsych.2010.08.028; de Tommaso M, 2015, EUR NEUROL, V74, P49, DOI 10.1159/000435833; DONAHUE LR, 1993, J ENDOCRINOL, V136, P91, DOI 10.1677/joe.0.1360091; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Eagle DM, 1999, BEHAV NEUROSCI, V113, P718, DOI 10.1037/0735-7044.113.4.718; Enkel T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00010; Fielding SA, 2012, BRAIN RES BULL, V88, P223, DOI 10.1016/j.brainresbull.2011.09.011; Figlewicz DP, 2006, PHYSIOL BEHAV, V89, P611, DOI 10.1016/j.physbeh.2006.07.023; Hayward MD, 2002, J NEUROSCI, V22, P8251; Hult S, 2011, CELL METAB, V13, P428, DOI 10.1016/j.cmet.2011.02.013; Hunt V P, 1989, J Neurosci Nurs, V21, P92; Jansson EKH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105662; KAGEL M C, 1992, Dysphagia, V7, P106, DOI 10.1007/BF02493441; Kanoski SE, 2014, NEUROPSYCHOPHARMACOL, V39, P605, DOI 10.1038/npp.2013.235; Kudwa AE, 2013, PLOS ONE; LEOPOLD NA, 1985, ARCH NEUROL-CHICAGO, V42, P57, DOI 10.1001/archneur.1985.04060010063017; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; McFadyen MP, 2003, GENES BRAIN BEHAV, V2, P214, DOI 10.1034/j.1601-183X.2003.00028.x; Morris MJ, 1998, REGUL PEPTIDES, V75-6, P441, DOI 10.1016/S0167-0115(98)00100-1; Morton AJ, 2013, J HUNTINGTONS DIS, V2, P3, DOI 10.3233/JHD-130050; Murray PG, 2013, AM J MED GENET C, V163C, P76, DOI 10.1002/ajmg.c.31357; Naarding P, 2009, J NEUROPSYCH CLIN N, V21, P266, DOI 10.1176/appi.neuropsych.21.3.266; Nader K, 1997, ANNU REV PSYCHOL, V48, P85, DOI 10.1146/annurev.psych.48.1.85; Oakeshott S, 2012, PLOS CURR; Oakeshott S, 2013, PLOS CURR; Paulsen JS, 2001, J NEUROL NEUROSUR PS, V71, P310, DOI 10.1136/jnnp.71.3.310; Pouladi MA, 2013, NAT REV NEUROSCI, V14, P708, DOI 10.1038/nrn3570; Pouladi MA, 2009, BRAIN, V132, P919, DOI 10.1093/brain/awp006; Reiner A, 2011, INT REV NEUROBIOL, V98, P325, DOI [10.1016/B978-0-12-387003-2.00014-8, 10.1016/B978-0-12-381328-2.00014-6]; Roth JD, 2012, DIABETES OBES METAB, V14, P608, DOI 10.1111/j.1463-1326.2012.01570.x; SCALLET AC, 1986, BRAIN RES, V374, P380, DOI 10.1016/0006-8993(86)90434-8; TANAKA K, 1978, EXP NEUROL, V62, P191, DOI 10.1016/0014-4886(78)90050-X; Tennant K. A., 2010, J VIS EXP; Thompson JC, 2002, J NEUROPSYCH CLIN N, V14, P37, DOI 10.1176/appi.neuropsych.14.1.37; Thompson JC, 2012, J NEUROPSYCH CLIN N, V24, P53, DOI 10.1176/appi.neuropsych.11030057; Trueman RC, 2012, BRAIN RES BULL, V88, P261, DOI 10.1016/j.brainresbull.2011.03.015; Urbach YK, 2014, J NEUROSCI METH, V234, P38, DOI 10.1016/j.jneumeth.2014.06.017; Vonsattel Jean Paul G, 2008, Handb Clin Neurol, V89, P599, DOI 10.1016/S0072-9752(07)01256-0; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Youn J, 2012, BEHAV BRAIN RES, V226, P397, DOI 10.1016/j.bbr.2011.09.034; Yu-Taeger L, 2012, J NEUROSCI, V32, P15426, DOI 10.1523/JNEUROSCI.1148-12.2012; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	61	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173232	10.1371/journal.pone.0173232	http://dx.doi.org/10.1371/journal.pone.0173232			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273120	Green Submitted, Green Published, gold			2022-12-26	WOS:000396073700046
J	Chen, PC; Shih, CH; Chu, TJ; Lee, YC; Tzeng, TD				Chen, Po-Cheng; Shih, Chun-Han; Chu, Ta-Jen; Lee, Ying-Chou; Tzeng, Tzong-Der			Phylogeography and genetic structure of the oriental river prawn Macrobrachium nipponense (Crustacea: Decapoda: Palaemonidae) in East Asia	PLOS ONE			English	Article							ERIOCHEIR-SENSU-STRICTO; LAST GLACIAL MAXIMUM; MOLECULAR SYSTEMATICS; POPULATION-GROWTH; TAIWAN; HISTORY; MTDNA; SEA; DIFFERENTIATION; CYPRINIDAE	The oriental river prawn (Macrobrachium nipponense) is mainly distributed in East Asia. The phylogeography, population genetic structure and historical demography of this species in the East Asia were examined by using partial sequences of the cytochrome oxidase subunit I (COI) and 16S rRNA in mitochondrial DNA. Ten populations that included 239 individuals were collected from Taiwan (Shihmen Reservoir, SMR, Mingte Reservoir, MTR and Chengching Lake Reservoir, CLR), mainland China (Taihu Lake, TLC, Min River, MRC, Jiulong River, JRC and Shenzhen Reservoir, SRC), Japan (Biwa Lake, BLJ and Kasumigaura Lake, KLJ) and Korea (Han River, HRK). The nucleotide diversity (p) of all individuals was 0.01134, with values ranging from 0.0089 (BLJ, Japan) to 0.01425 (MTR, Taiwan). A total of 83 haplotypes were obtained, and the haplotypes were divided into 2 main lineages: lineage A included the specimens from BLJ, KLJ, CLR, MTR, TLC, MRC and JRC, and lineage B comprised the ones from HRK, SRC, SMR, MTR, TLC, MRC and JRC. Lineage A could be further divided two sub-lineages (A1 and A2). Individuals of lineage A2 were only from TLC. Demographic expansion was observed in each lineage, starting within the second-to-latest interglacial period for lineage A and within the last glacial period for lineage B. All FST values among the ten populations were significantly different, except for the values between MRC and JRC, and SMR and SRC. The phylogeography and genetic structure ofM. nipponense in East Asia might be influenced by Pleistocene glacial cycles, lake isolation and human introduction. The possible dispersal routes of M. nipponense in the East Asia were also discussed.	[Chen, Po-Cheng; Lee, Ying-Chou] Natl Taiwan Univ, Coll Life Sci, Inst Fisheries Sci, Taipei, Taiwan; [Shih, Chun-Han] Tungnan Univ, Dept Leisure Management, New Taipei, Taiwan; [Chu, Ta-Jen] Chung Hua Univ, Dept Leisure & Recreat Management, Hsinchu, Taiwan; [Tzeng, Tzong-Der] Shu Te Univ, Dept Leisure Recreat & Tourism Management, Kaohsiung, Taiwan	National Taiwan University; Chung Hua University; Shu-Te University	Lee, YC (corresponding author), Natl Taiwan Univ, Coll Life Sci, Inst Fisheries Sci, Taipei, Taiwan.; Tzeng, TD (corresponding author), Shu Te Univ, Dept Leisure Recreat & Tourism Management, Kaohsiung, Taiwan.	i812@ntu.edu.tw; tdtzeng@stu.edu.tw	, 朱達仁/AGA-5114-2022		Ministry of Science and Technology [MOST 104-2611-M-366-001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by the Ministry of Science and Technology grant number MOST 104-2611-M-366-001.	Avise JC, 2000, PHYLOGEOGRAPHY HIST, P301; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bermingham E, 1998, MOL ECOL, V7, P499, DOI 10.1046/j.1365-294x.1998.00358.x; Chen P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134694; Chen RT, 2009, J CRUSTACEAN BIOL, V29, P232, DOI 10.1651/08-3072.1; Chiang TY, 2010, J FISH BIOL, V76, P1173, DOI 10.1111/j.1095-8649.2010.02589.x; Chiang TY, 1999, MOL ECOL, V8, P1037, DOI 10.1046/j.1365-294x.1999.00668.x; Chiang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050844; Crandall KA, 1996, SYST BIOL, V45, P1; CRANDALL KA, 1993, GENETICS, V134, P959; Craw D, 2007, GEOMORPHOLOGY, V84, P98, DOI 10.1016/j.geomorph.2006.07.008; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Feng JB, 2010, J FISH SCI CHN, V17, P1; Feng JianBin, 2008, Journal of Fisheries of China, V32, P517; Fu YX, 1997, GENETICS, V147, P915; GASCOYNE M, 1979, SCIENCE, V205, P806, DOI 10.1126/science.205.4408.806; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; HOELZEL AR, 1991, MOL BIOL EVOL, V8, P475; HUANG CY, 1995, TECTONICS, V14, P19, DOI 10.1029/94TC02452; Hudson RR, 1990, OXFORD SURVEYS EVOLU, V1, P1; Jiang S F, 2008, CHINESE AGR SCI BULL, V24, P554; Jiang SF., 2006, J YANGTZE U NATURAL, V3, P179; Liao TY, 2008, ZOOL STUD, V47, P383; Liu J, 2003, J LAKE SCI, V15, P177; Liu MY, 2007, ZOOL STUD, V46, P272; Liu MY, 2011, HYDROBIOLOGIA, V671, P1, DOI 10.1007/s10750-011-0699-z; LUNDBERG JG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P156; MANTEL N, 1967, CANCER RES, V27, P209; MASHIKO K, 1990, J CRUSTACEAN BIOL, V10, P306, DOI 10.2307/1548489; MASHIKO K, 1993, ZOOL SCI, V10, P161; Mashiko K, 2000, J CRUSTACEAN BIOL, V20, P118, DOI 10.1651/0278-0372(2000)020[0118:DOPWDS]2.0.CO;2; NEI M, 1981, GENETICS, V97, P145; NEI M, 1987, MOL EVOLUTIONARY GEN, P1, DOI DOI 10.7312/NEI-92038; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sambrook J, 2001, MOL CLONING LAB MANU, P66; Shih HT, 2006, J BIOGEOGR, V33, P980, DOI 10.1111/j.1365-2699.2006.01472.x; Stanley HF, 1996, MOL BIOL EVOL, V13, P368, DOI 10.1093/oxfordjournals.molbev.a025596; Su Xiang, 2011, Shengtaixue Zazhi, V30, P2007; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vilaca ST, 2010, MOL PHYLOGENET EVOL, V57, P585, DOI 10.1016/j.ympev.2010.07.010; Wang HY, 1999, MOL ECOL, V8, P1879, DOI 10.1046/j.1365-294x.1999.00787.x; Wang JP, 2004, MOL PHYLOGENET EVOL, V31, P1143, DOI 10.1016/j.ympev.2003.10.001; Wang JP, 2000, MOL ECOL, V9, P1483, DOI 10.1046/j.1365-294x.2000.01023.x; WANG PX, 1994, CATENA, V23, P341; WONG JTY, 1990, AQUACULTURE, V88, P151, DOI 10.1016/0044-8486(90)90290-4; Wu JT, 2008, WIRELESS COMMUNICATI, P1; Wu Yan, 2008, Shanghai Shuichan Daxue Xuebao, V17, P620; Xiao SB, 2004, J COASTAL RES, V20, P599, DOI 10.2112/1551-5036(2004)020[0599:THOTYR]2.0.CO;2; Xu JW, 2012, MOL PHYLOGENET EVOL, V64, P118, DOI 10.1016/j.ympev.2012.03.009; Xu JW, 2009, MOL PHYLOGENET EVOL, V52, P45, DOI 10.1016/j.ympev.2009.02.007; Yang Pin, 2007, Zoological Research, V28, P113; Yu HP, 1984, ACTA MARIMA AQUAC, V19, P117	57	11	12	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173490	10.1371/journal.pone.0173490	http://dx.doi.org/10.1371/journal.pone.0173490			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267807	Green Published, Green Submitted, gold			2022-12-26	WOS:000396060600037
J	Sun, LL; Wu, RH; Su, WC; Gao, ZG; Lu, CT				Sun, Lanlan; Wu, Renhai; Su, Wangcang; Gao, Zenggui; Lu, Chuantao			Physiological basis for isoxadifen-ethyl induction of nicosulfuron detoxification in maize hybrids	PLOS ONE			English	Article							CORN ZEA-MAYS; HERBICIDE SAFENERS; XENOBIOTIC DETOXIFICATION; PRIMISULFURON; METABOLISM; TOLERANCE; WHEAT; GLUTATHIONE; SELECTIVITY; ENZYME	Isoxadifen-ethyl can effectively alleviate nicosulfuron injury in the maize. However, the effects of safener isoxadifen-ethyl on detoxifying enzymes in maize is unknown. The individual and combined effects of the sulfonylurea herbicide nicosulfuron and the safener isoxadifen-ethyl on the growth and selected physiological processes of maize were evaluated. Bioassays showed that the EC50 values of nicosulfuron and nicosulfuron plus isoxadifen-ethyl for maize cultivar Zhengdan958 were 18.87 and 249.28 mg kg(-1), respectively, and were 24.8 and 275.51 mg kg(-1), respectively, for Zhenghuangnuo No. 2 cultivar. Evaluations of the target enzyme of acetolactate synthase showed that the I-50 values of nicosulfuron and nicosulfuron plus isoxadifen-ethyl for the ALS of Zhengdan958 were 15.46 and 28.56 mu mol L-1, respectively, and were 0.57 and 2.17 mu mol L-1, respectively, for the acetolactate synthase of Zhenghuangnuo No. 2. The safener isoxadifen-ethyl significantly enhanced tolerance of maize to nicosulfuron. The enhanced tolerance of maize to nicosulfuron in the presence of the safener, coupled with the enhanced injury observed in the presence of piperonyl butoxide, 1-aminobenzotriazole, and malathion, suggested cytochrome P450 monooxygenases may be involved in metabolism of nicosulfuron. We proposed that isoxadifen-ethyl increases plant metabolism of nicosulfuron through non-P450-catalyzed routes or through P450 monooxygenases not inhibited by piperonyl butoxide, 1-aminobenzotriazole, and malathion. Isoxadifen-ethyl, at a rate of 33 mg kg(-1), completely reversed the effects of all doses (37.5-300 mg kg(-1)) of nicosulfuron on both of the maize cultivars. When the two compounds were given simultaneously, isoxadifen-ethyl enhanced activity of glutathione S-transferases (GSTs) and acetolactate synthase activity in maize. The free acid 4,5-dihydro5,5-diphenyl-1,2-oxazole-3-carboxylic was equally effective at inducing GSTs as the parent ester and appeared to be the active safener. GST induction in the maize Zhenghuangnuo No. 2 was faster than in Zhengdan 958.	[Sun, Lanlan; Gao, Zenggui] Shenyang Agr Univ, Dept Plant Protect, Shenyang, Peoples R China; [Wu, Renhai; Su, Wangcang; Lu, Chuantao] Henan Acad Agr Sci, Inst Plant Protect, Zhengzhou, Peoples R China	Shenyang Agricultural University; Henan Academy of Agricultural Sciences	Gao, ZG (corresponding author), Shenyang Agr Univ, Dept Plant Protect, Shenyang, Peoples R China.; Lu, CT (corresponding author), Henan Acad Agr Sci, Inst Plant Protect, Zhengzhou, Peoples R China.	gaozenggui@sina.com; luchuantao@yeah.net			Special Fund for Agro-scientific Research in the Public Interest [201203098]	Special Fund for Agro-scientific Research in the Public Interest	The present study has been supported by the Special Fund for Agro-scientific Research in the Public Interest (201203098).	Baerg RJ, 1996, PESTIC BIOCHEM PHYS, V55, P10, DOI 10.1006/pest.1996.0030; Barroso A. L. de L., 2012, Comunicata Scientiae, V3, P255; Behringer C, 2011, PLANT CELL ENVIRON, V34, P1970, DOI 10.1111/j.1365-3040.2011.02392.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazier M, 2002, PHYTOCHEMISTRY, V59, P149, DOI 10.1016/S0031-9422(01)00458-7; Bunting JA, 2004, WEED SCI, V52, P711, DOI 10.1614/WS-04-008R; Cataneo AC, 2013, PLANTA DANINHA, V31, P387, DOI 10.1590/S0100-83582013000200016; Cavalieri SD, 2012, PLANTA DANINHA, V30, P377, DOI 10.1590/S0100-83582012000200017; Cieslik LF, 2014, ACTA SCI-AGRON, V36, P329, DOI 10.4025/actasciagron.v36i3.17630; Cummins I, 2011, DRUG METAB REV, V43, P266, DOI 10.3109/03602532.2011.552910; Davies J, 1999, PESTIC SCI, V55, P1043, DOI 10.1002/(SICI)1096-9063(199911)55:11&lt;1043::AID-PS60&gt;3.0.CO;2-L; DIEHL KE, 1995, PESTIC BIOCHEM PHYS, V51, P137, DOI 10.1006/pest.1995.1014; Dong XiaoWen, 2007, Acta Phytophylacica Sinica, V34, P182; Fan ZhiJin, 2003, Agricultural Sciences in China, V2, P176; FRAZIER TL, 1994, WEED SCI, V42, P168, DOI 10.1017/S004317450008022X; GAILLARD C, 1994, FEBS LETT, V352, P219, DOI 10.1016/0014-5793(94)00961-9; Grey TL, 2012, WEED TECHNOL, V26, P207, DOI 10.1614/WT-D-11-00143.1; Grey TL, 2000, HORTSCIENCE, V35, P1070, DOI 10.21273/HORTSCI.35.6.1070; [郭玉莲 Guo Yulian], 2011, [农业环境科学学报, Journal of Agro-Environment Science], V30, P645; Hatzios KK, 2004, WEED SCI, V52, P454, DOI 10.1614/P2002-168C; Hinz JRR, 1996, WEED SCI, V44, P219, DOI 10.1017/S0043174500093814; Jursik M, 2010, LISTY CUKROV REPAR, V126, P14; Kang ZH, 2012, J INTEGR AGR, V11, P1485, DOI 10.1016/S2095-3119(12)60148-8; KREUZ K, 1992, PESTIC BIOCHEM PHYS, V43, P232, DOI 10.1016/0048-3575(92)90036-Y; Kreuz K, 1996, PLANT PHYSIOL, V111, P349, DOI 10.1104/pp.111.2.349; LAMOUREUX GL, 1992, PESTIC BIOCHEM PHYS, V42, P128, DOI 10.1016/0048-3575(92)90060-D; Lei XT, 2008, AGROCHEM, V47, P540; Li W, 2014, CROPS, V2, P64; Matola T, 2007, CROP PROT, V26, P278, DOI 10.1016/j.cropro.2005.07.015; Meyer MD, 2010, AGRON J, V102, P1138, DOI 10.2134/agronj2010.0093; Mimmo T, 2015, CHEMOSPHERE, V119, P31, DOI 10.1016/j.chemosphere.2014.04.114; O'Sullivan J, 2000, CAN J PLANT SCI, V80, P419, DOI 10.4141/P99-066; Pataky JK, 2009, J AM SOC HORTIC SCI, V134, P252, DOI 10.21273/JASHS.134.2.252; Riechers DE, 2010, PLANT PHYSIOL, V153, P3, DOI 10.1104/pp.110.153601; ROBINSON DK, 1994, WEED SCI, V42, P614, DOI 10.1017/S0043174500077031; Rosinger C., 2014, Julius-Kuhn-Archiv, P516; Rosinger C, 2012, MODERN CROP PROTECTION COMPOUNDS, VOLS 1-3, 2ND EDITION, P371; Schulte W., 2009, BAYER CROPSCI J, V62, P35; Taylor VL, 2013, ENVIRON EXP BOT, V88, P93, DOI 10.1016/j.envexpbot.2011.12.030; Yang CH, 2007, WEED SCI, V55, P537, DOI 10.1614/WS-07-016.1; Ye F, 2016, ZEMDIRBYSTE, V103, P29, DOI 10.13080/z-a.2016.103.004; Yun MS, 2001, PEST MANAG SCI, V57, P283, DOI 10.1002/ps.298; Zhang Q, 2007, PROTEOMICS, V7, P1261, DOI 10.1002/pmic.200600423	43	17	17	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173502	10.1371/journal.pone.0173502	http://dx.doi.org/10.1371/journal.pone.0173502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267798	gold, Green Published, Green Submitted			2022-12-26	WOS:000396060600038
J	Tekko, T; Lakspere, T; Allikalt, A; End, J; Kolvart, KR; Jagomae, T; Terasmaa, A; Philips, MA; Visnapuu, T; Vaartnou, F; Gilbert, SF; Rinken, A; Vasar, E; Lillevali, K				Tekko, Triin; Lakspere, Triin; Allikalt, Anni; End, Jaanus; Kolvart, Karl Rene; Jagomae, Toomas; Terasmaa, Anton; Philips, Mari-Anne; Visnapuu, Tanel; Vaartnou, Fred; Gilbert, Scott F.; Rinken, Ago; Vasar, Eero; Lillevali, Kersti			Wfs1 is expressed in dopaminoceptive regions of the amniote brain and modulates levels of D1-like receptors	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; WOLFRAM-SYNDROME 1; ENDOPLASMIC-RETICULUM STRESS; NIGRA DOPAMINERGIC-NEURONS; TURTLE TRACHEMYS-SCRIPTA; FRESH-WATER TURTLE; MOLECULAR PARTNER; UP-REGULATION; ER STRESS; WFS1-DEFICIENT MICE	During amniote evolution, the construction of the forebrain has diverged across different lineages, and accompanying the structural changes, functional diversification of the homologous brain regions has occurred. This can be assessed by studying the expression patterns of marker genes that are relevant in particular functional circuits. In all vertebrates, the dopaminergic system is responsible for the behavioral responses to environmental stimuli. Here we show that the brain regions that receive dopaminergic input through dopamine receptor D-1 are relatively conserved, but with some important variations between three evolutionarily distant vertebrate lines-house mouse (Mus musculus), domestic chick (Gallus gallus domesticus) / common quail (Coturnix coturnix) and red-eared slider turtle (Trachemys scripta). Moreover, we find that in almost all instances, those brain regions expressing D-1 like dopamine receptor genes also express Wfsl. Wfsl has been studied primarily in the pancreas, where it regulates the endoplasmic reticulum (ER) stress response, cellular Ca2+ homeostasis, and insulin production and secretion. Using radioligand binding assays in wild type and Wfsli-mouse brains, we show that the number of binding sites of Dl-like dopamine receptors is increased in the hippocampus of the mutant mice. We propose that the functional link between Wfsl and Dl-like dopamine receptors is evolutionarily conserved and plays an important role in adjusting behavioral reactions to environmental stimuli.	[Tekko, Triin; Jagomae, Toomas; Terasmaa, Anton; Philips, Mari-Anne; Visnapuu, Tanel; Vasar, Eero; Lillevali, Kersti] Univ Tartu, Inst Biomed & Translat Med, Dept Physiol, Tartu, Estonia; [Tekko, Triin; Jagomae, Toomas; Terasmaa, Anton; Philips, Mari-Anne; Visnapuu, Tanel; Vasar, Eero; Lillevali, Kersti] Univ Tartu, Ctr Excellence Genom & Translat Med, Tartu, Estonia; [Lakspere, Triin; End, Jaanus; Vaartnou, Fred] Univ Tartu, Inst Mol & Cell Biol, Dept Dev Biol, Tartu, Estonia; [Allikalt, Anni; Kolvart, Karl Rene; Rinken, Ago] Univ Tartu, Inst Chem, Tartu, Estonia; [Gilbert, Scott F.] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA	University of Tartu; University of Tartu; University of Tartu; University of Tartu; Swarthmore College	Lillevali, K (corresponding author), Univ Tartu, Inst Biomed & Translat Med, Dept Physiol, Tartu, Estonia.; Lillevali, K (corresponding author), Univ Tartu, Ctr Excellence Genom & Translat Med, Tartu, Estonia.	kersti.lillevali@ut.ee	Lilleväli, Kersti/AGD-6838-2022; Rinken, Ago/AAG-7025-2020; Philips, Mari-Anne/AAZ-7624-2021; Visnapuu, Tanel/AAJ-5503-2020; Allikalt, Anni/AAD-1538-2022; Terasmaa, Anton/I-3312-2015	Lilleväli, Kersti/0000-0001-5470-3818; Rinken, Ago/0000-0002-7238-749X; Philips, Mari-Anne/0000-0001-7103-4038; Allikalt, Anni/0000-0002-3056-3088; Vasar, Eero/0000-0001-5226-345X; Terasmaa, Anton/0000-0002-5139-1764; Tekko, Triin/0000-0003-2669-5835	Estonian Science Foundation [8408]; Institutional investigation grant from the Estonian Research Council [IUT20-41, IUT20-17]; Estonian Research Council [PUT784]; Ministry of Education and Research [SF0180019s11]; European Union through the European Regional Development Fund (Competence Centre on Health Technology) [EU48695]; National Science Foundation [IOS 145177]; Centre of Excellence in Genomics and Translational Medicine, University of Tartu - European Union through the European Regional Development Fund [2014-2020.4.01.15-0012]; Direct For Biological Sciences [1457177] Funding Source: National Science Foundation	Estonian Science Foundation; Institutional investigation grant from the Estonian Research Council(Estonian Research Council); Estonian Research Council(Estonian Research Council); Ministry of Education and Research; European Union through the European Regional Development Fund (Competence Centre on Health Technology); National Science Foundation(National Science Foundation (NSF)); Centre of Excellence in Genomics and Translational Medicine, University of Tartu - European Union through the European Regional Development Fund; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Estonian Science Foundation, grant 8408 (www.etag.ee) to KL; Institutional investigation grant IUT20-41 from the Estonian Research Council (www.etag.ee) to EV; Institutional investigation grant IUT20-17 from the Estonian Research Council (www.etag.ee) to AR; Personal investigation grant PUT784 from the Estonian Research Council (www.etag.ee to AT; the Ministry of Education and Research (SF0180019s11) (www.hm.ee); European Union through the European Regional Development Fund (Competence Centre on Health Technology, EU48695)(1ww.eas.ee); National Science Foundation (www.nsf.gov) Grant IOS 145177 to SFG; and Centre of Excellence in Genomics and Translational Medicine, University of Tartu, funded by the European Union through the European Regional Development Fund (Project No. 2014-2020.4.01.15-0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan A, 2009, J COMP NEUROL, V515, P465, DOI 10.1002/cne.22083; BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; BRUCE LL, 1995, BRAIN BEHAV EVOLUT, V46, P224, DOI 10.1159/000113276; Bruce LL, 2009, EVOLUTIONARY NEUROSC, P233; Celada P, 1999, NEUROSCIENCE, V89, P813, DOI 10.1016/S0306-4522(98)00356-X; Chiu K, 2005, BRAIN RES, V1046, P207, DOI 10.1016/j.brainres.2005.04.016; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; Fonseca SG, 2005, J BIOL CHEM, V280, P39609, DOI 10.1074/jbc.M507426200; Fonseca SG, 2012, NAT CELL BIOL, V14, P1105, DOI 10.1038/ncb2578; Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678; Franco R, 2006, MOL PHARMACOL, V69, P1905, DOI 10.1124/mol.105.020685; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gabreels BATF, 1998, J CLIN ENDOCR METAB, V83, P4026, DOI 10.1210/jc.83.11.4026; Gharanei S, 2013, HUM MOL GENET, V22, P203, DOI 10.1093/hmg/dds400; Hatanaka M, 2011, HUM MOL GENET, V20, P1274, DOI 10.1093/hmg/ddq568; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Ishihara H, 2004, HUM MOL GENET, V13, P1159, DOI 10.1093/hmg/ddh125; Kaplinsky NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066357; Kawano J, 2009, NEUROSCI RES, V64, P213, DOI 10.1016/j.neures.2009.03.005; Kesaraju S, 2014, BRAIN RES, V1582, P247, DOI 10.1016/j.brainres.2014.07.044; Kesaraju S, 2009, J NEUROCHEM, V109, P1413, DOI 10.1111/j.1471-4159.2009.06068.x; Koido K, 2005, INT J NEUROPSYCHOPH, V8, P235, DOI 10.1017/S1461145704004791; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lu SM, 2014, P NATL ACAD SCI USA, V111, pE5292, DOI 10.1073/pnas.1421055111; LUTZ PL, 1995, AM J PHYSIOL-REG I, V268, pR1332, DOI 10.1152/ajpregu.1995.268.5.R1332; Luuk H, 2008, J COMP NEUROL, V509, P642, DOI 10.1002/cne.21777; Luuk H, 2009, BEHAV BRAIN RES, V198, P334, DOI 10.1016/j.bbr.2008.11.007; Martinez-Garcia F., 2009, EVOLUTIONARY NEUROSC, P313; Matto V, 2011, J PHYSIOL BIOCHEM, V67, P53, DOI 10.1007/s13105-010-0048-0; Milton SL, 2006, J BIOMED SCI, V13, P509, DOI 10.1007/s11373-006-9084-8; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nayak G, 2009, J NEUROCHEM, V110, P603, DOI 10.1111/j.1471-4159.2009.06157.x; Nilsson GE, 2004, J CEREBR BLOOD F MET, V24, P475, DOI 10.1097/00004647-200405000-00001; Osman AA, 2003, J BIOL CHEM, V278, P52755, DOI 10.1074/jbc.M310331200; POWERS AS, 1980, J HIRNFORSCH, V21, P125; Prentice HM, 2004, J CEREBR BLOOD F MET, V24, P826, DOI 10.1097/01.WCB.0000126565.27130.79; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; Rami A, 2003, NEUROBIOL DIS, V13, P75, DOI 10.1016/S0969-9961(03)00018-4; Reinart-Okugbeni R, 2013, BIOORGAN MED CHEM, V21, P4143, DOI 10.1016/j.bmc.2013.05.014; Rigoli L, 2011, CLIN GENET, V79, P103, DOI 10.1111/j.1399-0004.2010.01522.x; Sarinana J, 2014, P NATL ACAD SCI USA, V111, P8245, DOI 10.1073/pnas.1407395111; Shang LS, 2014, DIABETES, V63, P923, DOI 10.2337/db13-0717; Shen XX, 2011, MOL BIOL EVOL, V28, P3237, DOI 10.1093/molbev/msr148; Swift M, 2005, MOL PSYCHIATR, V10, P799, DOI 10.1038/sj.mp.4001681; SWIFT RG, 1990, LANCET, V336, P667, DOI 10.1016/0140-6736(90)92157-D; Takeda K, 2001, HUM MOL GENET, V10, P477, DOI 10.1093/hmg/10.5.477; Takei D, 2006, FEBS LETT, V580, P5635, DOI 10.1016/j.febslet.2006.09.007; Tekko T, 2014, INT J DEV NEUROSCI, V35, P80, DOI 10.1016/j.ijdevneu.2014.03.009; Tepper JM, 2007, PROG BRAIN RES, V160, P189, DOI 10.1016/S0079-6123(06)60011-3; Tonissaar M, 2008, NEUROSCIENCE, V152, P867, DOI 10.1016/j.neuroscience.2008.01.028; Ueda K, 2005, EUR J ENDOCRINOL, V153, P167, DOI 10.1530/eje.1.01945; Vicario A, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00090; Vinet J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-27; Visnapuu T, 2013, BEHAV BRAIN RES, V244, P90, DOI 10.1016/j.bbr.2013.01.046; WILSON AM, 1991, BRAIN RES, V540, P297, DOI 10.1016/0006-8993(91)90523-X; Windels F, 2006, EUR J NEUROSCI, V24, P1385, DOI 10.1111/j.1460-9568.2006.05015.x; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Xia Y, 2001, J COMP NEUROL, V436, P202; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E; Zatyka M, 2008, HUM MOL GENET, V17, P190, DOI 10.1093/hmg/ddm296; Zatyka M, 2015, HUM MOL GENET, V24, P814, DOI 10.1093/hmg/ddu499	63	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0172825	10.1371/journal.pone.0172825	http://dx.doi.org/10.1371/journal.pone.0172825			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267787	Green Submitted, gold, Green Published			2022-12-26	WOS:000396060600004
J	Liu, ZJ; Rong, QL; Zhou, W; Liang, GQ				Liu, Zhanjun; Rong, Qinlei; Zhou, Wei; Liang, Guoqing			Effects of inorganic and organic amendment on soil chemical properties, enzyme activities, microbial community and soil quality in yellow clayey soil	PLOS ONE			English	Article							LONG-TERM FERTILIZATION; RICE STRAW INCORPORATION; CROPPING SYSTEM; CARBON SEQUESTRATION; GREEN MANURE; PADDY SOILS; NITROGEN; RESPONSES; BIOMASS; LITTER	Understanding the effects of external organic and inorganic components on soil fertility and quality is essential for improving low-yielding soils. We conducted a field study over two consecutive rice growing seasons to investigate the effect of applying chemical fertilizer (NPK), NPK plus green manure (NPKG), NPK plus pig manure (NPKM), and NPK plus straw (NPKS) on the soil nutrient status, enzyme activities involved in C, N, P, and S cycling, microbial community and rice yields of yellow clayey soil. Results showed that the fertilized treatments significantly improved rice yields over the first three experimental seasons. Compared with the NPK treatment, organic amendments produced more favorable effects on soil productivity. Notably, the NPKM treatment exhibited the highest levels of nutrient availability, microbial biomass carbon (MBC), activities of most enzymes and the microbial community. This resulted in the highest soil quality index (SQI) and rice yield, indicating better soil fertility and quality. Significant differences in enzyme activities and the microbial community were observed among the treatments, and redundancy analysis showed that MBC and available N were the key determinants affecting the soil enzyme activities and microbial community. The SQI score of the non -fertilized control (0.72) was comparable to that of the NPK (0.77), NPKG (0.81) and NPKS (0.79) treatments but significantly lower compared with NPKM (0.85). The significant correlation between rice yield and SQI suggests that SQI can be a useful to quantify soil quality changes caused by different agricultural management practices. The results indicate that application of NPK plus pig manure is the preferred option to enhance SOC accumulation, improve soil fertility and quality, and increase rice yield in yellow clayey soil.	[Liu, Zhanjun] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Peoples R China; [Rong, Qinlei; Zhou, Wei; Liang, Guoqing] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Crop Nutr & Fertilizat, Beijing, Peoples R China	Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs	Zhou, W (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Crop Nutr & Fertilizat, Beijing, Peoples R China.	wzhou@caas.ac.cn	Rong, Qinlei/ABF-7363-2020; Zhang, Kevin/F-5215-2010; rong, qinlei/AAC-9833-2022		Special Fund for Agro-scientific Research in the Public Interest [201003016]; Ministry of Agriculture of the People's Republic of China; China Agriculture Research System; National Basic Research Program of China, Ministry of Science and Technology of the People's Republic of China [2013CB127405]	Special Fund for Agro-scientific Research in the Public Interest; Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs); China Agriculture Research System; National Basic Research Program of China, Ministry of Science and Technology of the People's Republic of China	Support was provided by The Special Fund for Agro-scientific Research in the Public Interest (201003016), Ministry of Agriculture of the People's Republic of China (WZ received the funding); and the earmarked fund for China Agriculture Research System and the National Basic Research Program of China (2013CB127405), Ministry of Science and Technology of the People's Republic of China (WZ received the funding).	Ai C, 2015, BIOL FERT SOILS, V51, P465, DOI 10.1007/s00374-015-0994-3; Alagoz Z, 2009, SOIL TILL RES, V103, P419, DOI 10.1016/j.still.2008.12.006; Almagro M, 2014, AGR ECOSYST ENVIRON, V196, P167, DOI 10.1016/j.agee.2014.06.027; ASMAR F, 1994, BIOL FERT SOILS, V17, P32, DOI 10.1007/BF00418669; Bhardwaj AK, 2011, AGR ECOSYST ENVIRON, V140, P419, DOI 10.1016/j.agee.2011.01.005; Bhattacharyya R, 2009, AGR ECOSYST ENVIRON, V132, P126, DOI 10.1016/j.agee.2009.03.007; Bhattacharyya R, 2015, EUR J AGRON, V70, P11, DOI 10.1016/j.eja.2015.06.006; Billings SA, 2008, GLOBAL CHANGE BIOL, V14, P1025, DOI 10.1111/j.1365-2486.2008.01562.x; Bray SR, 2012, SOIL BIOL BIOCHEM, V49, P30, DOI 10.1016/j.soilbio.2012.02.009; Bruun TB, 2006, AGR ECOSYST ENVIRON, V113, P139, DOI 10.1016/j.agee.2005.09.012; Cederlund H, 2014, APPL SOIL ECOL, V84, P62, DOI 10.1016/j.apsoil.2014.06.003; [陈海飞 Chen Haifei], 2014, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V20, P517; Chen X, 2011, BIOL FERT SOILS, V47, P323, DOI 10.1007/s00374-011-0542-8; Chen Y, 2010, J SOIL SEDIMENT, V10, P1018, DOI 10.1007/s11368-009-0123-8; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P2971, DOI 10.1016/j.soilbio.2007.05.031; Dong WY, 2014, APPL SOIL ECOL, V84, P140, DOI 10.1016/j.apsoil.2014.06.007; DORAN JW, 1994, SSSA SPEC PUBL, P3; Elzobair KA, 2016, CHEMOSPHERE, V142, P145, DOI 10.1016/j.chemosphere.2015.06.044; Fanin N, 2016, SOIL BIOL BIOCHEM, V94, P48, DOI 10.1016/j.soilbio.2015.11.007; Geisseler D, 2012, EUR J SOIL BIOL, V53, P107, DOI 10.1016/j.ejsobi.2012.09.006; Giacometti C, 2013, APPL SOIL ECOL, V64, P32, DOI 10.1016/j.apsoil.2012.10.002; Hai L, 2010, SOIL BIOL BIOCHEM, V42, P253, DOI 10.1016/j.soilbio.2009.10.023; Hall DJM, 2015, PEDOSPHERE, V25, P720, DOI 10.1016/S1002-0160(15)30053-9; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Huang M, 2015, FIELD CROP RES, V183, P126, DOI 10.1016/j.fcr.2015.07.022; Jiang YJ, 2014, ENVIRON MICROBIOL, V16, P3083, DOI 10.1111/1462-2920.12339; Li P, 2013, SOIL TILL RES, V126, P112, DOI 10.1016/j.still.2012.07.011; Li SY, 2016, SOIL TILL RES, V155, P199, DOI 10.1016/j.still.2015.08.009; Liebig MA, 2001, AGRON J, V93, P313, DOI 10.2134/agronj2001.932313x; Lima ACR, 2013, APPL SOIL ECOL, V64, P194, DOI 10.1016/j.apsoil.2012.12.009; Liu ZJ, 2014, BIOL FERT SOILS, V50, P537, DOI 10.1007/s00374-013-0864-9; Lu RK, 2000, SOIL ANALYTICALMETHO; Moeskops B, 2010, APPL SOIL ECOL, V45, P112, DOI 10.1016/j.apsoil.2010.03.005; Mohanty M, 2007, SOIL TILL RES, V92, P243, DOI 10.1016/j.still.2006.03.005; Navas M, 2011, APPL SOIL ECOL, V49, P242, DOI 10.1016/j.apsoil.2011.04.017; Papadopoulos A, 2014, GEODERMA, V213, P435, DOI 10.1016/j.geoderma.2013.08.033; Paz-Ferreiro J, 2007, NEW ZEAL J AGR RES, V50, P537, DOI 10.1080/00288230709510321; Paz-Ferreiro J, 2011, BIOL FERT SOILS, V47, P633, DOI 10.1007/s00374-011-0570-4; Qi YB, 2009, GEODERMA, V149, P325, DOI 10.1016/j.geoderma.2008.12.015; [荣勤雷 Rong Qinlei], 2014, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V20, P1168; Saetre P, 2000, SOIL BIOL BIOCHEM, V32, P909, DOI 10.1016/S0038-0717(99)00215-1; SHEN SM, 1984, SOIL BIOL BIOCHEM, V16, P437, DOI 10.1016/0038-0717(84)90049-X; Shukla MK, 2006, SOIL TILL RES, V87, P194, DOI 10.1016/j.still.2005.03.011; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Sun RB, 2015, APPL SOIL ECOL, V95, P171, DOI 10.1016/j.apsoil.2015.06.010; Tesfahunegn GB, 2011, GEODERMA, V163, P209, DOI 10.1016/j.geoderma.2011.04.016; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang W, 2015, SOIL TILL RES, V152, P8, DOI 10.1016/j.still.2015.03.011; Wu YP, 2009, GEODERMA, V150, P171, DOI 10.1016/j.geoderma.2009.02.003; Xie ZJ, 2016, FIELD CROP RES, V188, P142, DOI 10.1016/j.fcr.2016.01.006; Yan X, 2013, SOIL TILL RES, V130, P42, DOI 10.1016/j.still.2013.01.013; Yuan L, 2014, FIELD CROP RES, V155, P164, DOI 10.1016/j.fcr.2013.09.009; Zhang Q, 2015, APPL SOIL ECOL, V94, P59, DOI 10.1016/j.apsoil.2015.05.005; Zhang XY, 2015, SCI TOTAL ENVIRON, V536, P59, DOI 10.1016/j.scitotenv.2015.07.043; Zhu HH, 2010, PLANT SOIL, V331, P427, DOI 10.1007/s11104-009-0263-z; Zhu LQ, 2015, ECOL INDIC, V53, P144, DOI 10.1016/j.ecolind.2015.01.038	56	58	65	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172767	10.1371/journal.pone.0172767	http://dx.doi.org/10.1371/journal.pone.0172767			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28263999	Green Submitted, Green Published, gold			2022-12-26	WOS:000396054300017
J	Na, ML; Wang, WZ; Fei, Y; Josefsson, E; Ali, A; Jin, T				Na, Manli; Wang, Wanzhong; Fei, Ying; Josefsson, Elisabet; Ali, Abukar; Jin, Tao			Both anti-TNF and CTLA4 Ig treatments attenuate the disease severity of staphylococcal dermatitis in mice	PLOS ONE			English	Article							NECROSIS FACTOR THERAPY; RHEUMATOLOGY BIOLOGICS REGISTER; INTENSIVE-CARE-UNIT; AUREUS COLONIZATION; SKIN INFECTION; FACTOR-ALPHA; HUMAN NEUTROPHILS; SEPTIC ARTHRITIS; BRITISH SOCIETY; RISK	Background RA patients being treated with biologics are known to have an increased risk of infections. We recently demonstrated that both CTLA4 Ig and anti-TNF treatment aggravate systemic Staphylococcus aureus (S. aureus) infection in mice, but with distinct clinical manifestations. However, the effects of CTLA4 Ig and anti-TNF treatments on a local S. aureus infection (e.g., skin infection) might differ from their effects on a systemic infection. Aims The aim of this study was to examine the differential effects of anti-TNF versus CTLA4 Ig treatment on S. aureus skin infections in mice. Method Abatacept (CTLA4 Ig), etanercept (anti-TNF treatment) or PBS was given to NMRI mice subcutaneously inoculated with S. aureus strain SH1000. The clinical signs of dermatitis, along with histopathological changes due to skin infection, were compared between the groups. Results Both CTLA4 Ig and anti-TNF treatment resulted in less severe skin infections and smaller post-infectious hyperpigmentation compared with controls. Consistent with the clinical signs of dermatitis, smaller lesion size, more epithelial hyperplasia and more granulation were found in skin biopsies from mice receiving anti-TNF compared with PBS controls. However, both CTLA4 Ig and anti-TNF therapy tended to prolong the healing time, although this finding was not statistically significant. Serum MCP-1 levels were elevated in the anti-TNF group relative to the CTLA4 Ig and PBS groups, whereas IL-6 levels were higher in PBS controls than in the other two groups. Both anti-TNF and CTLA4 Ig treatments tended to down-regulate the necrosis/apoptosis ratio in the locally infected skin tissue. Importantly, no tangible difference was found in the bacterial burden among groups. Conclusion Both CTLA4 Ig and anti-TNF therapies attenuate disease severity but may prolong the healing time required for S. aureus skin infections. Neither treatment has an impact on bacterial clearance in skin tissues.	[Na, Manli; Josefsson, Elisabet; Ali, Abukar; Jin, Tao] Gothenburg Univ, Dept Rheumatol & Inflammat Res, Inst Med, Sahlgrenska Acad, S-41346 Gothenburg, Sweden; [Wang, Wanzhong] Umea Univ, Dept Med Biosci, Umea, Sweden; [Fei, Ying] GuiZhou Med Univ, Dept Microbiol & Immunol, Affiliated Hosp, Guiyang, Peoples R China; [Jin, Tao] Sahlgrens Univ Hosp, Dept Rheumatol, Gothenburg, Sweden	University of Gothenburg; Umea University; Guizhou Medical University; Sahlgrenska University Hospital	Jin, T (corresponding author), Gothenburg Univ, Dept Rheumatol & Inflammat Res, Inst Med, Sahlgrenska Acad, S-41346 Gothenburg, Sweden.; Jin, T (corresponding author), Sahlgrens Univ Hosp, Dept Rheumatol, Gothenburg, Sweden.	tao.jin@rheuma.gu.se	Na, Manli/AAM-9864-2020; Jin, Tao/K-3323-2015	Jin, Tao/0000-0001-9039-0628; Ali, Abukar/0000-0002-1963-3356; Na, Manli/0000-0002-7306-8941	Swedish Medical Research Council [523-2013-2750]; Swedish Medical Society [SLS-496741, SLS-402871]; Stiftelsen Clas Groschinskys Minnesfond [M1566, M14099, M1626]; Royal Society of Arts and Sciences in Gothenburg; Wilhelm and Martina Lundgren Foundation; Scandinavian Society for Antimicrobial Chemotherapy Foundation [SLS-501701]; Rune och Ulla Amlovs Stiftelse for Neurologisk och Reumatologisk Forskning [2015-00056, 2016-075]; Professor Nanna Svartz Fond [2015-00074]; Adlerbertska Forskningsstiftelsen	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Medical Society; Stiftelsen Clas Groschinskys Minnesfond; Royal Society of Arts and Sciences in Gothenburg; Wilhelm and Martina Lundgren Foundation; Scandinavian Society for Antimicrobial Chemotherapy Foundation; Rune och Ulla Amlovs Stiftelse for Neurologisk och Reumatologisk Forskning; Professor Nanna Svartz Fond; Adlerbertska Forskningsstiftelsen	This work was supported by the Swedish Medical Research Council (grant 523-2013-2750 to T. Jin), the Swedish Medical Society (SLS-496741 and SLS-402871 to T. Jin), the Stiftelsen Clas Groschinskys Minnesfond (grant M1566, M14099, and M1626 to T. Jin), the Royal Society of Arts and Sciences in Gothenburg (grant to T. Jin and ML. Na), the Wilhelm and Martina Lundgren Foundation (grant to T. Jin, ML. Na, and A. Ali), the Scandinavian Society for Antimicrobial Chemotherapy Foundation (grant SLS-501701 to T. Jin), Rune och Ulla Amlovs Stiftelse for Neurologisk och Reumatologisk Forskning (grant 2015-00056 and 2016-075 to T. Jin), Professor Nanna Svartz Fond (grant 2015-00074 to T. Jin), and Adlerbertska Forskningsstiftelsen (grant to T. Jin and ML. Na). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Alayan J, 2007, ORAL MICROBIOL IMMUN, V22, P304, DOI 10.1111/j.1399-302X.2007.00360.x; Ali A, 2015, J INFECT DIS, V212, P1308, DOI 10.1093/infdis/jiv212; Ali A, 2015, ARTHRITIS RHEUMATOL, V67, P107, DOI 10.1002/art.38902; Amar S, 1996, J INFLAMM, V47, P180; Askling J, 2008, CURR OPIN RHEUMATOL, V20, P138, DOI 10.1097/BOR.0b013e3282f4b392; Assuma R, 1998, J IMMUNOL, V160, P403; Bassetti S, 2005, J RHEUMATOL, V32, P2125; Bergkvist PI, 1997, SCAND J INFECT DIS, V29, P377, DOI 10.3109/00365549709011834; Bigbee CL, 2007, ARTHRITIS RHEUM-US, V56, P2557, DOI 10.1002/art.22750; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Davis Erica C, 2010, J Clin Aesthet Dermatol, V3, P20; Dewas C, 2003, J IMMUNOL, V171, P4392, DOI 10.4049/jimmunol.171.8.4392; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2287, DOI 10.1002/art.10524; Fei Y, 2011, J INFECT DIS, V204, P348, DOI 10.1093/infdis/jir266; FEIKEN E, 1995, J INVEST DERMATOL, V105, P120, DOI 10.1111/1523-1747.ep12313429; Feuerstein R, 2015, J IMMUNOL, V194, P2735, DOI 10.4049/jimmunol.1402566; Fraser TG, 2010, INFECT CONT HOSP EP, V31, P779, DOI 10.1086/654001; Galloway JB, 2013, ANN RHEUM DIS, V72, P229, DOI 10.1136/annrheumdis-2011-201108; Galloway JB, 2011, RHEUMATOLOGY, V50, P124, DOI 10.1093/rheumatology/keq242; Garcia-Doval I, 2010, ANN RHEUM DIS, V69, P1751, DOI 10.1136/ard.2009.125658; Honda H, 2010, INFECT CONT HOSP EP, V31, P584, DOI 10.1086/652530; Kaandorp CJE, 1995, ARTHRITIS RHEUM, V38, P1819, DOI 10.1002/art.1780381215; Keene A, 2005, INFECT CONT HOSP EP, V26, P622, DOI 10.1086/502591; Kengatharan KM, 1998, J EXP MED, V188, P305, DOI 10.1084/jem.188.2.305; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kwiecinski J, 2014, APMIS, V122, P1240, DOI 10.1111/apm.12295; Kwiecinski J, 2013, J INFECT DIS, V208, P990, DOI 10.1093/infdis/jit288; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Molne L, 2000, INFECT IMMUN, V68, P6162, DOI 10.1128/IAI.68.11.6162-6167.2000; Na M, 2016, INFECT IMMUN; Nam JL, 2014, ANN RHEUM DIS, V73, P516, DOI 10.1136/annrheumdis-2013-204577; Parker D, 2015, J INFECT DIS, V211, P835, DOI 10.1093/infdis/jiu525; Perez-Alvarez R, 2011, MEDICINE, V90, P359, DOI 10.1097/MD.0b013e3182380a76; Saha B, 1996, J IMMUNOL, V157, P3869; Sakiniene E, 1996, ARTHRITIS RHEUM, V39, P1596, DOI 10.1002/art.1780390921; Salliot C, 2009, ANN RHEUM DIS, V68, P25, DOI 10.1136/ard.2007.083188; Schiff M, 2014, ANN RHEUM DIS, V73, P86, DOI 10.1136/annrheumdis-2013-203843; Tseng CW, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005292; Tsiodras S, 2008, MAYO CLIN PROC, V83, P181; Tzianabos AO, 2000, INFECT IMMUN, V68, P6650, DOI 10.1128/IAI.68.12.6650-6655.2000; Varley CD, 2014, RHEUMATOLOGY, V53, P332, DOI 10.1093/rheumatology/ket351; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Wasson NJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-533; Yun HF, 2016, ARTHRITIS RHEUMATOL, V68, P56, DOI 10.1002/art.39399; Zacharioudakis IM, 2014, J AM SOC NEPHROL, V25, P2131, DOI 10.1681/ASN.2013091028	47	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173492	10.1371/journal.pone.0173492	http://dx.doi.org/10.1371/journal.pone.0173492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264025	Green Submitted, Green Published, gold			2022-12-26	WOS:000396054300066
J	Puller, C; Arbogast, P; Keeley, PW; Reese, BE; Haverkamp, S				Puller, Christian; Arbogast, Patrick; Keeley, Patrick W.; Reese, Benjamin E.; Haverkamp, Silke			Dendritic stratification differs among retinal OFF bipolar cell types in the absence of rod photoreceptors	PLOS ONE			English	Article							MOUSE RETINA; PRIMATE RETINA; GLUTAMATE RECEPTORS; ELECTRON-MICROSCOPY; KAINATE RECEPTORS; M-CONE; NRL; PATHWAY; INPUT; IDENTIFICATION	Retinal OFF bipolar cells show distinct connectivity patterns with photoreceptors in the wild type mouse retina. Some types are cone-specific while others penetrate further through the outer plexiform layer (OPL) to contact rods in addition to cones. To explore dendritic stratification of OFF bipolar cells in the absence of rods, we made use of the 'cone-full' WI mouse retina in which all photoreceptor precursor cells commit to a cone fate including those which would have become rods in wild -type retinas. The dendritic distribution of OFF bipolar cell types was investigated by confocal and electron microscopic imaging of immunolabeled tissue sections. The cells' dendrites formed basal contacts with cone terminals and expressed the corresponding glutamate receptor subunits at those sites, indicating putative synapses. All of the four analyzed cell populations showed distinctive patterns of vertical dendritic invasion through the OPL. This disparate behavior of dendritic extension in an environment containing only cone terminals demonstrates type -dependent specificity for dendritic outgrowth in OFF bipolar cells: rod terminals are not required for inducing dendritic extension into distal areas of the OPL.	[Puller, Christian] Carl von Ossietzky Univ Oldenburg, Dept Neurosci, Oldenburg, Germany; [Puller, Christian; Arbogast, Patrick; Haverkamp, Silke] Max Planck Inst Brain Res, Frankfurt, Germany; [Keeley, Patrick W.; Reese, Benjamin E.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Reese, Benjamin E.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Haverkamp, Silke] Goethe Univ, Inst Cellular & Mol Anat, Frankfurt, Germany	Carl von Ossietzky Universitat Oldenburg; Max Planck Society; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Goethe University Frankfurt	Puller, C (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Neurosci, Oldenburg, Germany.; Puller, C (corresponding author), Max Planck Inst Brain Res, Frankfurt, Germany.	christian.puller@uni-oldenburg.de		Puller, Christian/0000-0003-1730-8733	Deutsche Forschungsgemeinschft [HA 5277/2-2]; National Institutes of Health [EY-019968]; NATIONAL EYE INSTITUTE [R01EY019968] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by Deutsche Forschungsgemeinschft www.dfg.de (grant HA 5277/2-2 to SH) and National Institutes of Health nttps://neLnih.govi (grant EY-019968 to BER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens C, 2016, BIORXIV; Borghuis BG, 2014, J NEUROSCI, V34, P6128, DOI 10.1523/JNEUROSCI.4941-13.2014; Cheng CW, 2005, DEV BIOL, V287, P48, DOI 10.1016/j.ydbio.2005.08.029; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; Dunn FA, 2012, J NEUROSCI, V32, P10306, DOI 10.1523/JNEUROSCI.1581-12.2012; Euler T, 2014, NAT REV NEUROSCI, V15, P507, DOI 10.1038/nrn3783; Fyk-Kolodziej B, 2003, J COMP NEUROL, V464, P104, DOI 10.1002/cne.10784; Hack I, 1999, P NATL ACAD SCI USA, V96, P14130, DOI 10.1073/pnas.96.24.14130; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2001, J COMP NEUROL, V436, P471, DOI 10.1002/cne.1081; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Haverkamp S, 2008, J COMP NEUROL, V507, P1087, DOI 10.1002/cne.21612; Haverkamp S, 2006, J NEUROSCI, V26, P5248, DOI 10.1523/JNEUROSCI.4483-05.2006; Ichinose T, 2016, J PHYSIOL-LONDON, V594, P883, DOI 10.1113/JP271458; Keeley PW, 2010, J NEUROSCI, V30, P1677, DOI 10.1523/JNEUROSCI.5153-09.2010; KOLB H, 1970, PHILOS T R SOC B, V258, P261, DOI 10.1098/rstb.1970.0036; Li W, 2004, J COMP NEUROL, V474, P1, DOI 10.1002/cne.20075; Mataruga A, 2007, J COMP NEUROL, V502, P1123, DOI 10.1002/cne.21367; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Missotten L, 1965, ULTRASTRUCTURE HUMAN; Morrow EM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-2; Nikonov SS, 2005, J GEN PHYSIOL, V125, P287, DOI 10.1085/jgp.200409208; Oh ECT, 2007, P NATL ACAD SCI USA, V104, P1679, DOI 10.1073/pnas.0605934104; Pang JJ, 2012, J PHYSIOL-LONDON, V590, P845, DOI 10.1113/jphysiol.2011.224113; Puller C, 2013, NEUROSCIENCE, V243, P136, DOI 10.1016/j.neuroscience.2013.03.054; Raven MA, 2007, J NEUROSCI, V27, P3540, DOI 10.1523/JNEUROSCI.0372-07.2007; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; Strettoi E, 2004, J NEUROSCI, V24, P7576, DOI 10.1523/JNEUROSCI.2245-04.2004; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; Tsukamoto Y, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00105; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160	36	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173455	10.1371/journal.pone.0173455	http://dx.doi.org/10.1371/journal.pone.0173455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257490	Green Published, Green Accepted, gold			2022-12-26	WOS:000396021100092
J	Formanowicz, D; Radom, M; Zawierucha, P; Formanowicz, P				Formanowicz, Dorota; Radom, Marcin; Zawierucha, Piotr; Formanowicz, Piotr			Petri net-based approach to modeling and analysis of selected aspects of the molecular regulation of angiogenesis	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; NITRIC-OXIDE; ENDOTHELIAL-CELLS; BINDING; INVARIANTS; PATHWAYS; MONALISA	The functioning of both normal and pathological tissues depends on an adequate supply of oxygen through the blood vessels. A process called angiogenesis, in which new endothelial cells and smooth muscles interact with each other, forming new blood vessels either from the existing ones or from a primary vascular plexus, is particularly important and interesting, due to new therapeutic possibilities it offers. This is a multi-step and very complex process, so an accurate understanding of the underlying mechanisms is a significant task, especially in recent years, with the constantly increasing amount of new data that must be taken into account. A systems approach is necessary for these studies because it is not sufficient to analyze the properties of the building blocks separately and an analysis of the whole network of interactions is essential. This approach is based on building a mathematical model of the system, while the model is expressed in the formal language of a mathematical theory. Recently, the theory of Petri nets was shown to be especially promising for the modeling and analysis of biological phenomena. This analysis, based mainly on t-invariants, has led to a particularly important finding that a direct link (close connection) exist between transforming growth factor beta 1 (TGF-beta 1), endothelial nitric oxide synthase (eNOS), nitric oxide (NO), and hypoxia-inducible factor 1, the molecules that play a crucial roles during angiogenesis. We have shown that TGF-beta 1 may participate in the inhibition of angiogenesis through the upregulation of eNOS expression, which is responsible for catalyzing NO production. The results obtained in the previous studies, concerning the effects of NO on angiogenesis, have not been conclusive, and therefore, our study may contribute to a better understanding of this phenomenon.	[Formanowicz, Dorota] Poznan Univ Med Sci, Dept Clin Biochem & Lab Med, Grunwaldzka 6, PL-60780 Poznan, Poland; [Radom, Marcin; Formanowicz, Piotr] Poznan Univ Tech, Inst Comp Sci, Piotrowo 2, PL-60965 Poznan, Poland; [Zawierucha, Piotr] Poznan Univ Med Sci, Dept Histol & Embryol, Swiecickiego 6 St, PL-61781 Poznan, Poland; [Zawierucha, Piotr] Poznan Univ Med Sci, Dept Anat, Swiecickiego 6, PL-61781 Poznan, Poland; [Radom, Marcin; Formanowicz, Piotr] Polish Acad Sci, Inst Bioorgan Chem, Z Noskowskiego 12-14, PL-61704 Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Technology; Poznan University of Medical Sciences; Poznan University of Medical Sciences; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Formanowicz, P (corresponding author), Poznan Univ Tech, Inst Comp Sci, Piotrowo 2, PL-60965 Poznan, Poland.; Formanowicz, P (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Z Noskowskiego 12-14, PL-61704 Poznan, Poland.	piotr@cs.put.poznan.pl	Radom, Marcin/G-9534-2013; Radom, Marcin/AAJ-6958-2020; Formanowicz, Piotr/M-3606-2014; Formanowicz, Dorota/V-3901-2019	Radom, Marcin/0000-0002-4174-7069; Radom, Marcin/0000-0002-4174-7069; Formanowicz, Piotr/0000-0003-2719-3677; Formanowicz, Dorota/0000-0001-6691-3863; Zawierucha, Piotr/0000-0001-9087-3080	National Science Centre (Poland) [2012/07/6/ST6/01537]	National Science Centre (Poland)(National Science Centre, Poland)	This research has been supported by the National Science Centre (Poland) grant No. 2012/07/6/ST6/01537 (DF, MR, PF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balazki P, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0596-y; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Callapina M, 2005, FREE RADICAL BIO MED, V39, P925, DOI 10.1016/j.freeradbiomed.2005.05.009; Chowdhury R, 2011, J MOL BIOL, V410, P268, DOI 10.1016/j.jmb.2011.04.075; Cordero F, 2011, THEOR COMPUT SCI, V412, P6036, DOI 10.1016/j.tcs.2011.06.013; David R, 2010, DISCRETE, CONTINUOUS, AND HYBRID PETRI NETS, SECOND EDITION, P1, DOI 10.1007/978-3-642-10669-9; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Einloft J, 2013, BIOINFORMATICS, V29, P1469, DOI 10.1093/bioinformatics/btt165; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Formanowicz D, 2015, SCI REP-UK, V5, DOI 10.1038/srep18332; Formanowicz D, 2013, J BIOMED INFORM, V46, P1030, DOI 10.1016/j.jbi.2013.07.013; Formanowicz D, 2011, BIOPROC BIOSYST ENG, V34, P581, DOI 10.1007/s00449-010-0507-6; FORMANOWICZ P, 2011, BIOTECHNOLOGIA, V92, P217; Goligorsky MS, 1999, CLIN EXP PHARMACOL P, V26, P269, DOI 10.1046/j.1440-1681.1999.03029.x; Grafahrend-Belau E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-90; Stefanie G, 2008, BIOSYSTEMS, V92, P189, DOI 10.1016/j.biosystems.2008.02.005; Gu J, 2001, J BIOL CHEM, V276, P3550, DOI 10.1074/jbc.M009522200; Hashimoto T, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00033; Heiner M., 2012, LNCS, P398, DOI [DOI 10.1007/978-3-642-31131-4_22, DOI 10.1007/978-3-642-31131-422]; Heiner M, 2009, NAT COMPUT SER, P367, DOI 10.1007/978-3-540-88869-7_19; Hendrickson MD, 2015, RES REP BIOCHEM, V5, P147, DOI 10.2147/RRBC.S58280; Herrmann J, 2006, ARTERIOSCL THROM VAS, V26, P1948, DOI 10.1161/01.ATV.0000233387.90257.9b; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Iivanainen E, 2003, FASEB J, V17, P1609, DOI 10.1096/fj.02-0939com; Isenberg JS, 2005, P NATL ACAD SCI USA, V102, P13141, DOI 10.1073/pnas.0502977102; Jain A., 1988, ALGORITHMS CLUSTERIN; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019; Kaufman L., 1990, FINDING GROUPS DATA; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Klipp Edda, 2009, SYSTEMS BIOL TXB; Koch I, 2011, COMPUT BIOL SER, V16, P3, DOI 10.1007/978-1-84996-474-6_1; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Laemmle A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033433; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Matsuno H, 2006, IEICE T FUND ELECTR, VE89A, P3166, DOI 10.1093/ietfec/e89-a.11.3166; Moulton KS, 2006, CURR OPIN LIPIDOL, V17, P548, DOI 10.1097/01.mol.0000245261.71129.f0; MURATA T, 1989, P IEEE, V77, P541, DOI 10.1109/5.24143; Napione L, 2009, LECT N BIOINFORMAT, V5688, P281, DOI 10.1007/978-3-642-03845-7_19; Paik JY, 2005, J NUCL MED, V46, P365; Petri CA, 1962, COMMUNICATION, V3, P16; Raju Rajesh, 2014, J Signal Transduct, V2014, P962962, DOI 10.1155/2014/962962; Reisig W., 1985, PETRI NETS INTRO, DOI [10.1007/978-3-642-69968-9, DOI 10.1007/978-3-642-69968-9]; Reising W, 2013, UNDERSTANDING PETRI; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sackmann A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-482; Senger DR, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005090; Simon MP, 2008, J CELL PHYSIOL, V217, P809, DOI 10.1002/jcp.21558; Szallasi Z, 2006, SYST MOD CELL BIOL, DOI 10.7551/mitpress/9780262195485.001.0001.; Trane AE, 2014, J BIOL CHEM, V289, P13273, DOI 10.1074/jbc.M113.528695; Winder K., 2006, THESIS; Yasinska IM, 2003, FEBS LETT, V549, P105, DOI 10.1016/S0014-5793(03)00807-X	53	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173020	10.1371/journal.pone.0173020	http://dx.doi.org/10.1371/journal.pone.0173020			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253310	gold, Green Published, Green Submitted			2022-12-26	WOS:000396011300059
J	Jensen, JK; Wilkerson, CG				Jensen, Jacob Kruger; Wilkerson, Curtis Gene			Brachypodium as an experimental system for the study of stem parenchyma biology in grasses	PLOS ONE			English	Article							CARBOHYDRATE STORAGE; FLOWERING TIME; STARCH; WHEAT; MOBILIZATION; DEPOSITION; BARLEY; CULM; YIELD	Stem parenchyma is a major cell type that serves key metabolic functions for the plant especially in large grasses, such as sugarcane and sweet sorghum, where it serves to store sucrose or other products of photosynthesis. It is therefore desirable to understand the metabolism of this cell type as well as the mechanisms by which it provides its function for the rest of the plant. Ultimately, this information can be used to selectively manipulate this cell type in a controlled manner to achieve crop improvement. In this study, we show that Brachypodium distachyon is a useful model system for stem pith parenchyma biology. Brachypodium can be grown under condition where it resembles the growth patterns of important crops in that it produces large amounts of stem material with the lower leaves senescing and with significant stores of photosynthate located in the stem parenchyma cell types. We further characterize stem plastid morphology as a function of tissue types, as this organelle is central for a number of metabolic pathways, and quantify gene expression for the four main classes of starch biosynthetic genes. Notably, we find several of these genes differentially regulated between stem and leaf. These studies show, consistent with other grasses, that the stem functions as a specialized storage compartment in Brachypodium.	[Jensen, Jacob Kruger; Wilkerson, Curtis Gene] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Jensen, Jacob Kruger; Wilkerson, Curtis Gene] Michigan State Univ, DOE Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Wilkerson, Curtis Gene] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; United States Department of Energy (DOE); Michigan State University	Wilkerson, CG (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.; Wilkerson, CG (corresponding author), Michigan State Univ, DOE Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA.; Wilkerson, CG (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	wilker13@msu.edu		Jensen, Jacob K/0000-0003-0502-2383	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE))	This work was funded by the DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494; http://science.energy.gov/ber/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahaji A, 2014, BIOTECHNOL ADV, V32, P87, DOI 10.1016/j.biotechadv.2013.06.006; Blum A, 1998, EUPHYTICA, V100, P77, DOI 10.1023/A:1018303922482; Bonnett GD, 1992, ANN BOT; BORRELL AK, 1993, ANN BOT-LONDON, V71, P317, DOI 10.1006/anbo.1993.1041; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Cooper GM, 2000, CELL MOL APPROACH; Dockter C, 2015, J EXP BOT, V66, P3499, DOI 10.1093/jxb/eru521; Gale SY, 1985, PROGR PLANT BREEDING; McCormick AJ, 2009, J EXP BOT, V60, P357, DOI 10.1093/jxb/ern310; McKinley B, 2016, PLANT J; O'Neill BP, 2013, BIOSCI BIOTECH BIOCH, V77, P487, DOI 10.1271/bbb.120682; Ream TS, 2014, PLANT PHYSIOL, V164, P694, DOI 10.1104/pp.113.232678; Rooney WL, 2007, BIOFUEL BIOPROD BIOR, V1, P147, DOI 10.1002/bbb.15; Roulin S, 2002, PLANTA, V215, P51, DOI 10.1007/s00425-001-0721-1; SCHNYDER H, 1993, NEW PHYTOL, V123, P233, DOI 10.1111/j.1469-8137.1993.tb03731.x; Schwartz CJ, 2010, BIOENERG RES, V3, P38, DOI 10.1007/s12155-009-9069-3; Scofield GN, 2009, ANN BOT-LONDON, V103, P859, DOI 10.1093/aob/mcp010; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; STARK DM, 1992, SCIENCE, V258, P287, DOI 10.1126/science.258.5080.287; Streb Sebastian, 2012, Arabidopsis Book, V10, pe0160, DOI 10.1199/tab.0160; Tanackovic V, 2014, J EXP BOT, V65, P5179, DOI 10.1093/jxb/eru276; Tuncel A, 2013, PLANT SCI, V211, P52, DOI 10.1016/j.plantsci.2013.06.009; Turner SR, 1997, PLANT CELL, V9, P689, DOI 10.1105/tpc.9.5.689; Tyler L, 2016, PLANT GENOME, V9, P2; Vain P, 2008, PLANT BIOTECHNOL J, V6, P236, DOI 10.1111/j.1467-7652.2007.00308.x; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-88; WARDLAW IF, 1994, AUST J PLANT PHYSIOL, V21, P255, DOI 10.1071/PP9940255; Watt D.A., 2013, SUGARCANE PHYSL BIOC, P483, DOI DOI 10.1002/9781118771280.CH18; Wu LG, 2007, PLANT BIOTECHNOL J, V5, P109, DOI 10.1111/j.1467-7652.2006.00224.x; Xue GP, 2011, PLANT J, V68, P857, DOI 10.1111/j.1365-313X.2011.04737.x	32	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173095	10.1371/journal.pone.0173095	http://dx.doi.org/10.1371/journal.pone.0173095			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248997	gold, Green Published, Green Submitted			2022-12-26	WOS:000395983500074
J	Martin, R; Cordova, C; Gutierrez, B; Hernandez, M; Nieto, ML				Martin, Ruben; Cordova, Claudia; Gutierrez, Beatriz; Hernandez, Marita; Nieto, Maria L.			A dangerous liaison: Leptin and sPLA2-IIA join forces to induce proliferation and migration of astrocytoma cells	PLOS ONE			English	Article							SECRETORY PHOSPHOLIPASE A(2); GROWTH-FACTOR RECEPTOR; ESOPHAGEAL ADENOCARCINOMA CELLS; TYPE-2 DIABETES-MELLITUS; PANCREATIC BETA-CELLS; BREAST-CANCER CELLS; PROTEIN PHOSPHATASE; ALZHEIMERS-DISEASE; SIGNALING PATHWAY; BODY-WEIGHT	Glioblastoma, the most aggressive type of primary brain tumour, shows worse prognosis linked to diabetes or obesity persistence. These pathologies are chronic inflammatory conditions characterized by altered profiles of inflammatory mediators, including leptin and secreted phospholipase A(2)-IIA (sPLA(2)-IIA). Both proteins, in turn, display diverse pro-cancer properties in different cell types, including astrocytes. Herein, to understand the underlying relationship between obesity and brain tumors, we investigated the effect of leptin, alone or in combination with sPLA(2)-IIA on astrocytoma cell functions. sPLA(2)-IIA induced up-regulation of leptin receptors in 1321N1 human astrocytoma cells. Leptin, as well as sPLA(2)-IIA, increased growth and migration in these cells, through activation/phosphorylation of key proteins of survival cascades. Leptin, at concentrations with minimal or no activating effects on astrocytoma cells, enhanced growth and migration promoted by low doses of sPLA(2)-IIA. sPLA(2)-IIA alone induced a transient phosphorylation pattern in the Src/ERK/Akt/mTOR/p70S6K/rS6 pathway through EGFR transactivation, and co-addition of leptin resulted in a sustained phosphorylation of these signaling regulators. Mechanistically, EGFR transactivation and tyrosine-and serine/threonine-protein phosphatases revealed a key role in this leptin-sPLA(2)-IIA cross-talk. This cooperative partnership between both proteins was also found in primary astrocytes. These findings thus indicate that the adipokine leptin, by increasing the susceptibility of cells to inflammatory mediators, could contribute to worsen the prognosis of tumoral and neurodegenerative processes, being a potential mediator of some obesity- related medical complications.	[Martin, Ruben; Cordova, Claudia; Gutierrez, Beatriz; Hernandez, Marita; Nieto, Maria L.] UVa, CSIC, IBGM, Valladolid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM)	Nieto, ML (corresponding author), UVa, CSIC, IBGM, Valladolid, Spain.	mlnieto@ibgm.uva.es	Nieto, Maria L/G-7492-2015; hernández, marita/H-6122-2015	Nieto, Maria L/0000-0001-6842-799X; hernández, marita/0000-0002-3999-5653; Cordova Marcos, Claudia/0000-0002-2108-2629	FPI Program from the Autonomous Government of Castilla y Leon; FSE; Spanish Ministry of Science and Innovation [SAF2009-08407, SAF2016-81063]	FPI Program from the Autonomous Government of Castilla y Leon; FSE(European Social Fund (ESF)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the FPI Program from the Autonomous Government of Castilla y Leon (to RM and CC) co-funded by FSE, and by the Spanish Ministry of Science and Innovation (grant SAF2009-08407 and SAF2016-81063).	Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824; Beales ILP, 2007, MOL CELL ENDOCRINOL, V274, P60, DOI 10.1016/j.mce.2007.05.017; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Chambless LB, 2012, J NEURO-ONCOL, V106, P383, DOI 10.1007/s11060-011-0676-4; de Lartigue G, 2010, ENDOCRINOLOGY, V151, P3589, DOI 10.1210/en.2010-0106; Dong ZY, 2010, CARCINOGENESIS, V31, P1948, DOI 10.1093/carcin/bgq188; Eikelis N, 2004, AM J PHYSIOL-ENDOC M, V286, pE744, DOI 10.1152/ajpendo.00489.2003; Esler M, 1998, LANCET, V351, P879, DOI 10.1016/S0140-6736(05)70289-0; Ferla R, 2012, ONCOL LETT, V4, P1077, DOI 10.3892/ol.2012.843; Fiorio E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-305; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Gouwy M, 2004, J LEUKOCYTE BIOL, V76, P185, DOI 10.1189/jlb.1003479; Gouwy M, 2002, MOL PHARMACOL, V62, P173, DOI 10.1124/mol.62.1.173; Han GS, 2012, BRAIN RES BULL, V87, P274, DOI 10.1016/j.brainresbull.2011.11.007; Haydon AMM, 2006, GUT, V55, P62, DOI 10.1136/gut.2005.068189; Heldsinger A, 2011, J BIOL CHEM, V286, P11707, DOI 10.1074/jbc.M110.198945; Hernandez M, 1998, J BIOL CHEM, V273, P606, DOI 10.1074/jbc.273.1.606; Hernandez M, 2010, NEURO-ONCOLOGY, V12, P1014, DOI 10.1093/neuonc/noq078; Howe LR, 2013, CLIN CANCER RES, V19, P6074, DOI 10.1158/1078-0432.CCR-12-2603; Iwamoto N, 2007, J BIOL CHEM, V282, P33396, DOI 10.1074/jbc.M705224200; Konukoglu D, 2007, OBES SURG, V17, P672, DOI 10.1007/s11695-007-9113-3; Kuehnen P, 2011, ENDOCRINOLOGY, V152, P1800, DOI 10.1210/en.2010-1094; Kupert E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-513; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Liu JC, 2009, MOL PHARMACOL, V76, P1186, DOI 10.1124/mol.109.058297; Tusell JM, 2009, GLIA, V57, P524, DOI 10.1002/glia.20781; Menschikowski M, 2013, PATHOL ONCOL RES, V19, P839, DOI 10.1007/s12253-013-9652-y; Moses GSD, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-28; Naderali EK, 2009, AM J ALZHEIMERS DIS, V24, P445, DOI 10.1177/1533317509348208; Newman G, 2014, MOL CELL ENDOCRINOL, V382, P570, DOI 10.1016/j.mce.2013.03.025; Ning K, 2006, EMBO J, V25, P2377, DOI 10.1038/sj.emboj.7601118; Ogunwobi OO, 2008, BRIT J BIOMED SCI, V65, P121, DOI 10.1080/09674845.2008.11732814; Otero M, 2005, ARTHRITIS RES THER, V7, pR581, DOI 10.1186/ar1708; Otero M, 2007, LIFE SCI, V81, P1452, DOI 10.1016/j.lfs.2007.09.007; Quach ND, 2014, BIOCHEM PHARMACOL, V90, P338, DOI 10.1016/j.bcp.2014.05.022; Riolfi M, 2010, BRAIN PATHOL, V20, P481, DOI 10.1111/j.1750-3639.2009.00323.x; Saxena NK, 2008, CANCER RES, V68, P9712, DOI 10.1158/0008-5472.CAN-08-1952; Soma D, 2008, J SURG RES, V149, P9, DOI 10.1016/j.jss.2007.10.012; SOZZANI S, 1994, BIOCHEM BIOPH RES CO, V199, P761, DOI 10.1006/bbrc.1994.1294; Umemoto Y, 1997, BLOOD, V90, P3438, DOI 10.1182/blood.V90.9.3438; van Greevenbroek MMJ, 2013, NETH J MED, V71, P174; Wang L, 2011, BONE, V48, P1022, DOI 10.1016/j.bone.2011.02.012; Wang X, 2013, HUM PATHOL, V44, P2020, DOI 10.1016/j.humpath.2013.01.027; Wang ZQ, 2002, J BIOL CHEM, V277, P19470, DOI 10.1074/jbc.M201097200; Yagami T, 2014, MOL NEUROBIOL, V49, P863, DOI 10.1007/s12035-013-8565-9; Yeh WL, 2009, GLIA, V57, P454, DOI 10.1002/glia.20773	51	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0170675	10.1371/journal.pone.0170675	http://dx.doi.org/10.1371/journal.pone.0170675			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249041	Green Submitted, Green Published, gold			2022-12-26	WOS:000395983500006
J	Poffenbarger, HJ; Barker, DW; Helmers, MJ; Miguez, FE; Olk, DC; Sawyer, JE; Six, J; Castellano, MJ				Poffenbarger, Hanna J.; Barker, Daniel W.; Helmers, Matthew J.; Miguez, Fernando E.; Olk, Daniel C.; Sawyer, John E.; Six, Johan; Castellano, Michael J.			Maximum soil organic carbon storage in Midwest US cropping systems when crops are optimally nitrogen-fertilized	PLOS ONE			English	Article							RESIDUE DECOMPOSITION; CEREAL PRODUCTION; GLOBAL DILEMMA; NO-TILLAGE; CORN; MATTER; QUALITY; STABILIZATION; MANAGEMENT; DYNAMICS	Nitrogen fertilization is critical to optimize short-term crop yield, but its long-term effect on soil organic C (SOC) is uncertain. Here, we clarify the impact of N fertilization on SOC in typical maize-based (Zea mays L.) Midwest U.S. cropping systems by accounting for site-to-site variability in maize yield response to N fertilization. Within continuous maize and maize-soybean [Glycine max (L.) Merr.] systems at four Iowa locations, we evaluated changes in surface SOC over 14 to 16 years across a range of N fertilizer rates empirically determined to be insufficient, optimum, or excessive for maximum maize yield. Soil organic C balances were negative where no N was applied but neutral (maize-soybean) or positive (continuous maize) at the agronomic optimum N rate (AONR). For continuous maize, the rate of SOC storage increased with increasing N rate, reaching a maximum at the AONR and decreasing above the AONR. Greater SOC storage in the optimally fertilized continuous maize system than in the optimally fertilized maize-soybean system was attributed to greater crop residue production and greater SOC storage efficiency in the continuous maize system. Mean annual crop residue production at the AONR was 22% greater in the continuous maize system than in the maize-soybean system and the rate of SOC storage per unit residue C input was 58% greater in the monocrop system. Our results demonstrate that agronomic optimum N fertilization is critical to maintain or increase SOC of Midwest U.S. cropland.	[Poffenbarger, Hanna J.; Barker, Daniel W.; Miguez, Fernando E.; Sawyer, John E.; Castellano, Michael J.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Helmers, Matthew J.] Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA USA; [Olk, Daniel C.] USDA ARS, Natl Lab Agr & Environm, Ames, IA USA; [Six, Johan] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland	Iowa State University; Iowa State University; United States Department of Agriculture (USDA)	Poffenbarger, HJ (corresponding author), Iowa State Univ, Dept Agron, Ames, IA 50011 USA.	hpoffenb@iastate.edu	six, johan/J-5228-2015; Castellano, Michael J/A-9687-2008	six, johan/0000-0001-9336-4185; Castellano, Michael J/0000-0003-1411-7931	United States Department of Agriculture National Institute of Food and Agriculture [2014-67019-21629]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This study was funded by the United States Department of Agriculture National Institute of Food and Agriculture grant number 2014-67019-21629 to MJC, DCO, JES and JS, https://nifa.usda.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, NAT COORD MAJ LAND R; Barrett JE, 2002, ECOL APPL, V12, P878, DOI 10.1890/1051-0761(2002)012[0878:NRISEA]2.0.CO;2; BEARE MH, 1994, SOIL SCI SOC AM J, V58, P777, DOI 10.2136/sssaj1994.03615995005800030020x; Brown KH, 2014, GLOBAL CHANGE BIOL, V20, P1339, DOI 10.1111/gcb.12519; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Castellano MJ, 2015, GLOBAL CHANGE BIOL, V21, P3200, DOI 10.1111/gcb.12982; CERRATO ME, 1990, AGRON J, V82, P138, DOI 10.2134/agronj1990.00021962008200010030x; Chivenge P, 2011, AGR ECOSYST ENVIRON, V140, P361, DOI 10.1016/j.agee.2010.12.004; Clapp CE, 2000, SOIL TILL RES, V55, P127, DOI 10.1016/S0167-1987(00)00110-0; COLE CV, 1993, WATER AIR SOIL POLL, V70, P357, DOI 10.1007/BF01105007; David MB, 2009, J ENVIRON QUAL, V38, P200, DOI 10.2134/jeq2008.0132; Fonte SJ, 2009, SOIL SCI SOC AM J, V73, P961, DOI 10.2136/sssaj2008.0204; Gardner JB, 2009, ECOL APPL, V19, P2167, DOI 10.1890/08-1122.1; GREEN CJ, 1995, SOIL SCI SOC AM J, V59, P1065, DOI 10.2136/sssaj1995.03615995005900040016x; GREEN CJ, 1995, SOIL SCI SOC AM J, V59, P453, DOI 10.2136/sssaj1995.03615995005900020026x; Gregorich EG, 1996, SOIL SCI SOC AM J, V60, P472, DOI 10.2136/sssaj1996.03615995006000020019x; Gregorich EG, 2001, CAN J SOIL SCI, V81, P21, DOI 10.4141/S00-041; Hoben JP, 2011, GLOBAL CHANGE BIOL, V17, P1140, DOI 10.1111/j.1365-2486.2010.02349.x; Hong N, 2007, J ENVIRON QUAL, V36, P354, DOI 10.2134/jeq2006.0173; HUDSON BD, 1994, J SOIL WATER CONSERV, V49, P189; Huggins DR, 2007, SOIL SCI SOC AM J, V71, P145, DOI 10.2136/sssaj2005.0231; Iowa State University, 2016, IOW ENV MES; Johnson JMF, 2006, AGRON J, V98, P622, DOI 10.2134/agronj2005.0179; KASPAR TC, 1990, SOIL SCI SOC AM J, V54, P1112, DOI 10.2136/sssaj1990.03615995005400040032x; Khan SA, 2007, J ENVIRON QUAL, V36, P1821, DOI 10.2134/jeq2007.0099; Kong AYY, 2005, SOIL SCI SOC AM J, V69, P1078, DOI 10.2136/sssaj2004.0215; Lawlor PA, 2008, T ASABE, V51, P83, DOI 10.13031/2013.24229; Lorenz AJ, 2010, CROP SCI, V50, P1, DOI 10.2135/cropsci2009.02.0086; Mulvaney RL, 2009, J ENVIRON QUAL, V38, P2295, DOI 10.2134/jeq2008.0527; National Agricultural Statistics Service, 2015, QUICK STATS DAT; Nehring R, 2013, FERTILIZER USE PRICE; Nieder R, 2011, BIOL FERT SOILS, V47, P1, DOI 10.1007/s00374-010-0506-4; Olson KR, 2005, SOIL TILL RES, V81, P217, DOI 10.1016/j.still.2004.09.009; PARTON WJ, 1987, SOIL SCI SOC AM J, V51, P1173, DOI 10.2136/sssaj1987.03615995005100050015x; Paul EA, 2016, SOIL BIOL BIOCHEM, V98, P109, DOI 10.1016/j.soilbio.2016.04.001; Powlson DS, 2010, J ENVIRON QUAL, V39, P749, DOI 10.2134/jeq2010.0001le; Prince SD, 2001, ECOL APPL, V11, P1194, DOI 10.1890/1051-0761(2001)011[1194:NPPOUS]2.0.CO;2; PRISM Climate, 2016, 1981 2010 CLIM NORM; Puntel LA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01630; Robertson GP, 2013, BIOGEOCHEMISTRY, V114, P41, DOI 10.1007/s10533-012-9802-4; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Russell AE, 2009, ECOL APPL, V19, P1102, DOI 10.1890/07-1919.1; Sanford GR, 2012, AGR ECOSYST ENVIRON, V162, P68, DOI 10.1016/j.agee.2012.08.011; Sawyer J.E., 2006, CONCEPTS RATIONALE R; Schlesinger WH, 2000, AGR ECOSYST ENVIRON, V82, P121, DOI 10.1016/S0167-8809(00)00221-8; Stevens WB, 2005, AGRON J, V97, P1046, DOI 10.2134/agronj2003.0313; Strickland MS, 2010, SOIL BIOL BIOCHEM, V42, P1385, DOI 10.1016/j.soilbio.2010.05.007; U.S. Environmental Protection Agency, 2014, INV US GREENH GAS EM; U. S. Soil Survey, 1998, MOLL MAP; Van Groenigen JW, 2010, EUR J SOIL SCI, V61, P903, DOI 10.1111/j.1365-2389.2009.01217.x; Varvel GE, 2006, SOIL SCI SOC AM J, V70, P426, DOI 10.2136/sssaj2005.0100; Weil RR, 2004, ADV AGROECOL, P1; Williams CL, 2008, CROP SCI, V48, P1545, DOI 10.2135/cropsci2006.12.0837; Zhao X, 2016, FIELD CROP RES, V199, P156, DOI 10.1016/j.fcr.2016.07.015	54	83	84	10	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172293	10.1371/journal.pone.0172293	http://dx.doi.org/10.1371/journal.pone.0172293			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249014	Green Published, Green Submitted, gold			2022-12-26	WOS:000395983500035
J	Garcia-Gutierrez, V; Gomez-Casares, MT; Puerta, JM; Alonso-Dominguez, JM; Osorio, S; Hernandez-Boiuda, JC; Collado, R; Ramirez, MJ; Ibanez, F; Martin, ML; Rodriguez-Gambarte, JD; Martinez-Laperche, C; Gomez, M; Fiallo, DV; Redondo, S; Rodriguez, A; Ruiz-Nuno, C; Steegmann, JL; Jimenez-Velasco, A				Garcia-Gutierrez, Valentin; Gomez-Casares, Maria T.; Puerta, Jose M.; Alonso-Dominguez, Juan M.; Osorio, Santiago; Hernandez-Boiuda, Juan C.; Collado, Rosa; Ramirez, Maria J.; Ibanez, Fatima; Martin, Maria L.; Rodriguez-Gambarte, Juan D.; Martinez-Laperche, Carolina; Gomez, Montse; Fiallo, Dolly V.; Redondo, Sara; Rodriguez, Alicia; Ruiz-Nuno, Concepcion; Steegmann, Juan L.; Jimenez-Velasco, Antonio		Spanish Grp Chronic Myeloid	A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia	PLOS ONE			English	Article							MOLECULAR RESPONSE; FOLLOW-UP; IMATINIB; GUIDELINES; NILOTINIB; ASSAY; STANDARDIZATION; PERFORMANCE; SURVIVAL; OUTCOMES	In chronic myeloid leukemia (CML) patients, 3-month BCR-ABL1 levels have consistently been correlated with further outcomes. Monitoring molecular responses in CML using the GeneXpert (Cepheid) platform has shown an optimal correlation with standardized RQ-PCR (IS) when measuring BCR-ABL1 levels lower than 10%, as it is not accurate for values over 10%. The aim of the present study was to determine the predictive molecular value at three months on different outcome variables using the Xpert BCR-ABL1 Monitor (TM) assay (Xpert BCR-ABL1). We monitored 125 newly diagnosed consecutive CML patients in the chronic phase (CML-CP) using an automated method: Xpert BCR-ABL1. Only 5% of patients did not achieve an optimal response at 3 months, and the 10% BCR-ABL1 cutoff defined by RQ-PCR (IS) methods was unable to identify significant differences in the probabilities of achieving a complete cytogenetic response (CCyR) (50% vs. 87%, p = 0.1) or a major molecular response (MMR) (60% vs. 80%, p = 0.29) by 12 months. In contrast, a cutoff of 1.5% more accurately identified differences in the probabilities of achieving CCyR (98% vs. 54%, p< 0.001) and MMR (88% vs. 56%, p< 0.001) by 12 months, as well as probabilities of treatment changes (p = 0.005). Therefore, when using the Xpert BCR-ABL1 assay, a cutoff of 1.5% at 3 months could with high probability identify patients able to achieve an optimal response at 12 months.	[Garcia-Gutierrez, Valentin; Rodriguez-Gambarte, Juan D.] Hosp Univ Ramon y Cajal, Dept Hematol, Madrid, Spain; [Gomez-Casares, Maria T.; Fiallo, Dolly V.] Hosp Univ Doctor Negrin, Dept Hematol, Las Palmas Gran Canaria, Spain; [Puerta, Jose M.] Hosp Univ Virgen de las Nieves, Unidad Gest Clin Hematol & Hemoterapia, Granada, Spain; [Alonso-Dominguez, Juan M.] Univ Hosp, Fdn Jimenez Diaz, Madrid, Spain; [Osorio, Santiago; Martinez-Laperche, Carolina; Redondo, Sara] Hosp Univ Gregorio Maranon, Dept Hematol, Madrid, Spain; [Hernandez-Boiuda, Juan C.; Gomez, Montse] Hosp Clin, Dept Hematol, Valencia, Spain; [Collado, Rosa] Consorcio Hosp Gen Univ, Dept Hematol, Genet Lab, Valencia, Spain; [Ramirez, Maria J.] Hosp Jerez de la Frontera, Dept Hematol, Cadiz, Spain; [Ibanez, Fatima] Hosp San Pedro de Alcantara, Dept Hematol, Caceres, Spain; [Martin, Maria L.; Rodriguez, Alicia] Hosp Univ Virgen Macarena, Dept Hematol, Seville, Spain; [Ruiz-Nuno, Concepcion; Jimenez-Velasco, Antonio] Hosp Reg Univ Malaga, IBIMA, Dept Hematol, Malaga, Spain; [Steegmann, Juan L.] Hosp Univ Princesa, Dept Hematol, Madrid, Spain; [Steegmann, Juan L.] Hosp Univ Princesa, IIS IP, Madrid, Spain	Hospital Universitario Ramon y Cajal; Hospital Universitario Virgen de las Nieves; Fundacion Jimenez Diaz; General University Gregorio Maranon Hospital; Hospital Universitario Virgen Macarena; Universidad de Malaga; Hospital de La Princesa	Jimenez-Velasco, A (corresponding author), Hosp Reg Univ Malaga, IBIMA, Dept Hematol, Malaga, Spain.	a.jimenez.velasco@gmail.com	osorio, santiago/AAY-4337-2020; Collado Nieto, Rosa María/GZK-9557-2022; CASARES, MARIA TERESA GOMEZ/R-6060-2018; Martinez-Laperche, Carolina/G-8664-2013	CASARES, MARIA TERESA GOMEZ/0000-0003-0505-5126; Collado, Rosa/0000-0002-8205-6192; Fiallo Suarez, Dolly Viviana/0000-0002-2901-9405; Hernandez-Boluda, Juan Carlos/0000-0002-4289-3113; Rodriguez-Fernandez, Alicia/0000-0001-5999-7288; Martinez-Laperche, Carolina/0000-0001-6802-3485; Garcia, Valentin/0000-0003-4752-0815; Alonso-Dominguez, Juan Manuel/0000-0001-6233-5912	Asociacion Malaguena para la Investigacion en Leucemia (AMPILE)	Asociacion Malaguena para la Investigacion en Leucemia (AMPILE)	This work was partially supported by grants from the Asociacion Malaguena para la Investigacion en Leucemia (AMPILE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by grants from the Asociacion Malaguena para la Investigacion en Leucemia (AMPILE).	Baccarani M, 2012, ANN ONCOL, V23, P72, DOI 10.1093/annonc/mds228; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Branford S, 2008, BLOOD, V112, P3330, DOI 10.1182/blood-2008-04-150680; Branford S, 2012, J CLIN ONCOL, V30, P4323, DOI 10.1200/JCO.2011.40.5217; Brummendorf TH, 2015, BRIT J HAEMATOL, V168, P69, DOI 10.1111/bjh.13108; Cayuela JM, 2011, HAEMATOL-HEMATOL J, V96, P664, DOI 10.3324/haematol.2010.034389; Cross NCP, 2012, LEUKEMIA, V26, P2172, DOI 10.1038/leu.2012.104; Dufresne SD, 2007, ARCH PATHOL LAB MED, V131, P947; Enjeti A, 2015, PATHOLOGY, V47, P570, DOI 10.1097/PAT.0000000000000293; Foroni L, 2011, BRIT J HAEMATOL, V153, P179, DOI 10.1111/j.1365-2141.2011.08603.x; Hanfstein B, 2012, LEUKEMIA, V26, P2096, DOI 10.1038/leu.2012.85; Hughes TP, 2014, BLOOD, V123, P1353, DOI 10.1182/blood-2013-06-510396; Jabbour E, 2014, BLOOD, V123, P494, DOI 10.1182/blood-2013-06-511592; Jain P, 2013, BLOOD, V121, P4867, DOI 10.1182/blood-2013-03-490128; Lopez-Jorge CE, 2012, ANN HEMATOL, V91, P1245, DOI 10.1007/s00277-012-1468-4; McNiven M, 2012, PATHOLOGY, V44, P55, DOI 10.1097/PAT.0b013e32834e4203; O'Brien S, 2013, J NATL COMPR CANC NE, V11, P1327, DOI 10.6004/jnccn.2013.0157; O'Dwyer ME, 2014, LEUKEMIA RES, V38, P310, DOI 10.1016/j.leukres.2013.11.016; Pearson E, 2016, LEUKEMIA RES, V43, P1, DOI 10.1016/j.leukres.2016.02.001; Pfirrmann M, 2016, LEUKEMIA, V30, P48, DOI 10.1038/leu.2015.261	20	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173532	10.1371/journal.pone.0173532	http://dx.doi.org/10.1371/journal.pone.0173532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278193	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900008
J	Jiang, TT; Shi, LY; Wei, LL; Li, X; Yang, S; Wang, C; Liu, CM; Chen, ZL; Tu, HH; Li, ZJ; Li, JC				Jiang, Ting-Ting; Shi, Li-Ying; Wei, Li-Liang; Li, Xiang; Yang, Su; Wang, Chong; Liu, Chang-Ming; Chen, Zhong-Liang; Tu, Hui-Hui; Li, Zhong-Jie; Li, Ji-Cheng			Serum amyloid A, protein Z, and C4b-binding protein beta chain as new potential biomarkers for pulmonary tuberculosis	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR; ACUTE-PHASE RESPONSE; C-REACTIVE PROTEIN; ANTICOAGULANT PROTEIN; DIAGNOSTIC BIOMARKERS; PROTEOMIC SIGNATURE; VENOUS THROMBOSIS; ISCHEMIC-STROKE; TISSUE FACTOR; IDENTIFICATION	The aim of this study was to discover novel biomarkers for pulmonary tuberculosis (TB). Differentially expressed proteins in the serum of patients with TB were screened and identified by iTRAQ-two dimensional liquid chromatography tandem mass spectrometry analysis. A total of 79 abnormal proteins were discovered in patients with TB compared with healthy controls. Of these, significant differences were observed in 47 abnormally expressed proteins between patients with TB or pneumonia and chronic obstructive pulmonary disease (COPD). Patients with TB (n = 136) exhibited significantly higher levels of serum amyloid A (SAA), vitamin K-dependent protein Z (PROZ), and C4b-binding protein beta chain (C4BPB) than those in healthy controls (n = 66) (P<0.0001 for each) albeit significantly lower levels compared with those in patients with pneumonia (n = 72) (P<0.0001 for each) or COPD (n = 72) (P<0.0001, P<0.0001, P = 0.0016, respectively). After 6 months of treatment, the levels of SAA and PROZ were significantly increased (P = 0.022, P<0.0001, respectively), whereas the level of C4BPB was significantly decreased (P = 0.0038) in treated TB cases (n = 72). Clinical analysis showed that there were significant differences in blood clotting and lipid indices in patients with TB compared with healthy controls, patients with pneumonia or COPD, and treated TB cases (P<0.05). Correlation analysis revealed significant correlations between PROZ and INR (rs = 0.414, P = 0.044), and between C4BPB and FIB (rs = 0.617, P = 0.0002) in patients with TB. Receiver operating characteristic curve analysis revealed that the area under the curve value of the diagnostic model combining SAA, PROZ, and C4BPB to discriminate the TB group from the healthy control, pneumonia, COPD, and cured TB groups was 0.972, 0.928, 0.957, and 0.969, respectively. Together, these results suggested that SAA, PROZ, and C4BPB may serve as new potential biomarkers for TB. Our study may thus provide experimental data for the differential diagnosis of TB.	[Jiang, Ting-Ting; Li, Ji-Cheng] South China Univ Technol, Sch Med, Guangzhou, Guangdong, Peoples R China; [Shi, Li-Ying] Zhejiang Hosp, Dept Clin Lab, Hangzhou, Zhejiang, Peoples R China; [Wei, Li-Liang] Shaoxing Municipal Hosp, Dept Pneumol, Shaoxing, Peoples R China; [Li, Xiang] Zhejiang Prov Peoples Hosp, Key Lab Gastroenteropathy, Hangzhou, Zhejiang, Peoples R China; [Yang, Su; Wang, Chong; Liu, Chang-Ming; Chen, Zhong-Liang; Tu, Hui-Hui; Li, Zhong-Jie; Li, Ji-Cheng] Zhejiang Univ, Inst Cell Biol, Hangzhou, Zhejiang, Peoples R China	South China University of Technology; Zhejiang Provincial People's Hospital; Zhejiang University	Li, JC (corresponding author), South China Univ Technol, Sch Med, Guangzhou, Guangdong, Peoples R China.; Li, JC (corresponding author), Zhejiang Univ, Inst Cell Biol, Hangzhou, Zhejiang, Peoples R China.	lijichen@zju.edu.cn	Yang, Su/GWQ-4862-2022		National Basic Research Program of China [2014CB543002]; National Natural Science Foundation of China [81573709, 81273882]; scientific research fund project of South China University of Technology School of Medicine [yxy2016006]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); scientific research fund project of South China University of Technology School of Medicine	This work was supported by grants from National Basic Research Program of China (No.2014CB543002, Zhejiang University, received by JCL), National Natural Science Foundation of China (No.81573709, No.81273882, Zhejiang University, received by JCL), and scientific research fund project of South China University of Technology School of Medicine (NO. yxy2016006, South China University of Technology School of Medicine, received by TTJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Almawi WY, 2013, REPRODUCTION, V146, pR73, DOI 10.1530/REP-13-0072; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; Broze GJ, 2001, THROMB HAEMOSTASIS, V86, P8; Buil A, 2010, BLOOD, V115, P4644, DOI 10.1182/blood-2010-01-263038; Carlsson S, 2010, J BIOL CHEM, V285, P32038, DOI 10.1074/jbc.M110.148452; Cordovilla R, 2016, ARCH BRONCONEUMOL, V52, P368, DOI 10.1016/j.arbres.2015.12.002; DE FRUTOS PG, 1994, BLOOD, V84, P815; Deguchi H, 2013, THROMB HAEMOSTASIS, V109, P358, DOI 10.1160/TH12-10-0722; Emuakhagbon V, 2016, AM J SURG, V211, P768, DOI 10.1016/j.amjsurg.2015.11.028; Fujita M, 1997, INTERNAL MED, V36, P218, DOI 10.2169/internalmedicine.36.218; Golub JE, 2006, INT J TUBERC LUNG D, V10, P24; GRIFFIN JH, 1992, BLOOD, V79, P3203; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; Havey TC, 2012, AM J TROP MED HYG, V86, P264, DOI 10.4269/ajtmh.2012.11-0598; Huang X, 2012, BLOOD, V120, P1726, DOI 10.1182/blood-2012-03-419598; Jin GZ, 2011, J PROTEOME RES, V10, P3418, DOI 10.1021/pr200482t; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Kager LM, 2015, J INFECTION, V70, P324, DOI 10.1016/j.jinf.2014.10.006; Kishiwada M, 2008, J THROMB HAEMOST, V6, P1858, DOI 10.1111/j.1538-7836.2008.03129.x; Kobelt K, 2001, BRIT J HAEMATOL, V114, P169, DOI 10.1046/j.1365-2141.2001.02913.x; KOEDAM JA, 1988, J CLIN INVEST, V82, P1236, DOI 10.1172/JCI113721; Kothari H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114141; Kothari H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045700; Lange C, 2009, EUR RESPIR J, V33, P1250, DOI 10.1183/09031936.00019709; Lange C, 2010, RESPIROLOGY, V15, P220, DOI 10.1111/j.1440-1843.2009.01692.x; Lannergard A, 2009, SCAND J INFECT DIS, V41, P663, DOI 10.1080/00365540903127417; Liu JY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-506; Lwaleed BA, 2006, J PATHOL, V208, P327, DOI 10.1002/path.1871; Maurissen LFA, 2008, BLOOD, V111, P3034, DOI 10.1182/blood-2007-06-089987; McQuillan AM, 2003, STROKE, V34, P2415, DOI 10.1161/01.STR.0000092124.52084.4B; Nilsen MM, 2011, J PROTEOMICS, V74, P2995, DOI 10.1016/j.jprot.2011.06.027; Olivar R, 2013, J IMMUNOL, V190, P2857, DOI 10.4049/jimmunol.1200503; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Robson SC, 1996, BRIT J HAEMATOL, V93, P943, DOI 10.1046/j.1365-2141.1996.d01-1722.x; Rodriguez-Flores E, 2012, TUBERCULOSIS, V92, P497, DOI 10.1016/j.tube.2012.07.002; Sakamoto K, 2010, INFECT IMMUN, V78, P1004, DOI 10.1128/IAI.00451-09; Sanchez-Pernaute O, 2006, ANN RHEUM DIS, V65, P1279, DOI 10.1136/ard.2006.052118; Shah M, 2014, CURR OPIN INFECT DIS, V27, P403, DOI 10.1097/QCO.0000000000000090; Sharma R, 2015, J PROTEOME RES, V14, P2466, DOI 10.1021/pr501324n; Sierko E, 2012, THROMB RES, V129, pE112, DOI 10.1016/j.thromres.2011.10.027; Silva DR, 2012, COPD, V9, P426, DOI 10.3109/15412555.2012.683840; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Technical Guidance Group of the Fifth National TB Epidemiological Survey, 2012, CHINESE J ANTITUBERC, V34, P485; Turken O, 2002, INT J TUBERC LUNG D, V6, P927; Violi F, 2014, J THROMB HAEMOST, V12, P1391, DOI 10.1111/jth.12646; Wang C, 2016, INT J BIOL SCI, V12, P246, DOI 10.7150/ijbs.13805; Wang C, 2015, SCI REP-UK, V5, DOI 10.1038/srep15615; Wang C, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-52; Wei DH, 2016, J PROTEOME RES, V15, P487, DOI 10.1021/acs.jproteome.5b00838; Xu DD, 2015, PROTEOMICS, V15, P58, DOI 10.1002/pmic.201400366; Xu Y, 2014, INT J CLIN EXP PATHO, V7, P5569; Yang Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158611; Zha C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122322; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081076; Zhao Y, 2007, ARTERIOSCL THROM VAS, V27, P1645, DOI 10.1161/ATVBAHA.106.137455	57	26	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173304	10.1371/journal.pone.0173304	http://dx.doi.org/10.1371/journal.pone.0173304			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278182	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900070
J	Herrington, WG; Smith, M; Bankhead, C; Matsushita, K; Stevens, S; Holt, T; Hobbs, FDR; Coresh, J; Woodward, M				Herrington, William G.; Smith, Margaret; Bankhead, Clare; Matsushita, Kunihiro; Stevens, Sarah; Holt, Tim; Hobbs, F. D. Richard; Coresh, Josef; Woodward, Mark			Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England	PLOS ONE			English	Article							OBESITY-RELATED GLOMERULOPATHY; STAGE RENAL-DISEASE; LIFE-STYLE; BLOOD-PRESSURE; HYPERFILTRATION; ASSOCIATIONS; POPULATION; MORTALITY; EVENTS; COST	Background It is uncertain whether being overweight, but not obese, is associated with advanced chronic kidney disease (CKD) and how the size and shape of associations between body-mass index (BMI) and advanced CKD differs among different types of people. Methods We used Clinical Practice Research Datalink records (2000-2014) with linkage to English secondary care and mortality data to identify a prospective cohort with at least one BMI measure. Cox models adjusted for age, sex, smoking and social deprivation and subgroup analyses by diabetes, hypertension and prior cardiovascular disease assessed relationships between BMI and CKD stages 4-5 and end-stage renal disease (ESRD). Findings 1,405,016 adults aged 20-79 with mean BMI 27.4kg/m(2) (SD 5.6) were followed for 7.5 years. Compared to a BMI of 20 to <25kg/m(2), higher BMI was associated with a progressively increased risk of CKD stages 4-5 (hazard ratio 1.34, 95% CI 1.30-1.38 for BMI 25 to <30kg/m(2); 1.94, 1.87-2.01 for BMI 30 to <35kg/m(2); and 3.10, 2.95-3.25 for BMI >= 35kg/m(2)). The association between BMI and ESRD was shallower and reversed at low BMI. Current smoking, prior diabetes, hypertension or cardiovascular disease all increased risk of CKD, but the relative strength and shape of BMI-CKD associations, which were generally log-linear above a BMI of 25kg/m(2), were similar among those with and without these risk factors. There was direct evidence that being overweight was associated with increased risk of CKD stages 4-5 in these subgroups. Assuming causality, since 2000 an estimated 39% (36-42%) of advanced CKD in women and 26% (22-30%) in men aged 40-79 resulted from being overweight or obese. Conclusions This study provides direct evidence that being overweight increases risk of advanced CKD, that being obese substantially increases such risk, and that this remains true for those with and without diabetes, hypertension or cardiovascular disease. Strategies to reduce weight among those who are overweight, as well as those who are obese may reduce CKD risk, with each unit reduction in BMI yielding similar relative reductions in risk.	[Herrington, William G.] Univ Oxford, Nuffield Dept Populat Hlth NDPH, Oxford, England; [Herrington, William G.] Oxford Univ Hosp NHS Fdn Trust, Churchill Hosp, Oxford Kidney Unit, Oxford, England; [Smith, Margaret; Bankhead, Clare; Stevens, Sarah; Holt, Tim; Hobbs, F. D. Richard] Univ Oxford, Nuffield Dept Primary Care Hlth Sci NDPCHS, Oxford, England; [Matsushita, Kunihiro; Coresh, Josef; Woodward, Mark] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Woodward, Mark] Univ Oxford, George Inst Global Hlth, Oxford, England; [Woodward, Mark] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; Johns Hopkins University; University of Oxford; George Institute for Global Health; University of Sydney	Bankhead, C (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth NDPH, Oxford, England.	will.herrington@ndph.ox.ac.uk; clare.bankhead@phc.ox.ac.uk	Matsushita, Kunihiro/AAJ-5817-2020; Woodward, Mark/L-6817-2017; Matsushita, Kunihiro/B-1021-2018	Matsushita, Kunihiro/0000-0002-7179-718X; Matsushita, Kunihiro/0000-0002-7179-718X; Smith, Margaret/0000-0002-0946-742X; Woodward, Mark/0000-0001-9800-5296; Lay-Flurrie, Sarah/0000-0003-1094-8455	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme; NIHR; School for Primary Care Research; NIHR Collaboration for Leadership and Applied Health Research Care Oxford; Oxford Biomedical Research Centre; UK Medical Research Council (MRC) [A310]; British Heart Foundation; Cancer Research UK; Australian National Health and Medical Research Council [APP1080206, APP1052555]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100446] Funding Source: NIH RePORTER	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); School for Primary Care Research; NIHR Collaboration for Leadership and Applied Health Research Care Oxford; Oxford Biomedical Research Centre; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in decision to submit the manuscript for publication. This paper summarises independent research funded by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. FDRH at NDPCHS is supported by the NIHR, School for Primary Care Research, the NIHR Collaboration for Leadership and Applied Health Research & Care Oxford, and Oxford Biomedical Research Centre. WH at NDPH is supported by core funding from the UK Medical Research Council (MRC: reference A310), British Heart Foundation and Cancer Research UK. MW is supported by an Australian National Health and Medical Research Council Primary Fellowship (APP1080206) and program grant (APP1052555). NDPCHS met the CPRD access and data management costs.	Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704; Belhatem N, 2015, DIABETES RES CLIN PR, V108, P143, DOI 10.1016/j.diabres.2015.01.028; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Bhaskaran K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003389; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chagnac A, 2000, AM J PHYSIOL-RENAL, V278, pF817, DOI 10.1152/ajprenal.2000.278.5.F817; Chen HM, 2008, AM J KIDNEY DIS, V52, P58, DOI 10.1053/j.ajkd.2008.02.303; Chen HM, 2006, AM J KIDNEY DIS, V48, P772, DOI 10.1053/j.ajkd.2006.07.025; D'Agati VD, 2016, NAT REV NEPHROL, V12, P453, DOI 10.1038/nrneph.2016.75; Department for Communities and Local Government, 2015, ENGL IND DEPR 2015; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Fall T, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001474; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Foster MC, 2011, HYPERTENSION, V58, P784, DOI 10.1161/HYPERTENSIONAHA.111.175315; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goumenos DS, 2009, NEPHROL DIAL TRANSPL, V24, P3732, DOI 10.1093/ndt/gfp329; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b880; HM Treasury, 2016, BUDGET 2016 SOME OF; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holmes MV, 2014, AM J HUM GENET, V94, P198, DOI 10.1016/j.ajhg.2013.12.014; Honeycutt AA, 2013, J AM SOC NEPHROL, V24, P1478, DOI 10.1681/ASN.2012040392; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Iseki K, 2004, KIDNEY INT, V65, P1870, DOI 10.1111/j.1523-1755.2004.00582.x; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kerr M, 2012, NEPHROL DIAL TRANSPL, V27, P73, DOI 10.1093/ndt/gfs269; Knowler WC, 2014, LANCET DIABETES ENDO, V2, P801, DOI 10.1016/S2213-8587(14)70156-1; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lemoine S, 2014, CLIN J AM SOC NEPHRO, V9, P720, DOI 10.2215/CJN.03610413; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Lewko B, 2009, J CELL PHYSIOL, V221, P288, DOI 10.1002/jcp.21856; Lu JL, 2015, LANCET DIABETES ENDO, V3, P704, DOI 10.1016/S2213-8587(15)00128-X; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mascali A, 2016, INT J IMMUNOPATH PH, V29, P354, DOI 10.1177/0394632016643550; Melsom T, 2016, AM J KIDNEY DIS, V67, P841, DOI 10.1053/j.ajkd.2015.10.025; Montani JP, 2004, INT J OBESITY, V28, pS58, DOI 10.1038/sj.ijo.0802858; Moody A., HLTH SURVEY ENGLAND, V1; National Institute of Clinical Excellence, 2014, CHRON KIDN DIS EARL; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; Office of National Statistics, 2011, 2011 CENS POP EST UK; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Quinn MP, 2008, NEPHROL DIAL TRANSPL, V23, P542, DOI 10.1093/ndt/gfm599; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Ruggenenti P, 2012, DIABETES CARE, V35, P2061, DOI 10.2337/dc11-2189; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Smith DH, 2004, J AM SOC NEPHROL, V15, P1300, DOI 10.1097/01.ASN.0000125670.64996.BB; Stengel B, 2003, EPIDEMIOLOGY, V14, P479, DOI 10.1097/01.EDE.0000071413.55296.c4; Stevens PE, 2007, KIDNEY INT, V72, P92, DOI 10.1038/sj.ki.5002273; Tsuboi N, 2013, NEPHROL DIAL TRANSPL, V28, P108, DOI 10.1093/ndt/gft258; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vivante A, 2012, ARCH INTERN MED, V172, P1644, DOI 10.1001/2013.jamainternmed.85; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	59	49	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173515	10.1371/journal.pone.0173515	http://dx.doi.org/10.1371/journal.pone.0173515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273171	Green Published, Green Submitted, gold			2022-12-26	WOS:000396073700011
J	Rodriguez-Arboli, E; Mwamelo, K; Kalinjuma, AV; Furrer, H; Hatz, C; Tanner, M; Battegay, M; Letang, E				Rodriguez-Arboli, Eduardo; Mwamelo, Kim; Kalinjuma, Aneth Vedastus; Furrer, Hansjakob; Hatz, Christoph; Tanner, Marcel; Battegay, Manuel; Letang, Emilio		KIULARCO Study Grp	Incidence and risk factors for hypertension among HIV patients in rural Tanzania - A prospective cohort study	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SUB-SAHARAN AFRICA; BLOOD-PRESSURE; INFECTED PATIENTS; CARDIOVASCULAR-DISEASE; LIFE EXPECTANCY; PREVALENCE; ASSOCIATION; POPULATION; PREDICTORS	Introduction Scarce data are available on the epidemiology of hypertension among HIV patients in rural sub-Saharan Africa. We explored the prevalence, incidence and risk factors for incident hypertension among patients who were enrolled in a rural HIV cohort in Tanzania. Methods Prospective longitudinal study including HIV patients enrolled in the Kilombero and Ulanga Antiretroviral Cohort between 2013 and 2015. Non-ART na ve subjects at baseline and pregnant women during follow-up were excluded from the analysis. Incident hypertension was defined as systolic blood pressure >= 140 mmHg and/or diastolic blood pressure >= 90 mmHg on two consecutive visits. Cox proportional hazards models were used to assess the association of baseline characteristics and incident hypertension. Results Among 955 ART-na ve, eligible subjects, 111 (11.6%) were hypertensive at recruitment. Ten women were excluded due to pregnancy. The remaining 834 individuals contributed 7967 person-months to follow-up (median 231 days, IQR 119-421) and 80 (9.6%) of them developed hypertension during a median follow-up of 144 days from time of enrolment into the cohort [incidence rate 120.0 cases/1000 person-years, 95% confidence interval (CI) 97.2-150.0]. ART was started in 630 (75.5%) patients, with a median follow-up on ART of 7 months (IQR 4-14). Cox regression models identified age [adjusted hazard ratio (aHR) 1.34 per 10 years increase, 95% CI 1.07-1.68, p = 0.010], body mass index (aHR per 5 kg/m(2) 1.45, 95% CI 1.07-1.99, p = 0.018) and estimated glomerular filtration rate (aHR < 60 versus >= 60 ml/min/1.73 m(2) 3.79, 95% CI 1.60-8.99, p = 0.003) as independent risk factors for hypertension development. Conclusions The prevalence and incidence of hypertension were high in our cohort. Traditional cardiovascular risk factors predicted incident hypertension, but no association was observed with immunological or ART status. These data support the implementation of routine hypertension screening and integrated management into HIV programmes in rural sub-Saharan Africa.	[Rodriguez-Arboli, Eduardo] Virgen del Rocio Univ Hosp, Seville, Spain; [Mwamelo, Kim; Kalinjuma, Aneth Vedastus; Letang, Emilio] Ifakara Hlth Inst, Ifakara, Tanzania; [Furrer, Hansjakob] Univ Hosp Bern, Dept Infect Dis, Bern, Switzerland; [Furrer, Hansjakob] Univ Bern, Bern, Switzerland; [Hatz, Christoph; Tanner, Marcel; Letang, Emilio] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Hatz, Christoph; Tanner, Marcel; Battegay, Manuel; Letang, Emilio] Univ Basel, Basel, Switzerland; [Battegay, Manuel] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland; [Letang, Emilio] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain	Virgen del Rocio University Hospital; Ifakara Health Institute; University of Bern; University Hospital of Bern; University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Basel; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona	Letang, E (corresponding author), Ifakara Hlth Inst, Ifakara, Tanzania.; Letang, E (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Letang, E (corresponding author), Univ Basel, Basel, Switzerland.; Letang, E (corresponding author), Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.	emili.letang@unibas.ch	Furrer, Hansjakob/G-6768-2013	Furrer, Hansjakob/0000-0002-1375-3146; Rodriguez-Arboli, Eduardo/0000-0002-2237-6733	Government of the Canton of Basel, Switzerland; Ministry of Health and Socia Welfare of Tanzania; USAID through its local implementer TUNAJALI-Deloitte; Ifakara Health Institute; Swiss Tropical and Public Health Institute	Government of the Canton of Basel, Switzerland; Ministry of Health and Socia Welfare of Tanzania; USAID through its local implementer TUNAJALI-Deloitte(United States Agency for International Development (USAID)); Ifakara Health Institute; Swiss Tropical and Public Health Institute	The KIULARCO cohort receives funding from the Government of the Canton of Basel, Switzerland, the Ministry of Health and Socia Welfare of Tanzania, USAID through its local implementer TUNAJALI-Deloitte, The Ifakara Health Institute, and the Swiss Tropical and Public Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific funding for this work.	Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Ataklte F, 2015, HYPERTENSION, V65, P291, DOI 10.1161/HYPERTENSIONAHA.114.04394; Barnighausen T, 2008, J HUM HYPERTENS, V22, P236, DOI 10.1038/sj.jhh.1002308; Bergersen BM, 2003, EUR J CLIN MICROBIOL, V22, P731, DOI 10.1007/s10096-003-1034-z; Bloomfield GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022288; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Crane HM, 2006, AIDS, V20, P1019, DOI 10.1097/01.aids.0000222074.45372.00; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Dillon DG, 2013, INT J EPIDEMIOL, V42, P1754, DOI 10.1093/ije/dyt198; Haraka F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129185; Hatleberg CI, 2015, C RETR OPP INF CROI; Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Jerico C, 2005, AM J HYPERTENS, V18, P1396, DOI 10.1016/j.amjhyper.2005.05.016; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Joint United Nations Programme on HIV/AIDS, 2015, AIDS NUMB 2015; Letang E, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv046; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Malaza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047761; Mattana J, 1999, AM J MED SCI, V317, P232, DOI 10.1097/00000441-199904000-00004; McDonald CL, 2009, J AM COLL CARDIOL, V54, P1185, DOI 10.1016/j.jacc.2009.05.055; Medina-Torne Sheila, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P20, DOI 10.1177/1545109711418361; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Mulenga L, 2014, CLIN INFECT DIS, V58, P1473, DOI 10.1093/cid/ciu117; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Okello S, 2015, J HYPERTENS, V33, P2039, DOI 10.1097/HJH.0000000000000657; Palacios R, 2006, HIV MED, V7, P10, DOI 10.1111/j.1468-1293.2005.00333.x; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Peck RN, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0125-2; Phillips AN, 2010, AIDS, V24, P1561, DOI 10.1097/QAD.0b013e32833a6056; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Sander LD, 2015, TROP MED INT HEALTH, V20, P391, DOI 10.1111/tmi.12443; Seaberg EC, 2005, AIDS, V19, P953, DOI 10.1097/01.aids.0000171410.76607.f8; Thiebaut R, 2005, ANTIVIR THER, V10, P811; World Health Organization, 2000, WHO TECHN REP SER, V894; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082	40	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172089	10.1371/journal.pone.0172089	http://dx.doi.org/10.1371/journal.pone.0172089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273105	Green Published, Green Submitted, gold			2022-12-26	WOS:000396073700067
J	Farmer, NA; Heyman, WD; Karnauskas, M; Kobara, S; Smart, TI; Ballenger, JC; Reichert, MJM; Wyanski, DM; Tishler, MS; Lindeman, KC; Lowerre-Barbieri, SK; Switzer, TS; Solomon, JJ; McCain, K; Marhefka, M; Sedberry, GR				Farmer, Nicholas A.; Heyman, William D.; Karnauskas, Mandy; Kobara, Shinichi; Smart, Tracey I.; Ballenger, Joseph C.; Reichert, Marcel J. M.; Wyanski, David M.; Tishler, Michelle S.; Lindeman, Kenyon C.; Lowerre-Barbieri, Susan K.; Switzer, Theodore S.; Solomon, Justin J.; McCain, Kyle; Marhefka, Mark; Sedberry, George R.			Timing and locations of reef fish spawning off the southeastern United States	PLOS ONE			English	Article							NASSAU GROUPER; SHELF-EDGE; EPINEPHELUS-STRIATUS; PISCES SERRANIDAE; AGGREGATION SITES; CAYMAN ISLANDS; CLIMATE-CHANGE; REGIME SHIFTS; SNOWY GROUPER; FLORIDA-KEYS	Managed reef fish in the Atlantic Ocean of the southeastern United States (SEUS) support a multi-billion dollar industry. There is a broad interest in locating and protecting spawning fish from harvest, to enhance productivity and reduce the potential for overfishing. We assessed spatiotemporal cues for spawning for six species from four reef fish families, using data on individual spawning condition collected by over three decades of regional fishery-independent reef fish surveys, combined with a series of predictors derived from bathymetric features. We quantified the size of spawning areas used by reef fish across many years and identified several multispecies spawning locations. We quantitatively identified cues for peak spawning and generated predictive maps for Gray Triggerfish (Balistes capriscus), White Grunt (Haemulon plumierii), Red Snapper (Lutjanus campechanus), Vermilion Snapper (Rhomboplites aurorubens), Black Sea Bass (Centropristis striata), and Scamp (Mycteroperca phenax). For example, Red Snapper peak spawning was predicted in 24.7-29.0 degrees C water prior to the new moon at locations with high curvature in the 24-30 m depth range off northeast Florida during June and July. External validation using scientific and fisherydependent data collections strongly supported the predictive utility of our models. We identified locations where reconfiguration or expansion of existing marine protected areas would protect spawning reef fish. We recommend increased sampling off southern Florida (south of 27 degrees N), during winter months, and in high-relief, high current habitats to improve our understanding of timing and location of reef fish spawning off the southeastern United States.	[Farmer, Nicholas A.] NOAA, Natl Marine Fisheries Serv, Southeast Reg Off, St Petersburg, FL 33701 USA; [Heyman, William D.; McCain, Kyle] LGL Ecol Res Associates Inc, Bryan, TX USA; [Karnauskas, Mandy] NOAA, Natl Marine Fisheries Serv, Southeast Fishery Sci Ctr, Miami, FL USA; [Kobara, Shinichi] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Smart, Tracey I.; Ballenger, Joseph C.; Reichert, Marcel J. M.; Wyanski, David M.] Marine Resources Res Inst, South Carolina Dept Nat Resources, Charleston, SC 29412 USA; [Tishler, Michelle S.] Meadows Ecol Inc, Indialantic, FL USA; [Lindeman, Kenyon C.] Florida Inst Technol, Melbourne, FL 32901 USA; [Lowerre-Barbieri, Susan K.; Switzer, Theodore S.] Florida Fish & Wildlife Conservat Commiss, Florida Fish & Wildlife Res Inst, St Petersburg, FL USA; [Solomon, Justin J.] Florida Fish & Wildlife Conservat Commiss, Florida Fish & Wildlife Res Inst, Jacksonville Field Lab, Jacksonville, FL USA; [Marhefka, Mark] Abundant Seafood, Charleston, SC USA; [Sedberry, George R.] NOAA, Off Natl Marine Sanctuaries, Savannah, GA USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Texas A&M University System; Texas A&M University College Station; Florida Institute of Technology; Florida Fish & Wildlife Conservation Commission; Florida Fish & Wildlife Conservation Commission; National Oceanic Atmospheric Admin (NOAA) - USA	Farmer, NA (corresponding author), NOAA, Natl Marine Fisheries Serv, Southeast Reg Off, St Petersburg, FL 33701 USA.	nick.farmer@noaa.gov	Ballenger, Joseph/O-7078-2018; Kobara, Shinichi/J-1988-2012	Kobara, Shinichi/0000-0003-2125-3982; Wyanski, David/0000-0003-3495-7479; Tishler, Michelle/0000-0002-9234-7495; Karnauskas, Mandy/0000-0002-6631-0592; Ballenger, Joseph/0000-0003-4785-4698				AguilarPerera A, 1996, ENVIRON BIOL FISH, V45, P351, DOI 10.1007/BF00002527; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ault JS, 2006, B MAR SCI, V78, P633; Beyer HL, 2011, GEOSPATIAL MODELLING; Brooke S, 2005, OCULINA BANKS RESTOR, P607; Brown-Peterson NJ, 2011, MAR COAST FISH, V3, P52, DOI 10.1080/19425120.2011.555724; Burton ML, 2005, FISH B-NOAA, V103, P404; Carter J., 1999, Proceedings of the Gulf and Caribbean Fisheries Institute, V45, P631; CARTER J, 1994, B MAR SCI, V55, P228; Carter Jacque, 1994, Proceedings of the Gulf and Caribbean Fisheries Institute, V43, P65; Choat JH, 2012, FISH FISH SER, V35, P85, DOI 10.1007/978-94-007-1980-4_4; Claro Rodolfo, 2003, Gulf and Caribbean Research, V14, P91; Claydon JAB, 2014, J FISH BIOL, V2014, P1; Coleman FC, 1996, ENVIRON BIOL FISH, V47, P129, DOI 10.1007/BF00005035; Coleman FC, 2011, PROF GEOGR, V63, P456, DOI 10.1080/00330124.2011.585076; COLIN PL, 1991, ENVIRON BIOL FISH, V31, P229, DOI 10.1007/BF00000690; COLIN PL, 1988, B MAR SCI, V43, P249; Colin PL, 2003, MANUAL STUDY CONSERV; Cowie-Haskell BD, 2003, MAR TECHNOL SOC J, V37, P68, DOI 10.4031/002533203787537447; Craig A.K., 1966, GEOGRAPHY FISHING BR; Cuellar N, 1996, REPROD SEASONALITY M; De Mitcheson YS, 2008, CONSERV BIOL, V22, P1233, DOI 10.1111/j.1523-1739.2008.01020.x; de Mitcheson YS, 2016, BIOSCIENCE, V66, P295, DOI 10.1093/biosci/biw013; de Roos AM, 2006, P ROY SOC B-BIOL SCI, V273, P1873, DOI 10.1098/rspb.2006.3518; Domeier ML, 2012, FISH FISH SER, V35, P1, DOI 10.1007/978-94-007-1980-4_1; Domeier ML, 1997, B MAR SCI, V60, P698; Domeier ML, 1996, REPROD BIOL GRAY SNA, P189; Donaldson TJ, 2011, P GULF CARIB FISH I, V64, P227; Eklund AM, 2000, B MAR SCI, V66, P721; Erisman B, 2017, FISH FISH, V18, P128, DOI 10.1111/faf.12132; Fine JC, 1990, SEA FRONTIERS, V36, P42; Fine John C., 1992, Wildlife Conservation, V95, P68; FITZHUGH GR, 1993, FISH B-NOAA, V91, P244; FWC: Florida Fish and Wildlife Conservation Commission, 2001, SEAMAP BOTT MAPP PRO, P166; Garcia-Cagide Alida, 2001, P73; Gibson J, 2004, BELIZES EVOLVING SYS, P287; GILMORE RG, 1992, B MAR SCI, V51, P83; Gleason ACR, 2011, PROF GEOGR, V63, P443, DOI 10.1080/00330124.2011.585075; Gomez Gaspar Alfredo, 1993, Boletin del Instituto Oceanografico de Venezuela Universidad de Oriente, V32, P27; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harris PJ, 2002, B MAR SCI, V70, P113; Heyman W., 2004, SPAWNING AGGREGATION; Heyman W. D., 2014, ENHANCING STEWARDSHI, P73; HEYMAN WD, 2014, P GULF CARIBBEAN FIS, V66, P104; Heyman WD, 2016, COOPERATIVE RES MONI; Heyman WD, 2008, B MAR SCI, V83, P531; Heyman WD, 2012, ELSEV INSIGHT, P387, DOI 10.1016/B978-0-12-385140-6.00026-8; Heyman WD, 2011, PROF GEOGR, V63, P475, DOI 10.1080/00330124.2011.585078; Hilborn R, 2005, ARE SUSTAINABLE FISH, P247; Hood P.B., 1997, STUDY AGE STRUCTURE; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; HUNTER JR, 1986, FISH B-NOAA, V84, P895; Hunter JR, 1985, MEASUREMENT SPAWING, P79; Jeffrey CFG, 2012, INTEGRATED BIOGEOGRA; JOHANNES R E, 1978, Environmental Biology of Fishes, V3, P65, DOI 10.1007/BF00006309; Karnauskas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022067; Kobara S, 2013, OCEANOGR MAR BIOL, V51, P281; Kobara S, 2010, MAR ECOL PROG SER, V405, P243, DOI 10.3354/meps08512; Kobara S, 2008, MAR GEOD, V31, P231, DOI 10.1080/01490410802466397; Koenig CC, 2000, B MAR SCI, V66, P593; Kohavi R., 1995, PROC 14 INT JOINT C, P1137; Lecours V, 2015, MAR ECOL PROG SER, V535, P259, DOI 10.3354/meps11378; Lee T, 1985, SHELF CIRCULATION CA, P33; LGL Ecological Research Associates Inc, 2015, COOP PRED VER MULT S; Lindeman KC, 2000, B MAR SCI, V66, P929; LOBEL PS, 1980, ENVIRON BIOL FISH, V5, P251, DOI 10.1007/BF00005359; Lobel PS., 1978, ECOL MONOGR, V17, P349; Locascio JV, 2016, FISH B-NOAA, V114, P103, DOI 10.7755/FB.114.1.9; Lowerre-Barbieri S, 2016, FISH FISHERIES; Lowerre-Barbieri S, 2015, MAR ECOL PROG SER, V526, P125, DOI 10.3354/meps11212; Lowerre-Barbieri SK, 2011, MAR COAST FISH, V3, P71, DOI 10.1080/19425120.2011.556932; Lowerre-Barbieri SK, 2009, MAR ECOL PROG SER, V394, P231, DOI 10.3354/meps08262; MacKichan CA, 2007, REPROD BEHAV GRAY TR, P231; MATHESON RH, 1984, T AM FISH SOC, V113, P607, DOI 10.1577/1548-8659(1984)113<607:GMAYMF>2.0.CO;2; McGovern JC, 2005, B MAR SCI, V76, P47; McGovern JC, 2002, N AM J FISH MANAGE, V22, P1151, DOI 10.1577/1548-8675(2002)022<1151:TASDIL>2.0.CO;2; Meynard CN, 2007, J BIOGEOGR, V34, P1455, DOI 10.1111/j.1365-2699.2007.01720.x; MUNRO JL, 1973, J FISH BIOL, V5, P69, DOI 10.1111/j.1095-8649.1973.tb04431.x; [National Oceanic and Atmospheric Administration NOAA Fisheries Service], 2013, NMFSFSPO137 NOAA US; Padgett SM, 1997, AGE GROWTH REPROD BI; Palazon-Fernandez JL, 2007, SCI MAR, V71, P429, DOI 10.3989/scimar.2007.71n3429; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; SADOVY Y, 1994, P GULF CARIB FISH I, V43, P43; Sadovy Y., 1999, SYNOPSIS BIOL DATA N, P68; SAFMC: South Atlantic Fishery Management Council MPA Expert Workgroup, 2013, REP 2 MPA EXP WORKGR; Sala E, 2001, FISHERIES, V26, P23, DOI 10.1577/1548-8446(2001)026<0023:RDONGS>2.0.CO;2; Schobernd CM, 2009, B MAR SCI, V84, P67; SEDAR, 2013, SE DAT ASS REV SEDAR, P139; SEDAR (Southeast Data Assessment and Review), 2010, SEDAR 8 UPDATE ASSES; SEDBERRY GR, 2004, CHARACTERIZATION DEE; Sedberry GR, 2006, SPAWNING LOCATIONS A, P463; Silvano RAM, 2006, ENVIRON BIOL FISH, V76, P371, DOI 10.1007/s10641-006-9043-2; Simmons CM, 2012, B MAR SCI, V88, P197, DOI 10.5343/bms.2011.1012; Stallings CD, 2016, B MAR SCI, V92, P545, DOI 10.5343/bms.2016.1971; Tishler-Meadows MS, 2012, SPAWNING INDICATORS; Van Sant SB, 1994, PRELIMINARY EVIDENCE, P7; Vert-pre KA, 2013, P NATL ACAD SCI USA, V110, P1779, DOI 10.1073/pnas.1214879110; Wenner CA, 1986, CONTRIBUTIONS LIFE H; Whaylen L, 2004, ENVIRON BIOL FISH, V70, P305, DOI 10.1023/B:EBFI.0000033341.57920.a8; White DB, 2004, B MAR SCI, V75, P335; Wright D.J., 2012, ARCGIS BENTHIC TERRA; Wyanski DM, 2000, FISH B-NOAA, V98, P199; Zhao BX, 1997, T AM FISH SOC, V126, P181, DOI 10.1577/1548-8659(1997)126<0181:AGATCI>2.3.CO;2	106	25	28	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172968	10.1371/journal.pone.0172968	http://dx.doi.org/10.1371/journal.pone.0172968			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264006	Green Submitted, Green Published, gold			2022-12-26	WOS:000396054300029
J	Jing, Z; Kang, L				Jing, Zheng; Kang, Ling			High-order scheme for the source-sink term in a one-dimensional water temperature model	PLOS ONE			English	Article							METEOROLOGICAL CONDITIONS; THERMAL STRATIFICATION; SIMULATION; LAKE; TRANSPORT; CLIMATE	The source-sink term in water temperature models represents the net heat absorbed or released by a water system. This term is very important because it accounts for solar radiation that can significantly affect water temperature, especially in lakes. However, existing numerical methods for discretizing the source-sink term are very simplistic, causing significant deviations between simulation results and measured data. To address this problem, we present a numerical method specific to the source-sink term. A vertical one-dimensional heat conduction equation was chosen to describe water temperature changes. A two-step operator-splitting method was adopted as the numerical solution. In the first step, using the undetermined coefficient method, a high-order scheme was adopted for discretizing the source-sink term. In the second step, the diffusion term was discretized using the Crank-Nicolson scheme. The effectiveness and capability of the numerical method was assessed by performing numerical tests. Then, the proposed numerical method was applied to a simulation of Guozheng Lake (located in central China). The modeling results were in an excellent agreement with measured data.	[Jing, Zheng; Kang, Ling] Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan, Peoples R China	Huazhong University of Science & Technology	Kang, L (corresponding author), Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan, Peoples R China.	kling@hust.edu.cn			Hubei Support Plan of Science and Technology of China [2015BCA291]; National Key Research and Development Program of China [2016YFC0402204]	Hubei Support Plan of Science and Technology of China; National Key Research and Development Program of China	This study was partly supported by the Hubei Support Plan of Science and Technology of China (No. 2015BCA291) and the National Key Research and Development Program of China (Item Nos. 2016YFC0402204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan AKMQ, 1999, J HYDRAUL ENG-ASCE, V125, P912, DOI 10.1061/(ASCE)0733-9429(1999)125:9(912); Antonopoulos VZ, 2003, ECOL MODEL, V160, P39, DOI 10.1016/S0304-3800(02)00286-7; Blom JG, 2000, J COMPUT APPL MATH, V126, P381, DOI 10.1016/S0377-0427(99)00366-0; BOLTON D, 1980, MON WEATHER REV, V108, P1046, DOI 10.1175/1520-0493(1980)108<1046:TCOEPT>2.0.CO;2; Boxin J, 1980, J CENTRAL CHINA NORM, V3; Branco BF, 2007, THESIS; Carey CC, 2012, WATER RES, V46, P1394, DOI 10.1016/j.watres.2011.12.016; Cole T. M., 2006, EL061 US ARM ENG RES; Condie SA, 2001, J HYDRAUL ENG, V127, P286, DOI 10.1061/(ASCE)0733-9429(2001)127:4(286); DAKE JMK, 1969, WATER RESOUR RES, V5, P484, DOI 10.1029/WR005i002p00484; Danis PA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020833; EDINGER JE, 1968, WATER RESOUR RES, V4, P1137, DOI 10.1029/WR004i005p01137; Garcia-Navarro P, 2000, COMPUT FLUIDS, V29, P951, DOI 10.1016/S0045-7930(99)00038-9; GU R, 1990, COLD REG SCI TECHNOL, V18, P147, DOI 10.1016/0165-232X(90)90004-G; Hamrick JM, 1994, JMHSFWMD9401 CONS EN; Henderson-Sellers B, 1984, ENG LIMNOLOGY; HOLLY FM, 1977, J HYDR ENG DIV-ASCE, V103, P1259; HONDZO M, 1993, J HYDRAUL ENG, V119, P1251, DOI 10.1061/(ASCE)0733-9429(1993)119:11(1251); HONDZO M, 1991, J HYDRAUL ENG-ASCE, V117, P1352, DOI 10.1061/(ASCE)0733-9429(1991)117:10(1352); Ji Z.-G., 2008, HYDRODYNAMICS WATER; Kim KS, 1997, J HYDRAUL ENG-ASCE, V123, P30, DOI 10.1061/(ASCE)0733-9429(1997)123:1(30); KOMATSU T., 1985, J HYDROSCI HYDRAUL E, V3, P15; ROSATI A, 1988, J PHYS OCEANOGR, V18, P1601, DOI 10.1175/1520-0485(1988)018<1601:AGCMFU>2.0.CO;2; SINOKROT BA, 1993, WATER RESOUR RES, V29, P2299, DOI 10.1029/93WR00540; Siviglia A, 2009, J HYDRAUL ENG, V135, P651, DOI 10.1061/(ASCE)HY.1943-7900.0000054; STRANG G, 1968, SIAM J NUMER ANAL, V5, P506, DOI 10.1137/0705041; Thomann R.V., 1987, PRINCIPLES SURFACE W; Thomas LH, 1949, ELLIPTIC PROBLEMS LI, P1; Toro EF, 2007, J HYDRAUL RES, V45, P736, DOI 10.1080/00221686.2007.9521812; TSAY TK, 1992, J HYDRAUL ENG-ASCE, V118, P407, DOI 10.1061/(ASCE)0733-9429(1992)118:3(407); VALOCCHI AJ, 1992, WATER RESOUR RES, V28, P1471, DOI 10.1029/92WR00423; Xiaofeng Z, 2002, J HYDRODYNAMICS B, V14, P81	32	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173236	10.1371/journal.pone.0173236	http://dx.doi.org/10.1371/journal.pone.0173236			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264005	Green Published, Green Submitted, gold			2022-12-26	WOS:000396054300048
J	Morettini, M; Faelli, E; Perasso, L; Fioretti, S; Burattini, L; Ruggeri, P; Di Nardo, F				Morettini, Micaela; Faelli, Emanuela; Perasso, Luisa; Fioretti, Sandro; Burattini, Laura; Ruggeri, Piero; Di Nardo, Francesco			IVGTT-based simple assessment of glucose tolerance in the Zucker fatty rat: Validation against minimal models	PLOS ONE			English	Article							BETA-CELL FUNCTION; AGE-RELATED ANALYSIS; INSULIN SENSITIVITY; SURROGATE INDEXES; C-PEPTIDE; SECRETION; RESISTANCE; MICE; HUMANS; CLAMP	For the assessment of glucose tolerance from IVGTT data in Zucker rat, minimal model methodology is reliable but time-and money-consuming. This study aimed to validate for the first time in Zucker rat, simple surrogate indexes of insulin sensitivity and secretion against the glucose-minimal-model insulin sensitivity index (S-I) and against first-(Phi(1)) and second-phase (Phi(2)) beta-cell responsiveness indexes provided by C-peptide minimal model. Validation of the surrogate insulin sensitivity index (ISI) and of two sets of coupled insulin-based indexes for insulin secretion, differing from the cut-off point between phases (FPIR3-SPIR3, t = 3 min and FPIR5-SPIR5, t = 5 min), was carried out in a population of ten Zucker fatty rats (ZFR) and ten Zucker lean rats (ZLR). Considering the whole rat population (ZLR+ZFR), ISI showed a significant strong correlation with SI (Spearman's correlation coefficient, r = 0.88; P<0.001). Both FPIR3 and FPIR5 showed a significant (P<0.001) strong correlation with Phi(1) (r = 0.76 and r = 0.75, respectively). Both SPIR3 and SPIR5 showed a significant (P<0.001) strong correlation with Phi(2) (r = 0.85 and r = 0.83, respectively). ISI is able to detect (P<0.001) the well-recognized reduction in insulin sensitivity in ZFRs, compared to ZLRs. The insulin-based indexes of insulin secretion are able to detect in ZFRs (P<0.001) the compensatory increase of first-and second-phase secretion, associated to the insulin-resistant state. The ability of the surrogate indexes in describing glucose tolerance in the ZFRs was confirmed by the Disposition Index analysis. The model-based validation performed in the present study supports the utilization of low-cost, insulin-based indexes for the assessment of glucose tolerance in Zucker rat, reliable animal model of human metabolic syndrome.	[Morettini, Micaela; Fioretti, Sandro; Burattini, Laura; Di Nardo, Francesco] Univ Politecn Marche, Dept Informat Engn, Ancona, Italy; [Faelli, Emanuela; Perasso, Luisa; Ruggeri, Piero] Univ Genoa, Dept Expt Med, Genoa, Italy	Marche Polytechnic University; University of Genoa	Di Nardo, F (corresponding author), Univ Politecn Marche, Dept Informat Engn, Ancona, Italy.	f.dinardo@univpm.it	Morettini, Micaela/K-3097-2018; Burattini, Laura/I-7962-2012; Di Nardo, Francesco/AAD-1680-2019; faelli, emanuela/AAF-3607-2021	Morettini, Micaela/0000-0002-8327-8379; Burattini, Laura/0000-0002-9474-7046; Di Nardo, Francesco/0000-0002-5362-3776; ruggeri, piero/0000-0001-5939-1489				Alonso LC, 2012, OBESITY, V20, P1403, DOI 10.1038/oby.2012.36; Barrett PHR, 1998, METABOLISM, V47, P484, DOI 10.1016/S0026-0495(98)90064-6; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; BERGMAN RN, 1989, DIABETES, V38, P1512, DOI 10.2337/diabetes.38.12.1512; BERGMAN RN, 1987, J CLIN INVEST, V79, P790, DOI 10.1172/JCI112886; BRAY GA, 1977, FED PROC, V36, P148; Burattini R, 2011, MED BIOL ENG COMPUT, V49, P831, DOI 10.1007/s11517-011-0760-0; Carson ER, 1983, THE MATHEMATICAL MOD; COBELLI C, 1988, DIABETES, V37, P223, DOI 10.2337/diabetes.37.2.223; Di Nardo F, 2016, IFMBE PROC, V57, P545, DOI 10.1007/978-3-319-32703-7_106; Di Nardo F, 2009, EXP PHYSIOL, V94, P162, DOI 10.1113/expphysiol.2008.044529; Di Nardo F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125252; Di Nardo F, 2013, COMPUT METH PROG BIO, V110, P215, DOI 10.1016/j.cmpb.2012.10.007; Di Nardo F, 2010, COMPUT METH PROG BIO, V97, P189, DOI 10.1016/j.cmpb.2009.08.007; Ferrannini E, 2004, DIABETOLOGIA, V47, P943, DOI 10.1007/s00125-004-1381-z; Filipsson K, 1998, AM J PHYSIOL-ENDOC M, V274, pE834, DOI 10.1152/ajpendo.1998.274.5.E834; Flecknell PA., 1987, LAB ANIMAL ANAESTHES, P156; GALVIN P, 1992, DIABETIC MED, V9, P921, DOI 10.1111/j.1464-5491.1992.tb01732.x; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Lee S, 2008, AM J PHYSIOL-ENDOC M, V294, pE261, DOI 10.1152/ajpendo.00676.2007; Morettini M, 2016, IFMBE PROC, V57, P549, DOI 10.1007/978-3-319-32703-7_107; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Muniyappa R, 2009, AM J PHYSIOL-ENDOC M, V297, pE1023, DOI 10.1152/ajpendo.00397.2009; Natalucci S, 2003, EXP PHYSIOL, V88, P399, DOI 10.1113/eph8802565; Natalucci S, 2000, EXP PHYSIOL, V85, P775; Pacini G, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/986906; Pacini G, 2009, AM J PHYSIOL-REG I, V296, pR1316, DOI 10.1152/ajpregu.90575.2008; Quddusi S, 2003, DIABETES CARE, V26, P791, DOI 10.2337/diacare.26.3.791; Ruggeri P, 1999, PFLUGERS ARCHIV, V438, pR15; Ruggeri P, 2006, AM J PHYSIOL-REG I, V291, pR376, DOI 10.1152/ajpregu.00644.2005; Tura A, 2010, DIABETOLOGIA, V53, P144, DOI 10.1007/s00125-009-1547-9; Tura A, 2006, DIABETES RES CLIN PR, V72, P298, DOI 10.1016/j.diabres.2005.10.005	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173200	10.1371/journal.pone.0173200	http://dx.doi.org/10.1371/journal.pone.0173200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264067	Green Published, gold, Green Submitted			2022-12-26	WOS:000396054300044
J	Ducrotoy, MJ; Revie, CW; Shaw, APM; Musa, UB; Bertu, WJ; Gusi, AM; Ocholi, RA; Majekodunmi, AO; Welburn, SC				Ducrotoy, Marie J.; Revie, Crawford W.; Shaw, Alexandra P. M.; Musa, Usman B.; Bertu, Wilson J.; Gusi, Amahyel M.; Ocholi, Reuben A.; Majekodunmi, Ayodele O.; Welburn, Susan C.			Wealth, household heterogeneity and livelihood diversification of Fulani pastoralists in the Kachia Grazing Reserve, northern Nigeria, during a period of social transition	PLOS ONE			English	Article							CATTLE; CULTIVATION; MIGRATION; MAASAI	Background A mixed methods study was undertaken in the Kachia Grazing Reserve of northern Nigeria. Surveys in March, June and October 2011 included focus group discussions, key informant and in-depth household interviews, concerning livelihood practices, animal health, ownership, and productivity. In May 2011, 249 Fulani families fleeing post-election violence entered the reserve with their livestock, increasing the number of households by one third. Results Despite being settled within a grazing reserve, over half of households sent all their cattle away on seasonal transhumance and another third sent some away. Cattle accounted for 96% of total tropical livestock units (TLU), of which 26% were cattle kept permanently outside the reserve. While all households cited livestock as their main source of income, 90% grew crops and 55% derived income from off-farm activities. A multiple correspondence analysis showed that for each extra member of a household its TLU value increased by 2.0 [95% CI, 1.4 - 2.7], while for each additional marriage its TLU increased by 15.7 [95% CI, 7.1 - 24.3]. A strong association was also observed between small herds, small households with only one wife, alongside marked geographical wealth differences within the reserve. New immigrant families had larger household sizes (33) and livestock holdings (122 TLU) than old settlers (22 people and 67 TLU). Prior to the mass immigration, the distribution of TLU per person was unimodal: 41% of households were classified as 'poor' and 27% as 'medium', whereas post-immigration it was bi-modal, with 26% classified as 'very poor' and 28% as 'medium'. Conclusions While cattle remain the principal source of Fulani income and wealth, the inhabitants of Kachia Grazing Reserve have diversified their livelihood strategies to respond to changing circumstances and stress, especially the limited availability of grazing within the reserve and political insecurity outside, resulting in continued transhumance, the maintenance of smaller livestock holdings and pushing households into poverty.	[Ducrotoy, Marie J.; Shaw, Alexandra P. M.; Majekodunmi, Ayodele O.; Welburn, Susan C.] Univ Edinburgh, Div Infect & Pathway Med, Edinburgh Med Sch Biomed Sci, Coll Med & Vet Med, Chancellors Bldg,49 Little France Crescent, Edinburgh, Midlothian, Scotland; [Revie, Crawford W.] Univ Prince Edward Isl, Dept Hlth Management, Atlantic Vet Coll, Ctr Vet & Epidemiol Res, 550 Univ Ave, Charlottetown, PE, Canada; [Shaw, Alexandra P. M.] Avia GIS, Risschotlei 33, Zoersel, Belgium; [Musa, Usman B.] Ungwan Rimi GRA, Nigerian Inst Trypanosomiasis Res, PMB, Kaduna, Nigeria; [Bertu, Wilson J.; Gusi, Amahyel M.; Ocholi, Reuben A.] Natl Inst Vet Res, Brucellosis Res Unit, PMB 01, Vom, Plateau State, Nigeria	University of Edinburgh; University of Prince Edward Island	Welburn, SC (corresponding author), Univ Edinburgh, Div Infect & Pathway Med, Edinburgh Med Sch Biomed Sci, Coll Med & Vet Med, Chancellors Bldg,49 Little France Crescent, Edinburgh, Midlothian, Scotland.	sue.welburn@ed.ac.uk	Majekodunmi, Ayodele/ABR-1323-2022; Revie, Crawford/B-5002-2011	Majekodunmi, Ayodele/0000-0003-4986-8284; Revie, Crawford/0000-0002-5018-0340; Gusi, Amahyel/0000-0002-0600-5270	UK's Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H009213/1]; European Union [221948]; BBSRC [BB/H009213/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H009213/1] Funding Source: researchfish	UK's Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the UK's Biotechnology and Biological Sciences Research Council (BBSRC) under the 'Combating Infectious Diseases in Livestock for International Development' (CIDLID) scheme, grant number BB/H009213/1 [SCW and AOM]. The work was also supported by the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement no 221948, ICONZ (Integrated control of Neglected Zoonoses) [MJD, SCW, RAO]. Neither funder had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriansen HK, 2006, AGR HUM VALUES, V23, P215, DOI 10.1007/s10460-005-6108-3; Adunga E, 2013, INT J SOC ECON, V40, P207, DOI 10.1108/03068291311291509; [Anonymous], 2014, R LANG ENV STAT COMP; Asad T, 1979, NOTES DISSOLUTION AN; Awogbade MO., 1983, FULANI PASTORALISM J; Azuwike O.D., 2010, P BERL C HUM DIM GLO; Bassett T., 1986, ANN AM ASSOC GEOGR, V78, P453; Bonfiglioli AM., 1993, AGROPASTORALISM CHAD; CHAMBERS R, 1994, WORLD DEV, V22, P953, DOI 10.1016/0305-750X(94)90141-4; Dahl G., 1976, HAVING HERDS PASTORA; Ducrotoy MJ, 2016, PASTORALISM, V6, DOI 10.1186/s13570-016-0072-y; Ducrotoy MJ., 2015, THESIS; Enwezor FNC, 2009, VET PARASITOL, V159, P121, DOI 10.1016/j.vetpar.2008.10.032; [FAOSTAT-Food and Agriculture Organisation of the United Nations Statistics Division FAO], 2016, PROD LIV AN NIG 2014; Fratkin E., 2005, PASTORALISTS SETTLE; Hampshire K, 2002, J DEV STUD, V38, P15, DOI 10.1080/00220380412331322491; Hampshire K, 2006, AFRICA, V76, P402, DOI 10.1353/afr.2006.0044; Hopen C. E., 1958, PASTORAL FULBE FAMIL; Iro IS., 1995, THESIS; JABBAR MA, 1995, TROP ANIM HEALTH PRO, V27, P55, DOI 10.1007/BF02236341; Konczacki Z., 1978, EC PASTORALISM CASE; Little P.D., 2003, SOMALIA EC STATE; Little PD., 1982, P 3 INT C GOAT PROD, P428; Little PD, 2008, DEV CHANGE, V39, P587, DOI 10.1111/j.1467-7660.2008.00497.x; MACE R, 1993, CURR ANTHROPOL, V34, P363, DOI 10.1086/204183; Majekodunmi AO, 2014, PASTORALISM, V4, DOI 10.1186/s13570-014-0020-7; Manger Leif, 2000, PASTORALISTS ENV EXP, P1; McCabe JT, 2010, HUM ECOL, V38, P322, DOI 10.1007/s10745-010-9312-8; McCabe JT, 2003, HUM ORGAN, V62, P100, DOI 10.17730/humo.62.2.4rwrt1n3xptg29b8; Otte M.J., 2002, CATTLE SMALL RUMINAN; Potkanski T., 1997, PASTORAL LAND TENURE, V6; RIM, 1992, URB REP COMM MAN LIV; RIM, 1988, CATTL CULT HUM SETTL, P36; Santirso C., 2015, THESIS; Sieff DF, 1999, AGR SYST, V59, P1, DOI 10.1016/S0308-521X(98)00078-X; Spencer P., 1965, ANTHR AFRICAN STUDIE, V26; Spencer P, 2005, FOCAAL, P46, DOI 10.3167/092012905780909261; Stenning Derrick J., 1959, SAVANNAH NOMADS STUD; Suleiman H., 1986, SEM 2 NAT LIV DEV PR; Suleiman H., 1988, POLICY ISSUES AGROPA; SUTTER JW, 1987, AFRICA, V57, P196, DOI 10.2307/1159821; Swift J.J., 1988, MAJOR ISSUES PASTORA; Tache B, 2010, WORLD DEV, V38, P1168, DOI 10.1016/j.worlddev.2010.01.001; Tewolde W, 2010, AFR GEOGR REV, V29, P21, DOI 10.1080/19376812.2010.9756224; van Raay HGI., 1975, RURAL PLANNING SAVAN; Waters-Bayer A, 1984, P 2 ILCA NAPRI S KAD	46	11	12	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172866	10.1371/journal.pone.0172866	http://dx.doi.org/10.1371/journal.pone.0172866			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257477	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000396021100033
J	Gao, YS; Jia, XX; Tang, XJ; Fan, YF; Lu, JX; Huang, SH; Tang, MJ				Gao, Yu-shi; Jia, Xiao-xu; Tang, Xiu-jun; Fan, Yan-feng; Lu, Jun-xian; Huang, Sheng-hai; Tang, Meng-jun			The genetic diversity of chicken breeds from Jiangxi, assessed with BCDO2 and the complete mitochondrial DNA D-loop region	PLOS ONE			English	Article							MATERNAL ORIGINS; DOMESTICATION; GENOMES	The Jiangxi Province of China has numerous native domestic chicken breeds, including some black skin breeds. The genetic diversity of Jiangxi native chickens is largely unknown, and specifically, the genetic contribution of the grey junglefowl to black skin chickens is not well understood. To address these questions, the complete D-loop region of the mitochondrial DNA (mtDNA) and beta-carotene dioxygenase 2(BCDO2) gene was sequenced in a total of 209 chickens representing seven Jiangxi native breeds. Thirty-one polymorphic sites were identified across the complete mtDNA D-loop region sequence. Twenty-three haplotypes were observed in the seven breeds, which belonged to four distinct mitochondrial clades (A, B, C and E). Clade A and B were dominant in the chickens with a frequency of approximately 67.9%. There were five SNPs that defined two haplotypes, Wand Y in BCDO2. Four breeds had one haplotype and three breeds had two. We conclude that Jiangxi native chicken breeds have relatively low genetic diversity and likely share four common maternal lineages from two different maternal ancestors of junglefowl. Furthermore, some Jiangxi chicken populations may have been mixed with chickens with exotic lineage. Further research should be established to protect these domestic chicken resources.	[Gao, Yu-shi; Jia, Xiao-xu; Tang, Xiu-jun; Fan, Yan-feng; Lu, Jun-xian; Huang, Sheng-hai; Tang, Meng-jun] Jiangsu Inst Poultry Sci, Yangzhou, Jiangsu, Peoples R China		Gao, YS; Jia, XX (corresponding author), Jiangsu Inst Poultry Sci, Yangzhou, Jiangsu, Peoples R China.	gaoys100@sina.com; 596374801@qq.com			National Natural Science Foundation of China [31372277, 31501917, 31672382]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The National Natural Science Foundation of China (31372277, 31501917 and 31672382). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by The National Natural Science Foundation of China (31372277, 31501917 and 31672382).	Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Berry SD, 2009, GENETICS, V182, P923, DOI 10.1534/genetics.109.101741; Chang CS, 2012, ANIM GENET, V43, P172, DOI 10.1111/j.1365-2052.2011.02226.x; Chen GH, 2008, ASIAN AUSTRAL J ANIM, V21, P331, DOI 10.5713/ajas.2008.70125; China National Commission of Anima Genetic Resources, 2012, AN GEN RES CHIN CHIC; Di Lorenzo P, 2015, WORLD POULTRY SCI J, V71, P311, DOI 10.1017/S0043933915000318; Eriksson J, 2008, PLOS GENET, V4, P78; FAO, 2015, COPING CLIMATE CHANG; Hogue MR, 2013, ASIAN AUSTRAL J ANIM, V26, P157, DOI 10.5713/ajas.2012.12459; Jia XX, 2016, MITOCHONDRIAL DNA A, V27, P3001, DOI 10.3109/19401736.2015.1060478; Kawabe K, 2014, ASIAN AUSTRAL J ANIM, V27, P19, DOI 10.5713/ajas.2013.13443; Lancioni H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073712; Li HF, 2011, POULTRY SCI, V90, P2705, DOI 10.3382/ps.2011-01425; Li HF, 2010, MOL PHYLOGENET EVOL, V57, P634, DOI 10.1016/j.ympev.2010.07.011; Liao YY, 2016, MOL BIOL REP, V43, P415, DOI 10.1007/s11033-016-3976-0; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; Miao YW, 2013, HEREDITY, V110, P277, DOI 10.1038/hdy.2012.83; Miao YongWang, 2015, Journal of Yunnan Agricultural University, V30, P395; Muchadeyi FC, 2008, ANIM GENET, V39, P615, DOI 10.1111/j.1365-2052.2008.01785.x; Muira WM, 2008, P NATL ACAD SCI USA, V105, P17312, DOI 10.1073/pnas.0806569105; Oka T, 2007, ANIM GENET, V38, P287, DOI 10.1111/j.1365-2052.2007.01604.x; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sambrook J, 2001, MOL CLONING LAB 316; Shi NN, 2014, MOL ECOL, V23, P5393, DOI 10.1111/mec.12955; Smith DR, 2016, BRIEF FUNCT GENOMICS, V15, P47, DOI 10.1093/bfgp/elv027; Tadano R, 2007, POULTRY SCI, V86, P460, DOI 10.1093/ps/86.3.460; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ulfah M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2652-z; Vaarst M, 2015, WORLD POULTRY SCI J, V71, P609, DOI 10.1017/S0043933915002433; Vage DI, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-10; Wu GS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r245	34	20	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173192	10.1371/journal.pone.0173192	http://dx.doi.org/10.1371/journal.pone.0173192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257510	gold, Green Submitted, Green Published			2022-12-26	WOS:000396021100072
J	Van den Driessche, F; Vanhoutte, B; Brackman, G; Crabbe, A; Rigole, P; Vercruysse, J; Verstraete, G; Cappoen, D; Vervaet, C; Cos, P; Coenye, T				Van den Driessche, Freija; Vanhoutte, Bieke; Brackman, Gilles; Crabbe, Aurelie; Rigole, Petra; Vercruysse, Jurgen; Verstraete, Glenn; Cappoen, Davie; Vervaet, Chris; Cos, Paul; Coenye, Tom			Evaluation of combination therapy for Burkholderia cenocepacia lung infection in different in vitro and in vivo models	PLOS ONE			English	Article							HOST-PATHOGEN INTERACTIONS; CYSTIC-FIBROSIS PATIENTS; CEPACIA COMPLEX; CELL-CULTURE; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; MICROBIAL BIOFILMS; EPITHELIAL-CELLS; MICONAZOLE	Burkholderia cenocepacia is an opportunistic pathogen responsible for life-threatening infections in cystic fibrosis patients. B. cenocepacia is extremely resistant towards antibiotics and therapy is complicated by its ability to form biofilms. We investigated the efficacy of an alternative antimicrobial strategy for B. cenocepacia lung infections using in vitro and in vivo models. A screening of the NIH Clinical Collection 1&2 was performed against B. cenocepacia biofilms formed in 96-well microtiter plates in the presence of tobramycin to identify repurposing candidates with potentiator activity. The efficacy of selected hits was evaluated in a three-dimensional (3D) organotypic human lung epithelial cell culture model. The in vivo effect was evaluated in the invertebrate Galleria mellonella and in a murine B. cenocepacia lung infection model. The screening resulted in 60 hits that potentiated the activity of tobramycin against B. cenocepacia biofilms, including four imidazoles of which econazole and miconazole were selected for further investigation. However, a potentiator effect was not observed in the 3D organotypic human lung epithelial cell culture model. Combination treatment was also not able to increase survival of infected G. mellonella. Also in mice, there was no added value for the combination treatment. Although potentiators of tobramycin with activity against biofilms of B. cenocepacia were identified in a repurposing screen, the in vitro activity could not be confirmed nor in a more sophisticated in vitro model, neither in vivo. This stresses the importance of validating hits resulting from in vitro studies in physiologically relevant model systems.	[Van den Driessche, Freija; Brackman, Gilles; Crabbe, Aurelie; Rigole, Petra; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, Ghent, Belgium; [Vanhoutte, Bieke; Cappoen, Davie; Cos, Paul] Univ Antwerp, LMPH, Antwerp, Belgium; [Vercruysse, Jurgen; Verstraete, Glenn; Vervaet, Chris] Univ Ghent, Lab Pharmaceut Technol, Ghent, Belgium	Ghent University; University of Antwerp; Ghent University	Coenye, T (corresponding author), Univ Ghent, Lab Pharmaceut Microbiol, Ghent, Belgium.	Tom.Coenye@UGent.be	cos, paul/AAU-3896-2020; Cos, Paul/L-9717-2015; Coenye, Tom/A-6291-2014; Coenye, Tom/Z-1928-2019	cos, paul/0000-0003-4361-8911; Cos, Paul/0000-0003-4361-8911; Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601; Verstraete, Glenn/0000-0001-7811-3601; Cappoen, Davie/0000-0002-3115-8797; Crabbe, Aurelie/0000-0003-3084-4418	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) [12005]; Research Foundation Flanders	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders(FWO)	This work was funded by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen, SBO programme) (grant no. 12005) and by the Research Foundation Flanders (Odysseus grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BD, 2008, AM J TRANSPLANT, V8, P1025, DOI 10.1111/j.1600-6143.2008.02186.x; Bang CS, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-65; Barrila J, 2010, NAT REV MICROBIOL, V8, P791, DOI 10.1038/nrmicro2423; Bernal P, 2013, MICROB BIOTECHNOL, V6, P445, DOI 10.1111/1751-7915.12044; Bhandari K, 2009, EUR J MED CHEM, V44, P437, DOI 10.1016/j.ejmech.2008.01.006; Brackman G, 2011, ANTIMICROB AGENTS CH, V55, P2655, DOI 10.1128/AAC.00045-11; Brown D, 2015, NAT REV DRUG DISCOV, V14, P821, DOI 10.1038/nrd4675; Buroni S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-200; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Carterson AJ, 2005, INFECT IMMUN, V73, P1129, DOI 10.1128/IAI.73.2.1129-1140.2005; Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018; Coenye T, 2010, FUTURE MICROBIOL, V5, P1087, DOI 10.2217/FMB.10.68; Courtney J M, 2004, J Cyst Fibros, V3, P93, DOI 10.1016/j.jcf.2004.01.005; Crabbe A, 2011, CELL MICROBIOL, V13, P469, DOI 10.1111/j.1462-5822.2010.01548.x; Czaika VA, 2013, MYCOSES, V56, P16, DOI 10.1111/myc.12055; David J, 2014, MICROBES INFECT, V16, P735, DOI 10.1016/j.micinf.2014.04.001; DELOUVOIS J, 1980, J ANTIMICROB CHEMOTH, V6, P798, DOI 10.1093/jac/6.6.798; Douglas SG, RAUS RESP CARE PHARM; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Gonzalez-Lamothe R, 2009, INT J MOL SCI, V10, P3400, DOI 10.3390/ijms10083400; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Kikuchi K, 2005, BRIT J PHARMACOL, V144, P840, DOI 10.1038/sj.bjp.0706095; Lamothe J, 2008, MICROBIOL-SGM, V154, P3825, DOI 10.1099/mic.0.2008/023200-0; Lelkes PI, 1997, IN VITRO CELL DEV-AN, V33, P344; LiPuma JJ, 2005, CURR OPIN PULM MED, V11, P528, DOI 10.1097/01.mcp.0000181475.85187.ed; Martin DW, 2000, INFECT IMMUN, V68, P24, DOI 10.1128/IAI.68.1.24-29.2000; Martins M, 2008, INT J ANTIMICROB AG, V31, P198, DOI 10.1016/j.ijantimicag.2007.10.025; Murray S, 2008, AM J RESP CRIT CARE, V178, P363, DOI 10.1164/rccm.200712-1834OC; Nobre LS, 2010, J BACTERIOL, V192, P1527, DOI 10.1128/JB.01378-09; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Piel G, 1999, INT J PHARM, V180, P41, DOI 10.1016/S0378-5173(98)00403-7; Pietschmann S, 2009, VET RES COMMUN, V33, P489, DOI 10.1007/s11259-008-9194-z; Reik R, 2005, J CLIN MICROBIOL, V43, P2926, DOI 10.1128/JCM.43.6.2926-2928.2005; Schwab U, 2014, INFECT IMMUN, V82, P4729, DOI 10.1128/IAI.01876-14; Seed KD, 2008, INFECT IMMUN, V76, P1267, DOI 10.1128/IAI.01249-07; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; SUD IJ, 1982, ANTIMICROB AGENTS CH, V22, P470, DOI 10.1128/AAC.22.3.470; Sugita T, 2010, BIOL PHARM BULL, V33, P125, DOI 10.1248/bpb.33.125; Van den Driessche F, 2014, J MICROBIOL METH, V98, P31, DOI 10.1016/j.mimet.2013.12.011; Washington JA, 1983, DIAGN MICROBIOL INFE, V1, P25; Younis W, 2015, CURR PHARM DESIGN, V21, P4106, DOI 10.2174/1381612821666150506154434	43	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172723	10.1371/journal.pone.0172723	http://dx.doi.org/10.1371/journal.pone.0172723			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248999	Green Published, Green Submitted, gold			2022-12-26	WOS:000395983500053
J	Zhai, Z; Liu, W; Kaur, M; Luo, Y; Domenico, J; Samson, JM; Shellman, YG; Norris, DA; Dinarello, CA; Spritz, RA; Fujita, M				Zhai, Z.; Liu, W.; Kaur, M.; Luo, Y.; Domenico, J.; Samson, J. M.; Shellman, Y. G.; Norris, D. A.; Dinarello, C. A.; Spritz, R. A.; Fujita, M.			NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma	ONCOGENE			English	Article							CASPASE-1 ACTIVATION; EXPRESSION PROFILES; CELL-DEATH; CANCER; PROGRESSION; IMMUNITY; NALP1	Inflammasomes are mediators of inflammation, and constitutively activated NLRP3 inflammasomes have been linked to interleukin-1 beta (IL-1 beta)-mediated tumorigenesis in human melanoma. Whereas NLRP3 regulation of caspase-1 activation requires the adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD (caspase recruitment domain)), caspase-1 activation by another danger-signaling sensor NLRP1 does not require ASC because NLRP1 contains a C-terminal CARD domain that facilitates direct caspase-1 activation via CARD-CARD interaction. We hypothesized that NLRP1 has additional biological activities besides IL-1 beta maturation and investigated its role in melanoma tumorigenesis. NLRP1 expression in melanoma was confirmed by analysis of 216 melanoma tumors and 13 human melanoma cell lines. Unlike monocytic THP-1 cells with prominent nuclear localization of NLRP1, melanoma cells expressed NLRP1 mainly in the cytoplasm. Knocking down NLRP1 revealed a tumor-promoting property of NLRP1 both in vitro and in vivo. Mechanistic studies showed that caspase-1 activity, IL-1 beta production, IL-1 beta secretion and nuclear factor-kB activity were reduced by knocking down of NLRP1 in human metastatic melanoma cell lines 1205Lu and HS294T, indicating that NLRP1 inflammasomes are active in metastatic melanoma. However, unlike previous reports showing that NLRP1 enhances pyroptosis in macrophages, NLRP1 in melanoma behaved differently in the context of cell death. Knocking down NLRP1 increased caspase-2, -9 and 3/7 activities and promoted apoptosis in human melanoma cells. Immunoprecipitation revealed interaction of NLRP1 with CARD-containing caspase-2 and -9, whereas NLRP3 lacking a CARD motif did not interact with the caspases. Consistent with these findings, NLRP1 activation but not NLRP3 activation reduced caspase-2, -9 and 3/7 activities and provided protection against apoptosis in human melanoma cells, suggesting a suppressive role of NLRP1 in caspase-3/7 activation and apoptosis via interaction with caspase-2 and -9. In summary, we showed that NLRP1 promotes melanoma growth by enhancing inflammasome activation and suppressing apoptotic pathways. Our study demonstrates a tumor-promoting role of NLRP1 in cancer cells.	[Zhai, Z.; Liu, W.; Kaur, M.; Luo, Y.; Domenico, J.; Samson, J. M.; Shellman, Y. G.; Norris, D. A.; Fujita, M.] Univ Colorado Denver SOM, Dept Dermatol, 12801 E 17th Ave,RC-1 South,Room 4124, Aurora, CO 80045 USA; [Norris, D. A.; Fujita, M.] Denver Vet Affairs Med Ctr, Denver, CO USA; [Dinarello, C. A.] Univ Colorado Denver SOM, Dept Med, Aurora, CO 80045 USA; [Spritz, R. A.] Univ Colorado Denver SOM, Human Med Genet & Genom Program, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Fujita, M (corresponding author), Univ Colorado Denver SOM, Dept Dermatol, 12801 E 17th Ave,RC-1 South,Room 4124, Aurora, CO 80045 USA.	mayumi.fujita@ucdenver.edu	Dinarello, Charles/C-8524-2013	Zhai, Zili/0000-0001-5164-3696; Shellman, Yiqun/0000-0003-0598-5753	University of Colorado Cancer Center (UCCC) [P30CA046934]; Skin Diseases Research Cores Grant [P30AR057212]; NIH/NCATS Colorado CTSI [UL1 TR001082]; Veterans Affairs Merit Review [5I01BX001228]; NIH/NCI [R01CA197919]; Cancer League of Colorado; NIH/NIAMS [2R01AR045584];  [5T32AR007411-32]; NATIONAL CANCER INSTITUTE [R01CA197919, P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045584, T32AR007411, P30AR057212] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001228] Funding Source: NIH RePORTER	University of Colorado Cancer Center (UCCC); Skin Diseases Research Cores Grant; NIH/NCATS Colorado CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Veterans Affairs Merit Review(US Department of Veterans Affairs); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer League of Colorado; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank the University of Colorado Cancer Center (UCCC) Support Grant (P30CA046934), the Skin Diseases Research Cores Grant (P30AR057212), the Flow Cytometry Core (Christine Childs and Karen Helm) for helping with FACS, and Dr Archana Gopalan (University of Colorado Anschutz Medical Campus) for helping with animal experiments. Imaging experiments were performed in the University of Colorado Anschutz Medical Campus Advance Light Microscopy Core (Radu Moldovan) supported in part by NIH/NCATS Colorado CTSI Grant Number UL1 TR001082. ZZ and JMS are recipients of a training grant, 5T32AR007411-32. This work was supported, in whole or in part, by Veterans Affairs Merit Review Award 5I01BX001228 (to MF), NIH/NCI R01CA197919 (to MF), Cancer League of Colorado (to MF) and NIH/NIAMS 2R01AR045584 (to RAS and MF).	Ahmad I, 2013, TOXICOL APPL PHARM, V270, P70, DOI 10.1016/j.taap.2013.03.027; Bani MR, 1996, CANCER RES, V56, P3075; Baptiste-Okoh N, 2008, P NATL ACAD SCI USA, V105, P1937, DOI 10.1073/pnas.0711800105; Bouchier-Hayes L, 2002, EMBO REP, V3, P616, DOI 10.1093/embo-reports/kvf139; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Caporali S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-252; Cervantes J, 2008, CELL MICROBIOL, V10, P41, DOI 10.1111/j.1462-5822.2007.01012.x; Chanput W, 2014, INT IMMUNOPHARMACOL, V23, P37, DOI 10.1016/j.intimp.2014.08.002; Chavarria-Smith J, 2015, IMMUNOL REV, V265, P22, DOI 10.1111/imr.12283; Chow MT, 2012, CANCER RES, V72, P5721, DOI 10.1158/0008-5472.CAN-12-0509; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Datta-Mitra A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121626; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; Dunn JH, 2012, CANCER LETT, V314, P24, DOI 10.1016/j.canlet.2011.10.001; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Kabbarah O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010770; Kent A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00185; Kodiha M, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-25; Kolb R, 2014, PROTEIN CELL, V5, P12, DOI 10.1007/s13238-013-0001-4; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Labbe K, 2011, PROG INFLAMM RES SER, P17, DOI 10.1007/978-3-0348-0148-5_2; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Liu WM, 2013, J INVEST DERMATOL, V133, P518, DOI 10.1038/jid.2012.317; Lo CF, 2008, BIOCHEM BIOPH RES CO, V366, P664, DOI 10.1016/j.bbrc.2007.11.174; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meng XF, 2014, MOL NEUROBIOL, V49, P673, DOI 10.1007/s12035-013-8551-2; Modlin IM, 2006, ANN SURG, V244, P52, DOI 10.1097/01.sla.0000217617.06782.d5; Multhoff G, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00098; Newman ZL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000906; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Raskin L, 2013, J INVEST DERMATOL, V133, P2585, DOI 10.1038/jid.2013.197; Rayamajhi Manira, 2013, Methods Mol Biol, V1040, P85, DOI 10.1007/978-1-62703-523-1_7; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Solinas G, 2010, CANCER METAST REV, V29, P243, DOI 10.1007/s10555-010-9227-2; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Tarassishin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103432; TRASK DK, 1988, P NATL ACAD SCI USA, V85, P1417, DOI 10.1073/pnas.85.5.1417; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Watari K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099568; Zhong FL, 2016, CELL, V167, P187, DOI 10.1016/j.cell.2016.09.001	45	62	67	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 6	2017	36	27					3820	3830		10.1038/onc.2017.26	http://dx.doi.org/10.1038/onc.2017.26			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EZ6SM	28263976	Green Accepted, Green Submitted			2022-12-26	WOS:000404848200003
J	Marttila-Ichihara, F; Elima, K; Auvinen, K; Veres, TZ; Rantakari, P; Weston, C; Miyasaka, M; Adams, D; Jalkanen, S; Salmi, M				Marttila-Ichihara, Fumiko; Elima, Kati; Auvinen, Kaisa; Veres, Tibor Z.; Rantakari, Pia; Weston, Christopher; Miyasaka, Masayuki; Adams, David; Jalkanen, Sirpa; Salmi, Marko			Amine oxidase activity regulates the development of pulmonary fibrosis	FASEB JOURNAL			English	Article						IPF; AOC3 enzyme; myofibroblasts; reactive oxygen species	VASCULAR ADHESION PROTEIN-1; INTERSTITIAL LUNG-DISEASE; INNATE LYMPHOID-CELLS; MYOFIBROBLAST DIFFERENTIATION; IN-VIVO; FIBROGENIC RESPONSES; RESIDENT FIBROBLASTS; LEUKOCYTE MIGRATION; SMOOTH-MUSCLE; INFLAMMATION	In pulmonary fibrosis, an inflammatory reaction and differentiation of myofibroblasts culminate in pathologic deposition of collagen. Amine oxidase copper containing-3 (AOC3) is a cell-surface-expressed oxidase that regulates leukocyte extravasation. Here we analyzed the potential role of AOC3 using gene-modified and inhibitor-treatedmice in a bleomycin-induced pulmonary fibrosis model. Inflammation and fibrosis of lungswere assessed by histologic, flow cytometric, and quantitative PCR analysis. AOC3-deficient mice showed a 30-50% reduction in fibrosis, collagen synthesis, numbers ofmyofibroblasts, and accumulation of CD4(+) lymphocytes, NK T cells, macrophages, andtype 2 innate lymphoidcells compared with wild-type controlmice. AOC3-knock-inmice, which express a catalytically inactive form of AOC3, were also protected from lung fibrosis. In wild-type mice, a small-moleculeAOC3inhibitor treatment reduced leukocyte infiltration, myofibroblast differentiation, andfibrotic injury both in prophylactic and early therapeutic settings by about 50% but was unable to reverse the established fibrosis. AOC3 was also induced in myofibroblasts in human idiopathic pulmonary fibrosis. Thus, the oxidase activity of AOC3 contributes to the development of lung fibrosis mainly by regulating the accumulation of pathogenic leukocyte subtypes, which drive the fibrotic response.-Marttila-Ichihara, F., Elima, K., Auvinen, K., Veres, T. Z., Rantakari, P., Weston, C., Miyasaka, M., Adams, D., Jalkanen, S., Salmi, M. Amine oxidase activity regulates the development of pulmonary fibrosis.	[Marttila-Ichihara, Fumiko; Elima, Kati; Auvinen, Kaisa; Veres, Tibor Z.; Rantakari, Pia; Miyasaka, Masayuki; Jalkanen, Sirpa; Salmi, Marko] Univ Turku, MediC Res Lab, Tykistokatu 6 A, FIN-20520 Turku, Finland; [Elima, Kati] Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Jalkanen, Sirpa; Salmi, Marko] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland; [Weston, Christopher; Adams, David] Univ Birmingham, Ctr Liver Res, Birmingham, W Midlands, England; [Weston, Christopher; Adams, David] Univ Birmingham, NIHR Birmingham Biomed Res Unit, Birmingham, W Midlands, England; [Miyasaka, Masayuki] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan	University of Turku; University of Turku; University of Turku; University of Birmingham; University of Birmingham; Osaka University	Marttila-Ichihara, F (corresponding author), Univ Turku, MediC Res Lab, Tykistokatu 6 A, FIN-20520 Turku, Finland.	fumiko.marttila@utu.fi	Miyasaka, Masayuki/AAM-6343-2020; Adams, David H/C-9092-2009	Adams, David H/0000-0001-6776-0336; Weston, Chris/0000-0002-9651-1264; Rantakari, Pia/0000-0003-1638-5075	Finnish Academy; Sigrid Juselius Foundation; Medical Research Council [G0300101, MR/M009157/1, G0300102, MC_PC_14123, G0700301, G0802577, G0400496] Funding Source: researchfish; National Institute for Health Research [NF-SI-0616-10012, NF-SI-0512-10080] Funding Source: researchfish; MRC [MR/M009157/1, G0400496, G0300101, G0700301, G0300102, MC_PC_14123, G0802577] Funding Source: UKRI	Finnish Academy(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Finnish Academy and the Sigrid Juselius Foundation. The authors thank Biotie Therapies (Turku, Finland) for providing the SSAO knock-in mice; Joona Valtonen for advice; Heidi Gerke, Ruth Fair-Makela, Norma Jappinen, Emmi Lokka, and Laura Kahari for help with an animal experiment; and Sari Maki, Riikka Sjoroos, and Maritta Pohjansalo (all from MediCity Research Laboratory, University of Turku) for expert technical assistance.	Aalto K, 2011, BLOOD, V118, P3725, DOI 10.1182/blood-2010-09-311076; Ahluwalia N, 2014, AM J RESP CRIT CARE, V190, P867, DOI 10.1164/rccm.201403-0509PP; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Barron L, 2016, AM J PATHOL, V186, P2519, DOI 10.1016/j.ajpath.2016.07.004; Bocchino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014003; Bonder CS, 2005, IMMUNITY, V23, P153, DOI 10.1016/j.immuni.2005.06.007; Bono P, 1999, AM J PATHOL, V155, P1613, DOI 10.1016/S0002-9440(10)65477-6; Borthwick LA, 2013, BBA-MOL BASIS DIS, V1832, P1049, DOI 10.1016/j.bbadis.2012.09.014; Byers DE, 2013, J CLIN INVEST, V123, P3967, DOI 10.1172/JCI65570; Cai GQ, 2012, AM J PHYSIOL-LUNG C, V303, pL692, DOI 10.1152/ajplung.00390.2011; Della Latta V, 2015, PHARMACOL RES, V97, P122, DOI 10.1016/j.phrs.2015.04.012; Dunkel J, 2014, EUR J IMMUNOL, V44, P3232, DOI 10.1002/eji.201444563; Fischer A, 2012, LANCET, V380, P689, DOI 10.1016/S0140-6736(12)61079-4; Foot JS, 2013, J PHARMACOL EXP THER, V347, P365, DOI 10.1124/jpet.113.207613; Foot JS, 2012, BIOORG MED CHEM LETT, V22, P3935, DOI 10.1016/j.bmcl.2012.04.111; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hsia LT, 2016, P NATL ACAD SCI USA, V113, pE2162, DOI 10.1073/pnas.1603534113; Hung C, 2013, AM J RESP CRIT CARE, V188, P820, DOI 10.1164/rccm.201212-2297OC; Ishii T, 2006, EUR RESPIR J, V27, P300, DOI 10.1183/09031936.06.00090405; Jalkanen S, 2007, BLOOD, V110, P1864, DOI 10.1182/blood-2007-01-069674; Jarnicki AG, 2016, BRIT J PHARMACOL, V173, P3161, DOI 10.1111/bph.13573; Karikoski M, 2014, CLIN CANCER RES, V20, P6452, DOI 10.1158/1078-0432.CCR-14-1236; Katagiri D, 2016, KIDNEY INT, V89, P374, DOI 10.1038/ki.2015.327; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kiss J, 2008, EUR J IMMUNOL, V38, P3041, DOI 10.1002/eji.200838651; Kivi E, 2009, BLOOD, V114, P5385, DOI 10.1182/blood-2009-04-219253; Kliment CR, 2010, FREE RADICAL BIO MED, V49, P707, DOI 10.1016/j.freeradbiomed.2010.04.036; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Langenbach SY, 2007, CAN J PHYSIOL PHARM, V85, P727, DOI 10.1139/Y07-065; Li D, 2014, J ALLERGY CLIN IMMUN, V134, P1422, DOI 10.1016/j.jaci.2014.05.011; Manoury B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-11; Marttila-Ichihara F, 2006, ARTHRITIS RHEUM-US, V54, P2852, DOI 10.1002/art.22061; Marttila-Ichihara F, 2010, J IMMUNOL, V184, P3164, DOI 10.4049/jimmunol.0901794; Marttila-Ichihara F, 2009, CANCER RES, V69, P7875, DOI 10.1158/0008-5472.CAN-09-1205; Merinen M, 2005, AM J PATHOL, V166, P793, DOI 10.1016/S0002-9440(10)62300-0; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Nanthakumar CB, 2015, NAT REV DRUG DISCOV, V14, P693, DOI 10.1038/nrd4592; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008; O'Rourke AM, 2008, J PHARMACOL EXP THER, V324, P867, DOI 10.1124/jpet.107.131672; Roybal JD, 2011, MOL CANCER RES, V9, P25, DOI 10.1158/1541-7786.MCR-10-0497; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341; Salmi M, 2014, SEMIN IMMUNOPATHOL, V36, P163, DOI 10.1007/s00281-014-0417-9; Salter-Cid LM, 2005, J PHARMACOL EXP THER, V315, P553, DOI 10.1124/jpet.105.089649; Schilter HC, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0200-z; Schwaiblmair Martin, 2012, Open Respir Med J, V6, P63, DOI 10.2174/1874306401206010063; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; Spagnolo P, 2014, EXPERT REV CLIN IMMU, V10, P1005, DOI 10.1586/1744666X.2014.917050; Stolen CM, 2005, IMMUNITY, V22, P105, DOI 10.1016/j.immuni.2004.12.006; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Tumelty KE, 2014, J BIOL CHEM, V289, P2526, DOI 10.1074/jbc.M113.502617; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Volmer JB, 2006, J IMMUNOL, V176, P4449, DOI 10.4049/jimmunol.176.7.4449; Watcharotayangul J, 2012, J NEUROCHEM, V123, P116, DOI 10.1111/j.1471-4159.2012.07950.x; Weber SC, 2011, PEDIATR RES, V70, P236, DOI 10.1203/PDR.0b013e318225f748; Weston CJ, 2015, J CLIN INVEST, V125, P501, DOI 10.1172/JCI73722; Williamson JD, 2015, EXP LUNG RES, V41, P57, DOI 10.3109/01902148.2014.979516; Wong M, 2014, AM J PHYSIOL-RENAL, V307, pF908, DOI 10.1152/ajprenal.00698.2013; Xu HL, 2006, J PHARMACOL EXP THER, V317, P19, DOI 10.1124/jpet.105.096958; Yanaba K, 2013, INT J RHEUM DIS, V16, P442, DOI 10.1111/1756-185X.12094; Yang SZ, 2013, FASEB J, V27, P2382, DOI 10.1096/fj.12-219493; Yu PH, 2006, AM J PATHOL, V168, P718, DOI 10.2353/ajpath.2006.050970	67	6	8	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2477	2491		10.1096/fj.201600935R	http://dx.doi.org/10.1096/fj.201600935R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28251930				2022-12-26	WOS:000401553400022
J	Majkowska, I; Shitomi, Y; Ito, N; Gray, NS; Itoh, Y				Majkowska, Iwona; Shitomi, Yasuyuki; Ito, Noriko; Gray, Nathanael S.; Itoh, Yoshifumi			Discoidin domain receptor 2 mediates collagen-induced activation of membrane-type 1 matrix metalloproteinase in human fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GELATINASE-A ACTIVATION; RHEUMATOID-ARTHRITIS; IMATINIB MESYLATE; MT1-MMP MMP-14; CELL-SURFACE; EXPRESSION; INHIBITION; MECHANISM; DDR2; METASTASIS	Membrane-type 1 matrix metalloproteinase (MT1-MMP) is a membrane-bound MMP that is highly expressed in cells with invading capacity, including fibroblasts and invasive cancer cells. However, pathways of MT1-MMP up-regulation are not clearly understood. Apotential physiological stimulus for MT1MMPexpression is fibrillar collagen, and it has been shown that it up-regulates both MT1-MMP gene and functions in various cell types. However, the mechanisms of collagen-mediated MT1-MMP activation and its physiological relevance are not known. In this study, we identified discoidin domain receptor 2 (DDR2) as a crucial receptor that mediates this process in human fibroblasts. Knocking down DDR2, but not the 1 integrin subunit, a common subunit for all collagen-binding integrins, inhibited the collagen-induced MT1-MMP-dependent activation of pro-MMP-2 and up-regulation of MT1-MMP at the gene and protein levels. Interestingly, DDR2 knockdown or pharmacological inhibition of DDR2 also inhibited the MT1MMP- dependent cellular degradation of collagen film, suggesting that cell-surface collagen degradation by MT1-MMP involves DDR2-mediated collagen signaling. This DDR2-mediated mechanism is only present in non-transformed mesenchymal cells as collagen-induced MT1-MMP activation in HT1080 fibrosarcoma cells and MT1-MMP function in MDA-MB231 breast cancer cells were not affected by DDR kinase inhibition. DDR2activation was found to be noticeably more effective when cells were stimulated by collagen without the non-helical telopeptide region compared with intact collagen fibrils. Furthermore, DDR2-dependent MT1-MMP activation by cartilage was found to be more efficient when the tissue was partially damaged. These data suggest that DDR2 is a microenvironment sensor that regulates fibroblast migration in a collagen-rich environment.	[Majkowska, Iwona; Shitomi, Yasuyuki; Ito, Noriko; Itoh, Yoshifumi] Univ Oxford, Kennedy Inst Rheumatol, Roosevelt Dr, Oxford OX3 7FY, England; [Gray, Nathanael S.] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02215 USA	University of Oxford; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Itoh, Y (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Kennedy Inst Rheumatol, Roosevelt Dr, Oxford OX3 7FY, England.	yoshi.itoh@kennedy.ox.ac.uk		Itoh, Yoshifumi/0000-0002-2128-2823	Arthritis Research UK Program [19797]; Arthritis Research UK Centre for Osteoarthritis Pathogenesis [20205]; National Institutes of Health P01 Grant [CA154303-04]; Kennedy Trust for Rheumatology Research; MRC [G0802007] Funding Source: UKRI; Medical Research Council [G0802007] Funding Source: researchfish; Versus Arthritis [19797] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA154303] Funding Source: NIH RePORTER	Arthritis Research UK Program(Versus Arthritis); Arthritis Research UK Centre for Osteoarthritis Pathogenesis(Versus Arthritis); National Institutes of Health P01 Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kennedy Trust for Rheumatology Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Arthritis Research UK Program Grant 19797 (to Y. I.), Arthritis Research UK Centre for Osteoarthritis Pathogenesis Grant 20205 (Y. I.), National Institutes of Health P01 Grant CA154303-04 (to N. S. G.), and a Ph.D. studentship from the Kennedy Trust for Rheumatology Research (to I. M. and Y. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akashi N, 2011, MOD RHEUMATOL, V21, P267, DOI 10.1007/s10165-010-0392-5; Ando W, 2006, J BONE MINER METAB, V24, P274, DOI 10.1007/s00774-006-0684-1; AZZAM HS, 1992, CANCER RES, V52, P4540; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Carafoli F, 2009, STRUCTURE, V17, P1573, DOI 10.1016/j.str.2009.10.012; Day E, 2008, EUR J PHARMACOL, V599, P44, DOI 10.1016/j.ejphar.2008.10.014; Ellerbroek SM, 1999, CANCER RES, V59, P1635; Evans Richard D., 2007, V135, P239; Flynn LA, 2010, J MOL BIOL, V395, P533, DOI 10.1016/j.jmb.2009.10.073; Haas TL, 1998, J BIOL CHEM, V273, P3604, DOI 10.1074/jbc.273.6.3604; Honda S, 2001, CLIN EXP IMMUNOL, V126, P131, DOI 10.1046/j.1365-2249.2001.01624.x; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Itoh Y, 2015, MATRIX BIOL, V44-46, P207, DOI 10.1016/j.matbio.2015.03.004; Itoh Y, 2006, MOL BIOL CELL, V17, P5390, DOI 10.1091/mbc.e06-08-0740; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Juin A, 2014, J CELL BIOL, V207, P517, DOI 10.1083/jcb.201404079; Kadono Y, 1998, BIOCHEM BIOPH RES CO, V251, P681, DOI 10.1006/bbrc.1998.9531; Kaneko K, 2016, ARTHRITIS RHEUMATOL, V68, P521, DOI 10.1002/art.39414; Kim H, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1111/CHS0.12019; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Lafleur MA, 2006, J BIOL CHEM, V281, P6826, DOI 10.1074/jbc.M513084200; Lehti K, 1998, BIOCHEM J, V334, P345, DOI 10.1042/bj3340345; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Little CB, 2007, J CLIN INVEST, V117, P1627, DOI 10.1172/JCI30765; Manning HB, 2013, MATRIX BIOL, V32, P32, DOI 10.1016/j.matbio.2012.11.012; Miller MC, 2009, ARTHRITIS RHEUM-US, V60, P686, DOI 10.1002/art.24331; Morris EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08389; Nagase H., 2014, PROTEASES STRUCTURE, P433; Okada A, 1997, J CELL BIOL, V137, P67, DOI 10.1083/jcb.137.1.67; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; OVERALL CM, 1990, J BIOL CHEM, V265, P21141; Palmisano R, 2010, METHODS MOL BIOL, V622, P379, DOI 10.1007/978-1-60327-299-5_23; Paniagua RT, 2006, J CLIN INVEST, V116, P2633, DOI 10.1172/JCI28546; Petrow PK, 2002, ANN RHEUM DIS, V61, P391, DOI 10.1136/ard.61.5.391; Pratta MA, 2003, J BIOL CHEM, V278, P45539, DOI 10.1074/jbc.M303737200; Ren TT, 2014, J PATHOL, V234, P526, DOI 10.1002/path.4415; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sabeh F, 2010, J IMMUNOL, V184, P6396, DOI 10.4049/jimmunol.0904068; Saby C, 2016, ONCOTARGET, V7, P24908, DOI 10.18632/oncotarget.8795; Sakamoto T, 2011, J BIOL CHEM, V286, P14691, DOI 10.1074/jbc.M110.188714; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Sato K, 2000, J BIOL CHEM, V275, P25870, DOI 10.1074/jbc.M003700200; Stanton H, 1998, J CELL SCI, V111, P2789; Swanson CD, 2009, NAT REV RHEUMATOL, V5, P317, DOI 10.1038/nrrheum.2009.82; Tomasek JJ, 1997, J BIOL CHEM, V272, P7482, DOI 10.1074/jbc.272.11.7482; Xu HF, 2011, MATRIX BIOL, V30, P16, DOI 10.1016/j.matbio.2010.10.004; Xu L, 2005, J BIOL CHEM, V280, P548, DOI 10.1074/jbc.M411036200; Yang K, 2005, J BIOL CHEM, V280, P39058, DOI 10.1074/jbc.M506921200; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743	50	23	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6633	6643		10.1074/jbc.M116.770057	http://dx.doi.org/10.1074/jbc.M116.770057			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28270508	Green Published, hybrid			2022-12-26	WOS:000399813400016
J	Sinha, I; Poonia, P; Sawhney, S; Natarajan, K				Sinha, Ishani; Poonia, Poonam; Sawhney, Sonal; Natarajan, Krishnamurthy			Functional specialization of two paralogous TAF12 variants by their selective association with SAGA and TFIID transcriptional regulatory complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II TRANSCRIPTION; PROTEIN-ASSOCIATED FACTORS; HISTONE-FOLD; ACTIVATION DOMAIN; COACTIVATOR; YEAST; BINDING; GENE; INTERACTS; EVOLUTION	TATA box-binding protein (TBP)-associated factors (TAFs), evolutionarily conserved from yeast to humans, play a central role during transcription initiation. A subset of TAF proteins is shared in transcription factor II D(TFIID) and SAGA transcription regulatory complexes. Although higher eukaryotes contain multiple TAF variants that specify tissue-and developmental stage-specific organization of TFIID or SAGA complexes, in unicellular genomes, however, each TAF is encoded by a single gene. Surprisingly, we found that the genome of Candida albicans, the predominant human fungal pathogen, contains two paralogous TAF12 genes, CaTAF12L and CaTAF12, encoding H2B-like histone- fold domain-containing variants. Of the available fungal genome sequences, only seven other closely related diploid pathogenic Candida genomes encode the two TAF12 paralogs. Using affinity purifications from C. albicans cell extracts, we demonstrate that CaTAF12L uniquely associates with the SAGA complex and CaTAF12 associates with the TFIID complex. We further show that CaTAF12, but not CaTAF12L, is essential for C. albicans growth. Conditional depletion of the two TAF12 variant proteins caused distinct cellular and colony phenotypes. Together our results define a specialized organization of the TAF12 variants and non-redundant roles for the two TAF12 variants in the unicellular C. albicans genome.	[Sinha, Ishani; Poonia, Poonam; Sawhney, Sonal; Natarajan, Krishnamurthy] Jawaharlal Nehru Univ, Lab Eukaryot Gene Regulat, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Natarajan, K (corresponding author), Jawaharlal Nehru Univ, Lab Eukaryot Gene Regulat, Sch Life Sci, New Delhi 110067, India.	nat0200@mail.jnu.ac.in	Kumar, Shambhu/O-7598-2017	Kumar, Shambhu/0000-0003-0567-3346; Kumar, Shambhu/0000-0003-1225-1790	Department of Biotechnology; DST-PURSE; UPE2; DST-FIST; UGC-NRC; Council of Scientific and Industrial Research, New Delhi; Indian Council for Medical Research, New Delhi	Department of Biotechnology; DST-PURSE; UPE2; DST-FIST(Department of Science & Technology (India)); UGC-NRC; Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Indian Council for Medical Research, New Delhi(Indian Council of Agricultural Research (ICAR)Indian Council of Medical Research (ICMR))	This work was partially supported by a grant from the Department of Biotechnology and through the DST-PURSE and UPE2 grants, and departmental funding under DST-FIST and UGC-NRC grants. This work was also supported by junior and senior research fellowships from the Council of Scientific and Industrial Research, New Delhi (to I. S. and P. P.) and by a senior research fellowship from the Indian Council for Medical Research, New Delhi (to S. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Apone LM, 1998, NATURE, V393, P114, DOI 10.1038/30097; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Dikstein R, 1996, CELL, V87, P137, DOI 10.1016/S0092-8674(00)81330-6; Drysdale CM, 1998, MOL CELL BIOL, V18, P1711, DOI 10.1128/MCB.18.3.1711; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fishburn J, 2005, MOL CELL, V18, P369, DOI 10.1016/j.molcel.2005.03.029; Fitzpatrick DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-290; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Frontini M, 2005, MOL CELL BIOL, V25, P4638, DOI 10.1128/MCB.25.11.4638-4649.2005; Gangloff YG, 2000, MOL CELL BIOL, V20, P340, DOI 10.1128/MCB.20.1.340-351.2000; Gangloff YG, 2001, TRENDS BIOCHEM SCI, V26, P250, DOI 10.1016/S0968-0004(00)01741-2; Garbett KA, 2007, MOL CELL BIOL, V27, P297, DOI 10.1128/MCB.01558-06; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Guthrie C, 1991, METHOD ENZYMOL, V194, P3; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Han Y, 2014, EMBO J, V33, P2534, DOI 10.15252/embj.201488638; Herbig E, 2010, MOL CELL BIOL, V30, P2376, DOI 10.1128/MCB.01046-09; Hiller M, 2004, DEVELOPMENT, V131, P5297, DOI 10.1242/dev.01314; Hromatka BS, 2005, MOL BIOL CELL, V16, P4814, DOI 10.1091/mbc.E05-05-0435; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Lago C, 2004, GENE, V342, P231, DOI 10.1016/j.gene.2004.08.023; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Liu WL, 2008, MOL CELL, V29, P81, DOI 10.1016/j.molcel.2007.11.003; Liu WL, 2009, GENE DEV, V23, P1510, DOI 10.1101/gad.1790709; Maguire SL, 2013, MOL BIOL EVOL, V30, P1281, DOI 10.1093/molbev/mst042; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Mitsuzawa H, 2002, NUCLEIC ACIDS RES, V30, P1952, DOI 10.1093/nar/30.9.1952; Mitsuzawa H, 2001, J BIOL CHEM, V276, P17117, DOI 10.1074/jbc.M100248200; Moqtaderi Z, 1996, P NATL ACAD SCI USA, V93, P14654, DOI 10.1073/pnas.93.25.14654; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; Nagy Z, 2010, CELL MOL LIFE SCI, V67, P611, DOI 10.1007/s00018-009-0199-8; Natarajan K, 1998, MOL CELL, V2, P683, DOI 10.1016/S1097-2765(00)80166-5; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pointud JC, 2003, J CELL SCI, V116, P1847, DOI 10.1242/jcs.00391; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; Roberts SM, 1997, GENETICS, V147, P451; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; Sellam A, 2009, MOL BIOL CELL, V20, P2389, DOI 10.1091/mbc.E08-11-1093; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; Singh RP, 2011, J BIOL CHEM, V286, P25154, DOI 10.1074/jbc.M111.233569; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thuault S, 2002, J BIOL CHEM, V277, P45510, DOI 10.1074/jbc.M206556200; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; Wang PJ, 2002, HUM MOL GENET, V11, P2341, DOI 10.1093/hmg/11.19.2341; Weake VM, 2012, TRENDS CELL BIOL, V22, P177, DOI 10.1016/j.tcb.2011.11.005; Weake VM, 2009, GENE DEV, V23, P2818, DOI 10.1101/gad.1846409; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Wu PYJ, 2004, MOL CELL, V15, P199, DOI 10.1016/j.molcel.2004.06.005	56	4	4	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6047	6055		10.1074/jbc.C116.768549	http://dx.doi.org/10.1074/jbc.C116.768549			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28275052	Green Published, hybrid			2022-12-26	WOS:000399538700003
J	Lee, HJ; Lee, DG; Choi, SM; Park, SH; Cho, SY; Choi, JK; Kim, SH; Choi, JH; Yoo, JH; Cho, BS; Eom, KS; Lee, S; Kim, YJ; Kim, HJ; Min, CK; Kim, DW; Lee, JW; Min, WS; Jung, JI				Lee, Hyo-Jin; Lee, Dong-Gun; Choi, Su-Mi; Park, Sun Hee; Cho, Sung-Yeon; Choi, Jae-Ki; Kim, Si-Hyun; Choi, Jung-Hyun; Yoo, Jin-Hong; Cho, Byung-Sik; Eom, Ki-Seong; Lee, Seok; Kim, Yoo-Jin; Kim, Hee-Je; Min, Chang-Ki; Kim, Dong-Wook; Lee, Jong-Wook; Min, Woo-Sung; Jung, Im Jung			The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: High incidence compared with general population	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; IN-TUBE TEST; SINGLE-CENTER; MYCOBACTERIUM-TUBERCULOSIS; INFECTIOUS COMPLICATIONS; PULMONARY TUBERCULOSIS; CLINICAL CHARACTERISTICS; RISK; SURVEILLANCE; EXPERIENCE	Background The risk of developing tuberculosis (TB) in allogeneic hematopoietic stem cell transplantation (HSCT) recipients is expected to be relatively high in an intermediate TB burden country. This single-center retrospective study was conducted to investigate risk factors and the incidence of TB after allogeneic HSCT. Methods From January 2004 to March 2011, 845 adult patients were enrolled. Starting April 2009, patients were given isoniazid (INH) prophylaxis based on interferon-gamma release assay results. The incidence of TB was analyzed before and after April 2009, and compared it with that of the general population in Korea. Results TB was diagnosed in 21 (2.49%) of the 845 allogeneic HSCT patients. The median time to the development of TB was 386 days after transplantation (range, 49-886). Compared with the general population, the standardized incidence ratio of TB was 9.10 (95% CI; 5.59- 14.79). Extensive chronic graft-versus-host disease (GVHD) was associated with the development of TB (P = 0.003). Acute GVHD, conditioning regimen with total body irradiation and conditioning intensity were not significantly related. INH prophylaxis did not reduce the incidence of TB (P = 0.548). Among 21 TB patients, one patient had INH prophylaxis. Conclusion Allogeneic HSCT recipients especially those who suffer from extensive chronic GVHD are at a high risk of developing TB. INH prophylaxis did not statistically change the incidence of TB, however, further well-designed prospective studies are needed.	[Lee, Hyo-Jin; Lee, Dong-Gun; Choi, Su-Mi; Park, Sun Hee; Cho, Sung-Yeon; Choi, Jae-Ki; Kim, Si-Hyun; Choi, Jung-Hyun; Yoo, Jin-Hong] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea; [Lee, Hyo-Jin; Lee, Dong-Gun; Choi, Su-Mi; Park, Sun Hee; Cho, Sung-Yeon; Choi, Jae-Ki; Kim, Si-Hyun; Choi, Jung-Hyun; Yoo, Jin-Hong] Catholic Univ Korea, Coll Med, Vaccine Bio Res Inst, Seoul, South Korea; [Lee, Dong-Gun; Cho, Byung-Sik; Eom, Ki-Seong; Lee, Seok; Kim, Yoo-Jin; Kim, Hee-Je; Min, Chang-Ki; Kim, Dong-Wook; Lee, Jong-Wook; Min, Woo-Sung] Catholic Univ Korea, Coll Med, Catholic Blood & Marrow Transplantat Ctr, Seoul, South Korea; [Jung, Im Jung] Catholic Univ Korea, Coll Med, Dept Radiol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Lee, DG (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea.; Lee, DG (corresponding author), Catholic Univ Korea, Coll Med, Vaccine Bio Res Inst, Seoul, South Korea.; Lee, DG (corresponding author), Catholic Univ Korea, Coll Med, Catholic Blood & Marrow Transplantat Ctr, Seoul, South Korea.	symonlee@catholic.ac.kr	Park, Sun/GSD-9620-2022; Lee, Dong-Gun/AGF-9891-2022	Lee, Dong-Gun/0000-0003-4655-0641; Jung, Jung Im/0000-0001-8264-9388; Kim, Si-Hyun/0000-0002-6392-0221; Choi, Su-Mi/0000-0002-8187-5110	Catholic Research Coordinating Center of the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea [A070001]	Catholic Research Coordinating Center of the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea	The statistical consultation was supported by Catholic Research Coordinating Center of the Korea Health 21 R&D Project (A070001), Ministry of Health & Welfare, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The statistical consultation was supported by Catholic Research Coordinating Center of the Korea Health 21 R&D Project (A070001), Ministry of Health & Welfare, Republic of Korea.	Ahmed Parvez, 2005, JPMA Journal of the Pakistan Medical Association, V55, P378; Akan H, 2006, J HOSP INFECT, V62, P421, DOI 10.1016/j.jhin.2005.09.020; Al-Anazi KA, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00231; Al-Anazi Khalid Ahmed, 2007, Ann Clin Microbiol Antimicrob, V6, P16, DOI 10.1186/1476-0711-6-16; Aljurf M, 1999, BONE MARROW TRANSPL, V24, P551, DOI 10.1038/sj.bmt.1701930; Ambrossi GG, 2005, BONE MARROW TRANSPL, V36, P741, DOI 10.1038/sj.bmt.1705129; Arslan O, 1998, HAEMATOLOGIA, V29, P59; Budak-Alpdogan T, 2000, BIOL BLOOD MARROW TR, V6, P370, DOI 10.1016/S1083-8791(00)70013-9; Bumbacea D, 2012, EUR RESPIR J, V40, P990, DOI 10.1183/09031936.00000712; Cobelens FGJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006094; de la Camara R, 2000, BONE MARROW TRANSPL, V26, P291, DOI 10.1038/sj.bmt.1702506; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Eom KS, 2015, TRANSPL INFECT DIS, V17, P73, DOI 10.1111/tid.12341; Erdstein A A, 2004, Transpl Infect Dis, V6, P142, DOI 10.1111/j.1399-3062.2004.00068.x; Falzon D, 2013, LANCET INFECT DIS, V13, P690, DOI 10.1016/S1473-3099(13)70130-0; Fan WC, 2015, INT J TUBERC LUNG D, V19, P58, DOI 10.5588/ijtld.14.0301; George B, 2004, BONE MARROW TRANSPL, V33, P311, DOI 10.1038/sj.bmt.1704347; Ip MSM, 1998, AM J RESP CRIT CARE, V158, P1173, DOI 10.1164/ajrccm.158.4.9712072; Jung JI, 2009, J THORAC IMAG, V24, P10, DOI 10.1097/RTI.0b013e31818c6b97; Kim SH, 2013, TRANSPL INFECT DIS, V15, P49, DOI 10.1111/tid.12003; Kim SH, 2007, ARCH INTERN MED, V167, P2255, DOI 10.1001/archinte.167.20.2255; Korea Centers for Disease Control and Prevention, 2013, ANN REP NOT TUB KOR; Korea Centers for Disease Control and Prevention, 2012, REV NAT TUB CONTR PR; Ku SC, 2001, BONE MARROW TRANSPL, V27, P1293, DOI 10.1038/sj.bmt.1703092; Kumar R, 2009, BONE MARROW TRANSPL, V43, P115, DOI 10.1038/bmt.2008.307; Kwon JC, 2013, KOREAN J INTERN MED, V28, P187, DOI 10.3904/kjim.2013.28.2.187; Lee Dong-Gun, 2013, [The Korean Journal of Medicine, 대한내과학회지], V84, P158, DOI 10.3904/kjm.2013.84.2.158; Lee Dong-Gun, 2011, Korean Journal of Internal Medicine, V26, P220, DOI 10.3904/kjim.2011.26.2.220; Lee J, 2004, INT J HEMATOL, V79, P185, DOI 10.1532/IJH97.A10219; Lee YM, 2014, INFECT CHEMOTHER, V46, P248, DOI 10.3947/ic.2014.46.4.248; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Moon SM, 2013, TRANSPL INFECT DIS, V15, P104, DOI 10.1111/j.1399-3062.2012.00765.x; Park SH, 2006, J KOREAN MED SCI, V21, P199, DOI 10.3346/jkms.2006.21.2.199; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Roy V, 1997, BONE MARROW TRANSPL, V19, P467, DOI 10.1038/sj.bmt.1700686; Sester M, 2014, AM J RESP CRIT CARE, V190, P1168, DOI 10.1164/rccm.201405-0967OC; Shim TS, 2008, TUBERC RESPIR DIS, V65, P79, DOI 10.4046/trd.2008.65.2.79; Sun HY, 2013, TRANSPLANTATION, V95, P1173, DOI 10.1097/TP.0b013e31828719c8; Tuon FF, 2006, ACTA TROP, V99, P67, DOI 10.1016/j.actatropica.2006.07.004; Ullah K, 2007, TRANSPL P, V39, P3347, DOI 10.1016/j.transproceed.2007.08.099; Won YW, 2011, INT J HEMATOL, V93, P383, DOI 10.1007/s12185-011-0797-8; World Health Oraganization, 2016, EST TB MDR BURD PROD; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Yoo JH, 2004, BONE MARROW TRANSPL, V34, P497, DOI 10.1038/sj.bmt.1704636; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585	45	14	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173250	10.1371/journal.pone.0173250	http://dx.doi.org/10.1371/journal.pone.0173250			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278166	gold, Green Published			2022-12-26	WOS:000396087900060
J	Lee, JS; Yoo, JE; Kim, H; Rhee, H; Koh, MJ; Nahm, JH; Choi, JS; Lee, KH; Park, YN				Lee, Jee San; Yoo, Jeong Eun; Kim, Haeryoung; Rhee, Hyungjin; Koh, Myoung Ju; Nahm, Ji Hae; Choi, Jin Sub; Lee, Kee-Ho; Park, Young Nyun			Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma	PLOS ONE			English	Article							METABOLIC SYNDROME; MICROENVIRONMENT; TUMORIGENESIS; FIBROBLASTS; INFECTION; CANCER	Senescence secretome was recently reported to promote liver cancer in an obese mouse model. Steatohepatitic hepatocellular carcinoma (SH-HCC), a new variant of HCC, has been found in metabolic syndrome patients, and pericellular fibrosis, a characteristic feature of SH-HCC, suggests that alteration of the tumor stroma might play an important role in SHHCC development. Clinicopathological characteristics and tumor stroma showing senescence and senescence-associated secretory phenotype (SASP) were investigated in 21 SH-HCCs and 34 conventional HCCs (C-HCCs). The expression of a-smooth muscle actin (a-SMA), p21(Waf1/Cifi), y-H2AX, and IL-6 was investigated by immunohistochemistry or immunofluorescence. SH-HCCs were associated with older age, higher body mass index, and a higher incidence of metabolic syndrome, compared to C-HCC (P <0.05, all). The numbers of a-SMA-positive cancer-associated fibroblasts (CAFs) (P= 0.049) and a-SMA-positive CAFs co-expressing p21(Waf1/Cif1) (P = 0.038), y-H2AX (P = 0.065), and IL-6 (P = 0.048) were greater for SH-HCCs than C-HCCs. Additionally, non-tumoral liver from SH-HCCs showed a higher incidence of non-alcoholic fatty liver disease and a higher number of aSMA-positive stellate cells expressing y-H2AX and p21(Waf1/Cif1) than that from C-HCCs (P <0.05, all). In conclusion, SH-HCCs are considered to occur more frequently in metabolic syndrome patients. Therein, senescent and damaged CAFs, as well as non-tumoral stellate cells, expressing SASP including IL-6 may contribute to the development of SH-HCC.	[Lee, Jee San; Yoo, Jeong Eun; Rhee, Hyungjin; Koh, Myoung Ju; Nahm, Ji Hae; Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Lee, Jee San; Rhee, Hyungjin; Park, Young Nyun] Yonsei Univ, Coll Med, PLUS Project Med Sci BK21, Seoul, South Korea; [Lee, Jee San; Yoo, Jeong Eun; Rhee, Hyungjin; Koh, Myoung Ju; Nahm, Ji Hae; Park, Young Nyun] Yonsei Univ, Coll Med, Integrated Genom Res Ctr Metab Regulat, Seoul, South Korea; [Kim, Haeryoung] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Pathol, Seongnam, South Korea; [Choi, Jin Sub] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Lee, Kee-Ho] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Korea Institute of Radiological & Medical Sciences; Yonsei University; Yonsei University Health System	Park, YN (corresponding author), Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea.; Park, YN (corresponding author), Yonsei Univ, Coll Med, PLUS Project Med Sci BK21, Seoul, South Korea.; Park, YN (corresponding author), Yonsei Univ, Coll Med, Integrated Genom Res Ctr Metab Regulat, Seoul, South Korea.; Park, YN (corresponding author), Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea.	young0608@yuhs.ac	Rhee, Hyungjin/T-7619-2019	Nahm, Ji Hae/0000-0003-0902-866X; Kim, Haeryoung/0000-0002-4205-9081; Rhee, Hyungjin/0000-0001-7759-4458; Park, Young Nyun/0000-0003-0357-7967	National Research Foundation of Korea (NRF) grant - Korea government (MISP) [NRF-2012M3A9B6055350]	National Research Foundation of Korea (NRF) grant - Korea government (MISP)	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MISP) (Grant number: NRF-2012M3A9B6055350, to PYN). We declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2005, J HEPATOL, V42, P188, DOI 10.1016/j.jhep.2004.10.026; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Chen CL, 2008, GASTROENTEROLOGY, V135, P111, DOI 10.1053/j.gastro.2008.03.073; Cho HK, 2014, FEBS J, V281, P2228, DOI 10.1111/febs.12776; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Esposito K, 2014, J CLIN GASTROENTEROL, V48, P742, DOI 10.1097/MCG.0000000000000097; Gupta EK, 2014, CANCER GROWTH METAST, V7, P1, DOI 10.4137/CGM.S14205; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Jing YY, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-29; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; KASL, 2013, CLIN MOL HEPATOL, V19, P325, DOI 10.3350/cmh.2013.19.4.325; Kim GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105094; Kim K. J., 2007, J CREATIVE INFORM CO, V1, P1, DOI DOI 10.1053/J.GASTR0.2007.03.039; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Merican I, 2000, J GASTROEN HEPATOL, V15, P1356, DOI 10.1046/j.1440-1746.2000.0150121356.x; Na TY, 2009, HEPATOLOGY, V49, P1122, DOI 10.1002/hep.22740; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pollicino T, 2004, GASTROENTEROLOGY, V126, P102, DOI 10.1053/j.gastro.2003.10.048; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Salomao M, 2012, HUM PATHOL, V43, P737, DOI 10.1016/j.humpath.2011.07.005; Salomao M, 2010, AM J SURG PATHOL, V34, P1630, DOI 10.1097/PAS.0b013e3181f31caa; Shibahara J, 2014, HISTOPATHOLOGY, V64, P951, DOI 10.1111/his.12343; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347	28	25	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171922	10.1371/journal.pone.0171922	http://dx.doi.org/10.1371/journal.pone.0171922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273155	Green Submitted, gold, Green Published			2022-12-26	WOS:000396073700063
J	Ro, JS; Lee, JS; Kang, SC; Jung, HM				Ro, Jun-Soo; Lee, Jin-Seok; Kang, Sung-Chan; Jung, Hye-Min			Worry experienced during the 2015 Middle East Respiratory Syndrome (MERS) pandemic in Korea	PLOS ONE			English	Article							RISK; PERCEPTIONS; BREAST; BEHAVIOR; ANXIETY	Background Korea failed in its risk communication during the early stage of the Middle East Respiratory Syndrome (MERS) outbreak; consequently, it faced difficulties in managing MERS, while disease-related worry increased. Disease-related worry can help disease prevention and management, but can also have a detrimental effect. This study measured the overall level of disease-related worry during the MERS outbreak period in Korea and the influencing factors and levels of disease-related worry during key outbreak periods. Methods The cross-sectional survey included 1,000 adults who resided in Korea. An ordinal logistic regression was performed for the overall level of MERS-related worry, and influencing factors of worry were analyzed. A reliability test was performed on the levels of MERS-related worry during key outbreak periods. Results The overall level of MERS-related worry was 2.44. Multivariate analysis revealed that women and respondents w very poor subjective health status had higher levels of worry. Respondents with very high stress in daily life had higher levels of worry than those who reported having little stress. The reliability test results on MERS-related worry scores during key outbreak periods showed consistent scores during each period. Conclusion Level of worry increased in cases having higher perceived susceptibility and greater trust in informal information, while initial stage of outbreak was closely associated with that at later stages. These findings suggest the importance of managing the level of worry by providing timely and accurate disease-related information during the initial stage of disease outbreak.	[Ro, Jun-Soo] Armed Forces Med Res Inst, Res Ctr Infect & Environm Dis, Dept Infect Dis, Daejeon, South Korea; [Lee, Jin-Seok; Jung, Hye-Min] Seoul Natl Univ, Coll Med, Dept Hlth Policy & Management, Seoul, South Korea; [Lee, Jin-Seok; Kang, Sung-Chan] Seoul Natl Univ, Med Res Ctr, Inst Hlth Policy & Management, Seoul, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Seoul National University (SNU); Seoul National University (SNU)	Lee, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Hlth Policy & Management, Seoul, South Korea.; Lee, JS (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Hlth Policy & Management, Seoul, South Korea.	phealth@snu.ac.kr		Ro, Jun-soo/0000-0002-8156-5294; Kang, Sungchan/0000-0002-4876-3205; Jung, Hyemin/0000-0001-7339-7983	Ministry of Health and Welfare (Republic of Korea)	Ministry of Health and Welfare (Republic of Korea)(Ministry of Health & Welfare (MOHW), Republic of Korea)	Ministry of Health and Welfare (Republic of Korea) has supported J-SL, grant numbers: none, URLs: http://www.mohvi.go.kr/eng/index.jsp. The Funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akan H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-413; Balkhy HH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-42; Bults M, 2001, BMC PUBLIC HEALTH, V11; Cameron LD, 2006, PSYCHOL HEALTH, V21, P211, DOI 10.1080/14768320500230318; Cameron LD, 2001, J HEALTH PSYCHOL, V6, P47, DOI 10.1177/135910530100600104; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Choi JW, 2015, J KOREAN MED ASSOC, V58, P624, DOI 10.5124/jkma.2015.58.7.624; Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811; Diefenbach MA, 1999, HEALTH PSYCHOL, V18, P532, DOI 10.1037/0278-6133.18.5.532; Goodwin R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-166; Liao QY, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-169; Liao QY, 2011, INT J BEHAV MED, V18, P93, DOI 10.1007/s12529-010-9123-8; MERS, 2015, OS KOR CTR DIS CONTR; Raude J, 2009, EUR J EPIDEMIOL, V24, P339, DOI 10.1007/s10654-009-9351-x; Rubin G., 2009, BMJ-BRIT MED J, V339, P2651, DOI DOI 10.1136/BMJ.B2651; Sun GQ, 2016, PHYS LIFE REV, V19, P43, DOI 10.1016/j.plrev.2016.08.002; Xia ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144778	17	46	48	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173234	10.1371/journal.pone.0173234	http://dx.doi.org/10.1371/journal.pone.0173234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273131	Green Published, Green Submitted, gold			2022-12-26	WOS:000396073700047
J	Russo, J; Mateus, O; Marzola, M; Balbino, A				Russo, Joao; Mateus, Octavio; Marzola, Marco; Balbino, Ausenda			Two new ootaxa from the late Jurassic: The oldest record of crocodylomorph eggs, from the Lourinha Formation, Portugal	PLOS ONE			English	Article							CROCODILIAN EGGS; MIDDLE EOCENE; EGGSHELLS; MESOEUCROCODYLIA; DIVERSITY; CROCODYLIFORM; TRANSITION; ALLOMETRY; REVISION; DINOSAUR	The Late Jurassic Lourinha Formation is known for its abundant remains of dinosaurs, crocodylomorphs and other vertebrates. Among this record are nine localities that have produced either dinosaur embryos, eggs or eggshell fragments. Herein, we describe and identify the first crocodiloid morphotype eggs and eggshells from the Lourinha Formation, from five occurrences. One clutch from Cambelas, composed of 13 eggs, eggshell fragments from Casal da Rola and Peralta, one crushed egg and eggshells from Paimogo North, and four crushed eggs as well as eggshell fragments from Paimogo South. We observed and confirmed diagnostic morphological characters for crocodiloid eggshells and which are consistent with a crocodylomorph affinity, such as the ellipsoidal shape, wedgeshaped shell units, triangular extinction under cross-polarized light, and tabular ultrastructure. This material is distinctive enough to propose two new ootaxa within the oofamily Krokolithidae, Suchoolithus portucalensis, oogen. and oosp. nov., for the material from Cambelas, the most complete clutch known for crocodiloid eggs, and Krokolithes dinophilus, oosp. nov., for the remaining material. These are the oldest crocodylomorph eggs known, extending the fossil record for this group to the Late Jurassic. Furthermore, except for the clutch from Cambelas, the material was found with theropod eggs and nests, in the other four occurrences, which seem to suggest some form of biological relationship, still unclear at this point.	[Russo, Joao; Mateus, Octavio; Marzola, Marco; Balbino, Ausenda] Univ Nova Lisboa, Fac Ciencias & Tecnol, GeoBioTec, Caparica, Portugal; [Russo, Joao; Mateus, Octavio; Marzola, Marco] Museu Lourinha, Lourinha, Portugal; [Marzola, Marco] Univ Copenhagen, Dept Geosci & Nat Resource Management, Copenhagen, Denmark; [Balbino, Ausenda] Univ Evora, Dept Geociencias, Evora, Portugal	Universidade Nova de Lisboa; University of Copenhagen; University of Evora	Russo, J (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, GeoBioTec, Caparica, Portugal.; Russo, J (corresponding author), Museu Lourinha, Lourinha, Portugal.	jpvmrusso@gmail.com	Mateus, Octávio/F-2910-2010; Marzola, Marco/I-5121-2019	Mateus, Octávio/0000-0003-1253-3616; Marzola, Marco/0000-0002-7067-2502; Russo, Joao/0000-0001-7730-1395; Caceres Balbino, Ausenda/0000-0001-9441-1043	Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/BIA-EVF/11322/2009]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This research was partly funded by Fundacao para a Ciencia e Tecnologia (http://www.fct.pt/), Portugal, through the grant PTDC/BIA-EVF/11322/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, REV MUSEO ARGENTINE, V5, P13; Antunes MT, 2003, CR PALEVOL, V2, P77, DOI 10.1016/S1631-0683(03)00003-4; Antunes MT, 1998, MEM ACAD CIEN LISB, V37, P83; Araujo R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01924; Araujo R, 2012, J VERTEBR PALEONTOL, V32, P57; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; Bronzati M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140385; Bryan TA, 2005, MORPHOLOGICAL CONSTI; Buscalioni AD, 2008, CRETACEOUS RES, V29, P687, DOI 10.1016/j.cretres.2008.02.004; Canudo JI, 2010, J IBER GEOL, V36, P205, DOI 10.5209/rev_JIGE.2010.v36.n2.8; Carpenter K., 1999, EGGS NESTS BABY DINO; Carrano M, 2013, J VERTEBR PALEONTOL, V101; Castanhinha R, 2009, PORTUGAL J VERTEBR P, V29; de Lapparent AF, 1957, DINOSAURIENS PORTUGA; de Ricqles A, 2001, CR ACAD SCI II A, V332, P647, DOI 10.1016/S1251-8050(01)01580-4; Ensom P.C., 1997, P DORSET NATURAL HIS, V118, P79; Ensom PC, 2002, SPEC PAP PALAEONTOL, P221; Erben HK, 1970, ULTRASTRUKTUREN MINE; Erben HK, 1972, BIOMINERALISATION, V6, P32; Erickson BR, 1978, AMNIOTE EGG UPPER CR; FERGUSON M W J, 1982, Transactions of the Zoological Society of London, V36, P99; Ferguson M.W.J., 1985, Biology of Reptilia, V14, P329; Garcia G, 2000, GEOBIOS-LYON, V33, P113, DOI 10.1016/S0016-6995(00)80155-2; Garcia JJM, 1993, RESTOS INDIRECTOS DI; Grellet-Tinner G, 2008, DOC LAB GEOLOGIE LYO, V164; Hastings AK, 2015, PALAIOS, V30, P446, DOI 10.2110/palo.2014.062; Heller F, 1931, NOVA ACTA LEOPOLDINA, V1, P55; Hendrickx C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088905; Hill G., 1988, SEDIMENTOLOGY LITHOS; Hirsch K.F., 1992, Journal of Vertebrate Paleontology, V12, P59; Hirsch K.F., 1990, Journal of Vertebrate Paleontology, V10, P491; Hirsch Karl F., 1994, P137; HIRSCH KF, 1985, J PALEONTOL, V59, P531; Jackson FD, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1185432; Jackson FD, 2010, J VERTEBR PALEONTOL, V30, P1142, DOI 10.1080/02724634.2010.483537; Karl H-V, 2006, CLAUSTHALER GEOWISSE, V5, P59; KEROURIO P, 1987, GEOBIOS-LYON, V20, P275, DOI 10.1016/S0016-6995(87)80038-4; Kohring R., 1990, Journal of Vertebrate Paleontology, V10, P128; Kohring R, 1996, J VERTEBR PALEONTOL, V16, P67, DOI 10.1080/02724634.1996.10011285; KOHRING R, 1990, Palaeontologische Zeitschrift, V64, P329; Kohring R., 1992, FOSSILE KROKODIL EIS; Kohring R, 2000, EGGSHELLS GUIMAROTA, V87-90; Kohring Rolf, 1993, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V9, P1; Kohring Rolf, 1992, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V3, P253; Kohring Rolf R., 1995, Historical Biology, V10, P259; Krebs B., 1967, Palaeontologische Zeitschrift, V41, P46; Krebs B., 1968, CROCODILIEN MACHIMOS; KULLBERG JC, 2000, EVOLUCAO TECTONICA M; Kullberg JC, 2006, BACIA LUSITANIANA ES; Lapparent A. F., 1957, Memorias Servicos Geologicos Portugal NS, V2, P1; Larriera A, 2004, J HERPETOL, V38, P301, DOI 10.1670/145-03A; Mannion PD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9438; Mannion PD, 2013, ZOOL J LINN SOC-LOND, V168, P98, DOI 10.1111/zoj.12029; Markwick PJ, 1998, PALEOBIOLOGY, V24, P470, DOI 10.1017/S009483730002011X; Martins RM, 2011, MRS P; Marzola M, 2014, 12 ANN M EUR ASS VER, P109; Marzola M, 2015, HIST BIOL, V27, P115, DOI 10.1080/08912963.2013.871009; Mateus I, 1997, CR ACAD SCI II A, V325, P71, DOI 10.1016/S1251-8050(97)83275-2; Mateus I, 1998, MEM ACAD CIENC LISB, V37; Mateus O., 2006, N MEX MUS NAT HIST S, V36, P223; Mateus O., 2008, RES 10 C LUS ESP HER; Mateus O., 2013, HWAS INT DIN EXP S S, P66; Mateus O., 2006, PALEONTOLOGY GEOLOGY, V36, P123; Mateus O, 2014, CIENC TERRA SPEC; Mikhailov K.E., 1991, ACTA PALAENTOL POL, V36, P1991; Mikhailov K.E., 1997, FOSSIL RECENT EGGSHE; Mikhailov KE, 1996, J VERTEBR PALEONTOL, V16, P763, DOI 10.1080/02724634.1996.10011364; Moreno-Azanza M, 2014, THESIS; Moreno-Azanza M, 2015, 13 ANN M EUR ASS VER, P97; Moreno-Azanza M, 2015, CRETACEOUS RES, V56, P617, DOI 10.1016/j.cretres.2015.06.019; Moreno-Azanza M, 2014, HIST BIOL, V26, P195, DOI 10.1080/08912963.2013.786067; Murray CM, 2013, COPEIA, P268, DOI 10.1643/CH-11-136; Novas FE, 2009, J VERTEBR PALEONTOL, V29, P1316, DOI 10.1671/039.029.0409; Oliveira CEM, 2011, PALAEONTOLOGY, V54, P309, DOI 10.1111/j.1475-4983.2010.01028.x; Packard M.J., 1991, P53, DOI 10.1017/CBO9780511585739.006; PACKARD MJ, 1982, HERPETOLOGICA, V38, P136; Panades I, 2009, PAL ARCHS J VERTEBR, V6; Patnaik Rajeev, 1993, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V33, P91; Prasad GVR, 2015, CR PALEVOL, V14, P513, DOI 10.1016/j.crpv.2015.05.006; Ribeiro CMM, 2006, OVOS CROCODILOMORTOS, P285; Ribeiro CMM, 2011, OVOS CROCODILOMORFOS, P663; Ribeiro V, 2014, HIST BIOL, V26, P206, DOI 10.1080/08912963.2013.807254; Ribeiro V, 2012, J VERTEBR PALEONTOL, V32, P161; Rogers JV, 2000, J VERTEBR PALEONTOL, V20, P780, DOI 10.1671/0272-4634(2000)020[0780:ACCEFT]2.0.CO;2; Russo J, 2014, CROCODYLOMORPH EGGS; Salminen J, 2014, SPR GEOL, P873, DOI 10.1007/978-3-319-04364-7_165; Schmidt W. J., 1943, Z MORPHOL OKOL TIERE, V40, P17; Schneider S, 2009, INT J EARTH SCI, V98, P1949, DOI 10.1007/s00531-008-0359-3; Schwarz D, 2005, GEOBIOS-LYON, V38, P779, DOI 10.1016/j.geobios.2004.04.005; Schwarz D, 2004, CAN J EARTH SCI, V41, P1259, DOI 10.1139/E04-059; Schwarz D, 2002, PALAEONTOLOGY, V45, P185, DOI 10.1111/1475-4983.00233; Schwarz D, 2008, J VERTEBR PALEONTOL, V28, P264, DOI 10.1671/0272-4634(2008)28[264:TFDOLC]2.0.CO;2; Seiffert J, 1973, UPPER JURASSIC LIZAR; Singh SD, 1998, OFFENTLICHUNGEN FUHL, V4, P307; Somaweera R, 2013, HERPETOL MONOGR, V27, P23, DOI 10.1655/HERPMONOGRAPHS-D-11-00001; Srivastava R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144369; Stewart James R., 1997, P291, DOI 10.1016/B978-012676460-4/50010-X; Tanaka K, 2011, HIST BIOL, V23, P41, DOI 10.1080/08912963.2010.499171; Tennant JP, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2840; Tennant JP, 2014, PEERJ, V2, DOI 10.7717/peerj.599; Thorbjarnarson JB, 1996, HERPETOLOGICA, V52, P8; Tschopp E, 2015, PEERJ, V3, DOI 10.7717/peerj.857; Verdade L. M., 2001, Brazilian Journal of Biology, V61, P431, DOI 10.1590/S1519-69842001000300012; vonMeyer H, 1837, NEUES JB MINERAL GEO, V1837, P572; Young MT, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140269; Young MT, 2010, ZOOL J LINN SOC-LOND, V158, P801, DOI 10.1111/j.1096-3642.2009.00571.x; Zhao Zi-kui, 1975, Vertebrata Palasiatica, V13, P105	107	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171919	10.1371/journal.pone.0171919	http://dx.doi.org/10.1371/journal.pone.0171919			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273086	gold, Green Published, Green Submitted			2022-12-26	WOS:000396073700062
J	Uhlig, CH; Gutschalk, A				Uhlig, Christian Harm; Gutschalk, Alexander			Transient human auditory cortex activation during volitional attention shifting	PLOS ONE			English	Article							SPATIAL ATTENTION; SELECTIVE ATTENTION; VISUAL-CORTEX; BRAIN; MAINTENANCE; MODULATION; AUDITION; VISION; SENSITIVITY	While strong activation of auditory cortex is generally found for exogenous orienting of attention, endogenous, intra-modal shifting of auditory attention has not yet been demonstrated to evoke transient activation of the auditory cortex. Here, we used fMRI to test if endogenous shifting of attention is also associated with transient activation of the auditory cortex. In contrast to previous studies, attention shifts were completely self-initiated and not cued by transient auditory or visual stimuli. Stimuli were two dichotic, continuous streams of tones, whose perceptual grouping was not ambiguous. Participants were instructed to continuously focus on one of the streams and switch between the two after a while, indicating the time and direction of each attentional shift by pressing one of two response buttons. The BOLD response around the time of the button presses revealed robust activation of the auditory cortex, along with activation of a distributed task network. To test if the transient auditory cortex activation was specifically related to auditory orienting, a self-paced motor task was added, where participants were instructed to ignore the auditory stimulation while they pressed the response buttons in alternation and at a similar pace. Results showed that attentional orienting produced stronger activity in auditory cortex, but auditory cortex activation was also observed for button presses without focused attention to the auditory stimulus. The response related to attention shifting was stronger contralateral to the side where attention was shifted to. Contralateral-dominant activation was also observed in dorsal parietal cortex areas, confirming previous observations for auditory attention shifting in studies that used auditory cues.	[Uhlig, Christian Harm; Gutschalk, Alexander] Heidelberg Univ, Dept Neurol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Gutschalk, A (corresponding author), Heidelberg Univ, Dept Neurol, Heidelberg, Germany.	Alexander.Gutschalk@med.uni-heidelberg.de			Deutsche Forschungsgemeinschaft (DFG) [GU593/3-2]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	Research was supported by Deutsche Forschungsgemeinschaft (DFG, grant GU593/3-2). Open access publishing was supported by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Alho K, 1999, COGNITIVE BRAIN RES, V7, P335, DOI 10.1016/S0926-6410(98)00036-6; Braga RM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00164; Brosch M, 2005, J NEUROSCI, V25, P6797, DOI 10.1523/JNEUROSCI.1571-05.2005; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Coste CP, 2016, NEUROIMAGE, V128, P264, DOI 10.1016/j.neuroimage.2016.01.026; Cusack R, 2005, J COGNITIVE NEUROSCI, V17, P641, DOI 10.1162/0898929053467541; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Degerman A, 2006, BRAIN RES, V1077, P123, DOI 10.1016/j.brainres.2006.01.025; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Edmister WB, 1999, HUM BRAIN MAPP, V7, P89, DOI 10.1002/(SICI)1097-0193(1999)7:2<89::AID-HBM2>3.3.CO;2-E; Elkhetali AS, 2015, NEUROIMAGE, V107, P277, DOI 10.1016/j.neuroimage.2014.11.061; Ewertsen H. W., 1966, ACTA OTO-LARYNGOL, V63, P211, DOI [10.3109/00016486709123581, DOI 10.3109/00016486709123581]; Fedorenko E, 2013, P NATL ACAD SCI USA, V110, P16616, DOI 10.1073/pnas.1315235110; Feng WF, 2014, J NEUROSCI, V34, P9817, DOI 10.1523/JNEUROSCI.4869-13.2014; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gutschalk A, 2005, J NEUROSCI, V25, P5382, DOI 10.1523/JNEUROSCI.0347-05.2005; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Huang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044062; Hugdahl K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00430; Jack AI, 2006, NEURON, V51, P135, DOI 10.1016/j.neuron.2006.06.003; Jancke L, 2003, COGNITIVE BRAIN RES, V16, P257, DOI 10.1016/S0926-6410(02)00281-1; Joshi S, 2016, NEURON, V89, P221, DOI 10.1016/j.neuron.2015.11.028; Kondo HM, 2009, J NEUROSCI, V29, P12695, DOI 10.1523/JNEUROSCI.1549-09.2009; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Krumbholz K, 2009, HUM BRAIN MAPP, V30, P1457, DOI 10.1002/hbm.20615; Lee AKC, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00190; Maddox RK, 2014, CURR BIOL, V24, P748, DOI 10.1016/j.cub.2014.02.021; Martikainen MH, 2005, CEREB CORTEX, V15, P299, DOI 10.1093/cercor/bhh131; McGinley MJ, 2015, NEURON, V87, P179, DOI 10.1016/j.neuron.2015.05.038; Paltoglou AE, 2011, EUR J NEUROSCI, V33, P1733, DOI 10.1111/j.1460-9568.2011.07656.x; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; [R Core Team Team C], 2015, R FOUNDATION FOR STA; Reznik D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127651; Reznik D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5059; Riecke L, 1991, FREQUENCY SELECTIVE; Rif J., 1991, CLIN NEUROPHYSIOL, V79, P464, DOI [10.1016/0013-4694(91)90166-2, DOI 10.1016/0013-4694(91)90166-2]; Salmi J, 2007, BRAIN STRUCT FUNCT, V212, P181, DOI 10.1007/s00429-007-0152-2; Salmi J, 2007, EUR J NEUROSCI, V25, P3725, DOI 10.1111/j.1460-9568.2007.05616.x; Salmi J, 2009, BRAIN RES, V1286, P155, DOI 10.1016/j.brainres.2009.06.083; Schadwinkel S, 2011, J NEUROPHYSIOL, V105, P1977, DOI 10.1152/jn.00461.2010; Schneider DM, 2014, NATURE, V513, P189, DOI 10.1038/nature13724; Seydell-Greenwald A, 2014, HUM BRAIN MAPP, V35, P2233, DOI 10.1002/hbm.22323; Shomstein S, 2006, J NEUROSCI, V26, P435, DOI 10.1523/JNEUROSCI.4408-05.2006; Shomstein S, 2004, J NEUROSCI, V24, P10702, DOI 10.1523/JNEUROSCI.2939-04.2004; Smith DT, 2009, BRAIN STIMUL, V2, P81, DOI 10.1016/j.brs.2008.07.005; Steinschneider M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00240; Voisin J, 2006, J NEUROSCI, V26, P273, DOI 10.1523/JNEUROSCI.2967-05.2006; Werner-Reiss U, 2008, J NEUROSCI, V28, P3747, DOI 10.1523/JNEUROSCI.5044-07.2008; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Yellin D, 2015, NEUROIMAGE, V106, P414, DOI 10.1016/j.neuroimage.2014.11.034	56	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172907	10.1371/journal.pone.0172907	http://dx.doi.org/10.1371/journal.pone.0172907			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273110	Green Published, Green Submitted, gold			2022-12-26	WOS:000396073700032
J	Rossoni, RD; Fuchs, BB; de Barros, PP; Velloso, MD; Jorge, AOC; Junqueira, JC; Mylonakis, E				Rossoni, Rodnei Dennis; Fuchs, Beth Burgwyn; de Barros, Patricia Pimentel; Velloso, Marisol dos Santos; Cardoso Jorge, Antonio Olavo; Junqueira, Juliana Campos; Mylonakis, Eleftherios			Lactobacillus paracasei modulates the immune system of Galleria mellonella and protects against Candida albicans infection	PLOS ONE			English	Article							MODEL HOST; IN-VITRO; PROBIOTIC LACTOBACILLUS; ANTIMICROBIAL PEPTIDES; VIRULENCE FACTORS; GENE-EXPRESSION; INNATE IMMUNITY; LARVAE; RESPONSES; PATHOGENESIS	Probiotics have been described as a potential strategy to control opportunistic infections due to their ability to stimulate the immune system. Using the non-vertebrate model host Galleria mellonella, we evaluated whether clinical isolates of Lactobacillus spp. are able to provide protection against Candida albicans infection. Among different strains of Lactobacillus paracasei, Lactobacillus rhamnosus and Lactobacillus fermentum, we verified that L. paracasei 28.4 strain had the greatest ability to prolong the survival of larvae infected with a lethal dose of C. albicans. We found that the injection of 10(7) cells/larvae of L. paracasei into G. mellonella larvae infected by C. albicans increased the survival of these insects compared to the control group (P = 0.0001). After that, we investigated the immune mechanisms involved in the protection against C. albicans infection, evaluating the number of hemocytes and the gene expression of antifungal peptides. We found that L. paracasei increased the hemocyte quantity (2.38 x 10(6) cells/mL) in relation to the control group (1.29 x 10(6) cells/mL), indicating that this strain is capable of raising the number of circulating hemocytes into the G. mellonella hemolymph. Further, we found that L. paracasei 28.4 upregulated genes that encode the antifungal peptides galiomicin and gallerymicin. In relation to the control group, L. paracasei 28.4 increased gene expression of galiomicin by 6.67-fold and 17.29-fold for gallerymicin. Finally, we verified that the prophylactic provision of probiotic led to a significant reduction of the number of fungal cells in G. mellonella hemolymph. In conclusion, L. paracasei 28.4 can modulate the immune system of G. mellonella and protect against candidiasis.	[Rossoni, Rodnei Dennis; de Barros, Patricia Pimentel; Velloso, Marisol dos Santos; Cardoso Jorge, Antonio Olavo; Junqueira, Juliana Campos] Univ Estadual Paulista UNESP, Dept Biosci & Oral Diag, Sao Paulo, Brazil; [Rossoni, Rodnei Dennis; Fuchs, Beth Burgwyn; Mylonakis, Eleftherios] Brown Univ, Alpert Med Sch, Rhode Isl Hosp, Div Infect Dis, Providence, RI 02912 USA	Universidade Estadual Paulista; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Junqueira, JC (corresponding author), Univ Estadual Paulista UNESP, Dept Biosci & Oral Diag, Sao Paulo, Brazil.	juliana@ict.unesp.br	Rossoni, Rodnei D/K-2390-2013; de Barros, Patrícia Pimentel/M-8160-2019; De Barros, Patrícia Pimentel/B-3496-2016; Junqueira, Juliana/GQZ-4509-2022; Junqueira, Juliana Campos/Q-3108-2019	Rossoni, Rodnei D/0000-0002-9977-3040; de Barros, Patrícia Pimentel/0000-0003-4885-2811; De Barros, Patrícia Pimentel/0000-0003-4885-2811; Junqueira, Juliana Campos/0000-0001-6646-6856	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/25181-8, 2014/12458-4, 2015/09770-9]; FAPESP [2013/25181-8, 2014/12458-4, 2015/09770-9]; Brown/Brazil Initiative at Brown University	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brown/Brazil Initiative at Brown University	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2013/25181-8, 2014/12458-4 and 2015/09770-9). RDR received a doctoral fellowship from FAPESP (2013/25181-8, 2014/12458-4). JCJ received a grant from FAPESP (2015/09770-9). Funding was also made available through a grant from the Brown/Brazil Initiative at Brown University.	Abedin-Do A, 2015, IMMUNOTHERAPY-UK, V7, P1307, DOI 10.2217/imt.15.92; Aoudia N, 2016, FOOD MICROBIOL, V53, P51, DOI 10.1016/j.fm.2015.04.009; Arvanitis M, 2013, BBA-MOL BASIS DIS, V1832, P1378, DOI 10.1016/j.bbadis.2013.03.008; Barbosa JO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150457; Bergin D, 2003, MICROBES INFECT, V5, P1389, DOI 10.1016/j.micinf.2003.09.019; Bergin D, 2006, MICROBES INFECT, V8, P2105, DOI 10.1016/j.micinf.2006.03.005; Brown SE, 2009, INSECT BIOCHEM MOLEC, V39, P792, DOI 10.1016/j.ibmb.2009.09.004; Chassot F, 2010, CONTRACEPTION, V81, P331, DOI 10.1016/j.contraception.2009.12.011; Chibebe J, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-217; Chon H, 2009, J APPL MICROBIOL, V107, P1588, DOI 10.1111/j.1365-2672.2009.04343.x; Chon H, 2010, COMP IMMUNOL MICROB, V33, pE41, DOI 10.1016/j.cimid.2009.11.002; Coronado-Castellote Laura, 2013, J Clin Exp Dent, V5, pe279, DOI 10.4317/jced.51242; Fallon JP, 2011, VIRULENCE, V2, P413, DOI 10.4161/viru.2.5.17811; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Galdeano CM, 2006, CLIN VACCINE IMMUNOL, V13, P219, DOI 10.1128/CVI.13.2.219-226.2006; GANZ T, 1995, PHARMACOL THERAPEUT, V66, P191, DOI 10.1016/0163-7258(94)00076-F; Grounta A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161263; Guarner F, 2012, J CLIN GASTROENTEROL, V46, P468, DOI 10.1097/MCG.0b013e3182549092; Hasslof P, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-18; Hofs S, 2016, J MICROBIOL, V54, P149, DOI 10.1007/s12275-016-5514-0; Jiang QR, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0759-7; Jorjao Adeline Lacerda, 2015, ScientificWorldJournal, V2015, P716749, DOI 10.1155/2015/716749; Joyce SA, 2010, MICROBIOL-SGM, V156, P3456, DOI 10.1099/mic.0.040782-0; Junqueira JC, 2012, VIRULENCE, V3, P474, DOI 10.4161/viru.22493; Kim YG, 2006, MICROBES INFECT, V8, P994, DOI 10.1016/j.micinf.2005.10.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowenberger C, 2001, INSECT BIOCHEM MOLEC, V31, P219, DOI 10.1016/S0965-1748(00)00141-7; Martinez-Alvarez JA, 2014, REV IBEROAM MICOL, V31, P62, DOI 10.1016/j.riam.2013.09.015; Matsubara VH, 2016, APPL MICROBIOL BIOT, V100, P6415, DOI 10.1007/s00253-016-7527-3; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; Morales DK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000886; Mowlds P, 2008, MYCOPATHOLOGIA, V165, P5, DOI 10.1007/s11046-007-9069-9; Mowlds P, 2010, MICROBES INFECT, V12, P146, DOI 10.1016/j.micinf.2009.11.004; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Oliveira VMC, 2016, J APPL MICROBIOL, V121, P1737, DOI 10.1111/jam.13289; RATCLIFFE NA, 1985, IMMUNOL LETT, V10, P253, DOI 10.1016/0165-2478(85)90100-2; Ribeiro FC, 2017, J APPL MICROBIOL, V122, P201, DOI 10.1111/jam.13324; Ryan KA, 2009, J MED MICROBIOL, V58, P996, DOI 10.1099/jmm.0.009407-0; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Soloviev DA, 2011, INFECT IMMUN, V79, P1546, DOI 10.1128/IAI.00650-10; Song YL, 2000, FEMS MICROBIOL LETT, V187, P167, DOI 10.1016/S0378-1097(00)00196-8; Vilela SFG, 2015, VIRULENCE, V6, P29, DOI 10.4161/21505594.2014.981486; Vilmos P, 1998, IMMUNOL LETT, V62, P59, DOI 10.1016/S0165-2478(98)00023-6; Wagner RD, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-58; Wickens K, 2008, J ALLERGY CLIN IMMUN, V122, P788, DOI 10.1016/j.jaci.2008.07.011; Zdybicka-Barabas A, 2014, ARCH INSECT BIOCHEM, V87, P1, DOI 10.1002/arch.21175	47	53	55	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173332	10.1371/journal.pone.0173332	http://dx.doi.org/10.1371/journal.pone.0173332			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267809	gold, Green Published, Green Submitted			2022-12-26	WOS:000396060600022
J	Eliasson, P; Svensson, RB; Giannopoulos, A; Eismark, C; Kjaer, M; Schjerling, P; Heinemeier, KM				Eliasson, Pernilla; Svensson, Rene B.; Giannopoulos, Antonis; Eismark, Christian; Kjaer, Michael; Schjerling, Peter; Heinemeier, Katja M.			Simvastatin and atorvastatin reduce the mechanical properties of tendon constructs in vitro and introduce catabolic changes in the gene expression pattern	PLOS ONE			English	Article							ACHILLES-TENDON; COLLAGEN FIBRILLOGENESIS; STATIN THERAPY; RUPTURE; CELLS; FIBROBLASTS	Treatment with lipid-lowering drugs, statins, is common all over the world. Lately, the occurrence of spontaneous tendon ruptures or tendinosis have suggested a negative influence of statins upon tendon tissue. But how statins might influence tendons is not clear. In the present study, we investigated the effect of statin treatment on mechanical strength, cell proliferation, collagen content and gene expression pattern in a tendon-like tissue made from human tenocytes in vitro. Human tendon fibroblasts were grown in a 3D tissue culture model (tendon constructs), and treated with either simvastatin or atorvastatin, low or high dose, respectively, for up to seven days. After seven days of treatment, mechanical testing of the constructs was performed. Collagen content and cell proliferation were also determined. mRNA levels of several target genes were measured after one or seven days. The maximum force and stiffness were reduced by both statins after 7 days (p<0.05), while the cross sectional area was unaffected. Further, the collagen content was reduced by atorvastatin (p = 0.01) and the cell proliferation rate was decreased by both types of statins (p<0.05). Statin treatment also introduced increased mRNA levels of MMP-1, MMP-3, MMP-13, TIMP-1 and decreased levels of collagen type 1 and 3. In conclusion, statin treatment appears to have a negative effect on tendon matrix quality as seen by a reduced strength of the tendon constructs. Further, activated catabolic changes in the gene expression pattern and a reduced collagen content indicated a disturbed balance in matrix production of tendon due to statin administration.	[Eliasson, Pernilla; Svensson, Rene B.; Giannopoulos, Antonis; Eismark, Christian; Kjaer, Michael; Schjerling, Peter; Heinemeier, Katja M.] Bispebjerg Hosp, Dept Orthoped Surg M, Inst Sports Med Copenhagen, Copenhagen, Denmark; [Eliasson, Pernilla; Svensson, Rene B.; Giannopoulos, Antonis; Eismark, Christian; Kjaer, Michael; Schjerling, Peter; Heinemeier, Katja M.] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Hlth Aging, Copenhagen, Denmark; [Eliasson, Pernilla] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Linkoping University	Eliasson, P (corresponding author), Bispebjerg Hosp, Dept Orthoped Surg M, Inst Sports Med Copenhagen, Copenhagen, Denmark.; Eliasson, P (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Hlth Aging, Copenhagen, Denmark.; Eliasson, P (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	pernilla.eliasson@gmail.com	Svensson, Rene B./AGZ-3181-2022; Kjaer, Michael/W-6842-2019; Eliasson, Pernilla/AAY-2126-2020; Schjerling, Peter/F-6194-2011	Svensson, Rene B./0000-0002-1607-5379; Kjaer, Michael/0000-0002-4582-8755; Eliasson, Pernilla/0000-0001-6718-034X; Schjerling, Peter/0000-0001-7138-3211	Lundbeck Foundation; Nordea Foundation; IOC Sports medicine Copenhagen; Danish Medical Research Council [0602-02960B]; Swedish Society for Medical Research; Magnus Bergyall Foundation; Lions research foundation; Lundbeck Foundation [R198-2015-207] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0012491, NNF16OC0022846] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Nordea Foundation; IOC Sports medicine Copenhagen; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Society for Medical Research; Magnus Bergyall Foundation; Lions research foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by grants from Lundbeck Foundation), Nordea Foundation (Center of Healthy Aging grant), IOC Sports medicine Copenhagen, Danish Medical Research Council (grant number 0602-02960B), Swedish Society for Medical Research, Magnus Bergyall Foundation, and Lions research foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud JA, 2010, CLIN ORTHOP RELAT R, V468, P1493, DOI 10.1007/s11999-009-1151-9; Bayer ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086078; Bayer ML, 2010, BIOMATERIALS, V31, P4889, DOI 10.1016/j.biomaterials.2010.02.062; Beri A, 2008, ARTHRIT RHEUM-ARTHR, V59, P1202, DOI 10.1002/art.23917; Beri A, 2009, J CARDIOVASC PHARM, V53, P401, DOI 10.1097/FJC.0b013e3181a0ce8b; Carmont MR, 2009, PHYS THER SPORT, V10, P150, DOI 10.1016/j.ptsp.2009.01.003; Contractor T, 2015, AM J THER, V22, P377, DOI 10.1097/MJT.0000000000000039; Davis ME, 2015, J SHOULDER ELB SURG, V24, P280, DOI 10.1016/j.jse.2014.06.048; de Oliveira LP, 2015, FOOD CHEM TOXICOL, V77, P50, DOI 10.1016/j.fct.2014.12.014; de Oliveira LP, 2013, TOXICOLOGY, V311, P162, DOI 10.1016/j.tox.2013.06.010; Dolkart O, 2014, AM J SPORT MED, V42, P2869, DOI 10.1177/0363546514545856; Esenkaya Irfan, 2010, Orthopedics, V33, P398, DOI 10.3928/01477447-20100429-06; Ferri N, 2007, ARTERIOSCL THROM VAS, V27, P1043, DOI 10.1161/ATVBAHA.107.139881; Heinemeier KM, 2013, FASEB J, V27, P2074, DOI 10.1096/fj.12-225599; Herchenhan A, 2015, J BIOL CHEM, V290, P16440, DOI 10.1074/jbc.M115.641670; Herchenhan A, 2013, DEV DYNAM, V242, P2, DOI 10.1002/dvdy.23896; Hoffman KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042866; Jackevicius CA, 2008, NEW ENGL J MED, V358, P1819, DOI 10.1056/NEJMsa0801461; Kaleagasioglu F, 2015, KNEE SURG SPORTS TRA; KLEMP P, 1993, ANN RHEUM DIS, V52, P44, DOI 10.1136/ard.52.1.44; Kuzma-Kuzniarska M, 2015, J CELL PHYSIOL, V230, P2543, DOI 10.1002/jcp.25010; Lin TTL, 2015, AM J SPORT MED, V43, P2126, DOI 10.1177/0363546515588173; Lindner D, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/875742; Marie I, 2008, ARTHRIT RHEUM-ARTHR, V59, P367, DOI 10.1002/art.23309; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; NEUMAN RE, 1950, J BIOL CHEM, V184, P299; Oka S, 2013, TISSUE ENG PT A, V19, P1233, DOI [10.1089/ten.tea.2012.0325, 10.1089/ten.TEA.2012.0325]; Pullatt RC, 2007, AM J CARDIOL, V100, P152, DOI 10.1016/j.amjcard.2007.02.068; Savvidou C, 2012, J HAND SURG-ASIAN-PA, V17, P167, DOI 10.1142/S0218810412500153; Tsai WC, 2016, TOXICOL SCI, V149, P326, DOI 10.1093/toxsci/kfv239	30	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172797	10.1371/journal.pone.0172797	http://dx.doi.org/10.1371/journal.pone.0172797			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264197	Green Published, gold, Green Submitted			2022-12-26	WOS:000396054300018
J	Jumper, N; Hodgkinson, T; Paus, R; Bayat, A				Jumper, N.; Hodgkinson, T.; Paus, R.; Bayat, A.			Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSFORMING-GROWTH-FACTOR; LASER-CAPTURE MICRODISSECTION; IDIOPATHIC PULMONARY-FIBROSIS; OLIGOMERIC MATRIX PROTEIN; CELL-ADHESION MOLECULE-1; TRIPLE-HELIX REPEAT; STEM-CELLS; PROSTATE-CANCER; DRUG-RESISTANCE	Keloid disease (KD) is a fibroproliferative cutaneous tumour characterised by heterogeneity, excess collagen deposition and aggressive local invasion. Lack of a validated animal model and resistance to a multitude of current therapies has resulted in unsatisfactory clinical outcomes of KD management. In order to address KD from a new perspective, we applied for the first time a site-specific in situ microdissection and gene expression profiling approach, through combined laser capture microdissection and transcriptomic array. The aim here was to analyse the utility of this approach compared with established methods of investigation, including whole tissue biopsy and monolayer cell culture techniques. This study was designed to approach KD from a hypothesis-free and compartment-specific angle, using state-of-the-art microdissection and gene expression profiling technology. We sought to characterise expression differences between specific keloid lesional sites and elucidate potential contributions of significantly dysregulated genes to mechanisms underlying keloid pathobiology, thus informing future explorative research into KD. Here, we highlight the advantages of our in situ microdissection strategy in generating expression data with improved sensitivity and accuracy over traditional methods. This methodological approach supports an active role for the epidermis in the pathogenesis of KD through identification of genes and upstream regulators implicated in epithelial-mesenchymal transition, inflammation and immune modulation. We describe dermal expression patterns crucial to collagen deposition that are associated with TGF beta-mediated signalling, which have not previously been examined in KD. Additionally, this study supports the previously proposed presence of a cancer-like stem cell population in KD and explores the possible contribution of gene dysregulation to the resistance of KD to conventional therapy. Through this innovative in situ microdissection gene profiling approach, we provide better-defined gene signatures of distinct KD regions, thereby addressing KD heterogeneity, facilitating differential diagnosis with other cutaneous fibroses via transcriptional fingerprinting, and highlighting key areas for future KD research.	[Jumper, N.; Hodgkinson, T.; Bayat, A.] Univ Manchester, Plast & Reconstruct Surg Res, Oxford Rd, Manchester, Lancs, England; [Hodgkinson, T.] Univ Manchester, Ctr Tissue Injury & Repair, Manchester, Lancs, England; [Hodgkinson, T.; Paus, R.; Bayat, A.] MAHSC, Manchester, Lancs, England; [Paus, R.; Bayat, A.] Univ Manchester, Ctr Dermatol Res, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Bayat, A (corresponding author), Univ Manchester, Plast & Reconstruct Surg Res, Oxford Rd, Manchester, Lancs, England.; Bayat, A (corresponding author), MAHSC, Manchester, Lancs, England.; Bayat, A (corresponding author), Univ Manchester, Ctr Dermatol Res, Manchester, Lancs, England.	Ardeshir.Bayat@manchester.ac.uk	Hodgkinson, Tom/AAJ-1373-2021; Hodgkinson, Tom/E-5767-2016	Hodgkinson, Tom/0000-0002-3242-1593				Agarwal P, 2013, MATRIX BIOL, V32, P325, DOI 10.1016/j.matbio.2013.02.010; Alessio M, 1998, INT J CLIN LAB RES, V28, P47, DOI 10.1007/s005990050017; Andrews JP, 2016, MATRIX BIOL; Arno AI, 2014, BURNS, V40, P1255, DOI 10.1016/j.burns.2014.02.011; Ashcroft KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075600; Ashkenazi S, 2016, ONCOTARGET; Bagabir R, 2012, BRIT J DERMATOL, V167, P1053, DOI 10.1111/j.1365-2133.2012.11190.x; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Baraut J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0708-0; Bauer Y, 2015, AM J RESP CELL MOL, V52, P217, DOI 10.1165/rcmb.2013-0310OC; Bayat A, 2005, BRIT J PLAST SURG, V58, P28, DOI 10.1016/j.bjps.2004.04.024; Bekhouche M, 2016, FASEB J; Bekhouche M, 2015, MATRIX BIOL, V44-46, P46, DOI 10.1016/j.matbio.2015.04.001; Benevides L, 2015, CANCER RES, V75, P3788, DOI 10.1158/0008-5472.CAN-15-0054; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman B, 2002, J AM ACAD DERMATOL, V47, pS209, DOI 10.1067/mjd.2002.126585; Berschneider B, 2014, INT J BIOCHEM CELL B, V53, P432, DOI 10.1016/j.biocel.2014.06.011; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonyadi Rad E, 2016, CANC RES; Borthwick LA, 2015, CURRENT PATHOBIOLOGY, V3, P273, DOI [10.1007/s40139-015-0091-1, DOI 10.1007/S40139-015-0091-1]; Broder C, 2013, P NATL ACAD SCI USA, V110, P14219, DOI 10.1073/pnas.1305464110; Bujko M, 2015, ONCOL LETT, V9, P2463, DOI 10.3892/ol.2015.3107; Busch C, 2002, HUM PATHOL, V33, P290, DOI 10.1053/hupa.2002.32218; Butler PD, 2008, J AM COLL SURGEONS, V206, P731, DOI 10.1016/j.jamcollsurg.2007.12.001; Cal S, 2015, MATRIX BIOL, V44-46, P77, DOI 10.1016/j.matbio.2015.01.013; Charrad R, 2016, IMMUNOBIOLOGY, V221, P182, DOI 10.1016/j.imbio.2015.09.009; Chen Z, 2008, CYTOKINE, V41, P71, DOI 10.1016/j.cyto.2007.09.009; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; Clavel G, 2013, JOINT BONE SPINE, V80, P449, DOI 10.1016/j.jbspin.2013.04.014; Clement-Ziza M, 2008, RNA, V14, P2698, DOI 10.1261/rna.1261708; Colige A, 2004, J INVEST DERMATOL, V123, P656, DOI 10.1111/j.0022-202X.2004.23406.x; Colige A, 2002, J BIOL CHEM, V277, P5756, DOI 10.1074/jbc.M105601200; Conley SJ, 2016, ONCOGENE; Cruz PV, 2005, CANCER-AM CANCER SOC, V104, P354, DOI 10.1002/cncr.21159; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; De Marchi T, 2016, PROTEOMICS, V16, P1474, DOI 10.1002/pmic.201600004; Derynck R, 2014, CURR OPIN CELL BIOL, V31, P56, DOI 10.1016/j.ceb.2014.09.001; Ding Q, 2015, ONCOL REP, V33, P1783, DOI 10.3892/or.2015.3791; Do DV, 2012, BRIT J DERMATOL, V166, P1275, DOI 10.1111/j.1365-2133.2011.10721.x; Dong XL, 2013, BIOMED REP, V1, P833, DOI 10.3892/br.2013.169; Dulauroy S, 2012, NAT MED, V18, P1262, DOI 10.1038/nm.2848; Duran GE, 2015, MOL CANCER THER, V14, P193, DOI 10.1158/1535-7163.MCT-14-0155; El-Serag HB, 2009, SCAND J GASTROENTERO, V44, P787, DOI 10.1080/00365520902898127; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Eo HJ, 2016, MAR DRUGS, V14, DOI 10.3390/md14040069; Eriksson J., 2016, ONCOTARGET, DOI 10.18632/oncotarget.7604; Ferrandina G, 2006, CLIN CANCER RES, V12, P2774, DOI 10.1158/1078-0432.CCR-05-2715; Francois A, 2015, J AUTOIMMUN, V56, P1, DOI 10.1016/j.jaut.2014.08.003; Granel B, 2006, J RHEUMATOL, V33, P2015; Grant C, 2016, J CLIN PATHOL; Gu FM, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-150; Hackl C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-668; Hahn JM, 2013, WOUND REPAIR REGEN, V21, P530, DOI 10.1111/wrr.12060; Hakvoort TE, 1999, VIRCHOWS ARCH, V434, P221, DOI 10.1007/s004280050331; Harries MJ, 2013, J PATHOL, V231, P236, DOI 10.1002/path.4233; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; He S, 2010, BRIT J DERMATOL, V162, P538, DOI 10.1111/j.1365-2133.2009.09511.x; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honoki K, 2010, ONCOL REP, V24, P501, DOI 10.3892/or_00000885; Huang XW, 2008, J BIOL CHEM, V283, P29795, DOI 10.1074/jbc.M802515200; Hurley PJ, 2016, CLIN CANCER RES, V22, P448, DOI 10.1158/1078-0432.CCR-15-0256; Imaeda H, 2013, CLIN EXP IMMUNOL, V172, P410, DOI 10.1111/cei.12061; Inui S, 2011, AM J PATHOL, V179, P1951, DOI 10.1016/j.ajpath.2011.06.034; Isailovic N, 2015, J AUTOIMMUN, V60, P1, DOI 10.1016/j.jaut.2015.04.006; Jadidi-Niaragh F, 2013, TUMOR BIOL, V34, P929, DOI 10.1007/s13277-012-0628-4; Januchowski R, 2013, BIOMED PHARMACOTHER, V67, P669, DOI 10.1016/j.biopha.2013.04.005; Jian YC, 2014, CLIN LAB, V60, P29, DOI 10.7754/Clin.Lab.2013.121035; Jiliang S., 2016, ONCOTARGET; Johnston P, 2007, J HAND SURG-AM, V32A, P343, DOI 10.1016/j.jhsa.2006.12.010; Jones CD, 2015, DERMATOL REP, V7, DOI 10.4081/dr.2015.5880; Jones GC, 2005, ARTHRITIS RES THER, V7, P160, DOI 10.1186/ar1783; Jumper N, 2015, HISTOL HISTOPATHOL, V30, P1033, DOI 10.14670/HH-11-624; Jumper N, 2016, J INVEST DERMATOL, V136, P1500, DOI 10.1016/j.jid.2016.03.022; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamdje AHN, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.17; Kameda T, 2015, GENOM DATA, V4, P102, DOI 10.1016/j.gdata.2015.04.002; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Keane MP, 2007, J IMMUNOL, V178, P511, DOI 10.4049/jimmunol.178.1.511; Kelwick R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0676-3; Kerkhoff C, 2012, EXP DERMATOL, V21, P822, DOI 10.1111/j.1600-0625.2012.01571.x; Kesteloot F, 2007, HEPATOLOGY, V46, P1620, DOI 10.1002/hep.21868; Kolijn K, 2016, BMC RES NOTES, V9, P1; Kolodsick JE, 2004, J IMMUNOL, V172, P4068, DOI 10.4049/jimmunol.172.7.4068; Kumar Saran, 2012, Cancers (Basel), V4, P1252, DOI 10.3390/cancers4041252; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lan CCE, 2014, J EUR ACAD DERMATOL, V28, P204, DOI 10.1111/jdv.12086; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; Lebok P, 2016, ONCOL LETT, V11, P1987, DOI 10.3892/ol.2016.4206; LeClair R, 2007, TRENDS CARDIOVAS MED, V17, P202, DOI 10.1016/j.tcm.2007.05.004; Lee JYY, 2004, AM J DERMATOPATH, V26, P379, DOI 10.1097/00000372-200410000-00006; Lee WJ, 2015, WOUND REPAIR REGEN, V23, P435, DOI 10.1111/wrr.12300; Leguen I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139938; LEIGH IM, 1995, BRIT J DERMATOL, V133, P501, DOI 10.1111/j.1365-2133.1995.tb02696.x; Li J, 2011, BRIT J DERMATOL, V164, P1030, DOI 10.1111/j.1365-2133.2011.10215.x; Li SW, 2001, BIOCHEM J, V355, P271, DOI 10.1042/0264-6021:3550271; Lin XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067496; Loubaki L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081983; Lu F, 2007, PLAST RECONSTR SURG, V120, P625, DOI 10.1097/01.prs.0000270293.93612.7b; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Luo S, 2011, INT J LOW EXTR WOUND, V10, P122, DOI 10.1177/1534734611418157; Ma XY, 2015, INT J MOL MED, V35, P1246, DOI 10.3892/ijmm.2015.2135; Mabry KM, 2016, BIOMATERIALS, V74, P31, DOI 10.1016/j.biomaterials.2015.09.035; MacKenzie PI, 2011, MOL PHARMACOL, V79, P472, DOI 10.1124/mol.110.069336; Makhzami S, 2012, PIGM CELL MELANOMA R, V25, P783, DOI 10.1111/pcmr.12013; Mariani M, 2011, CURR MOL MED, V11, P726, DOI 10.2174/156652411798062368; Marmai C, 2011, AM J PHYSIOL-LUNG C, V301, pL71, DOI 10.1152/ajplung.00212.2010; Marttala J, 2016, MATRIX BIOL; Masuda A, 2016, J REPROD DEVELOP, V62, P213, DOI 10.1262/jrd.2015-137; McCarroll JA, 2015, CANCER RES, V75, P415, DOI 10.1158/0008-5472.CAN-14-2740; McCormick SM, 2015, CYTOKINE, V75, P38, DOI 10.1016/j.cyto.2015.05.023; Meech R, 2012, J BIOL CHEM, V287, P24122, DOI 10.1074/jbc.M112.343608; Michl P, 2003, CANCER RES, V63, P6265; Mitsui H, 2012, J INVEST DERMATOL, V132, P1615, DOI 10.1038/jid.2012.33; Miyamoto A, 2010, AM J DERMATOPATH, V32, P578, DOI 10.1097/DAD.0b013e3181cd35e0; Moon JH, 2008, STEM CELLS DEV, V17, P713, DOI 10.1089/scd.2007.0210; Morikawa Y, 2015, CHEM-BIOL INTERACT, V230, P30, DOI 10.1016/j.cbi.2015.02.005; Naitoh M, 2005, GENES CELLS, V10, P1081, DOI 10.1111/j.1365-2443.2005.00902.x; Nittka S, 2004, ONCOGENE, V23, P9306, DOI 10.1038/sj.onc.1208259; Okamoto Y, 2012, ARTHRITIS RHEUM-US, V64, P3726, DOI 10.1002/art.34643; Oliveira-Ferrer L, 2004, CANCER RES, V64, P8932, DOI 10.1158/0008-5472.CAN-04-0505; Oliveros JC., 2007, INTERACTIVE TOOL COM; Ong CT, 2010, BRIT J DERMATOL, V162, P1302, DOI 10.1111/j.1365-2133.2010.09660.x; Oriente A, 2000, J PHARMACOL EXP THER, V292, P988; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Pratap A, 2012, J DRUG TARGET, V20, P770, DOI 10.3109/1061186X.2012.719900; Qian LW, 2016, WOUND REPAIR REGEN, V24, P26, DOI 10.1111/wrr.12381; Qu M, 2013, MED HYPOTHESES, V81, P807, DOI 10.1016/j.mehy.2013.08.033; Raspaglio G, 2014, GENE, V542, P173, DOI 10.1016/j.gene.2014.03.037; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Roda G, 2009, INFLAMM BOWEL DIS, V15, P1775, DOI 10.1002/ibd.21023; Rotty JD, 2012, J CELL BIOL, V197, P381, DOI 10.1083/jcb.201107078; Ruff M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139179; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Santucci M, 2001, VIRCHOWS ARCH, V438, P457, DOI 10.1007/s004280000335; Seifert O, 2008, WOUND REPAIR REGEN, V16, P254, DOI 10.1111/j.1524-475X.2007.00343.x; Shang XY, 2012, NEOPLASIA, V14, P974, DOI 10.1593/neo.12942; Shekouh AR, 2003, PROTEOMICS, V3, P1988, DOI 10.1002/pmic.200300466; Shih Barbara, 2010, Eplasty, V10, pe24; Shih B, 2009, J HAND SURG-AM, V34A, P124, DOI 10.1016/j.jhsa.2008.09.017; Sidgwick GP, 2016, ARCH DERMATOL RES, V308, P297, DOI 10.1007/s00403-016-1645-8; Simoes BM, 2015, CELL REP, V12, P1968, DOI 10.1016/j.celrep.2015.08.050; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Song HM, 2016, BIOMOL THER, V24, P140, DOI 10.4062/biomolther.2015.109; Song N, 2012, HUM PATHOL, V43, P2024, DOI 10.1016/j.humpath.2011.12.026; Steplewski A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S29; Strzyz P., 2016, NATURE REV MOL CELL; Syed F, 2011, BRIT J DERMATOL, V164, P83, DOI 10.1111/j.1365-2133.2010.10048.x; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Touchi R, 2016, J PLAST RECONSTR AES, V69, pE35, DOI 10.1016/j.bjps.2015.11.006; Tsourlakis MC, 2014, AM J PATHOL, V184, P609, DOI 10.1016/j.ajpath.2013.11.007; Valcourt U, 2016, METHODS MOL BIOL, V1344, P147, DOI 10.1007/978-1-4939-2966-5_9; Van Beuge MM, 2015, TRANSL RES, V166, P762, DOI 10.1016/j.trsl.2015.09.006; van Leeuwen MCE, 2015, PRS-GLOB OPEN, V3, DOI 10.1097/GOX.0000000000000357; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Wang C, 2016, IEEE T COMPUT, V1, P1, DOI DOI 10.1109/TC.2015.2417542; Wang LY, 2011, INT J MOL MED, V27, P385, DOI 10.3892/ijmm.2011.594; Wang Q, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-137; Wang WM, 2006, BIOCHEM J, V398, P515, DOI 10.1042/BJ20060630; Wang WM, 2003, J BIOL CHEM, V278, P19549, DOI 10.1074/jbc.M300767200; Whitman M.C., 1993, GENEREVIEWS R; Wood N, 2003, J EXP MED, V197, P703, DOI 10.1084/jem.20020906; Wu CS, 2012, BRIT J DERMATOL, V167, P532, DOI 10.1111/j.1365-2133.2012.11023.x; Xie JJ, 2014, ONCOTARGET, V5, P8569, DOI 10.18632/oncotarget.2322; Xiong WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072772; Yan CH, 2006, CELL CYCLE, V5, P926, DOI 10.4161/cc.5.9.2714; Yan L, 2015, WOUND REPAIR REGEN, V23, P601, DOI 10.1111/wrr.12320; Yang YL, 2011, J CELL BIOCHEM, V112, P2558, DOI 10.1002/jcb.23180; Zalzali H, 2008, ONCOGENE, V27, P7131, DOI 10.1038/onc.2008.331; Zhang MZ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003082; Zhang QZ, 2009, PLOS ONE, V4, pA192, DOI 10.1371/journal.pone.0007798; Zhang Z, 2014, INT J MOL MED, V34, P253, DOI 10.3892/ijmm.2014.1760; Zheng JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053711; Zhong AM, 2016, AM J PATHOL, V186, P109, DOI 10.1016/j.ajpath.2015.09.005; Zhou H, 2016, INT J CARDIOL, V206, P87, DOI 10.1016/j.ijcard.2016.01.143; Zhou P, 2015, INT J CLIN EXP MED, V8, P15262; Zhou SH, 2014, INT J CLIN EXP PATHO, V7, P8532	178	29	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172955	10.1371/journal.pone.0172955	http://dx.doi.org/10.1371/journal.pone.0172955			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257480	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100046
J	Seidl, SE; Pessolano, LG; Bishop, CA; Best, M; Rich, CB; Stone, PJ; Schreiber, BM				Seidl, Stephanie E.; Pessolano, Lawrence G., Jr.; Bishop, Christopher A.; Best, Michael; Rich, Celeste B.; Stone, Phillip J.; Schreiber, Barbara M.			Toll-like receptor 2 activation and serum amyloid A regulate smooth muscle cell extracellular matrix	PLOS ONE			English	Article							ELASTIN GENE-TRANSCRIPTION; NITRIC-OXIDE SYNTHASE; IN-VITRO; PROTEASOME INHIBITORS; MESSENGER-RNA; C/EBP-BETA; EXPRESSION; MATRIX-METALLOPROTEINASE-9; MIGRATION; METALLOPROTEINASES	Smooth muscle cells contribute to extracellular matrix remodeling during atherogenesis. De-differentiated, synthetic smooth muscle cells are involved in processes of migration, pro-liferation and changes in expression of extracellular matrix components, all of which contribute to loss of homeostasis accompanying atherogenesis. Elevated levels of acute phase proteins, including serum amyloid A (SAA), are associated with an increased risk for athero-sclerosis. Although infection with periodontal and respiratory pathogens via activation of inflammatory cell Toll-like receptor (TLR) 2 has been linked to vascular disease, little is known about smooth muscle cell TLR2 in atherosclerosis. This study addresses the role of SAA and TLR2 activation on smooth muscle cell matrix gene expression and insoluble elas-tin accumulation. Cultured rat aortic smooth muscle cells were treated with SAA or TLR2 agonists and the effect on expression of matrix metallopeptidase 9 (MMP9) and tropoelastin studied. SAA up-regulated MMP9 expression. Tropoelastin is an MMP9 substrate and decreased tropoelastin levels in SAA-treated cells supported the concept of extracellular matrix remodeling. Interestingly, SAA-induced down-regulation of tropoelastin was not only evident at the protein level but at the level of gene transcription as well. Contributions of pro-teasomes, nuclear factor. B and CCAAT/enhancer binding protein a on regulation of MMP9 vs. tropoleastin expression were revealed. Effects on Mmp9 and Eln mRNA expres-sion persisted with long-term SAA treatment, resulting in decreased insoluble elastin accu-mulation. Interestingly, the SAA effects were TLR2-dependent and TLR2 activation by bacterial ligands also induced MMP9 expression and decreased tropoelastin expression. These data reveal a novel mechanism whereby SAA and/or infection induce changes in vas-cular elastin consistent with atherosclerosis.	[Seidl, Stephanie E.; Pessolano, Lawrence G., Jr.; Bishop, Christopher A.; Best, Michael; Rich, Celeste B.; Stone, Phillip J.; Schreiber, Barbara M.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Schreiber, BM (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	schreibe@bu.edu	Gao, Jing/M-8264-2018	Schreiber, Barbara/0000-0001-8560-4249; Stone, Phillip/0000-0001-6220-690X; Bishop, Christopher/0000-0003-2247-3602	National Institutes of Health [HL079201]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (grant #HL079201). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back M, 2010, PROG CARDIOVASC DIS, V52, P410, DOI 10.1016/j.pcad.2009.12.002; BERK JL, 1991, J BIOL CHEM, V266, P3192; Beutler B, 2000, CURR OPIN MICROBIOL, V3, P23, DOI 10.1016/S1369-5274(99)00046-6; Black LD, 2005, J APPL PHYSIOL, V98, P1434, DOI 10.1152/japplphysiol.00921.2004; Campbell LA, 2015, ARCH MED RES, V46, P339, DOI 10.1016/j.arcmed.2015.05.006; Chen ES, 2010, AM J RESP CRIT CARE, V181, P360, DOI 10.1164/rccm.200905-0696OC; Chen T, 2006, CANCER RES, V66, P2853, DOI 10.1158/0008-5472.CAN-05-3279; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Cho A, 2002, CIRC RES, V91, P845, DOI 10.1161/01.RES.0000040420.17366.2E; Cole JE, 2013, TRENDS PHARMACOL SCI, V34, P629, DOI 10.1016/j.tips.2013.09.008; Connolly M, 2012, ARTHRITIS RHEUM-US, V64, P1035, DOI 10.1002/art.33455; Connolly M, 2010, J IMMUNOL, V184, P6427, DOI 10.4049/jimmunol.0902941; Curtiss LK, 2009, J LIPID RES, V50, pS340, DOI 10.1194/jlr.R800056-JLR200; de Lara LGV, 2003, AM J PHYSIOL-LUNG C, V285, pL899, DOI 10.1152/ajplung.00082.2003; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Galis ZS, 2002, CIRC RES, V91, P852, DOI 10.1161/01.RES.0000041036.86977.14; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; Gebbia JA, 2004, J INFECT DIS, V189, P113, DOI 10.1086/380414; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; He RL, 2009, BLOOD, V113, P429, DOI 10.1182/blood-2008-03-139923; Heinz A, 2010, FEBS J, V277, P1939, DOI 10.1111/j.1742-4658.2010.07616.x; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; HOSPELHORN AC, 1988, J HISTOCHEM CYTOCHEM, V36, P1353, DOI 10.1177/36.10.3418110; HOUGLUM K, 1994, J CLIN INVEST, V94, P808, DOI 10.1172/JCI117400; Hungness ES, 2002, BIOCHEM BIOPH RES CO, V290, P469, DOI 10.1006/bbrc.2001.6168; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; JACOBS DM, 1977, J IMMUNOL, V118, P21; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Kao SJ, 2005, IMMUNOLOGY, V115, P366, DOI 10.1111/j.1365-2567.2005.02160.x; Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223; King VL, 2011, CURR OPIN LIPIDOL, V22, P302, DOI 10.1097/MOL.0b013e3283488c39; Krishack PA, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001858; Kuang PP, 2005, AM J PHYSIOL-CELL PH, V289, pC766, DOI 10.1152/ajpcell.00525.2004; Kuang PP, 2003, AM J PHYSIOL-CELL PH, V285, pC1349, DOI 10.1152/ajpcell.00173.2003; Kuang PP, 2002, AM J PHYSIOL-CELL PH, V283, pC58, DOI 10.1152/ajpcell.00314.2001; Kumon Y, 1997, SCAND J IMMUNOL, V46, P284, DOI 10.1046/j.1365-3083.1997.d01-128.x; LANSING AI, 1952, ANAT RECORD, V114, P555, DOI 10.1002/ar.1091140404; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee GL, 2012, ARTERIOSCL THROM VAS, V32, P2751, DOI 10.1161/ATVBAHA.112.300302; Lee HJ, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-15; Lee HS, 2008, AM J PHYSIOL-LUNG C, V294, pL225, DOI 10.1152/ajplung.00370.2007; Lemaitre V, 2009, ATHEROSCLEROSIS, V205, P107, DOI 10.1016/j.atherosclerosis.2008.11.030; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; LIN GF, 1994, J BIOL CHEM, V269, P77; Luttun A, 2004, CIRCULATION, V109, P1408, DOI 10.1161/01.CIR.0000121728.14930.DE; MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186; MURPHY G, 1991, BIOCHEM J, V277, P277, DOI 10.1042/bj2770277; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Qin ZY, 2015, PEPTIDES, V67, P64, DOI 10.1016/j.peptides.2015.03.006; Rippe RA, 1999, DNA CELL BIOL, V18, P751, DOI 10.1089/104454999314890; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; SATO H, 1993, ONCOGENE, V8, P395; Schreiber BM, 2002, AMYLOID, V9, P276, DOI 10.3109/13506120209114107; SCHREIBER BM, 1988, ATHEROSCLEROSIS, V69, P69, DOI 10.1016/0021-9150(88)90290-0; SCHREIBER BM, 1992, ATHEROSCLEROSIS, V95, P201, DOI 10.1016/0021-9150(92)90023-A; Shin HS, 2011, J IMMUNOL, V186, P1119, DOI 10.4049/jimmunol.1001647; Slocum C, 2016, J INTERN MED; STONE PJ, 1987, IN VITRO CELL DEV B, V23, P663; Sullivan CP, 2010, J BIOL CHEM, V285, P565, DOI 10.1074/jbc.M109.070565; TOSELLI P, 1992, MATRIX, V12, P321, DOI 10.1016/S0934-8832(11)80084-3; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017; Ye RD, 2015, J LEUKOCYTE BIOL, V98, P923, DOI 10.1189/jlb.3VMR0315-080R; ZANDOMENI R, 1982, P NATL ACAD SCI-BIOL, V79, P3167, DOI 10.1073/pnas.79.10.3167	65	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0171711	10.1371/journal.pone.0171711	http://dx.doi.org/10.1371/journal.pone.0171711			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257481	gold, Green Published, Green Submitted			2022-12-26	WOS:000396021100008
J	van de Ven, RM; Buitenweg, JIV; Schmand, B; Veltman, DJ; Aaronson, JA; Nijboer, TCW; Kruiper-Doesborgh, SJC; van Bennekom, CAM; Rasquin, SMC; Ridderinkhof, KR; Murre, JMJ				van de Ven, Renate M.; Buitenweg, Jessika I. V.; Schmand, Ben; Veltman, Dick J.; Aaronson, Justine A.; Nijboer, Tanja C. W.; Kruiper-Doesborgh, Suzanne J. C.; van Bennekom, Coen A. M.; Rasquin, Sascha M. C.; Ridderinkhof, K. Richard; Murre, Jaap M. J.			Brain training improves recovery after stroke but waiting list improves equally: A multicenter randomized controlled trial of a computer-based cognitive flexibility training	PLOS ONE			English	Article							WORKING-MEMORY; IMPAIRMENT; THERAPY; DYSFUNCTION; FREQUENCY; INJURY; ADULTS; TASK; LIFE	Background Brain training is currently widely used in an attempt to improve cognitive functioning. Computer-based training can be performed at home and could therefore be an effective add-on to available rehabilitation programs aimed at improving cognitive functioning. Several studies have reported cognitive improvements after computer training, but most lacked proper active and passive control conditions. Objective Our aim was to investigate whether computer-based cognitive flexibility training improves executive functioning after stroke. We also conducted within-group analyses similar to those used in previous studies, to assess inferences about transfer effects when comparisons to proper control groups are missing. Methods We conducted a randomized controlled, double blind trial. Adults (30 - 80 years old) who had suffered a stroke within the last 5 years were assigned to either an intervention group (n = 38), active control group (i. e., mock training; n = 35), or waiting list control group (n = 24). The intervention and mock training consisted of 58 half-hour sessions within a 12-week period. Cognitive functioning was assessed using several paper-and-pencil and computerized neuropsychological tasks before the training, immediately after training, and 4 weeks after training completion. Results and conclusions Both training groups improved on training tasks, and all groups improved on several transfer tasks (three executive functioning tasks, attention, reasoning, and psychomotor speed). Improvements remained 4 weeks after training completion. However, the amount of improvement in executive and general cognitive functioning in the intervention group was similar to that of both control groups (active control and waiting list). Therefore, this improvement was likely due to training-unspecific effects. Our results stress the importance to include both active and passive control conditions in the study design and analyses. Results from studies without proper control conditions should be interpreted with care.	[van de Ven, Renate M.; Buitenweg, Jessika I. V.; Schmand, Ben; Ridderinkhof, K. Richard; Murre, Jaap M. J.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Schmand, Ben] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, Amsterdam, Netherlands; [Veltman, Dick J.] Vrije Univ Amsterdam, Dept Psychiat, Med Ctr, Amsterdam, Netherlands; [Aaronson, Justine A.; van Bennekom, Coen A. M.] Heliomare Rehabil Ctr, Dept Res & Dev, Wijk Aan Zee, Netherlands; [Nijboer, Tanja C. W.] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Nijboer, Tanja C. W.] De Hoogstr Rehabil, Utrecht, Netherlands; [Nijboer, Tanja C. W.] Univ Utrecht, Dept Expt Psychol, Utrecht, Netherlands; [Kruiper-Doesborgh, Suzanne J. C.] Reade, Amsterdam Rehabil Res Ctr, Amsterdam, Netherlands; [Rasquin, Sascha M. C.] Maastricht Univ, Adelante Zorggrp, Caphri, Rehabil Med, Maastricht, Netherlands; [Ridderinkhof, K. Richard] Univ Amsterdam, ABC, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Maastricht University; Maastricht University Medical Centre (MUMC); University of Amsterdam	van de Ven, RM (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	r.m.vandeven@uva.nl	Murre, Jaap MJ/A-3813-2010	van Bennekom, coen/0000-0002-9754-261X	Netherlands Initiative Brain and Cognition part of the Organization for Scientific Research (NWO) [056-14-013]	Netherlands Initiative Brain and Cognition part of the Organization for Scientific Research (NWO)	This project is part of the research program "Treatment of cognitive disorders based on functional brain imaging" funded by the Netherlands Initiative Brain and Cognition, a part of the Organization for Scientific Research (NWO) under grant number 056-14-013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlund E, 2013, BRAIN INJURY, V27, P1649, DOI 10.3109/02699052.2013.830195; Benton AL., 1983, MULTILINGUAL APHASIA; Bhogal SK, 2003, STROKE, V34, P987, DOI 10.1161/01.STR.0000062343.64383.D0; Buitenweg JIV, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00183; Chen SHA, 1997, BRAIN INJURY, V11, P197; Cohen J.E., 1988, STAT POWER ANAL BEHA; Corbett A, 2015, J AM MED DIR ASSOC, V16, P990, DOI 10.1016/j.jamda.2015.06.014; Culbertson WC., 2005, TOWER LONDON DREXEL; De Luca R, 2014, DISABIL HEALTH J, V7, P356, DOI 10.1016/j.dhjo.2014.04.003; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Glass BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070350; Gray JM, 1992, NEUROPSYCHOL REHABIL, V2, P97, DOI [10.1080/09602019208401399, DOI 10.1080/09602019208401399]; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Hardy JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134467; Karbach J, 2009, DEVELOPMENTAL SCI, V12, P978, DOI 10.1111/j.1467-7687.2009.00846.x; Kurland J, 2010, APHASIOLOGY, V24, P737, DOI 10.1080/02687030903524711; Lampit A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001756; Lesniak M, 2008, DEMENT GERIATR COGN, V26, P356, DOI 10.1159/000162262; Lever AG, 2015, J ABNORM PSYCHOL, V124, P1014, DOI 10.1037/abn0000108; Lin ZC, 2014, J INT MED RES, V42, P659, DOI 10.1177/0300060513505809; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; Maaijwee NAMM, 2014, J NEUROL, V261, P1300, DOI 10.1007/s00415-014-7346-3; Mayo, 1933, HUMAN PROBLEMS IND C; Middleton LE, 2014, NEUROREHABILITATION, V34, P305, DOI 10.3233/NRE-131030; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nys GMS, 2006, J NEUROL SCI, V247, P149, DOI 10.1016/j.jns.2006.04.005; Raven J, 1998, SECTION 4 ADV PROGRE; Roethlisberger F.J., 1939, MANAGEMENT WORKER AC; Rogers RD, 1995, J EXPT PSYCHOL GEN, V124; RUFF R, 1994, BRAIN INJURY, V8, P3, DOI 10.3109/02699059409150954; Saan R, 1986, 15 WOORDENTEST A B V; Saghaei M., 2011, J BIOMED SCI ENG, V4, P734, DOI [10.4236/jbise.2011.411090, DOI 10.4236/JBISE.2011.411090]; Slagter HA, 2012, TRENDS COGN SCI, V16, P582, DOI 10.1016/j.tics.2012.10.001; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Thrane G, 2014, J REHABIL MED, V46, P833, DOI 10.2340/16501977-1859; Thurnstone LL, 1938, PRIMARY MENTAL ABILI; van de Ven RM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00150; van de Ven RM, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0397-y; Van Vleet TM, 2015, NEUROCASE, V21, P489, DOI 10.1080/13554794.2014.928329; Wechsler D, 1999, WECHSLER ADULT INTEL; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Zachary R., 1991, SHIPLEY I LIVING SCA	44	23	24	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172993	10.1371/journal.pone.0172993	http://dx.doi.org/10.1371/journal.pone.0172993			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257436	Green Submitted, Green Published, gold			2022-12-26	WOS:000396021100048
J	Zhang, MWB; Hong, YX; Husain, SF; Harris, KM; Ho, RCM				Zhang, Melvyn W. B.; Hong, Ying X.; Husain, Syeda F.; Harris, Keith M.; Ho, Roger C. M.			Analysis of print news media framing of ketamine treatment in the United States and Canada from 2000 to 2015	PLOS ONE			English	Article							RAPID ANTIDEPRESSANT; DEPRESSION; ABUSE; INFUSIONS; EFFICACY; TRIALS; MODEL	Objectives There are multifaceted views on the use of ketamine, a potentially addictive substance, to treat mental health problems. The past 15 years have seen growing media coverage of ketamine for medical and other purposes. This study examined the print news media coverage of medical and other uses of ketamine in North America to determine orientations and trends over time. Methods Print newspaper coverage of ketamine from 2000 to 2015 was reviewed, resulting in 43 print news articles from 28 North American newspapers. A 55-item structured coding instrument was applied to assess news reports of ketamine. Items captured negative and positive aspects, therapeutic use of ketamine, and adverse side effects. Chi-squares tested for changes in trends over time. Results In the 15-year reviewed period, the three most frequent themes related to ketamine were: abuse (68.2%), legal status (34.1%), and clinical use in anesthesia (31.8%). There was significant change in trends during two periods (2000-2007 and 2008-2015). In 2008-2015, print news media articles were significantly more likely to encourage clinical use of ketamine to treat depression (p = 0.002), to treat treatment resistant depression (p = 0.043), and to claim that ketamine is more effective than conventional antidepressants (p = 0.043). Conclusions Our review found consistent positive changes in the portrayals of ketamine by the print news media as a therapeutic antidepressant that mirror the recent scientific publications. These changes in news media reporting might influence the popularity of ketamine use to treat clinical depression. Guidance is required for journalists on objective reporting of medical research findings, including limitations of current research evidence and potential risks of ketamine.	[Zhang, Melvyn W. B.] Natl Univ Singapore, Ctr Healthcare Innovat & Med Engn, Singapore, Singapore; [Hong, Ying X.; Husain, Syeda F.; Ho, Roger C. M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore, Singapore; [Harris, Keith M.] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Harris, Keith M.] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia	National University of Singapore; National University of Singapore; University of Tasmania; University of Queensland	Zhang, MWB (corresponding author), Natl Univ Singapore, Ctr Healthcare Innovat & Med Engn, Singapore, Singapore.	melvynzhangweibin@gmail.com	Ho, Roger C./ABD-9061-2021; Harris, Keith M/K-9957-2013; Ho, Roger/ABD-8859-2021	Ho, Roger C./0000-0001-9629-4493; Harris, Keith M/0000-0002-1199-2856; Husain, Syeda Fabeha/0000-0001-7460-397X				Barr AM, 2002, TRENDS PHARMACOL SCI, V23, P475, DOI 10.1016/S0165-6147(02)02086-2; Bella T, 2015, AL JAZEERA AM   0212; Bonnet U, 2015, J PSYCHOACTIVE DRUGS, V47, P276, DOI 10.1080/02791072.2015.1072653; Borwein A, 2013, J PAIN, V14, P1686, DOI 10.1016/j.jpain.2013.08.012; Caddy C, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011612.pub2; Canadian Agency for Drugs and Technologies in Health, 2014, INTR KET TREATM MENT; Canpolat DG, 2016, PAK J MED SCI, V32, P682, DOI 10.12669/pjms.323.9834; Cartwright N., 2007, BIOSOCIETIES, V2, P11, DOI [10.1017/S1745855207005029, DOI 10.1017/S1745855207005029]; Dasgupta N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007758; Diamond PR, 2014, J PSYCHOPHARMACOL, V28, P536, DOI 10.1177/0269881114527361; Dillon P, 2003, DRUG ALCOHOL DEPEN, V69, P23, DOI 10.1016/S0376-8716(02)00243-0; Fan DP, 1996, SUBST USE MISUSE, V31, P1413, DOI 10.3109/10826089609063984; Hashimoto K, 2016, EXPERT OPIN THER TAR, V20, P1389, DOI 10.1080/14728222.2016.1238899; Hashimoto K, 2016, AM J PSYCHIAT, V173, P1044, DOI 10.1176/appi.ajp.2016.16040411; Hashimoto K, 2014, CLIN PSYCHOPHARM NEU, V12, P72, DOI 10.9758/cpn.2014.12.1.72; Ho R., 2016, BJPSYCH ADV, V22, P222, DOI 10.1192/apt.bp.114.014274; Katalinic N, 2013, AUST NZ J PSYCHIAT, V47, P710, DOI 10.1177/0004867413486842; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; KRYSTAL JH, 2005, NEUROSCI BULL, V32, P557, DOI DOI 10.1001/ARCHPSYC.62.9.985; Li JH, 2011, SUBST ABUSE REHABIL, V2, P11, DOI 10.2147/SAR.S15458; LO JN, 1975, ANESTHESIOLOGY, V43, P307, DOI 10.1097/00000542-197509000-00007; McCloud TL, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011611.pub2; McGinty EE, 2016, PSYCHIAT SERV, V67, P405, DOI 10.1176/appi.ps.201500065; Netherland J, CULT MED PSYCHIAT; Newport DJ, 2015, AM J PSYCHIAT, V172, P950, DOI 10.1176/appi.ajp.2015.15040465; Pal R, 2013, DRUG ALCOHOL DEPEN, V132, P189, DOI 10.1016/j.drugalcdep.2013.02.005; Papakostas GI, 2008, J PSYCHOPHARMACOL, V22, P843, DOI 10.1177/0269881107083808; Rasmussen KG, 2015, PROGR NEUROPSYCHOPHA; Sackeim HA, 2001, J CLIN PSYCHIAT, V62, pS10; Schatzberg AF, 2014, AM J PSYCHIAT, V171, P262, DOI 10.1176/appi.ajp.2014.13101434; Singh I, 2016, LANCET PSYCHIAT; Sisti D, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0527-z; Solovitch S., 2016, WASHINGTON POST; Soroka S, 2013, J HEALTH POLIT POLIC, V38, P893, DOI 10.1215/03616878-2334656; Substance Abuse and Mental Health Services Administration, 2003, DRUG AB WARN NETW D, VD-24; Tam YH, 2014, BJU INT, V114, P754, DOI 10.1111/bju.12675; Taylor MJ, 2006, ARCH GEN PSYCHIAT, V63, P1217, DOI 10.1001/archpsyc.63.11.1217; Trujillo KA, 2011, ILAR J, V52, P366, DOI 10.1093/ilar.52.3.366; Ubogu EE, 2003, EPILEPSY BEHAV, V4, P70, DOI 10.1016/S1525-5050(02)00643-1; Yang C, 2014, PSYCHOPHARMACOLOGY, V231, P2041, DOI 10.1007/s00213-014-3543-0; Zarate CA, 2012, BIOL PSYCHIAT, V71, P939, DOI 10.1016/j.biopsych.2011.12.010; Zhang MW, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0087-3; Zhang MW, 2015, LANCET PSYCHIAT, V2, P1057, DOI 10.1016/S2215-0366(15)00472-1; Zhang MWB, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00047; Zhang MWB, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4467; Zhang MW, 2016, AM J PSYCHIAT, V173, P431, DOI 10.1176/appi.ajp.2016.15111401; Zhang MW, 2016, ETHICS BEHAV; Zhu WL, 2016, NEUROSCI BULL, V32, P557, DOI 10.1007/s12264-016-0081-2	48	15	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173202	10.1371/journal.pone.0173202	http://dx.doi.org/10.1371/journal.pone.0173202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257514	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000396021100076
J	Chisha, Y; Terefe, W; Assefa, H; Lakew, S				Chisha, Yilma; Terefe, Wondwossen; Assefa, Huruy; Lakew, Serawit			Prevalence and factors associated with diabetic retinopathy among diabetic patients at Arbaminch General Hospital, Ethiopia: Cross sectional study	PLOS ONE			English	Article								Background Currently 93 million people are estimated as living with diabetic retinopathy worldwide. The prevalence and risk factors of diabetic retinopathy in developed countries have been well documented; but in Ethiopia, data on prevalence and associated factors of diabetic retinopathy is lacking. Objective To determine prevalence and factors associated with development of diabetic retinopathy among diabetic patients at Arbaminch General Hospital, Ethiopia. Method Cross-sectional study design with record review of 400 diabetic patients was conducted at Arbaminch General Hospital from November to January 2015. Among 400 diabetic patients, 270 patients with baseline information and without history of hypertension at baseline were included in this study. But patients with gestational diabetes and with retinopathy at baseline were excluded from the study. Consecutive sampling technique was applied to select study participants. Data of cohorts was extracted from medical record using pre tested structured extraction check list. Data cleaning, coding, categorizing, merging and analysis carried out by STATA version 12. Descriptive statistics was done and presented accordingly. Bivariate binary logistic regression analysis was done to select potential candidates for the full model at P-value cutoff point <= 0.25 and multivariable binary logistic regression analysis was made to estimate the independent effect of predictors on the occurrence of diabetic retinopathy. Model diagnostic tests were done, final model fitness was checked using Hosmer and Lemeshow chi square test. Finally, statistical significance was tested at P-value <0.05. Result Prevalence of diabetic retinopathy among diabetic patients at Arbaminch General Hospital was 13%. Adjusted analysis showed that the odds of diabetic retinopathy were statistically and significantly associated with baseline age (AOR = 6.06: 95% CI; 2.42, 15.21), baseline systolic blood pressure level (AOR = 4.38: 95% CI; 1.64, 11.68), family history of diabetes (AOR = 0.22: 95% CI; 0.08, 0.58) and duration of diabetes (AOR = 8.84: 95% CI; 3.56, 12.89). Conclusion and recommendation In the current study, prevalence of diabetic retinopathy was 13%. Since baseline age >= 60 years, baseline systolic blood pressure level >140 mmhg, duration of diabetes >= 6 years and patients with family history of diabetes were statistically and significantly related with diabetic retinopathy, special care should be given in addition to routine care.	[Chisha, Yilma] Arbaminch Coll Hlth Sci, Dept Biostat & Hlth Informat, Arbaminch, Ethiopia; [Terefe, Wondwossen; Assefa, Huruy] Mekelle Univ, Dept Biostat, Mekelle, Ethiopia; [Lakew, Serawit] Wolaita Sodo Univ, Dept Matern & Reprod Hlth Nursing, Wolaita, Ethiopia	Mekelle University	Lakew, S (corresponding author), Wolaita Sodo Univ, Dept Matern & Reprod Hlth Nursing, Wolaita, Ethiopia.	lserawit@yahoo.com	Chisha, Yilma/GOH-2697-2022		World Bank	World Bank(The World Bank India)	This work was World Bank sponsored, because this is from sub-Saharan Africa.	Almahdi S., 2013, MED SCI, V2, P512; [Anonymous], 2008, VIS 2020THE RIGHT SI; Brazionis L., 2008, HOMOCYSTEINE DIABETI, V31, P50, DOI [10.2337/dc07-0632, DOI 10.2337/DC07-0632]; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Dormann CF, 2012, NORDIC SOC OIKOS, V1, pEV1; Fauci Anthony S., 2008, HARRISONS PRINCIPLES, V2; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; IDA, 2011, DIAB FACTS; IDF, 2011, DIAB DEV WORLD 2011; Jones CD, 2012, DIABETES CARE, V35, P592, DOI 10.2337/dc11-0943; Matthews DR, 2004, ARCH OPHTHALMOL-CHIC, V122, P1631; Roaeid R.B., 2011, J DIABETOLOGY, V3, P1; Sleire Lene, 2011, THESIS; Surrena H., 2010, HDB BRUNNER SUDDARTH, V4; WHO, 2016, GLOB REP PSOR; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Worku D, 2010, ETHIOP J HEALTH SCI, V20, P33; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	18	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0171987	10.1371/journal.pone.0171987	http://dx.doi.org/10.1371/journal.pone.0171987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253261	Green Published, gold, Green Submitted			2022-12-26	WOS:000396011300010
J	Sasado, T; Kondoh, H; Furutani-Seiki, M; Naruse, K				Sasado, Takao; Kondoh, Hisato; Furutani-Seiki, Makoto; Naruse, Kiyoshi			Mutation in cpsf6/CFIm68 (Cleavage and Polyadenylation Specificity Factor Subunit 6) causes short 3 ' UTRs and disturbs gene expression in developing embryos, as revealed by an analysis of primordial germ cell migration using the medaka mutant naruto	PLOS ONE			English	Article							CLEAVAGE FACTOR-I; MICRORNA-MEDIATED REGULATION; POSTERIOR LATERAL-LINE; ALTERNATIVE POLYADENYLATION; CHEMOKINE RECEPTOR; ORYZIAS-LATIPES; CXC CHEMOKINE; ROBUSTNESS; ZEBRAFISH; GUIDANCE	Our previous studies analyzing medaka mutants defective in primordial germ cell (PGC) migration identified cxcr4b and cxcr7, which are both receptors of the chemokine sdf1/cxcl12, as key regulators of PGC migration. Among PGC migration mutants, naruto (nar) is unique in that the mutant phenotype includes gross morphological abnormalities of embryos, suggesting that the mutation affects a broader range of processes. A fine genetic linkage mapping and genome sequencing showed the nar gene encodes Cleavage and Polyadenylation Specificity Factor subunit 6 (CPSF6/CFIm68). CPSF6 is a component of the Cleavage Factor Im complex (CFIm) which plays a key role in pre-mRNA 3'-cleavage and polyadenylation. 3'RACE of sdf1a/b and cxcr7 transcripts in the mutant embryos indicated shorter 3'UTRs with poly A additions occurring at more upstream positions than wildtype embryos, suggesting CPSF6 functions to prevent premature 3'UTR cleavage. In addition, expression of the coding region sequences of sdf1a/b in nar mutants was more anteriorly extended in somites than wild-type embryos, accounting for the abnormally extended distribution of PGCs in nar mutants. An expected consequence of shortening 3'UTR is the escape from the degradation mechanism mediated by microRNAs interacting with distal 3'UTR sequence. The abnormal expression pattern of sdf1a coding sequence may be at least partially accounted for by this mechanism. Given the pleiotropic effects of nar mutation, further analysis using the nar mutant will reveal processes in which CPSF6 plays essential regulatory roles in poly A site selection and involvement of 3'UTRs in posttranscriptional gene regulation in various genes in vivo.	[Sasado, Takao; Naruse, Kiyoshi] Natl Inst Basic Biol, Lab Bioresources, Okazaki, Aichi, Japan; [Kondoh, Hisato] Kyoto Sangyo Univ, Fac Life Sci, Kyoto, Japan; [Furutani-Seiki, Makoto] Yamaguchi Univ, Sch Med, Ube, Yamaguchi, Japan; [Sasado, Takao] Tokyo Gakugei Univ, Dept Biol, Tokyo, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Kyoto Sangyo University; Yamaguchi University; Tokyo Gakugei University	Sasado, T (corresponding author), Natl Inst Basic Biol, Lab Bioresources, Okazaki, Aichi, Japan.; Sasado, T (corresponding author), Tokyo Gakugei Univ, Dept Biol, Tokyo, Japan.	tsasado@gmail.com		Sasado, Takao/0000-0003-4356-4650; Naruse, Kiyoshi/0000-0001-9185-3495	Japan Society for the Promotion of Science [21770245, 16K07381]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Young Scientists (B) (No. 21770245) and Grant-in-Aid for Scientific Research (C) (No. 16K07381) from the Japan Society for the Promotion of Science (https.//www.jsps.go.jp/english/e-grants/) to TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2009, ZOOL SCI, V26, P112, DOI 10.2108/zsj.26.112; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P647, DOI 10.1016/j.mod.2004.04.016; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Geisler R, 2002, ZEBRAFISH PRACTICAL, V261, P175; Gilmour D, 2004, NAT NEUROSCI, V7, P491, DOI 10.1038/nn1235; Goudarzi M, 2013, NAT GENET, V45, P1264, DOI 10.1038/ng.2793; Grabher C, 2003, GENE, V322, P57, DOI 10.1016/j.gene.2003.09.009; Gruber AR, 2012, RNA BIOL, V9, P1405, DOI 10.4161/rna.22570; HAMAGUCHI S, 1982, CELL TISSUE RES, V227, P139; Herpin A, 2008, DEV BIOL, V320, P319, DOI 10.1016/j.ydbio.2008.03.030; Herpin A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-3; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Hwang J, 2011, CURR OPIN GENET DEV, V21, P422, DOI 10.1016/j.gde.2011.03.008; Ishikawa Y, 2000, BIOESSAYS, V22, P487, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;487::AID-BIES11&gt;3.0.CO;2-8; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Kamasawa Masami, 2008, In Silico Biology, V8, P347; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kim S, 2010, GENES CELLS, V15, P1003, DOI 10.1111/j.1365-2443.2010.01436.x; Kimura T, 2010, BIOTECHNIQUES, V49, P582, DOI 10.2144/000113467; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kubo T, 2006, NUCLEIC ACIDS RES, V34, P6264, DOI 10.1093/nar/gkl794; Kunwar PS, 2006, ANNU REV CELL DEV BI, V22, P237, DOI 10.1146/annurev.cellbio.22.010305.103337; Kurokawa H, 2006, DEV GROWTH DIFFER, V48, P209, DOI 10.1111/j.1440-169x.2006.00858.x; Lewellis SW, 2012, SEMIN CELL DEV BIOL, V23, P333, DOI 10.1016/j.semcdb.2012.03.009; Li Q, 2004, DEV BIOL, V269, P123, DOI 10.1016/j.ydbio.2004.01.020; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lin YF, 2012, NUCLEIC ACIDS RES, V40, P8460, DOI 10.1093/nar/gks637; Maksym RB, 2009, EUR J PHARMACOL, V625, P31, DOI 10.1016/j.ejphar.2009.04.071; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Marin RM, 2011, NUCLEIC ACIDS RES, V39, P19, DOI 10.1093/nar/gkq768; Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Molyneaux K, 2004, INT J DEV BIOL, V48, P537, DOI 10.1387/ijdb.041833km; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Nakamura S, 2006, DEV BIOL, V295, P678, DOI 10.1016/j.ydbio.2006.03.052; Oshikawa M, 2008, DNA RES, V15, P123, DOI 10.1093/dnares/dsn010; OZATO K, 1994, DEV GROWTH DIFFER, V36, P437; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Raz E, 2009, DEVELOPMENT, V136, P1223, DOI 10.1242/dev.022418; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Sartini BL, 2008, BIOL REPROD, V78, P472, DOI 10.1095/biolreprod.107.064774; Sasado T, 2004, MECH DEVELOP, V121, P817, DOI 10.1016/j.mod.2004.03.022; Sasado T, 2008, DEV BIOL, V320, P328, DOI 10.1016/j.ydbio.2008.05.544; Sasado T, 2010, EXP ANIM TOKYO, V59, P13, DOI 10.1538/expanim.59.13; SATOH N, 1972, J EMBRYOL EXP MORPH, V28, P385; Shi YS, 2012, RNA, V18, P2105, DOI 10.1261/rna.035899.112; Shinomiya A, 2000, DEV GROWTH DIFFER, V42, P317; Singh AK, 2013, CYTOKINE GROWTH F R, V24, P41, DOI 10.1016/j.cytogfr.2012.08.007; Staton AA, 2013, NAT GENET, V45, P1266, DOI 10.1038/ng.2812; Staton AA, 2011, NAT GENET, V43, P204, DOI 10.1038/ng.758; Stebler J, 2004, DEV BIOL, V272, P351, DOI 10.1016/j.ydbio.2004.05.009; Takehana Y, 2005, MOL PHYLOGENET EVOL, V36, P417, DOI 10.1016/j.ympev.2005.01.016; Takeuchi T, 2010, MECH DEVELOP, V127, P146, DOI 10.1016/j.mod.2009.09.005; Tanaka M, 2001, P NATL ACAD SCI USA, V98, P2544, DOI 10.1073/pnas.041315498; Tanegashima K, 2013, FEBS LETT, V587, P1731, DOI 10.1016/j.febslet.2013.04.046; Tarbashevich K, 2010, CURR OPIN CELL BIOL, V22, P715, DOI 10.1016/j.ceb.2010.09.005; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Venkiteswaran G, 2013, CELL; Sanchez-Sanchez AV, 2010, STEM CELLS, V28, P1457, DOI 10.1002/stem.469; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Wittkopp N, 2009, MOL CELL BIOL, V29, P3517, DOI 10.1128/MCB.00177-09; Yang Q, 2011, STRUCTURE, V19, P368, DOI 10.1016/j.str.2010.12.021; Yasuoka A, 2004, MECH DEVELOP, V121, P729, DOI 10.1016/j.mod.2004.03.032; Zhang Y, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-127; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	81	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172467	10.1371/journal.pone.0172467	http://dx.doi.org/10.1371/journal.pone.0172467			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253363	gold, Green Submitted, Green Published			2022-12-26	WOS:000396011300020
J	Rodriguez-Caro, RC; Oedekoven, CS; Gracia, E; Anadon, JD; Buckland, ST; Esteve-Selma, MA; Martinez, J; Gimenez, A				Rodriguez-Caro, Roberto C.; Oedekoven, Cornelia S.; Gracia, Eva; Anadon, Jose D.; Buckland, Stephen T.; Esteve-Selma, Miguel A.; Martinez, Julia; Gimenez, Andres			Low tortoise abundances in pine forest plantations in forest-shrubland transition areas	PLOS ONE			English	Article							HABITAT SELECTION; TESTUDO-GRAECA; LANDSCAPE; FRAGMENTATION; CONSERVATION; BIODIVERSITY; COMMUNITIES; ASSEMBLAGES; GRADIENTS; PATTERNS	In the transition between Mediterranean forest and the arid subtropical shrublands of the southeastern Iberian Peninsula, humans have transformed habitat since ancient times. Understanding the role of the original mosaic landscapes in wildlife species and the effects of the current changes as pine forest plantations, performed even outside the forest ecological boundaries, are important conservation issues. We studied variation in the density of the endangered spur-thighed tortoise (Testudo graeca) in three areas that include the four most common land types within the species' range (pine forests, natural shrubs, dryland crop fields, and abandoned crop fields). Tortoise densities were estimated using a two-stage modeling approach with line transect distance sampling. Densities in dryland crop fields, abandoned crop fields and natural shrubs were higher (> 6 individuals/ha) than in pine forests (1.25 individuals/ha). We also found large variation in density in the pine forests. Recent pine plantations showed higher densities than mature pine forests where shrub and herbaceous cover was taller and thicker. We hypothesize that mature pine forest might constrain tortoise activity by acting as partial barriers to movements. This issue is relevant for management purposes given that large areas in the tortoise's range have recently been converted to pine plantations.	[Rodriguez-Caro, Roberto C.; Gracia, Eva; Gimenez, Andres] Univ Miguel Hernandez, Area Ecol, Dept Biol Aplicada, Av Univ, Elche, Spain; [Oedekoven, Cornelia S.; Buckland, Stephen T.] Univ St Andrews, Ctr Res Ecol & Environm Modeling, Buchanan Gardens, St Andrews, Fife, Scotland; [Anadon, Jose D.] CUNY Queens Coll, Dept Biol, New York, NY USA; [Esteve-Selma, Miguel A.] Univ Murcia, Area Ecol, Dept Ecol & Hidrol, Murcia, Spain; [Martinez, Julia] Fdn Nueva Cultura Agua, Zaragoza, Spain	Universidad Miguel Hernandez de Elche; University of St Andrews; City University of New York (CUNY) System; University of Murcia	Rodriguez-Caro, RC (corresponding author), Univ Miguel Hernandez, Area Ecol, Dept Biol Aplicada, Av Univ, Elche, Spain.	r.rodriguez@umh.es	Graciá, Eva/H-2270-2015; Giménez, Andrés/H-4354-2015; Rodríguez-Caro, Roberto/ABE-6957-2020; Buckland, Stephen T/A-1998-2012; Martinez-Fernandez, Julia/J-9681-2012; Esteve-Selma, Miguel Angel/ABG-7689-2020	Graciá, Eva/0000-0003-0790-163X; Giménez, Andrés/0000-0002-5248-9819; Rodríguez-Caro, Roberto/0000-0003-2321-9497; Martinez-Fernandez, Julia/0000-0001-8675-947X; Esteve-Selma, Miguel Angel/0000-0003-1803-3217; Buckland, Stephen/0000-0002-9939-709X; Oedekoven, Cornelia/0000-0002-5610-7814	Spanish Ministry of Science and European Regional Development Fund [CGL2012-33536, CGL2015-64144]; MINECIO/FEDER; Regional Government of the Community of Valencia [ACIF/2010/133, APOSTD/2015/048]	Spanish Ministry of Science and European Regional Development Fund; MINECIO/FEDER; Regional Government of the Community of Valencia	The Spanish Ministry of Science and European Regional Development Fund funded this work through Projects CGL2012-33536 and CGL2015-64144; MINECIO/FEDER. Regional Government of the Community of Valencia supported R.R-C. by a postgraduate grant (ACIF/2010/133) and E.G. by a postdoctoral grant (APOSTD/2015/048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1979, BIOMETRIKA, V66, P237, DOI 10.1093/biomet/66.2.237; Amo L, 2007, BIODIVERS CONSERV, V16, P3409, DOI 10.1007/s10531-006-9003-3; Anadon JD, 2006, BIODIVERS CONSERV, V15, P2287, DOI 10.1007/s10531-004-8226-4; Anadon JD, 2006, ECOGRAPHY, V29, P339, DOI 10.1111/j.2006.0906-7590.04486.x; Anderson DR, 2001, J WILDLIFE MANAGE, V65, P583, DOI 10.2307/3803111; Azor JS, 2015, FOREST ECOL MANAG, V354, P185, DOI 10.1016/j.foreco.2015.06.020; Barton PS, 2013, BIODIVERS CONSERV, V22, P2091, DOI 10.1007/s10531-013-0530-4; Belmonte-Serrano F., 2008, EROSION FORESTACIONE; Bignal EM, 1996, J APPL ECOL, V33, P413, DOI 10.2307/2404973; Billeter R, 2008, J APPL ECOL, V45, P141, DOI 10.1111/j.1365-2664.2007.01393.x; Blouin-Demers G, 2001, ECOLOGY, V82, P3025; Bottema S., 1990, MANS ROLE SHAPING E; Buckland S.T., 2001, pi; Buckland ST, 2009, J AGR BIOL ENVIR ST, V14, P432, DOI 10.1198/jabes.2009.08030; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calix M., 2018, EUROPEAN RED LIST SA; Anadon JD, 2009, CONSERV BIOL, V23, P617, DOI 10.1111/j.1523-1739.2008.01145.x; DARGIE TCD, 1987, J BIOGEOGR, V14, P197, DOI 10.2307/2844891; de Wit AMW, 1998, ADV ECOL SCI, V1, P165; Diaz JA, 2000, ANIM CONSERV, V3, P235, DOI 10.1017/S1367943000000950; Diaz M, 1998, J APPL ECOL, V35, P562, DOI 10.1046/j.1365-2664.1998.3540562.x; ESTEVE MA, 2003, RECURSOS NATURALES R, P248; Esteve-Selma MA, 2012, CLIMATIC CHANGE, V113, P663, DOI 10.1007/s10584-011-0378-0; Evans K. O., 2013, J WILDLIFE MANAGEMEN, DOI 10. 1002/jwmg. 502; Gao JiXi, 2012, Journal of Resources and Ecology, V3, P297, DOI 10.5814/j.issn.1674-764x.2012.04.002; Gimenez A., 2001, TECHNICAL REPORT; Goldstein MI, 2003, ECOL MODEL, V162, P155, DOI 10.1016/S0304-3800(03)00005-X; GREENBERG CH, 1994, CONSERV BIOL, V8, P1047, DOI 10.1046/j.1523-1739.1994.08041047.x; Jaggi C, 1999, AMPHIBIA-REPTILIA, V20, P25, DOI 10.1163/156853899506870; Kazmaier RT, 2001, J WILDLIFE MANAGE, V65, P653, DOI 10.2307/3803016; Lal R, 2010, BIOSCIENCE, V60, P708, DOI 10.1525/bio.2010.60.9.8; Leuteritz TEJ, 2005, BIOL CONSERV, V124, P451, DOI 10.1016/j.biocon.2005.02.003; Litzgus JD, 2000, J HERPETOL, V34, P178, DOI 10.2307/1565413; Lloret F, 2002, LANDSCAPE ECOL, V17, P745, DOI 10.1023/A:1022966930861; Lopez-Jurado L.F, 1979, NATURALIA HISPANICA, V17, P1, DOI [10.5061/dryad.q83bk3jhs, DOI 10.5061/DRYAD.Q83BK3JHS]; Luiselli L, 2008, ACTA HERPETOL, V3, P19; Mac Nally R, 2001, OECOLOGIA, V128, P116, DOI 10.1007/s004420100632; Maestre FT, 2004, FOREST ECOL MANAG, V198, P303, DOI 10.1016/j.foreco.2004.05.040; Martinez-Fernandez J, 2005, LAND DEGRAD DEV, V16, P529, DOI 10.1002/ldr.707; Meyfroidt P, 2011, ANNU REV ENV RESOUR, V36, P343, DOI 10.1146/annurev-environ-090710-143732; Oxbrough A, 2012, FOREST ECOL MANAG, V270, P11, DOI 10.1016/j.foreco.2012.01.006; Perez I., 2002, ANALES BIOL, V24, P55; RISSER PG, 1995, BIOSCIENCE, V45, P318, DOI 10.2307/1312492; Rodriguez-Caro R. C., 2016, J ZOOLOGY; Santos X, 2016, OECOLOGIA, V180, P205, DOI 10.1007/s00442-015-3453-9; Schreuder E, 2016, OECOLOGIA, V182, P1213, DOI 10.1007/s00442-016-3726-y; Stubbs David, 1995, P94; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Lantschner MV, 2011, MAMMALIA, V75, P249, DOI 10.1515/MAMM.2011.031; Walter H., 1979, VEGETATION EARTH ECO; Walter H., 1985, COMMUNITY ECOSYSTEMS, P167; White D, 1997, CONSERV BIOL, V11, P349, DOI 10.1046/j.1523-1739.1997.95458.x; WRIGHT J, 1988, CAN J ZOOL, V66, P1537, DOI 10.1139/z88-225	53	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173485	10.1371/journal.pone.0173485	http://dx.doi.org/10.1371/journal.pone.0173485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273135	gold, Green Published, Green Submitted			2022-12-26	WOS:000396073700009
J	Dale, ML; Horak, FB; Wright, WG; Schoneburg, BM; Nutt, JG; Mancini, M				Dale, Marian L.; Horak, Fay B.; Wright, W. Geoffrey; Schoneburg, Bernadette M.; Nutt, John G.; Mancini, Martina			Impaired perception of surface tilt in progressive supranuclear palsy	PLOS ONE			English	Article							PARKINSONS-DISEASE; VERTICALITY; RESPONSES; STANCE; STIMULATION; STABILITY; POSTURE	Introduction Progressive supranuclear palsy (PSP) is characterized by early postural instability and backward falls. The mechanisms underlying backward postural instability in PSP are not understood. The aim of this study was to test the hypothesis that postural instability in PSP is a result of dysfunction in the perception of postural verticality. Methods We gathered posturography data on 12 subjects with PSP to compare with 12 subjects with idiopathic Parkinson's Disease (PD) and 12 healthy subjects. Objective tests of postural impairment included: dynamic sensory perception tests of gravity and of surface oscillations, postural responses to surface perturbations, the sensory organization test of postural sway under altered sensory conditions and limits of stability in stance. Results Perception of toes up (but not toes down) surface tilt was reduced in subjects with PSP compared to both control subjects (p <= 0.001 standing, p <= 0.007 seated) and subjects with PD (p <= 0.03 standing, p <= 0.04 seated). Subjects with PSP, PD and normal controls accurately perceived the direction of gravity when standing on a tilting surface. Unlike PD and control subjects, subjects with PSP exerted less postural corrective torque in response to toes up surface tilts. Discussion Difficulty perceiving backward tilt of the surface or body may account for backward falls and postural impairments in patients with PSP. These observations suggest that abnormal central integration of sensory inputs for perception of body and surface orientation contributes to the pathophysiology of postural instability in PSP.	[Dale, Marian L.; Horak, Fay B.; Schoneburg, Bernadette M.; Nutt, John G.; Mancini, Martina] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Dale, Marian L.; Horak, Fay B.] Vet Affairs Portland Healthcare Syst VAPORHCS, PADRECC P3, Parkinsons Dis Res Educ & Clin Ctr, Portland, OR 97239 USA; [Wright, W. Geoffrey] Temple Univ, Dept Phys Therapy, Philadelphia, PA 19122 USA; [Wright, W. Geoffrey] Temple Univ, Dept Bioengn, Philadelphia, PA 19122 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania	Dale, ML (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA.; Dale, ML (corresponding author), Vet Affairs Portland Healthcare Syst VAPORHCS, PADRECC P3, Parkinsons Dis Res Educ & Clin Ctr, Portland, OR 97239 USA.	dalem@ohsu.edu	Dale, Marian/AAO-7163-2020	Dale, Marian/0000-0003-1010-982X; Mancini, Martina/0000-0002-4532-3984	Medical Research Foundation of Oregon; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD078492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006457] Funding Source: NIH RePORTER	Medical Research Foundation of Oregon; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Medical Research Foundation of Oregon: Early Clinical Investigator Grant awarded to BS. OHSU and FH have a significant financial interest in APDM, a company that may have a commercial interest in the results of this research and technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers DS, 2001, TRENDS NEUROSCI, V24, P347, DOI 10.1016/S0166-2236(00)01794-X; Barra J, 2010, BRAIN, V133, P3552, DOI 10.1093/brain/awq311; BLASZCZYK JW, 1994, GAIT POSTURE, V2, P11, DOI 10.1016/0966-6362(94)90012-4; BLASZCZYK JW, 1993, GAIT POSTURE, V1, P211, DOI 10.1016/0966-6362(93)90048-6; Boeve BF, 2012, PARKINSONISM RELA S1, V18, pS1142; BRANDT T, 1994, ANN NEUROL, V35, P403, DOI 10.1002/ana.410350406; Ganesan M, 2012, GAIT POSTURE, V35, P625, DOI 10.1016/j.gaitpost.2011.12.012; Henderson JM, 2000, BRAIN, V123, P1410, DOI 10.1093/brain/123.7.1410; HORAK FB, 1994, EXP BRAIN RES, V100, P93; Liao K, 2008, NEUROLOGY, V70, P802, DOI 10.1212/01.wnl.0000304134.33380.1e; Litvan I, 1996, NEUROLOGY, V46, P922, DOI 10.1212/WNL.46.4.922; Manckoundia P, 2007, CLIN NEUROPHYSIOL, V118, P786, DOI 10.1016/j.clinph.2006.11.274; MASDEU JC, 1988, ANN NEUROL, V23, P596, DOI 10.1002/ana.410230612; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; Maurer C, 2006, EXP BRAIN RES, V168, P41, DOI 10.1007/s00221-005-0087-x; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Ondo W, 2000, ARCH NEUROL-CHICAGO, V57, P1464, DOI 10.1001/archneur.57.10.1464; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Shinotoh H, 1999, Rinsho Shinkeigaku, V39, P33; Vaugoyeau M, 2011, HUM MOVEMENT SCI, V30, P405, DOI 10.1016/j.humov.2010.10.006; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Wright WG, 2007, EXP BRAIN RES, V182, P321, DOI 10.1007/s00221-007-0990-4; Wright WG, 2009, EXP BRAIN RES, V192, P683, DOI 10.1007/s00221-008-1581-8; Wright WG, 2003, ANN NY ACAD SCI, V1004, P531, DOI 10.1196/annals.1303.069; ZWEIG RM, 1987, ANN NEUROL, V22, P18, DOI 10.1002/ana.410220107; Zwergal A, 2011, NEUROLOGY, V77, P101, DOI 10.1212/WNL.0b013e318223c79d	26	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173351	10.1371/journal.pone.0173351	http://dx.doi.org/10.1371/journal.pone.0173351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267762	Green Submitted, Green Published, gold			2022-12-26	WOS:000396060600024
J	Lin, SY; Lin, CL; Ju, SW; Wang, IK; Lin, CC; Lin, CH; Hsu, WH; Liang, JA				Lin, Shih-Yi; Lin, Cheng-Li; Ju, Shu-Woei; Wang, I-Kuan; Lin, Cheng-Chieh; Lin, Chih-Hsueh; Hsu, Wu-Huei; Liang, Ji-An			Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study	PLOS ONE			English	Article							HEPATITIS-C VIRUS; OXIDATIVE STRESS; DISEASE; INTERFERON-ALPHA-2B; ASSOCIATION; RETINOPATHY; PREVALENCE; INFECTION; INDICATOR; STROKE	Purpose Hepatitis C virus (HCV) infection is associated with increased systemic oxidative stress, which leads to cardiovascular events, diabetes, and chronic kidney disease. Similarly, cataract is also associated with increased oxidative stress. The association between HCV infection and increased risk of cataract remains unclear. Methods A total of 11,652 HCV-infected patients and 46,608 age-and sex-matched non-HCV infected patients were identified during 2003-2011. All patient data were tracked until a diagnosis of cataract, death, or the end of 2011. Cumulative incidences and hazard ratios (HRs) were calculated. Results The mean follow-up durations were 5.29 and 5.86 years for the HCV and non-HCV cohorts, respectively. The overall incidence density rate for cataract was 1.36 times higher in the HCV cohort than in the non-HCV cohort (1.86 and 1.37 per 100 person-y, respectively). After adjusting for age, sex, comorbidities of diabetes, hypertension, hyperlipidemia, asthma, chronic obstructive pulmonary disease, coronary artery disease, and anxiety, patients with HCV infection had an increased risk of cataract compared with those without HCV infection [ adjusted HR = 1.23, 95% confidence interval (CI) = 1.14-1.32]. HCV-infected patients receiving interferon-ribavirin therapy had a 1.83 times higher (95% CI = 1.40-2.38) risk of cataract than non-HCV infected patients did. Conclusion HCV infection, even without the complication of cirrhosis, is associated with an increased risk of cataract, and this risk is higher in HCV-infected patients undergoing interferon-ribavirin therapy.	[Lin, Shih-Yi; Wang, I-Kuan; Lin, Cheng-Chieh; Lin, Chih-Hsueh; Hsu, Wu-Huei; Liang, Ji-An] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Lin, Shih-Yi; Ju, Shu-Woei; Wang, I-Kuan] China Med Univ Hosp, Div Nephrol, Taichung, Taiwan; [Lin, Shih-Yi; Ju, Shu-Woei; Wang, I-Kuan] China Med Univ Hosp, Kidney Inst, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Lin, Cheng-Chieh; Lin, Chih-Hsueh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Hsu, Wu-Huei] China Med Univ Hosp, Div Pulm & Crit Care Med, Taichung, Taiwan; [Hsu, Wu-Huei] China Med Univ, Taichung, Taiwan; [Liang, Ji-An] China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Liang, JA (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan.; Liang, JA (corresponding author), China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan.	d4615@mail.cmuh.org.tw	; Lin, Cheng-Chieh/P-2564-2015	Liang, Ji-An/0000-0002-4170-7155; Lin, Cheng-Chieh/0000-0002-9625-6216	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST105-2325-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Babizhayev MA, 2001, PEPTIDES, V22, P979, DOI 10.1016/S0196-9781(01)00407-7; Chen PC, 2011, STROKE, V42, P3034, DOI 10.1161/STROKEAHA.111.615534; Chen YC, 2014, KIDNEY INT, V85, P1200, DOI 10.1038/ki.2013.455; Chi MJ, 2011, ARCH GERONTOL GERIAT, V52, P284, DOI 10.1016/j.archger.2010.04.017; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; El-Zayadi AR, 2012, WORLD J GASTROENTERO, V18, P212, DOI 10.3748/wjg.v18.i3.212; Farel C, 2004, AIDS, V18, P1805, DOI 10.1097/00002030-200409030-00009; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Grimes CE, 2014, WORLD J SURG, V38, P252, DOI 10.1007/s00268-013-2243-y; Jain K, 2001, BRIT J OPHTHALMOL, V85, P1171, DOI 10.1136/bjo.85.10.1171; Ku JY, 2009, CLIN EXP OPHTHALMOL, V37, P743, DOI 10.1111/j.1442-9071.2009.02125.x; Levent G, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-25; Lin SY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002847; Lin SY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001141; Lonardo A, 2004, GASTROENTEROLOGY, V126, P586, DOI 10.1053/j.gastro.2003.11.020; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Negro F, 2009, WORLD J GASTROENTERO, V15, P1537, DOI 10.3748/wjg.15.1537; Okuse C, 2006, WORLD J GASTROENTERO, V12, P3756, DOI 10.3748/wjg.v12.i23.3756; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Pollreisz A, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/608751; Roed T, 2012, CLIN PHYSIOL FUNCT I, V32, P421, DOI 10.1111/j.1475-097X.2012.01152.x; Shiels A, 2013, CLIN GENET, V84, P120, DOI 10.1111/cge.12182; Sumida Y, 2000, J HEPATOL, V33, P616, DOI 10.1034/j.1600-0641.2000.033004616.x; Thorne JE, 2010, OPHTHALMOLOGY, V117, P1436, DOI 10.1016/j.ophtha.2009.12.003; VARMA SD, 1984, CURR EYE RES, V3, P35, DOI 10.3109/02713688408997186; Vashist P, 2011, OPHTHALMOLOGY, V118, P272, DOI 10.1016/j.ophtha.2010.05.020; Williams DL, 2006, VET OPHTHALMOL, V9, P292, DOI 10.1111/j.1463-5224.2006.00498.x; Yoshida K, 2002, J CATARACT REFR SURG, V28, P1789, DOI 10.1016/S0886-3350(02)01335-4	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173125	10.1371/journal.pone.0173125	http://dx.doi.org/10.1371/journal.pone.0173125			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264004	gold, Green Published, Green Submitted			2022-12-26	WOS:000396054300040
J	Mollerup, PM; Gamborg, M; Trier, C; Bojsoe, C; Nielsen, TRH; Baker, JL; Holm, JC				Mollerup, Pernille Maria; Gamborg, Michael; Trier, Caecilie; Bojsoe, Christine; Nielsen, Tenna Ruest Haarmark; Baker, Jennifer Lyn; Holm, Jens-Christian			A hospital-based child and adolescent overweight and obesity treatment protocol transferred into a community healthcare setting	PLOS ONE			English	Article							BODY-MASS INDEX; TASK-FORCE COTF; WAIST CIRCUMFERENCE; EUROPEAN ASSOCIATION; PEDIATRIC OBESITY; PUBERTAL CHANGES; PREVENTION; RECOMMENDATIONS; OUTCOMES; DISEASE	Background Due to the pandemic of child and adolescent overweight and obesity, improvements in overweight and obesity treatment availability and accessibility are needed. Methods In this prospective study, we investigated if reductions in body mass index (BMI) standard deviation scores (SDS) and waist circumference (WC) would occur during 1.5 years of community- based overweight and obesity treatment based upon an effective hospital-based overweight and obesity treatment protocol, The Children's Obesity Clinics' Treatment protocol. Height, weight, and WC were measured at all consultations. Changes in BMI SDS and WC were analyzed using linear mixed models based upon the repeated measures in each child. Results From June 2012 to January 2015, 1,001 children (455 boys) were consecutively enrolled in the community-based treatment program. Upon entry, the median age was 11 years (range: 3-18), and the median BMI SDS was 2.85 (range: 1.26-8.96) in boys and 2.48 (range: 1.08 -4.41) in girls. After 1.5 years of treatment BMI SDS was reduced in 74% of the children. BMI SDS was reduced by a mean of 0.38 (95% confidence interval (CI): 0.30-0.45, p<0.0001) in boys and 0.18 (95% CI: 0.12-0.25, p<0.0001) in girls after 1.5 years of treatment, independently of baseline age, BMI SDS, and Tanner stage (all p>0.08). WC was reduced by a mean of 3.8 cm (95% CI: 2.7-4.9, p>0.0001) in boys and 5.1 cm (95% CI: 4.0 -6.2, p>0.0001) in girls. The dropout rate was 31% after 1.5 years. A median of 4.5 consultation hours was invested per child per year. Conclusion BMI SDS and WC were reduced after 1.5 years of treatment. Hence, this community-based overweight and obesity treatment program may help accommodate the need for improvements in treatment availability and accessibility.	[Mollerup, Pernille Maria; Trier, Caecilie; Bojsoe, Christine; Nielsen, Tenna Ruest Haarmark; Holm, Jens-Christian] Copenhagen Univ Hosp Holbaek, Dept Pediat, Childrens Obes Clin, Holbaek, Denmark; [Gamborg, Michael; Baker, Jennifer Lyn] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Frederiksberg, Denmark; [Trier, Caecilie; Bojsoe, Christine; Nielsen, Tenna Ruest Haarmark; Baker, Jennifer Lyn; Holm, Jens-Christian] Univ Copenhagen, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Holm, Jens-Christian] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen	Mollerup, PM (corresponding author), Copenhagen Univ Hosp Holbaek, Dept Pediat, Childrens Obes Clin, Holbaek, Denmark.	Pmm@regionsjaelland.dk	Holm, Jens-Christian/T-4594-2017	Holm, Jens-Christian/0000-0003-4653-342X; Frithioff-Bojsoe, Christine/0000-0002-5005-7780	Region of Zealand; Region Zealand Health Scientific Research Foundation; Aase and Ejnar Danielsens Foundation; Danish Childhood Obesity Biobank [NCT00928473]; Innovation Fund Denmark [0603-00484B, 0603-00457B]; Novo Nordisk Foundation [NNF15OC0016544]	Region of Zealand; Region Zealand Health Scientific Research Foundation; Aase and Ejnar Danielsens Foundation; Danish Childhood Obesity Biobank; Innovation Fund Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The study was funded by the Region of Zealand, the Region Zealand Health Scientific Research Foundation, and the Aase and Ejnar Danielsens Foundation. The study was a part of the research project The Danish Childhood Obesity Biobank (ClinicalTrials.gov ID-no.: NCT00928473) conducted in collaboration with the TARGET (The Impact of our Genomes on Individual Treatment Response in Obese Children, www.target.ku.dk) and BIOCHILD (Genetics and Systems Biology of Childhood Obesity in India and Denmark, www.biochild.ku.dk) consortia, which are funded by grants from the Innovation Fund Denmark (0603-00484B and 0603-00457B), The Novo Nordisk Foundation (NNF15OC0016544) and the Region Zealand Health Scientific Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Croker H, 2012, INT J OBESITY, V36, P16, DOI 10.1038/ijo.2011.182; Danielsen YS, 2013, OBES RES CLIN PRACT, V7, pE116, DOI 10.1016/j.orcp.2012.06.003; Davis MM, 2007, PEDIATRICS, V120, pS229, DOI 10.1542/peds.2007-2329E; de Silva-Sanigorski A, 2011, COCHRANE DB SYST REV, V132, P128; Dhaliwal J, 2014, CHILD OBES, V10, P461, DOI 10.1089/chi.2014.0060; Farpour-Lambert NJ, 2015, OBESITY FACTS, V8, P342, DOI 10.1159/000441483; Fonvig CE, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0513-6; Foster BA, 2015, ACAD PEDIATR, V15, P353, DOI 10.1016/j.acap.2015.04.037; Foster GD, 2014, PEDIATR OBES, V9, pE63, DOI 10.1111/j.2047-6310.2013.00197.x; Foster GD, 2012, PEDIATRICS, V130, P652, DOI 10.1542/peds.2012-0344; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Holm JC, 2014, OBESITY FACTS, V7, P274, DOI 10.1159/000365773; Holm JC, 2011, INT J PEDIATR OBES, V6, P188, DOI 10.3109/17477166.2011.575157; Hvidt KN, 2014, J HYPERTENS, V32, P1470, DOI 10.1097/HJH.0000000000000188; Johnson ST, 2010, J PEDIATR-US, V156, P247, DOI 10.1016/j.jpeds.2009.08.010; Katzmarzyk PT, 2014, INT J OBESITY, V38, P887, DOI 10.1038/ijo.2014.49; Kolotourou M, 2015, CHILD OBES, V11, P325, DOI 10.1089/chi.2014.0092; Kolotourou M, 2013, CHILD OBES, V9, P350, DOI 10.1089/chi.2013.0019; Krebs NF, 2003, PEDIATRICS, V112, P424, DOI 10.1542/peds.112.2.424; Larsen LM, 2012, ACTA PAEDIATR, V101, P201, DOI 10.1111/j.1651-2227.2011.02551.x; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Matthiessen J, 2014, ACTA PAEDIATR, V103, P1083, DOI 10.1111/apa.12722; Most SW, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0332-9; Nielsen LA, 2015, OBESITY FACTS, V8, P319, DOI 10.1159/000441375; Nielsen TRH, 2012, CHILD OBES, V8, P533, DOI 10.1089/chi.2011.0098; Nowicka P, 2008, INT J PEDIATR OBES, V3, P141, DOI 10.1080/17477160802102475; Nysom K, 2001, INT J OBESITY, V25, P177, DOI 10.1038/sj.ijo.0801515; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Pearson S, 2010, ACTA PAEDIATR, V99, P1675, DOI 10.1111/j.1651-2227.2010.01897.x; Peirson Leslea, 2015, CMAJ Open, V3, pE23, DOI 10.9778/cmajo.20140053; Rasmussen AR, 2015, PEDIATRICS, V135, P86, DOI 10.1542/peds.2014-0793; Reinehr T, 2009, ATHEROSCLEROSIS, V207, P174, DOI 10.1016/j.atherosclerosis.2009.03.041; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Rosenbaum M, 2014, J ENDOCRINOL, V223, pT83, DOI 10.1530/JOE-14-0358; Sacher PM, 2010, OBESITY, V18, pS62, DOI 10.1038/oby.2009.433; Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813; Spear BA, 2007, PEDIATRICS, V120, pS254, DOI 10.1542/peds.2007-2329F; Watson PM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006519; Weiss R., 2004, NEW ENGL J MED, V350, P470; Wohlfahrt-Veje C, 2014, EUR J CLIN NUTR, V68, P664, DOI 10.1038/ejcn.2013.282; World Health Organization, 2008, WAIST CIRCUMFERENCE	46	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173033	10.1371/journal.pone.0173033	http://dx.doi.org/10.1371/journal.pone.0173033			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264043	Green Published, gold, Green Submitted			2022-12-26	WOS:000396054300036
J	Liu, L; Li, JY; Ji, HZ; Zhang, NA; Wang, YY; Zheng, GN; Wang, H; Luo, E				Liu, Li; Li, Jiayang; Ji, Huanzhong; Zhang, Nian; Wang, Yiyao; Zheng, Guangning; Wang, Hu; Luo, En			Cone-beam computed tomography evaluation of the maxillofacial features of patients with unilateral temporomandibular joint ankylosis undergoing condylar reconstruction with an autogenous coronoid process graft	PLOS ONE			English	Article							AIRWAY; BONE	Objective To evaluate the changes in the jaws and the upper airways of unilateral temporomandibular joint ankylosis patients who underwent condylar reconstruction via autogenous coronoid process grafts using cone-beam computed tomography (CBCT). Study design The 27 included patients underwent CBCT examinations at three stages: T0 (within two weeks before surgery), T1 (two weeks after surgery), and T2 (an average of 13 months after surgery). Forty items related to the maxillofacial hard tissues and the upper airway collected at the three times and the coronoid process graft volumes after surgery were compared. Results Some integral items related to the mandibular hard tissues exhibited statistical difference shortly after surgery. Some integral items related to maxillofacial hard tissues changing obviously long period after surgery may result from graft remodeling. Asymmetry-related item regarding local neo-condyle and some airway items were significantly different between T0 and T1. Due to variations in graft remodeling, some related local asymmetry items and airway items differed significantly between T0 and T2. Conclusions Anteriorly and inferiorly located neo-condyles and a trend toward the pronation of the mandible were observed and the narrowness of the upper airway was improved shortly after surgery. The grafts remodeled differently and some integral and asymmetry items related to neo-condyle changed. The improvements in the upper airway were slightly reduced.	[Liu, Li; Li, Jiayang; Ji, Huanzhong; Zhang, Nian; Wang, Yiyao; Zheng, Guangning; Wang, Hu; Luo, En] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Peoples R China; [Liu, Li; Zheng, Guangning; Wang, Hu] Sichuan Univ, West China Hosp Stomatol, Dept Oral Radiol, Natl Clin Res Ctr Oral Dis, Chengdu, Peoples R China; [Li, Jiayang; Ji, Huanzhong; Zhang, Nian; Wang, Yiyao; Luo, En] Sichuan Univ, West China Hosp Stomatol, Dept Oral & Maxillofacial Surg, Natl Clin Res Ctr Oral Dis, Chengdu, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Wang, H; Luo, E (corresponding author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Peoples R China.; Wang, H (corresponding author), Sichuan Univ, West China Hosp Stomatol, Dept Oral Radiol, Natl Clin Res Ctr Oral Dis, Chengdu, Peoples R China.; Luo, E (corresponding author), Sichuan Univ, West China Hosp Stomatol, Dept Oral & Maxillofacial Surg, Natl Clin Res Ctr Oral Dis, Chengdu, Peoples R China.	1328548883@qq.com; luoen521125@sina.com		Luo, En/0000-0002-7447-1097	National Natural Science Foundation of China [81621062]; Municipal Science and Technology Foundation of Chengdu [2015-HM01-00181-SF]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Municipal Science and Technology Foundation of Chengdu	This study was supported by Grants from the National Natural Science Foundation of China with NO. 81621062 and and the Municipal Science and Technology Foundation of Chengdu with NO. 2015-HM01-00181-SF. The funders had played role in study design, data collection and decision to publish.; This study was supported by grants from the National Natural Science Foundation of China with NO. 81621062 and the Municipal Science and Technology Foundation of Chengdu with NO. 2015-HM01-00181-SF.	Battagel JM, 1999, EUR J ORTHODONT, V21, P363, DOI 10.1093/ejo/21.4.363; Choung PH, 2001, ORAL SURG ORAL MED O, V91, P28, DOI 10.1067/moe.2001.111759; Lorenzoni DC, 2012, INT J DENT, V2012, DOI 10.1155/2012/813768; ElSheikh MM, 1996, J CRANIO MAXILL SURG, V24, P96, DOI 10.1016/S1010-5182(96)80020-5; Hashimoto K, 2003, ORAL SURG ORAL MED O, V95, P371, DOI 10.1067/moe.2003.120; Hong M, 1980, J CHINESE PLA POSTGR, V1, P54; Jafarian M, 2014, J CRANIOFAC SURG, V25, pE38, DOI 10.1097/SCS.0b013e3182a2ee26; Lee JJ, 1999, J ORAL MAXIL SURG, V57, P457, DOI 10.1016/S0278-2391(99)90290-2; Liao YF, 2004, LARYNGOSCOPE, V114, P1052, DOI 10.1097/00005537-200406000-00018; Muto T, 2008, INT J ORAL MAX SURG, V37, P419, DOI 10.1016/j.ijom.2007.12.012; ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017; Park SB, 2012, INT J ORAL MAX SURG, V41, P87, DOI 10.1016/j.ijom.2011.09.008; Sears CR, 2011, J ORAL MAXIL SURG, V69, pE385, DOI 10.1016/j.joms.2011.03.015; Ueno T, 2001, ANAT REC, V264, P348, DOI 10.1002/ar.10024; Zhang WN, 2014, BRIT J ORAL MAX SURG, V52, P928, DOI 10.1016/j.bjoms.2014.08.018; Zhu SS, 2008, ORAL SURG ORAL MED O, V106, P662, DOI 10.1016/j.tripleo.2008.03.028; Zhu SS, 2011, J ORAL MAXIL SURG, V69, pE565, DOI 10.1016/j.joms.2011.07.025; Zhu SS, 2006, ORAL SURG ORAL MED O, V101, P572, DOI 10.1016/j.tripleo.2005.08.023	18	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173142	10.1371/journal.pone.0173142	http://dx.doi.org/10.1371/journal.pone.0173142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257487	Green Published, gold			2022-12-26	WOS:000396021100065
J	Sae-Lim, P; Grova, L; Olesen, I; Varona, L				Sae-Lim, Panya; Grova, Lise; Olesen, Ingrid; Varona, Luis			A comparison of nonlinear mixed models and response to selection of tick-infestation on lambs	PLOS ONE			English	Article							TROPICAL BEEF-CATTLE; ANAPLASMA-PHAGOCYTOPHILUM; GENETIC-ANALYSIS; BOOPHILUS-MICROPLUS; GASTROINTESTINAL NEMATODES; TEMPERAMENT TRAITS; NELLORE CATTLE; RESISTANCE; SHEEP; POISSON	Tick-borne fever (TBF) is stated as one of the main disease challenges in Norwegian sheep farming during the grazing season. TBF is caused by the bacterium Anaplasma phagocytophilum that is transmitted by the tick Ixodes ricinus. A sustainable strategy to control tick-infestation is to breed for genetically robust animals. In order to use selection to genetically improve traits we need reliable estimates of genetic parameters. The standard procedures for estimating variance components assume a Gaussian distribution of the data. However, tick-count data is a discrete variable and, thus, standard procedures using linear models may not be appropriate. Thus, the objectives of this study were twofold: 1) to compare four alternative non-linear models: Poisson, negative binomial, zero-inflated Poisson and zero-inflated negative binomial based on their goodness of fit for quantifying genetic variation, as well as heritability for tick-count and 2) to investigate potential response to selection against tick-count based on truncation selection given the estimated genetic parameters from the best fit model. Our results showed that zero-inflated Poisson was the most parsimonious model for the analysis of tick count data. The resulting estimates of variance components and high heritability (0.32) led us to conclude that genetic determinism is relevant on tick count. A reduction of the breeding values for tick-count by one sire-dam genetic standard deviation on the liability scale will reduce the number of tick counts below an average of 1. An appropriate breeding scheme could control tick-count and, as a consequence, probably reduce TBF in sheep.	[Sae-Lim, Panya; Olesen, Ingrid] Nofima AS, Osloveien 1, As, Norway; [Grova, Lise] Norwegian Inst Bioecon Res NIBIO, Gunnars Veg 6, Tingvoll, Norway; [Varona, Luis] Univ Zaragoza, Fac Vet, Zaragoza, Spain	Nofima; Norwegian Institute of Bioeconomy Research; University of Zaragoza	Sae-Lim, P (corresponding author), Nofima AS, Osloveien 1, As, Norway.	panya.sae-lim@nofima.no	Varona, Luis/C-2744-2012	Varona, Luis/0000-0001-6256-5478	Norwegian Foundation for Research Levy on Agricultural Products [207737]; Agricultural Agreement Research Funds [207737]; More and Romsdal Council [127/2009]; County Governor in More and Romsdal [2010/5782/OTLO/]; More og Romsdal Council; County Governor in More og Romsdal	Norwegian Foundation for Research Levy on Agricultural Products; Agricultural Agreement Research Funds; More and Romsdal Council; County Governor in More and Romsdal; More og Romsdal Council; County Governor in More og Romsdal	This study was part of the TICKLESS project, which was funded by the Norwegian Foundation for Research Levy on Agricultural Products (FFL) and the Agricultural Agreement Research Funds (JA) (https://www.slf.dep.no/no/fou-midler/landbruks-og-matforskning), grant nr 207737, together with More and Romsdal Council (www.mrfylke.no), grant nr 127/2009, and the County Governor in More and Romsdal (www.fylkesmannen.no/More-og-Romsdal/), grant nr 2010/5782/OTLO/. PSL, LG and 10 received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was part of the TICKLESS project (project number 207737) which was funded by the Norwegian Foundation for Research Levy on Agricultural Products (FFL) and the Agricultural Agreement Research Funds (JA), the More og Romsdal Council and County Governor in More og Romsdal. We thank the farmers and technicians at NIBIO for collecting data of tick count on lambs.	Ali AA, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-22; Ayres DR, 2015, J APPL GENET, V56, P107, DOI 10.1007/s13353-014-0238-5; Ayres DR, 2013, J ANIM BREED GENET, V130, P417, DOI 10.1111/jbg.12036; Bishop SC, 2010, BREEDING FOR DISEASE RESISTANCE IN FARM ANIMALS, 3RD EDITION, P3, DOI 10.1079/9781845935559.0003; Budeli MA, 2009, S AFR J ANIM SCI, V39, P321; Burrow HM, 2001, LIVEST PROD SCI, V70, P213, DOI 10.1016/S0301-6226(01)00178-6; Dawson M, 1998, VET REC, V142, P623; Dugat T, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00061; FOGGIE A, 1951, J PATHOL BACTERIOL, V63, P1, DOI 10.1002/path.1700630103; FOULLEY JL, 1993, GENET SEL EVOL, V25, P101, DOI 10.1051/gse:19930107; FOULLEY JL, 1987, THEOR APPL GENET, V73, P870, DOI 10.1007/BF00289392; FOULLEY JL, 1993, GENET SEL EVOL, V25, P297, DOI 10.1051/gse:19930307; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Granquist EG, 2008, INFECT IMMUN, V76, P120, DOI 10.1128/IAI.01206-07; Granquist EG, 2010, VET IMMUNOL IMMUNOP, V133, P117, DOI 10.1016/j.vetimm.2009.07.009; Grova L, 2011, TICK BORNE FEVER SHE; Henderson C. R, 1984, APPL LINEAR MODELS A; Henshall JM, 2004, AUST J AGR RES, V55, P1109, DOI 10.1071/AR03085; HEWETSON RW, 1972, AUST VET J, V48, P299, DOI 10.1111/j.1751-0813.1972.tb05161.x; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; LEMOS AM, 1985, ANIM PROD, V41, P187, DOI 10.1017/S0003356100027847; Lynch M., 1998, GENETICS ANAL QUANTI; Matos CAP, 1997, J ANIM SCI, V75, P88; Meuwissen THE, 2001, GENETICS, V157, P1819; Mota RR, 2016, J ANIM SCI, V94, P1834, DOI 10.2527/jas.2015-0194; Muyobela J, 2015, TROP ANIM HEALTH PRO, V47, P1599, DOI 10.1007/s11250-015-0906-4; Mysterud A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-187; Naya H, 2008, GENET SEL EVOL, V40, P379, DOI 10.1051/gse:2008010; Neto LRP, 2011, VET PARASITOL, V180, P165, DOI 10.1016/j.vetpar.2011.05.048; NIBIO, 2016, NAT STAT SHEEP LOST; OLESEN I, 1994, J ANIM SCI, V72, P1166, DOI 10.2527/1994.7251166x; Passafaro TL, 2015, VET PARASITOL, V210, P224, DOI 10.1016/j.vetpar.2015.03.017; Pfeffer A, 2007, INT J PARASITOL, V37, P1589, DOI 10.1016/j.ijpara.2007.05.008; Porto-Neto LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113284; Prayaga KC, 2005, AUST J EXP AGR, V45, P971, DOI 10.1071/EA05045; Prayaga KC, 2003, AUST J AGR RES, V54, P1027, DOI 10.1071/AR03072; Raadsma HW, 2013, LIVEST SCI, V156, P115, DOI 10.1016/j.livsci.2013.06.011; RAADSMA HW, 1991, AUST J AGR RES, V42, P279, DOI 10.1071/AR9910279; Rajput Zahid Iqbal, 2006, J Zhejiang Univ Sci B, V7, P912, DOI 10.1631/jzus.2006.B0912; Regitano L, 2006, MOL ASPECTS BOVINE T; Rodrigues-Motta M, 2007, J DAIRY SCI, V90, P5306, DOI 10.3168/jds.2006-898; Rupp R, 2009, J DAIRY SCI, V92, P1203, DOI 10.3168/jds.2008-1435; Sorensen D, 1995, GENET SEL EVOL, V27, P1; Spiegelhalter D, 1996, MARKOV CHAIN MONTE C, P145; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; STEAR MJ, 1994, VET PARASITOL, V54, P161, DOI 10.1016/0304-4017(94)90089-2; Stear MJ, 2001, RES VET SCI, V71, P1, DOI 10.1053/rvsc.2001.0496; Stuen S, 2007, VET RES COMMUN, V31, P79, DOI 10.1007/s11259-007-0071-y; Stuen S., 2000, INVESTIGATION LAMB D, P111; Stuen S, 2003, THESIS; Stuen S, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00031; Stuen S, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-8; Tempelman RJ, 1996, BIOMETRICS, V52, P265, DOI 10.2307/2533161; Turner LB, 2010, ANIM PROD SCI, V50, P235, DOI 10.1071/AN09135; Ulvund MJ, 2012, SMALL RUMINANT RES, V106, P6, DOI 10.1016/j.smallrumres.2012.04.011; UTECH KBW, 1978, AUST J AGR RES, V29, P885, DOI 10.1071/AR9780885; Varona L, 2010, GENETICS, V184, P277, DOI 10.1534/genetics.109.110759; Vassallo M, 2000, J MED ENTOMOL, V37, P335, DOI 10.1603/0022-2585(2000)037[0335:MFSQNO]2.0.CO;2; WHARTON RH, 1970, AUST J AGR RES, V21, P163, DOI 10.1071/AR9700163; Woldehiwet Z, 2010, VET PARASITOL, V167, P108, DOI 10.1016/j.vetpar.2009.09.013	61	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172711	10.1371/journal.pone.0172711	http://dx.doi.org/10.1371/journal.pone.0172711			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257433	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000396021100023
J	Aguilar-Rodea, P; Zuniga, G; Rodriguez-Espino, BA; Cervantes, ALO; Arroyo, AEG; Moreno-Espinosa, S; Zamboni, DD; Martinez, BL; Castellanos-Cruz, MD; Parra-Ortega, I; Rojas, VLJ; Galindo, JCV; Velazquez-Guadarrama, N				Aguilar-Rodea, Pamela; Zuniga, Gerardo; Antonio Rodriguez-Espino, Benjamin; Olivares Cervantes, Alma Lidia; Gamino Arroyo, Ana Estela; Moreno-Espinosa, Sarbelio; de la Rosa Zamboni, Daniela; Lopez Martinez, Briceida; del Carmen Castellanos-Cruz, Maria; Parra-Ortega, Israel; Jimenez Rojas, Veronica Leticia; Vigueras Galindo, Juan Carlos; Velazquez-Guadarrama, Norma			Identification of extensive drug resistant Pseudomonas aeruginosa strains: New clone ST1725 and high-risk clone ST233	PLOS ONE			English	Article							GENETIC DIVERSITY; HOSPITALS; MARKERS	Several microorganisms produce nosocomial infections (NIs), among which Pseudomonas aeruginosa stands out as an opportunist pathogen with the capacity to develop multiresistance to first-choice antibiotics. From 2007 to 2013, forty-six NIs produced by P. aeruginosa were detected at a pediatric tertiary care hospital in Mexico with a significant mortality rate (17.39%). All isolates (n = 58/46 patients) were characterized by evaluating their response to several antibiotics as panresistant (PDR), extensively resistant (XDR), multiresistant (MDR) or sensitive (S). In addition, all isolates were typified through multilocus sequencing of seven genes: acsA, aroE, guaA, mutL, nuoD, ppsA and trpE. Furthermore, to establish the genetic relationships among these isolates, we carried out a phylogenetic inference analysis using maximum likelihood to construct a phylogenetic network. To assess evolutionary parameters, recombination was evaluated using the PHI test, and the ratio of nonsynonymous to synonymous substitutions was determined. Two of the strains were PDR (ST1725); 42 were XDR; four were MDR; and ten were S. Twenty-one new sequence types were detected. Thirty-three strains exhibited novel sequence type ST1725. The ratio of nonsynonym to synonym substitutions was 1: 1 considering all genes. Phylogenetic analysis showed that the genetic relationship of the PDR, XDR and MDR strains was mainly clonal; however, the PHI test and the phylogenetic network suggest that recombination events occurred to produce a non-clonal population. This study aimed not only to determine the genetic diversity of clinical P. aeruginosa but also to provide a warning regarding the identification and spreading of clone ST1725, its ability to cause outbreaks with high mortality rates, and to remain in the hospital environment for over seven years. These characteristics highlight the need to identify clonal outbreaks, especially where high resistance to most antibiotics is observed, and control measures are needed. This study also represents the first report of the PDR ST1725.	[Aguilar-Rodea, Pamela] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Posgrad Ciencias Quimicobiol, Mexico City, DF, Mexico; [Aguilar-Rodea, Pamela; Olivares Cervantes, Alma Lidia; Jimenez Rojas, Veronica Leticia; Vigueras Galindo, Juan Carlos; Velazquez-Guadarrama, Norma] Hosp Infantil Mexico Dr Federico Gomez, Lab Infectol, Mexico City, DF, Mexico; [Aguilar-Rodea, Pamela; Zuniga, Gerardo] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Zool, Lab Variac Biol & Evoluc, Mexico City, DF, Mexico; [Antonio Rodriguez-Espino, Benjamin] Hosp Infantil Mexico Dr Federico Gomez, Lab Invest & Diagnost Nefrol & Metab Mineral Oseo, Mexico City, DF, Mexico; [Gamino Arroyo, Ana Estela; Moreno-Espinosa, Sarbelio] Hosp Infantil Mexico Dr Federico Gomez, Dept Infectol, Mexico City, DF, Mexico; [de la Rosa Zamboni, Daniela] Hosp Infantil Mexico Dr Federico Gomez, Dept Epidemiol, Mexico City, DF, Mexico; [Lopez Martinez, Briceida] Hosp Infantil Mexico Dr Federico Gomez, Subdirecc Serv Auxiliares & Lab, Mexico City, DF, Mexico; [del Carmen Castellanos-Cruz, Maria; Parra-Ortega, Israel] Hosp Infantil Mexico Dr Federico Gomez, Dept Lab Clin, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; Hospital Infantil de Mexico Federico Gomez; Instituto Politecnico Nacional - Mexico; Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez	Velazquez-Guadarrama, N (corresponding author), Hosp Infantil Mexico Dr Federico Gomez, Lab Infectol, Mexico City, DF, Mexico.; Zuniga, G (corresponding author), Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Zool, Lab Variac Biol & Evoluc, Mexico City, DF, Mexico.	capotezu@hotmail.com; normave@himfg.edu.mx	Parra-Ortega, Israel/CAE-8579-2022; Velazquez-Guadarrama, Norma/M-3119-2017	Velazquez-Guadarrama, Norma/0000-0002-3620-7260; Aguilar-Rodea, Pamela/0000-0002-1522-2138; Gamino-Arroyo, Ana Estela/0000-0002-4214-9239	Federal Resources of the Hospital Infantil de Mexico Federico Gomez of the Secretaria de Salud (SSA) [HIM/2015/023.1164]	Federal Resources of the Hospital Infantil de Mexico Federico Gomez of the Secretaria de Salud (SSA)	This project was supported by Federal Resources of the Hospital Infantil de Mexico Federico Gomez number grant HIM/2015/023.1164 of the Secretaria de Salud (SSA). PAR was a CONACyT fellow (254430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Rodea P., 2013, THESIS; Arias-Flores R, 2016, MICROORG RESPONSIBLE, V54, P20; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Cabot G, 2012, ANTIMICROB AGENTS CH, V56, P6349, DOI 10.1128/AAC.01388-12; Cholley P, 2011, J CLIN MICROBIOL, V49, P2578, DOI 10.1128/JCM.00102-11; Clinical and Laboratory Standards Institute, 2016, M100S PERF STAND ANT; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Deplano A, 2005, J CLIN MICROBIOL, V43, P1198, DOI 10.1128/JCM.43.3.1198-1204.2005; Equiarte Luis E, 2007, ECOLOGIA MOL; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Garcia-Castillo M, 2011, J CLIN MICROBIOL, V49, P2905, DOI 10.1128/JCM.00753-11; Giske CG, 2006, J CLIN MICROBIOL, V44, P4309, DOI 10.1128/JCM.00817-06; Gomila M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-138; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Kidd TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044199; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lebeque Perez Y, 1999, REV CUBANA MED, V45; Lee JY, 2011, MICROB DRUG RESIST, V17, P299, DOI 10.1089/mdr.2010.0145; Lopez-Causape C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071001; Maatallah M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082069; Maatallah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025617; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; McCarthy K, 2015, SEMIN RESP CRIT CARE, V36, P44, DOI 10.1055/s-0034-1396907; Mudau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055985; Mulet X, 2013, ANTIMICROB AGENTS CH, V57, P5527, DOI 10.1128/AAC.01481-13; Olaechea PM, 2010, MED INTENSIVA, V34, P256, DOI 10.1016/j.medin.2009.11.013; Oliver A, 2015, DRUG RESIST UPDATE, V21-22, P41, DOI 10.1016/j.drup.2015.08.002; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sousa AM, 2014, PATHOGENS, V3, P680, DOI 10.3390/pathogens3030680; Zafer MM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0861-8	31	15	15	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172882	10.1371/journal.pone.0172882	http://dx.doi.org/10.1371/journal.pone.0172882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253282	gold, Green Submitted, Green Published			2022-12-26	WOS:000396011300044
J	Delfino-Machin, M; Madelaine, R; Busolin, G; Nikaido, M; Colanesi, S; Camargo-Sosa, K; Law, EWP; Toppo, S; Blader, P; Tiso, N; Kelsh, RN				Delfino-Machin, Mariana; Madelaine, Romain; Busolin, Giorgia; Nikaido, Masataka; Colanesi, Sarah; Camargo-Sosa, Karen; Law, Edward W. P.; Toppo, Stefano; Blader, Patrick; Tiso, Natascia; Kelsh, Robert N.			Sox10 contributes to the balance of fate choice in dorsal root ganglion progenitors	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SOX10; NEURAL CREST DEVELOPMENT; STEM-CELLS; WAARDENBURG-SYNDROME; SIGNALING PATHWAY; GENE-EXPRESSION; SENSORY NEURON; GLIAL FATE; IN-VIVO; HIRSCHSPRUNG-DISEASE	The development of functional peripheral ganglia requires a balance of specification of both neuronal and glial components. In the developing dorsal root ganglia (DRGs), these components form from partially-restricted bipotent neuroglial precursors derived from the neural crest. Work in mouse and chick has identified several factors, including Delta/Notch signaling, required for specification of a balance of these components. We have previously shown in zebrafish that the Sry-related HMG domain transcription factor, Sox10, plays an unexpected, but crucial, role in sensory neuron fate specification in vivo. In the same study we described a novel Sox10 mutant allele, sox10(baz1), in which sensory neuron numbers are elevated above those of wild-types. Here we investigate the origin of this neurogenic phenotype. We demonstrate that the supernumerary neurons are sensory neurons, and that enteric and sympathetic neurons are almost absent just as in classical sox10 null alleles; peripheral glial development is also severely abrogated in a manner similar to other sox10 mutant alleles. Examination of proliferation and apoptosis in the developing DRG reveals very low levels of both processes in wild-type and sox10(baz1), excluding changes in the balance of these as an explanation for the overproduction of sensory neurons. Using chemical inhibition of Delta-Notch-Notch signaling we demonstrate that in embryonic zebrafish, as in mouse and chick, lateral inhibition during the phase of trunk DRG development is required to achieve a balance between glial and neuronal numbers. Importantly, however, we show that this mechanism is insufficient to explain quantitative aspects of the baz1 phenotype. The Sox10(baz1) protein shows a single amino acid substitution in the DNA binding HMG domain; structural analysis indicates that this change is likely to result in reduced flexibility in the HMG domain, consistent with sequence-specific modification of Sox10 binding to DNA. Unlike other Sox10 mutant proteins, Sox10(baz1) retains an ability to drive neurogenin1 transcription. We show that overexpression of neurogenin1 is sufficient to produce supernumerary DRG sensory neurons in a wild-type background, and can rescue the sensory neuron phenotype of sox10 morphants in a manner closely resembling the baz1 phenotype. We conclude that an imbalance of neuronal and glial fate specification results from the Sox10 (baz1) protein's unique ability to drive sensory neuron specification whilst failing to drive glial development. The sox10(baz1) phenotype reveals for the first time that a Notch-dependent lateral inhibition mechanism is not sufficient to fully explain the balance of neurons and glia in the developing DRGs, and that a second Sox10-dependent mechanism is necessary. Sox10 is thus a key transcription factor in achieving the balance of sensory neuronal and glial fates.	[Delfino-Machin, Mariana; Nikaido, Masataka; Colanesi, Sarah; Camargo-Sosa, Karen; Law, Edward W. P.; Kelsh, Robert N.] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Delfino-Machin, Mariana; Nikaido, Masataka; Colanesi, Sarah; Camargo-Sosa, Karen; Law, Edward W. P.; Kelsh, Robert N.] Univ Bath, Ctr Regenerat Med, Bath, Avon, England; [Madelaine, Romain; Blader, Patrick] Univ Toulouse, CNRS, UMR5547, CBD,CBI,UPS, Toulouse, France; [Busolin, Giorgia; Tiso, Natascia] Univ Padua, Dept Biol, Padua, Italy; [Toppo, Stefano] Univ Padua, Dept Mol Med, Padua, Italy; [Delfino-Machin, Mariana] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Madelaine, Romain] Stanford Univ, Sch Med, Beckman Ctr, Stanford, CA 94305 USA; [Nikaido, Masataka] Univ Hyogo, Grad Sch Life Sci, Kobe, Hyogo, Japan; [Colanesi, Sarah] Univ Saarland, Dept Ophthalmol, Homburg, Saar, Germany; [Law, Edward W. P.] Univ Leicester, Dept Canc Studies, Leicester, Leics, England	University of Bath; University of Bath; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Padua; University of Padua; University System of Georgia; Georgia Institute of Technology; Stanford University; University of Hyogo; Saarland University; University of Leicester	Kelsh, RN (corresponding author), Univ Bath, Dept Biol & Biochem, Bath, Avon, England.; Kelsh, RN (corresponding author), Univ Bath, Ctr Regenerat Med, Bath, Avon, England.; Blader, P (corresponding author), Univ Toulouse, CNRS, UMR5547, CBD,CBI,UPS, Toulouse, France.; Tiso, N (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	patrick.blader@univ-tlse3.fr; natascia.tiso@unipd.it; bssrnk@bath.ac.uk	Toppo, Stefano/Z-5479-2019; Tiso, Natascia/E-2182-2011; Kelsh, Robert/B-6445-2008	Toppo, Stefano/0000-0002-0246-3119; Tiso, Natascia/0000-0002-5444-9853; Kelsh, Robert/0000-0002-9381-0066; Blader, Patrick/0000-0003-3299-6108	Biotechnological and Biological Sciences Research Council [BB/D000440/1]; University of Bath; Uehara Memorial Foundation; Wellcome Trust; Royal Society [JP100027]; CONACyT [329640/384511]; EU ZF-HEALTH grant [CT-2010-242048]; French Muscular Dystrophy Association [18572]; Ministry of Health [RF-2010-2309484]; University of Padova [CPDA128151, CPDA148582, CPDR124317/12, CPDA138081/13]; Fondation ARC [SFI20101201699]; BBSRC [BB/D000440/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D000440/1] Funding Source: researchfish	Biotechnological and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Bath; Uehara Memorial Foundation(Uehara Memorial Foundation); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); EU ZF-HEALTH grant; French Muscular Dystrophy Association(Association Francaise contre les Myopathies); Ministry of Health; University of Padova; Fondation ARC; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to the Biotechnological and Biological Sciences Research Council (http://www.bbsrc.ac.uk/), grant BB/D000440/1, RNK) and University of Bath (http://www.bath.ac.uk/) for funding this work, as well as to the Uehara Memorial Foundation (http://www.ueharazaidan.or.jp/) and a Wellcome Trust VIP award (http://www.wellcome.ac.uk/; MN), Royal Society International Collaboration Grant JP100027 (https://royalsociety.org/) to RNK and CONACyT (http://www.conacyt.mx/) grant 329640/384511 to KCS. NT is supported by the EU ZF-HEALTH grant (CT-2010-242048) (www.zf-health.org), by the French Muscular Dystrophy Association (AFM Telethon project POLYGON, 18572) (www.afm-telethon.com), by the Ministry of Health grant RF-2010-2309484 (www.salute.gov.it) and by the University of Padova projects OPTOZEN (CPDA128151) and TIGRE (CPDA148582) (http://www.unipd.it). GB is recipient of a post-doc fellowship Assegno di Ricerca Junior (CPDR124317/12) from the University of Padova (http://www.unipd.it). ST is supported by PRAT grant CPDA138081/13 from University of Padova (http://www.unipd.it). Work by RM and PB was funded by the Fondation ARC (http://www.fondation-arc.org; grant SFI20101201699). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An M, 2002, J COMP NEUROL, V446, P267, DOI 10.1002/cne.10214; Aoki Y, 2003, DEV BIOL, V259, P19, DOI 10.1016/S0012-1606(03)00161-1; Bernardos RL, 2005, DEV BIOL, V278, P381, DOI 10.1016/j.ydbio.2004.11.018; Blader P, 2003, MECH DEVELOP, V120, P211, DOI 10.1016/S0925-4773(02)00413-6; Blader P, 1997, DEVELOPMENT, V124, P4557; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Casari A, 2014, DEV BIOL, V396, P81, DOI 10.1016/j.ydbio.2014.09.025; Cornell RA, 2005, SEMIN CELL DEV BIOL, V16, P663, DOI 10.1016/j.semcdb.2005.06.009; Cornell RA, 2002, DEVELOPMENT, V129, P2639; Dooley CM, 2013, DEVELOPMENT, V140, P1003, DOI 10.1242/dev.087007; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dutton K, 2001, GENESIS, V30, P188, DOI 10.1002/gene.1062; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Elworthy S, 2003, DEVELOPMENT, V130, P2809, DOI 10.1242/dev.00461; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Gray M, 2001, DEV BIOL, V237, P306, DOI 10.1006/dbio.2001.0381; Greenwood AL, 1999, DEVELOPMENT, V126, P3545; Haddon C, 1998, DEVELOPMENT, V125, P359; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Honjo Y, 2008, DEVELOPMENT, V135, P2615, DOI 10.1242/dev.022178; Hou L, 2006, P NATL ACAD SCI USA, V103, P9081, DOI 10.1073/pnas.0603114103; Hu ZL, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-14; Ito Y, 2006, P NATL ACAD SCI USA, V103, P7871, DOI 10.1073/pnas.0602332103; Itoh M, 2001, MECH DEVELOP, V102, P263, DOI 10.1016/S0925-4773(01)00308-2; Jacob C, 2014, J NEUROSCI, V34, P6112, DOI 10.1523/JNEUROSCI.5212-13.2014; Jiang YJ, 1996, DEVELOPMENT, V123, P205; Kelsh RN, 2000, DEVELOPMENT, V127, P515; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kucenas S, 2008, NAT NEUROSCI, V11, P143, DOI 10.1038/nn2025; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lauter G, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-43; Le Douarin NM, 1999, NEURAL CREST, V2; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lee M, 2000, J BIOL CHEM, V275, P37978, DOI 10.1074/jbc.M003816200; Lopez-Schier H, 2005, P NATL ACAD SCI USA, V102, P1496, DOI 10.1073/pnas.0409361102; Ma QF, 2000, JARO-J ASSOC RES OTO, V1, P129, DOI 10.1007/s101620010017; Madelaine R, 2011, DEV BIOL, V350, P198, DOI 10.1016/j.ydbio.2010.10.025; Malmquist SJ, 2013, DEVELOPMENT, V140, P3986, DOI 10.1242/dev.084640; MARUSICH MF, 1994, J NEUROBIOL, V25, P143, DOI 10.1002/neu.480250206; Mayor R, 2013, DEVELOPMENT, V140, P2247, DOI 10.1242/dev.091751; McGraw HF, 2008, J NEUROSCI, V28, P12558, DOI 10.1523/JNEUROSCI.2079-08.2008; McGraw HF, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-23; Mead TJ, 2012, DEV DYNAM, V241, P376, DOI 10.1002/dvdy.23717; Milet C, 2012, DEV BIOL, V366, P22, DOI 10.1016/j.ydbio.2012.01.013; Mitsiadis TA, 1997, DEVELOPMENT, V124, P1473; Mollaaghababa R, 2003, ONCOGENE, V22, P3024, DOI 10.1038/sj.onc.1206442; Moro E, 2013, MOL GENET GENOMICS, V288, P231, DOI 10.1007/s00438-013-0750-z; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Nitzan E, 2013, DEVELOPMENT, V140, P2269, DOI 10.1242/dev.093294; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Paratore C, 2001, DEVELOPMENT, V128, P3949; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Pasini A, 2004, DEVELOPMENT, V131, P1529, DOI 10.1242/dev.01031; Pavan WJ, 2012, DEV BIOL, V366, P55, DOI 10.1016/j.ydbio.2012.02.038; Peirano RI, 2000, MOL CELL BIOL, V20, P3198, DOI 10.1128/MCB.20.9.3198-3209.2000; Perez SE, 1999, DEVELOPMENT, V126, P1715; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Prasad MK, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-40; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Schiavone M, 2014, DIS MODEL MECH, V7, P883, DOI 10.1242/dmm.014969; Schlierf B, 2006, J MOL BIOL, V361, P11, DOI 10.1016/j.jmb.2006.05.072; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Smithers L, 2000, MECH DEVELOP, V90, P119, DOI 10.1016/S0925-4773(99)00231-2; Sonnenberg-Riethmacher E, 2001, MECH DEVELOP, V109, P253, DOI 10.1016/S0925-4773(01)00547-0; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Thisse B., 2001, EXPRESSION ZEBRAFISH; Ungos JM, 2003, DEVELOPMENT, V130, P5351, DOI 10.1242/dev.00722; Verastegui C, 2000, J BIOL CHEM, V275, P30757, DOI 10.1074/jbc.C000445200; Wakamatsu Y, 2000, DEVELOPMENT, V127, P2811; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Zecchin E, 2007, DEV BIOL, V301, P192, DOI 10.1016/j.ydbio.2006.09.041; Zecchin E, 2005, DEV DYNAM, V233, P638, DOI 10.1002/dvdy.20366	88	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172947	10.1371/journal.pone.0172947	http://dx.doi.org/10.1371/journal.pone.0172947			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253350	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300051
J	Gschwantler-Kaulich, D; Tan, YY; Fuchs, EM; Hudelist, G; Kostler, WJ; Reiner, A; Leser, C; Salama, M; Attems, J; Deutschmann, C; Zielinski, CC; Singer, CF				Gschwantler-Kaulich, Daphne; Tan, Yen Y.; Fuchs, Eva-Maria; Hudelist, Gernot; Koestler, Wolfgang J.; Reiner, Angelika; Leser, Carmen; Salama, Mohamed; Attems, Johannes; Deutschmann, Christine; Zielinski, Christoph C.; Singer, Christian F.			PTEN expression as a predictor for the response to trastuzumab-based therapy in Her-2 overexpressing metastatic breast cancer	PLOS ONE			English	Article							ADJUVANT TRASTUZUMAB; 1ST-LINE TREATMENT; PIK3CA MUTATIONS; PHASE-II; P-AKT; RESISTANCE; CHEMOTHERAPY; DOCETAXEL; RECEPTOR; GROWTH	Background Even though trastuzumab is an effective therapy in early stage Her-2+ breast cancer, 40-50% of advanced Her-2+ breast cancer patients develop trastuzumab resistance. A potential resistance mechanism is aberrant downstream signal transmission due to loss of phosphatase and tensin homologue (PTEN). This study investigated the relationship between the expression of PTEN and trastuzumab response in Her-2 overexpressing metastatic breast cancer patients. Methods Between 2000 and 2007, 164 patients with Her-2+ metastatic breast cancer received trastuzumab-based therapy in our institution. We analyzed PTEN status by immunohistochemistry of 115 available tumor tissues and analyzed associations with other histopathological parameters, response rate, progression free survival (PFS) and overall survival (OS) with a median follow-up of 60 months. Results Eighty patients were PTEN positive (69.6%) and 35 patients PTEN negative (30.4%). We found a significant association of the expression of PTEN and p53 (p = 0.041), while there was no association with grading, hormone receptor status, IGFR or MIB. We found significantly more cases with progressive disease under trastuzumab-based therapy in patients with PTEN positive breast cancers (p = 0.018), while there was no significant correlation with PFS or OS. Conclusion In Her-2-positive metastatic breast cancers, PTEN positivity was significantly associated with progressive disease, but not with PFS or OS.	[Gschwantler-Kaulich, Daphne; Tan, Yen Y.; Hudelist, Gernot; Leser, Carmen; Deutschmann, Christine; Singer, Christian F.] Med Univ Vienna, Dept Obstet & Gynecol, Ctr Comprehens Canc, Vienna, Austria; [Tan, Yen Y.] QIMR Berghofer Med Res Inst, Herston, Qld, Australia; [Fuchs, Eva-Maria; Koestler, Wolfgang J.; Zielinski, Christoph C.] Med Univ Vienna, Div Clin Oncol, Dept Med 1, Vienna, Austria; [Fuchs, Eva-Maria; Koestler, Wolfgang J.; Zielinski, Christoph C.] Med Univ Vienna, Ctr Excellence Clin & Expt Oncol, Vienna, Austria; [Hudelist, Gernot] Wilhelminenspital Stadt Wien, Dept Obstet & Gynaecol, Vienna, Austria; [Reiner, Angelika] Sozialmed Zentrum Ost, Dept Pathol, Vienna, Austria; [Salama, Mohamed] Otto Wagner Hosp, Dept Thorac Surg, Vienna, Austria; [Attems, Johannes] Otto Wagner Hosp, Dept Pathol, Vienna, Austria	Medical University of Vienna; QIMR Berghofer Medical Research Institute; Medical University of Vienna; Medical University of Vienna; Wilhelminenspital; Donauspital	Gschwantler-Kaulich, D (corresponding author), Med Univ Vienna, Dept Obstet & Gynecol, Ctr Comprehens Canc, Vienna, Austria.	daphne.gschwantler@kaulich.at	Hudelist, Gernot/AAN-3849-2020; Tan, Yen/AAW-2357-2021; Salama, Mohamed/AAC-8377-2021	Tan, Yen/0000-0003-1063-5352; Salama, Mohamed/0000-0002-6191-1436; Attems, Johannes/0000-0003-1636-1700	Medical Research Council [G0400074, G0502157, G1100540, G0900652] Funding Source: Medline; MRC [G0400074, G1100540, G0900652, G0502157] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baraschesi M, 2012, VIRCHOWS ARCH, V461, DOI [doi: 10.1007/s00428-012-1267-2PMID: 22744290, DOI 10.1007/S00428-012-1267-2]; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Brufsky Adam, 2005, Clin Breast Cancer, V6, P247, DOI 10.3816/CBC.2005.n.027; Burnett JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15821; Dave B, 2011, J CLIN ONCOL, V29, P166, DOI 10.1200/JCO.2009.27.7814; Debska-Szmich S, 2015, POSTEP HIG MED DOSW, V69, P586, DOI 10.5604/17322693.1151339; Depowski PL, 2001, MODERN PATHOL, V14, P672, DOI 10.1038/modpathol.3880371; Esteva FJ, 2010, AM J PATHOL, V177, P1647, DOI 10.2353/ajpath.2010.090885; Fabi A, 2010, ONCOLOGY-BASEL, V78, P141, DOI 10.1159/000312656; Gallardo A, 2012, BRIT J CANCER, V106, P1367, DOI 10.1038/bjc.2012.85; Gori S, 2009, ANN ONCOL, V20, P648, DOI 10.1093/annonc/mdn681; GREEN S, 1992, INVEST NEW DRUG, V10, P239, DOI 10.1007/BF00944177; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Joensuu H, 2006, NEW ENGL J MED, V354, P809, DOI 10.1056/NEJMoa053028; Jones N, 2013, INT J CANCER, V133, P323, DOI 10.1002/ijc.28021; Kocar M, 2014, J BUON, V19, P900; Koo DH, 2015, TUMOR BIOL, V36, P5865, DOI 10.1007/s13277-015-3258-9; Li SY, 2006, BREAST CANCER RES TR, V96, P91, DOI 10.1007/s10549-005-9048-0; Li Xinjun, 2015, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V40, P973, DOI 10.11817/j.issn.1672-7347.2015.09.005; Liu JC, 2016, ONCOTARGET, V7, P9060, DOI 10.18632/oncotarget.6985; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Murphy CG, 2009, BIOL-TARGETS THER, V3, P289; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nguyen PL, 2008, J CLIN ONCOL, V26, P2373, DOI 10.1200/JCO.2007.14.4287; Ning L, 2016, TUMOR BIOL, V37, P5445, DOI 10.1007/s13277-015-4392-0; Okutur Kerem, 2015, Asian Pac J Cancer Prev, V16, P2645; Pandolfi PP, 2004, NEW ENGL J MED, V351, P2337, DOI 10.1056/NEJMcibr043143; Park YH, 2014, BRIT J CANCER, V110, P384, DOI 10.1038/bjc.2013.757; Pegram MD, 2004, JNCI-J NATL CANCER I, V96, P759, DOI 10.1093/jnci/djh133; Peiro G, 2007, HUM PATHOL, V38, P26, DOI 10.1016/j.humpath.2006.07.013; Perez EA, 2013, J CLIN ONCOL, V31, P2115, DOI 10.1200/JCO.2012.42.2642; Perez-Tenorio G, 2007, CLIN CANCER RES, V13, P3577, DOI 10.1158/1078-0432.CCR-06-1609; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Untch M, 2008, ANN ONCOL, V19, P1090, DOI 10.1093/annonc/mdn005; Viani GA, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-153; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Yonemori K, 2009, MED ONCOL, V26, P344, DOI 10.1007/s12032-008-9127-2	42	5	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172911	10.1371/journal.pone.0172911	http://dx.doi.org/10.1371/journal.pone.0172911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253285	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300046
J	Zhao, Q; Lu, YZ; Yu, HY; Gan, XQ				Zhao, Qian; Lu, Yuezhi; Yu, Haiyang; Gan, Xueqi			Low magnitude high frequency vibration promotes adipogenic differentiation of bone marrow stem cells via P38 MAPK signal	PLOS ONE			English	Article							OSTEOGENIC DIFFERENTIATION; INHIBITS ADIPOGENESIS; COMPRESSIVE FORCE; PATHWAY; PROLIFERATION; INCREASES	Low magnitude high frequency vibration (LMHFV) has been mainly reported for its influence on the musculoskeletal system, particularly the bone tissue. In the bone structure, osteogenic activity is the main focus of study with regards to LMHFV. However, adipogenesis, another important mode of differentiation in the bone marrow cavity that might be affected by LMHFV, is much less researched. Furthermore, the molecular mechanism of how LMHFV influences adipogenesis still needs to be understood. Here, we tested the effect of LMHFV (0.3g, 40 Hz, amplitude: 50 mu m), 15min/d, on multipotent stem cells (MSCs), which are the common progenitors of osteogenic, chondrogenic, adipogenic and myogenic cells. It is previously shown that LMHFV promotes osteogenesis of MSCs. In this study, we further revealed its effect on adipo-differentiation of bone marrow stem cells (BMSCs) and studied the underlying signaling pathway. We found that when treated with LMHFV, the cells showed a higher expression of PPAR gamma, C/EBP alpha, adiponectin and showed more oil droplets. After vibration, the protein expression of PPAR gamma increased, and the phosphorylation of p38 MAPK was enhanced. After treating cells with SB203580, a specific p38 inhibitor, both the protein level of PPAR. illustrated by immunofluorescent staining and the oil droplets number, were decreased. Altogether, this indicates that p38 MAPK is activated during adipogenesis of BMSCs, and this is promoted by LMHFV. Our results demonstrating that specific parameters of LMHFV promotes adipogenesis of MSCs and enhances osteogenesis, highlights an unbeneficial side effect of vibration therapy used for preventing obesity and osteoporosis.	[Zhao, Qian; Lu, Yuezhi; Yu, Haiyang; Gan, Xueqi] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Peoples R China	Sichuan University	Yu, HY; Gan, XQ (corresponding author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Peoples R China.	Yhyang6812@foxmail.com; smiling99938@qq.com			State Key Laboratory of Oral Disease (Sichuan University, Chengdu); Provincial Key Technology Research and Development Program of the Ministry of Science and Technology of Sichuan Province [2014SZ0037]; National Natural Science Foundation of China [81400483]	State Key Laboratory of Oral Disease (Sichuan University, Chengdu); Provincial Key Technology Research and Development Program of the Ministry of Science and Technology of Sichuan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the State Key Laboratory of Oral Disease (Sichuan University, Chengdu), the Provincial Key Technology Research and Development Program of the Ministry of Science and Technology of Sichuan Province (no. 2014SZ0037, http://xmgl.scst.gov.cn/index.html), to XG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by State Key Laboratory of Oral Disease (Sichuan University, Chengdu), and the National Natural Science Foundation of China (no. 81400483).	Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Beck BR, 2006, J BONE MINER METAB, V24, P505, DOI 10.1007/s00774-006-0717-9; Cho YL, 2015, BIOCHEM BIOPH RES CO, V467, P211, DOI 10.1016/j.bbrc.2015.10.004; Colaianni G, 2014, WORLD J ORTHOP, V5, P242, DOI 10.5312/wjo.v5.i3.242; Cristi-Montero C, 2013, NUTR HOSP, V28, P1365, DOI 10.3305/nh.2013.28.5.6656; Dumas V, 2010, CALCIFIED TISSUE INT, V87, P351, DOI 10.1007/s00223-010-9394-8; Edwards JH, 2015, WORLD J STEM CELLS, V7, P568, DOI 10.4252/wjsc.v7.i3.568; Hossain MG, 2010, J BIOSCI BIOENG, V109, P297, DOI 10.1016/j.jbiosc.2009.09.003; Ji J, 2015, BIOCHEM BIOPH RES CO, V460, P578, DOI 10.1016/j.bbrc.2015.03.072; Kim KJ, 2010, LIFE SCI, V86, P791, DOI 10.1016/j.lfs.2010.03.010; Li G, 2013, CELL PROLIFERAT, V46, P586, DOI 10.1111/cpr.12053; Li J, 2009, J CELL PHYSIOL, V221, P609, DOI 10.1002/jcp.21890; Liu GX, 2015, GENET MOL RES, V14, P6968, DOI 10.4238/2015.June.26.5; Liu XX, 2015, INT J BIOCHEM CELL B, V62, P15, DOI 10.1016/j.biocel.2015.02.009; Luu YK, 2009, J BONE MINER RES, V24, P50, DOI [10.1359/jbmr.080817, 10.1359/JBMR.080817]; Maekawa T, 2010, MOL CELL BIOL, V30, P613, DOI 10.1128/MCB.00685-09; Munshi Anupama, 2013, Genes Cancer, V4, P401, DOI 10.1177/1947601913485414; Nikukar H, 2013, ACS NANO, V7, P2758, DOI 10.1021/nn400202j; Nuttall ME, 2014, CALCIFIED TISSUE INT, V94, P78, DOI 10.1007/s00223-013-9807-6; Oh ES, 2011, LIFE SCI, V88, P169, DOI 10.1016/j.lfs.2010.11.007; Ozcivici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011178; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Rubin CT, 2007, P NATL ACAD SCI USA, V104, P17879, DOI 10.1073/pnas.0708467104; Sen B, 2011, J BIOMECH, V44, P593, DOI 10.1016/j.jbiomech.2010.11.022; Shoham N, 2014, BIOPHYS J, V106, P1421, DOI 10.1016/j.bpj.2014.01.045; Tong ZX, 2014, TISSUE ENG PT A, V20, P1922, DOI [10.1089/ten.tea.2013.0496, 10.1089/ten.TEA.2013.0496]; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Uddin SMZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073914; Yanagisawa M, 2007, LIFE SCI, V81, P405, DOI 10.1016/j.lfs.2007.06.004; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang CC, 2012, ARCH ORAL BIOL, V57, P1395, DOI 10.1016/j.archoralbio.2012.04.010; Zhou Y, 2011, EUR CELLS MATER, V22, P12, DOI 10.22203/eCM.v022a02	32	16	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172954	10.1371/journal.pone.0172954	http://dx.doi.org/10.1371/journal.pone.0172954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253368	Green Submitted, gold, Green Published			2022-12-26	WOS:000396011300052
J	Bond, ST; Howlett, KF; Kowalski, GM; Mason, S; Connor, T; Cooper, A; Streltsov, V; Bruce, CR; Walder, KR; McGee, SL				Bond, Simon T.; Howlett, Kirsten F.; Kowalski, Greg M.; Mason, Shaun; Connor, Timothy; Cooper, Adrian; Streltsov, Victor; Bruce, Clinton R.; Walder, Ken R.; McGee, Sean L.			Lysine post-translational modification of glyceraldehyde-3-phosphate dehydrogenase regulates hepatic and systemic metabolism	FASEB JOURNAL			English	Article						glycolysis; gluconeogenesis; liver metabolism; ketones; lysine acetylation	GLUCOSE-PRODUCTION; PROTEOMIC ANALYSIS; TRANSCRIPTIONAL REGULATION; GLUCONEOGENESIS; ACETYLATION; LIVER; INSULIN; ENZYMES; HUMANS; CELLS	Reciprocal regulation of hepatic glycolysis and gluconeogenesis contributes to systemic metabolic homeostasis. Recent evidence from lower order organisms has found that reversible post-translational modification of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), particularly acetylation, contributes to the reciprocal regulation of glycolysis/gluconeogenesis. However, whether this occurs in mammalian hepatocytes in vitro or in vivo is unknown. Several proteomics studies have identified 4 lysine residues in critical regions of mammalian GAPDH that are altered by multiple post-translational modifications. In FAO hepatoma cells, mutation of all 4 lysine residues (4K-RGAPDH) to mimic their unmodified state reduced GAPDH glycolytic activity and glycolytic flux and increased gluconeogenic GAPDH activity and glucose production. Hepatic expression of 4K-R GAPDH in mice increased GAPDH gluconeogenic activity and the contribution of gluconeogenesis to endogenous glucose production in the unfed state. Consistent with the increased reliance on the energy-consuming gluconeogenic pathway, plasma free fatty acids and ketones were elevated inmice expressing 4K-RGAPDH, suggesting enhanced lipolysis and hepatic fatty acid oxidation. In normal mice, food with holding and refeeding, as well as hormonal regulators of reciprocal glycolysis/gluconeogenesis, such as insulin, glucagon, and norepinephrine, had no effect on global GAPDH acetylation. However, GAPDH acetylation was reduced in obese and type 2 diabetic db/db mice. These findings show that post-translational modification of GAPDH lysine residues regulates hepatic and systemic metabolism, revealing an unappreciated role for hepatic GAPDH in substrate selection and utilization.-Bond, S. T., Howlett, K. F., Kowalski, G. M., Mason, S., Connor, T., Cooper, A., Streltsov, V., Bruce, C. R., Walder, K. R., McGee, S. L. Lysine post-translational modification of glyceraldehyde-3-phosphate dehydrogenase regulates hepatic and systemic metabolism.	[Bond, Simon T.; Connor, Timothy; Cooper, Adrian; Walder, Ken R.; McGee, Sean L.] Deakin Univ, Metab Res Unit, Sch Med, Geelong, Vic, Australia; [Bond, Simon T.; Connor, Timothy; Cooper, Adrian; Walder, Ken R.; McGee, Sean L.] Deakin Univ, Ctr Mol & Med Res, Geelong, Vic, Australia; [Howlett, Kirsten F.; Kowalski, Greg M.; Mason, Shaun; Bruce, Clinton R.] Deakin Univ, Sch Exercise & Nutr Sci, Burwood, NSW, Australia; [Howlett, Kirsten F.; Kowalski, Greg M.; Mason, Shaun; Bruce, Clinton R.] Deakin Univ, Inst Phys Act & Nutr, Burwood, NSW, Australia; [Streltsov, Victor] CSIRO Mfg Flagship, Parkville, Vic, Australia	Deakin University; Deakin University; Deakin University; Deakin University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	McGee, SL (corresponding author), Deakin Univ, Sch Med, Metab Res Unit, Metab Remodelling Lab, Waurn Ponds, Vic, Australia.	sean.mcgee@deakin.edu.au	Streltsov, Victor/M-9446-2019; bond, simon/L-9781-2019	Streltsov, Victor/0000-0002-7846-4396; bond, simon/0000-0003-1551-8614; Kowalski, Greg/0000-0002-1599-017X; Bruce, Clinton/0000-0002-0515-3343; Mason, Shaun/0000-0002-6138-2239	National Health and Medical Research Council of Australia [APP1127059]; Diabetes Australia Research Program; Centre for Molecular and Medical Research (Deakin University); Institute for Physical Activity and Nutrition	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Program; Centre for Molecular and Medical Research (Deakin University); Institute for Physical Activity and Nutrition	This study was supported by National Health and Medical Research Council of Australia Grant APP1127059, the Diabetes Australia Research Program, the Centre for Molecular and Medical Research (Deakin University; to S.L.M.), and funding from the Institute for Physical Activity and Nutrition (to C.R.B.). The authors declare no conflicts of interest.	Allick G, 2006, AM J PHYSIOL-ENDOC M, V290, pE1212, DOI 10.1152/ajpendo.00279.2005; CHAN TM, 1975, AM J PHYSIOL, V229, P1702, DOI 10.1152/ajplegacy.1975.229.6.1702; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Daran-Lapujade P, 2004, J BIOL CHEM, V279, P9125, DOI 10.1074/jbc.M309578200; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; FEHLMANN M, 1983, BIOCHEM J, V214, P845, DOI 10.1042/bj2140845; Fujimoto H, 2012, J COMPUT CHEM, V33, P239, DOI 10.1002/jcc.21956; Gastaldelli A, 2001, DIABETES, V50, P1807, DOI 10.2337/diabetes.50.8.1807; GROEN AK, 1986, BIOCHEM J, V237, P379, DOI 10.1042/bj2370379; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Kamimura N, 2011, OBESITY, V19, P1396, DOI 10.1038/oby.2011.6; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Kobayashi K, 2000, METABOLISM, V49, P22, DOI 10.1016/S0026-0495(00)90588-2; Kowalski GM, 2015, BBA-MOL CELL BIOL L, V1851, P210, DOI 10.1016/j.bbalip.2014.12.002; Kowalski GM, 2014, AM J PHYSIOL-ENDOC M, V307, pE859, DOI 10.1152/ajpendo.00165.2014; Kuriyama H, 2002, DIABETES, V51, P2915, DOI 10.2337/diabetes.51.10.2915; LAURENZA A, 1989, TRENDS PHARMACOL SCI, V10, P442, DOI 10.1016/S0165-6147(89)80008-2; LEMAIGRE FP, 1994, BIOCHEM J, V303, P1; Li TT, 2014, J BIOL CHEM, V289, P3775, DOI 10.1074/jbc.M113.531640; Locasale JW, 2011, CELL METAB, V14, P443, DOI 10.1016/j.cmet.2011.07.014; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; MAGNUSSON I, 1995, DIABETES, V44, P185, DOI 10.2337/diabetes.44.2.185; Martin SD, 2014, MOL METAB, V3, P408, DOI 10.1016/j.molmet.2014.02.001; McGee SL, 2014, FASEB J, V28, P3384, DOI 10.1096/fj.14-249359; McGee SL, 2004, DIABETES, V53, P1208, DOI 10.2337/diabetes.53.5.1208; McGee SL, 2003, DIABETES, V52, P926, DOI 10.2337/diabetes.52.4.926; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Nicholls C, 2012, CLIN EXP PHARMACOL P, V39, P674, DOI 10.1111/j.1440-1681.2011.05599.x; Nuttall FQ, 2008, DIABETES-METAB RES, V24, P438, DOI 10.1002/dmrr.863; Olsen JB, 2016, MOL CELL PROTEOMICS, V15, P892, DOI 10.1074/mcp.M115.053280; PRIPBUUS C, 1992, EUR J BIOCHEM, V209, P291, DOI 10.1111/j.1432-1033.1992.tb17288.x; Roden M, 2003, BEST PRACT RES CL EN, V17, P365, DOI 10.1016/S1521-690X(03)00031-9; Roden M, 2000, DIABETES, V49, P701, DOI 10.2337/diabetes.49.5.701; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Seidler N. W., 2012, GAPDH BIOL PROPERTIE, P985; Seidler NW, 2013, ADV EXP MED BIOL, V985, P179, DOI 10.1007/978-94-007-4716-6_6; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Seo J, 2004, J BIOCHEM MOL BIOL, V37, P35; Simon GM, 2012, P NATL ACAD SCI USA, V109, P11133, DOI 10.1073/pnas.1208669109; Staehr P, 2003, DIABETES, V52, P260, DOI 10.2337/diabetes.52.2.260; Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744; TAUNTON OD, 1974, J BIOL CHEM, V249, P7228; Ventura M, 2010, INT J BIOCHEM CELL B, V42, P1672, DOI 10.1016/j.biocel.2010.06.014; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Washizu T, 1999, RES VET SCI, V67, P205, DOI 10.1053/rvsc.1998.0305; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Yun M, 2000, BIOCHEMISTRY-US, V39, P10702, DOI 10.1021/bi9927080; Zannat MT, 2011, BIOCHEM BIOPH RES CO, V409, P171, DOI 10.1016/j.bbrc.2011.04.094; Zeng XY, 2012, BIOCHEM PHARMACOL, V84, P830, DOI 10.1016/j.bcp.2012.07.003; Zhang JY, 2015, CANCER BIOL MED, V12, P10, DOI 10.7497/j.issn.2095-3941.2014.0019; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	58	21	22	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2592	2602		10.1096/fj.201601215R	http://dx.doi.org/10.1096/fj.201601215R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28258188				2022-12-26	WOS:000401553400030
J	Palomino, R; Lee, HW; Millhauser, GL				Palomino, Rafael; Lee, Hsiau-Wei; Millhauser, Glenn L.			The agouti-related peptide binds heparan sulfate through segments critical for its orexigenic effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); glycosaminoglycan; heparan sulfate; heparin-binding protein; neuropeptide; AgRP; mc4r; syndecan	INVERSE AGONIST; NMR STRUCTURE; PROTEIN; AGRP; SYNDECAN-3; ACTIVATION; OBESITY; STATES	Syndecans potently modulate agouti-related peptide (AgRP) signaling in the central melanocortin system. Through heparan sulfate moieties, syndecans are thought to anchor AgRP near its receptor, enhancing its orexigenic effects. Original work proposed that the N-terminal domain of AgRP facilitates this interaction. However, this is not compatible with evidence that this domain is posttranslationally cleaved. Addressing this long-standing incongruity, we used calorimetry and magnetic resonance to probe interactions of AgRP peptides with glycosaminoglycans, including heparan sulfate. We show that mature, cleaved, C-terminal AgRP, not the N-terminal domain, binds heparan sulfate. NMR shows that the binding site consists of regions distinct from the melanocortin receptor-binding site. Using a library of designed AgRP variants, we find that the strength of the syndecan interaction perfectly tracks orexigenic action. Our data provide compelling evidence that AgRP is a heparan sulfate-binding protein and localizes critical regions in the AgRP structure required for this interaction.	[Palomino, Rafael; Lee, Hsiau-Wei; Millhauser, Glenn L.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Millhauser, GL (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	glennm@ucsc.edu		Lee, Hsiau-Wei/0000-0002-6060-6341	National Institutes of Health [F31 DK102343, DK064265, DK110403, S10OD018455]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110403, R01DK064265, F31DK102343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058903] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Fellowship F31 DK102343 (to R. P.) and National Institutes of Health Grants DK064265 and DK110403 (to G. L. M.). The 800-MHz NMR spectrometer was funded by National Institutes of Health Grant S10OD018455.The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chai BX, 2003, PEPTIDES, V24, P603, DOI 10.1016/S0196-9781(03)00104-9; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; Creemers JWM, 2006, ENDOCRINOLOGY, V147, P1621, DOI 10.1210/en.2005-1373; Denis RGP, 2015, CELL METAB, V22, P646, DOI 10.1016/j.cmet.2015.07.011; Duchesne L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001361; FALLER B, 1992, BIOCHEMISTRY-US, V31, P8285, DOI 10.1021/bi00150a023; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Ghamari-Langroudi M, 2015, NATURE, V520, P94, DOI 10.1038/nature14051; Hagan MM, 2001, ENDOCRINOLOGY, V142, P1050, DOI 10.1210/en.142.3.1050; Haskell-Luevano C, 2001, REGUL PEPTIDES, V99, P1, DOI 10.1016/S0167-0115(01)00234-8; Hoggard N, 2004, CLIN ENDOCRINOL, V61, P31, DOI 10.1111/j.1365-2265.2004.02056.x; Jackson PJ, 2006, CHEM BIOL, V13, P1297, DOI 10.1016/j.chembiol.2006.10.006; Jackson PJ, 2002, BIOCHEMISTRY-US, V41, P7565, DOI 10.1021/bi012000x; Karlsson-Lindahl L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034313; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Krasnow Stephanie M, 2010, Curr Opin Support Palliat Care, V4, P266, DOI 10.1097/SPC.0b013e32833e48e7; Liu TM, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00200; Lortat-Jacob H, 1996, J BIOL CHEM, V271, P16139, DOI 10.1074/jbc.271.27.16139; Madonna ME, 2012, ACS CHEM BIOL, V7, P394, DOI 10.1021/cb2003412; McNulty JC, 2001, BIOCHEMISTRY-US, V40, P15520, DOI 10.1021/bi0117192; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; OLSON ST, 1991, J BIOL CHEM, V266, P6342; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; Reizes O, 2006, PEPTIDES, V27, P274, DOI 10.1016/j.peptides.2005.02.030; Reizes O, 2003, ANN NY ACAD SCI, V994, P66, DOI 10.1111/j.1749-6632.2003.tb03163.x; Reizes O, 2001, CELL, V106, P105, DOI 10.1016/S0092-8674(01)00415-9; Sadir R, 2004, J BIOL CHEM, V279, P43854, DOI 10.1074/jbc.M405392200; Shen CP, 2002, J NEUROENDOCRINOL, V14, P607, DOI 10.1046/j.1365-2826.2002.00825.x; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Zheng Q, 2010, NEUROSCIENCE, V171, P1032, DOI 10.1016/j.neuroscience.2010.09.060	36	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7651	7661		10.1074/jbc.M116.772822	http://dx.doi.org/10.1074/jbc.M116.772822			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28264929	hybrid, Green Published			2022-12-26	WOS:000400761300031
J	Mohanty, RP; Buchheim, MA; Anderson, J; Levetin, E				Mohanty, Rashmi Prava; Buchheim, Mark Alan; Anderson, James; Levetin, Estelle			Molecular analysis confirms the long-distance transport of Juniperus ashei pollen	PLOS ONE			English	Article							MOUNTAIN CEDAR POLLEN; AIRBORNE-POLLEN; ALLERGENIC POLLEN; DNA; IDENTIFICATION; PCR; QUANTIFICATION; TRAJECTORIES; POLLINATION; SEQUENCES	Although considered rare, airborne pollen can be deposited far from its place of origin under a confluence of favorable conditions. Temporally anomalous records of Cupressacean pollen collected from January air samples in London, Ontario, Canada have been cited as a new case of long-distance transport. Data on pollination season implicated Juniperus ashei (mountain cedar), with populations in central Texas and south central Oklahoma, as the nearest source of the Cupressacean pollen in the Canadian air samples. This finding is of special significance given the allergenicity of mountain cedar pollen. While microscopy is used extensively to identify particles in the air spora, pollen from all members of the Cupressaceae, including Juniperus, are morphologically indistinguishable. Consequently, we implemented a molecular approach to characterize Juniperus pollen using PCR in order to test the long-distance transport hypothesis. Our PCR results using species-specific primers confirmed that the anomalous Cupressacean pollen collected in Canada was from J. ashei. Forward trajectory analysis from source areas in Texas and the Arbuckle Mountains in Oklahoma and backward trajectory analysis from the destination area near London, Ontario were completed using models implemented in HYSPLIT4 (Hybrid Single-Particle Lagrangian Integrated Trajectory). Results from these trajectory analyses strongly supported the conclusion that the J. ashei pollen detected in Canada had its origins in Texas or Oklahoma. The results from the molecular findings are significant as they provide a new method to confirm the long-distance transport of pollen that bears allergenic importance.	[Mohanty, Rashmi Prava; Buchheim, Mark Alan; Levetin, Estelle] Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA; [Anderson, James] Environm Allergy Assays, London, ON, Canada	University of Tulsa	Levetin, E (corresponding author), Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA.	estelle-levetin@utulsa.edu		Levetin, Estelle/0000-0002-2409-5142	University of Tulsa, Office of Research	University of Tulsa, Office of Research	This study was supported by University of Tulsa, Office of Research. Received by RPM.	Adams R.P., 2014, JUNIPERS WORLD GENUS; Bennett KD, 2006, HOLOCENE, V16, P1031, DOI 10.1177/0959683606069383; Borchert JR, 1950, ANN ASSOC AM GEOGR, V40, P1; BORTENSCHLAGER S, 1990, GRANA, V29, P129, DOI 10.1080/00173139009427743; Bowker GE, 2007, ATMOS ENVIRON, V41, P1587, DOI 10.1016/j.atmosenv.2006.10.047; Bunderson LD, 2015, INT J BIOMETEOROL, V59, P533, DOI 10.1007/s00484-014-0866-9; CAMBON G, 1992, CAN J BOT, V70, P2284, DOI 10.1139/b92-284; Campbell ID, 1999, NATURE, V399, P29, DOI 10.1038/19891; Chen PH, 2008, J INTEGR PLANT BIOL, V50, P375, DOI 10.1111/j.1744-7909.2007.00624.x; CHRISTIE AD, 1969, NAT CAN, V96, P531; Draxier RR, 1998, AUST METEOROL MAG, V47, P295; Draxler R, 2003, HYSPLIT4 MODEL HY BR; Fawley MW, 2004, J PHYCOL, V40, P223, DOI 10.1111/j.0022-3646.2004.03-081.x; Folloni S, 2012, MOL ECOL RESOUR, V12, P810, DOI 10.1111/j.1755-0998.2012.03168.x; Galimberti A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109363; Glaum MC, 2014, J ALLERGY CLIN IMMUN, V133, pAB18, DOI 10.1016/j.jaci.2013.12.090; GREGORY PH, 1978, PURE APPL GEOPHYS, V116, P309, DOI 10.1007/BF01636888; Hasegawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120393; Hirose Y, 2016, AEROBIOLOGIA, V32, P385, DOI 10.1007/s10453-015-9408-0; HJELMROOS M, 1991, GRANA, V30, P215, DOI 10.1080/00173139109427802; Isagi Y, 2010, SINGLE POLLEN GENOTY; Ito M, 2008, MOL ECOL, V17, P5092, DOI 10.1111/j.1365-294X.2008.03966.x; Jackson ST, 1999, BOT REV, V65, P39, DOI 10.1007/BF02856557; Jain SA, 2013, FOOD SCI TECH-BRAZIL, V33, P753, DOI 10.1590/S0101-20612013000400022; Kostia S, 1995, GENOME, V38, P1244, DOI 10.1139/g95-163; Levetin E, 2003, IMMUNOL ALLERGY CLIN, V23, P423, DOI 10.1016/S0889-8561(03)00019-5; LEVETIN E, 1986, ANN ALLERGY, V56, P295; Levetin E, 1998, AEROBIOLOGIA, V14, P21, DOI DOI 10.1007/BF02694591; Little E.L., 1971, MISC PUBL, V1146; Longhi S, 2009, ANN ALLERG ASTHMA IM, V103, P508, DOI 10.1016/S1081-1206(10)60268-2; Matsuki Y, 2007, MOL ECOL NOTES, V7, P194, DOI 10.1111/j.1471-8286.2006.01588.x; Matsuki Y, 2008, AM J BOT, V95, P925, DOI 10.3732/ajb.0800036; Mohanty RP, 2017, ANN ALLERG ASTHMA IM, V118, P204, DOI 10.1016/j.anai.2016.11.015; Mohanty RP, 2016, THESIS; Muller-Germann I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140949; Nakazawa F, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014032; NIKLAS KJ, 1985, BOT REV, V51, P328, DOI 10.1007/BF02861079; Parducci L, 2005, MOL ECOL, V14, P2873, DOI 10.1111/j.1365-294X.2005.02644.x; Petersen G, 1996, PLANT MOL BIOL, V31, P189, DOI 10.1007/BF00020620; Pettyjohn ME, 1997, AEROBIOLOGIA, V13, P259; Reid CE, 2009, ECOHEALTH, V6, P458, DOI 10.1007/s10393-009-0261-x; Ritchie J, 1963, MANITOBA POLLEN SPOR, V5, P95; Rogers CA, 1998, INT J BIOMETEOROL, V42, P65, DOI 10.1007/s004840050086; Rousseau DD, 2006, REV PALAEOBOT PALYNO, V141, P277, DOI 10.1016/j.revpalbo.2006.05.001; Rousseau DD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017539; Teng M, 2016, J ALLERGY CLIN IMMUN, V137, pAB119, DOI 10.1016/j.jaci.2015.12.519; Van de Water PK, 2003, INT J BIOMETEOROL, V48, P74, DOI 10.1007/s00484-003-0184-0; Zhou LJ, 2007, AM J BOT, V94, P477, DOI 10.3732/ajb.94.3.477	48	28	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173465	10.1371/journal.pone.0173465	http://dx.doi.org/10.1371/journal.pone.0173465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273170	Green Published, Green Submitted, gold			2022-12-26	WOS:000396073700006
J	Popovych, OV; Lysyansky, B; Rosenblum, M; Pikovsky, A; Tass, PA				Popovych, Oleksandr V.; Lysyansky, Borys; Rosenblum, Michael; Pikovsky, Arkady; Tass, Peter A.			Pulsatile desynchronizing delayed feedback for closed-loop deep brain stimulation	PLOS ONE			English	Article							COORDINATED RESET NEUROMODULATION; SUBTHALAMIC NUCLEUS STIMULATION; HIGH-FREQUENCY STIMULATION; ADVANCED PARKINSON-DISEASE; SUBJECTS MIMICKING TREMOR; STN-DBS; SYNCHRONY; MODEL; GAIT; OSCILLATIONS	High-frequency (HF) deep brain stimulation (DBS) is the gold standard for the treatment of medically refractory movement disorders like Parkinson's disease, essential tremor, and dystonia, with a significant potential for application to other neurological diseases. The standard setup of HF DBS utilizes an open-loop stimulation protocol, where a permanent HF electrical pulse train is administered to the brain target areas irrespectively of the ongoing neuronal dynamics. Recent experimental and clinical studies demonstrate that a closed loop, adaptive DBS might be superior to the open-loop setup. We here combine the notion of the adaptive high-frequency stimulation approach, that aims at delivering stimulation adapted to the extent of appropriately detected biomarkers, with specifically desynchronizing stimulation protocols. To this end, we extend the delayed feedback stimulation methods, which are intrinsically closed-loop techniques and specifically designed to desynchronize abnormal neuronal synchronization, to pulsatile electrical brain stimulation. We show that permanent pulsatile high-frequency stimulation subjected to an amplitude modulation by linear or nonlinear delayed feedback methods can effectively and robustly desynchronize a STN-GPe network of model neurons and suggest this approach for desynchronizing closedloop DBS.	[Popovych, Oleksandr V.; Lysyansky, Borys; Tass, Peter A.] Julich Res Ctr, Inst Neurosci & Med Neuromodulat, Julich, Germany; [Rosenblum, Michael; Pikovsky, Arkady] Univ Potsdam, Inst Phys & Astron, Potsdam, Germany; [Tass, Peter A.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Tass, Peter A.] Univ Cologne, Dept Neuromodulat, Cologne, Germany	Helmholtz Association; Research Center Julich; University of Potsdam; Stanford University; University of Cologne	Popovych, OV (corresponding author), Julich Res Ctr, Inst Neurosci & Med Neuromodulat, Julich, Germany.	o.popovych@fz-juelich.de	Popovych, Oleksandr V/H-8738-2013; Pikovsky, Arkady/A-5225-2015	Popovych, Oleksandr V/0000-0001-9994-1764; Pikovsky, Arkady/0000-0001-9682-7122	Helmholtz Society	Helmholtz Society(Helmholtz Association)	The study was funded by the Helmholtz Society (OVP, BL, PAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamchic I, 2014, MOVEMENT DISORD, V29, P1679, DOI 10.1002/mds.25923; Andres FG, 1999, J CLIN NEUROPHYSIOL, V16, P520, DOI 10.1097/00004691-199911000-00004; BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Beudel M, 2016, PARKINSONISM RELAT D, V22, pS123, DOI 10.1016/j.parkreldis.2015.09.028; BRITTON TC, 1993, ANN NEUROL, V33, P473, DOI 10.1002/ana.410330510; BRITTON TC, 1993, J NEUROL NEUROSUR PS, V56, P1085, DOI 10.1136/jnnp.56.10.1085; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Bronte-Stewart H, 2009, EXP NEUROL, V215, P20, DOI 10.1016/j.expneurol.2008.09.008; Butson CR, 2007, CLIN NEUROPHYSIOL, V118, P1889, DOI 10.1016/j.clinph.2007.05.061; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Cagnan H, 2013, BRAIN, V136, P3062, DOI 10.1093/brain/awt239; Carron R, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00112; Deniau JM, 2010, EUR J NEUROSCI, V32, P1080, DOI 10.1111/j.1460-9568.2010.07413.x; Dovzhenok A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058264; Eggermont JJ, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00029; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Ferraye MU, 2008, NEUROLOGY, V70, P1431, DOI 10.1212/01.wnl.0000310416.90757.85; Foutz TJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066008; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Grahn PJ, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00169; Graupe D, 2010, NEUROL RES, V32, P899, DOI 10.1179/016164110X12767786356354; Haken H, 1983, ADV SYNERGETICS; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Harnack D, 2004, J NEUROSCI METH, V138, P207, DOI 10.1016/j.jneumeth.2004.04.019; Hauptmann C, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016004; Holt AB, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005011; Hosain MK, 2014, AUSTRALAS PHYS ENG S, V37, P619, DOI 10.1007/s13246-014-0297-2; Johnson LA, 2016, BRAIN STIMUL, V9, P892, DOI 10.1016/j.brs.2016.06.051; Johnson MD, 2008, NEUROTHERAPEUTICS, V5, P294, DOI 10.1016/j.nurt.2008.01.010; Kiss IZ, 2007, SCIENCE, V316, P1886, DOI 10.1126/science.1140858; Kuhn AA, 2008, J NEUROSCI, V28, P6165, DOI 10.1523/JNEUROSCI.0282-08.2008; Kuhn AA, 2017, MOVEMENT DISORD, V32, P11, DOI 10.1002/mds.26703; Kuncel AM, 2004, CLIN NEUROPHYSIOL, V115, P2431, DOI 10.1016/j.clinph.2004.05.031; LILLY JC, 1955, SCIENCE, V121, P468, DOI 10.1126/science.121.3144.468; Linden H, 2011, NEURON, V72, P859, DOI 10.1016/j.neuron.2011.11.006; Little S, 2016, J NEUROL NEUROSUR PS, V87, P717, DOI 10.1136/jnnp-2015-310972; Little S, 2013, ANN NEUROL, V74, P449, DOI 10.1002/ana.23951; Little S, 2012, ANN NY ACAD SCI, V1265, P9, DOI 10.1111/j.1749-6632.2012.06650.x; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Luo M, 2009, BIOL CYBERN, V101, P241, DOI 10.1007/s00422-009-0334-5; Majtanik M, 2007, EFFEKTE SENSORISCHER; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020; Montaseri G, 2013, CHAOS, V23, DOI 10.1063/1.4817393; Moreau C, 2008, NEUROLOGY, V71, P80, DOI 10.1212/01.wnl.0000303972.16279.46; Moro E, 2002, NEUROLOGY, V59, P706, DOI 10.1212/WNL.59.5.706; Moro E, 2006, ARCH NEUROL-CHICAGO, V63, pE1, DOI 10.1001/archneur.63.9.noc60069; Nabi A, 2013, J COMPUT NEUROSCI, V34, P259, DOI 10.1007/s10827-012-0419-3; NINI A, 1995, J NEUROPHYSIOL, V74, P1800, DOI 10.1152/jn.1995.74.4.1800; Ozkurt TE, 2011, EXP NEUROL, V229, P324, DOI 10.1016/j.expneurol.2011.02.015; Parasuram H, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00065; Park C, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.042901; Pikovsky A, 1999, PHYS REV E, V59, P1633, DOI 10.1103/PhysRevE.59.1633; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Popovych OV, 2006, BIOL CYBERN, V95, P69, DOI 10.1007/s00422-006-0066-8; Popovych OV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117205; Popovych OV, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00058; Popovych OV, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026204; Popovych OV, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.164102; Priori A, 2013, EXP NEUROL, V245, P77, DOI 10.1016/j.expneurol.2012.09.013; Pyragas K, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/40002; Quinn EJ, 2015, MOVEMENT DISORD, V30, P1750, DOI 10.1002/mds.26376; Ratas I, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032914; Rizzone M, 2001, J NEUROL NEUROSUR PS, V71, P215, DOI 10.1136/jnnp.71.2.215; Rosa M, 2015, MOVEMENT DISORD, V30, P1003, DOI 10.1002/mds.26241; Rosenblum M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041904; Rosenblum MG, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.114102; Rosenblum M, 2006, INT J BIFURCAT CHAOS, V16, P1989, DOI 10.1142/S0218127406015842; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; Rubin JE, 2004, J COMPUT NEUROSCI, V16, P211, DOI 10.1023/B:JCNS.0000025686.47117.67; Schnitzler A, 2009, MOVEMENT DISORD, V24, P1629, DOI 10.1002/mds.22633; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Tass PA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011902; Tass P.A., 1999, PHASE RESETTING MED; Tass PA, 2006, BIOL CYBERN, V94, P58, DOI 10.1007/s00422-005-0028-6; Tass PA, 2003, BIOL CYBERN, V89, P81, DOI [10.1007/s00422-003-0425-7, 10.1007/S00422-003-0425-7]; Tass PA, 2001, EUROPHYS LETT, V53, P15, DOI 10.1209/epl/i2001-00117-6; Tass PA, 2000, PROG THEOR PHYS SUPP, P301, DOI 10.1143/PTPS.139.301; Tass PA, 2012, ANN NEUROL, V72, P816, DOI 10.1002/ana.23663; Tass PA, 2012, RESTOR NEUROL NEUROS, V30, P137, DOI 10.3233/RNN-2012-110218; Tass PA, 2012, BIOL CYBERN, V106, P27, DOI 10.1007/s00422-012-0479-5; Temperli P, 2003, NEUROLOGY, V60, P78, DOI 10.1212/WNL.60.1.78; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Tukhlina N, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011918; van Nuenen BFL, 2008, MOVEMENT DISORD, V23, P2404, DOI 10.1002/mds.21986; van Wijk BCM, 2016, CLIN NEUROPHYSIOL, V127, P2010, DOI 10.1016/j.clinph.2016.01.015; Volkmann J, 2002, MOVEMENT DISORD, V17, pS181, DOI 10.1002/mds.10162; Wang DD, 2016, NEUROBIOL DIS, V89, P213, DOI 10.1016/j.nbd.2016.02.015; Wang J, 2016, BRAIN STIMUL, V9, P611, DOI 10.1016/j.brs.2016.03.014; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Wilson CJ, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00050; Wilson D, 2014, SIAM J APPL DYN SYST, V13, P276, DOI 10.1137/120901702; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3; Wong R K, 1986, Adv Neurol, V44, P583; Wongsarnpigoon A, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046009; Xie T, 2012, J NEUROL NEUROSUR PS, V83, P1015, DOI 10.1136/jnnp-2011-302091; Yamamoto T, 2013, NEUROMODULATION, V16, P230, DOI 10.1111/j.1525-1403.2012.00521.x; Yanagisawa T, 2012, J NEUROSCI, V32, P15467, DOI 10.1523/JNEUROSCI.2929-12.2012; Yang AI, 2014, J NEUROSCI, V34, P12816, DOI 10.1523/JNEUROSCI.1895-14.2014; Yeung MKS, 1999, PHYS REV LETT, V82, P648, DOI 10.1103/PhysRevLett.82.648; Zhai Y, 2008, IND ENG CHEM RES, V47, P3502, DOI 10.1021/ie0708632	104	47	47	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173363	10.1371/journal.pone.0173363	http://dx.doi.org/10.1371/journal.pone.0173363			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273176	Green Published, Green Submitted, gold			2022-12-26	WOS:000396073700055
J	Gill, J; Connolly, P; Roth, M; Chung, SH; Zhang, WD; Piperdi, S; Hoang, B; Yang, R; Guzik, H; Morris, J; Gorlick, R; Geller, DS				Gill, Jonathan; Connolly, Patrick; Roth, Michael; Chung, So Hak; Zhang, Wendong; Piperdi, Sajida; Hoang, Bang; Yang, Rui; Guzik, Hillary; Morris, Jonathan; Gorlick, Richard; Geller, David S.			The effect of bone morphogenetic protein-2 on osteosarcoma metastasis	PLOS ONE			English	Article							STEM-CELLS; GROWTH; DIFFERENTIATION; EXPRESSION; RECEPTORS; ALLOGRAFT; SURGERY; SALVAGE; BMPS	Purpose Bone Morphogenetic Protein-2 (BMP-2) may offer the potential to enhance allograft-host osseous union in limb-salvage surgery following osteosarcoma resection. However, there is concern regarding the effect of locally applied BMP-2 on tumor recurrence and metastasis. The purpose of this project was to evaluate the effect of exogenous BMP-2 on osteosarcoma migration and invasion across a panel of tumor cell lines in vitro and to characterize the effect of BMP-2 on pulmonary osteosarcoma metastasis within a xenograft model. Experimental design The effect of BMP-2 on in vitro tumor growth and development was assessed across multiple standard and patient-derived xenograft osteosarcoma cell lines. Tumor migration capacity, invasion, and cell proliferation were characterized. In addition, the effect on metastasis was measured using a xenograft model following tail-vein injection. The effect of exogenous BMP-2 on the development of metastases was measured following both single and multiple BMP-2 administrations. Results There was no significant difference in migration capacity, invasion, or cell proliferation between the BMP-2 treated and the untreated osteosarcoma cell lines. There was no significant difference in pulmonary metastases between either the single-dose or multi-dose BMP-2 treated animals and the untreated control animals. Conclusions In the model systems tested, the addition of BMP-2 does not increase osteosarcoma proliferation, migration, invasion, or metastasis to the lungs.	[Gill, Jonathan; Connolly, Patrick; Roth, Michael; Zhang, Wendong; Piperdi, Sajida; Geller, David S.] Childrens Hosp Montefiore, Div Pediat Hematol Oncol & Blood & Marrow Cell Tr, Albert Einstein Coll Med, Bronx, NY 10467 USA; [Chung, So Hak] Kosin Univ, Coll Med, Busan, South Korea; [Hoang, Bang; Yang, Rui; Morris, Jonathan; Gorlick, Richard; Geller, David S.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Orthopaed Surg, Bronx, NY 10467 USA; [Guzik, Hillary] Albert Einstein Coll Med, Analyt Imaging Facil, Bronx, NY 10467 USA; [Gorlick, Richard] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Geller, DS (corresponding author), Childrens Hosp Montefiore, Div Pediat Hematol Oncol & Blood & Marrow Cell Tr, Albert Einstein Coll Med, Bronx, NY 10467 USA.; Geller, DS (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Orthopaed Surg, Bronx, NY 10467 USA.	dgellar@montefiore.org		Connolly, Patrick/0000-0002-9648-3670; GORLICK, RICHARD/0000-0001-8995-2929	Swim Across America; Matthew Foster Foundation; Barbara Bates Center for The Study of the History of Nursing; Barbara Epstein Foundation	Swim Across America; Matthew Foster Foundation; Barbara Bates Center for The Study of the History of Nursing; Barbara Epstein Foundation	This research was funded in part by Swim Across America, The Matthew Foster Foundation, Barbara Bates Center for The Study of the History of Nursing, and The Barbara Epstein Foundation. We would also like to thank the Pediatric Preclinical Testing Program for the use of their xenograft cell lines and Eugenie S. Kleinerman, MD who kindly provided the SaOS-LM7 cell line. We would also like to acknowledge Daewoong Pharmaceutical Co. Ltd., for graciously providing BMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayerza MA, 2010, CLIN ORTHOP RELAT R, V468, P2854, DOI 10.1007/s11999-010-1423-4; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Friedrich JB, 2008, J BONE JOINT SURG AM, V90A, P93, DOI 10.2106/JBJS.G.00551; Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1; Geller DS, 2014, CLIN CANC RES; Geng S, 2014, MOL CANCER THER, V13, P1431, DOI 10.1158/1535-7163.MCT-13-0934; Gobbi G, 2002, INT J ONCOL, V20, P143; Rici REG, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-17; Guo W, 1999, CLIN ORTHOP RELAT R, P175; GURNEY JG, 1999, CANC INCIDENCE SURVI, P99; Haydon RC, 2007, CLIN ORTHOP RELAT R, P237, DOI 10.1097/BLO.0b013e31802b683c; Hornicek FJ, 2001, CLIN ORTHOP RELAT R, P87; Houghton PJ, 2007, PEDIATR BLOOD CANCER, V49, P928, DOI 10.1002/pbc.21078; Jaffe N, 2002, CANCER-AM CANCER SOC, V95, P2202, DOI 10.1002/cncr.10944; Jia SF, 2002, ANTI-CANCER DRUG, V13, P155, DOI 10.1097/00001813-200202000-00007; Jia SF, 1999, CLIN EXP METASTAS, V17, P501, DOI 10.1023/A:1006623001465; Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98; Mirabello L, 2009, INT J CANCER, V125, P229, DOI 10.1002/ijc.24320; SIMON MA, 1986, J BONE JOINT SURG AM, V68A, P1331, DOI 10.2106/00004623-198668090-00005; Wang L, 2011, CANCER BIOL THER, V11, P457, DOI 10.4161/cbt.11.5.14372; Yang R, 2007, INT J CANCER, V121, P943, DOI 10.1002/ijc.22749	21	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173322	10.1371/journal.pone.0173322	http://dx.doi.org/10.1371/journal.pone.0173322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264040	Green Published, Green Submitted, gold			2022-12-26	WOS:000396054300053
J	Lamurias, A; Clarke, LA; Couto, FM				Lamurias, Andre; Clarke, Luka A.; Couto, Francisco M.			Extracting microRNA-gene relations from biomedical literature using distant supervision	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; TRANSCRIPTION FACTOR; SIMILARITY; DATABASE; NETWORK; KERNEL	Many biomedical relation extraction approaches are based on supervised machine learning, requiring an annotated corpus. Distant supervision aims at training a classifier by combining a knowledge base with a corpus, reducing the amount of manual effort necessary. This is particularly useful for biomedicine because many databases and ontologies have been made available for many biological processes, while the availability of annotated corpora is still limited. We studied the extraction of microRNA-gene relations from text. MicroRNA regulation is an important biological process due to its close association with human diseases. The proposed method, IBRel, is based on distantly supervised multi-instance learning. We evaluated IBRel on three datasets, and the results were compared with a co-occurrence approach as well as a supervised machine learning algorithm. While supervised learning outperformed on two of those datasets, IBRel obtained an F-score 28.3 percentage points higher on the dataset for which there was no training set developed specifically. To demonstrate the applicability of IBRel, we used it to extract 27 miRNA-gene relations from recently published papers about cystic fibrosis. Our results demonstrate that our method can be successfully used to extract relations from literature about a biological process without an annotated corpus. The source code and data used in this study are available athttps://github.com/AndreLamurias/IBRel.	[Lamurias, Andre; Couto, Francisco M.] Univ Lisbon, LaSIGE, Fac Ciencias, Lisbon, Portugal; [Clarke, Luka A.] Univ Lisbon, BioISI Biosyst & Integrat Sci Inst, Fac Ciencias, Lisbon, Portugal	Universidade de Lisboa; BIOISI; Universidade de Lisboa	Lamurias, A (corresponding author), Univ Lisbon, LaSIGE, Fac Ciencias, Lisbon, Portugal.	alamurias@lasige.di.fc.ul.pt	Couto, Francisco M/A-4066-2010; Clarke, Luka A/E-5843-2012; Lamurias, Andre/U-9729-2017	Couto, Francisco M/0000-0003-0627-1496; Clarke, Luka A/0000-0003-3254-9121; Lamurias, Andre/0000-0001-7965-6536	Portuguese Fundacao para a Ciencia e Tecnologia [PD/BD/106083/2015, PEst-OE/BIA/U14046/2011, UID/CEC/00408/2013]	Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Portuguese Fundacao para a Ciencia e Tecnologia (https://www.fct.mctes.pt/) through the PhD Grant ref. PD/BD/106083/2015 to AL, PEst-OE/BIA/U14046/2011 (BioFIG) to LAC, and UID/CEC/00408/2013 (LaSIGE) to AL and FMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagewadi S., 2014, F1000RESEARCH, V3; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bundschus M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-207; Bunescu R., 2006, P WORKSH LINK NAT LA, P49; Bunescu R.C., 2007, P ICML, P105, DOI DOI 10.1145/1273496.1273510; Chen YJ, 2016, WORKSH 30 AAAI C ART, P105; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Chowdhary R, 2012, AM J RESP CELL MOL, V47, P112, DOI 10.1165/rcmb.2011-0419OC; Craven M, 1999, Proc Int Conf Intell Syst Mol Biol, P77; Dietterich TG, 1997, ARTIF INTELL, V89, P31, DOI 10.1016/S0004-3702(96)00034-3; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Giuliano C., 2006, P 11 C EUR CHAPT ASS, P401; Guo L, 2016, SCI REP-UK, V6, DOI 10.1038/srep23700; Hamed M, 2015, NUCLEIC ACIDS RES, V43, pW283, DOI 10.1093/nar/gkv418; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang JS, 2015, IEEE INT C BIOINFORM, P975, DOI 10.1109/BIBM.2015.7359816; Jain S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-562; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kim JH, 2009, ARTECH HSE METH BIOE, P1, DOI 10.1109/ICIMW.2009.5324773; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krallinger M, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s1, 10.1186/gb-2008-9-S2-S4, 10.1186/gb-2008-9-s2-s4, 10.1186/gb-2008-9-S2-S1]; Lafferty John D., 2001, ICML 01, P282, DOI DOI 10.5555/645530.655813; Lamurias A, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/1758-2946-7-S1-S13; Lamurias A, 2014, J INTEGR BIOINFORMAT, V11, DOI 10.2390/biecoll-jib-2014-247; Leaman R., 2013, BIOCREATIVE CHALL EV, V2, P34; Leaman Robert, 2008, Pac Symp Biocomput, P652; Li G, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004391; Li Y., 2013, NUCLEIC ACIDS RES; Liu Y, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.42; Mack GS, 2007, NAT BIOTECHNOL, V25, P631, DOI 10.1038/nbt0607-631; Manning CD, 2014, PROCEEDINGS OF 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS: SYSTEM DEMONSTRATIONS, P55, DOI 10.3115/v1/p14-5010; Min B., 2013, P 2013 C N AM CHAPT, P777, DOI [DOI 10.1186/S40537-016-0043-6, 10.1609/aaai.v33i01.33016407]; Mintz M., 2009, P JOINT C 47 ANN M A, V2, P1003, DOI DOI 10.3115/1690219.1690287; Moschitti A., 2004, P 42 ANN M ASS COMP; Murray BS, 2010, MOL BIOSYST, V6, P1853, DOI 10.1039/c003961f; Naeem Haroon, 2010, BMC Bioinformatics, V11, P135, DOI 10.1186/1471-2105-11-135; Nguyen TVT, 2011, P 5 INT JOINT C NAT, P732; Palma G, 2014, LECT NOTES COMPUT SC, V8796, P131, DOI 10.1007/978-3-319-11964-9_9; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Poon H, 2015, BIOCOMPUT-PAC SYM, P120; Powers D. M., 2012, EACL 2012 13 C EUROP, P345; Ramachandran S, 2013, AM J RESP CELL MOL, V49, P544, DOI 10.1165/rcmb.2012-0430OC; Ravikumar Ke, 2012, J Biomed Semantics, V3 Suppl 3, pS2, DOI 10.1186/2041-1480-3-S3-S2; Rosenfeld B, 2007, P 16 ACM C C INF KNO, P411, DOI DOI 10.1145/1321440.1321499; Rozenfeld B, 2006, IEEE DATA MINING, P1032; Satre R., 2007, P 2 BIOCREATIVE CHAL, P209; Segura-Bedmar I., 2013, ASS COMPUT LINGUIST, V3206, P341; Segura-Bedmar I, 2011, J BIOMED INFORM, V44, P789, DOI 10.1016/j.jbi.2011.04.005; Wahba G, 1992, SFI STUDIES SCI COMP, VXII, P95; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Zelenko D, 2003, J MACH LEARN RES, V3, P1083, DOI 10.1162/153244303322533205; Zeng XX, 2016, BRIEF BIOINFORM, V17, P193, DOI 10.1093/bib/bbv033; Zou Q, 2016, BRIEF FUNCT GENOMICS, V15, P55, DOI 10.1093/bfgp/elv024	55	18	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0171929	10.1371/journal.pone.0171929	http://dx.doi.org/10.1371/journal.pone.0171929			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28263989	Green Submitted, Green Published, gold			2022-12-26	WOS:000396054300006
J	Thapa, S; Stewart, BA; Xue, QW; Chen, YQ				Thapa, Sushil; Stewart, Bob A.; Xue, Qingwu; Chen, Yuanquan			Manipulating plant geometry to improve microclimate, grain yield, and harvest index in grain sorghum	PLOS ONE			English	Article							WATER-USE EFFICIENCY; TRANSPIRATION EFFICIENCY; POPULATION-DENSITIES; CANOPY TEMPERATURE; WIDE-RANGE; DYNAMICS; GROWTH; CORN; IRRIGATION; DROUGHT	Cultivar selection, planting geometry, and plant population are the key factors determining grain sorghum yields in water deficit areas. The objective of this study was to investigate whether clump geometry (three plants clustered) improves microclimate within crop canopy when plants are grown under varying water levels. In a 2-yr sorghum (Sorghum bicolor L. Moench) greenhouse study, plants were grown at two geometries (clump and conventional evenly spaced planting, ESP), two water levels (high and low, representing well-watered and water-limited condition, respectively), and three soil surface treatments (lid covered, straw-mulched, and bare). Air temperature and relative humidity (RH) within the plant canopy were measured every five minutes at different growth stages. Mean vapor pressure deficits (VPDs) within the clumps were consistently lower than those for ESPs, indicating that clumps improved the microclimate. Clumps had significantly higher harvest index (HI) compared to ESPs (0.48 vs. 0.43), which was largely due to clumps having an average of 0.4 tillers per plant compared to 1.2 tillers per plant for ESPs. Grain yield in the current study was similar between clumps and ESPs. However, our results suggest that improved microclimate was likely a reason for clumps producing significantly higher grain yields compared to ESPs in previous studies.	[Thapa, Sushil; Stewart, Bob A.] West Texas A&M Univ, Dryland Agr Inst, Canyon, TX 79016 USA; [Thapa, Sushil; Xue, Qingwu] Texas A&M AgriLife Res & Extens Ctr, Amarillo, TX 79106 USA; [Chen, Yuanquan] China Agr Univ, Coll Agron, Beijing, Peoples R China	Texas A&M University System; West Texas A&M University; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; China Agricultural University	Thapa, S (corresponding author), West Texas A&M Univ, Dryland Agr Inst, Canyon, TX 79016 USA.; Thapa, S (corresponding author), Texas A&M AgriLife Res & Extens Ctr, Amarillo, TX 79106 USA.	sushil.thapa@ag.tamu.edu	Xue, Qingwu/AAE-2431-2020; Chen, Yuanquan/AAU-9492-2020	Xue, Qingwu/0000-0002-6470-3245				Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; ARNON I, 1975, PHYSL ASPECTS DRYLAN; ASTON AR, 1972, AGRON J, V64, P368, DOI 10.2134/agronj1972.00021962006400030034x; Badr MA, 2012, AGR WATER MANAGE, V110, P9, DOI 10.1016/j.agwat.2012.03.008; Bandaru V, 2006, AGRON J, V98, P1109, DOI 10.2134/agronj2005.0166; Ben-Gal A, 2002, PLANT SOIL, V247, P211, DOI 10.1023/A:1021556808595; Bennett T, 2006, PLANT MOL BIOL, V60, P843, DOI 10.1007/s11103-005-2763-4; BLUM A, 1970, AGRON J, V62, P333, DOI 10.2134/agronj1970.00021962006200030007x; Blum A., 2004, PHYSL BIOTECHNOLOGY, P141, DOI DOI 10.1201/9780203022030.CH4; CASAL JJ, 1985, ANN BOT-LONDON, V56, P553, DOI 10.1093/oxfordjournals.aob.a087040; CASAL JJ, 1986, ENVIRON EXP BOT, V26, P365, DOI 10.1016/0098-8472(86)90024-9; CRAUFURD PQ, 1993, EXP AGR, V29, P61, DOI 10.1017/S001447970002041X; CronkLab, 2016, CALC VAP PRESS DEF; DAVIS MH, 1994, CROP SCI, V34, P1604, DOI 10.2135/cropsci1994.0011183X003400060033x; Finlayson SA, 2010, PLANT PHYSIOL, V152, P1914, DOI 10.1104/pp.109.148833; Gallavotti A, 2013, J EXP BOT, V64, P2593, DOI 10.1093/jxb/ert141; Gardiol JM, 2003, J HYDROL, V271, P188, DOI 10.1016/S0022-1694(02)00347-5; Gautier H, 1999, ANN BOT-LONDON, V83, P423, DOI 10.1006/anbo.1998.0840; GERIK TJ, 1987, CROP SCI, V27, P1225, DOI 10.2135/cropsci1987.0011183X002700060027x; Glenn EP, 2008, SENSORS-BASEL, V8, P2136, DOI 10.3390/s8042136; Godin C, 1999, ANN BOT-LONDON, V84, P343, DOI 10.1006/anbo.1999.0923; Haefele SM, 2009, FIELD CROP RES, V111, P1, DOI 10.1016/j.fcr.2008.09.008; HAMMER GL, 1994, FIELD CROP RES, V36, P221, DOI 10.1016/0378-4290(94)90114-7; Hammer GL, 1997, AUST J AGR RES, V48, P649, DOI 10.1071/A96111; Huang JK, 2002, NATURE, V418, P678, DOI 10.1038/nature01015; Ingram DL, 1993, BULLETIN, V241, P1; JACKSON RD, 1977, WATER RESOUR RES, V13, P651, DOI 10.1029/WR013i003p00651; Jones Hamlyn G., 2003, Journal of Agricultural Meteorology, V59, P205, DOI 10.2480/agrmet.59.205; Jordan, 1987, WATER WATER POLICY W, P355; Jurik TW, 2004, FIELD CROP RES, V90, P335, DOI 10.1016/j.fcr.2004.04.002; Kapanigowda M, 2010, CROP IMPROV, V24, P271; Kapanigowda M, 2010, FIELD CROP RES, V118, P115, DOI 10.1016/j.fcr.2010.04.012; Kashif Khurshid, 2006, International Journal of Agriculture and Biology, V8, P593; Krishnareddy SR, 2009, J CROP IMPROV, V24, P1, DOI 10.1080/15427520903303808; Lafarge TA, 2002, ANN BOT-LONDON, V90, P87, DOI 10.1093/aob/mcf152; Lafarge TA, 2002, ANN BOT-LONDON, V90, P99, DOI 10.1093/aob/mcf153; LASCAR, 2008, HIGH ACC HUM TEMP DE; LIDDLE MJ, 1982, OIKOS, V38, P52, DOI 10.2307/3544567; Lin BB, 2007, AGR FOREST METEOROL, V144, P85, DOI 10.1016/j.agrformet.2006.12.009; MAAS SJ, 1987, AGRON J, V79, P739, DOI 10.2134/agronj1987.00021962007900040031x; Mahan JR, 2012, IRRIGATION SCI, V30, P127, DOI 10.1007/s00271-011-0269-1; Mantovani D, 2014, J HYDROL HYDROMECH, V62, P316, DOI 10.2478/johh-2014-0028; MITCHELL KJ, 1953, PHYSIOL PLANTARUM, V6, P21, DOI 10.1111/j.1399-3054.1953.tb08930.x; Mohammed S, 2012, J CROP IMPROV, V26, P130, DOI 10.1080/15427528.2011.618241; Ong C. K., 2007, Annals of Arid Zone, V46, P255; Pabin J., 2003, International Agrophysics, V17, P175; Prenger JJ, 2009, GREENHOUSE CONDENSAT; PRIHAR SS, 1990, AGRON J, V82, P1160, DOI 10.2134/agronj1990.00021962008200060027x; Rajan N, 2010, AGRON J, V102, P1641, DOI 10.2134/agronj2010.0076; Rooney WL, 2004, ADV AGRON, V83, P37, DOI 10.1016/S0065-2113(04)83002-5; Rosegrant MW, 2003, SCIENCE, V302, P1917, DOI 10.1126/science.1092958; SAS Institute Inc, 2009, STAT AN SYST US GUID; Shaheen A, 2010, AFR J AGR RES, V5, P2178; SHUTING D, 1993, BIOL PLANTARUM, V35, P273, DOI 10.1007/BF02925953; Sinclair T.R., 2010, PRINCIPLES ECOLOGY P; STEVENSON KR, 1971, AGRON J, V63, P327, DOI 10.2134/agronj1971.00021962006300020038x; Stewart BA, 2009, J CROP IMPROV, V23, P71, DOI 10.1080/15427520802418319; Stewart BA, 2015, AGRON J, V107, P1544, DOI 10.2134/agronj14.0038; STICKLER F. C, 1961, AGRON JOUR, V53, P187; Tanner C.B., 1983, LIMITATIONS EFFICIEN; Thapa S, 2016, J CROP IMPROV, V30, P614, DOI 10.1080/15427528.2016.1217445; Xin ZG, 2009, FIELD CROP RES, V111, P74, DOI 10.1016/j.fcr.2008.10.010; Zhang HP, 1998, PLANT SOIL, V201, P295, DOI 10.1023/A:1004328004860	63	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173511	10.1371/journal.pone.0173511	http://dx.doi.org/10.1371/journal.pone.0173511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264051	Green Published, gold, Green Submitted			2022-12-26	WOS:000396054300068
J	Buszko, M; Cardini, B; Oberhuber, R; Oberhuber, L; Jakic, B; Beierfuss, A; Wick, G; Cappellano, G				Buszko, Maja; Cardini, Benno; Oberhuber, Rupert; Oberhuber, Lukas; Jakic, Bojana; Beierfuss, Anja; Wick, Georg; Cappellano, Giuseppe			Differential depletion of total T cells and regulatory T cells and prolonged allotransplant survival in CD3. humanized mice treated with polyclonal anti human thymocyte globulin	PLOS ONE			English	Article							OKT3 MONOCLONAL-ANTIBODY; RABBIT ANTITHYMOCYTE GLOBULIN; KIDNEY-TRANSPLANT RECIPIENTS; NONOBESE DIABETIC MICE; IN-VIVO; TCR/CD3 COMPLEX; THERAPY; MECHANISMS; INDUCTION; AUTOIMMUNITY	Thymoglobulin (ATG) is a polyclonal rabbit antibody against human thymocytes used as a T cell-depleting agent to prevent or treat allotransplant rejection. The aim of the present study was to investigate the effect of low dose ATG treatment exclusively on T cells using a humanized BALB/c human CD3. transgenic mouse model expressing both human and murine T cell receptors (TCR). Mice received a single intravenous (i. v.) injection of ATG. Blood and peripheral lymphoid organs were obtained after different time points. We found a significant T cell depletion in this mouse model. In addition, regulatory T cells (Tregs) proved to be less sensitive to depletion than the rest of T cells and the Treg: non-Treg ratio was therefore increased. Finally, we also investigated the effect of ATG in a heterotopic allogenic murine model of heart transplantation. Survival and transplant function were significantly prolonged in ATG-treated mice. In conclusion, we showed (a) an immunosuppressive effect of ATG in this humanized mouse model which is exclusively mediated by reactivity against human CD3.; (b) provided evidence for a relative resistance of Tregs against this regimen; and (c) demonstrated the immunomodulatory effect of ATG under these experimental circumstances by prolongation of heart allograft survival.	[Buszko, Maja; Jakic, Bojana; Wick, Georg; Cappellano, Giuseppe] Med Univ Innsbruck, Lab Autoimmun, Div Expt Pathophysiol & Immunol, Bioctr, Innsbruck, Austria; [Cardini, Benno; Oberhuber, Rupert; Oberhuber, Lukas] Med Univ Innsbruck, Dept Visceral Transplant & Thorac Surg, Ctr Operat Med, Innsbruck, Austria; [Beierfuss, Anja] Med Univ Innsbruck, Cent Lab, Anim Facil, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Cappellano, G (corresponding author), Med Univ Innsbruck, Lab Autoimmun, Div Expt Pathophysiol & Immunol, Bioctr, Innsbruck, Austria.	giuseppe.cappellano@i-med.ac.at	Cappellano, Giuseppe/ABE-4980-2020; Jakic, Bojana/AAR-8584-2020	Jakic, Bojana/0000-0002-2339-5928; Cappellano, Giuseppe/0000-0001-5193-4688	SANOFI-Genzyme	SANOFI-Genzyme	This project has been supported by SANOFI-Genzyme (to GW). This support included the salaries of one PhD student (M. Buszko), part of the salary of a senior postdoc (G. Cappellano), a part time technician and a part time animal caretaker. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOWICZ D, 1989, TRANSPLANTATION, V47, P606, DOI 10.1097/00007890-198904000-00008; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; BLANCHARD J M, 1985, Microsurgery, V6, P169, DOI 10.1002/micr.1920060308; Bouvy AP, 2014, NEPHROL DIAL TRANSPL, V29, P1587, DOI 10.1093/ndt/gfu079; Carson BD, 2007, ANN NY ACAD SCI, V1103, P167, DOI 10.1196/annals.1394.022; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; CHATENOUD L, 1982, EUR J IMMUNOL, V12, P979, DOI 10.1002/eji.1830121116; Chung DT, 2007, INT IMMUNOL, V19, P1003, DOI 10.1093/intimm/dxm078; DELAHERA A, 1991, J EXP MED, V173, P7, DOI 10.1084/jem.173.1.7; Feng XM, 2014, HAEMATOLOGICA, V99, P1433, DOI 10.3324/haematol.2014.106542; HIRSCH R, 1988, J IMMUNOL, V140, P3766; Kuhn C, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001830; Minamimura K, 2006, J IMMUNOL, V176, P4125, DOI 10.4049/jimmunol.176.7.4125; Mohty M, 2007, LEUKEMIA, V21, P1387, DOI 10.1038/sj.leu.2404683; Mohty M, 2014, DRUGS, V74, P1605, DOI 10.1007/s40265-014-0277-6; Neff KS, 2011, TRANSPLANTATION, V92, P523, DOI 10.1097/TP.0b013e31822923f7; Nishio J, 2010, J EXP MED, V207, P1879, DOI 10.1084/jem.20100205; Oberhuber R, 2014, JOVE-J VIS EXP, DOI 10.3791/50753; Penaranda C, 2011, J IMMUNOL, V187, P2015, DOI 10.4049/jimmunol.1100713; Popow I, 2013, AM J TRANSPLANT, V13, P3103, DOI 10.1111/ajt.12514; Preville X, 2001, TRANSPLANTATION, V71, P460, DOI 10.1097/00007890-200102150-00021; Qu YY, 2010, CELL MOL IMMUNOL, V7, P419, DOI 10.1038/cmi.2010.45; Rojo JM, 2014, J LEUKOCYTE BIOL, V95, P441, DOI 10.1189/jlb.1112584; Ruzek MC, 2009, TRANSPLANTATION, V88, P170, DOI 10.1097/TP.0b013e3181abc061; Sebastian M, 2016, J IMMUNOL, V196, P144, DOI 10.4049/jimmunol.1501704; SHI YF, 1991, J IMMUNOL, V146, P3340; Simon G, 2008, DIABETES, V57, P405, DOI 10.2337/db06-1384; Starzl T. E., 1967, TRANSPLANTATION, V5, P1100; Steffens S, 2006, CIRCULATION, V114, P1977, DOI 10.1161/CIRCULATIONAHA.106.627430; Tang QZ, 2012, TRANSPL INT, V25, P1257, DOI 10.1111/j.1432-2277.2012.01565.x; THISTLETHWAITE JR, 1984, TRANSPLANTATION, V38, P695, DOI 10.1097/00007890-198412000-00029; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Xia CQ, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-70	33	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173088	10.1371/journal.pone.0173088	http://dx.doi.org/10.1371/journal.pone.0173088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257450	Green Submitted, Green Published, gold			2022-12-26	WOS:000396021100056
J	Hategeka, C; Shoveller, J; Tuyisenge, L; Kenyon, C; Cechetto, DF; Lynd, LD				Hategeka, Celestin; Shoveller, Jean; Tuyisenge, Lisine; Kenyon, Cynthia; Cechetto, David F.; Lynd, Larry D.			Pediatric emergency care capacity in a low-resource setting: An assessment of district hospitals in Rwanda	PLOS ONE			English	Article							QUALITY; KENYA; INDICATORS; COUNTRIES; CHILDREN	Background Health system strengthening is crucial to improving infant and child health outcomes in low-resource countries. While the knowledge related to improving newborn and child survival has advanced remarkably over the past few decades, many healthcare systems in such settings remain unable to effectively deliver pediatric advance life support management. With the introduction of the Emergency Triage, Assessment and Treatment plus Admission care (ETAT+)-a locally adapted pediatric advanced life support management program-in Rwandan district hospitals, we undertook this study to assess the extent to which these hospitals are prepared to provide this pediatric advanced life support management. The results of the study will shed light on the resources and support that are currently available to implement ETAT+, which aims to improve care for severely ill infants and children. Methods A cross-sectional survey was undertaken in eight district hospitals across Rwanda focusing on the availability of physical and human resources, as well as hospital services organizations to provide emergency triage, assessment and treatment plus admission care for severely ill infants and children. Results Many of essential resources deemed necessary for the provision of emergency care for severely ill infants and children were readily available (e.g. drugs and laboratory services). However, only 4/8 hospitals had BVM for newborns; while nebulizer and MDI were not available in 2/8 hospitals. Only 3/8 hospitals had F-75 and ReSoMal. Moreover, there was no adequate triage system across any of the hospitals evaluated. Further, guidelines for neonatal resuscitation and management of malaria were available in 5/8 and in 7/8 hospitals, respectively; while those for child resuscitation and management of sepsis, pneumonia, dehydration and severe malnutrition were available in less than half of the hospitals evaluated. Conclusions Our assessment provides evidence to inform new strategies to enhance the capacity of Rwandan district hospitals to provide pediatric advanced life support management. Identifying key gaps in the health care system is required in order to facilitate the implementation and scale up of ETAT+ in Rwanda. These findings also highlight a need to establish an outreach/mentoring program, embedded within the ongoing ETAT+ program, to promote cross-hospital learning exchanges.	[Hategeka, Celestin; Shoveller, Jean] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Hategeka, Celestin; Lynd, Larry D.] Univ British Columbia, Fac Pharmaceut Sci, Collaborat Outcomes Res & Evaluat, Vancouver, BC, Canada; [Tuyisenge, Lisine] Univ Teaching Hosp Kigali, Dept Pediat, Kigali, Rwanda; [Kenyon, Cynthia] London Hlth Sci Ctr, Childrens Hosp, Div Neonatal Perinatal Med, London, ON, Canada; [Cechetto, David F.] Western Univ, Dept Anat & Cell Biol, Schulich Sch Med & Dent, London, ON, Canada; [Lynd, Larry D.] Providence Hlth Res Inst, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario)	Hategeka, C (corresponding author), Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada.; Hategeka, C; Lynd, LD (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Collaborat Outcomes Res & Evaluat, Vancouver, BC, Canada.; Lynd, LD (corresponding author), Providence Hlth Res Inst, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada.	celestin.hategeka@alumni.ubc.ca; larry.lynd@ubc.ca		Hategeka, Celestin/0000-0001-7808-4652; Lynd, Larry/0000-0002-7622-3919	CIDA-Maternal Newborn and Child Health in Rwanda [S065358]	CIDA-Maternal Newborn and Child Health in Rwanda	DFC received a grant (CIDA-Maternal Newborn and Child Health in Rwanda, S065358) that contributed to funding the master's training for CH at the University of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe KK, 2000, AM J EMERG MED, V18, P126, DOI 10.1016/S0735-6757(00)90001-9; Aluvaala J, 2014, ARCH DIS CHILDHOOD; Association AH, 2005, PEDIATRICS, V117, pe989, DOI [10.1542/peds.2006-0219, DOI 10.1542/PEDS.2006-0219]; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Binagwaho A, 2013, NEW ENGL J MED, V369, P2054, DOI 10.1056/NEJMsr1302176; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; English M, 2004, LANCET, V364, P1622, DOI 10.1016/S0140-6736(04)17318-2; Gathara D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117048; Hategeka C., 2012, RWANDA MED J, V69, P34; Hategekimana C., 2015, EVALUATING IMPLEMENT; Hategekimana C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152882; Irimu GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039964; Khilnani P, 2010, INDIAN J CRIT CARE M, V14, P41, DOI 10.4103/0972-5229.63029; Mabey D, 2013, PRINCIPLES MED AFRIC; Maternal Newborn and Child Health in Rwanda (MNCHR), 2010, REP QUAL HLTH CAR RW; MENGE I, 1995, E AFR MED J, V72, P165; Ministry of Health of Rwanda, 2010, LIST NAT MED ESS; Ministry of Health of Rwanda, 2011, INT HLTH SYST STRENG; Ministry of Health of Rwanda, 2008, SERV PROV ASS SURV; Ministry of Health of Rwanda, 2012, RWAND ANN HLTH STAT; Ministry of Health of Rwanda, 2011, BAS PED PROT; Ministry of Health Rwanda, 2005, RWAND HLTH SECT POL; Molyneux EM, 2010, ANN TROP PAEDIATR, V30, P165, DOI 10.1179/146532810X12703902516482; Mwakyusa Sekela, 2006, BMC Int Health Hum Rights, V6, P9, DOI 10.1186/1472-698X-6-9; National Institute of Statistics of Rwanda, 2014, RWAND POP HOUS CENS; National Institute of Statistics of Rwanda (NISR) [Rwanda]; Ministry of Health (MOH) [Rwanda]; and ICF International, 2015, RWAND DEM HLTH SURV; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Ntoburi S, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-90; Ralston ME, 2013, LANCET, V381, P256, DOI 10.1016/S0140-6736(12)61191-X; Robison JA, 2012, PEDIATRICS, V130, pE676, DOI 10.1542/peds.2012-0026; Shoveller J, 2016, CRIT PUBLIC HEALTH, V26, P487, DOI 10.1080/09581596.2015.1117577; Slusher TM, 2011, SEMINARS PERINATOLOG; United Nations, MILL DEV GOALS 2000; WHO, 1987, HOSP HLTH ALL REP WH; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; World Health Organization (WHO), 2003, KANGAROO MOTHER CARE	36	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173233	10.1371/journal.pone.0173233	http://dx.doi.org/10.1371/journal.pone.0173233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257500	Green Published, gold, Green Submitted			2022-12-26	WOS:000396021100079
J	Pan, XD; Gu, DH; Mao, JH; Zhu, H; Chen, XF; Zheng, B; Shan, YX				Pan, Xiao-dong; Gu, Dong-hua; Mao, Jia-Hui; Zhu, Hua; Chen, Xinfeng; Zheng, Bing; Shan, Yuxi			Concurrent inhibition of mTORC1 and mTORC2 by WYE-687 inhibits renal cell carcinoma cell growth in vitro and in vivo	PLOS ONE			English	Article							PRECLINICAL EVALUATION; CANCER; RAPAMYCIN; EXPRESSION; RESISTANCE; APOPTOSIS; COMPLEX; TARGET; HK-2	Mammalian target of rapamycin (mTOR) in renal cell carcinoma (RCC) represents a valuable oncotarget for treatment. We here tested the potential anti-RCC activity by a novel mTOR kinase inhibitor WYE-687 in vitro and in vivo. WYE-687 was cytotoxic and anti-proliferative to established RCC cell lines (786-O and A498) and primary human RCC cells. Yet, it was non-cytotoxic toHK-2 tubular epithelial cells. WYE-687 provoked caspase-dependent apoptosis in the RCC cells. At the molecular level, WYE-687 almost completely blocked mTORC1 (p-S6K1 and p-S6) and mTORC2 (p-Akt Ser 473) activation in both 786-Ocells and primary human RCC cells, where it downregulated both hypoxia-inducible factor (HIF)-1 alpha and HIF-2 alpha expression. Significantly, oral administration of WYE-687 potently suppressed786-O tumor xenograft growth in nude mice. mTORC1/2 activation and HIF-1 alpha/2 alpha expression were also remarkably downregulated in WYE-687-treated tumor tissues. Thus, our preclinical results imply that WYE-687 may have important translational value for the treatment of RCC.	[Pan, Xiao-dong; Gu, Dong-hua; Shan, Yuxi] Soochow Univ, Affiliated Hosp 2, Dept Urol, Suzhou, Peoples R China; [Mao, Jia-Hui] Nantong Univ, Sch Med, Dept Pathophysiol, Nantong, Peoples R China; [Zhu, Hua; Chen, Xinfeng; Zheng, Bing] Nantong Univ, Affiliated Hosp 2, Dept Urol, Nantong, Peoples R China	Soochow University - China; Nantong University; Nantong University	Shan, YX (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Urol, Suzhou, Peoples R China.; Zheng, B (corresponding author), Nantong Univ, Affiliated Hosp 2, Dept Urol, Nantong, Peoples R China.	bingzhengnantong@163.com; drshanyuxisd@163.com			Nantong City Scientific Project [2014151B1]	Nantong City Scientific Project	This study is supported by Nantong City Scientific Project (2014151B1 to B.Z.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato RJ, 2000, SEMIN ONCOL, V27, P177; Chen MB, 2015, BIOCHEM BIOPH RES CO, V463, P954, DOI 10.1016/j.bbrc.2015.06.041; Cheng F, 2016, BIOCHEM BIOPH RES CO, V470, P324, DOI 10.1016/j.bbrc.2016.01.054; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21; Dutcher JP, 2011, MED ONCOL, V28, P1530, DOI 10.1007/s12032-010-9649-2; Fiori E, 2002, J EXP CLIN CANC RES, V21, P229; Gomez-Pinillos A, 2012, HEMATOL ONCOL CLIN N, V26, P483, DOI 10.1016/j.hoc.2012.02.014; Hasskarl J, 2014, RECENT RESULTS CANC, V201, P373, DOI 10.1007/978-3-642-54490-3_23; Husseinzadeh HD, 2011, CURR CLIN PHARMACOL, V6, P214, DOI 10.2174/157488411797189433; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Komoike Y, 2012, ARCH TOXICOL, V86, P37, DOI 10.1007/s00204-011-0742-x; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Konings IRHM, 2009, CURR CANCER DRUG TAR, V9, P439, DOI 10.2174/156800909788166556; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Li Z, 2016, ONCOTARGET; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Motzer RJ, 2013, NEW ENGL J MED, V369, P722, DOI 10.1056/NEJMoa1303989; Pal SK, 2013, CANCER TREAT REV, V39, P709, DOI 10.1016/j.ctrv.2012.12.015; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Schreiber KH, 2015, AGING CELL, V14, P265, DOI 10.1111/acel.12313; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Toschi A, 2008, J BIOL CHEM, V283, P34495, DOI 10.1074/jbc.C800170200; Uygur MC, 1999, J EXP CLIN CANC RES, V18, P397; Vilar E, 2011, MOL CANCER THER, V10, P395, DOI 10.1158/1535-7163.MCT-10-0905; Wu DY, 2013, ONCOL LETT, V5, P829, DOI 10.3892/ol.2013.1123; Yang FG, 2005, ACTA PHARMACOL SIN, V26, P753, DOI 10.1111/j.1745-7254.2005.00753.x; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005; Zhang YM, 2015, J INVEST DERMATOL, V135, P181, DOI 10.1038/jid.2014.326; Zheng B, 2014, CANC LETT; Zheng B, 2016, SCI REP-UK, V6, DOI 10.1038/srep29415; Zheng B, 2015, BIOCHEM BIOPH RES CO, V459, P234, DOI 10.1016/j.bbrc.2015.02.084; Zheng B, 2015, CANCER LETT, V357, P468, DOI 10.1016/j.canlet.2014.11.012; Zhou HY, 2012, CHIN J CANCER, V31, P8, DOI 10.5732/cjc.011.10281	41	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172555	10.1371/journal.pone.0172555	http://dx.doi.org/10.1371/journal.pone.0172555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257457	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100021
J	Wan, XJ; Wang, SB; Xu, JR; Zhuang, L; Xing, KP; Zhang, MY; Zhu, XT; Wang, LN; Gao, P; Xi, QY; Sun, JJ; Zhang, YL; Li, TJ; Shu, G; Jiang, QY				Wan, Xiaojuan; Wang, Songbo; Xu, Jingren; Zhuang, Lu; Xing, Kongping; Zhang, Mengyuan; Zhu, Xiaotong; Wang, Lina; Gao, Ping; Xi, Qianyun; Sun, Jiajie; Zhang, Yongliang; Li, Tiejun; Shu, Gang; Jiang, Qingyan			Dietary protein-induced hepatic IGF-1 secretion mediated by PPAR. activation	PLOS ONE			English	Article							GROWTH-FACTOR-I; MESSENGER-RIBONUCLEIC-ACID; GCN2 EIF2-ALPHA KINASE; ESSENTIAL AMINO-ACID; SIGNALING PATHWAY; RAT HEPATOCYTES; RECEPTOR-GAMMA; WEANLING PIGS; GROWING PIGS; TRANSFER-RNA	Dietary protein or amino acid (AA) is a crucial nutritional factor to regulate hepatic insulinlike growth factor-1 (IGF-1) expression and secretion. However, the underlying intracellular mechanism by which dietary protein or AA induces IGF-1 expression remains unknown. We compared the IGF-1 gene expression and plasma IGF-1 level of pigs fed with normal crude protein (CP, 20%) and low-protein levels (LP, 14%). RNA sequencing (RNA-seq) was performed to detect transcript expression in the liver in response to dietary protein. The results showed that serum concentrations and mRNA levels of IGF-1 in the liver were higher in the CP group than in the LP group. RNA-seq analysis identified a total of 1319 differentially expressed transcripts (667 upregulated and 652 downregulated), among which the terms "oxidative phosphorylation" , "ribosome", "gap junction", "PPAR signaling pathway", and "focal adhesion" were enriched. In addition, the porcine primary hepatocyte and HepG2 cell models also demonstrated that the mRNA and protein levels of IGF-1 and PPAR gamma increased with the increasing AA concentration in the culture. The PPAR gamma activator troglitazone increased IGF-1 gene expression and secretion in a dose dependent manner. Furthermore, inhibition of PPAR gamma effectively reversed the effects of the high AA concentration on the mRNA expression of IGF-1 and IGFBP-1 in HepG2 cells. Moreover, the protein levels of IGF-1 and PPAR gamma, as well as the phosphorylation of mTOR, significantly increased in HepG2 cells under high AA concentrations. mTOR phosphorylation can be decreased by the mTOR antagonist, rapamycin. The immunoprecipitation results also showed that high AA concentrations significantly increased the interaction of mTOR and PPAR gamma. In summary, PPAR gamma plays an important role in the regulation of IGF-1 secretion and gene expression in response to dietary protein.	[Wan, Xiaojuan; Wang, Songbo; Xu, Jingren; Zhuang, Lu; Xing, Kongping; Zhang, Mengyuan; Zhu, Xiaotong; Wang, Lina; Gao, Ping; Xi, Qianyun; Sun, Jiajie; Zhang, Yongliang; Shu, Gang; Jiang, Qingyan] South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Wan, Xiaojuan; Wang, Songbo; Xu, Jingren; Zhuang, Lu; Xing, Kongping; Zhang, Mengyuan; Zhu, Xiaotong; Wang, Lina; Gao, Ping; Xi, Qianyun; Sun, Jiajie; Zhang, Yongliang; Shu, Gang; Jiang, Qingyan] South China Agr Univ, Natl Engn Res Ctr Breeding Swine Ind, Guangzhou, Guangdong, Peoples R China; [Li, Tiejun] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Subtrop Agroecol, Changsha, Hunan, Peoples R China	South China Agricultural University; South China Agricultural University; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS	Jiang, QY (corresponding author), South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China.; Jiang, QY (corresponding author), South China Agr Univ, Natl Engn Res Ctr Breeding Swine Ind, Guangzhou, Guangdong, Peoples R China.	qyjiang@scau.edu.cn			National Key Basic Research Program of China (973 Program) [2013CB127304]; National Natural Science Foundation of China [31572480, 31372397]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We declared that this work was supported by grants from National Key Basic Research Program of China (973 Program) (No. 2013CB127304), National Natural Science Foundation of China (No. 31572480) and the National Natural Science Foundation of China (No. 31372397).	Abu Shehab M, 2014, ENDOCRINOLOGY, V155, P1327, DOI 10.1210/en.2013-1759; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005; Boisclair YR, 2001, J ENDOCRINOL, V170, P63, DOI 10.1677/joe.0.1700063; CAMPBELL RG, 1990, J ANIM SCI, V68, P3217; Carraro V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015716; Christiansen JJ, 2005, EUR J ENDOCRINOL, V152, P719, DOI 10.1530/eje.1.01898; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; Deng D, 2007, LIVEST SCI, V109, P224, DOI 10.1016/j.livsci.2007.01.104; Deval C, 2008, BIOCHIMIE, V90, P1716, DOI 10.1016/j.biochi.2008.07.004; Fang XL, 2012, MOL BIOL REP, V39, P10987, DOI 10.1007/s11033-012-2000-6; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gannon MC, 2011, METABOLISM, V60, P1300, DOI 10.1016/j.metabol.2011.01.016; Genolet R, 2005, J BIOL CHEM, V280, P24143, DOI 10.1074/jbc.M502649200; Gietzen DW, 2016, CELL REP, V16, P2049, DOI 10.1016/j.celrep.2016.08.021; Goya L, 2001, ENDOCRINOLOGY, V142, P5089, DOI 10.1210/en.142.12.5089; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Guay F, 2006, J ANIM SCI, V84, P3010, DOI 10.2527/jas.2005-559; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kessler KL, 2012, J ANIM PHYSL ANIM NU; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lecka-Czernik B, 2007, ENDOCRINOLOGY, V148, P903, DOI 10.1210/en.2006-1121; Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006; Li XW, 2008, J CELL BIOCHEM, V104, P965, DOI 10.1002/jcb.21680; Li ZR, 2014, P NATL ACAD SCI USA, V111, P13163, DOI 10.1073/pnas.1411571111; Lian J, 2008, MOL NUTR FOOD RES, V52, P393, DOI 10.1002/mnfr.200700005; MIURA Y, 1992, BRIT J NUTR, V67, P257, DOI 10.1079/BJN19920029; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Nyachoti CM, 2006, J ANIM SCI, V84, P125, DOI 10.2527/2006.841125x; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Okuno Y, 2010, ENDOCR J, V57, P303, DOI 10.1507/endocrj.K09E-113; Pedrosa RG, 2013, APPL PHYSIOL NUTR ME, V38, P694, DOI 10.1139/apnm-2012-0440; Peng Wei, 2012, Sci Transl Med, V4, p118ra11, DOI 10.1126/scitranslmed.3002629; Reindl KM, 2011, AM J PHYSIOL-REG I, V301, pR236, DOI 10.1152/ajpregu.00414.2010; Reynolds MR, 2015, BIOL CHEM; Savage MO, 2013, WORLD REV NUTR DIET, V106, P52, DOI 10.1159/000342577; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shu G, 2014, J NUTR BIOCHEM, V25, P1296, DOI 10.1016/j.jnutbio.2014.07.007; THISSEN JP, 1994, ENDOCRINOLOGY, V134, P1570, DOI 10.1210/en.134.3.1570; Vu-Dac N, 1998, J BIOL CHEM, V273, P25713, DOI 10.1074/jbc.273.40.25713; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Wright MB, 2014, MOL ENDOCRINOL, V28, P1756, DOI 10.1210/me.2013-1427; Wu L, 2015, TOXINS, V7, P1341, DOI 10.3390/toxins7041341; Wu YL, 2013, J BIOL INORG CHEM, V18, P623, DOI 10.1007/s00775-013-1007-3; Xi PB, 2012, J NUTR BIOCHEM, V23, P1012, DOI 10.1016/j.jnutbio.2011.05.009; Xiao F, 2016, ONCOTARGET, V7, P63679, DOI 10.18632/oncotarget.11626; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zervas S, 2002, J ANIM SCI, V80, P3238; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhang SH, 2013, AMINO ACIDS, V45, P1191, DOI 10.1007/s00726-013-1577-y	52	37	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173174	10.1371/journal.pone.0173174	http://dx.doi.org/10.1371/journal.pone.0173174			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257428	gold, Green Submitted, Green Published			2022-12-26	WOS:000396021100069
J	Acquah, GE; Via, BK; Fasina, OO; Adhikari, S; Billor, N; Eckhardt, LG				Acquah, Gifty E.; Via, Brian K.; Fasina, Oladiran O.; Adhikari, Sushil; Billor, Nedret; Eckhardt, Lori G.			Chemometric modeling of thermogravimetric data for the compositional analysis of forest biomass	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; THERMAL-DECOMPOSITION; CHEMICAL-COMPOSITION; LOBLOLLY-PINE; WOOD; DEVOLATILIZATION; PREDICTION; COMPONENTS; CHEMISTRY; KINETICS	The objective of this study was to investigated the use of chemometric modeling of thermogravimetric (TG) data as an alternative approach to estimate the chemical and proximate (i.e. volatile matter, fixed carbon and ash contents) composition of lignocellulosic biomass. Since these properties affect the conversion pathway, processing costs, yield and / or quality of products, a capability to rapidly determine these for biomass feedstock entering the process stream will be useful in the success and efficiency of bioconversion technologies. The 38-minute long methodology developed in this study enabled the simultaneous prediction of both the chemical and proximate properties of forest-derived biomass from the same TG data. Conventionally, two separate experiments had to be conducted to obtain such information. In addition, the chemometric models constructed with normalized TG data outperformed models developed via the traditional deconvolution of TG data. PLS and PCR models were especially robust in predicting the volatile matter (R-2-0.92; RPD-3.58) and lignin (R-2-0.82; RPD-2.40) contents of the biomass. The application of chemometrics to TG data also made it possible to predict some monomeric sugars in this study. Elucidation of PC loadings obtained from chemometric models also provided some insights into the thermal decomposition behavior of the chemical constituents of lignocellulosic biomass. For instance, similar loadings were noted for volatile matter and cellulose, and for fixed carbon and lignin. The findings indicate that common latent variables are shared between these chemical and thermal reactivity properties. Results from this study buttresses literature that have reported that the less thermally stable polysaccharides are responsible for the yield of volatiles whereas the more recalcitrant lignin with its higher percentage of elementary carbon contributes to the yield of fixed carbon.	[Acquah, Gifty E.; Via, Brian K.] Auburn Univ, Sch Forestry & Wildlife Sci, Forest Prod Dev Ctr, Auburn, AL 36849 USA; [Via, Brian K.; Fasina, Oladiran O.; Adhikari, Sushil] Auburn Univ, Dept Biosyst Engn, Ctr Bioenergy & Bioprod, Auburn, AL 36849 USA; [Billor, Nedret] Auburn Univ, Dept Math & Stat, Auburn, AL 36849 USA; [Eckhardt, Lori G.] Auburn Univ, Sch Forestry & Wildlife Sci, Forest Hlth Dynam Lab, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University	Acquah, GE (corresponding author), Auburn Univ, Sch Forestry & Wildlife Sci, Forest Prod Dev Ctr, Auburn, AL 36849 USA.	gea0002@auburn.edu			NSF IGERT: Integrated Biorefining for Sustainable Production of Fuels and Chemicals [1069004]; IGP, Good to Great Grant, USDA Southeastern Partnership for Integrated Biomass Supply Systems [2011-68005-30410]; Forest Health Cooperative and Regions Bank	NSF IGERT: Integrated Biorefining for Sustainable Production of Fuels and Chemicals; IGP, Good to Great Grant, USDA Southeastern Partnership for Integrated Biomass Supply Systems; Forest Health Cooperative and Regions Bank	The authors are most grateful to NSF IGERT: Integrated Biorefining for Sustainable Production of Fuels and Chemicals (Award #: 1069004), The IGP, Good to Great Grant, USDA Southeastern Partnership for Integrated Biomass Supply Systems (Grant #: 2011-68005-30410), The Forest Health Cooperative and Regions Bank for supporting this research with funding and/or materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquah GE, 2010, THESIS; Acquah GE, 2016, J ANAL METHODS CHEM, V2016, DOI 10.1155/2016/1839598; Acquah GE, 2015, J NEAR INFRARED SPEC, V23, P93, DOI 10.1255/jnirs.1153; Acquah GE, 2016, FOREST PROD J, V66, P164, DOI 10.13073/FPJ-D-14-00098; Allison GG, 2009, BIORESOURCE TECHNOL, V100, P6428, DOI 10.1016/j.biortech.2009.07.015; [Anonymous], 2005, PRINCIPLES POLYM SCI; [Anonymous], 2014, E113108 ASTM; ASTM standards, 2006, FUELS 872 882; Bassilakis R, 2001, FUEL, V80, P1765, DOI 10.1016/S0016-2361(01)00061-8; Basu P., 2010, BIOMASS GASIFICATION; Becidan M., 2007, THESIS; Biagini E, 2006, IND ENG CHEM RES, V45, P4486, DOI 10.1021/ie0514049; BROIDO A, 1969, J POLYM SCI A2, V7, P1761, DOI 10.1002/pol.1969.160071012; Carrier M, 2011, BIOMASS BIOENERG, V35, P298, DOI 10.1016/j.biombioe.2010.08.067; Celikbag Y, 2016, FOREST PROD J, V66, P29, DOI 10.13073/FPJ-D-14-00110; Chow S. Z., 1971, Wood & Fiber, V3, P166; Pereira BLC, 2013, BIORESOURCES, V8, P4574; Cozzani V, 1997, CAN J CHEM ENG, V75, P127, DOI 10.1002/cjce.5450750120; Dworzanski JP, 1991, J AM CHEM SOC, V36, P725; Elder T, 2011, THERMOCHIM ACTA, V512, P170, DOI 10.1016/j.tca.2010.10.001; European Committee for Standardization (CEN), 2005, 151482005E CENTS; Filzmoser P., 2009, MULTIVARIATE STAT AN, V66, P112; Francisco-Fernandez M, 2012, CHEMOMETR INTELL LAB, V118, P159, DOI 10.1016/j.chemolab.2012.07.003; Garcia R, 2013, BIORESOURCE TECHNOL, V139, P1, DOI 10.1016/j.biortech.2013.03.197; Hein PRG, 2009, CERNE, V15, P133; Gronli MG, 2002, IND ENG CHEM RES, V41, P4201, DOI 10.1021/ie0201157; Klass DL., 1998, BIOMASS RENEWABLE EN; Kumar A, 2008, BIOMASS BIOENERG, V32, P460, DOI 10.1016/j.biombioe.2007.11.004; Lande S, 2010, WOOD SCI TECHNOL, V44, P189, DOI 10.1007/s00226-009-0278-x; Lapuerta M, 2004, BIOMASS BIOENERG, V27, P385, DOI 10.1016/j.biombioe.2003.11.010; Lee S, 2006, J ANAL APPL PYROL, V86, P39; Martens H., 1992, MULTIVARIATE CALIBRA; McKendry P, 2002, BIORESOURCE TECHNOL, V83, P37, DOI 10.1016/S0960-8524(01)00118-3; Naik S, 2010, RENEW ENERG, V35, P1624, DOI 10.1016/j.renene.2009.08.033; National Renewable Energy Laboratory (NREL), 2008, NRELTP51042622; Natural Resources Canada, 2007, FOR BIOPR DIV CAN FO; Nkansah K, 2010, BIORESOURCE TECHNOL, V101, P4570, DOI 10.1016/j.biortech.2009.12.046; NREL, 2012, NRELTP51042618; Nuopponen MH, 2006, J AGR FOOD CHEM, V54, P34, DOI 10.1021/jf051066m; Ono K, 2003, J FOR RES, V8, P19; Owen K, 2015, T ASABE, V58, P509; Saldarriaga JF, 2015, FUEL, V140, P744, DOI 10.1016/j.fuel.2014.10.024; Singh S, 2015, FRONT ENERGY RES, DOI 10.3389/fenrg.2014.00062; Teleman A, 2009, PULP AND PAPER CHEMISTRY AND TECHNOLOGY, VOL 1: WOOD CHEMISTRY AND WOOD BIOTECHNOLOGY, P101; Toscano G, 2015, ENERGY, V83, P351, DOI 10.1016/j.energy.2015.02.032; Via BK, 2014, SENSORS-BASEL, V14, P13532, DOI 10.3390/s140813532; Werner K, 2014, J ANAL APPL PYROL, V110, P130, DOI 10.1016/j.jaap.2014.08.013; Williams PT, 2013, ADV THERMOCHEMICAL B, P771; Yang HP, 2006, ENERG FUEL, V20, P388, DOI 10.1021/ef0580117; Zhang JF, 2014, BIORESOURCE TECHNOL, V153, P379, DOI 10.1016/j.biortech.2013.12.004	50	16	16	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172999	10.1371/journal.pone.0172999	http://dx.doi.org/10.1371/journal.pone.0172999			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253322	gold, Green Published, Green Submitted			2022-12-26	WOS:000396011300057
J	Caputo, M; Balzerano, A; Arisi, I; D'Onofrio, M; Brandi, R; Bongiorni, S; Brancorsini, S; Frontini, M; Proietti-De-Santis, L				Caputo, Manuela; Balzerano, Alessio; Arisi, Ivan; D'Onofrio, Mara; Brandi, Rossella; Bongiorni, Silvia; Brancorsini, Stefano; Frontini, Mattia; Proietti-De-Santis, Luca			CSB ablation induced apoptosis is mediated by increased endoplasmic reticulum stress response	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; COCKAYNE-SYNDROME B; I TRANSCRIPTION; CANCER; REPAIR; P53; COMPONENT; DISEASES; ROLES; HIF-1	The DNA repair protein Cockayne syndrome group B (CSB) has been recently identified as a promising anticancer target. Suppression, by antisense technology, of this protein causes devastating effects on tumor cells viability, through a massive induction of apoptosis, while being non-toxic to non-transformed cells. To gain insights into the mechanisms underlying the pro-apoptotic effects observed after CSB ablation, global gene expression patterns were determined, to identify genes that were significantly differentially regulated as a function of CSB expression. Our findings revealed that response to endoplasmic reticulum stress and response to unfolded proteins were ranked top amongst the cellular processes affected by CSB suppression. The major components of the endoplasmic reticulum stress-mediated apoptosis pathway, including pro-apoptotic factors downstream of the ATF3-CHOP cascade, were dramatically up-regulated. Altogether our findings add new pieces to the understanding of CSB mechanisms of action and to the molecular basis of CS syndrome.	[Caputo, Manuela; Balzerano, Alessio; Bongiorni, Silvia; Proietti-De-Santis, Luca] Univ Tuscia, Dept Ecol & Biol, Unit Mol Genet Aging, Viterbo, Italy; [Arisi, Ivan; D'Onofrio, Mara; Brandi, Rossella] European Brain Res Inst EBRI Rita Levi Montalcini, Genom Facil, Rome, Italy; [Brancorsini, Stefano] Univ Perugia, Sect Terni, Dept Expt Med, Terni, Italy; [Frontini, Mattia] Univ Cambridge, Dept Haematol, Cambridge Biomed Campus, Cambridge, England; [Frontini, Mattia] Natl Hlth Serv NHS Blood & Transplant, Cambridge Biomed Campus, Cambridge, England; [Frontini, Mattia] Univ Cambridge, British Heart Fdn Ctr Excellence, Cambridge Biomed Campus, Cambridge, England	Tuscia University; University of Perugia; University of Cambridge; University of Cambridge	Proietti-De-Santis, L (corresponding author), Univ Tuscia, Dept Ecol & Biol, Unit Mol Genet Aging, Viterbo, Italy.	proietti@unitus.it	Arisi, Ivan/AAM-1152-2021; De Santis, Luca Proietti/A-4119-2015	Arisi, Ivan/0000-0002-0536-2508; De Santis, Luca Proietti/0000-0002-2715-9113; Bongiorni, Silvia/0000-0001-5111-0566	AIRC [IG13074]; Telethon [GGP11176]; FP7 European Collaborative Project PAINCAGE [603191]; Italian Research Council (EBRI-CNR)	AIRC(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); FP7 European Collaborative Project PAINCAGE; Italian Research Council (EBRI-CNR)	This work was supported by grants from AIRC (IG13074), Telethon (GGP11176), FP7 European Collaborative Project PAINCAGE (603191) and Italian Research Council (EBRI-CNR 2015-2017).	Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Bradsher J, 2002, MOL CELL, V10, P819, DOI 10.1016/S1097-2765(02)00678-0; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Caputo M, 2013, DNA REPAIR, V12, P293, DOI 10.1016/j.dnarep.2013.01.008; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chao MP, 2012, NAT REV CANCER, V12, P58, DOI 10.1038/nrc3171; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Clarke HJ, 2014, CANCER CELL, V25, P563, DOI 10.1016/j.ccr.2014.03.015; Cleaver JE, 2014, P NATL ACAD SCI USA, V111, P13487, DOI 10.1073/pnas.1414135111; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Filippi S, 2008, EMBO J, V27, P2545, DOI 10.1038/emboj.2008.180; Frontini M, 2012, AGING-US, V4, P89, DOI 10.18632/aging.100439; Frontini M, 2009, CELL CYCLE, V8, P693, DOI 10.4161/cc.8.5.7754; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Laine JP, 2006, TRENDS GENET, V22, P430, DOI 10.1016/j.tig.2006.06.006; Latini P, 2011, CELL CYCLE, V10, P3719, DOI 10.4161/cc.10.21.17905; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Natale V, 2011, AM J MED GENET A, V155A, P1081, DOI 10.1002/ajmg.a.33933; Nicolai S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128558; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; Schroder M, 2006, CURR MOL MED, V6, P5, DOI 10.2174/156652406775574569; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Sitia Roberto, 2004, Sci STKE, V2004, ppe27, DOI 10.1126/stke.2392004pe27; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Weidenheim KM, 2009, MECH AGEING DEV, V130, P619, DOI 10.1016/j.mad.2009.07.006; Yuan XJ, 2007, MOL CELL, V27, P585, DOI 10.1016/j.molcel.2007.06.021	36	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172399	10.1371/journal.pone.0172399	http://dx.doi.org/10.1371/journal.pone.0172399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253359	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300018
J	Tasaki, S; Nakayama, M; Shoji, W				Tasaki, Sohei; Nakayama, Madoka; Shoji, Wataru			Self-organization of bacterial communities against environmental pH variation: Controlled chemotactic motility arranges cell population structures in biofilms	PLOS ONE			English	Article							DENSE-BRANCHING-MORPHOLOGY; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; COLONY FORMATION; FLAGELLAR ROTATION; AGAR PLATES; GROWTH; PATTERNS; DYNAMICS; GRADIENT	As with many living organisms, bacteria often live on the surface of solids, such as foods, organisms, buildings and soil. Compared with dispersive behavior in liquid, bacteria on surface environment exhibit significantly restricted mobility. They have access to only limited resources and cannot be liberated from the changing environment. Accordingly, appropriate collective strategies are necessarily required for long-term growth and survival. However, in spite of our deepening knowledge of the structure and characteristics of individual cells, strategic self-organizing dynamics of their community is poorly understood and therefore not yet predictable. Here, we report a morphological change in Bacillus subtilis biofilms due to environmental pH variations, and present a mathematical model for the macroscopic spatiotemporal dynamics. We show that an environmental pH shift transforms colony morphology on hard agar media from notched `volcano-like' to round and front-elevated `crater-like'. We discover that a pH-dependent dose-response relationship between nutritional resource level and quantitative bacterial motility at the population level plays a central role in the mechanism of the spatio-temporal cell population structure design in biofilms.	[Tasaki, Sohei; Shoji, Wataru] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci FRIS, Sendai, Miyagi, Japan; [Tasaki, Sohei] Tohoku Univ, Grad Sch Sci, Sendai, Miyagi, Japan; [Nakayama, Madoka] Sendai Natl Coll Technol, Natori, Miyagi, Japan; [Shoji, Wataru] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University	Tasaki, S (corresponding author), Tohoku Univ, Frontier Res Inst Interdisciplinary Sci FRIS, Sendai, Miyagi, Japan.; Tasaki, S (corresponding author), Tohoku Univ, Grad Sch Sci, Sendai, Miyagi, Japan.	tasaki@tohoku.ac.jp	Tasaki, Sohei/AAP-6885-2020	Tasaki, Sohei/0000-0002-4259-0075	Japan Society for the Promotion of Science, KAKENHI [23570246]	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science, KAKENHI Grant Number 23570246 (WS), (URL: https://www.jsps.go.jp/english/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1967, J GEN MICROBIOL, V46, P175, DOI 10.1099/00221287-46-2-175; ADLER J, 1969, SCIENCE, V166, P1588, DOI 10.1126/science.166.3913.1588; ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Allen B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001549; Ben-Jacob E, 2000, ADV PHYS, V49, P395, DOI 10.1080/000187300405228; BENJACOB E, 1986, PHYS REV LETT, V57, P1903, DOI 10.1103/PhysRevLett.57.1903; BENJACOB E, 1990, NATURE, V343, P523, DOI 10.1038/343523a0; BENJACOB E, 1994, NATURE, V368, P46, DOI 10.1038/368046a0; Blanchard AE, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0188-5; Borges S, 2012, ANTON LEEUW INT J G, V101, P677, DOI 10.1007/s10482-011-9666-y; BROWN D A, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1388, DOI 10.1073/pnas.71.4.1388; Chen XB, 2000, BIOPHYS J, V78, P2280, DOI 10.1016/S0006-3495(00)76774-9; D'Uzo N., 2014, APPL ENVIRON MICROB, V80, P2176; DAWES IW, 1970, J BACTERIOL, V103, P529, DOI 10.1128/JB.103.3.529-535.1970; Dervaux J, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0051; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Eden M., 1961, P 4 BERK S MATH STAT, V4, P223; Fabian FW, 1933, J BACTERIOL, V26, P543, DOI 10.1128/JB.26.6.543-558.1933; FUJIKAWA H, 1989, J PHYS SOC JPN, V58, P3875, DOI 10.1143/JPSJ.58.3875; FUJIKAWA H, 1992, PHYSICA A, V189, P15, DOI 10.1016/0378-4371(92)90123-8; Golding I, 1998, PHYSICA A, V260, P510, DOI 10.1016/S0378-4371(98)00345-8; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Holt J., 1994, BERGEYS MANUAL DETER; Kawasaki K, 1997, J THEOR BIOL, V188, P177, DOI 10.1006/jtbi.1997.0462; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Kitsunezaki S, 1997, J PHYS SOC JPN, V66, P1544, DOI 10.1143/JPSJ.66.1544; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; MANSON MD, 1980, J MOL BIOL, V138, P541, DOI 10.1016/S0022-2836(80)80017-9; MATSUSHITA M, 1990, PHYSICA A, V168, P498, DOI 10.1016/0378-4371(90)90402-E; Mimura M, 2000, PHYSICA A, V282, P283, DOI 10.1016/S0378-4371(00)00085-6; Moissoglu K, 2014, CURR BIOL, V24, pR23, DOI 10.1016/j.cub.2013.10.075; Momeni B, 2013, ELIFE, V2, DOI 10.7554/eLife.00960; Muinonen-Martin AJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001966; Nostro A, 2012, APMIS, V120, P733, DOI 10.1111/j.1600-0463.2012.02900.x; OHGIWARI M, 1992, J PHYS SOC JPN, V61, P816, DOI 10.1143/JPSJ.61.816; ORDAL GW, 1977, J BACTERIOL, V129, P151, DOI 10.1128/JB.129.1.151-155.1977; ORDAL GW, 1975, SCIENCE, V189, P802, DOI 10.1126/science.808854; SHIOI J, 1980, J BACTERIOL, V144, P891, DOI 10.1128/JB.144.3.891-897.1980; SHIOI JI, 1978, J BACTERIOL, V133, P1083, DOI 10.1128/JB.133.3.1083-1088.1978; TSO WW, 1974, J BACTERIOL, V118, P560, DOI 10.1128/JB.118.2.560-576.1974; Tweedy L, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002404; Venkiteswaran G, 2013, CELL, V155, P674, DOI 10.1016/j.cell.2013.09.046; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; WAKITA J, 1994, J PHYS SOC JPN, V63, P1205, DOI 10.1143/JPSJ.63.1205; Wakita J, 1998, J PHYS SOC JPN, V67, P3630, DOI 10.1143/JPSJ.67.3630; Wakita J, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.094002; Wiegert T, 2001, MOL MICROBIOL, V41, P59, DOI 10.1046/j.1365-2958.2001.02489.x; Wilks JC, 2009, APPL ENVIRON MICROB, V75, P981, DOI 10.1128/AEM.01652-08; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400	50	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173195	10.1371/journal.pone.0173195	http://dx.doi.org/10.1371/journal.pone.0173195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253348	gold, Green Published, Green Submitted			2022-12-26	WOS:000396011300090
J	Ali, J; Xu, JL; Gao, YM; Ma, XF; Meng, LJ; Wang, Y; Pang, YL; Guan, YS; Xu, MR; Revilleza, JE; Franje, NJ; Zhou, SC; Li, ZK				Ali, Jauhar; Xu, Jian-Long; Gao, Yong-Ming; Ma, Xiu-Fang; Meng, Li-Jun; Wang, Ying; Pang, Yun-Long; Guan, Yong-Sheng; Xu, Mei-Rong; Revilleza, Jastin E.; Franje, Neil J.; Zhou, Shao-Chuan; Li, Zhi-Kang			Harnessing the hidden genetic diversity for improving multiple abiotic stress tolerance in rice (Oryza sativa L.)	PLOS ONE			English	Article							BACKCROSS INTROGRESSION LINES; DROUGHT TOLERANCE; SALT TOLERANCE; SELECTION; YIELD; DISSECTION; VARIETIES; MAIZE; FLOOD; QTLS	To develop superior rice varieties with improved yield in most rainfed areas of Asia/Africa, we started an introgression-breeding program for simultaneously improving yield and tolerances of multiple abiotic stresses. Using eight BC1 populations derived from a widely adaptable recipient and eight donors plus three rounds of phenotypic selection, we developed 496 introgression lines (ILs) with significantly higher yield under drought, salt and/or non-stress conditions in 5 years. Six new varieties were released in the Philippines and Pakistan and many more are being evaluated in multi-location yield trials for releasing in several countries. Marker-facilitated genetic characterization revealed three interesting aspects of the breeding procedure: (1) the donor introgression pattern in specific BC populations was characteristic; (2) introgression frequency in different genomic regions varied considerably, resulting primarily from strong selection for the target traits; and (3) significantly lower heterozygosity was observed in BC progenies selected for drought and salinity tolerance. Applying strong phenotypic selection under abiotic stresses in early segregating generations has major advantages for not only improving multiple abiotic stress tolerance but also achieving quicker homozygosity in early generations. This breeding procedure can be easily adopted by small breeding programs in developing countries to develop high-yielding varieties tolerant of abiotic stresses. The large set of trait-specific ILs can be used for genetic mapping of genes/QTL that affect target and non-target traits and for efficient varietal development by designed QTL pyramiding and genomics-based recurrent selection in our Green Super Rice breeding technology.	[Ali, Jauhar; Ma, Xiu-Fang; Meng, Li-Jun; Wang, Ying; Pang, Yun-Long; Guan, Yong-Sheng; Xu, Mei-Rong; Revilleza, Jastin E.; Franje, Neil J.] IRRI, Los Banos, Philippines; [Xu, Jian-Long; Gao, Yong-Ming; Meng, Li-Jun; Wang, Ying; Pang, Yun-Long; Guan, Yong-Sheng; Xu, Mei-Rong; Li, Zhi-Kang] CAAS, Inst Crop Sci, Beijing, Peoples R China; [Xu, Jian-Long; Li, Zhi-Kang] CAAS, Agr Genom Inst, Shenzhen Inst Breeding Innovat, Shenzhen, Peoples R China; [Ma, Xiu-Fang] Liaoning Acad Agr Sci, Shenyang, Peoples R China; [Zhou, Shao-Chuan] Guangdong Acad Agr Sci, Guangzhou, Guangdong, Peoples R China	CGIAR; International Rice Research Institute (IRRI); Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Guangdong Academy of Agricultural Sciences	Li, ZK (corresponding author), CAAS, Inst Crop Sci, Beijing, Peoples R China.; Li, ZK (corresponding author), CAAS, Agr Genom Inst, Shenzhen Inst Breeding Innovat, Shenzhen, Peoples R China.	lizhikang@caas.cn	Ali, Jauhar Ali or A. Jauhar/E-4432-2012; meng, li/GVT-2063-2022; Xu, Jianlong/AAI-8310-2020	Ali, Jauhar Ali or A. Jauhar/0000-0002-3177-2607; 	Bill & Melinda Gates Foundation [GD1393]; National 863 High Technology Research and Development Program from the Ministry of Science and Technology of China [2014AA10A601]; Shenzhen Peacock Plan [20130415095710361]; Natural Science Foundation of China [31261140369]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National 863 High Technology Research and Development Program from the Ministry of Science and Technology of China(National High Technology Research and Development Program of China); Shenzhen Peacock Plan; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants to ZL from Bill & Melinda Gates Foundation (http://www.gatesfoundation.org) (GD1393), to JX from National 863 High Technology Research and Development Program from the Ministry of Science and Technology of China (http://www.863.gov.cn) (2014AA10A601) and to ZL from Shenzhen Peacock Plan (http://www/szsti.gov.cn) (20130415095710361), and to JX from the Natural Science (http://www.nsfc.gov.cn/) Foundation of China (31261140369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AJ, 2006, FIELD CROP RES, V97, P66, DOI 10.1016/j.fcr.2005.08.016; Ali J., 2012, P 12 SABRAO C PLANT, P16; Asaduzzaman M., 2010, BANGL FOOD SEC INV F, P26; Banziger M, 1999, CROP SCI, V39, P1035, DOI 10.2135/cropsci1999.0011183X003900040012x; Beebe SE, 2008, CROP SCI, V48, P582, DOI 10.2135/cropsci2007.07.0404; BOLANOS J, 1993, FIELD CROP RES, V31, P269, DOI 10.1016/0378-4290(93)90066-V; Cooper M, 2014, J EXP BOT, V65, P6191, DOI 10.1093/jxb/eru064; FISCHER RA, 1978, AUST J AGR RES, V29, P897, DOI 10.1071/AR9780897; Gregorio GB, 2002, FIELD CROP RES, V76, P91, DOI 10.1016/S0378-4290(02)00031-X; Gregorio GB, 1997, IRRI DISCUSSION PAPE, V22, P2; Guan YS, 2010, J EXP BOT, V61, P4145, DOI 10.1093/jxb/erq212; He YX, 2010, PLANT BREEDING, V129, P167, DOI 10.1111/j.1439-0523.2009.01683.x; Ismail AM, 2013, FIELD CROP RES, V152, P83, DOI 10.1016/j.fcr.2013.01.007; Lafitte HR, 2006, FIELD CROP RES, V97, P77, DOI 10.1016/j.fcr.2005.08.017; Li Z.K., 2007, ADV MOL BREEDING DRO, P531, DOI DOI 10.1007/978-1-4020-5578-2_21; Li ZK, 2013, CURR OPIN PLANT BIOL, V16, P261, DOI 10.1016/j.pbi.2013.03.008; Li ZK, 2005, PLANT MOL BIOL, V59, P33, DOI 10.1007/s11103-005-8519-3; Meng LJ, 2013, PLANT BREEDING, V132, P604, DOI 10.1111/pbr.12097; Nagai I., 1962, JAPONICA RICE ITS BR, P843; Raman A, 2012, RICE, V5, DOI 10.1186/1939-8433-5-31; Singh R, 2016, PLANT SCI, V242, P278, DOI 10.1016/j.plantsci.2015.08.008; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Tuong TP, 2003, COMP ASSESS WAT MAN, V1, P53, DOI 10.1079/9780851996691.0053; Wang WJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0709-5; Wang Y, 2013, CROP J, V1, P134, DOI 10.1016/j.cj.2013.07.006; Wang Y, 2013, CROP SCI, V53, P430, DOI 10.2135/cropsci2012.06.0361; Wassmann R, 2009, ADV AGRON, V101, P59, DOI 10.1016/S0065-2113(08)00802-X; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; Zang JP, 2008, SCI CHINA SER C, V51, P583, DOI 10.1007/s11427-008-0081-1; Zhang F, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-55; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1	31	28	32	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172515	10.1371/journal.pone.0172515	http://dx.doi.org/10.1371/journal.pone.0172515			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278154	Green Submitted, Green Published, gold			2022-12-26	WOS:000396087900120
J	Kauhl, B; Heil, J; Hoebe, CJPA; Schweikart, J; Krafft, T; Dukers-Muijrers, NHTM				Kauhl, Boris; Heil, Jeanne; Hoebe, Christian J. P. A.; Schweikart, Juergen; Krafft, Thomas; Dukers-Muijrers, Nicole H. T. M.			Is the current pertussis incidence only the results of testing? A spatial and space-time analysis of pertussis surveillance data using cluster detection methods and geographically weighted regression modelling	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; UNITED-STATES; HEALTH-CARE; VACCINATION STRATEGIES; INCREASING INCIDENCE; POISSON REGRESSION; DISEASE BURDEN; EPIDEMIOLOGY; DIAGNOSIS; OUTBREAK	Background Despite high vaccination coverage, pertussis incidence in the Netherlands is amongst the highest in Europe with a shifting tendency towards adults and elderly. Early detection of outbreaks and preventive actions are necessary to prevent severe complications in infants. Efficient pertussis control requires additional background knowledge about the determinants of testing and possible determinants of the current pertussis incidence. Therefore, the aim of our study is to examine the possibility of locating possible pertussis outbreaks using space-time cluster detection and to examine the determinants of pertussis testing and incidence using geographically weighted regression models. Methods We analysed laboratory registry data including all geocoded pertussis tests in the southern area of the Netherlands between 2007 and 2013. Socio-demographic and infrastructure-related population data were matched to the geo-coded laboratory data. The spatial scan statistic was applied to detect spatial and space-time clusters of testing, incidence and test-positivity. Geographically weighted Poisson regression (GWPR) models were then constructed to model the associations between the age-specific rates of testing and incidence and possible population-based determinants. Results Space-time clusters for pertussis incidence overlapped with space-time clusters for testing, reflecting a strong relationship between testing and incidence, irrespective of the examined age group. Testing for pertussis itself was overall associated with lower socio-economic status, multi-person-households, proximity to primary school and availability of healthcare. The current incidence in contradiction is mainly determined by testing and is not associated with a lower socioeconomic status. Discussion Testing for pertussis follows to an extent the general healthcare seeking behaviour for common respiratory infections, whereas the current pertussis incidence is largely the result of testing. More testing would thus not necessarily improve pertussis control. Detecting outbreaks using space-time cluster detection is feasible but needs to adjust for the strong impact of testing on the detection of pertussis cases.	[Kauhl, Boris; Krafft, Thomas] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Publ Hlth & Primary Care CAPHRI, Dept Hlth Eth & Soc, Maastricht, Netherlands; [Heil, Jeanne; Hoebe, Christian J. P. A.; Dukers-Muijrers, Nicole H. T. M.] South Limburg Publ Hlth Serv GGD Zuid Limburg, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands; [Heil, Jeanne; Hoebe, Christian J. P. A.; Dukers-Muijrers, Nicole H. T. M.] MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands; [Schweikart, Juergen] Beuth Univ Appl Sci, Dept 3, Civil Engn & Geoinformat, Berlin, Germany	Maastricht University; Maastricht University	Kauhl, B (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Sch Publ Hlth & Primary Care CAPHRI, Dept Hlth Eth & Soc, Maastricht, Netherlands.	boris.kauhl@maastrichtuniversity.nl	Dukers-Muijrers, Nicole/M-7178-2014	Krafft, Thomas/0000-0002-6164-7815; Heil, Jeanne/0000-0002-0057-9599				[Anonymous], ESRI INT EXPL REGR R; Anselin L, 2005, EXPLORING SPATIAL DA; Barlow RS, 2014, CLIN INFECT DIS, V58, P1523, DOI 10.1093/cid/ciu156; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Calugar A, 2006, CLIN INFECT DIS, V42, P981, DOI 10.1086/500321; Campbell SM, 1996, FAM PRACT, V13, P75, DOI 10.1093/fampra/13.1.75; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P216; Chen J, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-57; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Cherry JD, 2003, PEDIATRICS, V112, P405, DOI 10.1542/peds.112.2.405; Choe YJ, 2012, INT J INFECT DIS, V16, pE850, DOI 10.1016/j.ijid.2012.07.012; Choisy M, 2012, P ROY SOC B-BIOL SCI, V279, P4574, DOI 10.1098/rspb.2012.1761; Chuk LMR, 2008, COMMUN DIS INTELL, V32, P449; Coleman M., 2009, Malaria Journal, V8; Coudeville L, 2008, EPIDEMIOL INFECT, V136, P604, DOI 10.1017/S0950268807009041; Cutler DM, 2006, ED HLTH EVALUATING T; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; de Melker HE, 2000, EMERG INFECT DIS, V6, P348, DOI 10.3201/eid0604.000404; de Melker HE, 2000, J CLIN MICROBIOL, V38, P800, DOI 10.1128/JCM.38.2.800-806.2000; DeBolt Chas, 2012, Morbidity and Mortality Weekly Report, V61, P517; Dhewantara PW, 2015, GEOSPATIAL HEALTH, V10, P255, DOI 10.4081/gh.2015.373; Dijkstra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072730; Fathima S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-48; Feldacker C, 2010, HEALTH PLACE, V16, P996, DOI 10.1016/j.healthplace.2010.06.004; Fisman DN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-694; Fotheringham A. S., 2003, GEOGRAPHICALLY WEIGH; Galanis E, 2006, CAN MED ASSOC J, V174, P451, DOI 10.1503/cmaj.050379; Gezondheidsraad, 2015, VACCINATIE TEGEN KIN; Giammanco A, 2003, VACCINE, V22, P112, DOI 10.1016/S0264-410X(03)00514-0; Greenberg DP, 2005, PEDIATR INFECT DIS J, V24, P721, DOI 10.1097/01.inf.0000172905.08606.a3; Guimaraes LM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1222-3; Haque U, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-63; He Q, 2008, FACTORS CONTRIBUTING; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Heil J, 2017, EUROSURVEIL IN PRESS; Hu MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038978; Huang B, 2010, INT J GEOGR INF SCI, V24, P383, DOI 10.1080/13658810802672469; Jenkinson D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5463; Kaczmarek MC, 2013, MED J AUSTRALIA, V198, P624, DOI 10.5694/mja13.10044; Kauhl B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135656; Kauhl B, 2015, HEALTH PLACE, V31, P111, DOI 10.1016/j.healthplace.2014.11.002; Kirkland K. B., 2007, Morbidity and Mortality Weekly Report, V56, P837; Kulldorff, 2010, SATSCAN SOFTWARE SPA; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 2013, SATSCAN TM USER GUID; Kulldorff M, 2011, SATSCAN USER GUIDE V; Lawson AB, 2000, STAT MED, V19, P2217; LOVETT A, 1989, PROF GEOGR, V41, P190, DOI 10.1111/j.0033-0124.1989.00190.x; LOVETT AA, 1986, SOC SCI MED, V23, P935, DOI 10.1016/0277-9536(86)90251-0; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Nakaya T, 2005, STAT MED, V24, P2695, DOI 10.1002/sim.2129; Nakaya T, 2012, GWR4 USER MANUAL WWW; Ndiath M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-453; Nuolivirta K, 2010, PEDIATR INFECT DIS J, V29, P1013, DOI 10.1097/INF.0b013e3181f537c6; Omer SB, 2008, AM J EPIDEMIOL, V168, P1389, DOI 10.1093/aje/kwn263; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Regidor E, 2004, SOC SCI MED, V59, P1975, DOI 10.1016/j.socscimed.2004.02.032; Robertson C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066168; Robertson C, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-16; Rozenbaum MH, 2012, EPIDEMIOL INFECT, V140, P1503, DOI 10.1017/S0950268811002354; Rozenbaum MH, 2012, VACCINE, V30, P7327, DOI 10.1016/j.vaccine.2012.06.026; Service NH, 2012, SHARP RIS WHOOP COUG; Shoff C, 2012, DEMOGR RES, V27, P377; Sizaire V, 2014, EUROSURVEILLANCE, P19; Smith SM, 2008, COCHRANE DB SYST REV, V1; Statistiek CBvd, 2010, TOEL WIJK BUURTK 201; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; te Beest DE, 2014, EPIDEMICS-NETH, V7, P1, DOI 10.1016/j.epidem.2014.02.001; Terry JB, 2015, COMMUN DIS INTELL, V39, pE27; Tozzi AE, 2005, CAN MED ASSOC J, V172, P509, DOI 10.1503/cmaj.1040766; van den Wijngaard CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010406; van der Maas NAT, 2013, VACCINE, V31, P4541, DOI 10.1016/j.vaccine.2013.07.060; van Lier A, 2013, EUR J PUBLIC HEALTH; van Lier E Alies, 2009, Ned Tijdschr Geneeskd, V153, P950; Verheij TJM, 2011, HUISARTS WET, V2011; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012; Waller L.A., 2004, APPL SPATIAL STAT PU; Wang T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-885; Ward A, 2005, INFECT CONT HOSP EP, V26, P288, DOI 10.1086/502541; Weisent J, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-45; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d; Wymann MN, 2011, VACCINE, V29, P2058, DOI 10.1016/j.vaccine.2011.01.017; Ziemann A, 2012, RESUSCITATION, V83, pe30; Zouari A, 2012, CRIT REV MICROBIOL, V38, P111, DOI 10.3109/1040841X.2011.622715	86	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172383	10.1371/journal.pone.0172383	http://dx.doi.org/10.1371/journal.pone.0172383			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278180	gold, Green Submitted, Green Published			2022-12-26	WOS:000396087900118
J	Yi, JY; Kim, HJ; Chung, MS				Yi, Ji Yoon; Kim, Hui Ju; Chung, Myong-Soo			Manufacture of low-benzo(a)pyrene sesame seed (Sesamum indicum L.) oil using a self-designed apparatus	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; OXIDATIVE STABILITY; VEGETABLE-OILS; CAKE EXTRACT; SOYBEAN OILS; FOOD; PROTEIN; BENZO(A)PYRENE; MUTAGENICITY; PYROLYSIS	The aim of this study was to lower benzo(a) pyrene (BaP) contents in sesame seed oil (SSO) during manufacture by using a self-designed apparatus, to determine its optimal conditions, and to analyze antioxidants in SSO which might be related to BaP content reduction. Washing and spin-drying steps reduce exogenous BaP contamination, and the reduced moisture in seeds lowered BaP content in final SSO. A ventilation system in the roasting step inhibits BaP formation and reabsorption, followed by a controlled compression step. The optimal condition, a single washing cycle with 2-min spin-drying, 1350-rpm ventilation, and a single compression cycle, reduced the BaP content in SSO to 2.93 mu g/kg, where the raw seeds had been spiked with 10-mu g/kg BaP. Total phenolic contents showed a reversal pattern to the distribution of BaP contents. Sesamol and sesamolin were quantified by a high performance liquid chromatography-ultraviolet detector, and it was suggested that sesamol which is a strong antioxidant might have prevented BaP formation during the roasting step. This study enabled the commercial production of low-BaP SSO, and the data could be used in further investigations of the BaP content reduction mechanism with quantitative chemical analysis of the SSO composition.	[Yi, Ji Yoon; Kim, Hui Ju; Chung, Myong-Soo] Ewha Womans Univ, Dept Food Sci & Engn, Seoul, South Korea	Ewha Womans University	Chung, MS (corresponding author), Ewha Womans Univ, Dept Food Sci & Engn, Seoul, South Korea.	mschung@ewha.ac.kr		Yi, Jiyoon/0000-0002-4323-3125	Korean Ministry of Food and Drug Safety [13162MFDS051]	Korean Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This research was supported by a grant (grant number: 13162MFDS051, recipient: MSC) from the Korean Ministry of Food and Drug Safety (http://www.mfds.go.kr/eng) in 2014 and 2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouGharbia HA, 1997, J AM OIL CHEM SOC, V74, P215, DOI 10.1007/s11746-997-0126-9; Anilakumar Kandangath Raghavan, 2010, Agriculturae Conspectus Scientificus, V75, P159; [Anonymous], 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.724; Bouaid A, 2007, FUEL, V86, P2596, DOI 10.1016/j.fuel.2007.02.014; Camargo MCR, 2003, FOOD CONTROL, V14, P49, DOI 10.1016/S0956-7135(02)00052-X; Chen BH, 2001, J AGR FOOD CHEM, V49, P5238, DOI 10.1021/jf0106906; Cheng WW, 2015, J AM OIL CHEM SOC, V92, P1725, DOI 10.1007/s11746-015-2734-0; Chung SY, 2011, FOOD CHEM, V129, P1420, DOI 10.1016/j.foodchem.2011.05.092; Dabrowska D, 2008, POL J ENVIRON STUD, V17, P17; Elleuch M, 2007, FOOD CHEM, V103, P641, DOI 10.1016/j.foodchem.2006.09.008; European Commission, 2006, OFFICIAL J EUROPEA L, V364, P5; FUKUDA Y, 1986, AGR BIOL CHEM TOKYO, V50, P857, DOI 10.1080/00021369.1986.10867500; Gfrerer M, 2003, J SEP SCI, V26, P1230, DOI 10.1002/jssc.200301422; Grougnet R, 2012, J AGR FOOD CHEM, V60, P108, DOI 10.1021/jf2040687; Guillen M. D., 1997, Reviews on Environmental Health, V12, P133; HOPIA A, 1986, J AM OIL CHEM SOC, V63, P889, DOI 10.1007/BF02540921; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P9; Janoszka B, 2004, ACTA CHROMATOGR, V14, P115; JOHNSON LA, 1979, J AM OIL CHEM SOC, V56, P463, DOI 10.1007/BF02671542; Kaur IP, 2000, MUTAT RES-GEN TOX EN, V470, P71, DOI 10.1016/S1383-5718(00)00096-6; Kazerouni N, 2001, FOOD CHEM TOXICOL, V39, P423, DOI 10.1016/S0278-6915(00)00158-7; KIKUGAWA K, 1983, J AM OIL CHEM SOC, V60, P1528, DOI 10.1007/BF02666577; LARSSON BK, 1987, J AM OIL CHEM SOC, V64, P365, DOI 10.1007/BF02549296; Lee JY, 2006, J FOOD SCI, V71, pC430, DOI 10.1111/j.1750-3841.2006.00137.x; Lee SW, 2010, FOOD CHEM, V118, P681, DOI 10.1016/j.foodchem.2009.05.040; McGrath TE, 2003, J ANAL APPL PYROL, V66, P51, DOI 10.1016/S0165-2370(02)00105-5; Ministry Of Food And Drug Safety, 2009, STAND SPEC EACH FOOD; Ministry Of Food And Drug Safety, 2009, COMM STAND SPEC GEN; Ministry Of Food And Drug Safety, 2009, SAMPL HANDL METH; Mohdaly AAA, 2011, IND CROP PROD, V34, P952, DOI 10.1016/j.indcrop.2011.02.018; Moret S, 2000, J CHROMATOGR A, V882, P245, DOI 10.1016/S0021-9673(00)00079-0; NAMIKI M, 1995, FOOD REV INT, V11, P281, DOI 10.1080/87559129509541043; NAMIKI M, 1990, CRIT REV FOOD SCI, V29, P273, DOI 10.1080/10408399009527528; National Toxicology Program, 2014, 13 REP CARC; NISBET ICT, 1992, REGUL TOXICOL PHARM, V16, P290, DOI 10.1016/0273-2300(92)90009-X; Orruno E, 2007, FOOD CHEM, V100, P926, DOI 10.1016/j.foodchem.2005.10.051; PEREZ G, 1986, CHEMOSPHERE, V15, P589, DOI 10.1016/0045-6535(86)90006-8; Rey-Salgueiro L, 2008, FOOD CHEM, V108, P607, DOI 10.1016/j.foodchem.2007.11.026; Camargo MCR, 2012, FOOD CHEM, V135, P937, DOI 10.1016/j.foodchem.2012.06.031; Saydut A, 2008, BIORESOURCE TECHNOL, V99, P6656, DOI 10.1016/j.biortech.2007.11.063; Sharma RK, 2006, J ANAL APPL PYROL, V75, P69, DOI 10.1016/j.jaap.2005.03.010; Shin BR, 2015, FOOD SCI BIOTECHNOL, V24, P2017, DOI 10.1007/s10068-015-0266-x; SLINKARD K, 1977, AM J ENOL VITICULT, V28, P49; Suja KP, 2005, FOOD CHEM, V91, P213, DOI 10.1016/j.foodchem.2003.09.001; Tan CP, 2002, FOOD CHEM, V76, P385, DOI 10.1016/S0308-8146(01)00272-2; Teixeira VH, 2007, FOOD CHEM, V104, P106, DOI 10.1016/j.foodchem.2006.11.007; Wu PF, 1998, MUTAT RES-FUND MOL M, V403, P29, DOI 10.1016/S0027-5107(98)00015-3; Yeo J, 2011, EUR J LIPID SCI TECH, V113, P910, DOI 10.1002/ejlt.201000553	48	3	3	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173585	10.1371/journal.pone.0173585	http://dx.doi.org/10.1371/journal.pone.0173585			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278179	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900014
J	Cardenas-Monroy, CA; Pohlmann, T; Pinon-Zarate, G; Matus-Ortega, G; Guerra, G; Feldbrugge, M; Pardo, JP				Cardenas-Monroy, Christian A.; Pohlmann, Thomas; Pinon-Zarate, Gabriela; Matus-Ortega, Genaro; Guerra, Guadalupe; Feldbruegge, Michael; Pardo, Juan Pablo			The mitochondrial alternative oxidase Aox1 is needed to cope with respiratory stress but dispensable for pathogenic development in Ustilago maydis	PLOS ONE			English	Article							CYANIDE-RESISTANT RESPIRATION; PLANT-MITOCHONDRIA; NEUROSPORA-CRASSA; OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; MAGNAPORTHE-GRISEA; ELECTRON-TRANSPORT; CANDIDA-ALBICANS; IMMUNOLOGICAL IDENTIFICATION; ASPERGILLUS-FUMIGATUS	The mitochondrial alternative oxidase is an important enzyme that allows respiratory activity and the functioning of the Krebs cycle upon disturbance of the respiration chain. It works as a security valve in transferring excessive electrons to oxygen, thereby preventing potential damage by the generation of harmful radicals. A clear biological function, besides the stress response, has so far convincingly only been shown for plants that use the alternative oxidase to generate heat to distribute volatiles. In fungi it was described that the alternative oxidase is needed for pathogenicity. Here, we investigate expression and function of the alternative oxidase at different stages of the life cycle of the corn pathogen Ustilago maydis (Aox1). Interestingly, expression of Aox1 is specifically induced during the stationary phase suggesting a role at high cell density when nutrients become limiting. Studying deletion strains as well as overexpressing strains revealed that Aox1 is dispensable for normal growth, for cell morphology, for response to temperature stress as well as for filamentous growth and plant pathogenicity. However, during conditions eliciting respiratory stress yeast-like growth as well as hyphal growth is strongly affected. We conclude that Aox1 is dispensable for the normal biology of the fungus but specifically needed to cope with respiratory stress.	[Cardenas-Monroy, Christian A.; Matus-Ortega, Genaro; Pardo, Juan Pablo] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City, DF, Mexico; [Pohlmann, Thomas; Feldbruegge, Michael] Heinrich Heine Univ Dusseldorf, Dept Biol, Cluster Excellence Plant Sci, Inst Microbiol, Dusseldorf, Germany; [Pinon-Zarate, Gabriela] Univ Nacl Autonoma Mexico, Fac Med, Dept Biol Celular & Tisular, Mexico City, DF, Mexico; [Guerra, Guadalupe] Inst Politecn Nacl, Dept Microbiol, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Heinrich Heine University Dusseldorf; Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico	Pardo, JP (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City, DF, Mexico.	pardov@bq.unam.mx	Piñon-Zarate, Gabriela/G-7645-2019; Feldbrügge, Michael/AAS-3939-2021	Piñon-Zarate, Gabriela/0000-0002-3080-9703; Feldbrügge, Michael/0000-0003-0046-983X; Matus, Genaro/0000-0002-4428-7299; Cardenas Monroy, Christian Adrian/0000-0002-3768-1618	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [PAPIIT IN209614]; Universidad Nacional Autonoma de Mexico (UNAM); Consejo Nacional de Ciencia y Tecnologia [CONACyT 254904]; CONACyT, Mexico [218133]; Secretaria de Investigacion y Posgrado [SIP 20150761]; Institute Politecnico Nacional (IPN); DFG/CONACyT [FOR1334]	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Investigacion y Posgrado; Institute Politecnico Nacional (IPN); DFG/CONACyT	Juan Pablo Pardo received a grant from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT IN209614), Universidad Nacional Autonoma de Mexico (UNAM) and Consejo Nacional de Ciencia y Tecnologia (CONACyT 254904). Christian A. Cardenas-Monroy received a doctoral fellowship grant from CONACyT, 218133, Mexico. Guadalupe Guerra received a grant from Secretaria de Investigacion y Posgrado (SIP 20150761), Institute Politecnico Nacional (IPN). Christian A. Cardenas-Monroy received a doctoral fellowship grant from CONACyT, Mexico. Research in the laboratory of M FeldbrUgge was supported by DFG/CONACyT FOR1334.	Affourtit C, 2002, FEBS LETT, V510, P121, DOI 10.1016/S0014-5793(01)03261-6; Akhter S, 2003, INFECT IMMUN, V71, P5794, DOI 10.1128/IAI.71.10.5794-5802.2003; Albury MS, 2009, PHYSIOL PLANTARUM, V137, P316, DOI 10.1111/j.1399-3054.2009.01270.x; Andronis EA, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00132; Avila-Adame C, 2003, PEST MANAG SCI, V59, P303, DOI 10.1002/ps.638; Avila-Adame C, 2002, MOL PLANT MICROBE IN, V15, P493, DOI 10.1094/MPMI.2002.15.5.493; Baumann S, 2014, EMBO REP, V15, P94, DOI 10.1002/embr.201338037; Biriukova E N, 2008, Mikrobiologiia, V77, P448; Brachmann A, 2001, MOL MICROBIOL, V42, P1047, DOI 10.1046/j.1365-2958.2001.02699.x; Brachmann A, 2004, MOL GENET GENOMICS, V272, P216, DOI 10.1007/s00438-004-1047-z; Brefort T, 2009, ANNU REV PHYTOPATHOL, V47, P423, DOI 10.1146/annurev-phyto-080508-081923; Cabrera-Orefice A, 2014, BIOCHIMIE, V102, P124, DOI 10.1016/j.biochi.2014.03.003; Capece A, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow015; Castro-Guerrero NA, 2004, J BIOENERG BIOMEMBR, V36, P459, DOI 10.1023/B:JOBB.0000047328.82733.ef; Chaudhuri M, 2005, PARASITOL RES, V96, P178, DOI 10.1007/s00436-005-1337-3; Chaudhuri M, 2006, TRENDS PARASITOL, V22, P484, DOI 10.1016/j.pt.2006.08.007; Clifton R, 2005, PLANT MOL BIOL, V58, P193, DOI 10.1007/s11103-005-5514-7; Costa JH, 2007, J PLANT PHYSIOL, V164, P718, DOI 10.1016/j.jplph.2006.04.001; Dahal K, 2016, NEW PHYTOL; DAY DA, 1994, PLANT PHYSIOL, V106, P1421, DOI 10.1104/pp.106.4.1421; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dejean L, 2000, BBA-BIOENERGETICS, V1457, P45, DOI 10.1016/S0005-2728(00)00053-0; Djamei A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002955; Dojcinovic D, 2005, PLANT MOL BIOL, V58, P159, DOI 10.1007/s11103-005-5390-1; EDWARDS DL, 1974, J BIOL CHEM, V249, P3551; ELTHON TE, 1989, PLANT PHYSIOL, V89, P1311, DOI 10.1104/pp.89.4.1311; Feldbrugge M, 2004, CURR OPIN MICROBIOL, V7, P666, DOI 10.1016/j.mib.2004.10.006; Fujita K, 2002, J APPL MICROBIOL, V92, P1035, DOI 10.1046/j.1365-2672.2002.01614.x; Fujita K, 2002, INT J FOOD MICROBIOL, V79, P193, DOI 10.1016/S0168-1605(02)00108-3; GEORGOPOULOS SG, 1970, J BACTERIOL, V103, P745, DOI 10.1128/JB.103.3.745-750.1970; Grahl N, 2012, MOL MICROBIOL, V84, P383, DOI 10.1111/j.1365-2958.2012.08034.x; Guerrero-Castillo S, 2012, BBA-BIOENERGETICS, V1817, P353, DOI 10.1016/j.bbabio.2011.11.007; Hans L., 1982, PHYSIOL PLANTARUM, V55, P478; Hernandez O, 2011, YEAST, V28, P771, DOI 10.1002/yea.1902; Ruiz OH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001353; Holliday R., 1974, HDB GENETICS, P575, DOI 10.1007/978-1-4899-1710-2_31; Honda Y, 2012, J BIOSCI BIOENG, V113, P338, DOI 10.1016/j.jbiosc.2011.10.026; Huh WK, 2001, BIOCHEM J, V356, P595, DOI 10.1042/0264-6021:3560595; Jarmuszkiewicz W, 1997, FEBS LETT, V411, P110, DOI 10.1016/S0014-5793(97)00676-5; Jarmuszkiewicz W, 2005, BBA-BIOENERGETICS, V1708, P71, DOI 10.1016/j.bbabio.2005.01.003; Johnson CH, 2003, YEAST, V20, P381, DOI 10.1002/yea.968; Joseph-Horne T, 2001, BBA-BIOENERGETICS, V1504, P179, DOI 10.1016/S0005-2728(00)00251-6; Juarez O, 2004, BBA-BIOENERGETICS, V1658, P244, DOI 10.1016/j.bbabio.2004.06.005; Juarez O, 2006, FEBS J, V273, P4603, DOI 10.1111/j.1742-4658.2006.05463.x; Kaffarnik F, 2003, EMBO J, V22, P5817, DOI 10.1093/emboj/cdg554; Kahmann R, 2004, NEW PHYTOL, V164, P31, DOI 10.1111/j.1469-8137.2004.01156.x; Kern A, 2007, MICROBIOL-SGM, V153, P1250, DOI 10.1099/mic.0.2006/001404-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBOWITZ AM, 1989, MOL CELL BIOL, V9, P1362, DOI 10.1128/MCB.9.3.1362; LAURIERE M, 1993, ANAL BIOCHEM, V212, P206, DOI 10.1006/abio.1993.1313; Leuthner B, 2005, MOL GENET GENOMICS, V272, P639, DOI 10.1007/s00438-004-1085-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magnani T, 2007, FEMS MICROBIOL LETT, V271, P230, DOI 10.1111/j.1574-6968.2007.00716.x; Martins VP, 2011, EUKARYOT CELL, V10, P237, DOI 10.1128/EC.00194-10; McDonald AE, 2009, J EXP BIOL, V212, P2627, DOI 10.1242/jeb.032151; MCINTOSH L, 1994, PLANT PHYSIOL, V105, P781, DOI 10.1104/pp.105.3.781; MICHEAHAMZEHPOUR M, 1987, EXPERIENTIA, V43, P439, DOI 10.1007/BF01940445; MILLAR AH, 1993, FEBS LETT, V329, P259, DOI 10.1016/0014-5793(93)80233-K; MINAGAWA N, 1992, FEBS LETT, V302, P217, DOI 10.1016/0014-5793(92)80444-L; MOORE AL, 1980, TRENDS BIOCHEM SCI, V5, P284, DOI 10.1016/0968-0004(80)90160-7; MOORE AL, 1992, BIOCHEM SOC T, V20, P361, DOI 10.1042/bst0200361; MOORE AL, 1991, BIOCHIM BIOPHYS ACTA, V1059, P121, DOI 10.1016/S0005-2728(05)80197-5; Moore AL, 2008, BIOCHEM SOC T, V36, P1022, DOI 10.1042/BST0361022; Moore AL, 2013, ANNU REV PLANT BIOL, V64, P637, DOI 10.1146/annurev-arplant-042811-105432; Nargang FE, 2012, G3-GENES GENOM GENET, V2, P1345, DOI 10.1534/g3.112.004218; Nihei C, 2002, BBA-MOL BASIS DIS, V1587, P234, DOI 10.1016/S0925-4439(02)00086-8; PENA A, 1969, BIOCHIM BIOPHYS ACTA, V180, P1, DOI 10.1016/0005-2728(69)90187-X; Pinon-Zarate G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/158980; Pohlmann T, 2015, ELIFE, V4, DOI 10.7554/eLife.06041; Rogov AG, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1615, DOI 10.1134/S0006297914130112; Ruy F, 2006, J BIOENERG BIOMEMBR, V38, P129, DOI 10.1007/s10863-006-9012-7; Saavedra E, 2008, FEMS YEAST RES, V8, P1313, DOI 10.1111/j.1567-1364.2008.00437.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schirawski J, 2010, SCIENCE, V330, P1546, DOI 10.1126/science.1195330; SHERALD JL, 1970, PLANT PHYSIOL, V46, P180, DOI 10.1104/pp.46.1.180; Shiba T, 2013, P NATL ACAD SCI USA, V110, P4580, DOI 10.1073/pnas.1218386110; Sierra-Campos E, 2009, MICROBIOL-SGM, V155, P604, DOI 10.1099/mic.0.020800-0; Sierra-Campos E, 2009, MITOCHONDRION, V9, P96, DOI 10.1016/j.mito.2009.01.003; Skirycz A, 2010, PLANT PHYSIOL, V152, P226, DOI 10.1104/pp.109.148965; Smith CA, 2009, PHYSIOL PLANTARUM, V137, P459, DOI 10.1111/j.1399-3054.2009.01305.x; Spellig T, 1996, MOL GEN GENET, V252, P503, DOI 10.1007/BF02172396; Terfruchte M, 2014, FUNGAL GENET BIOL, V62, P1, DOI 10.1016/j.fgb.2013.10.012; VANLERBERGHE GC, 1992, PLANT PHYSIOL, V100, P115, DOI 10.1104/pp.100.1.115; Veiga A, 2000, FEMS MICROBIOL LETT, V190, P93, DOI 10.1111/j.1574-6968.2000.tb09268.x; Veiga A, 2003, J APPL MICROBIOL, V95, P364, DOI 10.1046/j.1365-2672.2003.01992.x; Veiga A, 2003, FEMS YEAST RES, V3, P239, DOI 10.1016/S1567-1356(03)00036-9; Walker R, 2005, MOL BIOCHEM PARASIT, V139, P153, DOI 10.1016/j.molbiopara.2004.11.003; Wang J, 2011, PHYSIOL PLANTARUM, V142, P339, DOI 10.1111/j.1399-3054.2011.01471.x; Xiao M, 2010, Z NATURFORSCH C, V65, P463; Xu T, 2012, J MICROBIOL, V50, P594, DOI 10.1007/s12275-012-2015-7; Yan L, 2009, J ANTIMICROB CHEMOTH, V64, P764, DOI 10.1093/jac/dkp273; Yukioka H, 1998, BBA-GENE STRUCT EXPR, V1442, P161, DOI 10.1016/S0167-4781(98)00159-6; Zhou G., 2015, SHOCK VIB, V2015, P1, DOI DOI 10.1007/S11274-015-1877-3; Zhu Y, 2011, J INTEGR PLANT BIOL, V53, P7, DOI 10.1111/j.1744-7909.2010.01004.x	94	22	23	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173389	10.1371/journal.pone.0173389	http://dx.doi.org/10.1371/journal.pone.0173389			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273139	Green Submitted, Green Published, gold			2022-12-26	WOS:000396073700001
J	Eppler, FJ; Quast, T; Kolanus, W				Eppler, Felix J.; Quast, Thomas; Kolanus, Waldemar			Dynamin2 controls Rap1 activation and integrin clustering in human T lymphocyte adhesion	PLOS ONE			English	Article							CELL-MIGRATION; 2-DEPENDENT ENDOCYTOSIS; CR3-DEPENDENT ADHESION; IMMUNOLOGICAL SYNAPSE; RAP1-INDUCED ADHESION; ACTIN CYTOSKELETON; LEUKOCYTE ADHESION; EFFECTOR RIAM; SMALL GTPASE; RECEPTOR	Leukocyte trafficking is crucial to facilitate efficient immune responses. Here, we report that the large GTPase dynamin2, which is generally considered to have a key role in endocytosis and membrane remodeling, is an essential regulator of integrin-dependent human T lymphocyte adhesion and migration. Chemical inhibition or knockdown of dynamin2 expression significantly reduced integrin-dependent T cell adhesion in vitro. This phenotype was not observed when T cells were treated with various chemical inhibitors which abrogate endocytosis or actin polymerization. We furthermore detected dynamin2 in signaling complexes and propose that it controls T cell adhesion via FAK/Pyk2-and RapGEF1-mediated Rap1 activation. In addition, the dynamin2 inhibitor-induced reduction of lymphocyte adhesion can be rescued by Rap1a overexpression. We demonstrate that the dynamin2 effect on T cell adhesion does not involve integrin affinity regulation but instead relies on its ability to modulate integrin valency. Taken together, we suggest a previously unidentified role of dynamin2 in the regulation of integrin-mediated lymphocyte adhesion via a Rap1 signaling pathway.	[Eppler, Felix J.; Quast, Thomas; Kolanus, Waldemar] Univ Bonn, LIMES, Life & Med Sci Inst, Div Mol Immunol & Cell Biol, Bonn, Germany	University of Bonn	Kolanus, W (corresponding author), Univ Bonn, LIMES, Life & Med Sci Inst, Div Mol Immunol & Cell Biol, Bonn, Germany.	wkolanus@uni-bonn.de			DFG Collaborative Research Centers [SFB 645, SFB 704]	DFG Collaborative Research Centers	This work was funded by the DFG Collaborative Research Centers SFB 645 (to TQ and WK) and SFB 704 (to WK). FJE was a scholar of the NRW Graduate School LIMES Chemical Biology. WK is a member of the DFG Cluster of Excellence ImmunoSensation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon R, 2012, CURR OPIN CELL BIOL, V24, P670, DOI 10.1016/j.ceb.2012.06.001; ANDREW D, 1993, EUR J IMMUNOL, V23, P2217, DOI 10.1002/eji.1830230925; Arnaout M Amin, 2016, F1000Res, V5; Bazzoni G, 1998, TRENDS BIOCHEM SCI, V23, P30, DOI 10.1016/S0968-0004(97)01141-9; Beals CR, 2001, J IMMUNOL, V167, P6113, DOI 10.4049/jimmunol.167.11.6113; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bruzzaniti A, 2005, MOL BIOL CELL, V16, P3301, DOI 10.1091/mbc.e04-12-1117; Bruzzaniti A, 2009, MOL CELL BIOL, V29, P3644, DOI 10.1128/MCB.00851-08; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Carmona G, 2009, BLOOD, V113, P488, DOI 10.1182/blood-2008-02-138438; Chapman NM, 2014, IMMUNOL RES, V59, P23, DOI 10.1007/s12026-014-8527-y; Chu H, 2008, J IMMUNOL, V181, P3373, DOI 10.4049/jimmunol.181.5.3373; Chung KJ, 2014, MOL BIOL CELL, V25, P2948, DOI 10.1091/mbc.E14-04-0867; de Bruyn KMT, 2002, J BIOL CHEM, V277, P29468, DOI 10.1074/jbc.M204990200; Destaing O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077956; DRANSFIELD I, 1992, J CELL BIOL, V116, P1527, DOI 10.1083/jcb.116.6.1527; Duchniewicz M, 2006, MOL CELL BIOL, V26, P643, DOI 10.1128/MCB.26.2.643-653.2006; Durand CA, 2006, EUR J IMMUNOL, V36, P2235, DOI 10.1002/eji.200535004; Ebisuno Y, 2010, BLOOD, V115, P804, DOI 10.1182/blood-2009-03-211979; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Gahmberg CG, 2009, BBA-GEN SUBJECTS, V1790, P431, DOI 10.1016/j.bbagen.2009.03.007; Ginsberg MH, 2014, BMB REP, V47, P655, DOI 10.5483/BMBRep.2014.47.12.241; Glodek AM, 2007, LEUKEMIA, V21, P1723, DOI 10.1038/sj.leu.2404769; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Ichiba T, 1997, J BIOL CHEM, V272, P22215, DOI 10.1074/jbc.272.35.22215; Ichiba T, 1999, J BIOL CHEM, V274, P14376, DOI 10.1074/jbc.274.20.14376; Iwamoto DV, 2015, CURR OPIN CELL BIOL, V36, P41, DOI 10.1016/j.ceb.2015.06.009; Jacobelli J, 2009, J IMMUNOL, V182, P2041, DOI 10.4049/jimmunol.0803267; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2004, J BIOL CHEM, V279, P11875, DOI 10.1074/jbc.M310717200; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinashi T, 2005, IMMUNOLOGY, V116, P164, DOI 10.1111/j.1365-2567.2005.02214.x; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Klapproth S, 2015, BLOOD, V126, P2704, DOI 10.1182/blood-2015-05-647453; Kliche S, 2012, BLOOD, V119, P777, DOI 10.1182/blood-2011-06-362269; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lagarrigue F, 2016, BLOOD, V128, P479, DOI 10.1182/blood-2015-12-638700; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Lee MY, 2014, DEVELOPMENT, V141, P1465, DOI 10.1242/dev.104539; Lefort CT, 2012, BLOOD, V119, P4275, DOI 10.1182/blood-2011-08-373118; Lek HS, 2013, J BIOL CHEM, V288, P14698, DOI 10.1074/jbc.M112.430918; Ley K, 2016, NAT REV DRUG DISCOV, V15, P173, DOI 10.1038/nrd.2015.10; Li Y, 2007, CHANNELS, V1; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Nolz JC, 2008, J CELL BIOL, V182, P1231, DOI 10.1083/jcb.200801121; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Quast T, 2011, BLOOD, V118, P1818, DOI 10.1182/blood-2010-12-326595; Raab M, 2010, IMMUNITY, V32, P541, DOI 10.1016/j.immuni.2010.03.007; Radha V, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-31; Razidlo GL, 2013, DEV CELL, V24, P573, DOI 10.1016/j.devcel.2013.02.010; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Robertson MJ, 2014, NAT PROTOC, V9, P851, DOI 10.1038/nprot.2014.046; ROBINSON MK, 1992, J IMMUNOL, V148, P1080; Rognoni E, 2016, J CELL SCI, V129, P17, DOI 10.1242/jcs.161190; Rufanova VA, 2009, J CELL PHYSIOL, V219, P45, DOI 10.1002/jcp.21649; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Stritt S, 2015, BLOOD, V125, P219, DOI 10.1182/blood-2014-08-597542; Su WJ, 2015, BLOOD, V126, P2695, DOI 10.1182/blood-2015-05-644104; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tanaka M, 2016, INT J RHEUMATOL, V2016, DOI 10.1155/2016/8938916; te Boekhorst V, 2016, ANNU REV CELL DEV BI, V32, P491, DOI 10.1146/annurev-cellbio-111315-125201; Thompson HM, 2002, CURR BIOL, V12, P2111, DOI 10.1016/S0960-9822(02)01390-8; Tohyama Y, 2003, MOL BIOL CELL, V14, P2570, DOI 10.1091/mbc.E02-09-0615; Van Kolen K, 2006, CELL SIGNAL, V18, P1169, DOI 10.1016/j.cellsig.2005.09.005; Wang Y, 2011, MOL BIOL CELL, V22, P1529, DOI 10.1091/mbc.E10-09-0785; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Willinger T, 2015, P NATL ACAD SCI USA, V112, P4423, DOI 10.1073/pnas.1504279112; Willinger T, 2014, J EXP MED, V211, P685, DOI 10.1084/jem.20131343; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037	88	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172443	10.1371/journal.pone.0172443	http://dx.doi.org/10.1371/journal.pone.0172443			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273099	gold, Green Published, Green Submitted			2022-12-26	WOS:000396073700074
J	Makau, JN; Watanabe, K; Ishikawa, T; Mizuta, S; Hamada, T; Kobayashi, N; Nishida, N				Makau, Juliann Nzembi; Watanabe, Ken; Ishikawa, Takeshi; Mizuta, Satoshi; Hamada, Tsuyoshi; Kobayashi, Nobuyuki; Nishida, Noriyuki			Identification of small molecule inhibitors for influenza a virus using in silico and in vitro approaches	PLOS ONE			English	Article							STRUCTURE-BASED DISCOVERY; H1N1 2009 VIRUS; DRUG DISCOVERY; NEURAMINIDASE INHIBITORS; SEQUENCE CONSERVATION; ANTIINFLUENZA VIRUS; MUTATIONAL ANALYSIS; H5N1 NUCLEOPROTEIN; STRUCTURAL BASIS; AMINO-ACIDS	Influenza viruses have acquired resistance to approved neuraminidase-targeting drugs, increasing the need for new drug targets for the development of novel anti-influenza drugs. Nucleoprotein (NP) is an attractive target since it has an indispensable role in virus replication and its amino acid sequence is well conserved. In this study, we aimed to identify new inhibitors of the NP using a structure-based drug discovery algorithm, named Nagasaki University Docking Engine (NUDE), which has been established especially for the Destination for GPU Intensive Machine (DEGIMA) supercomputer. The hit compounds that showed high binding scores during in silico screening were subsequently evaluated for anti-influenza virus effects using a cell-based assay. A 4-hydroxyquinolinone compound, designated as NUD-1, was found to inhibit the replication of influenza virus in cultured cells. Analysis of binding between NUD-1 and NP using surface plasmon resonance assay and fragment molecular orbital calculations confirmed that NUD-1 binds to NP and could interfere with NP-NP interactions essential for virus replication. Time-of-addition experiments showed that the compound inhibited the mid-stage of infection, corresponding to assembly of the NP and other viral proteins. Moreover, NUD-1 was also effective against various types of influenza A viruses including a clinical isolate of A(H1N1)pdm09 influenza with a 50% inhibitory concentration range of 1.8-2.1 mu M. Our data demonstrate that the combined use of NUDE system followed by the cell-based assay is useful to obtain lead compounds for the development of novel anti-influenza drugs.	[Makau, Juliann Nzembi; Watanabe, Ken; Ishikawa, Takeshi; Mizuta, Satoshi; Kobayashi, Nobuyuki; Nishida, Noriyuki] Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki, Japan; [Makau, Juliann Nzembi] Nagasaki Univ, Leading Program, Grad Sch Biomed Sci, Nagasaki, Japan; [Hamada, Tsuyoshi] Nagasaki Univ, Nagasaki Adv Comp Ctr, Bunkyo Machi, Nagasaki, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Watanabe, K (corresponding author), Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki, Japan.	kenw@nagasaki-u.ac.jp	Ishikawa, Takeshi/AAH-5802-2019	Mizuta, Satoshi/0000-0002-9023-7671; WATANABE, Ken/0000-0002-2592-3472; Ishikawa, Takeshi/0000-0002-3187-1381	Takeda Science Foundation; JSPS Next Generation World-Leading Researchers (NEXT Program) [GR082]; JSPS KAKENHI [25460125, 16K00853]; Nagasaki University Leading Program for Nurturing Global Leaders in Tropical and Emerging Communicable Diseases - Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [16K00853] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); JSPS Next Generation World-Leading Researchers (NEXT Program); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nagasaki University Leading Program for Nurturing Global Leaders in Tropical and Emerging Communicable Diseases - Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Takeda Science Foundation (NN), a grant from JSPS Next Generation World-Leading Researchers (NEXT Program), Grant Number GR082 (TH), and a grant from JSPS KAKENHI, Grant Numbers 25460125 and 16K00853 (KW). JNM was supported by the Nagasaki University Leading Program for Nurturing Global Leaders in Tropical and Emerging Communicable Diseases, funded by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, analysis, the decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; Armstrong AJ, 2013, CLIN CANCER RES, V19, P6891, DOI 10.1158/1078-0432.CCR-13-1581; Avilov S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149986; Babar MM, 2015, INFECT GENET EVOL, V34, P200, DOI 10.1016/j.meegid.2015.06.030; Bengtsson AA, 2012, ARTHRITIS RHEUM-US, V64, P1579, DOI 10.1002/art.33493; Butler J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004065; Chan WH, 2010, J VIROL, V84, P7337, DOI 10.1128/JVI.02474-09; Charyasriwong S, 2016, DRUG DISCOV THER, V10, P201, DOI 10.5582/ddt.2016.01045; Charyasriwong S, 2015, ARCH MED RES, V46, P8, DOI 10.1016/j.arcmed.2014.12.002; Cheng HM, 2012, J MED CHEM, V55, P2144, DOI 10.1021/jm2013503; Cohen NC, 2007, CHEM BIOL DRUG DES, V70, P557, DOI 10.1111/j.1747-0285.2007.00599.x; Collins PJ, 2009, VACCINE, V27, P6317, DOI 10.1016/j.vaccine.2009.07.017; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Fukuoka M, 2012, BBA-GEN SUBJECTS, V1820, P90, DOI 10.1016/j.bbagen.2011.11.003; Garcia J, 2009, INFLUENZA OTHER RESP, V3, P69, DOI 10.1111/j.1750-2659.2009.00072.x; Gerritz SW, 2011, P NATL ACAD SCI USA, V108, P15366, DOI 10.1073/pnas.1107906108; Gibbs N, 2001, PROTEINS, V43, P186, DOI 10.1002/1097-0134(20010501)43:2<186::AID-PROT1030>3.0.CO;2-L; Hagiwara K, 2010, BIOCHEM BIOPH RES CO, V394, P721, DOI 10.1016/j.bbrc.2010.03.058; Haruyama T, 2013, J NAT MED-TOKYO, V67, P636, DOI 10.1007/s11418-012-0725-0; HATADA E, 1989, J BIOCHEM-TOKYO, V105, P537, DOI 10.1093/oxfordjournals.jbchem.a122702; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hurt AC, 2011, NEW ENGL J MED, V365, P2541, DOI 10.1056/NEJMc1111078; Hurt AC, 2009, J VIROL, V83, P10366, DOI 10.1128/JVI.01200-09; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Inoue M, 2010, EMERG INFECT DIS, V16, P1633, DOI 10.3201/eid1610.100688; Ishibashi D, 2016, EBIOMEDICINE, V9, P238, DOI 10.1016/j.ebiom.2016.06.010; Ishii K, 2008, DRUG DISCOV THER, V2, P24; Ishikawa T, 2009, CHEM PHYS LETT, V474, P195, DOI 10.1016/j.cplett.2009.04.045; Ishikawa T, 2009, J COMPUT CHEM, V30, P2594, DOI 10.1002/jcc.21265; Kakisaka M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005062; Kaldor SW, 1997, J MED CHEM, V40, P3979, DOI 10.1021/jm9704098; Kao RY, 2010, NAT BIOTECHNOL, V28, P600, DOI 10.1038/nbt.1638; Kawakami E, 2011, J VIROL METHODS, V173, P1, DOI 10.1016/j.jviromet.2010.12.014; Kitaura K, 1999, CHEM PHYS LETT, V312, P319, DOI 10.1016/S0009-2614(99)00937-9; Kukol A, 2014, VIROLOGY, V454, P40, DOI 10.1016/j.virol.2014.01.023; Labaronne A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090247; Lackenby A, 2008, Euro Surveill, V13; Lejal N, 2013, ANTIMICROB AGENTS CH, V57, P2231, DOI 10.1128/AAC.02335-12; Li Z, 2009, J VIROL, V83, P4153, DOI 10.1128/JVI.02642-08; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Makau JN, 2013, DRUG DISCOV THER, V7, P189, DOI 10.5582/ddt.2013.v7.5.189; Marella A, 2013, SAUDI PHARM J, V21, P1, DOI 10.1016/j.jsps.2012.03.002; McCauley J, 1999, CURR BIOL, V9, pR796, DOI 10.1016/S0960-9822(99)80491-6; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Mena I, 1999, J VIROL, V73, P1186, DOI 10.1128/JVI.73.2.1186-1194.1999; Mondal A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004826; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Ng AKL, 2012, J VIROL, V86, P6758, DOI 10.1128/JVI.00073-12; Njoroge FG, 2008, ACCOUNTS CHEM RES, V41, P50, DOI 10.1021/ar700109k; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Polman C, 2005, NEUROLOGY, V64, P987, DOI 10.1212/01.WNL.0000154520.48391.69; REED L. J., 1938, AMER JOUR HYG, V27, P493; Robb NC, 2009, J GEN VIROL, V90, P1398, DOI 10.1099/vir.0.009639-0; Saito R, 2003, J CLIN MICROBIOL, V41, P2164, DOI 10.1128/JCM.41.5.2164-2165.2003; Seibert CW, 2010, J VIROL, V84, P11219, DOI 10.1128/JVI.01424-10; Shen YF, 2011, P NATL ACAD SCI USA, V108, P16515, DOI 10.1073/pnas.1113107108; Storms AD, 2012, EMERG INFECT DIS, V18, P308, DOI 10.3201/eid1802.111466; Sugaya N, 2007, CLIN INFECT DIS, V44, P197, DOI 10.1086/509925; Takashita E, 2015, ANTIMICROB AGENTS CH, V59, P2607, DOI 10.1128/AAC.04836-14; Takashita E, 2015, ANTIVIR RES, V117, P27, DOI 10.1016/j.antiviral.2015.02.003; Takizawa N, 2006, MICROBES INFECT, V8, P823, DOI 10.1016/j.micinf.2005.10.005; Talele TT, 2010, CURR TOP MED CHEM, V10, P127, DOI 10.2174/156802610790232251; TARKOWSKI A, 1986, ARTHRITIS RHEUM, V29, P1405, DOI 10.1002/art.1780291115; van Montfort RLM, 2009, TRENDS BIOTECHNOL, V27, P315, DOI 10.1016/j.tibtech.2009.02.003; VUKANOVIC J, 1993, CANCER RES, V53, P1833; WANG CC, 1976, BIOCHEM PHARMACOL, V25, P343, DOI 10.1016/0006-2952(76)90225-2; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Watanabe K, 2014, ARCH MED RES, V45, P359, DOI 10.1016/j.arcmed.2014.05.006; Wlodawer A, 1998, ANNU REV BIOPH BIOM, V27, P249, DOI 10.1146/annurev.biophys.27.1.249; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379	72	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173582	10.1371/journal.pone.0173582	http://dx.doi.org/10.1371/journal.pone.0173582			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273150	Green Published, Green Submitted, gold			2022-12-26	WOS:000396073700018
J	Bartsch, MR; Bartsch, LA; Richardson, WB; Vallazza, JM; Lafrancois, BM				Bartsch, Michelle R.; Bartsch, Lynn A.; Richardson, William B.; Vallazza, Jon M.; Lafrancois, Brenda Moraska			Effects of food resources on the fatty acid composition, growth and survival of freshwater mussels	PLOS ONE			English	Article							ST-CROIX RIVER; BIOCHEMICAL TRACERS; VILLOSA-IRIS; UNIONIDAE; SEDIMENT; PHYTOPLANKTON; BIVALVES; DIETS; WEB; USA	Increased nutrient and sediment loading in rivers have caused observable changes in algal community composition, and thereby, altered the quality and quantity of food resources available to native freshwater mussels. Our objective was to characterize the relationship between nutrient conditions and mussel food quality and examine the effects on fatty acid composition, growth and survival of juvenile mussels. Juvenile Lampsilis cardium and L. siliquoidea were deployed in cages for 28 d at four riverine and four lacustrine sites in the lower St. Croix River, Minnesota/Wisconsin, USA. Mussel foot tissue and food resources (four seston fractions and surficial sediment) were analyzed for quantitative fatty acid (FA) composition. Green algae were abundant in riverine sites, whereas cyanobacteria were most abundant in the lacustrine sites. Mussel survival was high (95%) for both species. Lampsilis cardium exhibited lower growth relative to L. siliquoidea (p < 0.0001), but growth of L. cardium was not significantly different across sites (p = 0.13). In contrast, growth of L. siliquoidea was significantly greater at the most upstream riverine site compared to the lower three lacustrine sites (p = 0.002). In situ growth of Lampsilis siliquoidea was positively related to volatile solids (10 - 32 mu m fraction), total phosphorus (<10 and 10 - 32 mu m fractions), and select FA in the seston (docosapentaeonic acid, DPA, 22:5n3; 4,7,10,13,16-docosapentaenoic, 22:5n6; arachidonic acid, ARA, 20: 4n6; and 24: 0 in the <10 and 10 - 32 mu m fractions). Our laboratory feeding experiment also indicated high accumulation ratios for 22:5n3, 22:5n6, and 20:4n6 in mussel tissue relative to supplied algal diet. In contrast, growth of L. siliquiodea was negatively related to nearly all FAs in the largest size fraction (i.e., >63 mu m) of seston, including the bacterial FAs, and several of the FAs associated with sediments. Reduced mussel growth was observed in L. siliquoidea when the abundance of cyanobacteria exceeded 9% of the total phytoplankton biovolume. Areas dominated by cyanobacteria may not provide sufficient food quality to promote or sustain mussel growth.	[Bartsch, Michelle R.; Bartsch, Lynn A.; Richardson, William B.; Vallazza, Jon M.] US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI 54601 USA; [Lafrancois, Brenda Moraska] Natl Pk Serv, Ashland, WI USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior	Bartsch, MR (corresponding author), US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI 54601 USA.	mbartsch@usgs.gov		Bartsch, Michelle/0000-0002-9571-5564; Bartsch, Lynn/0000-0002-1483-4845	US National Park Service through Park-Oriented Biological Support (POBS); USGS SIR Cyclical Funds, Basis+ [3210BG4, 47]	US National Park Service through Park-Oriented Biological Support (POBS); USGS SIR Cyclical Funds, Basis+	This research was supported in part by the US National Park Service, through Park-Oriented Biological Support (POBS), USGS SIR Cyclical Funds, Basis+ number 3210BG4, Task 47.	Acker F, 2002, ANAL USGS NAWQA PROG, P87; American Public Health Association A. W. W. A. Water Environment Federation APHA AWWA and WEF, 1998, STANDARD METHODS EXA; Arts MT, 2001, CAN J FISH AQUAT SCI, V58, P122, DOI 10.1139/cjfas-58-1-122; Basen T, 2011, J N AM BENTHOL SOC, V30, P653, DOI 10.1899/10-087.1; Beck K, 2003, N AM J AQUACULT, V65, P203, DOI 10.1577/C02-031; Berntsson KM, 1997, AQUACULTURE, V154, P139, DOI 10.1016/S0044-8486(97)00041-0; Bohm M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094759; Bontes BM, 2007, HYDROBIOLOGIA, V584, P191, DOI 10.1007/s10750-007-0580-2; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; Budge SM, 2001, MAR CHEM, V76, P285, DOI 10.1016/S0304-4203(01)00068-8; Carmichael WW, 2001, HUM ECOL RISK ASSESS, V7, P1393, DOI 10.1080/20018091095087; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Christian AD, 2004, J N AM BENTHOL SOC, V23, P101, DOI 10.1899/0887-3593(2004)023<0101:TPAPFS>2.0.CO;2; Dillard G. E., 2007, BIBL PHYCOL, V112, P127; Duff JH, 1998, LIMNOL OCEANOGR, V43, P1378, DOI 10.4319/lo.1998.43.6.1378; Dzialowski AR, 2011, LAKE RESERV MANAGE, V27, P6, DOI 10.1080/07438141.2011.551027; Edlund MB, 2009, J PALEOLIMNOL, V41, P641, DOI 10.1007/s10933-008-9296-1; EMERSON K, 1975, J FISH RES BOARD CAN, V32, P2379, DOI 10.1139/f75-274; Eriksson L., 2006, MULTI MEGAVARIATE DA, V2nd, DOI DOI 10.1016/j.arabjc.2013.10.006; Etti H, 1999, SUSSWASSERFLORA MITT, V2/4; Gatenby CM, 1996, J N AM BENTHOL SOC, V15, P597, DOI 10.2307/1467810; Gatenby CM, 1997, AM MALACOL BULL, V14, P57; HAGAR AF, 1986, PHYSIOL ZOOL, V59, P419, DOI 10.1086/physzool.59.4.30158595; Hanson CE, 2010, AQUAT BOT, V93, P114, DOI 10.1016/j.aquabot.2010.04.004; Heathcote AJ, 2016, INLAND WATERS, V6, P250, DOI 10.5268/IW-6.2.941; Hebert CE, 2009, OECOLOGIA, V160, P15, DOI 10.1007/s00442-009-1285-1; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hornbach DJ, 2010, AQUAT CONSERV, V20, P250, DOI 10.1002/aqc.1081; Huisman J, 2004, ECOLOGY, V85, P2960, DOI 10.1890/03-0763; Knauer J, 1997, AQUACULTURE, V154, P293, DOI 10.1016/S0044-8486(97)00056-2; Komarek J., 2005, SUSSWASSERFLORA MITT; Komarek J, 1998, SUSSWASSERFLORA MITT; Krammer K., 1991, SUBETAWASSERFLORA MI, P576; Krammer K., 1986, SUSSWASSERFLORA MITT, V2/1, P1; Krammer K., 1988, SUSSWASSERFLORA MITT, V2, P596; KRYGER J, 1988, OECOLOGIA, V77, P34, DOI 10.1007/BF00380921; Lafrancois BM, 2009, J PALEOLIMNOL, V41, P603, DOI 10.1007/s10933-008-9294-3; Larson JH, 2016, ECOL APPL, V26, P873, DOI 10.1890/15-0440; Little RC, 1996, SAS SYSTEM MIXED MOD; Magdalene S, 2013, LAKE ST CROIX NUTR L; McGoldrick DJ, 2009, J GREAT LAKES RES, V35, P137, DOI 10.1016/j.jglr.2008.11.007; Newton TJ, 2013, J SHELLFISH RES, V32, P497, DOI 10.2983/035.032.0229; Nichols SJ, 2000, CAN J ZOOL, V78, P871, DOI 10.1139/cjz-78-5-871; Nichols SJ, 2005, J GREAT LAKES RES, V31, P87, DOI 10.1016/S0380-1330(05)70240-9; Oliver R. L., 2000, ECOLOGY CYANOBACTERI, P149, DOI [10.1007/0-306-46855-7_6, DOI 10.1007/0-306-46855-7_6]; OSTROVSKY I, 1993, HYDROBIOLOGIA, V271, P49, DOI 10.1007/BF00005695; Patrick R, 1966, DIATOMS UNITED STATE, VI; Patrick R, 1975, DIATOMS UNITED STATE, VII; Prepas EE, 1997, CAN J FISH AQUAT SCI, V54, P41, DOI 10.1139/cjfas-54-1-41; Raikow DF, 2001, LIMNOL OCEANOGR, V46, P514, DOI 10.4319/lo.2001.46.3.0514; Scott JT, 2009, HYDROBIOLOGIA, V625, P61, DOI 10.1007/s10750-008-9696-2; STOKES M, 1995, CATEGORICAL DATA ANA; Strandberg U, 2014, LIPIDS, V49, P591, DOI 10.1007/s11745-014-3902-y; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; Torres-Ruiz M, 2007, J N AM BENTHOL SOC, V26, P509, DOI 10.1899/06-070.1; Triplett LD, 2009, J PALEOLIMNOL, V41, P659, DOI 10.1007/s10933-008-9290-7; VANDERPLOEG HA, 1995, CAN J FISH AQUAT SCI, V52, P63, DOI 10.1139/f95-006; von Utermohl H, 1931, VERH INT VEREIN THEO, V5, P567; Wehr J. D., 2003, FRESHWATER ALGAE N A; WOLD S, 1994, CHEMOMETR INTELL LAB, V23, P149, DOI 10.1016/0169-7439(93)E0075-F; Zhukova NV, 1998, COMP BIOCHEM PHYS B, V120, P499, DOI 10.1016/S0305-0491(98)10036-6	61	16	16	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173419	10.1371/journal.pone.0173419	http://dx.doi.org/10.1371/journal.pone.0173419			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267810	Green Submitted, gold, Green Published			2022-12-26	WOS:000396060600030
J	Chan, YM; Lee, P; Jungles, S; Morris, G; Cadaoas, J; Skrinar, A; Vellard, M; Kakkis, E				Chan, Yiumo Michael; Lee, Paul; Jungles, Steve; Morris, Gabrielle; Cadaoas, Jaclyn; Skrinar, Alison; Vellard, Michel; Kakkis, Emil			Substantial deficiency of free sialic acid in muscles of patients with GNE myopathy and in a mouse model	PLOS ONE			English	Article							INCLUSION-BODY MYOPATHY; ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE; RIMMED VACUOLES; DISTAL MYOPATHY; SKELETAL-MUSCLE; N-ACETYLMANNOSAMINE; BIFUNCTIONAL ENZYME; ALPHA-DYSTROGLYCAN; KEY ENZYME; MUTATION	GNE myopathy (GNEM), also known as hereditary inclusion body myopathy (HIBM), is a late- onset, progressive myopathy caused by mutations in the GNE gene encoding the enzyme responsible for the first regulated step in the biosynthesis of sialic acid (SA). The disease is characterized by distal muscle weakness in both the lower and upper extremities, with the quadriceps muscle relatively spared until the late stages of disease. To explore the role of SA synthesis in the disease, we conducted a comprehensive and systematic analysis of both free and total SA levels in a large cohort of GNEM patients and a mouse model. A sensitive LC/MS/MS assay was developed to quantify SA in serum and muscle homogenates. Mean serum free SA level was 0.166 pg/mL in patients and 18% lower (p<0.001) than that of age -matched control samples (0.203 pg/mL). In biopsies obtained from patients, mean free SA levels of different muscles ranged from 0.046-0.075 pg/pmol Cr and were markedly lower by 72-85% (p<0.001) than free SA from normal controls. Free SA was shown to constitute a small fraction (3-7%) of the total SA pool in muscle tissue. Differences in mean total SA levels in muscle from patients compared with normal controls were less distinct and more variable between different muscles, suggesting a small subset of sialylation targets could be responsible for the pathogenesis of GNEM. Normal quadriceps had significantly lower levels of free SA (reduced by 39%) and total SA (reduced by 53%) compared to normal gastrocnemius. A lower SA requirement for quadriceps may be linked to the reported quadriceps sparing in GNEM. Analysis of SA levels in GneM74377A4743T mutant mice corroborated the human study results. These results show that serum and muscle free SA is severely reduced in GNEM, which is consistent with the biochemical defect in SA synthesis associated with GNE mutations. These results therefore support the approach of reversing SA depletion as a potential treatment for GNEM patients.	[Chan, Yiumo Michael; Lee, Paul; Jungles, Steve; Morris, Gabrielle; Cadaoas, Jaclyn; Skrinar, Alison; Vellard, Michel; Kakkis, Emil] Ultragenyx Pharmaceut Inc, Novato, CA 94949 USA		Chan, YM (corresponding author), Ultragenyx Pharmaceut Inc, Novato, CA 94949 USA.	ychan@ultragenyx.com			Ultragenyx	Ultragenyx	The study described in the manuscript was funded by Ultragenyx. In additional to providing support in the form of salaries for authors YMC, PL, SJ, GM, JC, AS, MV, EK, Ultragenyx designed the clinical study and commissioned the SA analysis by Intertek. The investigators conducted the study and collected the biopsies and sent them to the Intertek lab for clinical specimens. For mouse model this work was done internally at Ultragenyx and samples sent to Intertek.	Amsili S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002477; [Anonymous], 2006, BOILER MANUF, DOI [DOI 10.2200/S00010ED1V01Y200508IVM003, DOI 10.1074/JBC.M604903200]; Argov Z, 2003, NEUROLOGY, V60, P1519, DOI 10.1212/01.WNL.0000061617.71839.42; ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4; Broccolini A, 2005, NEUROMUSCULAR DISORD, V15, P177, DOI 10.1016/j.nmd.2004.10.001; Broccolini A, 2010, NEUROLOGY, V75, P265, DOI 10.1212/WNL.0b013e3181e8e8f1; Broccolini A, 2008, J NEUROCHEM, V105, P971, DOI 10.1111/j.1471-4159.2007.05208.x; Broccolini A, 2015, BBA-MOL BASIS DIS, V1852, P644, DOI 10.1016/j.bbadis.2014.08.007; Broccolini A, 2009, MUSCLE NERVE, V40, P340, DOI 10.1002/mus.21385; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Eisenberg I, 2001, EUR J HUM GENET, V9, P501, DOI 10.1038/sj.ejhg.5200665; Eisenberg I, 2008, HUM MOL GENET, V17, P3663, DOI 10.1093/hmg/ddn261; Eisenberg Iris, 2003, Hum Mutat, V21, P99, DOI 10.1002/humu.9100; Gagiannis D, 2007, GLYCOCONJUGATE J, V24, P125, DOI 10.1007/s10719-006-9019-7; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; Harazi A., 2016, MOL NEUROBIOL; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; Hinderlich S, 2004, FEBS LETT, V566, P105, DOI 10.1016/j.febslet.2004.04.013; Huizing M, 2004, MOL GENET METAB, V81, P196, DOI 10.1016/j.ymgme.2003.11.012; Huizing M, 2014, NEUROMUSCULAR DISORD, V24, P387, DOI 10.1016/j.nmd.2014.03.004; Huizing M, 2009, BBA-MOL BASIS DIS, V1792, P881, DOI 10.1016/j.bbadis.2009.07.001; Leoyklang P, 2014, BIOMARK MED, V8, P641, DOI [10.2217/BMM.14.2, 10.2217/bmm.14.2]; Lucka L, 1999, FEBS LETT, V454, P341, DOI 10.1016/S0014-5793(99)00837-6; Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220; Malicdan MCV, 2012, J BIOL CHEM, V287, P2689, DOI 10.1074/jbc.M111.297051; Malicdan MCV, 2009, NAT MED, V15, P690, DOI 10.1038/nm.1956; Marini M, 2014, ACTA HISTOCHEM, V116, P926, DOI 10.1016/j.acthis.2014.03.005; MitraniRosenbaum S, 1996, HUM MOL GENET, V5, P159, DOI 10.1093/hmg/5.1.159; Niethamer TK, 2012, MOL GENET METAB, V107, P748, DOI 10.1016/j.ymgme.2012.10.011; Nishino I, 2002, NEUROLOGY, V59, P1689, DOI 10.1212/01.WNL.0000041631.28557.C6; Nishino I, 2015, J NEUROL NEUROSUR PS, V86, P385, DOI 10.1136/jnnp-2013-307051; Noguchi S, 2004, J BIOL CHEM, V279, P11402, DOI 10.1074/jbc.M313171200; Reinke SO, 2009, BIOL CHEM, V390, P591, DOI 10.1515/BC.2009.073; Ricci E, 2006, NEUROLOGY, V66, P755, DOI 10.1212/01.wnl.0000200956.76449.3f; Saito F, 2004, NEUROMUSCULAR DISORD, V14, P158, DOI 10.1016/j.nmd.2003.09.006; Salama I, 2005, BIOCHEM BIOPH RES CO, V328, P221, DOI 10.1016/j.bbrc.2004.12.157; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Sela I, 2013, NEUROMOL MED, V15, P180, DOI 10.1007/s12017-012-8209-7; Seppala R, 1999, AM J HUM GENET, V64, P1563, DOI 10.1086/302411; Tarnopolsky MA, 1999, MUSCLE NERVE, V22, P1228, DOI 10.1002/(SICI)1097-4598(199909)22:9<1228::AID-MUS9>3.0.CO;2-6; TESCH PA, 1985, EUR J APPL PHYSIOL O, V54, P237, DOI 10.1007/BF00426139; van der Ham M, 2007, J CHROMATOGR B, V848, P251, DOI 10.1016/j.jchromb.2006.10.066; Voermans NC, 2010, CLIN NEUROPATHOL, V29, P71; Yonekawa T, 2014, BRAIN, V137, P2670, DOI 10.1093/brain/awu210	45	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173261	10.1371/journal.pone.0173261	http://dx.doi.org/10.1371/journal.pone.0173261			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267778	Green Submitted, gold, Green Published			2022-12-26	WOS:000396060600017
J	Fokkens, BT; Mulder, DJ; Schalkwijk, CG; Scheijen, JL; Smit, AJ; Los, LI				Fokkens, Bernardina T.; Mulder, Douwe J.; Schalkwijk, Casper G.; Scheijen, Jean L.; Smit, Andries J.; Los, Leonoor I.			Vitreous advanced glycation endproducts and alpha-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls	PLOS ONE			English	Article							END-PRODUCTS; SKIN AUTOFLUORESCENCE; PROLIFERATIVE VITREORETINOPATHY; AQUEOUS FLARE; PENTOSIDINE; PLASMA; METHYLGLYOXAL; DISEASE; 3-DEOXYGLUCOSONE; IDENTIFICATION	Purpose Advanced glycation endproducts (AGEs) and their precursors alpha-dicarbonyls are implicated in the progression of diabetic retinopathy. The purpose of this study was to assess AGEs and a-dicarbonyls in the vitreous of patients with type 2 diabetes mellitus (T2DM) with early stages or absence of diabetic retinopathy. Methods We examined vitreous samples obtained during vitrectomy from 31 T2DM patients presenting themselves with rhegmatogenous retinal detachment and compared these to 62 nondiabetic rhegmatogenous retinal detachment patients, matched on age, estimated glomerular filtration rate, smoking, intra-ocular lens implantation, and proliferative vitreoretinopathy. AGEs (pentosidine, N-epsilon-(carboxymethyl) lysine, N-epsilon-(carboxyethyl) lysine, and 5-hydro-5methylimidazolone) and a-dicarbonyls (3-deoxyglucosone, methylglyoxal, and glyoxal) were measured by ultra performance liquid chromatography or high performance liquid chromatography. Skin autofluorescence was measured by the AGE Reader. Results Mean age was 64 +/- 7.6 years for T2DM patients and 63 +/- 8.1 years for controls. For T2DM patients, median diabetes duration was 2.2 (0.3-7.4) years. Non-proliferative diabetic retinopathy was present in 1 patient and classified as absent or background retinopathy in 30 patients. Vitreous levels of pentosidine (2.20 vs. 1.59 mu mol/mol lysine, p = 0.012) and 3-deoxyglucosone (809 vs. 615 nmol/L, p = 0.001) were significantly elevated in T2DM patients compared to controls. Other AGEs and a-dicarbonyls in the vitreous were not significantly different. There was a trend for increased skin autofluorescence in T2DM patients as compared to controls (p = 0.07). Conclusions Pentosidine and 3-deoxyglucosone concentrations were increased in the vitreous of rhegmatogenous retinal detachment patients with a relatively short duration of diabetes compared to non-diabetic rhegmatogenous retinal detachment patients.	[Fokkens, Bernardina T.; Mulder, Douwe J.; Smit, Andries J.] Univ Groningen, Dept Internal Med, Univ Med Ctr Groningen, Groningen, Netherlands; [Fokkens, Bernardina T.; Smit, Andries J.] Univ Groningen, Res Inst GUIDE, Grad Sch Med Sci, Univ Med Ctr Groningen, Groningen, Netherlands; [Fokkens, Bernardina T.; Los, Leonoor I.] Univ Groningen, Dept Ophthalmol, Univ Med Ctr Groningen, Groningen, Netherlands; [Schalkwijk, Casper G.; Scheijen, Jean L.] Maastricht Univ, Lab Metab & Vasc Med, Dept Expt Internal Med, Maastricht, Netherlands; [Los, Leonoor I.] Univ Groningen, WJ Kolff Inst, Grad Sch Med Sci, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; Maastricht University; University of Groningen	Fokkens, BT (corresponding author), Univ Groningen, Dept Internal Med, Univ Med Ctr Groningen, Groningen, Netherlands.; Fokkens, BT (corresponding author), Univ Groningen, Res Inst GUIDE, Grad Sch Med Sci, Univ Med Ctr Groningen, Groningen, Netherlands.; Fokkens, BT (corresponding author), Univ Groningen, Dept Ophthalmol, Univ Med Ctr Groningen, Groningen, Netherlands.	bt.fokkens@umcg.nl	Scheijen, Jean/AAY-3799-2020	Schalkwijk, Casper G/0000-0003-0190-2690	Stichting Blindenhulp, The Netherlands	Stichting Blindenhulp, The Netherlands(Netherlands Government)	BTF was supported financially by Stichting Blindenhulp, The Netherlands (http://www.blindenhulp.nl/). This organization had no role in the design or conduct of this research.	AHMED MU, 1986, J BIOL CHEM, V261, P4889; Amann T, 1997, KLIN MONATSBL AUGENH, V210, P43, DOI 10.1055/s-2008-1035012; Beisswenger PJ, 2003, BIOCHEM SOC T, V31, P1358; Bishop PN, 2004, INVEST OPHTH VIS SCI, V45, P1041, DOI 10.1167/iovs.03-1017; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Choudhuri S, 2013, MOL VIS, V19, P100; de Groot L, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3538; DYER DG, 1991, J BIOL CHEM, V266, P11654; Gavin JR, 1999, DIABETES CARE, V22, pS5; Hanssen NMJ, 2013, J CLIN ENDOCR METAB, V98, pE1369, DOI 10.1210/jc.2013-1068; Komiya N, 2008, INT HEART J, V49, P681, DOI 10.1536/ihj.49.681; Lal S, 1997, ARCH BIOCHEM BIOPHYS, V342, P254, DOI 10.1006/abbi.1997.0117; Los LI, 2003, INVEST OPHTH VIS SCI, V44, P2828, DOI 10.1167/iovs.02-0588; Lu JX, 2011, CLIN BIOCHEM, V44, P307, DOI 10.1016/j.clinbiochem.2010.11.004; Lutgers HL, 2006, DIABETES CARE, V29, P2654, DOI 10.2337/dc05-2173; Maessen DE, 2015, DIABETES CARE, V38, P913, DOI 10.2337/dc14-2605; Matsumoto Y, 2002, JPN J OPHTHALMOL, V46, P406, DOI 10.1016/S0021-5155(02)00508-7; Matsumoto Y, 2002, JPN J OPHTHALMOL, V46, P510, DOI 10.1016/S0021-5155(02)00537-3; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P567, DOI 10.1196/annals.1333.065; Mulder DJ, 2006, DIABETES TECHNOL THE, V8, P523, DOI 10.1089/dia.2006.8.523; Nakamura N, 2003, DIABETES RES CLIN PR, V61, P93, DOI 10.1016/S0168-8227(03)00109-8; Nakamura T, 2010, OXID MED CELL LONGEV, V3, P304, DOI 10.4161/oxim.3.5.13069; Nakayama K, 2008, AM J NEPHROL, V28, P871, DOI 10.1159/000139653; Nowotny K, 2015, BIOMOLECULES, V5, P194, DOI 10.3390/biom5010194; Odani H, 1999, BIOCHEM BIOPH RES CO, V256, P89, DOI 10.1006/bbrc.1999.0221; Ogawa S, 2010, HYPERTENSION, V56, P471, DOI 10.1161/HYPERTENSIONAHA.110.156786; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Pachydaki SI, 2006, EXP EYE RES, V82, P807, DOI 10.1016/j.exer.2005.09.022; Peyroux J, 2006, PATHOL BIOL, V54, P405, DOI 10.1016/j.patbio.2006.07.006; Scheijen JLJM, 2014, CLIN CHEM LAB MED, V52, P85, DOI 10.1515/cclm-2012-0878; Scheijen JLJM, 2009, J CHROMATOGR B, V877, P610, DOI 10.1016/j.jchromb.2009.01.022; Schroder S, 2012, RETINA-J RET VIT DIS, V32, P38, DOI 10.1097/IAE.0b013e3182173753; SEBAG J, 1992, ARCH OPHTHALMOL-CHIC, V110, P1472, DOI 10.1001/archopht.1992.01080220134035; SELL DR, 1989, J BIOL CHEM, V264, P21597; Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074; Stinghen AEM, 2016, J AM SOC NEPHROL, V27, P354, DOI 10.1681/ASN.2014101047; Stitt AW, 1998, INVEST OPHTH VIS SCI, V39, P2517; Thompson J, 2001, PROLIFERATIVE VITREO, P2287; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Tome CC, 2005, GRAEF ARCH CLIN EXP, V243, P1272, DOI 10.1007/s00417-004-1108-3; van Deemter M, 2009, EXP EYE RES, V88, P1043, DOI 10.1016/j.exer.2009.01.004; van Deemter M, 2016, RETINA; van Eupen MGA, 2016, HYPERTENSION, V68, P956, DOI 10.1161/HYPERTENSIONAHA.116.07446; van Waateringe RP, 2016, EUR J CLIN INVEST, V46, P481, DOI 10.1111/eci.12627; Verzijl N, 2000, BIOCHEM J, V350, P381, DOI 10.1042/0264-6021:3500381; Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74; Xue J, 2014, BIOCHEMISTRY-US, V53, P3327, DOI 10.1021/bi500046t; Xue J, 2011, STRUCTURE, V19, P722, DOI 10.1016/j.str.2011.02.013; Yamagishi S, 2005, CURR DIABETES REV, V1, P93, DOI 10.2174/1573399052952631	50	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173379	10.1371/journal.pone.0173379	http://dx.doi.org/10.1371/journal.pone.0173379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264049	Green Published, Green Submitted, gold			2022-12-26	WOS:000396054300060
J	Maringe, C; Fowler, H; Rachet, B; Luque-Fernandez, MA				Maringe, Camille; Fowler, Helen; Rachet, Bernard; Luque-Fernandez, Miguel Angel			Reproducibility, reliability and validity of population-based administrative health data for the assessment of cancer non-related comorbidities	PLOS ONE			English	Article							CO-MORBIDITY; CHARLSON; INDEX; SURVIVAL; IMPACT; STAGE; LUNG; MORTALITY; DIAGNOSIS	Background Patients with comorbidities do not receive optimal treatment for their cancer, leading to lower cancer survival. Information on individual comorbidities is not straightforward to derive from population-based administrative health datasets. We described the development of a reproducible algorithm to extract the individual Charlson index comorbidities from such data. We illustrated the algorithm with 1,789 laryngeal cancer patients diagnosed in England in 2013. We aimed to clearly set out and advocate the time-related assumptions specified in the algorithm by providing empirical evidence for them. Methods Comorbidities were assessed from hospital records in the ten years preceding cancer diagnosis and internal reliability of the hospital records was checked. Data were right-truncated 6 or 12 months prior to cancer diagnosis to avoid inclusion of potentially cancer-related comorbidities. We tested for collider bias using Cox regression. Results Our administrative data showed weak to moderate internal reliability to identify comorbidities (ICC ranging between 0.1 and 0.6) but a notably high external validity (86.3%). We showed a reverse protective effect of non-cancer related Chronic Obstructive Pulmonary Disease (COPD) when the effect is split into cancer and non-cancer related COPD (Age-adjusted HR: 0.95, 95% CI:0.7-1.28 for non-cancer related comorbidities). Furthermore, we showed that a window of 6 years before diagnosis is an optimal period for the assessment of comorbidities. Conclusion To formulate a robust approach for assessing common comorbidities, it is important that assumptions made are explicitly stated and empirically proven. We provide a transparent and consistent approach useful to researchers looking to assess comorbidities for cancer patients using administrative health data.	[Maringe, Camille; Fowler, Helen; Rachet, Bernard; Luque-Fernandez, Miguel Angel] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Canc Survival Grp, London, England	University of London; London School of Hygiene & Tropical Medicine	Maringe, C (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Canc Survival Grp, London, England.	Camille.Maringe@lshtm.ac.uk	FERNANDEZ, MIGUEL ANGEL LUQUE/AAZ-5017-2020; FERNANDEZ, MIGUEL ANGEL LUQUE/AAK-7183-2021; FERNANDEZ, MIGUEL ANGEL LUQUE/L-4053-2015	FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; Rachet, Bernard/0000-0001-5837-7773; Fowler, Helen/0000-0003-2233-3183; Maringe, Camille/0000-0002-8739-9565	CRUK [C7923/A18525]; Cancer Research UK [18525, 11700] Funding Source: researchfish	CRUK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This study was funded by CRUK grant number C7923/A18525. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern TP, 2009, MED CARE, V47, P73, DOI 10.1097/MLR.0b013e318180913c; Ahn DH, 2013, CLIN LUNG CANCER, V14, P644, DOI 10.1016/j.cllc.2013.06.009; Akushevich Igor, 2011, ISRN Oncol, V2011, P415790, DOI 10.5402/2011/415790; [Anonymous], 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Bang UC, 2014, GASTROENTEROLOGY, V146, P989, DOI 10.1053/j.gastro.2013.12.033; Bannay A, 2016, MED CARE, V54, P188, DOI 10.1097/MLR.0000000000000471; Bernardini Judith, 2004, Adv Perit Dial, V20, P125; Braithwaite D, 2012, CANCER EPIDEM BIOMAR, V21, P1115, DOI 10.1158/1055-9965.EPI-11-1228; BRAMER G R, 1988, World Health Statistics Quarterly, V41, P32; Brewer N, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-132; Center for Disease Control and Prevention, 1988, MMWR-MORBID MORTAL W, V37, P1; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cole SR, 2010, INT J EPIDEMIOL, V39, P417, DOI 10.1093/ije/dyp334; Corkum M, 2012, CANCER CAUSE CONTROL, V23, P213, DOI 10.1007/s10552-011-9875-8; Crooks CJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007974; Daskivich TJ, 2015, J UROLOGY, V194, P73, DOI 10.1016/j.juro.2015.01.081; FEINSTEIN AR, 1970, J CHRON DIS, V23, P455, DOI 10.1016/0021-9681(70)90054-8; Fleming ST, 2005, MED CARE, V43, P132, DOI 10.1097/00005650-200502000-00006; Glymour MM, 2016, EPIDEMIOLOGY; Hatlen P, 2011, J THORAC ONCOL, V6, P1810, DOI 10.1097/JTO.0b013e31822a75be; Health and Social Care Information Centre, 2016, OPCS 4 CLASS; Hemmelgarn BR, 2003, AM J KIDNEY DIS, V42, P125, DOI 10.1016/S0272-6386(03)00415-3; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Howlader Nadia, 2014, Journal of the National Cancer Institute Monographs, P255, DOI 10.1093/jncimonographs/lgu022; Imamura K, 1997, J CLIN EPIDEMIOL, V50, P1011, DOI 10.1016/S0895-4356(97)00128-5; Kehl KL, 2015, J GERIATR ONCOL, V6, P202, DOI 10.1016/j.jgo.2015.01.005; Li B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-12; Li HJ, 2012, J CANCER EPIDEMIOL, V2012, DOI 10.1155/2012/291704; Lund L, 2009, J UROLOGY, V182, P35, DOI DOI 10.1016/J.JUR0.2009.02.136; MALENKA DJ, 1994, J CLIN EPIDEMIOL, V47, P1027, DOI 10.1016/0895-4356(94)90118-X; Navid A, 2015, BRIT J HOSP MED, V76, P707, DOI 10.12968/hmed.2015.76.12.707; Newschaffer CJ, 1997, J CLIN EPIDEMIOL, V50, P725, DOI 10.1016/S0895-4356(97)00050-4; Patterson RE, 2010, BREAST CANCER RES TR, V122, P859, DOI 10.1007/s10549-010-0732-3; Porta M, 2014, DICT EPIDEMIOLOGY; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Sarfati D, 2013, ASIA PACIFIC J CLIN; Sarfati D, 2014, J CLIN EPIDEMIOL, V67, P586, DOI 10.1016/j.jclinepi.2013.11.012; Sarfati D, 2012, J CLIN EPIDEMIOL, V65, P924, DOI 10.1016/j.jclinepi.2012.02.017; Sarfati D, 2010, NEW ZEAL MED J, V123, P50; Sarfati D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-116; Shack LG, 2010, POSTGRAD MED J, V86, P73, DOI 10.1136/pgmj.2009.084566; Sogaard Mette, 2013, Clin Epidemiol, V5, P3, DOI 10.2147/CLEP.S47150; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Terret C, 2009, LANCET ONCOL, V10, P80, DOI 10.1016/S1470-2045(08)70336-X; van Doorn C, 2001, J CLIN EPIDEMIOL, V54, P694, DOI 10.1016/S0895-4356(00)00367-X; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Weiss NS, 2006, CLIN EPIDEMIOLOGY ST, VIX	48	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172814	10.1371/journal.pone.0172814	http://dx.doi.org/10.1371/journal.pone.0172814			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28263996	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000396054300019
J	Vandecandelaere, I; Van Nieuwerburgh, F; Deforce, D; Coenye, T				Vandecandelaere, Ilse; Van Nieuwerburgh, Filip; Deforce, Dieter; Coenye, Tom			Metabolic activity, urease production, antibiotic resistance and virulence in dual species biofilms of Staphylococcus epidermidis and Staphylococcus aureus	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; PROTEIN-A; CAENORHABDITIS-ELEGANS; METHICILLIN RESISTANCE; DNA-BINDING; SUSCEPTIBILITY; INFECTIONS; MECHANISMS; PATHOGEN; SEQUENCE	In this paper, the metabolic activity in single and dual species biofilms of Staphylococcus epidermidis and Staphylococcus aureus isolates was investigated. Our results demonstrated that there was less metabolic activity in dual species biofilms compared to S. aureus biofilms. However, this was not observed if S. aureus and S. epidermidis were obtained from the same sample. The largest effect on metabolic activity was observed in biofilms of S. aureus Mu50 and S. epidermidis ET-024. A transcriptomic analysis of these dual species biofilms showed that urease genes and genes encoding proteins involved in metabolism were downregulated in comparison to monospecies biofilms. These results were subsequently confirmed by phenotypic assays. As metabolic activity is related to acid production, the pH in dual species biofilms was slightly higher compared to S. aureus Mu50 biofilms. Our results showed that S. epidermidis ET-024 in dual species biofilms inhibits metabolic activity of S. aureus Mu50, leading to less acid production. As a consequence, less urease activity is required to compensate for low pH. Importantly, this effect was biofilm-specific. Also S. aureus Mu50 genes encoding virulence-associated proteins (Spa, SpIF and Dps) were upregulated in dual species biofilms compared to monospecies biofilms and using Caenorhabditis elegans infection assays, we demonstrated that more nematodes survived when co-infected with S. epidermidis ET-024 and S. aureus mutants lacking functional spa, spIF or dps genes, compared to nematodes infected with S. epidermidis ET-024 and wild type S. aureus. Finally, S. epidermidis ET-024 genes encoding resistance to oxacillin, erythromycin and tobramycin were upregulated in dual species biofilms and increased resistance was subsequently confirmed. Our data indicate that both species in dual species biofilms of S. epidermidis and S. aureus influence each other's behavior, but additional studies are required necessary to elucidate the exact mechanism(s) involved.	[Vandecandelaere, Ilse; Coenye, Tom] Univ Ghent, Lab Farmaceut Microbiol, Ottergemsesteenweg, Ghent, Belgium; [Van Nieuwerburgh, Filip; Deforce, Dieter] Univ Ghent, Lab Farmaceut Biotechnol, Ottergemsesteenweg, Ghent, Belgium	Ghent University; Ghent University	Coenye, T (corresponding author), Univ Ghent, Lab Farmaceut Microbiol, Ottergemsesteenweg, Ghent, Belgium.	Tom.Coenye@UGent.be	Coenye, Tom/A-6291-2014; Van Nieuwerburgh, Filip/H-9697-2015; Deforce, Dieter LD/J-4725-2013; Coenye, Tom/Z-1928-2019	Coenye, Tom/0000-0002-6407-0601; Van Nieuwerburgh, Filip/0000-0001-8815-5485; Deforce, Dieter LD/0000-0002-0635-661X; Coenye, Tom/0000-0002-6407-0601	FWO-Vlaanderen [3G001211]; Interuniversity Attraction Poles Program initiated by the Belgian Science Policy Office [P7_28]	FWO-Vlaanderen(FWO); Interuniversity Attraction Poles Program initiated by the Belgian Science Policy Office	This research has been funded by FWO-Vlaanderen (project 3G001211, to TC and DDF) and by the Interuniversity Attraction Poles Program initiated by the Belgian Science Policy Office (grant P7_28, to TC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Becker K, 2012, GENOME ANNOUNCEMENTS, V10; Becker K, 2012, MANUAL CLIN MICROBIO, V10, P308; Becker K, 2014, INT J MED MICROBIOL, V304, P794, DOI 10.1016/j.ijmm.2014.06.007; Begun J, 2007, PLOS PATHOG, V3, P526, DOI 10.1371/journal.ppat.0030057; Bloemendaal ALA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011841; Bore E, 2007, MICROBIOL-SGM, V153, P2289, DOI 10.1099/mic.0.2007/005942-0; Bouchard D, 2012, J BACTERIOL, V194, P6292, DOI 10.1128/JB.01188-12; Brackman G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20321; Burne RA, 2000, MICROBES INFECT, V2, P533, DOI 10.1016/S1286-4579(00)00312-9; Cerca N, 2005, J ANTIMICROB CHEMOTH, V56, P331, DOI 10.1093/jac/dki217; Chatterjee Som S, 2013, Clin Epidemiol, V5, P205, DOI 10.2147/CLEP.S37071; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; COWAN ST, 1954, J GEN MICROBIOL, V10, P174, DOI 10.1099/00221287-10-1-174; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; He XS, 2014, ISME J, V8, P564, DOI 10.1038/ismej.2013.172; Heilmann C, 2011, ADV EXP MED BIOL, V715, P105, DOI 10.1007/978-94-007-0940-9_7; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Horsburgh MJ, J BACTERIOLOGY, V182, P468; Jin T, 2013, CELL PHYSIOL BIOCHEM, V32, P322, DOI 10.1159/000354440; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Martinez A, 1997, J BACTERIOL, V179, P5188, DOI 10.1128/jb.179.16.5188-5194.1997; McCarthy H, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00001; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; Molina-Manso D, 2013, INT J ANTIMICROB AG, V41, P521, DOI 10.1016/j.ijantimicag.2013.02.018; Otto M, 2001, INFECT IMMUN, V69, P1957, DOI 10.1128/IAI.69.3.1957-1960.2001; Otto M, 2014, CURR OPIN MICROBIOL, V17, P32, DOI 10.1016/j.mib.2013.11.004; Otto M, 2013, BIOESSAYS, V35, P4, DOI 10.1002/bies.201200112; Otto M, 2012, SEMIN IMMUNOPATHOL, V34, P201, DOI 10.1007/s00281-011-0296-2; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Palmqvist N, 2002, MICROB PATHOGENESIS, V33, P239, DOI 10.1006/mpat.2002.0533; Peacock SJ, 2015, ANNU REV BIOCHEM, V84, P577, DOI 10.1146/annurev-biochem-060614-034516; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Perkins SD, 2010, INT J MED MICROBIOL, V300, P503, DOI 10.1016/j.ijmm.2010.02.005; Reed SB, 2001, INFECT IMMUN, V69, P1521, DOI 10.1128/IAI.69.3.1521-1527.2001; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; Sachs George, 2011, Curr Gastroenterol Rep, V13, P540, DOI 10.1007/s11894-011-0226-4; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Szczuka E, 2015, FOLIA MICROBIOLOGICA; Vandecandelaere I, 2014, GENOME ANNOUNCEMENTS, V2; Vandecandelaere I, 2014, PATHOG DIS, V70, P321, DOI 10.1111/2049-632X.12133; Vandecandelaere I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038401; Wang XM, 2003, J MED MICROBIOL, V52, P989, DOI 10.1099/jmm.0.05360-0; Widaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040586; Ziebuhr W, 2006, INT J ANTIMICROB AG, V28, pS14, DOI 10.1016/j.ijantimicag.2006.05.012	47	17	17	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172700	10.1371/journal.pone.0172700	http://dx.doi.org/10.1371/journal.pone.0172700			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28263995	gold, Green Published			2022-12-26	WOS:000396054300015
J	Chen, VCH; Ng, MH; Chiu, WC; McIntyre, RS; Lee, Y; Lin, TY; Weng, JC; Chen, PC; Hsu, CY				Chen, Vincent Chin-Hung; Ng, Mei-Hing; Chiu, Wei-Che; McIntyre, Roger S.; Lee, Yena; Lin, Tsang-Yaw; Weng, Jun-Cheng; Chen, Pau-Chung; Hsu, Chung-Yao			Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; GLOBAL BURDEN; ANGLE; DISEASE; DRUGS; RISK	Background Selective serotonin reuptake inhibitors (SSRIs) are one of the most commonly prescribed classes of antidepressants. Glaucoma is the second leading cause of blindness globally and iatrogenic glaucoma has been implicated across disparate medication classes. Available studies that have sought to determine the association between SSRI exposure and glaucoma have provided mixed results. The aim of the study herein was to investigate whether an association exists between SSRI exposure and glaucoma incidence. Methods Glaucoma cases were identified from Taiwan's National Health Insurance Research Database with a new primary diagnosis of glaucoma between 1997 and 2009. The date wherein the cases were diagnosed with glaucoma was operationalized as the index date. The control group was comprised of individuals within the database who were not diagnosed with glaucoma. 15,865 glaucoma cases were compared to 77,014 sex-, age-, residence-and insurance premium-matched controls on measures of prescribed duration and dosage of SSRIs up to 365 days before index date to proxy SSRIs exposure. Results Individuals receiving SSRIs were at greater risk of glaucoma incidence (OR = 1.39; 95% CI = 1.29 - 1.50); the foregoing increased likelihood was reduced after adjusting for confounding variables (aOR = 1.09; 95% CI = 1.00,1.18). SSRI treatment of longer duration (i. e. > 365 days) and higher doses (>= 1 defined daily dose) were associated with greater risk of glaucoma incidence (aOR = 1.36; 95% CI = 1.08 - 1.71). Subgroup analysis showed that the effect of SSRIs on glaucoma was limited to individuals younger than 65 years of age (aOR = 1.37; 95% CI = 1.25 - 1.50), without diabetes (aOR = 1.39; 95% CI = 1.27 - 1.52), without hypertension (aOR = 1.46; 95% CI = 1.31 - 1.63) or hypercholesterolemia (aOR = 1.35; 95% CI = 1.23 - 1.48). Conclusion Treatment with SSRIs was associated with greater risk of having a diagnosis of glaucoma, particularly in individuals with longer duration and/or higher average dose of SSRI. Our findings suggest that individuals receiving SSRIs treatment for extended periods of time and/or at relatively higher therapeutic doses should be monitored for symptoms associated with glaucoma.	[Chen, Vincent Chin-Hung] Chiayi Chang Gung Mem Hosp, Dept Psychiat, Chang Gung Med Fdn, Chiayi, Taiwan; [Chen, Vincent Chin-Hung] Chang Gung Univ, Sch Med, Dept Psychiat, Taoyuan, Taiwan; [Ng, Mei-Hing; Lin, Tsang-Yaw] Minist Hlth & Welf, Tsaotun Psychiat Ctr, Nantou, Nantou, Taiwan; [Ng, Mei-Hing] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chiu, Wei-Che] Cathay Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Chiu, Wei-Che] Fu Jen Catholic Univ, Coll Med, Taipei, Taiwan; [McIntyre, Roger S.; Lee, Yena] Univ Toronto, Univ Hlth Network, Mood Disorders Psychopharmacol Unit, Toronto, ON, Canada; [McIntyre, Roger S.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [McIntyre, Roger S.] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada; [Weng, Jun-Cheng] Chung Shan Med Univ, Dept Med Imaging & Radiol Sci, Taichung, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan; [Hsu, Chung-Yao] Kaoshiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Hsu, Chung-Yao] Natl Taiwan Univ Hosp, Dept Environm & Occupat Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chung Shan Medical University; Cathay General Hospital; Fu Jen Catholic University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Chung Shan Medical University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Ng, MH (corresponding author), Minist Hlth & Welf, Tsaotun Psychiat Ctr, Nantou, Nantou, Taiwan.; Ng, MH (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	condensedmilk0@gmail.com	McIntyre, Roger/AAU-1000-2020; Lee, Yena/L-5505-2019; Chen, Pau-Chung/H-5686-2011; Students, MDPU/ABE-8402-2020; Lee, Yena/D-9016-2019	McIntyre, Roger/0000-0003-4733-2523; Lee, Yena/0000-0003-0629-9456; Chen, Pau-Chung/0000-0002-6242-5974; Lee, Yena/0000-0003-0629-9456; Hsu, Chung-Yao/0000-0002-9880-5944	Chang Gung Memorial Hospital [CMRPG6E0271]; Ministry of Science and Technology, Taiwan [NSC 102-2314-B- 040-004-MY3]; Tsaotun Psychiatric Center, Ministry of Health and Welfare, Taiwan [DOH103-HO-1113]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Tsaotun Psychiatric Center, Ministry of Health and Welfare, Taiwan	VC-HC has received grant (CMRPG6E0271) from Chang Gung Memorial Hospital and the Ministry of Science and Technology, Taiwan (NSC 102-2314-B- 040-004-MY3). M-HN has received a grant (DOH103-HO-1113) from Tsaotun Psychiatric Center, Ministry of Health and Welfare, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNETT NL, 1993, EXP EYE RES, V57, P209, DOI 10.1006/exer.1993.1116; Beg, 2015, INT J MED SCI PUBLIC, V4, P634; Casson RJ, 2012, CLIN EXP OPHTHALMOL, V40, P341, DOI 10.1111/j.1442-9071.2012.02773.x; Cazzola M, 2012, RESP MED, V106, P249, DOI 10.1016/j.rmed.2011.07.021; Chen HY, 2016, J CLIN PSYCHIAT, V77, pE692, DOI 10.4088/JCP.15m10038; Chen HY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002041; Chen V. C. H., 2015, PSYCHO-ONCOLOGY, V25, P803, DOI [10.1002/pon.3929, DOI 10.1002/P0N.3929]; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; COSTAGLIOLA C, 1993, BRIT J OPHTHALMOL, V77, P344, DOI 10.1136/bjo.77.6.344; Costagliola C, 2004, CNS DRUGS, V18, P475, DOI 10.2165/00023210-200418080-00001; Costagliola C, 2000, EXP EYE RES, V70, P551, DOI 10.1006/exer.1999.0773; Costagliola C, 2008, CURR NEUROPHARMACOL, V6, P293, DOI 10.2174/157015908787386104; Eke T, 1997, BRIT MED J, V314, P1387; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Ilyas S, 2012, BRIT J PSYCHIAT, V200, P393, DOI 10.1192/bjp.bp.111.104257; Kingman S, 2004, B WORLD HEALTH ORGAN, V82, P887; Lachkar Y, 2007, CURR OPIN OPHTHALMOL, V18, P129, DOI 10.1097/ICU.0b013e32808738d5; Lai SW, 2011, AM J GASTROENTEROL, V106, P1697, DOI 10.1038/ajg.2011.155; LIN CH, 2016, MEDICINE, V95, DOI DOI 10.1097/MD; Lin YC, 2012, J CHIN MED ASSOC, V75, P567, DOI 10.1016/j.jcma.2012.08.020; Mojtabai R, 2011, HEALTH AFFAIR, V30, P1434, DOI 10.1377/hlthaff.2010.1024; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Osborne N.N., 1982, P7; Razeghinejad MR, 2011, AM J MED, V124, P20, DOI 10.1016/j.amjmed.2010.08.011; Richa S, 2010, CNS DRUGS, V24, P501, DOI 10.2165/11533180-000000000-00000; RITCH R, 1994, ARCH OPHTHALMOL-CHIC, V112, P67, DOI 10.1001/archopht.1994.01090130077021; The Australian Adverse Drug Reactions Advisory Committee, 2001, AUSTR ADV DRUGS REAC, V20; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; WHO Collaborating Centre for Drug Statistics Methodology, 2014, GUID ATC CLASS DDD A; World Health Organization Collaborating Centre for Drug Statistics Methodology, 2014, ATC CLASS IND DDDS 2; Zelefsky JR, 2006, AM J OPHTHALMOL, V141, P1144, DOI 10.1016/j.ajo.2006.01.033	32	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173005	10.1371/journal.pone.0173005	http://dx.doi.org/10.1371/journal.pone.0173005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257449	Green Submitted, Green Published, gold			2022-12-26	WOS:000396021100049
J	James, AK; Passow, U; Brzezinski, MA; Parsons, RJ; Trapani, JN; Carlson, CA				James, Anna K.; Passow, Uta; Brzezinski, Mark A.; Parsons, Rachel J.; Trapani, Jennifer N.; Carlson, Craig A.			Elevated pCO(2) enhances bacterioplankton removal of organic carbon	PLOS ONE			English	Article							COMMUNITY STRUCTURE; GROWTH EFFICIENCY; OCEAN; SEAWATER; ACIDIFICATION; MATTER; CO2; PICOPLANKTON; MICROBES; DYNAMICS	Factors that affect the removal of organic carbon by heterotrophic bacterioplankton can impact the rate and magnitude of organic carbon loss in the ocean through the conversion of a portion of consumed organic carbon to CO2. Through enhanced rates of consumption, surface bacterioplankton communities can also reduce the amount of dissolved organic carbon (DOC) available for export from the surface ocean. The present study investigated the direct effects of elevated pCO(2) on bacterioplankton removal of several forms of DOC ranging from glucose to complex phytoplankton exudate and lysate, and naturally occurring DOC. Elevated pCO(2) (1000-1500 ppm) enhanced both the rate and magnitude of organic carbon removal by bacterioplankton communities compared to low (pre-industrial and ambient) pCO(2) (250-similar to 400 ppm). The increased removal was largely due to enhanced respiration, rather than enhanced production of bacterioplankton biomass. The results suggest that elevated pCO2 can increase DOC consumption and decrease bacterioplankton growth efficiency, ultimately decreasing the amount of DOC available for vertical export and increasing the production of CO2 in the surface ocean.	[James, Anna K.; Passow, Uta; Brzezinski, Mark A.; Carlson, Craig A.] Univ Calif Santa Barbara, Inst Marine Sci, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Parsons, Rachel J.; Trapani, Jennifer N.] BIOS, St Georges, Bermuda	University of California System; University of California Santa Barbara	James, AK (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	anna.james.k@gmail.com	Parsons, Rachel J/B-1475-2016	Parsons, Rachel/0000-0003-3634-8220	NSF [OCE 1041038, OCE 12-36905, OCE 1156626, OCE 1232779]; Division Of Ocean Sciences [1538428, 1436748] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	NSF OCE 1041038 - awarded to Uta Passow, Craig A Carlson, and Mark A Brzezinski NSF OCE 12-36905 - awarded to the Moorea Coral Reef LTER Simons Foundation International awarded to Craig A Carlson NSF OCE 1156626 awarded to Rachel A Parsons and Jennifer N Trapani NSF OCE 1232779 - awarded to the Santa Barbara Channel LTER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMERMAN JW, 1984, MAR ECOL PROG SER, V18, P31, DOI 10.3354/meps018031; [Anonymous], 2012, BIOGEOSCI DISCUSS, DOI DOI 10.5194/BGD-9-989-2012; Arnosti C, 2011, ANN REV MAR SCI; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bunse C, 2016, NATURE CLIM CHANGE; Carlson CA, 1999, AQUAT MICROB ECOL, V19, P229, DOI 10.3354/ame019229; Carlson CA, 2004, LIMNOL OCEANOGR, V49, P1073, DOI 10.4319/lo.2004.49.4.1073; Carlson CA, 2002, AQUAT MICROB ECOL, V30, P19, DOI 10.3354/ame030019; CARLSON CA, 1994, NATURE, V371, P405, DOI 10.1038/371405a0; Carlson CA, 2010, DEEP-SEA RES PT II, V57, P1433, DOI 10.1016/j.dsr2.2010.02.013; Cherrier J, 1996, MAR ECOL PROG SER, V139, P267, DOI 10.3354/meps139267; CHROST RJ, 1991, BROCK SPR S, P29; Del Giorgio P.A., 2000, MICROBIAL ECOLOGY OC, P289, DOI DOI 10.1146/ANNUREV.ECOLSYS.29.1.503; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Endres S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099228; Engel A, 2004, AQUAT MICROB ECOL; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; First MR, 2009, AQUAT MICROB ECOL, V57, P79, DOI 10.3354/ame01338; Fukuda R, 1998, APPL ENVIRON MICROB, V64, P3352; Gattuso J.-P., 2010, GUIDE BEST PRACTICES, P41, DOI DOI 10.1016/J.JOMS.2003.10.009; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Grossart HP, 2006, LIMNOL OCEANOGR, V51, P1, DOI 10.4319/lo.2006.51.1.0001; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Gundersen K, 2002, LIMNOL OCEANOGR, V47, P1525, DOI 10.4319/lo.2002.47.5.1525; Hales B, 2004, LIMNOL OCEANOGR-METH, V2, P356, DOI 10.4319/lom.2004.2.356; Halewood ER, 2012, AQUAT MICROB ECOL, V67, P189, DOI 10.3354/ame01586; Hansell DA, 2015, BIOGEOCHEMISTRY OF MARINE DISSOLVED ORGANIC MATTER, 2ND EDITION, P1; Hansell DA, 2009, OCEANOGRAPHY, V22, P202, DOI 10.5670/oceanog.2009.109; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hoppe HG, 1983, MAR ECOL PROG SER; Jiao N, 2011, MICROBIAL CARBON PUM; Johnson KS, 2002, DEEP-SEA RES PT I, V49, P1291, DOI 10.1016/S0967-0637(02)00020-1; Joint I, 2011, ISME J, V5, P1, DOI 10.1038/ismej.2010.79; KING GM, 1986, APPL ENVIRON MICROB, V51, P373, DOI 10.1128/AEM.51.2.373-380.1986; LEGENDRE L, 1988, MAR ECOL PROG SER, V47, P153, DOI 10.3354/meps047153; Letscher R.T., 2015, MAR CHEM; Lomas MW, 2013, DEEP-SEA RES PT II, V93, P16, DOI 10.1016/j.dsr2.2013.01.008; Mass EW, 2013, AQUAT MICROB ECOL; Motegi C, 2013, BIOGEOSCIENCES, V10, P3285, DOI 10.5194/bg-10-3285-2013; MUNSTER U, 1991, BROCK SPR S, P96; Nelson CE, 2012, ENVIRON MICROBIOL, V14, P1500, DOI 10.1111/j.1462-2920.2012.02738.x; Nelson CE, 2011, ISME J, V5, P1374, DOI 10.1038/ismej.2011.12; Newbold LK, 2012, ENVIRON MICROBIOL, V14, P2293, DOI 10.1111/j.1462-2920.2012.02762.x; Oliver AE, 2014, ENV MICROBIOL REP, V6, P574, DOI 10.1111/1758-2229.12159; Parsons RJ, 2014, ENV MICROBIOL; Passow U, 2012, MAR ECOL PROG SER; Piontek J, 2013, BIOGEOSCIENCES, V10, P297, DOI 10.5194/bg-10-297-2013; Piontek J, 2010, BIOGEOSCIENCES, V7, P1615, DOI 10.5194/bg-7-1615-2010; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Riebessell U, 2013, BIOGEOSCIENCES; Robbins L, 2010, 20101280 US GEOL SUR, V7, DOI DOI 10.1007/978-3-642-52335-9_1; Rost B, 2008, MAR ECOL PROG SER, V373, P227, DOI 10.3354/meps07776; Roy AS, 2013, BIOGEOSCIENCES, V10, P555, DOI 10.5194/bg-10-555-2013; SHERR E, 1988, LIMNOL OCEANOGR, V33, P1225, DOI 10.4319/lo.1988.33.5.1225; Sintes E, 2013, FEMS MICROBIOL ECOL, V83, P413, DOI 10.1111/1574-6941.12003; Siu N., 2014, OPEN J ECOL, V4, P434, DOI DOI 10.4236/oje.2014.48038; Sperling M, 2013, BIOGEOSCIENCES, V10, P181, DOI 10.5194/bg-10-181-2013; Taucher J, 2015, LIMNOL OCEANOGR; Tranvik LJ, 1993, COLLECTIONS; Wear EK, 2015, LIMNOL OCEANOGR, P1; Yamada N, 2010, J OCEANOGR, V66, P233, DOI 10.1007/s10872-010-0021-0; Zeebe R.E., 2001, ELSEV OCEANOGR SERIE; Zhang R, 2013, BIOGEOSCIENCES, V10, P3679, DOI 10.5194/bg-10-3679-2013	66	17	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173145	10.1371/journal.pone.0173145	http://dx.doi.org/10.1371/journal.pone.0173145			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257422	gold, Green Submitted, Green Published			2022-12-26	WOS:000396021100066
J	Li, Y; Wei, MS; Zhang, FX; Zhao, JL				Li, Ying; Wei, Musheng; Zhang, Fengxia; Zhao, Jianli			Comparison of two SVD-based color image compression schemes	PLOS ONE			English	Article							STRUCTURE-PRESERVING METHOD; SINGULAR-VALUE DECOMPOSITION; LEAST-SQUARES PROBLEM; K-SVD; ALGORITHM	Color image compression is a commonly used process to represent image data as few bits as possible, which removes redundancy in the data while maintaining an appropriate level of quality for the user. Color image compression algorithms based on quaternion are very common in recent years. In this paper, we propose a color image compression scheme, based on the real SVD, named real compression scheme. First, we form a new real rectangular matrix C according to the red, green and blue components of the original color image and perform the real SVD for C. Then we select several largest singular values and the corresponding vectors in the left and right unitary matrices to compress the color image. We compare the real compression scheme with quaternion compression scheme by performing quaternion SVD using the real structure-preserving algorithm. We compare the two schemes in terms of operation amount, assignment number, operation speed, PSNR and CR. The experimental results show that with the same numbers of selected singular values, the real compression scheme offers higher CR, much less operation time, but a little bit smaller PSNR than the quaternion compression scheme. When these two schemes have the same CR, the real compression scheme shows more prominent advantages both on the operation time and PSNR.	[Li, Ying; Wei, Musheng; Zhang, Fengxia; Zhao, Jianli] Liaocheng Univ, Coll Math Sci, Liaocheng, Shandong, Peoples R China; [Wei, Musheng] Shanghai Normal Univ, Coll Math & Sci, Shanghai, Peoples R China	Liaocheng University; Shanghai Normal University	Li, Y (corresponding author), Liaocheng Univ, Coll Math Sci, Liaocheng, Shandong, Peoples R China.	liyingld@163.com			National Natural Science Foundation of China [11171226, 11301247]; Natural Science Foundation of Shandong [ZR2012FQ005, ZR2014FM032]; Science and Technology Project of Department of education, Shandong Province [J15LI10]; science foundation of Liaocheng University [31805, 318011318]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province); Science and Technology Project of Department of education, Shandong Province; science foundation of Liaocheng University	This work was supported by the National Natural Science Foundation of China under grants 11171226 and 11301247, the Natural Science Foundation of Shandong under grant ZR2012FQ005, ZR2014FM032, Science and Technology Project of Department of education, Shandong Province J15LI10, the science foundation of Liaocheng University under grants 31805, 318011318.	Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; ANDREWS HC, 1976, IEEE T ACOUST SPEECH, V24, P26, DOI 10.1109/TASSP.1976.1162766; Bryt O, 2008, J VIS COMMUN IMAGE R, V19, P270, DOI 10.1016/j.jvcir.2008.03.001; Chew LW, 2008, INTERNATIONAL SYMPOSIUM OF INFORMATION TECHNOLOGY 2008, VOLS 1-4, PROCEEDINGS, P2336; Ghorbel O, 2012, PROCEEDINGS OF 2012 IEEE 14TH INTERNATIONAL CONFERENCE ON COMMUNICATION TECHNOLOGY, P1363, DOI 10.1109/ICCT.2012.6511432; Golub G., 2013, MATRIX COMPUTATIONS; Gonzalez R., 2001, DIGITAL IMAGE PROCES, V2; Jia ZG, 2013, J COMPUT APPL MATH, V239, P12, DOI 10.1016/j.cam.2012.09.018; Jiang TS, 2008, COMPUT PHYS COMMUN, V178, P795, DOI 10.1016/j.cpc.2008.01.038; Jiang TS, 2007, COMPUT PHYS COMMUN, V176, P481, DOI 10.1016/j.cpc.2006.12.005; Kumar V, 2012, DEV CIRC SYST ICDCS, P447; Li Y, 2016, J COMPUT APPL MATH, V305, P82, DOI 10.1016/j.cam.2016.03.031; Li Y, 2014, APPL MATH COMPUT, V235, P157, DOI 10.1016/j.amc.2014.02.068; Ma T, 2013, IEEE COMMUN SURV TUT, V15, P963, DOI 10.1109/SURV.2012.060912.00149; Prasantha HS, 2007, INT C COMP INT MULT; Rufai AM, 2014, DIGIT SIGNAL PROCESS, V24, P117, DOI 10.1016/j.dsp.2013.09.008; Sangwine S., QUATERNION TOOLBOX M; Sangwine SJ, 1996, ELECTRON LETT, V32, P1979, DOI 10.1049/el:19961331; Shih YT, 2012, APPL MATH COMPUT, V218, P10370, DOI 10.1016/j.amc.2012.03.070; Singh SK, 2009, UKSIM EURO SYMP COMP, P235, DOI 10.1109/EMS.2009.100; Wang MH, 2008, COMPUT PHYS COMMUN, V179, P203, DOI 10.1016/j.cpc.2008.02.016; Wang MH, 2013, APPL MATH COMPUT, V223, P354, DOI 10.1016/j.amc.2013.08.026; Wang MH, 2013, COMPUT PHYS COMMUN, V184, P2182, DOI 10.1016/j.cpc.2013.05.001; Wu P, 2012, ADV INTEL SOFT COMPU, V159, P465; ZainEldin H, 2015, AIN SHAMS ENG J, V6, P481, DOI 10.1016/j.asej.2014.11.001; Zhang FZ, 1997, LINEAR ALGEBRA APPL, V251, P21, DOI 10.1016/0024-3795(95)00543-9	26	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172746	10.1371/journal.pone.0172746	http://dx.doi.org/10.1371/journal.pone.0172746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257451	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100025
J	Ibanez, MI; Cabello, P; Luque-Almagro, VM; Saez, LP; Olaya, A; de Medina, VS; de Castro, MDL; Moreno-Vivian, C; Roldan, MD				Isabel Ibanez, Maria; Cabello, Purificacion; Manuel Luque-Almagro, Victor; Saez, Lara P.; Olaya, Alfonso; Sanchez de Medina, Veronica; Luque de Castro, Maria Dolores; Moreno-Vivian, Conrado; Dolores Roldan, Maria			Quantitative proteomic analysis of Pseudomonas pseudoalcaligenes CECT5344 in response to industrial cyanide-containing wastewaters using Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (LC-MS/MS)	PLOS ONE			English	Article							METAL-COMPLEXED CYANIDES; FLOW-INJECTION; GENOME SEQUENCE; ESCHERICHIA-COLI; WASTE-WATER; DEGRADATION; BIODEGRADATION; SIDEROPHORES; DESTRUCTION; RESISTANCE	Biological treatments to degrade cyanide are a powerful technology for cyanide removal from industrial wastewaters. It has been previously demonstrated that the alkaliphilic bacterium Pseudomonas pseudoalcaligenes CECT5344 is able to use free cyanide and several metal -cyanide complexes as the sole nitrogen source. In this work, the strain CECT5344 has been used for detoxification of the different chemical forms of cyanide that are present in alkaline wastewaters from the jewelry industry. This liquid residue also contains large concentrations of metals like iron, copper and zinc, making this wastewater even more toxic. To elucidate the molecular mechanisms involved in the bioremediation process, a quantitative proteomic analysis by LC-MS/MS has been carried out in P. pseudoalcaligenes CECT5344 cells grown with the jewelry residue as sole nitrogen source. Different proteins related to cyanide and cyanate assimilation, as well as other proteins involved in transport and resistance to metals were induced by the cyanide-containing jewelry residue. GntR-like regulatory proteins were also induced by this industrial residue and mutational analysis revealed that GntR-like regulatory proteins may play a role in the regulation of cyanide assimilation in P. pseudoalcaligenes CECT5344. The strain CECT5344 has been used in a batch reactor to remove at pH 9 the different forms of cyanide present in industrial wastewaters from the jewelry industry (0.3 g/L, ca. 12 mM total cyanide, including both free cyanide and metal-cyanide complexes). This is the first report describing the biological removal at alkaline pH of such as elevated concentration of cyanide present in a heterogeneous mixture from an industrial source.	[Isabel Ibanez, Maria; Manuel Luque-Almagro, Victor; Saez, Lara P.; Olaya, Alfonso; Moreno-Vivian, Conrado; Dolores Roldan, Maria] Univ Cordoba, Dept Bioquim & Biol Mol, Edificio Severo Ochoa,Campus Rabanales, Cordoba, Spain; [Cabello, Purificacion] Univ Cordoba, Dept Bot Ecol & Fisiol Vegetal, Edificio Celestino Mutis,Campus Rabanales, Cordoba, Spain; [Sanchez de Medina, Veronica; Luque de Castro, Maria Dolores] Univ Cordoba, Dept Quim Analit, Edificio Marie Curie,Campus Rabanales, Cordoba, Spain	Universidad de Cordoba; Universidad de Cordoba; Universidad de Cordoba	Roldan, MD (corresponding author), Univ Cordoba, Dept Bioquim & Biol Mol, Edificio Severo Ochoa,Campus Rabanales, Cordoba, Spain.	bb2rorum@uco.es	Luque-Almagro, Victor M./A-3516-2011; Cabello, Purificación/K-2805-2014; Moreno, Conrado/K-3976-2014; Roldán Ruiz, María Dolores/K-4370-2014	Roldán Ruiz, María Dolores/0000-0001-7173-8641; Luque-Almagro, Victor M./0000-0003-1447-4795	Ministerio de Economia y Competitividad [BIO2015-64311-R]; FEDER, UE; Junta de Andalucia, Spain [CVI-7560]	Ministerio de Economia y Competitividad(Spanish Government); FEDER, UE(European Commission); Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission)	This work was funded by Grant BIO2015-64311-R (Ministerio de Economia y Competitividad and FEDER, UE), and Grant CVI-7560 (Junta de Andalucia, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed E, 2014, MICROB BIOTECHNOL, V7, P196, DOI 10.1111/1751-7915.12117; Akcil A, 2003, BIOTECHNOL LETT, V25, P445, DOI 10.1023/A:1022608213814; Akcil A, 2003, BIOTECHNOL ADV, V21, P501, DOI 10.1016/S0734-9750(03)00099-5; Akcil A, 2003, MINER ENG, V16, P643, DOI 10.1016/S0892-6875(03)00101-8; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ASHCROFT JR, 1975, BIOCHEM J, V148, P349, DOI 10.1042/bj1480349; ASMUS E, 1953, FRESEN Z ANAL CHEM, V138, P414, DOI 10.1007/BF00461093; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Dash RR, 2009, J HAZARD MATER, V163, P1, DOI 10.1016/j.jhazmat.2008.06.051; DUBEY SK, 1995, WORLD J MICROB BIOT, V11, P257, DOI 10.1007/BF00367095; Dulermo R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124358; Ebbs S, 2004, CURR OPIN BIOTECH, V15, P231, DOI 10.1016/j.copbio.2004.03.006; Estepa J, 2012, ENV MICROBIOL REP, V4, P326, DOI 10.1111/j.1758-2229.2012.00337.x; FRENZEL W, 1990, ANAL CHIM ACTA, V233, P77, DOI 10.1016/S0003-2670(00)83463-7; Gijzen HJ, 2000, WATER RES, V34, P2447, DOI 10.1016/S0043-1354(99)00418-2; Goncalves MMM, 1998, ENVIRON TECHNOL, V19, P133, DOI 10.1080/09593331908616665; GUERINOT ML, 1990, J BACTERIOL, V172, P3298, DOI 10.1128/jb.172.6.3298-3303.1990; Gupta N, 2010, J HAZARD MATER, V176, P1, DOI 10.1016/j.jhazmat.2009.11.038; Gurbuz F, 2004, HYDROMETALLURGY, V72, P167, DOI 10.1016/j.hydromet.2003.10.004; Gurbuz F, 2009, J HAZARD MATER, V162, P74, DOI 10.1016/j.jhazmat.2008.05.008; Haine V, 2005, INFECT IMMUN, V73, P5578, DOI 10.1128/IAI.73.9.5578-5586.2005; HAYDON DJ, 1991, FEMS MICROBIOL LETT, V79, P291, DOI 10.1016/0378-1097(91)90101-F; Huertas MJ, 2010, J HAZARD MATER, V179, P72, DOI 10.1016/j.jhazmat.2010.02.059; Huertas MJ, 2006, BIOCHEM SOC T, V34, P152, DOI 10.1042/BST0340152; Hynninen A, 2009, MOL MICROBIOL, V74, P384, DOI 10.1111/j.1365-2958.2009.06868.x; Johnstone TC, 2015, DALTON T, V44, P6320, DOI 10.1039/c4dt03559c; Kavanaugh M., 2003, CYANIDE FORMATION FA; Luque-Almagro VM, 2015, J BIOTECHNOL, V214, P171, DOI 10.1016/j.jbiotec.2015.09.032; Luque-Almagro VM, 2008, APPL ENVIRON MICROB, V74, P6280, DOI 10.1128/AEM.00916-08; Luque-Almagro VM, 2007, ENVIRON MICROBIOL, V9, P1541, DOI 10.1111/j.1462-2920.2007.01274.x; Luque-Almagro VM, 2016, CURR OPIN BIOTECH, V38, P9, DOI 10.1016/j.copbio.2015.12.004; Luque-Almagro VM, 2013, ENVIRON MICROBIOL, V15, P253, DOI 10.1111/j.1462-2920.2012.02875.x; Luque-Almagro VM, 2011, BIOCHEM SOC T, V39, P269, DOI 10.1042/BST0390269; Luque-Almagro VM, 2011, MICROBIOL-SGM, V157, P739, DOI 10.1099/mic.0.045286-0; Luque-Almagro VM, 2005, BIOCHEM SOC T, V33, P168, DOI 10.1042/BST0330168; Luque-Almagro VM, 2005, APPL ENVIRON MICROB, V71, P940, DOI 10.1128/AEM.71.2.940-947.2005; Manat G, 2014, MICROB DRUG RESIST, V20, P199, DOI 10.1089/mdr.2014.0035; Cobos IM, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0267-8; MILOSAVLJEVIC EB, 1995, ENVIRON SCI TECHNOL, V29, P426, DOI 10.1021/es00002a019; MORRISON GR, 1971, ANAL BIOCHEM, V43, P527, DOI 10.1016/0003-2697(71)90283-1; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Papaefstathiou I, 1996, FRESEN J ANAL CHEM, V354, P442; Patil YB, 2000, PROCESS BIOCHEM, V35, P1139, DOI 10.1016/S0032-9592(00)00150-3; Patil YB, 2000, LETT APPL MICROBIOL, V30, P33, DOI 10.1046/j.1472-765x.2000.00648.x; Quan ZX, 2006, J MICROBIOL BIOTECHN, V16, P232; Quesada A, 2007, APPL ENVIRON MICROB, V73, P5118, DOI 10.1128/AEM.00503-07; Rao MD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.383604; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Rigali S, 2002, J BIOL CHEM, V277, P12507, DOI 10.1074/jbc.M110968200; Sambrook J., 2001, MOL CLONING LAB MANU; SHAKIR FK, 1994, ANAL BIOCHEM, V216, P232, DOI 10.1006/abio.1994.1031; Snell FD, 1949, COLORIMETRIC METHODS; Sulistyarti H, 1999, ANAL CHIM ACTA, V390, P133, DOI 10.1016/S0003-2670(99)00158-0; Sulistyarti H, 1997, ANAL CHIM ACTA, V357, P103, DOI 10.1016/S0003-2670(97)00518-7; Truong-Bolduc QC, 2011, J BACTERIOL, V193, P6207, DOI 10.1128/JB.05847-11; Vallejo-Pecharroman B, 1999, ANALYST, V124, P1261, DOI 10.1039/a902443c; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wibberg D, 2016, J BIOTECHNOL, V232, P61, DOI 10.1016/j.jbiotec.2016.04.008; Wibberg D, 2014, J BIOTECHNOL, V175, P67, DOI 10.1016/j.jbiotec.2014.02.004; Zhou X, 2016, MOL PLANT PATHOL	61	15	15	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172908	10.1371/journal.pone.0172908	http://dx.doi.org/10.1371/journal.pone.0172908			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253357	Green Published, gold			2022-12-26	WOS:000396011300045
J	Marchand, V; Charlier, N; Verrax, J; Buc-Calderon, P; Leveque, P; Gallez, B				Marchand, Valerie; Charlier, Nicolas; Verrax, Julien; Buc-Calderon, Pedro; Leveque, Philippe; Gallez, Bernard			Use of a cocktail of spin traps for fingerprinting large range of free radicals in biological systems	PLOS ONE			English	Article							DNA RADICALS; HYDROGEN-PEROXIDE; IN-VIVO; CELLS; HEPATOCYTES; SUPEROXIDE; METABOLISM; MECHANISMS; STABILITY; HYDROXYL	It is well established that the formation of radical species centered on various atoms is involved in the mechanism leading to the development of several diseases or to the appearance of deleterious effects of toxic molecules. The detection of free radical is possible using Electron Paramagnetic Resonance (EPR) spectroscopy and the spin trapping technique. The classical EPR spin-trapping technique can be considered as a "hypothesis-driven" approach because it requires an a priori assumption regarding the nature of the free radical in order to select the most appropriate spin-trap. We here describe a "data-driven" approach using EPR and a cocktail of spin-traps. The rationale for using this cocktail was that it would cover a wide range of biologically relevant free radicals and have a large range of hydrophilicity and lipophilicity in order to trap free radicals produced in different cellular compartments. As a proof-of-concept, we validated the ability of the system to measure a large variety of free radicals (O-, N-, C-, or S-centered) in well characterized conditions, and we illustrated the ability of the technique to unambiguously detect free radical production in cells exposed to chemicals known to be radical-mediated toxic agents.	[Marchand, Valerie; Charlier, Nicolas; Leveque, Philippe; Gallez, Bernard] Catholic Univ Louvain, Louvain Drug Res Inst, Biomed Magnet Resonance Res Grp, Brussels, Belgium; [Verrax, Julien; Buc-Calderon, Pedro] Catholic Univ Louvain, Louvain Drug Res Inst, Toxicol & Canc Biol Res Grp, Brussels, Belgium; [Buc-Calderon, Pedro] Univ Arturo Prat, Fac Ciencias Salud, Iquique, Chile	Universite Catholique Louvain; Universite Catholique Louvain; Universidad Arturo Prat	Gallez, B (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Biomed Magnet Resonance Res Grp, Brussels, Belgium.	bernard.Gallez@uclouvain.be			Belgian National Fund for Scientific Research (FNRS); Televie; Actions de Recherches Concertees-Communaute Francaise de Belgique-ARC	Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Televie; Actions de Recherches Concertees-Communaute Francaise de Belgique-ARC	This work is supported by grants from the Belgian National Fund for Scientific Research (FNRS), the Televie, the "Actions de Recherches Concertees-Communaute Francaise de Belgique-ARC". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti A., 2008, SPIN TRAPPING ELECT, P285; Barr DP, 1996, J BIOL CHEM, V271, P15498, DOI 10.1074/jbc.271.26.15498; Cocheme HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003; Davies MJ., 2008, ELECT PARAMAGNETIC R, P427; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; FINKELSTEIN E, 1979, MOL PHARMACOL, V16, P676; Fontmorin JM, 2016, WATER RES, V99, P24, DOI 10.1016/j.watres.2016.04.053; Gomez-Mejiba SE, 2009, FREE RADICAL BIO MED, V46, P853, DOI 10.1016/j.freeradbiomed.2008.12.020; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Halliwell B, 2011, TRENDS PHARMACOL SCI, V32, P125, DOI 10.1016/j.tips.2010.12.002; Halliwell B, 2009, FREE RADICAL BIO MED, V46, P531, DOI 10.1016/j.freeradbiomed.2008.11.008; HANNA PM, 1992, ARCH BIOCHEM BIOPHYS, V296, P640, DOI 10.1016/0003-9861(92)90620-C; Hix S, 2000, CHEM RES TOXICOL, V13, P1056, DOI 10.1021/tx000130l; Irwin ME, 2013, ANTIOXID REDOX SIGN, V18, P1349, DOI 10.1089/ars.2011.4258; KALYANARAMAN B, 1985, J BIOL CHEM, V260, P4003; Khan N, 2003, FREE RADICAL BIO MED, V34, P1473, DOI 10.1016/S0891-5849(03)00182-5; KLEIN E, 1976, INT J CANCER, V18, P421, DOI 10.1002/ijc.2910180405; Leinisch F, 2011, CHEM RES TOXICOL, V24, P2217, DOI 10.1021/tx2003323; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Olive G, 2000, FREE RADICAL BIO MED, V28, P403, DOI 10.1016/S0891-5849(99)00254-3; Ramirez DC, 2007, NAT PROTOC, V2, P512, DOI 10.1038/nprot.2007.5; Ramirez DC, 2006, NAT METHODS, V3, P123, DOI 10.1038/NMETH852; Ranguelova K, 2011, MAGN RESON CHEM, V49, P152, DOI 10.1002/mrc.2709; RUBIN R, 1984, ARCH BIOCHEM BIOPHYS, V228, P450, DOI 10.1016/0003-9861(84)90010-9; SINHA BK, 1983, J BIOL CHEM, V258, P796; THOR H, 1982, J BIOL CHEM, V257, P2419; TIMMINS GS, 1993, CARCINOGENESIS, V14, P1615, DOI 10.1093/carcin/14.8.1615; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; YAMAGUCHI S, 1994, FREE RADICAL BIO MED, V17, P389, DOI 10.1016/0891-5849(94)90165-1	30	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172998	10.1371/journal.pone.0172998	http://dx.doi.org/10.1371/journal.pone.0172998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253308	Green Published, gold, Green Submitted			2022-12-26	WOS:000396011300056
J	Nabeta, P; Havumaki, J; Ha, DTM; Caceres, T; Hang, PT; Collantes, J; Lan, NTN; Gotuzzo, E; Denkinger, CM				Nabeta, Pamela; Havumaki, Joshua; Dang Thi Minh Ha; Caceres, Tatiana; Pham Thu Hang; Collantes, Jimena; Nguyen Thi Ngoc Lan; Gotuzzo, Eduardo; Denkinger, Claudia M.			Feasibility of the TBDx automated digital microscopy system for the diagnosis of pulmonary tuberculosis	PLOS ONE			English	Article							SPUTUM SMEAR MICROSCOPY; FLUORESCENCE	Background Improved and affordable diagnostic or triage tests are urgently needed at the microscopy centre level. Automated digital microscopy has the potential to overcome issues related to conventional microscopy, including training time requirement and inconsistencies in results interpretation. Methods For this blinded prospective study, sputum samples were collected from adults with presumptive pulmonary tuberculosis in Lima, Peru and Ho Chi Minh City, Vietnam. TBDx performance was evaluated as a stand-alone and as a triage test against conventional microscopy and Xpert, with culture as the reference standard. Xpert was used to confirm positive cases. Findings A total of 613 subjects were enrolled between October 2014 and March 2015, with 539 included in the final analysis. The sensitivity of TBDx was 62-2% (95% CI 56.6-67.4) and specificity was 90.7% (95% CI 85.9-94.2) compared to culture. The algorithm assessing TBDx as a triage test achieved a specificity of 100% while maintaining sensitivity. Interpretation While the diagnostic performance of TBDx did not reach the levels obtained by experienced microscopists in reference laboratories, it is conceivable that it would exceed the performance of less experienced microscopists. In the absence of highly sensitive and specific molecular tests at the microscopy centre level, TBDx in a triage-testing algorithm would optimize specificity and limit overall cost without compromising the number of patients receiving up-front drug susceptibility testing for rifampicin. However, the algorithm would miss over one third of patients compared to Xpert alone.	[Nabeta, Pamela; Havumaki, Joshua; Denkinger, Claudia M.] FIND, Geneva, Switzerland; [Dang Thi Minh Ha; Pham Thu Hang; Nguyen Thi Ngoc Lan] Pham Ngoc Thach Hosp, TB Dept, Ho Chi Minh City, Vietnam; [Caceres, Tatiana; Collantes, Jimena; Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander Von Humboldt, Lima, Peru	Foundation For Innovative New Diagnostics; Universidad Peruana Cayetano Heredia	Nabeta, P (corresponding author), FIND, Geneva, Switzerland.	pamela.nabeta@finddx.org		CACERES, TATIANA/0000-0003-0516-5202	FIND; Department for International Development UK [204074-101]; Australian Agency for International Development [70957]; Bill and Melinda Gates Foundation [OPP1018924]	FIND; Department for International Development UK; Australian Agency for International Development; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	FIND funded the study, who in turn received funding from: Department for International Development UK (grant no. 204074-101) https://www.gov.uk/government/organisations/department-for-international-development, Australian Agency for International Development (grant no. 70957) http://dfat.gov.au/aid/pages/australias-aid-program.aspx, Bill and Melinda Gates Foundation (grant no. OPP1018924) http://www.gatesfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, WORLDS MOST PORT MOL; Cavanaugh JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152364; Chang J, 2012, LECT NOTES COMPUT SC, V7512, P345, DOI 10.1007/978-3-642-33454-2_43; Denkinger CM, 2015, J INFECT DIS, V211, pS39, DOI 10.1093/infdis/jiu682; Hillemann D, 2005, INT J TUBERC LUNG D, V9, P1409; Ismail NA, 2015, AM J RESP CRIT CARE, V191, P1443, DOI 10.1164/rccm.201502-0390OC; Jha S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157554; Kent PT, 1985, GUIDE LEVEL 3 LAB; Lewis JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050173; Lumb R, 2013, LAB DIAGNOSIS TUBERC, P3; Miotto P, 2012, EUR RESPIR J, V39, P1269, DOI 10.1183/09031936.00124711; Pantoja A, 2015, J INFECT DIS, V211, pS67, DOI 10.1093/infdis/jiu820; Siddiqi SH, 2006, MGIT BACTEC MGIT 960; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Van Rie A, 2008, J CLIN MICROBIOL, V46, P897, DOI 10.1128/JCM.01553-07; WHO, 2015, WORLD HEAL ORGAN, V58, P7250; World Health Organization, 2014, DEF REP FRAM TUB 201; World Health Organization, 2014, XPERT MTB RIF IMPL M; World Health Organization, 2013, POL UPD XPERT MTB RI; World Health Organization, 2014, HIGH PRIOR TARG PROD; World Health Organization, 2012, NAT EHLTH STRAT TOOL; World Health Organization Geneva, 2014, GLOB TUB CONTR WHO R; World Health Organization (WHO), 2012, TUB LAB BIOS MAN	23	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173092	10.1371/journal.pone.0173092	http://dx.doi.org/10.1371/journal.pone.0173092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253302	Green Published, gold, Green Submitted			2022-12-26	WOS:000396011300070
J	Shahzad, H; Giribabu, N; Karim, K; Kassim, NM; Muniandy, S; Salleh, N				Shahzad, Huma; Giribabu, Nelli; Karim, Kamarulzaman; Kassim, Normadiah M.; Muniandy, Sekaran; Salleh, Naguib			Combinatorial effects of quercetin and sex-steroids on fluid and electrolytes' (Na+, Cl-, HCO3-) secretory mechanisms in the uterus of ovariectomised female Sprague-Dawley rats	PLOS ONE			English	Article							EPITHELIAL SODIUM-CHANNEL; PROLIFERATIVE CHANGES; ADENYLYL-CYCLASE; EXPRESSION; ESTROGEN; CELLS; CFTR; PROGESTERONE; GENISTEIN; IMPLANTATION	Dysregulation of uterine fluid environment could impair successful reproduction and this could be due to the effect of environmental estrogens. Therefore, in this study, effect of quercetin, an environmental estrogen on uterine fluid and electrolytes concentrations were investigated under sex-steroid influence. Ovariectomised adult female Sprague-Dawley rats were given 10, 50 or 100mg/kg/day quercetin subcutaneously with 17-beta estradiol (E) for seven days or three days E, then three days E plus progesterone (P) (E+P) treatment. Uterine fluid secretion rate, Na+, Cl- and HCO3- concentrations were determined by in-vivo perfusion. Following sacrifice, uteri were harvested and levels of the proteins of interest were identified by Western blotting and Realtime PCR. Distribution of these proteins in the uterus was observed by immunofluorescence. Levels of uterine cAMP were measured by enzyme-linked immunoassay (EIA). Administration of quercetin at increasing doses increased uterine fluid secretion rate, Na+, Cl- and HCO3- concentrations, but to the levels lesser than that of E. In concordant, levels of CFTR, SLC4A4, ENaC (alpha, beta and gamma), Na+/K+-ATPase, GP alpha/beta, AC and cAMP in the uterus increased following increased in the doses of quercetin. Co-administration of quercetin with E caused uterine fluid secretion rate, Na+, Cl- and HCO3- concentrations to decrease. In concordant, uterine CFTR, SLC26A6, SLC4A4, ENaC (alpha, beta and.), Na+/K+-ATPase, GP alpha/beta, AC and cAMP decreased. Greatest effects were observed following co-administration of 10mg/kg/day quercetin with E. Co-administration of quercetin with E+P caused uterine fluid Na+ and HCO3- concentrations to increase but no changes in fluid secretion rate and Cl- concentration were observed. Co-administration of high dose quercetin (100 mg/kg/day) with E+P caused uterine CFTR, SLC26A6, AC, GP alpha/beta and ENaC (alpha, beta and gamma) to increase. Quercetin-induced changes in the uterine fluid secretion rate and electrolytes concentrations could potentially affect the uterine reproductive functions under female sex-steroid influence.	[Shahzad, Huma; Giribabu, Nelli; Karim, Kamarulzaman; Salleh, Naguib] Univ Malaya, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia; [Kassim, Normadiah M.] Univ Malaya, Dept Anat, Fac Med, Kuala Lumpur, Malaysia; [Muniandy, Sekaran] MAHSA Univ, Fac Med & Biomed Sci, Dept Biochem, Jalan Elmu,Off Jalan Univ, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Mahsa University	Salleh, N (corresponding author), Univ Malaya, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia.	naguib.salleh@gmail.com	SALLEH, NAGUIB/T-6426-2019; karim, kamarulzaman/ABA-4335-2021; kassim, normadiah/AAH-1335-2019; Salleh, Naguib/ABG-6960-2021; Nelli, Giribabu/C-1203-2017	Salleh, Naguib/0000-0002-4926-0490; Nelli, Giribabu/0000-0003-1263-103X	PPP grants, University of Malaya, Kuala Lumpur, Malaysia [PG070-2014A, PG234-2015B]	PPP grants, University of Malaya, Kuala Lumpur, Malaysia	This study was funded by PPP grants (PG070-2014A and PG234-2015B), University of Malaya, Kuala Lumpur, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudouin-Legros M, 2008, CELL PHYSIOL BIOCHEM, V21, P75, DOI 10.1159/000113749; Bentin-Ley U, 2011, EUR J OBSTET GYN R B, V156, P60, DOI 10.1016/j.ejogrb.2010.12.040; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Chinigarzadeh A, 2016, ENV TOXICOLOGY; Chinigarzadeh A, 2015, THERIOGENOLOGY, V84, P911, DOI 10.1016/j.theriogenology.2015.05.029; Chinigarzadeh A, 2014, CLINICS, V69, P111, DOI 10.6061/clinics/2014(02)07; D'Andrea G, 2015, FITOTERAPIA, V106, P256, DOI 10.1016/j.fitote.2015.09.018; deMedina FS, 1997, LIFE SCI, V61, P2049; Deng WB, 2013, THERIOGENOLOGY, V79, P1196, DOI 10.1016/j.theriogenology.2013.02.018; Gholami K, 2014, RES VET SCI, V96, P164, DOI 10.1016/j.rvsc.2013.11.005; Gholami K, 2013, INT J MED SCI, V10, P1121, DOI 10.7150/ijms.5918; Gomes IBS, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-184; Hamilton JA, 1998, HUM REPROD, V13, P3357, DOI 10.1093/humrep/13.12.3357; Hofmann-Lehmann R, 2000, AIDS RES HUM RETROV, V16, P1247, DOI 10.1089/08892220050117014; Kapiszewska M, 2007, DRUG CHEM TOXICOL, V30, P67, DOI 10.1080/01480540601017710; Li Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030167; Lin PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062462; Lu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078446; Miodini P, 1999, BRIT J CANCER, V80, P1150, DOI 10.1038/sj.bjc.6690479; Mokhtar HM, 2014, J STEROID BIOCHEM, V144, P361, DOI 10.1016/j.jsbmb.2014.08.007; Monteiro MMO, 2012, MOLECULES, V17, P12997, DOI 10.3390/molecules171112997; Park S, 2013, GASTROENTEROLOGY, V145, P232, DOI 10.1053/j.gastro.2013.03.047; Revuelta MP, 1999, J AUTON PHARMACOL, V19, P353, DOI 10.1111/j.1365-2680.1999.tb00008.x; Salleh N, 2005, J MEMBRANE BIOL, V206, P17, DOI 10.1007/s00232-005-0770-7; Shahzad H, 2015, J MED FOOD, V18, P1307, DOI 10.1089/jmf.2014.3293; Shahzad H, 2014, INT J CLIN EXP PATHO, V7, P5484; SI YM, 1993, MOL REPROD DEV, V36, P89, DOI 10.1002/mrd.1080360113; Uchiyama H, 2007, BIOMED RES-TOKYO, V28, P239, DOI 10.2220/biomedres.28.239; Wang Q, 2014, J IMMUNOL, V192, P3765, DOI 10.4049/jimmunol.1302421; Wang XD, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/745262; Wang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1145, DOI 10.1152/ajpcell.00627.2004; Yang JZ, 2011, FERTIL STERIL, V95, P2100, DOI 10.1016/j.fertnstert.2011.02.036	32	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172765	10.1371/journal.pone.0172765	http://dx.doi.org/10.1371/journal.pone.0172765			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253299	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300031
J	Ding, ZH; Fu, LL; Yan, Y; Tie, WW; Xia, ZQ; Wang, WQ; Peng, M; Hu, W; Zhang, JM				Ding, Zehong; Fu, Lili; Yan, Yan; Tie, Weiwei; Xia, Zhiqiang; Wang, Wenquan; Peng, Ming; Hu, Wei; Zhang, Jiaming			Genome-wide characterization and expression profiling of HD-Zip gene family related to abiotic stress in cassava	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; WATER-DEFICIT; PROTEIN; PLANT; DIFFERENTIATION; EVOLUTION; RESPONSES; DOMAINS; AUXIN	Homeodomain-leucine zipper (HD-Zip) gene family plays important roles in various abiotic stresses and hormone signaling in plants. However, no information is currently available regarding this family in cassava (Manihot esculenta), an important drought-tolerant crop in tropical and sub-tropical areas. Here, 57 HD-Zip genes (MeHDZ01-57) were identified in the cassava genome, and they were classified into four subfamilies based on phylogenetic analysis, which was further supported by their gene structure and conserved motif characteristics. Of which five gene pairs were involved in segmental duplication but none for tandem duplication, suggesting that segmental duplication was the main cause for the expansion of MeHDZ gene family in cassava. Global expression profiles revealed that MeHDZ genes were constitutively expressed, or not expressed, or tissue-specific expressed in examined tissues in both cultivated and wild subspecies. Transcriptomic analysis of three genotypes showed that most of MeHDZ genes responded differently to drought and polyethylene glycol treatments. Subsequently, quantitative RT-PCR analysis revealed comprehensive responses of twelve selected MeHDZ genes to various stimuli including cold, salt, and ABA treatments. These findings will increase our understanding of HD-Zip gene family involved in abiotic stresses and signaling transduction, and will provide a solid base for further functional characterization of MeHDZ genes in cassava.	[Ding, Zehong; Fu, Lili; Yan, Yan; Tie, Weiwei; Xia, Zhiqiang; Wang, Wenquan; Peng, Ming; Hu, Wei; Zhang, Jiaming] Chinese Acad Trop Agr Sci, Key Lab Biol & Genet Resources Trop Crops, Inst Trop Biosci & Biotechnol, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences	Ding, ZH; Hu, W; Zhang, JM (corresponding author), Chinese Acad Trop Agr Sci, Key Lab Biol & Genet Resources Trop Crops, Inst Trop Biosci & Biotechnol, Haikou, Hainan, Peoples R China.	dingzehong@itbb.org.cn; huwei2010916@126.com; zhangjiaming@itbb.org.cn	Zhang, Jiaming/GSD-8224-2022	Wang, Wenquan/0000-0002-7603-3437	International Science and Technology Cooperation Program of China [2010DFA62040, 2014DFA30680]; Natural Science Foundation of China [31471561]; Natural Science Foundation of Hainan Province [20163120, 20153048]	International Science and Technology Cooperation Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hainan Province	This study was supported by the International Science and Technology Cooperation Program of China (2010DFA62040, 2014DFA30680), the Natural Science Foundation of China (31471561), and the Natural Science Foundation of Hainan Province (20163120, 20153048).	Abe M, 2003, DEVELOPMENT, V130, P635, DOI 10.1242/dev.00292; Agalou A, 2008, PLANT MOL BIOL, V66, P87, DOI 10.1007/s11103-007-9255-7; An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; Ariel F, 2010, PLANT CELL, V22, P2171, DOI 10.1105/tpc.110.074823; Ariel FD, 2007, TRENDS PLANT SCI, V12, P419, DOI 10.1016/j.tplants.2007.08.003; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Brandt R, 2014, J INTEGR PLANT BIOL, V56, P518, DOI 10.1111/jipb.12185; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087156; Chew W, 2013, INT J MOL SCI, V14, P8122, DOI 10.3390/ijms14048122; Deng X, 2002, PLANT MOL BIOL, V49, P601, DOI 10.1023/A:1015501205303; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elhiti M, 2009, PLANT SIGNAL BEHAV, V4, P86, DOI 10.4161/psb.4.2.7692; Fu LL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030283; Henriksson E, 2005, PLANT PHYSIOL, V139, P509, DOI 10.1104/pp.105.063461; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hu RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031149; Hu W, 2016, SCI REP-UK, V6, DOI 10.1038/srep22783; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; Ilegems M, 2010, DEVELOPMENT, V137, P975, DOI 10.1242/dev.047662; Johannesson H, 2003, PLANT MOL BIOL, V51, P719, DOI 10.1023/A:1022567625228; Khaja Razi, 2006, V338, P9; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Kubo H, 1999, PLANT CELL, V11, P1217, DOI 10.1105/tpc.11.7.1217; Lee YH, 2001, BIOCHEM BIOPH RES CO, V284, P133, DOI 10.1006/bbrc.2001.4904; Li Z, 2014, GENE, V533, P218, DOI 10.1016/j.gene.2013.09.084; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mukherjee K, 2006, PLANT PHYSIOL, V140, P1142, DOI 10.1104/pp.105.073833; Nakamura M, 2006, PLANT PHYSIOL, V141, P1363, DOI 10.1104/pp.106.077388; Palena CM, 1999, BIOCHEM J, V341, P81, DOI 10.1042/0264-6021:3410081; Sawa S, 2002, PLANT J, V32, P1011, DOI 10.1046/j.1365-313X.2002.01488.x; Schrick K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r41; Sessa G, 2005, GENE DEV, V19, P2811, DOI 10.1101/gad.364005; Soderman E, 1996, PLANT J, V10, P375, DOI 10.1046/j.1365-313X.1996.10020375.x; Soderman E, 1999, PLANT MOL BIOL, V40, P1073, DOI 10.1023/A:1006267013170; Steindler C, 1999, DEVELOPMENT, V126, P4235; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor N, 2004, PLANT MOL BIOL, V56, P671, DOI 10.1007/s11103-004-4872-x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Utsumi Y, 2012, DNA RES, V19, P335, DOI 10.1093/dnares/dss016; Wei F, 2016, SCI REP, V6; Wei YX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00025; Xu J, 2013, PLANT PHYSIOL, V161, P1517, DOI 10.1104/pp.112.212803; Yang YM, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms5564, 10.1038/ncomms6110]; Yu H, 2008, PLANT CELL, V20, P1134, DOI 10.1105/tpc.108.058263; Zhang CH, 2014, GENET MOL RES, V13, P2654, DOI 10.4238/2014.April.8.8; Zhang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08414; Zhao PJ, 2015, J EXP BOT, V66, P1477, DOI 10.1093/jxb/eru507; Zhao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028488	52	31	36	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173043	10.1371/journal.pone.0173043	http://dx.doi.org/10.1371/journal.pone.0173043			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249019	Green Submitted, Green Published, gold			2022-12-26	WOS:000395983500071
J	Das, S; Pawale, VS; Dadireddy, V; Singh, AK; Ramakumar, S; Roy, RP				Das, Sreetama; Pawale, Vijaykumar S.; Dadireddy, Venkatareddy; Singh, Avinash Kumar; Ramakumar, Suryanarayanarao; Roy, Rajendra P.			Structure and specificity of a new class of Ca2+-independent housekeeping sortase from Streptomyces avermitilis provide insights into its non-canonical substrate preference	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS SORTASE; GRAM-POSITIVE BACTERIA; SURFACE-PROTEINS; CELL-WALL; TRANSPEPTIDASE-SRTA; CRYSTAL-STRUCTURES; BIOFILM FORMATION; IN-VITRO; LIGATION; ENZYME	Surface proteins in Gram-positive bacteria are incorporated into the cell wall through a peptide ligation reaction catalyzed by transpeptidase sortase. Six main classes (A-F) of sortase have been identified of which class A sortase is meant for housekeeping functions. The prototypic housekeeping sortase A (SaSrtA) from Staphylococcus aureus cleaves LPXTG-containing proteins at the scissile T-G peptide bond and ligates protein-LPXT to the terminal Gly residue of the nascent cross-bridge of peptidoglycan lipid II precursor. Sortase-mediated ligation ("sortagging") of LPXTG-containing substrates and Gly-terminated nucleophiles occurs in vitro as well as in cellulo in the presence of Ca2+ and has been applied extensively for protein conjugations. Although the majority of applications emanate from SaSrtA, low catalytic efficiency, LPXTG specificity restriction, and Ca2+ requirement (particularly for in cellulo applications) remain a drawback. Given that Gram-positive bacteria genomes encode a variety of sortases, natural sortase mining can be a viable complementary approach akin to engineering of wildtype SaSrtA. Here, we describe the structure and specificity of a new class E sortase (SavSrtE) annotated to perform housekeeping roles in Streptomyces avermitilis. Biochemical experiments define the attributes of an optimum peptide substrate, demonstrate Ca2+-independent activity, and provide insights about contrasting functional characteristics of SavSrtE and SaSrtA. Crystal structure, substrate docking, and mutagenesis experiments have identified a critical residue that dictates the preference for a non-canonical LAXTG recognition motif over LPXTG. These results have implications for rational tailoring of substrate tolerance in sortases. Besides, Ca2+-independent orthogonal specificity of SavSrtE is likely to expand the sortagging toolkit.	[Das, Sreetama; Dadireddy, Venkatareddy; Ramakumar, Suryanarayanarao] Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India; [Pawale, Vijaykumar S.; Singh, Avinash Kumar; Roy, Rajendra P.] Natl Inst Immunol, Delhi 110067, India	Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Ramakumar, S (corresponding author), Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India.; Roy, RP (corresponding author), Natl Inst Immunol, Delhi 110067, India.	ramak@physics.iisc.ernet.in; rproy@nii.ac.in		Das, Sreetama/0000-0002-4523-8915; Singh, Avinash/0000-0002-1841-395X	Department of Biotechnology (Government of India)	Department of Biotechnology (Government of India)(Department of Biotechnology (DBT) India)	We thank Dr. S. Kumaran for helpful discussions and Sushma Nagpal for technical help with peptide synthesis. The National Institute of Immunology was supported by core grants from the Department of Biotechnology (Government of India).	Antos JM, 2016, CURR OPIN STRUC BIOL, V38, P111, DOI 10.1016/j.sbi.2016.05.021; Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Bentley ML, 2008, J BIOL CHEM, V283, P14762, DOI 10.1074/jbc.M800974200; Bentley ML, 2007, J BIOL CHEM, V282, P6571, DOI 10.1074/jbc.M610519200; Bierne H, 2002, MOL MICROBIOL, V43, P869, DOI 10.1046/j.1365-2958.2002.02798.x; Biswas T, 2014, BIOCHEMISTRY-US, V53, P2515, DOI 10.1021/bi4016023; Bradshaw WJ, 2015, FEBS J, V282, P2097, DOI 10.1111/febs.13288; Chambers CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09449; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Cossart P, 2000, P NATL ACAD SCI USA, V97, P5013, DOI 10.1073/pnas.97.10.5013; Dasgupta S, 2011, J BIOL CHEM, V286, P23996, DOI 10.1074/jbc.M111.247650; Doncheva NT, 2011, TRENDS BIOCHEM SCI, V36, P179, DOI 10.1016/j.tibs.2011.01.002; Dorr BM, 2014, P NATL ACAD SCI USA, V111, P13343, DOI 10.1073/pnas.1411179111; Douillard FP, 2014, J BIOL CHEM, V289, P15764, DOI 10.1074/jbc.M113.542332; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Duong A, 2012, MOL MICROBIOL, V83, P992, DOI 10.1111/j.1365-2958.2012.07983.x; Elliot MA, 2003, GENE DEV, V17, P1727, DOI 10.1101/gad.264403; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Frankel BA, 2007, BIOCHEMISTRY-US, V46, P7269, DOI 10.1021/bi700448e; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hirakawa H, 2012, BIOTECHNOL BIOENG, V109, P2955, DOI 10.1002/bit.24585; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kattke MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167763; Kharat AS, 2003, INFECT IMMUN, V71, P2758, DOI 10.1128/IAI.71.5.2758-2765.2003; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Levesque CM, 2005, INFECT IMMUN, V73, P3773, DOI 10.1128/IAI.73.6.3773-3777.2005; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mashiach E, 2010, NUCLEIC ACIDS RES, V38, pW457, DOI 10.1093/nar/gkq373; Matsumoto T, 2012, BIOTECHNOL J, V7, P642, DOI 10.1002/biot.201100213; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Novick RP, 2000, TRENDS MICROBIOL, V8, P148, DOI 10.1016/S0966-842X(00)01741-8; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P97, DOI 10.1016/S0966-842X(01)01956-4; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Piotukh K, 2011, J AM CHEM SOC, V133, P17536, DOI 10.1021/ja205630g; Popp MWL, 2011, ANGEW CHEM INT EDIT, V50, P5024, DOI 10.1002/anie.201008267; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Samantaray S, 2008, J AM CHEM SOC, V130, P2132, DOI 10.1021/ja077358g; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Strijbis K, 2012, TRAFFIC, V13, P780, DOI 10.1111/j.1600-0854.2012.01345.x; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Zhang J, 2013, J BIOSCI BIOENG, V116, P298, DOI 10.1016/j.jbiosc.2013.03.006; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200	64	10	10	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7244	7257		10.1074/jbc.M117.782037	http://dx.doi.org/10.1074/jbc.M117.782037			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28270507	Green Published, hybrid			2022-12-26	WOS:000400478300034
J	Hargrove, TY; Friggeri, L; Wawrzak, Z; Qi, AD; Hoekstra, WJ; Schotzinger, RJ; York, JD; Guengerich, FP; Lepesheva, GI				Hargrove, Tatiana Y.; Friggeri, Laura; Wawrzak, Zdzislaw; Qi, Aidong; Hoekstra, William J.; Schotzinger, Robert J.; York, John D.; Guengerich, F. Peter; Lepesheva, Galina I.			Structural analyses of Candida albicans sterol 14 alpha-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFECTIOUS-DISEASES SOCIETY; TRYPANOSOMA-CRUZI; CHAGAS-DISEASE; FLUCONAZOLE RESISTANCE; SUBSTRATE PREFERENCES; ANTIFUNGAL AGENTS; MURINE MODEL; AMINO-ACID; CYP51; TARGET	With some advances in modern medicine (such as cancer chemotherapy, broad exposure to antibiotics, and immunosuppression), the incidence of opportunistic fungal pathogens such as Candida albicans has increased. Cases of drug resistance among these pathogens have become more frequent, requiring the development of new drugs and a better understanding of the targeted enzymes. Sterol 14 alpha-demethylase (CYP51) is a cytochrome P450 enzyme required for biosynthesis of sterols in eukaryotic cells and is the major target of clinical drugs for managing fungal pathogens, but some of the CYP51 key features important for rational drug design have remained obscure. We report the catalytic properties, ligand-binding profiles, and inhibition of enzymatic activity of C. albicans CYP51 by clinical antifungal drugs that are used systemically (fluconazole, voriconazole, ketoconazole, itraconazole, and posaconazole) and topically (miconazole and clotrimazole) and by a tetrazolebased drug candidate, VT-1161 (oteseconazole: (R)-2-(2,4difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)-1-(5-(4(2,2,2-trifluoroethoxy)phenyl)pyridin-2-yl) propan-2-ol). Among the compounds tested, the first-line drug fluconazole was the weakest inhibitor, whereas posaconazole and VT-1161 were the strongest CYP51 inhibitors. We determined the X-ray structures of C. albicans CYP51 complexes with posaconazole and VT-1161, providing a molecular mechanism for the potencies of these drugs, including the activity of VT-1161 against Candida krusei and Candida glabrata, pathogens that are intrinsically resistant to fluconazole. Our comparative structural analysis outlines phylum-specific CYP51 features that could direct future rational development of more efficient broadspectrum antifungals.	[Hargrove, Tatiana Y.; Friggeri, Laura; Qi, Aidong; York, John D.; Guengerich, F. Peter; Lepesheva, Galina I.] Vanderbilt Univ, Sch Med, Dept Biochem, 622 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Wawrzak, Zdzislaw] Northwestern Univ, Life Sci Collaborat Access Team, Synchrotron Res Ctr, Argonne, IL 60439 USA; [Hoekstra, William J.; Schotzinger, Robert J.] Viamet Pharmaceut, Durham, NC 27703 USA; [Lepesheva, Galina I.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA	Vanderbilt University; Northwestern University; Vanderbilt University	Lepesheva, GI (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 622 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	galina.i.lepesheva@vanderbilt.edu			United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067871] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Vanderbilt University is a member institution of the Life Sciences Collaborative Access Team at Sector 21 of the Advanced Photon Source (Argonne, IL). Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Andriani G, 2013, J MED CHEM, V56, P2556, DOI 10.1021/jm400012e; Antinori S, 2016, EUR J INTERN MED, V34, P21, DOI 10.1016/j.ejim.2016.06.029; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Cherkesova TS, 2014, FEBS LETT, V588, P3878, DOI 10.1016/j.febslet.2014.08.030; Correia MA., 2005, CYTOCHROME P450 STRU, P246; Dantas AD, 2016, CURR OPIN MICROBIOL, V34, P111, DOI 10.1016/j.mib.2016.08.006; Denning DW, 2015, SCIENCE, V347, P1414, DOI 10.1126/science.aaa6097; Desai JV, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0005-2014; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ene IV, 2012, CELL MICROBIOL, V14, P1319, DOI 10.1111/j.1462-5822.2012.01813.x; Friggeri L, 2014, J MED CHEM, V57, P6704, DOI 10.1021/jm500739f; Garvey EP, 2015, ANTIMICROB AGENTS CH, V59, P5567, DOI 10.1128/AAC.00185-15; GOTOH O, 1992, J BIOL CHEM, V267, P83; Hargrove TY, 2016, J LIPID RES, V57, P1552, DOI 10.1194/jlr.M069229; Hargrove TY, 2015, J BIOL CHEM, V290, P23916, DOI 10.1074/jbc.M115.677310; Hargrove TY, 2013, J BIOL CHEM, V288, P31602, DOI 10.1074/jbc.M113.497990; Hargrove TY, 2012, J LIPID RES, V53, P311, DOI 10.1194/jlr.M021865; Hargrove TY, 2011, J BIOL CHEM, V286, P26838, DOI 10.1074/jbc.M111.237099; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hoekstra WJ, 2016, ANTIMICROB AGENTS CH, V60, P1058, DOI 10.1128/AAC.02287-15; Hoekstra WJ, 2014, BIOORG MED CHEM LETT, V24, P3455, DOI 10.1016/j.bmcl.2014.05.068; Jampilek J, 2016, FUTURE MED CHEM, V8, P1393, DOI 10.4155/fmc-2016-0124; Jeong W, 2016, J ANTIMICROB CHEMOTH, V71, P3540, DOI 10.1093/jac/dkw322; JOHNSON EM, 1983, J ANTIMICROB CHEMOTH, V12, P303, DOI 10.1093/jac/12.4.303; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399; Lass-Florl C, 2011, DRUGS, V71, P2405, DOI 10.2165/11596540-000000000-00000; Lepesheva GI, 2007, CHEM BIOL, V14, P1283, DOI 10.1016/j.chembiol.2007.10.011; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Lepesheva GI, 2015, J INFECT DIS, V212, P1439, DOI 10.1093/infdis/jiv228; Lepesheva GI, 2011, BBA-PROTEINS PROTEOM, V1814, P88, DOI 10.1016/j.bbapap.2010.06.006; Lepesheva GI, 2010, J BIOL CHEM, V285, P25582, DOI 10.1074/jbc.M110.133215; Lepesheva GI, 2010, J BIOL CHEM, V285, P1773, DOI 10.1074/jbc.M109.067470; Lepesheva GI, 2006, J BIOL CHEM, V281, P3577, DOI 10.1074/jbc.M510317200; Lepesheva GI, 2004, BIOCHEMISTRY-US, V43, P10789, DOI 10.1021/bi048967t; Lepesheva GI, 2001, J BIOL CHEM, V276, P28413, DOI 10.1074/jbc.M102767200; Lepesheva GI, 1999, BBA-PROTEIN STRUCT M, V1434, P31, DOI 10.1016/S0167-4838(99)00156-9; Lupetti A, 2002, TRENDS MOL MED, V8, P76, DOI 10.1016/S1471-4914(02)02280-3; Mane A, 2016, MYCOSES, V59, P93, DOI 10.1111/myc.12439; Marichal P, 1999, MICROBIOL-SGM, V145, P2701, DOI 10.1099/00221287-145-10-2701; Morio F, 2010, DIAGN MICR INFEC DIS, V66, P373, DOI 10.1016/j.diagmicrobio.2009.11.006; Morschhauser J, 2016, J MICROBIOL, V54, P192, DOI 10.1007/s12275-016-5628-4; Noble SM, 2017, NAT REV MICROBIOL, V15, P96, DOI 10.1038/nrmicro.2016.157; Pappas PG, 2016, CLIN INFECT DIS, V62, P409, DOI 10.1093/cid/civ1194; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; SAAG MS, 1988, ANTIMICROB AGENTS CH, V32, P1, DOI 10.1128/AAC.32.1.1; Schell WA, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01817-16, 10.1128/aac.01817-16]; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Vanden Bossche H, 1988, STEROL BIOSYNTHESIS, V79-119, P79; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Wilson DT, 2016, THER CLIN RISK MANAG, V12, P1197, DOI 10.2147/TCRM.S90335; Yapar N, 2014, THER CLIN RISK MANAG, V10, P95, DOI 10.2147/TCRM.S40160; Zhang WJ, 2002, DRUG METAB DISPOS, V30, P314, DOI 10.1124/dmd.30.3.314	56	155	159	3	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6728	6743		10.1074/jbc.M117.778308	http://dx.doi.org/10.1074/jbc.M117.778308			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28258218	Green Published, hybrid			2022-12-26	WOS:000399813400024
J	Sherrard, LJ; Tai, AS; Wee, BA; Ramsay, KA; Kidd, TJ; Ben Zakour, NL; Whiley, DM; Beatson, SA; Bell, SC				Sherrard, Laura J.; Tai, Anna S.; Wee, Bryan A.; Ramsay, Kay A.; Kidd, Timothy J.; Ben Zakour, Nouri L.; Whiley, David M.; Beatson, Scott A.; Bell, Scott C.			Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis	PLOS ONE			English	Article							TRANSMISSIBLE STRAINS; PHYLOGENETIC ANALYSIS; CONVERGENT EVOLUTION; LUNG INFECTIONS; TOOL; SUSCEPTIBILITY; REGULATOR; SEQUENCE; CLASSIFICATION; ADAPTATION	A Pseudomonas aeruginosa AUST-02 strain sub-type (M3L7) has been identified in Australia, infects the lungs of some people with cystic fibrosis and is associated with antibiotic resistance. Multiple clonal lineages may emerge during treatment with mutations in chromosomally encoded antibiotic resistance genes commonly observed. Here we describe the within-host diversity and antibiotic resistance of M3L7 during and after antibiotic treatment of an acute pulmonary exacerbation using whole genome sequencing and show both variation and shared mutations in important genes. Eleven isolates from an M3L7 population (n = 134) isolated over 3 months from an individual with cystic fibrosis underwent whole genome sequencing. A phylogeny based on core genome SNPs identified three distinct phylogenetic groups comprising two groups with higher rates of mutation (hypermutators) and one nonhypermutator group. Genomes were screened for acquired antibiotic resistance genes with the result suggesting that M3L7 resistance is principally driven by chromosomal mutations as no acquired mechanisms were detected. Small genetic variations, shared by all 11 isolates, were found in 49 genes associated with antibiotic resistance including frame-shift mutations (mexA, mex7), premature stop codons (oprD, mexB) and mutations in quinolone-resistance determining regions (gyrA, parE). However, whole genome sequencing also revealed mutations in 21 genes that were acquired following divergence of groups, which may also impact the activity of antibiotics and multi-drug efflux pumps. Comparison of mutations with minimum inhibitory concentrations of anti-pseudomonal antibiotics could not easily explain all resistance profiles observed. These data further demonstrate the complexity of chronic and antibiotic resistant P. aeruginosa infection where a multitude of co-existing genotypically diverse sub-lineages might co-exist during and after intravenous antibiotic treatment.	[Sherrard, Laura J.; Tai, Anna S.; Ramsay, Kay A.; Bell, Scott C.] QIMR Berghofer Med Res Inst, Lung Bacteria Grp, Brisbane, Qld, Australia; [Tai, Anna S.; Ramsay, Kay A.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Tai, Anna S.; Bell, Scott C.] Prince Charles Hosp, Adult Cyst Fibrosis Ctr, Dept Thorac Med, Brisbane, Qld, Australia; [Tai, Anna S.] Sir Charles Gairdner Hosp, Dept Resp Med, Western Australia Adult Cyst Fibrosis Ctr, Perth, WA, Australia; [Wee, Bryan A.; Kidd, Timothy J.; Ben Zakour, Nouri L.; Beatson, Scott A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Kidd, Timothy J.] Queens Univ Belfast, Ctr Med Expt, Belfast, Antrim, North Ireland; [Kidd, Timothy J.] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Whiley, David M.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Whiley, David M.] Pathol Queensland, Dept Microbiol, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; Prince Charles Hospital; University of Queensland; Queens University Belfast; University of Queensland; University of Queensland	Bell, SC (corresponding author), QIMR Berghofer Med Res Inst, Lung Bacteria Grp, Brisbane, Qld, Australia.; Bell, SC (corresponding author), Prince Charles Hosp, Adult Cyst Fibrosis Ctr, Dept Thorac Med, Brisbane, Qld, Australia.	Scott.Bell@qimrberghofer.edu.au	Beatson, Scott/B-6985-2013; Bell, Scott/AAJ-4298-2020; Whiley, David M/E-8955-2011; ZAKOUR, Nouri L BEN/B-9338-2011; Kidd, Timothy/F-2149-2010; Bell, Scott C/A-7241-2011; Wee, Bryan/AAP-3461-2021	Beatson, Scott/0000-0002-1806-3283; Bell, Scott/0000-0001-8651-7139; Whiley, David M/0000-0001-5969-3161; ZAKOUR, Nouri L BEN/0000-0002-6949-1755; Kidd, Timothy/0000-0002-6135-6364; Bell, Scott C/0000-0001-8651-7139; Wee, Bryan/0000-0001-6135-5903	National Health and Medical Research Council [NHMRC: 455919]; Australian Infectious Diseases Research Centre (QIMRB-UQ seed grant); TPCH Foundation grant [MS2013-02]; Perpetual [AR01822]; Shelley Shephard Memorial Scholarship; NHMRC medical and dental Postgraduate Scholarship; Australian Cystic Fibrosis Research Trust Postgraduate Scholarship; Airways Infections, Inflammation & Cystic Fibrosis Group Scholarship; Queensland Health; Health Research Fellowship; NHMRC; CF Foundation Therapeutics (USA); TPCH Foundation; Childrens Health Foundation, Queensland; NHMRC [APP1090456, GNT1088448]; Australian Postgraduate Award; ERSEU RESPIRE2 Marie Sklodowska-Curie Postdoctoral Research Fellowship [4571-2013]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Infectious Diseases Research Centre (QIMRB-UQ seed grant); TPCH Foundation grant; Perpetual; Shelley Shephard Memorial Scholarship; NHMRC medical and dental Postgraduate Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Australian Cystic Fibrosis Research Trust Postgraduate Scholarship; Airways Infections, Inflammation & Cystic Fibrosis Group Scholarship; Queensland Health; Health Research Fellowship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CF Foundation Therapeutics (USA); TPCH Foundation; Childrens Health Foundation, Queensland; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); ERSEU RESPIRE2 Marie Sklodowska-Curie Postdoctoral Research Fellowship	This work was supported by project grant funding from the National Health and Medical Research Council (NHMRC: 455919), Australian Infectious Diseases Research Centre (QIMRB-UQ seed grant), TPCH Foundation grant (MS2013-02) and Perpetual (AR01822). L.J.S. is the recipient of The Shelley Shephard Memorial Scholarship. A.S.T is the recipient of NHMRC medical and dental Postgraduate Scholarship, Australian Cystic Fibrosis Research Trust Postgraduate Scholarship and Airways Infections, Inflammation & Cystic Fibrosis Group Scholarship. S.C.B. is the recipient of a Queensland Health, Health Research Fellowship and receives grant support from the NHMRC, CF Foundation Therapeutics (USA), TPCH Foundation and Childrens Health Foundation, Queensland. S.A.B. is the recipient of a NHMRC Fellowship (APP1090456). K.A.R. is the recipient of an Australian Postgraduate Award, PhD Scholarship. T.J.K is the recipient of an ERSEU RESPIRE2 Marie Sklodowska-Curie Postdoctoral Research Fellowship (MC RESPIRE2 first round, grant number 4571-2013) and a NHMRC Early Career Fellowship (GNT1088448). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2010, JAMA-J AM MED ASSOC, V304, P2145, DOI 10.1001/jama.2010.1665; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Bruchmann S, 2013, ANTIMICROB AGENTS CH, V57, P1361, DOI 10.1128/AAC.01581-12; Caballero JD, 2015, MBIO, V6, DOI 10.1128/mBio.00981-15; Caille O, 2014, J BACTERIOL, V196, P3890, DOI 10.1128/JB.01997-14; Campbell CT, 2016, ANN PHARMACOTHER, V50, P133, DOI 10.1177/1060028015621916; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Christensen LD, 2012, J ANTIMICROB CHEMOTH, V67, P1198, DOI 10.1093/jac/dks002; Chung JCS, 2012, J BACTERIOL, V194, P4857, DOI 10.1128/JB.01050-12; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; Croucher NJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1196; Cystic Fibrosis Trust, 2015, UK CYST FIBR REG 201; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dassner AM, 2016, INFECT DIS THER; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Dettman JR, 2013, P NATL ACAD SCI USA, V110, P21065, DOI 10.1073/pnas.1307862110; Feliziani S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004651; Fothergill JL, 2012, EUR RESPIR J, V40, P227, DOI 10.1183/09031936.00204411; George PM, 2011, BMJ-BRIT MED J, V342, pd1008, DOI DOI 10.1136/BMJ; Hurley MN, 2012, J CYST FIBROS, V11, P288, DOI 10.1016/j.jcf.2012.02.006; Jones AM, 2002, THORAX, V57, P924, DOI 10.1136/thorax.57.11.924; Jorth P, 2015, CELL HOST MICROBE, V18, P307, DOI 10.1016/j.chom.2015.07.006; Kidd TJ, 2015, LANCET RESP MED, V3, P640, DOI 10.1016/S2213-2600(15)00228-3; Kidd TJ, 2013, EUR RESPIR J, V41, P1091, DOI 10.1183/09031936.00060512; Kohler T, 1999, J BACTERIOL, V181, P6300; Kos VN, 2015, ANTIMICROB AGENTS CH, V59, P427, DOI 10.1128/AAC.03954-14; Marvig RL, 2015, NAT GENET, V47, P57, DOI 10.1038/ng.3148; Marvig RL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003741; Maseda H, 2000, FEMS MICROBIOL LETT, V192, P107, DOI 10.1016/S0378-1097(00)00419-5; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; O'Carroll MR, 2004, EUR RESPIR J, V24, P101, DOI 10.1183/09031936.04.00122903; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Parkins MD, 2012, CHEST, V141, P485, DOI 10.1378/chest.11-0917; Piddock LJV, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.120, 10.1038/nmicrobiol.2016.120]; Prickett MH, 2017, THORAX, V72, P40, DOI 10.1136/thoraxjnl-2015-208027; Robinson P, 2003, J CLIN MICROBIOL, V41, P5741, DOI 10.1128/JCM.41.12.5741.2003; Rodriguez-Martinez JM, 2009, ANTIMICROB AGENTS CH, V53, P1766, DOI 10.1128/AAC.01410-08; Sanbongi Y, 2009, MICROBIOL IMMUNOL, V53, P361, DOI 10.1111/j.1348-0421.2009.00137.x; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Smith AL, 2003, CHEST, V123, P1495, DOI 10.1378/chest.123.5.1495; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Syrmis MW, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-307; Tai AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144022; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Wick Ryan R, 2015, Bioinformatics, V31, P3350, DOI 10.1093/bioinformatics/btv383; Williams D, 2015, AM J RESP CRIT CARE, V191, P775, DOI 10.1164/rccm.201409-1646OC; Wolter DJ, 2008, CLIN INFECT DIS, V46, pE137, DOI 10.1086/588484; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang HK, 2012, NUCLEIC ACIDS RES, V40, pW569, DOI 10.1093/nar/gks576; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	57	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172179	10.1371/journal.pone.0172179	http://dx.doi.org/10.1371/journal.pone.0172179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273168	Green Published, gold			2022-12-26	WOS:000396073700068
J	Walters, MS; Salit, J; Ju, JH; Staudt, MR; Kaner, RJ; Rogalski, AM; Sodeinde, TB; Rahim, R; Strulovici-Barel, Y; Mezey, JG; Almulla, AM; Sattar, H; Mahmoud, M; Crystal, RG				Walters, Matthew S.; Salit, Jacqueline; Ju, Jin Hyun; Staudt, Michelle R.; Kaner, Robert J.; Rogalski, Allison M.; Sodeinde, Teniola B.; Rahim, Riyaad; Strulovici-Barel, Yael; Mezey, Jason G.; Almulla, Ahmad M.; Sattar, Hisham; Mahmoud, Mai; Crystal, Ronald G.			Waterpipe smoking induces epigenetic changes in the small airway epithelium	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ENDOPLASMIC-RETICULUM STRESS; GENOME-WIDE METHYLATION; DNA METHYLATION; CIGARETTE-SMOKING; GENE-EXPRESSION; CARCINOGENIC PAH; TOBACCO SMOKING; LUNG; PROTEOSTASIS	Waterpipe (also called hookah, shisha, or narghile) smoking is a common form of tobacco use in the Middle East. Its use is becoming more prevalent in Western societies, especially among young adults as an alternative form of tobacco use to traditional cigarettes. While the risk to cigarette smoking is well documented, the risk to waterpipe smoking is not well defined with limited information on its health impact at the epidemiologic, clinical and biologic levels with respect to lung disease. Based on the knowledge that airway epithelial cell DNA methylation is modified in response to cigarette smoke and in cigarette smoking-related lung diseases, we assessed the impact of light-use waterpipe smoking on DNA methylation of the small airway epithelium (SAE) and whether changes in methylation were linked to the transcriptional output of the cells. Small airway epithelium was obtained from 7 nonsmokers and 7 light-use (2.6 +/- 1.7 sessions/wk) waterpipe-only smokers. Genome-wide comparison of SAE DNA methylation of waterpipe smokers to nonsmokers identified 727 probesets differentially methylated (fold-change >1.5, p<0.05) representing 673 unique genes. Dominant pathways associated with these epigenetic changes include those linked to G-protein coupled receptor signaling, aryl hydrocarbon receptor signaling and xenobiotic metabolism signaling, all of which have been associated with cigarette smoking and lung disease. Of the genes differentially methylated, 11.3% exhibited a corresponding significant (p<0.05) change in gene expression with enrichment in pathways related to regulation of mRNA translation and protein synthesis (eIF2 signaling and regulation of eIF4 and p70S6K signaling). Overall, these data demonstrate that light-use waterpipe smoking is associated with epigenetic changes and related transcriptional modifications in the SAE, the cell population demonstrating the earliest pathologic abnormalities associated with chronic cigarette smoking.	[Walters, Matthew S.; Salit, Jacqueline; Ju, Jin Hyun; Staudt, Michelle R.; Kaner, Robert J.; Rogalski, Allison M.; Sodeinde, Teniola B.; Rahim, Riyaad; Strulovici-Barel, Yael; Mezey, Jason G.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA; [Kaner, Robert J.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Almulla, Ahmad M.; Sattar, Hisham] Hamad Med Corp, Pulm Sect, Doha, Qatar; [Mahmoud, Mai] Weill Cornell Med Coll, Doha, Qatar; [Walters, Matthew S.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Pulm,Crit Care & Sleep Med, Oklahoma City, OK USA	Cornell University; Cornell University; Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Oklahoma System; University of Oklahoma Health Sciences Center	Crystal, RG (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA.; Crystal, RG (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	geneticmedicine@med.cornell.edu		Staudt, Michelle/0000-0002-3364-0894; AlMulla, Dr. Ahmad/0000-0001-6550-6879; Walters, Matthew/0000-0003-0010-8444	National Heart, Lung, and Blood Institute [HL107882, HL107882-251, P20 HL113443]; National Institutes of Health [UL1 TR000457, RR024143]; Qatar National Research Fund [NPRP 09-742-3-194]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Qatar National Research Fund(Qatar National Research Fund (QNRF))	This work was supported by the National Heart, Lung, and Blood Institute through grants HL107882, HL107882-251 and P20 HL113443 to RGC, by the National Institutes of Health through grants UL1 TR000457 and RR024143 and by the Qatar National Research Fund through grant NPRP 09-742-3-194 to MSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl EA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-244; Al Rashidi M, 2008, FOOD CHEM TOXICOL, V46, P3546, DOI 10.1016/j.fct.2008.09.007; American Lung Association SCP, 2012, HOOK SMOK GROW THREA; Aslam Hafiz Muhammad, 2014, Int Arch Med, V7, P16, DOI 10.1186/1755-7682-7-16; AUERBACH O, 1957, NEW ENGL J MED, V256, P97, DOI 10.1056/NEJM195701172560301; Beane J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r201; Buro-Auriemma LJ, 2013, HUM MOL GENET, V22, P4726, DOI 10.1093/hmg/ddt326; Cervantes-Ortiz SL, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050124; Cobb CO, 2011, NICOTINE TOB RES, V13, P78, DOI 10.1093/ntr/ntq212; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Eissenberg T, 2009, AM J PREV MED, V37, P518, DOI 10.1016/j.amepre.2009.07.014; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hackett NR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-82; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Honeyman L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-16; Huang SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107055; Hukkanen J, 2002, CRIT REV TOXICOL, V32, P391, DOI 10.1080/20024091064273; Jeltsch A, 2014, TRENDS BIOCHEM SCI, V39, P310, DOI 10.1016/j.tibs.2014.05.002; Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001; Kelsen SG, 2012, PULM PHARMACOL THER, V25, P447, DOI 10.1016/j.pupt.2012.07.005; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Kim YJ, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-39; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Marcinak Stefan J, 2010, Proc Am Thorac Soc, V7, P356, DOI 10.1513/pats.201001-015AW; Maziak W, 2015, TOB CONTROL, V24, P3, DOI 10.1136/tobaccocontrol-2014-051903; Maziak W, 2011, ADDICT BEHAV, V36, P1, DOI 10.1016/j.addbeh.2010.08.030; Monzer B, 2008, FOOD CHEM TOXICOL, V46, P2991, DOI 10.1016/j.fct.2008.05.031; Moyer TP, 2002, CLIN CHEM, V48, P1460; Nicodemus-Johnson J, 2016, AM J RESP CRIT CARE, V193, P376, DOI 10.1164/rccm.201506-1243OC; Oakes SA, 2015, ANNU REV PATHOL-MECH, V10, P173, DOI 10.1146/annurev-pathol-012513-104649; Osorio F, 2013, SEMIN IMMUNOPATHOL, V35, P293, DOI 10.1007/s00281-013-0368-6; Pascual M, 2011, EPIGENETICS-US, V6, P1131, DOI 10.4161/epi.6.9.16061; Qiu WL, 2012, AM J RESP CRIT CARE, V185, P373, DOI 10.1164/rccm.201108-1382OC; Rabinovich EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033770; Raman T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-493; Roux PP, 2012, COLD SPRING HARB PER, V4; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Sanders YY, 2012, AM J RESP CRIT CARE, V186, P525, DOI 10.1164/rccm.201201-0077OC; Schaal C, 2014, MOL CANCER RES, V12, P14, DOI 10.1158/1541-7786.MCR-13-0541; Schivo M, 2014, CLIN REV ALLERG IMMU, V46, P34, DOI 10.1007/s12016-013-8372-0; Schubert J, 2013, TALANTA, V115, P665, DOI 10.1016/j.talanta.2013.06.022; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Sepetdjian E, 2013, NICOTINE TOB RES, V15, P1107, DOI 10.1093/ntr/nts255; Sepetdjian E, 2010, FOOD CHEM TOXICOL, V48, P3242, DOI 10.1016/j.fct.2010.08.033; Shihadeh A, 2015, TOB CONTROL, V24, P22, DOI 10.1136/tobaccocontrol-2014-051907; Smith-Simone S, 2008, NICOTINE TOB RES, V10, P393, DOI 10.1080/14622200701825023; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Staudt MR, 2014, AM J RESP CRIT CARE, V190, P955, DOI 10.1164/rccm.201406-1167LE; Stefanowicz D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044213; Steffen KK, 2016, CELL METAB, V23, P1004, DOI 10.1016/j.cmet.2016.05.013; Steiling K, 2013, AM J RESP CRIT CARE, V187, P933, DOI 10.1164/rccm.201208-1449OC; Strulovici-Barel Y, 2016, AM J RESP CRIT CARE; Thompson RF, 2008, BIOINFORMATICS, V24, P1161, DOI 10.1093/bioinformatics/btn096; Tilley AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022798; (TobReg) WSGoTPR, 2005, WAT TOB SMOK HLTH EF; Tsaprouni LG, 2014, EPIGENETICS-US, V9, P1382, DOI 10.4161/15592294.2014.969637; van 't Wout EFA, 2014, AM J RESP CELL MOL, V50, P1005, DOI 10.1165/rcmb.2014-0019TR; Vucic EA, 2014, AM J RESP CELL MOL, V50, P912, DOI 10.1165/rcmb.2013-0304OC; Wan ES, 2015, AM J RESP CELL MOL, V53, P246, DOI 10.1165/rcmb.2014-0103OC; Wei J, 2013, CHEST, V143, P1098, DOI 10.1378/chest.12-2133; Whalen R, 1998, SEMIN LIVER DIS, V18, P345, DOI 10.1055/s-2007-1007169; Yang IV, 2014, AM J RESP CRIT CARE, V190, P1263, DOI 10.1164/rccm.201408-1452OC; Yoo S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004898; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812	66	21	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171112	10.1371/journal.pone.0171112	http://dx.doi.org/10.1371/journal.pone.0171112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273093	Green Submitted, Green Published, gold			2022-12-26	WOS:000396073700093
J	Lai, SH; Liao, SL; Tsai, MH; Hua, MC; Chiu, CY; Yeh, KW; Yao, TC; Huang, JL				Lai, Shen-Hao; Liao, Sui-Ling; Tsai, Ming-Han; Hua, Man-Chin; Chiu, Chih-Yung; Yeh, Kuo-Wei; Yao, Tsung-Chieh; Huang, Jing-Long			Low cord-serum 25-hydroxyvitamin D levels are associated with poor lung function performance and increased respiratory infection in infancy	PLOS ONE			English	Article							VITAMIN-D; 1,25-DIHYDROXYVITAMIN D-3; WHEEZE; RISK; CHILDREN; ASTHMA; BIRTH; SENSITIZATION; PREVENTION; PREGNANCY	Background Perinatal vitamin D deficiency is associated with a higher risk of wheezing in childhood. However, the relationship between vitamin D levels and lung function in infancy has not been investigated. The aim of this study was to investigate the impact of perinatal vitamin D levels on respiratory function and disease outcome in infancy. Materials and methods Full-term infants without any chronic diseases or major anomalies were enrolled in the Prediction of Allergies in Taiwanese Children cohort study. Maternal and cord blood were collected for determining the 25(OH)D level. Questionnaires were recorded at birth and 6 months of age. Infant lung function, including tidal breathing analysis, respiratory mechanics, and forced tidal expiration, was tested at 6 months of age. Results A total of 122 mother infant pairs were enrolled in this study, and 71 infants underwent lung function testing at 6 months of age. 25(OH)D levels in maternal and cord serum were highly correlated (r(2) = 0.457, p < 0.0001). Infants with lower cord serum 25(OH)D levels (< 13.7 ng/ml) had higher resistance of respiratory system (p < 0.01) and a higher risk of a respiratory tract infection before the age of 6 months (p < 0.01). Conclusion Although a high correlation was found between maternal and cord vitamin D levels, the effect on respiratory outcome was different. Our study is the first to show that low cord 25(OH)D levels significantly relationship with poorer lung function performance and higher likelihood of a respiratory tract infection before 6 months of age.	[Lai, Shen-Hao; Yeh, Kuo-Wei; Yao, Tsung-Chieh; Huang, Jing-Long] Chang Gung Mem Hosp, Dept Pediat, Linkou Branch, Taoyuan, Taiwan; [Lai, Shen-Hao; Liao, Sui-Ling; Tsai, Ming-Han; Hua, Man-Chin; Chiu, Chih-Yung; Yeh, Kuo-Wei; Yao, Tsung-Chieh; Huang, Jing-Long] Chang Gung Univ, Dept Pediat, Taoyuan, Taiwan; [Lai, Shen-Hao; Liao, Sui-Ling; Tsai, Ming-Han; Hua, Man-Chin; Chiu, Chih-Yung; Yeh, Kuo-Wei; Yao, Tsung-Chieh; Huang, Jing-Long] Predict Allergies Taiwanese Children PATCH Cohort, Keelung, Taiwan; [Liao, Sui-Ling; Tsai, Ming-Han; Hua, Man-Chin; Chiu, Chih-Yung] Chang Gung Mem Hosp, Keelung Branch, Dept Pediat, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Yao, TC; Huang, JL (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Linkou Branch, Taoyuan, Taiwan.; Yao, TC; Huang, JL (corresponding author), Chang Gung Univ, Dept Pediat, Taoyuan, Taiwan.; Yao, TC; Huang, JL (corresponding author), Predict Allergies Taiwanese Children PATCH Cohort, Keelung, Taiwan.	yaotcmail@gmail.com; hjlong0182@gmail.com	Chiu, CY/Q-4238-2019; Yeh, Kuo-Wei/V-3725-2019	Huang, Jing-Long/0000-0002-3530-7753; Huang, Jing-Long/0000-0001-9280-920X				Bailey D, 2014, CLIN BIOCHEM, V47, P816, DOI 10.1016/j.clinbiochem.2014.01.015; Bailey D, 2013, CLIN BIOCHEM, V46, P190, DOI 10.1016/j.clinbiochem.2012.10.037; Baiz N, 2014, J ALLERGY CLIN IMMUN, V133, P147, DOI 10.1016/j.jaci.2013.05.017; Bates JHT, 2000, EUR RESPIR J, V16, P1180, DOI 10.1034/j.1399-3003.2000.16f26.x; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Brehm JM, 2010, J ALLERGY CLIN IMMUN, V126, P52, DOI 10.1016/j.jaci.2010.03.043; Camargo CA, 2007, AM J CLIN NUTR, V85, P788, DOI 10.1093/ajcn/85.3.788; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; CARLSEN KH, 1994, EUR RESPIR J, V7, P2154, DOI 10.1183/09031936.94.07122154; Carroll KN, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.002; Chawes BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099856; Chiu CY, 2015, PEDIAT ALLERG IMM-UK, V26, P337, DOI 10.1111/pai.12384; Cremers E, 2011, THORAX, V66, P474, DOI 10.1136/thx.2010.151985; DUNDAS I, 1995, AM J RESP CRIT CARE, V151, P1451, DOI 10.1164/ajrccm.151.5.7735599; Emmen JMA, 2012, CLIN CHEM LAB MED, V50, P1969, DOI 10.1515/cclm-2011-0085; Frey U, 2000, EUR RESPIR J, V16, P731, DOI 10.1034/j.1399-3003.2000.16d28.x; Gappa M, 2001, EUR RESPIR J, V17, P141, DOI 10.1183/09031936.01.17101410; GAPPA M, 1993, PEDIATR PULM, V15, P304, DOI 10.1002/ppul.1950150508; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Greer FR, 2008, AM J CLIN NUTR, V88, p529S, DOI 10.1093/ajcn/88.2.529S; Gunville Cameron F., 2013, Inflammation & Allergy Drug Targets, V12, P239; Haland G, 2006, NEW ENGL J MED, V355, P1682, DOI 10.1056/NEJMoa052885; Hammar KS, 2014, ACTA PAEDIATR, V103, P856, DOI 10.1111/apa.12666; Hendolin PH, 2000, J CLIN MICROBIOL, V38, P125; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Kim DH, 2008, AM J CARDIOL, V102, P1540, DOI 10.1016/j.amjcard.2008.06.067; Kinder BW, 2011, EXPERT REV CLIN IMMU, V7, P255, DOI [10.1586/eci.11.12, 10.1586/ECI.11.12]; Koistinen A, 2014, PEDIAT ALLERG IMM-UK, V25, P834, DOI 10.1111/pai.12308; Lai SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142797; Larose TL, 2015, EUR RESPIR J, V45, P1019, DOI 10.1183/09031936.00069714; Liao SL, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8175898; Liao SL, 2014, PEDIAT ALLERG IMM-UK, V25, P456, DOI 10.1111/pai.12247; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Modl M, 2000, AM J RESP CRIT CARE, V161, P763, DOI 10.1164/ajrccm.161.3.9812063; Niruban SJ, 2014, EUR J CLIN NUTR, V68, P1334, DOI 10.1038/ejcn.2014.121; Pike KC, 2012, THORAX, V67, P950, DOI 10.1136/thoraxjnl-2012-201888; Ren CL, 2014, PEDIATR PULM, V49, P1251, DOI 10.1002/ppul.23012; Rothers J, 2011, J ALLERGY CLIN IMMUN, V128, P1093, DOI 10.1016/j.jaci.2011.07.015; Saraf R., 2015, MATERN CHILD NUTR; Sly PD, 2000, EUR RESPIR J, V16, P741, DOI 10.1034/j.1399-3003.2000.16d29.x; Stelmach I, 2015, RESP MED, V109, P38, DOI 10.1016/j.rmed.2014.10.016; Stocks J, 2005, PROG RESPIR RES, V33, P78; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; Trump DL, 2010, CANCER J, V16, P1, DOI 10.1097/PPO.0b013e3181c51ee6; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; Visness CM, 2015, J ALLERGY CLIN IMMUN, V136, P1108, DOI 10.1016/j.jaci.2015.03.046; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Weisse K, 2013, ALLERGY, V68, P220, DOI 10.1111/all.12081; White JH, 2010, J STEROID BIOCHEM, V121, P234, DOI 10.1016/j.jsbmb.2010.03.034; Wu YW, 2014, PSYCHIAT DANUB, V26, P152; Yao TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099105; Young S, 2000, EUR RESPIR J, V15, P151, DOI 10.1034/j.1399-3003.2000.15a28.x; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	54	15	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173268	10.1371/journal.pone.0173268	http://dx.doi.org/10.1371/journal.pone.0173268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267792	Green Submitted, gold, Green Published			2022-12-26	WOS:000396060600018
J	Momen, NC; Ernst, A; Arendt, LH; Olsen, J; Li, J; Gissler, M; Rasmussen, F; Ramlau-Hansen, CH				Momen, Natalie C.; Ernst, Andreas; Arendt, Linn Hakonsen; Olsen, Jorn; Li, Jiong; Gissler, Mika; Rasmussen, Finn; Ramlau-Hansen, Cecilia Host			Maternal cancer and congenital anomalies in children - a Danish nationwide cohort study	PLOS ONE			English	Article							PREGNANCY-ASSOCIATED CANCER; BIRTH; MALFORMATIONS; RISK; PATIENT	Several studies on pregnancy-associated cancers have suggested an association with congenital anomalies in offspring. Previous studies have included maternal cancers diagnosed up to 2 years after pregnancy; however, long latency periods of some cancers mean that cancers diagnosed many years postpartum might have been present during pregnancy in a preclinical state. This paper considers the association between maternal cancers diagnosed from 2 years prior to pregnancy until the mother reaches 50 years of age, and congenital anomalies, as diagnosed at birth or within the first year of life. The current population-based study looks at associations of cancers in mothers with congenital anomalies in their children. Children were followed up from birth to diagnosis of a congenital anomaly, death, emigration or end of follow-up (whichever occurred first). A total of 56,016 children (2.6%) were considered exposed to a maternal cancer of any type; and they had a hazard ratio (HR) of 1.04 (95% confidence interval [CI]: 1.00, 1.09) compared with unexposed children. The greatest HR was seen among children whose mothers had been diagnosed with cancers before or during pregnancy (HR: 1.37, 95% CI: 1.07, 1.75). Similar results were seen when paternal cancers were used as a `negative control'. Statistically significant associations were seen for some specific congenital anomalies of organ systems (congenital anomalies of the musculoskeletal system [HR: 1.13, 95% CI: 1.02, 1.25]) and for some specific types of maternal cancer (leukaemia [HR: 1.31, 95% CI: 1.01, 1.61], The results of the main analyses suggest a small increase in risk of congenital anomalies in offspring of mothers diagnosed with cancer from 2 years before pregnancy, until the mother reaches 50 years of age; with the greatest increase seen for exposure in the pre-pregnancy and pregnancy period. These results may reflect shared causes for some cancers and some congenital anomalies. The similar results seen for paternal cancers indicate that the cause may be genetic or related to the families' social and environmental conditions.	[Momen, Natalie C.; Ernst, Andreas; Arendt, Linn Hakonsen; Ramlau-Hansen, Cecilia Host] Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, Aarhus, Denmark; [Olsen, Jorn; Li, Jiong] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA; [Gissler, Mika] THL Natl Inst Hlth & Welf, Helsinki, Finland; [Gissler, Mika] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Family Med, Stockholm, Sweden; [Rasmussen, Finn] Lund Univ, Dept Hlth Sci, Lund, Sweden	Aarhus University; Aarhus University; University of California System; University of California Los Angeles; Finland National Institute for Health & Welfare; Karolinska Institutet; Lund University	Momen, NC (corresponding author), Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, Aarhus, Denmark.	ncm@ph.au.dk	li, jiong/L-6534-2014; Momen, Natalie C/D-9272-2019	li, jiong/0000-0002-1716-8067; Momen, Natalie C/0000-0002-9832-8500; li, jiong/0000-0003-1125-026X; Ramlau-Hansen, Cecilia Host/0000-0003-3296-0121; Rasmussen, Finn/0000-0001-7915-7809; Ernst, Andreas/0000-0001-5533-8891; Gissler, Mika/0000-0001-8254-7525	Novo Nordisk Foundation [12535]; Nordic Cancer Union [2013_129830, 2015_176673]; European Research Council [ERC-2010-StG-260242-PROGEURO]; Danish Council for Independent Research [DFF-6110-00019]; Karen Elise Jensens Fond; Novo Nordisk Fonden [NNF14OC0012535] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Nordic Cancer Union; European Research Council(European Research Council (ERC)European Commission); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Karen Elise Jensens Fond; Novo Nordisk Fonden(Novo Nordisk Foundation)	The Novo Nordisk Foundation (http://www.novonordiskfonden.dk, 12535), the Nordic Cancer Union (http://www.ncu.nu/, 2013_129830, 2015_176673), the European Research Council (https://erc.europa.eu/, ERC-2010-StG-260242-PROGEURO), Danish Council for Independent Research (http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research, DFF-6110-00019), and Karen Elise Jensens Fond (http://www.kejfond.dk/, 2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiles J M, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS39, DOI 10.1016/j.ejon.2005.09.006; Braems G, 2011, ONCOLOGIST, V16, P1547, DOI 10.1634/theoncologist.2011-0121; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Cardonick E, 2010, AM J CLIN ONCOL-CANC, V33, P221, DOI 10.1097/COC.0b013e3181a44ca9; Chambers CD, 1998, TERATOLOGY, V58, P251, DOI 10.1002/(SICI)1096-9926(199812)58:6<251::AID-TERA6>3.0.CO;2-L; Dalberg K, 2006, PLOS MED, V3, P1597, DOI 10.1371/journal.pmed.0030336; DOUGLAS RG, 1990, BRIT J SURG, V77, P246, DOI 10.1002/bjs.1800770305; Eibye S, 2013, OBSTET GYNECOL, V122, P608, DOI 10.1097/AOG.0b013e3182a057a2; Frey HA, 2014, OBSTET GYNECOL, V124, P91, DOI 10.1097/AOG.0000000000000335; Garcia-Manero M, 2009, EJSO-EUR J SURG ONC, V35, P215, DOI 10.1016/j.ejso.2008.04.010; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Hansen D, 2000, LANCET, V356, P875, DOI 10.1016/S0140-6736(00)02676-3; HEDEGAARD M, 1993, BMJ-BRIT MED J, V307, P234, DOI 10.1136/bmj.307.6898.234; Howard J, 2013, MINIMUM LATENCY TYPE; Koren G, 1996, CANC PREGNANCY MATER; Lambe M, 1995, BRIT MED J, V311, P1607, DOI 10.1136/bmj.311.7020.1607; Langagergaard V, 2008, BRIT J CANCER, V98, P183, DOI 10.1038/sj.bjc.6604126; Langagergaard V, 2006, BRIT J CANCER, V94, P142, DOI 10.1038/sj.bjc.6602878; Langagergaard V, 2011, CLIN EPIDEMIOL, V3, P7; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; Lee YY, 2012, BJOG-INT J OBSTET GY, V119, P1572, DOI 10.1111/j.1471-0528.2012.03475.x; Liew Z, 2015, INT J EPIDEMIOL, V44, P345, DOI 10.1093/ije/dyu249; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Nadler DL., 2014, ADV EPIDEMIOL, V2014, P1, DOI [10.1155/2014/746769, DOI 10.1155/2014/746769]; Navrozoglou I, 2008, EJSO-EUR J SURG ONC, V34, P837, DOI 10.1016/j.ejso.2008.01.029; Nitenberg G, 2000, CRIT REV ONCOL HEMAT, V34, P137, DOI 10.1016/S1040-8428(00)00048-2; Pavlidis NA, 2002, ONCOLOGIST, V7, P279; RCOG, 2010, TERM PREGN FET ABN E; Ryan AM, 2016, P NUTR SOC, V75, P199, DOI 10.1017/S002966511500419X; Sun YL, 2016, CANCER EPIDEMIOL, V44, P59, DOI 10.1016/j.canep.2016.07.011; TIKKANEN J, 1991, EUR J EPIDEMIOL, V7, P628; VAINIO H, 1989, SCAND J WORK ENV HEA, V15, P13, DOI 10.5271/sjweh.1889; Van Calsteren K, 2010, J CLIN ONCOL, V28, P683, DOI 10.1200/JCO.2009.23.2801; Zhu JL, 2002, BRIT J CANCER, V87, P524, DOI 10.1038/sj.bjc.6600488	34	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173355	10.1371/journal.pone.0173355	http://dx.doi.org/10.1371/journal.pone.0173355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264065	Green Published, Green Submitted, gold			2022-12-26	WOS:000396054300055
J	Parker, AM; House, JK; Hazelton, MS; Bosward, KL; Sheehy, PA				Parker, Alysia M.; House, John K.; Hazelton, Mark S.; Bosward, Katrina L.; Sheehy, Paul A.			Comparison of culture and a multiplex probe PCR for identifying Mycoplasma species in bovine milk, semen and swab samples	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; BULK-TANK MILK; IN-VITRO AMPLIFICATION; RIBOSOMAL-RNA GENES; DAIRY-CATTLE; MASTITIS; INFECTION; DISEASE; CALVES; ASSAY	Mycoplasma spp. are a major cause of mastitis, arthritis and pneumonia in cattle, and have been associated with reproductive disorders in cows. While culture is the traditional method of identification the use of PCR has become more common. Several investigators have developed PCR protocols to detect M. bovis in milk, yet few studies have evaluated other sample types or other important Mycoplasma species. Therefore the objective of this study was to develop a multiplex PCR assay to detect M. bovis, M. californicum and M. bovigenitalium, and evaluate its analytical performance against traditional culture of bovine milk, semen and swab samples. The PCR specificity was determined and the limit of detection evaluated in spiked milk, semen and swabs. The PCR was then compared to culture on 474 field samples from individual milk, bulk tank milk (BTM), semen and swab (vaginal, preputial, nose and eye) samples. Specificity analysis produced appropriate amplification for all M. bovis, M. californicum and M. bovigenitalium isolates. Amplification was not seen for any of the other Mollicutes or eubacterial isolates. The limit of detection of the PCR was best in milk, followed by semen and swabs. When all three Mycoplasma species were present in a sample, the limit of detection increased. When comparing culture and PCR, overall there was no significant difference in the proportion of culture and PCR positive samples. Culture could detect significantly more positive swab samples. No significant differences were identified for semen, individual milk or BTM samples. PCR identified five samples with two species present. Culture followed by 16S-23S rRNA sequencing did not enable identification of more than one species. Therefore, the superior method for identification of M. bovis, M. californicum and M. bovigenitalium may be dependent on the sample type being analysed, and whether the identification of multiple target species is required.	[Parker, Alysia M.; House, John K.; Hazelton, Mark S.; Bosward, Katrina L.; Sheehy, Paul A.] Univ Sydney, Sydney Sch Vet Sci, Fac Sci, Camden, NSW, Australia	University of Sydney	Parker, AM (corresponding author), Univ Sydney, Sydney Sch Vet Sci, Fac Sci, Camden, NSW, Australia.	alysia.parker@sydney.edu.au	Bosward, Katrina/ABF-5091-2020	Bosward, Katrina/0000-0002-7561-2162; House, John/0000-0002-6174-6565	Dairy Australia [C100000545]	Dairy Australia(Dairy Australia)	This work was supported by Dairy Australia, No C100000545. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayling RD, 2004, VET REC, V155, P413, DOI 10.1136/vr.155.14.413; BENNETT RH, 1977, CORNELL VET, V67, P361; Biddle MK, 2005, JAVMA-J AM VET MED A, V227, P455, DOI 10.2460/javma.2005.227.455; Bielanski A, 2000, THERIOGENOLOGY, V53, P1213, DOI 10.1016/S0093-691X(00)00266-1; Boonyayatra S, 2012, J DAIRY SCI, V95, P196, DOI 10.3168/jds.2011-4531; Boonyayatra S, 2012, J VET DIAGN INVEST, V24, P7, DOI 10.1177/1040638711425936; Brenner J, 2009, ISR J VET MED, V64, P103; Byrne W, 2005, VET REC, V156, P767, DOI 10.1136/vr.156.24.767; Clothier KA, 2010, J VET DIAGN INVEST, V22, P956, DOI 10.1177/104063871002200618; Cole HH, 2013, REPROD DOMESTIC ANIM; Dairy Australia Limited, 2014, MYC DAIR HEARDS FACT; FISH NA, 1985, CAN VET J, V26, P13; Fox LK, 2012, VET CLIN N AM-FOOD A, V28, P225, DOI 10.1016/j.cvfa.2012.03.007; Fraser BC, 2014, AM J VET RES, V75, P200, DOI 10.2460/ajvr.75.2.200; Ghanem ME, 2013, THERIOGENOLOGY, V79, P180, DOI 10.1016/j.theriogenology.2012.09.027; GONZALEZ YRC, 1995, VET MICROBIOL, V47, P183, DOI 10.1016/0378-1135(95)00058-I; HALE HH, 1962, CORNELL VET, V52, P582; Hermeyer K, 2012, J VET DIAGN INVEST, V24, P364, DOI 10.1177/1040638711435145; Hewicker-Trautwein M, 2002, VET REC, V151, P699; Higuchi H, 2011, VET REC, V169, p442B, DOI 10.1136/vr.d5331; Hirose K, 2001, J VET MED SCI, V63, P691, DOI 10.1292/jvms.63.691; Infante-Martinez F, 1999, Rev Latinoam Microbiol, V41, P117; Justice-Allen A, 2011, J DAIRY SCI, V94, P3411, DOI 10.3168/jds.2010-3940; Kirk JH, 1997, J AM VET MED ASSOC, V211, P1036; Kobayashi H, 1998, J VET MED SCI, V60, P1299, DOI 10.1292/jvms.60.1299; MACKIE DP, 1982, VET REC, V110, P578, DOI 10.1136/vr.110.25.578; Maunsell FP, 2011, J VET INTERN MED, V25, P772, DOI 10.1111/j.1939-1676.2011.0750.x; Maunsell F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044523; McVey DS, 2013, VET MICROBIOLOGY; Nicholas RAJ, 2003, RES VET SCI, V74, P105, DOI 10.1016/S0034-5288(02)00155-8; Parker AM, 2016, VET MICROBIOL, V196, P118, DOI 10.1016/j.vetmic.2016.10.010; Petit T, 2008, VET REC, V162, P792, DOI 10.1136/vr.162.24.792; Punyapornwithaya V, 2010, PREV VET MED, V93, P66, DOI 10.1016/j.prevetmed.2009.08.008; Quinn PJ, 2013, VET MICROBIOLOGY MIC; Rossetti BC, 2010, MOL CELL PROBE, V24, P321, DOI 10.1016/j.mcp.2010.05.001; Sachse K, 2010, VET J, V186, P299, DOI 10.1016/j.tvjl.2009.10.008; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Stipkovits L, 2005, RES VET SCI, V78, P207, DOI 10.1016/j.rvsc.2004.09.005; Subramaniam S, 1998, MOL CELL PROBE, V12, P161, DOI 10.1006/mcpr.1998.0160; Tang J, 2000, J MICROBIOL METH, V39, P121, DOI 10.1016/S0167-7012(99)00107-4; Trachtenberg S, 2005, CURR BIOL, V15, pR483, DOI 10.1016/j.cub.2005.06.049; Wilson DJ, 2007, JAVMA-J AM VET MED A, V230, P1519, DOI 10.2460/javma.230.10.1519	42	24	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173422	10.1371/journal.pone.0173422	http://dx.doi.org/10.1371/journal.pone.0173422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264012	Green Published, Green Submitted, gold			2022-12-26	WOS:000396054300064
J	Joesaar, M; Viggor, S; Heinaru, E; Naanuri, E; Mehike, M; Leito, I; Heinaru, A				Joesaar, Merike; Viggor, Signe; Heinaru, Eeva; Naanuri, Eve; Mehike, Maris; Leito, Ivo; Heinaru, Ain			Strategy of Pseudomonas pseudoalcaligenes C70 for effective degradation of phenol and salicylate	PLOS ONE			English	Article							PUTIDA F1; BIODEGRADATION KINETICS; NAPHTHALENE-DEGRADATION; RING-CLEAVAGE; GROWTH; TOL; BENZENE; CLONING; PATHWAY; ACCUMULATION	Phenol- and naphthalene-degrading indigenous Pseudomonas pseudoalcaligenes strain C70 has great potential for the bioremediation of polluted areas. It harbours two chromosomally located catechol meta pathways, one of which is structurally and phylogenetically very similar to the Pseudomonas sp. CF600 dmp operon and the other to the P. stutzeri AN10 nah lower operon. The key enzymes of the catechol meta pathway, catechol 2,3-dioxygenase (C23O) from strain C70, PheB and NahH, have an amino acid identity of 85%. The metabolic and regulatory phenotypes of the wild-type and the mutant strain C70 Delta pheB lacking pheB were evaluated. qRT-PCR data showed that in C70, the expression of pheB- and nahH-encoded C23O was induced by phenol and salicylate, respectively. We demonstrate that strain C70 is more effective in the degradation of phenol and salicylate, especially at higher substrate concentrations, when these compounds are present as a mixture; i.e., when both pathways are expressed. Moreover, NahH is able to substitute for the deleted PheB in phenol degradation when salicylate is also present in the growth medium. The appearance of a yellow intermediate 2-hydroxymuconic semialdehyde was followed by the accumulation of catechol in salicylate-containing growth medium, and lower expression levels and specific activities of the C23O of the sal operon were detected. However, the excretion of the toxic intermediate catechol to the growth medium was avoided when the growth medium was supplemented with phenol, seemingly due to the contribution of the second meta pathway encoded by the phe genes.	[Joesaar, Merike; Viggor, Signe; Heinaru, Eeva; Naanuri, Eve; Mehike, Maris; Heinaru, Ain] Univ Tartu, Fac Sci & Technol, Inst Mol & Cell Biol, Tartu, Estonia; [Leito, Ivo] Univ Tartu, Fac Sci & Technol, Inst Chem, Tartu, Estonia	University of Tartu; University of Tartu	Joesaar, M (corresponding author), Univ Tartu, Fac Sci & Technol, Inst Mol & Cell Biol, Tartu, Estonia.	merike.joesaar@ut.ee	Leito, Ivo/U-9463-2019	Leito, Ivo/0000-0002-3000-4964	Institute of Molecular and Cell Biology, University of Tartu; Estonian Ministry of Education and Research [SF0180026s08, IUT20-19]; Estonian Science Foundation [7827]	Institute of Molecular and Cell Biology, University of Tartu; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation	This research was supported by the Institute of Molecular and Cell Biology, University of Tartu; by the research grants SF0180026s08 (Prof. Ain Heinaru), IUT20-19, and CELMS from the Estonian Ministry of Education and Research, and by the Estonian Science Foundation grant 7827. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Isolated strains are deposited in the Collection of Environmental and Laboratory Microbial Strains (CELMS; financed by the Estonian Ministry of Education and Research), the public catalogue of which is available on the Estonian Electronic Microbial dataBase (EEMB) website hilp://eemb.ut.ee. We are grateful to Sofia Tespelevits for assistance with the HPLC analysis of the samples. This manuscript was edited for English language by American Journal Experts (AJE).	ADAMS MARK H., 1959; [Anonymous], 2000, EURACHEM CITAC GUIDE; AOKI K, 1984, AGR BIOL CHEM TOKYO, V48, P2097, DOI 10.1080/00021369.1984.10866454; BAUCHOP T, 1960, J GEN MICROBIOL, V23, P457; Bertini L, 2013, BIOCHIMIE, V95, P241, DOI 10.1016/j.biochi.2012.09.018; Bosch R, 2000, GENE, V245, P65, DOI 10.1016/S0378-1119(00)00038-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CERDAN P, 1995, EUR J BIOCHEM, V229, P113, DOI 10.1111/j.1432-1033.1995.0113l.x; Choi KY, 2007, APPL ENVIRON MICROB, V73, P1370, DOI 10.1128/AEM.02379-06; Coronado E, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00300; Diaz E, 2013, CURR OPIN BIOTECH, V24, P431, DOI 10.1016/j.copbio.2012.10.010; GARCIAVALDES E, 1988, APPL ENVIRON MICROB, V54, P2478; George KW, 2012, MICROBIOL-SGM, V158, P2781, DOI 10.1099/mic.0.058230-0; George KW, 2011, ADV APPL MICROBIOL, V74, P1, DOI 10.1016/B978-0-12-387022-3.00005-7; George KW, 2011, MICROBIOL-SGM, V157, P89, DOI 10.1099/mic.0.042531-0; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HEGEMAN GD, 1966, J BACTERIOL, V91, P1140, DOI 10.1128/JB.91.3.1140-1154.1966; Heinaru E, 2001, FEMS MICROBIOL ECOL, V37, P79; Heinaru E, 2016, GENE, V589, P90, DOI 10.1016/j.gene.2016.05.022; HUGOUVIEUXCOTTEPATTAT N, 1990, J BACTERIOL, V172, P6651, DOI 10.1128/jb.172.12.6651-6660.1990; IlKim S, 1997, J BACTERIOL, V179, P5226; Jimenez JI, 2014, ENVIRON MICROBIOL, V16, P1767, DOI 10.1111/1462-2920.12361; Joesaar M, 2010, FEMS MICROBIOL ECOL, V72, P464, DOI 10.1111/j.1574-6941.2010.00858.x; Juang RS, 2006, BIOCHEM ENG J, V31, P133, DOI 10.1016/j.bej.2006.05.025; Juhanson J, 2009, FEMS MICROBIOL ECOL, V70, P446, DOI 10.1111/j.1574-6941.2009.00754.x; Junca H, 2004, MICROBIOL-SGM, V150, P4181, DOI 10.1099/mic.0.27451-0; Jutkina J, 2011, GENES-BASEL, V2, P853, DOI 10.3390/genes2040853; KEIL H, 1985, J BACTERIOL, V163, P248, DOI 10.1128/JB.163.1.248-255.1985; Kitayama A, 1996, J FERMENT BIOENG, V82, P217, DOI 10.1016/0922-338X(96)88811-8; Lee DS, 2005, J MICROBIOL BIOTECHN, V15, P859; Lovley DR, 2003, NAT REV MICROBIOL, V1, P35, DOI 10.1038/nrmicro731; Martinez-Garcia E, 2011, ENVIRON MICROBIOL, V13, P2702, DOI 10.1111/j.1462-2920.2011.02538.x; Monero A, 2003, BIOTECHNOL PROGR, V19, P676, DOI 10.1021/bp025764s; Munoz R, 2007, CHEMOSPHERE, V68, P244, DOI 10.1016/j.chemosphere.2007.01.016; Murakami S, 1999, BIOSCI BIOTECH BIOCH, V63, P859, DOI 10.1271/bbb.63.859; ODONNELL KJ, 1991, J GEN MICROBIOL, V137, P2831, DOI 10.1099/00221287-137-12-2831; Park W, 2004, APPL MICROBIOL BIOT, V64, P429, DOI 10.1007/s00253-003-1420-6; Perez-Pantoja D, 2003, J BACTERIOL, V185, P1534, DOI 10.1128/JB.185.5.1534-1542.2003; Pessione E, 2001, BIOL CHEM, V382, P1253, DOI 10.1515/BC.2001.156; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Powlowski Justin, 1994, Biodegradation, V5, P219, DOI 10.1007/BF00696461; Reardon KF, 2000, BIOTECHNOL BIOENG, V69, P385, DOI 10.1002/1097-0290(20000820)69:4<385::AID-BIT5>3.0.CO;2-Q; ROSSELLOMORA RA, 1994, APPL ENVIRON MICROB, V60, P966; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saez Pablo B., 1993, Biodegradation, V4, P3, DOI 10.1007/BF00701451; SALATREPAT JM, 1972, EUR J BIOCHEM, V28, P347, DOI 10.1111/j.1432-1033.1972.tb01920.x; SMITH MR, 1991, APPL MICROBIOL BIOT, V34, P536, DOI 10.1007/BF00180584; Sota M, 2006, J BACTERIOL, V188, P4057, DOI 10.1128/JB.00185-06; Suenaga H, 2009, FEMS MICROBIOL ECOL, V69, P472, DOI 10.1111/j.1574-6941.2009.00719.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vaillancourt FH, 2006, CRIT REV BIOCHEM MOL, V41, P241, DOI 10.1080/10409230600817422; VANDERMEER JR, 1992, MICROBIOL REV, V56, P677, DOI 10.1128/MMBR.56.4.677-694.1992; Vedler E, 2013, SYST APPL MICROBIOL, V36, P525, DOI 10.1016/j.syapm.2013.07.004; Widdel F, 2001, CURR OPIN BIOTECH, V12, P259, DOI 10.1016/S0958-1669(00)00209-3; Williams Peter A., 1994, Biodegradation, V5, P195, DOI 10.1007/BF00696460; YEN KM, 1982, P NATL ACAD SCI-BIOL, V79, P874, DOI 10.1073/pnas.79.3.874; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	57	13	14	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173180	10.1371/journal.pone.0173180	http://dx.doi.org/10.1371/journal.pone.0173180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257519	Green Submitted, Green Published, gold			2022-12-26	WOS:000396021100071
J	Maurer, L; Schwarz, F; Fischer-Rosinsky, A; Schlueter, N; Brachs, S; Mohlig, M; Pfeiffer, A; Mai, K; Spranger, J; Bobbert, T				Maurer, Lukas; Schwarz, Franziska; Fischer-Rosinsky, Antje; Schlueter, Nina; Brachs, Sebastian; Moehlig, Matthias; Pfeiffer, Andreas; Mai, Knut; Spranger, Joachim; Bobbert, Thomas			Renal function is independently associated with circulating betatrophin	PLOS ONE			English	Article							ANGIOPOIETIN-LIKE PROTEIN; TYPE-2 DIABETES SUBJECTS; GLUCOSE; HORMONE; LIPASIN; LEVEL; OBESE	Objective Betatrophin has been identified as a marker linking liver with beta cell function and lipid metabolism in murine models. Until now, the regulation of circulating betatrophin in humans is not entirely clear. We here analyzed the relation of betatrophin levels to phenotypes of the metabolic syndrome and speculated that renal function might influence circulating betatrophin levels and explain age-dependent changes of betatrophin. Subjects We analyzed blood samples from 535 individuals participating in the Metabolic Syndrome Berlin Potsdam study. Results In a crude analysis we found a positive correlation between betatrophin levels and HbA1c (r = 0.24; p < 0.001), fasting glucose (r = 0.20; p < 0.001) and triglycerides (r = 0.12; p = 0.007). Furthermore betatrophin was positively correlated with age (r = 0.47; p < 0.001), systolic blood pressure (r = 0.17; p < 0.001), intima media thickness (r = 0.26; p < 0.001) and negatively correlated with CKD-EPI eGFR (r = -0.33; p < 0.001) as an estimate of renal function. Notably, eGFR remained highly associated with betatrophin after adjustment for age, waist circumference, gender, HbA1c and lipid parameters in a multivariate linear regression model (beta = -0.197, p < 0.001). Conclusions Our data suggest that circulating levels of betatrophin depend on age, gender, waist circumference, total/HDL cholesterol ratio and renal function. Especially the association to eGFR highlights the importance for future studies to address renal function as possible influence on betatrophin regulation and consider eGFR as potential confounder when analyzing the role of betatrophin in humans.	[Maurer, Lukas; Schwarz, Franziska; Fischer-Rosinsky, Antje; Schlueter, Nina; Brachs, Sebastian; Moehlig, Matthias; Pfeiffer, Andreas; Mai, Knut; Spranger, Joachim; Bobbert, Thomas] Charite, Dept Endocrinol Diabet & Nutr, Berlin, Germany; [Maurer, Lukas; Fischer-Rosinsky, Antje; Mai, Knut; Spranger, Joachim] Charite, Expt & Clin Res Ctr, Berlin, Germany; [Maurer, Lukas; Fischer-Rosinsky, Antje; Mai, Knut; Spranger, Joachim] Max Delbruck Zentrum, Berlin, Germany; [Maurer, Lukas; Schwarz, Franziska; Fischer-Rosinsky, Antje; Schlueter, Nina; Brachs, Sebastian; Spranger, Joachim] Charite, Charite Ctr Cardiovasc Res CCR, Berlin, Germany; [Schlueter, Nina; Pfeiffer, Andreas] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany; [Pfeiffer, Andreas] German Inst Human Nutr, Dept Clin Nutr, Nuthetal, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Spranger, J (corresponding author), Charite, Dept Endocrinol Diabet & Nutr, Berlin, Germany.; Spranger, J (corresponding author), Charite, Expt & Clin Res Ctr, Berlin, Germany.; Spranger, J (corresponding author), Max Delbruck Zentrum, Berlin, Germany.; Spranger, J (corresponding author), Charite, Charite Ctr Cardiovasc Res CCR, Berlin, Germany.	joachim.spranger@charite.de	Mai, Knut/W-9904-2019; Pfeiffer, Andreas F.H./AAJ-2311-2020	Mai, Knut/0000-0003-0126-3155; Pfeiffer, Andreas F.H./0000-0002-6887-0016; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Brachs, Sebastian/0000-0002-6336-3939	Deutsches Zentrum fur Herz-Kreislauf-Forschung; Berlin Institute of Health; Deutsche Diabetes Gesellschaft; Deutsche Forschungsgemeinschaft DFG [KF0218]	Deutsches Zentrum fur Herz-Kreislauf-Forschung; Berlin Institute of Health; Deutsche Diabetes Gesellschaft; Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	The study was supported by the Deutsches Zentrum fur Herz-Kreislauf-Forschung (https://dzhk.de/), the Berlin Institute of Health (https://www.bihealth.org/), the Deutsche Diabetes Gesellschaft (http://www.deutsche-diabetes-gesellschaft.de/home.html) and the Deutsche Forschungsgemeinschaft DFG KF0218 (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10949; Barja-Fernandez S, 2015, J CLIN ENDOCR METAB, V100, pE1188, DOI 10.1210/JC.2015-1595; Bobbert T, 2013, DIABETES CARE, V36, P145, DOI 10.2337/dc12-0703; Chen CC, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-015-0326-9; Chen X, 2015, J CLIN ENDOCR METAB, V100, pE96, DOI 10.1210/jc.2014-2300; Crujeiras AB, 2015, INT J OBES LOND; Ebert T, 2014, J CLIN ENDOCR METAB, V99, pE2510, DOI 10.1210/jc.2013-4349; Ebert T, 2015, EUR J ENDOCRINOL, V173, P1, DOI 10.1530/EJE-14-0815; Espes D, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/323407; Espes D, 2014, DIABETOLOGIA, V57, P50, DOI 10.1007/s00125-013-3071-1; Fenzl A, 2014, DIABETOLOGIA, V57, P1204, DOI 10.1007/s00125-014-3208-x; Fu ZY, 2014, DIABETOLOGIA, V57, P2232, DOI 10.1007/s00125-014-3346-1; Fu ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05013; Fu ZY, 2013, BIOCHEM BIOPH RES CO, V430, P1126, DOI 10.1016/j.bbrc.2012.12.025; Gao T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133640; Gokulakrishnan K, 2015, DIABETES RES CLIN PR, V109, P71, DOI 10.1016/j.diabres.2015.04.028; Gomez-Ambrosi J, 2014, J CLIN ENDOCR METAB, V99, pE2004, DOI 10.1210/jc.2014-1568; Guo KF, 2015, OBESITY, V23, P793, DOI 10.1002/oby.21038; Gusarova V, 2014, CELL, V159, P691, DOI 10.1016/j.cell.2014.09.027; Hu H, 2014, DIABETES CARE, V37, P2718, DOI 10.2337/dc14-0602; Jiao Y, 2014, DIABETES, V63, P1283, DOI 10.2337/db13-1435; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mahmood D, 2014, INT J ARTIF ORGANS, V37, P13, DOI 10.5301/ijao.5000252; Maurer L, 2016, J CLIN ENDOCR METAB, V101, P4014, DOI 10.1210/jc.2016-1788; Merabet E, 1997, J CLIN ENDOCR METAB, V82, P847, DOI 10.1210/jc.82.3.847; Organization WH, 2005, REP WHO IDF CONS DEF; Pfau D, 2010, DIABETES CARE, V33, P171, DOI 10.2337/dc09-1351; Quagliarini F, 2012, P NATL ACAD SCI USA, V109, P19751, DOI 10.1073/pnas.1217552109; Ren G, 2012, AM J PHYSIOL-ENDOC M, V303, pE334, DOI 10.1152/ajpendo.00084.2012; Stein S, 2009, DIABETES CARE, V32, P126, DOI 10.2337/dc08-1054; Tokumoto S, 2015, DIABETIC MED, V32, P653, DOI 10.1111/dme.12696; Trebotic LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136701; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Wu S, 2014, PEDIAT DIABETES; Yamada H, 2015, ENDOCR J, V62, P417, DOI 10.1507/endocrj.EJ14-0525; Yi P, 2017, CELL, V168, P326, DOI 10.1016/j.cell.2016.12.017; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Zhang R, 2012, BIOCHEM BIOPH RES CO, V424, P786, DOI 10.1016/j.bbrc.2012.07.038	38	13	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173197	10.1371/journal.pone.0173197	http://dx.doi.org/10.1371/journal.pone.0173197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257453	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000396021100073
J	Nanwa, N; Sander, B; Krahn, M; Daneman, N; Lu, H; Austin, PC; Govindarajan, A; Rosella, LC; Cadarette, SM; Kwong, JC				Nanwa, Natasha; Sander, Beate; Krahn, Murray; Daneman, Nick; Lu, Hong; Austin, Peter C.; Govindarajan, Anand; Rosella, Laura C.; Cadarette, Suzanne M.; Kwong, Jeffrey C.			A population-based matched cohort study examining the mortality and costs of patients with community-onset Clostridium difficile infection identified using emergency department visits and hospital admissions	PLOS ONE			English	Article							ELDERLY CANCER-PATIENTS; UNITED-STATES; OF-ILLNESS; CARE; SURVEILLANCE; DISEASE; EPIDEMIOLOGY; DEATH	Few studies have evaluated the mortality or quantified the economic burden of community-onset Clostridium difficile infection (CDI). We estimated the attributable mortality and costs of community-onset CDI. We conducted a population-based matched cohort study. We identified incident subjects with community-onset CDI using health administrative data (emergency department visits and hospital admissions) in Ontario, Canada between January 1, 2003 and December 31, 2010. We propensity-score matched each infected subject to one uninfected subject and followed subjects in the cohort until December 31, 2011. We evaluated all-cause mortality and costs (unadjusted and adjusted for survival) from the healthcare payer perspective (2014 Canadian dollars). During our study period, we identified 7,950 infected subjects. The mean age was 63.5 years (standard deviation = 22.0), 62.7% were female, and 45.0% were very high users of the healthcare system. The relative risk for 30-day, 180-day, and 1-year mortality were 7.32 (95% confidence interval [CI], 5.94-9.02), 3.55 (95% CI, 3.17-3.97), and 2.59 (95% CI, 2.37-2.83), respectively. Mean attributable cumulative 30-day, 180-day, and 1-year costs (unadjusted for survival) were $7,434 (95% CI, $7,122-$7,762), $12,517 (95% CI, $11,687-$ 13,366), and $13,217 (95% CI, $12,062-$ 14,388). Mean attributable cumulative 1-,2-, and 3-year costs (adjusted for survival) were $10,700 (95% CI, $9,811-$11,645), $13,312 (95% CI, $ 12,024-$14,682), and $ 15,812 (95% CI, $ 14,159-$17,571). Infected subjects had considerably higher risk of all-cause mortality and costs compared with uninfected subjects. This study provides insight on an understudied patient group. Our study findings will facilitate assessment of interventions to prevent community-onset CDI.	[Nanwa, Natasha; Krahn, Murray; Cadarette, Suzanne M.] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Nanwa, Natasha; Sander, Beate; Krahn, Murray] Toronto Hlth Econ & Technol Assessment Collaborat, Toronto, ON, Canada; [Sander, Beate; Rosella, Laura C.; Kwong, Jeffrey C.] Publ Hlth Ontario, Toronto, ON, Canada; [Sander, Beate; Krahn, Murray; Daneman, Nick; Austin, Peter C.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Sander, Beate; Krahn, Murray; Daneman, Nick; Lu, Hong; Austin, Peter C.; Govindarajan, Anand; Rosella, Laura C.; Cadarette, Suzanne M.; Kwong, Jeffrey C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Krahn, Murray; Kwong, Jeffrey C.] Univ Hlth Network, Toronto, ON, Canada; [Krahn, Murray; Daneman, Nick] Univ Toronto, Dept Med, Toronto, ON, Canada; [Daneman, Nick; Austin, Peter C.] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Govindarajan, Anand] Mt Sinai Hosp, Toronto, ON, Canada; [Govindarajan, Anand] Univ Toronto, Dept Surg, Div Gen Surg, Toronto, ON, Canada; [Rosella, Laura C.; Kwong, Jeffrey C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of Toronto; University of Toronto	Nanwa, N (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada.	natasha.nanwa@mail.utoronto.ca	Sander, Beate/P-7665-2018	Sander, Beate/0000-0003-2128-9133; Cadarette, Suzanne/0000-0002-8584-9649; Krahn, Murray/0000-0001-5836-397X	CIHR operating grant [MOP 130553]; Institute for Clinical Evaluative Sciences (ICES); Public Health Ontario (PHO); Ontario Ministry of Health and Long-Term Care (MOHLTC)	CIHR operating grant(Canadian Institutes of Health Research (CIHR)); Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Public Health Ontario (PHO); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This study was supported by a CIHR operating grant (grant number: MOP 130553, grant recipient: Beate Sander), the Institute for Clinical Evaluative Sciences (ICES), and Public Health Ontario (PHO). ICES and PHO are funded by annual grants from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results, and conclusions reported in this article do not necessarily represent the views of CIHR, ICES, PHO, or the MOHLTC. Parts of this material are based on data and information compiled and provided by the Canadian Institute of Health Information (CINI). However, the analyses, conclusions, opinions and statements expressed herein are those of the authors, and not necessarily those of CIHI.	Agresti A, 2004, STAT MED, V23, P65, DOI 10.1002/sim.1589; Austin PC, 2014, STAT MED, V33, P4306, DOI 10.1002/sim.6276; Austin PC, 2011, MED CARE, V49, P932, DOI 10.1097/MLR.0b013e318215d5e2; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Bank of Canada, 2014, ANN AV EXCH RAT; Barlow WE, 2009, MED CARE, V47, pS33, DOI 10.1097/MLR.0b013e3181a2d847; Brown ML, 1999, MED CARE, V37, P1249, DOI 10.1097/00005650-199912000-00008; Canadian Agency for Drugs and Technologies in Health (CADTH), 2017, GUID EC EV HLTH TECH; Centers for Disease Control and Prevention, 2015, CLOSTR DIFF INF TRAC; Clohessy P, 2014, INT J INFECT DIS, V29, P152, DOI 10.1016/j.ijid.2014.08.009; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Hirshon JM, 2011, EMERG INFECT DIS, V17, P1946, DOI 10.3201/eid1710.110069; Karas JA, 2010, J INFECTION, V61, P1, DOI 10.1016/j.jinf.2010.03.025; Kuntz JL, 2012, INFECT CONT HOSP EP, V33, P1031, DOI 10.1086/667733; Kutty PK, 2008, INFECT CONT HOSP EP, V29, P197, DOI 10.1086/528813; Larg A, 2011, PHARMACOECONOMICS, V29, P653, DOI 10.2165/11588380-000000000-00000; Lash TL, 2011, LUNG, V189, P27, DOI 10.1007/s00408-010-9274-z; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lipscomb J, 2009, MED CARE, V47, pS1, DOI 10.1097/MLR.0b013e3181a7e401; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; Nanwa N, 2015, AM J GASTROENTEROL, V110, P511, DOI 10.1038/ajg.2015.48; Negron M, 2011, AMERICAN JOURNAL OF, V106, pS481; Organisation for Economic Co Operation and Development, 2014, PPPS EXCH RAT; Pillai DR, 2010, CLIN INFECT DIS, V50, P1685, DOI 10.1086/653007; RILEY GF, 1995, MED CARE, V33, P828, DOI 10.1097/00005650-199508000-00007; Sammons JS, 2013, CLIN INFECT DIS, V57, P1, DOI 10.1093/cid/cit155; Su CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071055; Tan XQ, 2014, INT J ANTIMICROB AG, V43, P47, DOI 10.1016/j.ijantimicag.2013.09.011; Tarricone R, 2006, HEALTH POLICY, V77, P51, DOI 10.1016/j.healthpol.2005.07.016; Wodchis WP, 2013, WORKING PAPER SERIES; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103	33	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172410	10.1371/journal.pone.0172410	http://dx.doi.org/10.1371/journal.pone.0172410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257438	gold, Green Published, Green Submitted			2022-12-26	WOS:000396021100017
J	Cohen, AD; Nencka, AS; Lebel, RM; Wang, Y				Cohen, Alexander D.; Nencka, Andrew S.; Lebel, R. Marc; Wang, Yang			Multiband multi-echo imaging of simultaneous oxygenation and flow timeseries for resting state connectivity	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; BOLD-CONTRAST SENSITIVITY; FMRI TIME-SERIES; FUNCTIONAL CONNECTIVITY; WHOLE-BRAIN; DIFFERENTIATING BOLD; SIGNAL CHANGES; EPI; MRI; PERFUSION	A novel sequence has been introduced that combines multiband imaging with a multi-echo acquisition for simultaneous high spatial resolution pseudo-continuous arterial spin labeling (ASL) and blood-oxygenation-level dependent (BOLD) echo-planar imaging (MBME ASL/BOLD). Resting-state connectivity in healthy adult subjects was assessed using this sequence. Four echoes were acquired with a multiband acceleration of four, in order to increase spatial resolution, shorten repetition time, and reduce slice-timing effects on the ASL signal. In addition, by acquiring four echoes, advanced multi-echo independent component analysis (ME-ICA) denoising could be employed to increase the signal-to-noise ratio (SNR) and BOLD sensitivity. Seed-based and dual-regression approaches were utilized to analyze functional connectivity. Cerebral blood flow (CBF) and BOLD coupling was also evaluated by correlating the perfusion-weighted timeseries with the BOLD timeseries. These metrics were compared between single echo (E2), multi-echo combined (MEC), multi-echo combined and denoised (MECDN), and perfusion-weighted (PW) timeseries. Temporal SNR increased for the MECDN data compared to the MEC and E2 data. Connectivity also increased, in terms of correlation strength and network size, for the MECDN compared to the MEC and E2 datasets. CBF and BOLD coupling was increased in major resting-state networks, and that correlation was strongest for the MECDN datasets. These results indicate our novel MBME ASL/BOLD sequence, which collects simultaneous high-resolution ASL/BOLD data, could be a powerful tool for detecting functional connectivity and dynamic neurovascular coupling during the resting state. The collection of more than two echoes facilitates the use of ME-ICA denoising to greatly improve the quality of resting state functional connectivity MRI.	[Cohen, Alexander D.; Nencka, Andrew S.; Wang, Yang] Med Coll Wisconsin, Dept Radiol, Milwaukee, WI 53226 USA; [Lebel, R. Marc] GE Healthcare, Calgary, AB, Canada	Medical College of Wisconsin; General Electric	Cohen, AD (corresponding author), Med Coll Wisconsin, Dept Radiol, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA.	acohen@mcw.edu			Daniel M. Soref Charitable Trust; GE Healthcare	Daniel M. Soref Charitable Trust; GE Healthcare(General ElectricGE Healthcare)	This work was partially supported by a grant from the Daniel M. Soref Charitable Trust (to Yang Wang). Author R. Marc Lebel is employed by GE Healthcare. The funder provided support in the form of salary for author RML, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Beckmann CF, OHBM 2009; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blicher JU, 2012, J CEREBR BLOOD F MET, V32, P2044, DOI 10.1038/jcbfm.2012.105; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chen JJ, 2015, BRAIN CONNECT, V5, P527, DOI 10.1089/brain.2015.0344; Chen L, 2015, NEUROIMAGE, V104, P452, DOI 10.1016/j.neuroimage.2014.10.027; Chuang KH, 2008, NEUROIMAGE, V40, P1595, DOI 10.1016/j.neuroimage.2008.01.006; Dai WY, 2016, J CEREBR BLOOD F MET, V36, P463, DOI 10.1177/0271678X15615339; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; de Vis JB, 2015, HUM BRAIN MAPP, V36, P3973, DOI 10.1002/hbm.22891; Ebisch SJH, 2011, HUM BRAIN MAPP, V32, P1013, DOI 10.1002/hbm.21085; Evans JW, 2015, NEUROIMAGE, V105, P189, DOI 10.1016/j.neuroimage.2014.10.051; Faraco CC, 2015, MAGN RESON MED, V73, P1579, DOI 10.1002/mrm.25268; Feinberg DA, 2013, MAGN RESON MED, V70, P1500, DOI 10.1002/mrm.24994; Feinberg DA, 2013, J MAGN RESON, V229, P90, DOI 10.1016/j.jmr.2013.02.002; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Garcia DM, 2005, MAGN RESON MED, V54, P366, DOI 10.1002/mrm.20556; Geranmayeh F, 2015, HUM BRAIN MAPP, V36, P1755, DOI 10.1002/hbm.22735; Ghariq E, 2014, NEUROIMAGE, V103, P316, DOI 10.1016/j.neuroimage.2014.09.051; Gonzalez-Castillo J, 2016, NEUROIMAGE, V141, P452, DOI 10.1016/j.neuroimage.2016.07.049; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hoge RD, 1999, MAGNET RESON MED, V42, P849, DOI 10.1002/(SICI)1522-2594(199911)42:5<849::AID-MRM4>3.0.CO;2-Z; Jann K, 2015, NEUROIMAGE, V106, P111, DOI 10.1016/j.neuroimage.2014.11.028; Jann K, 2013, BRAIN TOPOGR, V26, P569, DOI 10.1007/s10548-013-0280-3; Kim SG, 2012, J CEREBR BLOOD F MET, V32, P1188, DOI 10.1038/jcbfm.2012.23; Kim SG, 1997, MAGN RESON MED, V38, P59, DOI 10.1002/mrm.1910380110; Kim T, 2013, MAGN RESON MED, V70, P1653, DOI 10.1002/mrm.24880; Kundu P, 2015, BRAIN IMAGING BEHAV, V9, P56, DOI 10.1007/s11682-014-9346-4; Kundu P, 2014, NEUROIMAGE, V102, P861, DOI 10.1016/j.neuroimage.2014.07.025; Kundu P, 2013, P NATL ACAD SCI USA, V110, P16187, DOI 10.1073/pnas.1301725110; Kundu P, 2012, NEUROIMAGE, V60, P1759, DOI 10.1016/j.neuroimage.2011.12.028; Lee MS, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-7; Leontiev O, 2007, NEUROIMAGE, V35, P175, DOI 10.1016/j.neuroimage.2006.10.044; Li XF, 2015, NEUROIMAGE, V106, P170, DOI 10.1016/j.neuroimage.2014.10.029; Liang XY, 2014, NEUROIMAGE, V87, P265, DOI 10.1016/j.neuroimage.2013.11.013; Menon RS, 2002, MAGNET RESON MED, V47, P1, DOI 10.1002/mrm.10041; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Murphy K, 2007, NEUROIMAGE, V34, P565, DOI 10.1016/j.neuroimage.2006.09.032; Nencka AS, 2007, NEUROIMAGE, V37, P177, DOI 10.1016/j.neuroimage.2007.03.075; NOLL DC, 1991, IEEE T MED IMAGING, V10, P154, DOI 10.1109/42.79473; Olafsson V, 2015, NEUROIMAGE, V112, P43, DOI 10.1016/j.neuroimage.2015.02.052; Perthen JE, 2008, NEUROIMAGE, V40, P237, DOI 10.1016/j.neuroimage.2007.10.049; Poser BA, 2006, MAGN RESON MED, V55, P1227, DOI 10.1002/mrm.20900; Poser BA, 2009, NEUROIMAGE, V45, P1162, DOI 10.1016/j.neuroimage.2009.01.007; Posse S, 1999, MAGN RESON MED, V42, P87, DOI 10.1002/(SICI)1522-2594(199907)42:1<87::AID-MRM13>3.0.CO;2-O; Posse S, 2012, NEUROIMAGE, V62, P665, DOI 10.1016/j.neuroimage.2011.10.057; Schmithorst VJ, 2014, J MAGN RESON IMAGING, V39, P1104, DOI 10.1002/jmri.24273; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; St Lawrence KS, 2003, MAGNET RESON MED, V50, P99, DOI 10.1002/mrm.10502; Suchandrima Banerjee AT, 2012, INTERNATIONAL SOCIET; Tak S, 2015, BRAIN CONNECT, V5, P137, DOI 10.1089/brain.2014.0299; Tak S, 2014, NEUROIMAGE, V84, P672, DOI 10.1016/j.neuroimage.2013.09.057; Whittaker JR, 2016, NEUROIMAGE, V125, P198, DOI 10.1016/j.neuroimage.2015.10.023; Wise RG, 2013, NEUROIMAGE, V83, P135, DOI 10.1016/j.neuroimage.2013.06.008; Wong EC, 1997, NMR BIOMED, V10, P237, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<237::AID-NBM475>3.0.CO;2-X; Wu CW, 2009, NEUROIMAGE, V45, P694, DOI 10.1016/j.neuroimage.2008.12.066; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Yezhuvath US, 2009, NMR BIOMED, V22, P779, DOI 10.1002/nbm.1392; Zhou YX, 2015, MAGN RESON IMAGING, V33, P566, DOI 10.1016/j.mri.2015.02.018; Zhu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065884	65	13	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0169253	10.1371/journal.pone.0169253	http://dx.doi.org/10.1371/journal.pone.0169253			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253268	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300002
J	Cuomo, F; Roccabianca, S; Dillon-Murphy, D; Xiao, N; Humphrey, JD; Figueroa, CA				Cuomo, Federica; Roccabianca, Sara; Dillon-Murphy, Desmond; Xiao, Nan; Humphrey, Jay D.; Figueroa, C. Alberto			Effects of age-associated regional changes in aortic stiffness on human hemodynamics revealed by computational modeling	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ARTERIAL STIFFNESS; MECHANICAL CHARACTERIZATION; ASCENDING AORTA; ALL-CAUSE; PRESSURE; RISK; PATHOPHYSIOLOGY; HYPERTENSION; REFLECTION	Although considered by many as the gold standard clinical measure of arterial stiffness, carotid-to-femoral pulse wave velocity (cf-PWV) averages material and geometric properties over a large portion of the central arterial tree. Given that such properties may evolve differentially as a function of region in cases of hypertension and aging, among other conditions, there is a need to evaluate the potential utility of cf-PWV as an early diagnostic of progressive vascular stiffening. In this paper, we introduce a data-driven fluid-solid-interaction computational model of the human aorta to simulate effects of aging-related changes in regional wall properties (e.g., biaxial material stiffness and wall thickness) and conduit geometry (e.g., vessel caliber, length, and tortuosity) on several metrics of arterial stiffness, including distensibility, augmented pulse pressure, and cyclic changes in stored elastic energy. Using the best available biomechanical data, our results for PWV compare well to findings reported for large population studies while rendering a higher resolution description of evolving local and global metrics of aortic stiffening. Our results reveal similar spatio-temporal trends between stiffness and its surrogate metrics, except PWV, thus indicating a complex dependency of the latter on geometry. Lastly, our analysis highlights the importance of the tethering exerted by external tissues, which was iteratively estimated until hemodynamic simulations recovered typical values of tissue properties, pulse pressure, and PWV for each age group.	[Cuomo, Federica; Figueroa, C. Alberto] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Roccabianca, Sara] Michigan State Univ, Dept Mech Engn, E Lansing, MI 48824 USA; [Dillon-Murphy, Desmond; Xiao, Nan; Figueroa, C. Alberto] Kings Coll London, Dept Biomed Engn, London, England; [Humphrey, Jay D.] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Humphrey, Jay D.] Yale Sch Med, Vasc Biol & Therapeut Program, New Haven, CT USA; [Figueroa, C. Alberto] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Michigan State University; University of London; King's College London; Yale University; University of Michigan System; University of Michigan	Figueroa, CA (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.; Figueroa, CA (corresponding author), Kings Coll London, Dept Biomed Engn, London, England.; Figueroa, CA (corresponding author), Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.	figueroc@med.umich.edu	Figueroa, C. Alberto/B-7254-2012	Figueroa, C. Alberto/0000-0002-3934-6506; Dillon-Murphy, Desmond/0000-0002-5794-4593	NIH [R01 HL086418, R01 HL105297]; European Research Council [307532]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086418, R01HL105297] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by grants from the NIH (R01 HL086418, R01 HL105297) and by the European Research Council Starting Grant n. 307532.	Adji A, 2011, AM J HYPERTENS, V24, P5, DOI 10.1038/ajh.2010.192; Agabiti-Rosei E, 2007, HYPERTENSION, V50, P154, DOI 10.1161/HYPERTENSIONAHA.107.090068; Alastruey J, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0073; Arribas SM, 2006, PHARMACOL THERAPEUT, V111, P771, DOI 10.1016/j.pharmthera.2005.12.003; Baek S, 2007, COMPUT METHOD APPL M, V196, P3070, DOI 10.1016/j.cma.2006.06.018; Barodka VM, 2011, ANESTH ANALG, V112, P1048, DOI 10.1213/ANE.0b013e3182147e3c; Bellini C, 2014, ANN BIOMED ENG, V42, P488, DOI 10.1007/s10439-013-0928-x; Boutouyrie P, 2008, FUND CLIN PHARMACOL, V22, P241, DOI 10.1111/j.1472-8206.2008.00584.x; Cioffi G, 2016, EUR J PREV CARDIOL; Craiem D, 2012, ANN BIOMED ENG, V40, P1028, DOI 10.1007/s10439-011-0487-y; Cuomo F, 2015, ANN BIOMED ENG, V43, P1555, DOI 10.1007/s10439-015-1272-0; Dillon-Murphy D, 2016, BIOMECH MODEL MECHAN, V15, P857, DOI 10.1007/s10237-015-0729-2; Ferrari AU, 2003, J APPL PHYSIOL, V95, P2591, DOI 10.1152/japplphysiol.00601.2003; Ferruzzi J, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029431; Figueroa CA, 2006, COMPUT METHOD APPL M, V195, P5685, DOI 10.1016/j.cma.2005.11.011; Figueroa CA, 2009, COMPUT METHOD APPL M, V198, P3583, DOI 10.1016/j.cma.2008.09.013; Flamini V, 2015, MED ENG PHYS, V37, P48, DOI 10.1016/j.medengphy.2014.10.006; Gaddum NR, 2013, ANN BIOMED ENG, V41, P2617, DOI 10.1007/s10439-013-0854-y; Garcia-Herrera CM, 2013, BIOMECH MODEL MECHAN, V12, P1143, DOI 10.1007/s10237-013-0471-6; Garcia-Herrera CM, 2012, COMPUT METHOD BIOMEC, V15, P185, DOI 10.1080/10255842.2010.520704; Haskett D, 2010, BIOMECH MODEL MECHAN, V9, P725, DOI 10.1007/s10237-010-0209-7; Hodis S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051913; Humphrey JD, 2016, CIRC RES, V118, P379, DOI 10.1161/CIRCRESAHA.115.307722; Humphrey JD, 2002, ANN BIOMED ENG, V30, P509, DOI 10.1114/1.1467676; Jacobsen JCB, 2008, AM J PHYSIOL-REG I, V294, pR1379, DOI 10.1152/ajpregu.00407.2007; Jondeau G, 1999, CIRCULATION, V99, P2677, DOI 10.1161/01.CIR.99.20.2677; Koullias G, 2005, J THORAC CARDIOVASC, V130; Labrosse MR, 2013, J MECH BEHAV BIOMED, V17, P44, DOI 10.1016/j.jmbbm.2012.08.004; Lacolley P, 2009, CARDIOVASC RES, V81, P637, DOI 10.1093/cvr/cvn353; Lakatta EG, 2009, MED CLIN N AM, V93, P583, DOI 10.1016/j.mcna.2009.02.008; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Laurent S, 2015, CIRC RES, V116, P1007, DOI 10.1161/CIRCRESAHA.116.303596; Lemarie CA, 2010, J MOL CELL CARDIOL, V48, P433, DOI 10.1016/j.yjmcc.2009.09.018; Martin C, 2011, EUR J CARDIO-THORAC, V40, P28, DOI 10.1016/j.ejcts.2010.08.056; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; Mitchell GF, 2008, J APPL PHYSIOL, V105, P1652, DOI 10.1152/japplphysiol.90549.2008; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Moireau P, 2012, BIOMECH MODEL MECHAN, V11, P1, DOI 10.1007/s10237-011-0289-z; Mulvany MJ, 2012, BASIC CLIN PHARMACOL, V110, P49, DOI 10.1111/j.1742-7843.2011.00758.x; Najjar SS, 2008, J AM COLL CARDIOL, V51, P1377, DOI 10.1016/j.jacc.2007.10.065; Nichols W, 1998, MCDONALDS BLOOD FLOW; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Redheuil A, 2010, HYPERTENSION, V55, P319, DOI 10.1161/HYPERTENSIONAHA.109.141275; RILEY WA, 1992, STROKE, V23, P952, DOI 10.1161/01.STR.23.7.952; Roccabianca S, 2014, J MECH BEHAV BIOMED, V29, P618, DOI 10.1016/j.jmbbm.2013.01.026; Safar ME, 2010, NAT REV CARDIOL, V7, P442, DOI 10.1038/nrcardio.2010.96; Sawabe M, 2010, GERIATR GERONTOL INT, V10, pS213, DOI 10.1111/j.1447-0594.2010.00603.x; Sorkin JD, 1999, AM J EPIDEMIOL, V150, P969, DOI 10.1093/oxfordjournals.aje.a010106; Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011; Sugawara J, 2016, AM J HYPERTENS; Sugawara J, 2008, JACC-CARDIOVASC IMAG, V1, P739, DOI 10.1016/j.jcmg.2008.06.010; Vande Geest JP, 2004, J BIOMECH ENG-T ASME, V126, P815, DOI 10.1115/1.1824121; Vardoulis O, 2011, EUR J VASC ENDOVASC, V42, P704, DOI 10.1016/j.ejvs.2011.08.006; Vignon-Clementel IE, 2010, COMPUT METHOD BIOMEC, V13, P625, DOI 10.1080/10255840903413565; Vorp DA, 2003, ANN THORAC SURG, V75, P1210, DOI 10.1016/S0003-4975(02)04711-2; Wang KL, 2010, HYPERTENSION, V55, P799, DOI 10.1161/HYPERTENSIONAHA.109.139964; Weber T, 2009, J HYPERTENS, V27, P1624, DOI 10.1097/HJH.0b013e32832cb04e; Xiao N, 2012, SYSTEMATIC COMP 1 D, P1; Xiao N, 2013, J COMPUT PHYS, V244, P22, DOI 10.1016/j.jcp.2012.09.016; Zhou J, 1997, P NATL ACAD SCI USA, V94, P14255, DOI 10.1073/pnas.94.26.14255; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	61	38	40	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173177	10.1371/journal.pone.0173177	http://dx.doi.org/10.1371/journal.pone.0173177			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253335	Green Submitted, Green Published, gold			2022-12-26	WOS:000396011300086
J	Ji, HH; Wang, YL; Liu, GL; Chang, L; Chen, ZM; Zhou, DS; Xu, XT; Cui, W; Hong, QX; Jiang, LT; Li, JF; Zhou, XH; Li, Y; Guo, ZP; Zha, Q; Niu, YF; Weng, QY; Duan, SW; Wang, QW				Ji, Huihui; Wang, Yunliang; Liu, Guili; Chang, Lan; Chen, Zhongming; Zhou, Dongsheng; Xu, Xuting; Cui, Wei; Hong, Qingxiao; Jiang, Liting; Li, Jinfeng; Zhou, Xiaohui; Li, Ying; Guo, Zhiping; Zha, Qin; Niu, Yanfang; Weng, Qiuyan; Duan, Shiwei; Wang, Qinwen			Elevated OPRD1 promoter methylation in Alzheimer's disease patients	PLOS ONE			English	Article							GAMMA-SECRETASE ACTIVITY; DELTA-OPIOID RECEPTORS; DNA METHYLATION; TUMOR SUPPRESSORS; AMYLOID-BETA; RAT-BRAIN; BLOOD; HOMOCYSTEINE; PROTEIN; GENE	Aberrant DNA methylation has been observed in the patients with Alzheimer's disease (AD), a common neurodegenerative disorder in the elderly. OPRD1 encodes the delta opioid receptor, a member of the opioid family of G-protein-coupled receptors. In the current study, we compare the DNA methylation levels of OPRD1 promoter CpG sites (CpG1, CpG2, and CpG3) between 51 AD cases and 63 controls using the bisulfite pyrosequencing technology. Our results show that significantly higher CpG3 methylation is found in AD cases than controls. Significant associations are found between several biochemical parameters (including HDL-C and ALP) and CpG3 methylation. Subsequent luciferase reporter gene assay shows that DNA fragment containing the three OPRD1 promoter CpGs is able to regulate gene expression. In summary, our results suggest that OPRD1 promoter hyper-methylation is associated with the risk of AD.	[Ji, Huihui; Liu, Guili; Chang, Lan; Xu, Xuting; Cui, Wei; Hong, Qingxiao; Jiang, Liting; Duan, Shiwei; Wang, Qinwen] Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo, Zhejiang, Peoples R China; [Wang, Yunliang; Li, Jinfeng] 148 Cent Hosp PLA, Dept Neurol, Zibo, Shandong, Peoples R China; [Chen, Zhongming; Zhou, Dongsheng] Ningbo Kangning Hosp, Ningbo, Zhejiang, Peoples R China; [Zhou, Xiaohui] Xinjiang Med Univ, Dept Internal Med Cadres, Affiliated Hosp 1, Urumqi, Peoples R China; [Li, Ying] Ningbo 1 Hosp, Ningbo, Zhejiang, Peoples R China; [Guo, Zhiping] Lishui Univ, Sch Med, Lishui, Zhejiang, Peoples R China; [Zha, Qin; Niu, Yanfang; Weng, Qiuyan] Ningbo Univ, Affiliated Hosp, Ningbo, Zhejiang, Peoples R China	Ningbo University; Xinjiang Medical University; Lishui University; Ningbo University	Duan, SW; Wang, QW (corresponding author), Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo, Zhejiang, Peoples R China.; Zha, Q (corresponding author), Ningbo Univ, Affiliated Hosp, Ningbo, Zhejiang, Peoples R China.	zhaq666@163.com; duanshiwei@nbu.edu.cn; wangqinwen@nbu.edu.cn	li, jinfeng/GVS-5425-2022; Duan, Shiwei/AAA-4782-2022	Duan, Shiwei/0000-0001-7682-2877	National Natural Science Foundation of China [81471398, 81070873, 81371469]; 973 program from Ministry of Science and Technology of China [2013CB835100]; National Natural Science Foundation of Zhejiang [LY15090010]; Public technology research and social development project of Zhejiang Province [2015C33155]; Natural Science Foundation of Zhejiang Province [Y15H090032]; Ningbo Natural Science Fund [2014A610257]; Graduate Outstanding Dissertation Fund of Ningbo University [014-F01660148000]; Disciplinary Project of Ningbo University [1301350104900]; K. C. Wong Magna Fund in Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program from Ministry of Science and Technology of China(National Basic Research Program of China); National Natural Science Foundation of Zhejiang; Public technology research and social development project of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Ningbo Natural Science Fund; Graduate Outstanding Dissertation Fund of Ningbo University; Disciplinary Project of Ningbo University; K. C. Wong Magna Fund in Ningbo University	This research was supported by grants from the National Natural Science Foundation of China (81471398, 81070873, and 81371469), the 973 program from the Ministry of Science and Technology of China (2013CB835100), National Natural Science Foundation of Zhejiang (LY15090010), Public technology research and social development project of Zhejiang Province (2015C33155), Natural Science Foundation of Zhejiang Province (Y15H090032), Ningbo Natural Science Fund (2014A610257), Graduate Outstanding Dissertation Fund of Ningbo University (014-F01660148000), the Disciplinary Project of Ningbo University (1301350104900), and the K. C. Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by grants from the National Natural Science Foundation of China (81471398, 81070873, and 81371469), the 973 program from the Ministry of Science and Technology of China (2013CB835100), National Natural Science Foundation of Zhejiang (LY15090010), Public technology research and social development project of Zhejiang Province (2015C33155), Natural Science Foundation of Zhejiang Province (Y15H090032), Ningbo Natural Science Fund (2014A610257), Graduate Outstanding Dissertation Fund of Ningbo University (014-F01660148000), the Disciplinary Project of Ningbo University (B01350104900), and the K. C. Wong Magna Fund in Ningbo University.	Arosio B, 2012, NEURODEGENER DIS, V10, P207, DOI 10.1159/000333799; Arosio B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/169203; Barfield RT, 2014, GENET EPIDEMIOL, V38, P231, DOI 10.1002/gepi.21789; Chang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110773; Chao D, 2015, ACUPUNCTURE TREATMEN; Chao DM, 2007, J CEREBR BLOOD F MET, V27, P356, DOI 10.1038/sj.jcbfm.9600352; Chen H, 2015, CURR ALZHEIMER RES, V12, P88, DOI 10.2174/1567205012666141218144035; Cheng KC, 2013, PHARMACOL THERAPEUT, V139, P334, DOI 10.1016/j.pharmthera.2013.05.002; Cruz-Gordillo P, 2010, BRAIN BEHAV EVOLUT, V76, P154, DOI 10.1159/000320968; de la Monte SM, 2014, EUR NEUROPSYCHOPHARM, V24, P1954, DOI 10.1016/j.euroneuro.2014.06.008; de la Monte SM, 2014, BIOCHEM PHARMACOL, V88, P548, DOI 10.1016/j.bcp.2013.12.012; Dwyer BE, 2004, FREE RADICAL BIO MED, V36, P1471, DOI 10.1016/j.freeradbiomed.2004.03.009; EWING JF, 1992, J NEUROCHEM, V58, P1140, DOI 10.1111/j.1471-4159.1992.tb09373.x; Farre P, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0011-y; Guido M, 2006, CURR PHARM DESIGN, V12, P1001, DOI 10.2174/138161206776055895; Hannon E, 2015, EPIGENETICS-US, V10, P1024, DOI 10.1080/15592294.2015.1100786; HILLER JM, 1994, NEUROSCIENCE, V62, P829, DOI 10.1016/0306-4522(94)90480-4; Hodgson N, 2013, J ALZHEIMERS DIS, V36, P197, DOI 10.3233/JAD-130101; Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97; Houtepen LC, 2016, EPIGENOMICS; JANSEN KLR, 1990, NEUROSCIENCE, V39, P613, DOI 10.1016/0306-4522(90)90246-Z; Ji HH, 2015, NEUROSCI LETT, V606, P24, DOI 10.1016/j.neulet.2015.08.027; Kaut O, 2014, DEMENT GERIATR COGN, V38, P10, DOI 10.1159/000357126; Kim TS, 2006, INT J GERIATR PSYCH, V21, P344, DOI 10.1002/gps.1469; Kinoshita M, 2014, NEUROMOL MED, V16, P697, DOI 10.1007/s12017-014-8319-5; Koestler DC, 2013, EPIGENETICS-US, V8, P816, DOI 10.4161/epi.25430; Kreek M J, 1978, Ann N Y Acad Sci, V311, P110, DOI 10.1111/j.1749-6632.1978.tb16769.x; Kubota Takeo, 2013, Rinsho Shinkeigaku, V53, P1339; Lee CH, 2013, J PATHOL, V230, P298, DOI 10.1002/path.4173; Llado-Saz S, 2015, NEUROBIOL AGING, V36, P2791, DOI 10.1016/j.neurobiolaging.2015.06.023; Marioni RE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0584-6; Masliah E, 2013, EPIGENETICS-US, V8, P1030, DOI 10.4161/epi.25865; Mathieu-Kia AM, 2001, BRAIN RES, V893, P121, DOI 10.1016/S0006-8993(00)03302-3; MINAMI M, 1995, NEUROSCI RES, V23, P121, DOI 10.1016/0168-0102(95)00933-K; Miwa K, 2016, J ALZHEIMERS DIS, V49, P503, DOI 10.3233/JAD-150458; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Olianas MC, 2012, MOL PHARMACOL, V81, P154, DOI 10.1124/mol.111.075267; Peters MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9570; Polito L, 2016, EXP GERONTOL, V76, P9, DOI 10.1016/j.exger.2016.01.005; Pouryamout L, 2012, DRUGS, V72, P789, DOI 10.2165/11631830-000000000-00000; Rhein M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00182; Sarajarvi T, 2015, J ALZHEIMERS DIS, V48, P507, DOI 10.3233/JAD-150221; Sarajarvi T, 2011, MOL CELL BIOL, V31, P2326, DOI 10.1128/MCB.05015-11; Shang YL, 2015, J CELL BIOCHEM, V116, P252, DOI 10.1002/jcb.24962; Smith AK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-145; Stenz L, 2015, NEUROSCI RES, V91, P1, DOI 10.1016/j.neures.2014.10.003; Teng L, 2010, CELL RES, V20, P138, DOI 10.1038/cr.2010.3; Tylee DS, 2013, AM J MED GENET B, V162, P595, DOI 10.1002/ajmg.b.32150; Vitali C, 2014, CARDIOVASC RES, V103, P405, DOI 10.1093/cvr/cvu148; Vitvitsky VM, 2012, BBA-MOL BASIS DIS, V1822, P1671, DOI 10.1016/j.bbadis.2012.07.004; Wachman EM, 2014, J PEDIATR-US, V165, P472, DOI 10.1016/j.jpeds.2014.05.040; Walton E., 2015, SCHIZOPHR B; Wang GL, 2003, J BIOL CHEM, V278, P40550, DOI 10.1074/jbc.M302879200; Xu LT, 2015, BIOMED PHARMACOTHER, V70, P80, DOI 10.1016/j.biopha.2015.01.014; Zhuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047193	56	17	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172335	10.1371/journal.pone.0172335	http://dx.doi.org/10.1371/journal.pone.0172335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253273	Green Submitted, gold, Green Published			2022-12-26	WOS:000396011300016
J	Martinez, PP; Reiner, RC; Cash, BA; Rodo, X; Mondal, MS; Roy, M; Yunus, M; Faruque, ASG; Huq, S; King, AA; Pascual, M				Martinez, Pamela P.; Reiner, Robert C., Jr.; Cash, Benjamin A.; Rodo, Xavier; Mondal, Mohammad Shahjahan; Roy, Manojit; Yunus, Mohammad; Faruque, A. S. G.; Huq, Sayeeda; King, Aaron A.; Pascual, Mercedes			Cholera forecast for Dhaka, Bangladesh, with the 2015-2016 El Nino: Lessons learned	PLOS ONE			English	Article							TROPICAL PACIFIC; ENDEMIC CHOLERA; CLIMATE; VARIABILITY; DISEASE; LINKS; ENSO; SST	A substantial body of work supports a teleconnection between the El Nino-Southern Oscillation (ENSO) and cholera incidence in Bangladesh. In particular, high positive anomalies during the winter (Dec-Feb) in sea surface temperatures (SST) in the tropical Pacific have been shown to exacerbate the seasonal outbreak of cholera following the monsoons from August to November. Climate studies have indicated a role of regional precipitation over Bangladesh in mediating this long-distance effect. Motivated by this previous evidence, we took advantage of the strong 2015-2016 El Nino event to evaluate the predictability of cholera dynamics for the city in recent times based on two transmission models that incorporate SST anomalies and are fitted to the earlier surveillance records starting in 1995. We implemented a mechanistic temporal model that incorporates both epidemiological processes and the effect of ENSO, as well as a previously published statistical model that resolves space at the level of districts (thanas). Prediction accuracy was evaluated with "out-of-fit" data from the same surveillance efforts (post 2008 and 2010 for the two models respectively), by comparing the total number of cholera cases observed for the season to those predicted by model simulations eight to twelve months ahead, starting in January each year. Although forecasts were accurate for the low cholera risk observed for the years preceding the 2015-2016 El Nino, the models also predicted a high probability of observing a large outbreak in fall 2016. Observed cholera cases up to Oct 2016 did not show evidence of an anomalous season. We discuss these predictions in the context of regional and local climate conditions, which show that despite positive regional rainfall anomalies, rainfall and inundation in Dhaka remained low. Possible explanations for these patterns are given together with future implications for cholera dynamics and directions to improve their prediction for the city.	[Martinez, Pamela P.; Pascual, Mercedes] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA; [Reiner, Robert C., Jr.] Indiana Univ, Bloomington Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN USA; [Cash, Benjamin A.] George Mason Univ, Ctr Ocean Land Atmosphere Studies, Fairfax, VA 22030 USA; [Rodo, Xavier] Catalan Inst Res & Adv Studies ICREA, Catalunya, Spain; [Rodo, Xavier] ISGlobal, Climate & Hlth Program, Catalunya, Spain; [Mondal, Mohammad Shahjahan] Bangladesh Univ Engn & Technol, Inst Water & Flood Management, Dhaka, Bangladesh; [Roy, Manojit; King, Aaron A.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Yunus, Mohammad; Faruque, A. S. G.; Huq, Sayeeda] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [King, Aaron A.] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; [Pascual, Mercedes] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Chicago; Indiana University System; Indiana University Bloomington; Center for Ocean Land Atmosphere Studies; George Mason University; ICREA; ISGlobal; Bangladesh University of Engineering & Technology (BUET); University of Michigan System; University of Michigan; International Centre for Diarrhoeal Disease Research (ICDDR); University of Michigan System; University of Michigan; The Santa Fe Institute	Pascual, M (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.; Pascual, M (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	pascualmm@uchicago.edu	Mondal, M. Shahjahan/AAG-4055-2021; King, Aaron A/B-8092-2012; Rodó, Xavier/F-7663-2017	King, Aaron A/0000-0001-6159-3207; Rodó, Xavier/0000-0003-4843-6180; Martinez, Pamela/0000-0002-3607-0938; Cash, Benjamin/0000-0003-2295-3112; Yunus, Mohammed/0000-0003-1116-4978	Research and Policy in Infectious Disease Dynamics program of the Science and Technology Directorate; Department of Homeland Security; Fogarty International Center; National Institutes of Health; MIDAS; National Institute of General Medical Sciences [U54-GM111274]; NSF [AGS 1338427]; NOAA MAPP NOM MAPP [NA140AR4310160]; NASA [NNX14AM19G]; EPRI; NSF (Ecology and Evolution of Infectious Diseases, EEID); ICREA Funding Source: Custom	Research and Policy in Infectious Disease Dynamics program of the Science and Technology Directorate; Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIDAS; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NOAA MAPP NOM MAPP; NASA(National Aeronautics & Space Administration (NASA)); EPRI; NSF (Ecology and Evolution of Infectious Diseases, EEID)(National Science Foundation (NSF)); ICREA(ICREA)	Current donors providing unrestricted support to the icddr,b include the Government of the People's Republic of Bangladesh, Global Affairs Canada (GAC), the Swedish International Development Cooperative Agency (SIDA) and the Department for International Development (UK Aid). A.A.K. was supported by the Research and Policy in Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security and the Fogarty International Center, National Institutes of Health and by MIDAS, National Institute of General Medical Sciences U54-GM111274. B.A.C acknowledges the support of NSF AGS 1338427, NOAA MAPP NOM MAPP NA140AR4310160, and NASA NNX14AM19G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The case data used in this paper were collected with the support of icddr,b and its donors who provide unrestricted support to icddr,b for its operation and research. We gratefully acknowledge these donors whose names are listed in the funding information. We are also grateful to past programs at NOAA, also jointly with EPRI AND NSF (Ecology and Evolution of Infectious Diseases, EEID) for their support of research at the interface of infectious diseases and climate; these programs enabled the development of the methods applied here.	Akanda AS, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009914; Akanda AS, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039312; Balandin S, 2009, AUGMENT ALTERN COMM, V25, P1, DOI 10.1080/07434610902813549; Bouma MJ, ECOLOGY ETIOLOGY NEW, V20, P147; Cash BA, 2008, J CLIMATE, V21, P4647, DOI 10.1175/2007JCLI2001.1; Cash BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107223; Cash BA, 2010, J CLIMATE, V23, P2817, DOI 10.1175/2009JCLI2512.1; Cash BA, 2009, J CLIMATE, V22, P1641, DOI 10.1175/2008JCLI2177.1; Chen MY, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009132; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Faisal IM, 2003, NAT HAZARDS, V28, P85, DOI 10.1023/A:1021173832234; Hashizume M, 2008, EPIDEMIOLOGY, V19, P103, DOI 10.1097/EDE.0b013e31815c09ea; Hashizume M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060001; Hashizume M, 2009, EPIDEMIOLOGY, V20, pS153, DOI 10.1097/01.ede.0000362523.13023.65; Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103; Jutla A, 2015, AM J TROP MED HYG, V93, P1179, DOI 10.4269/ajtmh.14-0648; King A.A., 2016, J STAT SOFTW, V69, P1, DOI [10.18637/jss.v069.i12, DOI 10.18637/JSS.V069.I12]; King AA, 2015, P R SOC LONDON B, V282; Koelle K, 2005, NATURE, V436, P696, DOI 10.1038/nature03820; Martinez PP, 2016, P NATL ACAD SCI USA, V113, P4092, DOI 10.1073/pnas.1518977113; Matsuda F, 2008, EPIDEMIOL INFECT, V136, P73, DOI 10.1017/S0950268807008175; Nasr-Azadani F, 2015, CLIM RES, V64, P257, DOI 10.3354/cr01310; Pascual M, 2008, CLIM RES, V36, P131, DOI 10.3354/cr00730; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Perez-Saez J, 2016, ADV WATER RESOURCES; Ramirez IJ, 2016, ECOHEALTH, V13, P83, DOI 10.1007/s10393-015-1095-3; Reiner RC, 2012, P NATL ACAD SCI USA, V109, P2033, DOI 10.1073/pnas.1108438109; Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999; Roy M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0937-3; Xie PP, 2007, J HYDROMETEOROL, V8, P607, DOI 10.1175/JHM583.1	30	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172355	10.1371/journal.pone.0172355	http://dx.doi.org/10.1371/journal.pone.0172355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253325	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300017
J	Szwarc, MM; Kommagani, R; Peavey, MC; Hai, L; Lonard, DM; Lydon, JP				Szwarc, Maria M.; Kommagani, Ramakrishna; Peavey, Mary C.; Hai, Lan; Lonard, David M.; Lydon, John P.			A bioluminescence reporter mouse that monitors expression of constitutively active beta-catenin	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; TUMOR-SUPPRESSOR PROTEIN; SALIVARY-GLAND TUMORS; FUNCTIONAL INTERACTION; PROGESTERONE-RECEPTOR; IN-VIVO; ACTIVATION; TRANSDIFFERENTIATION; HOMOLOG; SYSTEM	This short technical report describes the generation and characterization of a bioluminescence reporter mouse that is engineered to detect and longitudinally monitor the expression of doxycycline-induced constitutively active beta-catenin. The new responder transgenic mouse contains the TetO-Delta N89 beta-Cat(TMILA) transgene, which consists of the tet-operator followed by a bicistronic sequence encoding a stabilized form of active beta-catenin (Delta N89 beta-catenin), an internal ribosome entry site, and the firefly luciferase gene. To confirm that the transgene operates as designed, TetO-Delta N89 beta-Cat(TMILA) transgenic mouse lines were crossed with an effector mouse that harbors the mouse mammary tumor virus-reverse tetracycline transactivator (MMTV-rtTA) transgene (termed MTB hereon), which primarily targets rtTA expression to the mammary epithelium. Following doxycycline administration, the resultant MTB/Cat(TMILA) bigenic reporter exhibited precocious lobuloalveologenesis, ductal hyperplasia, and mammary adenocarcinomas, which were visualized and monitored by in vivo bioluminescence detection. Therefore, we predict that the TetO-Delta N89 beta-Cat(TMILA) transgenic responder mouse-when crossed with the appropriate effector transgenic D will have wide-applicability to non-invasively monitor the influence of constitutively active beta-catenin expression on cell-fate specification, proliferation, differentiation, and neoplastic transformation in a broad spectrum of target tissues.	[Szwarc, Maria M.; Hai, Lan; Lonard, David M.; Lydon, John P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Kommagani, Ramakrishna] Washington Univ, Sch Med, Dept Obstet Gynecol, St Louis, MO USA; [Peavey, Mary C.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA	Baylor College of Medicine; Washington University (WUSTL); Baylor College of Medicine	Lydon, JP (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	jlydon@bcm.tmc.edu	Hai, Lan/Y-1993-2018	Kommagani, Ramakrishna/0000-0003-0403-0971	Cancer Prevention Research Institute of Texas pre-doctoral fellowship grant [CPRIT: RP101499]; Baylor College of Medicine Reproductive Endocrinology and Infertility Fellowship; National Institutes of Health (NIH)/National Institute of Child Health and Human Development (NICHD) [K99 HD080742]; NIH/NICHD [U01: HD-076596, R01: HD-042311]; Cancer Center Grant [P30 CA125123]; Knockout Mouse Project; NIH [U54 HG006348];  [U42 HG006352)]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD080742, K99HD080742, U01HD076596, R01HD042311] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD042311] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006348] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas pre-doctoral fellowship grant; Baylor College of Medicine Reproductive Endocrinology and Infertility Fellowship; National Institutes of Health (NIH)/National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Cancer Center Grant; Knockout Mouse Project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was funded in part by: a Cancer Prevention Research Institute of Texas pre-doctoral fellowship grant (CPRIT: RP101499 (to MMS)); a Baylor College of Medicine Reproductive Endocrinology and Infertility Fellowship (to MCP); a National Institutes of Health (NIH)/National Institute of Child Health and Human Development (NICHD) grant (K99 HD080742 (to RK)); a NIH/NICHD U01: HD-076596 (to DML)); and a NIH/NICHD: R01: HD-042311 grant (to JPL); and Cancer Center Grant (P30 CA125123) Knockout Mouse Project; (KOMP3) Grant (U42 HG006352) to the Genetically Engineered Mouse Core at Baylor College of Medicine and a NIH grant (U54 HG006348) to the Mouse Phenotyping Core at Baylor College of Medicine.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Chandrashekar C, 2011, INT J SURG PATHOL, V19, P433, DOI 10.1177/1066896909346366; Fernandez-Valdivia R, 2009, DEV BIOL, V328, P127, DOI 10.1016/j.ydbio.2009.01.019; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; GUMBINER BM, 1995, CURR OPIN CELL BIOL, V7, P634, DOI 10.1016/0955-0674(95)80104-9; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; Imbert A, 2001, J CELL BIOL, V153, P555, DOI 10.1083/jcb.153.3.555; Jarde T, 2013, ONCOGENE, V32, P883, DOI 10.1038/onc.2012.103; Kommagani R, 2014, GUIDE INVESTIGATION, P755; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; MEDINA D, 2000, METHODS MAMMARY GLAN, P137; Miyoshi K, 2002, ONCOGENE, V21, P5548, DOI 10.1038/sj.onc.1205686; Miyoshi K, 2002, P NATL ACAD SCI USA, V99, P219, DOI 10.1073/pnas.012414099; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; Mukherjee A, 2007, GENESIS, V45, P639, DOI 10.1002/dvg.20336; Mukherjee A, 2011, TRANSGENIC RES, V20, P827, DOI 10.1007/s11248-010-9466-6; Mukherjee A, 2010, FASEB J, V24, P4408, DOI 10.1096/fj.10-157982; Munemitsu S, 1996, MOL CELL BIOL, V16, P4088; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Wend P, 2010, J Stem Cells Regen Med, V6, P134; Wend P, 2013, EMBO J, V32, P1977, DOI 10.1038/emboj.2013.127	25	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173014	10.1371/journal.pone.0173014	http://dx.doi.org/10.1371/journal.pone.0173014			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253313	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300058
J	Zou, B; Wan, DL; Li, RL; Han, XM; Li, GJ; Wang, RG				Zou, Bo; Wan, Dongli; Li, Ruili; Han, Xiaomin; Li, Guojing; Wang, Ruigang			Calmodulin-binding protein CBP60g functions as a negative regulator in Arabidopsis anthocyanin accumulation	PLOS ONE			English	Article							PIGMENTATION; GENES; BIOSYNTHESIS; EXPRESSION; FAMILY; SUGAR; SUCROSE; LIGHT; CYTOKININS; INDUCTION	Anthocyanins, a kind of flavonoid, normally accumulate in the flowers and fruits and make them colorful. Anthocyanin accumulation is regulated via the different temporal and spatial expression of anthocyanin regulatory and biosynthetic genes. CBP60g, a calmodulin binding protein, has previously been shown to have a role in pathogen resistance, drought tolerance and ABA sensitivity. In this study, we found that CBP60g repressed anthocyanin accumulation induced by drought, sucrose and kinetin. The expression pattern of CBP60g was in accordance with the anthocyanin accumulation tissues. Real-time qPCR analysis revealed that the anthocyanin biosynthetic genes CHS, CHI and DFR, as well as two members of MBW complex, PAP1, a MYB transcription factor, and TT8, a bHLH transcription factor, were down regulated by CBP60g.	[Zou, Bo; Wan, Dongli; Li, Ruili; Han, Xiaomin; Li, Guojing; Wang, Ruigang] Inner Mongolia Agr Univ, Coll Life Sci, Hohhot, Peoples R China; [Wan, Dongli] Chinese Acad Agr Sci, Inst Grassland Res, Hohhot, Peoples R China; [Li, Ruili] Wulanchabu Ctr Dis Control & Prevent, Jining, Peoples R China; [Han, Xiaomin] Baotou Med Coll, Dept Histol & Embryol, Baotou, Peoples R China	Inner Mongolia Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Baotou Medical College	Wang, RG (corresponding author), Inner Mongolia Agr Univ, Coll Life Sci, Hohhot, Peoples R China.	wangruigang@imau.edu.cn		Li, Guojing/0000-0001-7882-3523	National Natural Science Foundation of China [31360056]; Inner Mongolia Science & Technology Plan-Innovation Team [20150304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Inner Mongolia Science & Technology Plan-Innovation Team	This work was supported by National Natural Science Foundation of China (No. 31360056), and Inner Mongolia Science & Technology Plan-Innovation Team (20150304) to Guojing Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NW, 2014, PLANT CELL, V26, P962, DOI 10.1105/tpc.113.122069; Albert NW, 2011, PLANT J, V65, P771, DOI 10.1111/j.1365-313X.2010.04465.x; Albert NW, 2009, J EXP BOT, V60, P2191, DOI 10.1093/jxb/erp097; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Boss PK, 1996, PLANT MOL BIOL, V32, P565, DOI 10.1007/BF00019111; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Das PK, 2012, MOL CELLS, V34, P501, DOI 10.1007/s10059-012-0151-x; Das PK, 2012, MOL CELLS, V34, P93, DOI 10.1007/s10059-012-0114-2; DEIKMAN J, 1995, PLANT PHYSIOL, V108, P47, DOI 10.1104/pp.108.1.47; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Gould KS, 2004, J BIOMED BIOTECHNOL, P314, DOI 10.1155/S1110724304406147; Guo JC, 2005, J PLANT GROWTH REGUL, V24, P93, DOI 10.1007/s00344-005-0005-2; Hughes NM, 2005, NEW PHYTOL, V168, P575, DOI 10.1111/j.1469-8137.2005.01546.x; Jeong SW, 2010, PLANT PHYSIOL, V154, P1514, DOI 10.1104/pp.110.161869; Jun JH, 2015, PLANT CELL, V27, P2860, DOI 10.1105/tpc.15.00476; Mita S, 1997, PLANT PHYSIOL, V114, P575, DOI 10.1104/pp.114.2.575; Ohto M, 2001, PLANT PHYSIOL, V127, P252, DOI 10.1104/pp.127.1.252; Peng H, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0888-z; Peng Xin-Xiang, 1996, Acta Botanica Sinica, V38, P463; Pourcel L, 2013, PLANT J, V74, P383, DOI 10.1111/tpj.12129; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; REDDY ASN, 1993, PLANT SCI, V94, P109, DOI 10.1016/0168-9452(93)90012-O; Reddy VS, 2002, J BIOL CHEM, V277, P9840, DOI 10.1074/jbc.M111626200; SAUNDERS MJ, 1983, DEV BIOL, V99, P41, DOI 10.1016/0012-1606(83)90252-X; Schulz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037287; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Shang YJ, 2011, NEW PHYTOL, V189, P602, DOI 10.1111/j.1469-8137.2010.03498.x; Shin DH, 2015, PLANT CELL REP, V34, P805, DOI 10.1007/s00299-015-1743-7; Shin DH, 2013, BIOCHEM BIOPH RES CO, V430, P634, DOI 10.1016/j.bbrc.2012.11.100; Simeunovic A, 2016, J EXP BOT, V67, P3855, DOI 10.1093/jxb/erw157; Tanaka Y, 2008, CURR OPIN BIOTECH, V19, P190, DOI 10.1016/j.copbio.2008.02.015; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Truman W, 2013, PLANT PHYSIOL, V163, P1741, DOI 10.1104/pp.113.227108; Truman W, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-216; Wan DL, 2012, PLANT CELL REP, V31, P1269, DOI 10.1007/s00299-012-1247-7; Wang L, 2011, PLANT J, V67, P1029, DOI 10.1111/j.1365-313X.2011.04655.x; Wang L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000301; Zhang YX, 2010, P NATL ACAD SCI USA, V107, P18220, DOI 10.1073/pnas.1005225107	39	6	7	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173129	10.1371/journal.pone.0173129	http://dx.doi.org/10.1371/journal.pone.0173129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253311	gold, Green Published, Green Submitted			2022-12-26	WOS:000396011300080
J	Terawaki, K; Kashiwase, Y; Sawada, Y; Hashimoto, H; Yoshimura, M; Ohbuchi, K; Sudo, Y; Suzuki, M; Miyano, K; Shiraishi, S; Higami, Y; Yanagihara, K; Hattori, T; Kase, Y; Ueta, Y; Uezono, Y				Terawaki, Kiyoshi; Kashiwase, Yohei; Sawada, Yumi; Hashimoto, Hirofumi; Yoshimura, Mitsuhiro; Ohbuchi, Katsuya; Sudo, Yuka; Suzuki, Masami; Miyano, Kanako; Shiraishi, Seiji; Higami, Yoshikazu; Yanagihara, Kazuyoshi; Hattori, Tomohisa; Kase, Yoshio; Ueta, Yoichi; Uezono, Yasuhito			Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the Kampo medicine rikkunshito on the model	PLOS ONE			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; NEUROPEPTIDE-Y-INNERVATION; LEUKEMIA-INHIBITORY FACTOR; CISPLATIN-INDUCED ANOREXIA; NUDE-MICE; ARCUATE NUCLEUS; HERBAL MEDICINE; 5-HT2C RECEPTOR; PLASMA GHRELIN; MELANOMA-CELLS	Cancer cachexia (CC) is a multifactorial disease characterized by decreased food intake and loss of body weight due to reduced musculature with or without loss of fat mass. Patients with gastric cancer have a high incidence of cachexia. We previously established a novel CC rat model induced by human gastric cancer-derived 85As2 cells in order to examine the pathophysiology of CC and identify potential therapeutics. In patients with CC, anorexia is often observed, despite elevation of ghrelin, suggesting that ghrelin resistance may develop in these patients. In this study, we aimed to clarify the occurrence of ghrelin resistance in CC rats accompanied by anorexia and we investigated whether rikkunshito (RKT), a traditional Japanese Kampo medicine that potentiates ghrelin signaling, ameliorated CC-related anorexia through alleviation of ghrelin resistance. 85As2-tumor-bearing rats developed severe CC symptoms, including anorexia and loss of body weight/musculature, with the latter symptoms being greater in cachectic rats than in non-tumor-bearing or pair-fed rats. CC rats showed poor responses to intraperitoneal injection of ghrelin. In CC rats, plasma ghrelin levels were elevated and hypothalamic anorexigenic peptide mRNA levels were decreased, whereas hypothalamic growth hormone secretagogue receptor (GHS-R) mRNA was not affected. In vitro, RKT directly enhanced ghrelin-induced GHS-R activation. RKT administrated orally for 7 days partly alleviated the poor response to ghrelin and ameliorated anorexia without affecting the elevation of plasma ghrelin levels in CC rats. The expression of hypothalamic orexigenic neuropeptide Y mRNA but not hypothalamic GHS-R mRNA was increased by RKT. Thus, the 85As2 cell-induced CC rat model developed ghrelin resistance, possibly contributing to anorexia and body weight loss. The mechanism through which RKT ameliorated anorexia in the CC rat model may involve alleviation of ghrelin resistance by enhancement of ghrelin signaling. These findings suggest that RKT may be a promising agent for the treatment of CC.	[Terawaki, Kiyoshi; Kashiwase, Yohei; Sawada, Yumi; Ohbuchi, Katsuya; Sudo, Yuka; Suzuki, Masami; Miyano, Kanako; Shiraishi, Seiji; Uezono, Yasuhito] Natl Canc Ctr, Res Inst, Div Canc Pathophysiol, Chuo Ku, Tokyo, Japan; [Terawaki, Kiyoshi; Ohbuchi, Katsuya; Hattori, Tomohisa; Kase, Yoshio] Tsumura & Co, Tsumura Res Labs, Kampo Sci Strategies Div, Ami, Ibaraki, Japan; [Kashiwase, Yohei; Sudo, Yuka; Higami, Yoshikazu] Tokyo Univ Sci, Lab Mol Pathol & Metab Dis, Fac Pharmaceut Sci, Noda, Chiba, Japan; [Hashimoto, Hirofumi; Yoshimura, Mitsuhiro; Ueta, Yoichi] Univ Occupat & Environm Hlth, Dept Physiol, Sch Med, Yahatanishi Ku, Kitakyushu, Fukuoka, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Biomarker Discovery, Kashiwa, Chiba, Japan; [Uezono, Yasuhito] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Support Canc Res, Chuo Ku, Tokyo, Japan; [Uezono, Yasuhito] Natl Canc Ctr, Innovat Ctr Support Palliat & Psychosocial Care, Chuo Ku, Tokyo, Japan	National Cancer Center - Japan; Tsumura & Company; Tokyo University of Science; University of Occupational & Environmental Health - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan	Uezono, Y (corresponding author), Natl Canc Ctr, Res Inst, Div Canc Pathophysiol, Chuo Ku, Tokyo, Japan.; Uezono, Y (corresponding author), Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Support Canc Res, Chuo Ku, Tokyo, Japan.; Uezono, Y (corresponding author), Natl Canc Ctr, Innovat Ctr Support Palliat & Psychosocial Care, Chuo Ku, Tokyo, Japan.	yuezono@ncc.go.jp	Shiraishi, Seiji/GPX-5566-2022	Hashimoto, Hirofumi/0000-0003-1575-836X; Higami, Yoshikazu/0000-0003-1381-0777; Miyano, Kanako/0000-0003-1673-6074	Ministry of Education, Culture, Sports, Science and Technology, Japan [22590510, 24590740]; Foundation for Promotion of Cancer Research in Japan; Ministry of Health, Labour and Welfare, Japan [H22-General-035]; Research Project for Improving Quality in Healthcare and Collecting Scientific Evidence on Integrative Medicine [15lk0310003h0001, 16lk0310020h0001]; Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED [15ck0106059h0002, 16nk0101311h0002]; National Cancer Center Research and Development Fund [23-A-2, 23-A-29, 23-A-38]; Tsumura & Co. (Ibaraki, Japan); Grants-in-Aid for Scientific Research [16K08537] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation for Promotion of Cancer Research in Japan; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Research Project for Improving Quality in Healthcare and Collecting Scientific Evidence on Integrative Medicine; Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Tsumura & Co. (Ibaraki, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant support was provided to KT by: 1. Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology, Japan [http://www.jsps.go.jp/j-grantsinaid/index.html] Grant no. 22590510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2. The Foundation for Promotion of Cancer Research in Japan [http://www.ncc.go.jp/jp/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Grant support was provided to Y. Uezono by: 1. The Third-term Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare, Japan; [http://www.mhlw.go.jp/] Grant no. H22-General-035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2. Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology, Japan; [http://www.jsps.go.jp/j-grantsinaid/index.html] Grant no. 24590740. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 3. Grants from the Research Project for Improving Quality in Healthcare and Collecting Scientific Evidence on Integrative Medicine [http://www.amed.go.jp/] Grant no. 15lk0310003h0001, 16lk0310020h0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 4. The Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED; [http://www.amed.go.jp/] Grant no. 15ck0106059h0002, 16nk0101311h0002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 5. The National Cancer Center Research and Development Fund [http://www.ncc.go.jp/jp/] Grant nos. 23-A-2, 23-A-29, and 23-A-38. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 6. A grant from Tsumura & Co. (Ibaraki, Japan) [https://www.tsumura.co.jp/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M, 2012, HEPATO-GASTROENTEROL, V59, P62, DOI 10.5754/hge11246; Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; Broberger C, 1999, NEUROENDOCRINOLOGY, V70, P295, DOI 10.1159/000054490; Chang JWC, 2003, J ENDOCRINOL, V179, P387, DOI 10.1677/joe.0.1790387; Currie PJ, 2005, AM J PHYSIOL-REG I, V289, pR353, DOI 10.1152/ajpregu.00756.2004; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Ebrahimi B, 2004, CANCER-AM CANCER SOC, V101, P2727, DOI 10.1002/cncr.20672; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fekete C, 2001, ENDOCRINOLOGY, V142, P2606, DOI 10.1210/en.142.6.2606; Fujitsuka N, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.25; Fujitsuka N, 2016, MOL PSYCHIATR; Fujitsuka N, 2009, BIOL PSYCHIAT, V65, P748, DOI 10.1016/j.biopsych.2008.10.031; Garcia JM, 2005, J CLIN ENDOCR METAB, V90, P2920, DOI 10.1210/jc.2004-1788; Grossberg AJ, 2010, ENDOCRINOLOGY, V151, P606, DOI 10.1210/en.2009-1135; Hanada T, 2003, BIOCHEM BIOPH RES CO, V301, P275, DOI 10.1016/S0006-291X(02)03028-0; Hayakawa T, 1999, DRUG EXP CLIN RES, V25, P211; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Laviano A, 2005, NAT CLIN PRACT ONCOL, V2, P158, DOI 10.1038/ncponc0112; Legradi G, 1998, ENDOCRINOLOGY, V139, P3262, DOI 10.1210/en.139.7.3262; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsumura T, 2010, J GASTROENTEROL, V45, P300, DOI 10.1007/s00535-009-0166-z; Miyano K, 2014, J PHARMACOL SCI, V126, P302, DOI 10.1254/jphs.14R13CP; MORI M, 1991, CANCER RES, V51, P6656; Muscaritoli M, 2006, EUR J CANCER, V42, P31, DOI 10.1016/j.ejca.2005.07.026; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Neary NM, 2004, J CLIN ENDOCR METAB, V89, P2832, DOI 10.1210/jc.2003-031768; PAXINOS G, 1982, THE RAT BRAIN IN STE; Peters MF, 2010, ASSAY DRUG DEV TECHN, V8, P219, DOI 10.1089/adt.2009.0232; Ramos EJB, 2004, CURR OPIN CLIN NUTR, V7, P427, DOI 10.1097/01.mco.0000134363.53782.cb; Ravasco P, 2004, SUPPORT CARE CANCER, V12, P246, DOI 10.1007/s00520-003-0568-z; Scott CW, 2010, DRUG DISCOV TODAY, V15, P704, DOI 10.1016/j.drudis.2010.06.008; Shimizu Y, 2003, CLIN CANCER RES, V9, P774; Suzuki H, 2014, NEUROGASTROENT MOTIL, V26, P950, DOI 10.1111/nmo.12348; Suzuki H, 2009, NEUROGASTROENT MOTIL, V21, P688, DOI 10.1111/j.1365-2982.2009.01290.x; Suzuki M, 2012, SYNAPSE, V66, P747, DOI 10.1002/syn.21559; Tack J, 2006, GUT, V55, P327, DOI 10.1136/gut.2004.060426; Takeda H, 2008, GASTROENTEROLOGY, V134, P2004, DOI 10.1053/j.gastro.2008.02.078; Terawaki K, 2014, AM J PHYSIOL-ENDOC M, V306, pE373, DOI 10.1152/ajpendo.00116.2013; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tominaga K, 2011, EVID-BASED COMPL ALT, V2011, DOI DOI 10.1093/ECAM/NEP173; TONI R, 1990, ENDOCRINOLOGY, V126, P2444, DOI 10.1210/endo-126-5-2444; Toshinai K, 2001, BIOCHEM BIOPH RES CO, V281, P1220, DOI 10.1006/bbrc.2001.4518; Tschop M, 2001, J ENDOCRINOL INVEST, V24, pRC19, DOI 10.1007/BF03351037; Vettor R, 2002, J ENDOCRINOL INVEST, V25, P836, DOI 10.1007/BF03344047; Walsh D, 2002, SUPPORT CARE CANCER, V10, P385, DOI 10.1007/s00520-001-0318-z; Wang W, 2006, INT J ONCOL, V28, P1393; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Yakabi K, 2010, REGUL PEPTIDES, V161, P97, DOI 10.1016/j.regpep.2010.02.003; Yanagihara K, 2013, NUTR CANCER, V65, P578, DOI 10.1080/01635581.2013.776089; Yanai M, 2013, J GASTROENTEROL, V48, P611, DOI 10.1007/s00535-012-0687-8; Yoshimura M, 2013, PEPTIDES, V46, P13, DOI 10.1016/j.peptides.2013.04.019; Zaki MH, 2004, INT J CANCER, V111, P592, DOI 10.1002/ijc.20270	52	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173113	10.1371/journal.pone.0173113	http://dx.doi.org/10.1371/journal.pone.0173113			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249026	gold, Green Published, Green Submitted			2022-12-26	WOS:000395983500077
J	Hanse, EA; Ruan, C; Kachman, M; Wang, D; Lowman, XH; Kelekar, A				Hanse, E. A.; Ruan, C.; Kachman, M.; Wang, D.; Lowman, X. H.; Kelekar, A.			Cytosolic malate dehydrogenase activity helps support glycolysis in actively proliferating cells and cancer	ONCOGENE			English	Article							LACTIC-DEHYDROGENASE; ALPHA-KETOGLUTARATE; METABOLISM; GROWTH; LACTATE; PATHWAY; GLUCOSE; SENSITIVITY; ACTIVATION; GENOMICS	Increased glucose consumption is a hallmark of cancer cells. The increased consumption and subsequent metabolism of glucose during proliferation creates the need for a constant supply of NAD, a co-factor in glycolysis. Regeneration of the NAD required to support enhanced glycolysis has been attributed to the terminal glycolytic enzyme, lactate dehydrogenase (LDH). However, loss of glucose carbons to biosynthetic pathways early in glycolysis reduces the carbon supply to LDH. Thus, alternative routes for NAD regeneration must exist to support the increased glycolytic rate while allowing for the diversion of glucose to generate biomass and support proliferation. Here we demonstrate, using a variety of cancer cell lines as well as activated primary T cells, that cytosolic malate dehydrogenase 1 (MDH1) is an alternative to LDH as a supplier of NAD. Moreover, our results indicate that MDH1 generates malate with carbons derived from glutamine, thus enabling utilization of glucose carbons for glycolysis and for biomass. Amplification of MDH1 occurs at an impressive frequency in human tumors and correlates with poor prognosis. Together, our findings suggest that proliferating cells rely on both MDH1 and LDH to replenish cytosolic NAD, and that therapies designed at targeting glycolysis must consider both dehydrogenases.	[Hanse, E. A.; Lowman, X. H.; Kelekar, A.] Univ Minnesota, Dept Lab Med & Pathol, 420 SE Washington Ave,MCB 5-126, Minneapolis, MN 55455 USA; [Hanse, E. A.; Lowman, X. H.; Kelekar, A.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Ruan, C.; Kachman, M.; Wang, D.] Univ Michigan, Michigan Reg Comprehens Metab Res Core, Ann Arbor, MI 48109 USA; [Lowman, X. H.] City Hope Canc Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan; City of Hope; Beckman Research Institute of City of Hope	Kelekar, A (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, 420 SE Washington Ave,MCB 5-126, Minneapolis, MN 55455 USA.	ameeta@umn.edu		Hanse, Eric/0000-0002-1234-0198	University of Minnesota Academic Health Center; National Institutes of Health (NIH) [R01 CA157971, 3002751553]; T32 training fellowship [CA009138]; F31 award [CA177119]; NIH Common Funds Project [U24 DK097153]; NATIONAL CANCER INSTITUTE [T32CA009138, P30CA077598, F31CA177119, R01CA157971, T32CA186895] Funding Source: NIH RePORTER	University of Minnesota Academic Health Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 training fellowship; F31 award; NIH Common Funds Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs David Sabatini and Kivanc Birsoy for the MDH1 KO Jurkat cells, and Hong-Duk Youn for the MDH1 construct. We would also like to thank Todd Rappe and University of Minnesota Nuclear Magnetic Resonance Core for help with nuclear magnetic resonance analysis. We are grateful to Dr David Bernlohr, Michael Downey, Yan Yan and Dr Jenna Benson for stimulating discussions. We also thank Drs Lucas Sullivan and Sandra Armstrong for valuable suggestions. This study was supported by a Seed Grant and an Infrastructure grant from the University of Minnesota Academic Health Center (to AK), National Institutes of Health (NIH) grant R01 CA157971, P/F grant, 3002751553, through the NIH-funded RCMC in Michigan (to AK), and by T32 training fellowship, CA009138, and F31 award, CA177119 (to EAH). The study utilized Metabolomics Core Services supported by grant U24 DK097153 of NIH Common Funds Project to the University of Michigan.	Augoff K, 2015, CANCER LETT, V358, P1, DOI 10.1016/j.canlet.2014.12.035; Billiard J, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-19; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Calvo MN, 2006, FEBS LETT, V580, P3308, DOI 10.1016/j.febslet.2006.04.093; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; GOLDBERG EB, 1965, J BIOL CHEM, V240, P2786; GOLDMAN RD, 1964, CANCER RES, V24, P389; Gui DY, 2016, CELL METAB, V24, P716, DOI 10.1016/j.cmet.2016.09.006; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lee SM, 2009, CELL DEATH DIFFER, V16, P738, DOI 10.1038/cdd.2009.5; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Liu L, 2016, NAT CHEM BIOL, V12, P345, DOI [10.1038/NCHEMBIO.2047, 10.1038/nchembio.2047]; Liu PP, 2014, CELL DEATH DIFFER, V21, P124, DOI 10.1038/cdd.2013.131; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; Lowman XH, 2010, MOL CELL, V40, P823, DOI 10.1016/j.molcel.2010.11.035; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Menzies KJ, 2016, NAT REV ENDOCRINOL, V12, P43, DOI 10.1038/nrendo.2015.181; Rani R, 2016, J MED CHEM, V59, P487, DOI 10.1021/acs.jmedchem.5b00168; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Wang YJ, 2016, J MENINGITIS, V1, P1, DOI DOI 10.1016/J.BMC1.2015.12.021; Winer LSP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109916; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003; Yang ZR, 2003, J BIOL CHEM, V278, P8804, DOI 10.1074/jbc.M211892200	33	53	55	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 6	2017	36	27					3915	3924		10.1038/onc.2017.36	http://dx.doi.org/10.1038/onc.2017.36			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EZ6SM	28263970	Green Accepted			2022-12-26	WOS:000404848200011
J	Abe, K; Nakajima, M; Yamashita, T; Matsunaga, H; Kamisuki, S; Nihira, T; Takahashi, Y; Sugimoto, N; Miyanaga, A; Nakai, H; Arakawa, T; Fushinobu, S; Taguchi, H				Abe, Koichi; Nakajima, Masahiro; Yamashita, Tetsuro; Matsunaga, Hiroki; Kamisuki, Shinji; Nihira, Takanori; Takahashi, Yuta; Sugimoto, Naohisa; Miyanaga, Akimasa; Nakai, Hiroyuki; Arakawa, Takatoshi; Fushinobu, Shinya; Taguchi, Hayao			Biochemical and structural analyses of a bacterial endo-beta-1,2-glucanase reveal a new glycoside hydrolase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme structure; glycosidase; Gram-negative bacteria; oligosaccharide; polysaccharide; -1; 2-glucan; Chitinophaga pinensis; endo--1; 2-glucanase; novel glycoside hydrolase family; sophorooligosaccharide	SEQUENCE-BASED CLASSIFICATION; CYCLIC-BETA-GLUCANS; STRUCTURE VALIDATION; PERIPLASMIC GLUCANS; ALGINATE LYASE; ACTIVE-SITE; BETA-1,2-GLUCAN; PURIFICATION; EVOLUTIONARY; ADAPTATION	-1,2-Glucan is an extracellular cyclic or linear polysaccharide from Gram-negative bacteria, with important roles in infection and symbiosis. Despite -1,2-glucan's importance in bacterial persistence and pathogenesis, only a few reports exist on enzymes acting on both cyclic and linear -1,2-glucan. To this end, we purified an endo--1,2-glucanase to homogeneity from cell extracts of the environmental species Chitinophaga arvensicola, and an endo--1,2-glucanase candidate gene (Cpin_6279) was cloned from the related species Chitinophaga pinensis. The Cpin_6279 protein specifically hydrolyzed linear -1,2-glucan with polymerization degrees of 5 and a cyclic counterpart, indicating that Cpin_6279 is an endo--1,2-glucananase. Stereochemical analysis demonstrated that the Cpin_6279-catalyzed reaction proceeds via an inverting mechanism. Cpin_6279 exhibited no significant sequence similarity with known glycoside hydrolases (GHs), and thus the enzyme defines a novel GH family, GH144. The crystal structures of the ligand-free and complex forms of Cpin_6279 with glucose (Glc) and sophorotriose (Glc--1,2-Glc--1,2-Glc) determined up to 1.7 angstrom revealed that it has a large cavity appropriate for polysaccharide degradation and adopts an (/)(6)-fold slightly similar to that of GH family 15 and 8 enzymes. Mutational analysis indicated that some of the highly conserved acidic residues in the active site are important for catalysis, and the Cpin_6279 active-site architecture provided insights into the substrate recognition by the enzyme. The biochemical characterization and crystal structure of this novel GH may enable discovery of other -1,2-glucanases and represent a critical advance toward elucidating structure-function relationships of GH enzymes.	[Abe, Koichi; Arakawa, Takatoshi; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Abe, Koichi; Nakajima, Masahiro; Matsunaga, Hiroki; Kamisuki, Shinji; Taguchi, Hayao] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan; [Yamashita, Tetsuro] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; [Kamisuki, Shinji] Azabu Univ, Sch Vet Med, Chuoh Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2298501, Japan; [Nihira, Takanori; Takahashi, Yuta; Sugimoto, Naohisa; Nakai, Hiroyuki] Niigata Univ, Fac Agr, Niigata 9502181, Japan; [Miyanaga, Akimasa] Tokyo Inst Technol, Dept Chem, Meguro Ku, Tokyo 1528551, Japan	University of Tokyo; Tokyo University of Science; Iwate University; Azabu University; Niigata University; Tokyo Institute of Technology	Nakajima, M (corresponding author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	m-nakajima@rs.tus.ac.jp	Nakajima, Masahiro/J-3566-2019; Fushinobu, Shinya/E-4987-2011; Arakawa, Takatoshi/K-9739-2013; Miyanaga, Akimasa/C-1472-2015	Nakajima, Masahiro/0000-0002-3182-0859; Fushinobu, Shinya/0000-0003-1346-6435; Arakawa, Takatoshi/0000-0001-6496-5440; Miyanaga, Akimasa/0000-0003-2219-6051; Taguchi, Hayao/0000-0001-5270-581X; Kamisuki, Shinji/0000-0001-8773-3909	Noda Institute for Scientific Research	Noda Institute for Scientific Research(Noda Institute for Scientific Research)	This work was supported in part by a Noda Institute for Scientific Research Grant (2013 Young Investigator Research Grant). The authors declare that they have no conflicts of interest with the contents of this article.	Abe K., 2015, J APPL GLYCOSCI, V62, P47, DOI [DOI 10.5458/JAG.JAG, 10.5458/jag.jag.JAG-2014_011, DOI 10.5458/JAG.JAG.JAG-2014_011]; AMEMURA A, 1985, J GEN MICROBIOL, V131, P301; AMEMURA A, 1986, J GEN MICROBIOL, V132, P2443; Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; Bakkevig K, 2005, J BACTERIOL, V187, P8375, DOI 10.1128/JB.187.24.8375-8384.2005; Bianchetti CM, 2015, J BIOL CHEM, V290, P11819, DOI 10.1074/jbc.M114.623579; Bohin JP, 2000, FEMS MICROBIOL LETT, V186, P11, DOI 10.1016/S0378-1097(00)00110-5; Bras JLA, 2011, P NATL ACAD SCI USA, V108, P5237, DOI 10.1073/pnas.1015006108; BREEDVELD MW, 1994, MICROBIOL REV, V58, P145, DOI 10.1128/MMBR.58.2.145-161.1994; Briones G, 2001, INFECT IMMUN, V69, P4528, DOI 10.1128/IAI.69.7.4528-4535.2001; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Del Rio TG, 2010, STAND GENOMIC SCI, V2, P87, DOI 10.4056/sigs.661199; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gay-Fraret J, 2012, FEMS MICROBIOL LETT, V333, P28, DOI 10.1111/j.1574-6968.2012.02595.x; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Han Yonghua, 2005, Journal of Bioinformatics and Computational Biology, V3, P697; Hemsworth GR, 2016, BIOCHEM SOC T, V44, P94, DOI 10.1042/BST20150180; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HISAMATSU M, 1982, J GEN MICROBIOL, V128, P1873; HISAMATSU M, 1992, CARBOHYD RES, V231, P137, DOI 10.1016/0008-6215(92)84014-J; Jain S, 2005, INFECT IMMUN, V73, P6429, DOI 10.1128/IAI.73.10.6429-6436.2005; Kawano S, 2002, J BIOSCI BIOENG, V94, P275, DOI 10.1263/jbb.94.275; KITAHATA S, 1987, AGR BIOL CHEM TOKYO, V51, P2701; Koseoglu VK, 2015, MOL MICROBIOL, V96, P728, DOI 10.1111/mmi.12966; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Liu JL, 2013, J PHYS CHEM B, V117, P10080, DOI 10.1021/jp402110j; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ma B, 2003, RAPID COMMUN MASS SP, V17, P2337, DOI 10.1002/rcm.1196; McKee LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139932; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; MENDOZA NS, 1983, J FERMENT TECHNOL, V61, P473; MILLER KJ, 1986, SCIENCE, V231, P48, DOI 10.1126/science.3941890; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakajima M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148870; Nakajima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092353; Nakajima M, 2012, APPL MICROBIOL BIOT, V93, P1989, DOI 10.1007/s00253-011-3538-2; Nakamura A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500263; NELSON TE, 1970, J BIOL CHEM, V245, P869; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; REESE ET, 1971, CARBOHYD RES, V18, P381, DOI 10.1016/S0008-6215(00)80274-8; REESE ET, 1961, CAN J MICROBIOL, V7, P309, DOI 10.1139/m61-038; Rigano LA, 2007, PLANT CELL, V19, P2077, DOI 10.1105/tpc.106.047944; Roslund MU, 2008, CARBOHYD RES, V343, P101, DOI 10.1016/j.carres.2007.10.008; Sova VV, 2003, BIOCHEMISTRY-MOSCOW+, V68, P529, DOI 10.1023/A:1023951525250; Stam MR, 2005, CARBOHYD RES, V340, P2728, DOI 10.1016/j.carres.2005.09.018; TALAGA P, 1994, J BACTERIOL, V176, P6538, DOI 10.1128/JB.176.21.6538-6544.1994; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	58	26	28	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7487	7506		10.1074/jbc.M116.762724	http://dx.doi.org/10.1074/jbc.M116.762724			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28270506	Green Published, hybrid			2022-12-26	WOS:000400761300018
J	Bikkavilli, RK; Zerayesus, SA; Van Scoyk, M; Wilson, L; Wu, PY; Baskaran, A; Tang, K; Raheem, S; Samuelson, BA; Reddy, NM; Reddy, SP; Cool, CD; Kosmider, B; Avasarala, S; Winn, RA				Bikkavilli, Rama Kamesh; Zerayesus, Sereke Adam; Van Scoyk, Michelle; Wilson, Lora; Wu, Pei-Ying; Baskaran, Abhinaya; Tang, Ke; Raheem, Syed; Samuelson, Blain A.; Reddy, Narsa M.; Reddy, Sekhar P.; Cool, Carlyne D.; Kosmider, Beata; Avasarala, Sreedevi; Winn, Robert A.			K-homology splicing regulatory protein (KSRP) promotes post-transcriptional destabilization of Spry4 transcripts in non-small cell lung cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell invasion; cell migration; mRNA decay; post-transcriptional regulation; RNA-binding protein; KSRP; NSCLC; Spry4	MESSENGER-RNA DECAY; AU-RICH ELEMENT; BINDING PROTEIN; EXPRESSION; CATENIN; COMPLEX; GROWTH; IDENTIFICATION; STABILIZATION; INVOLVEMENT	AU-rich element-binding proteins (ARE-BPs) offer post-transcriptional regulation of gene expression via physical interaction and recruitment of RNA decay machinery to the AU-rich elements within the 3-UTR of the target transcripts. However, the role of ARE-BPs in lung cancer remains poorly understood. In this study, we have identified that K-homology splicing regulatory protein (KSRP), an ARE-BP, is robustly up-regulated in human lung cancer. Importantly, Kaplan-Meier survival analysis indicated that elevated KSRP expression was correlated with poor overall survival of lung cancer patients. Furthermore, cigarette smoke, a leading risk factor for lung cancer, was also identified to be an important contributor to increased KSRP expression. Remarkably, silencing of KSRP decreased cell proliferation, reversed anchorage-independent growth, and reduced migration/invasion, suggesting an oncogenic role for KSRP in lung cancer. Finally, we provide mechanistic evidence that KSRP promotes the down-regulation of Spry4 by a previously unidentified mechanism, i.e. post-transcriptional mRNA regulation.	[Bikkavilli, Rama Kamesh; Zerayesus, Sereke Adam; Van Scoyk, Michelle; Wu, Pei-Ying; Baskaran, Abhinaya; Tang, Ke; Raheem, Syed; Samuelson, Blain A.; Avasarala, Sreedevi; Winn, Robert A.] Univ Illinois, Dept Med, Div Pulm Crit Care Sleep & Allergy, Rm 5160,Coll Med Res Bldg,909 S Wolcott Ave, Chicago, IL 60612 USA; [Reddy, Narsa M.; Reddy, Sekhar P.] Univ Illinois, Dept Pediat, Div Dev Biol & Basic Res, Chicago, IL 60612 USA; [Wilson, Lora; Cool, Carlyne D.] Univ Colorado Anschutz Med Campus, Sch Med, Dept Pathol, Aurora, CO 80045 USA; [Wilson, Lora; Cool, Carlyne D.] Univ Colorado Anschutz Med Campus, Sch Med, Div Pulm Sci & Crit Care Med, Aurora, CO 80045 USA; [Kosmider, Beata] Temple Univ, Lewis Katz Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Kosmider, Beata] Temple Univ, Lewis Katz Sch Med, Dept Thorac Med, Philadelphia, PA 19140 USA; [Kosmider, Beata] Temple Univ, Lewis Katz Sch Med, Dept Surg, Philadelphia, PA 19140 USA; [Kosmider, Beata] Temple Univ, Ctr Inflammat Translat & Clin Lung Res, Philadelphia, PA 19140 USA; [Kosmider, Beata] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Winn, Robert A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; National Jewish Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Winn, RA (corresponding author), Univ Illinois, Dept Med, Div Pulm Crit Care Sleep & Allergy, Rm 5160,Coll Med Res Bldg,909 S Wolcott Ave, Chicago, IL 60612 USA.	rwinn@uic.edu	Reddy, Narsa/AHE-5604-2022		National Institutes of Health [R01 CA138528, R01 HL118171]; NATIONAL CANCER INSTITUTE [U54CA203000, U54CA202997, U54CA202995, R01CA138528] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 CA138528 (to R. A. W.) and R01 HL118171 (to B. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bikkavilli RK, 2011, J CELL SCI, V124, P2310, DOI 10.1242/jcs.084046; Bikkavilli RK, 2010, J CELL SCI, V123, P1352, DOI 10.1242/jcs.056176; Bird CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079255; Bollmann F, 2014, NUCLEIC ACIDS RES, V42, P12555, DOI 10.1093/nar/gku1033; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Briata P, 2012, CELL DEATH DIFFER, V19, P478, DOI 10.1038/cdd.2011.117; Briata P, 2013, BBA-GENE REGUL MECH, V1829, P689, DOI 10.1016/j.bbagrm.2012.11.003; Briata P, 2011, FRONT BIOSCI-LANDMRK, V16, P1787, DOI 10.2741/3821; Cammas A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5190; Chou CF, 2006, MOL CELL BIOL, V26, P3695, DOI 10.1128/MCB.26.10.3695-3706.2006; Chou CF, 2015, J LIPID RES, V56, P227, DOI 10.1194/jlr.M050724; Chou CF, 2014, DIABETES, V63, P2949, DOI 10.2337/db13-1901; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Gherzi R, 2014, SEMIN CELL DEV BIOL, V34, P2, DOI 10.1016/j.semcdb.2014.05.004; Gherzi R, 2010, WIRES RNA, V1, P230, DOI 10.1002/wrna.2; Giovarelli M, 2013, BBA-GENE REGUL MECH, V1829, P469, DOI 10.1016/j.bbagrm.2013.02.008; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Khabar K. S., 2016, WILEY INTERDISCIP RE, V8, pe1368; King PH, 2014, J INTERF CYTOK RES, V34, P267, DOI 10.1089/jir.2013.0143; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Liu Y, 2011, MOL CELL, V41, P367, DOI 10.1016/j.molcel.2011.01.027; Masoumi-Moghaddam S, 2014, CANCER METAST REV, V33, P695, DOI 10.1007/s10555-014-9497-1; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Nechama M, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-70; Nicastro G, 2012, NAT STRUCT MOL BIOL, V19, P1282, DOI 10.1038/nsmb.2427; Pasero M, 2012, CELL REP, V2, P1159, DOI 10.1016/j.celrep.2012.10.020; Reddy NM, 2012, AM J PATHOL, V180, P562, DOI 10.1016/j.ajpath.2011.10.029; Repetto E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002823; Ruggiero T, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-28; Sechler M, 2015, J BIOL CHEM, V290, P15610, DOI 10.1074/jbc.M114.631820; Seok H, 2002, PROTEIN PEPTIDE LETT, V9, P511, DOI 10.2174/0929866023408454; Suswam EA, 2005, INT J CANCER, V113, P911, DOI 10.1002/ijc.20675; Tennis MA, 2010, MOL CANCER RES, V8, P833, DOI 10.1158/1541-7786.MCR-09-0400; Trabucchi M, 2010, ADV EXP MED BIOL, V700, P36, DOI 10.1007/978-1-4419-7823-3_4; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Winn RA, 2005, J BIOL CHEM, V280, P19625, DOI 10.1074/jbc.M409392200; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Zhang Kun, 2015, Zhongguo Fei Ai Za Zhi, V18, P219, DOI 10.3779/j.issn.1009-3419.2015.04.02	45	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7423	7434		10.1074/jbc.M116.757906	http://dx.doi.org/10.1074/jbc.M116.757906			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28275056	hybrid, Green Published			2022-12-26	WOS:000400761300013
J	Domingues, MJ; Martinez-Sanz, J; Papon, L; Larue, L; Mouawad, L; Bonaventure, J				Domingues, Melanie J.; Martinez-Sanz, Juan; Papon, Laura; Larue, Lionel; Mouawad, Liliane; Bonaventure, Jacky			Structure-based mutational analysis of ICAT residues mediating negative regulation of beta-catenin co-transcriptional activity	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; MELANOMA-CELLS; E-CADHERIN; BINDING; ACTIVATION; COMPLEX; TCF/LEF; PROLIFERATION; METASTASIS	ICAT (Inhibitor of beta-CAtenin and TCF) is a small acidic protein that negatively regulates beta-catenin co-transcriptional activity by competing with TCF/LEF factors in their binding to beta-catenin superhelical core. In melanoma cells, ICAT competes with LEF1 to negatively regulate the M-MITF and NEDD9 target genes. The structure of ICAT consists of two domains: the 3-helix bundle N-terminal domain binds to beta-catenin Armadillo (Arm) repeats 10-12 and the C-terminal tail binds to Arm repeats 5-9. To elucidate the structural mechanisms governing ICAT/beta-catenin interactions in melanoma cells, three ICAT residues Y15, K19 and V22 in the N-terminal domain, contacting hydrophobic beta-catenin residue F660, were mutated and interaction was assessed by immunoprecipitation. Despite the moderate hydrophobicity of the contact, its removal completely abolished the interaction. In the ICAT C-terminal tail consensus sequence, neutralization of the electrostatic interactions between residues D66, E75 and beta-catenin residues K435, K312, coupled to deletion of the hydrophobic contact between F71 and beta-catenin R386, markedly reduced, but failed to abolish the ICAT-mediated negative regulation of M-MITF and NEDD9 promoters. We conclude that in melanoma cells, anchoring of ICAT N-terminal domain to beta-catenin through the hook made by residue F660, trapped in the pincers formed by ICAT residues Y15 and V22, is crucial for stabilizing the ICAT/beta-catenin complex. This is a prerequisite for binding of the consensus peptide to Arm repeats 5-9 and competition with LEF1. Differences between ICAT and LEF1 in their affinity for beta-catenin may rely on the absence in ICAT of hydrophilic residues between D66 and F71.	[Domingues, Melanie J.; Martinez-Sanz, Juan; Papon, Laura; Larue, Lionel; Mouawad, Liliane; Bonaventure, Jacky] PSL Res Univ, Inst Curie, Orsay, France; [Domingues, Melanie J.; Martinez-Sanz, Juan; Papon, Laura; Larue, Lionel; Mouawad, Liliane; Bonaventure, Jacky] Univ Paris Saclay, Univ Paris Sud, Orsay, France; [Domingues, Melanie J.; Papon, Laura; Larue, Lionel; Bonaventure, Jacky] INSERM, U1021, Normal & Pathol Dev Melanocytes, Orsay, France; [Domingues, Melanie J.; Papon, Laura; Larue, Lionel; Bonaventure, Jacky] CNRS, UMR 3347, Orsay, France; [Domingues, Melanie J.; Papon, Laura; Larue, Lionel; Bonaventure, Jacky] Equipe Labellisee Ligue Canc, Orsay, France; [Martinez-Sanz, Juan; Mouawad, Liliane] INSERM, U1196, Chem Modelling & Imaging Biol, Orsay, France; [Martinez-Sanz, Juan; Mouawad, Liliane] CNRS, UMR 9187, Orsay, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Bonaventure, J (corresponding author), PSL Res Univ, Inst Curie, Orsay, France.; Bonaventure, J (corresponding author), Univ Paris Saclay, Univ Paris Sud, Orsay, France.; Bonaventure, J (corresponding author), INSERM, U1021, Normal & Pathol Dev Melanocytes, Orsay, France.; Bonaventure, J (corresponding author), CNRS, UMR 3347, Orsay, France.; Bonaventure, J (corresponding author), Equipe Labellisee Ligue Canc, Orsay, France.	jacky.bonaventure@i2bc.paris-saclay.fr	Mouawad, Liliane/N-1945-2018; Larue, Lionel/I-6532-2016	Mouawad, Liliane/0000-0002-7155-9712; 	La Fondation ARC contre le Cancer; Ligue Nationale contre le Cancer; INCa; Pair Melanoma and Canceropole IdF; Investissements d'Avenir [ANR-11-LBX-0038, ANR-10-IDEX-0001-02 PSL]; Ministere de I'Education Nationale de la Recherche et de la Technologie (MENRT); French program "Investissements d'Avenir - Institut Carnot" [ANR-11-CARN-008-01]	La Fondation ARC contre le Cancer; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); INCa(Institut National du Cancer (INCA) France); Pair Melanoma and Canceropole IdF; Investissements d'Avenir(French National Research Agency (ANR)); Ministere de I'Education Nationale de la Recherche et de la Technologie (MENRT); French program "Investissements d'Avenir - Institut Carnot"(French National Research Agency (ANR))	The work was supported by a grant from "La Fondation ARC contre le Cancer", Ligue Nationale contre le Cancer, INCa, Pair Melanoma and Canceropole IdF, and is under the program "lnvestissements d'Avenir" launched by the French Government and implemented by ANR Labex CelTisPhyBio (ANR-11-LBX-0038 and ANR-10-IDEX-0001-02 PSL). M.J. Domingues was the recipient of a fellowship from the Ministere de I'Education Nationale de la Recherche et de la Technologie (MENRT) and J. Martinez-Sanz was financed by the French program "Investissements d'Avenir - Institut Carnot" managed by the National Research Agency (ANR-11-CARN-008-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Domingues MJ, 2014, CANCER RES, V74, P1983, DOI 10.1158/0008-5472.CAN-13-0920; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fasolini M, 2003, J BIOL CHEM, V278, P21092, DOI 10.1074/jbc.M301781200; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gail R, 2005, J BIOL CHEM, V280, P7107, DOI 10.1074/jbc.M410215200; Gallagher SJ, 2013, ONCOGENE, V32, P2230, DOI 10.1038/onc.2012.229; Gottardi CJ, 2004, AM J PHYSIOL-CELL PH, V286, pC747, DOI 10.1152/ajpcell.00433.2003; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Graham TA, 2002, MOL CELL, V10, P563, DOI 10.1016/S1097-2765(02)00637-8; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huels DJ, 2015, EMBO J, V34, P2321, DOI 10.15252/embj.201591739; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jung HY, 2013, MOL CELL, V52, P193, DOI 10.1016/j.molcel.2013.08.028; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Li Y, 2011, ABSTR APPL ANAL, V22, P1, DOI DOI 10.1371/J0URNAL.P0NE.0026656; Mao CD, 2011, CRIT REV EUKAR GENE, V21, P207, DOI 10.1615/CritRevEukarGeneExpr.v21.i3.10; Mo R, 2009, J BIOL CHEM, V284, P28222, DOI 10.1074/jbc.M109.045039; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Poy F, 2001, NAT STRUCT BIOL, V8, P1053, DOI 10.1038/nsb720; Satoh K, 2004, P NATL ACAD SCI USA, V101, P8017, DOI 10.1073/pnas.0401733101; Selzer E, 2002, CANCER RES, V62, P2098; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Tago K, 2000, GENE DEV, V14, P1741; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049; Williams BO, 2000, ONCOGENE, V19, P5720, DOI 10.1038/sj.onc.1203921; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Yang PT, 2012, EMBO MOL MED, V4, P1294, DOI 10.1002/emmm.201201486	38	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172603	10.1371/journal.pone.0172603	http://dx.doi.org/10.1371/journal.pone.0172603			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273108	gold, Green Published, Green Submitted			2022-12-26	WOS:000396073700081
J	Ljones, K; Ness, HO; Solvang-Garten, K; Gaustad, SE; Hoydal, MA				Ljones, Kristine; Ness, Henning Ofstad; Solvang-Garten, Karin; Gaustad, Svein Erik; Hoydal, Morten Andre			Acute exhaustive aerobic exercise training impair cardiomyocyte function and calcium handling in Sprague-Dawley rats	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; ENDURANCE EXERCISE; MITOCHONDRIAL-FUNCTION; PERMEABILIZED FIBERS; ATRIAL-FIBRILLATION; FINE-STRUCTURE; HEART; INCREASES; CONTRACTILITY; PARTICIPANTS	Introduction Recent data from long-distance endurance participants suggest that cardiac function is impaired after completion. Existing data further indicate that right ventricular function is more affected than left ventricular function. The cellular mechanisms underpinning cardiac deterioration are limited and therefore the aim of this study was to examine cardiomyocyte and molecular responses of the right and left ventricle to an acute bout of exhaustive endurance exercise. Materials and methods Male Sprague-Dawley rats were assigned to sedentary controls or acute exhaustive endurance exercise consisting of a 120 minutes long forced treadmill run. The contractile function and Ca2+ handling properties in isolated cardiomyocytes, protein expression levels of sarcoplasmic reticulum Ca2+-ATPase and phospholamban including two of its phosphorylated states (serine 16 and threonine 17), and the mitochondrial respiration in permeabilized cardiac muscle fibers were analyzed. Results The exercise group showed a significant reduction in cardiomyocyte fractional shortening (right ventricle 1 Hz and 3 Hz p<0.001; left ventricle 1 Hz p<0.05), intracellular Ca2+ amplitude (right ventricle 1 and 3 Hz p<0.001; left ventricle 1 Hz p<0.01 and 3 Hz p<0.05) and rate of diastolic Ca2+ decay (right ventricle 1 Hz p<0.001 and 3 Hz p<0.01; left ventricle 1 and 3 Hz p<0.01). Cardiomyocyte relaxation during diastole was only significantly prolonged at 3 Hz in the right ventricle (p<0.05) compared to sedentary controls. We found an increase in phosphorylation of phospholamban at serine 16 and threonine 17 in the left (p<0.05), but not the right, ventricle from exhaustively exercised animals. The protein expression levels of sarcoplasmic reticulum Ca2+-ATPase and phospholamban was not changed. Furthermore, we found a reduction in maximal oxidative phosphorylation and electron transport system capacities of mitochondrial respiration in the right (p<0.01 and p<0.05, respectively), but not the left ventricle from rats subjected to acute exhaustive treadmill exercise. Conclusion Acute exhaustive treadmill exercise is associated with impairment of cardiomyocyte Ca2+ handling and mitochondrial respiration that causes depression in both contraction and diastolic relaxation of cardiomyocytes.	[Ljones, Kristine; Ness, Henning Ofstad; Solvang-Garten, Karin; Gaustad, Svein Erik; Hoydal, Morten Andre] Norwegian Univ Technol & Sci NTNU, Dept Circulat & Med Imaging, Trondheim, Norway; [Ljones, Kristine; Ness, Henning Ofstad; Solvang-Garten, Karin; Gaustad, Svein Erik] KG Jebsen Ctr Exercise Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Hoydal, MA (corresponding author), Norwegian Univ Technol & Sci NTNU, Dept Circulat & Med Imaging, Trondheim, Norway.	morten.hoydal@ntnu.no	Høydal, Morten A/K-2806-2012	Høydal, Morten A/0000-0003-1804-2578	Norwegian Research Council; Liaison Committee	Norwegian Research Council(Research Council of NorwayEuropean Commission); Liaison Committee	The PI is funded by the Norwegian Research Council with a grant to support Young Research talents. He receives a 3 year salary as a research scientist in this grant. He also receives general running cost finances from The Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU). Hennig Ness holds a PhD student grant from The Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU). This study is a part of his thesis. The grant finances his salary during this period. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal B, 2014, BBA-BIOENERGETICS, V1837, P354, DOI 10.1016/j.bbabio.2013.11.006; Aggarwal NT, 2013, ANTIOXID REDOX SIGN, V18, P432, DOI 10.1089/ars.2011.4234; [Anonymous], 2014, THE RIGHT HEART; BANISTER EW, 1971, AM J PHYSIOL, V220, P1935, DOI 10.1152/ajplegacy.1971.220.6.1935; BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; Burgoyne JR, 2012, CIRC RES, V111, P1091, DOI 10.1161/CIRCRESAHA.111.255216; Claessen G, 2014, MED SCI SPORT EXER, V46, P1717, DOI 10.1249/MSS.0000000000000282; Delgado J, 1999, J APPL PHYSIOL, V87, P152, DOI 10.1152/jappl.1999.87.1.152; Dell'Italia L J, 1991, Curr Probl Cardiol, V16, P653; DOUGLAS PS, 1990, J AM COLL CARDIOL, V15, P64, DOI 10.1016/0735-1097(90)90176-P; DOUGLAS PS, 1987, CIRCULATION, V76, P1206, DOI 10.1161/01.CIR.76.6.1206; Elliott AD, 2015, BRIT J SPORT MED, V49, P724, DOI 10.1136/bjsports-2014-093895; Germano G, 2012, EUR HEART J, V33, P137; Gnaiger E, 1995, J BIOENERG BIOMEMBR, V27, P583, DOI 10.1007/BF02111656; Gnaiger E., 2008, DRUGINDUCED MITOCHON, V327, P325, DOI [DOI 10.1002/9780470372531.CH12, 10.1002/9780470372531.ch12pp]; Grimsmo J, 2010, EUR J CARDIOV PREV R, V17, P100, DOI 10.1097/HJR.0b013e32833226be; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; JI LL, 1994, BIOCHEM PHARMACOL, V47, P877; Kemi OJ, 2007, J MOL CELL CARDIOL, V43, P354, DOI 10.1016/j.yjmcc.2007.06.013; KING DW, 1970, AM J PHYSIOL, V218, P1150, DOI 10.1152/ajplegacy.1970.218.4.1150; Knez WL, 2006, SPORTS MED, V36, P429, DOI 10.2165/00007256-200636050-00005; Kober F, 2004, MAGN RESON MATER PHY, V17, P157, DOI 10.1007/s10334-004-0086-0; La Gerche A, 2008, HEART, V94, P860, DOI 10.1136/hrt.2006.101063; La Gerche A, 2014, PULM CIRC, V4, P407, DOI 10.1086/677355; La Gerche A, 2012, EUR HEART J, V33, P998, DOI 10.1093/eurheartj/ehr397; La Gerche A, 2011, MED SCI SPORT EXER, V43, P974, DOI 10.1249/MSS.0b013e31820607a3; LAGUENS RP, 1967, CIRC RES, V21, P271, DOI 10.1161/01.RES.21.3.271; LAGUENS RP, 1966, EXPERIENTIA, V22, P244, DOI 10.1007/BF01900936; Contarteze RVL, 2008, COMP BIOCHEM PHYS A, V151, P415, DOI 10.1016/j.cbpa.2007.03.005; Lemieux H, 2010, J GERONTOL A-BIOL, V65, P1157, DOI 10.1093/gerona/glq141; MAHER JT, 1972, AM J PHYSIOL, V222, P207, DOI 10.1152/ajplegacy.1972.222.1.207; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Molina L, 2008, EUROPACE, V10, P618, DOI 10.1093/europace/eun071; Moraska A, 2000, AM J PHYSIOL-REG I, V279, pR1321, DOI 10.1152/ajpregu.2000.279.4.R1321; Mousavi N, 2009, AM J CARDIOL, V103, P1467, DOI 10.1016/j.amjcard.2009.01.294; Neilan TG, 2006, EUR HEART J, V27, P1079, DOI 10.1093/eurheartj/ehi813; Neilan TG, 2006, CIRCULATION, V114, P2325, DOI 10.1161/CIRCULATIONAHA.106.647461; Olah A, 2015, INT J CARDIOL, V182, P258, DOI 10.1016/j.ijcard.2014.12.045; Palmer BM, 1998, J APPL PHYSIOL, V85, P2159, DOI 10.1152/jappl.1998.85.6.2159; Periasamy M, 2008, CARDIOVASC RES, V77, P265, DOI 10.1093/cvr/cvm056; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; PIERCE GN, 1984, J APPL PHYSIOL, V57, P326, DOI 10.1152/jappl.1984.57.2.326; Predel HG, 2014, EUR HEART J, V35, P3091, DOI 10.1093/eurheartj/eht502; Scharhag J, 2006, EUR J CARDIOV PREV R, V13, P388, DOI 10.1097/00149831-200606000-00015; Schoenwolf GC, 2015, LARSENS HUMAN EMBRYO; Shave R, 2010, J AM COLL CARDIOL, V56, P169, DOI 10.1016/j.jacc.2010.03.037; Silva AM, 2012, METHODS MOL BIOL, V810, P7, DOI 10.1007/978-1-61779-382-0_2; Stowe DF, 2004, ANTIOXID REDOX SIGN, V6, P439, DOI 10.1089/152308604322899512; TAYLOR PB, 1976, EUR J APPL PHYSIOL O, V35, P111, DOI 10.1007/BF02333801; Taylor RS, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003331.pub4; Terblanche SE, 2001, COMP BIOCHEM PHYS A, V128, P889, DOI 10.1016/S1095-6433(00)00344-5; TERJUNG RL, 1973, AM J PHYSIOL, V225, P300, DOI 10.1152/ajplegacy.1973.225.2.300; Trivax JE, 2010, J APPL PHYSIOL, V108, P1148, DOI 10.1152/japplphysiol.01151.2009; Urhausen A, 2004, AM J CARDIOL, V94, P696, DOI 10.1016/j.amjcard.2004.05.050; VEKSLER VI, 1987, BIOCHIM BIOPHYS ACTA, V892, P191, DOI 10.1016/0005-2728(87)90174-5; Vollaard NBJ, 2005, SPORTS MED, V35, P1045, DOI 10.2165/00007256-200535120-00004; Wei X, 2015, TRENDS CARDIOVAS MED, V25, P529, DOI 10.1016/j.tcm.2014.12.014; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Whyte GP, 2008, MED SCI SPORT EXER, V40, P1416, DOI 10.1249/MSS.0b013e318172cefd; Wilson M, 2011, J APPL PHYSIOL, V110, P1622, DOI 10.1152/japplphysiol.01280.2010; Wisloff U, 2002, CARDIOVASC RES, V54, P162, DOI 10.1016/S0008-6363(01)00565-X	63	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173449	10.1371/journal.pone.0173449	http://dx.doi.org/10.1371/journal.pone.0173449			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273177	Green Published, Green Submitted, gold			2022-12-26	WOS:000396073700003
J	Weber, L; Al-Refae, K; Ebbert, J; Jagers, P; Altmuller, J; Becker, C; Hahn, S; Gisselmann, G; Hatt, H				Weber, Lea; Al-Refae, Klaudia; Ebbert, Juliane; Jaegers, Peter; Altmueller, Janine; Becker, Christian; Hahn, Stephan; Gisselmann, Guenter; Hatt, Hanns			Activation of odorant receptor in colorectal cancer cells leads to inhibition of cell proliferation and apoptosis	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; OLFACTORY RECEPTOR; PROSTATE-CANCER; EXPRESSION; GENE; PATHWAY; FAMILY; REVEALS; MEMBERS; TARGET	The analysis and functional characterization of ectopically expressed human olfactory receptors (ORs) is becoming increasingly important, as many ORs have been identified in several healthy and cancerous tissues. OR activation has been demonstrated to have influence on cancer cell growth and progression. Here, ORs were identified using RNA-Seq analyses and RT-PCR. We demonstrated the OR protein localization in HCT116 cells using immunocytochemistry (IHC). In order to analyze the physiological role of OR51B4, we deorphanized the receptor by the use of CRE-Luciferase assays, conducted calcium imaging experiments as well as scratch-and proliferation assays. Furthermore, western blot analyses revealed the involvement of different protein kinases in the ligand-dependent signaling pathway. Receptor knockdown via shRNA was used to analyze the involvement of OR51B4. We identified OR51B4, which is highly expressed in the colon cancer cell line HCT116 and in native human colon cancer tissues. We deorphanized the receptor and identified Troenan as an effective ligand. Troenan stimulation of HCT116 cells has anti-proliferative, anti-migratory and pro-apoptotic effects, mediated by changes in the intracellular calcium level upon PLC activation. These effects cause changes in the phosphorylation levels of p38, mTor and Akt kinases. Knockdown of the receptor via shRNA confirmed the involvement of OR51B4. This study emphasizes the importance of ectopically expressed ORs in the therapy for several diseases. The findings provide the basis for alternative treatments of colorectal cancer.	[Weber, Lea; Al-Refae, Klaudia; Ebbert, Juliane; Jaegers, Peter; Gisselmann, Guenter; Hatt, Hanns] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany; [Al-Refae, Klaudia] Univ Duisburg Essen, Univ Hosp, Inst Cell Biol Canc Res, Essen, Germany; [Altmueller, Janine; Becker, Christian] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Hahn, Stephan] Ruhr Univ Bochum, Dept Mol Gastrointestinal Oncol, Bochum, Germany	Ruhr University Bochum; University of Duisburg Essen; University of Cologne; Ruhr University Bochum	Weber, L (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany.	lea.weber@gmx.de	Hahn, Stephan/E-3880-2010; Hahn, Stephan A./AAV-6062-2021	Hahn, Stephan/0000-0003-0855-9741; Hahn, Stephan A./0000-0003-0855-9741; Altmuller, Janine/0000-0003-4372-1521; Szymonowicz, Klaudia/0000-0001-8296-6738	Heinrich and Alma Vogelsang Stiftung	Heinrich and Alma Vogelsang Stiftung	LW was funded by the Heinrich and Alma Vogelsang Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; LW was funded by the Heinrich and Alma Vogelsang Stiftung.	American Cancer Society, 2015, AM CANC SOC FACTS FI; Ataee R, 2010, EUR J CANCER PREV, V19, P138, DOI 10.1097/CEJ.0b013e3283354901; Bardon S, 2002, CANCER LETT, V181, P187, DOI 10.1016/S0304-3835(02)00047-2; Birkenkamp-Demtroder K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073593; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; Breer H, 1992, Curr Opin Neurobiol, V2, P439, DOI 10.1016/0959-4388(92)90177-M; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Busse D, 2014, J INVEST DERMATOL, V134, P2823, DOI 10.1038/jid.2014.273; Camilleri M, 2009, CURR OPIN ENDOCRINOL, V16, P53, DOI 10.1097/MED.0b013e32831e9c8e; Cerchiara T, 2015, NAT PROD COMMUN, V10, P547; COMPTON SJ, 1985, ANAL BIOCHEM, V151, P369, DOI 10.1016/0003-2697(85)90190-3; Cui T, 2013, EUR J ENDOCRINOL, V168, P253, DOI 10.1530/EJE-12-0814; Deliot N, 2015, BIOCH BIOPHYS ACTA; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Garaude J, 2008, MOL IMMUNOL, V45, P3463, DOI 10.1016/j.molimm.2008.03.016; Giandomenico V, 2013, J MOL ENDOCRINOL, V51, P277, DOI 10.1530/JME-13-0144; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Gonzalez-Kristeller DC, 2013, GENET MOL RES, V12, P3479, DOI 10.4238/2013.September.10.4; Grossi V, 2014, WORLD J GASTROENTERO, V20, P9744, DOI 10.3748/wjg.v20.i29.9744; Klasen K, 2010, CELL SIGNAL, V22, P150, DOI 10.1016/j.cellsig.2009.09.026; Krautwurst D, 2008, CHEM BIODIVERS, V5, P842, DOI 10.1002/cbdv.200890099; KURANAMI M, 1995, J SURG RES, V58, P233, DOI 10.1006/jsre.1995.1036; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Manteniotis S, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2015.70; Massberg D, 2015, ARCH BIOCHEM BIOPHYS, V566, P100, DOI 10.1016/j.abb.2014.12.004; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Sanz G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085110; Siddiqui E, 2005, ONCOL REP; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vandermoere F, 2007, MOL CELL PROTEOMICS, V6, P114, DOI 10.1074/mcp.M600335-MCP200; Veereman G, 2015, CRIT REV ONCOL HEMAT, V94, P122, DOI 10.1016/j.critrevonc.2014.12.004; Wang J. Q., 2015, SCI WORLD J, V2015, P1, DOI [DOI 10.1371/J0URNAL.P0NE.0124261, DOI 10.2118/174392-MS]; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Xu LL, 2000, CANCER RES, V60, P6568; Yun HJ, 2012, MOL CELL BIOCHEM, V363, P281, DOI 10.1007/s11010-011-1180-z; Zhang X, 2012, CYTOSKELETON, V69, P810, DOI 10.1002/cm.21055; Zhong HL, 2001, J PHARMACOL EXP THER, V297, P837; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120	49	40	41	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172491	10.1371/journal.pone.0172491	http://dx.doi.org/10.1371/journal.pone.0172491			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273117	Green Published, gold, Green Submitted			2022-12-26	WOS:000396073700076
J	Benammi, H; Erazi, H; El Hiba, O; Vinay, L; Bras, H; Viemari, JC; Gamrani, H				Benammi, Hind; Erazi, Hasna; El Hiba, Omar; Vinay, Laurent; Bras, Helene; Viemari, Jean-Charles; Gamrani, Halima			Disturbed sensorimotor and electrophysiological patterns in lead intoxicated rats during development are restored by curcumin I	PLOS ONE			English	Article							CATION-CHLORIDE COTRANSPORTERS; BODY-WEIGHT GAIN; SPINAL-CORD; LIPID-PEROXIDATION; MONOAMINE-OXIDASE; OXIDATIVE STRESS; MOUSE MODEL; EXPOSURE; SEROTONIN; BRAIN	Lead poisoning is one of the most significant health problem of environmental origin. It is known to cause different damages in the central and peripheral nervous system which could be represented by several neurophysiological and behavioral symptoms. In this study we firstly investigated the effect of lead prenatal exposure in rats to (3g/L), from neonatal to young age, on the motor/sensory performances, excitability of the spinal cord and gaits during development. Then we evaluated neuroprotective effects of curcumin I (Cur I) against lead neurotoxicity, by means of grasping and cliff avoidance tests to reveal the impairment of the sensorimotor functions in neonatal rats exposed prenatally to lead. In addition, extra cellular recordings of motor output in spinal cord revealed an hyper-excitability of spinal networks in lead treated rats. The frequency of induced fictive locomotion was also increased in treated rats. At the young age, rats exhibited an impaired locomotor gait. All those abnormalities were attenuated by Cur I treatment at a dose of 16g/kg. Based on our finding, Cur I has shown features of a potent chemical compound able to restore the neuronal and the relative locomotor behaviors disturbances induced by lead intoxication. Therefore, this chemical can be recommended as a new therapeutic trial against lead induced neurotoxicity.	[Benammi, Hind; Erazi, Hasna; El Hiba, Omar; Gamrani, Halima] Cadi Ayyad Univ, Neurosci Pharmacol & Environm Team, Fac Sci Semlalia, Marrakech, Morocco; [El Hiba, Omar] Chouaib Doukkali Univ, Dept Biol, Fac Sci, El Jadida, Morocco; [Vinay, Laurent; Bras, Helene; Viemari, Jean-Charles] Univ Aix Marseille, Inst Neurosci Timone, Unite Mixte Rech 7289, CNRS, Marseille, France	Cadi Ayyad University of Marrakech; Chouaib Doukkali University of El Jadida; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Gamrani, H (corresponding author), Cadi Ayyad Univ, Neurosci Pharmacol & Environm Team, Fac Sci Semlalia, Marrakech, Morocco.; Viemari, JC (corresponding author), Univ Aix Marseille, Inst Neurosci Timone, Unite Mixte Rech 7289, CNRS, Marseille, France.	jean-charles.viemari@univ-amu.fr; gamrani54@gmail.com	Bras, Helene/L-8915-2018	EL Hiba, Omar/0000-0002-0581-4164; Halima, GAMRANI/0000-0002-3962-7404; Viemari, Jean-Charles/0000-0001-6614-1461	Neuromed; CNRST	Neuromed; CNRST	This work was financially supported by Neuromed and CNRST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell A, 2002, BRAIN RES REV, V39, P154, DOI 10.1016/S0165-0173(02)00182-0; Ak T, 2008, CHEM-BIOL INTERACT, V174, P27, DOI 10.1016/j.cbi.2008.05.003; Amendola J, 2004, EUR J NEUROSCI, V20, P2822, DOI 10.1111/j.1460-9568.2004.03745.x; Arora V, 2011, PSYCHONEUROENDOCRINO, V36, P1570, DOI 10.1016/j.psyneuen.2011.04.012; Bachetti T, 2012, EXP CELL RES, V318, P1844, DOI 10.1016/j.yexcr.2012.06.008; Bagchi D, 2005, J INORG BIOCHEM, V99, P1155, DOI 10.1016/j.jinorgbio.2005.02.011; Basha Chand D, 2015, Interdiscip Toxicol, V8, P159, DOI 10.1515/intox-2015-0025; Basha D Chand, 2013, NEUROSCIRES; Beaudin SA, 2007, NEUROTOXICOL TERATOL, V29, P188, DOI 10.1016/j.ntt.2006.11.004; Benammi H, 2014, ACTA HISTOCHEM, V116, P920, DOI 10.1016/j.acthis.2014.03.002; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Bokara KK, 2008, BIOMETALS, V21, P9, DOI 10.1007/s10534-007-9088-5; Borodinsky LN, 2012, CURR OPIN NEUROBIOL, V22, P624, DOI 10.1016/j.conb.2012.02.004; Bouyatas MM, 2007, ACTA HISTOCHEM, V109, P421, DOI 10.1016/j.acthis.2007.05.002; Braga MFM, 1999, BRAIN RES, V826, P10, DOI 10.1016/S0006-8993(99)01193-2; Bulmus FG, 2013, TOXICOL ENVIRON CHEM, V95, P1019, DOI 10.1080/02772248.2013.829061; Canfield RL, 2003, CHILD NEUROPSYCHOL, V9, P35, DOI 10.1076/chin.9.1.35.14496; CAZALETS JR, 1992, J PHYSIOL-LONDON, V455, P187, DOI 10.1113/jphysiol.1992.sp019296; Chiodo LM, 2004, NEUROTOXICOL TERATOL, V26, P359, DOI 10.1016/j.ntt.2004.01.010; Ciftci O, 2010, IMMUNOPHARM IMMUNOT, V32, P99, DOI 10.3109/08923970903164318; Correa M, 2004, LIFE SCI, V74, P2009, DOI 10.1016/j.lfs.2003.08.042; Daniel S, 2004, J INORG BIOCHEM, V98, P266, DOI 10.1016/j.jinorgbio.2003.10.014; Deumens R, 2007, J NEUROSCI METH, V164, P120, DOI 10.1016/j.jneumeth.2007.04.009; Devi CB, 2005, INT J DEV NEUROSCI, V23, P375, DOI 10.1016/j.ijdevneu.2004.11.003; Ercal N, 1996, FREE RADICAL BIO MED, V21, P157, DOI 10.1016/0891-5849(96)00020-2; Fahr M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00175; Gilbert ME, 2007, NEUROTOXICOL TERATOL, V29, P385, DOI 10.1016/j.ntt.2007.01.006; Gonzalez-Salazar A, 2011, CARDIOVASC TOXICOL, V11, P357, DOI 10.1007/s12012-011-9128-9; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Holmes A, 2008, NEUROSCI BIOBEHAV R, V32, P1293, DOI 10.1016/j.neubiorev.2008.03.006; Hornung JP, 2003, J CHEM NEUROANAT, V26, P331, DOI 10.1016/j.jchemneu.2003.10.002; Hu H, 2006, ENVIRON HEALTH PERSP, V114, P1730, DOI 10.1289/ehp.9067; Huang Z, 2011, NEUROSCI LETT, V493, P145, DOI 10.1016/j.neulet.2011.02.030; Ishida T, 2004, J HEALTH SCI, V50, P474, DOI 10.1248/jhs.50.474; Jiang J, 2016, AQUACULTURE, V463, P174, DOI 10.1016/j.aquaculture.2016.05.040; Jung KK, 2006, LIFE SCI, V79, P2022, DOI 10.1016/j.lfs.2006.06.048; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; KALA SV, 1995, J NEUROCHEM, V65, P1631; Kapoor S, 2001, BIOPHYS CHEM, V92, P119, DOI 10.1016/S0301-4622(01)00188-0; Kato K, 1998, CELL STRESS CHAPERON, V3, P152, DOI 10.1379/1466-1268(1998)003<0152:SOTSIE>2.3.CO;2; Khalki L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080013; Khan MM, 2012, NEUROTOX RES, V22, P1, DOI 10.1007/s12640-011-9295-2; Koopmans GC, 2007, PHYSIOL BEHAV, V92, P993, DOI 10.1016/j.physbeh.2007.07.018; Kulkarni SK, 2008, PSYCHOPHARMACOLOGY B, V201; LASLEY SM, 1984, NEUROCHEM RES, V9, P1675, DOI 10.1007/BF00968078; Leret ML, 2002, BRAIN RES BULL, V58, P469, DOI 10.1016/S0361-9230(02)00819-5; Li YC, 2009, PROG NEURO-PSYCHOPH, V33, P435, DOI 10.1016/j.pnpbp.2009.01.006; Lopresti AL, 2012, J PSYCHOPHARMACOL, V26, P1512, DOI 10.1177/0269881112458732; Mameli O, 2001, BRAIN RES BULL, V55, P269, DOI 10.1016/S0361-9230(01)00467-1; Marchioro M, 1996, J PHARMACOL EXP THER, V279, P143; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Mello CF, 1998, BRAZ J MED BIOL RES, V31, P943, DOI 10.1590/S0100-879X1998000700010; Merce Correaa, 2004, LIFE SCI, V74, P2009, DOI [10.1016/j.lfs.2003.08.042PMID:14967196, DOI 10.1016/J.LFS.2003.08.042]; Moody WJ, 2005, PHYSIOL REV, V85, P883, DOI 10.1152/physrev.00017.2004; Moreira EG, 2001, NEUROTOXICOL TERATOL, V23, P489, DOI 10.1016/S0892-0362(01)00159-3; Mountney A, 2013, J NEUROSCI METH, V212, P1, DOI 10.1016/j.jneumeth.2012.08.025; Mudipalli A, 2007, INDIAN J MED RES, V126, P518; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nishimaru H, 1996, J PHYSIOL-LONDON, V497, P131, DOI 10.1113/jphysiol.1996.sp021755; Ono K, 2006, J NEUROCHEM, V97, P105, DOI 10.1111/j.1471-4159.2006.03707.x; Panahi Y, 2016, BIOMED PHARMACOTHER, V82, P578, DOI 10.1016/j.biopha.2016.05.037; Pearlstein E, 2005, EUR J NEUROSCI, V21, P1338, DOI 10.1111/j.1460-9568.2005.03971.x; Pflieger JF, 2002, J NEUROSCI, V22, P5108, DOI 10.1523/JNEUROSCI.22-12-05108.2002; Plusquellec P, 2007, NEUROTOXICOL TERATOL, V29, P527, DOI 10.1016/j.ntt.2007.07.002; Priyadarsini KI, 2014, MOLECULES, V19, P20091, DOI 10.3390/molecules191220091; Pyrzanowska J, 2010, PHARMACOL BIOCHEM BE, V95, P351, DOI 10.1016/j.pbb.2010.02.013; Rajeswari A., 2008, Inflammopharmacology, V16, P96, DOI 10.1007/s10787-007-1614-0; Ramesh GT, 2001, TOXICOL LETT, V123, P195, DOI 10.1016/S0378-4274(01)00395-2; Rezende VB, 2010, SCI TOTAL ENVIRON, V408, P4955, DOI 10.1016/j.scitotenv.2010.07.039; Rueter LE, 1997, REV NEUROSCIENCE, V8, P117; Sansar W, 2012, ACTA HISTOCHEM, V114, P41, DOI 10.1016/j.acthis.2011.02.003; Sansar W, 2011, ACTA HISTOCHEM, V113, P601, DOI 10.1016/j.acthis.2010.06.005; Santillan ME, 2010, NUTRITION, V26, P423, DOI 10.1016/j.nut.2009.06.005; Shukla PK, 2003, HUM EXP TOXICOL, V22, P653, DOI 10.1191/0960327103ht411oa; SMYTHE GA, 1989, AM J PHYSIOL, V256, pE231, DOI 10.1152/ajpendo.1989.256.2.E231; Stansfield KH, 2015, TRANSL PSYCHIAT, V10, P5; Trombini TV, 2001, PHARMACOL BIOCHEM BE, V68, P743, DOI 10.1016/S0091-3057(01)00473-7; Van den Heuvel DMA, 2008, PROG NEUROBIOL, V85, P75, DOI 10.1016/j.pneurobio.2008.01.003; Vinay L, 2000, EUR J NEUROSCI, V12, P4562, DOI 10.1046/j.0953-816X.2000.01321.x; WEINREICH K, 1977, NUTR METAB, V21, P201; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706; Xiang JJ, 2010, ENVIRON POLLUT, V158, P1376, DOI 10.1016/j.envpol.2010.01.002; Xiao C, 2006, BRAIN RES, V1088, P93, DOI 10.1016/j.brainres.2006.03.005; Xu Y, 2005, EUR J PHARMACOL, V518, P40, DOI 10.1016/j.ejphar.2005.06.002; Xu Y, 2006, BRAIN RES, V1122, P56, DOI 10.1016/j.brainres.2006.09.009; Yakovenko S, 2005, J NEUROPHYSIOL, V94, P1057, DOI 10.1152/jn.00991.2004; Zhao X, 2012, NEUROPHARMACOLOGY, V62, P843, DOI 10.1016/j.neuropharm.2011.08.050; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356	89	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0172715	10.1371/journal.pone.0172715	http://dx.doi.org/10.1371/journal.pone.0172715			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267745	Green Published, Green Submitted, gold			2022-12-26	WOS:000396060600001
J	Chang, CH; Wu, CP; Wang, JD; Lee, SW; Chang, CS; Yeh, HZ; Ko, CW; Lien, HC				Chang, Chung-Hsin; Wu, Cheng-Pin; Wang, Jung-Der; Lee, Shou-Wu; Chang, Chi-Sen; Yeh, Hong-Zen; Ko, Chung-Wang; Lien, Han-Chung			Alcohol and tea consumption are associated with asymptomatic erosive esophagitis in Taiwanese men	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; HELICOBACTER-PYLORI INFECTION; GASTRIC-ACID-SECRETION; RISK-FACTORS; BARRETTS-ESOPHAGUS; ENDOSCOPIC FINDINGS; BODY-MASS; PREVALENCE; COFFEE; POPULATION	Objective Asymptomatic erosive esophagitis (AEE) is commonly found in men, and might be a risk factor of developing esophageal adenocarcinoma. We aimed to determine if specific dietary habits increase the risk of AEE in asymptomatic Taiwanese men. Methods We recruited male adults undergoing upper gastrointestinal endoscopy for health check. We excluded subjects with reflux symptoms, or taking anti-reflux medications or drugs that potentially impair lower esophageal sphincter function or cause mucosal injury. The frequency of consuming reflux-provoking diets including alcohol, tea, coffee, tomato/citric juice, chocolate, sweet food, and spicy food was assessed. The erosive esophagitis was diagnosed based on the Los Angeles Classification after endoscopy. Frequent consumption of a specific diet was defined as >= 4 days/week of consuming that diet. Results A total of 1256 participants were recruited. After excluding 424 ineligible subjects, AEE was identified in 180 (22%) among 832 asymptomatic subjects. The risk of AEE increased with the number of days per week of consuming alcohol or tea: nondrinkers (19%, 17%), occasional drinkers (<1 day/week; 19%, 15%), regular drinkers (1-3 days/week; 26%, 21%), frequent drinkers (4-6 days/week; 32%, 22%), and daily drinkers (42%, 28%), respectively (trend test P < 0.001 for both). Multivariate analysis showed that hiatus hernia (adjusted odds ratio (aOR) 5.0, 95% confidence interval (CI) 2.6-9.6), drinking alcohol >= 4 days/week (aOR 2.3, 95% CI 1.3-4.0), and drinking tea >= 4 days/week (aOR 1.6, 95% CI 1.1-2.3) are independent risk factors of AEE. The risk of AEE was 3.8 times greater for those drinking both alcohol and tea >= 4 days/week than the non-drinkers.	[Chang, Chung-Hsin; Lee, Shou-Wu; Chang, Chi-Sen; Yeh, Hong-Zen; Ko, Chung-Wang; Lien, Han-Chung] Taichung Vet Gen Hosp, Div Gastroenterol, Taichung, Taiwan; [Wu, Cheng-Pin] China Med Univ Hosp, Hlth Examinat Ctr, Taichung, Taiwan; [Wu, Cheng-Pin] China Med Univ Hosp, Prevent Med Ctr, Taichung, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ, Dept Publ Hlth, Coll Med, Tainan, Taiwan; [Lee, Shou-Wu; Chang, Chi-Sen] Chung Shan Med Univ, Dept Internal Med, Taichung, Taiwan; [Yeh, Hong-Zen; Ko, Chung-Wang; Lien, Han-Chung] Natl Yang Ming Univ, Dept Internal Med, Taipei, Taiwan	Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Cheng Kung University; Chung Shan Medical University; National Yang Ming Chiao Tung University	Lien, HC (corresponding author), Taichung Vet Gen Hosp, Div Gastroenterol, Taichung, Taiwan.	lhc@vghtc.gov.tw			Rong Sing Medical Foundation [RSMF-101022]	Rong Sing Medical Foundation	This study was supported by research grants from the Rong Sing Medical Foundation, RSMF-101022. CSC received the funding. No additional external funding was received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre L, 2012, DIS ESOPHAGUS, V25, P535, DOI 10.1111/j.1442-2050.2011.01285.x; BERQUIST WE, 1981, J ALLERGY CLIN IMMUN, V67, P407, DOI 10.1016/0091-6749(81)90087-7; Boekema PJ, 1999, EUR J GASTROEN HEPAT, V11, P1271, DOI 10.1097/00042737-199911000-00015; Brooks PJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000050; Bujanda L, 2000, AM J GASTROENTEROL, V95, P3374, DOI 10.1111/j.1572-0241.2000.03347.x; Bytzer P, 2007, AM J GASTROENTEROL, V102, P1585, DOI 10.1111/j.1572-0241.2006.00911.x; Chen TS, 2007, J CLIN GASTROENTEROL, V41, P819, DOI 10.1097/01.mcg.0000225658.30803.79; Chen Z, 2011, ARCH SURG-CHICAGO, V146, P1164, DOI 10.1001/archsurg.2011.248; Chen ZH, 2011, ASIAN PAC J CANCER P, V12, P229; Chih PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077932; Cho JH, 2011, J GASTROEN HEPATOL, V26, P1034, DOI 10.1111/j.1440-1746.2011.06686.x; Choi JY, 2013, EUR J GASTROEN HEPAT, V25, P764, DOI 10.1097/MEG.0b013e32835f594c; Chu NF, 2005, OBES REV, V6, P271, DOI 10.1111/j.1467-789X.2005.00175.x; COHEN S, 1975, NEW ENGL J MED, V293, P897, DOI 10.1056/NEJM197510302931803; COHEN S, 1980, NEW ENGL J MED, V303, P122, DOI 10.1056/NEJM198007173030302; Dent J, 2012, CLIN GASTROENTEROL H, V10, P863, DOI 10.1016/j.cgh.2012.02.028; Du J, 2007, WORLD J GASTROENTERO, V13, P6009, DOI 10.3748/wjg.13.6009; FELDMAN M, 1995, GASTROENTEROLOGY, V108, P125, DOI 10.1016/0016-5085(95)90016-0; Gerson LB, 2002, GASTROENTEROLOGY, V123, P461, DOI 10.1053/gast.2002.34748; Goh KL, 2011, J GASTROEN HEPATOL, V26, P2, DOI 10.1111/j.1440-1746.2010.06534.x; Gudjonsson H, 1995, Laeknabladid, V81, P484; Johnson DA, 2004, GASTROENTEROLOGY, V126, P660, DOI 10.1053/j.gastro.2003.12.001; Kaltenbach T, 2006, ARCH INTERN MED, V166, P965, DOI 10.1001/archinte.166.9.965; Katz PO, 2013, AM J GASTROENTEROL, V108, P308, DOI 10.1038/ajg.2012.444; KEKKI M, 1982, SCAND J GASTROENTERO, V17, P737, DOI 10.3109/00365528209181087; Khan N, 2013, CURR PHARM DESIGN, V19, P6141, DOI 10.2174/1381612811319340008; Kim J, 2014, DIS ESOPHAGUS, V27, P311, DOI 10.1111/dote.12099; Kim N, 2008, ALIMENT PHARM THER, V27, P173, DOI 10.1111/j.1365-2036.2007.03561.x; Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091; Ko CW, 2002, GASTROENTEROL J TAIW, V19, P116; Kubo A, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-144; Labenz J, 2004, AM J GASTROENTEROL, V99, P1652, DOI 10.1111/j.1572-0241.2004.30390.x; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lee D, 2013, SCAND J GASTROENTERO, V48, P906, DOI 10.3109/00365521.2013.812236; Lei WY, 2015, DIGEST LIVER DIS, V47, P24, DOI 10.1016/j.dld.2014.09.017; Li YC, 2011, ADDICTION, V106, P1946, DOI 10.1111/j.1360-0443.2011.03514.x; Lien HC, 2009, J CLIN GASTROENTEROL, V43, P926, DOI 10.1097/MCG.0b013e318191e9d5; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Menon S, 2011, EUR J GASTROEN HEPAT, V23, P389, DOI 10.1097/MEG.0b013e328345d429; Menon S, 2011, EUR J GASTROEN HEPAT, V23, P133, DOI 10.1097/MEG.0b013e3283426f57; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Minatsuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069891; Moayyedi P, 2006, LANCET, V367, P2086, DOI 10.1016/S0140-6736(06)68932-0; Murao T, 2011, DIGEST DIS SCI, V56, P2857, DOI 10.1007/s10620-011-1679-x; Nazareth I, 2011, ALCOHOL ALCOHOLISM, V46, P600, DOI 10.1093/alcalc/agr078; Nilsson M, 2004, GUT, V53, P1730, DOI 10.1136/gut.2004.043265; Nilsson M, 2002, SCAND J GASTROENTERO, V37, P626, DOI 10.1080/00365520212502; Niu CY, 2012, WORLD J GASTROENTERO, V18, P7333, DOI 10.3748/wjg.v18.i48.7333; Nocon M, 2006, ALIMENT PHARM THER, V23, P169, DOI 10.1111/j.1365-2036.2006.02727.x; Nocon M, 2007, J GASTROEN HEPATOL, V22, P1728, DOI 10.1111/j.1440-1746.2006.04549.x; Nozu T, 2008, J GASTROENTEROL, V43, P27, DOI 10.1007/s00535-007-2120-2; Ou JL, 2012, J CHIN MED ASSOC, V75, P60, DOI 10.1016/j.jcma.2011.12.008; Pehl C, 1997, ALIMENT PHARM THER, V11, P483, DOI 10.1046/j.1365-2036.1997.00161.x; Peng S, 2009, ENDOSCOPY, V41, P1011, DOI 10.1055/s-0029-1215291; Pohl H, 2013, AM J GASTROENTEROL, V108, P200, DOI 10.1038/ajg.2012.387; Raghunath A, 2003, BMJ-BRIT MED J, V326, P737, DOI 10.1136/bmj.326.7392.737; Rao SSC, 2002, DIGEST DIS SCI, V47, P2763, DOI 10.1023/A:1021017524660; Ren LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16048; Ronkainen J, 2005, SCAND J GASTROENTERO, V40, P275, DOI 10.1080/00365520510011579; Ronkainen J, 2011, AM J GASTROENTEROL, V106, P1946, DOI 10.1038/ajg.2011.326; Shapiro M, 2007, ALIMENT PHARM THER, V25, P93, DOI 10.1111/j.1365-2036.2006.03170.x; Takabayashi F, 2004, J GASTROENTEROL, V39, P61, DOI 10.1007/s00535-003-1246-0; THOMAS FB, 1980, GASTROENTEROLOGY, V79, P1262; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Wang FW, 2010, DIGEST DIS SCI, V55, P1320, DOI 10.1007/s10620-009-0888-z; Wang PC, 2012, J GASTROEN HEPATOL, V27, P586, DOI 10.1111/j.1440-1746.2011.06881.x; WENDL B, 1994, ALIMENT PHARM THER, V8, P283; World Health Organization, GLOBAL STATUS REPORT; Zagari RM, 2008, GUT, V57, P1354, DOI 10.1136/gut.2007.145177; Zheng ZL, 2008, GASTROENTEROLOGY, V135, P72, DOI 10.1053/j.gastro.2008.03.039	71	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173230	10.1371/journal.pone.0173230	http://dx.doi.org/10.1371/journal.pone.0173230			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264069	Green Submitted, gold, Green Published			2022-12-26	WOS:000396054300047
J	Chinthamani, S; Settem, RP; Honma, K; Kay, JG; Sharma, A				Chinthamani, Sreedevi; Settem, Rajendra P.; Honma, Kiyonobu; Kay, Jason G.; Sharma, Ashu			Macrophage inducible C-type lectin (Mincle) recognizes glycosylated surface (S)-layer of the periodontal pathogen Tannerella forsythia	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; S-LAYER; EPITHELIAL-CELLS; T-CELLS; RECEPTORS; PROTEIN; IL-10; EXPRESSION; IMMUNITY	The oral pathogen Tannerella forsythia is implicated in the development of periodontitis, a common inflammatory disease that leads to the destruction of the gum and tooth supporting tissues, often leading to tooth loss. T. forsythia is a unique Gram-negative organism endowed with an elaborate protein O-glycosylation system that allows the bacterium to express a glycosylated surface (S)-layer comprising two high molecular weight glycoproteins modified with O-linked oligosaccharides. The T. forsythia S-layer has been implicated in the modulation of cytokine responses of antigen presenting cells, such as macrophages, that play a significant role during inflammation associated with periodontitis. The macrophage-inducible C-type lectin receptor (Mincle) is an FcR(Y)-coupled pathogen recognition receptor that recognizes a wide variety of sugar containing ligands from fungal and bacterial pathogens. In this study, we aimed to determine if Mincle might be involved in the recognition of T. forsythia S-layer and modulation of cytokine response of macrophages against the bacterium. Binding studies using recombinant Mincle-Fc fusion protein indicated a specific Ca2+-dependent binding of Mincle to T. forsythia S-layer. Subsequent experiments with Mincle-expressing and Mincle-knockdown macrophages revealed a role for Mincle/S-layer interaction in the induction of both pro-and anti-inflammatory cytokine secretion in macrophages stimulated with T. forsythia as well as its S-layer. Together, these studies revealed Mincle as an important macrophage receptor involved in the modulation of cytokine responses of macrophages against T. forsythia, and thus may play a critical role in orchestrating the host immune response against the bacterium.	[Chinthamani, Sreedevi; Settem, Rajendra P.; Honma, Kiyonobu; Kay, Jason G.; Sharma, Ashu] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Sharma, A (corresponding author), SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA.	sharmaa@buffalo.edu	; Homma, Kiyonobu/K-9084-2013; Sharma, Ashu/O-3149-2016	Kay, Jason/0000-0001-8944-6612; Settem, Rajendra Prasad/0000-0002-3577-7675; Homma, Kiyonobu/0000-0003-1342-4745; Sharma, Ashu/0000-0001-9252-0668	US Public Health [DE14749]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE023526, R01DE014749] Funding Source: NIH RePORTER	US Public Health(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by US Public Health, grant DE14749. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Crump KE, 2016, INFECT IMMUN; den Dunnen J, 2010, IMMUNOL LETT, V128, P12, DOI 10.1016/j.imlet.2009.09.008; Devi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15049; Fagan RP, 2014, NATURE REV MICROBIOL; Feinberg H, 2013, J BIOL CHEM, V288, P28457, DOI 10.1074/jbc.M113.497149; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Hasturk H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00118; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Horie T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163974; Igari K, 2014, ORAL BIOL DENT, V2; Inagaki S, 2006, INFECT IMMUN, V74, P5023, DOI 10.1128/IAI.00062-06; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Krauss JL, 2010, PERIODONTOL 2000, V52, P141, DOI 10.1111/j.1600-0757.2009.00324.x; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lam RS, 2014, J IMMUNOL, V193, P2349, DOI 10.4049/jimmunol.1400853; Lee RT, 2011, GLYCOBIOLOGY, V21, P512, DOI 10.1093/glycob/cwq193; Lee SW, 2006, GENE, V371, P102, DOI 10.1016/j.gene.2005.11.027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masumoto M, 1999, J IMMUNOL, V163, P5039; Mealey BL, 1999, PERIODONTOL 2000, V21, P197, DOI 10.1111/j.1600-0757.1999.tb00176.x; Meyer-Wentrup F, 2005, IMMUNITY, V22, P399, DOI 10.1016/j.immuni.2005.04.001; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Myneni SR, 2013, IMMUNOL INVEST, V42, P519, DOI 10.3109/08820139.2013.822761; Myneni SR, 2011, J IMMUNOL, V187, P501, DOI 10.4049/jimmunol.1100683; Patin EC, 2016, INNATE IMMUN-LONDON, V22, P181, DOI 10.1177/1753425916636671; Posch G, 2013, GLYCOBIOLOGY, V23, P568, DOI 10.1093/glycob/cws172; Posch G, 2011, J BIOL CHEM, V286, P38714, DOI 10.1074/jbc.M111.284893; Rabes A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117022; Richardson MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00288; Sakakibara J, 2007, MICROBIOL-SGM, V153, P866, DOI 10.1099/mic.0.29275-0; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sekot G, 2011, J DENT RES, V90, P109, DOI 10.1177/0022034510384622; Sekot G, 2012, ARCH MICROBIOL; Settem RP, 2013, MUCOSAL IMMUNOL, V6, P415, DOI 10.1038/mi.2012.85; Sharma A, 1998, INFECT IMMUN, V66, P5703, DOI 10.1128/IAI.66.12.5703-5710.1998; Sharma A, 2010, PERIODONTOL 2000, V54, P106, DOI 10.1111/j.1600-0757.2009.00332.x; Sharma A, 2014, J INFECT DIS, V209, P1837, DOI 10.1093/infdis/jit820; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Tanner ACR, 2006, PERIODONTOL 2000, V42, P88, DOI 10.1111/j.1600-0757.2006.00184.x; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651	48	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173394	10.1371/journal.pone.0173394	http://dx.doi.org/10.1371/journal.pone.0173394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264048	Green Submitted, Green Published, gold			2022-12-26	WOS:000396054300062
J	Gupta, NJ; Kumar, V; Panda, S				Gupta, Neelu Jain; Kumar, Vinod; Panda, Satchidananda			A camera-phone based study reveals erratic eating pattern and disrupted daily eating-fasting cycle among adults in India	PLOS ONE			English	Article							NIGHT-SHIFT WORK; CIRCADIAN-RHYTHMS; RISK; HEALTH; RESISTANCE; DISEASE; IMPACT; FOOD	The daily rhythm of feeding-fasting and meal-timing are emerging as important determinants of health. Circadian rhythm research in animal models and retrospective analyses of human nutrition data have shown that reduced length of overnight fasting or increased late night eating increases risk for metabolic diseases including obesity and diabetes. However, the daily rhythm in eating pattern in humans is rarely measured. Traditional methods to collect nutrition information through food diary and food log pay little attention to the timing of eating which may also change from day to day. We adopted a novel cell-phone based approach to longitudinally record all events of food and beverage intake in adults. In a feasibility study daily food-eating patterns of 93 healthy individuals were recorded for 21 days using camera phones. Analysis of the daily eating patterns of these individuals indicates deviation from conventional assumption that people eat three meals-a-day within a 12 h interval. We found that eating events are widespread throughout the day, with <30% of calories consumed before noon and >30% consumed in evening and late night hours. There was little difference in eating pattern between weekdays and weekends. In this cohort more than 50% of people spread their caloric intake events over 15 h or longer. One decile of the cohort who were spouses of shift-workers or had flexible work schedule spread their caloric intake over 20 h. Although the nutrition quality and diversity of food consumed is different between South-East Asian and Western countries, such overall disruption of daily eating-fasting rhythm is similar. Therefore, in view of hypothesis that disrupted daily eating pattern may contribute to the global increase in metabolic diseases and modification of daily eating pattern is a potential modifiable behavior to contain these diseases, monitoring eating pattern is an important aspect of lifestyle.	[Gupta, Neelu Jain; Kumar, Vinod] Univ Delhi, Dept Zool, Delhi, India; [Gupta, Neelu Jain] Mahanand Miss Harijan Coll, Dept Zool, Ghaziabad, Uttar Pradesh, India; [Panda, Satchidananda] Salk Inst Biol Sci, La Jolla, CA 92037 USA; [Panda, Satchidananda] Univ Calif San Diego, Ctr Circadian Biol, San Diego, CA 92093 USA	University of Delhi; Salk Institute; University of California System; University of California San Diego	Gupta, NJ (corresponding author), Univ Delhi, Dept Zool, Delhi, India.; Gupta, NJ (corresponding author), Mahanand Miss Harijan Coll, Dept Zool, Ghaziabad, Uttar Pradesh, India.; Panda, S (corresponding author), Salk Inst Biol Sci, La Jolla, CA 92037 USA.; Panda, S (corresponding author), Univ Calif San Diego, Ctr Circadian Biol, San Diego, CA 92093 USA.	drneelujgupta@hotmail.com; satchin@salk.edu	Gupta, Neelu Jain/I-9900-2014; Gupta, Neelu Jain/AAF-6721-2020	Gupta, Neelu Jain/0000-0003-4885-1827	American Federation of Aging Research [M14322]; Leona M. and Harry B. Helmsley Charitable Trust's [2012-PG-MED002]; UGC research award [F-30-50/2011]; Indo-US Science and Technology Forum (IUSSTF) IUSSTF/JC- Biological Timing [JC-15- 2013/2014-15]; Glenn Center for Aging; Joe W. and Dorothy Dorsett Brown Foundation	American Federation of Aging Research; Leona M. and Harry B. Helmsley Charitable Trust's; UGC research award; Indo-US Science and Technology Forum (IUSSTF) IUSSTF/JC- Biological Timing; Glenn Center for Aging; Joe W. and Dorothy Dorsett Brown Foundation	This work was partially supported by grants from American Federation of Aging Research #M14322, Leona M. and Harry B. Helmsley Charitable Trust's grant #2012-PG-MED002, the Glenn Center for Aging, Joe W. and Dorothy Dorsett Brown Foundation to SP and UGC research award (F-30-50/2011) to NJG, and a joint grant from the Indo-US Science and Technology Forum (IUSSTF) IUSSTF/JC- Biological Timing/JC-15- 2013/2014-15 to VK (http://www.iusstf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arble DM, 2015, SLEEP; Brown DL, 2009, AM J EPIDEMIOL, V169, P1370, DOI 10.1093/aje/kwp056; Cahill LE, 2013, CIRCULATION, V128, P337, DOI 10.1161/CIRCULATIONAHA.113.001474; Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001; Chung H, 2016, METABOLISM, V65, P1743, DOI 10.1016/j.metabol.2016.09.006; Davis S, 2001, JNCI-J NATL CANCER I, V93, P1557, DOI 10.1093/jnci/93.20.1557; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Garaulet M, 2013, INT J OBES LOND; Gill S, 2015, CELL METAB, V22, P789, DOI 10.1016/j.cmet.2015.09.005; Gill S, 2015, SCIENCE, V347, P1265, DOI 10.1126/science.1256682; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lucassen EA, 2016, CURR BIOL, V26, P1843, DOI 10.1016/j.cub.2016.05.038; Marinac CR, 2015, CANCER EPIDEM BIOMAR, V24, P783, DOI 10.1158/1055-9965.EPI-14-1292; Marinac CR, 2016, JAMA ONCOLOGY; Narayan KMV, 2007, DIABETES CARE, V30, P1562, DOI 10.2337/dc06-2544; Rothschild J, 2014, NUTR REV, V72, P308, DOI 10.1111/nure.12104; ROZA AM, 1984, AM J CLIN NUTR, V40, P168, DOI 10.1093/ajcn/40.1.168; Sherman H, 2012, FASEB J, V26, P3493, DOI 10.1096/fj.12-208868; Shetty PS, 2002, PUBLIC HEALTH NUTR, V5, P175, DOI 10.1079/PHN2001291; Six BL, 2011, J FOOD COMPOS ANAL, V24, P1160, DOI 10.1016/j.jfca.2011.06.006; Six BL, 2010, J AM DIET ASSOC, V110, P74, DOI 10.1016/j.jada.2009.10.010; Sookoian S, 2007, J INTERN MED, V261, P285, DOI 10.1111/j.1365-2796.2007.01766.x; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Tuomi T, 2016, CELL METAB, V23, P1067, DOI 10.1016/j.cmet.2016.04.009; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Zarrinpar A, 2016, TRENDS ENDOCRIN MET, V27, P69, DOI 10.1016/j.tem.2015.11.007; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	33	56	57	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172852	10.1371/journal.pone.0172852	http://dx.doi.org/10.1371/journal.pone.0172852			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264001	Green Submitted, gold, Green Published			2022-12-26	WOS:000396054300022
J	Pollak, J; Rai, KG; Funk, CC; Arora, S; Lee, E; Zhu, J; Price, ND; Paddison, PJ; Ramirez, JM; Rostomily, RC				Pollak, Julia; Rai, Karan G.; Funk, Cory C.; Arora, Sonali; Lee, Eunjee; Zhu, Jun; Price, Nathan D.; Paddison, Patrick J.; Ramirez, Jan-Marino; Rostomily, Robert C.			Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; CANCER; GLIOMA; TRANSPORTERS; TUMORS; IDENTIFICATION; BIOLOGY; CLONING; MODELS; GENES	Ion channels and transporters have increasingly recognized roles in cancer progression through the regulation of cell proliferation, migration, and death. Glioblastoma stem-like cells (GSCs) are a source of tumor formation and recurrence in glioblastoma multiforme, a highly aggressive brain cancer, suggesting that ion channel expression may be perturbed in this population. However, little is known about the expression and functional relevance of ion channels that may contribute to GSC malignancy. Using RNA sequencing, we assessed the enrichment of ion channels in GSC isolates and non-tumor neural cell types. We identified a unique set of GSC-enriched ion channels using differential expression analysis that is also associated with distinct gene mutation signatures. In support of potential clinical relevance, expression of selected GSC-enriched ion channels evaluated in human glioblastoma databases of The Cancer Genome Atlas and Ivy Glioblastoma Atlas Project correlated with patient survival times. Finally, genetic knockdown as well as pharmacological inhibition of individual or classes of GSC-enriched ion channels constrained growth of GSCs compared to normal neural stem cells. This first-in-kind global examination characterizes ion channels enriched in GSCs and explores their potential clinical relevance to glioblastoma molecular subtypes, gene mutations, survival outcomes, regional tumor expression, and experimental responses to loss-of-function. Together, the data support the potential biological and therapeutic impact of ion channels on GSC malignancy and provide strong rationale for further examination of their mechanistic and therapeutic importance.	[Pollak, Julia; Rai, Karan G.; Ramirez, Jan-Marino] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA; [Funk, Cory C.; Price, Nathan D.] Inst Syst Biol, Seattle, WA USA; [Arora, Sonali; Paddison, Patrick J.] Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA; [Lee, Eunjee; Zhu, Jun] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Zhu, Jun] Icahn Sch Med Mt Sinai, Dept Hematol & Med Oncol, Tisch Canc Inst, New York, NY 10029 USA; [Rostomily, Robert C.] Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA; [Rostomily, Robert C.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Rostomily, Robert C.] Houston Methodist Res Inst, Houston, TX 77030 USA; [Rostomily, Robert C.] Houston Methodist Hosp, Dept Neurosurg, Houston, TX USA	Seattle Children's Hospital; Institute for Systems Biology (ISB); Fred Hutchinson Cancer Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston	Rostomily, RC (corresponding author), Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA.; Rostomily, RC (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.; Rostomily, RC (corresponding author), Houston Methodist Res Inst, Houston, TX 77030 USA.; Rostomily, RC (corresponding author), Houston Methodist Hosp, Dept Neurosurg, Houston, TX USA.	rrostomily@houstonmethodist.org	Arora, Sonali/AAE-9407-2021	Arora, Sonali/0000-0002-6661-3024; Ramirez, Jan-Marino/0000-0002-5626-3999; Price, Nathan/0000-0002-4157-0267; Rostomily, Robert/0000-0003-1431-162X	National Cancer Institute of the National Institutes of Health [F32 CA199717, R01 CA190957, R01 CA193841]; National Human Genome Research Institute of the National Institutes of Health [U01 HG008451]; American Cancer Society [ACS-RSG-14-056-01]; Seattle Children's Research Institute; NATIONAL CANCER INSTITUTE [R01CA190957, F32CA199717] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG008451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091251] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); American Cancer Society(American Cancer Society); Seattle Children's Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers F32 CA199717 to JP, R01 CA190957 to PJP, and R01 CA193841 to PJP. This work was also supported by the National Human Genome Research Institute of the National Institutes of Health under award number U01 HG008451 to JZ, the American Cancer Society under award number ACS-RSG-14-056-01 to PJP, and Seattle Children's Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5729, DOI 10.1111/bph.13347; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2015, IVY GAP IVY GLIOBLAS; Arcangeli A, 2009, CURR MED CHEM, V16, P66, DOI 10.2174/092986709787002835; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Becchetti A, 2011, AM J PHYSIOL-CELL PH, V301, pC255, DOI 10.1152/ajpcell.00047.2011; Besson P, 2015, BBA-BIOMEMBRANES, V1848, P2493, DOI 10.1016/j.bbamem.2015.04.013; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; Brackenbury WJ, 2012, CHANNELS, V6, P352, DOI 10.4161/chan.21910; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; CONE CD, 1974, ANN NY ACAD SCI, V238, P420, DOI 10.1111/j.1749-6632.1974.tb26808.x; Cong D, 2015, CURR MED CHEM, V22, P37; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Cuddapah VA, 2011, AM J PHYSIOL-CELL PH, V301, pC541, DOI 10.1152/ajpcell.00102.2011; Das S, 2008, NAT CLIN PRACT NEURO, V4, P427, DOI 10.1038/ncpneuro0862; Engstrom PG, 2012, GENOME MED, V4, DOI 10.1186/gm377; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Hille B, 2001, ION CHANNELS EXCITAB, P1; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Joo KM, 2013, CELL REP, V3, P260, DOI 10.1016/j.celrep.2012.12.013; Joshi AD, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-17; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Leanza L, 2016, BBA-MOL CELL RES, V1863, P1385, DOI 10.1016/j.bbamcr.2015.11.032; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lehen'kyi V, 2011, AM J PHYSIOL-CELL PH, V301, pC1281, DOI 10.1152/ajpcell.00249.2011; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Litan A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00086; Liu XJ, 2002, J NEUROSCI, V22, P1840, DOI 10.1523/JNEUROSCI.22-05-01840.2002; Liu ZG, 2013, NEURO-ONCOLOGY, V15, P1173, DOI 10.1093/neuonc/not065; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; Osswald M, 2015, NATURE, V528, P93, DOI 10.1038/nature16071; Ouadid-Ahidouch H, 2015, BBA-BIOMEMBRANES, V1848, P2621, DOI 10.1016/j.bbamem.2015.02.015; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pla AF, 2012, AM J PHYSIOL-CELL PH, V302, pC9, DOI 10.1152/ajpcell.00280.2011; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Rao VR, 2015, CANCERS, V7, P849, DOI 10.3390/cancers7020813; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Simon O, 2015, J NEURO-ONCOL, V125, P225, DOI 10.1007/s11060-015-1896-9; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Sonoda Y, 2001, CANCER RES, V61, P4956; Sontheimer H, 2008, EXP BIOL MED, V233, P779, DOI 10.3181/0711-MR-308; STILLWELL EF, 1973, NATURE-NEW BIOL, V246, P110, DOI 10.1038/newbio246110a0; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Toledo CM, 2015, CELL REP, V13, P2425, DOI 10.1016/j.celrep.2015.11.021; Turner KL, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0095; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055587; Wang ZF, 2015, SCI REP-UK, V5, P1, DOI 10.1038/srep14187; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xia JZ, 2003, GENE, V313, P91, DOI 10.1016/S0378-1119(03)00633-4; Yang M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00185; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013	68	27	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172884	10.1371/journal.pone.0172884	http://dx.doi.org/10.1371/journal.pone.0172884			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264064	Green Submitted, gold, Green Published			2022-12-26	WOS:000396054300025
J	Farra, SD; Cheung, SS; Thomas, SG; Jacobs, I				Farra, Saro D.; Cheung, Stephen S.; Thomas, Scott G.; Jacobs, Ira			Rate dependent influence of arterial desaturation on self-selected exercise intensity during cycling	PLOS ONE			English	Article							LOCOMOTOR MUSCLE FATIGUE; TIDAL CARBON-DIOXIDE; CENTRAL MOTOR OUTPUT; PERCEIVED EXERTION; SKELETAL-MUSCLE; GROUP-III; ANTICIPATORY REDUCTION; SUPRASPINAL FACTORS; PROLONGED EXERCISE; PACING STRATEGIES	The purpose of this study was to clarify if Ratings of Perceived Exertion (RPE) and self-selected exercise intensity are sensitive not only to alterations in the absolute level of arterial saturation (SPO2) but also the rate of change in SPO2. Twelve healthy participants (31.6 +/- 3.9 y, 175.5 +/- 7.7 cm, 73.3 +/- 10.3 kg, 51 +/- 7 mL +/- kg (-1) +/- min -1 VO (2peak)) exercised four times on a cycle ergometer, freely adjusting power output (PO) to maintain RPE at 5 on Borg's 10-point scale with no external feedback to indicate their exercise intensity. The fraction of inspired oxygen (FIO2) was reduced during three of those trials such that SPO2 decreased during exercise from starting values (> 98%) to 70%. These trials were differentiated by the time over which the desaturation occurred: 3.9 +/- 1.4 min, -8.7 +/- 4.2% center dot min (-1) (FAST), 11.0 +/- 3.7 min, -2.8 +/- 1.3% center dot min (-1) (MED), and 19.5 +/- 5.8 min, -1.5 +/- 0.8% center dot min (-1) (SLOW) (P < 0.001). Compared to stable PO throughout the control condition (no SPO2 manipulation), PO signifi-cantly decreased across the experimental conditions (FAST = 2.8 +/- 2.1 W center dot % SPO2 (-1); MED = 2.5 +/- 1.8 W center dot % SPO2 (-1); SLOW = 1.8 +/- 1.6 W center dot % SPO2 (-1); P < 0.001). The rates of decline in PO during FAST and MED were similar, with both greater than SLOW. Our results confirm that decreases in absolute SPO2 impair exercise performance and that a faster rate of oxygen desaturation magnifies that impairment.	[Farra, Saro D.; Cheung, Stephen S.; Thomas, Scott G.; Jacobs, Ira] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Cheung, Stephen S.] Brock Univ, Dept Kinesiol, St Catharines, ON, Canada	University of Toronto; Brock University	Jacobs, I (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.	ira.jacobs@utoronto.ca	Cheung, Stephen/HGU-6191-2022; Cheung, Stephen/AAE-9136-2020; Thomas, Scott/G-4522-2012; Jacobs, Ira/AAE-9445-2021	Cheung, Stephen/0000-0002-6149-4978; Thomas, Scott/0000-0002-5564-4271; 	Province of Ontario's Research Program; Canada Research Chair	Province of Ontario's Research Program; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by the Province of Ontario's Research Program in Applied Sport Science. S.S. Cheung was supported by a Canada Research Chair.	Abbiss CR, 2005, SPORTS MED, V35, P865, DOI 10.2165/00007256-200535100-00004; Allgood GO, 2000, IEEE SYS MAN CYBERN, P2198, DOI 10.1109/ICSMC.2000.886442; Amann M, 2008, J PHYSIOL-LONDON, V586, P161, DOI 10.1113/jphysiol.2007.141838; Amann M, 2007, J PHYSIOL-LONDON, V581, P389, DOI 10.1113/jphysiol.2007.129700; Amann M, 2006, J PHYSIOL-LONDON, V575, P937, DOI 10.1113/jphysiol.2006.113936; Amann M, 2011, J PHYSIOL-LONDON, V589, P5299, DOI 10.1113/jphysiol.2011.213769; Amann M, 2009, HIGH ALT MED BIOL, V10, P149, DOI 10.1089/ham.2008.1105; BALSOM PD, 1994, ACTA PHYSIOL SCAND, V152, P279, DOI 10.1111/j.1748-1716.1994.tb09807.x; BARNARD P, 1987, J APPL PHYSIOL, V63, P685, DOI 10.1152/jappl.1987.63.2.685; BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; Bhambhani Y, 2001, EUR J APPL PHYSIOL, V84, P547, DOI 10.1007/s004210000372; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BORG GAV, 1973, MED SCI SPORT EXER, V5, P90; BROWN RM, 1974, J NEURAL TRANSM, V35, P293, DOI 10.1007/BF02205226; CHERNICK V, 1982, SCIENCE, V216, P1252, DOI 10.1126/science.7200636; CHERNICK V, 1980, PEDIATR RES, V14, P357, DOI 10.1203/00006450-198004000-00021; Clark SA, 2007, EUR J APPL PHYSIOL, V102, P45, DOI 10.1007/s00421-007-0554-0; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; DAVIS JN, 1973, J NEUROCHEM, V21, P783, DOI 10.1111/j.1471-4159.1973.tb07522.x; de Morree HM, 2012, PSYCHOPHYSIOLOGY, V49, P1242, DOI 10.1111/j.1469-8986.2012.01399.x; DUFFY TE, 1972, J NEUROCHEM, V19, P959, DOI 10.1111/j.1471-4159.1972.tb01417.x; EKBLOM B, 1975, J APPL PHYSIOL, V39, P71, DOI 10.1152/jappl.1975.39.1.71; ERECINSKA M, 1984, BRAIN RES, V304, P9, DOI 10.1016/0006-8993(84)90857-6; Eston R G, 1988, Br J Sports Med, V22, P153; ESTON RG, 1987, EUR J APPL PHYSIOL O, V56, P222, DOI 10.1007/BF00640648; Eston R, 2007, PSYCHOPHYSIOLOGY, V44, P779, DOI 10.1111/j.1469-8986.2007.00558.x; Farra SD, 2016, RESP PHYSIOL NEUROBI, V231, P28, DOI 10.1016/j.resp.2016.05.013; Faulkner J, 2008, J EXERC SCI FIT, V6, P1; Gallagher KM, 2001, J PHYSIOL-LONDON, V533, P861, DOI 10.1111/j.1469-7793.2001.t01-1-00861.x; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gandevia SC, 1996, J PHYSIOL-LONDON, V490, P529, DOI 10.1113/jphysiol.1996.sp021164; Gandevia SC, 1998, ACTA PHYSIOL SCAND, V162, P275, DOI 10.1046/j.1365-201X.1998.0299f.x; GARNER SH, 1990, J APPL PHYSIOL, V68, P1167, DOI 10.1152/jappl.1990.68.3.1167; Gibson ASC, 2006, SPORTS MED, V36, P705; GIBSON GE, 1978, J NEUROCHEM, V31, P757, DOI 10.1111/j.1471-4159.1978.tb00107.x; Gonzalez-Alonso J, 1999, J APPL PHYSIOL, V86, P1032, DOI 10.1152/jappl.1999.86.3.1032; Goodall S, 2012, J PHYSIOL-LONDON, V590, P2767, DOI 10.1113/jphysiol.2012.228890; Goodall S, 2010, J APPL PHYSIOL, V109, P1842, DOI 10.1152/japplphysiol.00458.2010; HAGBERG H, 1985, J CEREBR BLOOD F MET, V5, P413, DOI 10.1038/jcbfm.1985.56; HERMANSE.L, 1967, ACTA PHYSIOL SCAND, V71, P129, DOI 10.1111/j.1748-1716.1967.tb03719.x; HILL JM, 1992, J APPL PHYSIOL, V73, P2524, DOI 10.1152/jappl.1992.73.6.2524; Holloszy JO, 1996, ANNU REV NUTR, V16, P121, DOI 10.1146/annurev.nu.16.070196.001005; IVERSEN K, 1983, ACTA PHYSIOL SCAND, V118, P91, DOI 10.1111/j.1748-1716.1983.tb07247.x; Johnson BD, 2009, EUR J APPL PHYSIOL, V106, P493, DOI 10.1007/s00421-009-1036-3; KAUFMAN MP, 1984, J APPL PHYSIOL, V57, P644, DOI 10.1152/jappl.1984.57.3.644; Kaufman MP, 1996, COMPREHENSIVE PHYSL; Kayser B, 2003, EUR J APPL PHYSIOL, V90, P411, DOI 10.1007/s00421-003-0902-7; LI KY, 1990, J PHYSIOL-LONDON, V430, P1; Marcora S, 2009, J APPL PHYSIOL, V106, P2060, DOI 10.1152/japplphysiol.90378.2008; Marino FE, 2004, J APPL PHYSIOL, V96, P124, DOI 10.1152/japplphysiol.00582.2003; MATEIKA JH, 1995, EUR J APPL PHYSIOL, V71, P1, DOI 10.1007/BF00511228; MCLELLAN TM, 1982, INT J SPORTS MED, V3, P224, DOI 10.1055/s-2008-1026092; MCLELLAN TM, 1985, INT J SPORTS MED, V6, P30, DOI 10.1055/s-2008-1025809; Millet GY, 2012, J APPL PHYSIOL, V112, P1335, DOI 10.1152/japplphysiol.00804.2011; Morgan W P, 1977, Ann N Y Acad Sci, V301, P382, DOI 10.1111/j.1749-6632.1977.tb38215.x; Neary JP, 2008, CLIN PHYSIOL FUNCT I, V28, P364, DOI 10.1111/j.1475-097X.2008.00822.x; NEUBAUER JA, 1988, J APPL PHYSIOL, V65, P1324, DOI 10.1152/jappl.1988.65.3.1324; Noakes TD, 2007, J PHYSIOL-LONDON, V585, P919, DOI 10.1113/jphysiol.2007.145110; NOBLE BJ, 1973, MED SCI SPORT EXER, V5, P104; NOBLE BJ, 1983, MED SCI SPORT EXER, V15, P523; NOBLE BJ, 1973, MED SCI SPORT EXER, V5, P116; Nybo L, 2001, J APPL PHYSIOL, V91, P1055, DOI 10.1152/jappl.2001.91.3.1055; Puccini GD, 2007, PLOS COMPUT BIOL, V3, P813, DOI 10.1371/journal.pcbi.0030082; Pugh LG, 1964, J APPL PHYSIOL, V194, P31; Rasmussen P, 2010, J PHYSIOL-LONDON, V588, P1985, DOI 10.1113/jphysiol.2009.186767; Rasmussen P, 2007, J CEREBR BLOOD F MET, V27, P1082, DOI 10.1038/sj.jcbfm.9600416; Renfree A, 2012, INT J SPORT PHYSIOL, V7, P121, DOI 10.1123/ijspp.7.2.121; Romer LM, 2006, AM J PHYSIOL-REG I, V290, pR365, DOI 10.1152/ajpregu.00332.2005; Rosen R., 1985, ANTICIPATORY SYSTEMS, DOI DOI 10.1080/03081079.2012.726322; SAHLIN K, 1989, ACTA PHYSIOL SCAND, V136, P199, DOI 10.1111/j.1748-1716.1989.tb08653.x; SKINNER JS, 1973, MED SCI SPORT EXER, V5, P94; Slessarev M, 2007, J PHYSIOL-LONDON, V581, P1207, DOI 10.1113/jphysiol.2007.129395; Smith SA, 2003, J PHYSIOL-LONDON, V551, P1013, DOI 10.1113/jphysiol.2003.044925; Sommer LZ, 1998, EUR RESPIR J, V12, P698, DOI 10.1183/09031936.98.12030698; Somogyi RB, 2005, ANAESTH INTENS CARE, V33, P726, DOI 10.1177/0310057X0503300604; SQUIRES RW, 1982, MED SCI SPORT EXER, V14, P36, DOI 10.1249/00005768-198201000-00007; Tanaka M, 2012, NEUROSCI BIOBEHAV R, V36, P727, DOI 10.1016/j.neubiorev.2011.10.004; Tucker R, 2004, PFLUG ARCH EUR J PHY, V448, P422, DOI 10.1007/s00424-004-1267-4; Tucker R, 2009, BRIT J SPORT MED, V43, P392, DOI 10.1136/bjsm.2008.050799; Tucker R, 2009, BRIT J SPORT MED, V43, DOI 10.1136/bjsm.2009.057562; Tucker R, 2006, J PHYSIOL-LONDON, V574, P905, DOI 10.1113/jphysiol.2005.101733; Verges S, 2012, AM J PHYSIOL-REG I, V302, pR903, DOI 10.1152/ajpregu.00555.2011; Webster MA, 2012, F1000 BIOL REP, P421; Wehrlin JP, 2006, EUR J APPL PHYSIOL, V96, P404, DOI 10.1007/s00421-005-0081-9; West JB., 2008, RESP PHYSL ESSENTIAL; Wetter TJ, 1999, J APPL PHYSIOL, V87, P643, DOI 10.1152/jappl.1999.87.2.643; Williamson JW, 2006, EXP PHYSIOL, V91, P51, DOI 10.1113/expphysiol.2005.032037; WINN HR, 1981, AM J PHYSIOL, V241, pH235, DOI 10.1152/ajpheart.1981.241.2.H235; WOOD JD, 1968, J NEUROCHEM, V15, P603, DOI 10.1111/j.1471-4159.1968.tb08959.x	89	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0171119	10.1371/journal.pone.0171119	http://dx.doi.org/10.1371/journal.pone.0171119			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257415	Green Published, gold, Green Submitted			2022-12-26	WOS:000396021100005
J	Hock, BD; MacPherson, SA; McKenzie, JL				Hock, Barry D.; MacPherson, Sean A.; McKenzie, Judith L.			Idelalisib and caffeine reduce suppression of T cell responses mediated by activated chronic lymphocytic leukemia cells	PLOS ONE			English	Article							HUMAN B-CELLS; TUMOR MICROENVIRONMENT; LYMPH-NODE; ADENOSINE RECEPTORS; IMMUNE SUPPRESSION; KINASE-ACTIVITIES; HUMAN CANCER; CLL-CELLS; INHIBITION; EXPRESSION	Chronic lymphocytic leukemia (CLL) is associated with T cell dysfunction. Activated CLL cells are found within the lymphoid tumor micro-environment and overcoming immuno-suppression induced by these cells may improve anti-CLL immune responses. However, the mechanisms by which activated CLL cells inhibit T cell responses, and reagents targeting such mechanisms have not been identified. Here we demonstrate that the ability of in vitro activated CLL cells to suppress T cell proliferation is not reversed by the presence of ecto-nuclease inhibitors or blockade of IL-10, PD-1 and CTLA-4 pathways. Caffeine is both an adenosine receptor antagonist and a phosphatidylinositol-3-kinase, p110d (PI3Kd) inhibitor and, at physiologically relevant levels, significantly reversed suppression. Significant reversal of suppression was also observed with the PI3Kd specific inhibitor Idelalisib but not with adenosine receptor specific antagonists. Furthermore, addition of caffeine or Idelalisib to activated CLL cells significantly inhibited phosphorylation of AKT, a downstream kinase of PI3K, but did not affect CLL viability. These results suggest that caffeine, in common with Idelalisib, reduces the immuno-suppressive activity of activated CLL cells by inhibiting PI3Kd. These findings raise the possibility that these compounds may provide a useful therapeutic adjunct by reducing immuno-suppression within the tumor micro-environment of CLL.	[Hock, Barry D.; McKenzie, Judith L.] Christchurch Hosp, Haematol Res Grp, Christchurch, New Zealand; [Hock, Barry D.; MacPherson, Sean A.; McKenzie, Judith L.] Univ Otago, Dept Pathol, Christchurch, New Zealand; [MacPherson, Sean A.] Christchurch Hosp, Dept Haematol, Christchurch, New Zealand	Christchurch Hospital New Zealand; University of Otago; Christchurch Hospital New Zealand	Hock, BD (corresponding author), Christchurch Hosp, Haematol Res Grp, Christchurch, New Zealand.; Hock, BD (corresponding author), Univ Otago, Dept Pathol, Christchurch, New Zealand.	barry.hock@otago.ac.nz			Bone Marrow Cancer Research Trust; Ruth Spearing Cancer Research Trust	Bone Marrow Cancer Research Trust; Ruth Spearing Cancer Research Trust	This work was supported by grants from The Bone Marrow Cancer Research Trust and The Ruth Spearing Cancer Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnouri MW, 2015, PURINERG SIGNAL, V11, P389, DOI 10.1007/s11302-015-9460-9; Appleman LJ, 2000, J IMMUNOL, V164, P144, DOI 10.4049/jimmunol.164.1.144; Bagnara D, 2011, BLOOD, V117, P5463, DOI 10.1182/blood-2010-12-324210; Blanco B, 2015, IMMUNOL RES, V62, P175, DOI 10.1007/s12026-015-8648-y; Blunt Matthew D, 2015, Leuk Res Rep, V4, P60, DOI 10.1016/j.lrr.2015.09.001; Bode AM, 2007, CANCER LETT, V247, P26, DOI 10.1016/j.canlet.2006.03.032; Bouaziz JD, 2010, EUR J IMMUNOL, V40, P2686, DOI 10.1002/eji.201040673; Brown JR, 2014, BLOOD, V123, P3390, DOI 10.1182/blood-2013-11-535047; Brusa D, 2013, HAEMATOLOGICA, V98, P953, DOI 10.3324/haematol.2012.077537; Burger JA, 2014, SEMIN CANCER BIOL, V24, P71, DOI 10.1016/j.semcancer.2013.08.011; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Daly JW, 2007, CELL MOL LIFE SCI, V64, P2153, DOI 10.1007/s00018-007-7051-9; Davis JE, 2014, LEUKEMIA RES, V38, P1160, DOI 10.1016/j.leukres.2014.08.005; DiLillo DJ, 2013, LEUKEMIA, V27, P170, DOI 10.1038/leu.2012.165; Forconi F, 2015, BLOOD, V126, P573, DOI 10.1182/blood-2015-03-567388; Foukas LC, 2002, J BIOL CHEM, V277, P37124, DOI 10.1074/jbc.M202101200; Gibbs BF, 2015, ONCOTARGET, V6, P28678, DOI 10.18632/oncotarget.5212; Gilling CE, 2012, BRIT J HAEMATOL, V158, P216, DOI 10.1111/j.1365-2141.2012.09148.x; Gockeritz E, 2015, INT J CANCER, V137, P2234, DOI 10.1002/ijc.29579; Goodman WA, 2011, J IMMUNOL, V186, P3336, DOI 10.4049/jimmunol.1001455; Gorgun G, 2005, J CLIN INVEST, V115, P1797, DOI 10.1172/JCI24176; Haile ST, 2013, J IMMUNOL, V191, P2829, DOI 10.4049/jimmunol.1202777; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Hock BD, 2014, LEUKEMIA RES, V38, P1217, DOI 10.1016/j.leukres.2014.06.004; Hock BD, 2012, IMMUNOLOGY, V137, P249, DOI 10.1111/imm.12004; Hoellenriegel J, 2011, BLOOD, V118, P3603, DOI 10.1182/blood-2011-05-352492; Horenstein AL, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26246; Horrigan LA, 2006, PHARMACOL THERAPEUT, V111, P877, DOI 10.1016/j.pharmthera.2006.02.002; Jitschin R, 2014, BLOOD, V124, P750, DOI 10.1182/blood-2013-12-546416; Lee JW, 2015, EUR J PEDIATR, V174, P1671, DOI 10.1007/s00431-015-2581-x; Lemoine S, 2011, J AUTOIMMUN, V36, P228, DOI 10.1016/j.jaut.2011.01.005; McClanahan F, 2015, BLOOD, V126, P203, DOI 10.1182/blood-2015-01-622936; Mercadante ER, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00193; Mohr A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1132977; Motta M, 2005, LEUKEMIA, V19, P1788, DOI 10.1038/sj.leu.2403907; Muller-Haegele S, 2014, EXPERT REV CLIN IMMU, V10, P897, DOI 10.1586/1744666X.2014.915739; Musgrave IF, 2016, FORENSIC SCI MED PAT, V12, P299, DOI 10.1007/s12024-016-9786-9; Nicholas NS, 2016, BBA-MOL CELL RES, V1863, P471, DOI 10.1016/j.bbamcr.2015.11.003; Pasikowska M, 2016, BLOOD, V128, P563, DOI 10.1182/blood-2016-01-683128; Patten PEM, 2008, BLOOD, V111, P5173, DOI 10.1182/blood-2007-08-108605; Podshivalova K, 2013, CRIT REV IMMUNOL, V33, P435, DOI 10.1615/CritRevImmunol.2013006858; Ramsay AG, 2013, BLOOD, V121, P2704, DOI 10.1182/blood-2012-08-448332; Ramsay AG, 2012, BLOOD, V120, P1412, DOI 10.1182/blood-2012-02-411678; Riches JC, 2013, BLOOD, V121, P1612, DOI 10.1182/blood-2012-09-457531; Routledge DJM, 2016, BRIT J HAEMATOL, V174, P351, DOI 10.1111/bjh.14184; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sarkaria JN, 1999, CANCER RES, V59, P4375; Saze Z, 2013, BLOOD, V122, P9, DOI 10.1182/blood-2013-02-482406; Schulz M, 2012, CRIT CARE, V16, DOI 10.1186/cc11441; Serra S, 2011, BLOOD, V118, P6141, DOI 10.1182/blood-2011-08-374728; Shi M, 2009, J IMMUNOL, V183, P4493, DOI 10.4049/jimmunol.0804339; Spranger S, 2016, INT IMMUNOL, V28, P383, DOI 10.1093/intimm/dxw014; Stankovic T, 2014, LEUKEMIA LYMPHOMA, V55, P1227, DOI 10.3109/10428194.2013.829919; te Raa GD, 2014, BLOOD, V123, P717, DOI 10.1182/blood-2013-08-518183; ten Hacken E, 2016, BBA-MOL CELL RES, V1863, P401, DOI 10.1016/j.bbamcr.2015.07.009; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Till KJ, 2015, J IMMUNOL, V194, P2439, DOI 10.4049/jimmunol.1402304; Tretter T, 2008, BLOOD, V112, P4555, DOI 10.1182/blood-2008-02-140087; Varani K, 2005, CELL MOL LIFE SCI, V62, P2350, DOI 10.1007/s00018-005-5312-z; YELLIN MJ, 1994, J IMMUNOL, V153, P666; Zhuang JG, 2010, HAEMATOL-HEMATOL J, V95, P110, DOI 10.3324/haematol.2009.010272	61	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172858	10.1371/journal.pone.0172858	http://dx.doi.org/10.1371/journal.pone.0172858			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257435	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100032
J	Lu, J; Gu, BY; Wang, XL; Zhang, YH				Lu, Jing; Gu, Boyu; Wang, Xiaolin; Zhang, Yuhua			High-speed adaptive optics line scan confocal retinal imaging for human eye	PLOS ONE			English	Article							HUMAN CONE PHOTORECEPTORS; LASER OPHTHALMOSCOPE; IN-VIVO; PARAFOVEAL CAPILLARIES; DIABETIC-RETINOPATHY; LIGHT OPHTHALMOSCOPY; PERCEPTION; MOVEMENTS; TRACKING; SYSTEM	Purpose Continuous and rapid eye movement causes significant intraframe distortion in adaptive optics high resolution retinal imaging. To minimize this artifact, we developed a high speed adaptive optics line scan confocal retinal imaging system. Methods A high speed line camera was employed to acquire retinal image and custom adaptive optics was developed to compensate the wave aberration of the human eye's optics. The spatial resolution and signal to noise ratio were assessed in model eye and in living human eye. The improvement of imaging fidelity was estimated by reduction of intra-frame distor-tion of retinal images acquired in the living human eyes with frame rates at 30 frames/ second (FPS), 100 FPS, and 200 FPS. Results The device produced retinal image with cellular level resolution at 200 FPS with a digitization of 512x512 pixels/frame in the living human eye. Cone photoreceptors in the central fovea and rod photoreceptors near the fovea were resolved in three human subjects in normal chorioretinal health. Compared with retinal images acquired at 30 FPS, the intra-frame dis-tortion in images taken at 200 FPS was reduced by 50.9% to 79.7%. Conclusions We demonstrated the feasibility of acquiring high resolution retinal images in the living human eye at a speed that minimizes retinal motion artifact. This device may facilitate research involving subjects with nystagmus or unsteady fixation due to central vision loss.	[Lu, Jing; Gu, Boyu; Wang, Xiaolin; Zhang, Yuhua] Univ Alabama Birmingham, Sch Med, Dept Ophthalmol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Zhang, YH (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Ophthalmol, Birmingham, AL 35294 USA.	yuhuazhang@uabmc.edu	wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341	National Institutes of Health (NIH) [EY021903, EY024378, P30 EY003039]; National Science Foundation (NSF) [IIA-1539034]; EyeSight Foundation of Alabama; Buck Trust of Alabama; NATIONAL EYE INSTITUTE [R01EY024378, R21EY021903, P30EY003039] Funding Source: NIH RePORTER; Office Of The Director [1539034] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); EyeSight Foundation of Alabama; Buck Trust of Alabama; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by National Institutes of Health (NIH) (EY021903, EY024378, P30 EY003039); National Science Foundation (NSF) (IIA-1539034); Institutional support from Research to Prevent Blindness; EyeSight Foundation of Alabama; and Buck Trust of Alabama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, 1288 EMVA; Automated Imaging Association, 2004, SPEC CAM LINK INT ST; Bedggood Phillip, 2012, Biomed Opt Express, V3, P3264, DOI 10.1364/BOE.3.003264; Bedggood P, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907211; Burns SA, 2007, J OPT SOC AM A, V24, P1313, DOI 10.1364/JOSAA.24.001313; Carpenter RHS, 1988, MOVEMENTS EYES; Chen MF, 2015, INVEST OPHTH VIS SCI, V56, P674, DOI 10.1167/iovs.14-15936; Christoph Czeranowsky MS., 2015, WHITE PAPER DO YOU A; Chui TYP, 2012, BIOMED OPT EXPRESS, V3, P2537, DOI 10.1364/BOE.3.002537; Cooper RF, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.1.10; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Delori F. o. C., 2007, J OPT SOC AM A, V24, P1250; DITCHBURN RW, 1953, J PHYSIOL-LONDON, V119, P1; Dubra A, 2011, BIOMED OPT EXPRESS, V2, P1864, DOI 10.1364/BOE.2.001864; Dubra A, 2011, BIOMED OPT EXPRESS, V2, P1757, DOI 10.1364/BOE.2.001757; EIZENMAN M, 1985, VISION RES, V25, P1635, DOI 10.1016/0042-6989(85)90134-8; Ferguson RD, 2010, J OPT SOC AM A, V27, pA265, DOI 10.1364/JOSAA.27.00A265; Guevara-Torres A, 2016, BIOMED OPT EXPRESS, V7, P4228, DOI 10.1364/BOE.7.004228; Guevara-Torres A, 2015, BIOMED OPT EXPRESS, V6, P2106, DOI 10.1364/BOE.6.002106; Hammer DX, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2335470; Hammer DX, 2006, OPT EXPRESS, V14, P3354, DOI 10.1364/OE.14.003354; Hunter JJ, 2011, BIOMED OPT EXPRESS, V2, P139, DOI 10.1364/BOE.2.000139; Jonnal RS, 2007, OPT EXPRESS, V15, P16141, DOI 10.1364/OE.15.016141; Laser Institute of America, 2014, AM NAT STAND SAF US; Lu J, 2016, OPT LETT, V41, P3852, DOI 10.1364/OL.41.003852; Martial FP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043942; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2008, J VISION, V8, DOI [10.1167/8.14.28, 10.1167/8.14.i]; Meadway A, 2014, BIOMED OPT EXPRESS, V5, P713, DOI 10.1364/BOE.5.000713; Meadway A, 2013, OPT EXPRESS, V21, P29792, DOI 10.1364/OE.21.029792; Merino D, 2011, BIOMED OPT EXPRESS, V2, P2189, DOI 10.1364/BOE.2.002189; Morgan JIW, 2009, INVEST OPHTH VIS SCI, V50, P1350, DOI 10.1167/iovs.08-2618; Mujat M, 2009, OPT EXPRESS, V17, P10242, DOI 10.1364/OE.17.010242; Nuthmann A, 2010, PSYCHOL REV, V117, P382, DOI 10.1037/a0018924; Otero-Millan J, 2008, J VISION, V8, DOI 10.1167/8.14.21; Rha J, 2006, OPT EXPRESS, V14, P4552, DOI 10.1364/OE.14.004552; Rha J, 2009, OPT LETT, V34, P3782, DOI 10.1364/OL.34.003782; RIGGS LA, 1954, J OPT SOC AM, V44, P315, DOI 10.1364/JOSA.44.000315; Romero-Borja F, 2005, APPL OPTICS, V44, P4032, DOI 10.1364/AO.44.004032; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Roorda A, 2007, INVEST OPHTH VIS SCI, V48, P2297, DOI 10.1167/iovs.06-1450; Roorda A, 2015, ANNU REV VIS SCI, V1, P19, DOI 10.1146/annurev-vision-082114-035357; Roorda A, 2010, OPTOMETRY VISION SCI, V87, P260, DOI 10.1097/OPX.0b013e3181d39479; Scoles D, 2014, INVEST OPHTH VIS SCI, V55, P4244, DOI 10.1167/iovs.14-14542; Sheehy CK, 2012, BIOMED OPT EXPRESS, V3, P2611, DOI 10.1364/BOE.3.002611; Stevenson SB, 2005, BIOMEDICAL OPTICS, V2005; Talcott KE, 2011, INVEST OPHTH VIS SCI, V52, P2219, DOI 10.1167/iovs.10-6479; Tam J, 2012, OPTOMETRY VISION SCI, V89, pE692, DOI 10.1097/OPX.0b013e3182548b07; Tam J, 2011, INVEST OPHTH VIS SCI, V52, P9257, DOI 10.1167/iovs.11-8481; Tam J, 2011, BIOMED OPT EXPRESS, V2, P781, DOI 10.1364/BOE.2.000781; Tam J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3548880; Tam J, 2010, INVEST OPHTH VIS SCI, V51, P1691, DOI 10.1167/iovs.09-4483; Vienola KV, 2015, OPT LETT, V40, P5335, DOI 10.1364/OL.40.005335; Vogel CR, 2006, OPT EXPRESS, V14, P487, DOI 10.1364/OPEX.14.000487; Webb RH, 1996, REP PROG PHYS, V59, P427, DOI 10.1088/0034-4885/59/3/003; Webb Robert H., 1995, P55; Williams DR, 2011, VISION RES, V51, P1379, DOI 10.1016/j.visres.2011.05.002; Wilson T., 1984, THEORY PRACTICE SCAN; Yang Q, 2014, BIOMED OPT EXPRESS, V5, P3174, DOI 10.1364/BOE.5.003174; Yu YM, 2014, CHIN OPT LETT, V12, DOI [10.3788/COL201412.110602, 10.3788/COL201412.100601]; Yu YX, 2015, OPT EXPRESS, V23, P23035, DOI 10.1364/OE.23.023035; Zhang J, 2015, BIOMED OPT EXPRESS, V6, P2120, DOI 10.1364/BOE.6.002120; Zhang TJ, 2015, AM J OPHTHALMOL, V160, P290, DOI 10.1016/j.ajo.2015.04.034; Zhang YH, 2006, OPT LETT, V31, P1268, DOI 10.1364/OL.31.001268	64	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0169358	10.1371/journal.pone.0169358	http://dx.doi.org/10.1371/journal.pone.0169358			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257458	Green Submitted, gold, Green Published			2022-12-26	WOS:000396021100001
J	Pourcine, F; Dahan, K; Mihout, F; Cachanado, M; Brocheriou, I; Debiec, H; Ronco, P				Pourcine, Franck; Dahan, Karine; Mihout, Fabrice; Cachanado, Marine; Brocheriou, Isabelle; Debiec, Hanna; Ronco, Pierre			Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years	PLOS ONE			English	Article							PHOSPHOLIPASE A(2) RECEPTOR; DOMAIN-CONTAINING 7A; UNTREATED PATIENTS; NEPHROTIC SYNDROME; CONTROLLED-TRIAL; AUTOANTIBODIES; CYCLOPHOSPHAMIDE; TITER	Introduction Clinical course of membranous nephropathy (MN) is difficult to predict. Measurement of circulating anti-PLA2R autoantibodies (PLA2R-Ab) and detection in immune deposits of PLA2R antigen (PLA2R-Ag) are major advances in disease understanding. We evaluated the clinical significance of these biomarkers. Methods In this 14-year retrospective study, we collected data from 108 MN patients and assessed the relationship between clinical course, PLA2R-Ab and PLA2R-Ag. We also assessed THSD7A status. Results Eighty-five patients suffered from primary MN (PMN) and 23 patients from a secondary form. The median follow-up was 30.4 months [interquartile range, 17.7;56.7]. Among the 77 patients with PMN and available serum and/or biopsy, 69 (89.6%) had PLA2R-related disease as shown by anti-PLA2R-Ab and/or PLA2R-Ag, while 8 patients (8/77, 10.4%) were negative for both. There was no significant difference between these two groups in age at diagnosis and outcome assessed by proteinuria, serum albumin level and eGFR. Two of the 8 negative patients were positive for THSD7A. In patients with PLA2R related PMN, younger age, lower proteinuria, higher eGFR, and lower PLA2R-Ab level at baseline and after 6 months were associated with remission of proteinuria. Initial PLA2R-Ab titer <= 97.6 RU/mL and complete depletion of PLA2R-Ab within 6-months were significantly associated with spontaneous remission at the end of follow-up. In rituximab treated patients, lower PLA2R-Ab titer at initiation of treatment, and absence of PLA2R-Ab and higher serum albumin level at 3 months were significantly associated with remission. Noticeably, 81.8% of the patients who achieved remission completely cleared PLA2R-Ab. Depletion of PLA2R-Ab and increase of serum albumin level preceded the decrease of proteinuria. Conclusion Assessment of PLA2R autoimmunity is essential for patient management. Combination of PLA2R-Ab and PLA2R-Ag increases diagnosis sensitivity. PLA2R-Ab titer is a biomarker of disease severity at initial assessment, and the kinetics of the antibody are significantly correlated to disease evolution.	[Pourcine, Franck] Hop Henri Mondor, AP HP, Dept Nephrol & Transplantat, Creteil, France; [Dahan, Karine; Mihout, Fabrice; Ronco, Pierre] Hop Tenon, AP HP, Dept Nephrol & Dialysis, Paris, France; [Cachanado, Marine] Hop St Antoine, AP HP, Dept Clin Pharmacol, Paris, France; [Cachanado, Marine] Unite Rech Clin, Paris, France; [Brocheriou, Isabelle] Hop Tenon, AP HP, Dept Pathol, Paris, France; [Debiec, Hanna; Ronco, Pierre] Univ Paris, Univ Pierre & Marie Curie, Sorbonne Univ, Paris, France; [Debiec, Hanna; Ronco, Pierre] INSERM, Paris, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ronco, P (corresponding author), Hop Tenon, AP HP, Dept Nephrol & Dialysis, Paris, France.; Ronco, P (corresponding author), Univ Paris, Univ Pierre & Marie Curie, Sorbonne Univ, Paris, France.; Ronco, P (corresponding author), INSERM, Paris, France.	pierreronco@yahoo.fr	Debiec, Hanna/AAL-8144-2021; Ronco, Pierre/AAC-8390-2022	Debiec, Hanna/0000-0002-8946-8245; Franck, Pourcine/0000-0001-5601-6018	European Research Council [ERC-2012-ADG_20120314, 322947]; 7th Framework Programme of the European Community [2012-305608]	European Research Council(European Research Council (ERC)European Commission); 7th Framework Programme of the European Community	This study was funded by grants from the European Research Council ERC-2012-ADG_20120314 (Grant Agreement 322947) and from 7th Framework Programme of the European Community Contract 2012-305608 (European Consortium for High-Throughput Research in Kidney Diseases). Rituximab was provided by Hoffmann La Roche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by grants from the European Research Council ERC-2012-ADG_20120314 (Grant Agreement 322947) and from 7th Framework Programme of the European Community Contract 2012-305608 (European Consortium for High-Throughput Research in Rare Kidney Diseases). Rituximab was provided by Hoffmann-LaRoche. The authors confirm that they are not paid employees or consultants of Hoffmann-LaRoche, that no patents or products are in development in association with this study, and that no other perceivable competing interest exist between the authors and this company. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Bech AP, 2014, CLIN J AM SOC NEPHRO, V9, P1386, DOI 10.2215/CJN.10471013; Beck LH, 2011, J AM SOC NEPHROL, V22, P1543, DOI 10.1681/ASN.2010111125; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; CATTRAN DC, 1995, KIDNEY INT, V47, P1130, DOI 10.1038/ki.1995.161; Dahan K, 2016, J AM SOC NEPHROL; Debiec H, 2011, NEW ENGL J MED, V364, P689, DOI 10.1056/NEJMc1011678; DONADIO JV, 1988, KIDNEY INT, V33, P708, DOI 10.1038/ki.1988.56; Dong HR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156263; Hofstra JM, 2012, J AM SOC NEPHROL, V23, P1735, DOI 10.1681/ASN.2012030242; Hofstra JM, 2011, CLIN J AM SOC NEPHRO, V6, P1286, DOI 10.2215/CJN.07210810; Hoxha E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110681; Hoxha E, 2014, CLIN J AM SOC NEPHRO, V9, P1883, DOI 10.2215/CJN.03850414; Hoxha E, 2014, J AM SOC NEPHROL, V25, P1357, DOI 10.1681/ASN.2013040430; Jha V, 2007, J AM SOC NEPHROL, V18, P1899, DOI 10.1681/ASN.2007020166; Kanigicherla D, 2013, KIDNEY INT, V83, P940, DOI 10.1038/ki.2012.486; Polanco N, 2010, J AM SOC NEPHROL, V21, P697, DOI 10.1681/ASN.2009080861; PONTICELLI C, 1989, NEW ENGL J MED, V320, P8, DOI 10.1056/NEJM198901053200102; Ponticelli C, 2014, CLIN J AM SOC NEPHRO, V9, P609, DOI 10.2215/CJN.04160413; Qin HZ, 2016, J AM SOC NEPHROL; Radhakrishnan J, 2012, KIDNEY INT, V82, P840, DOI 10.1038/ki.2012.280; Ruggenenti P, 2015, J AM SOC NEPHROL, V26, P2545, DOI 10.1681/ASN.2014070640; SCHIEPPATI A, 1993, NEW ENGL J MED, V329, P85, DOI 10.1056/NEJM199307083290203; Stehle T, 2015, NEPHROL DIAL TRANSPL, V30, P1047, DOI 10.1093/ndt/gfv080; Svobodova B, 2013, NEPHROL DIAL TRANSPL, V28, P1839, DOI 10.1093/ndt/gfs439; Tomas NM, 2016, J CLIN INVEST, V126, P2519, DOI 10.1172/JCI85265; Tomas NM, 2014, NEW ENGL J MED, V371, P2277, DOI 10.1056/NEJMoa1409354; van den Brand JAJG, 2014, CLIN J AM SOC NEPHRO, V9, P1066, DOI 10.2215/CJN.08880813; Xie QH, 2015, AM J NEPHROL, V41, P345, DOI 10.1159/000431331	28	48	55	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173201	10.1371/journal.pone.0173201	http://dx.doi.org/10.1371/journal.pone.0173201			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257452	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100075
J	Friedrich, N; Pietzner, M; Cannet, C; Thuesen, BH; Hansen, T; Wallaschofski, H; Grarup, N; Skaaby, T; Budde, K; Pedersen, O; Nauck, M; Linneberg, A				Friedrich, Nele; Pietzner, Maik; Cannet, Claire; Thuesen, Betina H.; Hansen, Torben; Wallaschofski, Henri; Grarup, Niels; Skaaby, Tea; Budde, Kathrin; Pedersen, Oluf; Nauck, Matthias; Linneberg, Allan			Urinary metabolomics reveals glycemic and coffee associated signatures of thyroid function in two population-based cohorts	PLOS ONE			English	Article							IFCC WORKING GROUP; ASYMMETRIC DIMETHYLARGININE; HORMONE REGULATION; FUNCTION TESTS; IODINE INTAKE; METABOLISM; 3,5-DIIODOTHYRONINE; STANDARDIZATION; GLUCONEOGENESIS; THYROTOXICOSIS	Background Triiodothyronine (T3) and thyroxine (T4) as the main secretion products of the thyroid affect nearly every human tissue and are involved in a broad range of processes ranging from energy expenditure and lipid metabolism to glucose homeostasis. Metabolomics studies outside the focus of clinical manifest thyroid diseases are rare. The aim of the present investigation was to analyze the cross-sectional and longitudinal associations of urinary metabolites with serum free T4 (FT4) and thyroid-stimulating hormone (TSH). Methods Urine Metabolites of participants of the population-based studies Inter99 (n = 5620) and Health2006/Health2008 (n = 3788) were analyzed by H-1-NMR spectroscopy. Linear or mixed linear models were used to detect associations between urine metabolites and thyroid function. Results Cross-sectional analyses revealed positive relations of alanine, trigonelline and lactic acid with FT4 and negative relations of dimethylamine, glucose, glycine and lactic acid with log (TSH). In longitudinal analyses, lower levels of alanine, dimethylamine, glycine, lactic acid and N, N-dimethylglycine were linked to a higher decline in FT4 levels over time, whereas higher trigonelline levels were related to a higher FT4 decline. Moreover, the risk of hypothyroidism was higher in subjects with high baseline trigonelline or low lactic acid, alanine or glycine values. Conclusion The detected associations mainly emphasize the important role of thyroid hormones in glucose homeostasis. In addition, the predictive character of these metabolites might argue for a potential feedback of the metabolic state on thyroid function. Besides known metabolic consequences of TH, the link to the urine excretion of trigonelline, a marker of coffee consumption, represents a novel finding of this study and given the ubiquitous consumption of coffee requires further research.	[Friedrich, Nele; Thuesen, Betina H.; Skaaby, Tea; Linneberg, Allan] Capital Reg Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Friedrich, Nele; Pietzner, Maik; Wallaschofski, Henri; Budde, Kathrin; Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Cannet, Claire] Bruker BioSpin, Rheinstetten, Germany; [Hansen, Torben; Grarup, Niels; Pedersen, Oluf] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Sect Metab Genet, Copenhagen, Denmark; [Wallaschofski, Henri] Private Practice Endocrinol, Erfurt, Germany; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, Copenhagen, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark	Greifswald Medical School; Bruker Corporation; Bruker BioSpin GmbH; Novo Nordisk Foundation; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Friedrich, N (corresponding author), Capital Reg Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark.; Friedrich, N (corresponding author), Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany.	nele.friedrich@uni-greifswald.de	Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Grarup, Niels/K-2807-2015	Pedersen, Oluf/0000-0002-3321-3972; Grarup, Niels/0000-0001-5526-1070; Pietzner, Maik/0000-0003-3437-9963; Hansen, Torben/0000-0001-8748-3831; Thuesen, Betina/0000-0001-9772-4344; Linneberg, Allan/0000-0002-0994-0184	Danish Medical Research Council; Danish Centre for Evaluation and Health Technology Assessment; Novo Nordisk; Copenhagen County; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus foundation; lb Henriksens foundation; Beckett foundation; Velux Foundation; Danish Medical Research Council, Danish Agency for Science, Technology and Innovation; Aase and Ejner Danielsens Foundation; ALK-Abello NS (Hash Im, Denmark); Timber Merchant Vilhelm Bangs Foundation; MEKOS Laboratories (Denmark); Research Centre for Prevention and Health, the Capital Region of Denmark; European Union [657595]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Centre for Evaluation and Health Technology Assessment; Novo Nordisk(Novo Nordisk); Copenhagen County; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus foundation; lb Henriksens foundation; Beckett foundation; Velux Foundation(Velux Fonden); Danish Medical Research Council, Danish Agency for Science, Technology and Innovation(Danish Medical Research Council); Aase and Ejner Danielsens Foundation; ALK-Abello NS (Hash Im, Denmark); Timber Merchant Vilhelm Bangs Foundation; MEKOS Laboratories (Denmark); Research Centre for Prevention and Health, the Capital Region of Denmark; European Union(European Commission)	We would like to thank the participants in the Inter99, Health2006 and Health2008 cohort, all members of the Inter99/Health2006/Health2008 staff at Research Centre for Prevention and Health and The Steering Committee of the Inter99 study. The Inter99 study was supported by The Danish Medical Research Council, The Danish Centre for Evaluation and Health Technology Assessment, Novo Nordisk, Copenhagen County, The Danish Heart Foundation, The Danish Pharmaceutical Association, Augustinus foundation, lb Henriksens foundation and Beckett foundation. Establishment of the Health2006/Health2008 cohort was financially supported by The Velux Foundation; The Danish Medical Research Council, Danish Agency for Science, Technology and Innovation; The Aase and Ejner Danielsens Foundation; ALK-Abello NS (Hash Im, Denmark), Timber Merchant Vilhelm Bangs Foundation, MEKOS Laboratories (Denmark), and Research Centre for Prevention and Health, the Capital Region of Denmark. This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skfodowska-Curie Grant Agreement number 657595. Bruker BioSpin supports the current study in form of metabolite quantification for the NMR measurements, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Acheson KJ, 2004, AM J CLIN NUTR, V79, P40; Arikan E, 2007, J ENDOCRINOL INVEST, V30, P186, DOI 10.1007/BF03347423; Benvenga S, 2008, THYROID, V18, P293, DOI 10.1089/thy.2007.0222; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002; Cappelli C, 2014, EUR J ENDOCRINOL, V170, P95, DOI 10.1530/EJE-13-0693; Constantinou C, 2011, J PROTEOME RES, V10, P869, DOI 10.1021/pr100699m; FABER J, 1982, J CLIN ENDOCR METAB, V55, P8, DOI 10.1210/jcem-55-1-8; FELT V, 1982, HORM METAB RES, V14, P596, DOI 10.1055/s-2007-1019090; Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257; Gu LQ, 2011, ENDOCRINE, V39, P266, DOI 10.1007/s12020-011-9436-7; HARPER AE, 1956, AM J PHYSIOL, V184, P457, DOI 10.1152/ajplegacy.1956.184.3.457; Hermenegildo C, 2002, J CLIN ENDOCR METAB, V87, P5636, DOI 10.1210/jc.2002-020905; Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009; HIRATANI M, 1982, J ALLERGY CLIN IMMUN, V70, P481, DOI 10.1016/0091-6749(82)90012-4; Hu XL, 2011, ARTERIOSCL THROM VAS, V31, P1540, DOI 10.1161/ATVBAHA.110.222638; Ittermann T, 2016, THYROID, V26, P212, DOI 10.1089/thy.2015.0385; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Jourdan C, 2014, METABOLOMICS, V10, P152, DOI 10.1007/s11306-013-0563-4; Klieverik LP, 2008, AM J PHYSIOL-ENDOC M, V294, pE513, DOI 10.1152/ajpendo.00659.2007; Lang R, 2011, MOL NUTR FOOD RES, V55, P1613, DOI 10.1002/mnfr.201000656; Lang R, 2010, ANAL CHEM, V82, P1486, DOI 10.1021/ac902616k; Laurberg P, 1998, J CLIN ENDOCR METAB, V83, P765, DOI 10.1210/jc.83.3.765; Lehmphul I, 2014, THYROID, V24, P1350, DOI 10.1089/thy.2013.0688; Leiper JM, 2006, EUR J CLIN PHARMACOL, V62, P33, DOI 10.1007/s00228-005-0013-y; Lopez M, 2013, TRENDS MOL MED, V19, P418, DOI 10.1016/j.molmed.2013.04.004; Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/c4fo00042k, 10.1039/C4FO00042K]; Mariani LH, 2012, J AM SOC NEPHROL, V23, P22, DOI 10.1681/ASN.2010070766; Millatt LJ, 2000, EUR J ENDOCRINOL, V142, P493, DOI 10.1530/eje.0.1420493; Mitchell SC, 2008, FOOD CHEM TOXICOL, V46, P1734, DOI 10.1016/j.fct.2008.01.010; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Ogawa M, 2011, IND HEALTH, V49, P195, DOI 10.2486/indhealth.MS1164; Pietzner M, 2015, EUR THYROID J, V4, P92, DOI 10.1159/000381308; Pietzner M, 2015, METABOLOMICS, V11, P1316, DOI 10.1007/s11306-015-0788-5; RABE KF, 1995, EUR RESPIR J, V8, P637; Rasmussen LB, 2002, BRIT J NUTR, V87, P61, DOI 10.1079/BJN2001474; Ricos C, 1999, SCAND J CLIN LAB INV, V59, P491; SANDLER MP, 1983, J CLIN ENDOCR METAB, V56, P479, DOI 10.1210/jcem-56-3-479; Shibata T, 2003, POULTRY SCI, V82, P207, DOI 10.1093/ps/82.2.207; SINGH SP, 1978, ENDOCRINOLOGY, V102, P182, DOI 10.1210/endo-102-1-182; Sinha RA, 2014, TRENDS ENDOCRIN MET, V25, P538, DOI 10.1016/j.tem.2014.07.001; Thienpont LM, 2010, CLIN CHEM, V56, P912, DOI 10.1373/clinchem.2009.140194; Thienpont LM, 2010, CLIN CHEM, V56, P902, DOI 10.1373/clinchem.2009.140178; Tsikas D, 2007, J CHROMATOGR B, V851, P1, DOI 10.1016/j.jchromb.2007.02.020; Vita R, 2013, ENDOCRINE, V43, P154, DOI 10.1007/s12020-012-9772-2; WAHREN J, 1981, J CLIN INVEST, V67, P1056, DOI 10.1172/JCI110117; Wilson A, 2016, CURR OPIN LIPIDOL, V27, P148, DOI 10.1097/MOL.0000000000000274; Wojakowska A, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/258763; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055599; Wu S, 2013, J PHARMACEUT BIOMED, V72, P109, DOI 10.1016/j.jpba.2012.09.030; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; ZHANG AQ, 1995, CLIN CHIM ACTA, V233, P81, DOI 10.1016/0009-8981(95)91628-E	53	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173078	10.1371/journal.pone.0173078	http://dx.doi.org/10.1371/journal.pone.0173078			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253303	Green Published, gold, Green Submitted			2022-12-26	WOS:000396011300069
J	Guyomard-Rabenirina, S; Dartron, C; Falord, M; Sadikalay, S; Ducat, C; Richard, V; Breurec, S; Gros, O; Talarmin, A				Guyomard-Rabenirina, Stephanie; Dartron, Celia; Falord, Melanie; Sadikalay, Syndia; Ducat, Celia; Richard, Vincent; Breurec, Sebastien; Gros, Olivier; Talarmin, Antoine			Resistance to antimicrobial drugs in different surface waters and wastewaters of Guadeloupe	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; ESCHERICHIA-COLI; WASTE-WATER; ANTIBIOTIC-RESISTANCE; QUINOLONE RESISTANCE; ENTEROBACTERIACEAE; BACTERIA; EFFLUENT; MUNICIPAL; GENES	Objective The first aim of this study was to evaluate the antimicrobial resistance of Enterobacteriaceae in different water environments of Guadeloupe and especially those impacted by waste water treatment plants (WWTP) effluents. The second objective was to characterize the genetic basis for antibiotic resistance of extended-spectrum beta-lactamase (ESBL) and AmpC beta-lactamase producing Enterobacteriaceae isolates (ESBLE and AmpCE). Methods We have collected 70 surface waters (river and sea samples) impacted or not by WWTP and 18 waste waters from 2 WWTPs in 2012 and 2013. We i) determined the total and resistant bacterial counts and ii) tested isolated Enterobacteriaceae for their antimicrobial susceptibility. We also studied the genetic basis for antibiotic resistance of ESBLE and AmpCE, and the genetic background of Escherichia coli. Results In rivers, contamination with Escherichia coli and antibiotic resistant coliforms (ARC) increased from the source to the mouth. Highest levels of river contamination with E. coli (9.26 x 10(5) MPN/100mL) and ARC (2.26 x 10(8) CFU/mL) were observed in surface water sampled near the discharge. A total of 246 Enterobacteriaceae strains resistant to antibiotics were isolated, mostly from waste waters and from river water collected near the discharge. Among these strains, 33 were Extended Spectrum Beta Lactamase (ESBLE) and 8 E. coli were AmpC beta-lactamase producers. All the ESBLE were isolated from waste waters or from river water collected near the discharge. The bla(CTX-M) gene was present in 29 of the 33 ESBLE strains, with 24 belonging to group 1. Numerous strains (68.7%) showed more than one acquired antibiotic resistance mechanism. E. coli strains belonged to different phylogenetic groups; among the B2 group, most strains belonged to the ST131 clone. Conclusion Our results demonstrated that many human activities can supply antibiotic-resistant bacteria in surface water. Nevertheless, WWTPs were the most important supplier of ESBLE in water environment of Guadeloupe.	[Guyomard-Rabenirina, Stephanie; Falord, Melanie; Sadikalay, Syndia; Ducat, Celia; Breurec, Sebastien; Talarmin, Antoine] Inst Pasteur Guadeloupe, Unite Environm Sante, Les Abymes, Guadeloupe, France; [Dartron, Celia; Gros, Olivier] Univ Nice Sophia Antipolis, Univ Antilles, UPMC Univ Paris 06, Sorbonne Univ,EPS,IBPS,CNRS, Paris, France; [Richard, Vincent] Inst Pasteur Nouvelle Caledonie, BP61, Noumea 98845, New Caledonia; [Breurec, Sebastien] Univ Antilles, Pointe A Pitre, Guadeloupe, France; [Breurec, Sebastien] Ctr Hosp Univ Pointe A Pitre, Lab Microbiol Clin & Environm, Pointe A Pitre, Guadeloupe, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Cote d'Azur; Universite des Antilles; CHU Guadeloupe	Guyomard-Rabenirina, S (corresponding author), Inst Pasteur Guadeloupe, Unite Environm Sante, Les Abymes, Guadeloupe, France.	sguyomard@pasteur-guadeloupe.fr		Vincent, RICHARD/0000-0002-6961-1753	French overseas ministry; European Union [FEDER FED-1-1.4 32932]	French overseas ministry; European Union(European Commission)	This work was supported by the French overseas ministry and by grant FEDER FED-1-1.4 32932 from the European Union. https://www.europe-guadeloupe.fr/feder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2010, SCI TOTAL ENVIRON, V408, P6192, DOI 10.1016/j.scitotenv.2010.08.055; Amos GCA, 2014, J ANTIMICROB CHEMOTH, V69, P1785, DOI 10.1093/jac/dku079; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2015, ANTIMICROBIALS AGR E; Arlet G, 1997, FEMS MICROBIOL LETT, V152, P163, DOI 10.1111/j.1574-6968.1997.tb10423.x; Baquero F, 2015, EVOL APPL, V8, P223, DOI 10.1111/eva.12235; Ben Said L, 2016, SCI TOTAL ENVIRON, V550, P1103, DOI 10.1016/j.scitotenv.2016.01.042; Blaak H, 2014, VET MICROBIOL, V171, P448, DOI 10.1016/j.vetmic.2014.03.007; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Brechet C, 2014, CLIN INFECT DIS, V58, P1658, DOI 10.1093/cid/ciu190; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2009, J ANTIMICROB CHEMOTH, V64, P274, DOI 10.1093/jac/dkp194; Colomer-Lluch M, 2012, J ANTIMICROB CHEMOTH, P1; Comite de Bassin de la Guadeloupe, 2010, GEST EAU GUAD SOURC; da Silva MF, 2006, FEMS MICROBIOL ECOL, V55, P322, DOI 10.1111/j.1574-6941.2005.00032.x; Diwan V, 2012, J ANTIMICROB CHEMOTH, V67, P857, DOI 10.1093/jac/dkr564; Eckert C, 2004, ANTIMICROB AGENTS CH, V48, P1249, DOI 10.1128/AAC.48.4.1249-1255.2004; Galvin S, 2010, APPL ENVIRON MICROB, V76, P4772, DOI 10.1128/AEM.02898-09; Goni-Urriza M, 2000, APPL ENVIRON MICROB, V66, P125, DOI 10.1128/AEM.66.1.125-132.2000; Graham DW, 2011, ENVIRON SCI TECHNOL, V45, P418, DOI 10.1021/es102473z; Guardabassi L, 2002, WATER RES, V36, P1955, DOI 10.1016/S0043-1354(01)00429-8; Guessennd N, 2008, PATHOL BIOL, V56, P439, DOI 10.1016/j.patbio.2008.07.025; Guyomard-Rabenirina S, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0749-9; Harris S, 2014, SCI TOTAL ENVIRON, V468, P1078, DOI 10.1016/j.scitotenv.2013.09.017; Herindrainy P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022738; Huijbers PMC, 2015, ENVIRON SCI TECHNOL, V49, P11993, DOI 10.1021/acs.est.5b02566; Korzeniewska E, 2013, ECOTOX ENVIRON SAFE, V91, P96, DOI 10.1016/j.ecoenv.2013.01.014; Lu SY, 2010, APPL ENVIRON MICROB, V76, P5972, DOI 10.1128/AEM.00711-10; Martinez JL, 2009, P ROY SOC B-BIOL SCI, V276, P2521, DOI 10.1098/rspb.2009.0320; Mathers AJ, 2015, CLIN MICROBIOL REV, V28, P565, DOI 10.1128/CMR.00116-14; McArthur JV, 2000, APPL ENVIRON MICROB, V66, P3722, DOI 10.1128/AEM.66.9.3722-3726.2000; Mokracka J, 2012, WATER RES, V46, P3353, DOI 10.1016/j.watres.2012.03.037; Navidinia M, 2014, BRAZ J MICROBIOL, V45, P509, DOI 10.1590/S1517-83822014000200019; Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P11541, DOI 10.1021/es302657r; Roderova M, 2016, NEW MICROBIOL, V39, P124; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Saladin M, 2002, FEMS MICROBIOL LETT, V209, P161, DOI 10.1016/S0378-1097(02)00484-6; Servais P, 2009, SCI TOTAL ENVIRON, V408, P365, DOI 10.1016/j.scitotenv.2009.09.042; Societe Francaise de Microbiologie, 2013, COM ANT SOC FRANC MI; Watkinson AJ, 2007, APPL ENVIRON MICROB, V73, P5667, DOI 10.1128/AEM.00763-07; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; Zhang YL, 2009, SCI TOTAL ENVIRON, V407, P3702, DOI 10.1016/j.scitotenv.2009.02.013; [No title captured]	45	27	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173155	10.1371/journal.pone.0173155	http://dx.doi.org/10.1371/journal.pone.0173155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253356	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300083
J	Gravett, N; Bhagwandin, A; Sutcliffe, R; Landen, K; Chase, MJ; Lyamin, OI; Siegel, JM; Manger, PR				Gravett, Nadine; Bhagwandin, Adhil; Sutcliffe, Robert; Landen, Kelly; Chase, Michael J.; Lyamin, Oleg I.; Siegel, Jerome M.; Manger, Paul R.			Inactivity/sleep in two wild free-roaming African elephant matriarchs - Does large body size make elephants the shortest mammalian sleepers?	PLOS ONE			English	Article							GIRAFFE GIRAFFA-CAMELOPARDALIS; CHOBE NATIONAL-PARK; PHYLOGENETIC ANALYSIS; BEHAVIORAL SLEEP; MEMORY CONSOLIDATION; NOCTURNAL BEHAVIOR; LOXODONTA-AFRICANA; PROCAVIA-CAPENSIS; NEURAL SYSTEMS; ROCK HYRAX	The current study provides details of sleep (or inactivity) in two wild, free-roaming African elephant matriarchs studied in their natural habitat with remote monitoring using an actiwatch subcutaneously implanted in the trunk, a standard elephant collar equipped with a GPS system and gyroscope, and a portable weather station. We found that these two elephants were polyphasic sleepers, had an average daily total sleep time of 2 h, mostly between 02:00 and 06:00, and displayed the shortest daily sleep time of any mammal recorded to date. Moreover, these two elephants exhibited both standing and recumbent sleep, but only exhibited recumbent sleep every third or fourth day, potentially limiting their ability to enter REM sleep on a daily basis. In addition, we observed on five occasions that the elephants went without sleep for up to 46 h and traversed around 30 km in 10 h, possibly due to disturbances such as potential predation or poaching events, or a bull elephant in musth. They exhibited no form of sleep rebound following a night without sleep. Environmental conditions, especially ambient air temperature and relative humidity, analysed as wet-bulb globe temperature, reliably predict sleep onset and offset times. The elephants selected novel sleep sites each night and the amount of activity between sleep periods did not affect the amount of sleep. A number of similarities and differences to studies of elephant sleep in captivity are noted, and specific factors shaping sleep architecture in elephants, on various temporal scales, are discussed.	[Gravett, Nadine; Bhagwandin, Adhil; Manger, Paul R.] Univ Witwatersrand, Fac Hlth Sci, Sch Anat Sci, Johannesburg, South Africa; [Sutcliffe, Robert; Landen, Kelly; Chase, Michael J.] Elephants Borders, Kasane, Botswana; [Lyamin, Oleg I.; Siegel, Jerome M.] Univ Calif Los Angeles, Dept Psychiat, Sepulveda VAMC, Neurobiol Res 151A3, Los Angeles, CA USA	University of Witwatersrand; University of California System; University of California Los Angeles	Manger, PR (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Anat Sci, Johannesburg, South Africa.	Paul.Manger@wits.ac.za	Lyamin, Oleg/AAO-4881-2020	Lyamin, Oleg/0000-0003-2049-0943; Bhagwandin, Adhil/0000-0002-7748-0095; Bhagwandin, Adhil/0000-0003-0618-3314	National Research Foundation of South Africa [CPR20110602000019125, 81822]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034748] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001753] Funding Source: NIH RePORTER	National Research Foundation of South Africa(National Research Foundation - South Africa); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	This research was funded by the National Research Foundation of South Africa (www.nrf.ac.za) (reference: CPR20110602000019125, grant number: 81822, awarded to PRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1980, APPL ANIM ETHOL, V6, P257, DOI 10.1016/0304-3762(80)90027-9; ALLISON T, 1976, SCIENCE, V194, P732, DOI 10.1126/science.982039; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; BENEDICT FRANCIS G., 1938, JOUR MAMMAL, V19, P175, DOI 10.2307/1374612; Brockett RC, 1999, ZOO BIOL, V18, P101, DOI 10.1002/(SICI)1098-2361(1999)18:2&lt;101::AID-ZOO2&gt;3.0.CO;2-4; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Capellini I, 2008, FUNCT ECOL, V22, P847, DOI 10.1111/j.1365-2435.2008.01449.x; Capellini I, 2008, EVOLUTION, V62, P1764, DOI 10.1111/j.1558-5646.2008.00392.x; Chase MJ, 2016, PEERJ, V4, DOI 10.7717/peerj.2354; DALLAIRE A, 1974, PHYSIOL BEHAV, V12, P789, DOI 10.1016/0031-9384(74)90015-8; DALLAIRE A, 1986, VET CLIN N AM-EQUINE, V2, P591, DOI 10.1016/S0749-0739(17)30708-3; Davimes JG, 2016, J BIOL RHYTHM, V31, P365, DOI 10.1177/0748730416645729; Dell LA, 2016, J COMP NEUROL, V524, P2018, DOI 10.1002/cne.23931; Dell LA, 2016, J COMP NEUROL, V524, P2036, DOI 10.1002/cne.23930; Dell LA, 2012, J CHEM NEUROANAT, V44, P98, DOI 10.1016/j.jchemneu.2012.06.001; Gravett N, 2012, BRAIN BEHAV EVOLUT, V79, P155, DOI 10.1159/000335342; Gravett N, 2009, J CHEM NEUROANAT, V38, P57, DOI 10.1016/j.jchemneu.2009.02.005; GUY PR, 1976, E AFR WILDL J, V14, P285; Holdgate MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153301; Horback KM, 2014, ZOO BIOL, V33, P403, DOI 10.1002/zoo.21160; Hutchinson JR, 2006, J EXP BIOL, V209, P3812, DOI 10.1242/jeb.02443; Joubert D, 2006, AFR J ECOL, V44, P279, DOI 10.1111/j.1365-2028.2006.00626.x; Khume W., 1963, INT ZOO YB, V4, P113; Kurt F., 1960, MAMMALIA, V24, P259; LAWS R. M., 1966, EAST AFR WILDLIFE J, V4, P1; Lesku JA, 2006, AM NAT, V168, P441, DOI 10.1086/506973; Liljegren James C., 2008, Journal of Occupational and Environmental Hygiene, V5, P645, DOI 10.1080/15459620802310770; Lima SL, 2005, ANIM BEHAV, V70, P723, DOI 10.1016/j.anbehav.2005.01.008; Lyamin OI, 2000, J SLEEP RES, V9, P261; Lyamin OI, 2008, NEUROSCI BIOBEHAV R, V32, P1451, DOI 10.1016/j.neubiorev.2008.05.023; Manger PR, 2013, BRAIN BEHAV EVOLUT, V82, P68, DOI 10.1159/000352056; Manger PR, 2009, J NEUROSCI METH, V179, P16, DOI 10.1016/j.jneumeth.2009.01.001; Maseko BC, 2013, BRAIN BEHAV EVOLUT, V82, P83, DOI 10.1159/000352004; McKay G.M., 1973, Smithsonian Contributions to Zoology, VNo. 125, P1; MUKHAMETOV LM, 1992, EXPERIENTIA, V48, P417, DOI 10.1007/BF01923447; Patzke N, 2014, BRAIN STRUCT FUNCT, V219, P1587, DOI 10.1007/s00429-013-0587-6; Power RJ, 2009, AFR ZOOL, V44, P36, DOI 10.3377/004.044.0104; Pryaslova JP, 2009, BEHAV BRAIN RES, V201, P80, DOI 10.1016/j.bbr.2009.01.033; Rattenborg NC, 2008, BIOL LETTERS, V4, P402, DOI 10.1098/rsbl.2008.0203; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; Roth TC, 2006, J SLEEP RES, V15, P395, DOI 10.1111/j.1365-2869.2006.00559.x; Shoshani J, 2006, BRAIN RES BULL, V70, P124, DOI 10.1016/j.brainresbull.2006.03.016; Siegel JM, 2001, SCIENCE, V294, P1058, DOI 10.1126/science.1063049; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Stull R, 2011, J APPL METEOROL CLIM, V50, P2267, DOI 10.1175/JAMC-D-11-0143.1; TOBLER I, 1995, BEHAV BRAIN RES, V69, P35, DOI 10.1016/0166-4328(95)00025-O; TOBLER I, 1992, SLEEP, V15, P1; Tobler I, 1996, J SLEEP RES, V5, P21, DOI 10.1046/j.1365-2869.1996.00010.x; Vorster AP, 2015, NEUROSCI BIOBEHAV R, V50, P103, DOI 10.1016/j.neubiorev.2014.09.020; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Williams DC, 2008, J VET INTERN MED, V22, P630, DOI 10.1111/j.1939-1676.2008.0096.x; Wilson ML, 2006, ZOO BIOL, V25, P173, DOI 10.1002/zoo.20084; WYATT J R, 1974, East African Wildlife Journal, V12, P273; Yetish G, 2015, CURR BIOL, V25, P2862, DOI 10.1016/j.cub.2015.09.046; Zepelin H, 2000, PRINCIPLES PRACTICE, P82	56	48	48	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0171903	10.1371/journal.pone.0171903	http://dx.doi.org/10.1371/journal.pone.0171903			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249035	Green Submitted, Green Published, gold			2022-12-26	WOS:000395983500020
J	Schuett, J; Schuett, H; Oberoi, R; Koch, AK; Pretzer, S; Luchtefeld, M; Schieffer, B; Grote, K				Schuett, Jutta; Schuett, Harald; Oberoi, Raghav; Koch, Ann-Kathrin; Pretzer, Silke; Luchtefeld, Maren; Schieffer, Bernhard; Grote, Karsten			NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells	FASEB JOURNAL			English	Article						pattern recognition receptors; reactive oxygen species; immune factors; innate immunity; endothelial cell biology	NF-KAPPA-B; OXYGEN SPECIES PRODUCTION; RECEPTOR FAMILY; ACTIVATION; EXPRESSION; SUPEROXIDE; DISEASE; TLR2; ANGIOGENESIS; LIPOPEPTIDE	NADPH oxidase-generated reactive oxygen species (ROS) from immune cells are well known to be important for pathogen killing in response to TLR ligands. Here, we investigated a new aspect of NADPH oxidase in the TLR2/6-induced release of the immunologically relevant GM-CSF by endothelial cells. Stimulation of human endothelial cells with TLR2/6 agonist, MALP-2 (macrophage-activating lipopeptide of 2 kDa), induced NADPH oxidase activation and ROS formation. Inhibition by ROS scavengers and NADPH oxidase inhibitors blocked MALP-2-induced GM-CSF release. NADPH oxidase activators or ROS donors alone did not result in GM-CSF secretion; however, additional superoxide supply augmented MALP-2-induced GM-CSF secretion and restored GM-CSF levels after NADPH oxidase inhibition. MALP-2-dependent NF-kappa B activation was suppressed by NADPH oxidase inhibition, and inhibition of NF-kB completely blunted MALP-2-induced GM-CSF release. Vascular explants from mice that were deficient for the NADPH oxidase subunit p47(phox) showed diminished intimal superoxide production and GM-CSF release after ex vivo stimulation with MALP-2. Moreover, an increase in circulating progenitor cells after MALP-2 injection was completely abolished in p47(phox)-knockout mice. Finally, MALP-2 stimulation increased mRNA expression of the major subunit NADPH oxidase, (Nox)2, in endothelial cells, and Nox2 inhibition prevented MALP-2-induced GM-CSF release. Our findings identify a Nox2-containing NADPH oxidase as a crucial regulator of the immunologic important growth factor GM-CSF after TLR2/6 stimulation in endothelial cells.	[Schuett, Jutta; Schuett, Harald; Oberoi, Raghav; Koch, Ann-Kathrin; Luchtefeld, Maren; Schieffer, Bernhard; Grote, Karsten] Philipps Univ, Dept Cardiol & Angiol, Hans Meerwein Str 2, D-35043 Marburg, Germany; [Pretzer, Silke] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany	Philipps University Marburg; Hannover Medical School	Grote, K (corresponding author), Philipps Univ, Dept Cardiol & Angiol, Hans Meerwein Str 2, D-35043 Marburg, Germany.	karsten.grote@staff.uni-marburg.de		Vlacil, Ann-Kathrin/0000-0001-9743-0290; Grote, Karsten/0000-0001-7914-3159	German Research Foundation (DFG); Clinical Research Group [KFO 136, GR 2717/3-1]	German Research Foundation (DFG)(German Research Foundation (DFG)); Clinical Research Group	The authors thank Prof. Schinzel (Vasopharm GmbH, Wurzburg, Germany) for providing VAS2870. The authors also thank Danial Beppler (Philipps-University) and Mirja Sirisko (Hannover Medical School) for excellent technical assistance. This work was supported by a grant from the German Research Foundation (DFG), Clinical Research Group (KFO 136), GR 2717/3-1 (to K.G. and B.S.).	BABIOR BM, 1976, J CLIN INVEST, V58, P989, DOI 10.1172/JCI108553; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; Baldridge CW, 1933, AM J PHYSIOL, V103, P235, DOI 10.1152/ajplegacy.1932.103.1.235; Bosco EE, 2012, CHEM BIOL, V19, P228, DOI 10.1016/j.chembiol.2011.12.017; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Dinauer MC, 1997, J IMMUNOL, V158, P5581; Dupre-Crochet S, 2013, J LEUKOCYTE BIOL, V94, P657, DOI 10.1189/jlb.1012544; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Grote K, 2013, EUR CELLS MATER, V26, P66, DOI 10.22203/eCM.v026a05; Grote K, 2013, ARTERIOSCL THROM VAS, V33, P2097, DOI 10.1161/ATVBAHA.113.301799; Grote K, 2010, BLOOD, V115, P2543, DOI 10.1182/blood-2009-05-224402; Hercus TR, 2012, GROWTH FACTORS, V30, P63, DOI 10.3109/08977194.2011.649919; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jones SA, 1996, AM J PHYSIOL-HEART C, V271, pH1626, DOI 10.1152/ajpheart.1996.271.4.H1626; Kim JH, 2008, FREE RADICAL BIO MED, V45, P885, DOI 10.1016/j.freeradbiomed.2008.06.019; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Lelli A, 2013, GLIA, V61, P1542, DOI 10.1002/glia.22540; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Park HS, 2006, CARDIOVASC RES, V72, P447, DOI 10.1016/j.cardiores.2006.09.012; QUESENBERRY PJ, 1980, BLOOD, V56, P1060, DOI 10.1182/blood.V56.6.1060.1060; SASADA M, 1983, J BIOL CHEM, V258, P9631; Seki E, 2005, HEPATOLOGY, V41, P443, DOI 10.1002/hep.20603; Shimizu T, 2002, EUR J HAEMATOL, V68, P382, DOI 10.1034/j.1600-0609.2002.01627.x; Simon F, 2009, J HYPERTENS, V27, P1202, DOI 10.1097/HJH.0b013e328329e31c; Spiekermann S, 2003, CIRCULATION, V107, P1383, DOI 10.1161/01.CIR.0000056762.69302.46; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; van Nieuwenhuijze A, 2013, MOL IMMUNOL, V56, P675, DOI 10.1016/j.molimm.2013.05.002; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Yang CS, 2009, J IMMUNOL, V182, P3696, DOI 10.4049/jimmunol.0802217; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x; Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139	37	15	17	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2612	2624		10.1096/fj.201600729R	http://dx.doi.org/10.1096/fj.201600729R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28274989				2022-12-26	WOS:000401553400032
J	Hansson, B; Rippe, C; Kotowska, D; Wasserstrom, S; Sall, J; Goransson, O; Sward, K; Stenkula, KG				Hansson, Bjorn; Rippe, Catarina; Kotowska, Dorota; Wasserstrom, Sebastian; Sall, Johanna; Goransson, Olga; Sward, Karl; Stenkula, Karin G.			Rosiglitazone drives cavin-2/SDPR expression in adipocytes in a CEBP alpha-dependent manner	PLOS ONE			English	Article							CAVIN FAMILY; INSULIN-RESISTANCE; CAVEOLAE; RECEPTOR; TRANSCRIPTION; PTRF; MUTATIONS; DYNAMICS; SURFACE; CELLS	Caveolae are abundant adipocyte surface domains involved in insulin signaling, membrane trafficking and lipid homeostasis. Transcriptional control mechanisms for caveolins and cavins, the building blocks of caveolae, are thus arguably important for adipocyte biology and studies in this area may give insight into insulin resistance and diabetes. Here we addressed the hypothesis that one of the less characterized caveolar components, cavin-2 (SDPR), is controlled by CCAAT/Enhancer Binding Protein (CEBP alpha) and Peroxisome Proliferator- Activated Receptor Gamma (PPARG). Using human mRNA expression data we found that SDPR correlated with PPARG in several tissues. This was also observed during differentiation of 3T3-L1 fibroblasts into adipocytes. Treatment of 3T3-L1-derived adipocytes with the PPAR gamma-activator Rosiglitazone increased SDPR and CEBPa expression at both the mRNA and protein levels. Silencing of CEBPa antagonized these effects. Further, adenoviral expression of PPAR gamma/CEBP alpha or Rosiglitazone-treatment increased SDPR expression in primary rat adipocytes. The myocardin family coactivator MKL1 was recently shown to regulate SDPR expression in human coronary artery smooth muscle cells. However, we found that actin depolymerization, known to inhibit MKL1 and MKL2, was without effect on SDPR mRNA levels in adipocytes, even though overexpression of MKL1 and MKL2 had the capacity to increase caveolins and cavins and to repress PPAR gamma/CEBP alpha. Altogether, this work demonstrates that CEBPa expression and PPAR gamma-activity promote SDPR transcription and further supports the emerging notion that PPAR gamma/CEBP alpha and MKL1/MKL2 are antagonistic in adipocytes.	[Hansson, Bjorn; Rippe, Catarina; Kotowska, Dorota; Wasserstrom, Sebastian; Sall, Johanna; Goransson, Olga; Sward, Karl; Stenkula, Karin G.] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Stenkula, KG (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	karin.stenkula@med.lu.se	Säll, Johanna/C-1083-2015; Rippe, Catarina/B-4110-2010	Säll, Johanna/0000-0001-7337-4140; Rippe, Catarina/0000-0001-8621-9836; Goransson, Olga/0000-0002-7209-8022; Stenkula, Karin/0000-0002-0739-1150; Wasserstrom, Sebastian/0000-0001-9755-5974	Swedish Research Council [2013-3542, K2015-65X-22662-01-3]; Novo Nordisk Foundation; Diabetes Foundation; Magnus Bergvall Foundation; Crafoord Foundation; Albert Pahlsson Foundation; Royal Physiographic Society in Lund; Novo Nordisk Fonden [NNF15OC0016472] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Diabetes Foundation; Magnus Bergvall Foundation; Crafoord Foundation; Albert Pahlsson Foundation; Royal Physiographic Society in Lund; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was financially supported by the Swedish Research Council (2013-3542 to K.St., K2015-65X-22662-01-3 to K.Sw.), The Novo Nordisk Foundation, Diabetes Foundation, Magnus Bergvall Foundation, The Crafoord Foundation, Albert Pahlsson Foundation, and the Royal Physiographic Society in Lund.	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Bastiani M, 2010, J CELL SCI, V123, P3831, DOI 10.1242/jcs.070102; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Breen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034516; Burgermeister E, 2003, ONCOGENE, V22, P3888, DOI 10.1038/sj.onc.1206625; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Gustincich S, 1999, GENOMICS, V57, P120, DOI 10.1006/geno.1998.5733; Haakonsson AK, 2013, MOL ENDOCRINOL, V27, P1536, DOI 10.1210/me.2013-1080; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hansen CG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2808; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Henriksson E, 2015, J CELL SCI, V128, P472, DOI 10.1242/jcs.153932; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Karlsson M, 2004, EUR J BIOCHEM, V271, P2471, DOI 10.1111/j.1432-1033.2004.04177.x; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; Kovtun O, 2015, J CELL SCI, V128, P1269, DOI 10.1242/jcs.167866; Krawczyk KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133931; Lindahl M, 2015, J LIPID RES, V56, P2248, DOI 10.1194/jlr.M054767; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; McDonald ME, 2015, CELL, V160, P105, DOI 10.1016/j.cell.2014.12.005; Mineo C, 1998, J CELL BIOL, V141, P601, DOI 10.1083/jcb.141.3.601; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Nassar ZD, 2015, INT REV CEL MOL BIO, V320, P235, DOI 10.1016/bs.ircmb.2015.07.009; Nobusue H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4368; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Oshikawa J, 2004, P NATL ACAD SCI USA, V101, P12670, DOI 10.1073/pnas.0402053101; Panigrahy D, 2002, J CLIN INVEST, V110, P923, DOI 10.1172/JCI200215634; Regazzetti C, 2015, ENDOCRINOLOGY, V156, P789, DOI 10.1210/en.2014-1656; RODBELL M, 1964, J BIOL CHEM, V239, P375; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; Stralfors P, 2012, ADV EXP MED BIOL, V729, P111, DOI 10.1007/978-1-4614-1222-9_8; Talukder MAH, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12736; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X	37	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173412	10.1371/journal.pone.0173412	http://dx.doi.org/10.1371/journal.pone.0173412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278164	gold, Green Published, Green Submitted			2022-12-26	WOS:000396087900088
J	Alibhai, S; Jewell, Z; Evans, J				Alibhai, Sky; Jewell, Zoe; Evans, Jonah			The challenge of monitoring elusive large carnivores: An accurate and cost-effective tool to identify and sex pumas (Puma concolor) from footprints	PLOS ONE			English	Article							TIGERS PANTHERA-TIGRIS; LIONS FELIS-CONCOLOR; INDIVIDUAL TIGERS; COUGAR; IDENTIFICATION; BIOLOGY; TRACKS	Acquiring reliable data on large felid populations is crucial for effective conservation and management. However, large felids, typically solitary, elusive and nocturnal, are difficult to survey. Tagging and following individuals with VHF or GPS technology is the standard approach, but costs are high and these methodologies can compromise animal welfare. Such limitations can restrict the use of these techniques at population or landscape levels. In this paper we describe a robust technique to identify and sex individual pumas from footprints. We used a standardized image collection protocol to collect a reference database of 535 footprints from 35 captive pumas over 10 facilities; 19 females (300 footprints) and 16 males (235 footprints), ranging in age from 1-20 yrs. Images were processed in JMP data visualization software, generating one hundred and twenty three measurements from each footprint. Data were analyzed using a customized model based on a pairwise trail comparison using robust cross-validated discriminant analysis with a Ward's clustering method. Classification accuracy was consistently > 90% for individuals, and for the correct classification of footprints within trails, and > 99% for sex classification. The technique has the potential to greatly augment the methods available for studying puma and other elusive felids, and is amenable to both citizen-science and opportunistic/local community data collection efforts, particularly as the data collection protocol is inexpensive and intuitive.	[Alibhai, Sky; Jewell, Zoe] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Alibhai, Sky; Jewell, Zoe] SAS, JMP Div, Cary, NC 27513 USA; [Alibhai, Sky; Jewell, Zoe] North Carolina State Univ, Dept Mech & Aerosp Engn, Raleigh, NC 27695 USA; [Evans, Jonah] Texas Parks & Wildlife, Austin, TX USA	Duke University; University of North Carolina; North Carolina State University	Jewell, Z (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.; Jewell, Z (corresponding author), SAS, JMP Div, Cary, NC 27513 USA.; Jewell, Z (corresponding author), North Carolina State Univ, Dept Mech & Aerosp Engn, Raleigh, NC 27695 USA.	wildtrack.monitoring@gmail.com		Jewell, Zoe/0000-0002-4915-7952				Alibhai SK, 2001, ORYX, V35, P284, DOI 10.1017/S0030605300032014; Alibhai SK, 2001, J ZOOLOGY; Alibhai Sky K., 2008, Endangered Species Research, V4, P205, DOI 10.3354/esr00067; Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; Beausoleil R. A., 2008, P 9 MOUNT LION WORKS, P205; Beier P, 1996, WILDLIFE SOC B; Carbyn L, 2003, THE SWIFT FOX; Cattet M, 2008, J MAMMALOGY; Choate DM, 2006, WILDLIFE SOC B, V34, P782, DOI 10.2193/0091-7648(2006)34[782:EOCPEI]2.0.CO;2; Creel S., 2002, THE AFRICAN WILD DOG; Davidson GA, 2014, J WILDLIFE MANAGE, V78, P1104, DOI 10.1002/jwmg.758; Dyck MG, 2007, ECOLOGICAL COMPLEXIT; Edwards R. Y., 1959, Murrelet, V40, P14, DOI 10.2307/3534823; Elbroch LM, 2013, WILDLIFE BIOL, V19, P210, DOI 10.2981/12-114; Evans JW, 2009, J WILDLIFE MANAGEMEN; Foster RJ, 2012, J WILDLIFE MANAGEMEN; Funston PJ, 2010, J ZOOL, V281, P56, DOI 10.1111/j.1469-7998.2009.00682.x; Garcia KP, 2010, ZOOL STUD, V49, P577; Gogate MG, 1989, TIGER PUGMARK STUDIE; Grigione MM, 1999, BIOL CONSERV, V88, P25, DOI 10.1016/S0006-3207(98)00096-2; Gu J, 2014, WILDLIFE SOC B; Gu J, 2014, WILDLIFE SOC B, V38, P495, DOI 10.1002/wsb.432; Heilbrun RD, 2006, WILDLIFE SOC B; Herzog CJ, 2007, J WILDLIFE MANAGEMEN; Jewell Z., 2013, CONSERVATION BIOL; Jewell ZC, 2001, J ZOOL, V254, P1, DOI 10.1017/S0952836901000516; Jewell ZC, 2010, ENCY ANIMAL RIGHTS W; Jewell ZC, 2016, JOVE-J VIS EXP, DOI 10.3791/54034; Karanth KU, 2003, ANIM CONSERV, V6, P141, DOI 10.1017/S1367943003003184; Karanth KU, 2006, ECOLOGY; Kelly MJ, 2008, J MAMMALOGY; Klein DR, 1959, J WILDLIFE MANAGEMEN; Krausman PR, 2004, WILDLIFE SOC B; Lewison R, 2001, BIOL CONSERV, V99, P313, DOI 10.1016/S0006-3207(00)00197-X; Logan KA, 1999, WILDLIFE SOC B; Mardia KV, 1979, TESTS UNIVARIATE MUL; McBride R, 2015, SOUTHEAST NAT, V14, P351, DOI 10.1656/058.014.0215; McBride RT, 2008, SOUTHEAST NAT, V7, P381, DOI 10.1656/1528-7092-7.3.381; McDougal C., 1977, FACE TIGER; Miller CM, 2001, MEASUREMENTS JAGUAR; Milligan GW, 1978, PSYCHOMETRIKA, V45, P68; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Moorhouse TP, 2005, J APPL ECOL, V42, P91, DOI 10.1111/j.1365-2664.2005.00998.x; Murray DL, 2000, METH C CONS, P15; Panwar HS, 1979, PUBLICATIONS ASTRONO, P1063; Pimm SL, 2015, TRENDS ECOL EVOL, V30, P685, DOI 10.1016/j.tree.2015.08.008; Pirie TJ, 2016, WILDLIFE BIOL, V22, P13, DOI 10.2981/wlb.00129; Reeder DM, 2005, J MAMMALOGY; Riordan P, 1998, ANIM CONSERV, V1, P253, DOI 10.1111/j.1469-1795.1998.tb00036.x; Rosas-Rosas OC, 2003, WILDLIFE SOC B; Sagar SR, 1993, TECHNIQUE DISTINGUIS; Sankhala K., 2005, TIGER STORY INDIAN T; Sharma S, 2005, J ZOOL, V267, P9, DOI 10.1017/S0952836905007119; Sharma S, 2003, WILDLIFE SOC B, V31, P258; Shaw H.G., 2007, PUMA FIELD GUIDE; Shaw HG., 2007, IDENTIFICATION ASSES; SMALLWOOD KS, 1993, BIOL CONSERV, V65, P51, DOI 10.1016/0006-3207(93)90196-8; SMALLWOOD KS, 1995, BIOL CONSERV, V71, P251, DOI 10.1016/0006-3207(94)00034-N; Stander PE, 1997, J ZOOLOGY; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Taberlet P, 1999, BIOL J LINNEAN SOC; VANSICKLE WD, 1991, J WILDLIFE MANAGE, V55, P738; Wilson GJ, 2001, WILDLIFE RES, V28, P151, DOI 10.1071/WR00033; Wolfe ML, 2016, J WILDLIFE MANAGE, V80, P27, DOI 10.1002/jwmg.985; Wultsch C, 2014, MOL ECOLOGY RESOURCE; Zalewski A., 1973, WILDLIFE SOC B	66	16	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172065	10.1371/journal.pone.0172065	http://dx.doi.org/10.1371/journal.pone.0172065			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273159	Green Published, Green Submitted, gold			2022-12-26	WOS:000396073700066
J	Jorgensen, SB; Soraas, A; Sundsfjord, A; Liestol, K; Leegaard, TM; Jenum, PA				Jorgensen, Silje B.; Soraas, Arne; Sundsfjord, Arnfinn; Liestol, Knut; Leegaard, Truls M.; Jenum, Pal A.			Fecal carriage of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae after urinary tract infection - A three year prospective cohort study	PLOS ONE			English	Article							ESBL-PRODUCING ENTEROBACTERIACEAE; TRANSMISSION DYNAMICS; CHANGING EPIDEMIOLOGY; COLONIZATION; PREVALENCE; DURATION; TRAVEL	We have performed a prospective cohort study to investigate the duration of and risk factors for prolonged fecal carriage of ESBL-producing Escherichia coli or Klebsiella pneumoniae in patients with community acquired urinary tract infection caused by these bacteria. From 2009 to 2011, 101 Norwegian patients were recruited. Stool swabs and questionnaires were collected every three months for one year and at the end of the study in 2012. Information on antibiotic prescriptions was collected from the Norwegian Prescription Database. Stool samples were cultured directly on ChromID ESBL agar as well as in an enrichment broth, and culture positive isolates were examined by bla(CTX-M) multiplex PCR. Isolates without bla(CTX-M) were investigated for alternative ESBL-determinants with a commercial microarray system. Time to fecal clearance of ESBL producing Enterobacteriaceae was also analysed using Kaplan-Meier estimates. Uni- and multivariate logistic regression was used to compare groups according to previously described risk factors. The ESBL point prevalence of fecal carriage were 61% at 4 months, 56% at 7 months, 48% at 10 months, 39% at 13 months, 19% after two years, and 15% after three years or more. We found no correlation between duration of carriage, comorbidity, antibiotic use or travel to ESBL high-prevalence countries. Prolonged carriage was associated with E. coli isolates of phylogroup B2 or D. Importantly, comparative MLST and MLVA analyses of individual paired urine and fecal E. coli isolates revealed that ESBL production commonly occurred in diverse strains within the same host. When investigating cross-transmission of ESBL producing bacteria in health care institutions, this notion should be taken into account.	[Jorgensen, Silje B.; Soraas, Arne; Jenum, Pal A.] Vestre Viken Hosp Trust, Dept Lab Med, Sect Med Microbiol, Baerum, Norway; [Jorgensen, Silje B.; Leegaard, Truls M.] Akershus Univ Hosp, Dept Clin Microbiol & Infect Control, Lorenskog, Norway; [Soraas, Arne] Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway; [Sundsfjord, Arnfinn] Univ Hosp North Norway, Dept Microbiol & Infect Control, Norwegian Natl Advisory Unit Detect Antimicrobial, Tromso, Norway; [Sundsfjord, Arnfinn] Univ Tromso, Fac Hlth Sci, Dept Med Biol, Res Grp Host Microbe Interact, Tromso, Norway; [Liestol, Knut] Univ Oslo, Dept Informat, Oslo, Norway; [Leegaard, Truls M.; Jenum, Pal A.] Univ Oslo, Inst Clin Med, Oslo, Norway	University of Oslo; University of Oslo; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University of Oslo; University of Oslo	Jorgensen, SB (corresponding author), Vestre Viken Hosp Trust, Dept Lab Med, Sect Med Microbiol, Baerum, Norway.; Jorgensen, SB (corresponding author), Akershus Univ Hosp, Dept Clin Microbiol & Infect Control, Lorenskog, Norway.	silje.bakken.jorgensen@ahus.no	Sundsfjord, Arnfinn/F-9668-2018	Sundsfjord, Arnfinn/0000-0002-3728-2270; Jorgensen, Silje/0000-0002-3135-1431	Helse Sor-Ost RHF [2013060]; Helse Sor-Ost Regional Health Trust; Wellcome Trust [090532/Z/09/Z]	Helse Sor-Ost RHF; Helse Sor-Ost Regional Health Trust; Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by a research grant awarded to PAJ from Helse Sor-Ost RHF, grant number 2013060, www.helsesorost.no.; The inclusion group in this study is the same as the group included in a previous study by Soraas et al [8]. The study was funded by Helse Sor-Ost Regional Health Trust. Bjorn Arne Lindstedt and Inger Lobersli are acknowledged for excellent supervision of the implementation of the MLVA protocol, and Bettina Aasnes for her assistance in the microarray analysis. We thank the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics (funded by Wellcome Trust grant reference 090532/Z/09/Z) for the generation of the sequencing data.	Adler A, 2012, CLIN MICROBIOL INFEC, V18, pE497, DOI 10.1111/j.1469-0691.2012.03999.x; Birgand G, 2013, AM J INFECT CONTROL, V41, P443, DOI 10.1016/j.ajic.2012.05.015; Birkett CI, 2007, J MED MICROBIOL, V56, P52, DOI 10.1099/jmm.0.46909-0; Blaak H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127752; Chaudhry S, 2005, MED CARE, V43, P607, DOI 10.1097/01.mlr.0000163658.65008.ec; Christiansson M, 2011, SCAND J INFECT DIS, V43, P579, DOI 10.3109/00365548.2011.568953; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; de Kraker MEA, 2013, CLIN MICROBIOL INFEC, V19, P860, DOI 10.1111/1469-0691.12028; Feldman N, 2013, CLIN MICROBIOL INFEC, V19, pE190, DOI 10.1111/1469-0691.12099; Hilty M, 2012, CLIN INFECT DIS, V55, P967, DOI 10.1093/cid/cis581; Jorgensen SB, 2014, SCAND J INFECT DIS, V46, P462, DOI 10.3109/00365548.2014.896031; Karami N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083030; Kluytmans-van den Bergh MFQ, 2015, J CLIN MICROBIOL, V53, P2709, DOI 10.1128/JCM.01251-15; Lindstedt BA, 2007, J MICROBIOL METH, V69, P197, DOI 10.1016/j.mimet.2007.01.001; Lobersli I, 2012, J MICROBIOL METH, V88, P134, DOI 10.1016/j.mimet.2011.11.003; Naseer U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041232; Nielsen KL, 2014, J MED MICROBIOL, V63, P582, DOI 10.1099/jmm.0.068783-0; O'Connell N, 2015, J HOSP INFECT, V90, P102, DOI 10.1016/j.jhin.2015.01.018; Ostholm-Balkhed A, 2013, J ANTIMICROB CHEMOTH, V68, P2144, DOI 10.1093/jac/dkt167; Oteo J, 2010, CURR OPIN INFECT DIS, V23, P320, DOI 10.1097/QCO.0b013e3283398dc1; Overdevest I, 2016, EUROSURVEILLANCE, V21, P24, DOI 10.2807/1560-7917.ES.2016.21.42.30376; Papst L, 2015, INFECT DIS LOND, P1; Peirano G, 2011, J TRAVEL MED, V18, P299, DOI 10.1111/j.1708-8305.2011.00548.x; Pitout JDD, 2010, DRUGS, V70, P313, DOI 10.2165/11533040-000000000-00000; Rodriguez-Bano J, 2008, J ANTIMICROB CHEMOTH, V62, P1142, DOI 10.1093/jac/dkn293; Ruppe E, 2015, CLIN INFECT DIS, V61, P593, DOI 10.1093/cid/civ333; Se Sakshaug, 2015, DRUG CONSUMPTION NOR; Soraas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085889; Soraas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069581; Stoesser N, 2015, J CLIN MICROBIOL; Thomsen MCF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157718; Titelman E, 2014, CLIN MICROBIOL INFEC, V20, pO508, DOI 10.1111/1469-0691.12559; Tofteland S, 2007, J CLIN MICROBIOL, V45, P199, DOI 10.1128/JCM.01319-06; Tschudin-Sutter S, 2012, CLIN INFECT DIS, V55, P1505, DOI 10.1093/cid/cis770; Valverde A, 2008, J CLIN MICROBIOL, V46, P2796, DOI 10.1128/JCM.01008-08; van Smeden M, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0267-3; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3	38	29	30	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173510	10.1371/journal.pone.0173510	http://dx.doi.org/10.1371/journal.pone.0173510			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267783	gold, Green Published, Green Submitted			2022-12-26	WOS:000396060600040
J	Quatremere, G; Guiguet, M; Girardi, P; Liaud, MN; Mey, C; Benkhoucha, C; Barbier, F; Cattaneo, G; Simon, A; Castro, DR				Quatremere, Guillemette; Guiguet, Marguerite; Girardi, Patricia; Liaud, Marie-Noelle; Mey, Coline; Benkhoucha, Cynthia; Barbier, Franck; Cattaneo, Graciela; Simon, Anne; Castro, Daniela Rojas			How are women living with HIV in France coping with their perceived side effects of antiretroviral therapy? Results from the EVE study	PLOS ONE			English	Article							GENDER-DIFFERENCES; POSITIVE INDIVIDUALS; ADVERSE EVENTS; IMPACT; CARE; DISCONTINUATION; HIV/AIDS; COMMUNICATION; ENGAGEMENT; ADHERENCE	Objective Side effects of antiretroviral therapy (ART) can have a negative impact on health-related quality of life threatening long-term retention in HIV care and adherence to ART. The aim of the French community-based survey EVE was to document personal experiences with side effects, the related physician-patient communication, and solutions found to deal with them. Design Cross-sectional study of women between September 2013 to September 2014 Methods An anonymous online questionnaire included the HIV Symptom Distress Module, which explores 20 symptoms. Results In all, 301 women on ART participated in the study (median age: 49 years; median duration of ART: 14 years). They reported having experienced a median of 12 symptoms (Q1-Q3: 9-15) during the previous 12 months. Overall, 56% of them reported having found at least a partial solution to dealing with their symptoms. Women reporting financial difficulties were twice less likely to have found solutions to coping with their side effects (AOR: 0.5; 95% CI: 0.3-0.8). Feeling supported by the health-care provider (AOR: 2.1; 95% CI: 1.1-3.9) and being in contact with HIV/AIDS organisations (AOR: 1.9; 95% CI: 1.2-3.2) were positively associated with coping. Seventeen percent reported having modified their ART regimen to improve tolerance, with only 2 in 3 informing their physician afterwards. Reporting financial difficulties and living with more bothersome symptoms increased the risk of ART regimen modification without health-care provider consultation. Conclusion The EVE study has called attention to the large number of side effects experienced by WLWHIV, only half of whom have found self-care strategies to manage their symptoms. Modification of ART regimen by the women themselves was not uncommon.	[Quatremere, Guillemette; Girardi, Patricia; Liaud, Marie-Noelle; Mey, Coline; Benkhoucha, Cynthia; Barbier, Franck; Cattaneo, Graciela; Castro, Daniela Rojas] AIDES, Pantin, France; [Guiguet, Marguerite] UPMC Univ Paris 06, Sorbonne Univ, INSERM, IPLESP UMRS 1136, Paris, France; [Simon, Anne] Hop La Pitie Salpetriere, AP HP, CIDAG, Dept Internal Med, Paris, France; [Castro, Daniela Rojas] Univ Lyon 2, Social Psychol Res Grp GRePS, Lyon, France; [Castro, Daniela Rojas] SESSTIM, INSERM, U912, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Lyon 2; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Quatremere, G (corresponding author), AIDES, Pantin, France.	gquatremere@aides.org	Rojas, Daniela/AAF-1591-2019; Guiguet, Marguerite/L-8480-2018	ROJAS CASTRO, Daniela/0000-0002-5379-1438				Abel Elizabeth, 2003, J Assoc Nurses AIDS Care, V14, P61, DOI 10.1177/1055329003252879; Aidala AA, 2016, AM J PUBLIC HEALTH, V106, pE1, DOI 10.2105/AJPH.2015.302905; Al-Dakkak I, 2013, AIDS CARE, V25, P400, DOI 10.1080/09540121.2012.712667; Andany N, 2011, HIV CLIN TRIALS, V12, P89, DOI 10.1310/hct1202-89; Berg KM, 2004, J GEN INTERN MED, V19, P1111, DOI 10.1111/j.1525-1497.2004.30445.x; Bernier A, 2015, REV PANAM SALUD PUBL, V38, P209; Bunupuradah T, 2016, LANCET HIV, V3, pE343, DOI 10.1016/S2352-3018(16)30010-8; Butler K, 2016, LANCET HIV, V3, pE421, DOI 10.1016/S2352-3018(16)30054-6; Castro DR, SANTE PUBLIQUE, V21, P129; Chen Wei-Ti, 2013, J AIDS Clin Res, V4, P218; Chou FY, 2004, AIDS PATIENT CARE ST, V18, P109, DOI 10.1089/108729104322802533; Curno MJ, 2016, JAIDS-J ACQ IMM DEF, V71, P181, DOI 10.1097/QAI.0000000000000842; del Amo J, 2017, AIDS, V31, P253, DOI 10.1097/QAD.0000000000001270; Demange E, 2012, COLLABORATIVE RES CO; Dray-Spira R., 2013, Bulletin Epidemiologique Hebdomadaire, P285; Erlandson KM, 2014, AIDS, V28, P1939, DOI 10.1097/QAD.0000000000000384; Fagbami Oluwakemi, 2015, Open AIDS J, V9, P45, DOI 10.2174/1874613601509010045; Fasinu PS, 2016, CURR DRUG METAB, V17, P52, DOI 10.2174/1389200216666151103115053; Flickinger TE, 2013, JAIDS-J ACQ IMM DEF, V63, P362, DOI 10.1097/QAI.0b013e318295b86a; Gantner P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164240; Greig JM, 2014, CURR OPIN INFECT DIS, V27, P46, DOI 10.1097/QCO.0000000000000033; Hoffmann C, 2017, HIV MED, V18, P56, DOI 10.1111/hiv.12468; Jonassaint CR, 2013, AIDS CARE, V25, P1185, DOI 10.1080/09540121.2012.752788; Justice AC, 2001, J CLIN EPIDEMIOL, V54, pS77, DOI 10.1016/S0895-4356(01)00449-8; Kempf MC, 2009, JAIDS-J ACQ IMM DEF, V52, P336, DOI 10.1097/QAI.0b013e3181b628be; Koole O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147309; Ladenheim D, 2008, HIV MED, V9, P653, DOI 10.1111/j.1468-1293.2008.00610.x; Leach L L, 2015, Open AIDS J, V9, P66, DOI 10.2174/1874613601509010066; Liu CL, 2009, AIDS PATIENT CARE ST, V23, P965, DOI 10.1089/apc.2009.0134; McGowan JA, 2017, HIV MED, V18, P89, DOI 10.1111/hiv.12398; Nicastri E, 2007, J ANTIMICROB CHEMOTH, V60, P724, DOI 10.1093/jac/dkm302; Preau M, 2012, AIDS CARE, V24, P434, DOI 10.1080/09540121.2011.613909; Preau M, 2008, JAIDS-J ACQ IMM DEF, V47, P467, DOI 10.1097/QAI.0b013e31815f3bdc; Reeves PM, 2000, J HEALTH COMMUN, V5, P47, DOI 10.1080/10810730050019555; Remien RH, 2015, JAIDS-J ACQ IMM DEF, V69, pS16, DOI 10.1097/QAI.0000000000000577; Robison LS, 2008, AIDS RES HUM RETROV, V24, P1347, DOI 10.1089/aid.2008.0083; Sax PE, 2005, AIDS PATIENT CARE ST, V19, P563, DOI 10.1089/apc.2005.19.563; Squires K, 2016, LANCET HIV, V3, pE410, DOI 10.1016/S2352-3018(16)30016-9; Squires KE, 2011, AIDS PATIENT CARE ST, V25, P279, DOI 10.1089/apc.2010.0228; Tesfaye M, 2016, TROP MED INT HEALTH, V21, P735, DOI 10.1111/tmi.12705; Umeh OC, 2006, EXPERT OPIN DRUG MET, V2, P273, DOI 10.1517/17425255.2.2.273; UNAIDS, AIDS NUMB AIDS IS NO; World Health Organization, 2014, FAST TRACK COMB PREV	43	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173338	10.1371/journal.pone.0173338	http://dx.doi.org/10.1371/journal.pone.0173338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5OE	28264016	Green Published, Green Submitted, gold			2022-12-26	WOS:000396054300054
J	Quistgaard, EM; Molledo, MM; Low, C				Quistgaard, Esben M.; Molledo, Maria Martinez; Loew, Christian			Structure determination of a major facilitator peptide transporter: Inward facing PepT(St) from Streptococcus thermophilus crystallized in space group P3(1)21	PLOS ONE			English	Article							CENTERED MONOCLINIC CRYSTALS; X-RAY CRYSTALLOGRAPHY; ESCHERICHIA-COLI; EXPRESSION CLONING; MEMBRANE-PROTEINS; DYNAMIC MECHANISM; POT FAMILY; PACKING; DIPEPTIDES; COMPLEXES	Major facilitator superfamily (MFS) peptide transporters (typically referred to as PepT, POT or PTR transporters) mediate the uptake of di- and tripeptides, and so play an important dietary role in many organisms. In recent years, a better understanding of the molecular basis for this process has emerged, which is in large part due to a steep increase in structural information. Yet, the conformational transitions underlying the transport mechanism are still not fully understood, and additional data is therefore needed. Here we report in detail the detergent screening, crystallization, experimental MIRAS phasing, and refinement of the peptide transporter PepT(St) from Streptococcus thermophilus. The space group is P3(1)21, and the protein is crystallized in a monomeric inward facing form. The binding site is likely to be somewhat occluded, as the lobe encompassing transmembrane helices 10 and 11 is markedly bent towards the central pore of the protein, but the extent of this potential occlusion could not be determined due to disorder at the apex of the lobe. Based on structural comparisons with the seven previously determined P2(1)2(1)2(1) and C222(1) structures of inward facing PepTSt, the structural flexibility as well as the conformational changes mediating transition between the inward open and inward facing occluded states are discussed. In conclusion, this report improves our understanding of the structure and conformational cycle of PepTSt, and can furthermore serve as a case study, which may aid in supporting future structure determinations of additional MFS transporters or other integral membrane proteins.	[Quistgaard, Esben M.; Molledo, Maria Martinez; Loew, Christian] DESY, CSSB, Hamburg, Germany; [Quistgaard, Esben M.; Molledo, Maria Martinez; Loew, Christian] European Mol Biol Lab Hamburg, Hamburg, Germany; [Quistgaard, Esben M.; Loew, Christian] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Helmholtz-Center for Infection Research; European Molecular Biology Laboratory (EMBL); Karolinska Institutet	Low, C (corresponding author), DESY, CSSB, Hamburg, Germany.; Low, C (corresponding author), European Mol Biol Lab Hamburg, Hamburg, Germany.; Low, C (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	christian.loew@embl-hamburg.de	Molledo, Maria Martinez/AAB-6902-2021	Molledo, Maria Martinez/0000-0002-2948-0891; Quistgaard, Esben/0000-0002-1381-3364; Loew, Christian/0000-0003-0764-7483	European Union under BioStruct-X [N783]; Horizon 2020 programme of the European Union (iNEXT grant) [653706]; Swedish Research Council [621-2013-5905]	European Union under BioStruct-X; Horizon 2020 programme of the European Union (iNEXT grant); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This research was funded by the European Union's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (grant agreement N783), by the Horizon 2020 programme of the European Union (iNEXT grant, project no. 653706) and the Swedish Research Council (grant number 621-2013-5905).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrec M, 2007, PROTEINS, V69, P449, DOI 10.1002/prot.21507; Banatao DR, 2006, P NATL ACAD SCI USA, V103, P16230, DOI 10.1073/pnas.0607674103; Boggavarapu R, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0167-8; Boll M, 1996, P NATL ACAD SCI USA, V93, P284, DOI 10.1073/pnas.93.1.284; Brandsch M, 2013, CURR OPIN PHARMACOL, V13, P881, DOI 10.1016/j.coph.2013.08.004; Brandsch M, 2009, EXPERT OPIN DRUG MET, V5, P887, DOI 10.1517/17425250903042292; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Buschmann S, 2014, PROTEIN SCI, V23, P411, DOI 10.1002/pro.2423; Caffrey M, 2015, ACTA CRYSTALLOGR F, V71, P3, DOI 10.1107/S2053230X14026843; Carugo O, 1997, PROTEIN SCI, V6, P2261; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chaptal V, 2016, DATA BRIEF, V7, P726, DOI 10.1016/j.dib.2016.03.031; Chaptal V, 2016, BBA-BIOMEMBRANES, V1858, P326, DOI 10.1016/j.bbamem.2015.11.021; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Daniel H, 2006, PHYSIOLOGY, V21, P93, DOI 10.1152/physiol.00054.2005; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doki S, 2013, P NATL ACAD SCI USA, V110, P11343, DOI 10.1073/pnas.1301079110; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eyal E, 2005, J MOL BIOL, V351, P431, DOI 10.1016/j.jmb.2005.05.066; FEI YJ, 1994, NATURE, V368, P563, DOI 10.1038/368563a0; Fernandez PAA, 2004, CURR MICROBIOL, V49, P361, DOI 10.1007/s00284-004-4367-7; Fowler PW, 2015, STRUCTURE, V23, P290, DOI 10.1016/j.str.2014.12.012; Fukuda M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8097; Guettou F, 2014, NAT STRUCT MOL BIOL, V21, P728, DOI 10.1038/nsmb.2860; Guettou F, 2013, EMBO REP, V14, P804, DOI 10.1038/embor.2013.107; HENDERSON PJF, 1990, PHILOS T ROY SOC B, V326, P391, DOI 10.1098/rstb.1990.0020; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang CY, 2016, ACTA CRYSTALLOGR D, V72, P93, DOI 10.1107/S2059798315021683; Huang CY, 2015, ACTA CRYSTALLOGR D, V71, P1238, DOI 10.1107/S1399004715005210; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; JESSENMARSHALL AE, 1995, J BIOL CHEM, V270, P16251, DOI 10.1074/jbc.270.27.16251; Jiang DH, 2013, P NATL ACAD SCI USA, V110, P14664, DOI 10.1073/pnas.1308127110; JUILLARD V, 1995, APPL ENVIRON MICROB, V61, P3024, DOI 10.1128/AEM.61.8.3024-3030.1995; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Komarova NY, 2008, PLANT PHYSIOL, V148, P856, DOI 10.1104/pp.108.123844; LIU W, 1995, BBA-BIOMEMBRANES, V1235, P461, DOI 10.1016/0005-2736(95)80036-F; Low C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077984; Low C, 2013, BBA-GEN SUBJECTS, V1830, P3497, DOI 10.1016/j.bbagen.2013.02.001; Lyons JA, 2014, EMBO REP, V15, P886, DOI 10.15252/embr.201338403; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Newstead S, 2015, BBA-GEN SUBJECTS, V1850, P488, DOI 10.1016/j.bbagen.2014.05.011; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Parker JL, 2016, ADV EXP MED BIOL, V922, P61, DOI 10.1007/978-3-319-35072-1_5; Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042; Pike ACW, 2016, ACTA CRYSTALLOGR D, V72, P303, DOI 10.1107/S2059798316000401; Quistgaard EM, 2016, NAT REV MOL CELL BIO, V17, P123, DOI 10.1038/nrm.2015.25; Quistgaard EM, 2013, J STRUCT BIOL, V184, P375, DOI 10.1016/j.jsb.2013.09.009; Quistgaard EM, 2013, NAT STRUCT MOL BIOL, V20, P766, DOI 10.1038/nsmb.2569; Rapp CS, 2005, PROTEINS, V60, P103, DOI 10.1002/prot.20492; RONG LA, 1995, J BIOL CHEM, V270, P6456, DOI 10.1074/jbc.270.12.6456; Schulz GE, 2011, J MOL BIOL, V407, P640, DOI 10.1016/j.jmb.2011.02.003; Sikic Kresimir, 2010, Open Biochem J, V4, P83, DOI 10.2174/1874091X01004010083; Smith DE, 2013, MOL ASPECTS MED, V34, P323, DOI 10.1016/j.mam.2012.11.003; Solcan N, 2012, EMBO J, V31, P3411, DOI 10.1038/emboj.2012.157; Song G, 2007, J MOL BIOL, V369, P880, DOI 10.1016/j.jmb.2007.03.059; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; STROUD RM, 1995, PROTEIN SCI, V4, P2392, DOI 10.1002/pro.5560041118; Tate CG, 2010, METHODS MOL BIOL, V601, P187, DOI 10.1007/978-1-60761-344-2_12; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WEBB KE, 1990, J ANIM SCI, V68, P3011; YAMAGUCHI A, 1992, J BIOL CHEM, V267, P19155; Yan N, 2015, ANNU REV BIOPHYS, V44, P257, DOI 10.1146/annurev-biophys-060414-033901; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhao Y, 2014, STRUCTURE, V22, P1152, DOI 10.1016/j.str.2014.06.008	67	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173126	10.1371/journal.pone.0173126	http://dx.doi.org/10.1371/journal.pone.0173126			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264013	Green Submitted, Green Published, gold			2022-12-26	WOS:000396054300041
J	Reid, KM; Patel, S; Robinson, AJ; Bu, LJ; Jarungsriapisit, J; Moore, LJ; Salinas, I				Reid, Kristin M.; Patel, Sonal; Robinson, Aaron J.; Bu, Lijing; Jarungsriapisit, Jiraporn; Moore, Lindsey J.; Salinas, Irene			Salmonid alphavirus infection causes skin dysbiosis in Atlantic salmon (Salmo salar L.) post-smolts	PLOS ONE			English	Article							1ST LABORATORY CONFIRMATION; DISEASE-VIRUS SDV; SLEEPING-DISEASE; GUT MICROBIOTA; FRESH-WATER; COMMUNITY; PATHOGENESIS; CHALLENGE; SPAIN	Interactions among host, microbiota and viral pathogens are complex and poorly understood. The goal of the present study is to assess the changes in the skin microbial community of Atlantic salmon (Salmo salar L.) in response to experimental infection with salmonid alphavirus (SAV). The salmon skin microbial community was determined using 16S rDNA pyrosequencing in five different experimental groups: control, 7 days after infection with low-dose SAV, 14 days after infection with low-dose SAV, 7 days after infection with high-dose SAV, and 14 days after infection with high-dose SAV. Both infection treatment and time after infection were strong predictors of the skin microbial community composition. Skin samples from SAV3 infected fish showed an unbalanced microbiota characterized by a decreased abundance of Proteobacteria such as Oleispira sp. and increased abundances of opportunistic taxa including Flavobacteriaceae, Streptococcaceae and Tenacibaculum sp. These results demonstrate that viral infections can result in skin dysbiosis likely rendering the host more susceptible to secondary bacterial infections.	[Reid, Kristin M.; Robinson, Aaron J.; Bu, Lijing; Salinas, Irene] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Patel, Sonal; Jarungsriapisit, Jiraporn; Moore, Lindsey J.] Inst Marine Res, Bergen, Norway	University of New Mexico; Institute of Marine Research - Norway	Salinas, I (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	isalinas@unm.edu		Robinson, Aaron/0000-0002-1406-5636; Bu, Lijing/0000-0001-8625-2732; Patel, Sonal/0000-0003-4107-0497	NIH [P20GM103452]; Research Council of Norway [224885/E40]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110907] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of Norway(Research Council of Norway); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH grant P20GM103452, and Research Council of Norway, Research grant # 224885/E40. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by NIH grant P20GM103452, and Research Council of Norway, Research grant # 224885/E40. We also thank the UNM Center for Advanced Research Computing for computational resources used in this work and Dr. Darrell Dinwiddie for sharing the Illumina MiSeq. Authors thank Stig Maehle, and Ann Cathrine B. Einen at Institute of Marine Research, Norway, for help during sampling, and processing of skin samples for DNA isolation and quality assurance.	Andersen L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-198; Avadhanula V, 2006, J VIROL, V80, P1629, DOI 10.1128/JVI.80.4.1629-1636.2006; Bergmann SM, 2008, B EUR ASSOC FISH PAT, V28, P148; Borzym E, 2014, B VET I PULAWY, V58, P341, DOI 10.2478/bvip-2014-0053; Boutin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102649; Boutin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084772; Boutin S, 2012, VET MICROBIOL, V155, P355, DOI 10.1016/j.vetmic.2011.09.002; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cipriano R, 2011, HLTH DIS AQUATIC ORG, P156; Cosseau C, 2016, ONE HEALTH, V2, P33, DOI 10.1016/j.onehlt.2016.02.002; David R, 2011, NAT REV MICROBIOL, V9, P831, DOI 10.1038/nrmicro2691; Deriu E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005572; Derome N, 2016, ADV ENV MICROBIOLOGY, V3, P81, DOI 10.1007/978-3-319-28170-4_4; Eggset G, 1997, AQUACULTURE, V158, P179, DOI 10.1016/S0044-8486(97)00178-6; Eichmiller JJ, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0190-1; Gaulke CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154632; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Graham DA, 2007, J FISH DIS, V30, P569, DOI 10.1111/j.1365-2761.2007.00826.x; Graham DA, 2012, J FISH DIS, V35, P949, DOI 10.1111/j.1365-2761.2012.01427.x; Graham DA, 2011, J FISH DIS, V34, P273, DOI 10.1111/j.1365-2761.2010.01234.x; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Hennersdorf P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151594; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Jansen MD, 2010, J FISH DIS, V33, P391, DOI 10.1111/j.1365-2761.2009.01131.x; Jarungsriapisit J, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0520-8; Jarungsriapisit J, 2016, VET RES, V47, DOI 10.1186/s13567-016-0385-2; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Larsen A, 2013, FEMS MICROBIOL ECOL, V85, P483, DOI 10.1111/1574-6941.12136; Llewellyn MS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00207; Lokesh J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19707; Lowrey L, 2015, APPL ENVIRON MICROB, V81, P6915, DOI 10.1128/AEM.01826-15; McLoughlin MF, 2007, J FISH DIS, V30, P511, DOI 10.1111/j.1365-2761.2007.00848.x; Mesa MG, 1999, AQUACULTURE, V174, P25, DOI 10.1016/S0044-8486(99)00012-5; Mitchell KR, 2008, J IND MICROBIOL BIOT, V35, P1139, DOI 10.1007/s10295-008-0393-y; Olsen AB, 2011, DIS AQUAT ORGAN, V94, P189, DOI 10.3354/dao02324; Rahman T, 2015, FISH PATHOL, V50, P44, DOI 10.3147/jsfp.50.44; Robinson CM, 2014, ANNU REV VIROL, V1, P55, DOI 10.1146/annurev-virology-031413-085550; Schmidt V, 2016, APPL ENVIRON MICROB, V82, P4470, DOI 10.1128/AEM.00902-16; Schmidt-Posthaus H, 2014, DIS AQUAT ORGAN, V111, P165, DOI 10.3354/dao02766; Smrzlic IV, 2013, B EUR ASSOC FISH PAT, V33, P78; Sylvain FE, 2016, SCI REP-UK, V6, DOI 10.1038/srep32032; Teramoto M, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00644-16; TORANZO AE, 1993, AQUACULTURE, V114, P189, DOI 10.1016/0044-8486(93)90295-A; Vujkovic-Cvijin I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006438; Wilks J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002681	46	36	36	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172856	10.1371/journal.pone.0172856	http://dx.doi.org/10.1371/journal.pone.0172856			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264056	Green Published, gold, Green Submitted			2022-12-26	WOS:000396054300023
J	Requena-Mullor, JM; Lopez, E; Castro, AJ; Alcaraz-Segura, D; Castro, H; Reyes, A; Cabello, J				Requena-Mullor, Juan M.; Lopez, Enrique; Castro, Antonio J.; Alcaraz-Segura, Domingo; Castro, Hermelindo; Reyes, Andres; Cabello, Javier			Remote-sensing based approach to forecast habitat quality under climate change scenarios	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; BADGERS MELES-MELES; LANDSCAPE-SCALE; EUROPEAN BADGER; DISTRIBUTIONS; SELECTION; HETEROGENEITY; DIVERSITY; GRADIENT; IMPACTS	As climate change is expected to have a significant impact on species distributions, there is an urgent challenge to provide reliable information to guide conservation biodiversity policies. In addressing this challenge, we propose a remote sensing-based approach to forecast the future habitat quality for European badger, a species not abundant and at risk of local extinction in the arid environments of southeastern Spain, by incorporating environmental variables related with the ecosystem functioning and correlated with climate and land use. Using ensemble prediction methods, we designed global spatial distribution models for the distribution range of badger using presence-only data and climate variables. Then, we constructed regional models for an arid region in the southeast Spain using EVI (Enhanced Vegetation Index) derived variables and weighting the pseudo-absences with the global model projections applied to this region. Finally, we forecast the badger potential spatial distribution in the time period 2071-2099 based on IPCC scenarios incorporating the uncertainty derived from the predicted values of EVI-derived variables. By including remotely sensed descriptors of the temporal dynamics and spatial patterns of ecosystem functioning into spatial distribution models, results suggest that future forecast is less favorable for European badgers than not including them. In addition, change in spatial pattern of habitat suitability may become higher than when forecasts are based just on climate variables. Since the validity of future forecast only based on climate variables is currently questioned, conservation policies supported by such information could have a biased vision and overestimate or underestimate the potential changes in species distribution derived from climate change. The incorporation of ecosystem functional attributes derived from remote sensing in the modeling of future forecast may contribute to the improvement of the detection of ecological responses under climate change scenarios.	[Requena-Mullor, Juan M.; Lopez, Enrique; Castro, Antonio J.; Alcaraz-Segura, Domingo; Castro, Hermelindo; Reyes, Andres; Cabello, Javier] Univ Almeria, Andalusian Ctr Assessment & Monitoring Global Cha, Almeria, Spain; [Lopez, Enrique] Univ Almeria, Dept Educ, Didact Expt Sci Area, Almeria, Spain; [Castro, Antonio J.] Idaho State Univ, Dept Biol Sci, Gale Life Sci Bldg Rm 207,8th Ave,Mail Stop, Pocatello, ID 83209 USA; [Alcaraz-Segura, Domingo] Univ Granada, Dept Bot, Granada, Spain; [Castro, Hermelindo; Cabello, Javier] Univ Almeria, Dept Biol & Geol, Almeria, Spain	Universidad de Almeria; Universidad de Almeria; Idaho; Idaho State University; University of Granada; Universidad de Almeria	Requena-Mullor, JM (corresponding author), Univ Almeria, Andalusian Ctr Assessment & Monitoring Global Cha, Almeria, Spain.	juanmir@ual.es	Castro Martínez, Antonio J./Z-2469-2019; Alcaraz-Segura, Domingo/B-8063-2008; Cabello, Javier/N-5799-2014	Castro Martínez, Antonio J./0000-0003-1587-8564; Alcaraz-Segura, Domingo/0000-0001-8988-4540; Cabello, Javier/0000-0002-5123-964X; Requena-Mullor, Juan Miguel/0000-0002-5120-7947	Andalusian Center for the Assessment and Monitoring of Global Change (CAESCG); Andalusian Government (Project SEGALERT) [P09-RNM-5048]; Andalusian Government (Project GLOCHARID); ERDF; Ministry of Science and Innovation [CGL2010-22314]; National Science Foundation Idaho EPSCoR program [IIA-1301792]	Andalusian Center for the Assessment and Monitoring of Global Change (CAESCG); Andalusian Government (Project SEGALERT); Andalusian Government (Project GLOCHARID); ERDF(European Commission); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Science Foundation Idaho EPSCoR program	JRM received funding from the Andalusian Center for the Assessment and Monitoring of Global Change (CAESCG) (http://www.caescg.org/). Funding was also received from the Andalusian Government (http:/www.juntadeandalucia.es/medioambiente/site/portalweb/)(Projects GLOCHARID and SEGALERT P09-RNM-5048), the ERDF (http://ec.europa.eu/regional_policy/es/funding/erdf/), and the Ministry of Science and Innovation (http://www.idi.mineco.gob.es/portal/site/MICINN/) (Project CGL2010-22314, subprogram BOS, National Plant I+D+I 2010). AJC was partially funded by the National Science Foundation Idaho EPSCoR program under award no. IIA-1301792. (http://www.isu.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz-Segura D, 2006, GLOBAL ECOL BIOGEOGR, V15, P200, DOI 10.1111/j.1466-822x.2006.00215.x; Alcaraz-Segura D, 2013, REMOTE SENS-BASEL, V5, P127, DOI 10.3390/rs5010127; [Anonymous], 2006, GEN CLIM CHANG SCEN; [Anonymous], 2011, ECOLOGICAL NICHES GE; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Beale CM, 2008, P NATL ACAD SCI USA, V105, P14908, DOI 10.1073/pnas.0803506105; Booth G. D., 1994, IDENTIFYING PROXY SE; Buermann W, 2008, J BIOGEOGR, V35, P1160, DOI 10.1111/j.1365-2699.2007.01858.x; Cabello J, 2012, J ARID ENVIRON, V79, P76, DOI 10.1016/j.jaridenv.2011.12.006; Cabello J, 2012, BIODIVERS CONSERV, V21, P3287, DOI 10.1007/s10531-012-0370-7; Castro AJ, 2013, EARTH OBSERVATION EC, P105, DOI DOI 10.1201/B15628; Davidowitz G, 1998, J BIOGEOGR, V25, P553, DOI 10.1046/j.1365-2699.1998.2530553.x; Fischer C, 2005, J ZOOL, V266, P121, DOI 10.1017/S0952836905006576; Fryxell JM, 2005, ECOL LETT, V8, P328, DOI 10.1111/j.1461-0248.2005.00727.x; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; Huete AR, 2012, REMOTE SENS ENVIRON, V83, P195; Lara-Romero C, 2012, J ARID ENVIRON, V76, P43, DOI 10.1016/j.jaridenv.2011.08.004; Legendre P., 2012, NUMERICAL ECOLOGY; Macdonald DW, 2010, GLOBAL CHANGE BIOL, V16, P2913, DOI 10.1111/j.1365-2486.2010.02208.x; Maiorano L, 2011, PHILOS T R SOC B, V366, P2681, DOI 10.1098/rstb.2011.0121; Martonne E., 1926, GEOGR REV, V17, P397; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; Nouvellet P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068116; Palomo LJ., 2007, ATLAS LIBRO ROJO MAM; Parry M. L., 2007, CLIMATE CHANGE 2007; Paruelo JM, 1999, ECOSYSTEMS, V2, P64, DOI 10.1007/s100219900058; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Piquer-Rodriguez M, 2012, J NAT CONSERV, V20, P326, DOI 10.1016/j.jnc.2012.07.001; Quintas-Soriano C, 2014, LANDSCAPE ECOL, V29, P1069, DOI 10.1007/s10980-014-0032-0; Requena-Mullor J, 2016, MAMMAL RES, V61, P197, DOI 10.1007/s13364-016-0269-x; Requena-Mullor JM, 2014, LANDSCAPE ECOL, V29, P843, DOI 10.1007/s10980-014-0020-4; Revilla E, 2001, J ZOOL, V255, P291, DOI 10.1017/S0952836901001388; Ruimy A, 1994, J GEOPHYS RES-ATMOS, V99, P5263, DOI 10.1029/93JD03221; Thuiller W, 2014, BIOMOD2 ENSEMBLE PLA, P1; Verburg PH, 2015, ANTHROPOCENE, V12, P29, DOI 10.1016/j.ancene.2015.09.004; Virgos E, 1999, J BIOGEOGR, V26, P559, DOI 10.1046/j.1365-2699.1999.00320.x; Virgos Emilio, 2005, P283; Wenger SJ, 2013, GLOBAL CHANGE BIOL, V19, P3343, DOI 10.1111/gcb.12294; Whittaker RJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P76, DOI 10.1111/j.1466-8238.2006.00268.x; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Wilby RL, 1998, WATER RESOUR RES, V34, P2995, DOI 10.1029/98WR02577; Wilson PD, 2011, METHODS ECOL EVOL, V2, P623, DOI 10.1111/j.2041-210X.2011.00115.x; Zaccarelli N, 2013, ECOL INDIC, V28, P22, DOI 10.1016/j.ecolind.2011.07.008	46	9	9	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172107	10.1371/journal.pone.0172107	http://dx.doi.org/10.1371/journal.pone.0172107			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257501	Green Published, gold, Green Submitted			2022-12-26	WOS:000396021100012
J	Echtler, K; Konrad, I; Lorenz, M; Schneider, S; Hofmaier, S; Plenagl, F; Stark, K; Czermak, T; Tirniceriu, A; Eichhorn, M; Walch, A; Enders, G; Massberg, S; Schulz, C				Echtler, Katrin; Konrad, Ildiko; Lorenz, Michael; Schneider, Simon; Hofmaier, Sebastian; Plenagl, Florian; Stark, Konstantin; Czermak, Thomas; Tirniceriu, Anca; Eichhorn, Martin; Walch, Axel; Enders, Georg; Massberg, Steffen; Schulz, Christian			Platelet GPIIb supports initial pulmonary retention but inhibits subsequent proliferation of melanoma cells during hematogenic metastasis	PLOS ONE			English	Article							TUMOR-CELLS; ACTIVATED PLATELETS; ENDOTHELIAL-CELLS; IN-VIVO; INTEGRIN ALPHA(V)BETA(3); VASCULAR ENDOTHELIUM; ADHESION; GROWTH; ALPHA-IIB-BETA-3; EXPRESSION	Platelets modulate the process of cancer metastasis. However, current knowledge on the direct interaction of platelets and tumor cells is mostly based on findings obtained in vitro. We addressed the role of the platelet fibrinogen receptor glycoprotein IIb (integrin alpha IIb) for experimental melanoma metastasis in vivo. Highly metastatic B16-D5 melanoma cells were injected intravenously into GPIIb-deficient (GPIIb(-/-)) or wildtype (WT) mice. Acute accumulation of tumor cells in the pulmonary vasculature was assessed in real-time by confocal videofluorescence microscopy. Arrest of tumor cells was dramatically reduced in GPIIb(-/-) mice as compared to WT. Importantly, we found that mainly multicellular aggregates accumulated in the pulmonary circulation of WT, instead B16-D5 aggregates were significantly smaller in GPIIb(-/-) mice. While pulmonary arrest of melanoma was clearly dependent on GPIIb in this early phase of metastasis, we also addressed tumor progression 10 days after injection. Inversely, and unexpectedly, we found that melanoma metastasis was now increased in GPIIb(-/-) mice. In contrast, GPIIb did not regulate local melanoma proliferation in a subcutaneous tumor model. Our data suggest that the platelet fibrinogen receptor has a differential role in the modulation of hematogenic melanoma metastasis. While platelets clearly support early steps in pulmonary metastasis via GPIIb-dependent formation of platelet-tumor-aggregates, at a later stage its absence is associated with an accelerated development of melanoma metastases.	[Echtler, Katrin; Konrad, Ildiko; Lorenz, Michael; Plenagl, Florian; Stark, Konstantin; Czermak, Thomas; Tirniceriu, Anca; Massberg, Steffen; Schulz, Christian] Ludwig Maximilians Univ Munchen, Klinikum Univ, Med Klin & Poliklin 1, Munich, Germany; [Echtler, Katrin; Konrad, Ildiko; Lorenz, Michael; Plenagl, Florian; Stark, Konstantin; Czermak, Thomas; Tirniceriu, Anca; Eichhorn, Martin; Enders, Georg; Massberg, Steffen; Schulz, Christian] Ludwig Maximilians Univ Munchen, Walter Brendel Zentrum Expt Med, Munich, Germany; [Schneider, Simon; Hofmaier, Sebastian] Tech Univ Munich, Med Klin, Klinikum Rechts Isar, Munich, Germany; [Eichhorn, Martin] Ludwig Maximilians Univ Munchen, Klinikum Univ, Chirurg Klin, Munich, Germany; [Walch, Axel] German Res Ctr Environm Hlth, Res Unit Analyt Pathol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Konrad, Ildiko] Tech Univ Munich, Zentrum Praklin Forsch, Munich, Germany; [Eichhorn, Martin] Univ Klinikum Heidelberg, Thoraxklin, Heidelberg, Germany	University of Munich; University of Munich; Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Ruprecht Karls University Heidelberg	Schulz, C (corresponding author), Ludwig Maximilians Univ Munchen, Klinikum Univ, Med Klin & Poliklin 1, Munich, Germany.; Schulz, C (corresponding author), Ludwig Maximilians Univ Munchen, Walter Brendel Zentrum Expt Med, Munich, Germany.	Christian.Schulz@med.uni-muenchen.de	Eichhorn, Martin/GRE-9126-2022; Schulz, Christian/J-8545-2012; Massberg, Steffen/AAN-6054-2021; Walch, Axel/B-4554-2012; Stark, Konstantin/AAJ-2815-2020; Eichhorn, Martin/AAU-7204-2020	Eichhorn, Martin/0000-0002-0362-0374; Schulz, Christian/0000-0003-3878-7833; Walch, Axel/0000-0001-5578-4023; Stark, Konstantin/0000-0002-5369-8399; 	Wilhelm-Sander Foundation [2005.124.1.1]; Wilhelm Sander-Stiftung [2005.124.1.1]	Wilhelm-Sander Foundation; Wilhelm Sander-Stiftung	The study was supported the Wilhelm-Sander Foundation, grant 2005.124.1.1, http://www.wilhelm-sander-stiftung.de/cms/front_content.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are indebted to Sandra Kerstan, Lin Zhang, Christof Hoffmann and Birgit Niehuis for their help with in vitro experiments and Marie-Luise von Bruehl for support of intravital microscopy. We thank Luise Jennen for expert technical assistance in electron microscopy. We also thank Matthias Schiemann and Dirk Busch for help with fluorescence activated cell sorting. We thank Jon Frampton for providing GPIIb<SUP>-/-</SUP> mice. The study was supported by grants from the Wilhelm Sander-Stiftung (2005.124.1.1).	ALTERMAN AL, 1985, J NATL CANCER I, V75, P691; Amirkhosravi A, 1999, PLATELETS, V10, P285; Bakewell SJ, 2003, P NATL ACAD SCI USA, V100, P14205, DOI 10.1073/pnas.2234372100; BARTH A, 1995, J AM COLL SURGEONS, V181, pA193; Biggerstaff JP, 1999, CLIN EXP METASTAS, V17, P723, DOI 10.1023/A:1006763827882; Bombeli T, 1998, J EXP MED, V187, P329, DOI 10.1084/jem.187.3.329; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Burdick MM, 2004, AM J PHYSIOL-CELL PH, V287, pC539, DOI 10.1152/ajpcell.00450.2003; Camerer E, 2004, BLOOD, V104, P397, DOI 10.1182/blood-2004-02-0434; Cardones AR, 2003, CANCER RES, V63, P6751; Chandraratne S, 2015, ARTERIOSCL THROM VAS, V35, P589, DOI 10.1161/ATVBAHA.114.304447; Chen YQ, 1997, INT J CANCER, V72, P642, DOI 10.1002/(SICI)1097-0215(19970807)72:4<642::AID-IJC16>3.0.CO;2-D; COLLER BS, 1995, CIRCULATION, V92, P2373, DOI 10.1161/01.CIR.92.9.2373; Decristoforo C, 2006, NUCL MED BIOL, V33, P945, DOI 10.1016/j.nucmedbio.2006.09.001; Emambokus NR, 2003, IMMUNITY, V19, P33, DOI 10.1016/S1074-7613(03)00173-0; Erpenbeck L, 2010, J INVEST DERMATOL, V130, P576, DOI 10.1038/jid.2009.278; EVANS PM, 1984, CELL BIOL INT REP, V8, P659, DOI 10.1016/0309-1651(84)90046-8; FeldingHabermann B, 1996, J BIOL CHEM, V271, P5892, DOI 10.1074/jbc.271.10.5892; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; GIAVAZZI R, 1993, J CLIN INVEST, V92, P3038, DOI 10.1172/JCI116928; Gobbi G, 2006, INT J MOL MED, V18, P309; HART IR, 1979, AM J PATHOL, V97, P587; HEINZMANN U, 1994, HISTOCHEMISTRY, V101, P127, DOI 10.1007/BF00269359; Ho-Tin-Noe B, 2008, CANCER RES, V68, P6851, DOI 10.1158/0008-5472.CAN-08-0718; HONN KV, 1992, EXP CELL RES, V201, P23, DOI 10.1016/0014-4827(92)90344-8; Jain S, 2007, P NATL ACAD SCI USA, V104, P9024, DOI 10.1073/pnas.0700625104; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kroll MH, 1996, BLOOD, V88, P1525; Laemmel E, 2004, J VASC RES, V41, P400, DOI 10.1159/000081209; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Leblanc R, 2016, BLOOD, V128, P24, DOI 10.1182/blood-2016-01-636399; Liang S, 2008, ANN BIOMED ENG, V36, P661, DOI 10.1007/s10439-008-9445-8; Lonsdorf AS, 2012, J BIOL CHEM, V287, P2168, DOI 10.1074/jbc.M111.269811; Nezos A, 2011, CANCER TREAT REV, V37, P284, DOI 10.1016/j.ctrv.2010.10.002; Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100; Nieswandt B, 1999, CANCER RES, V59, P1295; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Pilch J, 2002, J BIOL CHEM, V277, P21930, DOI 10.1074/jbc.M201630200; Rakhmilevich AL, 2001, CLIN CANCER RES, V7, P952; Schreurs MWJ, 1997, MELANOMA RES, V7, P463, DOI 10.1097/00008390-199712000-00004; Schulz C, 2007, CIRCULATION, V116, P764, DOI 10.1161/CIRCULATIONAHA.107.695189; Schwarte LA, 2000, BASIC RES CARDIOL, V95, P510, DOI 10.1007/s003950070029; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Sperandio M, 2006, METHOD ENZYMOL, V416, P346, DOI 10.1016/S0076-6879(06)16023-1; Tam SH, 1998, CIRCULATION, V98, P1085, DOI 10.1161/01.CIR.98.11.1085; Terraube V, 2006, J THROMB HAEMOST, V4, P519, DOI 10.1111/j.1538-7836.2005.01770.x; Trikha M, 2002, CANCER RES, V62, P2824; Wagner SN, 2000, J INVEST DERMATOL, V115, P1082, DOI 10.1046/j.1523-1747.2000.00157.x; WEISS L, 1991, CELL BIOPHYS, V18, P73, DOI 10.1007/BF02989807; Winter H, 1999, J IMMUNOL, V163, P4462; ZHU DZ, 1991, P NATL ACAD SCI USA, V88, P9568, DOI 10.1073/pnas.88.21.9568	51	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172788	10.1371/journal.pone.0172788	http://dx.doi.org/10.1371/journal.pone.0172788			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253287	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300032
J	Novakovic, P; Harding, JCS; Al-Dissi, AN; Detmer, SE				Novakovic, Predrag; Harding, John C. S.; Al-Dissi, Ahmad N.; Detmer, Susan E.			Type 2 porcine reproductive and respiratory syndrome virus infection increases apoptosis at the maternal-fetal interface in late gestation pregnant gilts	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; IMPLANTATION SITES; CELL-DEATH; IN-VITRO; REPLICATION; PATHOGENESIS; PATHOLOGY; FETUSES; ISOLATE; VIVO	The pathogenesis of fetal death associated with porcine reproductive and respiratory syndrome (PRRS) is hypothesized to be a consequence of PRRS virus-induced apoptosis at the maternal-fetal interface (MFI). The objectives of this study were to evaluate distribution and degree of apoptosis in the uterine and fetal placental tissues during the experimental type 2 PRRS virus (PRRSV) infection and determine associations between apoptosis at the MFI, PRRSV RNA concentration and antigen staining intensity, PRRSV-induced microscopic lesions, and fetal preservation status. A total of 114 naive, high-health pregnant gilts were inoculated with type 2 PRRSV on gestation day 85 +/- 1 with euthanasia 21 days later; 19 sham-inoculated gilts served as controls. Two hundred and fifty samples of uterine tissue with fetal placenta were selected based on negative, low PRRSV RNA, and high PRRSV RNA concentration (0, < or > 2.7 log(10) copies/mg, respectively). TUNEL assay was used to detect apoptosis in the endometrium and at the MFI. PRRSV RNA concentration and numbers of PRRSV immunopositive cells in uterine and placental tissue were positively associated with the severity of apoptosis in the endometrium and the MFI (P<0.001, P<0.05 and P<0.001, respectively). The number of TUNEL positive cells at the MFI was also positively associated with the severity (P<0.001) of vasculitis, but not total numbers of inflammatory cells in the endometrium. Increased numbers of TUNEL positive cells at the MFI were associated with PRRSV load in the fetal thymus, and greater odds of meconium staining of the fetus at 21 days post infection (P<0.001 for both). These findings suggest an important role of apoptosis in the pathogenesis of uterine epithelial and trophoblastic cell death at the MFI. Moreover, apoptosis at the MFI is significantly associated with fetal demise during in utero type 2 PRRSV infection.	[Novakovic, Predrag; Harding, John C. S.] Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK, Canada; [Al-Dissi, Ahmad N.; Detmer, Susan E.] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Pathol, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Novakovic, P (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK, Canada.	predrag.novakovic@usask.ca		Detmer, Susan/0000-0002-4064-3460; Al-Dissi, Ahmad/0000-0002-3124-3502	Genome Canada; Genome Prairie (Saskatchewan Ministry of Agriculture and Food); Boehringer Ingelheim Vetmedica, Inc.	Genome Canada(Genome Canada); Genome Prairie (Saskatchewan Ministry of Agriculture and Food); Boehringer Ingelheim Vetmedica, Inc.(Boehringer Ingelheim)	Funding for this project was generously provided by Genome Canada, Genome Prairie (Saskatchewan Ministry of Agriculture and Food), and a Boehringer Ingelheim Vetmedica, Inc. PRRS Research Award, with administrative support provided by Genome Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dissi AN, 2007, VET PATHOL, V44, P823, DOI 10.1354/vp.44-6-823; Cano JP, 2009, CAN J VET RES, V73, P303; Cheon DS, 2001, J COMP PATHOL, V124, P231, DOI 10.1053/jcpa.2000.0457; Choi K, 2015, J COMP PATHOL, V152, P317, DOI 10.1016/j.jcpa.2015.03.002; Costers S, 2008, ARCH VIROL, V153, P1453, DOI 10.1007/s00705-008-0135-5; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Flores-Mendoza L, 2008, CLIN VACCINE IMMUNOL, V15, P720, DOI 10.1128/CVI.00224-07; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Han K, 2012, J COMP PATHOL, V147, P275, DOI 10.1016/j.jcpa.2011.12.010; Karniychuk UU, 2012, THERIOGENOLOGY, V78, P1527, DOI 10.1016/j.theriogenology.2012.06.015; Karniychuk UU, 2011, MICROB PATHOGENESIS, V51, P194, DOI 10.1016/j.micpath.2011.04.001; Kelly R, 2009, AM J EPIDEMIOL, V170, P148, DOI 10.1093/aje/kwp131; Kim TS, 2002, VIRUS RES, V85, P133, DOI 10.1016/S0168-1702(02)00029-1; Labarque G, 2003, VET RES, V34, P249, DOI 10.1051/vetres:2003001; Ladinig A, 2014, PLOS ONE, V9, P96; Ladinig A, 2015, VET RES, V46, DOI 10.1186/s13567-015-0251-7; Ladinig A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109541; Lager KM, 1996, J VET DIAGN INVEST, V8, P275, DOI 10.1177/104063879600800301; Novakovic P, 2016, VET RES, V47, DOI 10.1186/s13567-016-0364-7; Novakovic P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151198; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Rowland RRR, 2010, VIRUS RES, V154, P114, DOI 10.1016/j.virusres.2010.09.001; Sirinarumitr T, 1998, J GEN VIROL, V79, P2989, DOI 10.1099/0022-1317-79-12-2989; Sur JH, 1998, VET PATHOL, V35, P506, DOI 10.1177/030098589803500605; Tanir H. Mete, 2005, Archives of Gynecology and Obstetrics, V273, P98, DOI 10.1007/s00404-005-0028-8; Thanawongnuwech R, 1997, VET IMMUNOL IMMUNOP, V59, P323, DOI 10.1016/S0165-2427(97)00078-0; Thanawongnuwech Roongroje, 2000, Animal Health Research Reviews, V1, P95, DOI 10.1017/S1466252300000086	27	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173360	10.1371/journal.pone.0173360	http://dx.doi.org/10.1371/journal.pone.0173360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253336	Green Published, gold			2022-12-26	WOS:000396011300103
J	Biza, KV; Nastou, KC; Tsiolaki, PL; Mastrokalou, CV; Hamodrakas, SJ; Iconomidou, VA				Biza, Konstantina V.; Nastou, Katerina C.; Tsiolaki, Paraskevi L.; Mastrokalou, Chara V.; Hamodrakas, Stavros J.; Iconomidou, Vassiliki A.			The amyloid interactome: Exploring protein aggregation	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; HIGH-DENSITY-LIPOPROTEIN; HUMAN SERUM-ALBUMIN; INTERACTION NETWORKS; ALZHEIMERS-DISEASE; SYSTEMS BIOLOGY; BETA-PROTEIN; A-BETA; NEURODEGENERATIVE DISEASES; MOLECULAR CHAPERONES	Protein-protein interactions are the quintessence of physiological activities, but also participate in pathological conditions. Amyloid formation, an abnormal protein-protein interaction process, is a widespread phenomenon in divergent proteins and peptides, resulting in a variety of aggregation disorders. The complexity of the mechanisms underlying amyloid formation/amyloidogenicity is a matter of great scientific interest, since their revelation will provide important insight on principles governing protein misfolding, self-assembly and aggregation. The implication of more than one protein in the progression of different aggregation disorders, together with the cited synergistic occurrence between amyloidogenic proteins, highlights the necessity for a more universal approach, during the study of these proteins. In an attempt to address this pivotal need we constructed and analyzed the human amyloid interactome, a protein-protein interaction network of amyloidogenic proteins and their experimentally verified interactors. This network assembled known interconnections between well-characterized amyloidogenic proteins and proteins related to amyloid fibril formation. The consecutive extended computational analysis revealed significant topological characteristics and unraveled the functional roles of all constituent elements. This study introduces a detailed protein map of amyloidogenicity that will aid immensely towards separate intervention strategies, specifically targeting sub-networks of significant nodes, in an attempt to design possible novel therapeutics for aggregation disorders.	[Biza, Konstantina V.; Nastou, Katerina C.; Tsiolaki, Paraskevi L.; Mastrokalou, Chara V.; Hamodrakas, Stavros J.; Iconomidou, Vassiliki A.] Univ Athens, Sect Cell Biol & Biophys, Dept Biol, Sch Sci, Athens, Greece	National & Kapodistrian University of Athens	Iconomidou, VA (corresponding author), Univ Athens, Sect Cell Biol & Biophys, Dept Biol, Sch Sci, Athens, Greece.	veconom@biol.uoa.gr	Iconomidou, Vassiliki/AAM-2003-2020	Iconomidou, Vassiliki/0000-0002-9472-5146; Tsiolaki, Paraskevi L./0000-0002-9525-6433; Nastou, Katerina/0000-0003-3611-5726	Greek State Scholarships Foundation	Greek State Scholarships Foundation(Greek Ministry of Development-GSRT)	This project was financially supported by the Greek State Scholarships Foundation, through the program: "RESEARCH PROJECTS FOR EXCELLENCE IKY/SIEMENS" (2015-2017).	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Antony H, 2012, CANCER METAST REV, V31, P1, DOI 10.1007/s10555-011-9325-9; Arimon M, 2008, J MOL BIOL, V384, P1157, DOI 10.1016/j.jmb.2008.09.063; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bader S, 2008, FEBS LETT, V582, P1220, DOI 10.1016/j.febslet.2008.02.015; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Beerten J, 2015, BIOINFORMATICS, V31, P1698, DOI 10.1093/bioinformatics/btv027; Bergman P, 2016, J INTERN MED, V280, P139, DOI 10.1111/joim.12479; Bergstrom J, 2004, LAB INVEST, V84, P981, DOI 10.1038/labinvest.3700124; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Calero M, 2012, METHODS MOL BIOL, V849, P213, DOI 10.1007/978-1-61779-551-0_15; Carter DB, 2005, SUB CELL BIOCHEM, V38, P255; Carver JA, 2003, IUBMB LIFE, V55, P661, DOI 10.1080/15216540310001640498; Chauhan VPS, 1999, BIOCHEM BIOPH RES CO, V258, P241, DOI 10.1006/bbrc.1999.0623; Chen JX, 2006, PROCEEDINGS OF THE 2006 IEEE INTERNATIONAL CONFERENCE ON VEHICULAR ELECTRONICS AND SAFETY, P367; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Collavin L, 2010, CELL DEATH DIFFER, V17, P901, DOI 10.1038/cdd.2010.35; Csermely Peter, 2008, Novartis Found Symp, V291, P45; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; D'Souza A, 2014, AMYLOID, V21, P71, DOI 10.3109/13506129.2013.876984; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; de Sousa MM, 2000, AM J PATHOL, V156, P1911, DOI 10.1016/S0002-9440(10)65064-X; Dominguez-Prieto M, 2017, J ALZHEIMERS DIS, V55, P171, DOI 10.3233/JAD-160346; Doyle JC, 2005, P NATL ACAD SCI USA, V102, P14497, DOI 10.1073/pnas.0501426102; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; ERIKSEN N, 1980, P NATL ACAD SCI-BIOL, V77, P6860, DOI 10.1073/pnas.77.11.6860; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Franz M, 2016, BIOINFORMATICS, V32, P309, DOI 10.1093/bioinformatics/btv557; Fronczak A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056110; Fukuyama H, 2013, P NATL ACAD SCI USA, V110, P10717, DOI 10.1073/pnas.1304380110; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Gillis J, 2014, J PROTEOMICS, V100, P44, DOI 10.1016/j.jprot.2014.01.020; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Goni J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-52; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gunawardana CG, 2015, MOL CELL PROTEOMICS, V14, P3000, DOI 10.1074/mcp.M115.050724; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Guo JP, 2006, P NATL ACAD SCI USA, V103, P1953, DOI 10.1073/pnas.0509386103; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Huang LQ, 2015, ARCH BIOCHEM BIOPHYS, V568, P46, DOI 10.1016/j.abb.2015.01.007; Hye A, 2006, BRAIN, V129, P3042, DOI 10.1093/brain/awl279; Iconomidou VA, 2000, FEBS LETT, V479, P141, DOI 10.1016/S0014-5793(00)01888-3; ISOBE T, 1993, INTERNAL MED, V32, P919, DOI 10.2169/internalmedicine.32.919; Jalili M, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.012803; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Kerrien S, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-44; Koudinov AR, 1998, CLIN CHIM ACTA, V270, P75, DOI 10.1016/S0009-8981(97)00207-6; Kudva YC, 1997, FEBS LETT, V416, P117, DOI 10.1016/S0014-5793(97)01180-0; Landreh M, 2015, J BIOL CHEM, V290, P26430, DOI 10.1074/jbc.R115.653097; Lee S, 2006, BIOCHEM BIOPH RES CO, V347, P527, DOI 10.1016/j.bbrc.2006.06.128; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; Levy Efrat, 2008, Expert Rev Neurother, V8, P687, DOI 10.1586/14737175.8.5.687; Li X, 2007, J BIOMED INFORM, V40, P453, DOI 10.1016/j.jbi.2007.01.001; Licata L, 2016, METHODS MOL BIOL, V1415, P55, DOI 10.1007/978-1-4939-3572-7_3; Lotia S, 2013, BIOINFORMATICS, V29, P1350, DOI 10.1093/bioinformatics/btt138; Lu JH, 2014, P NATL ACAD SCI USA, V111, P5189, DOI 10.1073/pnas.1322357111; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Morales R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003537; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Nastou KC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/397145; Palotai R, 2008, IUBMB LIFE, V60, P10, DOI 10.1002/iub.8; Pawlicki S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-273; Petta I, 2016, MOL THER, V24, P707, DOI 10.1038/mt.2015.214; Rao L, 2013, J COMPUT CHEM, V34, P1636, DOI 10.1002/jcc.23303; Rao V Srinivasa, 2014, Int J Proteomics, V2014, P147648, DOI 10.1155/2014/147648; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Ray I, 2000, BRAIN RES, V853, P344, DOI 10.1016/S0006-8993(99)02315-X; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Silva JV, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-014-0432-9; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; Soti C, 2007, EXP GERONTOL, V42, P113, DOI 10.1016/j.exger.2006.05.017; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Taboada P, 2006, J PHYS CHEM B, V110, P20733, DOI 10.1021/jp064861r; Teng PK, 2009, PROTEIN ENG DES SEL, V22, P531, DOI 10.1093/protein/gzp037; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tizon B, 2010, J ALZHEIMERS DIS, V19, P885, DOI 10.3233/JAD-2010-1291; Tourette C, 2014, J BIOL CHEM, V289, P6709, DOI 10.1074/jbc.M113.523696; Tsigelny IF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003135; Ulbrich L, 2014, CELL MOL NEUROBIOL, V34, P205, DOI 10.1007/s10571-013-0004-y; Uversky V.N., 1999, MED SCI MONITOR, V5, P1001; Uversky V.N., 1999, MED SCI MONITOR, V5, P1238; Van Dongen S., 2000, THESIS; Vega L, 2009, J ALZHEIMERS DIS, V17, P795, DOI 10.3233/JAD-2009-1093; Velayudhan L, 2012, J ALZHEIMERS DIS, V28, P369, DOI 10.3233/JAD-2011-110611; Vinayagam A, 2014, NAT METHODS, V11, P94, DOI [10.1038/nmeth.2733, 10.1038/NMETH.2733]; Virok DP, 2011, J PROTEOME RES, V10, P1538, DOI 10.1021/pr1009096; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Westermark GT, 2008, EXP DIABETES RES, DOI 10.1155/2008/429274; Westermark P, 1997, AM J PATHOL, V150, P67; Wilhelmus MMM, 2007, MOL NEUROBIOL, V35, P203, DOI 10.1007/s12035-007-0029-7; Wilhelmus MMM, 2009, NEUROBIOL AGING, V30, P229, DOI 10.1016/j.neurobiolaging.2007.06.001; Wiltzius JJW, 2009, PROTEIN SCI, V18, P1521, DOI 10.1002/pro.145; Wozniak PP, 2015, BIOINFORMATICS, V31, P3395, DOI 10.1093/bioinformatics/btv375; Xiao Fan Wang, 2003, IEEE Circuits and Systems Magazine, V3, P6, DOI 10.1109/MCAS.2003.1228503; Yan JM, 2007, AM J PATHOL, V171, P172, DOI 10.2353/ajpath.2007.060576; Yerbury J., 2010, CURR CHEM BIOL, V4, P89; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yook SH, 2002, P NATL ACAD SCI USA, V99, P13382, DOI 10.1073/pnas.172501399; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	114	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173163	10.1371/journal.pone.0173163	http://dx.doi.org/10.1371/journal.pone.0173163			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249044	Green Submitted, gold, Green Published			2022-12-26	WOS:000395983500080
J	Englund-Ogge, L; Birgisdottir, BE; Sengpiel, V; Brantsaeter, AL; Haugen, M; Myhre, R; Meltzer, HM; Jacobsson, B				Englund-Ogge, Linda; Birgisdottir, Bryndis Eva; Sengpiel, Verena; Brantsaeter, Anne Lise; Haugen, Margareta; Myhre, Ronny; Meltzer, Helle Margrete; Jacobsson, Bo			Meal frequency patterns and glycemic properties of maternal diet in relation to preterm delivery: Results from a large prospective cohort study	PLOS ONE			English	Article							NORWEGIAN MOTHER; CHILD COHORT; INSULIN-RESISTANCE; PREGNANT-WOMEN; MULTIPLE-PROTEINS; AMNIOTIC-FLUID; LABOR; BIRTH; RISK; MOBA	Background Dietary habits are linked to high maternal glucose levels, associated with preterm delivery. The aim of this study was to examine the associations between meal frequency and glycemic properties of maternal diet in relation to preterm delivery. Methods This prospective cohort study included 66,000 women from the Norwegian Mother and Child Cohort Study (MoBa). Meal frequency and food intake data were obtained from a validated food frequency questionnaire during mid-pregnancy. Principal component factor analysis was used with a data-driven approach, and three meal frequency patterns were identified: "snack meal", "main meal", and "evening meal". Pattern scores were ranked in quartiles. Glycemic index and glycemic load were estimated from table values. Intakes of carbohydrates, added sugar, and fiber were reported in grams per day and divided into quartiles. Gestational age was obtained from the Medical Birth Registry of Norway. Preterm delivery was defined as birth at <37 gestational weeks. A Cox regression model was used to assess associations with preterm delivery. Results After adjustments, the "main meal" pattern was associated with a reduced risk of preterm delivery, with hazard ratios (HRs) of 0.89 (95% confidence interval (CI): 0.80, 0.98) and 0.90 (95% CI: 0.81, 0.99) for the third and fourth quartiles, respectively, and p for trend of 0.028. This was mainly attributed to the group of women with BMI >= 25 kg/m(2), with HRs of 0.87 (95% CI: 0.79, 0.96) and 0.89 (95% CI: 0.80, 0.98) for the third and fourth quartiles, respectively, and p for trend of 0.010. There was no association between glycemic index, glycemic load, carbohydrates, added sugar, fiber, or the remaining meal frequency patterns and pre-term delivery. Conclusion Regular consumption of main meals (breakfast, lunch, dinner) was associated with a lower risk of preterm delivery. Diet should be further studied as potential contributing factors for preterm delivery.	[Englund-Ogge, Linda; Sengpiel, Verena] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden; [Birgisdottir, Bryndis Eva; Brantsaeter, Anne Lise; Haugen, Margareta; Meltzer, Helle Margrete] Domain Infect Control & Environm Hlth, Dept Environm Exposure & Epidemiol, Oslo, Norway; [Birgisdottir, Bryndis Eva] Univ Iceland, Natl Univ Hosp, Fac Food Sci & Nutr, Unit Nutr Res, Reykjavik, Iceland; [Myhre, Ronny; Jacobsson, Bo] Inst Publ Hlth, Dept Genet & Bioinformat, Domain Hlth Data & Digitalizat, Oslo, Norway; [Jacobsson, Bo] Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynecol, Gothenburg, Sweden	Sahlgrenska University Hospital; Landspitali National University Hospital; University of Iceland; University of Gothenburg	Englund-Ogge, L (corresponding author), Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden.	linda.englund-ogge@vgregion.se	Brantsaeter, Anne Lise/H-7014-2016; Jacobsson, Bo/O-8007-2014	Brantsaeter, Anne Lise/0000-0001-6315-7134; Jacobsson, Bo/0000-0001-5079-2374; Birgisdottir, Bryndis Eva/0000-0002-5788-4551; Meltzer, Helle Margrete/0000-0002-3591-7017	Freemanson's Directorate Board for Children [ES236011]; Adlerbertska Foundation; Norwegian Research Council [FUGE 183220/S10, FRIMEDKLI-05 ES236011]; Jane and Dan Olsson Foundation; Swedish Medical Society [SLS 2008-21198]; Swedish government [ALFGBG-2863, ALFGBG-11522]; Norwegian Ministry of Health; Ministry of Education and Research [N01-ES-75558]; NIH/NINDS [UO1 NS 047537-01, UO1 NS 047537-06A1]; Norwegian Research Council/FUGE [151918/S10]	Freemanson's Directorate Board for Children; Adlerbertska Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); Jane and Dan Olsson Foundation; Swedish Medical Society; Swedish government; Norwegian Ministry of Health; Ministry of Education and Research; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Norwegian Research Council/FUGE(Research Council of Norway)	This work was supported by Freemanson's Directorate Board for Children, ES236011, MD Linda Englund Ogge; Adlerbertska Foundation, MD Linda Englund Ogge; the Norwegian Research Council, FUGE 183220/S10, MD Linda Englund Ogge; Norwegian Research Council, FRIMEDKLI-05 ES236011, MD Linda Englund Ogge; Jane and Dan Olsson Foundation, MD Linda Englund Ogge; Swedish Medical Society, SLS 2008-21198, MD Linda Englund Ogge; Swedish government grants to researchers in public health service, ALFGBG-2863, MD Linda Englund Ogge; Swedish government grants to researchers in public health service, ALFGBG-11522, MD Linda Englund Ogge; the Norwegian Ministry of Health and the Ministry of Education and Research, N01-ES-75558; NIH/NINDS, UO1 NS 047537-01; NIH/NINDS, UO1 NS 047537-06A1; Norwegian Research Council/FUGE, 151918/S10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; BINIENDA Z, 1989, AM J OBSTET GYNECOL, V160, P746, DOI 10.1016/S0002-9378(89)80073-0; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Brantsaeter AL, 2008, MATERN CHILD NUTR, V4, P28, DOI 10.1111/j.1740-8709.2007.00103.x; Carmichael SL, 2012, AM J PERINATOL; Carmichael SL, 2013, AM J PERINAT, V30, P579, DOI 10.1055/s-0032-1329686; Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; Dahl LB, 2000, ACTA OBSTET GYN SCAN, V79, P1075, DOI 10.1034/j.1600-0412.2000.0790121075.x; Dekker GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039154; Duffey KJ, 2012, EUR J CLIN NUTR, V66, P244, DOI 10.1038/ejcn.2011.166; Englund-Ogge L, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1446; Englund-Ogge L, 2012, AM J CLIN NUTR, V96, P552, DOI 10.3945/ajcn.111.031567; Farshchi HR, 2004, EUR J CLIN NUTR, V58, P1071, DOI 10.1038/sj.ejcn.1601935; Hillesund ER, 2014, EUR J EPIDEMIOL, V29, P753, DOI 10.1007/s10654-014-9948-6; Holst RM, 2005, ACTA OBSTET GYN SCAN, V84, P551, DOI 10.1111/j.0001-6349.2005.00708.x; Holst RM, 2009, OBSTET GYNECOL, V114, P268, DOI 10.1097/AOG.0b013e3181ae6a08; Iams JD, 2010, AM J OBSTET GYNECOL, V203, P89, DOI 10.1016/j.ajog.2010.02.004; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Jolliffe I. T, PRINCIPAL COMPONENT, Vsecond; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; KAPLAN M, 1983, JAMA-J AM MED ASSOC, V250, P1317, DOI 10.1001/jama.250.10.1317; Knudsen VK, 2014, EUR J CLIN NUTR, V68, P736, DOI 10.1038/ejcn.2014.38; Krentz AJ, 2013, DIABETIC MED, V30, P535, DOI 10.1111/dme.12063; Kulovitz MG, 2014, NUTRITION, V30, P386, DOI 10.1016/j.nut.2013.08.009; Lautt W Wayne, 2007, Ther Clin Risk Manag, V3, P761; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Magnus P, 2016, INT J EPIDEMIOL, V45, P382, DOI 10.1093/ije/dyw029; Matthan NR, 2016, AM J CLIN NUTR, V104, P1004, DOI 10.3945/ajcn.116.137208; Mattson MP, 2014, P NATL ACAD SCI USA, V111, P16647, DOI 10.1073/pnas.1413965111; Mattson MP, 2005, ANNU REV NUTR, V25, P237, DOI 10.1146/annurev.nutr.25.050304.092526; Meltzer HM, 2008, MATERN CHILD NUTR, V4, P14, DOI 10.1111/j.1740-8709.2007.00104.x; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Monzavi R, 2006, PEDIATRICS, V117, pE1111, DOI 10.1542/peds.2005-1532; Moreli JB, 2015, DIABETES RES CLIN PR, V107, P362, DOI 10.1016/j.diabres.2015.01.005; Morken NH, 2005, ACTA OBSTET GYN SCAN, V84, P558, DOI 10.1111/j.0001-6349.2005.00765.x; Morrens A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0958-0; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Musilova I, 2016, J MATERN-FETAL NEO M, V29, P2915, DOI 10.3109/14767058.2015.1112372; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Nordiska ministerradet NMs, 2004, NORD NUTR REC 2004 I; Overby NC, 2013, FOOD NUTR RES, P57; Owe KM, 2012, MED SCI SPORT EXER, V44, P1067, DOI 10.1249/MSS.0b013e3182442fc9; Rhodes ET, 2010, AM J CLIN NUTR, V92, P1306, DOI 10.3945/ajcn.2010.30130; RIMESTAD AH, 2001, NORWEGIAN FOOD COMPO; Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545; Scholl TO, 2001, AM J EPIDEMIOL, V154, P514, DOI 10.1093/aje/154.6.514; Scifres C, 2015, OBSTET GYNECOL, V126, P316, DOI 10.1097/AOG.0000000000000928; Sheard NF, 2004, DIABETES CARE, V27, P2266, DOI 10.2337/diacare.27.9.2266; Siega-Riz AM, 2001, AM J EPIDEMIOL, V153, P647, DOI 10.1093/aje/153.7.647; Silver M, 1982, J Reprod Fertil Suppl, V32, P511; Tsiartas P, 2012, BJOG-INT J OBSTET GY, V119, P866, DOI 10.1111/j.1471-0528.2012.03328.x; Venn BJ, 2007, EUR J CLIN NUTR, V61, pS122, DOI 10.1038/sj.ejcn.1602942; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Wolever TMS, 2013, EUR J CLIN NUTR, V67, P522, DOI 10.1038/ejcn.2013.27; Woolhead C, 2015, AM J CLIN NUTR, V102, P316, DOI 10.3945/ajcn.114.106112; Yuan Wei, 2010, BMC Res Notes, V3, P119, DOI 10.1186/1756-0500-3-119	58	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172896	10.1371/journal.pone.0172896	http://dx.doi.org/10.1371/journal.pone.0172896			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249018	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000395983500062
J	Huang, L; Wang, Z; Liu, C; Xu, C; Mbofung, RM; McKenzie, JA; Khong, H; Hwu, P; Peng, W				Huang, L.; Wang, Z.; Liu, C.; Xu, C.; Mbofung, R. M.; McKenzie, J. A.; Khong, H.; Hwu, P.; Peng, W.			CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner	ONCOGENE			English	Article							PLASMACYTOID DENDRITIC CELLS; COMBINING TARGETED THERAPY; METASTATIC MELANOMA; IMMUNE-RESPONSES; VACCINE ADJUVANT; CANCER VACCINES; T-CELLS; TUMOR; ANTIGEN; DNA	Combining immunotherapy with targeted therapy has increasingly become an appealing therapeutic paradigm for cancer treatment due to its great potential for generating durable and synergistic antitumor response. In this study, however, we unexpectedly found that two types of CpG-based tumor peptide vaccine treatments consistently negated the antitumor activity of a selective BRAF inhibitor in tumors with BRAF mutation rather than showing a synergistic antitumor effect. Our further studies demonstrated that CpG alone was sufficient to dampen BRAF inhibitor-induced antitumor responses, suggesting that the impaired antitumor activity of the BRAF inhibitor observed in mice receiving CpG-based peptide vaccine is mainly dependent upon the use of CpG. Mechanistically, CpG increased the number of circulating B cells, which produced elevated amounts of tumor necrosis factor-alpha (TNF alpha) that contributed to the increased tumor resistance to BRAF inhibitors. More importantly, B-cell depletion or TNF alpha neutralization can restore the antitumor effect of BRAF inhibition in mice receiving CpG treatment, indicating that TNF alpha-secreting B cells play an indispensable role in BRAF inhibitor resistance induced by CpG. Taken together, our results strongly suggest that precautions must be implemented when designing combinatorial approaches for cancer treatment, because distinct regimens, despite their respective therapeutic benefit as monotherapy, may together provide antagonistic clinical outcomes.	[Huang, L.; Wang, Z.; Liu, C.; Xu, C.; Mbofung, R. M.; McKenzie, J. A.; Khong, H.; Hwu, P.; Peng, W.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Peng, W (corresponding author), Univ Texas MD Anderson Canc Ctr, 7455 Fannin St Unit 904, Houston, TX 77054 USA.; Hwu, P (corresponding author), Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA.	phwu@mdanderson.org; wpeng@mdanderson.org	Huang, Lu/I-4148-2018	Mbofung, Rina/0000-0003-3872-3143; Khong, Hiep/0000-0003-4888-7862	National Cancer Institute [R01CA116206, P01CA128913, R01CA187076, P50CA093459, P30CA016672]; NATIONAL CANCER INSTITUTE [R01CA116206, R01CA187076, P30CA016672, P50CA093459, P01CA128913] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Hussein Tawbi for constructive comments on the manuscript. The research was supported in part by the following National Cancer Institute grants: R01CA116206 (to PH), P01CA128913 (to PH), R01CA187076 (to PH and MD), P50CA093459 and P30CA016672 (MDACC Melanoma SPORE and MDACC CCSG for JAM and Flow facility, respectively). By the Cancer Prevention and Research Institute of Texas (CPRIT RP140106 to JAM) and by philanthropic contributions to MDACC Melanoma Moon Shot Program; Melanoma Research Alliance Team Science Award; Dr Miriam and Sheldon G Adelson Medical Research Foundation; Aim at Melanoma Foundation, Miriam and Jim Mulva research funds; Jurgen Sager & Transocean Melanoma Research Fund; El Paso Foundation for Melanoma Research; GillsonLogenbaugh Foundation. We thank Cherie Butts from Biogen for providing antimouse CD20 antibody.	Avalos AM, 2009, J IMMUNOL, V183, P6262, DOI 10.4049/jimmunol.0901941; Bauer S, 2002, CURR TOP MICROBIOL, V270, P145; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Cooper ZA, 2014, CANCER IMMUNOL RES, V2, P643, DOI 10.1158/2326-6066.CIR-13-0215; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davila E, 2003, CANCER RES, V63, P3281; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gray-Schopfer VC, 2007, CANCER RES, V67, P122, DOI 10.1158/0008-5472.CAN-06-1880; Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105; Hanten JA, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-39; Hu-Lieskovan S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4691; Hu-Lieskovan S, 2014, J CLIN ONCOL, V32, P2248, DOI 10.1200/JCO.2013.52.1377; Jerome V, 2006, J IMMUNOTHER, V29, P294; Kim S, 2008, J IMMUNOTHER, V31, P446, DOI 10.1097/CJI.0b013e31816d1d6a; Kim Teresa, 2014, Cancer Biology Medicine, V11, P237, DOI 10.7497/j.issn.2095-3941.2014.04.002; Koya RC, 2012, CANCER RES, V72, P3928, DOI 10.1158/0008-5472.CAN-11-2837; Liu CW, 2008, J CLIN INVEST, V118, P1165, DOI 10.1172/JCI33583; Liu CW, 2013, CLIN CANCER RES, V19, P393, DOI 10.1158/1078-0432.CCR-12-1626; Lou YY, 2011, J IMMUNOTHER, V34, P279, DOI 10.1097/CJI.0b013e31820d2a05; Mehta NK, 2015, CANCER IMMUNOL RES, V3, P836, DOI 10.1158/2326-6066.CIR-15-0112; Melief CJM, 2015, J CLIN INVEST, V125, P3401, DOI 10.1172/JCI80009; Menon Dinoop R, 2013, Pigment Cell Melanoma Res, V26, P912, DOI 10.1111/pcmr.12139; Pashenkov M, 2006, J CLIN ONCOL, V24, P5716, DOI 10.1200/JCO.2006.07.9129; Peng WY, 2010, CLIN CANCER RES, V16, P5458, DOI 10.1158/1078-0432.CCR-10-0712; Perricone MA, 2004, J IMMUNOTHER, V27, P273, DOI 10.1097/00002371-200407000-00003; Ribas A, 2013, NEW ENGL J MED, V368, P1365, DOI 10.1056/NEJMc1302338; Rothenfusser S, 2002, HUM IMMUNOL, V63, P1111, DOI 10.1016/S0198-8859(02)00749-8; Scheiermann J, 2014, VACCINE, V32, P6377, DOI 10.1016/j.vaccine.2014.06.065; Shirota H, 2015, VACCINES-BASEL, V3, P390, DOI 10.3390/vaccines3020390; Shirota H, 2014, EXPERT REV VACCINES, V13, P299, DOI 10.1586/14760584.2014.863715; Smith MP, 2014, CANCER DISCOV, V4, P1214, DOI 10.1158/2159-8290.CD-13-1007; Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373; Tadmor T, 2011, CANCER IMMUNOL IMMUN, V60, P609, DOI 10.1007/s00262-011-0972-z; Vollmer J, 2009, ADV DRUG DELIVER REV, V61, P195, DOI 10.1016/j.addr.2008.12.008; Weiner GJ, 1997, P NATL ACAD SCI USA, V94, P10833, DOI 10.1073/pnas.94.20.10833	35	7	9	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 13	2017	36	28					4081	4086		10.1038/onc.2017.35	http://dx.doi.org/10.1038/onc.2017.35			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FA3YD	28263973	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000405379900013
J	Tao, T; Sondalle, SB; Shi, H; Zhu, S; Perez-Atayde, AR; Peng, J; Baserga, SJ; Look, AT				Tao, T.; Sondalle, S. B.; Shi, H.; Zhu, S.; Perez-Atayde, A. R.; Peng, J.; Baserga, S. J.; Look, A. T.			The pre-rRNA processing factor DEF is rate limiting for the pathogenesis of MYCN-driven neuroblastoma	ONCOGENE			English	Article							POLYMERASE I TRANSCRIPTION; SMALL-SUBUNIT PROCESSOME; NUCLEOLAR RNA; C-MYC; GRANULOCYTE DIFFERENTIATION; SACCHAROMYCES-CEREVISIAE; PROMINENT NUCLEOLI; RDNA TRANSCRIPTION; TUMOR INITIATION; CANCER	The nucleolar factor, digestive organ expansion factor (DEF), has a key role in ribosome biogenesis, functioning in pre-ribosomal RNA (pre-rRNA) processing as a component of the small ribosomal subunit (SSU) processome. Here we show that the peripheral sympathetic nervous system (PSNS) is very underdeveloped in def-deficient zebrafish, and that def haploinsufficiency significantly decreases disease penetrance and tumor growth rate in a MYCN-driven transgenic zebrafish model of neuroblastoma that arises in the PSNS. Consistent with these findings, DEF is highly expressed in human neuroblastoma, and its depletion in human neuroblastoma cell lines induces apoptosis. Interestingly, overexpression of MYCN in zebrafish and in human neuroblastoma cells results in the appearance of intermediate pre-rRNAs species that reflect the processing of pre-rRNAs through Pathway 2, a pathway that processes pre-rRNAs in a different temporal order than the more often used Pathway 1. Our results indicate that DEF and possibly other components of the SSU processome provide a novel site of vulnerability in neuroblastoma cells that could be exploited for targeted therapy.	[Tao, T.; Shi, H.; Look, A. T.] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, 450 Brookline Ave,Mayer 630, Boston, MA 02115 USA; [Sondalle, S. B.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Shi, H.; Peng, J.] Zhejiang Univ, Coll Anim Sci, Hangzhou, Zhejiang, Peoples R China; [Zhu, S.] Mayo Clin, Canc Ctr, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA; [Zhu, S.] Mayo Clin, Ctr Individualized Med, Rochester, MN USA; [Zhu, S.] Mayo Clin, Ctr Canc, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Perez-Atayde, A. R.] Harvard Med Sch, Childrens Hosp Boston, Dept Pathol, Boston, MA 02115 USA; [Baserga, S. J.] Yale Univ, Dept Mol Biophys & Biochem, 333 Cedar St, New Haven, CT 06520 USA; [Baserga, S. J.] Yale Univ, Dept Genet, 333 Cedar St, New Haven, CT 06520 USA; [Baserga, S. J.] Yale Univ, Dept Therapeut Radiol, 333 Cedar St, New Haven, CT 06520 USA; [Baserga, S. J.] Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06520 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Yale University; Zhejiang University; Mayo Clinic; Mayo Clinic; Mayo Clinic; Harvard University; Boston Children's Hospital; Harvard Medical School; Yale University; Yale University; Yale University; Yale University	Look, AT (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, 450 Brookline Ave,Mayer 630, Boston, MA 02115 USA.; Baserga, SJ (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 333 Cedar St, New Haven, CT 06520 USA.; Baserga, SJ (corresponding author), Yale Univ, Dept Genet, 333 Cedar St, New Haven, CT 06520 USA.; Baserga, SJ (corresponding author), Yale Univ, Dept Therapeut Radiol, 333 Cedar St, New Haven, CT 06520 USA.; Baserga, SJ (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.	susan.baserga@yale.edu; thomas_look@dfci.harvard.edu	Sondalle, Samuel/C-1283-2014	Sondalle, Samuel/0000-0002-4144-9897; Tao, Ting/0000-0003-1260-2351	Innovation Award from Alex's Lemonade Stand Foundation; NIH [CA180692, GM115710, GM07205, HD007149, F30DK109582]; National Natural Science Foundation of China [31330050]; Young Investigator Award from Alex's Lemonade Stand Foundation; David Abraham Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK109582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205, R01GM115710] Funding Source: NIH RePORTER	Innovation Award from Alex's Lemonade Stand Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Investigator Award from Alex's Lemonade Stand Foundation; David Abraham Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank John R Gilbert for editorial review of the manuscript and critical comments, and Hillary Layden and Shawna Chamberlin for their excellent care of the zebrafish. This work was supported by an Innovation Award from Alex's Lemonade Stand Foundation (ATL), NIH grant CA180692 (ATL), NIH grant GM115710 (SJB), a National Natural Science Foundation of China (No. 31330050; JP), a Young Investigator Award from Alex's Lemonade Stand Foundation (TT), NIH grants GM07205, HD007149 and F30DK109582 (SBS), and David Abraham Fellowship (HS).	An M, 2002, J COMP NEUROL, V446, P267, DOI 10.1002/cne.10214; Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; Boglev Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003279; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Borovjagin AV, 1999, J MOL BIOL, V286, P1347, DOI 10.1006/jmbi.1999.2527; Bywater MJ, 2013, NAT REV CANCER, V13, P299, DOI 10.1038/nrc3496; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Chan JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001754; Charette JM, 2010, RNA, V16, P2156, DOI 10.1261/rna.2359810; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dave B, 2014, P NATL ACAD SCI USA, V111, P8838, DOI 10.1073/pnas.1320769111; Derenzini M, 2009, HISTOPATHOLOGY, V54, P753, DOI 10.1111/j.1365-2559.2008.03168.x; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Essers PB, 2014, DEV BIOL, V385, P304, DOI 10.1016/j.ydbio.2013.10.029; Etchin J, 2011, METHOD CELL BIOL, V105, P309, DOI 10.1016/B978-0-12-381320-6.00013-8; Fleurie A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004275; Fumagalli S, 2012, GENE DEV, V26, P1028, DOI 10.1101/gad.189951.112; Gandin V, 2008, NATURE, V455, P684, DOI 10.1038/nature07267; George RE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000255; Goldfeder MB, 2010, FEBS J, V277, P2838, DOI 10.1111/j.1742-4658.2010.07701.x; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Griffin JN, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005018; Hannan KM, 2013, BBA-GENE REGUL MECH, V1829, P342, DOI 10.1016/j.bbagrm.2012.10.014; Harscoet E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012829; Hein N, 2013, TRENDS MOL MED, V19, P643, DOI 10.1016/j.molmed.2013.07.005; Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269; Huang M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014415; Kang J, 2016, ONCOTARGET, V7, P48887, DOI 10.18632/oncotarget.10346; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; Kobayashi C, 2005, CANCER-AM CANCER SOC, V103, P174, DOI 10.1002/cncr.20717; Kocak H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.84; Langenau DM, 2008, ONCOGENE, V27, P4242, DOI 10.1038/onc.2008.56; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Mitchell NC, 2015, CELL SIGNAL, V27, P2045, DOI 10.1016/j.cellsig.2015.07.018; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Montanaro L, 2013, ONCOTARGETS THER, V6, P909, DOI 10.2147/OTT.S36627; Murphy DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008154; Nakaguro M, 2015, CANCER SCI, V106, P237, DOI 10.1111/cas.12598; Nakamura Y, 2007, BIOCHEM BIOPH RES CO, V354, P892, DOI 10.1016/j.bbrc.2007.01.057; Pei DS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003533; Peltonen K, 2014, CANCER CELL, V25, P77, DOI 10.1016/j.ccr.2013.12.009; Pestov Dimitri G, 2008, Curr Protoc Cell Biol, VChapter 22, DOI 10.1002/0471143030.cb2211s39; Pezzolo A, 2009, NEURO-ONCOLOGY, V11, P192, DOI 10.1215/15228517-2008-086; Phipps KR, 2011, WIRES RNA, V2, P1, DOI 10.1002/wrna.57; Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335; Poortinga G, 2015, ONCOGENE, V34, P403, DOI 10.1038/onc.2014.13; Poortinga G, 2011, NUCLEIC ACIDS RES, V39, P3267, DOI 10.1093/nar/gkq1205; Preti M, 2013, NUCLEIC ACIDS RES, V41, P4709, DOI 10.1093/nar/gkt160; Quin JE, 2014, BBA-MOL BASIS DIS, V1842, P802, DOI 10.1016/j.bbadis.2013.12.009; SAVINO R, 1990, EMBO J, V9, P2299, DOI 10.1002/j.1460-2075.1990.tb07401.x; Sloan KE, 2013, J CELL BIOL, V200, P577, DOI 10.1083/jcb.201207131; Stanke M, 1999, DEVELOPMENT, V126, P4087; Stewart RA, 2006, DEV BIOL, V292, P174, DOI 10.1016/j.ydbio.2005.12.035; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Tao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058858; Tao T, 2013, CELL RES, V23, P620, DOI 10.1038/cr.2013.16; Tornoczky T, 2007, PATHOL ONCOL RES, V13, P269, DOI 10.1007/BF02940304; Wang HZ, 2009, CELL RES, V19, P1150, DOI 10.1038/cr.2009.99; Wang LL, 2013, CANCER-AM CANCER SOC, V119, P3718, DOI 10.1002/cncr.28251; Wang MS, 2014, NUCLEIC ACIDS RES, V42, P11180, DOI 10.1093/nar/gku787; Wang Y, 2012, INT J ANTENN PROPAG, V2012, DOI 10.1155/2012/636349; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WEINBERG RA, 1970, J MOL BIOL, V47, P169, DOI 10.1016/0022-2836(70)90337-2; WEINBERG RA, 1967, P NATL ACAD SCI USA, V58, P1088, DOI 10.1073/pnas.58.3.1088; Wilkins BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077670; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010; Zhu ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096576	78	17	17	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 6	2017	36	27					3852	3867		10.1038/onc.2016.527	http://dx.doi.org/10.1038/onc.2016.527			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EZ6SM	28263972	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000404848200006
J	McCoy, JM; Stewart, RJ; Uboldi, AD; Li, DD; Schroder, J; Scott, NE; Papenfuss, AT; Lehane, AM; Foster, LJ; Tonkin, CJ				McCoy, James M.; Stewart, Rebecca J.; Uboldi, Alessandro D.; Li, Dongdi; Schroder, Jan; Scott, Nicollas E.; Papenfuss, Anthony T.; Lehane, Adele M.; Foster, Leonard J.; Tonkin, Christopher J.			A forward genetic screen identifies a negative regulator of rapid Ca2+-dependent cell egress (MS1) in the intracellular parasite Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular genetics; parasite; proteomics; signaling; Toxoplasma gondii; Ca2+ signalling; apicomplexa; forward genetic screen; host cell egress	DEPENDENT PROTEIN-KINASE; MICRONEME SECRETION; CALCIUM; EXPRESSION; INHIBITORS	Toxoplasma gondii, like all apicomplexan parasites, uses Ca2+ signaling pathways to activate gliding motility to power tissue dissemination and host cell invasion and egress. A group of plant-like Ca2+-dependent protein kinases (CDPKs) transduces cytosolic Ca2+ flux into enzymatic activity, but how they function is poorly understood. To investigate how Ca2+ signaling activates egress through CDPKs, we performed a forward genetic screen to isolate gain-of-function mutants from an egress-deficient cdpk3 knockout strain. We recovered mutants that regained the ability to egress from host cells that harbored mutations in the gene Suppressor of Ca2+-dependent Egress 1 (SCE1). Global phosphoproteomic analysis showed that SCE1 deletion restored many cdpk3-dependent phosphorylation events to near wild-type levels. We also show that CDPK3-dependent SCE1 phosphorylation is required to relieve its suppressive activity to potentiate egress. In summary, our work has uncovered a novel component and suppressor of Ca2+-dependent cell egress during Toxoplasma lytic growth.	[McCoy, James M.; Stewart, Rebecca J.; Uboldi, Alessandro D.; Schroder, Jan; Papenfuss, Anthony T.; Tonkin, Christopher J.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [McCoy, James M.; Stewart, Rebecca J.; Uboldi, Alessandro D.; Schroder, Jan; Papenfuss, Anthony T.; Tonkin, Christopher J.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [McCoy, James M.; Stewart, Rebecca J.; Uboldi, Alessandro D.] Univ Melbourne, Dept Comp & Informat Syst, Melbourne, Vic 3010, Australia; [Li, Dongdi; Lehane, Adele M.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia; [Schroder, Jan; Papenfuss, Anthony T.] Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia; [Scott, Nicollas E.; Foster, Leonard J.] Univ British Columbia, Vancouver, BC V6T 1Z4, Canada	Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; Australian National University; Peter Maccallum Cancer Center; University of British Columbia	Tonkin, CJ (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	tonkin@wehi.edu.au	Lehane, Adele M/B-4127-2012; Tonkin, Christopher/K-6534-2019; Papenfuss, Anthony T/C-6297-2008	Lehane, Adele M/0000-0002-0050-9101; Tonkin, Christopher/0000-0002-7036-6222; Papenfuss, Anthony T/0000-0002-1102-8506; SCHROEDER, JAN/0000-0001-5270-0605; Scott, Nichollas/0000-0003-2556-8316				Asano T, 2011, PLANT MOL BIOL, V75, P179, DOI 10.1007/s11103-010-9717-1; Azevedo MF, 2013, BIOCHEM J, V452, P433, DOI 10.1042/BJ20130124; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Borges-Pereira L, 2015, J BIOL CHEM, V290, P26914, DOI 10.1074/jbc.M115.652511; Brochet M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001806; Bullen HE, 2016, CELL HOST MICROBE, V19, P349, DOI 10.1016/j.chom.2016.02.006; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Coleman BI, 2012, JOVE-J VIS EXP, DOI 10.3791/3807; Donald RGK, 2002, EUKARYOT CELL, V1, P317, DOI 10.1128/EC.1.3.317-328.2002; DONALD RGK, 1995, P NATL ACAD SCI USA, V92, P5749, DOI 10.1073/pnas.92.12.5749; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Gaji RY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005268; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Garrison E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003049; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Howard BL, 2015, ACS CHEM BIOL, V10, P1145, DOI 10.1021/cb501004q; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Jones J, 2003, AM FAM PHYSICIAN, V67, P2131; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Lourido S, 2013, ACS CHEM BIOL, V8, P1155, DOI 10.1021/cb400115y; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Mccoy JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003066; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Moreno SNJ, 1996, BIOCHEM J, V313, P655, DOI 10.1042/bj3130655; Morlon-Guyot J, 2014, CELL MICROBIOL, V16, P95, DOI 10.1111/cmi.12186; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Sidik SM, 2016, J BIOL CHEM, V291, P9566, DOI 10.1074/jbc.M115.703546; Sidik SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100450; Soldati D, 1995, MOL BIOCHEM PARASIT, V74, P87, DOI 10.1016/0166-6851(95)02487-5; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; Stewart RJ, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12685; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Tham WH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005343; Treeck M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004197; Uboldi AD, 2015, CELL HOST MICROBE, V18, P670, DOI 10.1016/j.chom.2015.11.004; Wang JL, 2016, PARASITOL RES, V115, P697, DOI 10.1007/s00436-015-4791-6	42	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7662	7674		10.1074/jbc.M117.775114	http://dx.doi.org/10.1074/jbc.M117.775114			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28258212	Green Published, hybrid			2022-12-26	WOS:000400761300032
J	Snyder, JC; Rochelle, LK; Ray, C; Pack, TF; Bock, CB; Lubkov, V; Lyerly, HK; Waggoner, AS; Barak, LS; Caron, MG				Snyder, Joshua C.; Rochelle, Lauren K.; Ray, Caroline; Pack, Thomas F.; Bock, Cheryl B.; Lubkov, Veronica; Lyerly, H. Kim; Waggoner, Alan S.; Barak, Larry S.; Caron, Marc G.			Inhibiting clathrin-mediated endocytosis of the leucine-rich G protein-coupled receptor-5 diminishes cell fitness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; V-ATPASE; WNT/BETA-CATENIN; PLASMA-MEMBRANE; WNT RECEPTORS; NATURAL-PRODUCTS; BREAST-CANCER; BETA-ARRESTIN; LGR5; EXPRESSION	The leucine-rich G protein-coupled receptor-5 (LGR5) is expressed in adult tissue stem cells of many epithelia, and its overexpression is negatively correlated with cancer prognosis. LGR5 potentiates WNT/beta-catenin signaling through its unique constitutive internalization property that clears negative regulators of the WNT-receptor complex from the membrane. However, both the mechanism and physiological relevance of LGR5 internalization are unclear. Therefore, a natural product library was screened to discover LGR5 internalization inhibitors and gain mechanistic insight into LGR5 internalization. The plant lignan justicidin B blocked the constitutive internalization of LGR5. Justicidin B is structurally similar to more potent vacuolar-type H+-ATPase inhibitors, which all inhibited LGR5 internalization by blocking clathrin-mediated endocytosis. We then tested the physiological relevance of LGR5 internalization blockade in vivo. A LGR5-rainbow (LBOW) mouse line was engineered to express three different LGR5 isoforms along with unique fluorescent protein lineage reporters in the same mouse. In this manner, the effects of each isoform on cell fate can be simultaneously assessed through simple fluorescent imaging for each lineage reporter. LBOW mice express three different forms of LGR5, a wild-type form that constitutively internalizes and two mutant forms whose internalization properties have been compromised by genetic perturbations within the carboxyl-terminal tail. LBOW was activated in the intestinal epithelium, and a year-long lineage-tracing course revealed that genetic blockade of LGR5 internalization diminished cell fitness. Together these data provide proof-of-concept genetic evidence that blocking the clathrin-mediated endocytosis of LGR5 could be used to pharmacologically control cell behavior.	[Snyder, Joshua C.; Rochelle, Lauren K.; Ray, Caroline; Barak, Larry S.; Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27712 USA; [Snyder, Joshua C.; Lubkov, Veronica; Lyerly, H. Kim] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27712 USA; [Pack, Thomas F.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27712 USA; [Bock, Cheryl B.] Duke Univ, Med Ctr, Duke Canc Inst Transgen Core, Durham, NC 27712 USA; [Waggoner, Alan S.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Waggoner, Alan S.] Carnegie Mellon Univ, Mol Biosensor & Imaging Ctr, Pittsburgh, PA 15213 USA	Duke University; Duke University; Duke University; Duke University; Carnegie Mellon University; Carnegie Mellon University	Snyder, JC; Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3287, Durham, NC 27710 USA.	joshua.snyder@duke.edu; marc.caron@duke.edu	Lyerly, Herbert Kim/AAX-4925-2020; Lyerly, Herbert K/B-6528-2014	Lyerly, Herbert Kim/0000-0002-0063-4770; Lyerly, Herbert K/0000-0002-0063-4770; Pack, Thomas/0000-0002-1240-8324; Snyder, Joshua/0000-0002-9787-3371; Lubkov, Veronica/0000-0002-5264-7549	NCI, National Institutes of Health [5P30CA014236-42]; NATIONAL CANCER INSTITUTE [P30CA014236, R21CA173245, K12CA100639, R33CA191198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA041160, P30DA029925] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Yushi Bai for management of our small molecular libraries and robotic pipetting systems. We also thank Dr. Harvey McMahon for the gift of the plasmid encoding the AP-180 carboxyl-terminal fragment. We are grateful to Dr. Michael Forgac for helpful advice and discussion of this manuscript. Dr. P. J. Nicholls provided image acquisition and analysis consultations. The Duke Transgenic Core was supported by NCI, National Institutes of Health Grant 5P30CA014236-42.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2013, DEVELOPMENT, V140, P2484, DOI 10.1242/dev.083113; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen HW, 2013, ANTIVIR RES, V99, P371, DOI 10.1016/j.antiviral.2013.06.014; Coma I, 2009, J BIOMOL SCREEN, V14, P66, DOI 10.1177/1087057108326664; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Cotter K, 2016, ONCOTARGET, V7, P46142, DOI 10.18632/oncotarget.10063; Cotter K, 2015, J BIOL CHEM, V290, P3680, DOI 10.1074/jbc.M114.611210; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Deng C, 2013, J CELL SCI, V126, P2060, DOI 10.1242/jcs.123471; Di Gregorio A, 2016, DEV CELL, V38, P621, DOI 10.1016/j.devcel.2016.08.012; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Greathouse GA, 1940, PLANT PHYSIOL, V15, P563, DOI 10.1104/pp.15.3.563; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Harvey AL, 2015, NAT REV DRUG DISCOV, V14, P111, DOI 10.1038/nrd4510; Hemmati S, 2016, MOLECULES, V21, DOI 10.3390/molecules21070820; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jiang YY, 2016, BMC CANCER, V16, DOI 10.1186/s12885-015-1986-2; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Kozik P, 2013, NAT CELL BIOL, V15, P50, DOI 10.1038/ncb2652; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; McDonald T, 1998, BIOCHEM BIOPH RES CO, V247, P266, DOI 10.1006/bbrc.1998.8774; Menard L, 1996, BIOCHEMISTRY-US, V35, P4155, DOI 10.1021/bi952961+; Miller RL, 2005, AM J PHYSIOL-CELL PH, V288, pC1134, DOI 10.1152/ajpcell.00084.2004; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Perez-Vilar J, 1997, J BIOL CHEM, V272, P33410, DOI 10.1074/jbc.272.52.33410; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Ruiz A, 2014, J AGR FOOD CHEM, V62, P12407, DOI 10.1021/jf502929z; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Snippert HJ, 2014, EMBO REP, V15, P62, DOI 10.1002/embr.201337799; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Snyder JC, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0216-3; Snyder JC, 2015, J CELL SCI, V128, P1230, DOI 10.1242/jcs.166322; Snyder JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084476; Snyder JC, 2013, J BIOL CHEM, V288, P10286, DOI 10.1074/jbc.M112.447540; Sorensen MG, 2007, J BONE MINER RES, V22, P1640, DOI 10.1359/JBMR.070613; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Strack RL, 2009, BIOCHEMISTRY-US, V48, P8279, DOI 10.1021/bi900870u; Stransky L, 2016, PHYSIOL REV, V96, P1071, DOI 10.1152/physrev.00035.2015; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Weissman Tamily A, 2011, Cold Spring Harb Protoc, V2011, P851, DOI 10.1101/pdb.prot5632; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302; Zhao XH, 2001, J CELL SCI, V114, P353; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	63	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7208	7222		10.1074/jbc.M116.756635	http://dx.doi.org/10.1074/jbc.M116.756635			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28275053	hybrid, Green Published			2022-12-26	WOS:000400478300031
J	Li, KT; Cheng, XX; Tilevik, A; Davis, SJ; Zhu, C				Li, Kaitao; Cheng, Xiaoxiao; Tilevik, Andreas; Davis, Simon J.; Zhu, Cheng			In situ and in silico kinetic analyses of programmed cell death-1 (PD-1) receptor, programmed cell death ligands, and B7-1 protein interaction network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS; CRYSTAL-STRUCTURE; BINDING-KINETICS; TCR; EXPRESSION; AFFINITY; ADHESION; COMPLEX; FRAMEWORK; SURFACES	Programmed cell death-1 (PD-1) is an inhibitory receptor with an essential role in maintaining peripheral tolerance and is among the most promising immunotherapeutic targets for treating cancer, autoimmunity, and infectious diseases. A complete understanding of the consequences of PD-1 engagement by its ligands, PD-L1 and PD-L2, and of PD-L1 binding to B7-1 requires quantitative analysis of their interactions at the cell surface. We present here the first complete in situ kinetic analysis of the PD-1/PD-ligands/B7-1 system. Consistent with previous solution measurements, we observed higher in situ affinities for human (h) than murine (m) PD-1 interactions, stronger binding of hPD-1 to hPD-L2 than hPD-L1, and comparable binding of mPD-1 to both ligands. However, in contrast to the relatively weak solution affinities, the in situ affinities of PD-1 are as high as those of the T cell receptor for agonist pMHC and of LFA-1 (lymphocyte function-associated antigen 1) for ICAM-1 (intercellular adhesion molecule 1) but significantly lower than that of the B7-1/CTLA-4 interaction, suggesting a distinct basis for PD-1-versus CTLA-4-mediated inhibition. Notably, the in situ interactions of PD-1 are much stronger than that of B7-1 with PD-L1. Overall, the in situ affinity ranking greatly depends on the on-rate instead of the off-rate. In silico simulations predict that PD-1/PD-L1 interactions dominate at interfaces between activated T cells and mature dendritic cells and that these interactions will be highly sensitive to the dynamics of PD-L1 and PD-L2 expression. Our results provide a kinetic framework for better understanding inhibitory PD-1 activity in health and disease.	[Li, Kaitao; Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA; [Cheng, Xiaoxiao; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Oxford OX3 9DU, England; [Cheng, Xiaoxiao; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, MRC, Human Immunol Unit, Oxford OX3 9DU, England; [Tilevik, Andreas] Univ Skovde, Sch Biosci, Syst Biol Res Ctr, Box 408, Skovde, Sweden; [Zhu, Cheng] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Zhu, Cheng] Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University of Oxford; University of Oxford; University of Skovde; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Zhu, C (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu		Zhu, Cheng/0000-0002-1718-565X	National Institutes of Health [R01AI044902]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044902] Funding Source: NIH RePORTER; MRC [MC_UU_12010/4, MC_UU_00008/4] Funding Source: UKRI; Medical Research Council [MC_UU_12010/4, MC_UU_00008/4] Funding Source: researchfish; Wellcome Trust [207547/Z/17/Z] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by National Institutes of Health Grant R01AI044902 (to C. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Baruch K, 2016, NAT MED, V22, P135, DOI 10.1038/nm.4022; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bhatia S, 2005, P NATL ACAD SCI USA, V102, P15569, DOI 10.1073/pnas.0507257102; Butte MJ, 2008, MOL IMMUNOL, V45, P3567, DOI 10.1016/j.molimm.2008.05.014; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; CHAN PY, 1992, MOL BIOL CELL, V3, P157, DOI 10.1091/mbc.3.2.157; Chen W, 2008, BIOPHYS J, V94, P694, DOI 10.1529/biophysj.107.117895; Chen W, 2008, CELL MOL BIOENG, V1, P276, DOI 10.1007/s12195-008-0024-8; Cheng XX, 2013, J BIOL CHEM, V288, P11771, DOI 10.1074/jbc.M112.448126; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; DAVIS SJ, 1990, J BIOL CHEM, V265, P10410; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dong HD, 1999, NAT MED, V5, P1365; Dustin ML, 2001, ANNU REV CELL DEV BI, V17, P133, DOI 10.1146/annurev.cellbio.17.1.133; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Ghiotto M, 2010, INT IMMUNOL, V22, P651, DOI 10.1093/intimm/dxq049; Hong JS, 2015, J IMMUNOL, V195, P3557, DOI 10.4049/jimmunol.1501407; Huang J, 2004, J BIOL CHEM, V279, P44915, DOI 10.1074/jbc.M407039200; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jansson A, 2005, J IMMUNOL, V175, P1575, DOI 10.4049/jimmunol.175.3.1575; Jin HT, 2011, CURR TOP MICROBIOL, V350, P17, DOI 10.1007/82_2010_116; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kleffel S, 2015, CELL, V162, P1242, DOI 10.1016/j.cell.2015.08.052; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lazar-Molnar E, 2008, P NATL ACAD SCI USA, V105, P10483, DOI 10.1073/pnas.0804453105; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; Liu BY, 2015, EUR J IMMUNOL, V45, P2099, DOI 10.1002/eji.201445358; Liu BY, 2014, EUR J IMMUNOL, V44, P239, DOI 10.1002/eji.201343774; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Park HJ, 2015, J IMMUNOL, V194, P5801, DOI 10.4049/jimmunol.1401936; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Schildberg FA, 2016, IMMUNITY, V44, P955, DOI 10.1016/j.immuni.2016.05.002; Seo YJ, 2016, IMMUNITY, V45, P988, DOI 10.1016/j.immuni.2016.10.024; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Wang L. F., 2008, WATER SAV IRRIG, V2008, P1, DOI DOI 10.1038/NATURE07065; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Youngnak P, 2003, BIOCHEM BIOPH RES CO, V307, P672, DOI 10.1016/S0006-291X(03)01257-9; Zak KM, 2015, STRUCTURE, V23, P2341, DOI 10.1016/j.str.2015.09.010; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200; Zhang XW, 2004, IMMUNITY, V20, P337, DOI 10.1016/S1074-7613(04)00051-2; Zhang Y, 2013, J MATER CHEM B, V1, P132, DOI 10.1039/c2tb00071g	55	11	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6799	6809		10.1074/jbc.M116.763888	http://dx.doi.org/10.1074/jbc.M116.763888			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28270509	hybrid, Green Published			2022-12-26	WOS:000399813400030
J	Stone, MR; Thomas, K; Wilkinson, M; Stevenson, E; Gibson, AS; Jones, AM; Thompson, KG				Stone, Mark R.; Thomas, Kevin; Wilkinson, Michael; Stevenson, Emma; Gibson, Alan St Clair; Jones, Andrew M.; Thompson, Kevin G.			Exploring the performance reserve: Effect of different magnitudes of power output deception on 4,000 m cycling time-trial performance	PLOS ONE			English	Article							INTEROCEPTIVE SENSITIVITY; ENERGY-EXPENDITURE; PACING STRATEGIES; MAXIMAL WORK; EXERCISE; FATIGUE; PERCEPTION; AWARENESS; DURATION; DISTANCE	Purpose The aim of the present study was to investigate whether a magnitude of deception of 5% in power output would lead to a greater reduction in the amount of time taken for participants to complete a 4000 m cycling TT than a magnitude of deception of 2% in power output, which we have previously shown can lead to a small change in 4000 m cycling TT performance. Methods Ten trained male cyclists completed four, 4000 m cycling TTs. The first served as a habituation and the second as a baseline for future trials. During trials three and four participants raced against a pacer which was set, in a randomized order, at a mean power output equal to 2% (+2% TT) or 5% (+5% TT) higher than their baseline performance. However participants were misled into believing that the power output of the pacer was an accurate representation of their baseline performance on both occasions. Cardiorespiratory responses were recorded throughout each TT, and used to estimate energy contribution from aerobic and anaerobic metabolism. Results Participants were able to finish the +2% TT in a significantly shorter duration than at baseline ( p = 0.01), with the difference in performance likely attributable to a greater anaerobic contribution to total power output ( p = 0.06). There was no difference in performance between the +5% TT and +2% TT or baseline trials. Conclusions Results suggest that a performance reserve is conserved, involving anaerobic energy contribution, which can be utilised given a belief that the exercise will be sustainable however there is an upper limit to how much deception can be tolerated. These findings have implications for performance enhancement in athletes and for our understanding of the nature of fatigue during high-intensity exercise.	[Stone, Mark R.] Buckinghamshire New Univ, Ctr Human Performance Hlth & Wellbeing, High Wycombe, Bucks, England; [Thomas, Kevin; Wilkinson, Michael] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Stevenson, Emma] Newcastle Univ, Inst Cellular Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Gibson, Alan St Clair] Univ Waikato, Sch Hlth Sport & Human Performance, Hamilton, New Zealand; [Jones, Andrew M.] Univ Exeter, Sch Sport & Hlth Sci, Exeter, Devon, England; [Thompson, Kevin G.] Univ Canberra, Res Inst Sport & Exercise UCRISE, Canberra, ACT, Australia	Buckinghamshire New University; Northumbria University; Newcastle University - UK; University of Waikato; University of Exeter; University of Canberra	Thompson, KG (corresponding author), Univ Canberra, Res Inst Sport & Exercise UCRISE, Canberra, ACT, Australia.	kevin.thompson@canberra.edu.au	Wilkinson, Michael/AAY-2686-2021	Wilkinson, Michael/0000-0002-1174-5185; Stone, Mark/0000-0003-0735-287X; Thomas, Kevin/0000-0003-2973-5337; Thompson, Kevin/0000-0003-3985-1622	Faculty of Health and Life Sciences, Northumbria University, UK; English Institute of Sport; English Institute of Sport, Northumbria University, UK	Faculty of Health and Life Sciences, Northumbria University, UK; English Institute of Sport; English Institute of Sport, Northumbria University, UK	Funding was provided by the English Institute of Sport and the Faculty of Health and Life Sciences, Northumbria University, UK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the English Institute of Sport for supporting this research. The authors declare that there are no conflicts of interest.	Amann M, 2009, J PHYSIOL-LONDON, V587, P271, DOI 10.1113/jphysiol.2008.163303; Baron B, 2011, BRIT J SPORT MED, V45, P511, DOI 10.1136/bjsm.2009.059964; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cohen J.E., 1988, STAT POWER ANAL BEHA; Corbett J, 2009, BRIT J SPORT MED, V43, P770, DOI 10.1136/bjsm.2008.056416; de Koning J J, 1999, J Sci Med Sport, V2, P266, DOI 10.1016/S1440-2440(99)80178-9; Edwards AM, 2013, SPORTS MED, V43, P1057, DOI 10.1007/s40279-013-0091-4; Flyger N., 2008, ISN B, V1, P27; Foster C, 2004, INT J SPORTS MED, V25, P198, DOI 10.1055/s-2003-45260; Foster C, 2003, MED SCI SPORT EXER, V35, P826, DOI 10.1249/01.MSS.0000065001.17658.68; Foster C, 2009, BRIT J SPORT MED, V43, P765, DOI 10.1136/bjsm.2008.054841; Gibson AS, 2004, BRIT J SPORT MED, V38, P797, DOI 10.1136/bjsm.2003.009852; HARDY CJ, 1989, J SPORT EXERCISE PSY, V11, P304, DOI 10.1123/jsep.11.3.304; Herbert BM, 2007, INT J PSYCHOPHYSIOL, V65, P214, DOI 10.1016/j.ijpsycho.2007.04.007; Herbert BM, 2007, PSYCHOPHYSIOLOGY, V44, P194, DOI 10.1111/j.1469-8986.2007.00493.x; Hettinga FJ, 2012, BRIT J SPORT MED, V46, P30, DOI 10.1136/bjsm.2009.064261; Hettinga FJ, 2006, MED SCI SPORT EXER, V38, P1484, DOI 10.1249/01.mss.0000228956.75344.91; Lambert EV, 2005, BRIT J SPORT MED, V39, P52, DOI 10.1136/bjsm.2003.011247; Mauger AR, 2009, MED SCI SPORT EXER, V41, P451, DOI 10.1249/MSS.0b013e3181854957; Micklewright D, 2010, BRIT J SPORT MED, V44, P952, DOI 10.1136/bjsm.2009.057315; Morton RH, 2009, J SCI MED SPORT, V12, P332, DOI 10.1016/j.jsams.2007.11.006; Noakes TD, 2004, BRIT J SPORT MED, V38, P648, DOI 10.1136/bjsm.2003.009761; Noakes TD, 2004, J APPL PHYSIOL, V96, P1571, DOI 10.1152/japplphysiol.01124.2003; Noordhof DA, 2011, INT J SPORTS MED, V32, P422, DOI 10.1055/s-0031-1271676; Perreault S, 1998, J SPORT EXERCISE PSY, V20, P421, DOI 10.1123/jsep.20.4.421; Pires FD, 2012, BRIT J SPORT MED, V46, P18, DOI 10.1136/bjsm.2010.079053; Pohl J, 1997, DIABETES CARE, V20, P796, DOI 10.2337/diacare.20.5.796; Renfree A, 2014, SPORTS MED, V44, P147, DOI 10.1007/s40279-013-0107-0; SERRESSE O, 1988, INT J SPORTS MED, V9, P456, DOI 10.1055/s-2007-1025051; SERRESSE O, 1991, INT J SPORTS MED, V12, P543, DOI 10.1055/s-2007-1024731; Shei RJ, 2016, INT J SPORTS MED, V37, P341, DOI 10.1055/s-0035-1565139; Stone MR, 2011, EUR J APPL PHYSIOL, V111, P1807, DOI 10.1007/s00421-010-1818-7; Stone MR, 2012, MED SCI SPORT EXER, V44, P534, DOI 10.1249/MSS.0b013e318232cf77; Swart J, 2009, BRIT J SPORT MED, V43, P782, DOI 10.1136/bjsm.2008.055889; Taylor D, 2014, PHYSIOL BEHAV, V133, P45, DOI 10.1016/j.physbeh.2014.05.002; Tucker R, 2009, BRIT J SPORT MED, V43, P392, DOI 10.1136/bjsm.2008.050799; Williams EL, 2015, J SCI MED SPORT, V18, P486, DOI 10.1016/j.jsams.2014.07.003	37	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173120	10.1371/journal.pone.0173120	http://dx.doi.org/10.1371/journal.pone.0173120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278174	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000396087900044
J	Kendall, EA; Azman, AS; Cobelens, FG; Dowdy, DW				Kendall, Emily A.; Azman, Andrew S.; Cobelens, Frank G.; Dowdy, David W.			MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TREATMENT OUTCOMES; FOLLOW-UP; MATHEMATICAL-MODEL; DRUG-RESISTANCE; SOUTH-AFRICA; METAANALYSIS; TRANSMISSION; DISEASE; REINFECTION	Background In 2013, approximately 480,000 people developed active multidrug-resistant tuberculosis (MDR-TB), while only 97,000 started MDR-TB treatment. We sought to estimate the impact of improving access to MDR-TB diagnosis and treatment, under multiple diagnostic algorithm and treatment regimen scenarios, on ten-year projections of MDR-TB incidence and mortality. Methods We constructed a dynamic transmission model of an MDR-TB epidemic in an illustrative East/Southeast Asian setting. Using approximate Bayesian computation, we investigated a wide array of potential epidemic trajectories consistent with current notification data and known TB epidemiology. Results Despite an overall projected decline in TB incidence, data-consistent simulations suggested that MDR-TB incidence is likely to rise between 2015 and 2025 under continued 2013 treatment practices, although with considerable uncertainty (median 17% increase, 95% Uncertainty Range [UR] -38% to + 137%). But if, by 2017, all identified active TB patients with previously-treated TB could be tested for drug susceptibility, and 85% of those with MDR-TB could initiate MDR-appropriate treatment, then MDR-TB incidence in 2025 could be reduced by 26% (95% UR 4-52%) relative to projections under continued current practice. Also expanding this drug-susceptibility testing and appropriate MDR-TB treatment to treatment-naive as well as previously-treated TB cases, by 2020, could reduce MDR-TB incidence in 2025 by 29% (95% UR 6-55%) compared to continued current practice. If this diagnosis and treatment of all MDR-TB in known active TB cases by 2020 could be implemented via a novel second-line regimen with similar effectiveness and tolerability as current first-line therapy, a 54% (95% UR 20-74%) reduction in MDR-TB incidence compared to current-practice projections could be achieved by 2025. Conclusions Expansion of diagnosis and treatment of MDR-TB, even using current sub-optimal second-line regimens, is expected to significantly decrease MDR-TB incidence at the population level. Focusing MDR diagnostic efforts on previously-treated cases is an efficient first-step approach.	[Kendall, Emily A.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; [Azman, Andrew S.; Dowdy, David W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Cobelens, Frank G.] Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Amsterdam; Academic Medical Center Amsterdam	Kendall, EA (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA.	ekendal2@jhmi.edu		Kendall, Emily/0000-0002-0083-422X; Cobelens, Frank/0000-0002-4367-1133; Azman, Andrew/0000-0001-8662-9077	NIH [T32 AI007291-24]; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007291] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH T32 AI007291-24 (to EAK; www.nih.gov) and by Bill and Melinda Gates Foundation Work Order 10 (to DWD; www.gatesfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Cegielski JP, 2014, CLIN INFECT DIS, V59, P1049, DOI 10.1093/cid/ciu572; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Dharmadhikari AS, 2014, INT J TUBERC LUNG D, V18, P1019, DOI 10.5588/ijtld.13.0834; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Dowdy DW, 2013, AM J RESP CRIT CARE, V187, P543, DOI 10.1164/rccm.201207-1217OC; Dye C, 2000, P NATL ACAD SCI USA, V97, P8180, DOI 10.1073/pnas.140102797; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Falzon D, 2015, EUR RESPIR J, V45, P150, DOI 10.1183/09031936.00101814; Falzon D, 2013, LANCET INFECT DIS, V13, P690, DOI 10.1016/S1473-3099(13)70130-0; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Gosling RD, 2011, CLIN MICROBIOL INFEC, V17, P1617, DOI 10.1111/j.1469-0691.2011.03660.x; Grandjean L, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001843; Hoa NB, 2014, TROP MED INT HEALTH, V19, P1076, DOI 10.1111/tmi.12347; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Korenromp EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038816; Kruk ME, 2008, TROP MED INT HEALTH, V13, P703, DOI 10.1111/j.1365-3156.2008.02042.x; MacPherson P, 2014, B WORLD HEALTH ORGAN, V92, P126, DOI 10.2471/BLT.13.124800; Mak A, 2008, AM J RESP CRIT CARE, V178, P306, DOI 10.1164/rccm.200802-240OC; Marx FM, 2014, CLIN INFECT DIS, V58, P1676, DOI 10.1093/cid/ciu186; Mayer Kenneth, 2013, J Int Assoc Provid AIDS Care, V12, P208, DOI 10.1177/2325957413475839; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Mehra M, 2013, INT J TUBERC LUNG D, V17, P1186, DOI 10.5588/ijtld.12.0959; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Millet JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064898; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Okada K, 2012, INT J TUBERC LUNG D, V16, P1619, DOI 10.5588/ijtld.12.0201; Palmero DJ, 2004, INT J TUBERC LUNG D, V8, P778; Reid A, 2015, INT J TUBERC LUNG D, V19, P5, DOI 10.5588/ijtld.14.0078; Sachdeva KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131438; Schnippel K, 2013, TROP MED INT HEALTH, V18, P109, DOI 10.1111/tmi.12018; Shrestha S, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu073; Sloot R, 2014, AM J RESP CRIT CARE, V190, P1044, DOI 10.1164/rccm.201406-1159OC; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Hoang TTT, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2338-5; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Trauer JM, 2014, J THEOR BIOL, V358, P74, DOI 10.1016/j.jtbi.2014.05.023; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Wares Fraser, 2014, Indian J Tuberc, V61, P298; Weiss P, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-333; WHO, 2014, GLOB TUB REP 2014	50	24	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172748	10.1371/journal.pone.0172748	http://dx.doi.org/10.1371/journal.pone.0172748			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273116	Green Submitted, Green Published, gold			2022-12-26	WOS:000396073700028
J	Perumal, N; Manicam, C; Steinicke, M; Funke, S; Pfeiffer, N; Grus, FH				Perumal, Natarajan; Manicam, Caroline; Steinicke, Matthias; Funke, Sebastian; Pfeiffer, Norbert; Grus, Franz H.			Characterization of the human aqueous humour proteome: A comparison of the genders	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; OPEN-ANGLE GLAUCOMA; PROSTAGLANDIN D SYNTHASE; MACULAR DEGENERATION; MASS-SPECTROMETRY; COMPUTATIONAL PLATFORM; TEAR PROTEOME; AGE; IDENTIFICATION; ANGIOGENESIS	Aqueous humour (AH) is an important biologic fluid that maintains normal intraocular pressure and contains proteins that regulate the homeostasis of ocular tissues. Any alterations in the protein compositions are correlated to the pathogenesis of various ocular disorders. In recent years, gender-based medicine has emerged as an important research focus considering the prevalence of certain diseases, which are higher in a particular sex. Nevertheless, the inter-gender variations in the AH proteome are unknown. Therefore, this study endeavoured to characterize the AH proteome to assess the differences between genders. Thirty AH samples of patients who underwent cataract surgery were categorized according to their gender. Label-free quantitative discovery mass spectrometry-based proteomics strategy was employed to characterize the AH proteome. A total of 147 proteins were identified with a false discovery rate of less than 1% and only the top 10 major AH proteins make up almost 90% of the total identified proteins. A large number of proteins identified were correlated to defence, immune and inflammatory mechanisms, and response to wounding. Four proteins were found to be differentially abundant between the genders, comprising SERPINF1, SERPINA3, SERPING1 and PTGDS. The findings emerging from our study provide the first insight into the gender-based proteome differences in the AH and also highlight the importance in considering potential sex-dependent changes in the proteome of ocular pathologies in future studies employing the AH.	[Perumal, Natarajan; Manicam, Caroline; Steinicke, Matthias; Funke, Sebastian; Pfeiffer, Norbert; Grus, Franz H.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Expt & Translat Ophthalmol, Mainz, Germany	Johannes Gutenberg University of Mainz	Grus, FH (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Expt & Translat Ophthalmol, Mainz, Germany.	grus@eye-research.org	Pfeiffer, Norbert/AAO-7586-2020	Perumal, Natarajan/0000-0002-2612-5907				Abe R, 2004, AM J PATHOL, V164, P1225, DOI 10.1016/S0002-9440(10)63210-5; ANDO H, 1993, INVEST OPHTH VIS SCI, V34, P3541; Badock V, 2001, ELECTROPHORESIS, V22, P2856, DOI 10.1002/1522-2683(200108)22:14<2856::AID-ELPS2856>3.0.CO;2-U; Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; BECERRA SP, 1995, J BIOL CHEM, V270, P25992, DOI 10.1074/jbc.270.43.25992; Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; Bouck N, 2002, TRENDS MOL MED, V8, P330, DOI 10.1016/S1471-4914(02)02362-6; Bouhenni RA, 2011, EXP EYE RES, V92, P67, DOI 10.1016/j.exer.2010.11.004; Chelbi ST, 2012, HUM MOL GENET; Cheng JW, 2013, J GLAUCOMA, V22, P301, DOI 10.1097/IJG.0b013e31824083ca; Chowdhury UR, 2010, INVEST OPHTH VIS SCI, V51, P4921, DOI 10.1167/iovs.10-5531; Cox J, 2014, MOL CELLULAR PROTEOM; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davis AE, 2008, MOL IMMUNOL, V45, P4057, DOI 10.1016/j.molimm.2008.06.028; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Drabovich AP, 2015, BBA-PROTEINS PROTEOM, V1854, P677, DOI 10.1016/j.bbapap.2014.09.006; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; Duan X, 2008, PROTEOMIC ANAL AQUEO; Duan XM, 2010, MOL VIS, V16, P2839; Escoffier P, 2010, J PROTEOME RES, V9, P789, DOI 10.1021/pr9006602; Fan BJ, 2008, INVEST OPHTH VIS SCI, V49, P1886, DOI 10.1167/iovs.07-0414; Filleur S, 2009, J CELL BIOCHEM, V106, P769, DOI 10.1002/jcb.22072; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Funatsu H, 2006, OPHTHALMOLOGY, V113, P294, DOI 10.1016/j.ophtha.2005.10.030; Funding M, 2005, ACTA OPHTHALMOL SCAN, V83, P31, DOI 10.1111/j.1600-0420.2005.00381.x; Funke S, 2012, J PROTEOMICS, V75, P3177, DOI 10.1016/j.jprot.2012.03.018; GABELT BT, 1990, EXP EYE RES, V51, P87, DOI 10.1016/0014-4835(90)90174-S; Gerashchenko DY, 1998, INVEST OPHTH VIS SCI, V39, P198; Granger J, 2005, PROTEOMICS, V5, P4713, DOI 10.1002/pmic.200401331; Grus F, 2008, TRANSTHYRETIN COMPLE; Grus FH, 2007, PROTEOM CLIN APPL, V1, P876, DOI 10.1002/prca.200700105; Gunther R, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-14; Herbert B, 2000, ELECTROPHORESIS, V21, P3639, DOI 10.1002/1522-2683(200011)21:17<3639::AID-ELPS3639>3.0.CO;2-V; Hohenstein-Blaul NVU, 2013, EXP EYE RES, V117, P126, DOI 10.1016/j.exer.2013.07.015; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huttenhain R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003989; Izzotti A, 2010, J PROTEOME RES, V9, P4831, DOI 10.1021/pr1005372; Ji YH, 2015, CLIN BIOCHEM, V48, P1304, DOI 10.1016/j.clinbiochem.2015.08.006; Kalsheker NA, 1996, INT J BIOCHEM CELL B, V28, P961, DOI 10.1016/1357-2725(96)00032-5; Kim TW, 2012, J PROTEOME RES, V11, P4034, DOI 10.1021/pr300080s; Kliuchnikova A, 2016, PROTEOMICS; Kramer M, 2005, OCUL IMMUNOL INFLAMM, V13, P305, DOI 10.1080/09273940590950990; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Miike K, 2010, PROTEOMICS, V10, P2678, DOI 10.1002/pmic.200900496; Munoz E, 1999, NEUROLOGY, V52, P297, DOI 10.1212/WNL.52.2.297; Murthy KR, 2015, OMICS, V19, P283, DOI 10.1089/omi.2015.0029; Nahnsen S, 2013, MOL CELL PROTEOMICS, V12, P549, DOI 10.1074/mcp.R112.025163; NAKAMURA M, 1988, J BIOL CHEM, V263, P19218; Nobl M, 2016, EXP EYE RES, V146, P107, DOI 10.1016/j.exer.2016.01.001; Ogata N, 2005, AM J OPHTHALMOL, V140, P937, DOI 10.1016/j.ajo.2005.05.037; Ohno-Matsui K, 2001, J CELL PHYSIOL, V189, P323, DOI 10.1002/jcp.10026; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Perumal N, 2016, SCI REPORTS, V6; Perumal N, 2014, PROTEOMICS, V14, P1698, DOI 10.1002/pmic.201300039; Pettipher R, 2007, NAT REV DRUG DISCOV, V6, P313, DOI 10.1038/nrd2266; Pieragostino D, 2015, PROTEOM CLIN APPL, V9, P169, DOI 10.1002/prca.201400084; Pike RN, 2005, FEBS J, V272, P4842, DOI 10.1111/j.1742-4658.2005.04880.x; Pluskal MG, 2002, PROTEOMICS, V2, P145, DOI 10.1002/1615-9861(200202)2:2<145::AID-PROT145>3.0.CO;2-Y; Richardson MR, 2009, MOL VIS, V15, P2740; Rudnicka AR, 2006, INVEST OPHTH VIS SCI, V47, P4254, DOI 10.1167/iovs.06-0299; Rudnicka AR, 2012, OPHTHALMOLOGY, V119, P571, DOI 10.1016/j.ophtha.2011.09.027; Rychli K, 2009, EXPERT OPIN THER TAR, V13, P1295, DOI 10.1517/14728220903241641; Sacca SC, 2012, INVEST OPHTH VIS SCI, V53, P4242, DOI 10.1167/iovs.11-8902; Smith W, 1997, AUST NZ J OPHTHALMOL, V25, pS13; Soria J, 2015, MOL VIS, V21, P451; Stastna M, 2007, PROTEOMICS, V7, P4358, DOI 10.1002/pmic.200700300; Stoermer KA, 2011, VIROLOGY, V411, P362, DOI 10.1016/j.virol.2010.12.045; Tombran-Tink J, 2003, TRENDS MOL MED, V9, P244, DOI 10.1016/S1471-4914(03)00074-1; Tong HP, 2006, CLIN BIOCHEM, V39, P267, DOI 10.1016/j.clinbiochem.2005.11.013; Tsiligiannis SE, 2012, REPROD SCI; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; Vajaranant TS, 2010, CURR OPIN OPHTHALMOL, V21, P91, DOI 10.1097/ICU.0b013e3283360b7e; Wang XY, 2002, HUM GENET, V110, P356, DOI 10.1007/s00439-002-0697-3; Yang HY, 2013, INT J LEGAL MED, V127, P1065, DOI 10.1007/s00414-013-0848-1; Yang Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158611; Yang SM, 2011, J CLIN ENDOCR METAB, V96, P831, DOI 10.1210/jc.2010-2140; Yao JQ, 2013, INT J MOL MED, V32, P1421, DOI 10.3892/ijmm.2013.1509; Yao JQ, 2013, PROTEOM CLIN APPL, V7, P550, DOI 10.1002/prca.201200012; Zhang QB, 2013, J EXP MED, V210, P191, DOI 10.1084/jem.20111843; Zhou L, 2012, PROG RETIN EYE RES, V31, P527, DOI 10.1016/j.preteyeres.2012.06.002; Zurbig P, 2012, ELECTROPHORESIS, V33, P3617, DOI 10.1002/elps.201200360	84	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172481	10.1371/journal.pone.0172481	http://dx.doi.org/10.1371/journal.pone.0172481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273097	Green Submitted, Green Published, gold			2022-12-26	WOS:000396073700075
J	Del Mistro, A; Frayle, H; Rizzi, M; Fantin, G; Ferro, A; Angeletti, PM; Rossi, PG; Altobelli, E				Del Mistro, Annarosa; Frayle, Helena; Rizzi, Martina; Fantin, Gianpiero; Ferro, Antonio; Angeletti, Paolo Matteo; Rossi, Paolo Giorgi; Altobelli, Emma			Methylation analysis and HPV genotyping of self-collected cervical samples from women not responding to screening invitation and review of the literature	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS DNA; INCREASE PARTICIPATION; SOCIOECONOMIC GROUPS; FOLLOW-UP; CANCER; TRIAGE; SPECIFICITY; CYTOLOGY; PROGRAM; VALIDATION	Aim of the study To assess the feasibility of partial HPV genotyping and methylation analysis of CADM1, MAL, and miR124-2 genes as triage tests in assaying self-collected cervical samples positive for high-risk HPV on primary screening, and to review the literature regarding host cellular gene methylation analysis of self-collected cervical samples. Material and methods Women residing in North-East Italy who had failed to respond to the invitation to participate in an organized population-based program were invited to provide a self-sample. Their stored baseline (self-collected) and follow-up (clinician-collected) cervical samples were included in the study. DNA was extracted from HPV-positive (Qiagen's Hybrid Capture 2, HC2) samples. Partial genotyping with separate detection of HPV types 16 and 18 was performed with a hybrid capture-based method and a quantitative PCR assay. Methylation was assayed with a quantitative methylation-specific PCR. Results High-risk HPV infection was detected in 48% of baseline and 71% of follow-up HC2-positive samples. Methylation was demonstrated respectively in 15% and 23.5% of baseline and follow- up samples and chiefly involved a single gene (miR124-2). Invalid quantitative PCR results were recorded in 5% of self-collected samples. The specificity of miR124-1, MAL, and CADM1 methylation was 84%, 94%, and 98%, respectively, and the specificity of the three markers combined was 84%. Sensitivity was not estimated due to the lack of CIN2+ samples. The systematic review showed that different methylation assays yield different accuracy values. Conclusion Self-collected samples are suitable for methylation assays included in reflex triage testing. The reproducibility and accuracy of the methylation tests described in the literature should be improved.	[Del Mistro, Annarosa; Frayle, Helena; Rizzi, Martina] Veneto Inst Oncol IOV IRCCS, Immunol & Diagnost Mol Oncol Unit, Padua, Italy; [Fantin, Gianpiero] Local Hlth Unit 7, Maternal & Child Dept, Treviso, Italy; [Ferro, Antonio] Local Hlth Unit 17, Prevent Dept, Padua, Italy; [Angeletti, Paolo Matteo] Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy; [Rossi, Paolo Giorgi] Local Hlth Author, Interinst Epidemiol Unit, Reggio Emilia, Italy; [Rossi, Paolo Giorgi] IRCCS, Arcispedale S Maria Nuova Res Hosp, Reggio Emilia, Italy; [Altobelli, Emma] Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy; [Altobelli, Emma] Univ Aquila, AUSL Teramo, Epidemiol & Biostat Unit, Laquila, Italy	IRCCS Istituto Oncologico Veneto (IOV); University of L'Aquila; University of L'Aquila; University of L'Aquila	Altobelli, E (corresponding author), Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy.; Altobelli, E (corresponding author), Univ Aquila, AUSL Teramo, Epidemiol & Biostat Unit, Laquila, Italy.	emma.altobelli@cc.univaq.it	Rossi, Paolo Giorgi/K-6367-2016; Frayle, Helena/S-7496-2018	Rossi, Paolo Giorgi/0000-0001-9703-2460; Frayle, Helena/0000-0002-4906-3075				Ahmadipour H, 2016, ASIAN PAC J CANC PRE, V17; Altobelli E, 2016, LANCET ONCOL; Altobelli E, 2016, MOL CLIN ONCOL, V5, P348, DOI 10.3892/mco.2016.909; Altobelli E, 2015, INT J GYNECOL CANCER, V25, P474, DOI 10.1097/IGC.0000000000000374; Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Boers A, 2014, BRIT J CANCER, V111, P1095, DOI 10.1038/bjc.2014.392; Bogler T, 2015, CAN FAM PHYSICIAN, V61, pE459; Camilloni L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-464; Carozzi F, 2008, LANCET ONCOL, V9, P937, DOI 10.1016/S1470-2045(08)70208-0; Carrasquillo O, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-299; Castle PE, 2008, J CLIN MICROBIOL, V46, P2595, DOI 10.1128/JCM.00824-08; Chang CC, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1411-x; De Strooper LMA, 2016, GYNECOL ONCOL, V141, P341, DOI 10.1016/j.ygyno.2016.02.012; De Strooper LMA, 2014, J CLIN PATHOL, V67, P1067, DOI 10.1136/jclinpath-2014-202616; Del Mistro A, 2010, GYNECOL ONCOL, V117, P77, DOI 10.1016/j.ygyno.2010.01.003; Dijkstra MG, 2014, ANN ONCOL, V25, P927, DOI 10.1093/annonc/mdt538; Duke P, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0206-1; Ebisch RMF, 2016, INT J CANCER, V139, P691, DOI 10.1002/ijc.30090; Eijsink JJH, 2011, GYNECOL ONCOL, V120, P280, DOI 10.1016/j.ygyno.2010.10.029; Gillio-Tos A, 2013, J CLIN MICROBIOL, V51, P2901, DOI 10.1128/JCM.01047-13; Giorgi-Rossi P, 2012, INT J CANCER, V130, P1387, DOI 10.1002/ijc.26147; Hesselink AT, 2014, INT J CANCER, V135, P880, DOI 10.1002/ijc.28723; Hesselink AT, 2014, J CLIN MICROBIOL, V52, P890, DOI 10.1128/JCM.03195-13; Hillemanns P, 2016, ONCOL RES TREAT, V39, P501, DOI 10.1159/000448385; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Overmeer RM, 2009, J PATHOL, V219, P327, DOI 10.1002/path.2598; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Rossi PG, 2015, BRIT J CANCER, V112, P667, DOI 10.1038/bjc.2015.11; Sancho-Garnier H, 2013, INT J CANCER, V133, P2681, DOI 10.1002/ijc.28283; Schiffman M, 2015, J CLIN MICROBIOL, V53, P52, DOI 10.1128/JCM.02116-14; Schiffman M, 2015, CANCER EPIDEM BIOMAR, V24, P1304, DOI 10.1158/1055-9965.EPI-14-1353; Serraino D, 2015, PREV MED, V75, P56, DOI 10.1016/j.ypmed.2015.01.034; Tamalet C, 2016, J CLIN VIROL, V78, P102, DOI 10.1016/j.jcv.2016.02.027; Vaccarella S, 2016, LANCET ONCOL; Verdoodt F, 2015, EUR J CANCER, V51, P2375, DOI 10.1016/j.ejca.2015.07.006; Verhoef VMJ, 2014, GYNECOL ONCOL, V135, P58, DOI 10.1016/j.ygyno.2014.08.003; Verhoef VMJ, 2014, LANCET ONCOL, V15, P315, DOI 10.1016/S1470-2045(14)70019-1; Virtanen A, 2015, INT J CANCER, V136, pE677, DOI 10.1002/ijc.29176; Zorzi M, 2013, BJOG-INT J OBSTET GY, V120, P1260, DOI 10.1111/1471-0528.12272	40	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172226	10.1371/journal.pone.0172226	http://dx.doi.org/10.1371/journal.pone.0172226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28263992	gold, Green Submitted, Green Published			2022-12-26	WOS:000396054300008
J	Wessels, D; Lusche, DF; Voss, E; Kuhl, S; Buchele, EC; Klemme, MR; Russell, KB; Ambrose, J; Soll, BA; Bossler, A; Milhem, M; Goldman, C; Soll, DR				Wessels, Deborah; Lusche, Daniel F.; Voss, Edward; Kuhl, Spencer; Buchele, Emma C.; Klemme, Michael R.; Russell, Kanoe B.; Ambrose, Joseph; Soll, Benjamin A.; Bossler, Aaron; Milhem, Mohammed; Goldman, Charles; Soll, David R.			Melanoma cells undergo aggressive coalescence in a 3D Matrigel model that is repressed by anti-CD44	PLOS ONE			English	Article							CD44 SPLICE VARIANTS; MOTION ANALYSIS; TUMOR-GROWTH; 3-DIMENSIONAL RECONSTRUCTION; FLUORESCENCE MICROSCOPY; MONOCLONAL-ANTIBODIES; MALIGNANT-MELANOMA; HUMAN FIBROBLASTS; NEURAL CREST; S100 PROTEIN	Using unique computer-assisted 3D reconstruction software, it was previously demonstrated that tumorigenic cell lines derived from breast tumors, when seeded in a 3D Matrigel model, grew as clonal aggregates which, after approximately 100 hours, underwent coalescence mediated by specialized cells, eventually forming a highly structured large spheroid. Non-tumorigenic cells did not undergo coalescence. Because histological sections of melanomas forming in patients suggest that melanoma cells migrate and coalesce to form tumors, we tested whether they also underwent coalescence in a 3D Matrigel model. Melanoma cells exiting fragments of three independent melanomas or from secondary cultures derived from them, and cells from the melanoma line HTB-66, all underwent coalescence mediated by specialized cells in the 3D model. Normal melanocytes did not. However, coalescence of melanoma cells differed from that of breast-derived tumorigenic cell lines in that they 1) coalesced immediately, 2) underwent coalescence as individual cells as well as aggregates, 3) underwent coalescence far faster and 4) ultimately formed long, flat, fenestrated aggregates that were extremely dynamic. A screen of 51 purified monoclonal antibodies (mAbs) targeting cell surface-associated molecules revealed that two mAbs, anti-beta 1 integrin/(CD29) and anti-CD44, blocked melanoma cell coalescence. They also blocked coalescence of tumorigenic cells derived from a breast tumor. These results add weight to the commonality of coalescence as a characteristic of tumorigenic cells, as well as the usefulness of the 3D Matrigel model and software for both investigating the mechanisms regulating tumorigenesis and screening for potential anti-tumorigenesis mAbs.	[Wessels, Deborah; Lusche, Daniel F.; Voss, Edward; Kuhl, Spencer; Buchele, Emma C.; Klemme, Michael R.; Russell, Kanoe B.; Ambrose, Joseph; Soll, Benjamin A.; Soll, David R.] Univ Iowa, Dept Biol, Dev Studies Hybridoma Bank, Iowa City, IA 52242 USA; [Bossler, Aaron] Univ Iowa Hosp & Clin, Dept Mol Pathol, Iowa City, IA 52242 USA; [Milhem, Mohammed] Univ Iowa Hosp & Clin, Dept Internal Med, Iowa City, IA 52242 USA; [Goldman, Charles] Mercy Hosp Syst Des Moines, Des Moines, IA USA	University of Iowa; University of Iowa; University of Iowa	Soll, DR (corresponding author), Univ Iowa, Dept Biol, Dev Studies Hybridoma Bank, Iowa City, IA 52242 USA.	david-soll@uiowa.edu		Bossler, Aaron/0000-0002-8748-2510; Milhem, Mohammed/0000-0003-4663-6824; Lusche, Daniel Felix/0000-0002-8848-4198	Monoclonal Antibody Research Institute; Developmental Studies Hybridoma Bank; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	Monoclonal Antibody Research Institute; Developmental Studies Hybridoma Bank; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Monoclonal Antibody Research Institute and the Developmental Studies Hybridoma Bank, the latter a National Resource created by the National Institutes of Health (NIH) housed at the University of Iowa.	Ahrens T, 2001, ONCOGENE, V20, P3399, DOI 10.1038/sj.onc.1204435; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ambrose J, 2015, AM J CANCER RES, V5, P3485; Aung PP, 2015, J CLIN PATHOL, V68, P963, DOI 10.1136/jclinpath-2015-202887; Babapoor S, 2016, MODERN PATHOL, V29, P461, DOI 10.1038/modpathol.2016.44; Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; BELITSOS PC, 1990, J IMMUNOL, V144, P1661; Blessing K, 1998, HISTOPATHOLOGY, V32, P139; Boyd DD, 2003, AM J PATHOL, V162, P619, DOI 10.1016/S0002-9440(10)63855-2; BRINSTER RL, 1984, CELL, V37, P367, DOI 10.1016/0092-8674(84)90367-2; BRONNERFRASER M, 1980, J COMP NEUROL, V193, P423, DOI 10.1002/cne.901930209; Cabezon T, 2013, MOL CELL PROTEOMICS, V12, P381, DOI 10.1074/mcp.M112.019786; Chen YF, 2014, J INVEST DERMATOL, V134, P335, DOI 10.1038/jid.2013.327; Cheon DJ, 2011, ANNU REV PATHOL-MECH, V6, P95, DOI 10.1146/annurev.pathol.3.121806.154244; Chu TY, 1999, GENE CHROMOSOME CANC, V24, P127, DOI 10.1002/(SICI)1098-2264(199902)24:2<127::AID-GCC5>3.0.CO;2-8; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Costa S, 2016, AM J SURG PATHOL, V40, P368, DOI 10.1097/PAS.0000000000000568; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dixit R, 2003, PLANT J, V36, P280, DOI 10.1046/j.1365-313X.2003.01868.x; Dobrucki JW, 2007, BIOPHYS J, V93, P1778, DOI 10.1529/biophysj.106.096636; Doganer BA, 2016, TRENDS CELL BIOL, V26, P262, DOI 10.1016/j.tcb.2015.11.002; Ertao Z., 2016, J EXP CLIN CANC RES, V35, P1, DOI DOI 10.1186/s13046-016-0336-9; Ezin AM, 2009, DEV BIOL, V330, P221, DOI 10.1016/j.ydbio.2009.03.018; Facista Alexander, 2012, Genome Integr, V3, P3, DOI 10.1186/2041-9414-3-3; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Franklin WA, 1997, J CLIN INVEST, V100, P2417, DOI DOI 10.1172/JCI119782; FRIDMAN R, 1991, JNCI-J NATL CANCER I, V83, P769, DOI 10.1093/jnci/83.11.769; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; GLASGOW BJ, 1987, J CUTAN PATHOL, V14, P223, DOI 10.1111/j.1600-0560.1987.tb01337.x; GOODFELLOW PN, 1982, EUR J IMMUNOL, V12, P659, DOI 10.1002/eji.1830120807; Gov NS, 2007, P NATL ACAD SCI USA, V104, P15970, DOI 10.1073/pnas.0708037104; GOWN AM, 1986, AM J PATHOL, V123, P195; Guida S, 2016, BRIT J DERMATOL, V174, P610, DOI 10.1111/bjd.14286; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; GUO YJ, 1994, CANCER RES, V54, P1561; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heaphy CM, 2009, BREAST CANCER RES TR, V118, P229, DOI 10.1007/s10549-009-0504-0; HeroldMende C, 1996, J PATHOL, V179, P66, DOI 10.1002/(SICI)1096-9896(199605)179:1<66::AID-PATH544>3.0.CO;2-5; HERRMANN LR, 1976, J ENG MECH DIV-ASCE, V102, P749; Im Sungbin, 1992, Yonsei Medical Journal, V33, P344; Jensen EC, 2012, ANAT REC, V295, P2031, DOI 10.1002/ar.22602; Jones TD, 2005, CLIN CANCER RES, V11, P6512, DOI 10.1158/1078-0432.CCR-05-0891; Jothy S, 1996, TUMOR BIOL, V17, P58, DOI 10.1159/000217967; Jungbauer S, 2004, CHEMPHYSCHEM, V5, P85, DOI 10.1002/cphc.200300868; Kadara H, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju004; Kerosuo L, 2012, SEMIN CELL DEV BIOL, V23, P320, DOI 10.1016/j.semcdb.2012.03.010; Kibbey Maura C., 1994, Journal of Tissue Culture Methods, V16, P227, DOI 10.1007/BF01540656; Kirfel G, 2004, PROTOPLASMA, V223, P67, DOI 10.1007/s00709-003-0031-5; KOZLOWSKI JM, 1984, J NATL CANCER I, V72, P913; Kuhl S, 2016, CHEMOTAXIS METHODS P; Kutzner H, 2012, MODERN PATHOL, V25, P838, DOI 10.1038/modpathol.2012.35; Leotlela PD, 2007, ONCOGENE, V26, P3846, DOI 10.1038/sj.onc.1210155; Ley K, 2016, NAT REV DRUG DISCOV, V15, P173, DOI 10.1038/nrd.2015.10; Li X, 2015, CANCER GENET-NY, V208, P25, DOI 10.1016/j.cancergen.2014.11.005; Lochhead P, 2014, ETIOLOGIC FIELD EFFE; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; LOWE SW, 1994, COLD SPRING HARB SYM, V59, P419, DOI 10.1101/SQB.1994.059.01.047; Lynch SP, 2013, ONCOLOGIST, V18, P1167, DOI 10.1634/theoncologist.2013-0167; Ma Q, 2012, ONCOL LETT, V3, P797, DOI 10.3892/ol.2012.558; MIHM MC, 1971, NEW ENGL J MED, V284, P1078, DOI 10.1056/NEJM197105132841907; Moody G, 2016, INT J CANCER, V139, P1340, DOI 10.1002/ijc.30180; MOORE GE, 1971, SURG GYNECOL OBSTETR, V132, P427; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; NERI A, 1982, J NATL CANCER I, V68, P507; Nonaka D, 2008, J CUTAN PATHOL, V35, P1014, DOI 10.1111/j.1600-0560.2007.00953.x; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; Omelchenko T, 2003, P NATL ACAD SCI USA, V100, P10788, DOI 10.1073/pnas.1834401100; Pampaloni F, 2014, INTEGR BIOL-UK, V6, P988, DOI 10.1039/c4ib00121d; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Perona Rosario, 2006, Clin Transl Oncol, V8, P77, DOI 10.1007/s12094-006-0162-1; Piotrowicz RS, 2011, MOL CANCER THER, V10, P2072, DOI 10.1158/1535-7163.MCT-11-0351; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Poston T, 1998, COMPUT GRAPH FORUM, V17, pC137, DOI 10.1111/1467-8659.00261; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; PRICE JE, 1990, CANCER RES, V50, P717; Provance DW, 1996, P NATL ACAD SCI USA, V93, P14554, DOI 10.1073/pnas.93.25.14554; Raso-Barnett L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053883; RODECK U, 1993, CANCER METAST REV, V12, P219, DOI 10.1007/BF00665954; Russ J.C, 1992, IMAGE PROCESSING HDB; Saalbach A, 1998, ARCH DERMATOL RES, V290, P360, DOI 10.1007/s004030050318; Scherer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118628; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Seiter S, 1996, CLIN CANCER RES, V2, P447; Seiter S, 1996, VIRCHOWS ARCH, V428, P141; Siiskonen Hanna, 2013, BMC Cancer, V13, P181, DOI 10.1186/1471-2407-13-181; Sironen RK, 2011, EXP CELL RES, V317, P383, DOI 10.1016/j.yexcr.2010.11.017; Sixma JJ, 1997, THROMB HAEMOSTASIS, V78, P434; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Smoller BR, 2006, MODERN PATHOL, V19, pS34, DOI 10.1038/modpathol.3800508; Soll DR, 2009, EUKARYOT CELL, V8, P1381, DOI 10.1128/EC.00121-09; Soll David R, 2003, ScientificWorldJournal, V3, P827; Soll DR, 1999, COMPUT MED IMAG GRAP, V23, P3, DOI 10.1016/S0895-6111(98)00058-5; Soll DR, 1995, INT REV CYTOL, V163, P43; Soll DR, 2000, SCANNING, V22, P249, DOI 10.1002/sca.4950220404; Soll DR, 2001, METH MOL B, V161, P45; Soll DR, 1998, TECH MOD B, P25; Song PI, 2002, J INVEST DERMATOL, V119, P424, DOI 10.1046/j.1523-1747.2002.01847.x; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Sung Myong-Hee, 2013, Cells, V2, P284, DOI 10.3390/cells2020284; SWEENEY TM, 1991, CANCER METAST REV, V10, P245, DOI 10.1007/BF00050795; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; Wang YG, 2012, EXP MOL MED, V44, P387, DOI 10.3858/emm.2012.44.6.044; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; WESSELS D, 1994, CELL MOTIL CYTOSKEL, V27, P1, DOI 10.1002/cm.970270102; Wessels DJ, 2016, METHODS MOL BIOL, V1365, P265, DOI 10.1007/978-1-4939-3124-8_14; Wong PP, 2014, ONCOGENE, V33, P4579, DOI 10.1038/onc.2014.45; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; ZAMBRUNO G, 1993, J CELL SCI, V105, P179	117	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173400	10.1371/journal.pone.0173400	http://dx.doi.org/10.1371/journal.pone.0173400			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264026	Green Published, gold, Green Submitted			2022-12-26	WOS:000396054300063
J	Inzaugarat, ME; De Matteo, E; Baz, P; Lucero, D; Garcia, CC; Ballerga, EG; Daruich, J; Sorda, JA; Wald, MR; Chernavsky, AC				Eugenia Inzaugarat, Maria; De Matteo, Elena; Baz, Placida; Lucero, Diego; Claudia Garcia, Cecilia; Ballerga, Esteban Gonzalez; Daruich, Jorge; Sorda, Juan Antonio; Wald, Miriam Ruth; Claudia Chernavsky, Alejandra			New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans	PLOS ONE			English	Article							OXIDATIVE STRESS; NADPH OXIDASE; LEPTIN; STEATOHEPATITIS; INFLAMMATION; ACTIVATION; MECHANISMS; CELLS; EXPRESSION; SIGNATURE	Introduction The immune system acts on different metabolic tissues that are implicated in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Leptin and linoleic acid have the ability to potentially affect immune cells, whereas curcumin is a known natural polyphenol with antioxidant and anti-inflammatory properties. Aims This study was designed to evaluate the pro-inflammatory and pro-oxidant effects of leptin and linoleic acid on immune cells from patients with NAFLD and to corroborate the modulatory effects of curcumin and its preventive properties against the progression of NAFLD using a high-fat diet (HFD)-induced NAFLD/nonalcoholic steatohepatitis mouse model. Results The ex vivo experiments showed that linoleic acid increased the production of reactive oxygen species in monocytes and liver macrophages, whereas leptin enhanced tumor necrosis factor-alpha (TNF-alpha) production in monocytes and interferon-gamma production in circulating CD4(+) cells. Conversely, oral administration of curcumin prevented HFD-induced liver injury, metabolic alterations, intrahepatic CD4(+) cell accumulation and the linoleic acid-and leptin-induced pro-inflammatory and pro-oxidant effects on mouse liver macrophages. Conclusion Our findings provide new evidence for the therapeutic potential of curcumin to treat human NAFLD. However, the development of a preventive treatment targeting human circulating monocytes and liver macrophages as well as peripheral and hepatic CD4(+) cells requires additional research.	[Eugenia Inzaugarat, Maria; Baz, Placida; Claudia Garcia, Cecilia; Claudia Chernavsky, Alejandra] Univ Buenos Aires, CONICET, Inst Inmunol Genet & Metab, Buenos Aires, DF, Argentina; [De Matteo, Elena] Hosp Ninos Dr R Gutierrez, Serv Patol, Buenos Aires, DF, Argentina; [Lucero, Diego] Univ Buenos Aires, Fac Farm & Bioquim, Dept Bioquim Clin, Lab Lipidos & Arterioesclerosis, Buenos Aires, DF, Argentina; [Ballerga, Esteban Gonzalez; Daruich, Jorge; Sorda, Juan Antonio] Univ Buenos Aires, Hosp Clin Jose de San Martin, Div Gastroenterol, Buenos Aires, DF, Argentina; [Wald, Miriam Ruth] Univ Catolica Argentina, Consejo Nacl Invest Cient & Tecn, Inst Invest Biomed BIOMED, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Pontifical Catholic University of Argentina	Chernavsky, AC (corresponding author), Univ Buenos Aires, CONICET, Inst Inmunol Genet & Metab, Buenos Aires, DF, Argentina.	alejandra.cher@yahoo.com.ar		Lucero, Diego/0000-0003-2833-5681; Wald, Miriam/0000-0001-9216-2880; Garcia, Cecilia/0000-0001-7120-2038	University of Buenos Aires [CM05]; National Council for Scientific and Technological Investigation [PIP0051]; National Agency for the Promotion of Technology and Science [PICT 2012-2598]	University of Buenos Aires(University of Buenos Aires); National Council for Scientific and Technological Investigation; National Agency for the Promotion of Technology and Science	ACCH received the following fundings: Grant CM05 from the University of Buenos Aires, PIP0051 from the National Council for Scientific and Technological Investigation, PICT 2012-2598 from the National Agency for the Promotion of Technology and Science.	Abe Y, 1999, PHARMACOL RES, V39, P41, DOI 10.1006/phrs.1998.0404; Aggarwal BB, 2010, ANNU REV NUTR, V30, P173, DOI 10.1146/annurev.nutr.012809.104755; Alkhouri N, 2014, DIGEST DIS SCI, V59, P1617, DOI 10.1007/s10620-014-3031-8; [Anonymous], 2013, J BUILD CONSTR PLAN, DOI DOI 10.4236/JBCPR.2013.11001; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Balteau M, 2011, CARDIOVASC RES, V92, P237, DOI 10.1093/cvr/cvr230; Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727; Cassano S, 2014, METABOLISM, V63, P1272, DOI 10.1016/j.metabol.2014.06.010; Chatterjee S, 2013, J HEPATOL, V58, P778, DOI 10.1016/j.jhep.2012.11.035; De Almeida IT, 2002, CLIN NUTR, V21, P219, DOI 10.1054/clnu.2001.0529; Farrell GC, 2014, LIVER INT, V34, P1084, DOI 10.1111/liv.12335; Feldstein AE, 2010, J LIPID RES, V51, P3046, DOI 10.1194/jlr.M007096; Huang XD, 2008, WORLD J GASTROENTERO, V14, P2888, DOI 10.3748/wjg.14.2888; Kleiner DE, 2012, SEMIN LIVER DIS, V32, P3, DOI 10.1055/s-0032-1306421; Lam QLK, 2007, CELL MOL IMMUNOL, V4, P1; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Meli R, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00177; Oner-Iyidogan Y, 2014, CAN J PHYSIOL PHARM, V92, P805, DOI 10.1139/cjpp-2014-0174; Polyzos SA, 2015, METABOLISM, V64, P60, DOI 10.1016/j.metabol.2014.10.012; Procaccini C, 2015, METABOLISM, V64, P92, DOI 10.1016/j.metabol.2014.10.014; Procaccini C, 2012, J IMMUNOL, V189, P2941, DOI 10.4049/jimmunol.1200935; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229; Sanchez-Margalet V, 2003, CLIN EXP IMMUNOL, V133, P11, DOI 10.1046/j.1365-2249.2003.02190.x; Sellmayer A, 1996, CELL SIGNAL, V8, P397, DOI 10.1016/0898-6568(96)00077-0; Shapiro H, 2005, NUTR RES REV, V18, P212, DOI 10.1079/NRR2005106; Shishodia S, 2013, BIOFACTORS, V39, P37, DOI 10.1002/biof.1041; Sutti S, 2014, HEPATOLOGY, V59, P886, DOI 10.1002/hep.26749; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; Vonghia L, 2013, INT J MOL SCI, V14, P19867, DOI 10.3390/ijms141019867; Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001	34	38	42	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172900	10.1371/journal.pone.0172900	http://dx.doi.org/10.1371/journal.pone.0172900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257515	gold, Green Published, Green Submitted			2022-12-26	WOS:000396021100038
J	Mootien, S; Kaplan, PM				Mootien, Saraspadee; Kaplan, Paul M.			Monoclonal antibodies specific for Bacteroides fragilis enterotoxins BFT1 and BFT2 and their use in immunoassays	PLOS ONE			English	Article							METALLOPROTEASE TOXIN GENE; HELICOBACTER-PYLORI INFECTION; INFLAMMATORY-BOWEL-DISEASE; DIARRHEAL DISEASE; COLORECTAL-CANCER; GASTRIC-CANCER; TUMORIGENESIS; COMMENSAL; CHILDREN	We have developed 22 mouse IgG(1) monoclonal antibodies (mAbs) against Bacteroides fragilis zinc metalloprotease toxins 1 and 2 (BFT1 and BFT2). Mice were immunized with recombinant BFT1 or BFT2 proteins with metalloprotease activity. Eight of the mAbs bind specifically to BFT1. One mAb, 2H6, binds specifically to BFT2. The remaining 13 mAbs bind to both BFT1 and BFT2. The eight BFT1-specific mAbs recognize at least five different epitopes on the toxin. Four of the BFT1-specific mAbs neutralized rBFT1 metalloprotease activity. Only one of these four mAbs, 1D9, neutralizes the cytotoxic effect of BFT1. Here, we describe the development of enzyme-linked immunosorbent assays (ELISAs) to detect BFT1 or BFT2 toxin in an isotype-specific manner. The sandwich ELISAs have a detection limit of 20 to 40 ng/ml when purified recombinant BFT protein is diluted into PBS. The sandwich ELISA can be used to distinguish and quantify levels of rBFT1 and rBFT2 in stool. This ELISA can be an important tool to investigate the association between BFT expression by enterotoxigenic B. fragilis and diseases such as diarrhea, inflammatory bowel disease and colorectal cancer.	[Mootien, Saraspadee; Kaplan, Paul M.] L2 Diagnost LLC, New Haven, CT 06511 USA		Mootien, S (corresponding author), L2 Diagnost LLC, New Haven, CT 06511 USA.	smootien@l2dx.com			NIH SBIR Grant [1 R43 A1092976-01A1]; L2 Diagnostics LLC	NIH SBIR Grant; L2 Diagnostics LLC	This study was funded by an NIH SBIR Grant awarded to SM: Grant Number 1 R43 A1092976-01A1. L2 Diagnostics LLC provided support in the form of salaries for authors SM and PMK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Asaka M, 2002, INTERNAL MED, V41, P1, DOI 10.2169/internalmedicine.41.1; Basset C, 2004, DIGEST DIS SCI, V49, P1425, DOI 10.1023/B:DDAS.0000042241.13489.88; Basset Christelle, 2002, Science Progress, V85, P13, DOI 10.3184/003685002783238898; Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787; Chung GT, 1999, INFECT IMMUN, V67, P4945, DOI 10.1128/IAI.67.9.4945-4949.1999; Delzenne NM, 2015, DIABETOLOGIA; Demarest SJ, 2010, MABS-AUSTIN, V2, P190, DOI 10.4161/mabs.2.2.11220; Durmaz B, 2005, ANAEROBE, V11, P318, DOI 10.1016/j.anaerobe.2005.06.001; Franco AA, 2005, INFECT IMMUN, V73, P5273, DOI 10.1128/IAI.73.8.5273-5277.2005; Franco AA, 1997, INFECT IMMUN, V65, P1007, DOI 10.1128/IAI.65.3.1007-1013.1997; Gharaibeh DN, 2013, J MICROBIOL METH, V94, P125, DOI 10.1016/j.mimet.2013.05.009; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; Kato N, 2000, FEMS MICROBIOL LETT, V182, P171, DOI 10.1111/j.1574-6968.2000.tb08892.x; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P591; MYERS LL, 1987, AM J VET RES, V48, P774; MYERS LL, 1984, INFECT IMMUN, V44, P241, DOI 10.1128/IAI.44.2.241-244.1984; Nguyen TV, 2005, J CLIN MICROBIOL, V43, P755, DOI 10.1128/JCM.43.2.755-760.2005; Nishizawa T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/794378; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Pathela P, 2005, J INFECT DIS, V191, P1245, DOI 10.1086/428947; Prindiville TP, 2000, EMERG INFECT DIS, V6, P171, DOI 10.3201/eid0602.000210; Qin HY, 2014, WORLD J GASTROENTERO, V20, P14126, DOI 10.3748/wjg.v20.i39.14126; Rhee KJ, 2009, INFECT IMMUN, V77, P1708, DOI 10.1128/IAI.00814-08; Robizadeh S, 2007, INFLAMM BOWEL DIS, V13, P1475, DOI 10.1002/ibd.20265; SANJOAQUIN VH, 1995, SCAND J INFECT DIS, V27, P211, DOI 10.3109/00365549509019011; Sears CL, 2001, TOXICON, V39, P1737, DOI 10.1016/S0041-0101(01)00160-X; Sears CL, 2009, CLIN MICROBIOL REV, V22, P349, DOI 10.1128/CMR.00053-08; Shiryaev SA, 2014, FEBS J, V281, P2487, DOI 10.1111/febs.12804; Slyepchenko A, 2014, CNS NEUROL DISORD-DR, V13, P1770; Terada S, 1993, Kansenshogaku Zasshi, V67, P772; Toprak NU, 2006, CLIN MICROBIOL INFEC, V12, P782, DOI 10.1111/j.1469-0691.2006.01494.x; VANTASSELL RL, 1994, CLIN DIAGN LAB IMMUN, V1, P578, DOI 10.1128/CDLI.1.5.578-584.1994; Viljoen KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119462; WEIKEL CS, 1992, INFECT IMMUN, V60, P321, DOI 10.1128/IAI.60.2.321-327.1992; Wick EC, 2010, CURR OPIN INFECT DIS, V23, P470, DOI 10.1097/QCO.0b013e32833da1eb; Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979; Wu SG, 2003, GASTROENTEROLOGY, V124, P392, DOI 10.1053/gast.2003.50047; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yong X, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0111-0; Zhou LH, 2015, NEUROPSYCH DIS TREAT, V11, P715, DOI 10.2147/NDT.S61997	40	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173128	10.1371/journal.pone.0173128	http://dx.doi.org/10.1371/journal.pone.0173128			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257448	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100062
J	Ojo, OB; Lougue, S; Woldegerima, WA				Ojo, Oluwatobi Blessing; Lougue, Siaka; Woldegerima, Woldegebriel Assefa			Bayesian generalized linear mixed modeling of Tuberculosis using informative priors	PLOS ONE			English	Article								TB is rated as one of the world's deadliest diseases and South Africa ranks 9th out of the 22 countries with hardest hit of TB. Although many pieces of research have been carried out on this subject, this paper steps further by inculcating past knowledge into the model, using Bayesian approach with informative prior. Bayesian statistics approach is getting popular in data analyses. But, most applications of Bayesian inference technique are limited to situations of non-informative prior, where there is no solid external information about the distribution of the parameter of interest. The main aim of this study is to profile people living with TB in South Africa. In this paper, identical regression models are fitted for classical and Bayesian approach both with non-informative and informative prior, using South Africa General Household Survey (GHS) data for the year 2014. For the Bayesian model with informative prior, South Africa General Household Survey dataset for the year 2011 to 2013 are used to set up priors for the model 2014.	[Ojo, Oluwatobi Blessing; Woldegerima, Woldegebriel Assefa] AIMS Cameroon, African Inst Math Sci, Math Sci, Limbe, Cameroon; [Lougue, Siaka] Univ Kwazulu Natal, Sch Math Stat & Comp Sci, Durban, South Africa; [Woldegerima, Woldegebriel Assefa] Mekelle Univ, Dept Math, Mekelle, Ethiopia; [Ojo, Oluwatobi Blessing] Lagos State Polytech, Dept Math & Stat, Lagos, Nigeria	University of Kwazulu Natal; Mekelle University	Lougue, S (corresponding author), Univ Kwazulu Natal, Sch Math Stat & Comp Sci, Durban, South Africa.	siaka@aims.ac.za	Woldegerima, Woldegebriel Assefa/HGB-5068-2022	Woldegerima, Woldegebriel Assefa/0000-0002-0336-7831				Bernardo J. M., 2009, WILEY SERIES PROBABI; Centers for Disease Control and Prevention, TUB DAT STAT; Dale M Needham, 2011, TROP MED INT HEALTH, V6, P256; Gelman A., 2007, DATA ANAL USING REGR; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Getoor L, 2004, ARTIF INTELL MED, V30, P233, DOI 10.1016/j.artmed.2003.11.003; Hilbe JM, 2009, CH CRC TEXT STAT SCI, P1; Hosmer D.W., 2013, WILEY SERIES PROBABI, DOI DOI 10.1002/0471722146; Hosmer D. W., 2015, SPRINGER SERIES STAT; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Millet JP, 2013, EUR SPINE J, V22, P539, DOI 10.1007/s00586-012-2334-8; Ntzoufras I., 2011, WILEY SERIES COMPUTA; R Core Team, 2013, R LANG ENV STAT COMP; Ryan KJ., 2004, SHERRIS MED MICROBIO; Statistics South Africa (SSA), 2016, GEN HOUS SURV 2014 R	16	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172580	10.1371/journal.pone.0172580	http://dx.doi.org/10.1371/journal.pone.0172580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257437	Green Submitted, gold, Green Published			2022-12-26	WOS:000396021100022
J	Wahmkow, G; Cassel, M; Mayer, F; Baur, H				Wahmkow, Gunnar; Cassel, Michael; Mayer, Frank; Baur, Heiner			Effects of different medial arch support heights on rearfoot kinematics	PLOS ONE			English	Article							FOOT ORTHOSES; PATELLOFEMORAL PAIN; OVERUSE INJURIES; RUNNING ECONOMY; RUNNERS; WALKING; MOTION; REPEATABILITY; PRONATION; ORTHOTICS	Background Foot orthoses are usually assumed to be effective by optimizing mechanically dynamic rear-foot configuration. However, the effect from a foot orthosis on kinematics that has been demonstrated scientifically has only been marginal. The aim of this study was to examine the effect of different heights in medial arch-supported foot orthoses on rear foot motion during gait. Methods Nineteen asymptomatic runners (36 +/- 11years, 180 +/- 5cm, 79 +/- 10kg; 41 +/- 22km/week) participated in the study. Trials were recorded at 3.1 mph (5 km/h) on a treadmill. Athletes walked barefoot and with 4 different not customized medial arch-supported foot orthoses of various arch heights (N: 0 mm, M: 30 mm, H: 35 mm, E: 40mm). Six infrared cameras and the 'Oxford Foot Model A were used to capture motion. The average stride in each condition was calculated from 50 gait cycles per condition. Eversion excursion and internal tibia rotation were analyzed. Descriptive statistics included calculating the mean +/- SD and 95% CIs. Group differences by condition were analyzed by one factor (foot orthoses) repeated measures ANOVA (a = 0.05). Results Eversion excursion revealed the lowest values for N and highest for H (B: 4.6 degrees +/- 2.2 degrees; 95% CI [3.1; 6.2]/N: 4.0 degrees +/- 1.7 degrees; [2.9; 5.2]/M: 5.2 degrees +/- 2.6 degrees; [3.6;6.8]/H: 6.2 degrees +/- 3.3 degrees; [4.0;8.5]/E:5.1 degrees +/- 3.5 degrees; [2.8;7.5]) (p> 0.05). Range of internal tibia rotation was lowest with orthosis H and highest with E (B: 13.3 degrees +/- 3.2 degrees; 95% CI [11.0;15.6]/N: 14.5 degrees +/- 7.2 degrees; [9.2;19.6]/M: 13.8 degrees +/- 5.0 degrees; [10.8;16.8]/H: 12.3 degrees +/- 4.3 degrees; [9.0; 15.6]/E:14.9 degrees +/- 5.0 degrees; [11.5;18.3]) (p> 0.05). Differences between conditions were small and the intrasubject variation high. Conclusion Our results indicate that different arch support heights have no systematic effect on eversion excursion or the range of internal tibia rotation and therefore might not exert a crucial influence on rear foot alignment during gait.	[Wahmkow, Gunnar; Cassel, Michael; Mayer, Frank; Baur, Heiner] Univ Potsdam, Dept Sports Med, Univ Outpatient Clin, Potsdam, Germany; [Baur, Heiner] Bern Univ Appl Sci, Hlth, Physiotherapy, Bern, Switzerland	University of Potsdam	Wahmkow, G (corresponding author), Univ Potsdam, Dept Sports Med, Univ Outpatient Clin, Neuen Palais 10,Haus 12, Potsdam, Germany.	gwahmkow@uni-potsdam.de	Baur, Heiner/M-9995-2019; Baur, Heiner/A-8673-2017	Baur, Heiner/0000-0002-4780-225X	German Federal Ministry of Economics and Technology (BMWi Bundesministerium fur Wirtschaft und Technologie), Berlin, Germany [KA0121102KF7]	German Federal Ministry of Economics and Technology (BMWi Bundesministerium fur Wirtschaft und Technologie), Berlin, Germany	The study was supported by the German Federal Ministry of Economics and Technology (BMWi Bundesministerium fur Wirtschaft und Technologie), Berlin, Germany, Project KA0121102KF7 (Program: PRO INNO II "PROgramm zur Forderung der Erhohung der INNOvationskompetenz mittelstandischer Unternehmen"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the German Federal Ministry of Economics and Technology (BMWi Bundesministerium fur Wirtschaft and Technologie), Berlin, Germany, Project KA0121102KF7 (Program: PRO INNO II "PROgramm zur Forderung der Erhohung der INNOvationskompetenz mittelstandischer Unternehmen"). The authors deeply appreciate proofreading and language support from Caroline Curten, Freiburg (D).	Baur H, 2011, MED SCI SPORT EXER, V43, P1500, DOI 10.1249/MSS.0b013e31820c64ae; Borom AH, 2003, D DREZS ORTHOPAEDI D, P2276; Burns J, 2005, J AM PODIAT MED ASSN, V95, P235, DOI 10.7547/0950235; Carson MC, 2001, J BIOMECH, V34, P1299, DOI 10.1016/S0021-9290(01)00101-4; Collins N, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1735; Donoghue OA, 2008, SPORT BIOMECH, V7, P194, DOI 10.1080/14763140701841407; Fromme A, 1997, Sportverletz Sportschaden, V11, P52, DOI 10.1055/s-2007-993366; Hahni M, 2016, J FOOT ANKLE RES, V9, DOI 10.1186/s13047-016-0176-z; Heise GD, 1996, INT J SPORTS MED, V17, P128; Hirschmuller A, 2011, BRIT J SPORT MED, V45, P959, DOI 10.1136/bjsm.2008.055830; Kapandji IA., 2006, FUNKTIONELLE ANATOMI, V4; Liu AM, 2012, MED SCI SPORT EXER, V44, P2384, DOI 10.1249/MSS.0b013e318265df1d; MacLean C, 2006, CLIN BIOMECH, V21, P623, DOI 10.1016/j.clinbiomech.2006.01.005; Mann RW, 2002, CLIN J SPORT MED, V12, P57, DOI 10.1097/00042752-200201000-00019; MARTIN PE, 1993, MED SCI SPORT EXER, V25, P508; Mayer F, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.031732; McPoil TG, 2000, J AM PODIAT MED ASSN, V90, P2, DOI 10.7547/87507315-90-1-2; Mills K, 2010, BRIT J SPORT MED, V44, P1035, DOI 10.1136/bjsm.2009.066977; Mundermann A, 2003, CLIN BIOMECH, V18, P254, DOI 10.1016/S0268-0033(02)00186-9; Mundermann A, 2003, MED SCI SPORT EXER, V35, P1710, DOI 10.1249/01.MSS.0000089352.47259.CA; NAWOCZENSKI DA, 1995, J ORTHOP SPORT PHYS, V21, P317, DOI 10.2519/jospt.1995.21.6.317; Nester CJ, 2003, GAIT POSTURE, V17, P180, DOI 10.1016/S0966-6362(02)00065-6; Nester CJ, 2003, FOOT ANKLE INT, V24, P164, DOI 10.1177/107110070302400211; Nielsen RO, 2014, BRIT J SPORT MED, V48, P440, DOI 10.1136/bjsports-2013-092202; Nigg B M, 2001, Exerc Sport Sci Rev, V29, P37, DOI 10.1097/00003677-200101000-00008; Nigg BM, 2003, MED SCI SPORT EXER, V35, P314, DOI 10.1249/01.MSS.0000048828.02268.79; Novacheck TF, 1998, GAIT POSTURE, V7, P77, DOI 10.1016/S0966-6362(97)00038-6; Huerta JP, 2009, J AM PODIAT MED ASSN, V99, P415, DOI 10.7547/0990415; Reschke A, 2012, MED SCI SPORTS EXERC, V44, pS715; Richards CE, 2009, BRIT J SPORT MED, V43, P159, DOI 10.1136/bjsm.2008.046680; Rodrigues P, 2013, GAIT POSTURE, V37, P526, DOI 10.1016/j.gaitpost.2012.09.027; Stacoff A, 2000, CLIN BIOMECH, V15, P54, DOI 10.1016/S0268-0033(99)00028-5; Stacoff A, 2001, MED SCI SPORT EXER, V33, P311; Stebbins J, 2006, GAIT POSTURE, V23, P401, DOI 10.1016/j.gaitpost.2005.03.002; Stefanyshyn DJ, 2006, AM J SPORT MED, V34, P1844, DOI 10.1177/0363546506288753; Theologis TN, 2003, J BONE JOINT SURG BR, V85B, P572, DOI 10.1302/0301-620X.85B4.13696; Wen DY, 1997, MED SCI SPORT EXER, V29, P1291, DOI 10.1097/00005768-199710000-00003; Williams DS, 2003, MED SCI SPORT EXER, V35, P2060, DOI 10.1249/01.MSS.0000098988.17182.8A; Williams DS, 2001, CLIN BIOMECH, V16, P341, DOI 10.1016/S0268-0033(01)00005-5	39	9	9	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172334	10.1371/journal.pone.0172334	http://dx.doi.org/10.1371/journal.pone.0172334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257426	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100016
J	Liu, HY; Chen, CC; Lin, YY; Chen, YJ; Liu, BH; Wong, SC; Wu, CY; Chang, YT; Chou, HYE; Ding, ST				Liu, Hui-Yu; Chen, Chih-Chien; Lin, Yuan-Yu; Chen, Yu-Jen; Liu, Bing-Hsien; Wong, Shiu-Chung; Wu, Cheng-Yu; Chang, Yun-Tsui; Chou, Han-Yi E.; Ding, Shih-Torng			Chitosan-assisted differentiation of porcine adipose tissue-derived stem cells into glucose-responsive insulin-secreting clusters	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; UMBILICAL-CORD BLOOD; ISLET-LIKE CLUSTERS; GROWTH-FACTOR-ALPHA; IN-VITRO; BONE-MARROW; SPHEROID FORMATION; PROGENITOR CELLS; ACTIVIN-A; EXPRESSION	The unique advantage of easy access and abundance make the adipose-derived stem cells (ADSCs) a promising system of multipotent cells for transplantation and regenerative medicine. Among the available sources, porcine ADSCs (pADSCs) deserve especial attention due to the close resemblance of human and porcine physiology, as well as for the upcoming availability of humanized porcine models. Here, we report on the isolation and conversion of pADSCs into glucose-responsive insulin-secreting cells. We used the stromal-vascular fraction of the dorsal subcutaneous adipose from 9-day-old male piglets to isolate pADSCs, and subjected the cells to an induction scheme for differentiation on chitosan-coated plates. This one-step procedure promoted differentiation of pADSCs into pancreatic islet-like clusters (PILC) that are characterized by the expression of a repertoire of pancreatic proteins, including pancreatic and duodenal homeobox (Pdx-1), insulin gene enhancer protein (ISL-1) and insulin. Upon glucose challenge, these PILC secreted high amounts of insulin in a dose-dependent manner. Our data also suggest that chitosan plays roles not only to enhance the differentiation potential of pADSCs, but also to increase the glucose responsiveness of PILCs. Our novel approach is, therefore, of great potential for transplantation-based amelioration of type 1 diabetes.	[Liu, Hui-Yu; Chen, Chih-Chien; Lin, Yuan-Yu; Liu, Bing-Hsien; Wong, Shiu-Chung; Chang, Yun-Tsui; Ding, Shih-Torng] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan; [Liu, Hui-Yu; Chen, Yu-Jen; Wu, Cheng-Yu; Ding, Shih-Torng] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan; [Chou, Han-Yi E.] Natl Taiwan Univ, Grad Inst Oral Biol, Taipei, Taiwan; [Ding, Shih-Torng] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan; [Chou, Han-Yi E.] Natl Taiwan Univ, Grad Inst Oral Biol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Ding, ST (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.; Ding, ST (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan.; Chou, HYE (corresponding author), Natl Taiwan Univ, Grad Inst Oral Biol, Taipei, Taiwan.; Ding, ST (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.; Chou, HYE (corresponding author), Natl Taiwan Univ, Grad Inst Oral Biol, Taipei, Taiwan.	hyechou@gmail.com; sding@ntu.edu.tw	Lin, Yuan-Yu/AAD-5190-2021	Ding, Shih-Torng/0000-0002-9866-1776; Lin, Yuan-Yu/0000-0002-3397-3218	National Taiwan University Cutting-Edge Steering Research Project [NTU-CESRP-102R7615-2]; Ministry of Science and Technology in Taiwan [NSC 101-2811-B-029-003]	National Taiwan University Cutting-Edge Steering Research Project; Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Taiwan University Cutting-Edge Steering Research Project (NTU-CESRP-102R7615-2). CCC was supported by the postdoctoral grant (NSC 101-2811-B-029-003) from Ministry of Science and Technology in Taiwan.	Brafman DA, 2010, BIOMATERIALS, V31, P9135, DOI 10.1016/j.biomaterials.2010.08.007; Cawthorn WP, 2012, TRENDS ENDOCRIN MET, V23, P270, DOI 10.1016/j.tem.2012.01.003; Chandra V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020615; Chandra V, 2009, STEM CELLS, V27, P1941, DOI 10.1002/stem.117; Chang CM, 2007, BIOCHEM BIOPH RES CO, V357, P414, DOI 10.1016/j.bbrc.2007.03.157; Chao KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001451; Chen CH, 2008, J NUTR, V138, P674, DOI 10.1093/jn/138.4.674; Cheng NC, 2012, BIOMATERIALS, V33, P1748, DOI 10.1016/j.biomaterials.2011.11.049; Chhabra P, 2013, STEM CELL TRANSL MED, V2, P328, DOI 10.5966/sctm.2012-0116; Cignarelli A, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.13; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dai CS, 2005, AM J PATHOL, V167, P429, DOI 10.1016/S0002-9440(10)62987-2; Dave SD, 2015, CLIN EXP MED, V15, P41, DOI 10.1007/s10238-013-0266-1; Dave Shruti D, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS65, DOI 10.4103/2230-8210.94264; Demeterco C, 2000, J CLIN ENDOCR METAB, V85, P3892, DOI 10.1210/jc.85.10.3892; Dufrane D, 2012, WORLD J GASTROENTERO, V18, P6885, DOI 10.3748/wjg.v18.i47.6885; Ham DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079076; Haque N, 2013, SCI WORLD J, DOI 10.1155/2013/632972; Hsu SH, 2012, BIOMATERIALS, V33, P2642, DOI 10.1016/j.biomaterials.2011.12.032; Huang GS, 2011, BIOMATERIALS, V32, P6929, DOI 10.1016/j.biomaterials.2011.05.092; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kang HM, 2009, STEM CELLS, V27, P1999, DOI 10.1002/stem.127; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7; Khorsandi L, 2015, CELL TISSUE RES, V361, P745, DOI 10.1007/s00441-015-2140-9; Kim SJ, 2012, J BIOSCI BIOENG, V113, P771, DOI 10.1016/j.jbiosc.2012.02.007; Kobayashi E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-8; Li L, 2004, DIABETES, V53, P608, DOI 10.2337/diabetes.53.3.608; Lin GT, 2009, STEM CELLS DEV, V18, P1399, DOI 10.1089/scd.2009.0010; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Liu BH, 2005, J ANIM SCI, V83, P1516; Liu BH, 2013, BIORESEARCH OPEN ACC, V2, P28, DOI 10.1089/biores.2012.0285; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Moshtagh PR, 2013, J PHYSIOL BIOCHEM, V69, P451, DOI 10.1007/s13105-012-0228-1; Noguchi H, 2010, TRANSPL P, V42, P2081, DOI 10.1016/j.transproceed.2010.05.097; OTONKOSKI T, 1993, J CLIN INVEST, V92, P1459, DOI 10.1172/JCI116723; Penney DP, 2002, BIOTECH HISTOCHEM, V77, P237, DOI 10.1080/714028210; Ramesh A, 2013, CURR DIABETES REV, V9, P294, DOI 10.2174/15733998113099990063; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sneddon JB, 2012, NATURE, V491, P765, DOI 10.1038/nature11463; Sosa-Pineda B, 2004, MOL CELLS, V18, P289; Sun B, 2007, BIOCHEM BIOPH RES CO, V354, P919, DOI 10.1016/j.bbrc.2007.01.069; Tai CC, 2009, J BIOL CHEM, V284, P32239, DOI 10.1074/jbc.M109.024661; Tang DQ, 2004, DIABETES, V53, P1721, DOI 10.2337/diabetes.53.7.1721; Tateishi K, 2008, J BIOL CHEM, V283, P31601, DOI 10.1074/jbc.M806597200; Timper K, 2006, BIOCHEM BIOPH RES CO, V341, P1135, DOI 10.1016/j.bbrc.2006.01.072; Van Hoof D, 2009, STEM CELL RES, V3, P73, DOI 10.1016/j.scr.2009.08.003; Wang RN, 1997, DIABETOLOGIA, V40, P887, DOI 10.1007/s001250050764; WANG TC, 1993, J CLIN INVEST, V92, P1349, DOI 10.1172/JCI116708; Wong RSY, 2011, EXP DIABETES RES, DOI 10.1155/2011/406182; Xie QP, 2009, DIFFERENTIATION, V77, P483, DOI 10.1016/j.diff.2009.01.001; Yang KC, 2013, J BIOMED MATER RES A, V101, P2273, DOI 10.1002/jbm.a.34547; Yang LJ, 2002, P NATL ACAD SCI USA, V99, P8078, DOI 10.1073/pnas.122210699; Yaturu S, 2013, WORLD J DIABETES, V4, P1, DOI 10.4239/wjd.v4.i1.1; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	58	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172922	10.1371/journal.pone.0172922	http://dx.doi.org/10.1371/journal.pone.0172922			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253305	gold, Green Published, Green Submitted			2022-12-26	WOS:000396011300047
J	Ozaki, R; Kuroda, K; Ikemoto, Y; Ochiai, A; Matsumoto, A; Kumakiri, J; Kitade, M; Itakura, A; Muter, J; Brosens, JJ; Takeda, S				Ozaki, Rie; Kuroda, Keiji; Ikemoto, Yuko; Ochiai, Asako; Matsumoto, Akemi; Kumakiri, Jun; Kitade, Mari; Itakura, Atsuo; Muter, Joanne; Brosens, Jan J.; Takeda, Satoru			Reprogramming of the retinoic acid pathway in decidualizing human endometrial stromal cells	PLOS ONE			English	Article							VITAMIN-A; RECEPTOR; PROTEIN; BIOSYNTHESIS; METABOLISM; ACTIVATION; EXPRESSION; HEALTH; DEHYDROGENASES; EXPANSION	Upon breaching of the endometrial surface epithelium, the implanting embryo embeds in the decidualizing stroma. Retinoic acid (RA), a metabolite of vitamin A, is an important morphogen during embryonic and fetal development, although the role of the RA pathway in the surrounding decidual cells is not understood. Here we show that decidual transformation of human endometrial stromal cells (HESCs) results in profound reprogramming of the RA signaling and metabolism pathways. Differentiating HESCs downregulate the intracellular carrier proteins CRABP2 and FABP5, responsible for transfer and binding of RA to the nuclear receptors RAR and PPAR beta/delta, respectively. Furthermore, the expression of RAR, the receptor that mediates the pro-apoptotic effects of RA, was also inhibited. By contrast, PPAR beta/delta, which transduces the differentiation responses of RA, was upregulated. Decidualization was also associated with increased expression of retinol-binding protein 4 (RBP4) and various enzymes involved in the metabolism of RA and its precursor, retinaldehyde (Rald), including CYP26A1, DHRS3, and RDH12. Exposure of differentiating HESCs to RA or Rald reversed the inhibition of the CRABP2-RAR pathway, perturbed the expression of decidual marker genes and triggered cell death. Taken together, the data demonstrate that decidualizing HESCs silence RA signaling by downregulating key cytoplasmic binding proteins and by increasing retinoid metabolism. However, excessive RA exposure is toxic for decidual cells and triggers a response that may lead to pregnancy failure.	[Ozaki, Rie; Kuroda, Keiji; Ikemoto, Yuko; Ochiai, Asako; Matsumoto, Akemi; Kumakiri, Jun; Kitade, Mari; Itakura, Atsuo; Takeda, Satoru] Juntendo Univ, Fac Med, Dept Obstet & Gynaecol, Tokyo, Japan; [Muter, Joanne; Brosens, Jan J.] Warwick Med Sch, Div Biomed Sci, Clin Sci Res Labs, Coventry, W Midlands, England; [Brosens, Jan J.] Univ Hosp Coventry & Warwickshire, Tommys Natl Miscarriage Res Ctr, Coventry, W Midlands, England	Juntendo University; University of Warwick; University of Warwick	Kuroda, K (corresponding author), Juntendo Univ, Fac Med, Dept Obstet & Gynaecol, Tokyo, Japan.	arthur@juntendo.ac.jp		Brosens, Jan/0000-0003-0116-9329; Kuroda, Keiji/0000-0003-2759-9159	Japan society for the promotion of science [25861508]; Uehara Memorial Foundation; Juntendo university	Japan society for the promotion of science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Juntendo university	Support was provided by the Japan society for the promotion of science, KAKENHI Grant Number 25861508 [https://www.jsps.go.jp/english/e-grants/index.html]; the Uehara Memorial Foundation [http://www.ueharazaidan.or.jp/]; and Juntendo university young investigator award 2013 [http://www2.med.juntendo.ac.jp/blog/intra/gakujyutsuka1/003/cat61/].	Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Brar AK, 1996, MOL HUM REPROD, V2, P185, DOI 10.1093/molehr/2.3.185; Brosens JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03894; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Cerignoli F, 2002, CANCER RES, V62, P1196; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; Collins MD, 1999, ANNU REV PHARMACOL, V39, P399, DOI 10.1146/annurev.pharmtox.39.1.399; Courtney R, 2008, J CLIN ENDOCR METAB, V93, P550, DOI 10.1210/jc.2007-1912; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; Deisenroth C, 2011, J BIOL CHEM, V286, P28343, DOI 10.1074/jbc.M111.254227; Diaz-Gimeno P, 2011, FERTIL STERIL, V95, P50, DOI 10.1016/j.fertnstert.2010.04.063; Ding NZ, 2003, REPRODUCTION, V125, P817, DOI 10.1530/reprod/125.6.817; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; GEELEN JAG, 1979, CRC CR REV TOXICOL, V6, P351, DOI 10.3109/10408447909043651; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Haeseleer F, 2002, J BIOL CHEM, V277, P45537, DOI 10.1074/jbc.M208882200; Han BC, 2010, J CELL PHYSIOL, V223, P471, DOI 10.1002/jcp.22056; Kam RKT, 2013, J BIOL CHEM, V288, P31477, DOI 10.1074/jbc.M113.514984; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; Kuroda K, 2013, MOL ENDOCRINOL, V27, P192, DOI 10.1210/me.2012-1247; Lee J, 2011, FERTIL STERIL, V95, P2599, DOI 10.1016/j.fertnstert.2011.04.065; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Muter J, 2015, FASEB J, V29, P1603, DOI 10.1096/fj.14-267195; NAPOLI JL, 1993, J NUTR, V123, P362, DOI 10.1093/jn/123.suppl_2.362; Napoli JL, 1996, FASEB J, V10, P993, DOI 10.1096/fasebj.10.9.8801182; Pavone ME, 2010, J CLIN ENDOCR METAB, V95, pE300, DOI 10.1210/jc.2010-0459; PILCH SM, 1987, J NUTR, V117, P636, DOI 10.1093/jn/117.4.636; SAFAVI K, 1992, ARCH DERMATOL, V128, P1130, DOI 10.1001/archderm.128.8.1130; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Salker MS, 2011, NAT MED, V17, P1509, DOI 10.1038/nm.2498; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Teklenburg G., 2010, PLOS ONE, V5; Weimar CH, 2012, PLOS ONE, V7; Wolf G, 2008, NUTR REV, V66, P55, DOI 10.1111/j.1753-4887.2007.00006.x; Zheng WL, 2000, ENDOCRINOLOGY, V141, P802, DOI 10.1210/en.141.2.802; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	39	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173035	10.1371/journal.pone.0173035	http://dx.doi.org/10.1371/journal.pone.0173035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253328	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300063
J	Portnoff, AD; Gao, CH; Borrok, MJ; Gao, XZ; Gao, CS; Rainey, GJ				Portnoff, Alyse D.; Gao, Cuihua; Borrok, M. Jack; Gao, Xizhe; Gao, Changshou; Rainey, G. Jonah			An antidote approach to reduce risk and broaden utility of antibody-based therapeutics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL FC-RECEPTOR; HALF-LIFE; MONOCLONAL-ANTIBODIES; AMINO-ACID; HUMAN IGG1; IMMUNOGLOBULIN-G; CLICK CHEMISTRY; LIVING CELLS; COPPER-FREE; PROTEIN	Antibody therapeutics offer effective treatment options for a broad range of diseases. One of the greatest benefits of antibody therapeutics is their extraordinarily long serum half-life, allowing infrequent dosing with long-lasting effects. A characteristic of antibodies that drives long half-life is the ability to interact with the recycling receptor, FcRn, in a pH-dependent manner. The benefit of long half-life, however, carries with it liabilities. Although the positive effects of antibody therapeutics are long-lasting, any acute adverse events or chronic negative impacts, such as immunosuppression in the face of an infection, are also long-lasting. Therefore, we sought to develop antibodies with a chemical handle that alone would enjoy the long half-life of normal antibodies but, upon addition of a small-molecule antidote, would interact with the chemical handle and inhibit the antibody recycling mechanism, thus leading to rapid degradation and shortened half-life in vivo. Here we present a proof of concept study where we identify sites to incorporate a non-natural amino acid that can be chemically modified to modulate FcRn interaction in vitro and antibody half-life in vivo. This is an important first step in developing safer therapeutics, and the next step will be development of technology that can perform the modifying chemistry in vivo.	[Portnoff, Alyse D.; Gao, Cuihua; Borrok, M. Jack; Gao, Changshou; Rainey, G. Jonah] MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA; [Gao, Xizhe] MedImmune, Dept Translat Sci, Gaithersburg, MD 20878 USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune	Gao, CS (corresponding author), MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA.; Rainey, GJ (corresponding author), MabVax Therapeut Holdings Inc, San Diego, CA 92121 USA.	gaoc@medimmune.com; jrainey@mabvax.com						Borrok MJ, 2015, J BIOL CHEM, V290, P4282, DOI 10.1074/jbc.M114.603712; Brennan FR, 2010, MABS-AUSTIN, V2, P233, DOI 10.4161/mabs.2.3.11782; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chang PV, 2010, P NATL ACAD SCI USA, V107, P1821, DOI 10.1073/pnas.0911116107; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171, DOI 10.4049/jimmunol.169.9.5171; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; de Graaf AJ, 2009, BIOCONJUGATE CHEM, V20, P1281, DOI 10.1021/bc800294a; Deis LN, 2015, P NATL ACAD SCI USA, V112, P9028, DOI 10.1073/pnas.1424724112; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Ghetie V, 2002, IMMUNOL RES, V25, P97, DOI 10.1385/IR:25:2:097; Giamberardino MA, 2016, INTERN EMERG MED, V11, P1045, DOI 10.1007/s11739-016-1489-4; Hinton PR, 2006, J IMMUNOL, V176, P346, DOI 10.4049/jimmunol.176.1.346; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; KIM JK, 1994, EUR J IMMUNOL, V24, P542, DOI 10.1002/eji.1830240308; Kubota T, 2009, CANCER SCI, V100, P1566, DOI 10.1111/j.1349-7006.2009.01222.x; Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Li J, 2014, NAT CHEM BIOL, V10, P1003, DOI 10.1038/nchembio.1656; Murrey HE, 2015, J AM CHEM SOC, V137, P11461, DOI 10.1021/jacs.5b06847; Nguyen DP, 2009, J AM CHEM SOC, V131, P8720, DOI 10.1021/ja900553w; Ning XH, 2008, ANGEW CHEM INT EDIT, V47, P2253, DOI 10.1002/anie.200705456; Novarra S, 2016, MABS-AUSTIN, V8, P1118, DOI 10.1080/19420862.2016.1186321; Ober RJ, 2004, P NATL ACAD SCI USA, V101, P11076, DOI 10.1073/pnas.0402970101; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012; Pyzik M, 2015, J IMMUNOL, V194, P4595, DOI 10.4049/jimmunol.1403014; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; Reichert JM, 2016, MABS-AUSTIN, V8, P197, DOI 10.1080/19420862.2015.1125583; Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Rossin R, 2013, BIOCONJUGATE CHEM, V24, P1210, DOI 10.1021/bc400153y; Salvana EMT, 2009, CLIN MICROBIOL REV, V22, P274, DOI 10.1128/CMR.00040-08; Sonzini S, 2016, ANGEW CHEM INT EDIT, V55, P14000, DOI 10.1002/anie.201606763; Stefan N, 2014, BIOCONJUGATE CHEM, V25, P2144, DOI 10.1021/bc500468s; Tabrizi MA, 2006, DRUG DISCOV TODAY, V11, P81, DOI 10.1016/S1359-6446(05)03638-X; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; VanBrunt MP, 2015, BIOCONJUGATE CHEM, V26, P2249, DOI 10.1021/acs.bioconjchem.5b00359; Wan W, 2014, BBA-PROTEINS PROTEOM, V1844, P1059, DOI 10.1016/j.bbapap.2014.03.002; Ward ES, 2009, ADV IMMUNOL, V103, P77, DOI 10.1016/S0065-2776(09)03004-1; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601	42	2	2	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8498	8506		10.1074/jbc.M117.775528	http://dx.doi.org/10.1074/jbc.M117.775528			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28258216	Green Published, hybrid			2022-12-26	WOS:000401788600032
J	Morales, C; Li, ZH				Morales, Crystal; Li, Zihai			Drosophila canopy b is a cochaperone of glycoprotein 93	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; CELL-SURFACE EXPRESSION; SHOCK-PROTEIN GP96; MASTER CHAPERONE; INTEGRIN SUBUNIT; PRAT4A; MELANOGASTER; MORPHOGENESIS; REGULATOR; ORTHOLOG	Drosophila gp93 was identified as the ortholog of the mammalian endoplasmic reticulum-resident chaperone gp96. gp93 was found capable of rescuing gp96 client proteins, such as Tolllike receptors ( TLRs) and integrins, in a gp96-deficient murine cell line. Mammalian gp96 was further found to require the cochaperone canopy 3 ( CNPY3) for proper folding and expression of TLRs, but not integrins. In Drosophila, two possible CNPY family members have been identified but have not yet been characterized. Therefore, we sought to determine the role of Drosophila CNPYa and CNPYb in gp93 biology. Because of higher similarities between CNPY3 and CNPYb, we postulated that CNPYb would be a TLR-specific cochaperone of gp93. Indeed, CNPYb addition in gp93-expressing cells improved TLR expression. CNPYb and gp93 were further found to physically interact. Mutational analysis of cysteine residues in CNPYb identified differential dependence of these cysteines in chaperone function. Our study is the first to characterize Drosophila CNPY molecules. We further uncover more gp93 biology by identifying CNPYb as a cochaperone. A better understanding of this simpler Drosophila system will enable application to the mammalian system, such as has been done with Escherichia coli, yeast, and mammalian HSP90.	[Morales, Crystal; Li, Zihai] Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Morales, Crystal] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT 06030 USA	Medical University of South Carolina; University of Connecticut	Li, ZH (corresponding author), Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA.	zihai@musc.edu			National Institutes of Health [R01AI070603]; NATIONAL CANCER INSTITUTE [P30CA138313, P01CA186866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01AI070603. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Devenport D, 2004, DEVELOPMENT, V131, P5405, DOI 10.1242/dev.01427; Do HT, 2012, J BIOL CHEM, V287, P12602, DOI 10.1074/jbc.M112.341248; Hart BE, 2012, J BIOL CHEM, V287, P16550, DOI 10.1074/jbc.M112.342717; Hirate Y, 2006, CURR BIOL, V16, P421, DOI 10.1016/j.cub.2006.01.055; Kiyokawa T, 2008, INT IMMUNOL, V20, P1407, DOI 10.1093/intimm/dxn098; Konno K, 2006, BIOCHEM BIOPH RES CO, V339, P1076, DOI 10.1016/j.bbrc.2005.11.123; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Matsui T, 2011, P NATL ACAD SCI USA, V108, P9881, DOI 10.1073/pnas.1017248108; Maynard JC, 2010, DEV BIOL, V339, P295, DOI 10.1016/j.ydbio.2009.12.023; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Shibata T, 2012, INT IMMUNOL, V24, P613, DOI 10.1093/intimm/dxs068; Stark KA, 1997, DEVELOPMENT, V124, P4583; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; Takada Y., 2007, BIOL, V8, P215, DOI DOI 10.1186/GB-2007-8-5-215; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Wakabayashi Y, 2006, J IMMUNOL, V177, P1772, DOI 10.4049/jimmunol.177.3.1772; WEHRLI M, 1993, MECH DEVELOP, V43, P21, DOI 10.1016/0925-4773(93)90020-X; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; YEE GH, 1993, DEVELOPMENT, V118, P845	23	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6657	6666		10.1074/jbc.M116.755538	http://dx.doi.org/10.1074/jbc.M116.755538			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28275054	Green Published, hybrid			2022-12-26	WOS:000399813400018
J	Linc, G; Gaal, E; Molnar, I; Icso, D; Badaeva, E; Molnar-Lang, M				Linc, Gabriella; Gaal, Eszter; Molnar, Istvan; Icso, Diana; Badaeva, Ekaterina; Molnar-Lang, Marta			Molecular cytogenetic (FISH) and genome analysis of diploid wheatgrasses and their phylogenetic relationship	PLOS ONE			English	Article							THINOPYRUM-BESSARABICUM; KARYOTYPE ANALYSIS; SALT TOLERANCE; DNA-SEQUENCES; RIBOSOMAL-RNA; COMMON WHEAT; BREAD WHEAT; CHROMOSOMES; TRITICEAE; IDENTIFICATION	This paper reports detailed FISH-based karyotypes for three diploid wheatgrass species Agropyron cristatum (L.) Beauv., Thinopyrum bessarabicum (Savul.& Rayss) A. Love, Pseudoroegneria spicata (Pursh) A. Love, the supposed ancestors of hexaploid Thinopyrum intermedium (Host) Barkworth & D.R. Dewey, compiled using DNA repeats and comparative genome analysis based on COS markers. Fluorescence in situ hybridization (FISH) with repetitive DNA probes proved suitable for the identification of individual chromosomes in the diploid JJ, StSt and PP genomes. Of the seven microsatellite markers tested only the (GAA) n trinucleotide sequence was appropriate for use as a single chromosome marker for the P. spicata A(S) chromosome. Based on COS marker analysis, the phylogenetic relationship between diploid wheatgrasses and the hexaploid bread wheat genomes was established. These findings confirmed that the J and E genomes are in neighbouring clusters.	[Linc, Gabriella; Gaal, Eszter; Molnar, Istvan; Icso, Diana; Molnar-Lang, Marta] Hungarian Acad Sci, Inst Agr, Dept Plant Genet Resources, Agr Res Ctr, Martonvasar, Hungary; [Badaeva, Ekaterina] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Russian Academy of Sciences; Vavilov Institute of General Genetics	Linc, G (corresponding author), Hungarian Acad Sci, Inst Agr, Dept Plant Genet Resources, Agr Res Ctr, Martonvasar, Hungary.	linc.gabriella@agrar.mta.hu	Badaeva, Ekaterina D./N-4368-2017; Molnar, istvan/L-9779-2019	Badaeva, Ekaterina D./0000-0001-7101-9639; Molnar, Istvan/0000-0002-7167-9319	National Science Foundation Grants [OTKA K108555, K104382]; Hungarian Academy of Sciences [MTA KEP 5/2016]; Janos Bolyai Research Fellowship	National Science Foundation Grants(National Science Foundation (NSF)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Janos Bolyai Research Fellowship(Hungarian Academy of Sciences)	This work was financed by grants from the National Science Foundation Grants (OTKA K108555 to GL and K104382 to MML), the Hungarian Academy of Sciences (MTA KEP 5/2016 to GL), and by a Janos Bolyai Research Fellowship to IM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adonina IG, 2015, COMP CYTOGENET, V9, P533, DOI 10.3897/CompCytogen.v9i4.5120; Badaeva ED, 1996, GENOME, V39, P1150, DOI 10.1139/g96-145; Badaeva ED, 1996, GENOME, V39, P293, DOI 10.1139/g96-040; Badaeva ED, 2015, CYTOGENET GENOME RES, V146, P71, DOI 10.1159/000433458; Badaeva ED, 2010, CHROMOSOME RES, V18, P697, DOI 10.1007/s10577-010-9151-x; BEDBROOK JR, 1980, CELL, V19, P545, DOI 10.1016/0092-8674(80)90529-2; Burt C, 2011, THEOR APPL GENET, V123, P1387, DOI 10.1007/s00122-011-1674-9; Ceoloni C., 2015, ALIEN INTROGRESSION, P273, DOI DOI 10.1007/978-3-319-23494-6_11; Colmer TD, 2006, J EXP BOT, V57, P1059, DOI 10.1093/jxb/erj124; DEVOS KM, 1993, THEOR APPL GENET, V85, P673, DOI 10.1007/BF00225004; Dewey D.R., 1984, GENE MANIPULATION PL, P209, DOI DOI 10.1007/978-1-4613-2429-4_9; DVORAK J, 1981, CAN J GENET CYTOL, V23, P481; DVORAK J, 1984, CAN J GENET CYTOL, V26, P628; ENDO TR, 1984, CHROMOSOMA, V89, P361, DOI 10.1007/BF00331253; Fedak G, 2005, CYTOGENET GENOME RES, V109, P360, DOI 10.1159/000082420; FEDAK G, 1985, EUPHYTICA, V34, P673, DOI 10.1007/BF00035403; Fominaya A, 1997, GENOME, V40, P689, DOI 10.1139/g97-791; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; GERLACH WL, 1979, NUCL ACIDS RES, V7; Howard T, 2011, J EXP BOT, V62, P2217, DOI 10.1093/jxb/erq423; HSIAO C, 1995, GENOME, V38, P211, DOI 10.1139/g95-026; HSIAO C, 1986, CAN J GENET CYTOL, V28, P109, DOI 10.1139/g86-015; Hu LJ, 2012, GENES GENOM, V34, P67, DOI 10.1007/s13258-011-0153-7; JAUHAR PP, 1990, GENOME, V33, P944, DOI 10.1139/g90-143; JIANG J, 1993, THEOR APPL GENET, V86, P41, DOI 10.1007/BF00223806; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; Juchimiuk-Kwasniewska J, 2011, J APPL GENET, V52, P23, DOI 10.1007/s13353-010-0017-x; Kellogg EA, 1996, SYST BOT, V21, P321, DOI 10.2307/2419662; Kosman E, 2005, MOL ECOL, V14, P415, DOI 10.1111/j.1365-294X.2005.02416.x; Le HT, 1989, PLANT MOL BIO REP, V7, P150, DOI DOI 10.1007/BF02669631; Li DY, 2002, ANN BOT-LONDON, V90, P445, DOI 10.1093/aob/mcf213; Linc G, 2012, CYTOGENET GENOME RES, V136, P138, DOI 10.1159/000334835; Linc G, 1999, GENOME, V42, P497, DOI 10.1139/gen-42-3-497; Love A., 1984, Feddes Repertorium, V95, P425; Mahelka V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-127; Mason-Gamer RJ, 2005, AM J BOT, V92, P1045, DOI 10.3732/ajb.92.6.1045; McIntosh R. A., 1988, Proceedings of the seventh international wheat genetics symposium, held at Cambridge, UK, 13-19 July 1988., P1225; Megyeri M., 2012, Acta Agronomica Hungarica, V60, P87, DOI 10.1556/AAgr.60.2012.2.1; Molnar I, 2016, PLANT J; Molnar I, 2014, THEOR APPL GENET, V127, P1091, DOI 10.1007/s00122-014-2282-2; Molnar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070844; Molnar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027708; Murphy KM, 2007, J SUSTAIN AGR, V31, P137, DOI 10.1300/J064v31n01_11; NAGAKI K, 1995, GENOME, V38, P479, DOI 10.1139/g95-063; OMIELAN JA, 1991, GENOME, V34, P961, DOI 10.1139/g91-149; Parida SK, 2006, THEOR APPL GENET, V112, P808, DOI 10.1007/s00122-005-0182-1; Pedersen C, 1997, GENOME, V40, P589, DOI 10.1139/g97-077; Quraishi UM, 2009, FUNCT INTEGR GENOMIC, V9, P473, DOI 10.1007/s10142-009-0129-8; RAYBURN AL, 1987, AM J BOT, V74, P574, DOI 10.2307/2443837; RAYBURN AL, 1986, J HERED, V77, P253, DOI 10.1093/oxfordjournals.jhered.a110231; Said M, 2014, PLANT MOL CYTOGENETI; Schneider A, 2005, GENOME, V48, P1070, DOI 10.1139/G05-062; SCHULZSCHAEFFER J, 1962, AM J BOT, V49, P940, DOI 10.2307/2439206; SCHULZSCHAEFFER J, 1987, CROP SCI, V27, P822, DOI 10.2135/cropsci1987.0011183X002700040058x; SCHWARZACHER T, 1989, ANN BOT-LONDON, V64, P315, DOI 10.1093/oxfordjournals.aob.a087847; Schwarzacher T, 2000, ANN BOT, V86, P433; Sepsi A, 2008, THEOR APPL GENET, V116, P825, DOI 10.1007/s00122-008-0716-4; TAEB M, 1993, GENOME, V36, P825, DOI 10.1139/g93-110; Vrana J, 2000, GENETICS, V156, P2033; Wang RRC, 2014, J SYST EVOL, V52, P697, DOI 10.1111/jse.12084; Wang RRC, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P77, DOI 10.1007/978-3-642-14228-4_2; WANG RRC, 1989, GENOME, V32, P802, DOI 10.1139/g89-514; WANG RRC, 1985, CAN J GENET CYTOL, V27, P722, DOI 10.1139/g85-108; Yang CT, 2014, CARYOLOGIA, V67, P234, DOI 10.1080/0144235X.2014.974351; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhang H, 1998, THEOR APPL GENET, V96, P69, DOI 10.1007/s001220050710	66	27	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173623	10.1371/journal.pone.0173623	http://dx.doi.org/10.1371/journal.pone.0173623			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278169	Green Accepted, Green Published, gold			2022-12-26	WOS:000396087900019
J	Dhayat, SA; Mirgorod, P; Lenschow, C; Senninger, N; Anthoni, C; Vowinkel, T				Dhayat, Sameer A.; Mirgorod, Philip; Lenschow, Christina; Senninger, Norbert; Anthoni, Christoph; Vowinkel, Thorsten			Challenges in pancreatic adenocarcinoma surgery - National survey and current practice guidelines	PLOS ONE			English	Article							LENGTH-OF-STAY; LIVER METASTASES; CLINICAL PATHWAYS; CANCER; RESECTION; PANCREATICODUODENECTOMY; IMPACT; COSTS	Background Pancreatic ductal adenocarcinoma (PDAC) remains one of the most deadly cancers in Europe and the USA. There is consensus that radical tumor surgery is the only viable option for any long-term survival in patients with PDAC. So far, limited data are available regarding the routine surgical management of patients with advanced PDAC in the light of surgical guidelines. Methods A national survey on perioperative management of patients with PDAC and currently applied criteria on their tumor resectability in German university and community hospitals was carried out. Results With a response rate of 81.6% (231/283) a total of 95 (41.1%) participating departments practicing pancreatic surgery in Germany are certified as competence and reference centers for surgical diseases of the pancreas in 2016. More than 95% of them indicate to carry out structured and interdisciplinary therapies along with an interdisciplinary pre-and postoperative tumor board. The majority of survey respondents prefer the pylorus-preserving partial pancreatoduodenectomy (93.1%) with standard lymphadenectomy for cancer of the pancreatic head. Intraoperative histological evaluation of the resection margins is used regularly by 99% of the survey respondents. 98.7% of survey respondents carry out partial or complete vein resection, 126 respondents (54.5%) would resect tumor adjacent arteries, and 102 respondents (44.2%) would perform metastasectomy if complete PDAC resection (R0) is possible. Conclusion Evidence-based and standardized pancreatic surgery is practiced by a large number of hospitals in Germany. However, a significant number of survey respondents support an extended radical tumor resection in patients with advanced PDAC even when not indicated by current clinical guidelines.	[Dhayat, Sameer A.; Mirgorod, Philip; Lenschow, Christina; Senninger, Norbert; Anthoni, Christoph; Vowinkel, Thorsten] Univ Hosp Muenster, Dept Gen & Visceral Surg, Munster, Germany	University of Munster	Dhayat, SA (corresponding author), Univ Hosp Muenster, Dept Gen & Visceral Surg, Munster, Germany.	sameer.dhayat@ukmuenster.de						Bellon E, 2016, UPDATES SURG, V68, P247, DOI 10.1007/s13304-016-0407-7; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Bockhorn M, 2014, SURGERY, V155, P977, DOI 10.1016/j.surg.2014.02.001; Buc E, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-347; Callery MP, 2009, ANN SURG ONCOL, V16, P1727, DOI 10.1245/s10434-009-0408-6; Conroy T, 2016, EUR J CANCER, V57, P10, DOI 10.1016/j.ejca.2015.12.026; Crippa S, 2016, EJSO-EUR J SURG ONC, V42, P1533, DOI 10.1016/j.ejso.2016.06.398; Crippa S, 2016, EUR J SURG ONCOL; Doi R, 2008, SURG TODAY, V38, P1021, DOI 10.1007/s00595-007-3745-8; Ducreux M, 2015, ANN ONCOL, V26, pV56, DOI 10.1093/annonc/mdv295; Evans DB, 2009, ANN SURG ONCOL, V16, P1736, DOI 10.1245/s10434-009-0416-6; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Hackert T, 2016, EUR J SURG ONCOL; Kelly KJ, 2013, J GASTROINTEST SURG, V17, P1209, DOI 10.1007/s11605-013-2178-5; Kruger S, 2016, PANCREATOLOGY, V16, P593, DOI 10.1016/j.pan.2016.03.016; Malvezzi M., 2015, ANN ONCOL, V2015, P1, DOI DOI 10.1093/ANN0NC/MDV001; Meguid RA, 2008, J AM COLL SURGEONS, V206, P622, DOI 10.1016/j.jamcollsurg.2007.11.011; Michalski CW, 2008, DIGEST SURG, V25, P473, DOI 10.1159/000184739; Muller MK, 2009, LANGENBECK ARCH SURG, V394, P31, DOI 10.1007/s00423-008-0352-0; Rotter T, 2012, EVAL HEALTH PROF, V35, P3, DOI 10.1177/0163278711407313; Seufferlein T, 2013, Z GASTROENTEROL, V51, P1395, DOI 10.1055/s-0033-1356220; Shaib WL, 2016, ONCOLOGIST, V21, P178, DOI 10.1634/theoncologist.2015-0316; Shrikhande SV, 2007, ANN SURG ONCOL, V14, P118, DOI 10.1245/s10434-006-9131-8; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tachezy M, 2016, SURGERY, V160, P136, DOI 10.1016/j.surg.2016.02.019; Tang KZ, 2016, PANCREATOLOGY, V16, P28, DOI 10.1016/j.pan.2015.11.007; Tempero MA, 2014, J NATL COMPR CANC NE, V12, P1083, DOI 10.6004/jnccn.2014.0106; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wagner M, 2004, BRIT J SURG, V91, P586, DOI 10.1002/bjs.4484; Wong JC, 2008, CLIN GASTROENTEROL H, V6, P1301, DOI 10.1016/j.cgh.2008.09.014; Yoshioka R, 2014, BRIT J SURG, V101, P523, DOI 10.1002/bjs.9420; Yu XZ, 2014, EJSO-EUR J SURG ONC, V40, P371, DOI 10.1016/j.ejso.2014.01.010; Zanini N, 2015, UPDATES SURG-ITALY, V67, P19, DOI 10.1007/s13304-015-0283-6; Zhou YM, 2012, WORLD J SURG, V36, P884, DOI 10.1007/s00268-012-1461-z	34	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173374	10.1371/journal.pone.0173374	http://dx.doi.org/10.1371/journal.pone.0173374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267771	Green Published, gold, Green Submitted			2022-12-26	WOS:000396060600027
J	Puttkammer, N; Domercant, JW; Adler, M; Yuhas, K; Myrtil, M; Young, P; Francois, K; Grand'Pierre, R; Lowrance, D				Puttkammer, Nancy; Domercant, Jean Wysler; Adler, Michelle; Yuhas, Krista; Myrtil, Martine; Young, Paul; Francois, Kesner; Grand'Pierre, Reynold; Lowrance, David			ART attrition and risk factors among Option B plus patients in Haiti: A retrospective cohort study	PLOS ONE			English	Article							POISSON REGRESSION APPROACH; CLUSTER RANDOMIZED-TRIAL; TO-CHILD-TRANSMISSION; ANTIRETROVIRAL THERAPY; MALAWI; CARE; HIV; RETENTION; IMPACT; PROGRAM	Objectives In October 2012, the Haitian Ministry of Health endorsed the "Option B+" strategy to eliminate mother-to-child transmission of HIV and achieve HIV epidemic control. The objective of this paper is to assess and identify risk factors for attrition from the national ART program among Option B+ patients in the 12 months after ART initiation. Design This retrospective cohort study included patients newly initiating ART from October 2012-August 2013 at 68 ART sites covering 45% of all newly enrolled ART patients in all regions of Haiti. Methods With data from electronic medical records, we carried out descriptive analysis of sociodemographic, clinical, and pregnancy-related correlates of ART attrition, and used a modified Poisson regression approach to estimate relative risks in a multivariable model. Results There were 2,166 Option B+ patients who initiated ART, of whom 1,023 were not retained by 12 months (47.2%). One quarter (25.3%) dropped out within 3 months of ART initiation. Protective factors included older age, more advanced HIV disease progression, and any adherence counseling prior to ART initiation, while risk factors included starting ART late in gestation, starting ART within 7 days of HIV testing, and using an atypical ART regimen. Discussion Our study demonstrates early ART attrition among Option B+ patients and contributes evidence on the characteristics of women who are most at risk of attrition in Haiti. Our findings highlight the importance of targeted strategies to support retention among Option B+ patients.	[Puttkammer, Nancy] Univ Washington, Dept Global Hlth, Int Training & Educ Ctr Hlth I TECH, Seattle, WA 98195 USA; [Domercant, Jean Wysler; Lowrance, David] US Ctr Dis Control & Prevent, Port Au Prince, Haiti; [Adler, Michelle] US Ctr Dis Control & Prevent, Kampala, Uganda; [Yuhas, Krista] Univ Washington, Ctr AIDS Res, Seattle, WA 98195 USA; [Myrtil, Martine] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Young, Paul] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Francois, Kesner; Grand'Pierre, Reynold] Govt Haiti, Minist Publ Hlth & Populat, Port Au Prince, Haiti	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Centers for Disease Control & Prevention - USA	Puttkammer, N (corresponding author), Univ Washington, Dept Global Hlth, Int Training & Educ Ctr Hlth I TECH, Seattle, WA 98195 USA.	nputt@uw.edu		Puttkammer, Nancy/0000-0002-6693-9278	Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Health Resources and Services Administration [U91HA0680]; US Centers for Disease Control and Prevention [NU2GGH001130-04-00]; International Training and Education Center for Health (I-TECH) at the University of Washington; NIAID of the National Institute of Health; NCI of the National Institute of Health; NIMH of the National Institute of Health; NIDA of the National Institute of Health; NICHD of the National Institute of Health; NHLBI of the National Institute of Health; NIA of the National Institute of Health; NIGMS of the National Institute of Health; NIDDK of the National Institute of Health [AI027757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Health Resources and Services Administration; US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); International Training and Education Center for Health (I-TECH) at the University of Washington; NIAID of the National Institute of Health; NCI of the National Institute of Health; NIMH of the National Institute of Health; NIDA of the National Institute of Health; NICHD of the National Institute of Health; NHLBI of the National Institute of Health; NIA of the National Institute of Health; NIGMS of the National Institute of Health; NIDDK of the National Institute of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research has been supported by the Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Health Resources and Services Administration, under award number U91HA0680, and the US Centers for Disease Control and Prevention (https://www.cdc.gov/), under award number NU2GGH001130-04-00, to the International Training and Education Center for Health (I-TECH) at the University of Washington. Research reported in this publication was also supported by NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA, NIGMS, NIDDK of the National Institutes of Health (https://www.nih.gov/) under award number AI027757 to the University of Washington Center for AIDS Research (CFAR). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention, the National Institutes of Health, or the Health Resources and Services Administration.	Cataldo F, 2016, J ACQUIR IMMUNE DEFI; Cayemittes M, 2013, ENQUETE MORTALITE MO; Chan AK, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20672; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Desinor O, 2011, B EPIDEMIOLOGIQUE PR; Dionne-Odom J, 2016, AIDS RES TREAT, V2016, DOI 10.1155/2016/6284290; Domercant J, 2015, ATTRITION ANTIRETROV; Domercant JW, 2015, MMWR-MORBID MORTAL W, V64, P137; Ebuy H, 2015, INT J INFECT DIS, V33, P123, DOI 10.1016/j.ijid.2014.12.026; Ford D, 2016, J ACQUIRED IMMUNE DE; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Herce ME, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1065-y; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kieffer MP, 2014, JAIDS-J ACQ IMM DEF, V67, pS188, DOI 10.1097/QAI.0000000000000372; Kim MH, 2015, JAIDS-J ACQ IMM DEF, V68, pE77, DOI 10.1097/QAI.0000000000000517; Kim MH, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17389; Kim MH, 2015, WHY DID I STOP BARRI; Llenas-Garcia J, 2015, RETENTION CARE HIV I; Lober William B, 2008, AMIA Annu Symp Proc, P434; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Matheson AI, 2012, INT J MED INFORM, V81, P244, DOI 10.1016/j.ijmedinf.2012.01.011; Moga T, 2015, TAKING LESSONS LEARN; (MSPP) M.d.l.S.P.e.d.l.P., 2015, ET OP DEP CAS CASC P; Mukherjee JS, 2006, JAIDS-J ACQ IMM DEF, V43, pS123, DOI 10.1097/01.qai.0000248348.25630.74; Mutede BR, 2015, IMPROVING RETENTION; Ortblad KF, 2013, AIDS, V27, P2003, DOI 10.1097/QAD.0b013e328362ba67; [PNLS MSPP], 2014, DECL ENG VIH SIDA; Price AJ, 2014, SEX TRANSM INFECT, V90, P309, DOI 10.1136/sextrans-2013-051336; Rosenberg NE, 2015, LANCET HIV, V2, pE483, DOI 10.1016/S2352-3018(15)00182-4; Rosenberg NE, 2014, JAIDS-J ACQ IMM DEF, V67, pS114, DOI 10.1097/QAI.0000000000000319; Sam-Agudu NA, 2014, JAIDS-J ACQ IMM DEF, V67, pS132, DOI 10.1097/QAI.0000000000000331; Schmitz K, 2015, RETAINING MOTHER BAB; Sherr K, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-55; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS, 2014, THE GAP REP; UNICEF, 2014, UNICEF DAT MON HLTH; van Lettow M, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18994; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; World Health Organization, 2015, GUIDELINE ON WHEN TO; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	42	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173123	10.1371/journal.pone.0173123	http://dx.doi.org/10.1371/journal.pone.0173123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264045	Green Published, gold, Green Submitted			2022-12-26	WOS:000396054300039
J	Kim, D; Jung, YG; Roh, S				Kim, Daehwan; Jung, Yeon-Gil; Roh, Sangho			Microarray analysis of embryo-derived bovine pluripotent cells: The vulnerable state of bovine embryonic stem cells	PLOS ONE			English	Article							SELF-RENEWAL; CULTURE-CONDITIONS; REGULATES PLURIPOTENCY; NUCLEAR TRANSFER; MOUSE EMBRYOS; IN-VITRO; BLASTOCYSTS; LINES; EXPRESSION; DIFFERENTIATION	Although there are many studies about pluripotent stem cells, little is known about pluripotent pathways and the difficulties of maintaining the pluripotency of bovine cells in vitro. Here, we investigated differently expressed genes (DEG) in bovine embryo-derived stem like cells (eSLCs) from various origins to validate their distinct characteristics of pluripotency and differentiation. We identified core pluripotency markers and additional markers which were not determined as pluripotency markers yet in bovine eSLCs. Using the KEGG database, TGF beta, WNT, and LIF signaling were related to the maintenance of pluripotency. In contrast, some DEGs related to the LIF pathway were down-regulated, suggesting that reactivation of the pathway may be required for the establishment of true bovine embryonic stem cells (ESCs). Interestingly, oncogenes were co-down-regulated, while tumor suppressor genes were co-up-regulated in eSLCs, implying that this pattern may induce abnormal teratomas. These data analyses of signaling pathways provide essential information on authentic ESCs in addition to providing evidence for pluripotency in bovine eSLCs.	[Kim, Daehwan; Roh, Sangho] Seoul Natl Univ, Cellular Reprogramming & Embryo Biotechnol Lab, Sch Dent, Dent Res Inst, Seoul, South Korea; [Jung, Yeon-Gil] ET Biotech Co Ltd, Jangsu, South Korea	Seoul National University (SNU)	Roh, S (corresponding author), Seoul Natl Univ, Cellular Reprogramming & Embryo Biotechnol Lab, Sch Dent, Dent Res Inst, Seoul, South Korea.	sangho@snu.ac.kr		Roh, Sangho/0000-0001-8082-6459	National Research Foundation of Korea (NRF) through the Oromaxillofacial Dysfunction Research Center [2015048003]; Technology Development Program for Agriculture and Forestry, Ministry of Agriculture, Food and Rural Affairs (MAFRA), Republic of Korea [111160-04]; ET Biotech Co. Ltd.	National Research Foundation of Korea (NRF) through the Oromaxillofacial Dysfunction Research Center; Technology Development Program for Agriculture and Forestry, Ministry of Agriculture, Food and Rural Affairs (MAFRA), Republic of Korea; ET Biotech Co. Ltd.	This study was supported by a grant from the National Research Foundation of Korea (NRF, No. 2015048003 through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University) and the Technology Development Program for Agriculture and Forestry, Ministry of Agriculture, Food and Rural Affairs (MAFRA; 111160-04), Republic of Korea. ET Biotech Co. Ltd. provided support in the form of salaries for author YGJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballabeni A, 2011, P NATL ACAD SCI USA, V108, P19252, DOI 10.1073/pnas.1116794108; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cao SB, 2009, J EXP ZOOL PART A, V311A, P368, DOI 10.1002/jez.535; Carter MG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r61; Chang G, 2009, GENOMICS, V93, P112, DOI 10.1016/j.ygeno.2008.09.011; Chiou SH, 2013, J EXP MED, V210, P85, DOI 10.1084/jem.20121044; Christophorou MA, 2014, NATURE, V507, P104, DOI 10.1038/nature12942; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Donald CD, 2003, LAB INVEST, V83, P501, DOI 10.1097/01.LAB.0000063929.61760.F6; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Farifteh F, 2014, CELL J, V15, P316; FISHEL, 1994, CELL, V77, pU17; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Furusawa T, 2004, BIOL REPROD, V70, P1452, DOI 10.1095/biolreprod.103.024190; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gong GC, 2010, CELL REPROGRAM, V12, P151, DOI 10.1089/cell.2009.0049; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jares P, 2007, NAT REV CANCER, V7, P750, DOI 10.1038/nrc2230; Jin MZ, 2012, CYTOTECHNOLOGY, V64, P379, DOI 10.1007/s10616-011-9408-z; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kawaguchi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135403; Khaled WT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6987; Kim D, 2016, REPROD FERT DEVELOP, V28, P1762, DOI 10.1071/RD14071; Komiya T, 2006, ONCOGENE, V25, P6128, DOI 10.1038/sj.onc.1209627; Laner-Plamberger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075317; Li P, 2013, STEM CELL REV REP, V9, P709, DOI 10.1007/s12015-013-9452-5; Li Y -M, 2005, NO FRUITS, V3, P3, DOI DOI 10.1182/BL00D-2004-07-2681; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Mai QY, 2007, CELL RES, V17, P1008, DOI 10.1038/cr.2007.102; Mitalipov SM, 2006, REPROD FERT DEVELOP, V18, P817, DOI 10.1071/RD06112; Mitalipova M, 2001, Cloning, V3, P59, DOI 10.1089/15204550152475563; Moustakas A, 2001, J CELL SCI, V114, P4359; Munoz M, 2008, REPROD DOMEST ANIM, V43, P32, DOI 10.1111/j.1439-0531.2008.01229.x; Munoz M, 2008, THERIOGENOLOGY, V69, P1159, DOI 10.1016/j.theriogenology.2008.02.014; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Panarace M, 2007, THERIOGENOLOGY, V67, P142, DOI 10.1016/j.theriogenology.2006.09.036; Park S, 2015, ANIM REPROD SCI, V161, P47, DOI 10.1016/j.anireprosci.2015.08.003; Perez-Iratxeta C, 2005, FEBS LETT, V579, P1795, DOI 10.1016/j.febslet.2005.02.020; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Robert C, 2011, MOL REPROD DEV, V78, P651, DOI 10.1002/mrd.21364; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SAITO S, 1992, ROUX ARCH DEV BIOL, V201, P134, DOI 10.1007/BF00188711; Saito S, 2002, FEBS LETT, V531, P389, DOI 10.1016/S0014-5793(02)03550-0; Saito Shigeo, 2004, Hum Cell, V17, P107; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; Sharov AA, 2010, METHOD ENZYMOL, V477, P511, DOI 10.1016/S0076-6879(10)77025-7; Stranzinger GF, 1996, INT J EXP PATHOL, V77, P263; TALBOT NC, 1995, MOL REPROD DEV, V42, P35, DOI 10.1002/mrd.1080420106; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ushizawa Koichi, 2004, Reprod Biol Endocrinol, V2, P77; Verma V, 2013, STEM CELLS DEV, V22, P1728, DOI 10.1089/scd.2012.0481; Walker EJ, 2012, CANCER RES, V72, P636, DOI 10.1158/0008-5472.CAN-11-2266; Wang L, 2005, BIOL REPROD, V73, P149, DOI 10.1095/biolreprod.104.037150; Wang LL, 2012, CELL RES, V22, P1082, DOI 10.1038/cr.2012.77; Wang SW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.420; Wu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep28343; Yang PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003453; Yang SH, 2014, CELL REP, V7, P1968, DOI 10.1016/j.celrep.2014.05.037; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang M, 2014, NAT GENET, V46, P1170, DOI 10.1038/ng.3116; Zheng XF, 2012, STEM CELLS, V30, P910, DOI 10.1002/stem.1070	71	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173278	10.1371/journal.pone.0173278	http://dx.doi.org/10.1371/journal.pone.0173278			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257460	gold, Green Published, Green Submitted			2022-12-26	WOS:000396021100082
J	Nakaoka, T; Iga, M; Yamada, T; Koujima, I; Takeshima, M; Zhou, XY; Suzuki, Y; Ogihara, MH; Kataoka, H				Nakaoka, Takayoshi; Iga, Masatoshi; Yamada, Tetsuya; Koujima, Ikumi; Takeshima, Mika; Zhou, Xiangying; Suzuki, Yutaka; Ogihara, Mari H.; Kataoka, Hiroshi			Deep sequencing of the prothoracic gland transcriptome reveals new players in insect ecdysteroidogenesis	PLOS ONE			English	Article							DELTA-AMINOLEVULINATE SYNTHASE; DROSOPHILA-MELANOGASTER; NAD KINASE; CYTOCHROME-P450 ENZYME; ECDYSONE SYNTHESIS; MOLTING HORMONE; BOMBYX-MORI; P450 ENZYME; BIOSYNTHESIS; GENE	Ecdysteroids are steroid hormones that induce molting and determine developmental timing in arthropods. In insect larva, the prothoracic gland (PG) is a major organ for ecdysone synthesis and release. Released ecdysone is converted into the active form, 20-hydroxyecdysone (20E) in the peripheral tissues. All processes from ecdysone synthesis and release from the PG to its conversion to 20E are called ecdysteroidogenesis and are under the regulation of numerous factors expressed in the PG and peripheral tissues. Classical genetic approaches and recent transcriptomic screening in the PG identified several genes responsible for ecdysone synthesis and release, whereas the regulatory mechanism remains largely unknown. We analyzed RNA-seq data of the silkworm Bombyx mori PG and employed the fruit fly Drosophila melanogaster GAL4/UAS binary RNAi system to comprehensively screen for genes involved in ecdysone synthesis and/or release. We found that the genes encoding delta-aminolevulinic acid synthase (CG3017/alas) and putative NAD kinase (CG33156) were highly expressed in the PG of both B. mori and D. melanogaster. Neither alas nor CG33156 RNAi-induced larvae could enter into the pupal stage, and they had a lower abundance of the active form ecdysteroids in their prolonged larval stage. These results demonstrated that alas and CG33156 are indispensable for ecdysteroidogenesis.	[Nakaoka, Takayoshi; Iga, Masatoshi; Yamada, Tetsuya; Koujima, Ikumi; Takeshima, Mika; Zhou, Xiangying; Ogihara, Mari H.; Kataoka, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Suzuki, Yutaka] Univ Tokyo, Dept Computat Biol & Med Sci, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan	University of Tokyo; University of Tokyo	Kataoka, H (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	kataoka@k.u-tokyo.ac.jp			Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Japan Society for the Promotion of Science [25252023]	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science to H.K. (Grant# 25252023). https://www.jsps.go.jp/english/e-grants/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISHOP DF, 1981, ARCH BIOCHEM BIOPHYS, V206, P380, DOI 10.1016/0003-9861(81)90105-3; BISHOP DF, 1990, GENOMICS, V7, P207, DOI 10.1016/0888-7543(90)90542-3; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Danielsen ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004343; de Mena IR, 1999, J BIOL CHEM, V274, P37321, DOI 10.1074/jbc.274.52.37321; Gilbert LI, 2005, VITAM HORM, V73, P31, DOI 10.1016/S0083-6729(05)73002-8; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Huang X, 2005, DEVELOPMENT, V132, P5115, DOI 10.1242/dev.02079; Iga M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103239; Iga M, 2012, BIOL PHARM BULL, V35, P838, DOI 10.1248/bpb.35.838; Komura-Kawa T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005712; Lavrynenko O, 2015, DEVELOPMENT, V142, P3758, DOI 10.1242/dev.124982; Lerner F, 2001, BIOCHEM BIOPH RES CO, V288, P69, DOI 10.1006/bbrc.2001.5735; Love NR, 2015, P NATL ACAD SCI USA, V112, P1386, DOI 10.1073/pnas.1417290112; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Niwa R, 2005, INSECT MOL BIOL, V14, P563, DOI 10.1111/j.1365-2583.2005.00587.x; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Ogihara MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124953; Ohashi K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2262; Okano S, 2010, GENES CELLS, V15, P77, DOI 10.1111/j.1365-2443.2009.01366.x; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; WATANABE N, 1983, BIOCHEM BIOPH RES CO, V113, P377, DOI 10.1016/0006-291X(83)91737-0; Yamanaka N, 2015, CELL, V163, P907, DOI 10.1016/j.cell.2015.10.022; Yin CL, 2016, NUCLEIC ACIDS RES, V44, pD801, DOI 10.1093/nar/gkv1204; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428	32	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172951	10.1371/journal.pone.0172951	http://dx.doi.org/10.1371/journal.pone.0172951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257485	gold, Green Published, Green Submitted			2022-12-26	WOS:000396021100045
J	Ross, I; Mejia, C; Melendez, J; Chan, PA; Nunn, AC; Powderly, W; Goodenberger, K; Liu, JX; Mayer, KH; Patel, RR				Ross, Ian; Mejia, Carlos; Melendez, Johanna; Chan, Philip A.; Nunn, Amy C.; Powderly, William; Goodenberger, Katherine; Liu, Jingxia; Mayer, Kenneth H.; Patel, Rupa R.			Awareness and attitudes of pre-exposure prophylaxis for HIV prevention among physicians in Guatemala: Implications for country-wide implementation	PLOS ONE			English	Article							HEALTH-CARE PROVIDERS; RANDOMIZED CLINICAL-TRIAL; ANTIRETROVIRAL PROPHYLAXIS; DRUG-RESISTANCE; UNITED-STATES; HIGH-RISK; MEN; INFECTION; WOMEN; PREP	Introduction HIV continues to be a major health concern with approximately 2.1 million new infections occurring worldwide in 2015. In Central America, Guatemala had the highest incident number of HIV infections (3,700) in 2015. Antiretroviral pre-exposure prophylaxis (PrEP) was recently recommended by the World Health Organization (WHO) as an efficacious intervention to prevent HIV transmission. PrEP implementation efforts are underway in Guatemala and success will require providers that are knowledgeable and willing to prescribe PrEP. We sought to explore current PrEP awareness and prescribing attitudes among Guatemalan physicians in order to inform future PrEP implementation efforts. Methods We conducted a cross-sectional survey of adult internal medicine physicians at the main teaching hospital in Guatemala City in March 2015. The survey included demographics, medical specialty, years of HIV patient care, PrEP awareness, willingness to prescribe PrEP, previous experience with post-exposure prophylaxis, and concerns about PrEP. The primary outcome was willingness to prescribe PrEP, which was assessed using a 5-point Likert scale for different at-risk population scenarios. Univariate and multivariate logistic regression was performed to identify predictors for willingness to prescribe PrEP. Results Eighty-seven physicians completed the survey; 66% were male, 64% were internal medicine residency trainees, and 10% were infectious disease (ID) specialists. Sixty-nine percent of physicians were PrEP aware, of which 9% had previously prescribed PrEP. Most (87%) of respondents were willing to prescribe PrEP to men who have sex with men (MSM), sex workers, injection drug users, or HIV-uninfected persons having known HIV-positive sexual partners. Concerns regarding PrEP included development of resistance (92%), risk compensation (90%), and cost (64%). Univariate logistic regression showed that younger age, being a resident trainee, and being a non-ID specialist were significant predictors for willingness to prescribe PrEP. In multivariate logistic regression, being a non-ID specialist was a significant predictor. Conclusions Guatemalan physicians at an urban public hospital were PrEP aware and willing to prescribe, but few have actually done so yet. Future education programs should address the concerns identified, including the low potential for the development of antiretroviral resistance. These findings can aid PrEP implementation efforts in Guatemala.	[Ross, Ian; Powderly, William; Goodenberger, Katherine; Patel, Rupa R.] Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA; [Mejia, Carlos; Melendez, Johanna] Roosevelt Hosp, Div Infect Dis, Guatemala City, Guatemala; [Chan, Philip A.] Brown Univ, Div Infect Dis, Providence, RI 02912 USA; [Nunn, Amy C.] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA; [Liu, Jingxia] Washington Univ, Sch Med, Div Publ Hlth Sci, St Louis, MO USA; [Mayer, Kenneth H.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Mayer, Kenneth H.] Harvard Med Sch, Div Infect Dis, Boston, MA USA; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA USA	Washington University (WUSTL); Brown University; Brown University; Washington University (WUSTL); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Fenway Health	Patel, RR (corresponding author), Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA.	rupapatel@email.wustl.edu		Chan, Philip/0000-0003-0964-5895; Powderly, William/0000-0001-7808-3086	Washington University in St. Louis Mentors in Medicine International Grant; Washington University Institute of Clinical and Translational Sciences [UL1TR000448]; National Center for Advancing Translational Sciences of the National Institutes of Health [KL2TR000450]; National Institute of Allergy And Infectious Diseases [1K23AI096923]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000450, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH083620] Funding Source: NIH RePORTER	Washington University in St. Louis Mentors in Medicine International Grant; Washington University Institute of Clinical and Translational Sciences; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	IR is supported by the Washington University in St. Louis Mentors in Medicine International Grant. RRP is supported by the Washington University Institute of Clinical and Translational Sciences grant UL1TR000448, sub-award KL2TR000450, from the National Center for Advancing Translational Sciences of the National Institutes of Health. PAC is supported by the National Institute of Allergy And Infectious Diseases (1K23AI096923). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews CD, 2015, CURR OPIN HIV AIDS, V10, P258, DOI 10.1097/COH.0000000000000161; [Anonymous], 2014, PREEXP PROPH PREV HI; Auerbach JD, 2015, J INT AIDS SOC, V18, P30, DOI 10.7448/IAS.18.4.19983; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten J.M., 2016, N ENGL J MED; Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; Caceres CF, 2015, J INT AIDS SOC S3, V18; Chakrapani V, 2015, AIDS PATIENT CARE ST, V29, P569, DOI 10.1089/apc.2015.0143; Chan PA, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20903; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hankins C, 2015, J INT AIDS SOC, V18, P71, DOI 10.7448/IAS.18.4.19973; Karris MY, 2014, CLIN INFECT DIS, V58, P704, DOI 10.1093/cid/cit796; Krakower D, 2014, AIDS BEHAV, V18, P1712, DOI 10.1007/s10461-014-0839-3; Krakower D, 2012, CURR OPIN HIV AIDS, V7, P593, DOI 10.1097/COH.0b013e3283590446; Lehman DA, 2015, J INFECT DIS, V211, P1211, DOI 10.1093/infdis/jiu677; Liegler T, 2014, J INFECT DIS, V210, P1217, DOI 10.1093/infdis/jiu233; Liu AY, 2013, JAIDS-J ACQ IMM DEF, V64, P87, DOI 10.1097/QAI.0b013e31828f097a; Marcus JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081997; Marrazzo JM, 2014, JAMA-J AM MED ASSOC, V312, P390, DOI 10.1001/jama.2014.7999; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Mimiaga MJ, 2014, AIDS CARE, V26, P684, DOI 10.1080/09540121.2013.845289; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Mugo NR, 2016, CURR OPIN HIV AIDS, V11, P80, DOI 10.1097/COH.0000000000000224; Mugwanya KK, 2015, JAMA INTERN MED, V175, P246, DOI 10.1001/jamainternmed.2014.6786; Nel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147743; Puro V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-217; Schackman BR, 2012, CURR OPIN HIV AIDS, V7, P587, DOI 10.1097/COH.0b013e3283582c8b; Tang EC, 2014, AIDS RES HUM RETROV, V30, P416, DOI [10.1089/aid.2013.0212, 10.1089/AID.2013.0212]; Tellalian D, 2013, AIDS PATIENT CARE ST, V27, P553, DOI 10.1089/apc.2013.0173; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tripathi A, 2012, SOUTH MED J, V105, P199, DOI 10.1097/SMJ.0b013e31824f1a1b; UNAIDS and Stop AIDS Alliance, 2015, COMM DEL, P23; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; White JM, 2012, AIDS PATIENT CARE ST, V26, P395, DOI 10.1089/apc.2012.0030; WHO, 2014, CONSOLIDATED GUIDELI; Wolitski R., 2004, AIDS OTHER MANIFESTA, P997; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2005, GUAT SUMM COUNTR PRO	41	20	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173057	10.1371/journal.pone.0173057	http://dx.doi.org/10.1371/journal.pone.0173057			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257475	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100053
J	Acevedo, LM; Raya, AI; Martinez-Moreno, JM; Aguilera-Tejero, E; Rivero, JLL				Acevedo, Luz M.; Raya, Ana I.; Martinez-Moreno, Julio M.; Aguilera-Tejero, Escolastico; Rivero, Jose-Luis L.			Mangiferin protects against adverse skeletal muscle changes and enhances muscle oxidative capacity in obese rats	PLOS ONE			English	Article							HEAVY-CHAIN ISOFORMS; INSULIN-RESISTANCE; ANTIDIABETIC ACTIVITY; MEDICINAL PROPERTIES; ZUCKER RATS; FIBER TYPES; ACTIVATION; HYPERGLYCEMIA; HYPERLIPIDEMIA; METABOLISM	Obesity-related skeletal muscle changes include muscle atrophy, slow-to-fast fiber-type transformation, and impaired mitochondrial oxidative capacity. These changes relate with increased risk of insulin resistance. Mangiferin, the major component of the plant Mangifera indica, is a well-known anti-inflammatory, anti-diabetic, and antihyperlipidemic agent. This study tested the hypothesis that mangiferin treatment counteracts obesity-induced fiber atrophy and slow-to-fast fiber transition, and favors an oxidative phenotype in skeletal muscle of obese rats. Obese Zucker rats were fed gelatin pellets with (15 mg/kg BW/day) or without (placebo group) mangiferin for 8 weeks. Lean Zucker rats received the same gelatin pellets without mangiferin and served as non-obese and non-diabetic controls. Lesser diameter, fiber composition, and histochemical succinic dehydrogenase activity (an oxidative marker) of myosin-based fiber-types were assessed in soleus and tibialis cranialis muscles. A multivariate discriminant analysis encompassing all fiber-type features indicated that obese rats treated with mangiferin displayed skeletal muscle phenotypes significantly different compared with both lean and obese control rats. Mangiferin significantly decreased inflammatory cytokines, preserved skeletal muscle mass, fiber cross-sectional size, and fiber-type composition, and enhanced muscle fiber oxidative capacity. These data demonstrate that mangiferin attenuated adverse skeletal muscle changes in obese rats.	[Acevedo, Luz M.; Rivero, Jose-Luis L.] Univ Cordoba, Dept Comparat Anat & Pathol Anat, Lab Muscular Biopathol, Cordoba, Spain; [Raya, Ana I.; Aguilera-Tejero, Escolastico] Univ Cordoba, Dept Anim Med & Surg, Cordoba, Spain; [Raya, Ana I.; Martinez-Moreno, Julio M.; Aguilera-Tejero, Escolastico] Univ Cordoba, Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain; [Acevedo, Luz M.] Cent Univ Venezuela, Dept Ciencias Biomed, Maracay, Venezuela	Universidad de Cordoba; Universidad de Cordoba; Universidad de Cordoba; University of Central Venezuela	Rivero, JLL (corresponding author), Univ Cordoba, Dept Comparat Anat & Pathol Anat, Lab Muscular Biopathol, Cordoba, Spain.	an1lorij@uco.es	Raya, Ana I/A-9548-2017; Martínez, Julio Manuel/AAA-6724-2020; RIVERO, JOSE/O-4129-2019	Raya, Ana I/0000-0002-4489-9447; Martínez, Julio Manuel/0000-0002-1945-5078; RIVERO, JOSE/0000-0001-7706-609X	Spanish Government Grant from the Institute de Salud Carlos III [PI14/00467]; European Funds; PAI Group [CTS-179]; Junta de Andalucia, Spain [P10 AGR-5963]	Spanish Government Grant from the Institute de Salud Carlos III; European Funds; PAI Group; Junta de Andalucia, Spain(Junta de Andalucia)	The work reported here was supported by a Spanish Government Grant from the Institute de Salud Carlos III (PI14/00467) with co-financing from European Funds. L.M.A., and J.L.L.R. were supported by grants of the PAI Group CTS-179 and Project P10 AGR-5963, Junta de Andalucia, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo LM, 2006, CELL TISSUE RES, V323, P283, DOI 10.1007/s00441-005-0057-4; Acevedo LM, 2016, J APPL PHYSIOL; Acevedo LM, 2015, AM J PHYSIOL-RENAL, V309, pF638, DOI 10.1152/ajprenal.00195.2015; Aderibigbe AO, 1999, PHYTOTHER RES, V13, P504, DOI 10.1002/(SICI)1099-1573(199909)13:6&lt;504::AID-PTR533&gt;3.0.CO;2-9; Apontes P, 2014, DIABETES, V63, P3626, DOI 10.2337/db14-0006; Atlantis E, 2009, METABOLISM, V58, P1013, DOI 10.1016/j.metabol.2009.02.027; Benard O, 2015, MINI-REV MED CHEM, V15, P582, DOI 10.2174/1389557515666150401111410; BOTTINELLI R, 1991, J PHYSIOL-LONDON, V437, P655, DOI 10.1113/jphysiol.1991.sp018617; Caiozzo VJ, 2003, AM J PHYSIOL-REG I, V285, pR570, DOI 10.1152/ajpregu.00646.2002; Couturier A, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-16; Couturier A, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-48; Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261; DeNies MS, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.204; Giron MD, 2009, CLIN NUTR, V28, P565, DOI 10.1016/j.clnu.2009.04.018; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Guo FC, 2011, MOL NUTR FOOD RES, V55, P1809, DOI 10.1002/mnfr.201100392; Han J, 2015, J ETHNOPHARMACOL, V172, P368, DOI 10.1016/j.jep.2015.05.016; Han J, 2015, MOL CELL ENDOCRINOL, V405, P63, DOI 10.1016/j.mce.2015.02.008; HICKEY MS, 1995, AM J PHYSIOL-ENDOC M, V268, pE453, DOI 10.1152/ajpendo.1995.268.3.E453; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Holloway GP, 2009, AM J CLIN NUTR, V89, p455S, DOI 10.3945/ajcn.2008.26717B; Huang THW, 2006, TOXICOL APPL PHARM, V210, P225, DOI 10.1016/j.taap.2005.05.003; Jakubiec-Puka A, 1999, ACTA BIOCHIM POL, V46, P823, DOI 10.18388/abp.1999_4154; Kumar BD, 2013, PHARMACOGN MAG, V9, P72, DOI 10.4103/0973-1296.108145; Lally JSV, 2012, DIABETOLOGIA, V55, P479, DOI 10.1007/s00125-011-2367-2; LARSSON L, 1988, J NEUROL SCI, V85, P27, DOI 10.1016/0022-510X(88)90033-0; LILLIOJA S, 1987, J CLIN INVEST, V80, P415, DOI 10.1172/JCI113088; Lim J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090137; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mahali SK, 2014, J CELL PHYSIOL, V229, P1972, DOI 10.1002/jcp.24647; Martins AR, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-30; Miura T, 2001, PHYTOMEDICINE, V8, P85, DOI 10.1078/0944-7113-00009; Miura T, 2001, BIOL PHARM BULL, V24, P1009, DOI 10.1248/bpb.24.1009; Miura T, 2001, BIOL PHARM BULL, V24, P1091, DOI 10.1248/bpb.24.1091; Muruganandan S, 2005, J ETHNOPHARMACOL, V97, P497, DOI 10.1016/j.jep.2004.12.010; Niu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030782; Oberbach A, 2006, DIABETES CARE, V29, P895, DOI 10.2337/diacare.29.04.06.dc05-1854; Pal PB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107220; Perry BD, 2016, EXERC IMMUNOL REV, V22, P94; Pompeani N, 2014, J NEGAT RESULTS BIOM, V13, DOI 10.1186/s12952-014-0019-z; Rasbach KA, 2010, P NATL ACAD SCI USA, V107, P21866, DOI 10.1073/pnas.1016089107; Ringseis R, 2013, J NUTR, V143, P125, DOI 10.3945/jn.112.164038; Rivero JLL, 1999, HISTOCHEM CELL BIOL, V111, P277, DOI 10.1007/s004180050358; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Sellamuthu PS, 2014, PAK J PHARM SCI, V27, P161; Sellamuthu Periyar Selvam, 2013, ISRN Pharmacol, V2013, P750109, DOI 10.1155/2013/750109; Serrano AL, 2000, PFLUG ARCH EUR J PHY, V441, P263, DOI 10.1007/s004240000408; Shah K A, 2010, Pharmacogn Rev, V4, P42, DOI 10.4103/0973-7847.65325; Stohs SJ, 2015, PHYTOTHER RES, V29, P986, DOI 10.1002/ptr.5382; Tsubaki M, 2015, AM J TRANSL RES, V7, P1371; Valero T, 2014, CURR PHARM DESIGN, V20, P5507, DOI 10.2174/138161282035140911142118; Vyas A, 2012, MINI-REV MED CHEM, V12, P412, DOI 10.2174/138955712800493870; Wang F, 2014, PHARM BIOL, V52, P68, DOI 10.3109/13880209.2013.814691; Wessels B, 2015, DIABETES OBES METAB, V17, P52, DOI 10.1111/dom.12388	54	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173028	10.1371/journal.pone.0173028	http://dx.doi.org/10.1371/journal.pone.0173028			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253314	Green Submitted, Green Published, gold			2022-12-26	WOS:000396011300061
J	Shetelig, C; Limalanathan, S; Eritsland, J; Hoffmann, P; Seljeflot, I; Gran, JM; Aukrust, P; Ueland, T; Andersen, GO				Shetelig, Christian; Limalanathan, Shanmuganathan; Eritsland, Jan; Hoffmann, Pavel; Seljeflot, Ingebjorg; Gran, Jon Michael; Aukrust, Pal; Ueland, Thor; Andersen, Geir Oystein			Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function	PLOS ONE			English	Article							SERUM OSTEOPROTEGERIN; MAGNETIC-RESONANCE; RANK LIGAND; SALVAGE; PLAQUE; STEMI	Background Elevated levels of osteoprotegerin (OPG) have been associated with adverse outcomes in ST-elevation myocardial infarction (STEMI). However, the role of OPG in myocardial injury and adverse remodeling in STEMI patients remains unclear. The aims of this observational cohort study were to evaluate: 1) the temporal profile of OPG during STEMI, 2) possible associations between OPG measured acutely and after 4 months, with infarct size, adverse left ventricular (LV) remodeling, microvascular obstruction (MVO) and myocardial salvage and 3) the effect of heparin administration on OPG levels. Methods Blood samples were drawn repeatedly from 272 STEMI patients treated with primary percutaneous coronary intervention (PCI). Cardiac magnetic resonance imaging (CMR) was performed in the acute phase and after 4 months. The effect of heparin administration on OPG levels was studied in 20 patients referred to elective coronary angiography. Results OPG levels measured acutely were significantly higher than Day 1 and during follow-up. OPG levels were correlated with age. No association was found between early OPG levels and CMR measurements at 4 months. Patients with >median OPG levels measured at Day 1 had larger final infarct size, lower LV ejection fraction (LVEF) at 4 months and higher frequency of MVO. There were no associations between OPG and change in end-diastolic volume or myocardial salvage. OPG remained associated with infarct size and LVEF after adjustment for relevant covariates, except peak troponin T and CRP. A 77% increase in OPG levels following heparin administration was found in patients undergoing elective coronary angiography. Conclusions OPG was found to be associated with myocardial injury, but not with LV remodeling or myocardial salvage. The use of OPG as a biomarker in STEMI patients seems to be limited by a strong association with age, confounding effect of heparin administration, and little additive value to established biomarkers.	[Shetelig, Christian; Limalanathan, Shanmuganathan; Eritsland, Jan; Hoffmann, Pavel; Seljeflot, Ingebjorg; Andersen, Geir Oystein] Univ Oslo, Ulleval Hosp, Dept Cardiol, Oslo, Norway; [Shetelig, Christian; Limalanathan, Shanmuganathan; Eritsland, Jan; Seljeflot, Ingebjorg; Andersen, Geir Oystein] Univ Oslo, Ulleval Hosp, Ctr Clin Heart Res, Oslo, Norway; [Shetelig, Christian; Seljeflot, Ingebjorg; Aukrust, Pal; Ueland, Thor] Univ Oslo, Fac Med, Oslo, Norway; [Limalanathan, Shanmuganathan] Feiring Heart Clin, Feiring, Norway; [Eritsland, Jan; Seljeflot, Ingebjorg; Andersen, Geir Oystein] Ctr Heart Failure Res, Oslo, Norway; [Hoffmann, Pavel] Univ Oslo, Ulleval Hosp, Sect Intervent Cardiol, Oslo, Norway; [Gran, Jon Michael] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Dept Biostat, Oslo, Norway; [Gran, Jon Michael] Univ Oslo, Oslo, Norway; [Aukrust, Pal; Ueland, Thor] Natl Hosp Norway, Oslo Univ Hosp, Internal Med Res Inst, Oslo, Norway; [Aukrust, Pal] Natl Hosp Norway, Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Aukrust, Pal; Ueland, Thor] Univ Oslo, KG Jebsen Inflammatory Res Ctr, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo	Shetelig, C (corresponding author), Univ Oslo, Ulleval Hosp, Dept Cardiol, Oslo, Norway.; Shetelig, C (corresponding author), Univ Oslo, Ulleval Hosp, Ctr Clin Heart Res, Oslo, Norway.; Shetelig, C (corresponding author), Univ Oslo, Fac Med, Oslo, Norway.	chrshe@ous-hf.no	Andersen, Geir/AAR-3010-2020		Norwegian Health and Rehabilitation Foundation; Center for Heart Failure Research, University of Oslo, Oslo, Norway	Norwegian Health and Rehabilitation Foundation; Center for Heart Failure Research, University of Oslo, Oslo, Norway	This work was supported by The Norwegian Health and Rehabilitation Foundation and Center for Heart Failure Research, University of Oslo, Oslo, Norway.	Abedin M, 2007, AM J CARDIOL, V99, P513, DOI 10.1016/j.amjcard.2006.08.064; Andersen GO, 2011, HEART, V97, P460, DOI 10.1136/hrt.2010.206714; Bjerre M, 2014, SCAND CARDIOVASC J, V48, P209, DOI 10.3109/14017431.2014.917767; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Crisafulli A, 2005, CLIN SCI, V109, P389, DOI 10.1042/CS20050058; Desch S, 2012, INT J CARDIOVAS IMAG, V28, P263, DOI 10.1007/s10554-011-9802-9; Eitel I, 2010, J AM COLL CARDIOL, V55, P2470, DOI 10.1016/j.jacc.2010.01.049; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Erkol A, 2012, ATHEROSCLEROSIS, V221, P254, DOI 10.1016/j.atherosclerosis.2011.12.031; Fuernau G, 2013, INT J CARDIOL, V167, P2134, DOI 10.1016/j.ijcard.2012.05.101; Hofbauer LC, 2000, J BONE MINER RES, V15, P2, DOI 10.1359/jbmr.2000.15.1.2; Jono S, 2002, CIRCULATION, V106, P1192, DOI 10.1161/01.CIR.0000031524.49139.29; Kiechl S, 2004, CIRCULATION, V109, P2175, DOI 10.1161/01.CIR.0000127957.43874.BB; Limalanathan S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000679; Limalanathan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071780; Limalanathan S, 2010, CARDIOLOGY, V116, P103, DOI 10.1159/000316965; Lindberg S, 2014, CAN J CARDIOL, V30, P1523, DOI 10.1016/j.cjca.2014.08.015; Masci PG, 2010, JACC-CARDIOVASC IMAG, V3, P45, DOI 10.1016/j.jcmg.2009.06.016; Nybo M, 2008, ATHEROSCLEROSIS, V201, P33, DOI 10.1016/j.atherosclerosis.2008.03.026; Omland T, 2008, J AM COLL CARDIOL, V51, P627, DOI 10.1016/j.jacc.2007.09.058; Sandberg WJ, 2006, ARTERIOSCL THROM VAS, V26, P857, DOI 10.1161/01.ATV.0000204334.48195.6a; Schoppet M, 2003, J CLIN ENDOCR METAB, V88, P1024, DOI 10.1210/jc.2002-020775; Schoppet M, 2002, ARTERIOSCL THROM VAS, V22, P549, DOI 10.1161/01.ATV.0000012303.37971.DA; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Ueland T, 2004, J AM COLL CARDIOL, V44, P1970, DOI 10.1016/j.jacc.2004.06.076; Ueland T, 2005, CIRCULATION, V111, P2461, DOI 10.1161/01.CIR.0000165119.62099.14; Ueland T, 2001, EUR J ENDOCRINOL, V145, P685, DOI 10.1530/eje.0.1450685; Vik A, 2011, J THROMB HAEMOST, V9, P638, DOI 10.1111/j.1538-7836.2011.04222.x; Vik A, 2007, THROMB HAEMOSTASIS, V98, P148, DOI 10.1160/TH06-11-0671; Westman PC, 2016, J AM COLL CARDIOL, V67, P2050, DOI 10.1016/j.jacc.2016.01.073; Yamaguchi K, 1998, J BIOL CHEM, V273, P5117, DOI 10.1074/jbc.273.9.5117; Zannettino ACW, 2005, J CELL PHYSIOL, V204, P714, DOI 10.1002/jcp.20354	32	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173034	10.1371/journal.pone.0173034	http://dx.doi.org/10.1371/journal.pone.0173034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253327	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300062
J	Westphal, R; Simmons, C; Mesquita, MB; Wood, TC; Williams, SCR; Vernon, AC; Cash, D				Westphal, Robert; Simmons, Camilla; Mesquita, Michel B.; Wood, Tobias C.; Williams, Steve C. R.; Vernon, Anthony C.; Cash, Diana			Characterization of the resting-state brain network topology in the 6-hydroxydopamine rat model of Parkinson's disease	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; BASAL GANGLIA; MOTOR CORTEX; MODULAR ORGANIZATION; 6-OHDA LESION; MRI; REORGANIZATION; CONNECTOME; ISOFLURANE; PLASTICITY	Resting-state functional MRI (rsfMRI) is an imaging technology that has recently gained attention for its ability to detect disruptions in functional brain networks in humans, including in patients with Parkinson's disease (PD), revealing early and widespread brain network abnormalities. This methodology is now readily applicable to experimental animals offering new possibilities for cross-species translational imaging. In this context, we herein describe the application of rsfMRI to the unilaterally-lesioned 6-hydroxydopamine (6-OHDA) rat, a robust experimental model of the dopamine depletion implicated in PD. Using graph theory to analyse the rsfMRI data, we were able to provide meaningful and translatable measures of integrity, influence and segregation of the underlying functional brain architecture. Specifically, we confirm that rats share a similar functional brain network topology as observed in humans, characterised by small-worldness and modularity. Interestingly, we observed significantly reduced functional connectivity in the 6-OHDA rats, primarily in the ipsilateral (lesioned) hemisphere as evidenced by significantly lower node degree, local efficiency and clustering coefficient in the motor, orbital and sensorimotor cortices. In contrast, we found significantly, and bilaterally, increased thalamic functional connectivity in the lesioned rats. The unilateral deficits in the cortex are consistent with the unilateral nature of this model and further support the validity of the rsfMRI technique in rodents. We thereby provide a methodological framework for the investigation of brain networks in other rodent experimental models of PD, as well as of animal models in general, for cross-comparison with human data.	[Westphal, Robert; Simmons, Camilla; Mesquita, Michel B.; Wood, Tobias C.; Williams, Steve C. R.; Cash, Diana] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Neuroimaging, London, England; [Vernon, Anthony C.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London, England	University of London; King's College London; University of London; King's College London	Westphal, R (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Neuroimaging, London, England.	robert.westphal@kcl.ac.uk	Williams, Steve C/D-6979-2011; Wood, Tobias/B-7576-2012	Williams, Steve C/0000-0003-4299-1941; Cash, diana/0000-0001-5021-1234; Simmons, Camilla/0000-0002-8561-4241; Vernon, Anthony/0000-0001-7305-1069; opoku, anita/0000-0001-7243-8157; Wood, Tobias/0000-0001-7640-5520; Mesquita, Michel/0000-0002-5594-5605	Lily Safra Hope Foundation; BBSRC [BB/N009088/1] Funding Source: UKRI; MRC [MC_PC_14105, MR/N026063/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N009088/1] Funding Source: researchfish; Medical Research Council [MR/N026063/1, MC_PC_14105] Funding Source: researchfish	Lily Safra Hope Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was kindly supported by the Lily Safra Hope Foundation http://www.edmondjsafra.org/ (Imaging Parkinson's Pathology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Binicewicz FZ, 2015, BRAIN STRUCTURE FUNC; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brazhnik E, 2012, J NEUROSCI, V32, P7869, DOI 10.1523/JNEUROSCI.0943-12.2012; Brett M, 2002, PRESENTED AT THE 8TH; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carlson JD, 1999, BRAIN RES, V828, P12, DOI 10.1016/S0006-8993(99)01268-8; Casteels C, 2008, EUR J NUCL MED MOL I, V35, P124, DOI 10.1007/s00259-007-0558-3; Castillo-Gomez E, 2008, EXP NEUROL, V214, P97, DOI 10.1016/j.expneurol.2008.07.018; Claassen DO, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.573; D'Souza DV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106156; Debeir T, 2005, EXP NEUROL, V193, P444, DOI 10.1016/j.expneurol.2005.01.007; Decressac M, 2012, EXP NEUROL, V235, P306, DOI 10.1016/j.expneurol.2012.02.012; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; DUNNETT SB, 1987, BRAIN RES, V415, P63, DOI 10.1016/0006-8993(87)90269-1; EGER EI, 1981, ANESTHESIOLOGY, V55, P559, DOI 10.1097/00000542-198111000-00014; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Gaser C, 2012, NEUROIMAGE, V63, P47, DOI 10.1016/j.neuroimage.2012.06.066; Gass N, 2014, EUR NEUROPSYCHOPHARM, V24, P381, DOI 10.1016/j.euroneuro.2013.12.004; Gottlich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077336; Gozzi A, 2015, NEUROIMAGE; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hou ZY, 2010, J CLIN NEUROSCI, V17, P628, DOI 10.1016/j.jocn.2009.07.101; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Jang DP, 2012, NEUROSCI LETT, V513, P187, DOI 10.1016/j.neulet.2012.02.034; KOZLOWSKI MR, 1980, BRAIN RES, V197, P167, DOI 10.1016/0006-8993(80)90442-4; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lebedev AV, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00045; Liang ZF, 2015, NEUROIMAGE, V104, P89, DOI 10.1016/j.neuroimage.2014.10.013; Liang ZF, 2012, J NEUROSCI, V32, P10183, DOI 10.1523/JNEUROSCI.1020-12.2012; Liu CR, 2016, NEUROIMAGE, V139, P259, DOI 10.1016/j.neuroimage.2016.06.037; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Luo CY, 2015, J NEUROL, V262, P1557, DOI 10.1007/s00415-015-7750-3; Machado AGG, 2003, EPILEPSIA, V44, P500, DOI 10.1046/j.1528-1157.2003.37602.x; Marin C, 2007, EUR J NEUROSCI, V25, P259, DOI 10.1111/j.1460-9568.2006.05265.x; Masamoto K, 2009, EUR J NEUROSCI, V30, P242, DOI 10.1111/j.1460-9568.2009.06812.x; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; MOLINARI M, 1985, EXP BRAIN RES, V57, P305; Moran RJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002124; MORELLI M, 1993, SYNAPSE, V13, P264, DOI 10.1002/syn.890130309; Nagano-Saito A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00187; Nakajima S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084899; PAPA SM, 1994, BRAIN RES, V662, P69, DOI 10.1016/0006-8993(94)90796-X; PAXINOS G, 1997, THE RAT BRAIN IN STE; Pelled G, 2007, J MAGN RESON IMAGING, V26, P863, DOI 10.1002/jmri.21051; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rolinski M, 2015, NEUROIMAGE-CLIN, V8, P126, DOI 10.1016/j.nicl.2015.04.003; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Sarkaki A, 2012, AVICENNA J PHYTOMEDI, V2, P222; Schwarz AJ, 2008, MAGN RESON IMAGING, V26, P914, DOI 10.1016/j.mri.2008.01.048; Sforazzini F, 2016, BRAIN STRUCT FUNCT, V221, P941, DOI 10.1007/s00429-014-0948-9; Skidmore FM, 2013, NEUROIMAGE, V75, P249, DOI 10.1016/j.neuroimage.2011.06.056; SPIRDUSO WW, 1985, BRAIN RES, V335, P45, DOI 10.1016/0006-8993(85)90274-4; Stocco A, 2010, PSYCHOL REV, V117, P541, DOI 10.1037/a0019077; Ueno T, 2014, NEUROBIOLOGY DIS; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Valdes-Hernandez Pedro Antonio, 2011, Front Neuroinform, V5, P26, DOI 10.3389/fninf.2011.00026; Vemuri P, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt100; Vernon AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017269; Wang JH, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fnhum.2015.00386, 10.3389/fnhum.2015.00458]; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Werner CJ, 2014, HUM BRAIN MAPP, V35, P2582, DOI 10.1002/hbm.22351; Westphal R, 2016, NEUROSCIENCE, V334, P166, DOI 10.1016/j.neuroscience.2016.07.046; WOOTEN GF, 1981, J NEUROSCI, V1, P285; Yu QB, 2012, CURR TOP MED CHEM, V12, P2415, DOI 10.2174/156802612805289890; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zerbi V, 2014, J NEUROSCI, V34, P13963, DOI 10.1523/JNEUROSCI.0684-14.2014	76	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172394	10.1371/journal.pone.0172394	http://dx.doi.org/10.1371/journal.pone.0172394			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249008	Green Published, Green Submitted, gold			2022-12-26	WOS:000395983500039
J	Wang, GY; Wood, CN; Dolorito, JA; Libove, E; Epstein, EH				Wang, G. Y.; Wood, C. N.; Dolorito, J. A.; Libove, E.; Epstein, E. H., Jr.			Differing tumor-suppressor functions of Arf and p53 in murine basal cell carcinoma initiation and progression	ONCOGENE			English	Article							DNA-DAMAGE RESPONSE; DEFICIENT MICE; IN-VIVO; EXPRESSION; SKIN; TUMORIGENESIS; MUTATIONS; HEDGEHOG; GROWTH; GENES	Human basal cell carcinomas (BCCs) very frequently carry p53 mutations, and p53 loss markedly accelerates murine BCC carcinogenesis. We report here our studies of the mechanism by which p53 is activated to suppress BCC carcinogenesis. We find that aberrant hedgehog signaling in microscopic BCCs activates p53 in part via Arf (that is, the oncogene-induced stress pathway) but not via the DNA damage response pathway. However, Arf loss and p53 loss produce differing outcomes-loss of p53 promotes both tumor initiation and progression; loss of Arf promotes tumor progression but not initiation. Intriguingly, increased expression of Arf in tumor stromal cells, as in tumor keratinocytes themselves, contributes to suppression of BCC carcinogenesis.	[Wang, G. Y.; Wood, C. N.; Dolorito, J. A.; Libove, E.; Epstein, E. H., Jr.] Childrens Hosp Oakland Res Inst, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Wang, GY; Epstein, EH (corresponding author), Childrens Hosp Oakland Res Inst, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	gwang@chori.org; eepstein@chori.org		Wood, Carla/0000-0002-6813-7981	NIH [R01CA163611]; American Skin Association; Skin Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA163611] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Skin Association; Skin Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Peter Lamb at Exelixis for providing XL-139 and Charles Sherr for both providing mice carrying the Arf-GFP allele and for wise, ongoing counsel. This work was supported by NIH grant # R01CA163611 (PI: EHE), the American Skin Association (PI: GYW) and the Skin Cancer Foundation (PI: GYW).	Abe Y, 2008, P NATL ACAD SCI USA, V105, P4838, DOI 10.1073/pnas.0712216105; Abulaiti A, 2006, CANCER RES, V66, P10505, DOI 10.1158/0008-5472.CAN-06-2351; Adolphe C, 2006, CANCER RES, V66, P2081, DOI 10.1158/0008-5472.CAN-05-2146; Aszterbaum M, 1999, NAT MED, V5, P1285, DOI 10.1038/15242; Barlow C, 2000, P NATL ACAD SCI USA, V97, P871, DOI 10.1073/pnas.97.2.871; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Busch SE, 2014, ONCOGENE, V33, P2665, DOI 10.1038/onc.2013.208; Campaner S, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-6; Carbonneau CL, 2012, BLOOD, V119, P717, DOI 10.1182/blood-2011-06-361626; Chen DL, 2013, MOL CELL, V51, P46, DOI 10.1016/j.molcel.2013.05.006; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Herranz S, 2012, ONCOIMMUNOLOGY, V1, P1227, DOI 10.4161/onci.21207; Hutchin ME, 2005, GENE DEV, V19, P214, DOI 10.1101/gad.1258705; Inoue K, 1999, P NATL ACAD SCI USA, V96, P3993, DOI 10.1073/pnas.96.7.3993; Ismail F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021271; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1999, CANCER RES, V59, P2464; Kanellou P, 2009, BRIT J DERMATOL, V160, P1215, DOI 10.1111/j.1365-2133.2009.09079.x; Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242; Konig S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093555; KRAEMER KH, 1984, CARCINOGENESIS, V5, P511, DOI 10.1093/carcin/5.4.511; Lacour JP, 2002, BRIT J DERMATOL, V146, P17, DOI 10.1046/j.1365-2133.146.s61.5.x; LEWIS JG, 1987, CARCINOGENESIS, V8, P889, DOI 10.1093/carcin/8.7.889; Li ZJ, 2014, ONCOGENE, V33, P2674, DOI 10.1038/onc.2013.212; Mancuso M, 2004, CANCER RES, V64, P934, DOI 10.1158/0008-5472.CAN-03-2460; Nitzki F, 2010, CANCER RES, V70, P2739, DOI 10.1158/0008-5472.CAN-09-3743; Orlando G, 2014, NUCLEIC ACIDS RES, V42, P2320, DOI 10.1093/nar/gkt1185; Qian H, 2002, ONCOGENE, V21, P7901, DOI 10.1038/sj.onc.1205974; Reifenberger J, 2005, BRIT J DERMATOL, V152, P43, DOI 10.1111/J.1365-2133.2005.06353.X; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Saridaki Z, 2000, J INVEST DERMATOL, V115, P719, DOI 10.1046/j.1523-1747.2000.00098.x; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Wang GY, 2011, J INVEST DERMATOL, V131, P2298, DOI 10.1038/jid.2011.204; Wang GY, 2011, CANCER CELL, V19, P114, DOI 10.1016/j.ccr.2010.11.007; Wang Y, 2003, CANCER RES, V63, P4389; Watters D, 1999, J BIOL CHEM, V274, P34277, DOI 10.1074/jbc.274.48.34277; Wetmore C, 2001, CANCER RES, V61, P513; Young NP, 2011, CANCER RES, V71, P4040, DOI 10.1158/0008-5472.CAN-10-4563; Zerrouqi A, 2012, J CLIN INVEST, V122, P1283, DOI 10.1172/JCI38596; Zibat A, 2009, CARCINOGENESIS, V30, P918, DOI 10.1093/carcin/bgp068; Zindy F, 2003, P NATL ACAD SCI USA, V100, P15930, DOI 10.1073/pnas.2536808100	47	6	6	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 29	2017	36	26					3772	3780		10.1038/onc.2017.12	http://dx.doi.org/10.1038/onc.2017.12			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY9WM	28263978				2022-12-26	WOS:000404349700012
J	Choi, WS; Cowling, BJ; Noh, JY; Song, JY; Wie, SH; Lee, JS; Seo, YB; Lee, J; Jeong, HW; Kim, YK; Kim, SW; Park, KH; Lee, SH; Cheong, HJ; Kim, WJ				Choi, Won Suk; Cowling, Benjamin J.; Noh, Ji Yun; Song, Joon Young; Wie, Seong-Heon; Lee, Jin Soo; Seo, Yu Bin; Lee, Jacob; Jeong, Hye Won; Kim, Young Keun; Kim, Shin-Woo; Park, Kyong-Hwa; Lee, Sun Hee; Cheong, Hee Jin; Kim, Woo Joo			Disease burden of 2013-2014 seasonal influenza in adults in Korea	PLOS ONE			English	Article							RESPIRATORY-INFECTIONS; PATTERNS	Background This study was performed to investigate the disease burden of seasonal influenza in adults >= 20 years of age in Korea, based on surveillance data from the Hospital-based Influenza Morbidity & Mortality Surveillance (HIMM) network. Materials and methods The HIMM network is composed of two surveillance systems: emergency room-based and inpatients-based surveillance. A total of ten university hospitals all over the country are included in the surveillance network. The adult catchment population of the HIMM network was calculated by using the data of each hospital and the database of the Health Insurance Review and Assessment Service (HIRA) of Korea. The incidence rates of laboratory-confirmed medically-attended influenza, laboratory-confirmed influenza-related admission and laboratory-confirmed influenza-related death were calculated based on the catchment population. The socioeconomic burden of influenza was estimated using the human capital approach. Results During the 2013-2014 influenza season, the calculated adult catchment population of the HIMM network was 1,380,000. The incidence of medically-attended laboratory-confirmed influenza infection was 242.8 per 100,000 adults. The incidence of laboratory-confirmed influenza-related admission was 57.9 per 100,000 adults. The incidence of laboratory-confirmed influenza-related death was 3.1 per 100,000 adults. The total socioeconomic cost of 2013-2014 seasonal influenza in Korean adult population was estimated as 125 million USD (1 USD = 1,100 KRW). Conclusion The disease burden of 2013-2014 seasonal influenza in Korean adult population is very high and indicates that more active prevention and control policies will be needed to decrease the burden. Additional researches will be needed to assess the burden of seasonal influenza in the Korean child population.	[Choi, Won Suk; Noh, Ji Yun; Song, Joon Young; Cheong, Hee Jin; Kim, Woo Joo] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea; [Cowling, Benjamin J.] Univ Hong Kong, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Pokfulam, Hong Kong, Peoples R China; [Wie, Seong-Heon] Catholic Univ Korea, Coll Med, St Vincents Hosp, Div Infect Dis,Dept Internal Med, Seoul, South Korea; [Lee, Jin Soo] Inha Univ, Sch Med, Inha Univ Hosp, Div Infect Dis,Dept Internal Med, Incheon, South Korea; [Seo, Yu Bin; Lee, Jacob] Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Div Infect Dis,Dept Internal Med, Seoul, South Korea; [Jeong, Hye Won] Chungbuk Natl Univ, Coll Med, Chungbuk Univ Hosp, Div Infect Dis,Dept Internal Med, Cheongju, South Korea; [Kim, Young Keun] Yonsei Univ, Wonju Coll Med, Wonju Christian Hosp, Div Infect Dis,Dept Internal Med, Wonju, South Korea; [Kim, Shin-Woo] Kyungpook Natl Univ, Coll Med, Dept Internal Med, Daegu, South Korea; [Park, Kyong-Hwa] Chonnam Natl Univ, Sch Med, Div Infect Dis, Gwangju, South Korea; [Lee, Sun Hee] Pusan Natl Univ, Coll Med, Dept Internal Med, Busan, South Korea; [Kim, Woo Joo] Transgovt Enterprise Pandem Influenza Korea, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); University of Hong Kong; World Health Organization; Catholic University of Korea; Inha University; Inha University Hospital; Hallym University; Chungbuk National University; Yonsei University; Kyungpook National University; Chonnam National University; Pusan National University	Kim, WJ (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea.; Kim, WJ (corresponding author), Transgovt Enterprise Pandem Influenza Korea, Seoul, South Korea.	wjkim@korea.ac.kr	Choi, Won Suk/V-2730-2017; Cowling, Benjamin/C-4263-2009	Choi, Won Suk/0000-0001-5874-4764; Song, Joon Young/0000-0002-0148-7194; Cowling, Benjamin/0000-0002-6297-7154; Cheong, Hee Jin/0000-0002-2532-1463	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A103001]	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (Grant No.: A103001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, WKLY EPIDEMIOL REC, V89, P245; [Anonymous], 2012, WKLY EPIDEMIOL REC, V87, P461; Choi WS, 2010, J CLIN VIROL, V47, P325, DOI 10.1016/j.jcv.2010.01.003; Fedson DS, 2005, VACCINE, V23, P5133, DOI 10.1016/j.vaccine.2005.06.010; He DH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11013; Jung Young-Ho, 2006, J Prev Med Public Health, V39, P499; Kee SY, 2007, J INFECTION, V55, P273, DOI 10.1016/j.jinf.2007.04.354; Kim YW, 2013, SCAND J INFECT DIS, V45, P390, DOI 10.3109/00365548.2012.749423; Lai PL, 2011, HUM VACCINES, V7, P217, DOI 10.4161/hv.7.0.14607; MoEa Labor, 2014, 2013 SURVEY REPORT L; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; No IC, 1997, SOCIOECONOMIC COSTS; Office KNS, KOR STAT INF SERV; Park M, 2015, AM J PREVENTIVE MED; Pitman RJ, 2007, J INFECTION, V54, P530, DOI 10.1016/j.jinf.2006.09.017; Seo NG, 2013, REPORT KOREA HLTH PA; Song JY, 2013, J MED VIROL, V85, P910, DOI 10.1002/jmv.23548; Suh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084121; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; YSea Shin, 2010, REPORT DAILY NURSING; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552	22	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172012	10.1371/journal.pone.0172012	http://dx.doi.org/10.1371/journal.pone.0172012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278158	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900114
J	Tudor, D; Nenu, I; Filip, GA; Olteanu, D; Cenariu, M; Tabaran, F; Ion, RM; Gligor, L; Baldea, I				Tudor, Diana; Nenu, Iuliana; Filip, Gabriela Adriana; Olteanu, Diana; Cenariu, Mihai; Tabaran, Flaviu; Ion, Rodica Mariana; Gligor, Lucian; Baldea, Ioana			Combined regimen of photodynamic therapy mediated by Gallium phthalocyanine chloride and Metformin enhances anti-melanoma efficacy	PLOS ONE			English	Article							IN-VITRO; PHOTOPHYSICAL PROPERTIES; ALUMINUM-PHTHALOCYANINE; NITRIC-OXIDE; CANCER-CELLS; TNF-ALPHA; KAPPA-B; ALA-PDT; MELANOMA; APOPTOSIS	Background Melanoma therapy is challenging, especially in advanced cases, due to multiple developed tumor defense mechanisms. Photodynamic therapy (PDT) might represent an adjuvant treatment, because of its bimodal action: tumor destruction and immune system awakening. In this study, a combination of PDT mediated by a metal substituted phthalocyanine-Gal-lium phthalocyanine chloride (GaPc) and Metformin was used against melanoma. The study aimed to: (1) find the anti-melanoma efficacy of GaPc-PDT, (2) assess possible bene-ficial effects of Metformin addition to PDT, (3) uncover some of the mechanisms underlining cell killing and anti-angiogenic effects. Methods Two human lightly pigmented melanoma cell lines: WM35 and M1/15 subjected to previous Metformin exposure were treated by GaPc-PDT. Cell viability, death mechanism, cytoskele-ton alterations, oxidative damage, were assessed by means of colorimetry, flowcytometry, confocal microscopy, spectrophotometry, ELISA, Western Blotting. Results GaPc proved an efficient photosensitizer. Metformin addition enhanced cell killing by mech-anisms dependent on the cell line, namely apoptosis in the metastatic M1/15 and necrosis in the radial growth phase, WM35. Cell death mechanism relied on the inhibition of nuclear transcription factor (NF)-kappa B activation and tumor necrosis factor (TNF) D related apoptosis-inducing ligand (TRAIL) sensitization, leading to TRAIL and TNF-alpha induced apoptosis. Met-formin diminished the anti-angiogenic effect of PDT. Conclusions Metformin addition to GaPc-PDT increased tumor cell killing through enhanced oxidative damage and induction of proapoptotic mechanisms, but altered PDT anti-angiogenic effects. General significance Combination of Metformin and PDT might represent a solution to enhance the efficacy, lead-ing to a potential adjuvant role of PDT in melanoma therapy.	[Tudor, Diana; Nenu, Iuliana; Filip, Gabriela Adriana; Olteanu, Diana; Baldea, Ioana] Univ Med & Pharm, Dept Physiol, Cluj Napoca, Romania; [Cenariu, Mihai] Univ Agr Sci & Vet Med, Dept Biochem, Cluj Napoca, Romania; [Tabaran, Flaviu] Univ Agr Sci & Vet Med, Dept Pathol, Cluj Napoca, Romania; [Ion, Rodica Mariana] Natl Inst Res & Dev Chem & Petrochem ICECHIM, Nanomed Res Grp, Bucharest, Romania; [Gligor, Lucian] OSRAM Romania, OSRAM Opto Semicond, Global City Business Pk, Voluntari, Ilfov, Romania	Iuliu Hatieganu University of Medicine & Pharmacy; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; National Institute Research & Development in Chemistry & Petrochemistry; Osram	Filip, GA (corresponding author), Univ Med & Pharm, Dept Physiol, Cluj Napoca, Romania.	adrianafilip33@yahoo.com	Ion, Rodica-Mariana/B-2839-2008; Adriana, Filip Gabriela/AAB-7418-2019; Cenariu, Mihai Cosmin/C-2558-2012; Tudor, Diana/ABB-8826-2020; Tudor, Diana Valentina/O-5516-2017; Ioana, Baldea/Y-6129-2019; Tabaran, Flaviu/D-8562-2011; Olteanu, Elena Diana/A-4750-2017; Baldea, Ioana/C-4360-2011	Ion, Rodica-Mariana/0000-0002-9842-3321; Adriana, Filip Gabriela/0000-0002-7447-4925; Cenariu, Mihai Cosmin/0000-0001-6501-0128; Tudor, Diana Valentina/0000-0002-5997-8586; Tabaran, Flaviu/0000-0001-5744-0451; Olteanu, Elena Diana/0000-0002-3034-3659; Baldea, Ioana/0000-0003-4046-7310	University of Medicine and Pharmacy, Cluj-Napoca, Romania [1493/4/28.01.2014, 4945/4/08.03.2016]; OSRAM Opto Semiconductors, OSRAM Romania;  [PN-III-P2-2.1-PED-2016-1521]	University of Medicine and Pharmacy, Cluj-Napoca, Romania; OSRAM Opto Semiconductors, OSRAM Romania; 	This paper was supported by 1493/4/28.01.2014, 4945/4/08.03.2016 Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania and National Grant PN-III-P2-2.1-PED-2016-1521. We also affirm that the paper doesn't have any grants or contracts from a government agency, a non profit foundation, or a company supporting the preparation of the manuscript or the described research. The OSRAM Opto Semiconductors, OSRAM Romania provided support in the form of salaries for authors [LG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.77; Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Ali H, 1999, CHEM REV, V99, P2379, DOI 10.1021/cr980439y; Baldea I, 2012, J PHYSIOL PHARMACOL, V63, P109; Baldea I, 2016, J PHOTOCH PHOTOBIO B, V161, P402, DOI 10.1016/j.jphotobiol.2016.06.012; Baldea Ioana, 2015, Clujul Med, V88, P175, DOI 10.15386/cjmed-419; Baldea I, 2015, J PHOTOCH PHOTOBIO B, V151, P142, DOI 10.1016/j.jphotobiol.2015.07.019; Baldea I, 2013, J DERMATOL SCI, V72, P168, DOI 10.1016/j.jdermsci.2013.06.004; Berwick M, MELANOMA 2016, P17; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonnett R, 2001, TETRAHEDRON, V57, P9513, DOI 10.1016/S0040-4020(01)00952-8; Bro?yna AA, 2016, J CUTANEOUS PATHOLOG; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2016, ONCOTARGET, V7, P17844, DOI 10.18632/oncotarget.7528; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Cerezo M, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12267; Cerezo M, 2013, MOL CANCER THER, V12, P1605, DOI 10.1158/1535-7163.MCT-12-1226-T; Chen B, 2006, CRITICAL REV EUKARVO, V16; Collins-Gold L., 2000, MOD DRUG DISCOVERY, V3, P44; Cretney E, 2006, IMMUNOL CELL BIOL, V84, P87, DOI 10.1111/j.1440-1711.2005.01413.x; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Eggermont AMM, 2014, LANCET, V383, P816, DOI 10.1016/S0140-6736(13)60802-8; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Filip A, 2011, J MED FOOD, V14, P761, DOI 10.1089/jmf.2010.0142; Alvarez MG, 2004, PHOTODIAGN PHOTODYN, V1, P335, DOI 10.1016/S1572-1000(04)00068-7; Gorlach Agnes, 2008, Biochem J, V412, pe17, DOI 10.1042/BJ20080920; Griffith TS, 1998, J IMMUNOL, V161, P2833; Guldi DM, 2000, J AM CHEM SOC, V122, P8289, DOI 10.1021/ja001578b; Hegyesi H, 2001, J INVEST DERMATOL, V117, P151, DOI 10.1046/j.0022-202x.2001.01406.x; Hirsch HA, 2009, CANCER RES, V69, P8832, DOI 10.1158/0008-5472.CAN-09-3869; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Jakubowska M, 2013, NITRIC OXIDE-BIOL CH, V35, P79, DOI 10.1016/j.niox.2013.08.004; Janjetovic K, 2011, EUR J PHARMACOL, V668, P373, DOI 10.1016/j.ejphar.2011.07.004; Kleemann B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103762; Kumar R, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-27; Lang K, 2004, COORDIN CHEM REV, V248, P321, DOI 10.1016/j.ccr.2004.02.004; Leanne B J, 2008, METAL BASED DRUGS, V2008; Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81; LINSKY JP, 1980, INORG CHEM, V19, P3131, DOI 10.1021/ic50212a061; Liu F, 2009, J INVEST DERMATOL, V129, P422, DOI 10.1038/jid.2008.255; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Maduray K, 2013, J PHOTOCH PHOTOBIO B, V128, P58, DOI 10.1016/j.jphotobiol.2013.08.003; Martin MJ, 2012, CANCER DISCOV, V2, P344, DOI 10.1158/2159-8290.CD-11-0280; Medina VA, 2010, BRIT J PHARMACOL, V161, P755, DOI 10.1111/j.1476-5381.2010.00961.x; Meier F, 2000, AM J PATHOL, V156, P193, DOI 10.1016/S0002-9440(10)64719-0; Menendez JA, 2015, CELL CYCLE, V14, P3801, DOI 10.1080/15384101.2015.1022697; Moiseeva O, 2013, AGING-US, V5, P330, DOI 10.18632/aging.100556; Monge-Fuentes V, 2014, NANO REV EXP, V5, DOI 10.3402/nano.v5.24381; Muehlmann LA, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0095-3; Muehlmann LA, 2014, INT J NANOMED, V9, P1199, DOI 10.2147/IJN.S57420; Nenu I, 2015, TUMOR BIOL, V36, P6589, DOI 10.1007/s13277-015-3639-0; Nenu I, 2014, J PHOTOCH PHOTOBIO B, V138, P80, DOI 10.1016/j.jphotobiol.2014.04.027; Niehr F, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-76; Nombona N, 2012, J PHOTOCH PHOTOBIO B, V107, P35, DOI 10.1016/j.jphotobiol.2011.11.007; Nyman ES, 2004, J PHOTOCH PHOTOBIO B, V73, P1, DOI 10.1016/j.jphotobiol.2003.10.002; Ochoa-Gonzalez F, 2016, PLOS ONE, V11; OHKURA T, 1984, ARCH BIOCHEM BIOPHYS, V235, P63, DOI 10.1016/0003-9861(84)90255-8; Oleinick NL, 2002, PHOTOCH PHOTOBIO SCI, V1, P1, DOI 10.1039/b108586g; Olteanu D, 2014, J PHOTOCH PHOTOBIO B, V136, P54, DOI 10.1016/j.jphotobiol.2014.04.018; Pan XB, 2015, COLLOID SURFACE B, V130, P292, DOI 10.1016/j.colsurfb.2015.04.028; Plonka PM, 2003, EXP DERMATOL, V12, P356, DOI 10.1034/j.1600-0625.2002.120401.x; Pluskalova M, 2006, J PHOTOCH PHOTOBIO B, V83, P205, DOI 10.1016/j.jphotobiol.2006.01.003; Popescu T, 2014, LIFE SCI, V117, P75, DOI 10.1016/j.lfs.2014.09.022; Pustelny K, 2007, NITRIC OXIDE-BIOL CH, V16, P202, DOI 10.1016/j.niox.2006.10.002; Raghunath Arathi, 2015, BMC Res Notes, V8, P170, DOI 10.1186/s13104-015-1128-6; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Salani B, 2014, ENDOCR-RELAT CANCER, V21, pR461, DOI 10.1530/ERC-14-0284; Schallreuter KU, 2008, EXP DERMATOL, V17, P395, DOI 10.1111/j.1600-0625.2007.00675.x; Sharma KV, 2012, PHOTODIAGN PHOTODYN, V9, P156, DOI 10.1016/j.pdpdt.2011.09.003; Sharma SK, RESISTANCE PHOTODYNA, P229; Slattery ML, 2010, CARCINOGENESIS; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; SLOMINSKI A, 1985, ANTICANCER RES, V5, P403; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Song CW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00362; Spagnolo F, 2012, ARCH DERMATOL RES, V304, P177, DOI 10.1007/s00403-012-1223-7; SPIKES JD, 1986, PHOTOCHEM PHOTOBIOL, V43, P691, DOI 10.1111/j.1751-1097.1986.tb05648.x; Swavey S., 2013, RECENT ADV BIOL THER; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Uzdensky A, 2005, BBA-GEN SUBJECTS, V1722, P43, DOI 10.1016/j.bbagen.2004.11.011; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Wolnicka-Glubisz A, 2015, ARCH DERMATOL RES, V307, P89, DOI 10.1007/s00403-014-1523-1; Wood JM, 2004, BIOCHEM BIOPH RES CO, V325, P1412, DOI 10.1016/j.bbrc.2004.10.185; Yuan CY, 2015, TISSUE ENG PT A, V21, P1163, DOI [10.1089/ten.tea.2014.0058, 10.1089/ten.TEA.2014.0058]; Zabierowski SE, 2008, J CLIN ONCOL, V26, P2890, DOI 10.1200/JCO.2007.15.5465; Zhuang LQ, 2006, HUM PATHOL, V37, P1286, DOI 10.1016/j.humpath.2006.04.026	91	20	20	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173241	10.1371/journal.pone.0173241	http://dx.doi.org/10.1371/journal.pone.0173241			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278159	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900057
J	Htun, NM; Magliano, DJ; Zhang, ZY; Lyons, J; Petit, T; Nkuipou-Kenfack, E; Ramirez-Torres, A; von zur Muhlen, C; Maahs, D; Schanstra, JP; Pontillo, C; Pejchinovski, M; Snell-Bergeon, JK; Delles, C; Mischak, H; Staessen, JA; Shaw, JE; Koeck, T; Peter, K				Htun, Nay M.; Magliano, Dianna J.; Zhang, Zhen-Yu; Lyons, Jasmine; Petit, Thibault; Nkuipou-Kenfack, Esther; Ramirez-Torres, Adela; von zur Muhlen, Constantin; Maahs, David; Schanstra, Joost P.; Pontillo, Claudia; Pejchinovski, Martin; Snell-Bergeon, Janet K.; Delles, Christian; Mischak, Harald; Staessen, Jan A.; Shaw, Jonathan E.; Koeck, Thomas; Peter, Karlheinz			Prediction of acute coronary syndromes by urinary proteome analysis	PLOS ONE			English	Article							MASS-SPECTROMETRY; EXTRACELLULAR-MATRIX; MYOCARDIAL-INFARCTION; BIOMARKER DISCOVERY; CLINICAL PROTEOMICS; GENERAL-POPULATION; PLAQUE RUPTURE; ARTERY-DISEASE; ATHEROSCLEROSIS; PROGRESSION	Identification of individuals who are at risk of suffering from acute coronary syndromes (ACS) may allow to introduce preventative measures. We aimed to identify ACS-related urinary peptides, that combined as a pattern can be used as prognostic biomarker. Proteomic data of 252 individuals enrolled in four prospective studies from Australia, Europe and North America were analyzed. 126 of these had suffered from ACS within a period of up to 5 years post urine sampling (cases). Proteomic analysis of 84 cases and 84 matched controls resulted in the discovery of 75 ACS-related urinary peptides. Combining these to a peptide pattern, we established a prognostic biomarker named Acute Coronary Syndrome Predictor 75 (ACSP75). ACSP75 demonstrated reasonable prognostic discrimination (c-statistic = 0.664), which was similar to Framingham risk scoring (c-statistics = 0.644) in a validation cohort of 42 cases and 42 controls. However, generating by a composite algorithm named Acute Coronary Syndrome Composite Predictor (ACSCP), combining the biomarker pattern ACSP75 with the previously established urinary proteomic biomarker CAD238 characterizing coronary artery disease as the underlying aetiology, and age as a risk factor, further improved discrimination (c-statistic = 0.751) resulting in an added prognostic value over Framingham risk scoring expressed by an integrated discrimination improvement of 0.273 +/- 0.048 (P < 0.0001) and net reclassification improvement of 0.405 +/- 0.113 (P = 0.0007). In conclusion, we demonstrate that urinary peptide biomarkers have the potential to predict future ACS events in asymptomatic patients. Further large scale studies are warranted to determine the role of urinary biomarkers in clinical practice.	[Htun, Nay M.; Peter, Karlheinz] Baker IDI Heart & Diabet Inst, Atherothrombosis & Vasc Biol, Melbourne, Vic, Australia; [Htun, Nay M.; Peter, Karlheinz] Monash Univ, Dept Med, Melbourne, Vic, Australia; [Magliano, Dianna J.; Lyons, Jasmine; Shaw, Jonathan E.] Baker IDI Heart & Diabet Inst, Clin Diabet & Epidemiol, Melbourne, Vic, Australia; [Zhang, Zhen-Yu; Petit, Thibault; Staessen, Jan A.] Univ Leuven, Dept Cardiovasc Sci, KU Leuven, Studies Coordinating Ctr,Res Unit Hypertens & Car, Leuven, Belgium; [Nkuipou-Kenfack, Esther; Ramirez-Torres, Adela; Pontillo, Claudia; Pejchinovski, Martin; Mischak, Harald; Koeck, Thomas] Mosaiques Diagnost GmbH, Hannover, Germany; [Ramirez-Torres, Adela] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA; [von zur Muhlen, Constantin] Univ Heart Ctr Freiburg, Dept Cardiol, Freiburg, Germany; [Maahs, David] Stanford Sch Med, Dept Paediat, Stanford, CA USA; [Maahs, David; Snell-Bergeon, Janet K.] Univ Colorado, Sch Med, Barbara Davis Ctr Diabet, Aurora, CO USA; [Schanstra, Joost P.] INSERM, U1048, Inst Cardiovasc & Metab Dis, Toulouse, France; [Schanstra, Joost P.] Univ Toulouse III Paul Sabatier, Toulouse, France; [Delles, Christian; Mischak, Harald] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Staessen, Jan A.] Maastricht Univ, R&D VitaK Grp, Maastricht, Netherlands	Baker Heart and Diabetes Institute; Monash University; Baker Heart and Diabetes Institute; KU Leuven; Mosaiques Diagnostics GmbH (MOS); Sanford Burnham Prebys Medical Discovery Institute; Universitats Herzzentrum Freiburg; Stanford University; University of Colorado System; University of Colorado Anschutz Medical Campus; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Glasgow; Maastricht University	Peter, K (corresponding author), Baker IDI Heart & Diabet Inst, Atherothrombosis & Vasc Biol, Melbourne, Vic, Australia.; Peter, K (corresponding author), Monash Univ, Dept Med, Melbourne, Vic, Australia.	Karlheinz.Peter@bakeridi.edu.au	/S-2765-2019; Staessen, Jan A/A-1065-2011; Zhang, Zhenyu/GZL-8479-2022; Schanstra, Joost P/X-7724-2018	/0000-0002-8040-2258; Staessen, Jan A/0000-0002-3026-1637; Zhang, Zhenyu/0000-0002-3785-7417; Schanstra, Joost P/0000-0002-7471-372X; Maahs, David/0000-0002-4602-7909; Magliano, Dianna/0000-0002-9507-6096; Snell-Bergeon, Janet/0000-0002-9337-3740; Mischak, Harald/0000-0003-0323-0306	European Union grant EU-MASCARA [HEALTH-FP7-278249]; European Union grant HOMAGE [HEALTH-FP7-305507]; European Union grant SYSVASC [HEALTH-FP7-603288]; European Research Council Advanced Researcher Grant EXPLORE [2011-294713]; National Health and Medical Research Council of Australia (NHMRC) - European Union Collaborative Research Grant [GNT1102158]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium [G.0881.13, G.0880.13]; Cardiac Society of Australia and New Zealand (CSANZ); NHMRC, Australia; NHMRC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	European Union grant EU-MASCARA; European Union grant HOMAGE; European Union grant SYSVASC; European Research Council Advanced Researcher Grant EXPLORE; National Health and Medical Research Council of Australia (NHMRC) - European Union Collaborative Research Grant; Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium(FWO); Cardiac Society of Australia and New Zealand (CSANZ); NHMRC, Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project was partly supported by the European Union grants EU-MASCARA (HEALTH-FP7-278249), HOMAGE (HEALTH-FP7-305507), SYSVASC (HEALTH-FP7-603288), the European Research Council Advanced Researcher Grant EXPLORE (2011-294713) and the National Health and Medical Research Council of Australia (NHMRC) - European Union Collaborative Research Grant GNT1102158. The Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (G.0881.13 and G.0880.13) supported the FLEMENGHO study. N. M. Htun was supported by scholarships from the Cardiac Society of Australia and New Zealand (CSANZ) and NHMRC, Australia. D. J. Magliano, J. E. Shaw and K. Peter are supported by research fellowships from the NHMRC. The funders provided support in the form of salaries for authors [NMH, DJM, ENK, JPS, CD, HM, JAS, JES, TK, KP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Adiguzel E, 2009, VASC MED, V14, P73, DOI 10.1177/1358863X08094801; Amabile N, 2014, EUR HEART J, V35, P2972, DOI 10.1093/eurheartj/ehu153; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown CE, 2015, PROTEOM CLIN APPL, V9, P610, DOI 10.1002/prca.201400195; Chen YC, 2013, CIRC RES, V113, P252, DOI 10.1161/CIRCRESAHA.113.301562; Chistiakov DA, 2013, CARDIOL REV, V21, P270, DOI 10.1097/CRD.0b013e31828c5ced; Coon JJ, 2008, PROTEOM CLIN APPL, V2, P964, DOI 10.1002/prca.200800024; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dakna M, 2009, J CHROMATOGR B, V877, P1250, DOI 10.1016/j.jchromb.2008.10.048; Delles C, 2010, J HYPERTENS, V28, P2316, DOI 10.1097/HJH.0b013e32833d81b7; Duner P, 2015, ATHEROSCLEROSIS, V240, P26, DOI 10.1016/j.atherosclerosis.2015.02.043; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Girolami Mark, 2006, Drug Discov Today Technol, V3, P13, DOI 10.1016/j.ddtec.2006.03.010; Haubitz M, 2009, MOL CELL PROTEOMICS, V8, P2296, DOI 10.1074/mcp.M800529-MCP200; Hoefer IE, 2015, EUR HEART J, V36, P2635, DOI 10.1093/eurheartj/ehv236; Hong SN, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000307; Kong CH, 2013, INTERACT CARDIOV TH, V16, P11, DOI 10.1093/icvts/ivs421; Laiho K, 1998, CLIN RHEUMATOL, V17, P234, DOI 10.1007/BF01451054; Lan TH, 2013, CARDIOVASC PATHOL, V22, P401, DOI 10.1016/j.carpath.2013.01.003; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Neisius U, 2012, J HYPERTENS, V30, P67, DOI 10.1097/HJH.0b013e32834e12d8; Neuhoff NV, 2004, RAPID COMMUN MASS SP, V18, P149, DOI 10.1002/rcm.1294; Newby AC, 2014, CURR OPIN LIPIDOL, V25, P358, DOI 10.1097/MOL.0000000000000111; Nkuipou-Kenfack E, 2014, AGEING RES REV, V18, P74, DOI 10.1016/j.arr.2014.09.002; Pejchinovski M, 2015, PROTEOM CLIN APPL, V9, P453, DOI 10.1002/prca.201400113; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Ponticos M, 2014, J BIOMED RES, V28, P25, DOI 10.7555/JBR.27.20130064; R Core Team, 2018, R LANG ENV STAT COMP; Rocchiccioli S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-260; Rossing K, 2008, J AM SOC NEPHROL, V19, P1283, DOI 10.1681/ASN.2007091025; Schanstra JP, 2015, J AM SOC NEPHROL, V26, P1999, DOI 10.1681/ASN.2014050423; Seidelmann SB, 2016, CIRCULATION, V134, P1328, DOI 10.1161/CIRCULATIONAHA.116.023425; Shami A, 2014, CURR OPIN LIPIDOL, V25, P394, DOI 10.1097/MOL.0000000000000112; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Van der Donckt C, 2015, EUR HEART J, V36, P1049, DOI 10.1093/eurheartj/ehu041; Vassiliadis E, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-140; Vivanco F, 2008, BIOMARK INSIGHTS, V3, P101; von zur Muhlen C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013847; von zur Muhlen C, 2009, J PROTEOME RES, V8, P335, DOI 10.1021/pr800615t; Wittke S, 2005, ELECTROPHORESIS, V26, P1476, DOI 10.1002/elps.200410140; Yayan J, 2013, VASC HEALTH RISK MAN, V9, P435, DOI 10.2147/VHRM.S45704; Yin XY, 2014, ARTERIOSCL THROM VAS, V34, P939, DOI 10.1161/ATVBAHA.113.302918; Zhang ZY, 2015, HYPERTENSION, V66, P52, DOI 10.1161/HYPERTENSIONAHA.115.05296; Zhang ZY, 2014, INT J CARDIOL, V176, P158, DOI 10.1016/j.ijcard.2014.07.014; Zimmerli LU, 2008, MOL CELL PROTEOMICS, V7, P290, DOI 10.1074/mcp.M700394-MCP200; Zurbig Petra, 2009, Methods Mol Biol, V564, P105, DOI 10.1007/978-1-60761-157-8_6	47	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172036	10.1371/journal.pone.0172036	http://dx.doi.org/10.1371/journal.pone.0172036			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273075	Green Published, Green Accepted, gold			2022-12-26	WOS:000396073700065
J	Soma, M; Iwama, M				Soma, Masayo; Iwama, Midori			Mating success follows duet dancing in the Java sparrow	PLOS ONE			English	Article							FEMALE CHOICE; COURTSHIP DISPLAY; BENGALESE FINCHES; SEXUAL SELECTION; SONG PERFORMANCE; MAGPIE-LARKS; BIRDS; COORDINATION; PREFERENCES; COMPLEXITY	Mutual interactions between sexes have multiple signalling functions. Duet singing in songbirds is related to mutual mate guarding, joint resource defence, and signalling commitment. Coordinated visual displays of mating pairs are thought to perform similar functions, but are less well understood. The current study evaluated mutual interactions in an Estrildid species to explore the relative importance of duet dancing and male singing in mating success of pairs in a first encounter. When Java sparrows (Lonchura oryzivora) court prospective mates, only males sing. However, both males and females perform courtship dances, often in a duet-like manner. These dances are typically terminated by female copulation solicitation displays (CSDs). In the current study, we observed higher mating success when courtship dances were mutually exchanged, and when males sang. However, the sex initiating the courtship did not affect mating success. Most females produced CSDs after duet dancing but before hearing the entire song, indicating that duet dancing played a crucial role in mating. This finding highlights an unexplored aspect of duetting behaviour in the process of mutual mate choice. These results conflict with the majority of past songbird research, which has interpreted songs as primary behavioural sexual signals.	[Soma, Masayo] Hokkaido Univ, Fac Sci, Dept Biol, Behav Neurobiol Grp,Kita Ku, Kita 10,Nishi 8, Sapporo, Hokkaido, Japan; [Iwama, Midori] Hokkaido Univ, Behav Neurobiol Grp, Biosystems Sci Course, Grad Sch Life Sci,Kita Ku, Kita 10,Nishi 8, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Soma, M (corresponding author), Hokkaido Univ, Fac Sci, Dept Biol, Behav Neurobiol Grp,Kita Ku, Kita 10,Nishi 8, Sapporo, Hokkaido, Japan.	masayo.soma@sci.hokudai.ac.jp		Soma, Masayo/0000-0002-8596-1956	Japan Society for the Promotion of Science [23680027, 16H06177]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The work was supported by Japan Society for the Promotion of Science Grants-in-Aid for Young Scientists (Nos. 23680027, 16H06177) received by MS, http://www.jsps.go.jp/english/ index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; ARROWOOD PC, 1988, BEHAVIOUR, V106, P129, DOI 10.1163/156853988X00133; Barske J, 2011, P ROY SOC B-BIOL SCI, V278, P3523, DOI 10.1098/rspb.2011.0382; Borgia G, 1998, ANIM BEHAV, V56, P1121, DOI 10.1006/anbe.1998.0908; Byers J, 2010, ANIM BEHAV, V79, P771, DOI 10.1016/j.anbehav.2010.01.009; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; CATCHPOLE CK, 1987, TRENDS ECOL EVOL, V2, P94, DOI 10.1016/0169-5347(87)90165-0; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Clutton-Brock T, 2009, ANIM BEHAV, V77, P3, DOI 10.1016/j.anbehav.2008.08.026; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; Dalziell AH, 2013, CURR BIOL, V23, P1132, DOI 10.1016/j.cub.2013.05.018; Dunn AM, 1996, ETHOLOGY, V102, P529; Dunning JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089438; Edward DA, 2011, TRENDS ECOL EVOL, V26, P647, DOI 10.1016/j.tree.2011.07.012; Elie JE, 2010, ANIM BEHAV, V80, P597, DOI 10.1016/j.anbehav.2010.06.003; Funghi C, 2015, BEHAV PROCESS, V115, P74, DOI 10.1016/j.beproc.2015.03.010; Fusani L, 1997, BEHAVIOUR, V134, P321, DOI 10.1163/156853997X00566; Fusani L, 2014, NEUROSCI BIOBEHAV R, V46, P534, DOI 10.1016/j.neubiorev.2014.07.017; Geberzahn N, 2013, J COMP PSYCHOL, V127, P352, DOI 10.1037/a0033154; Goodwin, 1982, ESTRILDID FINCHES WO; Hall ML, 2007, CURR BIOL, V17, pR406, DOI 10.1016/j.cub.2007.04.022; Hall ML, 2004, BEHAV ECOL SOCIOBIOL, V55, P415, DOI 10.1007/s00265-003-0741-x; Hall ML, 2000, ANIM BEHAV, V60, P667, DOI 10.1006/anbe.2000.1517; Hasegawa A, 2011, ORNITHOL SCI, V10, P73, DOI 10.2326/osj.10.73; Hoepfner AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065525; HUNTER FM, 1993, TRENDS ECOL EVOL, V8, P21, DOI 10.1016/0169-5347(93)90126-A; Kagawa H, 2013, BEHAV PROCESS, V99, P138, DOI 10.1016/j.beproc.2013.07.012; Konter A, 2014, WILSON J ORNITHOL, V126, P140, DOI 10.1676/13-161.1; Langmore NE, 1998, TRENDS ECOL EVOL, V13, P136, DOI 10.1016/S0169-5347(97)01241-X; MALACARNE G, 1991, ETHOL ECOL EVOL, V3, P207, DOI 10.1080/08927014.1991.9525369; Marshall-Ball L, 2006, ANIM BEHAV, V71, P823, DOI 10.1016/j.anbehav.2005.05.021; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; Morisaka Tadamichi, 2008, Ornithological Science, V7, P75, DOI 10.2326/1347-0558(2008)7[75:VIPFCS]2.0.CO;2; NUECHTERLEIN GL, 1982, CONDOR, V84, P350; O'Loghlen AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036130; Ota N, BIOASOUSTIC IN PRESS; Ota N, 2015, SCI REP-UK, V5, DOI 10.1038/srep16614; Ota N, 2014, J AVIAN BIOL, V45, P566, DOI 10.1111/jav.00383; Patricelli GL, 2006, ANIM BEHAV, V71, P49, DOI 10.1016/j.anbehav.2005.03.029; PETRIE M, 1992, ANIM BEHAV, V44, P790, DOI 10.1016/S0003-3472(05)80309-4; Rek P, 2016, ANIM BEHAV, V117, P35, DOI 10.1016/j.anbehav.2016.04.024; Restall R., 1996, MUNIAS AND MANNIKINS; Riebel K, 2009, ADV STUD BEHAV, V40, P197, DOI 10.1016/S0065-3454(09)40006-8; SEARCY WA, 1992, AM ZOOL, V32, P71; Servedio MR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3020; SOMA M, 2015, FRONT ECOL EVOL, V3, DOI DOI 10.3389/FEV0.2015.00004; Soma M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124876; Soma M, 2011, BEHAV ECOL, V22, P363, DOI 10.1093/beheco/arq219; Torres R, 2003, BEHAV ECOL SOCIOBIOL, V55, P65, DOI 10.1007/s00265-003-0669-1; Ullrich R, 2016, ANIM BEHAV, V112, P285, DOI 10.1016/j.anbehav.2015.11.012; Wachtmeister CA, 2001, ANIM BEHAV, V61, P861, DOI 10.1006/anbe.2001.1684; Woolley SMN, 1997, J NEUROSCI, V17, P6380; Zanollo V, 2013, ETHOLOGY, V119, P344, DOI 10.1111/eth.12071	53	18	19	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172655	10.1371/journal.pone.0172655	http://dx.doi.org/10.1371/journal.pone.0172655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273111	Green Published, gold			2022-12-26	WOS:000396073700084
J	Wang, Z; Fan, GQ; Dong, YP; Zhai, XQ; Deng, MJ; Zhao, ZL; Liu, WS; Cao, YB				Wang, Zhe; Fan, Guoqiang; Dong, Yanpeng; Zhai, Xiaoqiao; Deng, Minjie; Zhao, Zhenli; Liu, Wenshan; Cao, Yabing			Implications of polyploidy events on the phenotype, microstructure, and proteome of Paulownia australis	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; STRESS; GENE; PLANTS; MECHANISMS; GLYCINEBETAINE; PHOTOSYNTHESIS; TRANSCRIPTOME; LIGNIFICATION; PHYSIOLOGY	Polyploidy events are believed to be responsible for increasing the size of plant organs and enhancing tolerance to environmental stresses. Autotetraploid Paulownia australis plants exhibit superior traits compared with their diploid progenitors. Although some transcriptomics studies have been performed and some relevant genes have been revealed, the molecular and biological mechanisms regulating the predominant characteristics and the effects of polyploidy events on P. australis remain unknown. In this study, we compared the phenotypes, microstructures, and proteomes of autotetraploid and diploid P. australis plants. Compared with the diploid plant, the leaves of the autotetraploid plant were longer and wider, and the upper epidermis, lower epidermis, and palisade layer of the leaves were thicker, the leaf spongy parenchyma layer was thinner, the leaf cell size was bigger, and cell number was lower. In the proteome analysis, 3,010 proteins were identified and quantified, including 773 differentially abundant proteins. These results may help to characterize the P. australis proteome profile. Differentially abundant proteins related to cell division, glutathione metabolism, and the synthesis of cellulose, chlorophyll, and lignin were more abundant in the autotetraploid plants. These results will help to enhance the understanding of variations caused by polyploidy events in P. australis. The quantitative real-time PCR results provided details regarding the expression patterns of the proteins at mRNA level. We observed a limited correlation between transcript and protein levels. These observations may help to clarify the molecular basis for the predominant autotetraploid characteristics and be useful for plant breeding in the future.	[Wang, Zhe; Fan, Guoqiang; Dong, Yanpeng; Deng, Minjie; Zhao, Zhenli; Liu, Wenshan; Cao, Yabing] Henan Agr Univ, Inst Paulownia, Zhengzhou, Henan, Peoples R China; [Wang, Zhe; Fan, Guoqiang; Dong, Yanpeng; Deng, Minjie; Zhao, Zhenli; Liu, Wenshan; Cao, Yabing] Henan Agr Univ, Coll Forestry, Zhengzhou, Henan, Peoples R China; [Zhai, Xiaoqiao] Forestry Acad Henan, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Henan Agricultural University	Fan, GQ (corresponding author), Henan Agr Univ, Inst Paulownia, Zhengzhou, Henan, Peoples R China.; Fan, GQ (corresponding author), Henan Agr Univ, Coll Forestry, Zhengzhou, Henan, Peoples R China.	zlxx64@126.com		Wang, Zhe/0000-0001-6671-694X	Key Science and Technology Program of Henan Province of China [152107000097]; Natural Science Foundation of Henan Province of China [162300410158]; Distinguished Talents Foundation of Henan Province of China [174200510001]	Key Science and Technology Program of Henan Province of China; Natural Science Foundation of Henan Province of China; Distinguished Talents Foundation of Henan Province of China	This work was supported by the Key Science and Technology Program of Henan Province of China (152107000097), the Natural Science Foundation of Henan Province of China (162300410158), and the Distinguished Talents Foundation of Henan Province of China (174200510001).	Allario T, 2011, J EXP BOT, V62, P2507, DOI 10.1093/jxb/erq467; Ates S, 2008, AFR J BIOTECHNOL, V7, P4153; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Boudet AM, 2000, PLANT PHYSIOL BIOCH, V38, P81, DOI 10.1016/S0981-9428(00)00166-2; Chao DY, 2013, SCIENCE, V341, P658, DOI 10.1126/science.1240561; Chen THH, 2011, PLANT CELL ENVIRON, V34, P1, DOI 10.1111/j.1365-3040.2010.02232.x; Chen ZJ, 2010, TRENDS PLANT SCI, V15, P57, DOI 10.1016/j.tplants.2009.12.003; Dai FW, 2015, INT J MOL SCI, V16, P22938, DOI 10.3390/ijms160922938; Deng BL, 2012, PLANT GROWTH REGUL, V66, P37, DOI 10.1007/s10725-011-9626-6; [邓敏捷 Deng Minjie], 2013, [河南农业大学学报, Journal of Henan Agricultural University], V47, P698; Dong YP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00892; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Dudits D, 2016, PLANT PHYSIOL, V170, P1504, DOI 10.1104/pp.15.01679; Fan GQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149617; Fan GuoQiang, 2010, Journal of Northeast Forestry University, V38, P22; Fan GuoQiang, 2009, Journal of Northwest A & F University - Natural Science Edition, V37, P83; [范国强 Fan Guoqiang], 2007, [林业科学, Scientia Silvae Sinicae], V43, P31; [范国强 FAN GuoQiang], 2007, [植物生理学通讯, Plant Physiology Communications], V43, P109; Giri J, 2011, PLANT SIGNAL BEHAV, V6, P1746, DOI 10.4161/psb.6.11.17801; Giribaldi M, 2010, J PROTEOMICS, V73, P1647, DOI 10.1016/j.jprot.2010.05.002; Gonzalez LMG, 2012, PLANT CELL ENVIRON, V35, P682, DOI 10.1111/j.1365-3040.2011.02444.x; Guerfel M, 2009, SCI HORTIC-AMSTERDAM, V119, P257, DOI 10.1016/j.scienta.2008.08.006; Hall T, 2008, TREES LIFE J, V3, P3; Hartmann MD, 2006, J MOL BIOL, V364, P411, DOI 10.1016/j.jmb.2006.09.001; HELL R, 1988, PHYSIOL PLANTARUM, V72, P70, DOI 10.1111/j.1399-3054.1988.tb06624.x; Henkes S, 2001, PLANT CELL, V13, P535, DOI 10.1105/tpc.13.3.535; Herrmann K, 2001, ENCY LIFE SCI; Hou QC, 2015, ANN BOT-LONDON, V115, P465, DOI 10.1093/aob/mcu152; Ipekci Z, 2003, PLANT CELL REP, V22, P16, DOI 10.1007/s00299-003-0650-5; JAWORSKI EG, 1972, J AGR FOOD CHEM, V20, P1195, DOI 10.1021/jf60184a057; Jiang ZF, 2012, ECOTOXICOLOGY, V21, P759, DOI 10.1007/s10646-011-0836-5; Koh J, 2012, NEW PHYTOL, V196, P292, DOI 10.1111/j.1469-8137.2012.04251.x; Kong F, 2011, PLANT MOL BIOL REP, V29, P927, DOI 10.1007/s11105-011-0301-x; Lackner DH, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r25; Lan P, 2012, MOL CELL PROTEOMICS, V11, P1156, DOI 10.1074/mcp.M112.020461; Li WL, 1996, AM J BOT, V83, P15, DOI 10.2307/2445949; Li XD, 2012, PLANTA, V236, P579, DOI 10.1007/s00425-012-1629-7; Ma JJ, 2012, SCI CHINA LIFE SCI, V55, P68, DOI 10.1007/s11427-012-4268-0; Marenco RA, 2009, PHOTOSYNTHETICA, V47, P184, DOI 10.1007/s11099-009-0031-6; Marmagne A, 2010, NEW PHYTOL, V186, P216, DOI 10.1111/j.1469-8137.2009.03139.x; May MJ, 1998, J EXP BOT, V49, P649, DOI 10.1093/jexbot/49.321.649; Nassar NMA, 2008, GENET MOL RES, V7, P276, DOI 10.4238/vol7-2gmr399; Ng DWK, 2012, HEREDITY, V108, P419, DOI 10.1038/hdy.2011.92; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Qian CT, 2005, PLANT BREEDING, V124, P272, DOI 10.1111/j.1439-0523.2005.01066.x; Qiao JJ, 2012, J PROTEOME RES, V11, P5286, DOI 10.1021/pr300504w; Sahashi Norio, 1995, Annals of the Phytopathological Society of Japan, V61, P481, DOI 10.3186/jjphytopath.61.481; Shen YY, 2015, J PROTEOMICS, V112, P274, DOI 10.1016/j.jprot.2014.10.006; Song Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep29843; Sugiyama SI, 2005, ANN BOT-LONDON, V96, P931, DOI 10.1093/aob/mci245; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Tal M, 1979, Basic Life Sci, V13, P61; Tan FQ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0450-4; Tian XX, 2013, J PROTEOMICS, V78, P326, DOI 10.1016/j.jprot.2012.10.002; Tsukaya H, 2008, PLOS BIOL, V6, P1373, DOI 10.1371/journal.pbio.0060174; Wang SZ, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0891-4; Wang Yang, 2013, Acta Agriculturae Jiangxi, V25, P39; Wang Y, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00220, 10.3389/fpls.2013.00314]; Xu EK, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0828-8; Yu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115153; [张晓申 Zhang Xiaoshen], 2013, [河南农业大学学报, Journal of Henan Agricultural University], V47, P543; [张晓申 Zhang Xiaoshen], 2012, [河南农业大学学报, Journal of Henan Agricultural University], V46, P646	62	18	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172633	10.1371/journal.pone.0172633	http://dx.doi.org/10.1371/journal.pone.0172633			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273106	gold, Green Published, Green Submitted			2022-12-26	WOS:000396073700083
J	Zhou, BX; Li, J; Liang, XL; Yang, ZF; Jiang, ZH				Zhou, Beixian; Li, Jing; Liang, Xiaoli; Yang, Zifeng; Jiang, Zhihong			Transcriptome profiling of influenza A virus-nfected lung epithelial (A549) cells with lariciresinol-4-beta-D-glucopyranoside treatment	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; DNA-DAMAGE-RESPONSE; ISATIS-INDIGOTICA; TELOMERE LENGTH; CYCLE ARREST; ANTIVIRAL ACTIVITY; I INTERFERON; IKK-EPSILON; INFECTION; EXPRESSION	The influenza A virus is an acute contagious pathogen that affects the human respiratory system and can cause severe lung disease and even death. Lariciresino1-4-beta-D-glucopyranoside is a lignan that is extracted from Isatis indigotica, which is a medicinal herb plant that was commonly applied to treat infections, the common cold, fever and inflammatory diseases. Our previous study demonstrated that lariciresino1-4-beta-D-glucopyranoside possesses anti-viral and anti-inflammatory properties. However, the comprehensive and detailed mechanisms that underlie the effect of lariciresino1-4-beta-D-glucopyranoside interventions against influenza virus infection remain to be elucidated. In this study, we employed high-throughput RNA sequencing (RNA-seq) to investigate the transcriptomic responses of influenza A virus-infected lung epithelial (A549) cells with lariciresino1-4-beta-D-glucopyranoside treatment. The transcriptome data show that infection with influenza A virus prompted the activation of 368 genes involved in RIG-I signalling, the inflammatory response, interferon a/beta signalling and gene expression that was not affected by lariciresino1-4-beta-D-glucopyranoside treatment. Lariciresino1-4-beta-D-glucopyranoside exerted its pharmacological actions on the immune system, signal transduction, cell cycle and metabolism, which may be an underlying defense mechanism against influenza virus infection. In addition, 166 differentially expressed genes (DEGs) were uniquely expressed in lariciresino1-4-beta-D-glucopyranoside-treated cells, which were concentrated in the cell cycle, DNA repair, chromatin organization, gene expression and biosynthesis domains. Among them, six telomere-associated genes were up-regulated by lariciresino1-4-beta-D-glucopyranoside treatment, which have been implicated in telomere regulation and stability. Collectively, we employed RNAseq analysis to provide comprehensive insight into the mechanism of lariciresino1-4-beta-D-glucopyranoside against influenza virus infection.	[Zhou, Beixian; Yang, Zifeng; Jiang, Zhihong] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China; [Li, Jing; Liang, Xiaoli; Yang, Zifeng] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Ctr Resp Dis, State Key Lab Resp Dis,Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China	Macau University of Science & Technology; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Yang, ZF; Jiang, ZH (corresponding author), Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China.; Yang, ZF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Ctr Resp Dis, State Key Lab Resp Dis,Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China.	jeffyah@163.com; zhjiang@must.edu.mo		Jiang, Zhi-Hong/0000-0002-7956-2481	National Natural Science Foundation of China [U1201227, 81428024]; Science and Technology Development Fund in Macao Special Administrative Region [019/2013/A1]; Ministry of Science and Technology of China [2015DFM30010]; Guangzhou Postdoctoral Research Foundation, China [2015LJ]; Natural Science Foundation of Guangdong Province, China [2014A030310115]; Scientific Research Project of College Directly Under the Guangzhou Education Bureau [1201430183]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Fund in Macao Special Administrative Region; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Guangzhou Postdoctoral Research Foundation, China(China Postdoctoral Science Foundation); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Scientific Research Project of College Directly Under the Guangzhou Education Bureau	This study was supported by the National Natural Science Foundation of China (Grant no. U1201227) (http://www.nsfc.gov.cn/publish/portal1/); the Science and Technology Development Fund in Macao Special Administrative Region (Grant no. 019/2013/A1) (http://www.fdct.gov.mo/about); the National Natural Science Foundation of China (Grant no. 81428024) (http://www.nsfc.gov.cn/publish/portal1/); the Ministry of Science and Technology of China (Grant no. 2015DFM30010) (http://www.most.gov.cn/index.htm); the Guangzhou Postdoctoral Research Foundation, China (Grant no. 2015LJ) (http://www.hrssgz.gov.cn/gzbsh/); the Natural Science Foundation of Guangdong Province, China (Grant no. 2014A030310115) (http://www.gdstc.gov.cn/); and the Scientific Research Project of College Directly Under the Guangzhou Education Bureau (Grant no. 1201430183) (http://www.gzedu.gov.cn/).	Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; Billharz R, 2009, J VIROL, V83, P10557, DOI 10.1128/JVI.00330-09; Chakrabarti AK, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-219; Challacombe JF, 2004, PHYSIOL GENOMICS, V18, P51, DOI 10.1152/physiolgenomics.00155.2003; Chan RWY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051057; Chen JF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-857; Chen MH, 2012, J NAT PROD, V75, P1167, DOI 10.1021/np3002833; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Coulombe F, 2014, IMMUNITY, V40, P554, DOI 10.1016/j.immuni.2014.02.013; Davies C, 2015, J VIROL, V89, P6057, DOI 10.1128/JVI.03673-14; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Deng Z, 2014, CELL REP, V9, P2263, DOI 10.1016/j.celrep.2014.11.019; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Di Pietro A, 2013, J VIROL, V87, P4523, DOI 10.1128/JVI.02548-12; Dixit E, 2013, ADV IMMUNOL, V117, P99, DOI 10.1016/B978-0-12-410524-9.00004-9; Fernandes HS, 2016, EXPERT OPINION THERA, P1; Fox JM, 2013, J GEN VIROL, V94, P1451, DOI 10.1099/vir.0.053124-0; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hai R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3854; Hale BG, 2010, FUTURE MICROBIOL, V5, P23, DOI [10.2217/fmb.09.108, 10.2217/FMB.09.108]; Hayase Y, 2003, INTERVIROLOGY, V46, P319, DOI 10.1159/000073211; Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Huang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066546; Itsui Y, 2006, J VIRAL HEPATITIS, V13, P690, DOI 10.1111/j.1365-2893.2006.00732.x; Izumi Y, 2007, NEUROSCI LETT, V426, P54, DOI 10.1016/j.neulet.2007.08.054; Jiang W, 2013, J VIROL, V87, P3039, DOI 10.1128/JVI.03176-12; Kash JC, 2004, J VIROL, V78, P9499, DOI 10.1128/JVI.78.17.9499-9511.2004; KATZE MG, 1986, J VIROL, V60, P1027, DOI 10.1128/JVI.60.3.1027-1039.1986; Kaufer BB, 2011, J EXP MED, V208, P605, DOI 10.1084/jem.20101402; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Kumar V, 2010, ROBBINS COTRAN PATHO, P43; Lam WY, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-554; Lamontagne J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005438; Lee TKW, 2003, CARCINOGENESIS, V24, P1729, DOI 10.1093/carcin/bgg145; Li G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-59; Li J, 2015, J ETHNOPHARMACOL, V174, P379, DOI 10.1016/j.jep.2015.08.037; Li N, 2015, CELL MOL LIFE SCI, V72, P2973, DOI 10.1007/s00018-015-1879-1; Li YT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-398; Maines TR, 2012, J INFECT DIS, V205, P474, DOI 10.1093/infdis/jir768; Marjuki H, 2015, J VIROL, V89, P5419, DOI 10.1128/JVI.03513-14; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; O'Bryan JM, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-37; Oguin TH, 2014, J BIOL CHEM, V289, P25405, DOI 10.1074/jbc.M114.558817; Onomoto K, 2014, TRENDS IMMUNOL, V35, P420, DOI 10.1016/j.it.2014.07.006; Park SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16512; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Prakash A, 2005, J BIOL CHEM, V280, P18651, DOI 10.1074/jbc.M501289200; Quan R, 2016, SCI REP-UK, V6, DOI 10.1038/srep27917; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Sanda C, 2006, J INTERF CYTOK RES, V26, P462, DOI 10.1089/jir.2006.26.462; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Sprenger H, 1996, J EXP MED, V184, P1191, DOI 10.1084/jem.184.3.1191; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Tang J., 2010, KAOGU, V2010, P9, DOI DOI 10.1016/J.JP0WS0UR.2009.11.036; van der Sluijs KF, 2006, J INFECT DIS, V193, P214, DOI 10.1086/498911; Vijayakumar P, 2015, GENE, V559, P77, DOI 10.1016/j.gene.2015.01.016; Vijayan M, 2014, SCIENTIFICA CAIRO, V2014; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Wang XY, 2006, PHYTOTHER RES, V20, P335, DOI 10.1002/ptr.1892; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei-yang YE., 2011, AFRICAN J PHARM PHAR, V5; Yang Q, 2000, J BIOL CHEM, V275, P36892, DOI 10.1074/jbc.M005319200; Yang ZF, 2015, SCIENCE, V347, pS35; Zhu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep22243; Zou W, 2013, SCI REP-UK, V3, DOI 10.1038/srep01601	72	17	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173058	10.1371/journal.pone.0173058	http://dx.doi.org/10.1371/journal.pone.0173058			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273165	gold, Green Published, Green Submitted			2022-12-26	WOS:000396073700037
J	Santos, NW; Yoshimura, EH; Mareze-Costa, CE; Machado, E; Agustinho, BC; Pereira, LM; Brito, MN; Brito, NA; Zeoula, LM				Santos, Nadine W.; Yoshimura, Emerson H.; Mareze-Costa, Cecilia E.; Machado, Erica; Agustinho, Bruna C.; Pereira, Lucelia M.; Brito, Marcia N.; Brito, Nilton A.; Zeoula, Lucia M.			Supplementation of cow milk naturally enriched in polyunsaturated fatty acids and polyphenols to growing rats	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; DAIRY-COWS; ANTIOXIDANT CAPACITY; METABOLISM; EXPRESSION; EXTRACT; PLASMA	This study investigated whether intake of cow milk, naturally enriched with polyunsaturated fatty acids (PUFA, omega-3) and polyphenols (from propolis extract and vitamin E), from manipulation of cow's diet, would result in positive metabolic effects in rats from weaning until adulthood. Male Wistar rats were fed a standard chow diet or a hypercaloric diet (metabolically disturbed rats, obese) which was supplemented with either whole common milk, milk enriched with PUFA (PUFA-M) or milk enriched with PUFA and polyphenols (PUFA/P-M), at 5mL/kg body weight,having water as control. Whole milk supplementation increased initial weight gain and reduced gain in the adulthood of rats. Intake of common milk reduced cholesterol levels in non-obese rats and reduced insulin resistance in obese rats. PUFA-milk showed a decreasing effect on plasma triacylglycerol and VLDL concentrations, increasing plasma HDL concentration and reducing adipocyte size of non-obese rats, but no effect was observed in obese rats. PUFA/P-milk in obese rats resulted in greater deposition of muscle mass and mesenteric fat, with a tendency to lower LDL levels, and resulted a visceral fat accumulation in non-obese rats. Thus, whole common milk and PUFA-rich milk have shown to be beneficial in a normal metabolic condition, whereas common milk and milk enriched with PUFA and polyphenols improve metabolic effects of obesity.	[Santos, Nadine W.; Yoshimura, Emerson H.; Machado, Erica; Agustinho, Bruna C.; Pereira, Lucelia M.; Zeoula, Lucia M.] Univ Estadual Maringa, Dept Zootecnia, Maringa, Parana, Brazil; [Mareze-Costa, Cecilia E.; Brito, Marcia N.; Brito, Nilton A.] Univ Estadual Maringa, Dept Ciencias Fisiol, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	Santos, NW (corresponding author), Univ Estadual Maringa, Dept Zootecnia, Maringa, Parana, Brazil.	nadine@zootecnista.com.br		Woruby Santos, Nadine/0000-0003-0996-8213	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Brasilia, DF, Brazil) [482858/2011-7]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Brasilia, DF, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) is acknowledged for the financial support (482858/2011-7, Brasilia, DF, Brazil).	Aguiar SC, 2014, ANIM FEED SCI TECH, V193, P148, DOI 10.1016/j.anifeedsci.2014.04.006; [Anonymous], [No title captured]; AOAC, 2007, OFFICIAL METHODS ANA, V18th; Azain MJ, 2000, J NUTR, V130, P1548; Bauman DE, 2006, J DAIRY SCI, V89, P1235, DOI 10.3168/jds.S0022-0302(06)72192-0; BERNARDIS LL, 1968, J ENDOCRINOL, V40, P527, DOI 10.1677/joe.0.0400527; Bernstein AM, 2012, METAANALYSIS SHOWS D, P1; Brazilian Institute of Geography and Statistics, 2008, ANTHR NUTR STAT CHIL; Brazilian Ministry of Health, 2008, FEED GUID BRAZ POP P; Bu DP, 2007, J DAIRY SCI, V90, P998, DOI 10.3168/jds.S0022-0302(07)71585-0; Choi SS, 2011, BIOCHEM PHARMACOL, V81, P925, DOI 10.1016/j.bcp.2011.01.002; Connor WE, 2000, AM J CLIN NUTR, V71, p171S, DOI 10.1093/ajcn/71.1.171S; Crichton GE, 2011, OBES REV, V12, pe190, DOI 10.1111/j.1467-789X.2010.00837.x; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Faure P, 1995, ANAL FREE RADICALS B, P238; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foletto MD, 2015, ACTA SCI-HEALTH SCI, V37, P19, DOI 10.4025/actascihealthsci.v37i1.18614; Gagnon N, 2009, BRIT J NUTR, V102, P1015, DOI 10.1017/S0007114509344104; Harris S, 1997, FATTY ACIDS SERUMLIP, P65; Hartman L, 1973, Lab Pract, V22, P475; Hu FB, 2016, OPTIMAL DIETS PREVEN, V288, P2569; Ikeda R, 2011, BBA-GEN SUBJECTS, V1810, P695, DOI 10.1016/j.bbagen.2011.04.007; Kim TN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115407; Kiokias SN, 2006, FOOD BIOPHYS, V1, P115, DOI 10.1007/s11483-006-9015-2; Landi F, 2014, CURR OPIN CLIN NUTR, V17, P25, DOI 10.1097/MCO.0000000000000018; Lima DC, 2008, METAB BRAIN DIS, V23, P361, DOI [10.1007/s11011-008-9101-x, DOI 10.1007/S11011-008-9101-X]; Monika P, 2015, PHYTOMEDICINE, V22, P939, DOI 10.1016/j.phymed.2015.07.001; Noakes M, 1996, AM J CLIN NUTR, V63, P42, DOI 10.1093/ajcn/63.1.42; Rainer L, 2004, J AM DIET ASSOC, V104, P963, DOI 10.1016/j.jada.2004.03.016; RODBELL M, 1964, J BIOL CHEM, V239, P375; Roza NAV, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.28536; Santos NW, 2014, LIVEST SCI, V159, P37, DOI 10.1016/j.livsci.2013.11.015; Santos NW, 2016, LIVEST SCI, V191, P132, DOI 10.1016/j.livsci.2016.07.012; Simionato JI, 2010, J BRAZIL CHEM SOC, V21, P520, DOI 10.1590/S0103-50532010000300018; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Stancliffe RA, 2011, AM J CLIN NUTR AM SO; VYNCKE W, 1970, FETTE SEIFEN ANSTRICHM, V72, P1084, DOI 10.1002/lipi.19700721218; Zhao XW, 2013, ANIM FEED SCI TECH, V185, P35, DOI 10.1016/j.anifeedsci.2013.06.009; Zhu QY, 2002, J AGR FOOD CHEM, V50, P6929, DOI 10.1021/jf0206163; Zulueta A, 2009, INT DAIRY J, V19, P380, DOI 10.1016/j.idairyj.2009.02.003	40	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0172909	10.1371/journal.pone.0172909	http://dx.doi.org/10.1371/journal.pone.0172909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267800	Green Published, Green Submitted, gold			2022-12-26	WOS:000396060600005
J	Sun, YY; Zhang, JQ; Qin, L; Yan, C; Zhang, XJ; Liu, DD				Sun, Yuying; Zhang, Jiquan; Qin, Lei; Yan, Cui; Zhang, Xiaojun; Liu, Dandan			Identification and validation of sRNAs in Edwardsiella tarda S08	PLOS ONE			English	Article							SMALL NONCODING RNAS; VI SECRETION SYSTEM; ESCHERICHIA-COLI; BACTERIAL GENOMES; REGULATORY RNAS; VIBRIO-CHOLERAE; OUTER-MEMBRANE; HOST INFECTION; III SECRETION; VIRULENCE	Bacterial small non-coding RNAs (sRNAs) are known as novel regulators involved in virulence, stress responsibility, and so on. Recently, a lot of new researches have highlighted the critical roles of sRNAs in fine-tune gene regulation in both prokaryotes and eukaryotes. Edwardsiella tarda (E. tarda) is a gram-negative, intracellular pathogen that causes edward-siellosis in fish. Thus far, no sRNA has been reported in E. tarda. The present study represents the first attempt to identify sRNAs in E. tarda S08. Ten sRNAs were validated by RNA sequencing and quantitative PCR (qPCR). ET_sRNA_1 and ET_sRNA_2 were homolous to tmRNA and GcvB, respectively. However, the other candidate sRNAs have not been reported till now. The cellular abundance of 10 validated sRNA was detected by qPCR at different growth phases to monitor their biosynthesis. Nine candidate sRNAs were expressed in the late-stage of exponential growth and stationary stages of growth (36 similar to 60 h). And the expression of the nine sRNAs was growth phase-dependent. But ET_sRNA_10 was almost expressed all the time and reached the highest peak at 48 h. Their targets were predicted by TargetRNA2 and each sRNA target contains some genes that directly or indirectly relate to virulence. These results preliminary showed that sRNAs probably play a regulatory role of virulence in E. tarda.	[Sun, Yuying; Qin, Lei; Yan, Cui; Zhang, Xiaojun; Liu, Dandan] Huaihai Inst Technol, Coll Marine Life & Fisheries, Lianyungang, Peoples R China; [Sun, Yuying] Jiangsu Marine Resources Dev Res Inst, Lianyungang, Peoples R China; [Sun, Yuying] Huaihai Inst Technol, Coinnovat Ctr Jiangsu Marine Bioind Technol, Lianyungang, Peoples R China; [Zhang, Jiquan] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China	Jiangsu Ocean University; Jiangsu Ocean University; Chinese Academy of Sciences; Institute of Oceanology, CAS	Zhang, JQ (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	zhangjiquan@qdio.ac.cn	zhang, jin/GXV-9154-2022	zhang, Jiquan/0000-0001-5063-339X	National Natural Science Foundation of China [41306165]; Natural Science Foundation of Jiangsu Province [BK20140442]; Priority Academic Program Development of Jiangsu Higher Education Institutions, China Postdoctoral Foundation Fund [2011M501169]; 521 High-Level Talent Education Project of Lianyungang	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions, China Postdoctoral Foundation Fund; 521 High-Level Talent Education Project of Lianyungang	The project was supported by The National Natural Science Foundation of China (41306165), The Natural Science Foundation of Jiangsu Province (BK20140442), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, China Postdoctoral Foundation Funding (2011M501169) and the fifth-batch "521 High-Level Talent Education Project of Lianyungang".	Abu-Qatouseh LF, 2010, J MOL MED, V88, P565, DOI 10.1007/s00109-010-0597-2; Acebo P, 2012, RNA, V18, P530, DOI 10.1261/rna.027359.111; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altuvia S, 2007, CURR OPIN MICROBIOL, V10, P257, DOI 10.1016/j.mib.2007.05.003; Busi F, 2010, BIOCHIMIE, V92, P1458, DOI 10.1016/j.biochi.2010.06.020; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Gao DQ, 2014, FEMS MICROBIOL LETT, V353, P132, DOI 10.1111/1574-6968.12420; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; Guillier M, 2006, MOL MICROBIOL, V59, P231, DOI 10.1111/j.1365-2958.2005.04929.x; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Lenz DH, 2005, MOL MICROBIOL, V58, P1186, DOI 10.1111/j.1365-2958.2005.04902.x; Li Wuju, 2012, Genomics Proteomics & Bioinformatics, V10, P276, DOI 10.1016/j.gpb.2012.09.004; Liu EF, 2014, J BASIC MICROB, V54, P678, DOI 10.1002/jobm.201300622; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livny J, 2005, NUCLEIC ACIDS RES, V33, P4096, DOI 10.1093/nar/gki715; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Morohoshi T, 2004, J BIOSCI BIOENG, V98, P274, DOI 10.1016/S1389-1723(04)00281-6; Mraheil MA, 2010, MICROB BIOTECHNOL, V3, P658, DOI 10.1111/j.1751-7915.2010.00171.x; Papenfort K, 2015, FEMS MICROBIOL REV, V39, P362, DOI 10.1093/femsre/fuv016; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Papenfort K, 2009, RES MICROBIOL, V160, P278, DOI 10.1016/j.resmic.2009.03.004; Patenge N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-550; Pichon C, 2012, NUCLEIC ACIDS RES, V40, P2846, DOI 10.1093/nar/gkr1141; Pichon C, 2008, BIOINFORMATICS, V24, P2807, DOI 10.1093/bioinformatics/btn560; Pulvermacher SC, 2009, MICROBIOL-SGM, V155, P106, DOI 10.1099/mic.0.023598-0; Raabe CA, 2011, RNA, V17, P1357, DOI 10.1261/rna.2682311; Rao PSS, 2003, MICROBIOL-SGM, V149, P2635, DOI 10.1099/mic.0.26478-0; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Romby P, 2010, CELL MOL LIFE SCI, V67, P217, DOI 10.1007/s00018-009-0162-8; Sahr T, 2012, RNA BIOL, V9, P503, DOI 10.4161/rna.20270; Sakai T, 2009, MICROBIOL IMMUNOL, V53, P131, DOI 10.1111/j.1348-0421.2009.00108.x; Schroeder CLC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2293-7; Shioya K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023948; Soutourina OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003493; Sridhar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011970; Stauffer Lorraine T, 2012, ISRN Microbiol, V2012, P697308, DOI 10.5402/2012/697308; Sun Y, 2012, INFECT IMMUN, V80, P2948, DOI 10.1128/IAI.00063-12; Tan YP, 2005, MICROBIOL-SGM, V151, P2301, DOI 10.1099/mic.0.28005-0; Tjaden B, 2008, J MATH BIOL, V56, P183, DOI 10.1007/s00285-007-0079-5; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Tu KC, 2007, GENE DEV, V21, P221, DOI 10.1101/gad.1502407; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; Vecerek B, 2007, EMBO J, V26, P965, DOI 10.1038/sj.emboj.7601553; Wang LM, 2014, VET MICROBIOL, V171, P165, DOI 10.1016/j.vetmic.2014.03.030; Wang X, 2010, FISH SHELLFISH IMMUN, V29, P1082, DOI 10.1016/j.fsi.2010.08.025; Wang YF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00164; Warrier I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100147; Williams KP, 2000, NUCLEIC ACIDS RES, V28, P168, DOI 10.1093/nar/28.1.168; Xiao JF, 2009, APPL MICROBIOL BIOT, V83, P151, DOI 10.1007/s00253-009-1924-9; Xie HX, 2014, INFECT IMMUN, V82, P3436, DOI 10.1128/IAI.01065-13; Xu T, 2014, J APPL MICROBIOL, V116, P236, DOI 10.1111/jam.12357; Zhang M, 2008, MICROBIOL-SGM, V154, P2060, DOI 10.1099/mic.0.2008/017343-0; Zhang M, 2009, APPL ENVIRON MICROB, V75, P3882, DOI 10.1128/AEM.02690-08; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zheng WJ, 2011, FISH SHELLFISH IMMUN, V31, P985, DOI 10.1016/j.fsi.2011.08.018	57	3	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0172783	10.1371/journal.pone.0172783	http://dx.doi.org/10.1371/journal.pone.0172783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267754	Green Submitted, Green Published, gold			2022-12-26	WOS:000396060600003
J	Chen, A; Leith, M; Tu, R; Tahim, G; Sudra, A; Bhargava, S				Chen, Aaron; Leith, Matthew; Tu, Roger; Tahim, Gurpreet; Sudra, Anish; Bhargava, Swapnil			Effects of diluents on cell culture viability measured by automated cell counter	PLOS ONE			English	Article							ANIMAL-CELLS; SHEAR SENSITIVITY; PLURONIC F68; BIOREACTOR; MECHANISMS; REDUCTION; SERUM	Commercially available automated cell counters based on trypan blue dye-exclusion are widely used in industrial cell culture process development and manufacturing to increase throughput and eliminate inherent variability in subjective interpretation associated with manual hemocytometers. When using these cell counters, sample dilution is often necessary to stay within the assay measurement range; however, the effect of time and diluents on cell culture is not well understood. This report presents the adverse effect of phosphate buffered saline as a diluent on cell viability when used in combination with an automated cell counter. The reduced cell viability was attributed to shear stress introduced by the automated cell counter. Furthermore, length of time samples were incubated in phosphate buffered saline also contributed to the observed drop in cell viability. Finally, as erroneous viability measurements can severely impact process decisions and product quality, this report identifies several alternative diluents that can maintain cell culture viability over time in order to ensure accurate representation of cell culture conditions.	[Chen, Aaron; Leith, Matthew; Tu, Roger; Tahim, Gurpreet; Bhargava, Swapnil] Seattle Genet Inc, BioProc Dev, Bothell, WA 98021 USA; [Sudra, Anish] Seattle Genet Inc, Clin Mfg, Bothell, WA USA	Seattle Genetics; Seattle Genetics	Chen, A (corresponding author), Seattle Genet Inc, BioProc Dev, Bothell, WA 98021 USA.	cwchen@seagen.com		Tu, Roger/0000-0002-7899-1604	Seattle Genetics, Inc.	Seattle Genetics, Inc.	The funder, Seattle Genetics, Inc., provided support in the form of salaries for authors AC, ML, RT, GT, AS and SB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALRUBEAI M, 1995, BIOTECHNOL BIOENG, V45, P463, DOI 10.1002/bit.260450602; Amanullah A, 2010, BIOTECHNOL BIOENG, V106, P57, DOI 10.1002/bit.22664; Chen A, 2009, BIOTECHNOL BIOENG, V102, P148, DOI 10.1002/bit.22031; Evans HM, 1914, SCIENCE, V39, P443, DOI 10.1126/science.39.1004.443; GARCIABRIONES M, 1992, ANN NY ACAD SCI, V665, P219, DOI 10.1111/j.1749-6632.1992.tb42586.x; GRAMER MJ, 1993, BIOTECHNOL PROGR, V9, P366, DOI 10.1021/bp00022a003; Hsu WT, 2012, CYTOTECHNOLOGY, V64, P667, DOI 10.1007/s10616-012-9446-1; Huang YM, 2010, BIOTECHNOL PROGR, V26, P1400, DOI 10.1002/btpr.436; JORDAN M, 1994, BIOTECHNOL BIOENG, V43, P446, DOI 10.1002/bit.260430603; Keane JT, 2003, BIOTECHNOL BIOENG, V81, P211, DOI 10.1002/bit.10472; Kostov Y, 2001, BIOTECHNOL BIOENG, V72, P346, DOI 10.1002/1097-0290(20010205)72:3<346::AID-BIT12>3.0.CO;2-X; Koterba KL, 2012, J BIOTECHNOL, V157, P261, DOI 10.1016/j.jbiotec.2011.11.009; KRETZMER G, 1991, APPL MICROBIOL BIOT, V34, P613, DOI 10.1007/BF00167909; Legmann R, 2009, BIOTECHNOL BIOENG, V104, P1107, DOI 10.1002/bit.22474; Lew C, INSTRUMENT TO INSTRU; MICHAELS JD, 1991, BIOTECHNOL BIOENG, V38, P169, DOI 10.1002/bit.260380209; Pappenheimer AM, 1917, J EXP MED, V25, P633, DOI 10.1084/jem.25.5.633; RAMIREZ OT, 1990, BIOTECHNOL BIOENG, V36, P911, DOI 10.1002/bit.260360906; Shukla AA, 2010, TRENDS BIOTECHNOL, V28, P253, DOI 10.1016/j.tibtech.2010.02.001; Szabo S E, 2004, Lab Hematol, V10, P109, DOI 10.1532/LH96.04020; Trexler-Schmidt M, 2010, BIOTECHNOL BIOENG, V106, P452, DOI 10.1002/bit.22699; VANDERPOL LA, 1993, BIOTECHNOL PROGR, V9, P504, DOI 10.1021/bp00023a009	22	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173375	10.1371/journal.pone.0173375	http://dx.doi.org/10.1371/journal.pone.0173375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264018	gold, Green Published			2022-12-26	WOS:000396054300058
J	Verhage, L; Severing, EI; Bucher, J; Lammers, M; Busscher-Lange, J; Bonnema, G; Rodenburg, N; Proveniers, MCG; Angenent, GC; Immink, RGH				Verhage, Leonie; Severing, Edouard I.; Bucher, Johan; Lammers, Michiel; Busscher-Lange, Jacqueline; Bonnema, Guusje; Rodenburg, Nicole; Proveniers, Marcel C. G.; Angenent, Gerco C.; Immink, Richard G. H.			Splicing-related genes are alternatively spliced upon changes in ambient temperatures in plants	PLOS ONE			English	Article							PRE-MESSENGER-RNA; CIRCADIAN CLOCK; SR45 PROTEIN; ARABIDOPSIS; EXPRESSION; RESPONSES; GROWTH; QUANTIFICATION; IDENTIFICATION; TRANSCRIPTS	Plants adjust their development and architecture to small variations in ambient temperature. In a time in which temperatures are rising world-wide, the mechanism by which plants are able to sense temperature fluctuations and adapt to it, is becoming of special interest. By performing RNA-sequencing on two Arabidopsis accession and one Brassica species exposed to temperature alterations, we showed that alternative splicing is an important mechanism in ambient temperature sensing and adaptation. We found that amongst the differentially alternatively spliced genes, splicing related genes are enriched, suggesting that the splicing machinery itself is targeted for alternative splicing when temperature changes. Moreover, we showed that many different components of the splicing machinery are targeted for ambient temperature regulated alternative splicing. Mutant analysis of a splicing related gene that was differentially spliced in two of the genotypes showed an altered flowering time response to different temperatures. We propose a two-step mechanism where temperature directly influences alternative splicing of the splicing machinery genes, followed by a second step where the altered splicing machinery affects splicing of downstream genes involved in the adaptation to altered temperatures.	[Verhage, Leonie; Angenent, Gerco C.; Immink, Richard G. H.] Wageningen Univ & Res, Mol Biol Lab, Pb Wageningen, Netherlands; [Verhage, Leonie; Severing, Edouard I.; Lammers, Michiel; Busscher-Lange, Jacqueline; Angenent, Gerco C.; Immink, Richard G. H.] Wageningen Univ & Res, Wageningen Plant Res, Biosci, Pb Wageningen, Netherlands; [Severing, Edouard I.] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Bucher, Johan; Bonnema, Guusje] Wageningen Univ & Res, Wageningen UR Plant Breeding, Pb Wageningen, Netherlands; [Rodenburg, Nicole; Proveniers, Marcel C. G.] Univ Utrecht, Inst Environm Biol, Mol Plant Physiol, Utrecht, Netherlands	Wageningen University & Research; Wageningen University & Research; Max Planck Society; Wageningen University & Research; Utrecht University	Immink, RGH (corresponding author), Wageningen Univ & Res, Mol Biol Lab, Pb Wageningen, Netherlands.; Immink, RGH (corresponding author), Wageningen Univ & Res, Wageningen Plant Res, Biosci, Pb Wageningen, Netherlands.	richard.immink@wur.nl	Immink, Richard G.H./A-9825-2011; Proveniers, Marcel C. G./B-7919-2011	Immink, Richard/0000-0002-0182-4138; Proveniers, Marcel/0000-0001-7896-6049; Verhage, Leonie/0000-0001-6402-3605	NWO-ALW/TTI-GG project (Dutch Scientific Organisation/Technological Top Institute Green Genetics, the Netherlands) [828.11.005]; Syngenta; Bejo Seeds B.V.; Rijk Zwaan Breeding B.V.; Netherlands Genomics Initiative (NGI) [40-41009-98-8003]	NWO-ALW/TTI-GG project (Dutch Scientific Organisation/Technological Top Institute Green Genetics, the Netherlands); Syngenta(Syngenta); Bejo Seeds B.V.; Rijk Zwaan Breeding B.V.; Netherlands Genomics Initiative (NGI)	This work was funded by a NWO-ALW/TTI-GG project (Dutch Scientific Organisation/Technological Top Institute Green Genetics, the Netherlands) entitled Thermoflow: Flowering time regulation in Brassica species by ambient temperatures (828.11.005), together with Syngenta, Bejo Seeds B.V. and Rijk Zwaan Breeding B.V. Part of the RNAseq analyses have been performed in the framework of a Horizon Breakthrough project of the Netherlands Genomics Initiative (NGI), entitled Role of alternative splicing in plants adaptation to a changing environment (40-41009-98-8003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126516; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Barta A, 2008, CURR TOP MICROBIOL, V326, P83; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; BOOIJ R, 1987, NETH J AGR SCI, V35, P435; Carvalho RF, 2010, PLANT PHYSIOL, V154, P772, DOI 10.1104/pp.110.155523; Cho S, 2015, P NATL ACAD SCI USA, V112, P9926, DOI 10.1073/pnas.1500639112; David CJ, 2011, GENE DEV, V25, P972, DOI 10.1101/gad.2038011; Ding F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-431; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Forment J, 2002, PLANT J, V30, P511, DOI 10.1046/j.1365-313X.2002.01311.x; Gu L, 2014, PLANT PHYSIOL BIOCH, V82, P309, DOI 10.1016/j.plaphy.2014.07.006; Gu XF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2947; HOFFMAN BE, 1992, GENE DEV, V6, P2554, DOI 10.1101/gad.6.12b.2554; Huang XY, 2013, PLANT CELL, V25, P637, DOI 10.1105/tpc.112.107896; James AB, 2012, PLANT CELL, V24, P961, DOI 10.1105/tpc.111.093948; Kalyna M, 2003, MOL BIOL CELL, V14, P3565, DOI 10.1091/mbc.E03-02-0109; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Koini MA, 2009, CURR BIOL, V19, P408, DOI 10.1016/j.cub.2009.01.046; Leviatan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066511; Ling ZH, 2015, PLANT J, V84, P228, DOI 10.1111/tpj.12997; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pose D, 2013, NATURE, V503, P414, DOI 10.1038/nature12633; Reddy ASN, 2013, PLANT CELL, V25, P3657, DOI 10.1105/tpc.113.117523; Rosloski SM, 2013, PLANT MOL BIOL, V81, P57, DOI 10.1007/s11103-012-9982-2; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Seo PJ, 2012, PLANT CELL, V24, P2427, DOI 10.1105/tpc.112.098723; Streitner C, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24638; Streitner C, 2012, NUCLEIC ACIDS RES, V40, P11240, DOI 10.1093/nar/gks873; Sureshkumar S, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.55, 10.1038/nplants.2016.55]; Syed NH, 2012, TRENDS PLANT SCI, V17, P616, DOI 10.1016/j.tplants.2012.06.001; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vitulo N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-99; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang BB, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r102; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243; Zhang XN, 2009, PLANT PHYSIOL, V150, P1450, DOI 10.1104/pp.109.138180	42	36	38	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172950	10.1371/journal.pone.0172950	http://dx.doi.org/10.1371/journal.pone.0172950			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257507	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100044
J	Friedman, D; Fryzek, J; Jiang, XH; Bloomfield, A; Ambrose, CS; Wong, PC				Friedman, Deborah; Fryzek, Jon; Jiang, Xiaohui; Bloomfield, Adam; Ambrose, Christopher S.; Wong, Pierre C.			Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses	PLOS ONE			English	Article							YOUNG-CHILDREN; PALIVIZUMAB PROPHYLAXIS; INFANTS; EPIDEMIOLOGY; CONTEMPORARY; GUIDELINES; INFECTION; MORBIDITY; RATES	Children with hemodynamically significant congenital heart disease (CHD) are at elevated risk of morbidity and mortality due to respiratory syncytial virus (RSV) disease compared to their healthy peers. Previous studies have demonstrated lower RSV hospitalization risk among all children with CHD at 12-23 months of age versus 0-11 months of age. However, RSV hospitalization risk at 12-23 months of age by specific CHD diagnosis has not been characterized. Both case-control and cohort studies were conducted using data from the US National Inpatient Sample from 1997 to 2013 to characterize relative risk of RSV hospitalization among children 12-23 months of age with CHD. Related CHD diagnoses were combined for analysis. Hospitalizations for RSV and unspecified bronchiolitis were described by length of stay, mechanical ventilation use, mortality, and total charges. Over the 17-year period, 1,168,886 live birth hospitalizations with CHD were identified. Multiple specific CHD conditions had an elevated odds ratio or relative risk of RSV hospitalization. Mean total RSV hospitalization charges were significantly higher among children with CHD relative to those without CHD ($19,650 vs $7,939 in 2015 dollars) for this period. Compared to children without CHD, children with Ebstein's anomaly, transposition of the great arteries, aortic stenosis, heterotaxia, and aortic arch anomalies had 367-, 344-, 203-, 117- and 47-fold increased risk of inpatient RSV mortality, respectively. Unspecified bronchiolitis hospitalization odds and relative risk across CHD diagnoses were similar to those observed with RSV hospitalization; however, unspecified bronchiolitis hospitalizations were associated with shorter mean days of stay and less frequently associated with mechanical ventilation or mortality. Among children with more severe CHD diagnoses, RSV disease remains an important health risk through the second year of life. These data can help inform decisions regarding interventions to protect children with CHD from severe RSV disease during their second year of life.	[Friedman, Deborah] New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA; [Fryzek, Jon; Jiang, Xiaohui] EpidStat Inst, Rockville, MD USA; [Bloomfield, Adam; Ambrose, Christopher S.] AstraZeneca, Gaithersburg, MD 20878 USA; [Wong, Pierre C.] Childrens Hosp, Div Cardiol, Los Angeles, CA USA	New York Medical College; AstraZeneca; Children's Hospital Los Angeles	Friedman, D (corresponding author), New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA.; Bloomfield, A (corresponding author), AstraZeneca, Gaithersburg, MD 20878 USA.	Deborah_Friedman@NYMC.edu; Adam.Bloomfield@astrazeneca.com		Bloomfield, Adam/0000-0002-5429-7378; Ambrose, Christopher/0000-0003-4175-7336	AstraZeneca	AstraZeneca(AstraZeneca)	This research was funded by AstraZeneca. DF is a consultant to AstraZeneca and a member of the Speakers Bureau. JF and XJ provided consultant/research support for AstraZeneca, as employees of EpidStat. AstraZeneca provided Epidstat with research support for this study. AB and CSA are employees of AstraZeneca and hold stock or stock options. PCW has received grant/research support through his institution from AstraZeneca. The specific roles of these authors are articulated in the 'author contributions' section. Editorial assistance was provided by The Lockwood Group (Stamford, CT, USA) and funded by AstraZeneca. Palivizumab is marketed by MedImmune, a specialty care division of AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JS, 2003, PEDIATRICS, V112, P1442; Agency for Healthcare Research and Quality, 2012, PED QUAL IND 7 TECHN; Agency for Healthcare Research and Quality, 2006, MEAS PED HLTH CAR QU; Altman CA, 2000, PEDIATR CARDIOL, V21, P433, DOI 10.1007/s002460010103; American Academy of Pediatrics, 2012, RED BOOK REP COMM IN; Bollani L, 2015, RECOMMENDATIONS PROP; Boyce TG, 2000, J PEDIATR-US, V137, P865, DOI 10.1067/mpd.2000.110531; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Breese C, 2013, PEDIATRICS, V132, pE341, DOI 10.1542/peds.2013-0303; Cheng HH, 2016, CONGENIT HEART DIS, V11, P80, DOI 10.1111/chd.12293; Chu PY, 2016, CARDIOL YOUNG, V10, P1; Doucette A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152208; Feinstein JA, 2014, PEDIATRICS, V133, pE1575, DOI 10.1542/peds.2013-3060; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Figueras Aloy J, 2015, AN PEDIAT BARC, V82; Forster J, 2012, GUIDELINE PREVENTION; Friedman DM, 2016, CLIN PEDIATR, V55, P724, DOI 10.1177/0009922815604598; Frohnert Barbara Kathleen, 2005, J Perinatol, V25, P737, DOI 10.1038/sj.jp.7211382; Granbom E, 2016, PEDIAT CARDIOL; Granbom E, 2014, ACTA PAEDIATR, V103, P840, DOI 10.1111/apa.12658; Hon KL, 2012, J CRIT CARE, V27, P464, DOI 10.1016/j.jcrc.2011.12.001; Jung Jo Won, 2011, Korean J Pediatr, V54, P192, DOI 10.3345/kjp.2011.54.5.192; Langley GF, 2011, PEDIATR INFECT DIS J, V30, P510, DOI 10.1097/INF.0b013e3182184ae7; Li A, 2016, PEDIAT INFECT DIS J; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Makari D, 2015, CLIN PEDIATR, V54, P594, DOI 10.1177/0009922814546040; MOLER FW, 1992, CRIT CARE MED, V20, P1406, DOI 10.1097/00003246-199210000-00008; Nakazawa M, 2006, PEDIATR INT, V48, P190, DOI 10.1111/j.1442-200X.2006.02179.x; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Ozyurt A, 2015, PEDIATR PULM, V50, P1025, DOI 10.1002/ppul.23102; Paes BA, 2011, CAN RESPIR J, V18, pE10, DOI 10.1155/2011/493056; Panozzo CA, 2010, PEDIATRICS, V126, pE116, DOI 10.1542/peds.2009-3221; Peter G, 1997, RED BOOK REP COMM IF; Public Health England, 2013, IMM INF DIS RESP SYN; Robinson Joan L, 2015, Paediatr Child Health, V20, P321; Simon A, 2007, EUR J PEDIATR, V166, P1273, DOI 10.1007/s00431-007-0426-y; Stockman LJ, 2012, PEDIATR INFECT DIS J, V31, P5, DOI 10.1097/INF.0b013e31822e68e6; Strickland MJ, 2008, CARDIOL YOUNG, V18, P92, DOI 10.1017/S1047951108002515; Svensson B, 2011, ACTA PAEDIATR, V100, P407, DOI 10.1111/j.1651-2227.2010.02029.x; Welke KF, 2009, ANN THORAC SURG, V87, P216, DOI 10.1016/j.athoracsur.2008.10.032; Whelan Barbara, 2016, Drugs Ther Perspect, V32, P119	41	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172512	10.1371/journal.pone.0172512	http://dx.doi.org/10.1371/journal.pone.0172512			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253361	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300023
J	Markovic, R; Peltan, J; Gosak, M; Horvat, D; Zalik, B; Seguy, B; Chauvel, R; Malandain, G; Couffinhal, T; Duplaa, C; Marhl, M; Roux, E				Markovic, Rene; Peltan, Julien; Gosak, Marko; Horvat, Denis; Zalik, Borut; Seguy, Benjamin; Chauvel, Remi; Malandain, Gregoire; Couffinhal, Thierry; Duplaa, Cecile; Marhl, Marko; Roux, Etienne			Planar cell polarity genes frizzled4 and frizzled6 exert patterning influence on arterial vessel morphogenesis	PLOS ONE			English	Article							RETINAL VASCULAR DEVELOPMENT; HUMAN CEREBRAL-CORTEX; BLOOD-BRAIN-BARRIER; WNT/BETA-CATENIN; TISSUE POLARITY; PATHWAY; ANGIOGENESIS; NORRIN; KIDNEY; TREE	Quantitative analysis of the vascular network anatomy is critical for the understanding of the vasculature structure and function. In this study, we have combined microcomputed tomography (microCT) and computational analysis to provide quantitative three-dimensional geometrical and topological characterization of the normal kidney vasculature, and to investigate how 2 core genes of the Wnt/planar cell polarity, Frizzled4 and Frizzled6, affect vascular network morphogenesis. Experiments were performed on frizzled4 (Fzd4(-/-)) and frizzled6 (Fzd6(-/-)) deleted mice and littermate controls (WT) perfused with a contrast medium after euthanasia and exsanguination. The kidneys were scanned with a high-resolution (16 mu m) microCT imaging system, followed by 3D reconstruction of the arterial vasculature. Computational treatment includes decomposition of 3D networks based on Diameter-Defined Strahler Order (DDSO). We have calculated quantitative (i) Global scale parameters, such as the volume of the vasculature and its fractal dimension (ii) Structural parameters depending on the DDSO hierarchical levels such as hierarchical ordering, diameter, length and branching angles of the vessel segments, and (iii) Functional parameters such as estimated resistance to blood flow alongside the vascular tree and average density of terminal arterioles. In normal kidneys, fractal dimension was 2.07 +/- 0.11 (n = 7), and was significantly lower in Fzd4(-/-)(1.71 +/- 0.04; n = 4), and Fzd6(-/-)(1.54 +/- 0.09; n = 3) kidneys. The DDSO number was 5 in WT and Fzd4(-/-), and only 4 in Fzd6(-/-). Scaling characteristics such as diameter and length of vessel segments were altered in mutants, whereas bifurcation angles were not different from WT. Fzd4 and Fzd6 deletion increased vessel resistance, calculated using the Hagen-Poiseuille equation, for each DDSO, and decreased the density and the homogeneity of the distal vessel segments. Our results show that our methodology is suitable for 3D quantitative characterization of vascular networks, and that Fzd4 and Fzd6 genes have a deep patterning effect on arterial vessel morphogenesis that may determine its functional efficiency.	[Markovic, Rene; Gosak, Marko; Marhl, Marko] Univ Maribor, Fac Nat Sci & Math, Dept Phys, Maribor, Slovenia; [Markovic, Rene; Marhl, Marko] Univ Maribor, Fac Educ, Maribor, Slovenia; [Peltan, Julien; Seguy, Benjamin; Chauvel, Remi; Couffinhal, Thierry; Duplaa, Cecile; Roux, Etienne] INSERM, Biol Cardiovasc Dis U1034, Pessac, France; [Peltan, Julien; Chauvel, Remi; Couffinhal, Thierry; Roux, Etienne] Univ Bordeaux, Biol Cardiovasc Dis U1034, Pessac, France; [Peltan, Julien; Seguy, Benjamin; Chauvel, Remi; Couffinhal, Thierry] Ctr Hosp Univ Bordeaux, Serv Malad Cardiaques & Vasc, Bordeaux, France; [Gosak, Marko; Marhl, Marko] Univ Maribor, Inst Physiol, Fac Med, Maribor, Slovenia; [Horvat, Denis; Zalik, Borut] Univ Maribor, Fac Elect Engn & Comp Sci, Maribor, Slovenia; [Malandain, Gregoire] INRIA, Morpheme Team, Sophia Antipolis, France	University of Maribor; University of Maribor; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; University of Maribor; University of Maribor; Inria	Roux, E (corresponding author), INSERM, Biol Cardiovasc Dis U1034, Pessac, France.	etienne.roux@u-bordeaux.fr	Žalik, Borut/X-1320-2019; Duplàa, cecile/GLU-6264-2022; Couffinhal, Thierry/M-6857-2014; Markovič, Rene/M-3148-2019	Duplàa, cecile/0000-0001-8003-3969; Couffinhal, Thierry/0000-0002-9217-2533; Markovič, Rene/0000-0001-9068-6373; Gosak, Marko/0000-0001-9735-0485	French-Slovenian Hubert-Curien partnership Proteus [33325NL]	French-Slovenian Hubert-Curien partnership Proteus	Financial support for researchers' mobility: French-Slovenian Hubert-Curien partnership Proteus no 33325NL Endothelial planar cell polarity and vascular network structure and functionality http://www.campusfrance.org/fr/PHC.	Cassot F, 2006, MICROCIRCULATION, V13, P1, DOI 10.1080/10739680500383407; Cassot F, 2009, MICROCIRCULATION, V16, P331, DOI 10.1080/10739680802662607; Cassot F, 2010, BRAIN RES, V1313, P62, DOI 10.1016/j.brainres.2009.12.007; Chen YJ, 2015, STROKE, V46, P529, DOI 10.1161/STROKEAHA.114.007265; CROSS SS, 1993, J PATHOL, V170, P479, DOI 10.1002/path.1711700412; Cvjetkovic N, 2015, MOL GENET GENOM MED, V3, P440, DOI 10.1002/mgg3.155; Denton KM, 2000, AM J PHYSIOL-REG I, V279, pR629, DOI 10.1152/ajpregu.2000.279.2.R629; Descamps B, 2012, CIRC RES, V110, P47, DOI 10.1161/CIRCRESAHA.111.250936; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Dufourcq P, 2008, AM J PATHOL, V172, P37, DOI 10.2353/ajpath.2008.070130; El Abbadi NK, 2013, J COMPUT SCI, V9, P1389; Franco CA, 2016, ELIFE, V5, DOI 10.7554/eLife.07727; GILGARCIA J, 1992, HISTOL HISTOPATHOL, V7, P563; Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Hua ZL, 2014, DEVELOPMENT, V141, P3944, DOI 10.1242/dev.110189; Huo YL, 2016, J BIOMECH, V49, P2531, DOI 10.1016/j.jbiomech.2016.01.044; Huo YL, 2009, BIOPHYS J, V96, P339, DOI 10.1016/j.bpj.2008.09.038; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Kaimovitz B, 2005, ANN BIOMED ENG, V33, P1517, DOI 10.1007/s10439-005-7544-3; KASSAB GS, 1993, AM J PHYSIOL, V265, pH366, DOI 10.1152/ajpheart.1993.265.1.H366; KASSAB GS, 1993, AM J PHYSIOL, V265, pH350, DOI 10.1152/ajpheart.1993.265.1.H350; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; Kilander MBC, 2014, CELL SIGNAL, V26, P1943, DOI 10.1016/j.cellsig.2014.05.012; Kilander MBC, 2014, FASEB J, V28, P2293, DOI 10.1096/fj.13-246363; Korn C, 2014, DEVELOPMENT, V141, P1757, DOI 10.1242/dev.104422; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Leandro JJG, 2001, P 14 BRAZ S COMP GRA; Leroux L, 2010, MOL THER, V18, P1545, DOI 10.1038/mt.2010.108; Lopes R, 2009, MED IMAGE ANAL, V13, P634, DOI 10.1016/j.media.2009.05.003; Lorthois S, 2010, J THEOR BIOL, V262, P614, DOI 10.1016/j.jtbi.2009.10.037; Losa GA, 2009, RIV BIOL-BIOL FORUM, V102, P29; Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036; Manniesing R, 2006, MED IMAGE ANAL, V10, P200, DOI 10.1016/j.media.2005.09.001; Masckauchan THN, 2006, PHYSIOLOGY, V21, P181, DOI 10.1152/physiol.00058.2005; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Paes KT, 2011, INVEST OPHTH VIS SCI, V52, P6452, DOI 10.1167/iovs.10-7146; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Ren Y, 2008, AM J PHYSIOL-HEART C, V298, pH1769; Rodriguez-Gomez I, 2013, J ENDOCRINOL, V216, P43, DOI 10.1530/JOE-12-0208; Serra J, 1983, IMAGE ANAL MATH MORP; Sewduth RN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5832; Shi OY, 2014, NEUROL SCI, V35, P1701, DOI 10.1007/s10072-014-1815-4; Stark MR, 2000, MECH DEVELOP, V98, P121, DOI 10.1016/S0925-4773(00)00440-8; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; STRAHLER AN, 1957, EOS T AM GEOPHYS UNI, V38, P913, DOI DOI 10.1029/TR038I006P00913; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Wilson NJ, 2013, J DERMATOL SCI, V70, P58, DOI 10.1016/j.jdermsci.2012.12.005; Xie WJ, 2003, PATTERN RECOGN, V36, P1529, DOI 10.1016/S0031-3203(02)00348-5; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Zagorchev Lyubomir, 2010, J Angiogenes Res, V2, P7, DOI 10.1186/2040-2384-2-7; Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3	54	7	7	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0171033	10.1371/journal.pone.0171033	http://dx.doi.org/10.1371/journal.pone.0171033			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253274	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300003
J	Miyaki, E; Hiraga, N; Imamura, M; Uchida, T; Kan, H; Tsuge, M; Abe-Chayama, H; Hayes, CN; Makokha, GN; Serikawa, M; Aikata, H; Ochi, H; Ishida, Y; Tateno, C; Ohdan, H; Chayama, K				Miyaki, Eisuke; Hiraga, Nobuhiko; Imamura, Michio; Uchida, Takuro; Kan, Hiromi; Tsuge, Masataka; Abe-Chayama, Hiromi; Hayes, C. Nelson; Makokha, Grace Naswa; Serikawa, Masahiro; Aikata, Hiroshi; Ochi, Hidenori; Ishida, Yuji; Tateno, Chise; Ohdan, Hideki; Chayama, Kazuaki			Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus	PLOS ONE			English	Article							HEPATOCYTE CHIMERIC MOUSE; DENDRITIC CELLS; T-CELLS; VIROLOGICAL RESPONSE; IMMUNE-RESPONSES; THERAPY; LIVER; HCV; EPIDEMIOLOGY; INFECTIONS	Interferon (IFN) inhibits hepatitis C virus (HCV) replication through up-regulation of intrahepatic IFN-stimulated gene expression but also through activation of host immune cells. In the present study, we analyzed the immune cell-mediated antiviral effects of IFN-alpha using HCV-infected mice. Urokinase-type plasminogen activator (uPA)-severe combined immunodeficiency (SCID) mice with transplanted human hepatocytes were infected with genotype 1b HCV and injected with human peripheral blood mononuclear cells (PBMCs). IFN-alpha treatment following human PBMC transplantation resulted in a significant reduction in serum HCV RNA titers and a higher human CD45-positive mononuclear cell chimerism compared to mice without human PBMC transplantation. In mice with human PBMCs treated with IFN-alpha, serum concentrations of IFN-gamma increased, and natural killer T (NKT) cells, especially type I NKT cells, produced IFN-gamma. Mice in which IFN-gamma signaling was blocked using antibody or in which transplanted PBMCs were depleted for type I NKT cells showed similar levels of anti-HCV effect compared with mice treated only with IFN-alpha. These results show that IFN-alpha stimulates IFN-gamma expression in type 1 NKT cells and enhances the inhibition of HCV replication. We propose that type 1 NKT cells might represent a new therapeutic target for chronic hepatitis C patients.	[Miyaki, Eisuke; Hiraga, Nobuhiko; Imamura, Michio; Uchida, Takuro; Kan, Hiromi; Tsuge, Masataka; Abe-Chayama, Hiromi; Hayes, C. Nelson; Makokha, Grace Naswa; Serikawa, Masahiro; Aikata, Hiroshi; Chayama, Kazuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Appl Life Sci, Hiroshima, Japan; [Miyaki, Eisuke; Hiraga, Nobuhiko; Imamura, Michio; Uchida, Takuro; Kan, Hiromi; Tsuge, Masataka; Abe-Chayama, Hiromi; Hayes, C. Nelson; Makokha, Grace Naswa; Serikawa, Masahiro; Aikata, Hiroshi; Ochi, Hidenori; Ishida, Yuji; Tateno, Chise; Ohdan, Hideki; Chayama, Kazuaki] Hiroshima Univ, Liver Res Project Ctr, Hiroshima, Japan; [Ochi, Hidenori; Chayama, Kazuaki] Inst Phys & Chem Res RIKEN, Ctr Genom Med, Lab Digest Dis, Hiroshima, Japan; [Ishida, Yuji; Tateno, Chise] PhoenixBio Co Ltd, Higashihiroshima, Japan; [Ohdan, Hideki] Hiroshima Univ, Grad Sch Biomed Sci, Div Frontier Med Sci, Programs Biomed Res,Dept Surg, Hiroshima, Japan	Hiroshima University; Hiroshima University; RIKEN; PHOENIXBIO CO. LTD.; Hiroshima University	Chayama, K (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Appl Life Sci, Hiroshima, Japan.; Chayama, K (corresponding author), Hiroshima Univ, Liver Res Project Ctr, Hiroshima, Japan.; Chayama, K (corresponding author), Inst Phys & Chem Res RIKEN, Ctr Genom Med, Lab Digest Dis, Hiroshima, Japan.	chayama@hiroshima-u.ac.jp	Tsuge, Masataka/G-5246-2019; Ohdan, Hideki/G-4719-2019; Uchida, Takuro/G-5011-2019; Hayes, C. Nelson N/G-4596-2019; Abe-Chayama, Hiromi/M-8256-2019	Tsuge, Masataka/0000-0001-7591-8287; Ohdan, Hideki/0000-0002-9066-1288; Chayama, Kazuaki/0000-0002-5530-5341; Makokha, Grace Naswa/0000-0002-2171-5609	Research Program on Hepatitis from Japan Agency for Medical Research and Development, AMED [15fk0210001h0002]	Research Program on Hepatitis from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This research is supported by research funding from the Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED (grant number: 15fk0210001h0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. PhoenixBio Co. Ltd. provided support in the form of salaries for authors YI and CT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahlenstiel G, 2011, GASTROENTEROLOGY, V141, P1231, DOI 10.1053/j.gastro.2011.06.069; Amadei B, 2010, GASTROENTEROLOGY, V138, P1536, DOI 10.1053/j.gastro.2010.01.006; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Deignan T, 2002, J HEPATOL, V37, P101, DOI 10.1016/S0168-8278(02)00072-7; Dill MT, 2012, GASTROENTEROLOGY, V143, P777, DOI 10.1053/j.gastro.2012.05.044; Doherty DG, 1999, J IMMUNOL, V163, P2314; Edlich B, 2012, HEPATOLOGY, V55, P39, DOI 10.1002/hep.24628; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Hiraga N, 2011, HEPATOLOGY, V54, P781, DOI 10.1002/hep.24460; Kim DY, 2014, GUT LIVER, V8, P471, DOI 10.5009/gnl14083; Klenerman P, 2012, GUT, V61, P1226, DOI 10.1136/gutjnl-2011-300620; Kosaka K, 2013, BIOCHEM BIOPH RES CO, V441, P230, DOI 10.1016/j.bbrc.2013.10.040; Lanford RE, 2006, HEPATOLOGY, V43, P961, DOI 10.1002/hep.21167; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Ohdan H, 2003, TRANSPLANTATION, V76, P791, DOI 10.1097/01.TP.0000074603.36553.BD; Ohira M, 2009, J CLIN INVEST, V119, P3226, DOI 10.1172/JCI38374; Okazaki A, 2012, HEPATOLOGY, V56, P555, DOI 10.1002/hep.25651; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Park SH, 2014, IMMUNITY, V40, P13, DOI 10.1016/j.immuni.2013.12.010; REYES VE, 1987, TRANSPLANTATION, V43, P412, DOI 10.1097/00007890-198703000-00018; Rossini A, 2001, DIGEST DIS SCI, V46, P2389, DOI 10.1023/A:1012303315214; Sarrazin C., 2015, J HEPATOL; Shirakawa H, 2008, HEPATOLOGY, V48, P1753, DOI 10.1002/hep.22543; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Taniguchi M, 2010, INT IMMUNOL, V22, P1, DOI 10.1093/intimm/dxp104; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Tsuge M, 2005, HEPATOLOGY, V42, P1046, DOI 10.1002/hep.20892; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Werner JM, 2013, HEPATOLOGY, V58, P1621, DOI 10.1002/hep.26353	34	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172412	10.1371/journal.pone.0172412	http://dx.doi.org/10.1371/journal.pone.0172412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253324	Green Submitted, Green Published, gold			2022-12-26	WOS:000396011300019
J	Geillon, F; Gondcaille, C; Raas, Q; Dias, AMM; Pecqueur, D; Truntzer, C; Lucchi, G; Ducoroy, P; Falson, P; Savary, S; Trompier, D				Geillon, Flore; Gondcaille, Catherine; Raas, Quentin; Dias, Alexandre M. M.; Pecqueur, Delphine; Truntzer, Caroline; Lucchi, Geraldine; Ducoroy, Patrick; Falson, Pierre; Savary, Stephane; Trompier, Doriane			Peroxisomal ATP-binding cassette transporters form mainly tetramers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; PROTEIN-PROTEIN INTERACTIONS; ACID AMIDE HYDROLASE; CHAIN FATTY-ACIDS; ABC TRANSPORTERS; SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; PLASMA-MEMBRANE; PMP70 ABCD3; CELL-LINES	ABCD1 and its homolog ABCD2 are peroxisomal ATP-binding cassette (ABC) half-transporters of fatty acyl-CoAs with both distinct and overlapping substrate specificities. Although it is established that ABC half-transporters have at least to dimerize to generate a functional unit, functional equivalents of tetramers (i.e. dimers of full-length transporters) have also been reported. However, oligomerization of peroxisomal ABCD transporters is incompletely understood but is of potential significance because more complex oligomerization might lead to differences in substrate specificity. In this work, we have characterized the quaternary structure of the ABCD1 and ABCD2 proteins in the peroxisomal membrane. Using various biochemical approaches, we clearly demonstrate that both transporters exist as both homo-and heterotetramers, with a predominance of homotetramers. In addition to tetramers, some larger molecular ABCD assemblies were also found but represented only a minor fraction. By using quantitative co-immunoprecipitation assays coupled with tandem mass spectrometry, we identified potential binding partners of ABCD2 involved in polyunsaturated fatty-acid metabolism. Interestingly, we identified calcium ATPases as ABCD2-binding partners, suggesting a role of ABCD2 in calcium signaling. In conclusion, we have shown here that ABCD1 and its homolog ABCD2 exist mainly as homotetramers in the peroxisomal membrane.	[Geillon, Flore; Gondcaille, Catherine; Raas, Quentin; Dias, Alexandre M. M.; Savary, Stephane; Trompier, Doriane] Univ Bourgogne Franche Comte, Lab BioperoxIL EA7270, 6 Bd Gabriel, F-21000 Dijon, France; [Pecqueur, Delphine; Truntzer, Caroline; Lucchi, Geraldine; Ducoroy, Patrick] Univ Bourgogne Franche Comte, CLIPP ICMUB, 6 Bd Gabriel, F-21000 Dijon, France; [Falson, Pierre] Univ Lyon 1, CNRS UMR5086, Drug Resistance & Membrane Prot Team, Mol Microbiol & Struct Biochem Lab,IBCP, 7 Passage Vercors, F-69367 Lyon, France	Universite de Bourgogne; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Trompier, D (corresponding author), Univ Bourgogne Franche Comte, Lab BioperoxIL EA7270, 6 Bd Gabriel, F-21000 Dijon, France.	doriane.trompier@u-bourgogne.fr	Savary, Stephane/C-8137-2011	Savary, Stephane/0000-0002-9237-1727; Lucchi, Geraldine/0000-0003-2103-486X; Falson, Pierre/0000-0002-9760-4577; Truntzer, Caroline/0000-0003-0895-4813; Trompier, Doriane/0000-0002-0746-1753	regional council of Burgundy; University of Burgundy	regional council of Burgundy(Region Bourgogne-Franche-Comte); University of Burgundy	This work was supported by grants from the regional council of Burgundy and from the University of Burgundy. The authors declare that they have no conflicts of interest with the contents of this article.	Abel S, 2011, J PHYS CHEM B, V115, P487, DOI 10.1021/jp109545v; Berger J, 1999, EUR J BIOCHEM, V265, P719, DOI 10.1046/j.1432-1327.1999.00772.x; Boger DL, 2000, BIOORG MED CHEM LETT, V10, P2613, DOI 10.1016/S0960-894X(00)00528-X; Brown I, 2010, CARCINOGENESIS, V31, P1584, DOI 10.1093/carcin/bgq151; Clough T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S6; Costello JL, 2017, J CELL BIOL, V216, P331, DOI 10.1083/jcb.201607055; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Ferdinandusse S, 2015, HUM MOL GENET, V24, P361, DOI 10.1093/hmg/ddu448; Flavigny E, 1999, FEBS LETT, V448, P261, DOI 10.1016/S0014-5793(99)00379-8; Frixel S, 2016, INT J MOL MED, V38, P558, DOI 10.3892/ijmm.2016.2650; Geillon F, 2014, J BIOL CHEM, V289, P24511, DOI 10.1074/jbc.M114.575506; Genin EC, 2011, J BIOL CHEM, V286, P8075, DOI 10.1074/jbc.M110.211912; Gloeckner CJ, 2000, BIOCHEM BIOPH RES CO, V271, P144, DOI 10.1006/bbrc.2000.2572; Gueugnon F, 2006, BIOCHEM BIOPH RES CO, V341, P150, DOI 10.1016/j.bbrc.2005.12.152; Guimaraes CP, 2005, J HUM GENET, V50, P99, DOI 10.1007/s10038-004-0226-4; Guimaraes CP, 2004, BBA-MOL BASIS DIS, V1689, P235, DOI 10.1016/j.bbadis.2004.04.001; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; Hillebrand M, 2007, J BIOL CHEM, V282, P26997, DOI 10.1074/jbc.M702122200; Hillebrand M, 2012, J BIOL CHEM, V287, P210, DOI 10.1074/jbc.M111.272732; Hua R, 2017, J CELL BIOL, V216, P367, DOI 10.1083/jcb.201608128; Huang T, 2012, BRIEF BIOINFORM, V13, P586, DOI 10.1093/bib/bbs004; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; Kruska N, 2015, BBA-MOL BASIS DIS, V1852, P925, DOI 10.1016/j.bbadis.2015.01.005; Langmann T, 2003, CLIN CHEM, V49, P230, DOI 10.1373/49.2.230; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Liu J, 2010, J LIPID RES, V51, P162, DOI 10.1194/jlr.M900237-JLR200; Liu LX, 1999, J BIOL CHEM, V274, P32738, DOI 10.1074/jbc.274.46.32738; Liu XX, 2015, BIOCHEM BIOPH RES CO, V456, P129, DOI 10.1016/j.bbrc.2014.11.046; Locher KP, 2016, NAT STRUCT MOL BIOL, V23, P487, DOI 10.1038/nsmb.3216; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; Lousa CD, 2013, P NATL ACAD SCI USA, V110, P1279, DOI 10.1073/pnas.1218034110; Madsen L, 1998, J LIPID RES, V39, P583; Makkar RS, 2006, ARCH BIOCHEM BIOPHYS, V451, P128, DOI 10.1016/j.abb.2006.05.003; Matar-Merheb R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018036; Monroe ME, 2008, COMPUT BIOL CHEM, V32, P215, DOI 10.1016/j.compbiolchem.2008.02.006; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Nagata KO, 2013, P NATL ACAD SCI USA, V110, P5034, DOI 10.1073/pnas.1220703110; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Netik A, 1999, HUM MOL GENET, V8, P907, DOI 10.1093/hmg/8.5.907; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; Nury T, 2017, J STEROID BIOCHEM, V169, P123, DOI 10.1016/j.jsbmb.2016.03.037; PETER GF, 1991, J BIOL CHEM, V266, P16745; Pujol A, 2004, HUM MOL GENET, V13, P2997, DOI 10.1093/hmg/ddh323; Schrader Michael, 2013, Subcell Biochem, V69, P1, DOI 10.1007/978-94-007-6889-5_1; Shani N, 1996, ANN NY ACAD SCI, V804, P770, DOI 10.1111/j.1749-6632.1996.tb18697.x; Smith KD, 1999, NEUROCHEM RES, V24, P521, DOI 10.1023/A:1022535930009; Tanaka AR, 2002, J BIOL CHEM, V277, P40142, DOI 10.1074/jbc.M205079200; Troffer-Charlier N, 1998, EUR J CELL BIOL, V75, P254, DOI 10.1016/S0171-9335(98)80121-0; Trompier D., 2013, MORGAN CLAYPOOL LIFE, DOI [10.4199/C00075ED1V01Y201303GBD004, DOI 10.4199/C00075ED1V01Y201303GBD004]; Trompier D, 2006, J BIOL CHEM, V281, P20283, DOI 10.1074/jbc.M601072200; Trompier D, 2014, BIOCHEM BIOPH RES CO, V446, P651, DOI 10.1016/j.bbrc.2014.01.025; Van Horn CG, 2005, BIOCHEMISTRY-US, V44, P1635, DOI 10.1021/bi047721l; van Roermund CWT, 2014, BBA-MOL CELL BIOL L, V1841, P563, DOI 10.1016/j.bbalip.2013.12.001; van Roermund CWT, 2011, BBA-MOL CELL BIOL L, V1811, P148, DOI 10.1016/j.bbalip.2010.11.010; van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866; Wei BQQ, 2006, J BIOL CHEM, V281, P36569, DOI 10.1074/jbc.M606646200; Wiesinger C, 2013, J BIOL CHEM, V288, P19269, DOI 10.1074/jbc.M112.445445; Wong K, 2016, BBA-MOL CELL RES, V1863, P19, DOI 10.1016/j.bbamcr.2015.10.002; Woudenberg J, 2010, HEPATOLOGY, V52, P623, DOI 10.1002/hep.23684; Yang YY, 2007, J BIOL CHEM, V282, P8821, DOI 10.1074/jbc.M700152200	61	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6965	6977		10.1074/jbc.M116.772806	http://dx.doi.org/10.1074/jbc.M116.772806			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28258215	Green Published, hybrid			2022-12-26	WOS:000400478300009
J	Obeid, S; Wankell, M; Charrez, B; Sternberg, J; Kreuter, R; Esmaili, S; Ramezani-Moghadam, M; Devine, C; Read, S; Bhathal, P; Lopata, A; Ahlensteil, G; Qiao, L; George, J; Hebbard, L				Obeid, Stephanie; Wankell, Miriam; Charrez, Berenice; Sternberg, Jade; Kreuter, Roxane; Esmaili, Saeed; Ramezani-Moghadam, Mehdi; Devine, Carol; Read, Scott; Bhathal, Prithi; Lopata, Andreas; Ahlensteil, Golo; Qiao, Liang; George, Jacob; Hebbard, Lionel			Adiponectin confers protection from acute colitis and restricts a B cell immune response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; INTESTINAL EPITHELIAL-CELLS; MICE LACKING ADIPONECTIN; INDUCED COLON-CANCER; BODY-MASS INDEX; CROHNS-DISEASE; ULCERATIVE-COLITIS; INSULIN-RESISTANCE; DEFICIENCY ROLE	Adiponectin demonstrates beneficial effects in various metabolic diseases, including diabetes, and in bowel cancer. Recent data also suggest a protective role in colitis. However, the precise molecular mechanisms by which adiponectin and its receptors modulate colitis and the nature of the adaptive immune response in murine models are yet to be elucidated. Adiponectin knock-out mice were orally administered dextran sulfate sodium for 7 days and were compared with wild-type mice. The severity of disease was analyzed histopathologically and through cytokine profiling. HCT116 colonic epithelial cells were employed to analyze the in vitro effects of adiponectin and AdipoR1 interactions in colonic injury following dextran sulfate sodium treatment. Adiponectin knock-out mice receiving dextran sulfate sodium exhibited severe colitis, had greater inflammatory cell infiltration, and an increased presence of activated B cells compared with controls. This was accompanied by an exaggerated proinflammatory cytokine profile and increased STAT3 signaling. Adiponectin knock-out mouse colons had markedly reduced proliferation and increased epithelial apoptosis and cellular stress. In vitro, adiponectin reduced apoptotic, antiproliferative, and stress signals and restored STAT3 signaling. Following the abrogation of AdipoR1 in vitro, these protective effects of adiponectin were abolished. In summary, adiponectin maintains intestinal homeostasis and protects against murine colitis through interactions with its receptor AdipoR1 and by modulating adaptive immunity.	[Obeid, Stephanie; Esmaili, Saeed; Ramezani-Moghadam, Mehdi; Devine, Carol; Read, Scott; Ahlensteil, Golo; Qiao, Liang; George, Jacob; Hebbard, Lionel] Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, Sydney, NSW 2145, Australia; [Obeid, Stephanie; Esmaili, Saeed; Ramezani-Moghadam, Mehdi; Devine, Carol; Read, Scott; Ahlensteil, Golo; Qiao, Liang; George, Jacob; Hebbard, Lionel] Univ Sydney, Sydney, NSW 2145, Australia; [Bhathal, Prithi] Univ Melbourne, Melbourne, Vic 3010, Australia; [Wankell, Miriam; Charrez, Berenice; Sternberg, Jade; Kreuter, Roxane; Lopata, Andreas; Hebbard, Lionel] James Cook Univ, Dept Mol & Cell Biol, Townsville, Qld 4811, Australia; [Hebbard, Lionel] James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld 4811, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Melbourne; James Cook University; James Cook University	Hebbard, L (corresponding author), Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, Sydney, NSW 2145, Australia.; Hebbard, L (corresponding author), Univ Sydney, Sydney, NSW 2145, Australia.; Hebbard, L (corresponding author), James Cook Univ, Dept Mol & Cell Biol, Townsville, Qld 4811, Australia.; Hebbard, L (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld 4811, Australia.	lionel.hebbard@jcu.edu.au	Ahlenstiel, Golo/U-1990-2017; Lopata, Andreas L/O-2143-2017; Hebbard, Lionel/O-1489-2017; Read, Scott/K-6462-2019; Hebbard, Lionel/W-4057-2019	Ahlenstiel, Golo/0000-0003-0026-1457; Lopata, Andreas L/0000-0002-2940-9235; Hebbard, Lionel/0000-0002-7094-9065; Read, Scott/0000-0001-6775-2061; Esmaili, Saeed/0000-0002-2843-7277	Robert W. Storr Bequest; National Health and Medical Research Council of Australia (NHMRC) Program [APP1053206]; NHMRC [1047417, 1087297]; Cancer Council NSW Project [1070076, 1069733]; Cancer Council Queensland Project Grant [1123436]; James Cook Development Grant	Robert W. Storr Bequest; National Health and Medical Research Council of Australia (NHMRC) Program(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW Project(Cancer Council New South Wales); Cancer Council Queensland Project Grant(Cancer Council Queensland); James Cook Development Grant	This work was supported by The Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney, National Health and Medical Research Council of Australia (NHMRC) Program Grant APP1053206, NHMRC project Grants 1047417 (to L. Q.) and 1087297 (to J. G. and L. H.), Cancer Council NSW Project Grants 1070076 (to L. Q.) and 1069733 (to L. H.), Cancer Council Queensland Project Grant 1123436 (to L. H., J. G., and L. Q.), and James Cook Development Grant 2016 (to L. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham C, 2009, ANNU REV MED, V60, P97, DOI 10.1146/annurev.med.60.051407.123757; Alexander KL, 2014, IMMUNOL REV, V260, P206, DOI 10.1111/imr.12180; Araki Y, 2006, ONCOL REP, V16, P1357; Arsenescu V, 2011, DIGEST DIS SCI, V56, P2818, DOI 10.1007/s10620-011-1692-0; Berkowitz D, 2013, HUM IMMUNOL, V74, P1519, DOI 10.1016/j.humimm.2013.08.285; Bersudsky M, 2014, GUT, V63, P598, DOI 10.1136/gutjnl-2012-303329; Blain A, 2002, CLIN NUTR, V21, P51, DOI 10.1054/clnu.2001.0503; Burisch J, 2015, SCAND J GASTROENTERO, V50, P942, DOI 10.3109/00365521.2015.1014407; Chimen M, 2015, NAT MED, V21, P467, DOI 10.1038/nm.3842; COCKS BG, 1993, INT IMMUNOL, V5, P657, DOI 10.1093/intimm/5.6.657; Cupi ML, 2014, J IMMUNOL, V192, P6083, DOI 10.4049/jimmunol.1302238; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Fayad R, 2007, GASTROENTEROLOGY, V132, P601, DOI 10.1053/j.gastro.2006.11.026; Folco EJ, 2009, J BIOL CHEM, V284, P25569, DOI 10.1074/jbc.M109.019786; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Harpsoe MC, 2014, INT J EPIDEMIOL, V43, P843, DOI 10.1093/ije/dyu045; Hass DJ, 2006, CLIN GASTROENTEROL H, V4, P482, DOI 10.1016/j.cgh.2005.12.015; Hebbard L, 2014, BEST PRACT RES CL EN, V28, P59, DOI 10.1016/j.beem.2013.11.005; Kamada Y, 2003, GASTROENTEROLOGY, V125, P1796, DOI 10.1053/j.gastro.2003.08.029; Kappelman MD, 2013, DIGEST DIS SCI, V58, P519, DOI 10.1007/s10620-012-2371-5; Kaur K, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0079-y; Kawashima R, 2011, GASTROENTEROLOGY, V141, P2119, DOI 10.1053/j.gastro.2011.08.040; Kim AY, 2010, MOL ENDOCRINOL, V24, P1441, DOI 10.1210/me.2009-0498; Konter JM, 2012, J IMMUNOL, V188, P854, DOI 10.4049/jimmunol.1100426; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mann ER, 2014, WORLD J GASTROENTERO, V20, P9653, DOI 10.3748/wjg.v20.i29.9653; Mendall MA, 2011, DIGEST DIS SCI, V56, P837, DOI 10.1007/s10620-010-1541-6; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Motoshima H, 2004, BIOCHEM BIOPH RES CO, V315, P264, DOI 10.1016/j.bbrc.2004.01.049; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nigro E, 2013, INT J BIOCHEM CELL B, V45, P1145, DOI 10.1016/j.biocel.2013.03.003; Nishihara T, 2006, GASTROENTEROLOGY, V131, P853, DOI 10.1053/j.gastro.2006.06.015; Noronha AM, 2009, J LEUKOCYTE BIOL, V86, P1007, DOI 10.1189/jlb.0309203; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Roberts-Thomson IC, 2011, EXPERT REV GASTROENT, V5, P703, DOI [10.1586/egh.11.74, 10.1586/EGH.11.74]; Rush JS, 2001, EUR J IMMUNOL, V31, P1150, DOI 10.1002/1521-4141(200104)31:4<1150::AID-IMMU1150>3.0.CO;2-V; Saxena A, 2013, INT J COLORECTAL DIS, V28, P1267, DOI 10.1007/s00384-013-1664-2; Saxena A, 2012, BBA-MOL BASIS DIS, V1822, P527, DOI 10.1016/j.bbadis.2011.12.006; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Sideri A, 2015, AM J PHYSIOL-GASTR L, V308, pG591, DOI 10.1152/ajpgi.00269.2014; SNOOK JA, 1989, Q J MED, V72, P835; Song J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.220; Steed H, 2009, OBESITY FACTS, V2, P370, DOI 10.1159/000262276; Stevceva L, 2001, GENES IMMUN, V2, P309, DOI 10.1038/sj.gene.6363782; Takatsu K, 2009, ADV IMMUNOL, V101, P191, DOI 10.1016/S0065-2776(08)01006-7; Wang ZV, 2008, HYPERTENSION, V51, P8, DOI 10.1161/HYPERTENSIONAHA.107.099424; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Yokota T, 2003, J IMMUNOL, V171, P5091, DOI 10.4049/jimmunol.171.10.5091	54	20	26	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6569	6582		10.1074/jbc.M115.712646	http://dx.doi.org/10.1074/jbc.M115.712646			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28258220	hybrid, Green Published			2022-12-26	WOS:000399813400012
J	Yerabham, ASK; Mas, PJ; Decker, C; Soares, DC; Weiergraber, OH; Nagel-Steger, L; Willbold, D; Hart, DJ; Bradshaw, NJ; Korth, C				Yerabham, Antony S. K.; Mas, Philippe J.; Decker, Christina; Soares, Dinesh C.; Weiergraeber, Oliver H.; Nagel-Steger, Luitgard; Willbold, Dieter; Hart, Darren J.; Bradshaw, Nicholas J.; Korth, Carsten			A structural organization for the Disrupted in Schizophrenia 1 protein, identified by high-throughput screening, reveals distinctly folded regions, which are bisected by mental illness-related mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE ANALYSES; CIRCULAR-DICHROISM SPECTRA; EVOLUTIONARY HISTORY; DISC1; DISEASE; DOMAIN; RISK; TRANSCRIPTION; HOMEOSTASIS; EXPRESSION	Disrupted in Schizophrenia 1 (DISC1) is a scaffolding protein of significant importance for neurodevelopment and a prominent candidate protein in the pathology of major mental illness. DISC1 modulates a number of critical neuronal signaling pathways through protein-protein interactions; however, the mechanism by which this occurs and how DISC1 causes mental illness is unclear, partly because knowledge of the structure of DISC1 is lacking. A lack of homology with known proteins has hindered attempts to define its domain composition. Here, we employed the high-throughput Expression of Soluble Proteins by Random Incremental Truncation (ESPRIT) technique to identify discretely folded regions of human DISC1 via solubility assessment of tens of thousands of fragments of recombinant DISC1. We identified four novel structured regions, named D, I, S, and C, at amino acids 257-383, 539-655, 635-738, and 691-836, respectively. One region (D) is located in a DISC1 section previously predicted to be unstructured. All regions encompass coiled-coil or alpha-helical structures, and three are involved in DISC1 oligomerization. Crucially, three of these domains would be lost or disrupted by a chromosomal translocation event after amino acid 597, which has been strongly linked to major mental illness. Furthermore, we observed that a known illness-related frameshift mutation after amino acid 807 causes the C region to form aberrantly multimeric and aggregated complexes with an unstable secondary structure. This newly revealed domain architecture of DISC1, therefore, provides a powerful framework for understanding the critical role of this protein in a variety of devastating mental illnesses.	[Yerabham, Antony S. K.; Bradshaw, Nicholas J.; Korth, Carsten] Heinrich Heine Univ, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Decker, Christina; Nagel-Steger, Luitgard; Willbold, Dieter] Heinrich Heine Univ, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Mas, Philippe J.] Univ Grenoble Alpes, EMBL, CEA, ISBG CNRS, F-38042 Grenoble, France; [Soares, Dinesh C.] Univ Edinburgh, Inst Genet & Mol Med, Ctr Genom & Expt Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Weiergraeber, Oliver H.; Nagel-Steger, Luitgard; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst ICS Struct Biochem 6, D-52425 Julich, Germany; [Hart, Darren J.] Univ Grenoble Alpes, CNRS, CEA, Inst Biol Struct IBS, F-38044 Grenoble, France	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL); University of Edinburgh; Helmholtz Association; Research Center Julich; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Bradshaw, NJ (corresponding author), Univ Rijeka, Dept Biotechnol, Radmile Matejcic 2, Rijeka 51000, Croatia.; Korth, C (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Neuropathol, Moorenstr 5, D-40225 Dusseldorf, Germany.	nicholas.bradshaw@hhu.de; ckorth@hhu.de	Weiergräber, Oliver H./G-8940-2013; Nagel-Steger, Luitgard/H-6415-2013; Bradshaw, Nicholas J./A-5625-2009; Willbold, Dieter/A-6280-2013; Soares, Dinesh/A-4425-2012; Hart, Darren/C-4858-2015	Weiergräber, Oliver H./0000-0002-2410-3691; Nagel-Steger, Luitgard/0000-0001-5232-2149; Bradshaw, Nicholas J./0000-0001-5581-8828; Willbold, Dieter/0000-0002-0065-7366; Yerabham, Antony Sravan Kumar/0000-0003-4194-8386; Soares, Dinesh/0000-0001-7557-0495; Mas, Philippe/0000-0002-8060-0289; Hart, Darren/0000-0002-3502-2002	French Infrastructure for Integrated Structural Biology [ANR-10-INSB-05-02]; Grenoble Alliance for Integrated Structural & Cell Biology within the Grenoble Partnership for Structural Biology (PSB) [ANR-10-LABX-49-01]	French Infrastructure for Integrated Structural Biology; Grenoble Alliance for Integrated Structural & Cell Biology within the Grenoble Partnership for Structural Biology (PSB)	The ESPRIT platform of the Grenoble Instruct Centre (ISBG: UMS 3518 CNRS-CEA-UJF-EMBL) receives financial support from the French Infrastructure for Integrated Structural Biology (ANR-10-INSB-05-02) and the Grenoble Alliance for Integrated Structural & Cell Biology (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB).	Bord L, 2006, NEUROSCI RES, V56, P286, DOI 10.1016/j.neures.2006.07.010; Bradshaw NJ, 2012, NEUROPHARMACOLOGY, V62, P1230, DOI 10.1016/j.neuropharm.2010.12.027; Burdick KE, 2008, HUM MOL GENET, V17, P2462, DOI 10.1093/hmg/ddn146; Bussow K, 1998, NUCLEIC ACIDS RES, V26, P5007, DOI 10.1093/nar/26.21.5007; Cohn E. J., 1943, PROTEINS AMINO ACIDS; Durchschlag H., 1986, THERMODYNAMIC DATA B; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ghirlando R, 2011, METHODS, V54, P145, DOI 10.1016/j.ymeth.2010.12.005; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2006, HUM MOL GENET, V15, P3313, DOI 10.1093/hmg/ddl407; Korth C, 2012, PRION, V6, P134, DOI 10.4161/pri.18989; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Leliveld SR, 2008, J NEUROSCI, V28, P3839, DOI 10.1523/JNEUROSCI.5389-07.2008; Leliveld SR, 2009, BIOCHEMISTRY-US, V48, P7746, DOI 10.1021/bi900901e; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Nadal M, 2010, P NATL ACAD SCI USA, V107, P16078, DOI 10.1073/pnas.1007144107; Narayanan S, 2011, J BIOL CHEM, V286, P44266, DOI 10.1074/jbc.M111.271593; Ottis P, 2011, BIOL PSYCHIAT, V70, P604, DOI 10.1016/j.biopsych.2011.03.027; Puranik S, 2014, PLANT CELL, V26, P3603, DOI 10.1105/tpc.114.127910; Sachs NA, 2005, MOL PSYCHIATR, V10, P758, DOI 10.1038/sj.mp.4001667; Sanchez-Pulido L, 2011, HUM MOL GENET, V20, pR175, DOI 10.1093/hmg/ddr374; Sawamura N, 2008, MOL PSYCHIATR, V13, P1138, DOI 10.1038/mp.2008.101; Shimizu S, 2008, BIOCHEM BIOPH RES CO, V377, P1051, DOI 10.1016/j.bbrc.2008.10.100; Shinoda T, 2007, J NEUROSCI, V27, P4, DOI 10.1523/JNEUROSCI.3825-06.2007; Soares DC, 2011, ACS CHEM NEUROSCI, V2, P609, DOI 10.1021/cn200062k; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sukackaite R, 2014, J BIOL CHEM, V289, P13903, DOI 10.1074/jbc.M114.557843; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Taylor MS, 2003, GENOMICS, V81, P67, DOI 10.1016/S0888-7543(02)00026-5; Thomson PA, 2016, NPJ SCHIZOPHR, V2, DOI 10.1038/npjschz.2016.24; Trossbach SV, 2016, MOL PSYCHIATR, V21, P1561, DOI 10.1038/mp.2015.194; Wang Q, 2011, MOL PSYCHIATR, V16, P1006, DOI 10.1038/mp.2010.87; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yerabham ASK, 2013, BIOL CHEM, V394, P1425, DOI 10.1515/hsz-2013-0178; Yumerefendi H, 2010, J STRUCT BIOL, V172, P66, DOI 10.1016/j.jsb.2010.02.021	40	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6468	6477		10.1074/jbc.M116.773903	http://dx.doi.org/10.1074/jbc.M116.773903			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	ES8NI	28249940	Green Published, hybrid			2022-12-26	WOS:000399813400005
J	Matsumoto, T; Tabara, Y; Murase, K; Takahashi, Y; Setoh, K; Kawaguchi, T; Muro, S; Kadotani, H; Kosugi, S; Sekine, A; Yamada, R; Nakayama, T; Mishima, M; Matsuda, F; Chin, KZ				Matsumoto, Takeshi; Tabara, Yasuharu; Murase, Kimihiko; Takahashi, Yoshimitsu; Setoh, Kazuya; Kawaguchi, Takahisa; Muro, Shigeo; Kadotani, Hiroshi; Kosugi, Shinji; Sekine, Akihiro; Yamada, Ryo; Nakayama, Takeo; Mishima, Michiaki; Matsuda, Fumihiko; Chin, Kazuo			Combined association of clinical and lifestyle factors with non-restorative sleep: The Nagahama Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; NONRESTORATIVE SLEEP; INSOMNIA SYMPTOMS; DURATION; RISK; MORTALITY; QUALITY; HEART; PREVALENCE; WOMEN	Background Non-restorative sleep (NRS) was suggested to be associated with cardiovascular outcomes. However, causative factors for NRS have not been fully elucidated. This study aimed to clarify factors and their relationships with NRS to better understand the clinical and epidemiological implications of NRS and to develop a score that can objectively evaluate NRS status. Methods Study subjects consisted of 9,788 community residents (age 53.6 +/- 13.4 y). Subjective NRS as well as possible clinical and lifestyle factors for NRS were investigated by questionnaires. Other clinical parameters were obtained from personal records of information obtained at the baseline examination. Results A total of 3,261 participants complained of NRS. Factors independently associated with subjective NRS were younger age (odds ratio = 1.43), use of a hypnotic drug (2.04), irregular sleep schedule (2.02), short sleep duration (< 5 h, 11.7; 5-6 h, 4.81; 6-7 h, 2.40), frequent sleepiness (2.33), routine stress (4.63), no habitual exercise (1.61), nocturia symptoms (1.43), symptoms of gastroesophageal reflux disease (1.44), and depression (1.46) (all P < 0.001). The NRS score comprised of these 10 factors was linearly associated with the frequency of subjective NRS (P-trend < 0.001). Frequency of individuals with a high NRS score was greater in women (52.3%) than in men (42.1%, P<0.001), while no clear association was observed with common risk factors for cardiovascular diseases. Conclusions NRS was a phenomenon representing various clinical and lifestyle features. Careful attention should be paid to individuals with a high NRS score who might be at risk for mental fatigue and have unfavorable lifestyle factors.	[Matsumoto, Takeshi; Murase, Kimihiko; Muro, Shigeo; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Tabara, Yasuharu; Setoh, Kazuya; Kawaguchi, Takahisa; Yamada, Ryo; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Takahashi, Yoshimitsu; Nakayama, Takeo] Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan; [Kadotani, Hiroshi] Shiga Univ Med Sci, Dept Sleep & Behav Sci, Shiga, Japan; [Kosugi, Shinji] Kyoto Univ, Sch Publ Hlth, Dept Med Eth & Med Genet, Kyoto, Japan; [Sekine, Akihiro] Chiba Univ, Ctr Prevent Med Sci, Chiba, Japan; [Chin, Kazuo] Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Shiga University of Medical Science; Kyoto University; Chiba University; Kyoto University	Chin, KZ (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan.	chink@kuhp.kyoto-u.ac.jp	KOSUGI, Shinji/HCH-0631-2022; Kadotani, Hiroshi/A-7908-2015; TAKAHASHI, Yoshimitsu/GZB-2656-2022; Matsumoto, Takeshi/AAR-4323-2020; NAKAYAMA, Takeo/HCH-0537-2022; KOSUGI, Shinji/GYR-2946-2022	Kadotani, Hiroshi/0000-0001-7474-3315; 	Ministry of Education, Culture, Sports, Science & Technology in Japan; Takeda Science Foundation; Japanese Ministry of Education, Culture, Sports, Science and Technology; Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare of Japan; Japan Vascular Disease Research Foundation; Health, Labour and Welfare Sciences Research Grants, Research on Region Medical	Ministry of Education, Culture, Sports, Science & Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Vascular Disease Research Foundation(Japan Vascular Disease Research Foundation); Health, Labour and Welfare Sciences Research Grants, Research on Region Medical	This study was supported by a University Grant, a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science & Technology in Japan, a research grant from the Takeda Science Foundation, grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare of Japan, the Japan Vascular Disease Research Foundation, and Health, Labour and Welfare Sciences Research Grants, Research on Region Medical. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Chandola T, 2010, SLEEP, V33, P739, DOI 10.1093/sleep/33.6.739; Doi Y, 2003, SLEEP, V26, P467, DOI 10.1093/sleep/26.4.467; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; Hasan A, 2012, SLEEP BREATH, V16, P111, DOI 10.1007/s11325-010-0463-z; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; Ikehara S, 2009, SLEEP, V32, P295, DOI 10.1093/sleep/32.3.295; Jackson CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-552; Jordan AS, 2014, LANCET, V383, P736, DOI 10.1016/S0140-6736(13)60734-5; Kim CW, 2015, ARTERIOSCL THROM VAS, V35, P2238, DOI 10.1161/ATVBAHA.115.306110; Kusano M, 2004, J GASTROENTEROL, V39, P888, DOI 10.1007/s00535-004-1417-7; Laugsand LE, 2014, EUR HEART J, V35, P1382, DOI 10.1093/eurheartj/eht019; Laugsand LE, 2014, SLEEP, V37, P1776, DOI 10.5665/sleep.4170; Leineweber C, 2003, J PSYCHOSOM RES, V54, P121, DOI 10.1016/S0022-3999(02)00475-0; Li YP, 2014, CIRCULATION, V129, P737, DOI 10.1161/CIRCULATIONAHA.113.004500; Murase K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140058; Murase K, 2014, SLEEP, V37, P1810, DOI 10.5665/sleep.4176; Ohayon MM, 2005, ARCH INTERN MED, V165, P35, DOI 10.1001/archinte.165.1.35; Ohayon MM, 2002, J SLEEP RES, V11, P339, DOI 10.1046/j.1365-2869.2002.00317.x; Ohayon MM, 2002, J PSYCHOSOM RES, V53, P593, DOI 10.1016/S0022-3999(02)00449-X; Phillips B, 2005, J CLIN SLEEP MED, V1, P277; Prather AA, 2013, J PSYCHIATR RES, V47, P1228, DOI 10.1016/j.jpsychires.2013.05.004; Sarsour K, 2010, SLEEP MED, V11, P965, DOI 10.1016/j.sleep.2010.08.007; Shakeel N, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-014-0420-0; Sutherland K, 2015, SLEEP BIOL RHYTHMS, V13, P26, DOI 10.1111/sbr.12098; United Nations, 2015, STESASERA390 UN; Vernon MK, 2010, SLEEP MED REV, V14, P205, DOI 10.1016/j.smrv.2009.10.002; Wakasugi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108718; Walsh JK, 2011, SLEEP, V34, P997, DOI 10.5665/SLEEP.1150; Whinnery J, 2014, SLEEP, V37, P601, DOI 10.5665/sleep.3508; Williams ED, 2015, PSYCHOL MED, V45, P1861, DOI 10.1017/S0033291714002967; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yamazaki Shin, 2005, Health Qual Life Outcomes, V3, P48; Zhang JH, 2012, SLEEP MED, V13, P570, DOI 10.1016/j.sleep.2011.12.012	35	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0171849	10.1371/journal.pone.0171849	http://dx.doi.org/10.1371/journal.pone.0171849			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278155	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900112
J	Miroshnichenko, D; Chaban, I; Chernobrovkina, M; Dolgov, S				Miroshnichenko, Dmitry; Chaban, Inna; Chernobrovkina, Mariya; Dolgov, Sergey			Protocol for efficient regulation of in vitro morphogenesis in einkorn (Triticum monococcum L.), a recalcitrant diploid wheat species	PLOS ONE			English	Article							PLANT-REGENERATION; SOMATIC EMBRYOGENESIS; IMMATURE EMBRYOS; CALLUS INDUCTION; MATURE EMBRYOS; AESTIVUM L; DIVERSE SET; DURUM DESF.; BARLEY; THIDIAZURON	Einkorn (Triticum monococcum L.) is A-genome diploid wheat that has a potential to become a useful model for understanding the biology and genomics in Triticeae. Unfortunately, the application of modern technologies such as genetic engineering, RNAi-based gene silencing and genome editing is not available for einkorn as there is no efficient in vitro tissue culture and plant regeneration system. In the present study an efficient and simple protocol for plant regeneration via direct or indirect somatic embryogenesis and organogenesis has been developed. Various auxins used as sole inductors in einkorn displayed low effect for morphogenesis (0-8%) and plant regeneration (1-2 shoots per explant). The addition of Daminozide, the inhibitor of biosynthesis of gibberellins, together with auxin significantly improved the formation of morphogenic structures, especially when Dicamba (51.4%) and Picloram (56.6%) were used for combination; furthermore, the simultaneous addition of cytokinin into induction medium significantly promoted in vitro performance. Among the tested cytokinins, the urea-type substances, such as TDZ and CPPU were more effective than the adenine type ones, BA and Zeatin, for the regulation of morphogenesis; especially, TDZ was more effective than CPPU for shoot formation (11.73 vs. 7.04 per regenerating callus). The highest morphogenic response of 90.2% with the production of more than 10 shoots per initial explant was observed when 3.0 mg/L Dicamba, 50.0 mg/L Daminozide and 0.25 mg/L TDZ were combined together. Along with the identification of appropriate induction medium, the optimal developmental stage for einkorn was found as partially transparent immature embryo in size of around 1.0 mm. Although in the present study the critical balance between plant growth regulators was established for einkorn only, we assume that further the proposed strategy could be successfully applied to other recalcitrant cereal species and genotypes.	[Miroshnichenko, Dmitry] RAS, Inst Basic Biol Problems, Pushchino, Moscow Region, Russia; [Miroshnichenko, Dmitry; Dolgov, Sergey] RAS, Branch Shemyakin & Ovchinnikov Inst Bioorgan Chem, Pushchino, Moscow Region, Russia; [Chaban, Inna; Chernobrovkina, Mariya; Dolgov, Sergey] All Russia Res Inst Agr Biotechnol, Moscow, Russia	Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; All-Russia Research Institute of Agricultural Biotechnology	Miroshnichenko, D (corresponding author), RAS, Inst Basic Biol Problems, Pushchino, Moscow Region, Russia.; Miroshnichenko, D (corresponding author), RAS, Branch Shemyakin & Ovchinnikov Inst Bioorgan Chem, Pushchino, Moscow Region, Russia.	miroshnichenko@bibch.ru	Inna, Chaban/ABE-4287-2020; Miroshnichenko, Dmitry/U-7330-2017; Chernobrovkina, Mariya/L-4713-2017; Dolgov, Sergey/AAV-3465-2021	Miroshnichenko, Dmitry/0000-0003-3975-7484; dolgov, sergey/0000-0003-1399-3235	Russian Science Foundation [16-14-10155]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation, Grant number: 16-14-10155 (http:rscf.ru/en/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikina O, 2016, CROP BREED APPL BIOT, V16, P307, DOI 10.1590/1984-70332016v16n4a46; Bakos F, 2009, SEX PLANT REPROD, V22, P15, DOI 10.1007/s00497-008-0087-7; Barro F, 1999, EUPHYTICA, V108, P161, DOI 10.1023/A:1003676830857; Biesaga-Koscielniak J, 2010, ACTA PHYSIOL PLANT, V32, P1047, DOI 10.1007/s11738-010-0495-9; Bouamama B, 2011, IN VITRO CELL DEV-PL, V47, P321, DOI 10.1007/s11627-011-9357-4; BROWN C, 1989, J PLANT PHYSIOL, V133, P727, DOI 10.1016/S0176-1617(89)80080-X; Brown RGS, 1997, PHYSIOL PLANTARUM, V101, P309, DOI 10.1034/j.1399-3054.1997.1010208.x; CARMAN JG, 1987, PLANT CELL TISS ORG, V10, P115, DOI 10.1007/BF00035909; Chang Y, 2003, PLANT CELL REP, V21, P733, DOI 10.1007/s00299-003-0607-8; Chauhan H, 2007, PLANT CELL TISS ORG, V91, P191, DOI 10.1007/s11240-007-9285-5; Delporte F, 2014, PROTOPLASMA, V251, P1455, DOI 10.1007/s00709-014-0647-7; Delporte F, 2012, PLANT SIGNAL BEHAV, V7, P1608, DOI 10.4161/psb.22424; Elhiti M, 2011, METHODS MOL BIOL, V710, P229, DOI 10.1007/978-1-61737-988-8_17; Eudes F, 2003, PLANT CELL TISS ORG, V73, P147, DOI 10.1023/A:1022800512708; Fernandez S, 1999, PLANT GROWTH REGUL, V28, P147, DOI 10.1023/A:1006142504577; Fu FL, 2011, AFR J BIOTECHNOL, V10, P2618; Ganeshan S, 2006, PLANT CELL TISS ORG, V85, P63, DOI 10.1007/s11240-005-9049-z; Guo B, 2011, AFR J BIOTECHNOL, V10, P8984; GUSSMAN CD, 1993, PLANT GROWTH REGUL, V12, P149, DOI 10.1007/BF00144596; Haliloglu K, 2005, J PLANT BIOCHEM BIOT, V14, P155, DOI 10.1007/BF03263244; Harlan J.R., 1981, WHEAT SCI TODAY TOMO, P1; HE DG, 1986, PLANT SCI, V45, P119, DOI 10.1016/0168-9452(86)90047-6; He GY, 2001, EUPHYTICA, V119, P369, DOI 10.1023/A:1017587628995; Hess JR, 1998, CROP SCI, V38, P249, DOI 10.2135/cropsci1998.0011183X003800010042x; Jha AK, 2007, PLANT CELL REP, V26, P285, DOI 10.1007/s00299-006-0252-0; JOHANSSON L, 1986, POTATO RES, V29, P179, DOI 10.1007/BF02357649; Konieczny R, 2003, PLANT CELL TISS ORG, V73, P177, DOI 10.1023/A:1022877807237; Kothari SL, 1998, J PLANT BIOCHEM BIOT, V7, P93, DOI 10.1007/BF03263042; Kumar S, 2005, BIOL PLANTARUM, V49, P629, DOI 10.1007/s10535-005-0064-z; Leon E, 2006, PLANT BREEDING, V125, P580, DOI 10.1111/j.1439-0523.2006.01262.x; Li BC, 2003, IN VITRO CELL DEV-PL, V39, P20, DOI 10.1079/IVP2002356; Longin CFH, 2016, TRENDS PLANT SCI, V21, P731, DOI 10.1016/j.tplants.2016.05.005; MESSENS E, 1990, P NATL ACAD SCI USA, V87, P4368, DOI 10.1073/pnas.87.11.4368; Miroshnichenko D., 2009, Australian Journal of Crop Science, V3, P83; Miroshnichenko D. N., 2013, Russian Agricultural Sciences, V39, P24, DOI 10.3103/S1068367413010175; Miroshnichenko D, 2016, PLANT CELL TISS ORG, V125, P495, DOI 10.1007/s11240-016-0965-x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murthy BNS, 1998, IN VITRO CELL DEV-PL, V34, P267, DOI 10.1007/BF02822732; Ozgen M, 2017, PLANT GENET RESOUR-C, V15, P45, DOI 10.1017/S1479262115000350; OZIASAKINS P, 1982, PROTOPLASMA, V110, P95, DOI 10.1007/BF01281535; Pellegrineschi A, 2002, GENOME, V45, P421, DOI 10.1139/G01-154; Przetakiewicz A, 2003, PLANT CELL TISS ORG, V73, P245, DOI 10.1023/A:1023030511800; Pullman GS, 2005, PLANT CELL REP, V23, P596, DOI 10.1007/s00299-004-0880-1; Rademacher W, 2000, ANNU REV PLANT PHYS, V51, P501, DOI 10.1146/annurev.arplant.51.1.501; Rasco-Gaunt S, 2001, J EXP BOT, V52, P865, DOI 10.1093/jexbot/52.357.865; Rawat N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-205; Running Bi, 2008, Frontiers of Agriculture in China, V2, P262, DOI 10.1007/s11703-008-0038-y; Schulze J, 2007, FRUIT VEG CEREAL SCI, V1, P64; Seldimirova OA, 2016, IN VITRO CELL DEV-PL, V52, P251, DOI 10.1007/s11627-016-9767-4; Shan He, 2014, Journal of Northeast Agricultural University (English Edition), V21, P12; Shan XY, 2000, IN VITRO CELL DEV-PL, V36, P207, DOI 10.1007/s11627-000-0038-y; She MY, 2013, MOL BIOTECHNOL, V54, P451, DOI 10.1007/s12033-012-9583-y; Takumi S, 1997, GENES GENET SYST, V72, P63, DOI 10.1266/ggs.72.63; Viertel K, 1998, J PLANT PHYSIOL, V152, P167, DOI 10.1016/S0176-1617(98)80128-4; Ward KA, 2001, IN VITRO CELL DEV-PL, V37, P361; Yang S, 2015, ACTA PHYSIOL PLANT, V37, P1; Yin N, 2012, PLANT MOL BIOL REP, V30, P949, DOI 10.1007/s11105-011-0403-5; Zaharieva M, 2014, GENET RESOUR CROP EV, V61, P677, DOI 10.1007/s10722-014-0084-7; Zale JM, 2004, PLANT CELL TISS ORG, V76, P277, DOI 10.1023/B:TICU.0000009248.32457.4c	59	17	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173533	10.1371/journal.pone.0173533	http://dx.doi.org/10.1371/journal.pone.0173533			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273182	Green Submitted, Green Published, gold			2022-12-26	WOS:000396073700014
J	Zhang, XY; Wu, Y; Xiao, G; Tang, ZP; Wang, MY; Liu, FC; Zhu, XF				Zhang, Xinying; Wu, Yan; Xiao, Gao; Tang, Zhenping; Wang, Meiyin; Liu, Fuchang; Zhu, Xuefeng			Simultaneous photocatalytic and microbial degradation of dye-containing wastewater by a novel g-C3N4-P-25/photosynthetic bacteria composite	PLOS ONE			English	Article							TIO2-COATED BIOFILM CARRIER; BRILLIANT RED X-3B; VISIBLE-LIGHT; AZO-DYE; DECOLORIZATION; ALGINATE; REMOVAL; BIODEGRADATION; NANOPARTICLES; COMBINATION	Azo dyes are very resistant to light-induced fading and biodegradation. Existing advanced oxidative pre-treatment methods based on the generation of non-selective radicals cannot efficiently remove these dyes from wastewater streams, and post-treatment oxidative dye removal is problematic because it may leave many byproducts with unknown toxicity profiles in the outgoing water, or cause expensive complete mineralization. These problems could potentially be overcome by combining photocatalysis and biodegradation. A novel visible-light-responsive hybrid dye removal agent featuring both photocatalysts (g-C3N4-P-25) and photosynthetic bacteria encapsulated in calcium alginate beads was prepared by self-assembly. This system achieved a removal efficiency of 94% for the dye reactive brilliant red X-3b and also reduced the COD of synthetic wastewater samples by 84.7%, successfully decolorized synthetic dye-contaminated wastewater and reduced its COD, demonstrating the advantages of combining photocatalysis and biocatalysis for wastewater purification. The composite apparently degrades X-3b by initially converting the dye into aniline and phenol derivatives whose aryl moieties are then attacked by free radicals to form alkyl derivatives, preventing the accumulation of aromatic hydrocarbons that might suppress microbial activity. These alkyl intermediates are finally degraded by the photosynthetic bacteria.	[Zhang, Xinying; Wu, Yan; Xiao, Gao; Tang, Zhenping; Wang, Meiyin; Liu, Fuchang] Fuzhou Univ, Coll Environm & Resources, Fuzhou, Fujian, Peoples R China; [Zhang, Xinying] Fuzhou Univ, Res Inst Photocatalysis, State Key Lab Photocatalysis Energy & Environm, Fuzhou, Peoples R China; [Zhu, Xuefeng] Delft Univ Technol, Fac Civil Engn & GeoSci, Sect Sanit Engn, Dept Water Management, Delft, Netherlands	Fuzhou University; Fuzhou University; Delft University of Technology	Zhang, XY (corresponding author), Fuzhou Univ, Coll Environm & Resources, Fuzhou, Fujian, Peoples R China.; Zhang, XY (corresponding author), Fuzhou Univ, Res Inst Photocatalysis, State Key Lab Photocatalysis Energy & Environm, Fuzhou, Peoples R China.; Zhu, XF (corresponding author), Delft Univ Technol, Fac Civil Engn & GeoSci, Sect Sanit Engn, Dept Water Management, Delft, Netherlands.	xyz_8471@163.com; X.Zhu-1@tudelft.nl	xiao, gao/K-1226-2014; Xiao, Gao/D-8205-2019; xuefeng, zhu/AAJ-9371-2020	xiao, gao/0000-0002-6166-8771; Xiao, Gao/0000-0002-6166-8771; xuefeng, zhu/0000-0002-1910-629X	State Key Laboratory of Photocatalysis on Energy and Environment [2014C05]; Fujian Provincial Department of Science and Technology [2015R1004-3]; Environmental Protection Department of Fujian Province [2015R024]	State Key Laboratory of Photocatalysis on Energy and Environment; Fujian Provincial Department of Science and Technology; Environmental Protection Department of Fujian Province	This work was financially supported by the State Key Laboratory of Photocatalysis on Energy and Environment (2014C05), the Fujian Provincial Department of Science and Technology (CN) (2015R1004-3) and by Environmental Protection Department of Fujian Province (2015R024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarelli JQ, 2009, WATER SCI TECHNOL, V60, P1081, DOI 10.2166/wst.2009.459; An TC, 2003, J CHEM TECHNOL BIOT, V78, P1142, DOI 10.1002/jctb.915; Banat IM, 1996, BIORESOURCE TECHNOL, V58, P217, DOI 10.1016/S0960-8524(96)00113-7; Benzaquen TB, 2016, J CHEM TECHNOL BIOT, V91, P718, DOI 10.1002/jctb.4635; Brosillon S, 2008, DESALINATION, V222, P331, DOI 10.1016/j.desal.2007.01.153; Cao CH, 2013, APPL SURF SCI, V271, P105, DOI 10.1016/j.apsusc.2013.01.135; Chemlal R, 2014, ECOL ENG, V73, P281, DOI 10.1016/j.ecoleng.2014.09.043; Chen CY, 2014, CHEMOSPHERE, V117, P494, DOI 10.1016/j.chemosphere.2014.08.069; Cui D, 2014, BIORESOURCE TECHNOL, V163, P254, DOI 10.1016/j.biortech.2014.03.165; Daneshvar N, 2007, BIORESOURCE TECHNOL, V98, P1176, DOI 10.1016/j.biortech.2006.05.025; dos Santos AB, 2007, BIORESOURCE TECHNOL, V98, P2369, DOI 10.1016/j.biortech.2006.11.013; Gnanapragasam G, 2011, BIORESOURCE TECHNOL, V102, P627, DOI 10.1016/j.biortech.2010.08.012; Hao RR, 2016, APPL CATAL B-ENVIRON, V187, P47, DOI 10.1016/j.apcatb.2016.01.026; Hayat H, 2015, SEP PURIF TECHNOL, V154, P149, DOI 10.1016/j.seppur.2015.09.025; Kumar AN, 2015, BIORESOURCE TECHNOL, V188, P56, DOI 10.1016/j.biortech.2015.01.098; Kumar M, 2016, ARCH BIOCHEM BIOPHYS, V605, P41, DOI 10.1016/j.abb.2016.03.026; Kumar M, 2015, SCRIPTA MATER, V105, P46, DOI 10.1016/j.scriptamat.2015.04.030; Kumar M, 2013, J ENVIRON BIOL, V34, P1; Laera G, 2011, BIORESOURCE TECHNOL, V102, P7012, DOI 10.1016/j.biortech.2011.04.056; Li GZ, 2012, WATER RES, V46, P6489, DOI 10.1016/j.watres.2012.09.029; Li GZ, 2012, BIOTECHNOL BIOENG, V109, P884, DOI 10.1002/bit.24366; Li GZ, 2011, ENVIRON SCI TECHNOL, V45, P8359, DOI 10.1021/es2016523; Li JH, 2016, J PHOTOCH PHOTOBIO A, V317, P151, DOI 10.1016/j.jphotochem.2015.11.008; Liu W, 2012, CHEM ENG J, V209, P386, DOI 10.1016/j.cej.2012.08.033; Lotito AM, 2012, CHEM ENG J, V195, P261, DOI 10.1016/j.cej.2012.05.006; Marsolek MD, 2008, BIOTECHNOL BIOENG, V101, P83, DOI 10.1002/bit.21889; Montazerozohori M, 2013, ENVIRON PROG SUSTAIN, V32, P1061, DOI 10.1002/ep.11709; Ozdemir S, 2013, BIORESOURCE TECHNOL, V146, P135, DOI 10.1016/j.biortech.2013.07.066; Pawar RC, 2014, APPL CATAL B-ENVIRON, V144, P57, DOI 10.1016/j.apcatb.2013.06.022; Saratale RG, 2011, J TAIWAN INST CHEM E, V42, P138, DOI 10.1016/j.jtice.2010.06.006; Sarkar S, 2015, ECOTOX ENVIRON SAFE, V121, P263, DOI 10.1016/j.ecoenv.2015.02.035; Tian X, 2009, INT J HYDROGEN ENERG, V34, P4708, DOI 10.1016/j.ijhydene.2009.03.042; Wang XN, 2015, ULTRASON SONOCHEM, V23, P93, DOI 10.1016/j.ultsonch.2014.10.005; Wei S, 2014, POLYM COMPOSITE, V08, P1292; Xiao HH, 2015, APPL SURF SCI, V358, P313, DOI 10.1016/j.apsusc.2015.07.213; Xie YB, 2003, J MOL CATAL A-CHEM, V206, P419, DOI 10.1016/S1381-1169(03)00454-0; Yurtsever A, 2015, BIORESOURCE TECHNOL, V192, P564, DOI 10.1016/j.biortech.2015.06.024; Zhao KY, 2014, CATAL TODAY, V236, P127, DOI 10.1016/j.cattod.2014.03.041; Zhou DD, 2015, ENVIRON SCI TECHNOL, V49, P7776, DOI 10.1021/acs.est.5b00989; Zhuang Y, 2016, J ENVIRON CHEM ENG, V4, P147, DOI 10.1016/j.jece.2015.11.014	40	22	23	4	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172747	10.1371/journal.pone.0172747	http://dx.doi.org/10.1371/journal.pone.0172747			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273118	Green Submitted, Green Published, gold			2022-12-26	WOS:000396073700087
J	Grabchak, M; Marcon, E; Lang, G; Zhang, ZY				Grabchak, Michael; Marcon, Eric; Lang, Gabriel; Zhang, Zhiyi			The generalized Simpson's entropy is a measure of biodiversity	PLOS ONE			English	Article							SPECIES-DIVERSITY; DISCOVERY RATES; RICHNESS; EVENNESS	Modern measures of diversity satisfy reasonable axioms, are parameterized to produce diversity profiles, can be expressed as an effective number of species to simplify their interpretation, and come with estimators that allow one to apply them to real-world data. We introduce the generalized Simpson's entropy as a measure of diversity and investigate its properties. We show that it has many useful features and can be used as a measure of biodiversity. Moreover, unlike most commonly used diversity indices, it has unbiased estimators, which allow for sound estimation of the diversity of poorly sampled, rich communities.	[Grabchak, Michael; Zhang, Zhiyi] Univ North Carolina Charlotte, Dept Math & Stat, Charlotte, NC 28223 USA; [Marcon, Eric] Univ Guyane, Univ Antilles, AgroParisTech, UMR EcoFoG,CNRS,CIRAD,INRA, BP 709, F-97310 Kourou, France; [Lang, Gabriel] Univ Paris Saclay, INRA, AgroParisTech, UMR Mia 518, F-75015 Paris, France	University of North Carolina; University of North Carolina Charlotte; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; INRAE; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Marcon, E (corresponding author), Univ Guyane, Univ Antilles, AgroParisTech, UMR EcoFoG,CNRS,CIRAD,INRA, BP 709, F-97310 Kourou, France.	eric.marcon@ecofog.gf	Marcon, Eric/B-5631-2009	Marcon, Eric/0000-0002-5249-321X	Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-25-01]	Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR))	This work has benefited from an "Investissement d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-25-01).	Beck J, 2010, METHODS ECOL EVOL, V1, P38, DOI 10.1111/j.2041-210X.2009.00003.x; Brose U, 2003, ECOLOGY, V84, P2364, DOI 10.1890/02-0558; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; Cao L, 2014, ENTROPYESTIMATION ES; Chao A, 2015, METHODS ECOL EVOL, V6, P873, DOI 10.1111/2041-210X.12349; Chao AN, 2013, METHODS ECOL EVOL, V4, P1091, DOI 10.1111/2041-210X.12108; Corona P, 2015, BIODIVERSIT IN PRESS; Dalton H, 1920, ECON J, V30, P348, DOI 10.2307/2223525; DAROCZY Z, 1970, INFORM CONTROL, V16, P36, DOI 10.1016/S0019-9958(70)80040-7; Dauby G, 2012, ECOGRAPHY, V35, P661, DOI 10.1111/j.1600-0587.2011.06860.x; FADDEEV D. K., 1956, USP MAT NAUK, V11, P227; Gourlet-Fleury S., 2004, ECOLOGY MANAGEMENT N; Gregorius HR, 2014, WEB ECOL, V14, P51, DOI 10.5194/we-14-51-2014; GREGORIUS HR, 1991, THEOR POPUL BIOL, V40, P269, DOI 10.1016/0040-5809(91)90056-L; Harvda J, 1967, KYBERNETIKA, V3, P30; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Marcon E., 2015, PRACTICAL ESTIMATION; Marcon E, 2015, J STAT SOFTW, V67, P1; Marcon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090289; Olszewski TD, 2004, OIKOS, V104, P377, DOI 10.1111/j.0030-1299.2004.12519.x; PATIL GP, 1982, J AM STAT ASSOC, V77, P548, DOI 10.2307/2287709; R Development Core Team, 2016, R LANG ENV STAT COMP; Renyi A., 1961, 4 BERK S MATH STAT P, V1; Ricotta C, 2005, ACTA BIOTHEOR, V53, P29, DOI 10.1007/s10441-005-7001-6; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; TOTHMERESZ B, 1995, J VEG SCI, V6, P283, DOI 10.2307/3236223; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; Zhang ZY, 2016, J NONPARAMETR STAT, V28, P563, DOI 10.1080/10485252.2016.1190357; Zhang ZY, 2010, J STAT PLAN INFER, V140, P1731, DOI 10.1016/j.jspi.2009.12.023	33	16	16	3	149	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173305	10.1371/journal.pone.0173305	http://dx.doi.org/10.1371/journal.pone.0173305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267765	Green Published, Green Submitted, gold			2022-12-26	WOS:000396060600021
J	Piedra, FA; Mei, MH; Avadhanula, V; Mehta, R; Aideyan, L; Garofalo, RP; Piedra, PA				Piedra, Felipe-Andres; Mei, Minghua; Avadhanula, Vasanthi; Mehta, Reena; Aideyan, Letisha; Garofalo, Roberto P.; Piedra, Pedro A.			The interdependencies of viral load, the innate immune response, and clinical outcome in children presenting to the emergency department with respiratory syncytial virus-associated bronchiolitis	PLOS ONE			English	Article							ANTIBODY-MEDIATED RESTRICTION; DISEASE SEVERITY; G-PROTEIN; HOSPITALIZED INFANTS; INFECTION; PATHOGENESIS; REPLICATION; MULTICENTER; MACROPHAGES; COMMUNITY	Respiratory syncytial virus (RSV) causes significant infant morbidity and mortality. For decades severe RSV-induced disease was thought to result from an uncontrolled host response to viral replication, but recent work suggests that a strong innate immune response early in infection is protective. To shed light on host-virus interactions and the viral determinants of disease, copy numbers of five RSV genes (NS1, NS2, N, G, F) were measured by quantitative real-time polymerase chain reaction (qPCR) in nasal wash samples from children with RSV-associated bronchiolitis. Correlations were sought with host cytokines/chemokines and biomarkers. Associations with disposition from the emergency department (hospitalized or sent home) and pulse oximetry 02 saturation levels were also sought. Additionally, RNase P copy number was measured and used to normalize nasal wash data. RSV gene copy numbers were found to significantly correlate with both cytokine/chemokine and biomarker levels; and RNase P-normalized viral gene copy numbers (NS1, NS2, N and G) were significantly higher in infants with less severe disease. Moreover, three of the normalized viral gene copy numbers (NS1, NS2, and N) correlated significantly with arterial O-2 saturation levels. The data support a model where a higher viral load early in infection can promote a robust innate immune response that protects against progression into hypoxic RSV-induced lower respiratory tract illness.	[Piedra, Felipe-Andres; Mei, Minghua; Avadhanula, Vasanthi; Aideyan, Letisha; Piedra, Pedro A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Mehta, Reena] Allergy & Asthma Specialists PC, Saddle River, NJ USA; [Garofalo, Roberto P.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Piedra, Pedro A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Mei, Minghua] Eli Lilly & Co, Statist Oncol, Indianapolis, IN 46285 USA	Baylor College of Medicine; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine; Eli Lilly	Piedra, PA (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.; Piedra, PA (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	ppiedra@bcm.edu	, VA/AAO-6566-2020; Garofalo, Roberto P./AAF-7385-2022; Garofalo, Roberto P./ABL-2322-2022	Piedra, Pedro/0000-0002-5839-0879	Department of Defense; Postdoctoral Fellowship from the National Institute of Environmental Health Sciences [T32-07254]	Department of Defense(United States Department of Defense); Postdoctoral Fellowship from the National Institute of Environmental Health Sciences	This work was supported by the Department of Defense (https://urldefense.proofpoint.com/v2/url?u=http-3A_www.defense.gov_&d=DwIGaQ&c=ZQs-KZ8oxEw0p81sqgiaRA&r=8HfluFGqdfRYRuWe3HyiMA&m=PYV_85UrZLaXMsZpeX6cRhl19l8q2G5RutrxhnOWcMk&s=W5VY_4LzMqd1U6ND2m5hHnonN4l5-HBG7ygLctfsPEQ&e=) [W81XWH1010146 to RPG] and a Postdoctoral Fellowship from the National Institute of Environmental Health Sciences (https://urldefense.proofpoint.com/v2/url?u=http-3A_www.niehs.nih.gov_&d=DwIGaQ&c=ZQs-KZ8oxEw0p81sqgiaRA&r=8HfluFGqdfRYRuWe3HyiMA&m=PYV_85UrZLaXMsZpeX6cRhl19l8q2G5RutrxhnOWcMk&s=egZ4Nl6jAxKtJFK-tBHFo3Gy0OMiA1Q5EeZ72qgW7SM&e=) [T32-07254 to RM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, DATA ANAL ABI PRISM; Avadhanula V, 2015, J INFECT DIS, V211, P582, DOI 10.1093/infdis/jiu473; Bennett BL, 2007, J INFECT DIS, V195, P1532, DOI 10.1086/515575; Buckingham SC, 2000, PEDIATR INFECT DIS J, V19, P113, DOI 10.1097/00006454-200002000-00006; Bukreyev A, 2012, J VIROL, V86, P10880, DOI 10.1128/JVI.01162-12; Bukreyev A, 2008, J VIROL, V82, P12191, DOI 10.1128/JVI.01604-08; Chirkova T, 2013, J VIROL, V87, P13466, DOI 10.1128/JVI.01741-13; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; DeVincenzo JP, 2005, J INFECT DIS, V191, P1861, DOI 10.1086/430008; Fodha I, 2007, J MED VIROL, V79, P1951, DOI 10.1002/jmv.21026; FULGINITI VA, 1969, AM J EPIDEMIOL, V89, P435, DOI 10.1093/oxfordjournals.aje.a120956; Fuller JA, 2013, J MED VIROL, V85, P924, DOI 10.1002/jmv.23455; Graham BS, 2000, IMMUNOPHARMACOLOGY, V48, P237, DOI 10.1016/S0162-3109(00)00233-2; Harcourt JL, 2004, J INFECT DIS, V190, P1936, DOI 10.1086/425516; Hasegawa K, 2015, J INFECT DIS, V211, P1550, DOI 10.1093/infdis/jiu658; Hasegawa K, 2014, PEDIATR INFECT DIS J, V33, P11, DOI 10.1097/INF.0b013e3182a5f324; Houben ML, 2010, J MED VIROL, V82, P1266, DOI 10.1002/jmv.21771; JOHNSON KM, 1961, JAMA-J AM MED ASSOC, V176, P663; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Krathwohl MD, 2006, VACCINE, V24, P2987, DOI 10.1016/j.vaccine.2005.11.032; Laham FR, 2010, PEDIATRICS, V125, pE225, DOI 10.1542/peds.2009-0411; Laham FR, 2004, J INFECT DIS, V189, P2047, DOI 10.1086/383350; Legg JP, 2003, AM J RESP CRIT CARE, V168, P633, DOI 10.1164/rccm.200210-1148OC; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Lopez CB, 2014, J VIROL, V88, P8720, DOI 10.1128/JVI.00707-14; Mansbach JM, 2012, ARCH PEDIAT ADOL MED, V166, P700, DOI 10.1001/archpediatrics.2011.1669; McLellan JS, 2013, CURR TOP MICROBIOL, V372, P83, DOI 10.1007/978-3-642-38919-1_4; Mehta R, 2014, INFLUENZA OTHER RESP, V8, P617, DOI 10.1111/irv.12276; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nicholson EG, 2016, J INFECT DIS; Openshaw PJM, 2005, CLIN MICROBIOL REV, V18, P541, DOI 10.1128/CMR.18.3.541-555.2005; Pathak KB, 2009, VIRUSES-BASEL, V1, P895, DOI 10.3390/v1030895; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Polack FP, 2002, J EXP MED, V196, P859, DOI 10.1084/jem.20020781; Scagnolari C, 2012, MED MICROBIOL IMMUN, V201, P311, DOI 10.1007/s00430-012-0233-6; Spann KM, 2004, J VIROL, V78, P4363, DOI 10.1128/JVI.78.8.4363-4369.2004; Sun Y, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005122; Swedan S, 2009, J VIROL, V83, P9682, DOI 10.1128/JVI.00715-09; Tapia LI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090786; Tripp RA, 2004, VIRAL IMMUNOL, V17, P165, DOI 10.1089/0882824041310513; Wright PF, 2002, J INFECT DIS, V185, P1011, DOI 10.1086/339822; Yang P, 2015, VIROLOGY, V485, P223, DOI 10.1016/j.virol.2015.07.016; Yokota S, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/184328; Zheng JM, 2015, DISCRETE DYN NAT SOC, V2015, DOI 10.1155/2015/782630; Zorc JJ, 2010, PEDIATRICS, V125, P342, DOI 10.1542/peds.2009-2092	46	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0172953	10.1371/journal.pone.0172953	http://dx.doi.org/10.1371/journal.pone.0172953			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267794	Green Submitted, gold, Green Published			2022-12-26	WOS:000396060600006
J	Euesden, J; Danese, A; Lewis, CM; Maughan, B				Euesden, Jack; Danese, Andrea; Lewis, Cathryn M.; Maughan, Barbara			A bidirectional relationship between depression and the autoimmune disorders - New perspectives from the National Child Development Study	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; MENTAL-DISORDERS; RISK-FACTORS; INFLAMMATION; DISEASES; EPIDEMIOLOGY; SCHIZOPHRENIA; SMOKING; ANXIETY; STRESS	Background Depression and the autoimmune disorders are comorbid-the two classes of disorders overlap in the same individuals at a higher frequency than chance. The immune system may influence the pathological processes underlying depression; understanding the origins of this comorbidity may contribute to dissecting the mechanisms underlying these disorders. Method We used population cohort data from the 1958 British birth cohort study (the National Child Development Study) to investigate the ages at onset of depression and 23 autoimmune disorders. We used self-report data to ascertain life-time history of depression, autoimmune disorders and their ages at onset. We modelled the effect of depression onset on subsequent autoimmune disorder onset, and vice versa, and incorporated polygenic risk scores for depression and autoimmune disorder risk. Results In our analytic sample of 8174 individuals, 315 reported ever being diagnosed with an autoimmune disorder (3.9%), 1499 reported ever experiencing depression (18.3%). There was significant comorbidity between depression and the autoimmune disorders (OR = 1.66, 95% CI = 1.27-2.15). Autoimmune disorder onset associated with increased subsequent hazard of depression onset (HR = 1.39, 95% CI = 1.11-1.74, P = 0.0037), independently of depression genetic risk. Finally, depression increased subsequent hazard of autoimmune disorder onset (HR = 1.40, 95% CI = 1.09-1.80, P = 0.0095), independently of autoimmune disorder genetic risk. Discussion Our results point to a bidirectional relationship between depression and the autoimmune disorders. This suggests that shared risk factors may contribute to this relationship, including both common environmental exposures that increase baseline inflammation levels, and shared genetic factors.	[Euesden, Jack; Danese, Andrea; Lewis, Cathryn M.; Maughan, Barbara] Kings Coll London, MRC, SGDP Ctr, Inst Psychiat Psychol & Neurosci, London, England; [Euesden, Jack] Univ Bristol, Integrat Epidemiol Unit, Bristol, Avon, England; [Danese, Andrea] Kings Coll London, Dept Child & Adolescent Psychiat, Inst Psychiat Psychol & Neurosci, London, England; [Lewis, Cathryn M.] Kings Coll London, Div Genet & Mol Med, London, England	University of London; King's College London; University of Bristol; University of London; King's College London; University of London; King's College London	Euesden, J (corresponding author), Kings Coll London, MRC, SGDP Ctr, Inst Psychiat Psychol & Neurosci, London, England.	jack.euesden@kcl.ac.uk	Danese, Andrea/ABF-1471-2020; Lewis, Cathryn/A-5225-2010	Danese, Andrea/0000-0001-8718-5412; Euesden, Jack/0000-0002-6790-1925; Maughan, Barbara/0000-0002-8887-3484; Lewis, Cathryn/0000-0002-8249-8476	Medical Research Council; Wellcome Trust [076113, 085475, 090355]; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre, South London and the Maudsley NHS Foundation Trust; King's College London; MRC [G1001799, MR/N01104X/1, MR/N01104X/2] Funding Source: UKRI; Medical Research Council [MR/N01104X/2, 1242800, MR/N01104X/1, G1001799] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre, South London and the Maudsley NHS Foundation Trust; King's College London(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council PhD Studentship to JE. Funding for the project was provided by the Wellcome Trust Agreement under award 076113, 085475 and 090355. This study was also supported by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre, South London and the Maudsley NHS Foundation Trust and King's College London.	Andersson NW, 2015, PSYCHOL MED, V45, P3559, DOI 10.1017/S0033291715001488; BEISER M, 1993, AM J PSYCHIAT, V150, P1349; Benros ME, 2011, AM J PSYCHIAT, V168, P1303, DOI 10.1176/appi.ajp.2011.11030516; Bjorngaard JH, 2013, PSYCHOL MED, V43, P711, DOI 10.1017/S0033291712001274; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; BURKE KC, 1990, ARCH GEN PSYCHIAT, V47, P511; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Danese A, 2011, MOL PSYCHIATR, V16, P244, DOI 10.1038/mp.2010.5; Danese A, 2008, ARCH GEN PSYCHIAT, V65, P409, DOI 10.1001/archpsyc.65.4.409; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Di Giuseppe D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4498; Dickens C, 2002, PSYCHOSOM MED, V64, P52, DOI 10.1097/00006842-200201000-00008; Dube SR, 2009, PSYCHOSOM MED, V71, P243, DOI 10.1097/PSY.0b013e3181907888; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Euesden JM, PSYCHOSOM M IN PRESS; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; HOLLAND PW, 1986, J AM STAT ASSOC, V81, P945, DOI 10.2307/2289064; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Kohler O, 2014, JAMA PSYCHIAT, V71, P1381, DOI 10.1001/jamapsychiatry.2014.1611; Kurina LM, 2001, J EPIDEMIOL COMMUN H, V55, P716, DOI 10.1136/jech.55.10.716; Lu MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep20647; Martin J, 2016, AM J EPIDEMIOL, V183, P1149, DOI 10.1093/aje/kww009; Matthews KA, 2010, BRAIN BEHAV IMMUN, V24, P96, DOI 10.1016/j.bbi.2009.08.005; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Moffitt TE, 2010, PSYCHOL MED, V40, P899, DOI 10.1017/S0033291709991036; Musselman DL, 2001, NEW ENGL J MED, V344, P961, DOI 10.1056/NEJM200103293441303; Nanni V, 2012, AM J PSYCHIAT, V169, P141, DOI 10.1176/appi.ajp.2011.11020335; Nissen HA, 1936, NEW ENGL J MED, V214, P576, DOI 10.1056/NEJM193603192141205; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Patten SB, 2003, NEUROLOGY, V61, P1524, DOI 10.1212/01.WNL.0000095964.34294.B4; Pedersen M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2022; Peyrot WJ, 2014, BRIT J PSYCHIAT, V205, P113, DOI 10.1192/bjp.bp.113.143081; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; R Development Core Team, 2008, R A LANGUAGE AND ENV; Raison Charles L, 2013, Cerebrum, V2013, P10; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Sheehy C, 2006, RHEUMATOLOGY, V45, P1325, DOI 10.1093/rheumatology/kel231; Smith DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075362; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Van de Velde S, 2010, SOC SCI MED, V71, P305, DOI 10.1016/j.socscimed.2010.03.035; WEISSMAN MM, 1977, ARCH GEN PSYCHIAT, V34, P98; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277	48	47	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							E0173015	10.1371/journal.pone.0173015	http://dx.doi.org/10.1371/journal.pone.0173015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5OE	28264010	Green Published, Green Submitted, gold			2022-12-26	WOS:000396054300033
J	Hayashi, K; Furuya, A; Sakamaki, Y; Akagi, T; Shinoda, Y; Sadakata, T; Hashikawa, T; Shimizu, K; Minami, H; Sano, Y; Nakayama, M; Furuichi, T				Hayashi, Kanehiro; Furuya, Asako; Sakamaki, Yuriko; Akagi, Takumi; Shinoda, Yo; Sadakata, Tetsushi; Hashikawa, Tsutomu; Shimizu, Kazuki; Minami, Haruka; Sano, Yoshitake; Nakayama, Manabu; Furuichi, Teiichi			The brain-specific RasGEF very-KIND is required for normal dendritic growth in cerebellar granule cells and proper motor coordination	PLOS ONE			English	Article							EXCHANGE FACTOR; MICE LACKING; C-LOBE; PROTEIN; CAPS2	Very-KIND/Kndc1/KIAA1768 (v-KIND) is a brain-specific Ras guanine nucleotide exchange factor carrying two sets of the kinase non-catalytic C-lobe domain (KIND), and is predominantly expressed in cerebellar granule cells. Here, we report the impact of v-KIND deficiency on dendritic and synaptic growth in cerebellar granule cells in v-KIND knockout (KO) mice. Furthermore, we evaluate motor function in these animals. The gross anatomy of the cerebellum, including the cerebellar lobules, layered cerebellar cortex and densely-packed granule cell layer, in KO mice appeared normal, and was similar to wild-type (WT) mice. However, KO mice displayed an overgrowth of cerebellar granule cell dendrites, compared with WT mice, resulting in an increased number of dendrites, dendritic branches and terminals. Immunoreactivity for vGluT2 (a marker for excitatory presynapses of mossy fiber terminals) was increased in the cerebellar glomeruli of KO mice, compared with WT mice. The postsynaptic density around the terminals of mossy fibers was also increased in KO mice. Although there were no significant differences in locomotor ability between KO and WT animals in their home cages or in the open field, young adult KO mice had an increased grip strength and a tendency to exhibit better motor performance in balance-related tests compared with WT animals. Taken together, our results suggest that v-KIND is required for compact dendritic growth and proper excitatory synaptic connections in cerebellar granule cells, which are necessary for normal motor coordination and balance.	[Hayashi, Kanehiro; Furuya, Asako; Shinoda, Yo; Sadakata, Tetsushi; Furuichi, Teiichi] RIKEN Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama, Japan; [Hayashi, Kanehiro] Keio Univ, Sch Med, Dept Anat, Shinjuku Ku, Tokyo, Japan; [Furuya, Asako] RIKEN Brain Sci Inst, Lab Mental Biol, Wako, Saitama, Japan; [Sakamaki, Yuriko; Akagi, Takumi; Hashikawa, Tsutomu] RIKEN Brain Sci Inst, Res Resource Ctr, Wako, Saitama, Japan; [Sakamaki, Yuriko] Tokyo Med & Dent Univ, Res Ctr Med & Dent Sci, Bunkyo Ku, Tokyo, Japan; [Akagi, Takumi] Nippon Med Sch, Dept Physiol, Bunkyo Ku, Tokyo, Japan; [Shinoda, Yo] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo, Japan; [Sadakata, Tetsushi] Gunma Univ, Adv Sci Res Leaders Dev Unit, Maebashi, Gunma, Japan; [Shimizu, Kazuki; Minami, Haruka; Sano, Yoshitake; Furuichi, Teiichi] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba, Japan; [Nakayama, Manabu] Kazusa DNA Res Inst, Dev Technol Dept, Chromosome Engn Team, Kisarazu, Chiba, Japan	RIKEN; Keio University; RIKEN; RIKEN; Tokyo Medical & Dental University (TMDU); Nippon Medical School; Tokyo University of Pharmacy & Life Sciences; Gunma University; Tokyo University of Science; Kazusa DNA Research Institute	Furuichi, T (corresponding author), RIKEN Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama, Japan.; Furuichi, T (corresponding author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba, Japan.	tfuruichi@rs.tus.ac.jp	Furuichi, Teiichi/B-5086-2014; Shinoda, Yo/H-3091-2019; Sadakata, Tetsushi/W-9324-2018	Furuichi, Teiichi/0000-0002-9676-1888; Shinoda, Yo/0000-0003-3253-2194; Sadakata, Tetsushi/0000-0003-0276-4162; Sano, Yoshitake/0000-0001-5188-3104	Japan Society for the Promotion of Science (KAKENHI) [20300134, 23300137, 26290026, 15K14356, 15K06745]; Hamaguchi Foundation for the Advancement of Biochemistry; Tokyo University of Science; Grants-in-Aid for Scientific Research [15K14356] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hamaguchi Foundation for the Advancement of Biochemistry(Hamaguchi Foundation for the Advancement of Biochemistry); Tokyo University of Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants from the Japan Society for the Promotion of Science (KAKENHI 20300134, 23300137, 26290026, 15K14356, 15K06745), the Hamaguchi Foundation for the Advancement of Biochemistry, and Tokyo University of Science.	Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; Ceccarelli M, 2015, DEV BIOL, V408, P109, DOI 10.1016/j.ydbio.2015.10.007; Ciccarelli FD, 2003, TRENDS BIOCHEM SCI, V28, P349, DOI 10.1016/S0968-0004(03)00116-6; Delvendahl I, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00093; Eccles JC, 1967, CEREBELLUM NEURONAL; Galliano E, 2013, CELL REP, V3, P1239, DOI 10.1016/j.celrep.2013.03.023; Gan WB, 2009, COLD SPRING HARB PRO, V4, P1; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Huang J, 2007, J CELL BIOL, V179, P539, DOI 10.1083/jcb.200702036; Huang JH, 2011, FEBS J, V278, P1651, DOI 10.1111/j.1742-4658.2011.08085.x; Ito M, 2000, BRAIN RES, V886, P237, DOI 10.1016/S0006-8993(00)03142-5; Ito M, 1997, INT REV NEUROBIOL, V41, P475, DOI 10.1016/S0074-7742(08)60366-9; Kadotani H, 1996, J NEUROSCI, V16, P7859; Ma QL, 2014, J NEUROSCI, V34, P7124, DOI 10.1523/JNEUROSCI.3439-13.2014; Mees A, 2005, GENE EXPR PATTERNS, V6, P79, DOI 10.1016/j.modgep.2005.04.015; Nakayama M, 2006, FASEB J, V20, P1718, DOI 10.1096/fj.06-5952fje; PALKOVIT.M, 1972, BRAIN RES, V45, P15, DOI 10.1016/0006-8993(72)90213-2; Ramon, 1909, HISTOLOGIE SYSTEME N; Rieff HI, 2006, EUR J NEUROSCI, V23, P2225, DOI 10.1111/j.1460-9568.2006.04727.x; Rylkova D, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0075-15.2015; Sadakata T, 2007, J CLIN INVEST, V117, P931, DOI 10.1172/JCI29031; Sadakata T, 2007, J NEUROSCI, V27, P2472, DOI 10.1523/JNEUROSCI.2279-06.2007; Shinoda Y, 2011, P NATL ACAD SCI USA, V108, P373, DOI 10.1073/pnas.1012220108; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1	24	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173175	10.1371/journal.pone.0173175	http://dx.doi.org/10.1371/journal.pone.0173175			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264072	gold, Green Published, Green Submitted			2022-12-26	WOS:000396054300043
J	Helluy, X; Sauter, M; Ye, YX; Lykowsky, G; Kreutner, J; Yilmaz, A; Jahns, R; Boivin, V; Kandolf, R; Jakob, PM; Hiller, KH; Klingel, K				Helluy, Xavier; Sauter, Martina; Ye, Yu-Xiang; Lykowsky, Gunthard; Kreutner, Jakob; Yilmaz, Ali; Jahns, Roland; Boivin, Valerie; Kandolf, Reinhard; Jakob, Peter M.; Hiller, Karl-Heinz; Klingel, Karin			In vivo T2*weighted MRI visualizes cardiac lesions in murine models of acute and chronic viral myocarditis	PLOS ONE			English	Article							COXSACKIEVIRUS B3-INDUCED MYOCARDITIS; ADENINE-NUCLEOTIDE TRANSLOCATOR; RESONANCE; CARDIOMYOPATHY; SUSCEPTIBILITY; REPLICATION; EXPRESSION; INFARCTION; INFECTION; DIAGNOSIS	Objective Acute and chronic forms of myocarditis are mainly induced by virus infections. As a consequence of myocardial damage and inflammation dilated cardiomyopathy and chronic heart failure may develop. The gold standard for the diagnosis of myocarditis is endomyocardial biopsies which are required to determine the etiopathogenesis of cardiac inflammatory processes. However, new non-invasive MRI techniques hold great potential in visualizing cardiac non-ischemic inflammatory lesions at high spatial resolution, which could improve the investigation of the pathophysiology of viral myocarditis. Results Here we present the discovery of a novel endogenous T2* MRI contrast of myocardial lesions in murine models of acute and chronic CVB3 myocarditis. The evaluation of infected hearts ex vivo and in vivo by 3D T2w and T2*w MRI allowed direct localization of virus-induced myocardial lesions without any MRI tracer or contrast agent. T2* w weighted MRI is able to detect both small cardiac lesions of acute myocarditis and larger necrotic areas at later stages of chronic myocarditis, which was confirmed by spatial correlation of MRI hypointensity in myocardium with myocardial lesions histologically. Additional in vivo and ex vivo MRI analysis proved that the contrast mechanism was due to a strong paramagnetic tissue alteration in the vicinity of myocardial lesions, effectively pointing towards iron deposits as the primary contributor of contrast. The evaluation of the biological origin of the MR contrast by specific histological staining and transmission electron microscopy revealed that impaired iron metabolism primarily in mitochondria caused iron deposits within necrotic myocytes, which induces strong magnetic susceptibility in myocardial lesions and results in strong T2* contrast. Conclusion This T2*w MRI technique provides a fast and sensitive diagnostic tool to determine the patterns and the severity of acute and chronic enteroviral myocarditis and the precise localization of tissue damage free of MR contrast agents.	[Helluy, Xavier; Ye, Yu-Xiang] Univ Wurzburg, Inst Phys, Dept Expt Phys V, Wurzburg, Germany; [Sauter, Martina; Kandolf, Reinhard; Klingel, Karin] Univ Hosp Tuebingen, Inst Pathol & Neuropathol, Dept Mol Pathol, Tubingen, Germany; [Ye, Yu-Xiang] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Ye, Yu-Xiang] Harvard Med Sch, Boston, MA USA; [Lykowsky, Gunthard; Kreutner, Jakob; Jakob, Peter M.; Hiller, Karl-Heinz] Res Ctr Magnet Resonance Bavaria MRB, Wurzburg, Germany; [Yilmaz, Ali] Univ Hosp Munster, Dept Cardiol & Angiol, Munster, Germany; [Jahns, Roland] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany; [Jahns, Roland] Univ Hosp Wurzburg, Interdisziplinary Bank Biomat & Data Ibdw, Wurzburg, Germany; [Boivin, Valerie] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany; [Hiller, Karl-Heinz] Fraunhofer Inst Integrated Circuits, Magnet Resonance & XRay Imaging Dept, Wurzburg, Germany	University of Wurzburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Wurzburg; University of Munster; University of Wurzburg; University of Wurzburg; University of Wurzburg; Fraunhofer Gesellschaft	Klingel, K (corresponding author), Univ Hosp Tuebingen, Inst Pathol & Neuropathol, Dept Mol Pathol, Tubingen, Germany.	Karin.Klingel@med.uni-tuebingen.de			German Federal Ministry of Education and Research [01EZ0818, 13EZ0817]; Deutsche Herzstiftung e.V.	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Herzstiftung e.V.	This work was financially supported by a grant from the German Federal Ministry of Education and Research (WN; grant-ID 01EZ0818 and 13EZ0817), and in part by the Deutsche Herzstiftung e.V. (Ye, Y-X).	Brunner S, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-43; Caforio ALP, 2013, EUR HEART J, V34, P2636, DOI 10.1093/eurheartj/eht210; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Dorner A, 2000, J AM COLL CARDIOL, V35, P1778, DOI 10.1016/S0735-1097(00)00644-6; Ebermann L, 2012, LAB INVEST, V92, P125, DOI 10.1038/labinvest.2011.145; Grant SC, 2001, IEEE T MAGN, V37, P2989, DOI 10.1109/20.947051; Gruhle S, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0287-z; Jacoby C, 2014, MAGN RESON MATER PHY, V27, P101, DOI 10.1007/s10334-013-0391-6; Khan FA, 2007, INT J INFECT DIS, V11, P482, DOI 10.1016/j.ijid.2007.04.007; KLINGEL K, 1992, P NATL ACAD SCI USA, V89, P314, DOI 10.1073/pnas.89.1.314; Klingel K, 2014, IMAGE MONTH ASS IRON; Moon JC, 2007, REV ESP CARDIOL, V60, P1, DOI 10.1016/S0300-8932(07)74976-X; Pankuweit S, 2013, HEART FAIL REV, V18, P683, DOI 10.1007/s10741-012-9357-4; POSSE S, 1990, J MAGN RESON, V88, P473, DOI 10.1016/0022-2364(90)90282-E; Reichenbach JR, 2011, SUSCEPTIBILITY WEIGH, P1; Sagar S, 2012, LANCET, V379, P738, DOI 10.1016/S0140-6736(11)60648-X; Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854; Schulze K, 1999, CARDIOVASC RES, V44, P91, DOI 10.1016/S0008-6363(99)00204-7; Szalay G, 2009, CIRC RES, V104, P851, DOI 10.1161/CIRCRESAHA.109.193805; Thorek DLJ, 2006, ANN BIOMED ENG, V34, P23, DOI 10.1007/s10439-005-9002-7; Ursu ON, 2014, CELL PHYSIOL BIOCHEM, V33, P52, DOI 10.1159/000356649; Weinstein JS, 2010, J CEREBR BLOOD F MET, V30, P15, DOI 10.1038/jcbfm.2009.192; Ye Y, 2012, CIRCULATION; Ye YX, 2013, CIRCULATION, V128, P1878, DOI 10.1161/CIRCULATIONAHA.113.000731; Yilmaz A, 2013, EUR HEART J, V34, P462, DOI 10.1093/eurheartj/ehs366	25	7	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172084	10.1371/journal.pone.0172084	http://dx.doi.org/10.1371/journal.pone.0172084			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264039	Green Submitted, Green Published, gold			2022-12-26	WOS:000396054300007
J	Kim, JI; Lee, I; Park, S; Bae, JY; Yoo, K; Cheong, HJ; Noh, JY; Hong, KW; Lemey, P; Vrancken, B; Kim, J; Nam, M; Yun, SH; Cho, WI; Song, JY; Kim, WJ; Park, MS; Song, JW; Kee, SH; Song, KJ; Park, MS				Kim, Jin Il; Lee, Ilseob; Park, Sehee; Bae, Joon-Yong; Yoo, Kirim; Cheong, Hee Jin; Noh, Ji Yun; Hong, Kyung Wook; Lemey, Philippe; Vrancken, Bram; Kim, Juwon; Nam, Misun; Yun, Soo-Hyeon; Cho, Woo In; Song, Joon Young; Kim, Woo Joo; Park, Mee Sook; Song, Jin-Won; Kee, Sun-Ho; Song, Ki-Joon; Park, Man-Seong			Phylogenetic relationships of the HA and NA genes between vaccine and seasonal influenza A(H3N2) strains in Korea	PLOS ONE			English	Article							RECEPTOR-BINDING; VIRUS; HEMAGGLUTININ; NEURAMINIDASE; EVOLUTION; GLYCOSYLATION; SITES; MODEL; MAFFT	Seasonal influenza is caused by two influenza A subtype (H1N1 and H3N2) and two influenza B lineage (Victoria and Yamagata) viruses. Of these antigenically distinct viruses, the H3N2 virus was consistently detected in substantial proportions in Korea during the 2010/11-2013/14 seasons when compared to the other viruses and appeared responsible for the influenza-like illness rate peak during the first half of the 2011/12 season. To further scrutinize possible causes for this, we investigated the evolutionary and serological relationships between the vaccine and Korean H3N2 strains during the 2011/12 season for the main antigenic determinants of influenza viruses, the hemagglutinin (HA) and neuraminidase (NA) genes. In the 2011/12 season, when the number of H3N2 cases peaked, the majority of the Korean strains did not belong to the HA clade of A/Perth/16/2009 vaccine, and no Korean strains were of this lineage in the NA segment. In a serological assay, post-vaccinated human sera exhibited much reduced hemagglutination inhibition antibody titers against the non-vaccine clade Korean H3N2 strains. Moreover, Korean strains harbored several amino acid differences in the HA antigenic sites and in the NA with respect to vaccine lineages during this season. Of these, the HA antigenic site C residues 45 and 261 and the NA residue 81 appeared to be the signatures of positive selection. In subsequent seasons, when H3N2 cases were lower, the HA and NA genes of vaccine and Korean strains were more phylogenetically related to each other. Combined, our results provide indirect support for using phylogenetic clustering patterns of the HA and possibly also the NA genes in the selection of vaccine viruses and the assessment of vaccine effectiveness.	[Kim, Jin Il; Lee, Ilseob; Park, Sehee; Bae, Joon-Yong; Yoo, Kirim; Kim, Juwon; Nam, Misun; Yun, Soo-Hyeon; Cho, Woo In; Park, Mee Sook; Song, Jin-Won; Kee, Sun-Ho; Song, Ki-Joon; Park, Man-Seong] Korea Univ, Coll Med, Inst Viral Dis, Dept Microbiol, Seoul, South Korea; [Cheong, Hee Jin; Noh, Ji Yun; Song, Joon Young; Kim, Woo Joo] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea; [Hong, Kyung Wook] Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea; [Lemey, Philippe; Vrancken, Bram] Katholieke Univ Leuven, Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Leuven, Belgium	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Hallym University; KU Leuven	Park, MS (corresponding author), Korea Univ, Coll Med, Inst Viral Dis, Dept Microbiol, Seoul, South Korea.	manseong.park@gmail.com	Lemey, Philippe/C-3755-2018; Vrancken, Bram/D-9538-2018; Kim, Young-jin/GSD-3168-2022; Vrancken, Bram/AAF-7901-2019; Park, Man-Seong/AAF-1207-2020; Hong, Kyung-Wook/T-3067-2018; Song, Jin/HHS-8731-2022	Lemey, Philippe/0000-0003-2826-5353; Vrancken, Bram/0000-0001-6547-5283; Vrancken, Bram/0000-0001-6547-5283; Hong, Kyung-Wook/0000-0002-3227-9558; Kim, Jin Il/0000-0001-8833-2138; Bae, Joon-Yong/0000-0002-2483-4208; Cheong, Hee Jin/0000-0002-2532-1463; PARK, Mee Sook/0000-0002-0665-3964; Song, Joon Young/0000-0002-0148-7194	National Research Foundation of Korea [NRF-2016M3A9B6915715]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant from the National Research Foundation of Korea, NRF-2016M3A9B6915715, to Professor Man-Seong Park. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, DESCR PROC SEAS H5N1; Bedford T, 2014, ELIFE, V3, DOI 10.7554/eLife.01914; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; CDC. Centers for Disease Control and Prevention, 2014, FLU VIR CAN CHANG DR; Chan MCW, 2013, J CLIN VIROL, V56, P219, DOI 10.1016/j.jcv.2012.11.002; Choi WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0098716; Cowling BJ, 2016, VACCINE, V34, P61, DOI 10.1016/j.vaccine.2015.11.016; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Fielding JE, 2016, VACCINE, V34, P4905, DOI 10.1016/j.vaccine.2016.08.067; Fonville JM, 2016, J INFECT DIS, V213, P31, DOI 10.1093/infdis/jiv367; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; HIERHOLZER JC, 1969, APPL MICROBIOL, V18, P824, DOI 10.1128/AEM.18.5.824-833.1969; Hirst GK, 1943, J EXP MED, V78, p4O7, DOI 10.1084/jem.78.5.407; Ho HP, 2014, INFLUENZA OTHER RESP, V8, P557, DOI 10.1111/irv.12256; Il Kim Jin, 2012, Journal of Bacteriology and Virology, V42, P363, DOI 10.4167/jbv.2012.42.4.363; 이일섭, 2013, Journal of Bacteriology and Virology, V43, P9, DOI 10.4167/jbv.2013.43.1.9; Johansson BE, 2011, EXPERT REV VACCINES, V10, P1683, DOI [10.1586/erv.11.130, 10.1586/ERV.11.130]; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KCDC. Korea Centers for Disease Control and Prevention, 2016, WEEKL REP INC INFL O; Kim JI, 2013, J VIROL, V87, P7539, DOI 10.1128/JVI.00373-13; Kim JI, 2012, BMB REP, V45, P653, DOI 10.5483/BMBRep.2012.45.11.137; Kim JI, 2012, YONSEI MED J, V53, P886, DOI 10.3349/ymj.2012.53.5.886; Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529; Lin YP, 2010, J VIROL, V84, P6769, DOI 10.1128/JVI.00458-10; Luksza M, 2014, NATURE, V507, P57, DOI 10.1038/nature13087; Memoli MJ, 2016, MBIO, V7, DOI 10.1128/mBio.00417-16; Neher RA, 2015, BIOINFORMATICS, V31, P3546, DOI 10.1093/bioinformatics/btv381; Park Sehee, 2012, Journal of Bacteriology and Virology, V42, P284, DOI 10.4167/jbv.2012.42.4.284; Parker L, 2016, J GEN VIROL, V97, P1333, DOI 10.1099/jgv.0.000457; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Savulescu C, 2014, VACCINE, V32, P4404, DOI 10.1016/j.vaccine.2014.06.063; Shaw ML., 2013, FIELDS VIROLOGY, V6; Skowronski DM, 2014, J INFECT DIS, V210, P126, DOI 10.1093/infdis/jiu048; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Sun HL, 2013, MBIO, V4, DOI 10.1128/mBio.00230-13; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Thorlund K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-134; Valenciano M, 2013, EUROSURVEILLANCE, V18, P12; Westgeest KB, 2014, J VIROL, V88, P2844, DOI 10.1128/JVI.02163-13; WHO, 2012, REC COMP INFL VIR VA; WHO, 2009, REC COMP INFL VIR VA; WHO, 2013, REC COMP INFL VIR VA; WHO. World Health Organization, 2016, INFL VACC REAG 19 SE; WHO. World Health Organization, 2009, EMERGENCIES PREPARED; WHO. World Health Organization, 2016, INFL LAB SURV INF GL; Wie SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062685; Wikramaratna PS, 2015, VACCINE, V33, P5380, DOI 10.1016/j.vaccine.2015.08.065; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wohlbold TJ, 2015, MBIO, V6, DOI 10.1128/mBio.02556-14; World Health Organization, 2010, REC VIR INFL VACC US; World Health Organization, 2011, REC VIR INFL VACC US; World Health Organization (WHO), 2008, REC COMP INFL VIR VA; Yen HL, 2011, P NATL ACAD SCI USA, V108, P14264, DOI 10.1073/pnas.1111000108	61	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172059	10.1371/journal.pone.0172059	http://dx.doi.org/10.1371/journal.pone.0172059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257427	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100011
J	Sato, T; Sugawara, J; Aizawa, N; Iwama, N; Takahashi, F; Nakamura-Kurakata, M; Saito, M; Sugiyama, T; Kunikata, H; Nakazawa, T; Yaegashi, N				Sato, Takahiro; Sugawara, Junichi; Aizawa, Naoko; Iwama, Noriyuki; Takahashi, Fumiaki; Nakamura-Kurakata, Michiyo; Saito, Masatoshi; Sugiyama, Takashi; Kunikata, Hiroshi; Nakazawa, Toru; Yaegashi, Nobuo			Longitudinal changes of ocular blood flow using laser speckle flowgraphy during normal pregnancy	PLOS ONE			English	Article							RETINAL MICROVASCULAR CALIBER; OPHTHALMIC ARTERY DOPPLER; PREECLAMPSIA; CIRCULATION; VELOCIMETRY; PRESSURE; VELOCITY; WOMEN	Purpose Innovative laser speckle flowgraphy (LSFG) enables noninvasive evaluation of retinal microcirculation and the usefulness has been reported in the field of ophthalmology. LSFG has allowed us to measure the real time changes of retinal blood flow without pupillary dilatations and contrast media. Herein, we investigated the change of retinal blood flow in normal pregnant women during gestation using LSFG. Methods A prospective cohort study was conducted in 53 pregnant women who visited our institution between January, 2013 and July, 2014. Finally, a total of 41 participants without any obstetric complications were available for evaluation. Retinal blood flow was measured with LSFG in a total of 4 times during pregnancy (T1. 11-13 weeks, T2. 19-21 weeks, T3. 28-30 weeks, T4. 34-36 weeks) and mean blur rate (MBR), blowout score (BOS), flow acceleration index (FAI), and resistive index (RI) are analyzed from these measurements. Relations between LSFG parameters and mean arterial blood pressure (MAP) are determined throughout pregnancy. Results MBR showed no significant changes throughout pregnancy. BOS showed a tendency to increase in the 3rd trimester. FAI values showed a slight increase from the 1st to 2nd trimester while a significant decrease was noted in the 3rd trimester. RI exhibited no changes between the 1st and 2nd trimesters, values decreased significantly after the 3rd trimester. MAP was positively correlated with BOS, and negatively correlated with FAI and RI. Conclusion The present study clearly demonstrated that profiles of LSFG parameters demonstrated a decrease of resistance in retinal blood vessels. These changes in indices provide a highly sensitive reflection of physiological changes in vascular resistance due to pregnancy. Thus, LSFG may be useful, as a non-invasive, diagnostic tool to detect pregnancy related disorders such as preeclampsia.	[Sato, Takahiro; Sugawara, Junichi; Iwama, Noriyuki; Takahashi, Fumiaki; Nakamura-Kurakata, Michiyo; Saito, Masatoshi; Yaegashi, Nobuo] Tohoku Univ, Dept Obstet & Gynecol, Grad Sch Med, Sendai, Miyagi, Japan; [Sugawara, Junichi] Tohoku Univ, Tohoku Med Megabank Org, Div Fetomaternal Med Sci, Sendai, Miyagi, Japan; [Aizawa, Naoko; Kunikata, Hiroshi; Nakazawa, Toru] Tohoku Univ, Dept Ophthalmol, Grad Sch Med, Sendai, Miyagi, Japan; [Sugiyama, Takashi] Ehime Univ, Grad Sch Med, Dept Obstet & Gynecol, Matsuyama, Ehime, Japan	Tohoku University; Tohoku University; Tohoku University; Ehime University	Sugawara, J (corresponding author), Tohoku Univ, Dept Obstet & Gynecol, Grad Sch Med, Sendai, Miyagi, Japan.; Sugawara, J (corresponding author), Tohoku Univ, Tohoku Med Megabank Org, Div Fetomaternal Med Sci, Sendai, Miyagi, Japan.	jsugawara@med.tohoku.ac.jp	Sugawara, Junichi/O-2190-2013	Iwama, Noriyuki/0000-0002-6808-0911; Sugiyama, Takashi/0000-0002-3715-0075	JST grant from JSPS KAKENHI [26861306]; Grants-in-Aid for Scientific Research [26861306] Funding Source: KAKEN	JST grant from JSPS KAKENHI; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a JST grant from JSPS KAKENHI Grants-in-Aid for Scientific Research (B) (M.K. 26861306). The funder had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Aizawa N, 2011, CLIN OPHTHALMOL, V5, P1171, DOI 10.2147/OPTH.S22093; Alm A., 1992, ADLERS PHYSL EYE, P198; Belfort MA, 1999, AM J OBSTET GYNECOL, V180, P601, DOI 10.1016/S0002-9378(99)70261-9; Correa-Silva EP, 2012, INT J GYNECOL OBSTET, V117, P251, DOI 10.1016/j.ijgo.2012.01.012; Diniz ALD, 2008, INT J GYNECOL OBSTET, V100, P216, DOI 10.1016/j.ijgo.2007.07.013; Duvekot J J, 1994, Obstet Gynecol Surv, V49, pS1, DOI 10.1097/00006254-199412011-00001; FUJII H, 1994, MED BIOL ENG COMPUT, V32, P302, DOI 10.1007/BF02512526; Hata T, 1997, AM J OBSTET GYNECOL, V177, P174, DOI 10.1016/S0002-9378(97)70458-7; Isono H, 2003, ARCH OPHTHALMOL-CHIC, V121, P225; Konishi N, 2002, OPT REV, V9, P163, DOI 10.1007/s10043-002-0163-4; KYLE PM, 1993, BRIT J OBSTET GYNAEC, V100, P85, DOI 10.1111/j.1471-0528.1993.tb12957.x; Liu LX, 2014, CARDIOVASC RES, V101, P545, DOI 10.1093/cvr/cvu009; Lupton SJ, 2013, HYPERTENSION, V62, P899, DOI 10.1161/HYPERTENSIONAHA.113.01890; Lupton SJ, 2013, HYPERTENSION, V61, P880, DOI 10.1161/HYPERTENSIONAHA.111.00698; Mahendru AA, 2014, J HYPERTENS, V32, P849, DOI 10.1097/HJH.0000000000000090; Matias DS, 2012, J CLIN ULTRASOUND, V40, P576, DOI 10.1002/jcu.21949; Nitta F, 2014, CLIN OPHTHALMOL, V8, P1119, DOI 10.2147/OPTH.S62022; Riskin-Mashiah S, 2002, AM J OBSTET GYNECOL, V187, P1667, DOI 10.1067/mob.2002.127594; Takata M, 2002, OBSTET GYNECOL, V100, P931, DOI 10.1016/S0029-7844(02)02244-5; TAMAKI Y, 1995, EXP EYE RES, V60, P373, DOI 10.1016/S0014-4835(05)80094-6; Tsuda S, 2014, CURR EYE RES, V39, P1207, DOI 10.3109/02713683.2014.905608; Williams KP, 2004, ULTRASOUND OBST GYN, V23, P254, DOI 10.1002/uog.955	22	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173127	10.1371/journal.pone.0173127	http://dx.doi.org/10.1371/journal.pone.0173127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257508	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100061
J	Wu, L; Lei, YP; Lan, SB; Hu, CX				Wu, Li; Lei, Yaping; Lan, Shubin; Hu, Chunxiang			Photosynthetic recovery and acclimation to excess light intensity in the rehydrated lichen soil crusts	PLOS ONE			English	Article							THERMAL-ENERGY DISSIPATION; PHOTOSYSTEM-II; CO2 EXCHANGE; WATER RELATIONS; CHLOROPHYLL FLUORESCENCE; SUCCESSIONAL STAGES; REACTION CENTERS; CYANOBACTERIUM; DESERT; ACTIVATION	As an important successional stage and main type of biological soil crusts (BSCs) in Shapotou region of China (southeastern edge of Tengger Desert), lichen soil crusts (LSCs) often suffer from many stresses, such as desiccation and excess light intensity. In this study, the chlorophyll fluorescence and CO2 exchange in the rehydrated LSCs were detected under a series of photosynthetically active radiation (PAR) gradients to study the photosynthetic acclimation of LSCs. The results showed that although desiccation leaded to the loss of photosynthetic activity in LSCs, the fluorescence parameters including Fo, Fv and Fv/Fm of LSCs could be well recovered after rehydration. After the recovery of photosynthetic activity, the effective photosynthetic efficiency phi(PSII) detected by Imaging PAM had declined to nearly 0 within both the lichen thallus upper and lower layers when the PAR increased to 200 mu E m(-2) s(-1), however the net photosynthesis detected by the CO2 gas analyzer in the LSCs still appeared when the PAR increased to 1000 mu E m(-2) s(-1). Our results indicate that LSCs acclimating to high PAR, on the one hand is ascribed to the special structure in crust lichens, making the incident light into the lichen thallus be weakened; on the other hand the massive accumulation of photosynthetic pigments in LSCs also provides a protective barrier for the photosynthetic organisms against radiation damage. Furthermore, the excessive light energy absorbed by crust lichens is also possibly dissipated by the increasing non-photochemical quenching, therefore to some extent providing some protection for LSCs.	[Wu, Li; Lei, Yaping] Wuhan Univ Technol, Sch Resources & Environm Engn, Wuhan, Peoples R China; [Lan, Shubin; Hu, Chunxiang] Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan, Peoples R China	Wuhan University of Technology; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Lan, SB (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan, Peoples R China.	shblan@ihb.ac.cn			National Natural Science Foundation of China [31300100, 31300322, 31670456]; Youth Innovation Promotion Association CAS [2017385]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association CAS	This study was kindly supported by grants from the National Natural Science Foundation of China (Nos. 31300100, 31300322 and 31670456) and Youth Innovation Promotion Association CAS (2017385). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Belnap J., 2001, BIOL SOIL CRUSTS STR, DOI [10.1639/0007-2745(2002)105[0500:]2.0.co;2, DOI 10.1639/0007-2745(2002)105[0500:]2.0.CO;2]; BILGER W, 1989, J PLANT PHYSIOL, V134, P261, DOI 10.1016/S0176-1617(89)80240-8; Bukhov NG, 2004, PLANTA, V219, P110, DOI 10.1007/s00425-003-1195-0; Cabrajic AVJ, 2010, PLANT CELL ENVIRON, V33, P840, DOI 10.1111/j.1365-3040.2009.02110.x; ELDRIDGE DJ, 1994, AUST J SOIL RES, V32, P389, DOI 10.1071/SR9940389; Gao K, 2007, J PHOTOCH PHOTOBIO B, V89, P117, DOI 10.1016/j.jphotobiol.2007.09.006; GARCIAPICHEL F, 1991, J PHYCOL, V27, P395, DOI 10.1111/j.0022-3646.1991.00395.x; GARCIAPICHEL F, 1992, PHOTOCHEM PHOTOBIOL, V56, P17, DOI 10.1111/j.1751-1097.1992.tb09596.x; Harel Y, 2004, PLANT PHYSIOL, V136, P3070, DOI 10.1104/pp.104.047712; Heber U, 2006, J EXP BOT, V57, P2993, DOI 10.1093/jxb/erl058; Heber U, 2010, NEW PHYTOL, V185, P459, DOI 10.1111/j.1469-8137.2009.03064.x; Housman DC, 2006, J ARID ENVIRON, V66, P620, DOI 10.1016/j.jaridenv.2005.11.014; Hu CX, 2003, ACTA BOT SIN, V45, P917; Kranner I, 2008, BRYOLOGIST, V111, P576, DOI 10.1639/0007-2745-111.4.576; Lan SB, 2012, PLANT SOIL, V351, P325, DOI 10.1007/s11104-011-0966-9; Lan SB, 2012, ENVIRON EARTH SCI, V65, P77, DOI 10.1007/s12665-011-1066-0; Lan SB, 2010, EUR J SOIL BIOL, V46, P381, DOI 10.1016/j.ejsobi.2010.08.002; Lange OL, 1998, FUNCT ECOL, V12, P195, DOI 10.1046/j.1365-2435.1998.00192.x; Lange OL, 2004, LICHENOLOGIST, V36, P329, DOI 10.1017/S0024282904014392; LANGE OL, 1992, FUNCT ECOL, V6, P519, DOI 10.2307/2390048; LANGE OL, 1994, FUNCT ECOL, V8, P253, DOI 10.2307/2389909; Lange OL, 2006, FLORA, V201, P268, DOI 10.1016/j.flora.2005.08.003; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Nishiyama Y, 2001, EMBO J, V20, P5587, DOI 10.1093/emboj/20.20.5587; Ohad I, 2011, PHYSIOL PLANTARUM, V142, P79, DOI 10.1111/j.1399-3054.2011.01466.x; Ohad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011000; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; Wu L, 2013, EUR J SOIL BIOL, V55, P77, DOI 10.1016/j.ejsobi.2012.12.006; Wu L, 2011, MICROB ECOL, V62, P715, DOI 10.1007/s00248-011-9828-5; Zaady E, 2000, SOIL BIOL BIOCHEM, V32, P959, DOI 10.1016/S0038-0717(00)00004-3; Zhao XM, 2008, J ARID ENVIRON, V72, P370, DOI 10.1016/j.jaridenv.2007.07.002	32	6	7	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172537	10.1371/journal.pone.0172537	http://dx.doi.org/10.1371/journal.pone.0172537			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257469	Green Submitted, Green Published, gold			2022-12-26	WOS:000396021100019
J	Hien, AS; Soma, DD; Hema, O; Bayili, B; Namountougou, M; Gnankine, O; Baldet, T; Diabate, A; Dabire, KR				Hien, Aristide Sawdetuo; Soma, Dieudonne Diloma; Hema, Omer; Bayili, Bazoma; Namountougou, Moussa; Gnankine, Olivier; Baldet, Thierry; Diabate, Abdoulaye; Dabire, Kounbobr Roch			Evidence that agricultural use of pesticides selects pyrethroid resistance within Anopheles gambiae s.l. populations from cotton growing areas in Burkina Faso, West Africa	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; MALARIA CONTROL; MOLECULAR-FORMS; BENIN; SPECIATION; MORTALITY; MUTATION; CAMEROON; KNOCK; GENE	Many studies have shown the role of agriculture in the selection and spread of resistance of Anopheles gambiae s.l. to insecticides. However, no study has directly demonstrated the presence of insecticides in breeding sources as a source of selection for this resistance. It is in this context that we investigated the presence of pesticide residues in breeding habitats and their formal involvement in vector resistance to insecticides in areas of West Africa with intensive farming. This study was carried out from June to November 2013 in Dano, southwest Burkina Faso in areas of conventional (CC) and biological cotton (BC) growing. Water and sediment samples collected from breeding sites located near BC and CC fields were submitted for chromatographic analysis to research and titrate the residual insecticide content found there. Larvae were also collected in these breeding sites and used in toxicity tests to compare their mortality to those of the susceptible strain, Anopheles gambiae Kisumu. All tested mosquitoes (living and dead) were analyzed by PCR for species identification and characterization of resistance genes. The toxicity analysis of water from breeding sites showed significantly lower mortality rates in breeding site water from biological cotton (WBC) growing sites compared to that from conventional cotton (WCC) sites respective to both An. gambiae Kisumu (WBC: 80.75% vs WCC: 92.75%) and a wild-type strain (49.75% vs 66.5%). The allele frequencies L1014F, L1014S kdr, and G116S ace - 1(R) mutations conferring resistance, respectively, to pyrethroids and carbamates / organophosphates were 0.95, 0.4 and 0.12. Deltamethrin and lambda-cyhalothrin were identified in the water samples taken in October/November from mosquitoes breeding in the CC growing area. The concentrations obtained were respectively 0.0147ug/L and 1.49 ug/L to deltamethrin and lambdacyhalothrin. Our results provided evidence by direct analysis (biological and chromatographic tests) of the role of agriculture as a source of selection pressure on vectors to insecticides used in growing areas.	[Hien, Aristide Sawdetuo; Soma, Dieudonne Diloma; Bayili, Bazoma; Diabate, Abdoulaye; Dabire, Kounbobr Roch] IRSS DRO, Malaria & Trop Neglected Res Unit, Bobo Dioulasso, Burkina Faso; [Hema, Omer] INERA, Programme Coton, Farako Ba, Bobo Dioulasso, Burkina Faso; [Namountougou, Moussa] Univ Polytech Bobo Dioulasso, Inst Rural Dev, Bobo Dioulasso, Burkina Faso; [Gnankine, Olivier] Univ Joseph Ki Zerbo, UFR Life Sci, Ouagadougou, Burkina Faso; [Baldet, Thierry] CIRAD, Campus Baillarguet, Montpellier, France	CIRAD	Hien, AS; Dabire, KR (corresponding author), IRSS DRO, Malaria & Trop Neglected Res Unit, Bobo Dioulasso, Burkina Faso.	aristide.hien@yahoo.fr; dabire_roch@hotmail.com	Gnankine, Olivier/AAH-4974-2019; Dabire, Roch Kounbobr/ABF-3525-2020	Gnankine, Olivier/0000-0002-6006-6533; DIABATE, Abdoulaye/0000-0002-9666-9395	PRIPA of IDRC [104263-009]	PRIPA of IDRC	This study was financially supported by the PRIPA project 104263-009 of IDRC granted to DKR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuelmaali SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080549; Akogbeto MC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-22; Antonio-Nkondjio C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-154; Awolola TS, 2005, ACTA TROP, V95, P204, DOI 10.1016/j.actatropica.2005.06.002; Binka FN, 1996, TROP MED INT HEALTH, V1, P147; Chandre F, 1999, B WORLD HEALTH ORGAN, V77, P230; Chouaibou M, 2008, TROP MED INT HEALTH, V13, P476, DOI 10.1111/j.1365-3156.2008.02025.x; Czeher C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-189; Dabire KR, 2012, INSECTICIDES - PEST ENGINEERING, P479; Dabire KR, 2009, T ROY SOC TROP MED H, V103, P1113, DOI 10.1016/j.trstmh.2009.01.008; Dabire KR, 2009, TROP MED INT HEALTH, V14, P396, DOI 10.1111/j.1365-3156.2009.02243.x; Dabire RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141645; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; ELISSA N, 1993, ANN SOC BELG MED TR, V73, P291; ELLIOTT M, 1989, PESTIC SCI, V27, P337, DOI 10.1002/ps.2780270403; Fanello C, 2003, INSECT MOL BIOL, V12, P241, DOI 10.1046/j.1365-2583.2003.00407.x; Guimaraes RM, 2007, CAD SAUDE PUBLICA, V23, P2835, DOI 10.1590/S0102-311X2007001200004; Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Namountougou M, 2013, ACTA TROP, V125, P123, DOI 10.1016/j.actatropica.2012.10.012; Nkya TE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-28; Protopopoff N, 2008, TROP MED INT HEALTH, V13, P1479, DOI 10.1111/j.1365-3156.2008.02164.x; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; WHO, 2014, WORLD MAL REP 2014, P242; World Health Organization, 1998, WHOCDSCPCMAL1998; Yadouleton A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-60; Yadouleton AW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-83	31	45	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173098	10.1371/journal.pone.0173098	http://dx.doi.org/10.1371/journal.pone.0173098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253316	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300073
J	Khan, SA; Manzoor, S; Alamgir; Ali, A; Khan, DM; Khalil, U				Khan, Sajjad Ahmad; Manzoor, Sadaf; Alamgir; Ali, Amjad; Khan, Dost Muhammad; Khalil, Umair			Rules for resolving Mendelian inconsistencies in nuclear pedigrees typed for two-allele markers	PLOS ONE			English	Article							GENOTYPING ERRORS; LINKAGE ANALYSIS; GENETIC-LINKAGE; IDENTIFICATION; MUTATIONS; LOCI; PAIR	Gene-mapping studies, regularly, rely on examination for Mendelian transmission of marker alleles in a pedigree as a way of screening for genotyping errors and mutations. For analysis of family data sets, it is, usually, necessary to resolve or remove the genotyping errors prior to consideration. At the Center of Inherited Disease Research (CIDR), to deal with their large-scale data flow, they formalized their data cleaning approach in a set of rules based on PedCheck output. We scrutinize via carefully designed simulations that how well CIDR's data cleaning rules work in practice. We found that genotype errors in siblings are detected more often than in parents for less polymorphic SNPs and vice versa for more polymorphic SNPs. Through computer simulations, we conclude that some of the CIDR's rules work poorly in some circumstances, and we suggest a set of modified data cleaning rules that may work better than CIDR's rules.	[Khan, Sajjad Ahmad; Khan, Dost Muhammad; Khalil, Umair] Abdul Wali Khan Univ Mardan, Dept Stat, Khyber Pukhtunkhwa, Pakistan; [Khan, Sajjad Ahmad; Manzoor, Sadaf; Ali, Amjad] Islamia Coll, Dept Stat, Peshawar, Khyber Pukhtunk, Pakistan; [Alamgir] Univ Peshawar, Dept Stat, Khyber Pukhtunkhwa, Pakistan	University of Peshawar	Khan, SA (corresponding author), Abdul Wali Khan Univ Mardan, Dept Stat, Khyber Pukhtunkhwa, Pakistan.; Khan, SA (corresponding author), Islamia Coll, Dept Stat, Peshawar, Khyber Pukhtunk, Pakistan.	sajjadkhan@awkum.edu.pk	Khan, Dost Muhammad/AAA-7465-2020; Khan, Sajjad Ahmad/AAE-5527-2020	Khan, Dost Muhammad/0000-0002-3919-8136; Khan, Sajjad Ahmad/0000-0001-6630-7222				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, EUR J HUM GENET, V9, P130, DOI 10.1038/sj.ejhg.5200594; Badzioch MD, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S40; Beekman M, 2013, AGING CELL, V12, P184, DOI 10.1111/acel.12039; BRZUSTOWICZ LM, 1993, AM J HUM GENET, V53, P1137; BUETOW KH, 1991, AM J HUM GENET, V49, P985; Cherny SS, 2001, GENET EPIDEMIOL, V21, pS117, DOI 10.1002/gepi.2001.21.s1.s117; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Douglas JA, 2002, AM J HUM GENET, V70, P487, DOI 10.1086/338919; Ewen KR, 2000, AM J HUM GENET, V67, P727, DOI 10.1086/303048; Gordon D, 1999, HUM HERED, V49, P65, DOI 10.1159/000022846; Goring HHH, 2000, AM J HUM GENET, V66, P1107, DOI 10.1086/302798; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Hao K, 2004, GENOMICS, V84, P623, DOI 10.1016/j.ygeno.2004.05.003; Hess MA, 2012, MOL ECOL RESOUR, V12, P1114, DOI 10.1111/1755-0998.12002; Kang SJ, 2004, GENET EPIDEMIOL, V26, P132, DOI 10.1002/gepi.10301; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LATHROP GM, 1983, AM J HUM GENET, V35, P241; Mukhopadhyay N, 2005, BIOINFORMATICS, V21, P2556, DOI 10.1093/bioinformatics/bti364; Mukhopadhyay N, 2004, HUM HERED, V58, P175, DOI 10.1159/000083545; Neale BM, 2008, STAT GENETICS GENE M; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTT J, 1992, AM J HUM GENET, V51, P283; Seaman SR, 2005, HUM HERED, V59, P157, DOI 10.1159/000085939; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Terwilliger J., 1994, HDB HUMAN GENETIC LI; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P217, DOI 10.1002/gepi.1370100402; Terwilliger JD, 1990, AM J HUM GENET S, V47, pA201; Zhu ZB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133421; Ziegler A, 2006, STAT APPROACH GENETI	30	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172807	10.1371/journal.pone.0172807	http://dx.doi.org/10.1371/journal.pone.0172807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253278	Green Published, gold, Green Submitted			2022-12-26	WOS:000396011300037
J	Lacmata, ST; Kuiate, JR; Ding, YM; Xian, M; Liu, HZ; Boudjeko, T; Feng, XJ; Zhao, G				Lacmata, Stephen Tamekou; Kuiate, Jules-Roger; Ding, Yamei; Xian, Mo; Liu, Huizhou; Boudjeko, Thaddee; Feng, Xinjun; Zhao, Guang			Enhanced poly(3-hydroxypropionate) production via beta-alanine pathway in recombinant Escherichia coli	PLOS ONE			English	Article							ASPARTATE-ALPHA-DECARBOXYLASE; CORYNEBACTERIUM-GLUTAMICUM; BIOSYNTHESIS; GLYCEROL; POLYESTERS	Poly(3-hydroxypropionate) (P3HP) is a thermoplastic with great compostability and biocompatibility, and can be produced through several biosynthetic pathways, in which the glycerol pathway achieved the highest P3HP production. However, exogenous supply of vitamin B-12 was required to maintain the activity of glycerol dehydratase, resulting in high production cost. To avoid the addition of VB12, we have previously constructed a P3HP biosynthetic route with beta-alanine as intermediate, and the present study aimed to improve the P3HP production of this pathway. L-aspartate decarboxylase PanD was found to be the rate-limiting enzyme in the beta-alanine pathway firstly. To improve the pathway efficiency, PanD was screened from four different sources (Escherichia coli, Bacillus subtilis, Pseudomonas fluorescens, and Corynebacterium glutamicum). And PanD from C. glutamicum was found to have the highest activity, the P3HP production was improved in flask cultivation with this enzyme. To further improve the production, the host strain was screened and the culture condition was optimized. Under optimal conditions, production and content of P3HP reached to 10.2 g/L and 39.1% (wt/wt [cell dry weight]) in an aerobic fed-batch fermentation. To date, this is the highest P3HP production without VB12.	[Lacmata, Stephen Tamekou; Xian, Mo; Liu, Huizhou; Feng, Xinjun; Zhao, Guang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Key Lab Biobased Mat, Qingdao, Peoples R China; [Lacmata, Stephen Tamekou; Kuiate, Jules-Roger] Univ Dschang, Fac Sci, Dept Biochem, Lab Microbiol & Antimicrobials Subst, Dschang, Cameroon; [Ding, Yamei] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Boudjeko, Thaddee] Univ Yaounde, Lab Phytoptotect & Valorizat Vegetals Resources, Biotechnol Nkolbisson Ctr, Dept Biochem, Yaounde, Cameroon; [Zhao, Guang] Randian Technol Co Ltd, Tianjin, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS; University of Yaounde I	Feng, XJ; Zhao, G (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Key Lab Biobased Mat, Qingdao, Peoples R China.; Zhao, G (corresponding author), Randian Technol Co Ltd, Tianjin, Peoples R China.	fengxj@qibebt.ac.cn; zhaoguang@qibebt.ac.cn	zhao, guang/E-4702-2013; Feng, Xinjun/G-5786-2017	zhao, guang/0000-0003-0002-5972; Feng, Xinjun/0000-0002-0195-4258	CAS [ZDRW-ZS-2016-3M, KGZD-EW-606-1-3]; Shandong Province Postdoctoral Innovation Foundation [201603076]; Taishan Scholars Climbing Program of Shandong [TSPD20150210]	CAS(Defence Research & Development Organisation (DRDO)Chinese Academy of Sciences); Shandong Province Postdoctoral Innovation Foundation; Taishan Scholars Climbing Program of Shandong	This work was supported by the 100-Talent Project of CAS (for GZ), CAS Key Program (ZDRW-ZS-2016-3M for GZ and KGZD-EW-606-1-3 for MX), Shandong Province Postdoctoral Innovation Foundation (201603076 for XF), and Taishan Scholars Climbing Program of Shandong (No. TSPD20150210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Andreessen B, 2010, APPL ENVIRON MICROB, V76, P4919, DOI 10.1128/AEM.01015-10; BRANDL H, 1988, APPL ENVIRON MICROB, V54, P1977, DOI 10.1128/AEM.54.8.1977-1982.1988; CRONAN JE, 1980, J BACTERIOL, V141, P1291, DOI 10.1128/JB.141.3.1291-1297.1980; Delvigne F, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-15; Dusch N, 1999, APPL ENVIRON MICROB, V65, P1530; Feng XJ, 2015, BIOENGINEERED, V6, P77, DOI 10.1080/21655979.2015.1011027; Fernandez-Castane A, 2012, J BIOTECHNOL, V157, P391, DOI 10.1016/j.jbiotec.2011.12.007; Gao YQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097845; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; Nozaki S, 2012, MICROBIOLOGYOPEN, V1, P298, DOI 10.1002/mbo3.34; Schmitzberger F, 2003, EMBO J, V22, P6193, DOI 10.1093/emboj/cdg575; Shen Y, 2014, BIOTECHNOL LETT, V36, P1681, DOI 10.1007/s10529-014-1527-0; Sorokin A, 1996, MICROBIOL-SGM, V142, P2005, DOI 10.1099/13500872-142-8-2005; Stuecker TN, 2012, MBIO, V3, DOI 10.1128/mBio.00158-12; Wang Q, 2014, BIOTECHNOL LETT, V36, P2257, DOI 10.1007/s10529-014-1600-8; Wang Q, 2013, BIORESOURCE TECHNOL, V131, P548, DOI 10.1016/j.biortech.2013.01.096; Wang Q, 2012, J MICROBIOL, V50, P693, DOI 10.1007/s12275-012-2234-y	18	9	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173150	10.1371/journal.pone.0173150	http://dx.doi.org/10.1371/journal.pone.0173150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253372	Green Published, gold, Green Submitted			2022-12-26	WOS:000396011300081
J	Prieto, I; del Puerto-Nevado, L; Gonzalez, N; Portal-Nunez, S; Zazo, S; Corton, M; Minguez, P; Gomez-Guerrero, C; Arce, JM; Sanz, AB; Mas, S; Aguilera, O; Alvarez-Llamas, G; Esbrit, P; Ortiz, A; Ayuso, C; Egido, J; Rojo, F; Garcia-Foncilias, J				Prieto, Isabel; del Puerto-Nevado, Laura; Gonzalez, Nieves; Portal-Nunez, Sergio; Zazo, Sandra; Corton, Marta; Minguez, Pablo; Gomez-Guerrero, Carmen; Miguel Arce, Jose; Belen Sanz, Ana; Mas, Sebastian; Aguilera, Oscar; Alvarez-Llamas, Gloria; Esbrit, Pedro; Ortiz, Alberto; Ayuso, Carmen; Egido, Jesus; Rojo, Federico; Garcia-Foncilias, Jesus		DiabetesCancerConnect Consortium	Colon cancer modulation by a diabetic environment: A single institutional experience	PLOS ONE			English	Article							COLORECTAL-CANCER; ANTITUMOR-ACTIVITY; DETECTION BIAS; METFORMIN; RISK; TYPE-2; MORTALITY; POPULATION; MELLITUS; IMPACT	Background Multiple observational studies suggest an increased risk of colon cancer in patients with diabetes mellitus (DM). This can theoretically be the result of an influence of the diabetic environment on carcinogenesis or the tumor biologic behavior. Aim To gain insight into the influence of a diabetic environment on colon cancer characteristics and outcomes. Material and methods Retrospective analysis of clinical records in an academic tertiary care hospital with detailed analysis of 81 diabetic patients diagnosed of colon cancer matched with 79 non-diabetic colon cancer patients. The impact of streptozotocin-induced diabetes on the growth of colon cancer xenografts was studied in mice. Results The incidence of DM in 1,137 patients with colorectal cancer was 16%. The diabetic colon cancer cases and non-diabetic colon cancer controls were well matched for demographic and clinical variables. The ECOG Scale Performance Status was higher (worse) in diabetics (ECOG >= 1, 29.1% of controls vs 46.9% of diabetics, p = 0.02), but no significant differences were observed in tumor grade, adjuvant therapy, tumor site, lymphovascular invasion, stage, recurrence, death or cancer-related death. Moreover, no differences in tumor variables were observed between patients treated or not with metformin. In the xenograft model, tumor growth and histopathological characteristics did not differ between diabetic and nondiabetic animals. Conclusion Our findings point towards a mild or negligible effect of the diabetes environment on colon cancer behavior, once cancer has already developed.	[Prieto, Isabel; Aguilera, Oscar] UAM, Oncohlth Inst, Radiat Oncol, IIS,Fdn Jimenez Diaz, Madrid, Spain; [del Puerto-Nevado, Laura; Garcia-Foncilias, Jesus] UAM, Oncohlth Inst, Translat Oncol Div, IIS,Fdn Jimenez Diaz, Madrid, Spain; [Gonzalez, Nieves; Gomez-Guerrero, Carmen; Belen Sanz, Ana; Mas, Sebastian; Ortiz, Alberto; Egido, Jesus] UAM, Renal Vasc & Diabet Res Lab, IIS, Fdn Jimenez Diaz, Madrid, Spain; [Gonzalez, Nieves; Gomez-Guerrero, Carmen; Mas, Sebastian; Egido, Jesus] Spanish Biomed Res Network Diabet & Associated Me, Madrid, Spain; [Portal-Nunez, Sergio; Esbrit, Pedro] UAM, Bone & Mineral Metab Lab, IIS, Fdn Jimenez Diaz, Madrid, Spain; [Zazo, Sandra; Rojo, Federico] UAM, Dept Pathol, IIS, Fdn Jimenez Diaz, Madrid, Spain; [Corton, Marta; Minguez, Pablo; Ayuso, Carmen] UAM, Dept Genet, IIS, Fdn Jimenez Diaz, Madrid, Spain; [Miguel Arce, Jose] Fdn Jimenez Diaz, Hlth Informat Management Dept, Madrid, Spain; [Alvarez-Llamas, Gloria] UAM, Immunoallergy & Prote Lab, IIS, Fdn Jimenez Diaz, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz	Prieto, I (corresponding author), UAM, Oncohlth Inst, Radiat Oncol, IIS,Fdn Jimenez Diaz, Madrid, Spain.	iprieto@fjd.es	Llamas, Gloria Alvarez/AAA-8090-2020; Alvarez-Llamas, Gloria/C-8938-2015; Sanz, Ana Belen/C-9489-2013; ortiz, alberto/Y-7582-2018; Miguez, Pablo/D-4822-2013; Mas, S/T-1489-2018; Portal-Núñez, Sergio/L-7391-2014	Llamas, Gloria Alvarez/0000-0002-3313-721X; Alvarez-Llamas, Gloria/0000-0002-3313-721X; Sanz, Ana Belen/0000-0002-0255-5689; ortiz, alberto/0000-0002-9805-9523; Miguez, Pablo/0000-0003-4099-9421; Mas, S/0000-0001-6604-3327; Portal-Núñez, Sergio/0000-0003-0659-1545; Corton, Marta/0000-0003-0087-1626; Ayuso, Carmen/0000-0002-9242-7065; J, Garcia-Foncillas/0000-0002-7591-8006; Rojo, Federico/0000-0001-9989-0290	Institute de Salud Carlos III-Fondos FEDER [PIE13/00051, P114/00386]; Institute de Salud Carlos III and Alberto Ortiz [MS1114/00031, RETICEF RD12/0043/008, MS12/03256, MS12/03262, CPI115/00027, RD012/0021, RD016/007]; Institute de Salud Carlos III [PIE13/00051]	Institute de Salud Carlos III-Fondos FEDER; Institute de Salud Carlos III and Alberto Ortiz; Institute de Salud Carlos III(Instituto de Salud Carlos III)	This study was supported by a grant from the Institute de Salud Carlos III-Fondos FEDER (PIE13/00051; P114/00386). Nieves Gonzalez (MS1114/00031), Sergio Portal (RETICEF RD12/0043/008), Marta Colton (MS12/03256), Ana Belen Sanz (MS12/03262) and Gloria Alvarez-Llamas (CPI115/00027) are recipients of a research contract from Institute de Salud Carlos III and Alberto Ortiz belongs to REDINREN RD012/0021 and RD016/007. Pablo Minguez, Sebastian Mas and Irene Bejarano are recipients of a research contract from the Institute de Salud Carlos III (PIE13/00051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algamas-Dimantov A, 2014, ONCOTARGET, V5, P9851, DOI 10.18632/oncotarget.2453; Aljada A, 2012, PHARMACOL THERAPEUT, V133, P108, DOI 10.1016/j.pharmthera.2011.09.004; Barbosa-Desongles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074179; Cogliano V, 2010, J NATL CANCER I, V102, P134, DOI 10.1093/jnci/djp446; Faria MCD, 2015, CHEM-BIOL INTERACT, V229, P119, DOI 10.1016/j.cbi.2015.01.027; Dankner R, 2016, AM J EPIDEMIOL, V183, P1098, DOI 10.1093/aje/kwv290; De Bruijn KMJ, 2014, EUR J CANCER, V50, P2449, DOI 10.1016/j.ejca.2014.06.019; de Kort S, 2016, EUR J GASTROEN HEPAT, V28, P896, DOI 10.1097/MEG.0000000000000626; Deng LY, 2012, DIGEST DIS SCI, V57, P1576, DOI 10.1007/s10620-012-2055-1; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Graham ML, 2011, COMPARATIVE MED, V61, P356; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hajjar J, 2013, EXPERT OPIN INV DRUG, V22, P1511, DOI 10.1517/13543784.2013.833604; Harding JL, 2015, DIABETES CARE, V38, P264, DOI 10.2337/dc14-1996; He J, 2010, BRIT J CANCER, V103, P120, DOI 10.1038/sj.bjc.6605721; Hosono K, 2010, CANCER PREV RES, V3, P1077, DOI 10.1158/1940-6207.CAPR-10-0186; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Jarvandi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074616; Jiang Y, 2011, EUR J EPIDEMIOL, V26, P863, DOI 10.1007/s10654-011-9617-y; Johnson JA, 2012, DIABETOLOGIA, V55, P1607, DOI 10.1007/s00125-012-2525-1; Kapiteijn E, 2001, J PATHOL, V195, P171, DOI 10.1002/path.918; Lee J, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3233-y; Lee KM, 2016, ONCOTARGET, V7, P38500, DOI 10.18632/oncotarget.9522; Lega IC, 2014, CANCER EPIDEM BIOMAR, V23, P1974, DOI 10.1158/1055-9965.EPI-14-0327; Li FY, 2009, J ZHEJIANG UNIV-SC B, V10, P219, DOI 10.1631/jzus.B0820273; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Masur K, 2011, BRIT J CANCER, V104, P345, DOI 10.1038/sj.bjc.6606050; Minoo P, 2010, INT J ONCOL, V37, P707, DOI 10.3892/ijo_00000720; Renehan AG, 2012, DIABETOLOGIA, V55, P1619, DOI 10.1007/s00125-012-2526-0; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Sharma A, 2014, CLIN COLORECTAL CANC, V13, P54, DOI 10.1016/j.clcc.2013.10.002; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Suh S, 2011, DIABETES METAB J, V35, P193, DOI 10.4093/dmj.2011.35.3.193; Sui XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097781; Vissers PAJ, 2016, J CANCER SURVIV, V10, P406, DOI 10.1007/s11764-015-0486-3; Wang JY, 2013, JPN J CLIN ONCOL, V43, P258, DOI 10.1093/jjco/hys228; Wang M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11503; Wang Y, 2014, GENET MOL RES, V13, P7173, DOI 10.4238/2014.September.5.3; Wu L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10147	39	5	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172300	10.1371/journal.pone.0172300	http://dx.doi.org/10.1371/journal.pone.0172300			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253286	gold, Green Published, Green Submitted			2022-12-26	WOS:000396011300015
J	Yamaguchi, N; Nakayama, Y; Yamaguchi, N				Yamaguchi, Noritaka; Nakayama, Yuji; Yamaguchi, Naoto			Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; TRANSCRIPTION FACTOR; ACQUIRED-RESISTANCE; BINDING; INHIBITION; ACTIVATION; PHENOTYPE; ALPHA; RELB; GENE	The selective estrogen receptor (ER) modulator tamoxifen inhibits ER signaling in breast cancer cells, and it is used for the treatment of ER-positive breast cancer. However, this type of cancer often acquires resistance to tamoxifen, and a better understanding of the molecular mechanisms underlying tamoxifen resistance is required. In this study, we established tamoxifen-resistant (TAM-R) breast cancer cells by long-term tamoxifen treatment of ER-positive breast cancer MCF7 cells. In TAM-R cells, expression of not only ER alpha, a major form of ER in breast cancer, but also its transcriptional partner forkhead box protein A1 (FOXA1) was found to be reduced. In contrast, activation of the transcription factor nuclear factor-kappa B (NF-kappa B) and expression of its target IL6 were increased in these cells. Stable expression of FOXA1, but not ER alpha, reduced the expression of IL6 in the FOXA1- and ER alpha-negative breast cancer MDA-MB231 cells and TAM-R cells, without affecting the activation of the NF-kappa B signaling pathways. Conversely, FOXA1 knockdown induced IL6 expression in MCF7 cells. Chromatin immunoprecipitation assays revealed that FOXA1 bound to the promoter region of IL6 and repressed recruitment of the NF-kappa B complex to this region. TAM-R cells were found to have high mammosphere-forming activity, characteristics of cancer stem cells, and this activity was suppressed by NF-kappa B and IL6 signaling inhibitors. Taken together, these results suggest that FOXA1 suppresses expression of IL6 through inhibition of NF-kappa B recruitment to the IL6 promoter in an ER alpha-independent manner and that reduction in FOXA1 expression induces IL6 expression and contributes to cancer stem cell-like properties in TAM-R cells.	[Yamaguchi, Noritaka; Yamaguchi, Naoto] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Mol Cell Biol, Chiba 2608675, Japan; [Nakayama, Yuji] Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Kyoto 6078414, Japan	Chiba University; Kyoto Pharmaceutical University	Yamaguchi, N (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Lab Mol Cell Biol, Chuo Ku, Inohana 1-8-1, Chiba 2608675, Japan.	yamaguchinoritaka@chiba-u.jp		Nakayama, Yuji/0000-0001-7882-0066	Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University) [16K08227, 15K07922]; Promotion and Mutual Aid Corporation for Private Schools of Japan (Chiba University) [16K08227, 15K07922]; Hamaguchi Foundation for the Advancement of Biochemistry; Japan Foundation for Applied Enzymology	Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University); Promotion and Mutual Aid Corporation for Private Schools of Japan (Chiba University); Hamaguchi Foundation for the Advancement of Biochemistry(Hamaguchi Foundation for the Advancement of Biochemistry); Japan Foundation for Applied Enzymology	This work was supported in part by Grants-in-aid for Scientific Research C 16K08227 (to Noritaka Yamaguchi) and 15K07922 (to Naoto Yamaguchi), Scientific Research from the Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University and Chiba University), and grants from The Hamaguchi Foundation for the Advancement of Biochemistry (to Noritaka Yamaguchi) and the Japan Foundation for Applied Enzymology (to Naoto Yamaguchi). The authors declare that they have no conflicts of interest with the contents of this article.	Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Bernardo GM, 2013, ONCOGENE, V32, P554, DOI 10.1038/onc.2012.62; Bernardo GM, 2012, BIOSCIENCE REP, V32, P113, DOI 10.1042/BSR20110046; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; Caizzi L, 2014, P NATL ACAD SCI USA, V111, P4892, DOI 10.1073/pnas.1315445111; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cottu P, 2014, CLIN CANCER RES, V20, P4314, DOI 10.1158/1078-0432.CCR-13-3230; deGraffenried LA, 2004, ANN ONCOL, V15, P885, DOI 10.1093/annonc/mdh232; Ellis AJ, 2015, EXPERT OPIN DRUG SAF, V14, P921, DOI 10.1517/14740338.2015.1014799; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Gu ZP, 2002, CANCER RES, V62, P3428; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Kasahara K, 2007, J CELL PHYSIOL, V211, P220, DOI 10.1002/jcp.20931; Li ZW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-215; Malik S, 2010, MOL CELL BIOL, V30, P399, DOI 10.1128/MCB.00907-09; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; McFarland BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078728; Nehra R, 2010, FASEB J, V24, P2040, DOI 10.1096/fj.09-138305; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Rodriguez-Barrueco R, 2015, GENE DEV, V29, P1631, DOI 10.1101/gad.262642.115; Rondon-Lagos M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081357; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Soutto M, 2011, J CLIN INVEST, V121, P1753, DOI 10.1172/JCI43922; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Yamaguchi N., 2016, J CELL BIOC IN PRESS; Yamaguchi N, 2008, BIOCHEM BIOPH RES CO, V365, P711, DOI 10.1016/j.bbrc.2007.11.064; Yamaguchi N, 2015, BIOCHEM J, V471, P67, DOI 10.1042/BJ20150372; Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x; Yamamoto M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3299; Yde CW, 2012, BREAST CANCER RES TR, V135, P67, DOI 10.1007/s10549-012-2053-1; Zhang WZ, 2013, CANCER CELL, V23, P647, DOI 10.1016/j.ccr.2013.03.012	36	37	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8136	8148		10.1074/jbc.M116.763276	http://dx.doi.org/10.1074/jbc.M116.763276			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28270510	Green Published, hybrid			2022-12-26	WOS:000401788600002
J	Jo, I; Kim, D; Bang, YJ; Ahn, J; Choi, SH; Ha, NC				Jo, Inseong; Kim, Dukyun; Bang, Ye-Ji; Ahn, Jinsook; Choi, Sang Ho; Ha, Nam-Chul			The hydrogen peroxide hypersensitivity of OxyR2 in Vibrio vulnificus depends on conformational constraints	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; DISTINCT CHARACTERISTICS; 2-CYS PEROXIREDOXINS; REDOX SWITCH; EXPRESSION; REGULATOR; PROTEIN; SUITE	Most Gram-negative bacteria respond to excessive levels of H2O2 using the peroxide-sensing transcriptional regulator OxyR, which can induce the expression of antioxidant genes to restore normality. Vibrio vulnificus has two distinct OxyRs (OxyR1 and OxyR2), which are sensitive to different levels of H2O2 and induce expression of two different peroxidases, Prx1 and Prx2. Although OxyR1 has both high sequence similarity and H2O2 sensitivity comparable with that of other OxyR proteins, OxyR2 exhibits limited sequence similarity and is more sensitive to H2O2. To investigate the basis for this difference, we determined crystal structures and carried out biochemical analyses of OxyR2. The determined structure of OxyR2 revealed a flipped conformation of the peptide bond before Glu-204, a position occupied by glycine in other OxyR proteins. Activity assays showed that the sensitivity to H2O2 was reduced to the level of other OxyR proteins by the E204G mutation. We solved the structure of the OxyR2-E204G mutant with the same packing environment. The structure of the mutant revealed a dual conformation of the peptide bond before Gly-204, indicating the structural flexibility of the region. This structural duality extended to the backbone atoms of Gly-204 and the imidazole ring of His-205, which interact with H2O2 and invariant water molecules near the peroxidatic cysteine, respectively. Structural comparison suggests that Glu-204 in OxyR2 provides rigidity to the region that is important in H2O2 sensing, compared with the E204G structure or other OxyR proteins. Our findings provide a structural basis for the higher sensitivity of OxyR2 to H2O2 and also suggest a molecular mechanism for bacterial regulation of expression of antioxidant genes at divergent concentrations of cellular H2O2.	[Jo, Inseong; Kim, Dukyun; Bang, Ye-Ji; Ahn, Jinsook; Choi, Sang Ho; Ha, Nam-Chul] Seoul Natl Univ, Res Inst Agr & Life Sci, Ctr Food Safety & Toxicol, Dept Agr Biotechnol, Seoul 08826, South Korea; [Kim, Dukyun; Bang, Ye-Ji; Choi, Sang Ho] Seoul Natl Univ, Natl Res Lab Mol Microbiol & Toxicol, Seoul 08826, South Korea; [Bang, Ye-Ji] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA	Seoul National University (SNU); Seoul National University (SNU); University of Texas System; University of Texas Southwestern Medical Center Dallas	Choi, SH; Ha, NC (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Ctr Food Safety & Toxicol, Dept Agr Biotechnol, Seoul 08826, South Korea.; Choi, SH (corresponding author), Seoul Natl Univ, Natl Res Lab Mol Microbiol & Toxicol, Seoul 08826, South Korea.	choish@snu.ac.kr; hanc210@snu.ac.kr	Jo, Inseong/AGY-9957-2022; Ahn, Jinsook/AAE-5827-2022	Ahn, Jinsook/0000-0002-4175-5181; Jo, Inseong/0000-0002-7964-4751; Bang, Ye-Ji/0000-0003-4009-0824; Choi, Sang Ho/0000-0003-3865-1039	R&D Convergence Center Support Program; Ministry of Agriculture, Food, and Rural Affairs Republic of Korea; Mid-career Researcher Program through the National Research Foundation [2015R1A2A1A13001654]; Ministry of Science, ICT, and Future Planning, Republic of Korea	R&D Convergence Center Support Program; Ministry of Agriculture, Food, and Rural Affairs Republic of Korea; Mid-career Researcher Program through the National Research Foundation; Ministry of Science, ICT, and Future Planning, Republic of Korea	This research was supported by the R&D Convergence Center Support Program (to S. H. C. and N.-C. H.), funded by Ministry of Agriculture, Food, and Rural Affairs Republic of Korea, and by Mid-career Researcher Program Grant 2015R1A2A1A13001654 (to S. H. C.) through the National Research Foundation, funded by the Ministry of Science, ICT, and Future Planning, Republic of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Bang YJ, 2016, J BIOL CHEM, V291, P16038, DOI 10.1074/jbc.M115.710343; Bang YJ, 2012, J BIOL CHEM, V287, P42516, DOI 10.1074/jbc.M112.421214; Cha SS, 2012, ACTA CRYSTALLOGR D, V68, P1253, DOI 10.1107/S0907444912024420; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Echols N, 2012, J APPL CRYSTALLOGR, V45, P581, DOI 10.1107/S0021889812017293; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goo SY, 2006, INFECT IMMUN, V74, P5586, DOI 10.1128/IAI.00171-06; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hishinuma S, 2006, ENVIRON MICROBIOL, V8, P2115, DOI 10.1111/j.1462-2920.2006.01088.x; Horseman MA, 2011, INT J INFECT DIS, V15, pE157, DOI 10.1016/j.ijid.2010.11.003; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Jo I, 2015, P NATL ACAD SCI USA, V112, P6443, DOI 10.1073/pnas.1424495112; Kim S, 2014, MOL MICROBIOL, V93, P992, DOI 10.1111/mmi.12712; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Lee MA, 2014, J MICROBIOL, V52, P1036, DOI 10.1007/s12275-014-4531-0; Lim JG, 2014, J BIOL CHEM, V289, P36263, DOI 10.1074/jbc.M114.611020; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Sainsbury S, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-10; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Stadtman ER, 2001, ANN NY ACAD SCI, V928, P22; STORZ G, 1990, TRENDS GENET, V6, P363, DOI 10.1016/0168-9525(90)90278-E; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; STORZ G, 1992, J NUTR, V122, P627, DOI 10.1093/jn/122.suppl_3.627; Svintradze DV, 2013, ACTA CRYSTALLOGR D, V69, P2091, DOI 10.1107/S0907444913019471; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winterbourn CC, 2016, MOL CELLS, V39, P26, DOI 10.14348/molcells.2016.2325; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	30	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7223	7232		10.1074/jbc.M116.743765	http://dx.doi.org/10.1074/jbc.M116.743765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28264933	Green Published, hybrid			2022-12-26	WOS:000400478300032
J	Raihan, MJ; Farzana, FD; Sultana, S; Haque, MA; Rahman, AS; Waid, JL; McCormick, B; Choudhury, N; Ahmed, T				Raihan, Mohammad Jyoti; Farzana, Fahmida Dil; Sultana, Sabiha; Haque, Md Ahshanul; Rahman, Ahmed Shafiqur; Waid, Jillian L.; McCormick, Ben; Choudhury, Nuzhat; Ahmed, Tahmeed			Examining the relationship between socio-economic status, WASH practices and wasting	PLOS ONE			English	Article							CHILD UNDERNUTRITION; ACUTE MALNUTRITION; WATER; INTERVENTION; ENTEROPATHY; PREVENTION; DIARRHEA; DISINFECTION; PREVALENCE; SANITATION	Childhood wasting is a global problem and is significantly more pronounced in low and middle income countries like Bangladesh. Socio Economic Status (SES) and Water, Sanitation and Hygiene (WASH) practices may be significantly associated with wasting. Most previous research is consistent about the role of SES, but the significance of WASH in the context of wasting remains ambiguous. The effect of SES and WASH on weight for length (WHZ) is examined using a Structural Equation Model (SEM) to explicitly describe the direct and indirect role of WASH in the context of SES. A nationally representative survey of 10,478 Bangladeshi children under 5 were examined. An expert defined SEM was used to construct latent variables for SES and WASH. The SEM included a direct pathway from SES to WHZ and an indirect pathway from SES to WHZ via WASH along with regression of relevant covariates on the outcome WHZ and the latent variables. Both SES (p<0.01) and WASH (p<0.05) significantly affect WHZ. SES (p<0.01) also significantly affects WASH. Other structural components showed that child's age (p<0.01) affects WHZ and types of residence (p<0.01) affects SES. WASH practices at least partially mediate the association between SES and wasting status. WASH and SES are both significantly associated with WHZ.	[Raihan, Mohammad Jyoti; Farzana, Fahmida Dil; Haque, Md Ahshanul; Rahman, Ahmed Shafiqur; Choudhury, Nuzhat; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh; [Sultana, Sabiha; Ahmed, Tahmeed] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Waid, Jillian L.] Helen Keller Int, Dhaka, Bangladesh; [McCormick, Ben] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA	International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh Rural Advancement Committee BRAC; BRAC University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Ahmed, T (corresponding author), Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh.; Ahmed, T (corresponding author), BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh.	tahmeed@icddrb.org		McCormick, Ben/0000-0002-8060-0502	European Commission; EU	European Commission(European CommissionEuropean Commission Joint Research Centre); EU(European Commission)	This study was made possible by the committed contribution and partnership of James P Grant School of Public Health (JPGSPH), BRAC University and icddr,b. This project itself is a joint partnership between JPGSPH, BRAC University, Bangladesh Bureau of Statistics and Helen Keller International (HKI), Bangladesh and funded by European Commission.; This manuscript was made possible by the committed contribution and partnership of James P Grant School of Public Health (JPGSPH), BRAG University (BU) and icddr,b. The manuscript is based on data collected and shared by FSNSP, implemented by JPGSPH, BU, Helen Keller International, Bangladesh and Bangladesh Bureau of Statistics and funded by EU. This manuscript has been reviewed by FSNSP technical reviewers for scientific content and consistency of data interpretation with previous FSNSP publications and significant comments have been incorporated prior to submission for publication. We acknowledge the following donors for providing unrestricted support to icddr,b's effort and advancement to its strategic plan: Government of the People's Republic of Bangladesh; Canada (Global Affairs, Canada-GAC), Sweden (Sida), and the United Kingdom (DFID).	Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Arnold B, 2009, INT J EPIDEMIOL, V38, P1651, DOI 10.1093/ije/dyp241; Arnold BF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003476; Banda K, 2007, T ROY SOC TROP MED H, V101, P1124, DOI 10.1016/j.trstmh.2007.05.004; BLACK RE, 1980, J INFECT DIS, V142, P660, DOI 10.1093/infdis/142.5.660; Bloss E, 2004, J TROP PEDIATRICS, V50, P260, DOI 10.1093/tropej/50.5.260; Chavance M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-37; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Cogill B, 2003, ANTHROPOMETRIC INDIC; Dangour AD, 2013, COCHRANE DATABASE SY, V8; de Pee S, 2015, FOOD NUTR BULL, V36, pS24, DOI 10.1177/15648265150361S104; du Preez M, 2011, ENVIRON SCI TECHNOL, V45, P9315, DOI 10.1021/es2018835; Ehiri J, 2003, HAND WASHING PREVENT; Frozanfar MK, 2016, NAGOYA J MED SCI, V78, P41; Fuchs C, 2014, INT J PEDIAT, V2014, DOI 10.1155/2014/267806; Gross R, 2006, LANCET, V367, P1209, DOI 10.1016/S0140-6736(06)68509-7; Gunzler Douglas, 2013, Shanghai Arch Psychiatry, V25, P390, DOI 10.3969/j.issn.1002-0829.2013.06.009; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Helen Keller International B, 2014, FSNSP HIST; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Imdad A, 2011, CURR OPIN CLIN NUTR, V14, P276, DOI 10.1097/MCO.0b013e328345364a; Isunju JB, 2011, PUBLIC HEALTH, V125, P368, DOI 10.1016/j.puhe.2011.03.008; Kennedy E, 2015, FOOD NUTR BULL, V36, pS9, DOI 10.1177/15648265150361S102; Khan NZ, 2009, J TROP PEDIATRICS, V55, P177, DOI 10.1093/tropej/fmn108; Langford R, 2011, AM J HUM BIOL, V23, P621, DOI 10.1002/ajhb.21189; Lin A, 2013, AM J TROP MED HYG, V89, P130, DOI 10.4269/ajtmh.12-0629; LOWBURY EJL, 1964, BMJ-BRIT MED J, V2, P230, DOI 10.1136/bmj.2.5403.230; Luby SP, 2004, JAMA-J AM MED ASSOC, V291, P2547, DOI 10.1001/jama.291.21.2547; Luby SP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001052; Manary MJ, 2008, BMJ, V337; MITTERMAYER H, 1975, ZBL BAKT MIK HYG B, V160, P163; Mohsena M, 2010, PUBLIC HEALTH NUTR, V13, P1498, DOI 10.1017/S1368980010001758; Ngure FM, 2014, ANN NY ACAD SCI, V1308, P118, DOI 10.1111/nyas.12330; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Pelletier David L., 2002, COMMON UNDERSTANDING; Psaki SR, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-8; Rayhan MI, 2006, PAK J NUTR, V5, P558, DOI [DOI 10.3923/PJN.2006.558.562, 10.3923/pjn.2006.558.562]; Schofield C, 1996, B WORLD HEALTH ORGAN, V74, P223; Sharma K, 2012, JOURNAL OF NEPAL HEA; Shekar M, 2006, REPOSITIONING NUTR C; Siddiqi M.N.A., 2011, ASIAN J MED SCI, V2, P113, DOI [10.3126/ajms.v2i2.3662, DOI 10.3126/AJMS.V2I2.3662]; Smith LC, 2005, WORLD DEV, V33, P1285, DOI 10.1016/j.worlddev.2005.03.002; VanderWeele TJ, 2012, AM J EPIDEMIOL; Vidal M, 2005, J CLIN MICROBIOL, V43, P5362, DOI 10.1128/JCM.43.10.5362-5365.2005; Waddington H., 2009, WATER SANITATION HYG; Walker JE, 1925, J INFECT DIS, V37, P181, DOI 10.1093/infdis/37.2.181; Wang YF, 2006, FOOD NUTR BULL, V27, pS175, DOI 10.1177/15648265060274S502; WHO, 2015, CHILD GROWTH IND THE; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA	49	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172134	10.1371/journal.pone.0172134	http://dx.doi.org/10.1371/journal.pone.0172134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278161	Green Published, gold			2022-12-26	WOS:000396087900115
J	Figueiredo, PHS; Lima, MMO; Costa, HS; Gomes, RT; Neves, CDC; de Oliveira, ES; Alves, FL; Rodrigues, VGB; Maciel, EHB; Balthazar, CH				Scheidt Figueiredo, Pedro Henrique; Oliveira Lima, Marcia Maria; Costa, Henrique Silveira; Gomes, Rosalina Tossige; Cunha Neves, Camila Danielle; de Oliveira, Evandro Silveira; Alves, Frederico Lopes; Brandao Rodrigues, Vanessa Gomes; Barroso Maciel, Emilio Henrique; Balthazar, Claudio Heitor			The role of the inspiratory muscle weakness in functional capacity in hemodialysis patients	PLOS ONE			English	Article							SHUTTLE WALK TEST; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; EXERCISE CAPACITY; REFERENCE VALUES; HEART-FAILURE; MORTALITY; STRENGTH; DISEASE; CKD	Introduction Inspiratory muscle function may be affected in patients with End-Stage Renal Disease (ESRD), further worsening the functional loss in these individuals. However, the impact of inspiratory muscle weakness (IMW) on the functional capacity (FC) of hemodialysis patients remains unknown. Thus, the present study aimed to evaluate the impact of IMW on FC in ESRD patients undergoing hemodialysis. Materials and methods ESRD patients on hemodialysis treatment for more than six months were evaluated for inspiratory muscle strength and FC. Inspiratory muscle strength was evaluated based on maximal inspiratory pressure (MIP). IMW was defined as MIP values less than 70% of the predicted value. FC was evaluated using the Incremental Shuttle Walk test (ISWT). Patients whose predicted peak oxygen uptake (VO(2)peak) over the distance walked during the ISWT was less than 16mL/kg/min were considered to have FC impairment. Associations between variables were assessed by linear and logistic regression, with adjustment for age, sex, body mass index (BMI), presence of diabetes and hemoglobin level. Receiver-operating characteristic (ROC) analysis was used to determine different cutoff values of the MIP for normal inspiratory muscle strength and FC. Results Sixty-five ERSD patients (67.7% male), aged 48.2 (44.5-51.9) years were evaluated. MIP was an independent predictor of the distance walked during the ISWT (R (2) = 0.44). IMW was an independent predictor of VO(2)peak < 16mL/kg/min. (OR = 5.7; p = 0.048) in adjusted logistic regression models. ROC curves showed that the MIP cutoff value of 82cmH(2)O had a sensitivity of 73.5% and specificity of 93.7% in predicting normal inspiratory strength and a sensitivity and specificity of 76.3% and 70.4%, respectively, in predicting VO(2)peak >= 16mL/ kg/min. Conclusions IMW is associated with reduced FC in hemodialysis patients. Evaluation of the MIP may be important to functional monitoring in clinical practice and can help in the stratification of patients eligible to perform exercise testing.	[Scheidt Figueiredo, Pedro Henrique] Univ Fed Vales Jequitinhonha & Mucuri, Postgrad Course Physiol Sci, Multicentr Program Physiol Sci, Diamantina, MG, Brazil; [Scheidt Figueiredo, Pedro Henrique; Oliveira Lima, Marcia Maria; Gomes, Rosalina Tossige; Cunha Neves, Camila Danielle; de Oliveira, Evandro Silveira; Balthazar, Claudio Heitor] Univ Fed Vales Jequitinhonha & Mucuri, Phys Therapy Sch, Cardiovasc Rehabil Lab LABCAR, Diamantina, MG, Brazil; [Costa, Henrique Silveira] Univ Fed Minas Gerais, Sch Med, Postgrad Program Infect Dis & Trop Med, Belo Horizonte, MG, Brazil; [Alves, Frederico Lopes; Brandao Rodrigues, Vanessa Gomes; Barroso Maciel, Emilio Henrique] Santa Casa Caridade Diamantina Hosp, Hemodialysis Unit, Diamantina, MG, Brazil; [Scheidt Figueiredo, Pedro Henrique; Balthazar, Claudio Heitor] Rodovia MGT 367,Km 583,5000,Alto da Jacuba,39, Diamantina, MG, Brazil	Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Minas Gerais	Figueiredo, PHS (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri, Postgrad Course Physiol Sci, Multicentr Program Physiol Sci, Diamantina, MG, Brazil.; Figueiredo, PHS (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri, Phys Therapy Sch, Cardiovasc Rehabil Lab LABCAR, Diamantina, MG, Brazil.; Figueiredo, PHS (corresponding author), Rodovia MGT 367,Km 583,5000,Alto da Jacuba,39, Diamantina, MG, Brazil.	phsfig@yahoo.com.br	Figueiredo, Pedro Henrique/AAP-2158-2020; Costa, Henrique Silveira/H-8286-2014	Costa, Henrique Silveira/0000-0002-1426-7246				Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Alves R, 2016, EUR J PHYS REHAB MED, V52, P20; Axelsson J, 2004, AM J CLIN NUTR, V80, P1222, DOI 10.1093/ajcn/80.5.1222; Cahalin LP, 2015, HEART FAIL CLIN, V11, P149, DOI 10.1016/j.hfc.2014.09.002; Carrero JJ, 2008, CLIN NUTR, V27, P557, DOI 10.1016/j.clnu.2008.04.007; Chen CT, 2013, SCI WORLD J, DOI 10.1155/2013/643954; Cury JL, 2010, BRAZ J PHYS THER, V14, P91, DOI 10.1590/S1413-35552010005000008; Dempsey JA, 2006, RESP PHYSIOL NEUROBI, V151, P242, DOI 10.1016/j.resp.2005.12.015; Dipp T, 2010, REV BRAS MED ESPORTE, V16, P246, DOI 10.1590/S1517-86922010000400002; Dourado VZ, 2013, J BRAS PNEUMOL, V39, P190, DOI 10.1590/S1806-37132013000200010; Eknoyan G, 2004, KIDNEY INT, V66, P1310, DOI 10.1111/j.1523-1755.2004.00894.x; Fassbinder Tânia Regina Cavinatto, 2015, Braz. J. Nephrol., V37, P47, DOI 10.5935/0101-2800.20150008; Finkelstein FO, 2009, KIDNEY INT, V76, P946, DOI 10.1038/ki.2009.307; Fragoso CAV, 2014, J AM GERIATR SOC, V62, P622, DOI 10.1111/jgs.12738; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Hart N, 2002, AM J RESP CRIT CARE, V165, P1265, DOI 10.1164/rccm.2110016; Hill K, 2012, RESPIROLOGY, V17, P278, DOI 10.1111/j.1440-1843.2011.02089.x; Ikizler TA, 2002, AM J PHYSIOL-ENDOC M, V282, pE107, DOI 10.1152/ajpendo.2002.282.1.E107; Iyasere O, 2014, POSTGRAD MED J, V90, P340, DOI 10.1136/postgradmedj-2013-132251; Johansen KL, 2010, KIDNEY INT, V78, P1164, DOI 10.1038/ki.2010.312; Johansen KL, 2012, CLIN J AM SOC NEPHRO; Kaminski DM, 2011, CLIN AUTON RES, V21, P29, DOI 10.1007/s10286-010-0087-1; Katayama A, 2014, ENVIRON HEALTH PREV, V19, P220, DOI 10.1007/s12199-014-0380-z; Kovelis Demetria, 2008, J. bras. pneumol., V34, P907, DOI 10.1590/S1806-37132008001100004; Kutner NG, 2015, AM J KIDNEY DIS, V66, P297, DOI 10.1053/j.ajkd.2015.01.024; Moreno AM, 2014, BRAZ J MED BIOL RES, V47, P972, DOI 10.1590/1414-431X20143896; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P719, DOI 10.1590/S0100-879X1999000600007; Neves CDC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117563; Painter P, 2012, CLIN J AM SOC NEPHRO; Painter P, 2009, ADV CHRONIC KIDNEY D, V16, P437, DOI 10.1053/j.ackd.2009.09.002; Parreira VF, 2014, CHEST, V145, P1357, DOI 10.1378/chest.13-2071; Petchey WG, 2011, CLIN J AM SOC NEPHRO, V6, P512, DOI 10.2215/CJN.06880810; Pinheiro MB, 2014, EUR J PHYS REHAB MED, V50, P301; Polkey MI, 2016, AM J RESP CRITICAL C; Pomidori L, 2016, J NEPHROL, P1; Reis MS, 2014, PHYSIOTHER RES INT, V19, P16, DOI 10.1002/pri.1552; Reis MS, 2010, CLINICS, V65, P369, DOI 10.1590/S1807-59322010000400004; Rosa CSC, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0183-5; Silva Vanessa Giendruczak da, 2011, Braz. J. Nephrol., V33, P62; Singer J, 2011, J CARDIOPULM REHABIL, V31, P111, DOI 10.1097/HCR.0b013e3182033663; SINGH SJ, 1992, THORAX, V47, P1019, DOI 10.1136/thx.47.12.1019; Stack AG, 2005, AM J KIDNEY DIS, V45, P690, DOI 10.1053/j.ajkd.2004.12.013; Tavana Sasan, 2015, Tanaffos, V14, P128; Torino C, 2014, KIDNEY BLOOD PRESS R, V39, P205, DOI 10.1159/000355798; van der Palen J, 2004, THORAX, V59, P1063, DOI 10.1136/thx.2004.021915; WEBER KT, 1985, AM J CARDIOL, V55, pA22, DOI 10.1016/0002-9149(85)90792-1; Weiner DE, 2006, AM J KIDNEY DIS, V48, P392, DOI 10.1053/j.ajkd.2006.05.021; Yamada K, 2016, J CARD FAIL, V22, P38, DOI 10.1016/j.cardfail.2015.10.010	48	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173159	10.1371/journal.pone.0173159	http://dx.doi.org/10.1371/journal.pone.0173159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278163	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900051
J	Hildebrandt, W; Schwarzbach, H; Pardun, A; Hannemann, L; Bogs, B; Konig, AM; Mahnken, AH; Hildebrandt, O; Koehler, U; Kinscherf, R				Hildebrandt, Wulf; Schwarzbach, Hans; Pardun, Anita; Hannemann, Lena; Bogs, Bjoern; Koenig, Alexander M.; Mahnken, Andreas H.; Hildebrandt, Olaf; Koehler, Ulrich; Kinscherf, Ralf			Age-related differences in skeletal muscle microvascular response to exercise as detected by contrast-enhanced ultrasound (CEUS)	PLOS ONE			English	Article							LIMB VASCULAR CONDUCTANCE; BLOOD-FLOW; HEALTHY HUMANS; CAPILLARY RECRUITMENT; GLUCOSE-UPTAKE; ENDOTHELIAL DYSFUNCTION; REGIONAL SPECIFICITY; INSULIN-RESISTANCE; OLDER MEN; IN-VIVO	Background Aging involves reductions in exercise total limb blood flow and exercise capacity. We hypothesized that this may involve early age-related impairments of skeletal muscle microvascular responsiveness as previously reported for insulin but not for exercise stimuli in humans. Methods Using an isometric exercise model, we studied the effect of age on contrast-enhanced ultrasound (CEUS) parameters, i.e. microvascular blood volume (MBV), flow velocity (MFV) and blood flow (MBF) calculated from replenishment of Sonovue contrast-agent microbubbles after their destruction. CEUS was applied to the vastus lateralis (VLat) and intermedius (VInt) muscle in 15 middle-aged (MA, 43.6 +/- 1.5 years) and 11 young (YG, 24.1 +/- 0.6 years) healthy males before, during, and after 2 min of isometric knee extension at 15% of peak torque (PT). In addition, total leg blood flow as recorded by femoral artery Doppler-flow. Moreover, fibertype-specific and overall capillarisation as well as fiber composition were additionally assessed in Vlat biopsies obtained from CEUS site. MA and YG had similar quadriceps muscle MRT-volume or PT and maximal oxygen uptake as well as a normal cardiovascular risk factors and intima-media-thickness. Results During isometric exercise MA compared to YG reached significantly lower levels in MFV (0.123 +/- 0.016 vs. 0.208 +/- 0.036 a.u.) and MBF (0.007 +/- 0.001 vs. 0.012 +/- 0.002 a.u.). In the VInt the (post-occlusive hyperemia) post-exercise peaks in MBV and MBF were significantly lower in MA vs. YG. Capillary density, capillary fiber contacts and femoral artery Doppler were similar between MA and YG. Conclusions In the absence of significant age-related reductions in capillarisation, total leg blood flow or muscle mass, healthy middle-aged males reveal impaired skeletal muscle microcirculatory responses to isometric exercise. Whether this limits isometric muscle performance remains to be assessed.	[Hildebrandt, Wulf; Schwarzbach, Hans; Pardun, Anita; Hannemann, Lena; Bogs, Bjoern; Kinscherf, Ralf] Univ Marburg, Inst Anat & Cell Biol, Dept Med Cell Biol, Marburg, Germany; [Koenig, Alexander M.; Mahnken, Andreas H.] Univ Hosp Giessen, Dept Diagnost & Intervent Radiol, Baldingerstr, Marburg, Germany; [Koenig, Alexander M.; Mahnken, Andreas H.] Marburg UKGM Univ, Baldingerstr, Marburg, Germany; [Hildebrandt, Olaf; Koehler, Ulrich] Univ Hosp Giessen & Marburg UKGM, Div Pneumol, Internal Med, Dept Sleep Med, Baldingerstr, Marburg, Germany	Philipps University Marburg; University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg	Hildebrandt, W (corresponding author), Univ Marburg, Inst Anat & Cell Biol, Dept Med Cell Biol, Marburg, Germany.	Wulf.Hildebrandt@staff.uni-marburg.de	Kinscherf, Ralf/AAV-7164-2021	Mahnken, Andreas H./0000-0001-8077-9306	von Behring Rontgen Stiftung [580071]	von Behring Rontgen Stiftung	WH received a grant of the von Behring Rontgen Stiftung (Grant number 580071). The funders had no role in study design, data collection and anaylsis, decission to publish, or preparation of the mansucript.	BARON AD, 1994, AM J PHYSIOL, V266, pE248, DOI 10.1152/ajpendo.1994.266.2.E248; Barrett EJ, 2013, REV ENDOCR METAB DIS, V14, P21, DOI 10.1007/s11154-012-9232-6; Beere PA, 1999, CIRCULATION, V100, P1085, DOI 10.1161/01.CIR.100.10.1085; Behnke BJ, 2005, RESP PHYSIOL NEUROBI, V146, P259, DOI 10.1016/j.resp.2004.12.009; Budui SL, 2015, CLIN CASES MINER BON, V12, P22, DOI 10.11138/ccmbm/2015.12.1.022; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0; Clark Michael G, 2002, Semin Vasc Med, V2, P21, DOI 10.1055/s-2002-23506; Clerk LH, 2006, DIABETES, V55, P1436, DOI 10.2337/db05-1373; Clerk LH, 2004, DIABETES-METAB RES, V20, P3, DOI 10.1002/dmrr.414; Credeur DP, 2015, J APPL PHYSIOL, V118, P455, DOI 10.1152/japplphysiol.00785.2014; Dawson D, 2002, AM J PHYSIOL-ENDOC M, V282, pE714, DOI 10.1152/ajpendo.00373.2001; Degens H., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P246; DEHN MM, 1972, J APPL PHYSIOL, V33, P805, DOI 10.1152/jappl.1972.33.6.805; DeSouza CA, 2000, CIRCULATION, V102, P1351, DOI 10.1161/01.CIR.102.12.1351; Dinenno FA, 1999, CIRCULATION, V100, P164, DOI 10.1161/01.CIR.100.2.164; Dinenno FA, 2001, J PHYSIOL-LONDON, V534, P287, DOI 10.1111/j.1469-7793.2001.00287.x; Dinenno FA, 2000, AM J PHYSIOL-HEART C, V278, pH1205, DOI 10.1152/ajpheart.2000.278.4.H1205; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Donato AJ, 2006, AM J PHYSIOL-HEART C, V290, pH272, DOI 10.1152/ajpheart.00405.2005; Durham WJ, 2010, FASEB J, V24, P4117, DOI 10.1096/fj.09-150177; Frisbee JC, 2014, J PHYSL, P1, DOI [10.1113/jphysiol.2013.268060_1, DOI 10.1113/JPHYSIOL.2013.268060_1]; Frisbee JC, 2014, AM J PHYSIOL-HEART C, V307, pH1714, DOI 10.1152/ajpheart.00605.2014; Gavin TP, 2007, J PHYSIOL-LONDON, V585, P231, DOI 10.1113/jphysiol.2007.143198; Groen BBL, 2014, J APPL PHYSIOL, V116, P998, DOI 10.1152/japplphysiol.00919.2013; HIGGINBOTHAM MB, 1986, AM J CARDIOL, V57, P1374, DOI 10.1016/0002-9149(86)90221-3; Hirai DM, 2012, AM J PHYSIOL-HEART C, V303, pH1076, DOI 10.1152/ajpheart.00477.2012; Hirai DM, 2011, J APPL PHYSIOL, V111, P989, DOI 10.1152/japplphysiol.00490.2011; Hofmann MA, 2001, J CLIN INVEST, V107, P675, DOI 10.1172/JCI10588; IRION GL, 1987, J GERONTOL, V42, P660, DOI 10.1093/geronj/42.6.660; JASPERSE JL, 1994, J PHYSIOL-LONDON, V474, P353, DOI 10.1113/jphysiol.1994.sp020027; Keske MA, 2016, J PHYSIOL-LONDON, V594, P2223, DOI 10.1113/jphysiol.2014.283549; Krix M, 2010, EUR J RADIOL, V76, P110, DOI 10.1016/j.ejrad.2009.05.007; LAAKSO M, 1990, J CLIN INVEST, V85, P1844, DOI 10.1172/JCI114644; LIND L, 1993, AM HEART J, V125, P1494, DOI 10.1016/0002-8703(93)90446-G; MARTIN WH, 1991, CIRCULATION, V84, P654, DOI 10.1161/01.CIR.84.2.654; McDaniel J, 2010, J PHYSIOL-LONDON, V588, P4507, DOI 10.1113/jphysiol.2010.198770; Mitchell WK, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.119; Musch TI, 2004, J APPL PHYSIOL, V96, P81, DOI 10.1152/japplphysiol.00729.2003; Phillips BE, 2015, J PHYSIOL-LONDON, V593, P2721, DOI 10.1113/JP270343; Poole DC, 2014, J PHYSIOL-LONDON, V592, P5133, DOI 10.1113/jphysiol.2014.282145; Poole DC, 2013, EXP PHYSIOL, V98, P1645, DOI 10.1113/expphysiol.2013.073874; Porsch-Ozcurumez MK, 1997, THESIS JUSTUS LIEBIG; Proctor DN, 2006, MICROCIRCULATION, V13, P325, DOI 10.1080/10739680600618967; Proctor DN, 2005, J APPL PHYSIOL, V98, P193, DOI 10.1152/japplphysiol.00704.2004; Proctor DN, 1998, J APPL PHYSIOL, V85, P68, DOI 10.1152/jappl.1998.85.1.68; Richards JC, 2014, J PHYSIOL-LONDON, V592, P4775, DOI 10.1113/jphysiol.2014.278358; Ridout SJ, 2005, J APPL PHYSIOL, V99, P2067, DOI 10.1152/japplphysiol.00825.2005; Roth GA, 2011, B WORLD HEALTH ORGAN, V89, P92, DOI 10.2471/BLT.10.079947; Ryan NA, 2006, J APPL PHYSIOL, V100, P178, DOI 10.1152/japplphysiol.00827.2005; Seals DR, 2006, EXP GERONTOL, V41, P501, DOI 10.1016/j.exger.2006.01.001; Sinkler SY, 2014, AM J PHYSIOL-HEART C, V307, pH830, DOI 10.1152/ajpheart.00368.2014; Sjoberg KA, 2011, AM J PHYSIOL-HEART C, V301, pH450, DOI 10.1152/ajpheart.01174.2010; Skilton MR, 2005, AM J PHYSIOL-HEART C, V288, pH1404, DOI 10.1152/ajpheart.00484.2004; Solomon TPJ, 2011, J CLIN ENDOCR METAB, V96, P1377, DOI 10.1210/jc.2010-2069; Steinberg HO, 1997, CIRCULATION, V96, P3287; Vincent MA, 2004, DIABETES, V53, P1418, DOI 10.2337/diabetes.53.6.1418; Vincent MA, 2002, DIABETES, V51, P42, DOI 10.2337/diabetes.51.1.42; Vincent MA, 2006, AM J PHYSIOL-ENDOC M, V290, pE1191, DOI 10.1152/ajpendo.00497.2005; Wagenmakers AJM, 2016, J PHYSIOL-LONDON, V594, P2207, DOI 10.1113/jphysiol.2014.284513; WAHREN J, 1974, SCAND J CLIN LAB INV, V33, P79, DOI 10.3109/00365517409114201; Weber MA, 2007, J MOL MED, V85, P887, DOI 10.1007/s00109-007-0220-3; Wei K, 1998, CIRCULATION, V97, P473; Womack L, 2009, J AM COLL CARDIOL, V53, P2175, DOI 10.1016/j.jacc.2009.02.042; YANG YJ, 1989, J CLIN INVEST, V84, P1620, DOI 10.1172/JCI114339; Zhang L, 2004, DIABETES, V53, P447, DOI 10.2337/diabetes.53.2.447	65	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172771	10.1371/journal.pone.0172771	http://dx.doi.org/10.1371/journal.pone.0172771			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273102	Green Submitted, gold, Green Published			2022-12-26	WOS:000396073700030
J	Lee, CW; Fang, SY; Tsai, DC; Huang, N; Hsu, CC; Chen, SY; Chiu, AWH; Liu, CJL				Lee, Chia-Wei; Fang, Shao-You; Tsai, Der-Chong; Huang, Nicole; Hsu, Chih-Chien; Chen, Shing-Yi; Chiu, Allen Wen-Hsiang; Liu, Catherine Jui-Ling			Prevalence and association of refractive anisometropia with near work habits among young schoolchildren: The evidence from a population-based study	PLOS ONE			English	Article							CILIARY MUSCLE THICKNESS; OCULAR AXIAL LENGTH; SCHOOL-CHILDREN; MYOPIA; ERROR; ACCOMMODATION; NEARWORK; DESIGN; AGE; EYE	Background Lifestyle behaviour may play a role in refractive error among children, but the association between near work habits and refractive anisometropia remains unclear. Methods We estimated the prevalence of refractive anisometropia and examined its association with near work activities among 23,114 children in the Myopia Investigation Study in Taipei who were grade 2 elementary school students at baseline in 2013 and 2014. Baseline data on demographics, medical history, parental history and near work habits were collected by parent-administered questionnaire survey. Refractive status was determined by cycloplegic autorefraction. Refractive anisometropia was defined as the spherical equivalent difference >= 1.0 diopter between eyes. Results The prevalence of refractive anisometropia was 5.3% (95% confidence interval [CI], 5.0% to 5.6%). The prevalence and severity of refractive anisometropia increased with both myopic and hyperopic refractive error. Multivariate logistic regression analysis revealed that refractive anisometropia was significantly associated with myopia (odds ratio [OR], 2.98; 95% CI, 2.53-3.51), hyperopia (OR, 2.37; 95% CI, 1.98-2.83), degree of astigmatism (OR, 1.005; 95% CI, 1.005-1.006), amblyopia (OR, 2.54; 95% CI, 2.06-3.12), male gender (OR, 0.88; 95% CI, 0.78-0.99) and senior high school level of maternal education (OR, 0.69; 95% CI, 0.52-0.92). Though anisometropic children were more likely to spend more time on near work (crude OR, 1.15; 95% CI, 1.02-1.29) and to have less eye-to-object distance in doing near work (crude OR, 1.15; 95% CI, 1.01-1.30), these associations became insignificant after additional adjustment for ocular, demographic and parental factors. Conclusions The present study provides large-scale, population-based evidence showing no independent association between refractive anisometropia and near work habits, though myopia is associated with refractive anisometropia.	[Lee, Chia-Wei; Hsu, Chih-Chien; Liu, Catherine Jui-Ling] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Fang, Shao-You] Natl Taiwan Univ, Children & Family Res Ctr, Taipei, Taiwan; [Tsai, Der-Chong; Chiu, Allen Wen-Hsiang; Liu, Catherine Jui-Ling] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Tsai, Der-Chong] Natl Yang Ming Univ Hosp, Dept Ophthalmol, Yilan, Taiwan; [Huang, Nicole] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei, Taiwan; [Hsu, Chih-Chien] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Chen, Shing-Yi] Taipei City Govt, Dept Hlth, Taipei, Taiwan	Taipei Veterans General Hospital; National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Liu, CJL (corresponding author), Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.; Tsai, DC; Liu, CJL (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Tsai, DC (corresponding author), Natl Yang Ming Univ Hosp, Dept Ophthalmol, Yilan, Taiwan.	11803@ymuh.ym.edu.tw; jlliu@vghtpe.gov.tw		Huang, Nicole/0000-0002-6629-1176	Taipei City Government [H10237, P10303]	Taipei City Government	The present study was supported by grants H10237 and P10303 from the Taipei City Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afsari S, 2013, BRIT J OPHTHALMOL, V97, P1095, DOI 10.1136/bjophthalmol-2012-302637; Bailey MD, 2008, INVEST OPHTH VIS SCI, V49, P4353, DOI 10.1167/iovs.08-2008; Borchert M, 2010, OPHTHALMOLOGY, V117, P148, DOI 10.1016/j.ophtha.2009.06.008; Deng L, 2012, INVEST OPHTH VIS SCI, V53, P3782, DOI 10.1167/iovs.11-8727; GEE SS, 1988, OPHTHALMOLOGY, V95, P1276; Ghosh A, 2014, OPTOMETRY VISION SCI, V91, P322, DOI 10.1097/OPX.0000000000000166; Giordano L, 2009, OPHTHALMOLOGY, V116, P739, DOI 10.1016/j.ophtha.2008.12.030; Guzowski M, 2003, AM J OPHTHALMOL, V136, P551, DOI 10.1016/S0002-9394(03)00246-0; Hsu CC, 2016, J CHIN MED ASS, P30078; Hu YY, 2016, INVEST OPHTH VIS SCI, V57, P979, DOI 10.1167/iovs.15-18647; Huang HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140419; Huang Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114910, 10.1371/journal.pone.0131053]; Huynh SC, 2006, BRIT J OPHTHALMOL, V90, P597, DOI 10.1136/bjo.2005.083154; Kuchem MK, 2013, OPTOMETRY VISION SCI, V90, P1312, DOI 10.1097/OPX.0000000000000070; Lewis HA, 2012, OPTOMETRY VISION SCI, V89, P727, DOI 10.1097/OPX.0b013e318253de7e; Lin Z, 2013, OPHTHAL PHYSL OPT, V33, P311, DOI 10.1111/opo.12049; Mallen EAH, 2006, INVEST OPHTH VIS SCI, V47, P1251, DOI 10.1167/iovs.05-1086; Mutti DO, 2002, INVEST OPHTH VIS SCI, V43, P3633; O'Donoghue L, 2013, INVEST OPHTH VIS SCI, V54, P602, DOI 10.1167/iovs.12-11066; Ojaimi E, 2005, OPHTHAL EPIDEMIOL, V12, P59, DOI 10.1080/09286580490921296; PARSSINEN O, 1990, OPTOMETRY VISION SCI, V67, P256, DOI 10.1097/00006324-199004000-00005; Qin XJ, 2005, INVEST OPHTH VIS SCI, V46, P4024, DOI 10.1167/iovs.05-0120; Read SA, 2010, INVEST OPHTH VIS SCI, V51, P6262, DOI 10.1167/iovs.10-5457; Saw SM, 2002, ARCH OPHTHALMOL-CHIC, V120, P620, DOI 10.1001/archopht.120.5.620; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P332; Sherwin JC, 2012, OPHTHALMOLOGY, V119, P2141, DOI 10.1016/j.ophtha.2012.04.020; SORSBY A, 1962, VISION RES, V2, P43, DOI 10.1016/0042-6989(62)90062-7; Swarbrick HA, 2015, OPHTHALMOLOGY, V122, P620, DOI 10.1016/j.ophtha.2014.09.028; Tong L, 2006, INVEST OPHTH VIS SCI, V47, P3247, DOI 10.1167/iovs.05-0906; Tsai DC, 2015, CLIN EXP OPHTHALMOL, V43, P612, DOI 10.1111/ceo.12532; VONNOORDEN GK, 1987, INVEST OPHTH VIS SCI, V28, P750; Weale RA, 2002, OPHTHALMIC RES, V34, P389, DOI 10.1159/000067040; Woodman EC, 2011, BRIT J OPHTHALMOL, V95, P652, DOI 10.1136/bjo.2010.180323; Yamashita T, 1999, OPHTHAL PHYSL OPT, V19, P30, DOI 10.1046/j.1475-1313.1998.00407.x; Yekta A, 2010, CLIN EXP OPHTHALMOL, V38, P242, DOI 10.1111/j.1442-9071.2010.02247.x	35	9	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173519	10.1371/journal.pone.0173519	http://dx.doi.org/10.1371/journal.pone.0173519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273153	Green Published, gold, Green Submitted			2022-12-26	WOS:000396073700012
J	Lee, DH; Seubert, S; Huhn, K; Brecht, L; Rotger, C; Waschbisch, A; Schlachetzki, J; Klausmeyer, A; Melms, A; Wiese, S; Winkler, J; Linker, RA				Lee, De-Hyung; Seubert, Silvia; Huhn, Konstantin; Brecht, Lukas; Roetger, Caroline; Waschbisch, Anne; Schlachetzki, Johannes; Klausmeyer, Alice; Melms, Arthur; Wiese, Stefan; Winkler, Juergen; Linker, Ralf A.			Fingolimod effects in neuroinflammation: Regulation of astroglial glutamate transporters?	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; OLIGODENDROCYTE PROGENITOR CELLS; MULTIPLE-SCLEROSIS LESIONS; CENTRAL-NERVOUS-SYSTEM; 1-PHOSPHATE RECEPTOR 1; RAT MODEL; FTY720; SPHINGOSINE; PROLIFERATION; EXPRESSION	Fingolimod is an oral sphingosine-1-phosphate-receptor modulator which reduces the recirculation of immune cells and may also directly target glial cells. Here we investigate effects of fingolimod on expression of astroglial glutamate transporters under pro-inflammatory conditions. In astrocyte cell culture, the addition of pro-inflammatory cytokines led to a significant downregulation of glutamate transporters glutamate transporter-1 ( slc1a2/SLC1A2) and glutamate aspartate transporter ( slc1a3/SLC1A3) expression on the mRNA or protein level. In this setting, the direct application of fingolimod-1 phosphate ( F1P) on astrocytes did not change expression levels of slc1a2 and slc1a3 mRNA. The analysis of both transporters on the protein level by Western Blot and immunocytochemistry did also not reveal any effect of F1P. On a functional level, the addition of conditioned supernatants from F1P treated astrocytes to neuronal cell culture did not result in increased neurite growth. In experimental autoimmune encephalomyelitis as a model of multiple sclerosis, fingolimod treatment reduced T cell and macrophages/microglia mediated inflammation and also diminished astrocyte activation. At the same time, fingolimod restored the reduced expression of slc1a2 and slc1a3 in the inflamed spinal cord on the mRNA level and of SLC1A2 and SLC1A3 on the protein level, presumably via indirect, anti-inflammatory mechanisms. These findings provide further evidence for a predominantly peripheral effect of the compound in neuroinflammation.	[Lee, De-Hyung; Seubert, Silvia; Huhn, Konstantin; Brecht, Lukas; Roetger, Caroline; Waschbisch, Anne; Melms, Arthur; Linker, Ralf A.] Friedrich Alexander Univ, Dept Neurol, Erlangen, Germany; [Schlachetzki, Johannes; Winkler, Juergen] Friedrich Alexander Univ, Dept Mol Neurol, Erlangen, Germany; [Klausmeyer, Alice; Wiese, Stefan] Ruhr Univ, Inst Mol Neurobiol, Bochum, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Ruhr University Bochum	Lee, DH (corresponding author), Friedrich Alexander Univ, Dept Neurol, Erlangen, Germany.	de-hyung.lee@uk-erlangen.de	Linker, Ralf/AAD-8884-2020	Winkler, Jurgen/0000-0003-0630-9204	Deutsche Forschungsgemeinschaft (DFG); Novartis Pharma Germany; Novartis Pharma	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Novartis Pharma Germany; Novartis Pharma	The microscope used in this study was funded by the Deutsche Forschungsgemeinschaft (DFG). Novartis Pharma Germany supported previous research on fingolimod and provided fingolimod-1 phosphate for the present study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Katrin Bitterer, the Department of Neurology, University Hospital Erlangen, for expert technical assistance. RAL holds an endowed professorship supported by Novartis Pharma.	Al-Izki S, 2011, MULT SCLER J, V17, P939, DOI 10.1177/1352458511400476; Balatoni B, 2007, BRAIN RES BULL, V74, P307, DOI 10.1016/j.brainresbull.2007.06.023; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; Brunkhorst R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070124; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Colombo E, 2014, ANN NEUROL, V76, P325, DOI 10.1002/ana.24217; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Deogracias R, 2012, P NATL ACAD SCI USA, V109, P14230, DOI 10.1073/pnas.1206093109; Ettle B, 2014, MOL CELL NEUROSCI, V62, P68, DOI 10.1016/j.mcn.2014.06.012; Foster CA, 2007, J PHARMACOL EXP THER, V323, P469, DOI 10.1124/jpet.107.127183; Foster CA, 2009, BRAIN PATHOL, V19, P254, DOI 10.1111/j.1750-3639.2008.00182.x; Fujino M, 2003, J PHARMACOL EXP THER, V305, P70, DOI 10.1124/jpet.102.045658; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Herrero-Herranz E, 2007, AM J PATHOL, V171, P589, DOI 10.2353/ajpath.2007.061241; Kanno T, 2011, LIFE SCI, V89, P137, DOI 10.1016/j.lfs.2011.05.021; Kataoka H, 2005, CELL MOL IMMUNOL, V2, P439; Korn T, 2005, FASEB J, V19, P1878, DOI 10.1096/fj.05-3748fje; Korn T, 2007, NEUROMOL MED, V9, P1, DOI 10.1385/NMM:9:1:1; Kraft P, 2013, STROKE, V44, P3202, DOI 10.1161/STROKEAHA.113.002880; Linker RA, 2010, BRAIN, V133, P2248, DOI 10.1093/brain/awq179; Liu Jing, 2013, J Toxicol, V2013, P967029, DOI 10.1155/2013/967029; Lublin F, 2016, LANCET, V387, P1075, DOI 10.1016/S0140-6736(15)01314-8; Mandolesi G, 2013, J NEUROSCI, V33, P12105, DOI 10.1523/JNEUROSCI.5369-12.2013; Miron VE, 2008, ANN NEUROL, V63, P61, DOI 10.1002/ana.21227; Mullershausen F, 2007, J NEUROCHEM, V102, P1151, DOI 10.1111/j.1471-4159.2007.04629.x; Newcombe J, 2008, BRAIN PATHOL, V18, P52, DOI 10.1111/j.1750-3639.2007.00101.x; Papadopoulos D, 2010, J NEUROSCI RES, V88, P346, DOI 10.1002/jnr.22196; Pitt D, 2003, NEUROLOGY, V61, P1113, DOI 10.1212/01.WNL.0000090564.88719.37; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Rolland WB, 2013, EXP NEUROL, V241, P45, DOI 10.1016/j.expneurol.2012.12.009; Sorensen SD, 2003, MOL PHARMACOL, V64, P1199, DOI 10.1124/mol.64.5.1199; Van Doorn R, 2010, GLIA, V58, P1465, DOI 10.1002/glia.21021; Wang Y, 2010, APOPTOSIS, V15, P1382, DOI 10.1007/s10495-010-0481-0; Webb M, 2004, J NEUROIMMUNOL, V153, P108, DOI 10.1016/j.jneuroim.2004.04.015; Woodcock JM, 2010, CELL SIGNAL, V22, P1291, DOI 10.1016/j.cellsig.2010.04.004; Yan XS, 2014, GLIA, V62, P1093, DOI 10.1002/glia.22665; Zhang J, 2015, NEUROBIOL DIS, V76, P57, DOI 10.1016/j.nbd.2015.01.006	37	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171552	10.1371/journal.pone.0171552	http://dx.doi.org/10.1371/journal.pone.0171552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273090	gold, Green Published, Green Submitted			2022-12-26	WOS:000396073700058
J	Li, R; Wang, H; Pan, XH; Ma, QQ; Chen, L; Zhou, X; Jiang, TT; He, L; Chen, JF; Zhang, XL; Luo, Y; Xi, SJ; Lv, X; Xia, SC				Li, Runhua; Wang, Hui; Pan, Xiaohong; Ma, Qiaoqin; Chen, Lin; Zhou, Xin; Jiang, Tingting; He, Lin; Chen, Junfang; Zhang, Xingliang; Luo, Yan; Xi, Shengjun; Lv, Xin; Xia, Shichang			Prevalence of condomless anal intercourse and recent HIV testing and their associated factors among men who have sex with men in Hangzhou, China: A respondent-driven sampling survey	PLOS ONE			English	Article							RISK BEHAVIOR; SOCIAL SUPPORT; HUNAN PROVINCE; BLACK-MEN; PREVENTION; INFECTION; TRANSMISSION; METAANALYSIS; MSM; PROBABILITY	Men who have sex with men (MSM) are a large high-risk population for HIV infection in recent years in China. A cross-sectional survey was conducted in Hangzhou, China, to determine rates of condomless anal intercourse (CAI), recent HIV testing (in the recent year) and associated factors using respondent-driven sampling. Questionnaires using face-to-face interviews were employed to collect data on sexual risk behaviors and HIV testing. Five hundred eleven MSM were recruited, of which 459 (89.8%) had anal intercourse in the past 6 months. Of these 459 participants, 457 (99.6%) answered whether they had taken an HIV test in the recent year, so only their data were analyzed. Weighted data were analyzed using bivariate and multivariate logistic regression analysis. The CAI rate with male partners in the past 6 months was 43.7% (95% confidence interval [CI], 34.0-51.5%), while the rate of condomless vaginal intercourse (CVI) was 21.6% (95% CI, 15.6-32.3%). The prevalence of recent HIV testing was 56.8% (95% CI, 48.7-66.5%), while the prevalence of HIV and syphilis were 8.8% and 6.5%, respectively. Multivariate analysis indicated that CAI was associated with earlier homosexual debut, suicidal inclinations, childhood sexual abuse, HIV testing in the recent year, and lower estimate of HIV prevalence. Recent HIV testing was associated with homosexual debut age, engaging in CAI with male partners in the past 6 months, having oral sex in the past 6 months, self-perceived higher likelihood of HIV infection, knowing about antiretroviral therapy for HIV/AIDS, receiving AIDS/sexually transmitted infection (STI) interventions in the past year, and syphilis infection. Given high prevalence of HIV and syphilis, high levels of CAI and CVI, and low HIV testing rate, the results indicated high risk of HIV infection and transmission among MSM. HIV prevention interventions should target MSM with early homosexual debut and psychosocial health problems, while HIV/AIDS education among MSM should focus on increasing knowledge of HIV risk, estimated HIV prevalence and antiretroviral therapy, and improving risk perception of HIV acquisition.	[Li, Runhua; Wang, Hui; Pan, Xiaohong; Ma, Qiaoqin; Chen, Lin; Zhou, Xin; Jiang, Tingting; He, Lin; Xia, Shichang] Zhejiang Prov Ctr Dis Control & Prevent, Dept HIV AIDS & STDs Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Li, Runhua] Ningbo Univ, Sch Med, Dept Epidemiol & Hlth Stat, Ningbo, Zhejiang, Peoples R China; [Chen, Junfang; Zhang, Xingliang; Luo, Yan] Ctr Dis Control & Prevent Hangzhou City, Hangzhou, Zhejiang, Peoples R China; [Xi, Shengjun; Lv, Xin] Ctr Dis Control & Prevent Xiacheng Dist, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Ningbo University	Xia, SC (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept HIV AIDS & STDs Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	shchxia@cdc.zj.cn		Li, Runhua/0000-0003-1971-0726	Special Project of Major Science and Technology of Zhejiang Province, China [2013C03047-1]	Special Project of Major Science and Technology of Zhejiang Province, China	The study was funded by Special Project of Major Science and Technology of Zhejiang Province, China (2013C03047-1 (http://www.zjkjt.gov.cn/news/node01/detail0101/2013/010148798.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D, 2012, LANCET, V380, P439, DOI 10.1016/S0140-6736(12)60920-9; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Balthasar H, 2009, ARCH SEX BEHAV, V38, P1000, DOI 10.1007/s10508-008-9382-5; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; BROWNE A, 1986, PSYCHOL BULL, V99, P66, DOI 10.1037/0033-2909.99.1.66; Buttram ME, 2013, J COMMUN HEALTH, V38, P62, DOI 10.1007/s10900-012-9582-8; Center for Disease Control and Prevention of Zhejiang Province, 2013, ANN REP HIV EP SURV; Centers for Disease Control and Prevention, 2013, COND STDS FACT SHEET; Chow EPF, 2015, AIDS CARE, V27, P1332, DOI 10.1080/09540121.2015.1058892; Chow EPF, 2010, JAIDS-J ACQ IMM DEF, V55, pE32, DOI 10.1097/QAI.0b013e3181f3d3c1; Clark JL, 2008, SEX TRANSM INFECT, V84, P449, DOI 10.1136/sti.2008.031310; Darbes LA, 2005, HEALTH PSYCHOL, V24, P617, DOI 10.1037/0278-6133.24.6.617; Darbes LA, 2012, AIDS BEHAV, V16, P159, DOI 10.1007/s10461-010-9868-8; Fonner VA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001224.pub4; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Herbst JH, 2005, JAIDS-J ACQ IMM DEF, V39, P228; Horth RZ, 2015, AIDS BEHAV, V19, P1978, DOI 10.1007/s10461-015-1044-8; Huang Qin, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P1297; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Johnson WD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001230.pub2; Kelly JA, 2010, AIDS EDUC PREV, V22, P483, DOI 10.1521/aeap.2010.22.6.483; Kendall C, 2008, AIDS BEHAV, V12, pS97, DOI 10.1007/s10461-008-9390-4; Lee E, 2013, GAY COMMUNITY PERIOD, P1; Li R, 2016, HEALTH PSYCHOL, V35, P148, DOI 10.1037/hea0000265; Li XF, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000124; Ma QQ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2591-7; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V51, P340, DOI 10.1097/QAI.0b013e3181a24b38; National Health and Family Planning Commission of the People's Republic of China, 2015, 2015 CHIN AIDS RESP; Outlaw AY, 2011, AIDS PATIENT CARE ST, V25, pS23, DOI 10.1089/apc.2011.9879; Pan XH, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008466; Paz-Bailey G, 2013, MMWR-MORBID MORTAL W, V62, P958; Smith DK, 2015, JAIDS-J ACQ IMM DEF, V68, P337, DOI 10.1097/QAI.0000000000000461; State Council AIDS Working Committee Office (SCAWCO), 2012, 2012 CHIN AIDS RESP, P1; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Tang WM, 2013, AIDS BEHAV, V17, P1415, DOI 10.1007/s10461-013-0413-4; Trapence G, 2012, LANCET, V380, P400, DOI 10.1016/S0140-6736(12)60834-4; Valdiserri RO, 2007, PLOS MED, V4, P975, DOI 10.1371/journal.pmed.0040200; van Kesteren NMC, 2007, PATIENT EDUC COUNS, V65, P5, DOI 10.1016/j.pec.2006.09.003; Volz E, 2008, J OFF STAT, V24, P79; Wei CY, 2012, SEX TRANSM INFECT, V88, P622, DOI 10.1136/sextrans-2012-050619; Wejnert C, 2009, SOCIOL METHODOL, V39, P73, DOI 10.1111/j.1467-9531.2009.01216.x; Williamson LM, 2009, SEX TRANSM INFECT, V85, P550, DOI 10.1136/sti.2008.033886; World Health Organization, 2011, PREVENTION TREATMENT; World Health Organization (WHO), 2010, COND HIV PREV; Xing JM, 2008, CHINESE MED J-PEKING, V121, P2342, DOI 10.1097/00029330-200811020-00023; Xu JJ, 2011, SEX TRANSM DIS, V38, P89, DOI 10.1097/OLQ.0b013e3181f0bc5e; Zhao YJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000534; Zhong F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103136; Zhu YX, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3076-z; Zou HC, 2012, AIDS BEHAV, V16, P1717, DOI 10.1007/s10461-012-0225-y	52	19	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0167730	10.1371/journal.pone.0167730	http://dx.doi.org/10.1371/journal.pone.0167730			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273077	gold, Green Published, Green Submitted			2022-12-26	WOS:000396073700089
J	Zinni, M; Zuena, AR; Marconi, V; Petrella, C; Fusco, I; Giuli, C; Canu, N; Severini, C; Broccardo, M; Theodorou, V; Lattanzi, R; Casolini, P				Zinni, Manuela; Zuena, Anna Rita; Marconi, Veronica; Petrella, Carla; Fusco, Ilaria; Giuli, Chiara; Canu, Nadia; Severini, Cinzia; Broccardo, Maria; Theodorou, Vassilia; Lattanzi, Roberta; Casolini, Paola			Maternal exposure to low levels of corticosterone during lactation protects adult rat progeny against TNBS-induced colitis: A study on GR-mediated anti-inflammatory effect and prokineticin system	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INDUCED LEUCINE-ZIPPER; NF-KAPPA-B; PSYCHOSOCIAL STRESS; ULCERATIVE-COLITIS; LIFE EVENTS; INTESTINAL INFLAMMATION; RELAPSE; ACTIVATION; HORMONE	The early phase of life represents a critical period for the development of an organism. Interestingly, early life experiences are able to influence the development of the gastrointestinal tract and the reactivity to colonic inflammatory stress. We recently demonstrated that adult male rats exposed to low doses of corticosterone during lactation (CORT-nursed rats) are protected against experimental colitis induced by the intracolonic infusion of 2,4,6-trinitrobenzenesulfonic acid (TNBS). Based on these interesting results, we wanted to better investigate which cellular actors could be involved in the protection of CORT-nursed rats from TNBS-induced experimental colitis. Therefore, in the present work, we focused our attention on different factors implicated in GR-mediated anti-inflammatory effect. To address this issue, colonic tissues, collected from control and CORT-nursed healthy animals and from control and CORT-nursed colitic rats, were processed and the following inflammatory factors were evaluated: the expression of (i) glucocorticoid receptors (GR), (ii) glucocorticoid-induced leucine zipper (GILZ), (iii) phospho-p65NF-kappa B, (iv) the pro-inflammatory cytokines IL-1 beta and TNF-alpha, (v) the prokineticins PK2 and PK2L and (vi) their receptors PKR1 and PKR2. We found that adult CORT-nursed rats, in comparison to controls, showed increased expression of colonic GR and reduced expression of pro-inflammatory molecules (IL-1 beta, TNF-alpha, PK2 and PK2L) in response to inflammatory colitis. The observed changes were associated with an increase in GILZ colonic expression and with a reduction in phospo-p65NF-kappa B colonic expression.	[Zinni, Manuela; Zuena, Anna Rita; Marconi, Veronica; Fusco, Ilaria; Giuli, Chiara; Broccardo, Maria; Lattanzi, Roberta; Casolini, Paola] Univ Roma La Sapienza, Dept Physiol & Pharmacol Vittorio Erspamer, Rome, Italy; [Petrella, Carla; Canu, Nadia; Severini, Cinzia] CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [Canu, Nadia] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Theodorou, Vassilia] INRA, UMR TOXALIM Neurogastroenterol & Nutr Team, El Purpan, Toulouse, France	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); University of Rome Tor Vergata; INRAE	Casolini, P (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol Vittorio Erspamer, Rome, Italy.	paola.casolini@uniroma1.it	Petrella, Carla/AAX-1265-2020; Severini, Cinzia/AAX-3569-2020	Petrella, Carla/0000-0003-0651-1816; Severini, Cinzia/0000-0002-6932-704X; FUSCO, Ilaria/0000-0002-8175-6939	 [000126_14_Ateneo 2014 Casolini]		This work was supported by the "000126_14_Ateneo 2014 Casolini" grant.	Ahmad T, 2004, GASTROENTEROLOGY, V126, P1533, DOI 10.1053/j.gastro.2004.01.061; ANGELUCCI L, 1985, NEUROBEH TOXICOL TER, V7, P511; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Bach O, 1990, Z Gesamte Hyg, V36, P442; Barreau F, 2004, GUT, V53, P501, DOI 10.1136/gut.2003.024174; Bereshchenko O, 2014, CELL REP, V7, P464, DOI 10.1016/j.celrep.2014.03.004; BIFULCO A, 1991, BRIT J PSYCHIAT, V159, P115, DOI 10.1192/bjp.159.1.115; Bitton A, 2008, GUT, V57, P1386, DOI 10.1136/gut.2007.134817; Bitton A, 2003, AM J GASTROENTEROL, V98, P2203, DOI 10.1016/S0002-9270(03)00750-0; Cannarile L, 2009, GASTROENTEROLOGY, V136, P530, DOI 10.1053/j.gastro.2008.09.024; Casolini P, 2007, J NEUROSCI, V27, P7041, DOI 10.1523/JNEUROSCI.1074-07.2007; Catalani A, 2011, NEUROSCI BIOBEHAV R, V35, P1502, DOI 10.1016/j.neubiorev.2010.10.017; Chen JC, 2005, MOL PHARMACOL, V67, P2070, DOI 10.1124/mol.105.011619; Collins SM, 2001, AM J PHYSIOL-GASTR L, V280, pG315, DOI 10.1152/ajpgi.2001.280.3.G315; DUFFY LC, 1991, BEHAV MED, V17, P101, DOI 10.1080/08964289.1991.9937553; Ergang P, 2008, DIGEST DIS SCI, V53, P2160, DOI 10.1007/s10620-007-0125-6; FAVA GA, 1977, PSYCHOTHER PSYCHOSOM, V27, P93; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; GARRETT VD, 1991, J BEHAV MED, V14, P87, DOI 10.1007/BF00844770; Giannini E, 2009, P NATL ACAD SCI USA, V106, P14646, DOI 10.1073/pnas.0903720106; GREENE BR, 1994, BEHAV RES THER, V32, P217, DOI 10.1016/0005-7967(94)90114-7; Gue M, 1997, AM J PHYSIOL-GASTR L, V272, pG84, DOI 10.1152/ajpgi.1997.272.1.G84; Inman CF, 2005, J IMMUNOL METHODS, V302, P156, DOI 10.1016/j.jim.2005.05.005; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kisliouk T, 2005, ANN ANAT, V187, P529, DOI 10.1016/j.aanat.2005.07.005; Lattanzi R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/301292; Levenstein S, 2000, AM J GASTROENTEROL, V95, P1213, DOI 10.1111/j.1572-0241.2000.02012.x; Li J, 2004, AM J GASTROENTEROL, V99, P1129, DOI 10.1111/j.1572-0241.2004.04155.x; Maccari S, 2014, J NEUROENDOCRINOL, V26, P707, DOI 10.1111/jne.12175; Maftei D, 2014, BRIT J PHARMACOL, V171, P4850, DOI 10.1111/bph.12793; Marsango S, 2009, PEPTIDES, V30, P2182, DOI 10.1016/j.peptides.2009.09.007; Milde AM, 2004, PHYSIOL BEHAV, V81, P71, DOI 10.1016/j.physbeh.2004.01.002; MORTEAU O, 1994, DIGEST DIS SCI, V39, P1239, DOI 10.1007/BF02093789; Negri L, 2011, CURR PHARM BIOTECHNO, V12, P1720, DOI 10.2174/138920111798357410; NORTH CS, 1991, ANN INTERN MED, V114, P381, DOI 10.7326/0003-4819-114-5-381; PAAR GH, 1988, PSYCHOTHER PSYCH MED, V38, P376; Petrella C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113389; Qiu BS, 1999, NAT MED, V5, P1178, DOI 10.1038/13503; Reber SO, 2006, ENDOCRINOLOGY, V147, P4968, DOI 10.1210/en.2006-0347; Riccardi C, 2001, ADV EXP MED BIOL, V495, P31; RILEY SA, 1990, GUT, V31, P179, DOI 10.1136/gut.31.2.179; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Ronchetti S, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00170; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; SCHULMAN G, 1994, AM J PHYSIOL, V266, pC729, DOI 10.1152/ajpcell.1994.266.3.C729; Shanahan F, 2001, GASTROENTEROLOGY, V120, P622, DOI 10.1053/gast.2001.22122; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Targownik LE, 2015, AM J GASTROENTEROL, V110, P1001, DOI 10.1038/ajg.2015.147; vanTol EAF, 1996, GUT, V39, P385, DOI 10.1136/gut.39.3.385; Veenema AH, 2008, ENDOCRINOLOGY, V149, P2727, DOI 10.1210/en.2007-1469; Vidal A, 2006, AM J GASTROENTEROL, V101, P775, DOI 10.1111/j.1572-0241.2006.00476.x; VONWIETERSHEIM J, 1992, PSYCHOTHER PSYCHOSOM, V58, P103, DOI 10.1159/000288617; Watson RP, 2012, NEUROGASTROENT MOTIL, V24, P65, DOI 10.1111/j.1365-2982.2011.01804.x; Watson RP, 2012, NEUROGASTROENT MOTIL, V24, pe12, DOI DOI 10.1111/J.1365-2982.2011.01804.X; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Yorty JL, 2004, AM J PHYSIOL-REG I, V287, pR1316, DOI 10.1152/ajpregu.00685.2003	58	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173484	10.1371/journal.pone.0173484	http://dx.doi.org/10.1371/journal.pone.0173484			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5QM	28267767	Green Published, gold, Green Submitted			2022-12-26	WOS:000396060600035
J	Drummond, NM; Hayduk-Costa, G; Leguerrier, A; Carlsen, AN				Drummond, Neil M.; Hayduk-Costa, Gabrielle; Leguerrier, Alexandra; Carlsen, Anthony N.			Effector-independent reduction in choice reaction time following bi-hemispheric transcranial direct current stimulation over motor cortex	PLOS ONE			English	Article							VOLUNTARY MOVEMENT; TDCS; FACILITATION; EXCITABILITY	Increased reaction times (RT) during choice-RT tasks stem from a requirement for additional processing as well as reduced motor-specific preparatory activation. Transcranial direct current stimulation (tDCS) can modulate primary motor cortex excitability, increasing (anodal stimulation) or decreasing (cathodal stimulation) excitability in underlying cortical tissue. The present study investigated whether lateralized differences in choice-RT would result from the concurrent modulation of left and right motor cortices using bi-hemispheric tDCS. Participants completed a choice-RT task requiring either a left or right wrist extension. In forced-choice trials an illuminated target indicated the required response, whereas in free-choice trials participants freely selected either response upon illumination of a central fixation. Following a pre-test trial block, offline bi-hemispheric tDCS (1 mA) was applied over the left and right motor cortices for 10 minutes, which was followed by a post-tDCS block of RT trials. Twelve participants completed three experimental sessions, two with real tDCS (anode right, anode left), as well as a sham tDCS session. Post-tDCS results showed faster RTs for both right and left responses irrespective of tDCS polarity during forced-choice trials, while sham tDCS had no effect. In contrast, no stimulation-related RT or response selection differences were observed in free-choice trials. The present study shows evidence of an effector-independent speeding of response initiation in a forced-choice RT task following bihemispheric tDCS and yields novel information regarding the functional effect of bi-hemispheric tDCS.	[Drummond, Neil M.; Hayduk-Costa, Gabrielle; Leguerrier, Alexandra; Carlsen, Anthony N.] Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Ottawa, ON, Canada	University of Ottawa	Carlsen, AN (corresponding author), Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Ottawa, ON, Canada.	tony.carlsen@uottawa.ca		Carlsen, Anthony/0000-0001-6015-8991; Drummond, Neil/0000-0003-1161-4334	Natural Sciences and Engineering Research Council of Canada Discovery Grant [RGPIN: 418361-2012]; Ontario Ministry of Research and Innovation (CA) [ER14-10-133]	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Research and Innovation (CA)	This research was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant awarded to ANC (RGPIN: 418361-2012; www.nserc-crsng.gc.ca/index_eng.asp). This research is also supported by Ontario Ministry of Research and Innovation (CA), grant no. ER14-10-133 to ANC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Bolognini N, 2011, NEUROREHAB NEURAL RE, V25, P819, DOI 10.1177/1545968311411056; Bolzoni F, 2013, J PHYSIOL-LONDON, V591, P3381, DOI 10.1113/jphysiol.2012.244764; Carlsen AN, 2015, BEHAV BRAIN RES, V279, P68, DOI 10.1016/j.bbr.2014.11.009; Carlsen AN, 2012, CLIN NEUROPHYSIOL, V123, P21, DOI 10.1016/j.clinph.2011.04.028; Datta Abhishek, 2012, Front Psychiatry, V3, P91, DOI 10.3389/fpsyt.2012.00091; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hayduk-Costa G, 2013, BEHAV BRAIN RES, V257, P208, DOI 10.1016/j.bbr.2013.09.030; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; Jentzsch I, 2004, PSYCHOPHYSIOLOGY, V41, P231, DOI 10.1111/j.1469-8986.2004.00155.x; Kabakov AY, 2012, J NEUROPHYSIOL, V107, P1881, DOI 10.1152/jn.00715.2011; KLAPP ST, 1995, J EXP PSYCHOL HUMAN, V21, P1015, DOI 10.1037/0096-1523.21.5.1015; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Kumru H, 2006, NEUROSCI LETT, V406, P66, DOI 10.1016/j.neulet.2006.07.012; Kuo HI, 2013, BRAIN STIMUL, V6, P644, DOI 10.1016/j.brs.2012.09.010; Leuthold H, 2004, J PSYCHOPHYSIOL, V18, P77, DOI 10.1027/0269-8803.18.23.77; McCambridge AB, 2014, J NEUROPHYSIOL, V111, P2187, DOI 10.1152/jn.00879.2013; Molinuevo JL, 2000, CLIN NEUROPHYSIOL, V111, P2008, DOI 10.1016/S1388-2457(00)00443-0; Mordillo-Mateos L, 2012, BRAIN STIMUL, V5, P214, DOI 10.1016/j.brs.2011.05.001; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; Paquette C, 2011, J CEREBR BLOOD F MET, V31, P2086, DOI 10.1038/jcbfm.2011.72; Sehm B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00183; Sommer MA, 2003, CURR OPIN NEUROBIOL, V13, P663, DOI 10.1016/j.conb.2003.10.014; Vines BW, 2006, NEUROREPORT, V17, P671, DOI 10.1097/00001756-200604240-00023; Waters-Metenier S, 2014, J NEUROSCI, V34, P1037, DOI 10.1523/JNEUROSCI.2282-13.2014; Williams JA, 2010, PHYS THER, V90, P398, DOI 10.2522/ptj.20090075	29	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172714	10.1371/journal.pone.0172714	http://dx.doi.org/10.1371/journal.pone.0172714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28263998	Green Submitted, Green Published, gold			2022-12-26	WOS:000396054300016
J	Kebede, HK; Gesesew, HA; Woldehaimanot, TE; Goro, KK				Kebede, Hafte Kahsay; Gesesew, Hailay Abrha; Woldehaimanot, Tewodros Eyob; Goro, Kabaye Kumela			Antimicrobial use in paediatric patients in a teaching hospital in Ethiopia	PLOS ONE			English	Article							ANTIBIOTIC USE; PRESCRIPTIONS; SURVEILLANCE; CHILDREN; EUROPE	Background Antibiotics use in in children are different from adults due to a lack of data on pharmacokinetics, pharmacodynamics, efficacy and safety of drugs, different physiological spectrum, pediatrics populations being vulnerable to the majority of the illnesses, and the adverse effect of their irrational use is more serious. However, antibiotic use is not explored much in a paediatric population. The current study focused on antibiotic use among pediatric population using data from a tertiary hospital in Ethiopia. Methods A retrospective cross-sectional study collated data from 614 pediatrics patients admitted in pediatrics ward at Jimma University Teaching Hospital, Southwest Ethiopia. Descriptive analyses were performed to describe the type and pattern of antibiotics. The number of prescriptions per a patient was also compared with the WHO standard. Data analysis was carried out using SPSS version 20 for mackintosh. Results Antimicrobials were prescribed for 407(86.4%) patients of which 85.9% were in the form of injectables. A total of 1241 (90%) medicines were administered parenterally followed by oral 110 (8%). The maximum number of medicines per prescription was eight for all types of drugs in general, and five for antimicrobials in particular. All antimicrobials were prescribed empirically without any microbiological evidence. Pneumonia, sepsis and meningitis were the main reasons for antimicrobial use in the ward. Out of the total of 812 antibiotics prescribed; Penicillin G crystalline was the most (20%) frequently prescribed, followed by gentamicin (19%) and ampicillin (16). Conclusions Majority of the prescribed antibiotics were antimicrobials, and was in the form of injectables. Antimicrobials were over prescribed and the number of drugs per prescription was also far from WHO recommendation. Strict prescribing standard guidelines and treatment habits should be developed in the country, to prevent antimicrobial resistance.	[Kebede, Hafte Kahsay] Filtu Hosp, Somali, Ethiopia; [Gesesew, Hailay Abrha] Jimma Univ, Dept Epidemiol, Coll Hlth Sci, Jimma, Ethiopia; [Gesesew, Hailay Abrha] Flinders Univ S Australia, Discipline Publ Hlth, Fac Med Nursing & Hlth Sci, Adelaide, SA, Australia; [Woldehaimanot, Tewodros Eyob; Goro, Kabaye Kumela] Jimma Univ, Dept Clin Pharm, Coll Hlth Sci, Jimma, Ethiopia	Jimma University; Flinders University South Australia; Jimma University	Gesesew, HA (corresponding author), Jimma Univ, Dept Epidemiol, Coll Hlth Sci, Jimma, Ethiopia.; Gesesew, HA (corresponding author), Flinders Univ S Australia, Discipline Publ Hlth, Fac Med Nursing & Hlth Sci, Adelaide, SA, Australia.	hailushepi@gmail.com	Gesesew, Hailay/AAF-6486-2020	Gesesew, Hailay/0000-0002-3531-4400	Jimma University	Jimma University	This research was funded by Jimma University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulgafar O J, 2011, J CLIN DIAGNOSTIC RE, V5, P566; Abula T., 1999, Ethiopian Journal of Health Development, V13, P135; Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P47, DOI 10.1093/jac/dkr457; Ansam S, 2006, AN NAJAH U J RES, V20, P191; Bozic B, 2015, ARCH DIS CHILD, V100, P966, DOI 10.1136/archdischild-2015-308274; Buccellato E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139097; Cars O, 2001, LANCET, V357, P1851, DOI 10.1016/S0140-6736(00)04972-2; Ceyhan M, 2010, INT J INFECT DIS, V14, pE55, DOI 10.1016/j.ijid.2009.03.013; Desta Z, 1997, E AFR MED J, V74, P758; DiPiro JT, 2002, PHARMACOTHERAPY PATH; FDRE, 2010, HLTH SECT DEV PROGR; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Isah AO, 2004, DEV STANDARD VALUES; Jan D, 2001, HLTH ISSUES, V69, P1; Katzung B G, 2001, BASIC CLIN PHARMACOL, P200; Majed A-A, 2015, EUROPEAN SCI J, V11, P253; Mathew B, 2013, IRJIPS, V1; Menassie K, 2004, CROSS SECTIONAL SURV; Mestawot F, 2013, INT J BASIC CLIN PHA, V2, P718; Minyahil A., 2013, J APPL PHARM SCI, V3, P93; Mukonzo JK, 2013, J MULTIDISCIP HEALTH, V6, P303, DOI 10.2147/JMDH.S49075; Nwolisa CE, 2006, J TROP PEDIATRICS, V52, P197, DOI 10.1093/tropej/fmi095; Palikhe N, 2004, Kathmandu Univ Med J (KUMJ), V2, P6; Paruk F, 2012, SAMJ S AFR MED J, V102, P613, DOI 10.7196/SAMJ.5833; Raveh D, 2001, QJM-INT J MED, V94, P141, DOI 10.1093/qjmed/94.3.141; Resi D, 2003, J ANTIMICROB CHEMOTH, V52, P282, DOI 10.1093/jac/dkg302; SCHOLLENBERG E, 1980, CAN MED ASSOC J, V122, P49; Thrane N, 1999, PEDIATR INFECT DIS J, V18, P333, DOI 10.1097/00006454-199904000-00004; [WHO MoH], 2003, BAS ASS PHARM SECT E; [WHO AHO], 2016, AFR HLTH OBS WHO AN; WHO, 1985, C EXP NAIR 25 29 NOV; WHO. World Health Organization, 2010, MED RAT US MED; Wubante Y, 2005, S W ETHIOPIA ETHIOPI, V15, P147	33	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173290	10.1371/journal.pone.0173290	http://dx.doi.org/10.1371/journal.pone.0173290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264021	Green Published, Green Submitted, gold			2022-12-26	WOS:000396054300049
J	Lu, S; Mirchevska, G; Phatak, SS; Li, DM; Luka, J; Calderone, RA; Fonzi, WA				Lu, Sha; Mirchevska, Gordana; Phatak, Sayali S.; Li, Dongmei; Luka, Janos; Calderone, Richard A.; Fonzi, William A.			Dynamic time warping assessment of high-resolution melt curves provides a robust metric for fungal identification	PLOS ONE			English	Article							ACCURATE IDENTIFICATION; MEDICALLY IMPORTANT; TRANSCRIBED SPACER; DNA; REGION; PCR; SPP.; ALIGNMENTS; VALIDATION; SIMULATION	Fungal infections are a global problem imposing considerable disease burden. One of the unmet needs in addressing these infections is rapid, sensitive diagnostics. A promising molecular diagnostic approach is high-resolution melt analysis (HRM). However, there has been little effort in leveraging HRM data for automated, objective identification of fungal species. The purpose of these studies was to assess the utility of distance methods developed for comparison of time series data to classify HRM curves as a means of fungal species identification. Dynamic time warping (DTW), first introduced in the context of speech recognition to identify temporal distortion of similar sounds, is an elastic distance measure that has been successfully applied to a wide range of time series data. Comparison of HRM curves of the rDNA internal transcribed spacer (ITS) region from 51 strains of 18 fungal species using DTW distances allowed accurate classification and clustering of all 51 strains. The utility of DTW distances for species identification was demonstrated by matching HRM curves from 243 previously identified clinical isolates against a database of curves from standard reference strains. The results revealed a number of prior misclassifications, discriminated species that are not resolved by routine phenotypic tests, and accurately identified all 243 test strains. In addition to DTW, several other distance functions, Edit Distance on Real sequence (EDR) and Shape-based Distance (SBD), showed promise. It is concluded that DTW-based distances provide a useful metric for the automated identification of fungi based on HRM curves of the ITS region and that this provides the foundation for a robust and automatable method applicable to the clinical setting.	[Lu, Sha] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou, Guangdong, Peoples R China; [Mirchevska, Gordana] Univ Sts Cyril & Methodius, Inst Microbiol & Parasitol, Skopje, Macedonia; [Phatak, Sayali S.; Li, Dongmei; Calderone, Richard A.; Fonzi, William A.] Georgetown Univ, Dept Microbiol & Immunol, Washington, DC 20057 USA; [Luka, Janos] Walter Reed Army Inst Res, Silver Spring, MD USA	Sun Yat Sen University; Saints Cyril & Methodius University of Skopje; Georgetown University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Fonzi, WA (corresponding author), Georgetown Univ, Dept Microbiol & Immunol, Washington, DC 20057 USA.	fonziw@georgetown.edu						Alnuaimi AD, 2014, MOL ORAL MICROBIOL, V29, P117, DOI 10.1111/omi.12050; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arancia S, 2011, DIAGN MICR INFEC DIS, V69, P283, DOI 10.1016/j.diagmicrobio.2010.10.003; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Bergman A, 2007, EUR J CLIN MICROBIOL, V26, P813, DOI 10.1007/s10096-007-0369-2; Blake RD, 1999, BIOINFORMATICS, V15, P370, DOI 10.1093/bioinformatics/15.5.370; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Chen L., 2004, P 30 INT C VER LARG, V30, P792, DOI DOI 10.1016/B978-012088469-8/50070-X; Chen L., 2005, P 2005 ACM SIGMOD IN, P491, DOI DOI 10.1145/1066157.1066213; Costa JM, 2010, J MICROBIOL METH, V80, P306, DOI 10.1016/j.mimet.2010.01.002; Decat E, 2013, RES MICROBIOL, V164, P110, DOI 10.1016/j.resmic.2012.10.017; Ding H, 2008, PROC VLDB ENDOW, V1, P1542; Dunyach C, 2008, DIAGN MICR INFEC DIS, V60, P263, DOI 10.1016/j.diagmicrobio.2007.09.014; Dwight Z, 2011, BIOINFORMATICS, V27, P1019, DOI 10.1093/bioinformatics/btr065; Erali M, 2008, EXP MOL PATHOL, V85, P50, DOI 10.1016/j.yexmp.2008.03.012; Erali M, 2010, METHODS, V50, P250, DOI 10.1016/j.ymeth.2010.01.013; Ferrari MD, 2013, J CLIN MICROBIOL, V51, P3826, DOI 10.1128/JCM.01050-13; Fraley SI, 2016, SCI REP-UK, V6, DOI 10.1038/srep19218; Gago S, 2014, MED MYCOL, V52, P470, DOI 10.1093/mmy/myu009; Gago S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-13; Gago S, 2011, J CLIN MICROBIOL, V49, P3663, DOI 10.1128/JCM.01091-11; Gee SF, 2002, J CLIN MICROBIOL, V40, P556, DOI 10.1128/JCM.40.2.556-574.2002; Giorgino T, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i07; Gundry CN, 2008, NUCLEIC ACIDS RES, V36, P3401, DOI 10.1093/nar/gkn204; Hrncirova K, 2010, J CLIN MICROBIOL, V48, P3392, DOI 10.1128/JCM.01109-10; Jackson AP, 2009, GENOME RES, V19, P2231, DOI 10.1101/gr.097501.109; Jaumot J, 2005, CHEMOMETR INTELL LAB, V76, P101, DOI 10.1016/j.chemolab.2004.12.007; Keogh E, 2003, DATA MIN KNOWL DISC, V7, P349, DOI 10.1023/A:1024988512476; Keogh E., 2006, P 32 INT C VER LARG, P882, DOI DOI 10.5555/1182635.1164203; Maechler M., 2015, CLUSTER CLUSTER ANAL; Mandviwala T, 2010, J MOL DIAGN, V12, P91, DOI 10.2353/jmoldx.2010.090085; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; Merenstein D, 2013, AIDS RES HUM RETROV, V29, P30, DOI [10.1089/aid.2012.0269, 10.1089/AID.2012.0269]; Merseguel KB, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0793-3; Meyer D., 2015, PROXY DISTANCE SIMIL; Mori U., 2016, TSDIST DISTANCE MEAS; Nemcova E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116940; Paparrizos J, 2016, SIGMOD REC, V45, P69, DOI 10.1145/2949741.2949758; Pasligh J, 2010, J MICROBIOL IMMUNOL, V43, P147, DOI 10.1016/S1684-1182(10)60023-0; Plachy R, 2005, J MICROBIOL METH, V60, P107, DOI 10.1016/j.mimet.2004.09.003; Rabiner LR, 1993, FUNDAMENTALS SPEECH, pxxxv; Rasmussen JP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-107; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Reja V, 2010, METHODS, V50, pS10, DOI 10.1016/j.ymeth.2010.02.006; Ripley B. D, 2016, GGDENDRO CREATE DEND; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sarda-Espinosa A, 2016, DTWCLUST TIME SERIES; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Somogyvari F, 2012, IN VIVO, V26, P979; STEGER G, 1994, NUCLEIC ACIDS RES, V22, P2760, DOI 10.1093/nar/22.14.2760; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; Team RC, 2015, R LANG ENV STAT COMP; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Trtkova J, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-234; Venables WN, 2002, MODERN APPL STAT S, pxi; Vlachos M, 2002, PROC INT CONF DATA, P673, DOI 10.1109/ICDE.2002.994784; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	60	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173320	10.1371/journal.pone.0173320	http://dx.doi.org/10.1371/journal.pone.0173320			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264030	gold, Green Submitted, Green Published			2022-12-26	WOS:000396054300052
J	Haddad, SA; Palmer, JR; Lunetta, KL; Ng, MCY; Ruiz-Narvaez, EA				Haddad, Stephen A.; Palmer, Julie R.; Lunetta, Kathryn L.; Ng, Maggie C. Y.; Ruiz-Narvaez, Edward A.		MEDIA Consortium	A novel TCF7L2 type 2 diabetes SNP identified from fine mapping in African American women	PLOS ONE			English	Article							GENETIC ARCHITECTURE; WHITE ADULTS; RISK; ASSOCIATION; METAANALYSIS; MECHANISMS; VARIANTS; PATHWAY; LOCI	SNP rs7903146 in the Wnt pathway's TCF7L2 gene is the variant most significantly associated with type 2 diabetes to date, with associations observed across diverse populations. We sought to determine whether variants in other Wnt pathway genes are also associated with this disease. We evaluated 69 genes involved in the Wnt pathway, including TCF7L2, for associations with type 2 diabetes in 2632 African American cases and 2596 controls from the Black Women's Health Study. Tag SNPs for each gene region were genotyped on a custom Affymetrix Axiom Array, and imputation was performed to 1000 Genomes Phase 3 data. Gene-based analyses were conducted using the adaptive rank truncated product (ARTP) statistic. The PSMD2 gene was significantly associated with type 2 diabetes after correction for multiple testing (corrected p = 0.016), based on the nine most significant single variants in the +/-20 kb region surrounding the gene, which includes nearby genes EIF4G1, ECE2, and EIF2B5. Association data on four of the nine variants were available from an independent sample of 8284 African American cases and 15,543 controls; associations were in the same direction, but weak and not statistically significant. TCF7L2 was the only other gene associated with type 2 diabetes at nominal p <0.01 in our data. One of the three variants in the best gene-based model for TCF7L2, rs114770437, was not correlated with the GWAS index SNP rs7903146 and may represent an independent association signal seen only in African ancestry populations. Data on this SNP were not available in the replication sample.	[Haddad, Stephen A.; Palmer, Julie R.; Ruiz-Narvaez, Edward A.] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA; [Lunetta, Kathryn L.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Ng, Maggie C. Y.] Wake Forest Sch Med, Ctr Diabet Res, Ctr Genom & Personalized Med Res, Winston Salem, NC USA	Boston University; Boston University; Wake Forest University	Haddad, SA (corresponding author), Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA.	sahaddad@bu.edu	Liu, Simin/I-3689-2014; Bielinski, Suzette/A-2238-2009; Loos, Ruth/Q-2862-2016	Liu, Simin/0000-0003-2098-3844; Bielinski, Suzette/0000-0002-2905-5430; Patel, Sanjay/0000-0002-9142-5172; Loos, Ruth/0000-0002-8532-5087; Rich, Stephen/0000-0003-3872-7793; Pankow, James/0000-0001-7076-483X; Pacheco, Jennifer/0000-0001-8021-5818; Evans, Michele/0000-0002-8546-2831; Lunetta, Kathryn/0000-0002-9268-810X	National Institute on Minority Health and Health Disparities [R01MD007015]; National Cancer Institute [R01CA058420, R01CA098663, UM1CA164974]; American Heart Association [11SDG7390014]; NATIONAL CANCER INSTITUTE [UM1CA164974] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R01MD007015 (to EAR) from the National Institute on Minority Health and Health Disparities (http://www.nimhd.nih.gov/); R01CA058420, R01CA098663 (to JRP), and UM1CA164974 from the National Cancer Institute (http://www.cancer.gov/); and 11SDG7390014 (to EAR) from the American Heart Association (http://www.heart.org/HEARTORG/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	1000 Genomes Project Consortium, 2012, Nature, V491, P56, DOI 10.1038/nature11632; Baarsma HA, 2013, PHARMACOL THERAPEUT, V138, P66, DOI 10.1016/j.pharmthera.2013.01.002; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cooke JN, 2012, DIABETES CARE, V35, P287, DOI 10.2337/dc11-0957; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Haiman CA, 2012, DIABETES, V61, P1642, DOI 10.2337/db11-1296; Hara K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/hmg/ddt399; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hwang SG, 2005, J BIOL CHEM, V280, P12758, DOI 10.1074/jbc.M413367200; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; Krishnan S, 2010, AM J EPIDEMIOL, V171, P564, DOI 10.1093/aje/kwp443; Lanting LC, 2005, DIABETES CARE, V28, P2280, DOI 10.2337/diacare.28.9.2280; Liew CW, 2014, P NATL ACAD SCI USA, V111, pE2319, DOI 10.1073/pnas.1323066111; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Ng MCY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004517; Ortmann J, 2006, EXP BIOL MED, V231, P1030; Palmer ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029202; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Qi QB, 2012, J DIABETES, V4, P203, DOI 10.1111/j.1753-0407.2012.00224.x; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Rosenberg L, 1995, J Am Med Womens Assoc (1972), V50, P56; Saito-Diaz K, 2013, GROWTH FACTORS, V31, P1, DOI 10.3109/08977194.2012.752737; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Vimalananda VG, 2015, DIABETOLOGIA, V58, P699, DOI 10.1007/s00125-014-3480-9; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Waller-Evans H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082825; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zhang H, 2016, ARTP2 PATHWAY AND GE	39	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172577	10.1371/journal.pone.0172577	http://dx.doi.org/10.1371/journal.pone.0172577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253288	Green Published, gold, Green Submitted			2022-12-26	WOS:000396011300024
J	Izuhara, M; Kuwabara, Y; Saito, N; Yamamoto, E; Hakuno, D; Nakashima, Y; Horie, T; Baba, O; Nishiga, M; Nakao, T; Nishino, T; Nakazeki, F; Ide, Y; Kimura, M; Kimura, T; Ono, K				Izuhara, Masayasu; Kuwabara, Yasuhide; Saito, Naritatsu; Yamamoto, Erika; Hakuno, Daihiko; Nakashima, Yasuhiro; Horie, Takahiro; Baba, Osamu; Nishiga, Masataka; Nakao, Tetsushi; Nishino, Tomohiro; Nakazeki, Fumiko; Ide, Yuya; Kimura, Masahiro; Kimura, Takeshi; Ono, Koh			Prevention of neointimal formation using miRNA-126-containing nanoparticle-conjugated stents in a rabbit model	PLOS ONE			English	Article							OLIGONUCLEOTIDES; ANGIOGENESIS; TRANSLATION; MECHANISMS; THROMBOSIS; DELIVERY; PLATFORM; DISEASE; MIR-126	Background Despite recent progress with drug-eluting stents, restenosis and thrombosis after endovascular intervention are still major limitations in the treatment of cardiovascular diseases. These problems are possibly caused by inappropriate inhibition of neointimal formation and retardation of re-endothelialization on the surface of the stents. miR-126 has been shown to have the potential to enhance vascular endothelial cell proliferation. Methods and results We designed and constructed a 27-nt double strand RNA (dsRNA) conjugated to cholesterol, which has high membrane permeability, and formed mature miR-126 after transfection. For site-specific induction of miR-126, we utilized poly (DL-lactide-co-glycolide) nanoparticles (NPs). miR-126-dsRNA-containing NPs (miR-126 NPs) significantly reduced the protein expression of a previously identified miR-126 target, SPRED1, in human umbilical vascular endothelial cells (HUVECs), and miR-126 NPs enhanced the proliferation and migration of HUVECs. On the other hand, miR-126 NPs reduced the proliferation and migration of vascular smooth muscle cells, via the suppression of IRS-1. Finally, we developed a stent system that eluted miR-126. This delivery system exhibited significant inhibition of neointimal formation in a rabbit model of restenosis. Conclusions miR-126 NP-conjugated stents significantly inhibited the development of neointimal hyperplasia in rabbits. The present study may indicate the possibility of a novel therapeutic option to prevent restenosis after angioplasty.	[Izuhara, Masayasu; Kuwabara, Yasuhide; Saito, Naritatsu; Yamamoto, Erika; Hakuno, Daihiko; Nakashima, Yasuhiro; Horie, Takahiro; Baba, Osamu; Nishiga, Masataka; Nakao, Tetsushi; Nishino, Tomohiro; Nakazeki, Fumiko; Ide, Yuya; Kimura, Masahiro; Kimura, Takeshi; Ono, Koh] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan	Kyoto University	Ono, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan.	kohono@kuhp.kyoto-u.ac.jp	NAKAO, TETSUSHI/GRF-6084-2022	NAKAO, TETSUSHI/0000-0001-9979-2682; Nishiga, Masataka/0000-0001-5676-7671	Ministry of Education, Science, and Culture of Japan [20590864]; Translational Research Network Program from the Japan Agency for Medical Research and Development	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Translational Research Network Program from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported in part by grants from the Ministry of Education, Science, and Culture of Japan (20590864) and by Translational Research Network Program from the Japan Agency for Medical Research and Development. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura M, 1998, CIRCULATION, V97, P2003, DOI 10.1161/01.CIR.97.20.2003; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Curcio A, 2011, CIRC J, V75, P1287, DOI 10.1253/circj.CJ-11-0366; Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kimura T, 2012, CIRCULATION, V125, P584, DOI 10.1161/CIRCULATIONAHA.111.046599; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Li HM, 2014, ONCOL REP, V32, P1225, DOI 10.3892/or.2014.3327; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Tahara K, 2008, INT J PHARMACEUT, V354, P210, DOI 10.1016/j.ijpharm.2007.11.002; Tahara K, 2011, BIOMATERIALS, V32, P870, DOI 10.1016/j.biomaterials.2010.09.034; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089; Zhou J, 2013, CIRC RES, V113, P40, DOI 10.1161/CIRCRESAHA.113.280883; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	21	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172798	10.1371/journal.pone.0172798	http://dx.doi.org/10.1371/journal.pone.0172798			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253326	gold, Green Submitted, Green Published			2022-12-26	WOS:000396011300033
J	Li, P; Xiao, ZT; Braciak, TA; Ou, QJ; Chen, G; Oduncu, FS				Li, Pan; Xiao, Zhitao; Braciak, Todd A.; Ou, Qingjian; Chen, Gong; Oduncu, Fuat S.			A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; YOUNG-PATIENTS; COLON-CANCER; MORPHOLOGY; PROGNOSIS; PATTERN; IMPACT; MODEL; OLD	Background The progression of colorectal cancer (CRC) may differ depending on the location of the tumor and the age of onset of the disease. Previous studies also suggested that the molecular basis of CRC varies with tumor location, which could affect the clinical management of patients. Therefore, we performed survival analysis looking at different age groups and mismatch repair status (MMR) of CRC patients according to primary tumor location in an attempt to identify subgroups of CRC that might help in the prognosis of disease. Methods A group of 2233 patients operated on to remove their CRC tumors were analyzed (521 with right colon cancer, 740 with left colon cancer and 972 with rectal cancer). The expression of four MMR genes was assessed by immunohistochemistry (IHC), independent of clinical criteria. From the data collected, a predictive model for overall survival (OS) could be constructed for some associations of tumor location and age of onset using Kaplan-Meier, logistic and Cox regression analysis. Results When tumor location was considered as the lone factor, we found no statistical difference in overall survival (OS) between right cancer (68%), left cancer (67%) or rectal cancer tumor locations (71%) (HR: 1.17, 95% CI (confidence interval): 0.97-1.43, P = 0.057). When age of onset was considered, middle age (40-59 years) and older (60-85 years) patients were found to have higher OS than younger onset cancer (20-39 years) patients (69% vs 71% vs 59%, HR: 1.07, 95% confidence interval (CI): 0.91-1.25, P = 0.008). When both age of onset and tumor location were considered in combination as disease factors, we found that the subgroup of patients with left colon cancer from middle age (69%) and older (67%) aged patients had higher OS than younger (54%) patients (HR: 0.89, 95% CI: 0.68-1.16, P = 0.048). However in patients with right colon cancers, we found no statistical difference is OS between younger, middle age or older grouped patients (60% vs 71% vs 67%, HR: 0.84, 95% CI: 0.61-1.16, P = 0.194). With regard to rectal located cancers, we found that younger (62%) and middle age (68) patients had lower OS than older (77%) patients (HR: 1.46, 95% CI: 1.13-1.88, P = 0.004). The rates of deficient MMR (dMMR) was 10.4%. We found no statistical difference in OS stratified by tumor locations. However, right colon cancer patients with dMMR (86%) had higher OS than those with proficient MMR (pMMR) (63%) (HR: 3.01, 95% CI: 1.82-4.97, P<0.001). Left colon cancer patients with dMMR (76%) also had higher OS than those with pMMR (66%) (HR: 1.67, 95% CI: 0.95-2.92, P = 0.01). Oppositely, rectal cancer patients with dMMR (60%) had lower OS than those pMMR (68%) (HR: 0.77, 95% CI: 0.51-1.17, P = 0.04). Conclusions These data demonstrate that primary tumor location can be an important factor when considered along with age of onset for the prognosis of CRC. Primary tumor location is also an important factor to evaluate the predictive effect of MMR status for the prognosis of CRC.	[Li, Pan; Braciak, Todd A.; Oduncu, Fuat S.] Ludwig Maximilians Univ Munchen, Dept Hematol & Oncol, Med Klin & Poliklin 4, Munich, Germany; [Xiao, Zhitao; Ou, Qingjian; Chen, Gong] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Dept Colorectal Surg, Guangzhou, Guangdong, Peoples R China	University of Munich; State Key Lab Oncology South China; Sun Yat Sen University	Oduncu, FS (corresponding author), Ludwig Maximilians Univ Munchen, Dept Hematol & Oncol, Med Klin & Poliklin 4, Munich, Germany.; Chen, G (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Dept Colorectal Surg, Guangzhou, Guangdong, Peoples R China.	chengong@sysucc.org.cn; fuat.oduncu@med.uni-muenchen.de						Andrieu N, 2004, GUT, V53, P1322, DOI 10.1136/gut.2003.036376; Boisen MK, 2013, ANN ONCOL, V24, P2554, DOI 10.1093/annonc/mdt253; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Breivik J, 1997, INT J CANCER, V74, P664, DOI 10.1002/(SICI)1097-0215(19971219)74:6<664::AID-IJC18>3.0.CO;2-5; Cusack JC, 1996, J AM COLL SURGEONS, V183, P105; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fukatsu H, 2007, DIGEST LIVER DIS, V39, P40, DOI 10.1016/j.dld.2006.07.015; Glebov OK, 2003, CANCER EPIDEM BIOMAR, V12, P755; Han NY, 2014, TURK J GASTROENTEROL, V25, P661, DOI 10.5152/tjg.2014.5616; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Jass JR, 1998, GUT, V42, P673, DOI 10.1136/gut.42.5.673; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khodapasand Ehsan, 2015, Iranian Biomedical Journal, V19, P69, DOI 10.6091/ibj.1366.2015; Li M, 2011, J SURG RES, V167, P231, DOI 10.1016/j.jss.2010.10.040; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Loupakis F, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju427; Matanoski G, 2006, CANCER-AM CANCER SOC, V107, P1112, DOI 10.1002/cncr.22008; Meguid RA, 2008, ANN SURG ONCOL, V15, P2388, DOI 10.1245/s10434-008-0015-y; Minoo P, 2010, INT J ONCOL, V37, P707, DOI 10.3892/ijo_00000720; Nawa T, 2008, J GASTROEN HEPATOL, V23, P418, DOI 10.1111/j.1440-1746.2007.04923.x; O'Connell JB, 2004, AM J SURG, V187, P343, DOI 10.1016/j.amjsurg.2003.12.020; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Papagiorgis PC, 2012, ONCOL LETT, V3, P1129, DOI 10.3892/ol.2012.621; Perea J, 2015, AM J CANCER RES, V5, P2308; Rees M, 2008, ANN SURG, V247, P125, DOI 10.1097/SLA.0b013e31815aa2c2; Sanchez JA, 2009, BRIT J SURG, V96, P1196, DOI 10.1002/bjs.6683; Schellerer VS, 2012, INT J COLORECTAL DIS, V27, P71, DOI 10.1007/s00384-011-1291-8; Sinicrope FA, 2006, GASTROENTEROLOGY, V131, P729, DOI 10.1053/j.gastro.2006.06.005; Tan KK, 2009, J GASTROINTEST SURG, V13, P642, DOI 10.1007/s11605-008-0757-7; Tran B, 2011, CANCER-AM CANCER SOC, V117, P4623, DOI 10.1002/cncr.26086; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901	32	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172799	10.1371/journal.pone.0172799	http://dx.doi.org/10.1371/journal.pone.0172799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253296	gold, Green Published, Green Submitted			2022-12-26	WOS:000396011300034
J	Vonk, JM; Scholtens, S; Postma, DS; Moffatt, MF; Jarvis, D; Ramasamy, A; Wjst, M; Omenaas, ER; Bouzigon, E; Demenais, F; Nadif, R; Siroux, V; Polonikov, AV; Solodilova, M; Ivanov, VP; Curjuric, I; Imboden, M; Kumar, A; Probst-Hensch, N; Ogorodova, LM; Puzyrev, VP; Bragina, EY; Freidin, MB; Nolte, IM; Farrall, AM; Cookson, WOCM; Strachan, DP; Koppelman, GH; Boezen, HM				Vonk, J. M.; Scholtens, S.; Postma, D. S.; Moffatt, M. F.; Jarvis, D.; Ramasamy, A.; Wjst, M.; Omenaas, E. R.; Bouzigon, E.; Demenais, F.; Nadif, R.; Siroux, V.; Polonikov, A. V.; Solodilova, M.; Ivanov, V. P.; Curjuric, I.; Imboden, M.; Kumar, A.; Probst-Hensch, N.; Ogorodova, L. M.; Puzyrev, V. P.; Bragina, E. Yu; Freidin, M. B.; Nolte, I. M.; Farrall, A. M.; Cookson, W. O. C. M.; Strachan, D. P.; Koppelman, G. H.; Boezen, H. M.			Adult onset asthma and interaction between genes and active tobacco smoking: The GABRIEL consortium	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; ENVIRONMENT INTERACTION; CHILDHOOD ASTHMA; HUMAN-DISEASES; LARGE-SCALE; EXPOSURE; DECLINE; EGEA	Background Genome-wide association studies have identified novel genetic associations for asthma, but without taking into account the role of active tobacco smoking. This study aimed to identify novel genes that interact with ever active tobacco smoking in adult onset asthma. Methods We performed a genome-wide interaction analysis in six studies participating in the GABRIEL consortium following two meta-analyses approaches based on 1) the overall interaction effect and 2) the genetic effect in subjects with and without smoking exposure. We performed a discovery meta-analysis including 4,057 subjects of European descent and replicated our findings in an independent cohort (LifeLines Cohort Study), including 12,475 subjects. Results First approach: 50 SNPs were selected based on an overall interaction effect at p<10(-4). The most pronounced interaction effect was observed for rs9969775 on chromosome 9 (discovery meta-analysis: ORint = 0.50, p = 7.63*10(-5), replication: ORint = 0.65, p = 0.02). Second approach: 35 SNPs were selected based on the overall genetic effect in exposed subjects (p <10(-4)). The most pronounced genetic effect was observed for rs5011804 on chromosome 12 (discovery meta-analysis ORint = 1.50, p = 1.21*10(-4); replication: ORint = 1.40, p = 0.03). Conclusions Using two genome-wide interaction approaches, we identified novel polymorphisms in non annotated intergenic regions on chromosomes 9 and 12, that showed suggestive evidence for interaction with active tobacco smoking in the onset of adult asthma.	[Vonk, J. M.; Scholtens, S.; Nolte, I. M.; Boezen, H. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Vonk, J. M.; Postma, D. S.; Koppelman, G. H.; Boezen, H. M.] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands; [Postma, D. S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Moffatt, M. F.; Cookson, W. O. C. M.] Div Resp Sci, Imperial Coll, London, England; [Jarvis, D.; Ramasamy, A.] Imperial Coll, Populat Hlth & Occupat Disease, London, England; [Jarvis, D.] Imperial Coll, MRC PHE Ctr Environm & Hlth, London, England; [Wjst, M.] Tech Univ, Inst Med Stat & Epidemiol IMSE, Klinikum Rechts Isar, Munich, Germany; [Wjst, M.] Inst Lung Biol & Dis iLBD, Comprehens Pneumol Ctr CPC, Helmholtz Ctr Munich, Neuherberg, Germany; [Omenaas, E. R.] Haukeland Hosp, Clin Res Ctr, Bergen, Norway; [Bouzigon, E.; Demenais, F.] Univ Paris Diderot, Inst Univ Hernatol, Sorbonne Paris Cite, Paris, France; [Bouzigon, E.; Demenais, F.] INSERM, UMR 946, Paris, France; [Nadif, R.] INSERM, U1168, VIMA Aging & chron Dis, Epidemiol & publ Hlth approaches, Villejuif, France; [Nadif, R.] Univ Versailles St Quentin Yvelines, UMR S 1168, Montigny Le Bretonneux, France; [Siroux, V.] INSERM, IAB, Team Environm Epidemiol Appl Reprod & Resp Hlth, Grenoble, France; [Siroux, V.] Univ Grenoble Alpes, IAB, Team Environm Epidemiol Appl Reprod & Resp Hlth, Grenoble, France; [Siroux, V.] CHU Grenoble, IAB, Team Environm Epidemiol Appl Reprod & Resp Hlth, Grenoble, France; [Vonk, J. M.; Polonikov, A. V.; Solodilova, M.; Ivanov, V. P.] Kursk State Med Univ, Dept Biol, Russian Federat, Med Genet & Ecol, Kursk, Russia; [Curjuric, I.; Imboden, M.; Kumar, A.; Probst-Hensch, N.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Curjuric, I.; Imboden, M.; Kumar, A.; Probst-Hensch, N.] Univ Basel, Basel, Switzerland; [Kumar, A.; Farrall, A. M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Ogorodova, L. M.; Puzyrev, V. P.] Siberian State Med Univ, Tomsk, Russia; [Puzyrev, V. P.; Bragina, E. Yu; Freidin, M. B.] Res Inst Med Genet, Tomsk, Russia; [Strachan, D. P.] Univ London, Populat Hlth Res Inst, St Georges, London, England; [Koppelman, G. H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; Imperial College London; Imperial College London; Imperial College London; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bergen; Haukeland University Hospital; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Kursk State Medical University; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Oxford; Wellcome Centre for Human Genetics; Siberian State Medical University; Russian Academy of Sciences; Tomsk National Research Medical Center; Research Institute of Medical Genetics - Tomsk; University of London; University of Groningen	Vonk, JM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	j.m.vonk@umcg.nl	Ivanov, Vladimir/U-3794-2019; Solodilova, Maria/GSJ-2104-2022; Vonk, Judith/K-8477-2019; siroux, valerie/N-1865-2013; Bouzigon, Emmanuelle/L-2766-2017; Vonk, Judith M/ABA-3009-2020; Koppelman, Gerard/AAG-9187-2020; Cookson, William/HHC-1790-2022; Bragina, Elena/AAF-7983-2019; Demenais, Florence/G-3298-2013; Polonikov, Alexey/R-7537-2016; Puzyrev, Valery P/S-3144-2016; Ogorodova, Ludmila M/S-5058-2016; Nadif, Rachel/R-2876-2016; Ramasamy, Adaikalavan/G-2632-2010; Freydin, Maxim/A-5603-2011; Bragina, Elena/A-8049-2014	Solodilova, Maria/0000-0003-4607-4913; Vonk, Judith/0000-0001-7531-4547; siroux, valerie/0000-0001-7329-7237; Bouzigon, Emmanuelle/0000-0001-5756-4286; Vonk, Judith M/0000-0001-7531-4547; Demenais, Florence/0000-0001-8361-0936; Polonikov, Alexey/0000-0001-6280-247X; Puzyrev, Valery P/0000-0002-2113-4556; Ogorodova, Ludmila M/0000-0002-2962-1076; Nadif, Rachel/0000-0003-4938-9339; Ramasamy, Adaikalavan/0000-0002-7598-2892; Freydin, Maxim/0000-0002-1439-6259; Bragina, Elena/0000-0002-1103-3073; Scholtens, Salome/0000-0002-0651-5203; Koppelman, Gerard/0000-0001-8567-3252; Jarvis, Deborah/0000-0002-1753-3896	European Commission [018996, LSH-2004-1.2.5-1]; National Institute for Health Research [NF-SI-0512-10126] Funding Source: researchfish; Wellcome Trust [096964/Z/11/Z] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	The GABRIEL study (a multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community) was supported by the European Commission, contract number 018996 under the Integrated Program LSH-2004-1.2.5-1. The separate cohort were also supported by local funding organizations (see supplementary material). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Berg ND, 2012, J ALLERGY CLIN IMMUN, V129, P374, DOI 10.1016/j.jaci.2011.08.045; Bookman EB, 2011, GENET EPIDEMIOL, V35, P217, DOI 10.1002/gepi.20571; BURCHFIEL CM, 1995, AM J RESP CRIT CARE, V151, P1778, DOI 10.1164/ajrccm.151.6.7767520; Curjuric I, 2011, EUR RESPIR J, V37, P492, DOI 10.1183/09031936.00188609; Curjuric I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040175; Ege MJ, 2011, J ALLERGY CLIN IMMUN, V127, P138, DOI 10.1016/j.jaci.2010.09.041; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Goodhead I, 2015, CURR OPIN MICROBIOL, V23, P102, DOI 10.1016/j.mib.2014.11.012; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Liu ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025099; Liu X, 2004, CURR OPIN GENET DEV, V14, P241, DOI 10.1016/j.gde.2004.04.011; MCWHORTER WP, 1989, AM REV RESPIR DIS, V139, P721, DOI 10.1164/ajrccm/139.3.721; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Mukherjee B, 2012, AM J EPIDEMIOL, V175, P177, DOI 10.1093/aje/kwr367; Oryszczyn MP, 2000, AM J RESP CRIT CARE, V161, P1241, DOI 10.1164/ajrccm.161.4.9905027; PEAT JK, 1990, THORAX, V45, P32, DOI 10.1136/thx.45.1.32; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Scholtens S, 2014, J ALLERGY CLIN IMMUN, V133, P885, DOI 10.1016/j.jaci.2013.08.049; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Siroux V, 2000, EUR RESPIR J, V15, P470, DOI 10.1034/j.1399-3003.2000.15.08.x; Strachan DP, 1996, BRIT MED J, V312, P1195; Surakka I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002333; VESTERINEN E, 1988, THORAX, V43, P534, DOI 10.1136/thx.43.7.534; Vogelberg C, 2007, EUR RESPIR J, V30, P672, DOI 10.1183/09031936.00152906	28	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172716	10.1371/journal.pone.0172716	http://dx.doi.org/10.1371/journal.pone.0172716			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253294	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000396011300029
J	Voracova, K; Hajek, J; Mares, J; Urajova, P; Kuzma, M; Cheel, J; Villunger, A; Kapuscik, A; Bally, M; Novak, P; Kabelac, M; Krumschnabel, G; Lukes, M; Voloshko, L; Kopecky, J; Hrouzek, P				Voracova, Katerina; Hajek, Jan; Mares, Jan; Urajova, Petra; Kuzma, Marek; Cheel, Jose; Villunger, Andreas; Kapuscik, Alexandra; Bally, Marcel; Novak, Petr; Kabelac, Martin; Krumschnabel, Gerhard; Lukes, Martin; Voloshko, Ludmila; Kopecky, Jiri; Hrouzek, Pavel			The cyanobacterial metabolite nocuolin A is a natural oxadiazine that triggers apoptosis in human cancer cells	PLOS ONE			English	Article							ENZYMES; 1,3,4-OXADIAZOLE; 1,2,3-OXADIAZOLE; SCAFFOLD; BENZENE; PRODUCT; PATHWAY; GROWTH; AGENTS; GENES	Oxadiazines are heterocyclic compounds containing N-N-O or N-N-C-O system within a six membered ring. These structures have been up to now exclusively prepared via organic synthesis. Here, we report the discovery of a natural oxadiazine nocuolin A (NoA) that has a unique structure based on 1,2,3-oxadiazine. We have identified this compound in three independent cyanobacterial strains of genera Nostoc, Nodularia, and Anabaena and recognized the putative gene clusters for NoA biosynthesis in their genomes. Its structure was characterized using a combination of NMR, HRMS and FTIR methods. The compound was first isolated as a positive hit during screening for apoptotic inducers in crude cyanobacterial extracts. We demonstrated that NoA-induced cell death has attributes of caspase-dependent apoptosis. Moreover, NoA exhibits a potent anti-proliferative activity (0.7-4.5 mu M) against several human cancer lines, with p53-mutated cell lines being even more sensitive. Since cancers bearing p53 mutations are resistant to several conventional anti-cancer drugs, NoA may offer a new scaffold for the development of drugs that have the potential to target tumor cells independent of their p53 status. As no analogous type of compound was previously described in the nature, NoA establishes a novel class of bioactive secondary metabolites.	[Voracova, Katerina; Hajek, Jan; Mares, Jan; Urajova, Petra; Cheel, Jose; Kapuscik, Alexandra; Lukes, Martin; Kopecky, Jiri; Hrouzek, Pavel] CAS Vvi, Inst Microbiol, Ctr Algatech, Trebon, Czech Republic; [Voracova, Katerina; Hajek, Jan; Mares, Jan; Kabelac, Martin; Hrouzek, Pavel] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Hajek, Jan; Mares, Jan] Biol Ctr CAS Vvi, Inst Hydrobiol, Ceske Budejovice, Czech Republic; [Mares, Jan] Inst Bot CAS Vvi, Ctr Phycol, Prague, Czech Republic; [Kuzma, Marek; Novak, Petr] Inst Microbiol CAS, Lab Mol Struct Characterizat, Prague, Czech Republic; [Villunger, Andreas; Krumschnabel, Gerhard] Med Univ Innsbruck, Div Dev Immunol, Bioctr Innsbruck, Innsbruck, Austria; [Villunger, Andreas] Tyrolean Canc Res Inst, Innsbruck, Austria; [Bally, Marcel] British Columbia Canc Agcy, Dept Expt Therapeut, Vancouver, BC, Canada; [Voloshko, Ludmila] St Petersburg State Univ, St Petersburg, Russia	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Medical University of Innsbruck; British Columbia Cancer Agency; Saint Petersburg State University	Hrouzek, P (corresponding author), CAS Vvi, Inst Microbiol, Ctr Algatech, Trebon, Czech Republic.; Hrouzek, P (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.	hrouzekp@gmail.com	Novak, Petr/F-9655-2014; Cheel, José/J-8401-2014; Voracova, Katerina/ABH-9514-2020; Kuzma, Marek/F-5468-2015; Mareš, Jan/B-2395-2009; Urajová, Petra/I-1663-2014; Lukeš, Martin/AAV-4722-2020	Novak, Petr/0000-0001-8688-529X; Cheel, José/0000-0001-5789-9297; Kuzma, Marek/0000-0001-7415-2734; Mareš, Jan/0000-0002-5745-7023; Lukeš, Martin/0000-0003-3493-9780; Krumschnabel, Gerhard/0000-0003-0804-1248; Hrouzek, Pavel/0000-0002-2061-0266	Czech Science Foundation [P503/12/P614, 14-18067S]; Ministry of Education, Youth and Sports of the Czech Republic, National Programme of Sustainability I [LO1416]; project ALGAIN [CZ.1.07/2.3.00/30.0059]; programme "Projects of Large Infrastructure for Research, Development, and Innovations" [LM2010005]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic, National Programme of Sustainability I; project ALGAIN; programme "Projects of Large Infrastructure for Research, Development, and Innovations"	This study was supported by Czech Science Foundation projects No. P503/12/P614 and No. 14-18067S and by the Ministry of Education, Youth and Sports of the Czech Republic, National Programme of Sustainability I, ID: LO1416. J. Cheel was supported by the project ALGAIN (reg. nr. CZ.1.07/2.3.00/30.0059). Access to computing and storage facilities owned by parties and projects contributing to the National Grid Infrastructure MetaCentrum, provided under the programme "Projects of Large Infrastructure for Research, Development, and Innovations" (LM2010005), is greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MB, 1955, PLANT PHYSIOL, V30, P366, DOI 10.1104/pp.30.4.366; Bajaj S, 2015, EUR J MED CHEM, V97, P124, DOI 10.1016/j.ejmech.2015.04.051; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Bohle DS, 2009, J ORG CHEM, V74, P1621, DOI 10.1021/jo802343k; Carbone M, 2011, ORG LETT, V13, P2516, DOI 10.1021/ol200234r; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dittmann E, 2013, FEMS MICROBIOL REV, V37, P23, DOI 10.1111/j.1574-6976.2012.12000.x; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Goyal A, 2012, J MOL BIOL, V416, P221, DOI 10.1016/j.jmb.2011.12.031; IRIE S, 1987, J BACTERIOL, V169, P5174, DOI 10.1128/jb.169.11.5174-5179.1987; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Khalilullah H, 2012, MINI-REV MED CHEM, V12, P789, DOI 10.2174/138955712801264800; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; KUKOR JJ, 1991, J BACTERIOL, V173, P4587, DOI 10.1128/jb.173.15.4587-4594.1991; Marek R, 2007, CURR ORG CHEM, V11, P1154, DOI 10.2174/138527207781662519; Mares J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111904; Mares J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066323; Mehlen P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001521; Mohareb RM, 2011, BIOORGAN MED CHEM, V19, P2707, DOI 10.1016/j.bmc.2011.02.051; NESMEYANOV AN, 1960, DOKL AKAD NAUK SSSR+, V133, P851; NGUYEN MT, 1985, ANGEW CHEM INT EDIT, V24, P713, DOI 10.1002/anie.198507131; Qiao Q, 2016, SCI REP, V6; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Saha R, 2013, MINI-REV MED CHEM, V13, P1027, DOI 10.2174/1389557511313070007; Scheffner M, 1998, PHARMACOL THERAPEUT, V78, P129, DOI 10.1016/S0163-7258(98)00003-5; Semenov SG, 2011, RUSS J GEN CHEM+, V81, P1555, DOI 10.1134/S1070363211070243; Simunek P, 2004, EUR J ORG CHEM, V2004, P5055, DOI 10.1002/ejoc.200400287; Simunek P, 2003, ORG BIOMOL CHEM, V1, P3250, DOI 10.1039/b303206j; Sun J, 2013, MINI-REV MED CHEM, V13, P1725; Taton A, 2003, APPL ENVIRON MICROB, V69, P5157, DOI 10.1128/AEM.69.9.5157-5169.2003; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tondres ZV, 2012, CHALCOGENADIAZOLES C; Van Wagoner RM, 2007, ADV APPL MICROBIOL, V61, P89, DOI 10.1016/S0065-2164(06)61004-6; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Welker M, 2006, FEMS MICROBIOL REV, V30, P530, DOI 10.1111/j.1574-6976.2006.00022.x	37	24	25	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172850	10.1371/journal.pone.0172850	http://dx.doi.org/10.1371/journal.pone.0172850			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253280	Green Submitted, Green Published, gold			2022-12-26	WOS:000396011300042
J	Chim, L; Salkeld, G; Kelly, P; Lipworth, W; Hughes, DA; Stockler, MR				Chim, Lesley; Salkeld, Glenn; Kelly, Patrick; Lipworth, Wendy; Hughes, Dyfrig A.; Stockler, Martin R.			Societal perspective on access to publicly subsidised medicines: A cross sectional survey of 3080 adults in Australia	PLOS ONE			English	Article							DISCRETE-CHOICE; CANCER DRUGS; PREFERENCES; HEALTH; COSTS; LIFE; CARE; END	Background Around the world government agencies responsible for the selection and reimbursement of prescribed medicines and other health technologies are considering how best to bring community preferences into their decision making. In particular, community views about the distribution or equity of funding across the population. These official committees and agencies often have access to the best available and latest evidence on clinical effectiveness, safety and cost from large clinical trials and population-based studies. All too often they do not have access to high quality evidence about community views. We therefore, conducted a large and representative population-based survey in Australia to determine what community members think about the factors that do and should influence government spending on prescribed medicines. Methods A choice-based survey was designed to elicit the importance of individual criteria when considering the equity of government spending on prescribed medicines. A representative sample of 3080 adult Australians completed the survey by allocating a hypothetical budget to different combinations of money spent on two patient populations. Societal preferences were inferred from absolute majority responses i.e. populations with more than 50% of respondents' allocation for a particular allocation criterion. Results This study shows that, all else being equal, severity of disease, diseases for which there is no alternative treatment available on the government formulary, diseases that affect patients who are not financially well off, and life-style unrelated diseases are supported by the public as resource allocation criteria. Where 'all else is not equal', participants allocated more resources to the patient population that gained considerable improvement in health and fewer resources to those that gained little improvement in health. This result held under all scenarios except for 'end-of-life treatments'. Responses to cost (and corresponding number of patients treated) trade-off scenarios indicated a significant reduction in the proportion of respondents choosing to divide resources equally and a shift in preference towards devoting resources to the population that were more costly to treat for all criteria with the exception of severity of disease. Conclusions The general public have clear views on what's fair in terms of government spending on prescribed medicines. In addition to supporting the application of the 'rule of rescue', important considerations for government spending included the severity of disease being treated, diseases for which there is no alternative treatment available on the government formulary, diseases that affect patients who are not financially well off and life-style unrelated diseases. This study shows that the general public are willing to share their views on what constitutes an equitable allocation of the government's drug budget. The challenge remains to how best to consider those views alongside clinical and economic considerations.	[Chim, Lesley; Kelly, Patrick] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Chim, Lesley] Alex Pharmaceut, Sydney, NSW, Australia; [Salkeld, Glenn] Univ Wollongong, Fac Social Sci, Wollongong, NSW, Australia; [Lipworth, Wendy] Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW, Australia; [Hughes, Dyfrig A.] Bangor Univ, Bangor Inst Hlth & Med Res, Ctr Hlth Econ & Med Evaluat, Bangor, Gwynedd, Wales; [Stockler, Martin R.] Univ Sydney, NHMRC, Clin Trials Ctr, Sydney, NSW, Australia; [Stockler, Martin R.] Concord Hosp, Concord Canc Ctr, Sydney, NSW, Australia; [Stockler, Martin R.] Chris OBrien Lifehouse, Sydney, NSW, Australia	University of Sydney; University of Wollongong; University of Sydney; Bangor University; University of Sydney; Concord Repatriation General Hospital; University of Sydney	Chim, L (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia.; Chim, L (corresponding author), Alex Pharmaceut, Sydney, NSW, Australia.	lesleychim@gmail.com	Hughes, Dyfrig/H-5252-2012	Hughes, Dyfrig/0000-0001-8247-7459; Kelly, Patrick/0000-0002-5015-0977; Lipworth, Wendy/0000-0002-0234-657X	National Health and Medical Research Council of Australia [6633003]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was undertaken as part of the Screening and Diagnostic Test Evaluation Program funded by the National Health and Medical Research Council of Australia under Program Grant number 6633003. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PHARM BEN SCHEM QUIC; Australian Government Department of Health, 2015, GUID PREP SUBM PHARM; Campaigns, CAMP; Cancer Drugs Alliance, 2015, CANC DRUGS ALL SUBM; Chim L, 2010, PHARMACOECONOMICS, V28, P463, DOI 10.2165/11533000-000000000-00000; Daroudi R, 2016, INT J HEALTH POLICY, V5, P99, DOI 10.15171/ijhpm.2015.186; Department of Health, LIF SAV DRUGS PROGR; Desser AS, 2013, PHARMACOECONOMICS, V31, P1051, DOI 10.1007/s40273-013-0093-y; Dolan P, 2005, HEALTH ECON, P14; Finkelstein EA, 2015, HEALTH POLICY, V119, P1482, DOI 10.1016/j.healthpol.2015.09.001; Gallego G, 2007, HEALTH EXPECT, V10, P224, DOI 10.1111/j.1369-7625.2007.00439.x; George B, 2001, PHARMACOECONOMICS, V19, P1103, DOI 10.2165/00019053-200119110-00004; Ghinea N, 2016, MED J AUSTRALIA, V204, P214, DOI 10.5694/mja15.01309; Harris AH, 2008, MED DECIS MAKING, V28, P713, DOI 10.1177/0272989X08315247; Hosmer D, 2000, APPL LOGISTIC RERESS; Lees Ann, 2002, Health Expect, V5, P47, DOI 10.1046/j.1369-6513.2002.00157.x; Linley WG, 2013, HEALTH ECON, V22, P948, DOI 10.1002/hec.2872; MacKenzie R, 2008, J ROY SOC MED, V101, P1; MacLeod TE, 2016, PATIENT, V9, P201, DOI 10.1007/s40271-015-0139-7; McKie John, 2009, Aust New Zealand Health Policy, V6, P11, DOI 10.1186/1743-8462-6-11; Mileshkin L, 2009, J CLIN ONCOL, V27, P5830, DOI 10.1200/JCO.2009.22.7793; Neumann PJ, 2010, HEALTH AFFAIR, V29, P196, DOI 10.1377/hlthaff.2009.0077; NHS England, 2015, GUID SUPP OP CDF 201; Pharmaceutical Benfits Advisory Committee, 2015, PHARM BEN ADV COMM S; PharmaDispatch, 2015, PAT HAV SUFF SYST NE; Rare Cancer Australia, 2015, RAR CANC AUSTR SUBM; Senate Community Affairs Reference Committee, 2015, AV NEW INN SPEC CANC; Shah KK, 2015, SOC SCI MED, V124, P48, DOI 10.1016/j.socscimed.2014.11.022; Shah KK, 2009, HEALTH POLICY, V93, P77, DOI 10.1016/j.healthpol.2009.08.005; Tordrup D, 2013, APPL HEALTH ECON HEA, V11, P639, DOI 10.1007/s40258-013-0056-7; van Exel J, 2015, SOC SCI MED, V126, P128, DOI 10.1016/j.socscimed.2014.12.023; Vogler S, 2016, HEALTH POLICY TECHN, V5, P213, DOI 10.1016/j.hlpt.2016.03.009; Whitty JA, 2012, VALUE HEALTH, V15, pA306, DOI 10.1016/j.jval.2012.08.642; Whitty JA, 2011, APPL HEALTH ECON HEA, V9, P73, DOI 10.2165/11537150-000000000-00000; Whitty JA, 2015, HEALTH POLICY, V119, P127, DOI 10.1016/j.healthpol.2014.09.003; Whitty JA, 2014, MED DECIS MAKING, V34, P638, DOI 10.1177/0272989X14526640; Wilson A, 2011, VALUE HEALTH, V14, P944, DOI 10.1016/j.jval.2011.05.004; Wortley S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010265	38	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172971	10.1371/journal.pone.0172971	http://dx.doi.org/10.1371/journal.pone.0172971			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4NF	28249013	Green Published, Green Submitted, gold			2022-12-26	WOS:000395983500066
J	Malchenko, S; Sredni, ST; Bi, Y; Margaryan, NV; Boyineni, J; Mohanam, I; Tomita, T; Davuluri, RV; Soares, MB				Malchenko, Sergey; Sredni, Simone Treiger; Bi, Yingtao; Margaryan, Naira V.; Boyineni, Jerusha; Mohanam, Indra; Tomita, Tadanori; Davuluri, Ramana V.; Soares, Marcelo B.			Stabilization of HIF-1 alpha and HIF-2 alpha, up-regulation of MYCC and accumulation of stabilized p53 constitute hallmarks of CNS-PNET animal model	PLOS ONE			English	Article							STEM-CELLS; C-MYC; NUCLEAR-LOCALIZATION; GENETIC INSTABILITY; EXPRESSION ANALYSIS; NESTIN EXPRESSION; FACTOR YB-1; TUMOR; CANCER; HYPOXIA	Recently, we described a new animal model of CNS primitive neuroectodermal tumors (CNS-PNET), which was generated by orthotopic transplantation of human Radial Glial (RG) cells into NOD-SCID mice's brain sub-ventricular zone. In the current study we conducted comprehensive RNA-Seq analyses to gain insights on the mechanisms underlying tumorigenesis in this mouse model of CNS-PNET. Here we show that the RNA-Seq profiles derived from these tumors cluster with those reported for patients' PNETs. Moreover, we found that (i) stabilization of HIF-1 alpha and HIF-2 alpha, which are involved in mediation of the hypoxic responses in the majority of cell types, (ii) up-regulation of MYCC, a key onco-protein whose dysregulation occurs in similar to 70% of human tumors, and (iii) accumulation of stabilized p53, which is commonly altered in human cancers, constitute hallmarks of our tumor model, and might represent the basis for CNS-PNET tumorigenesis in this model. We discuss the possibility that these three events might be interconnected. These results indicate that our model may prove invaluable to uncover the molecular events leading to MYCC and TP53 alterations, which would be of broader interest considering their relevance to many human malignancies. Lastly, this mouse model might prove useful for drug screening targeting MYCC and related members of its protein interaction network.	[Malchenko, Sergey; Boyineni, Jerusha; Mohanam, Indra; Soares, Marcelo B.] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA; [Sredni, Simone Treiger; Tomita, Tadanori] Northwestern Univ, Div Pediat Neurosurg, Dept Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Sredni, Simone Treiger] Ann & Robert H Lurie Childrens Hosp Chicago, Canc Biol & Epigen Program, Stanley Manne Childrens Res Inst, Chicago, IL 60611 USA; [Bi, Yingtao; Davuluri, Ramana V.] Northwestern Univ, Dept Prevent Med, Div Hlth & Biomed Informat, Feinberg Sch Med, Chicago, IL 60611 USA; [Bi, Yingtao] Abbvie Biores Ctr, Worcester, MA USA; [Margaryan, Naira V.] West Virginia Univ, Dept Biochem, Robert C Byrd Hlth Sci Ctr, Morgantown, WV USA	University of Illinois System; University of Illinois Peoria; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; AbbVie; West Virginia University	Malchenko, S (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA.	sergeynm@uicomp.uic.edu		Sredni, Simone/0000-0002-1715-3885	Abbvie Bioresearch Center; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011297] Funding Source: NIH RePORTER	Abbvie Bioresearch Center(AbbVie); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by a gift from Mr Glen Barton, whose generosity and vision to contribute to the development of a Cancer Research Center at the University of Illinois College of Medicine at Peoria (UICOMP) has been transformative to this medical school. Abbvie Bioresearch Center provided support in the form of salary for author (YB) but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andoniadou CL, 2012, ACTA NEUROPATHOL, V124, P259, DOI 10.1007/s00401-012-0957-9; Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; Behdad A, 2010, BRAIN PATHOL, V20, P441, DOI 10.1111/j.1750-3639.2009.00314.x; BENNETT WP, 1992, CHEST, V101, pS19, DOI 10.1378/chest.101.3_Supplement.19S; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2016, ONCOGENE, P1; Doe MR, 2012, CANCER RES, V72, P949, DOI 10.1158/0008-5472.CAN-11-2371; Dolecek TA, 2013, NEURO-ONCOLOGY, V15, P646; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Faury D, 2007, J CLIN ONCOL, V25, P1196, DOI 10.1200/JCO.2006.07.8626; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Gabay M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014241; Gallant P, 2006, CURR TOP MICROBIOL, V302, P235; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hill RM, 2015, CANCER CELL, V27, P72, DOI 10.1016/j.ccell.2014.11.002; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Homer C, 2005, ONCOGENE, V24, P8314, DOI 10.1038/sj.onc.1208998; Huang LE, 2007, J MOL MED, V85, P139, DOI 10.1007/s00109-006-0133-6; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Janz M, 2002, INT J CANCER, V97, P278, DOI 10.1002/ijc.1610; Kahlert UD, 2012, FOLIA NEUROPATHOL, V50, P357, DOI 10.5114/fn.2012.32365; Karlsson A, 2003, BLOOD, V101, P2797, DOI 10.1182/blood-2002-10-3091; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Khan Z, 2013, CANCER INVEST, V31, P404, DOI 10.3109/07357907.2013.802800; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kozono D, 2015, P NATL ACAD SCI USA, V112, pE4055, DOI 10.1073/pnas.1501967112; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu ZG, 2014, NEURO-ONCOLOGY, V16, P787, DOI 10.1093/neuonc/not244; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Malchenko S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121707; Malchenko S, 2014, GENE, V534, P400, DOI 10.1016/j.gene.2013.07.101; Manoranjan B, 2015, ADV EXP MED BIOL, V853, P49, DOI 10.1007/978-3-319-16537-0_4; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Nasi S, 2001, FEBS LETT, V490, P153, DOI 10.1016/S0014-5793(01)02118-4; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Palma CS, 2013, GENET MOL RES, V12, P1054, DOI 10.4238/2013.April.2.22; Pei YX, 2012, CANCER CELL, V21, P155, DOI 10.1016/j.ccr.2011.12.021; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Picard D, 2012, LANCET ONCOL, V13, P838, DOI 10.1016/S1470-2045(12)70257-7; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Reynolds TY, 1996, CANCER RES, V56, P5754; Sakurada K, 2008, NEUROSURG REV, V31, P173, DOI 10.1007/s10143-007-0115-3; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Seymour T, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00159; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Soucek L, 2013, GENE DEV, V27, P504, DOI 10.1101/gad.205542.112; Sturm D, 2016, CELL, V164, P1060, DOI 10.1016/j.cell.2016.01.015; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Yemelyanova A, 2011, MODERN PATHOL, V24, P1248, DOI 10.1038/modpathol.2011.85; Young SL, 2011, MOL BIOL EVOL, V28, P2961, DOI 10.1093/molbev/msr132; Zaika A, 1999, J BIOL CHEM, V274, P27474, DOI 10.1074/jbc.274.39.27474; Zhang YF, 2003, ONCOGENE, V22, P2782, DOI 10.1038/sj.onc.1206357	78	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173106	10.1371/journal.pone.0173106	http://dx.doi.org/10.1371/journal.pone.0173106			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249000	Green Published, gold, Green Submitted			2022-12-26	WOS:000395983500075
J	Yang, M; Schiapparelli, P; Nguyen, HN; Igarashi, A; Zhang, Q; Abbadi, S; Amzel, LM; Sesaki, H; Quinones-Hinojosa, A; Iijima, M				Yang, Jr-M; Schiapparelli, P.; Nguyen, H-N; Igarashi, A.; Zhang, Q.; Abbadi, S.; Amzel, L. M.; Sesaki, H.; Quinones-Hinojosa, A.; Iijima, M.			Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization	ONCOGENE			English	Article							MESENCHYMAL STEM-CELLS; TUMOR-SUPPRESSOR; PHOSPHATASE-ACTIVITY; MIGRATION; GENE; PHOSPHORYLATION; ACTIVATION; SURVIVAL; BINDING	PTEN is a PIP3 phosphatase that antagonizes oncogenic PI3-kinase signalling. Due to its critical role in suppressing the potent signalling pathway, it is one of the most mutated tumour suppressors, especially in brain tumours. It is generally thought that PTEN deficiencies predominantly result from either loss of expression or enzymatic activity. By analysing PTEN in malignant glioblastoma primary cells derived from 16 of our patients, we report mutations that block localization of PTEN at the plasma membrane and nucleus without affecting lipid phosphatase activity. Cellular and biochemical analyses as well as structural modelling revealed that two mutations disrupt intramolecular interaction of PTEN and open its conformation, enhancing polyubiquitination of PTEN and decreasing protein stability. Moreover, promoting mono-ubiquitination increases protein stability and nuclear localization of mutant PTEN. Thus, our findings provide a molecular mechanism for cancer-associated PTEN defects and may lead to a brain cancer treatment that targets PTEN mono-ubiquitination.	[Yang, Jr-M; Nguyen, H-N; Igarashi, A.; Zhang, Q.; Sesaki, H.; Iijima, M.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725N Wolfe St,107 Hunterian, Baltimore, MD 21205 USA; [Schiapparelli, P.; Abbadi, S.; Quinones-Hinojosa, A.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Schiapparelli, P.; Amzel, L. M.; Quinones-Hinojosa, A.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD USA; [Schiapparelli, P.; Quinones-Hinojosa, A.] Mayo Clin, Coll Med, Dept Neurosurg, 4500 San Pablo Rd, Jacksonville, FL 32224 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Mayo Clinic	Iijima, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725N Wolfe St,107 Hunterian, Baltimore, MD 21205 USA.; Quinones-Hinojosa, A (corresponding author), Mayo Clin, Coll Med, Dept Neurosurg, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	Quinones-Hinojosa.Alfredo@mayo.edu; miijima@jhmi.edu		schiapparelli, paula/0000-0003-4551-6337; Yang, Jr-Ming/0000-0002-6296-8987	NIH [GM084015, GM089853, NS070024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070024] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants to Miho Iijima (GM084015), Hiromi Sesaki (GM089853) and Alfredo Quinones-Hinojosa (NS070024).	Abbadi S, 2014, MOL CANCER RES, V12, P1547, DOI 10.1158/1541-7786.MCR-14-0106-T; Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Bolduc D, 2013, ELIFE, V2, DOI 10.7554/eLife.00691; Chaichana KL, 2014, NEURO-ONCOLOGY, V16, P113, DOI 10.1093/neuonc/not137; Chaichana KL, 2011, J NEUROSURG, V114, P587, DOI 10.3171/2010.8.JNS1081; Chaichana KL, 2009, J NEUROSCI METH, V180, P116, DOI 10.1016/j.jneumeth.2009.02.014; Chen CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002446; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Ermoian RP, 2002, CLIN CANCER RES, V8, P1100; Feng Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.521; Garzon-Muvdi T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001320; Gil A, 2007, CELL DEATH DIFFER, V14, P395, DOI 10.1038/sj.cdd.4402073; Guerrero-Cazares H, 2011, J COMP NEUROL, V519, P1165, DOI 10.1002/cne.22566; Nguyen HN, 2015, SCI REP-UK, V5, DOI 10.1038/srep12600; Nguyen HN, 2014, P NATL ACAD SCI USA, V111, pE2684, DOI 10.1073/pnas.1409433111; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042; Kim DH, 2009, ADV FUNCT MATER, V19, P1579, DOI 10.1002/adfm.200801174; Kondapalli KC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7289; Lang V, 2015, METHODS, V77-78, P112, DOI 10.1016/j.ymeth.2014.09.001; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Levy AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092165; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li Q, 2014, CLIN CANCER RES, V20, P2375, DOI 10.1158/1078-0432.CCR-13-1415; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Liu FH, 2005, J CELL BIOCHEM, V96, P221, DOI 10.1002/jcb.20525; Maccario H, 2007, BIOCHEM J, V405, P439, DOI 10.1042/BJ20061837; Nguyen HN, 2014, ONCOGENE, V33, P5688, DOI 10.1038/onc.2013.507; Nguyen HN, 2015, ONCOGENE, V34, P3737, DOI 10.1038/onc.2014.293; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Riddick G, 2011, NAT REV NEUROL, V7, P439, DOI 10.1038/nrneurol.2011.100; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Smith CL, 2016, CELL REP, V15, P2616, DOI 10.1016/j.celrep.2016.05.042; Smith CL, 2015, STEM CELL TRANSL MED, V4, P239, DOI 10.5966/sctm.2014-0149; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Tzeng SY, 2011, BIOMATERIALS, V32, P5402, DOI 10.1016/j.biomaterials.2011.04.016; Wang XJ, 2008, BIOCHEM J, V414, P221, DOI 10.1042/BJ20080674; Wang Y, 2011, MOL BIOL CELL, V22, P2270, DOI 10.1091/mbc.E10-11-0926; Yang JM, 2015, METHODS, V77-78, P119, DOI 10.1016/j.ymeth.2014.10.018; Zhang P, 2010, P NATL ACAD SCI US; Zhang PB, 2010, P NATL ACAD SCI USA, V107, P11829, DOI 10.1073/pnas.1006153107; Zhu MX, 2015, STEM CELLS DEV, V24, P160, DOI 10.1089/scd.2014.0076	50	44	46	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 29	2017	36	26					3673	3685		10.1038/onc.2016.493	http://dx.doi.org/10.1038/onc.2016.493			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY9WM	28263967	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000404349700003
J	Kawamata, T; Horie, T; Matsunami, M; Sasaki, M; Ohsumi, Y				Kawamata, Tomoko; Horie, Tetsuro; Matsunami, Miou; Sasaki, Michiko; Ohsumi, Yoshinori			Zinc starvation induces autophagy in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ALKALINE-PHOSPHATASE; KINASE; GENES; DEFICIENCY; INDUCTION; PATHWAY; COMPLEX; GROWTH	Zinc is an essential nutrient for all forms of life. Within cells, most zinc is bound to protein. Because zinc serves as a catalytic or structural cofactor for many proteins, cells must maintain zinc homeostasis under severely zinc-deficient conditions. In yeast, the transcription factor Zap1 controls the expression of genes required for uptake and mobilization of zinc, but to date the fate of existing zinc-binding proteins under zinc starvation remains poorly understood. Autophagy is an evolutionarily conserved cellular degradation/recycling process in which cytoplasmic proteins and organelles are sequestered for degradation in the vacuole/lysosome. In this study, we investigated how autophagy functions under zinc starvation. Zinc depletion induced non-selective autophagy, which is important for zinc-limited growth. Induction of autophagy by zinc starvation was not directly related to transcriptional activation of Zap1. Instead, TORC1 inactivation directed zinc starvation-induced autophagy. Abundant zinc proteins, such as Adh1, Fba1, and ribosomal protein Rpl37, were degraded in an autophagy-dependent manner. But the targets of autophagy were not restricted to zinc-binding proteins. When cellular zinc is severely depleted, this non-selective autophagy plays a role in releasing zinc from the degraded proteins and recycling zinc for other essential purposes.	[Kawamata, Tomoko; Horie, Tetsuro; Matsunami, Miou; Sasaki, Michiko; Ohsumi, Yoshinori] Tokyo Inst Technol, Inst Innovat Res, Res Unit Cell Biol, Yokohama, Kanagawa 2268503, Japan; [Horie, Tetsuro] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Res Ctr Odontol, Chiyoda Ku, Tokyo 1028159, Japan; [Kawamata, Tomoko] Japan Soc Promot Sci, Tokyo, Japan	Tokyo Institute of Technology; Nippon Dental University; Japan Society for the Promotion of Science	Ohsumi, Y (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Res Unit Cell Biol, Yokohama, Kanagawa 2268503, Japan.	yohsumi@iri.titech.ac.jp	, 堀江哲郎/AAV-2371-2020; Kawamata-HORIE, Tomoko/B-1699-2017; Ohsumi, Yoshinori/C-6449-2009	, 堀江哲郎/0000-0002-6713-6725; Kawamata-HORIE, Tomoko/0000-0002-3990-1194; Ohsumi, Yoshinori/0000-0003-2384-2166	Ministry of Education, Culture, Sports, Science and Technology of Japan [23000015, 16H06375]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research 23000015 (to Y. O.) and 16H06375 (to Y. O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bird AJ, 2006, EMBO J, V25, P5726, DOI 10.1038/sj.emboj.7601453; de Loubresse NG, 2014, NATURE, V513, P517, DOI 10.1038/nature13737; Ehrensberger KM, 2011, TRENDS BIOCHEM SCI, V36, P524, DOI 10.1016/j.tibs.2011.07.002; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Fujioka Y, 2014, NAT STRUCT MOL BIOL, V21, P513, DOI 10.1038/nsmb.2822; HARTWELL LH, 1974, BACTERIOL REV, V38, P164, DOI 10.1128/MMBR.38.2.164-198.1974; Horie T, 2017, J BIOL CHEM, V292, P8533, DOI 10.1074/jbc.M116.762963; Huang HH, 2015, EMBO J, V34, P154, DOI 10.15252/embj.201489083; Hwang JJ, 2010, BIOMETALS, V23, P997, DOI 10.1007/s10534-010-9346-9; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; KANEKO Y, 1987, GENE, V58, P137; Kawamata T, 2008, MOL BIOL CELL, V19, P2039, DOI 10.1091/mbc.E07-10-1048; Kim S, 2000, J BIOL CHEM, V275, P25979, DOI 10.1074/jbc.M001975200; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lee SJ, 2009, GLIA, V57, P1351, DOI 10.1002/glia.20854; Liuzzi JP, 2013, BIOL TRACE ELEM RES, V156, P350, DOI 10.1007/s12011-013-9816-3; Liuzzi JP, 2014, BIOMETALS, V27, P1087, DOI 10.1007/s10534-014-9773-0; Lynch CJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE25, DOI 10.1152/ajpendo.2001.281.1.E25; Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; North M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002699; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Qiao W, 2009, MOL MICROBIOL, V72, P320, DOI 10.1111/j.1365-2958.2009.06644.x; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Regalla LM, 2006, TOP CURR GENET, V14, P37; Reggiori Fulvio, 2012, Int J Cell Biol, V2012, P219625, DOI 10.1155/2012/219625; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Sutter BM, 2013, CELL, V154, P403, DOI 10.1016/j.cell.2013.06.041; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Yamamoto H, 2016, DEV CELL, V38, P86, DOI 10.1016/j.devcel.2016.06.015; Zimbro M.J., 2009, DIFCO BBL MANUAL MAN	37	43	44	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8520	8530		10.1074/jbc.M116.762948	http://dx.doi.org/10.1074/jbc.M116.762948			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28264932	Green Published, hybrid			2022-12-26	WOS:000401788600034
J	Kolbel, H; Hauffa, BP; Wudy, SA; Bouikidis, A; Della Marina, A; Schara, U				Koelbel, Heike; Hauffa, Berthold P.; Wudy, Stefan A.; Bouikidis, Anastasios; Della Marina, Adela; Schara, Ulrike			Hyperleptinemia in children with autosomal recessive spinal muscular atrophy type I-III	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; PUBERTAL CHANGES; MOUSE MODEL; LEPTIN; DISEASE; METABOLISM; GROWTH; RESISTANCE; SURVIVAL; INFANTS	Background Autosomal-recessive proximal spinal muscular atrophies (SMA) are disorders characterized by a ubiquitous deficiency of the survival of motor neuron protein that leads to a multisystemic disorder, which mostly affects alpha motor neurons. Disease progression is clinically associated with failure to thrive or weight loss, mainly caused by chewing and swallowing difficulties. Although pancreatic involvement has been described in animal models, systematic endocrinological evaluation of the energy metabolism in humans is lacking. Methods In 43 patients with SMA type I-III (8 type I; 22 type II; 13 type III), aged 0.6-21.8 years, auxological parameters, pubertal stage, motor function (Motor Function Measurement 32- MFM32) as well as levels of leptin, insulin glucose, hemoglobin A1c, Homeostasis Model Assessment index and an urinary steroid profile were determined. Results Hyperleptinemia was found in 15/35 (43%) of our patients; 9/15 (60%) of the hyperleptinemic patients were underweight, whereas 1/15 (7%) was obese. Hyperleptinemia was associated with SMA type (p = 0.018). There was a significant association with decreased motor function (MFM32 total score in hyperleptinemia 28.5%, in normoleptinemia 54.7% p = 0.008, OR 0.969; 95%-CI: 0.946-0.992). In addition, a higher occurrence of hirsutism, premature pub-arche and a higher variability of the urinary steroid pattern were found. Conclusion Hyperleptinemia is highly prevalent in underweight children with SMA and is associated with disease severity and decreased motor function. Neuronal degradation of hypothalamic cells or an increase in fat content by muscle remodeling could be the cause of hyperleptinemia.	[Koelbel, Heike; Della Marina, Adela; Schara, Ulrike] Univ Duisburg Essen, Childrens Hosp 1, Dept Neuropediat Dev Neurol & Social Pediat, Essen, Germany; [Hauffa, Berthold P.] Univ Duisburg Essen, Childrens Hosp 2, Dept Pediat Endocrinol, Essen, Germany; [Wudy, Stefan A.] Justus Liebig Univ, Ctr Child & Adolescent Med, Div Pediat Endocrinol & Diabetol, Steroid Res & Mass Spectrometry Unit, Giessen, Germany; [Bouikidis, Anastasios] Univ Duisburg Essen, Childrens Hosp 3, Dept Pediat Pulmonol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; Justus Liebig University Giessen; University of Duisburg Essen	Kolbel, H (corresponding author), Univ Duisburg Essen, Childrens Hosp 1, Dept Neuropediat Dev Neurol & Social Pediat, Essen, Germany.	heike.koelbel@uk-essen.de	Wudy, Stefan/ABC-7173-2020					Bach JR, 2007, AM J PHYS MED REHAB, V86, P349, DOI 10.1097/PHM.0b013e31804b1d66; Badoud F, 2015, FASEB J, V29, P748, DOI 10.1096/fj.14-263913; Bluher M, 2015, METABOLISM, V64, P131, DOI 10.1016/j.metabol.2014.10.016; Blum WF, 1997, J CLIN ENDOCR METAB, V82, P2904, DOI 10.1210/jc.82.9.2904; Bonda DJ, 2014, J NEUROCHEM, V128, P162, DOI 10.1111/jnc.12380; Bottai D, 2013, BRAIN PATHOL, V23, P613, DOI 10.1111/bpa.12071; Bowerman M, 2012, ANN NEUROL, V72, P256, DOI 10.1002/ana.23582; Butchbach MER, 2010, BIOCHEM BIOPH RES CO, V391, P835, DOI 10.1016/j.bbrc.2009.11.148; Cano SJ, 2014, MUSCLE NERVE, V49, P422, DOI 10.1002/mus.23937; Clark NM, 2014, REPROD SCI, V21, P1034, DOI 10.1177/1933719114522525; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Crawford TO, 1999, ANN NEUROL, V45, P337, DOI 10.1002/1531-8249(199903)45:3<337::AID-ANA9>3.0.CO;2-U; Araujo APDC, 2009, J PEDIATR-US, V155, P292, DOI 10.1016/j.jpeds.2009.01.071; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440, DOI 10.1210/jcem-21-11-1440; Fredriks AM, 2005, EUR J PEDIATR, V164, P216, DOI 10.1007/s00431-004-1586-7; Fuller HR, 2016, NEUROMUSCULAR DISORD, V26, P560, DOI 10.1016/j.nmd.2016.06.004; Ito Y, 2004, BRAIN DEV-JPN, V26, P53, DOI 10.1016/S0387-7604(03)00075-5; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; LaMarca NH, 2013, J CHILD NEUROL, V28, P1517, DOI 10.1177/0883073812460096; Lim MA, 2014, HUM MOL GENET, V23, P4995, DOI 10.1093/hmg/ddu214; Mannaa Mohannad M, 2009, J Clin Neuromuscul Dis, V10, P85, DOI 10.1097/CND.0b013e318190310f; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moore GE, 2016, NEUROMUSCULAR DISORD, V26, P395, DOI 10.1016/j.nmd.2016.05.005; Rudnik-Schoneborn S, 2008, J MED GENET, V45, P635, DOI 10.1136/jmg.2008.057950; Rudnik-Schoneborn S, 2010, MUSCLE NERVE, V42, P144, DOI 10.1002/mus.21654; Sainz N, 2015, METABOLISM, V64, P35, DOI 10.1016/j.metabol.2014.10.015; Sproule DM, 2012, J CHILD NEUROL, V27, P845, DOI 10.1177/0883073811415680; Sproule DM, 2011, J CHILD NEUROL, V26, P1252, DOI 10.1177/0883073811405053; Sproule DM, 2011, J CHILD NEUROL, V26, P309, DOI 10.1177/0883073810380457; Sproule DM, 2009, NEUROMUSCULAR DISORD, V19, P391, DOI 10.1016/j.nmd.2009.03.009; Stojanovic VR, 2010, ACTA NEUROL SCAND, V121, P94, DOI 10.1111/j.1600-0404.2009.01237.x; Vitte JM, 2004, AM J PATHOL, V165, P1731, DOI 10.1016/S0002-9440(10)63428-1; Wang CH, 2007, J CHILD NEUROL, V22, P1027, DOI 10.1177/0883073807305788; Welt CK, 2013, J CLIN ENDOCR METAB, V98, P4629, DOI 10.1210/jc.2013-2375; Willers SM, 2015, ANN NUTR METAB, V66, P63, DOI 10.1159/000369979; Wishart TM, 2010, HUM MOL GENET, V19, P4216, DOI 10.1093/hmg/ddq340; Wudy SA, 2004, HORM METAB RES, V36, P415, DOI 10.1055/s-2004-814565; Yildiz BO, 2010, HUM REPROD UPDATE, V16, P51, DOI 10.1093/humupd/dmp024	41	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173144	10.1371/journal.pone.0173144	http://dx.doi.org/10.1371/journal.pone.0173144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278160	gold, Green Published, Green Submitted			2022-12-26	WOS:000396087900049
J	Liu, P; Li, C; Zheng, N; Xu, Q; Yu, SB; Sui, HJ				Liu, Pei; Li, Chan; Zheng, Nan; Xu, Qiang; Yu, Sheng-Bo; Sui, Hong-Jin			The myodural bridge existing in the Nephocaena phocaenoides	PLOS ONE			English	Article							POSTERIOR MINOR MUSCLE; CONNECTIVE-TISSUE; SPINAL DURA; ATTACHMENTS; MICROSCOPY; INTERSPACE; ANEURYSMS; COLLAGEN; MATER	Recent studies have identified that the myodural bridge (MDB) between the rectus capitis posterior minor (RCPmi) and the cervical spinal dura mater in the posterior atlanto-occipital interspace in humans. And it was supposed that the MDB may play essential physiological roles. As a result, the MDB is possibly a highly conserved structure in the evolution of mammals. However, there is little confirmative description about the existence of the MDB in marine mammals. The objective of this study was to explore the existence and the fiber property of the MDB in the Neophocaena phocaenoides. Six cadavers of the Neophocaena phocaenoides with formalin fixation were used in this study. One was used for head and neck CT scanning and three-dimensional (3D) reconstruction and suboccipital region dissection, two were for sectional observation by P45 plastinated sheets of head and neck, and three were for histological analysis of suboccipial structures. This is the first study to demonstrate the existence of the MDB in the aquatic mammals. The rectus capitis dorsal minor (RCDmi) originated from the inferior border of the occiput and inserted into the cervical spinal dura mater. At the ventral aspect of the RCDmi, the MDB directly extended through the posterior atlanto-occipital interspace and connected with the cervical spinal dura mater which was consisted of type. collagen. In addition, the dorsal atlanto-occipital membrane was not found in the Neophocaena phocaenoides. The tendinous myodural bridge extended from the RCDmi to the spinal dura mater through the posterior atlanto-occipital interspace in the Neophocaena phocaenoides.	[Liu, Pei] Dalian Med Univ, Affiliated Hosp 1, Dalian, Peoples R China; [Li, Chan; Zheng, Nan; Yu, Sheng-Bo; Sui, Hong-Jin] Dalian Med Univ, Dept Anat, Coll Basic Med, Dalian, Peoples R China; [Xu, Qiang] Chinese Peoples Liberat Army Gen Hosp, Dept Radiol, Affiliated Hosp 403, Dalian, Peoples R China; [Sui, Hong-Jin] Dalian Hoffen Preservat Inst, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University; Chinese People's Liberation Army General Hospital	Yu, SB; Sui, HJ (corresponding author), Dalian Med Univ, Dept Anat, Coll Basic Med, Dalian, Peoples R China.; Sui, HJ (corresponding author), Dalian Hoffen Preservat Inst, Dalian, Peoples R China.	ysbdmu@126.com; suihj@hotmail.com		Liu, Pei/0000-0002-1761-8339	Natural Science Foundation of China [NSFC31571234, NSFC31600972]; Liaoning province natural science funds [2014023017]; Liaoning province department of education funds [L2015156, L2016012]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning province natural science funds; Liaoning province department of education funds	This study was supported by the Natural Science Foundation of China (NSFC31571234), http://www.nsfc.gov.cn/, recipient HJS; Liaoning province natural science funds (2014023017), http://kjjh.Ininfo.gov.cn/, HJS; Liaoning province department of education funds (L2015156), http:// kjc.sie.edu.cn/, SBY; Natural Science Foundation of China (NSFC31600972) and Liaoning province department of education funds (L2016012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnautovic KI, 1997, J NEUROSURG, V86, P252, DOI 10.3171/jns.1997.86.2.0252; Canham PB, 1999, NEUROL RES, V21, P618, DOI 10.1080/01616412.1999.11740986; Connor Richard C, 1994, DM PETERSON LIVES WH; ECKENHOFF JE, 1970, SURG GYNECOL OBSTETR, V131, P72; Enix Dennis E, 2014, J Can Chiropr Assoc, V58, P184; HACK GD, 1995, SPINE, V20, P2484, DOI 10.1097/00007632-199512000-00003; Hamada J, 2000, J NEUROSURG, V92, P1023, DOI 10.3171/jns.2000.92.6.1023; Harrison SRR, 1999, HDB MARINE MAMMALS 2, V6, P411; Humphreys BK, 2003, CLIN ANAT, V16, P152, DOI 10.1002/ca.10109; KAHN JL, 1992, ACTA ANAT, V144, P65; Mitchell BS, 1998, J MANIP PHYSIOL THER, V21, P145; Nash L, 2005, SPINE, V30, P1359, DOI 10.1097/01.brs.0000166159.31329.92; Reed JZ, 2000, J COMP PHYSIOL B, V170, P1, DOI 10.1007/s003600050001; Ruiz DS, 2002, AM J NEURORADIOL, V23, P1500; Scali F, 2013, SPINE J, V13, P558, DOI 10.1016/j.spinee.2013.01.015; Scali F, 2013, CLIN ANAT, V26, P444, DOI 10.1002/ca.22094; Scali F, 2011, SPINE, V36, pE1612, DOI 10.1097/BRS.0b013e31821129df; Sui HJ, 2006, China patent, Patent No. [ZL 031341098, 031341098]; [隋鸿锦 Sui Hongjin], 2013, [中国临床解剖学杂志, Chinese Journal of Clinical Anatomy], V31, P489; Takahashi S, 2015, EUROPEAN RADIOLOGY, V15, P1694; WOLMAN M, 1986, HISTOCHEMISTRY, V85, P41, DOI 10.1007/BF00508652; Wurtz Maurizio, 2003, NADIA REPETTO DOLPHI; Xu Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep31787; Yuan XY, 2016, ANAT SCI INT, V91, P175, DOI 10.1007/s12565-015-0282-1; Zheng N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103451; Zumpano MP, 2006, CLIN ANAT, V19, P522, DOI 10.1002/ca.20220	26	12	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173630	10.1371/journal.pone.0173630	http://dx.doi.org/10.1371/journal.pone.0173630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278181	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900022
J	Pankow, JF; Kim, K; McWhirter, KJ; Luo, W; Escobedo, JO; Strongin, RM; Duell, AK; Peyton, DH				Pankow, James F.; Kim, Kilsun; McWhirter, Kevin J.; Luo, Wentai; Escobedo, Jorge O.; Strongin, Robert M.; Duell, Anna K.; Peyton, David H.			Benzene formation in electronic cigarettes	PLOS ONE			English	Article							CONVERSION; SMOKE	Background/Objective The heating of the fluids used in electronic cigarettes ("e-cigarettes") used to create "vaping" aerosols is capable of causing a wide range of degradation reaction products. We investigated formation of benzene (an important human carcinogen) from e-cigarette fluids containing propylene glycol (PG), glycerol (GL), benzoic acid, the flavor chemical benzaldehyde, and nicotine. Methods/Main results Three e-cigarette devices were used: the JUUL (TM) "pod" system (provides no user accessible settings other than flavor cartridge choice), and two refill tank systems that allowed a range of user accessible power settings. Benzene in the e-cigarette aerosols was determined by gas chromatography/mass spectrometry. Benzene formation was ND (not detected) in the JUUL system. In the two tank systems benzene was found to form from propylene glycol (PG) and glycerol (GL), and from the additives benzoic acid and benzaldehyde, especially at high power settings. With 50:50 PG+GL, for tank device 1 at 6W and 13W, the formed benzene concentrations were 1.9 and 750 mu g/m(3). For tank device 2, at 6W and 25W, the formed concentrations were ND and 1.8 mu g/m(3). With benzoic acid and benzaldehyde at similar to 10 mg/mL, for tank device 1, values at 13W were as high as 5000 mu g/m(3). For tank device 2 at 25W, all values were <=-100 mu g/m(3). These values may be compared with what can be expected in a conventional (tobacco) cigarette, namely 200,000 pg/m3. Thus, the risks from benzene will be lower from e cigarettes than from conventional cigarettes. However, ambient benzene air concentrations in the U.S. have typically been 1 mu g/m(3), so that benzene has been named the largest single known cancer-risk air toxic in the U.S. For non-smokers, chronically repeated exposure to benzene from e-cigarettes at levels such as 100 or higher mu g/m(3) will not be of negligible risk.	[Pankow, James F.; Kim, Kilsun; Luo, Wentai; Escobedo, Jorge O.; Strongin, Robert M.; Duell, Anna K.; Peyton, David H.] Portland State Univ, Dept Chem, Portland, OR 97207 USA; [Pankow, James F.; McWhirter, Kevin J.; Luo, Wentai] Portland State Univ, Dept Civil & Environm Engn, Portland, OR 97207 USA	Portland State University; Portland State University	Pankow, JF (corresponding author), Portland State Univ, Dept Chem, Portland, OR 97207 USA.; Pankow, JF (corresponding author), Portland State Univ, Dept Civil & Environm Engn, Portland, OR 97207 USA.	pankowj@pdx.edu	Escobedo, Jorge O/F-1735-2010; Kim, Kilsun/AAM-7581-2021; Strongin, Robert M./F-1026-2010	Escobedo, Jorge O/0000-0001-8858-663X; Peyton, David/0000-0001-5828-055X; /0000-0001-5855-5162	NIH; FDA [R01ES025257]; NIEHS; FDA Center for Tobacco Products (CTP); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025257] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FDA(United States Department of Health & Human Services); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); FDA Center for Tobacco Products (CTP)(United States Department of Health & Human Services); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	NIH and FDA supported this work via award R01ES025257. In particular, the work reported in this publication was supported by NIEHS and the FDA Center for Tobacco Products (CTP) (https://www.nih.gov/). The funders had no role in study design, data collection and analysis, ecision to publish, or preparation of the manuscript.	BAKER RR, 1974, NATURE, V247, P404; Borgerding MF, 2000, 1999 MASSACHUSETTS B; George BJ, 2011, ATMOS ENVIRON, V45, P3301, DOI 10.1016/j.atmosenv.2011.03.031; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Hoang TQ, 2010, ENERG FUEL, V24, P3804, DOI 10.1021/ef100160y; Hua M, 2013, TOB CONTROL, V22, P103, DOI 10.1136/tobaccocontrol-2011-050226; International Agency for Research on Cancer (IARC), 2012, MON EV CARC RISK H F, V100-F; Jensen RP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42549; Jensen RP, 2015, NEW ENGL J MED, V372, P392, DOI 10.1056/NEJMc1413069; Kim YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16383; Kosmider L, 2014, NICOTINE TOB RES, V16, P1319, DOI 10.1093/ntr/ntu078; McAuley TR, 2012, INHAL TOXICOL, V24, P850, DOI 10.3109/08958378.2012.724728; Nef J. U., 1904, LIEBIGS ANN CHEM, V335, P247; OPRIS I, 1981, REV CHIM-BUCHAREST, V32, P234; Pankow JF, 2007, CANCER EPIDEM BIOMAR, V16, P584, DOI 10.1158/1055-9965.EPI-06-0762; Pankow JF, 2017, J AEROSOL SCI, V107, P9, DOI 10.1016/j.jaerosci.2017.02.003; Pankow JF, 2004, CHEM RES TOXICOL, V17, P805, DOI 10.1021/tx0342316; Sleiman M, 2016, ENVIRON SCI TECHNOL, V50, P9644, DOI 10.1021/acs.est.6b01741; Tierney P. A, 2015, TOB CONTROL; U.S. Environmental Protection Agency, 2003, EPAS REP ENV AMB CON	20	118	120	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173055	10.1371/journal.pone.0173055	http://dx.doi.org/10.1371/journal.pone.0173055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273096	Green Submitted, gold, Green Published			2022-12-26	WOS:000396073700036
J	Wang, Y; Stewart, E; Desjardins, L; Hadway, J; Morrison, L; Crukley, C; Lee, TY				Wang, Yong; Stewart, Errol; Desjardins, Lise; Hadway, Jennifer; Morrison, Laura; Crukley, Cathie; Lee, Ting-Yim			Assessment of intratumor hypoxia by integrated F-18-FDG PET/perfusion CT in a liver tumor model	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ADVANCED BREAST-CANCER; BLOOD-FLOW; METABOLISM; MARKERS; PIMONIDAZOLE; SURROGATE; THERAPY; CERVIX; FDG	Objectives Hypoxia in solid tumors occurs when metabolic demands in tumor cells surpass the delivery of oxygenated blood. We hypothesize that the F-18-fluorodeoxyglucose (F-18-FDG) metabolism and tumor blood flow mismatch would correlate with tumor hypoxia. Methods Liver perfusion computed tomography (CT) and F-18-FDG positron emission tomography (PET) imaging were performed in twelve rabbit livers implanted with VX2 carcinoma. Under CT guidance, a fiber optic probe was inserted into the tumor to measure the partial pressure of oxygen (pO(2)). Tumor blood flow (BF) and standardized uptake value (SUV) were measured to calculate flow-metabolism ratio (FMR). Tumor hypoxia was further identified using pimonidazole immunohistochemical staining. Pearson correlation analysis was performed to determine the correlation between the imaging parameters and pO(2) and pimonidazole staining. Results Weak correlations were found between blood volume (BV) and pO(2) level (r = 0.425, P = 0.004), SUV and pO2 (r = -0.394, P = 0.007), FMR and pimonidazole staining score (r = -0.388, P = 0.031). However, there was stronger correlation between tumor FMR and pO(2) level (r = 0.557, P < 0.001). Conclusions FMR correlated with tumor oxygenation and pimonidazole staining suggesting it may be a potential hypoxic imaging marker in liver tumor.	[Wang, Yong] Huazhong Univ Sci & Technol, Union Hosp, Dept Radiol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Wang, Yong; Lee, Ting-Yim] Western Univ, Schulich Sch Med & Dent, Dept Med Biophys, London, ON, Canada; [Stewart, Errol; Desjardins, Lise; Hadway, Jennifer; Morrison, Laura; Lee, Ting-Yim] Lawson Hlth Res Inst, Imaging Program, London, ON, Canada; [Crukley, Cathie; Lee, Ting-Yim] Robarts Res Inst, Imaging Res Labs, London, ON, Canada	Huazhong University of Science & Technology; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Lee, TY (corresponding author), Western Univ, Schulich Sch Med & Dent, Dept Med Biophys, London, ON, Canada.	tlee@imaging.robarts.ca	Stewart, Errol/AAO-5739-2020; Lee, Ting-Yim/M-1721-2013; Lee, Ting-Yim/J-3947-2019	Lee, Ting-Yim/0000-0001-7605-9752	Ontario Institute of Cancer Research (Wester REB) [103184]	Ontario Institute of Cancer Research (Wester REB)	TYL was funded by Ontario Institute of Cancer Research (Wester REB #103184) http://oicr.on.ca./.	ARTEEL GE, 1995, BRIT J CANCER, V72, P889, DOI 10.1038/bjc.1995.429; Busk M, 2008, INT J CANCER, V122, P2726, DOI 10.1002/ijc.23449; Busk M, 2009, RADIOTHER ONCOL, V92, P429, DOI 10.1016/j.radonc.2009.08.026; Cherk MH, 2006, J NUCL MED, V47, P1921; Christian N, 2010, RADIOTHER ONCOL, V97, P183, DOI 10.1016/j.radonc.2010.02.020; Dierckx RA, 2008, EUR J NUCL MED MOL I, V35, P1544, DOI 10.1007/s00259-008-0758-5; Dunnwald LK, 2008, J CLIN ONCOL, V26, P4449, DOI 10.1200/JCO.2007.15.4385; Enjilela E, 2015, COMPRESSED SENSING B; Fleming IN, 2015, BRIT J CANCER, V112, P238, DOI 10.1038/bjc.2014.610; Goh V, 2012, J NUCL MED, V53, P687, DOI 10.2967/jnumed.111.098525; Jankovic B, 2006, CYTOM PART B-CLIN CY, V70B, P45, DOI 10.1002/cyto.b.20086; Jensen NKG, 2013, ACAD RADIOL, V20, P414, DOI 10.1016/j.acra.2012.09.027; Komar G, 2009, CLIN CANCER RES, V15, P5511, DOI 10.1158/1078-0432.CCR-09-0414; Mandeville HC, 2012, RADIOLOGY, V264, P581, DOI 10.1148/radiol.12111505; Mankoff DA, 2002, J NUCL MED, V43, P500; Mankoff DA, 2009, CLIN CANCER RES, V15, P5294, DOI 10.1158/1078-0432.CCR-09-1448; Miles KA, 2008, CANCER IMAGING, V8, P81, DOI 10.1102/1470-7330.2008.0011; Nordsmark M, 2001, INT J RADIAT ONCOL, V49, P581, DOI 10.1016/S0360-3016(00)01493-0; Olive PL, 2001, ACTA ONCOL, V40, P917; Semple SIK, 2004, EUR RADIOL, V14, P2038, DOI 10.1007/s00330-004-2454-6; SHANBHAG AG, 1994, CVGIP-GRAPH MODEL IM, V56, P414, DOI 10.1006/cgip.1994.1037; Stewart EE, 2008, PHYS MED BIOL, V53, P4249, DOI 10.1088/0031-9155/53/16/003; Stewart EE, 2006, RADIOLOGY, V239, P740, DOI 10.1148/radiol.2393041382; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Zimny M, 2006, EUR J NUCL MED MOL I, V33, P1426, DOI 10.1007/s00259-006-0175-6	25	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173016	10.1371/journal.pone.0173016	http://dx.doi.org/10.1371/journal.pone.0173016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264009	Green Submitted, Green Published, gold			2022-12-26	WOS:000396054300034
J	Norelli, JL; Wisniewski, M; Fazio, G; Burchard, E; Gutierrez, B; Levin, E; Droby, S				Norelli, John L.; Wisniewski, Michael; Fazio, Gennaro; Burchard, Erik; Gutierrez, Benjamin; Levin, Elena; Droby, Samir			Genotyping-by-sequencing markers facilitate the identification of quantitative trait loci controlling resistance to Penicillium expansum in Malus sieversii	PLOS ONE			English	Article							X DOMESTICA-BORKH.; FIRE BLIGHT RESISTANCE; BLUE MOLD; DISEASE RESISTANCE; CULTIVATED APPLE; QTL ANALYSIS; VALIDATION; GERMPLASM; SELECTION; GENOME	Blue mold caused by Penicillium expansum is the most important postharvest disease of apple worldwide and results in significant financial losses. There are no defined sources of resistance to blue mold in domesticated apple. However, resistance has been described in wild Malus sieversii accessions, including plant introduction (PI) 613981. The objective of the present study was to identify the genetic loci controlling resistance to blue mold in this accession. We describe the first quantitative trait loci (QTL) reported in the Rosaceae tribe Maleae conditioning resistance to P. expansum on genetic linkage group 3 (qM-Pe3.1) and linkage group 10 (qM-Pe10.1). These loci were identified in a M. x domestica 'Royal Gala' X M. sieversii PI613981 family (GMAL4593) based on blue mold lesion diameter seven days post-inoculation in mature, wounded apple fruit inoculated with P. expansum. Phenotypic analyses were conducted in 169 progeny over a four year period. PI613981 was the source of the resistance allele for qM-Pe3.1, a QTL with a major effect on blue mold resistance, accounting for 27.5% of the experimental variability. The QTL mapped from 67.3 to 74 cM on linkage group 3 of the GMAL4593 genetic linkage map. qM-Pe10.1 mapped from 73.6 to 81.8 cM on linkage group 10. It had less of an effect on resistance, accounting for 14% of the experimental variation. 'Royal Gala' was the primary contributor to the resistance effect of this QTL. However, resistance-associated alleles in both parents appeared to contribute to the least square mean blue mold lesion diameter in an additive manner at qM-Pe10.1. A GMAL4593 genetic linkage map composed of simple sequence repeats and 'Golden Delicious' single nucleotide polymorphism markers was able to detect qM-Pe10.1, but failed to detect qM-Pe3.1. The subsequent addition of genotyping-by-sequencing markers to the linkage map provided better coverage of the PI613981 genome on linkage group 3 and facilitated discovery of qM-Pe3.1. A DNA test for qM-Pe3.1 has been developed and is currently being evaluated for its ability to predict blue mold resistance in progeny segregating for qMPe3.1. Due to the long juvenility of apple, the availability of a DNA test to screen for the presence of qM-Pe3.1 at the seedling stage will greatly improve efficiency of breeding apple for blue mold resistance.	[Norelli, John L.; Wisniewski, Michael; Burchard, Erik] ARS, Appalachian Fruit Res Stn, USDA, Kearneysville, WV 25430 USA; [Fazio, Gennaro; Gutierrez, Benjamin] ARS, Plant Genet Resources Res, USDA, Geneva, NY USA; [Levin, Elena; Droby, Samir] Agr Res Org, Dept Postharvest Sci, Volcani Ctr, Bet Dagan, Israel	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Norelli, JL (corresponding author), ARS, Appalachian Fruit Res Stn, USDA, Kearneysville, WV 25430 USA.	jay.norelli@ars.usda.gov		Gutierrez, Benjamin/0000-0002-9706-7521; Fazio, Gennaro/0000-0001-6929-3751; Wisniewski, Michael/0000-0002-7481-5590	BARD [US-4774-14C]; United States Israel Binational Agricultural Research and Development Fund; Washington Tree Fruit Research Commission [AP-08-804, CP-10-101]; USDA National Institute of Food and Agriculture Specialty Crop Research Initiative [2014-51181-22378]	BARD(US-Israel Binational Science Foundation); United States Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); Washington Tree Fruit Research Commission; USDA National Institute of Food and Agriculture Specialty Crop Research Initiative	This research was funded in large-part by Research Grant No. US-4774-14C from BARD, The United States Israel Binational Agricultural Research and Development Fund (https://www.bard-isus.com/); and additionally by the Washington Tree Fruit Research Commission (http://www.treefruitresearch.com/) project numbers AP-08-804 and CP-10-101; and the USDA National Institute of Food and Agriculture Specialty Crop Research Initiative (https://nifa.usda.gov/funding-opportunity/specialty-crop-research-initiative-scri) research-initiative-scri) project RosBREED: Combining disease resistance with horticultural quality in new Rosaceous cultivars (2014-51181-22378). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen B, 2004, J AGR FOOD CHEM, V52, P2421, DOI 10.1021/jf035406k; [Anonymous], 2014, R LANG ENV STAT COMP; Bassett CL, 2011, HORTSCIENCE, V46, P1079, DOI 10.21273/HORTSCI.46.8.1079; Baumgartner IO, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-0994-y; Bianco L, 2016, PLANT J, V86, P62, DOI 10.1111/tpj.13145; Bianco L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110377; Blanpied G. D., 1992, INFORM B, V221; Boocock J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2096-x; Bus VGM, 2005, NEW PHYTOL, V166, P1035, DOI 10.1111/j.1469-8137.2005.01395.x; CAPPELLINI RA, 1987, PLANT DIS, V71, P852; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; CHEVREAU E, 1987, THEOR APPL GENET, V75, P90, DOI 10.1007/BF00249147; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cornille A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002703; Costa F, 2010, J EXP BOT; Cowey R, 2014, BREEDING SCI, V64, P83, DOI 10.1270/jsbbs.64.83; CROSBY JA, 1992, FRUIT VARIETIES J, V46, P145; Droby S, 2016, POSTHARVEST BIOL TEC, V122, P22, DOI 10.1016/j.postharvbio.2016.04.006; Ellis ML, 2012, CROP SCI, V52, P2224, DOI 10.2135/cropsci2011.11.0624; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fahrentrapp J, 2013, TREE GENET GENOMES, V9, P237, DOI 10.1007/s11295-012-0550-3; Flachowsky H, 2007, PLANT BREEDING, V126, P137, DOI 10.1111/j.1439-0523.2007.01344.x; Flachowsky H, 2011, NEW PHYTOL, V192, P364, DOI 10.1111/j.1469-8137.2011.03813.x; Forsline P. L., 2003, Horticultural Reviews, V29, P1, DOI 10.1002/9780470650868.ch1; Gardner KM, 2014, G3, V4, P1691; Gianfranceschi L, 1998, THEOR APPL GENET, V96, P1069, DOI 10.1007/s001220050841; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Hyma KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134880; Janisiewicz WJ, 2002, ANNU REV PHYTOPATHOL, V40, P411, DOI 10.1146/annurev.phyto.40.120401.130158; JANISIEWICZ WJ, 1992, PHYTOPATHOLOGY, V82, P1364, DOI 10.1094/Phyto-82-1364; Janisiewicz WJ, 2008, HORTSCIENCE, V43, P420, DOI 10.21273/HORTSCI.43.2.420; JANSEN RC, 1994, GENETICS, V138, P871; JANSEN RC, 1994, GENETICS, V136, P1447; Jurick WM, 2011, PLANT BREEDING, V130, P481, DOI 10.1111/j.1439-0523.2011.01849.x; Kamphuis LG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-30; Konstantinou S, 2011, PLANT DIS, V95, P666, DOI 10.1094/PDIS-11-10-0856; Korban SS, 2009, GENOME, V52, P148, DOI [10.1139/G08-109, 10.1139/g08-109]; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kumar S, 2014, PLANT GENET RESOUR-C, V12, P330, DOI 10.1017/S1479262114000136; LANDER ES, 1989, GENETICS, V121, P185; Le Roux PM, 2012, MOL BREEDING, V30, P857, DOI 10.1007/s11032-011-9669-4; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; LIEBHARD R, 2004, MOL BREEDING, V10, P217; Luby J, 2001, HORTSCIENCE, V36, P225, DOI 10.21273/HORTSCI.36.2.225; Maliepaard C, 1998, THEOR APPL GENET, V97, P60, DOI 10.1007/s001220050867; McClure KA, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.43; McCouch S, 2004, PLOS BIOL, V2, P1507, DOI 10.1371/journal.pbio.0020347; Micheletti D, 2011, TREE GENET GENOMES, V7, P857, DOI 10.1007/s11295-011-0380-8; Noiton DAM, 1996, J AM SOC HORTIC SCI, V121, P773, DOI 10.21273/JASHS.121.5.773; Norelli JL, 2014, ACTA HORTIC, V1053, P199; Olmstead J, GENOME DATABASE ROSA; Parravicini G, 2011, MOL PLANT PATHOL, V12, P493, DOI 10.1111/j.1364-3703.2010.00690.x; Peace CP, 2014, TREE GENET GENOMES, V10, P1679, DOI 10.1007/s11295-014-0788-z; PHIPPS JB, 1991, SYST BOT, V16, P303, DOI 10.2307/2419283; Pindo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-12; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Richards CM, 2009, J AM SOC HORTIC SCI, V134, P228, DOI 10.21273/JASHS.134.2.228; Richards CM, 2009, TREE GENET GENOMES, V5, P339, DOI 10.1007/s11295-008-0190-9; Robinson JP, 2001, PLANT SYST EVOL, V226, P35, DOI 10.1007/s006060170072; Rosenberger D, 1997, ENG SERV PUBL, V112; Rosenberger D.A., 1990, COMPENDIUM APPLE PEA, P54; Ru S, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0834-5; Silfverberg-Dilworth E, 2006, TREE GENET GENOMES, V2, P202, DOI 10.1007/s11295-006-0045-1; Spotts RA, 1999, PLANT DIS, V83, P1051, DOI 10.1094/PDIS.1999.83.11.1051; Tahir II, 2015, EUR J HORTIC SCI, V80, P117, DOI 10.17660/eJHS.2015/80.3.4; Tobler AR, 2005, J BIOMOL TECH, V16, P389; USDA-ARS, 2000, PLANT MAT INTR 2000, P223; Van Ooijen JW, 2013, GENETIC MAPPING IN EXPERIMENTAL POPULATIONS, P101; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; Van Ooijen JW, 1999, HEREDITY, V83, P613, DOI 10.1038/sj.hdy.6886230; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vilanova L, 2014, POSTHARVEST BIOL TEC, V88, P54, DOI 10.1016/j.postharvbio.2013.09.009; Volk GM, 2015, AM J BOT, V102, P1198, DOI 10.3732/ajb.1500095; Volk GM, 2013, HORTSCIENCE, V48, P1440, DOI 10.21273/HORTSCI.48.12.1440; Volk GM, 2014, GENET RESOURCES CROP; Wan YZ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0839-2; Wang AD, 2012, MOL BREEDING, V29, P379, DOI 10.1007/s11032-011-9554-1; Wisniewski M, 2016, POSTHARVEST BIOL TEC, V122, P3, DOI 10.1016/j.postharvbio.2016.05.012; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Zhang W, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00161	81	33	35	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172949	10.1371/journal.pone.0172949	http://dx.doi.org/10.1371/journal.pone.0172949			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257442	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100043
J	Winkler, M; Gartner, S; Wrensch, F; Krawczak, M; Sauermann, U; Poehlmann, S				Winkler, Michael; Gaertner, Sabine; Wrensch, Florian; Krawczak, Michael; Sauermann, Ulrike; Poehlmann, Stefan			Rhesus macaque IFITM3 gene polymorphisms and SIV infection	PLOS ONE			English	Article							INDUCED TRANSMEMBRANE PROTEIN-3; HOST-CELL ENTRY; SYNONYMOUS MUTATIONS; VIRUS-REPLICATION; SEVERE INFLUENZA; DENGUE VIRUS; HIV-1; RESTRICTION; RESISTANCE; GENOME	Interferon-induced transmembrane proteins (IFITMs) have been recognized as important antiviral effectors of the innate immune system, both in cell culture and in infected humans. In particular, polymorphisms of the human IFITM3 gene have been shown to affect disease severity and progression in influenza A virus (FLUAV) and human immunodeficiency virus (HIV) infection, respectively. Rhesus macaques (Macaca mulatta) are commonly used to model human infections and the experimental inoculation of these animals with simian immunodeficiency virus (SIV) is one of the best models for HIV/AIDS in humans. However, information on the role of IFITM3 in SIV infection of rhesus macaques is currently lacking. We show that rhesus macaque (rh) IFITM3 inhibits SIV and FLUAV entry in cell culture, although with moderately reduced efficiency as compared to its human counterpart. We further report the identification of 16 polymorphisms in the rhIFITM3 gene, three of which were exonic and synonymous while the remainder was located in non-coding regions. Employing previously characterized samples from two cohorts of SIV-infected rhesus macaques, we investigated the relationship between these rhIFITM3 polymorphisms and both AIDS-free survival time and virus load. In cohort 1, several intronic polymorphisms were significantly associated with virus load or survival. However, an association with both parameters was not observed and significance was lost in most cases when animals were stratified for the presence of MHC allele Mamu-A1*001. Moreover, no significant genotype-phenotype associations were detected in cohort 2. These results suggest that, although IFITM3 can inhibit SIV infection in cell culture, genetic variation in rhIFITM3 might have only a minor impact on the course of SIV infection in experimentally infected animals.	[Winkler, Michael; Gaertner, Sabine; Wrensch, Florian; Poehlmann, Stefan] Leibniz Inst Primate Res, Infect Biol Unit, Deutsch Primatenzentrum, Gottingen, Germany; [Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany; [Sauermann, Ulrike] Leibniz Inst Primate Res, Infect Models Unit, Deutsch Primatenzentrum, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); University of Kiel; Deutsches Primatenzentrum (DPZ)	Winkler, M; Poehlmann, S (corresponding author), Leibniz Inst Primate Res, Infect Biol Unit, Deutsch Primatenzentrum, Gottingen, Germany.	MWinkler@dpz.eu; SPoehlmann@dpz.eu	Krawczak, Michael/A-8964-2010; Pöhlmann, Stefan/H-2395-2011	Krawczak, Michael/0000-0003-2603-1502; Pöhlmann, Stefan/0000-0001-6086-9136; Wrensch, Florian/0000-0002-7258-5453; Winkler, Michael/0000-0002-6198-554X	Leibniz foundation (Graduate School Emerging Infectious Diseases)	Leibniz foundation (Graduate School Emerging Infectious Diseases)	The study was supported by the Leibniz foundation (Graduate School Emerging Infectious Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almen MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031961; Bailey CC, 2013, J BIOL CHEM, V288, P32184, DOI 10.1074/jbc.M113.514356; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Bertram S, 2013, J VIROL, V87, P6150, DOI 10.1128/JVI.03372-12; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chutiwitoonchai N, 2013, MICROBES INFECT, V15, P280, DOI 10.1016/j.micinf.2012.12.003; Compton AA, 2016, EMBO REP, V17, P1657, DOI 10.15252/embr.201642771; Compton AA, 2014, CELL HOST MICROBE, V16, P736, DOI 10.1016/j.chom.2014.11.001; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Diederichs S, 2016, EMBO MOL MED, V8, P442, DOI 10.15252/emmm.201506055; Ding SL, 2014, VIROLOGY, V454, P11, DOI 10.1016/j.virol.2014.01.020; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Foster TL, 2016, CELL HOST MICROBE, V20, P429, DOI 10.1016/j.chom.2016.08.006; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Hens J, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0099-6; Hickford D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-155; Hofmann-Winkler H, 2015, J INFECT DIS, V212, pS172, DOI 10.1093/infdis/jiv101; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Hunt RC, 2014, TRENDS GENET, V30, P308, DOI 10.1016/j.tig.2014.04.006; Javed A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142086; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; Ling SL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24029; Lu J., 2011, J WIREL COMMUN NETWO, V1, P1, DOI DOI 10.1128/JVI.01531-10; Mills TC, 2014, J INFECT DIS, V209, P1028, DOI 10.1093/infdis/jit468; Narayana SK, 2015, J BIOL CHEM, V290, P25946, DOI 10.1074/jbc.M115.657346; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Qian J, 2015, VIROLOGY, V474, P10, DOI 10.1016/j.virol.2014.10.015; Sauermann Ulrike, 2001, Current Molecular Medicine (Hilversum), V1, P515; Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074; Siddiqui RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025474; Smith SE, 2014, CURR OPIN VIROL, V4, P71, DOI 10.1016/j.coviro.2013.11.004; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Tartour K, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0103-y; Wang Y P Q, 2017, J VIROLOGY; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111; Weston S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104341; Wilkins J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156739; Williams DEJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110096; Wrensch F, 2014, VIRUSES-BASEL, V6, P3683, DOI 10.3390/v6093683; Xie MR, 2015, J VIROL, V89, P3049, DOI 10.1128/JVI.03416-14; Xuan Y, 2015, EPIDEMIOL INFECT, V143, P2975, DOI 10.1017/S0950268815000278; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yu JY, 2015, CELL REP, V13, P145, DOI 10.1016/j.celrep.2015.08.055; Zhang Y., 2015, J NANOMATER, V2015, P1, DOI DOI 10.1080/10298436.2015.1019502; Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433; Zhang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049265; Zhao XS, 2014, P NATL ACAD SCI USA, V111, P6756, DOI 10.1073/pnas.1320856111; Zimin AV, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-20	48	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172847	10.1371/journal.pone.0172847	http://dx.doi.org/10.1371/journal.pone.0172847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257482	Green Published, gold			2022-12-26	WOS:000396021100031
J	Saiwaew, S; Sritabal, J; Piaraksa, N; Keayarsa, S; Ruengweerayut, R; Utaisin, C; Sila, P; Niramis, R; Udomsangpetch, R; Charunwatthana, P; Pongponratn, E; Pukrittayakamee, S; Leitgeb, AM; Wahlgren, M; Lee, SJ; Day, NPJ; White, NJ; Dondorp, AM; Chotivanich, K				Saiwaew, Somporn; Sritabal, Juntima; Piaraksa, Nattaporn; Keayarsa, Srisuda; Ruengweerayut, Ronnatrai; Utaisin, Chirapong; Sila, Patima; Niramis, Rangsan; Udomsangpetch, Rachanee; Charunwatthana, Prakaykaew; Pongponratn, Emsri; Pukrittayakamee, Sasithon; Leitgeb, Anna M.; Wahlgren, Mats; Lee, Sue J.; Day, Nicholas P. J.; White, Nicholas J.; Dondorp, Arjen M.; Chotivanich, Kesinee			Effects of sevuparin on rosette formation and cytoadherence of Plasmodium falciparum infected erythrocytes	PLOS ONE			English	Article							MEMBRANE PROTEIN-1 PFEMP1; MICROVASCULAR ENDOTHELIAL-CELLS; MULTIPLE ADHESION MOLECULES; HUMAN CEREBRAL MALARIA; IN-VITRO; PARASITIZED ERYTHROCYTES; HEPARAN-SULFATE; UNCOMPLICATED MALARIA; SEQUESTRATION; RECEPTOR	In severe falciparum malaria cytoadherence of parasitised red blood cells (PRBCs) to vascular endothelium (causing sequestration) and to uninfected red cells (causing rosette formation) contribute to microcirculatory flow obstruction in vital organs. Heparin can reverse the underlying ligand-receptor interactions, but may increase the bleeding risks. As a heparin-derived polysaccharide, sevuparin has been designed to retain anti-adhesive properties, while the antithrombin-binding domains have been eliminated, substantially diminishing its anticoagulant activity. Sevuparin has been evaluated recently in patients with uncomplicated falciparum malaria, and is currently investigated in a clinical trial for sickle cell disease. The effects of sevuparin on rosette formation and cytoadherence of Plasmodium falciparum isolates from Thailand were investigated. Trophozoite stages of P. falciparum-infected RBCs (Pf-iRBCs) were cultured from 49 patients with malaria. Pf-iRBCs were treated with sevuparin at 37 degrees C and assessed in rosetting and in cytoadhesion assays with human dermal microvascular endothelial cells (HDMECs) under static and flow conditions. The proportion of Pf-iRBCs forming rosettes ranged from 6.5% to 26.0% (median = 12.2%). Rosetting was dose dependently disrupted by sevuparin (50% disruption by 250 mu g/mL). Overall 57% of P. falciparum isolates bound to HDMECs under static conditions; median (interquartile range) Pf-iRBC binding was 8.5 (3.0-38.0) Pf-iRBCs/1000 HDMECs. Sevuparin in concentrations >= 100 mu g/mL inhibited cytoadherence. Sevuparin disrupts P. falciparum rosette formation in a dose dependent manner and inhibits cytoadherence to endothelial cells. The data support assessment of sevuparin as an adjunctive treatment to the standard therapy in severe falciparum malaria.	[Saiwaew, Somporn; Sritabal, Juntima; Piaraksa, Nattaporn; Keayarsa, Srisuda; Charunwatthana, Prakaykaew; Pukrittayakamee, Sasithon; Chotivanich, Kesinee] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Ruengweerayut, Ronnatrai] Mae Sot Hosp, Mae Sot, Tak, Thailand; [Utaisin, Chirapong; Sila, Patima] Mae Ramat Hosp, Mae Ramat, Tak, Thailand; [Niramis, Rangsan] Queen Sirikit Natl Inst Child Hlth, Bangkok, Thailand; [Udomsangpetch, Rachanee] Mahidol Univ, Fac Med Technol, Ctr Res & Innovat, Nakhon Pathom, Thailand; [Pongponratn, Emsri] Mahidol Univ, Fac Trop Med, Dept Trop Pathol, Bangkok, Thailand; [Leitgeb, Anna M.] Dilaforette AB, Stockholm, Sweden; [Wahlgren, Mats] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Lee, Sue J.; Day, Nicholas P. J.; White, Nicholas J.; Dondorp, Arjen M.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Lee, Sue J.; Day, Nicholas P. J.; White, Nicholas J.; Dondorp, Arjen M.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England	Mahidol University; Mahidol University; Mahidol University; Karolinska Institutet; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Chotivanich, K (corresponding author), Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand.	nok@tropmedres.ac	White, Nick/AAC-6527-2019	White, Nick/0000-0002-1897-1978	Thailand Research Fund for The Royal Golden Jubilee Ph.D programme [PHD/0231/2552]; Wellcome Trust of Great Britain, United Kingdom	Thailand Research Fund for The Royal Golden Jubilee Ph.D programme; Wellcome Trust of Great Britain, United Kingdom	This study was supported by Thailand Research Fund for The Royal Golden Jubilee Ph.D programme (PHD/0231/2552)-(Main part of the study); this funder had no input on the study design, execution, analysis, or writing of the manuscript. Faculty of Tropical Medicine, Mahidol University, Mahidol-Oxford research unit (MORU), Bangkok, Thailand (this funder had no input on the study design, execution, analysis, or writing of the manuscript) funded by the Wellcome Trust of Great Britain, United Kingdom (this funder had no input on the study design, execution, analysis, or writing of the manuscript), and the Swedish Research Council (VR) (designed the experiments), the Swedish Foundation for Strategic Research (SSF) (designed the experiments), and the Swedish International Development Agency (SIDA) (designed the experiments). Dilaforette AB (designed the experiments, wrote the paper).	Abdi AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep19882; Adams Y, 2005, PARASITOL RES, V97, P290, DOI 10.1007/s00436-005-1426-3; Adams Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073999; Albrecht L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-17; Barragan A, 2000, BLOOD, V95, P3594, DOI 10.1182/blood.V95.11.3594.011k21_3594_3599; Barragan A, 1999, EXP PARASITOL, V91, P133, DOI 10.1006/expr.1998.4349; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Bull PC, 2016, PARASITOLOGY, V143, P171, DOI 10.1017/S0031182015001274; CARLSON J, 1992, AM J TROP MED HYG, V46, P595, DOI 10.4269/ajtmh.1992.46.595; CARLSON J, 1993, SCAND J INFECT DIS, P1; CARLSON J, 1992, J EXP MED, V176, P1311, DOI 10.1084/jem.176.5.1311; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Chen Q, 1998, J EXP MED, V187, P15, DOI 10.1084/jem.187.1.15; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Chen QJ, 2004, VACCINE, V22, P2701, DOI 10.1016/j.vaccine.2004.02.015; Chotivanich K, 2004, J INFECT DIS, V189, P1052, DOI 10.1086/381900; Ghumra A, 2008, J IMMUNOL, V181, P1988, DOI 10.4049/jimmunol.181.3.1988; HO M, 1991, INFECT IMMUN, V59, P873, DOI 10.1128/IAI.59.3.873-878.1991; Ho M, 1999, AM J PHYSIOL-CELL PH, V276, pC1231, DOI 10.1152/ajpcell.1999.276.6.C1231; Hsieh FL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12837; JAROONVESAMA N, 1972, LANCET, V1, P221; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Kyriacou HM, 2007, ANTIMICROB AGENTS CH, V51, P1321, DOI 10.1128/AAC.01216-06; LEECH JH, 1984, J EXP MED, V159, P1567, DOI 10.1084/jem.159.6.1567; Leitgeb AM, 2011, AM J TROP MED HYG, V84, P390, DOI 10.4269/ajtmh.2011.10-0256; Lindgren M, 2015, J THROMB HAEMOST, V13, P369; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Moll K, 2007, INFECT IMMUN, V75, P211, DOI 10.1128/IAI.00749-06; MUNIR M, 1976, Paediatrica Indonesiana, V16, P489; MUNIR M, 1980, Paediatrica Indonesiana, V20, P47; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; OCKENHOUSE CF, 1991, J INFECT DIS, V164, P163, DOI 10.1093/infdis/164.1.163; Omi K, 2003, AM J HUM GENET, V72, P364, DOI 10.1086/346091; Pain A, 2001, P NATL ACAD SCI USA, V98, P1805, DOI 10.1073/pnas.98.4.1805; Pettersson F, 2005, INFECT IMMUN, V73, P7736, DOI 10.1128/IAI.73.11.7736-7746.2005; PONGPONRATN E, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P219; PONGPONRATN E, 1991, AM J TROP MED HYG, V44, P168, DOI 10.4269/ajtmh.1991.44.168; Rampengan T H, 1991, Paediatr Indones, V31, P59; ROBERTS DD, 1985, NATURE, V318, P64, DOI 10.1038/318064a0; Rogerson SJ, 1999, AM J TROP MED HYG, V61, P467, DOI 10.4269/ajtmh.1999.61.467; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; SHEEHY TW, 1967, ANN INTERN MED, V66, P807, DOI 10.7326/0003-4819-66-4-807; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; SILAMUT K, 1993, T ROY SOC TROP MED H, V87, P436, DOI 10.1016/0035-9203(93)90028-O; Skidmore MA, 2008, J MED CHEM, V51, P1453, DOI 10.1021/jm701337t; Smith JD, 2013, CELL MICROBIOL, V15, P1976, DOI 10.1111/cmi.12183; SMITSKAM.H, 1971, BRIT MED J, V1, P714, DOI 10.1136/bmj.1.5751.714; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stevenson L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005022; SWERLICK RA, 1992, J IMMUNOL, V148, P78; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; Udomsangpetch R, 1996, BLOOD, V88, P2754, DOI 10.1182/blood.V88.7.2754.bloodjournal8872754; UDOMSANGPETCH R, 1989, J EXP MED, V169, P1835, DOI 10.1084/jem.169.5.1835; Udomsangpetch R, 1997, J IMMUNOL, V158, P4358; Vogt AM, 2004, BIOCHEM J, V381, P593, DOI 10.1042/BJ20040762; Vogt AM, 2003, BLOOD, V101, P2405, DOI 10.1182/blood-2002-07-2016; Vogt AM, 2006, PLOS PATHOG, V2, P853, DOI 10.1371/journal.ppat.0020100; Wassmer SC, 2011, CELL MICROBIOL, V13, P198, DOI 10.1111/j.1462-5822.2010.01528.x; WHITE NJ, 1992, ADV PARASIT, V31, P83, DOI 10.1016/S0065-308X(08)60021-4; Xiao LH, 1996, INFECT IMMUN, V64, P1373, DOI 10.1128/IAI.64.4.1373-1378.1996; Xiao LH, 1996, EXP PARASITOL, V84, P42, DOI 10.1006/expr.1996.0088; Yipp BG, 2000, BLOOD, V96, P2292, DOI 10.1182/blood.V96.6.2292.h8002292_2292_2298; Yipp BG, 2003, BLOOD, V101, P2850, DOI 10.1182/blood-2002-09-2841	66	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172718	10.1371/journal.pone.0172718	http://dx.doi.org/10.1371/journal.pone.0172718			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249043	gold, Green Published, Green Submitted			2022-12-26	WOS:000395983500052
J	Honjo, K; Munakata, S; Tashiro, Y; Salama, Y; Shimazu, H; Eiamboonsert, S; Dhahri, D; Ichimura, A; Dan, T; Miyata, T; Takeda, K; Sakamoto, K; Hattori, K; Heissig, B				Honjo, Kumpei; Munakata, Shinya; Tashiro, Yoshihiko; Salama, Yousef; Shimazu, Hiroshi; Eiamboonsert, Salita; Dhahri, Douaa; Ichimura, Atsuhiko; Dan, Takashi; Miyata, Toshio; Takeda, Kazuyoshi; Sakamoto, Kazuhiro; Hattori, Koichi; Heissig, Beate			Plasminogen activator inhibitor-1 regulates macrophage-dependent postoperative adhesion by enhancing EGF-HER1 signaling in mice	FASEB JOURNAL			English	Article						small bowel obstruction; epidermal growth factor; PAI-1; plasminogen activator; mesothelial cell	MESOTHELIAL CELLS; PAI-1 EXPRESSION; PREVENTION; MIGRATION; MATRIX; MOLECULE; FIBROSIS; RELEASE	Adhesive small bowel obstruction remains a common problem for surgeons. After surgery, platelet aggregation contributes to coagulation cascade and fibrin clot formation. With clotting, fibrin degradation is simultaneously enhanced, driven by tissue plasminogen activator-mediated cleavage of plasminogen to form plasmin. The aim of this study was to investigate the cellular events and proteolytic responses that surround plasminogen activator inhibitor (PAI-1; Serpine1) inhibition of postoperative adhesion. Peritoneal adhesion was induced by gauze deposition in the abdominal cavity in C57BL/6 mice and those that were deficient in fibrinolytic factors, such as Plat(-/-) and Serpine1(-/-) . In addition, C57BL/6 mice were treated with the novel PAI-1 inhibitor, TM5275. Some animals were treated with clodronate to deplete macrophages. Epidermal growth factor (EGF) experiments were performed to understand the role of macrophages and how EGF contributes to adhesion. In the early phase of adhesive small bowel obstruction, increased PAI-1 activity was observed in the peritoneal cavity. Genetic and pharmacologic PAI-1 inhibition prevented progression of adhesion and increased circulating plasmin. Whereas Serpine1(-/-) mice showed intra-abdominal bleeding, mice that were treated with TM5275 did not. Mechanistically, PAI-1, in combination with tissue plasminogen activator, served as a chemoattractant for macrophages that, in turn, secreted EGF and up-regulated the receptor, HER1, on peritoneal mesothelial cells, which led to PAI-1 secretion, further fueling the vicious cycle of impaired fibrinolysis at the adhesive site. Controlled inhibition of PAI-1 not only enhanced activation of the fibrinolytic system, but also prevented recruitment of EGF-secreting macrophages. Pharmacologic PAI-1 inhibition ameliorated adhesion formation in a macrophage-dependent manner.	[Honjo, Kumpei; Munakata, Shinya; Tashiro, Yoshihiko; Salama, Yousef; Shimazu, Hiroshi; Eiamboonsert, Salita; Dhahri, Douaa; Hattori, Koichi; Heissig, Beate] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Dynam, Tokyo, Japan; [Honjo, Kumpei; Munakata, Shinya; Tashiro, Yoshihiko; Sakamoto, Kazuhiro] Juntendo Univ, Grad Sch Med, Dept Coloproctol Surg, Tokyo, Japan; [Hattori, Koichi] Juntendo Univ, Grad Sch Med, Fac Med, Ctr Genom & Regenerat Med, Tokyo, Japan; [Takeda, Kazuyoshi; Heissig, Beate] Juntendo Univ, Grad Sch Med, Dept Immunol, Tokyo, Japan; [Takeda, Kazuyoshi; Heissig, Beate] Juntendo Univ, Grad Sch Med, Atopy Ctr, Tokyo, Japan; [Ichimura, Atsuhiko; Dan, Takashi; Miyata, Toshio] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Sendai, Miyagi, Japan	University of Tokyo; Juntendo University; Juntendo University; Juntendo University; Juntendo University; Tohoku University	Heissig, B (corresponding author), IMSUT, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Dynam, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	heissig@ims.u-tokyo.ac.jp	Miyata, Toshio/A-4872-2010; Heissig, Beate/AAF-6771-2021; Hattori, Koichi/AAF-6862-2021; Al-Dhahri, Douaa/AAA-8324-2019; salama, Yousef/AAP-8365-2021	Heissig, Beate/0000-0002-0348-5934; Shimazu, Hiroshi/0000-0002-1240-936X; Ichimura, Atsuhiko/0000-0003-0366-5211; AL-Dhahri, Douaa/0000-0003-0141-1728; Salama, Yousef/0000-0001-6254-6381	Japan Society for the Promotion of Science [16K09821, 26461415]; Start-Up Grant [15H06603]; Wakate B Grant [15K21373]; Ministry of Education, Culture, Sports, Science and Technology [18013021];  [22112007]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Start-Up Grant; Wakate B Grant; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	The authors thank Robert Whittier (Juntendo University Faculty of Medicine) for kindly providing editorial assistance to the authors during the preparation of this manuscript. The authors thank the Division of Molecular and Biochemical Research, Research Support Center (Juntendo University Graduate School of Medicine) for technical assistance. This work was supported, in part, by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science [Kiban-C Grant 16K09821 (to B.H.), Grant 26461415 (to K.H.), Start-Up Grant 15H06603 (to S.M.), and Wakate B Grant 15K21373 (to Y.T.)], and by Grants-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology (Grant 18013021; to B.H.), and Grants-in-Aid for Scientific Research on Innovative Areas (Grant 22112007; to B.H.).	Asano T, 2005, BJU INT, V96, P1409, DOI 10.1111/j.1464-410X.2005.05816.x; Bauman KA, 2010, J CLIN INVEST, V120, P1950, DOI 10.1172/JCI38369; Burnett SH, 2006, J SURG RES, V131, P296, DOI 10.1016/j.jss.2005.08.026; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Cho HJ, 2009, J CELL BIOCHEM, V107, P335, DOI 10.1002/jcb.22130; diZeregal GS, 2001, HUM REPROD UPDATE, V7, P547, DOI 10.1093/humupd/7.6.547; Eddy AA, 2009, THROMB HAEMOSTASIS, V101, P656, DOI 10.1160/TH08-12-0779; Ergul Emre, 2008, Int J Surg, V6, P253, DOI 10.1016/j.ijsu.2007.05.010; FUKASAWA M, 1989, J SURG RES, V46, P256, DOI 10.1016/0022-4804(89)90067-X; Heissig B, 2016, ADV DRUG DELIVER REV, V99, P172, DOI 10.1016/j.addr.2015.11.010; Higgins Stephen P, 2009, Cell Commun Insights, V2, P1; HillWest JL, 1995, J SURG RES, V59, P759, DOI 10.1006/jsre.1995.1236; Holmdahl L, 1997, EUR J SURG, V163, P24; Holmdahl L, 2001, SURGERY, V129, P626, DOI 10.1067/msy.2001.113039; Ichimura A, 2013, ARTERIOSCL THROM VAS, V33, P935, DOI 10.1161/ATVBAHA.113.301224; Izuhara Y, 2010, J CEREBR BLOOD F MET, V30, P904, DOI 10.1038/jcbfm.2009.272; Jankun Jerzy, 2013, Cardiovascular & Hematological Disorders - Drug Targets, V13, P144; Kalff JC, 1998, ANN SURG, V228, P652, DOI 10.1097/00000658-199811000-00004; Kosaka H, 2008, NAT MED, V14, P437, DOI 10.1038/nm1733; Lin L, 2014, AM J PATHOL, V184, P2757, DOI 10.1016/j.ajpath.2014.06.013; Maciver AH, 2011, INT J SURG, V9, P589, DOI 10.1016/j.ijsu.2011.08.008; MENZIES D, 1991, SURG GYNECOL OBSTET, V172, P362; Munakata S, 2015, GASTROENTEROLOGY, V148, P565, DOI 10.1053/j.gastro.2014.12.001; Ohki M, 2010, BLOOD, V115, P4302, DOI 10.1182/blood-2009-08-236851; Paugh BS, 2008, FASEB J, V22, P455, DOI 10.1096/fj.07-8276com; Samarakoon R, 2005, J CELL PHYSIOL, V204, P236, DOI 10.1002/jcp.20279; Sato A, 2015, LEUKEMIA, V29, P145, DOI 10.1038/leu.2014.151; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Sulaiman H, 2002, BIOCHEM SOC T, V30, P126, DOI 10.1042/BST0300126; Szaba FM, 2002, BLOOD, V99, P1053, DOI 10.1182/blood.V99.3.1053; Tjarnstrom J, 1999, EUR J SURG, V165, P834; VANHINSBERGH VWM, 1990, BLOOD, V75, P1490; Wang L, 2016, J AM SOC NEPHROL, V27, P2631, DOI 10.1681/ASN.2015030299; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wyrzykowska P, 2010, BBA-GENE REGUL MECH, V1799, P616, DOI 10.1016/j.bbagrm.2010.08.004	36	30	31	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2625	2637		10.1096/fj.201600871RR	http://dx.doi.org/10.1096/fj.201600871RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28270519	Green Submitted			2022-12-26	WOS:000401553400033
J	Dellicour, S; Gerard, M; Prunier, JG; Dewulf, A; Kuhlmann, M; Michez, D				Dellicour, Simon; Gerard, Maxence; Prunier, Jerome G.; Dewulf, Alexandre; Kuhlmann, Michael; Michez, Denis			Distribution and predictors of wing shape and size variability in three sister species of solitary bees	PLOS ONE			English	Article							IN-FLIGHT MORPHOLOGY; BODY-SIZE; PHENOTYPIC PLASTICITY; MORPHOMETRIC-ANALYSIS; GEOGRAPHIC-VARIATION; GENETIC-VARIATION; R-PACKAGE; HYMENOPTERA; POPULATIONS; EVOLUTION	Morphological traits can be highly variable over time in a particular geographical area. Different selective pressures shape those traits, which is crucial in evolutionary biology. Among these traits, insect wing morphometry has already been widely used to describe phenotypic variability at the inter-specific level. On the contrary, fewer studies have focused on intraspecific wing morphometric variability. Yet, such investigations are relevant to study potential convergences of variation that could highlight micro-evolutionary processes. The recent sampling and sequencing of three solitary bees of the genus Melitta across their entire species range provides an excellent opportunity to jointly analyse genetic and morphometric variability. In the present study, we first aim to analyse the spatial distribution of the wing shape and centroid size (used as a proxy for body size) variability. Secondly, we aim to test different potential predictors of this variability at both the intra- and inter-population levels, which includes genetic variability, but also geographic locations and distances, elevation, annual mean temperature and precipitation. The comparison of spatial distribution of intrapopulation morphometric diversity does not reveal any convergent pattern between species, thus undermining the assumption of a potential local and selective adaptation at the population level. Regarding intra-specific wing shape differentiation, our results reveal that some tested predictors, such as geographic and genetic distances, are associated with a significant correlation for some species. However, none of these predictors are systematically identified for the three species as an important factor that could explain the intra-specific morphometric variability. As a conclusion, for the three solitary bee species and at the scale of this study, our results clearly tend to discard the assumption of the existence of a common pattern of intra-specific signal/structure within the intra-specific wing shape and body size variability.	[Dellicour, Simon] Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, Minderbroedersstaat 10, Leuven, Belgium; [Gerard, Maxence; Dewulf, Alexandre; Michez, Denis] Univ Mons, Res Inst Biosci, Lab Zool, Pl Parc 23, Mons, Belgium; [Prunier, Jerome G.] Univ Toulouse, CNRS, Stn Ecol Theor & Expt, Moulis, France; [Kuhlmann, Michael] Univ Kiel, Zool Museum, Hegewischstr 3, Kiel, Germany; [Kuhlmann, Michael] Nat Hist Museum, Dept Life Sci, Cromwell Rd, London, England	KU Leuven; University of Mons; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Kiel; Natural History Museum London	Dellicour, S (corresponding author), Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, Minderbroedersstaat 10, Leuven, Belgium.	simon.dellicour@kuleuven.be	Prunier, Jérôme G./H-4332-2019; Dellicour, Simon/AAE-9054-2020; Michez, Denis/L-1370-2019	Prunier, Jérôme G./0000-0003-4110-2567; Dellicour, Simon/0000-0001-9558-1052; Michez, Denis/0000-0001-8880-1838; Gerard, Maxence/0000-0002-2485-0662	Belgian Fonds pour la Recherche Scientifique (FRS-FNRS) [FRFC 2.4613.10]; Fonds Wetenschappelijk Onderzoek (FWO, Flanders, Belgium); Belgian Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA)	Belgian Fonds pour la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds Wetenschappelijk Onderzoek (FWO, Flanders, Belgium)(FWO); Belgian Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS)	This research project was funded by the Belgian Fonds pour la Recherche Scientifique (FRS-FNRS; FRFC 2.4613.10). SD is a postdoctoral research fellow funded by the Fonds Wetenschappelijk Onderzoek (FWO, Flanders, Belgium) and MG is supported by a grant from the Belgian Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Allen J. A., 1877, Radical Review, Vi, P108; Angilletta MJ, 2003, AM NAT, V162, P332; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Berwaerts K, 2002, FUNCT ECOL, V16, P484, DOI 10.1046/j.1365-2435.2002.00650.x; Bitner-Mathe BC, 1999, HEREDITY, V83, P688, DOI 10.1038/sj.hdy.6886060; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bots J, 2009, CAN J ZOOL, V87, P86, DOI 10.1139/Z08-141; Cardini A, 2007, J BIOGEOGR, V34, P1663, DOI 10.1111/j.1365-2699.2007.01731.x; Cassel-Lundhagen A, 2009, ECOGRAPHY, V32, P591, DOI 10.1111/j.1600-0587.2008.05685.x; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Clemente-Carvalho RBG, 2011, MOL PHYLOGENET EVOL, V61, P79, DOI 10.1016/j.ympev.2011.05.017; May-Itza WD, 2010, CONSERV GENET, V11, P2079, DOI 10.1007/s10592-010-0087-7; Dellicour S, 2015, MOL ECOL, V24, P1074, DOI 10.1111/mec.13085; Dellicour S, 2014, MOL ECOL RESOUR, V14, P647, DOI 10.1111/1755-0998.12200; Dellicour S, 2014, MOL PHYLOGENET EVOL, V70, P412, DOI 10.1016/j.ympev.2013.08.013; Demirci B, 2012, J VECTOR ECOL, V37, P197, DOI 10.1111/j.1948-7134.2012.00217.x; Dillon ME, 2006, INTEGR COMP BIOL, V46, P49, DOI 10.1093/icb/icj007; Dinca V, 2011, MOL ECOL, V20, P3921, DOI 10.1111/j.1365-294X.2011.05223.x; Fields Development Team, 2006, FIELDS TOOLS SPATIAL; Francuski L, 2013, ANN ZOOL FENN, V50, P262, DOI 10.5735/085.050.0502; Frankino WA, 2005, SCIENCE, V307, P718, DOI 10.1126/science.1105409; Frazier MR, 2008, J EXP BIOL, V211, P2116, DOI 10.1242/jeb.019422; Garnier S, 2005, J EVOLUTION BIOL, V18, P269, DOI 10.1111/j.1420-9101.2004.00854.x; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Grimaldi David, 2005, pi; Habel JC, 2012, J INSECT CONSERV, V16, P571, DOI 10.1007/s10841-011-9442-3; Harrison JF, 2000, ANNU REV PHYSIOL, V62, P179, DOI 10.1146/annurev.physiol.62.1.179; Hartl DL, 2007, PRINCIPLES POPULATIO, P565; HAWKINS BA, 1995, ECOL ENTOMOL, V20, P195, DOI 10.1111/j.1365-2311.1995.tb00446.x; HAWKINS BA, 1995, OECOLOGIA, V102, P31, DOI 10.1007/BF00333307; HEINRICH B, 1974, SCIENCE, V185, P747, DOI 10.1126/science.185.4153.747; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann AA, 2002, EVOLUTION, V56, P1068, DOI 10.1111/j.0014-3820.2002.tb01418.x; Johansson F, 2009, BIOL J LINN SOC, V97, P362, DOI 10.1111/j.1095-8312.2009.01211.x; Klepsatel P, 2014, EVOLUTION, V68, P1385, DOI 10.1111/evo.12351; Kolliker-Ott UM, 2003, OIKOS, V100, P563, DOI 10.1034/j.1600-0706.2003.12063.x; Lima CBS, 2014, SOCIOBIOLOGY, V61, P478; Loh R, 2005, GENETICA, V125, P271, DOI 10.1007/s10709-005-0367-1; Loh R, 2008, J GENET, V87, P209, DOI 10.1007/s12041-008-0034-2; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Matta BP, 2004, HEREDITY, V93, P330, DOI 10.1038/sj.hdy.6800508; Merckx T, 2006, OIKOS, V113, P226, DOI 10.1111/j.2006.0030-1299.14501.x; Michez D, 2009, ZOOL SCR, V38, P171, DOI 10.1111/j.1463-6409.2008.00362.x; Michez D, 2007, ANN SOC ENTOMOL FR, V43, P379, DOI 10.1080/00379271.2007.10697535; Milankov V, 2009, ZOOL J LINN SOC-LOND, V155, P819, DOI 10.1111/j.1096-3642.2008.00462.x; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Miller MP, 2006, MOL ECOL, V15, P145, DOI 10.1111/j.1365-294X.2005.02765.x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NEWTON RG, 1967, APPLIED STATISTICS, V16, P51; Nimon K, 2008, BEHAV RES METHODS, V40, P457, DOI 10.3758/BRM.40.2.457; Oleksa A, 2015, APIDOLOGIE, V46, P49, DOI 10.1007/s13592-014-0300-7; Outomuro D, 2013, J EVOLUTION BIOL, V26, P1866, DOI 10.1111/jeb.12203; Outomuro D, 2011, BIOL J LINN SOC, V102, P263, DOI 10.1111/j.1095-8312.2010.01591.x; Peat J, 2005, FUNCT ECOL, V19, P145, DOI 10.1111/j.0269-8463.2005.00946.x; Perrard A, 2014, J EVOLUTION BIOL, V27, P2665, DOI 10.1111/jeb.12523; Pizzo A, 2006, BIOL J LINN SOC, V89, P197, DOI 10.1111/j.1095-8312.2006.00674.x; Prunier JG, 2015, MOL ECOL, V24, P263, DOI 10.1111/mec.13029; Ray RP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10851; Ray-Mukherjee J, 2014, METHODS ECOL EVOL, V5, P320, DOI 10.1111/2041-210X.12166; Ricklefs RE, 2004, NATURE, V430, P338, DOI 10.1038/nature02700; Roggero A., 2005, SHILAP Revista de Lepidopterologia, V33, P101; Rohlf F.J., 2013, TPS SMALL VERSION 1; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Rohlf FJ, 2013, TPS DIG 2 17; Rohlf FJ, 2013, TPS UTIL PROGRAM VER; Shelomi M, 2012, AM NAT, V180, P511, DOI 10.1086/667595; Sota T, 2000, POPUL ECOL, V42, P279, DOI 10.1007/PL00012006; Stillwell RC, 2008, EVOLUTION, V62, P2534, DOI 10.1111/j.1558-5646.2008.00467.x; Stillwell RC, 2007, AM NAT, V170, P358, DOI 10.1086/520118; Tynkkynen K, 2004, J EVOLUTION BIOL, V17, P759, DOI 10.1111/j.1420-9101.2004.00733.x; Vargas REM, 2010, INFECT GENET EVOL, V10, P580, DOI 10.1016/j.meegid.2010.01.004; Wainwright PC, 2007, ANNU REV ECOL EVOL S, V38, P381, DOI 10.1146/annurev.ecolsys.38.091206.095706; Wakeling JM, 1997, J EXP BIOL, V200, P543; Wang IJ, 2013, EVOLUTION, V67, P3403, DOI 10.1111/evo.12134; WATSON DF, 1985, GEO-PROCESSING, V2, P315; Watson DF, 1992, CONTOURING GUIDE ANA; WOOTTON RJ, 1992, ANNU REV ENTOMOL, V37, P113, DOI 10.1146/annurev.en.37.010192.000553; Wright S, 1943, GENETICS, V28, P114; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	80	22	22	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173109	10.1371/journal.pone.0173109	http://dx.doi.org/10.1371/journal.pone.0173109			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273178	gold, Green Submitted, Green Published			2022-12-26	WOS:000396073700039
J	Dias, IR; Haddad, CFB; Argolo, AJS; Orrico, VGD				Dias, Iuri Ribeiro; Baptista Haddad, Celio Fernando; Suzart Argolo, Antonio Jorge; Dill Orrico, Victor Goyannes			The 100th: An appealing new species of Dendropsophus (Amphibia: Anura: Hylidae) from northeastern Brazil	PLOS ONE			English	Article							ATLANTIC RAIN-FOREST; SOUTHERN BAHIA; PHYLOGENETIC-RELATIONSHIPS; ELEGANS ANURA; AMAZON BASIN; TREEFROG; FROGS; STATE	We describe a new species of the Dendropsophus leucophyllatus Group from the Atlantic Forest of the southern region of State of Bahia, Brazil. It can be distinguished from all species of the D. leucophyllatus Group on the basis of morphological characters (especially its unique dorsal pattern and snout in dorsal view), advertisement calls and divergence in mitochondrial DNA gene sequences. The inclusion of D. anceps on the group remains controversial but our phylogenetic analyses do not recover the new species as sister to syntopic species of the D. leucophyllatus Group (with or without D. anceps). These results also highlight the palimpsest that is past relation between the Atlantic and Amazon forests.	[Dias, Iuri Ribeiro; Suzart Argolo, Antonio Jorge] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil; [Dias, Iuri Ribeiro; Dill Orrico, Victor Goyannes] Univ Estadual Santa Cruz, Programa Posgrad Zool, Ilheus, BA, Brazil; [Baptista Haddad, Celio Fernando] Univ Estadual Paulista, Dept Zool, Inst Biociencias, Campus Rio Claro, Sao Paulo, Brazil; [Baptista Haddad, Celio Fernando] Ctr Aquicultura CAUNESP, Campus Rio Claro, Sao Paulo, Brazil	Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz; Universidade de Sao Paulo; Universidade Estadual Paulista	Dias, IR (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil.; Dias, IR (corresponding author), Univ Estadual Santa Cruz, Programa Posgrad Zool, Ilheus, BA, Brazil.	iurirdias@hotmail.com	Haddad, Célio F. B./C-4267-2012; Dias, Iuri Ribeiro/AAC-8099-2019; Argolo, Antônio/AAQ-3403-2021; Orrico, Victor G. D./G-9796-2012; Fapesp, Biota/F-8655-2017	Haddad, Célio F. B./0000-0002-7044-5764; Dias, Iuri Ribeiro/0000-0002-2825-3494; Orrico, Victor G. D./0000-0002-4560-4006; Fapesp, Biota/0000-0002-9887-8449	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [404417/2015-9, 150372/2016-7]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP [2007/57067-9, 2012/12500-5, 2008/50928-1, 2013/50741-7]; Fundacao o Boticario de Protecao a Natureza [0991_20132]; CNPq; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/57067-9, 2012/12500-5]; FAPESP [2008/50928-1, 2013/50741-7]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao o Boticario de Protecao a Natureza; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Scholarships were provided by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Project: 404417/2015-9 and Process: #150372/2016-7) to IRD and by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP-#2007/57067-9; #2012/12500-5; #2008/50928-1 and #2013/50741-7 (P.I. Cello F. B. Haddad) and Fundacao o Boticario de Protecao a Natureza (0991_20132) partially funded this study. Cello Haddad thanks to CNPq for a research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank J.D. Lynch (ICN), J.M. Daza (MHUA), S. Ron (QCAZ), L.B. Nascimento (MCNAM), H. da Silva (UFRRJ), U. Caramaschi and J.P. Pombal jr (MNRJ), T. Grant and H. Zaher (MZUSP), and R.W. Heyer (USNM) for access to collections under their care. To P. Taucce, Maria Lucia Del-Grande and C. Cassini for help during the development of this manuscript. To Antonio L. A. Neto, Juliana A. de Jesus, Marcelo Sena, Marcos V. Nova and Tadeu T. Medeiros for the field assistance. To J. Faivovich, Juan M. Guayasamin and an anonymous reviewer for invaluable comments on previous versions of this manuscript. Scholarships were provided by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to IRD and by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP #2007/57067-9 and # 2012/12500-5) to VGDO. Grants by FAPESP #2008/50928-1, #2013/50741-7 (P.I. Celio Haddad) and Fundacao o Boticario de Protecao a Natureza (0991_20132) partially funded this study. Celio Haddad thanks to CNPq for a research fellowship.	Bastos Rogerio Pereira, 1995, Naturalia (Rio Claro), V20, P165; Bastos RP, 1996, J HERPETOL, V30, P355, DOI 10.2307/1565172; Batista A, 2014, ZOOTAXA, V3826, P449, DOI 10.11646/zootaxa.3826.3.2; BOKERMANN W. C. A., 1966, REV BRASIL BIOL, V26, P15; Caldwell JP, 2005, OCCASIONAL PAPERS SA, V16, P1; Camurugi F, 2010, BIOTA NEOTROP, V10, P305, DOI 10.1590/S1676-06032010000200032; Canedo C, 2004, HERPETOLOGICA, V60, P495, DOI 10.1655/03-66; Canedo C, 2012, MOL PHYLOGENET EVOL, V65, P610, DOI 10.1016/j.ympev.2012.07.016; Caramaschi U, 2013, HERPETOLOGICA, V69, P480; Caramaschi U, 2012, ZOOLOGIA-CURITIBA, V29, P343, DOI 10.1590/S1984-46702012000400007; Carcerelli LC, 1992, REV BRAS BIOL, V52, P415; Carvalho-e-Silva Sergio Potsch, 2003, Rev. Bras. Zool., V20, P553, DOI 10.1590/S0101-81752003000300029; Cochran D.M., 1970, B US NATL MUSEUM, V288, P1, DOI DOI 10.5962/BHL.PART.6346; Conte CE, 2010, BIOTA NEOTROP, V10, P201, DOI 10.1590/S1676-06032010000200024; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Cruz Carlos Alberto Goncalves, 2007, South American Journal of Herpetology, V2, P47, DOI 10.2994/1808-9798(2007)2[47:ANSOCA]2.0.CO;2; da Silva Muniz Sergio Luiz, 2016, Herpetology Notes, V9, P99; De La Riva Ignacio, 1997, Amphibia-Reptilia, V18, P433, DOI 10.1163/156853897X00486; de Sa RO, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-241; Dias Iuri Ribeiro, 2014, Herpetology Notes, V7, P627; Dias IR, 2014, ZOOKEYS, P105, DOI 10.3897/zookeys.449.7494; DUELLMAN W E, 1978, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Duellman W. E., 1966, University of Kansas Publications of the Museum of Natural History, V17, P263; Duellman W.E., 1970, Monograph Mus nat Hist Univ Kans, V1, P1; Duellman W. E., 2001, MONOGRAPHS MUSEUM NA, V1-2, P1; Duellman W. E., 1986, BIOL AMPHIBIANS; DUELLMAN WE, 1983, COPEIA, P639, DOI 10.2307/1444328; DUELLMAN WILLIAM E., 1967, HERPETOLOGICA, V23, P169; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Fernandes DS, 2004, HERPETOLOGICA, V60, P245, DOI 10.1655/02-85; Ferreira RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142893; Fouquet A, 2011, ZOOTAXA, P59, DOI 10.11646/zootaxa.3035.1.3; Fouquet A, 2014, J BIOGEOGR, V41, P855, DOI 10.1111/jbi.12250; Fouquet A, 2012, MOL PHYLOGENET EVOL, V65, P547, DOI 10.1016/j.ympev.2012.07.012; Frost D. R., 2016, AMPHIBIANS SPECIES W; Gehara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103958; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gomes F.B.R., 2006, CHECK LIST, V2, P22; HEYER W R, 1990, Arquivos de Zoologia (Sao Paulo), V31, P231; IZECKSOHN E, 1981, Revista Brasileira de Biologia, V41, P19; Izecksohn E, 2001, ANFIBIOS MUNICIPIO R; Junca FA, 2008, ZOOTAXA, P61, DOI 10.11646/zootaxa.1907.1.4; Jungfer KH, 2010, SALAMANDRA, V46, P204; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lescure J, 2000, PATRIMOINES NATURELS, V45, P1; Lutz B., 1973, pi; MARQUEZ R, 1993, BIOTROPICA, V25, P426, DOI 10.2307/2388866; Martins I. A., 2003, Braz. J. Biol., V63, P507, DOI 10.1590/S1519-69842003000300017; Miller M.A., 2010, P GAT COMP ENV WORKS; Morais AR, 2012, HERPETOL J, V22, P249; Motta AP, 2012, ZOOTAXA, P18, DOI 10.11646/zootaxa.3249.1.2; MYERS C W, 1982, American Museum Novitates, P1; Napoli M., 1998, B MUS NAC NOVA SER Z, V391, P1; Napoli MF, 2011, ZOOTAXA, P37; Napoli MF, 2011, ZOOTAXA, P33, DOI 10.11646/zootaxa.2739.1.3; Orrico VGD, 2014, ZOOTAXA, V3881, P341, DOI 10.11646/zootaxa.3881.4.3; Orrico VGD, 2013, J HERPETOL, V47, P615, DOI 10.1670/12-208; Peloso PLV, 2016, S AM J HERPETOL, V11, P66, DOI 10.2994/SAJH-D-16-00003.1; Rambaut A., 2014, TRACER V1 6; Recoder RS, 2010, ZOOTAXA, P36; Rivera-Correa M, 2013, ZOOTAXA, V3686, P447, DOI 10.11646/zootaxa.3686.4.3; Rodriguez LO., 1994, GUIDE FROGS IQUITOS; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SAVAGE J M, 1967, Beitraege zur Neotropischen Fauna, V5, P111; Savage Jay M., 1997, Herpetological Review, V28, P131; Savage Jay M., 2002, pi; Silvano DL, 2003, CORREDOR BIODIVERSID; Teixeira M, 2012, ZOOTAXA, P25; Teixeira M, 2013, ZOOTAXA, V3702, P459, DOI 10.11646/zootaxa.3702.5.5; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WELLS KD, 1981, COPEIA, P615; Zina J, 2014, BRAZ J BIOL, V74, P146, DOI 10.1590/1519-6984.22912	73	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171678	10.1371/journal.pone.0171678	http://dx.doi.org/10.1371/journal.pone.0171678			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273092	Green Published, gold, Green Submitted			2022-12-26	WOS:000396073700059
J	Matsubara, Y; Kimachi, M; Fukuma, S; Onishi, Y; Fukuhara, S				Matsubara, Yukiko; Kimachi, Miho; Fukuma, Shingo; Onishi, Yoshihiro; Fukuhara, Shunichi			Development of a new risk model for predicting cardiovascular events among hemodialysis patients: Population-based hemodialysis patients from the Japan Dialysis Outcome and Practice Patterns Study (J-DOPPS)	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CONGESTIVE-HEART-FAILURE; CORONARY-ARTERY DISEASE; MORTALITY RISK; MINERAL METABOLISM; UNITED-STATES; ATHEROSCLEROSIS; ASSOCIATION; CALCIUM; ANEMIA	Background Cardiovascular (CV) events are the primary cause of death and becoming bedridden among hemodialysis (HD) patients. The Framingham risk score (FRS) is useful for predicting incidence of CV events in the general population, but is considerd to be unsuitable for the prediction of the incidence of CV events in HD patients, given their characteristics due to atypical relationships between conventional risk factors and outcomes. We therefore aimed to develop a new prognostic prediction model for prevention and early detection of CV events among hemodialysis patients. Methods We enrolled 3,601 maintenance HD patients based on their data from the Japan Dialysis Outcomes and Practice Patterns Study (J-DOPPS), phases 3 and 4. We longitudinaly assessed the association between several potential candidate predictors and composite CV events in the year after study initiation. Potential candidate predictors included the component factors of FRS and other HD-specific risk factors. We used multivariable logistic regression with backward stepwise selection to develop our new prediction model and generated a calibration plot. Additinially, we performed bootstrapping to assess the internal validity. Results We observed 328 composite CV events during 1-year follow-up. The final prediction model contained six variables: age, diabetes status, history of CV events, dialysis time per session, and serum phosphorus and albumin levels. The new model showed significantly better discrimination than the FRS, in both men (c-statistics: 0.76 for new model, 0.64 for FRS) and women (c-statistics: 0.77 for new model, 0.60 for FRS). Additionally, we confirmed the consistency between the observed results and predicted results using the calibration plot. Further, we found similar discrimination and calibration to the derivation model in the boot-strapping cohort. Conclusions We developed a new risk model consisting of only six predictors. Our new model predicted CV events more accurately than the FRS.	[Matsubara, Yukiko] Akane Fdn Omachi Tsuchiya Clin, Dept Artificial Organs, Hiroshima, Japan; [Matsubara, Yukiko] Hiroshima Med Univ, Hiroshima, Japan; [Kimachi, Miho; Fukuma, Shingo; Fukuhara, Shunichi] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan; [Kimachi, Miho; Fukuma, Shingo; Onishi, Yoshihiro] IHope Int, Inst Hlth Outcomes & Proc Evaluat Res, Kyoto, Japan; [Fukuma, Shingo; Fukuhara, Shunichi] Fukushima Med Univ, Ctr Innovat Res Communities & Clin Excellence, Fukushima, Japan	Hiroshima University; Kyoto University; Fukushima Medical University	Fukuma, S (corresponding author), Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan.	fukuma.shingo.3m@kyoto-u.ac.jp	Fukuma, Shingo/S-6584-2019	Fukuma, Shingo/0000-0002-8379-8761				Akdag I, 2008, NEPHRON CLIN PRACT, V108, pC99, DOI 10.1159/000113526; Beddhu S, 2004, J AM SOC NEPHROL, V15, P733, DOI 10.1097/01.ASN.0000113319.57131.28; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; Canaud B, 2011, CLIN J AM SOC NEPHRO, V6, P1651, DOI 10.2215/CJN.03530410; Cavanaugh KL, 2008, AM J KIDNEY DIS, V52, P118, DOI 10.1053/j.ajkd.2008.02.001; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; DEGOULET P, 1982, NEPHRON, V31, P103, DOI 10.1159/000182627; Floege J, 2015, KIDNEY INT, V87, P996, DOI 10.1038/ki.2014.419; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Frank H, 2004, KIDNEY INT, V66, P832, DOI 10.1111/j.1523-1755.2004.00810.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goodkin DA, 2004, AM J KIDNEY DIS, V44, pS16, DOI 10.1053/j.akjd.2004.08.006; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Herzog CA, 2011, KIDNEY INT, V80, P572, DOI 10.1038/ki.2011.223; Huang JC, 2013, NEPHROLOGY, V18, P510, DOI 10.1111/nep.12094; Iaina A, 2005, NAT CLIN PRACT CARD, V2, P95, DOI 10.1038/ncpcardio0094; Johansen KL, 2015, BLOOD PURIFICAT, V40, P288, DOI 10.1159/000441575; Joki N, 1997, NEPHROL DIAL TRANSPL, V12, P718, DOI 10.1093/ndt/12.4.718; Jurkovitz C, 2006, CURR OPIN NEPHROL HY, V15, P117, DOI 10.1097/01.mnh.0000214769.11609.2d; KNOTTNERUS JA, 1995, PRIMARY CARE, V22, P341; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LINDNER A, 1974, NEW ENGL J MED, V290, P697, DOI 10.1056/NEJM197403282901301; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Murtagh FEM, 2007, NEPHROL DIAL TRANSPL, V22, P1955, DOI 10.1093/ndt/gfm153; Ohtake T, 2005, J AM SOC NEPHROL, V16, P1141, DOI 10.1681/ASN.2004090765; Okwuosa TM, 2011, J AM COLL CARDIOL, V57, P1838, DOI 10.1016/j.jacc.2010.11.053; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Shoji T, 2011, CLIN J AM SOC NEPHRO, V6, P1112, DOI 10.2215/CJN.09961110; Silverberg DS, 2003, KIDNEY INT, V64, pS40, DOI 10.1046/j.1523-1755.64.s87.7.x; Silverberg DS, 2003, NEPHROL DIAL TRANSPL, V18, P141, DOI 10.1093/ndt/18.1.141; Stack AG, 2001, J AM SOC NEPHROL, V12, P1516, DOI 10.1681/ASN.V1271516; Steyerberg EW, 2005, J CLIN EPIDEMIOL, V58, P383, DOI 10.1016/j.jclinepi.2004.07.008; Steyerberg EW, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.2005.07.008; Steyerberg EW, 1999, J CLIN EPIDEMIOL, V52, P935, DOI 10.1016/S0895-4356(99)00103-1; Sumida K, 2016, NEPHROL DIAL TRANSPL, V31, P298, DOI 10.1093/ndt/gfv402; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Wang JL, 2012, NEPHRON CLIN PRACT, V121, pC102, DOI 10.1159/000345159; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Xiao JB, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0089097, 10.1155/2014/584164, 10.1371/journal.pone.0093842]; Young EW, 2000, KIDNEY INT, V57, pS74, DOI 10.1046/j.1523-1755.2000.07413.x; Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x	45	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173468	10.1371/journal.pone.0173468	http://dx.doi.org/10.1371/journal.pone.0173468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273175	Green Published, gold, Green Submitted			2022-12-26	WOS:000396073700008
J	Tornbom, K; Sunnerhagen, KS; Danielsson, A				Tornbom, Karin; Sunnerhagen, Katharina S.; Danielsson, Anna			Perceptions of physical activity and walking in an early stage after stroke or acquired brain injury	PLOS ONE			English	Article							QUALITATIVE CONTENT-ANALYSIS; PERCEIVED BARRIERS; REHABILITATION; EXERCISE; SURVIVORS; FACILITATORS; INDIVIDUALS; PERFORMANCE; POPULATION; INTERVIEWS	Background Physical activity has been established as being highly beneficial for health after stroke. There are considerable global efforts to find rehabilitation programs that encourage increased physical activity for persons with stroke. However, many persons with stroke or acquired brain injury do not reach recommended levels of physical activity and increased knowledge about why is needed. We aimed to explore views and experiences of physical activity and walking among persons with stroke or acquired brain injury. Method A qualitative study was conducted, among persons with stroke (n = 8) or acquired brain injury (n = 2) from a rehabilitation unit at Sahlgrenska University Hospital in Sweden. Semi-structured in-depth interviews were held about perceptions and experiences of walking and physical activity in general. Data were analyzed using qualitative content analysis, with categories that were determined inductively. Results Physical activity in general and walking ability more specifically were considered very important by the participants. However, physical activity was, regardless of exercising habits pre-injury, associated with different kinds of negative feelings and experiences. Commonly reported internal barriers in the current study were; fatigue, fear of falling or getting hurt in traffic, lack of motivation and depression. Reported external barriers were mostly related to walking, for example; bad weather, uneven ground, lack of company or noisy or too busy surroundings. Conclusion Persons with stroke or acquired brain injury found it difficult to engage in and sustain an eligible level of physical activity. Understanding individual concerns about motivators and barriers surrounding physical activity may facilitate the work of forming tailor-made rehabilitation for these groups, so that the levels of physical activity and walking can increase.	[Tornbom, Karin; Sunnerhagen, Katharina S.; Danielsson, Anna] Univ Gothenburg, Sahlgrenska Acad, Res Grp Rehabil Med, Inst Neurosci & Physiol,Dept Clin Neurosci, Gothenburg, Sweden; [Tornbom, Karin; Sunnerhagen, Katharina S.] Univ Gothenburg, Ctr Person Ctr Care GPCC, Gothenburg, Sweden; [Danielsson, Anna] Univ Gothenburg, Dept Hlth & Rehabil, Unit Physiotherapy, Inst Neurosci & Physiol,Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Tornbom, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Res Grp Rehabil Med, Inst Neurosci & Physiol,Dept Clin Neurosci, Gothenburg, Sweden.; Tornbom, K (corresponding author), Univ Gothenburg, Ctr Person Ctr Care GPCC, Gothenburg, Sweden.	karin.tornbom@neuro.gu.se	Sunnerhagen, Katharina Stibrant/AAE-2405-2020	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400; Danielsson, Anna/0000-0002-6496-4066	John and Brit Wennerstrom foundation for Neurological Research; Norrbacka-Eugenia foundation [808-12]; Rune and Ulla Amlovs foundation for Neurological Research; Swedish Stroke association; Hjalmar Svensson foundation [HJSV2012056]; Swedish Stroke Centre West	John and Brit Wennerstrom foundation for Neurological Research; Norrbacka-Eugenia foundation; Rune and Ulla Amlovs foundation for Neurological Research; Swedish Stroke association; Hjalmar Svensson foundation; Swedish Stroke Centre West	John and Brit Wennerstrom foundation for Neurological Research; The Norrbacka-Eugenia foundation, 808-12; Rune and Ulla Amlovs foundation for Neurological Research; The Swedish Stroke association; Hjalmar Svensson foundation, HJSV2012056; and The Swedish Stroke Centre West. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billinger SA, 2014, STROKE, V45, P2532, DOI 10.1161/STR.0000000000000022; BOHANNON RW, 1988, INT J REHABIL RES, V11, P181, DOI 10.1097/00004356-198806000-00012; Bonner NS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164120; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; Combs SA, 2013, DISABIL REHABIL, V35, P860, DOI 10.3109/09638288.2012.717575; Damush TM, 2007, REHABIL NURS, V32, P253, DOI 10.1002/j.2048-7940.2007.tb00183.x; Danielsson A, 2014, PM&R, V6, P139, DOI 10.1016/j.pmrj.2013.08.593; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Duncan PW, 2005, STROKE, V36, pE100, DOI 10.1161/01.STR.0000180861.54180.FF; English C, 2016, TOP STROKE REHABIL, V23, P62, DOI 10.1179/1945511915Y.0000000009; English C, 2016, PHYS THER, V96, P193, DOI 10.2522/ptj.20140522; Evenson KR, 2014, J CARDIOPULM REHABIL, V34, P406, DOI 10.1097/HCR.0000000000000064; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gallagher Patti, 2011, Can J Neurosci Nurs, V33, P24; Galvin R, 2009, INT J REHABIL RES, V32, P238, DOI 10.1097/MRR.0b013e32832b083c; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hankey GJ, 2003, CEREBROVASC DIS, V16, P14, DOI 10.1159/000069936; Harris Jocelyn E, 2004, Physiother Can, V56, P171, DOI 10.2310/6640.2004.00017; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Idowu OA, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.274.6669; Ivey FM, 2008, J CARDIOPULM REHABIL, V28, P2, DOI 10.1097/01.HCR.0000311501.57022.a8; Jaracz K, 2014, NEUROL NEUROCHIR POL, V48, P280, DOI 10.1016/j.pjnns.2014.07.004; Kirkevold Marit, 2014, BMC Psychol, V2, P4, DOI 10.1186/2050-7283-2-4; Kucukdeveci AA, 2011, J REHABIL MED, V43, P661, DOI 10.2340/16501977-0844; Luker J, 2015, ARCH PHYS MED REHAB, V96, P1698, DOI 10.1016/j.apmr.2015.03.017; Maclean N, 2000, SOC SCI MED, V50, P495; Maclean N, 2000, BMJ-BRIT MED J, V321, P1051, DOI 10.1136/bmj.321.7268.1051; Mead GE, 2007, J AM GERIATR SOC, V55, P892, DOI 10.1111/j.1532-5415.2007.01185.x; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Mossberg KA, 2010, J HEAD TRAUMA REHAB, V25, P173, DOI 10.1097/HTR.0b013e3181dc98ff; Nadeau SE, 2016, NEUROREHAB NEURAL RE, V30, P615, DOI 10.1177/1545968315613851; Nicholson S, 2013, INT J STROKE, V8, P357, DOI 10.1111/j.1747-4949.2012.00880.x; Nicholson SL, 2014, DISABIL REHABIL, V36, P1857, DOI 10.3109/09638288.2013.874506; Ohman A, 2005, J REHABIL MED, V37, P273, DOI 10.1080/16501970510040056; Patterson S, 2009, INT J THER REHABIL, V16, P659, DOI 10.12968/ijtr.2009.16.12.45422; Peters K, 2015, NURSE RES, V22, P6, DOI 10.7748/nr.22.4.6.s2; Resnick B, 2008, TOP STROKE REHABIL, V15, P494, DOI 10.1310/tsr1505-494; Riks-Stroke, 2015, RIKS STROK YEARL RAP; Rimmer JH, 2008, J REHABIL RES DEV, V45, P315, DOI 10.1682/JRRD.2007.02.0042; Rimmer JH, 2010, AM J PHYS MED REHAB, V89, P249, DOI 10.1097/PHM.0b013e3181c9fa9d; Robison J, 2009, DISABIL REHABIL, V31, P1555, DOI 10.1080/09638280802639327; Salbach NM, 2009, PHYS THER, V89, P556, DOI 10.2522/ptj.20080249; Sunnehagen KS, 2000, SCAND J REHABIL MED, V32, P159; Vanroy C, 2016, TOP STROKE REHABIL, V23, P98, DOI 10.1080/10749357.2015.1116227; Veluswamy SK, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-27; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Witte US, 1997, SCAND J REHABIL MED, V29, P161; World Health Organization (WHO), 2016, PHYS ACTIVITY	48	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173463	10.1371/journal.pone.0173463	http://dx.doi.org/10.1371/journal.pone.0173463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273158	Green Published, gold			2022-12-26	WOS:000396073700005
J	Matsubayashi, M; Shimada, Y; Li, YY; Harada, H; Kubota, K				Matsubayashi, Miri; Shimada, Yusuke; Li, Yu-You; Harada, Hideki; Kubota, Kengo			Phylogenetic diversity and in situ detection of eukaryotes in anaerobic sludge digesters	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; HYBRIDIZATION; COMMUNITY; DNA; MICROORGANISMS; IDENTIFICATION; AMPLIFICATION; BACTERIA; ARCHAEA; TOOLS	Eukaryotic communities in aerobic wastewater treatment processes are well characterized, but little is known about them in anaerobic processes. In this study, abundance, diversity and morphology of eukaryotes in anaerobic sludge digesters were investigated by quantitative real-time PCR (qPCR), 18S rRNA gene clone library construction and catalyzed reporter deposition-fluorescence in situ hybridization (CARD-FISH). Samples were taken from four different anaerobic sludge digesters in Japan. Results of qPCR of rRNA genes revealed that Eukarya accounted from 0.1% to 1.4% of the total number of microbial rRNA gene copy numbers. The phylogenetic affiliations of a total of 251 clones were Fungi, Alveolata, Viridiplantae, Amoebozoa, Rhizaria, Stramenopiles and Metazoa. Eighty-five percent of the clones showed less than 97.0% sequence identity to described eukaryotes, indicating most of the eukaryotes in anaerobic sludge digesters are largely unknown. Clones belonging to the uncultured lineage LKM11 in Cryptomycota of Fungi were most abundant in anaerobic sludge, which accounted for 50% of the total clones. The most dominant OTU in each library belonged to either the LKM11 lineage or the uncultured lineage A31 in Alveolata. Principal coordinate analysis indicated that the eukaryotic and prokaryotic community structures were related. The detection of anaerobic eukaryotes, including the members of the LKM11 and A31 lineages in anaerobic sludge digesters, by CARD-FISH revealed their sizes in the range of 2-8 mu m. The diverse and uncultured eukaryotes in the LKM11 and the A31 lineages are common and ecologically relevant members in anaerobic sludge digester.	[Matsubayashi, Miri; Li, Yu-You; Kubota, Kengo] Tohoku Univ, Dept Civil & Environm Engn, Sendai, Miyagi, Japan; [Shimada, Yusuke] Tohoku Univ, Dept Frontier Sci Adv Environm, Sendai, Miyagi, Japan; [Harada, Hideki] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University	Kubota, K (corresponding author), Tohoku Univ, Dept Civil & Environm Engn, Sendai, Miyagi, Japan.	kengo.kubota.a7@tohoku.ac.jp	Li, Yu-You/A-1735-2017; li, Yu/HCI-9086-2022; li, yu/HGL-9518-2022; Kubota, Kengo/C-8870-2009	Kubota, Kengo/0000-0002-1913-272X; Li, Yu-You/0000-0002-3659-5005	JSPS KAKENHI Grant [JP26289179]; Strategic Funds for the Promotion of Science & Technology, Ministry of Education, Culture, Sports, Sciences and Technology, Japan (MEXT)	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Strategic Funds for the Promotion of Science & Technology, Ministry of Education, Culture, Sports, Sciences and Technology, Japan (MEXT)	This research was supported by JSPS KAKENHI Grant Number JP26289179 and the Strategic Funds for the Promotion of Science & Technology, Ministry of Education, Culture, Sports, Sciences and Technology, Japan (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Brad T, 2008, APPL ENVIRON MICROB, V74, P3959, DOI 10.1128/AEM.02820-07; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Capo E, 2015, MICROB ECOL, V70, P865, DOI 10.1007/s00248-015-0627-2; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dawson SC, 2002, P NATL ACAD SCI USA, V99, P8324, DOI 10.1073/pnas.062169599; Ishii K, 2004, FEMS MICROBIOL ECOL, V50, P203, DOI 10.1016/j.femsec.2004.06.015; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Kubota K, 2006, APPL ENVIRON MICROB, V72, P5311, DOI 10.1128/AEM.03039-05; Kubota K, 2006, J MICROBIOL METH, V66, P521, DOI 10.1016/j.mimet.2006.02.002; Kubota K, 2013, MICROBES ENVIRON, V28, P3, DOI 10.1264/jsme2.ME12107; Lasken RS, 2007, CURR OPIN MICROBIOL, V10, P510, DOI 10.1016/j.mib.2007.08.005; Leis S, 2014, ANAEROBE, V29, P34, DOI 10.1016/j.anaerobe.2013.12.002; Lepere C, 2007, FEMS MICROBIOL ECOL, V61, P483, DOI 10.1111/j.1574-6941.2007.00359.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luo QW, 2005, APPL ENVIRON MICROB, V71, P6175, DOI 10.1128/AEM.71.10.6175-6184.2005; Matsunaga K, 2014, MICROBES ENVIRON, V29, P401, DOI 10.1264/jsme2.ME14112; Monchy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039924; Musat N, 2012, FEMS MICROBIOL REV, V36, P486, DOI 10.1111/j.1574-6976.2011.00303.x; Nagahama T, 2011, ENVIRON MICROBIOL, V13, P2359, DOI 10.1111/j.1462-2920.2011.02507.x; Ntougias S, 2011, J HAZARD MATER, V186, P1862, DOI 10.1016/j.jhazmat.2010.12.099; Okabe S, 2004, MICROB ENV, V19, P83, DOI DOI 10.1264/JSME2.19.83; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stoddard SF, 2015, NUCLEIC ACIDS RES, V43, pD593, DOI 10.1093/nar/gku1201; Sundberg C, 2013, FEMS MICROBIOL ECOL, V85, P612, DOI 10.1111/1574-6941.12148; WEBSTER CE, 1987, J MED VET MYCOL, V25, P47; Yamaguchi T, 2015, ENVIRON MICROBIOL, V17, P2532, DOI 10.1111/1462-2920.12745; Yilmaz LS, 2011, APPL ENVIRON MICROB, V77, P1118, DOI 10.1128/AEM.01733-10; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	32	25	27	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172888	10.1371/journal.pone.0172888	http://dx.doi.org/10.1371/journal.pone.0172888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264042	Green Published, Green Submitted, gold			2022-12-26	WOS:000396054300027
J	Dijkstra, H; Wolff, D; van Melle, JP; Bartelds, B; Willems, TP; Oudkerk, M; Hillege, H; van den Berg, AP; Ebels, T; Berger, RMF; Sijens, PE				Dijkstra, Hildebrand; Wolff, Djoeke; van Melle, Joost P.; Bartelds, Beatrijs; Willems, Tineke P.; Oudkerk, Matthijs; Hillege, Hans; van den Berg, Aad P.; Ebels, Tjark; Berger, Rolf M. F.; Sijens, Paul E.			Diminished liver microperfusion in Fontan patients: A biexponential DWI study	PLOS ONE			English	Article							INTRAVOXEL INCOHERENT MOTION; DIFFUSION-WEIGHTED MRI; CHRONIC PASSIVE CONGESTION; CONGENITAL HEART-DISEASE; CHRONIC HEPATITIS-C; TRICUSPID-ATRESIA; HEPATOCELLULAR-CARCINOMA; PERFUSION MEASUREMENT; INITIAL-EXPERIENCE; CARDIAC CIRRHOSIS	It has been demonstrated that hepatic apparent diffusion coefficients (ADC) are decreasing in patients with a Fontan circulation. It remains however unclear whether this is a true decrease of molecular diffusion, or rather reflects decreased microperfusion due to decreased portal blood flow. The purpose of this study was therefore to differentiate diffusion and microperfusion using intravoxel incoherent motion (IVIM) modeled diffusion-weighted imaging (DWI) for different liver segments in patients with a Fontan circulation, compare to a control group, and relate with liver function, chronic hepatic congestion and hepatic disease. For that purpose, livers of 59 consecutively included patients with Fontan circulation (29 men; mean-age, 19.1 years) were examined (Oct 2012-Dec 2013) with 1.5T MRI and DWI (b = 0,50,100,250,500, 750,1500,1750 s/mm(2)). IVIM (D-slow,D-fast,f(fast)) and ADC were calculated for eight liver segments, compared to a control group (19 volunteers; 10 men; mean-age, 32.9 years), and correlated to follow-up duration, clinical variables, and laboratory measurements associated with liver function. The results demonstrated that microperfusion was reduced (p < 0.001) in Fontan livers compared to controls with -38.1% for D-fast and -32.6% for f(fast). Molecular diffusion (D-slow) was similar between patients and controls, while ADC was significantly lower (-14.3%) in patients (p < 0.001). ADC decreased significantly with follow-up duration after Fontan operation (r = -0.657). D-slow showed significant inverse correlations (r = -0.591) with follow-up duration whereas D-fast and f(fast) did not. From these results it was concluded that the decreasing ADC values in Fontan livers compared with controls reflect decreases in hepatic microperfusion rather than any change in molecular diffusion. However, with the time elapsed since the Fontan operation molecular diffusion and ADC decreased while microperfusion remained stable. This indicates that after Fontan operation initial blood flow effects on the liver are followed by intracellular changes preceding the formation of fibrosis and cirrhosis.	[Dijkstra, Hildebrand] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Ctr Med Imaging North East Netherlands, Groningen, Netherlands; [Wolff, Djoeke; Bartelds, Beatrijs; Berger, Rolf M. F.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Ctr Congenital Heart Dis,Dept Pediat Cardiol, Groningen, Netherlands; [van Melle, Joost P.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Ctr Congenital Heart Dis, Groningen, Netherlands; [Willems, Tineke P.; Sijens, Paul E.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [Oudkerk, Matthijs] Univ Groningen, Univ Med Ctr Groningen, Ctr Med Imaging North East Netherlands, Groningen, Netherlands; [Hillege, Hans] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van den Berg, Aad P.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol, Groningen, Netherlands; [Ebels, Tjark] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiothorac Surg, Ctr Congenital Heart Dis, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Dijkstra, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Ctr Med Imaging North East Netherlands, Groningen, Netherlands.	h.dijkstra01@umcg.nl		Oudkerk, Matthijs/0000-0003-2800-4110; Ebels, Tjark/0000-0002-7124-0058; Dijkstra, Hildebrand/0000-0001-6664-902X	Sebald Foundation	Sebald Foundation	This work was supported by the Sebald Foundation (to RMFB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano Y, 1998, ACTA RADIOL, V39, P440; Asrani SK, 2013, NEW ENGL J MED, V368, P1756, DOI 10.1056/NEJMc1214222; Asrani SK, 2012, HEPATOLOGY, V56, P1160, DOI 10.1002/hep.25692; Bakan AA, 2012, EUR RADIOL, V22, P682, DOI 10.1007/s00330-011-2295-z; BISMUTH H, 1982, WORLD J SURG, V6, P3, DOI 10.1007/BF01656368; Boulanger Y, 2003, NMR BIOMED, V16, P132, DOI 10.1002/nbm.818; Cornel M., 2017, VOLKSGEZONDHEID TOEK; Couinaud C, 1957, FOIE ETUDES ANATOMIQ; Dijkstra H, 2012, EUR RADIOL, V22, P891, DOI 10.1007/s00330-011-2313-1; DUNN GD, 1973, AM J MED SCI, V265, P175, DOI 10.1097/00000441-197303000-00001; FONTAN F, 1971, THORAX, V26, P240, DOI 10.1136/thx.26.3.240; Fredenburg TB, 2011, RADIOGRAPHICS, V31, P453, DOI 10.1148/rg.312105027; Ghaferi AA, 2005, J THORAC CARDIOV SUR, V129, P1348, DOI 10.1016/j.jtcvs.2004.10.005; Greenway SC, 2015, J HEART LUNG TRANSPL; Hagiwara M, 2008, RADIOLOGY, V246, P926, DOI 10.1148/radiol.2463070077; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Johnson JA, 2013, J THORAC CARDIOV SUR, V146, P140, DOI 10.1016/j.jtcvs.2012.09.005; Kanda T, 2012, EUR J RADIOL, V81, P2470, DOI 10.1016/j.ejrad.2011.10.009; Kandpal H, 2009, AM J ROENTGENOL, V192, P915, DOI 10.2214/AJR.08.1260; Kiesewetter CH, 2007, HEART, V93, P579, DOI 10.1136/hrt.2006.094516; Koh DM, 2006, EUR RADIOL, V16, P1898, DOI 10.1007/s00330-006-0201-x; KREUTZER G, 1973, J THORAC CARDIOV SUR, V66, P613, DOI 10.1016/s0022-5223(19)40598-9; Kwee TC, 2009, MAGN RESON MATER PHY, V22, P319, DOI 10.1007/s10334-009-0183-1; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEBIHAN D, 1991, JMRI-J MAGN RESON IM, V1, P7, DOI 10.1002/jmri.1880010103; LEMMER JH, 1983, J THORAC CARDIOV SUR, V86, P757; Leporq B, 2012, J MAGN RESON IMAGING, V35, P1380, DOI 10.1002/jmri.23594; Lewin M, 2007, HEPATOLOGY, V46, P658, DOI 10.1002/hep.21747; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; MULLER MF, 1994, RADIOLOGY, V190, P475; Namimoto T, 1997, RADIOLOGY, V204, P739, DOI 10.1148/radiology.204.3.9280252; Nasu Katsuhiro, 2006, Radiat Med, V24, P438, DOI 10.1007/s11604-006-0053-y; Ozkurt H, 2014, IRAN J RADIOL, V11, DOI 10.5812/iranjradiol.3555; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Pundi K, 2015, AM J CARDIOL; Ronot M, 2010, RADIOLOGY, V256, P135, DOI 10.1148/radiol.10091295; Rychik J, 2012, PEDIATR CARDIOL, V33, P1001, DOI 10.1007/s00246-012-0315-7; SAFRAN AP, 1967, AM J PATHOL, V50, P447; Sandrasegaran K, 2009, AM J ROENTGENOL, V193, P1556, DOI 10.2214/AJR.09.2436; SHERLOCK S, 1951, BRIT HEART J, V13, P273; Shinagawa H, 2008, CIRC J, V72, P364, DOI 10.1253/circj.72.364; TURNER R, 1990, RADIOLOGY, V177, P407, DOI 10.1148/radiology.177.2.2217777; Van Beers BE, 2001, AM J ROENTGENOL, V176, P667, DOI 10.2214/ajr.176.3.1760667; Wang X, 2013, EUR J RADIOL, V82, P220, DOI 10.1016/j.ejrad.2012.09.015; Wang Yi, 2011, AJR Am J Roentgenol, V196, P553, DOI 10.2214/AJR.10.4580; Wolff D, 2016, INT J CARDIOL, V202, P595, DOI 10.1016/j.ijcard.2015.09.088; Wolff D, 2014, EUR J CARDIO-THORAC, V45, P602, DOI 10.1093/ejcts/ezt461	47	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173149	10.1371/journal.pone.0173149	http://dx.doi.org/10.1371/journal.pone.0173149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257439	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100067
J	Majeed, M; Bani, S; Natarajan, S; Pandey, A; Naveed, S				Majeed, Muhammed; Bani, Sarang; Natarajan, Sankaran; Pandey, Anjali; Naveed, S.			Evaluation of 90 day repeated dose oral toxicity and reproductive/developmental toxicity of 3 '-hydroxypterostilbene in experimental animals	PLOS ONE			English	Article							APOPTOSIS-INDUCING AGENTS; SPHAEROPHYSA-SALSULA; ANTIOXIDANT; PTEROSTILBENE	3'-Hydroxypterostilbene (3'-HPT) is one of the active constituents of Sphaerophysa salsula and Pterocarpus marsupium. Despite many proposed therapeutic applications, the safety profile of 3'-HPT has not been established. The present work investigated 90 day repeated oral dose and reproductive (developmental) toxicity of 3'-HPT as a test substance in rats as per OECD guidelines. 90 day toxicity was conducted in sixty Sprague Dawley rats of each sex (120 rats), grouped into six dosage groups of 0 (control), 0 (control recovery), 20 (low dose), 80 (mid dose), 200 (high dose) and 200 (high dose recovery) mg/kg bwt/day (body weight/day) respectively. For the reproductive toxicity study forty Wistar rats of each sex (80 rats) divided into four dosage groups received 0 (vehicle control), 20 (low dose), 100 (mid dose) and 200 (high dose) mg/kg bwt/day of 3'-HPT respectively for a period of two weeks while pre-mating, mating, on the day before sacrifice, in females during pregnancy and four days of lactation period. Results showed no significant differences in body weight, food intake, absolute organ weight, haematology, with no adverse effects (toxicity) on biochemical values nor any abnormal clinical signs or behavioural changes were observed in any of the control/treatment groups, including reproductive and developmental parameters, gross and histopathological changes. In conclusion, the results suggested a No-Observed-Adverse-Effect-Level (NOAEL) of 200 mg/kg bwt/day in rats after oral administration, implying 3'-HPT did not exhibit any toxicity under the study conditions employed.	[Majeed, Muhammed] Sami Labs Ltd, Bangalore, Karnataka, India; [Bani, Sarang; Pandey, Anjali] Sami Labs Ltd, Dept Biol Res, Bangalore, Karnataka, India; [Natarajan, Sankaran] Sami Labs Ltd, Ctr Res & Dev, Bangalore, Karnataka, India; [Naveed, S.] ClinWorld Private Ltd, ClinWorld, Bangalore, Karnataka, India		Naveed, S (corresponding author), ClinWorld Private Ltd, ClinWorld, Bangalore, Karnataka, India.	naveed@clinworld.org			Sami Labs Limited; ClinWorld (P) Limited	Sami Labs Limited; ClinWorld (P) Limited	This work was sponsored by Sami Labs Limited. There was no external funding involved. The funder provided support in the form of salaries for authors of both Sami Labs Limited and ClinWorld (P) Limited [MM, SB, AP, SN and NVS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors affiliated to Sami Labs or ClinWorld are articulated in the 'author contributions' section.	GILL MT, 1987, J NAT PROD, V50, P36, DOI 10.1021/np50049a006; Ma ZJ, 2002, FITOTERAPIA, V73, P313, DOI 10.1016/S0367-326X(02)00074-6; Majeed M, 2015, United States patent US, Patent No. [9050284 B2, 9050284]; Majeed M, 2016, United States Patent US, Patent No. [9458075 B1, 9458075]; Monagas M, 2006, J AGR FOOD CHEM, V54, P319, DOI 10.1021/jf051807j; Nagabhushanam K., 2009, PharmaChem, V8, P2; OECD, 1995, OECD GUID TEST CHEM; OECD (Organization for Economic Co-operation and Development), 1998, FISH SHORT TERM TOX; Roberti M, 2003, J MED CHEM, V46, P3546, DOI 10.1021/jm030785u; Roupe KA, 2006, CURR CLIN PHARMACOL, V1, P81, DOI 10.2174/157488406775268246; Shao X, 2010, RAPID COMMUN MASS SP, V24, P1770, DOI 10.1002/rcm.4579; Takemotoa JK, 2015, J PHARM PHARM SCI, V18, P713, DOI 10.18433/J33W4C; Tolomeo M, 2005, INT J BIOCHEM CELL B, V37, P1709, DOI 10.1016/j.biocel.2005.03.004; Venkateswarlu S, 2003, BIOSCI BIOTECH BIOCH, V67, P2463, DOI 10.1271/bbb.67.2463	14	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172770	10.1371/journal.pone.0172770	http://dx.doi.org/10.1371/journal.pone.0172770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257483	Green Submitted, gold, Green Published			2022-12-26	WOS:000396021100026
J	Pettersson, K; Yousaf, K; Ranstam, J; Westgren, M; Ajne, G				Pettersson, Kristina; Yousaf, Khurram; Ranstam, Jonas; Westgren, Magnus; Ajne, Gunilla			Predictive value of traction force measurement in vacuum extraction: Development of a multivariate prognostic model	PLOS ONE			English	Article							NEONATAL SUBGALEAL HEMATOMA; RISK-FACTORS; DELIVERY; FETAL; TERM; COMPLICATIONS; HEMORRHAGE; INJURIES; NEWBORN; INFANTS	Objective To enable early prediction of strong traction force vacuum extraction. Design Observational cohort. Setting Karolinska University Hospital delivery ward, tertiary unit. Population and sample size Term mid and low metal cup vacuum extraction deliveries June 2012 D February 2015, n = 277. Methods Traction forces during vacuum extraction were collected prospectively using an intelligent handle. Levels of traction force were analysed pairwise by subjective category strong versus non-strong extraction, in order to define an objective predictive value for strong extraction. Statistical analysis A logistic regression model based on the shrinkage and selection method lasso was used to identify the predictive capacity of the different traction force variables. Predictors Total (time force integral, Newton minutes) and peak traction (Newton) force in the first to third pull; difference in traction force between the second and first pull, as well as the third and first pull respectively. Accumulated traction force at the second and third pull. Outcome Subjectively categorized extraction as strong versus non-strong. Results The prevalence of strong extraction was 26%. Prediction including the first and second pull: AUC 0,85 (CI 0,80-0,90); specificity 0,76; sensitivity 0,87; PPV 0,56; NPV 0,94. Prediction including the first to third pull: AUC 0,86 (CI 0,80-0,91); specificity 0,87; sensitivity 0,70; PPV 0,65; NPV 0,89. Conclusion Traction force measurement during vacuum extraction can help exclude strong category extraction from the second pull. From the third pull, two-thirds of strong extractions can be predicted.	[Pettersson, Kristina; Westgren, Magnus; Ajne, Gunilla] Karolinska Univ Hosp, Obstet & Gynecol, Stockholm, Sweden; [Pettersson, Kristina; Yousaf, Khurram; Westgren, Magnus; Ajne, Gunilla] Karolinska Inst, Clintec, Stockholm, Sweden; [Yousaf, Khurram] Royal Inst Technol, Sch Technol & Hlth, Stockholm, Sweden; [Ranstam, Jonas] Swedish Patient Insurance, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Royal Institute of Technology	Pettersson, K (corresponding author), Karolinska Univ Hosp, Obstet & Gynecol, Stockholm, Sweden.	kristina.a.pettersson@karolinska.se	Ranstam, Jonas/A-4386-2009	Ranstam, Jonas/0000-0002-8287-7273; Ajne, Gunilla/0000-0003-2276-3212	Swedish Patient Insurance (LOF); VINNOVA Swedish Innovations Agency; Karolinska Institute, Dept. of Obstetrics and Gynecology; Stockholm County Council (Agreement for Research and Education of Doctors) [551176]; Stockholm County Council (Combined Clinical Residency and PhD Training Program)	Swedish Patient Insurance (LOF); VINNOVA Swedish Innovations Agency; Karolinska Institute, Dept. of Obstetrics and Gynecology; Stockholm County Council (Agreement for Research and Education of Doctors); Stockholm County Council (Combined Clinical Residency and PhD Training Program)	This study was supported by grants provided by the Swedish Patient Insurance (LOF), VINNOVA Swedish Innovations Agency, the Karolinska Institute, Dept. of Obstetrics and Gynecology, the Stockholm County Council (Agreement for Research and Education of Doctors, 551176, and KP was supported by the Stockholm County Council (Combined Clinical Residency and PhD Training Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, A CODE OF PRACTICE F; [Anonymous], 1998, GUIDE TO THE MEASURE; [Anonymous], 2009, THE ELEMENTS OF STAT; Bailit JL, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.11.007; Baskett TF, 2008, J OBSTET GYNAECOL CA, V30, P573, DOI 10.1016/S1701-2163(16)32890-0; Boo NY, 2005, BJOG-INT J OBSTET GY, V112, P1516, DOI 10.1111/j.1471-0528.2005.00732.x; Chadwick LM, 1996, J PAEDIATR CHILD H, V32, P228, DOI 10.1111/j.1440-1754.1996.tb01559.x; Colditz MJ, 2015, J PAEDIATR CHILD H, V51, P140, DOI 10.1111/jpc.12698; Doumouchtsis SK, 2006, CURR OPIN OBSTET GYN, V18, P129, DOI 10.1097/01.gco.0000192983.76976.68; Ekeus C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-36; Eskander R, 2012, J MATERN-FETAL NEO M, V25, P2039, DOI 10.3109/14767058.2012.675374; European Police Office (Europol), 2015, THB FIN BUS MOD ASS; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; ISSEL EP, 1977, ZBL GYNAKOL, V99, P487; Kilani RA, 2006, AM J PERINAT, V23, P41, DOI 10.1055/s-2005-923438; Macfarlane AJ, 2016, BJOG-INT J OBSTET GY, V123, P559, DOI 10.1111/1471-0528.13284; Martin J. A., 2013, NATL VITAL STA REP, V64, P1; MOOLGAOKER AS, 1979, OBSTET GYNECOL, V54, P299; O'Mahony F, 2005, BJOG-INT J OBSTET GY, V112, P619, DOI 10.1111/j.1471-0528.2004.00508.x; Peaceman AM, 2015, OBSTET GYNECOL, V126, pE56, DOI 10.1097/AOG.0000000000001147; Pettersson K, 2015, BJOG-INT J OBSTET GY, V122, P1809, DOI 10.1111/1471-0528.13222; PLAUCHE WC, 1979, OBSTET GYNECOL, V53, P750; Royal College of Obstetricians and Gynaecologists, 2011, GREEN GUID; StataCorp, 2013, STATA STATISTICAL SO; Steyerberg EW, 2016, J CLIN EPIDEMIOL, V69, P245, DOI 10.1016/j.jclinepi.2015.04.005; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Towner D, 1999, NEW ENGL J MED, V341, P1709, DOI 10.1056/NEJM199912023412301; Tutschek B, 2011, BJOG-INT J OBSTET GY, V118, P62, DOI 10.1111/j.1471-0528.2010.02775.x; Vacca A, 2006, AUST NZ J OBSTET GYN, V46, P124, DOI 10.1111/j.1479-828X.2006.00540.x; Walsh CA, 2013, OBSTET GYNECOL, V121, P122, DOI [10.1097/AOG.0b013e3182749ac9, http://10.1097/AOG.0b013e3182749ac9]	30	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0171938	10.1371/journal.pone.0171938	http://dx.doi.org/10.1371/journal.pone.0171938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257459	Green Published, gold, Green Submitted			2022-12-26	WOS:000396021100010
J	Pauletto, M; Milan, M; Huvet, A; Corporeau, C; Suquet, M; Planas, JV; Moreira, R; Figueras, A; Novoa, B; Patarnello, T; Bargelloni, L				Pauletto, Marianna; Milan, Massimo; Huvet, Arnaud; Corporeau, Charlotte; Suquet, Marc; Planas, Josep V.; Moreira, Rebeca; Figueras, Antonio; Novoa, Beatriz; Patarnello, Tomaso; Bargelloni, Luca			Transcriptomic features of Pecten maximus oocyte quality and maturation	PLOS ONE			English	Article							OYSTER CRASSOSTREA-GIGAS; PROTEIN DISULFIDE-ISOMERASE; EARLY EMBRYONIC-DEVELOPMENT; PACIFIC OYSTER; BLASTOCYST FORMATION; GAMETE QUALITY; MESSENGER-RNA; EGG QUALITY; SCALLOP; GENE	The king scallop Pecten maximus is a high valuable species of great interest in Europe for both fishery and aquaculture. Notably, there has been an increased investment to produce seed for enhancement programmes of wild scallop populations. However, hatchery production is a relatively new industry and it is still underdeveloped. Major hurdles are spawning control and gamete quality. In the present study, a total of 14 scallops were sampled in the bay of Brest (Brittany, France) to compare transcriptomic profiles of mature oocytes collected by spawning induction or by stripping. To reach such a goal, a microarray analysis was performed by using a custom 8x60K oligonucleotide microarray representing 45,488 unique scallop contigs. First we identified genes that were differentially expressed depending on oocyte quality, estimated as the potential to produce D-larvae. Secondly, we investigated the transcriptional features of both stripped and spawned oocytes. Genes coding for proteins involved in cytoskeletal dynamics, serine/threonine kinases signalling pathway, mRNA processing, response to DNA damage, apoptosis and cell-cycle appeared to be of crucial importance for both oocyte maturation and developmental competence. This study allowed us to dramatically increase the knowledge about transcriptional features of oocyte quality and maturation, as well as to propose for the first time putative molecular markers to solve a major bottleneck in scallop aquaculture.	[Pauletto, Marianna; Milan, Massimo; Patarnello, Tomaso; Bargelloni, Luca] Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy; [Huvet, Arnaud; Corporeau, Charlotte; Suquet, Marc] IFREMER, CNRS, UMR 6539,UBO,IRD, Lab Sci Environm Marin LEMAR, Plouzane, France; [Planas, Josep V.] Univ Barcelona, Fac Biol, Dept Fisiol & Immunol, Barcelona, Spain; [Planas, Josep V.] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Moreira, Rebeca; Figueras, Antonio; Novoa, Beatriz] Inst Invest Marinas IIM CSIC, Vigo, Pontevedra, Spain	University of Padua; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); University of Barcelona; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Pauletto, M (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy.	marianna.pauletto@unipd.it	Figueras, Antonio/AAB-8921-2019; Pauletto, Marianna/K-5518-2019; Novoa, Beatriz/K-3785-2014; MILAN, MASSIMO/ABE-6936-2021	Figueras, Antonio/0000-0002-0617-0030; Pauletto, Marianna/0000-0002-2424-7484; MILAN, MASSIMO/0000-0003-0246-9008; Planas, Josep/0000-0002-6525-9617; Huvet, Arnaud/0000-0001-6912-881X; Moreira, Rebeca/0000-0001-7797-7221; Corporeau, charlotte/0000-0003-1187-358X; Novoa, Beatriz/0000-0003-4888-8419	EU [REPROSEED: FP 7-KBBE-2009-1-2-11]	EU(European Commission)	This research was supported by the EU Project "Research to improve Production of SEED" (REPROSEED: FP 7-KBBE-2009-1-2-11) (http://www.reproseed.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdu U, 2007, J CELL SCI, V120, P1042, DOI 10.1242/jcs.03414; Agnese M, 2013, J CELL PHYSIOL, V228, P547, DOI 10.1002/jcp.24161; Aji L.P., 2011, JURNAL PENELITIAN SA, V14, P33; Andersen S, 2011, CAN J ZOOL, V89, P579, DOI [10.1139/Z11-035, 10.1139/z11-035]; Avazeri N, 2000, MOL BIOL CELL, V11, P4369, DOI 10.1091/mbc.11.12.4369; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; BEAUMONT AR, 1983, MAR BIOL, V76, P285, DOI 10.1007/BF00393030; Bobe J., 2015, Animal Frontiers, V5, P66, DOI 10.2527/af.2015-0010; Bobe J, 2010, GEN COMP ENDOCR, V165, P535, DOI 10.1016/j.ygcen.2009.02.011; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Boudry P, 2002, AQUACULTURE, V204, P283, DOI 10.1016/S0044-8486(01)00841-9; Boulais M, 2015, AQUACULTURE, V437, P201, DOI 10.1016/j.aquaculture.2014.11.025; Calvert Meredith E, 2003, Reprod Biol Endocrinol, V1, P27, DOI 10.1186/1477-7827-1-27; Cannuel R, 2005, AQUAT LIVING RESOUR, V18, P35, DOI 10.1051/alr:2005003; Castets MD, 2012, THERIOGENOLOGY, V78, P432, DOI 10.1016/j.theriogenology.2012.02.023; Corporeau C, 2012, J PROTEOMICS, V75, P5554, DOI 10.1016/j.jprot.2012.07.040; Cui XS, 2007, MOL REPROD DEV, V74, P785, DOI 10.1002/mrd.20571; De la Fuente R, 2006, NAT CELL BIOL, V8, P1448, DOI 10.1038/ncb1513; de Sousa JT, 2015, AQUACULTURE, V446, P17, DOI 10.1016/j.aquaculture.2015.04.018; Di Emidio G, 2014, HUM REPROD, V29, P2006, DOI 10.1093/humrep/deu160; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Ellerman DA, 2006, DEV CELL, V10, P831, DOI 10.1016/j.devcel.2006.03.011; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V315, P897, DOI 10.1016/j.bbrc.2004.01.145; FAO, 2016, PECT MAX SPEC FACT S; Fava LL, 2012, J CELL SCI, V125, P5911, DOI 10.1242/jcs.115105; Fujii W, 2011, BIOL REPROD, V85, P1124, DOI 10.1095/biolreprod.111.091801; Fujino Y, 1996, HUM REPROD, V11, P1480; GOBET I, 1994, DEV BIOL, V164, P540, DOI 10.1006/dbio.1994.1222; Goode S, 1996, DEV BIOL, V178, P35, DOI 10.1006/dbio.1996.0196; Gosling E., 2015, MARINE BIVALVE MOLLU, V2nd; GRUFFYDD LD, 1970, HELGOLAND WISS MEER, V20, P486, DOI 10.1007/BF01609924; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Heikinheimo O, 1998, MOL HUM REPROD, V4, P745, DOI 10.1093/molehr/4.8.745; Hold N, 2013, CAN J FISH AQUAT SCI, V70, P330, DOI 10.1139/cjfas-2012-0378; Homer H, 2013, REPRODUCTION, V146, pR61, DOI 10.1530/REP-13-0163; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Ito M, 2008, FERTIL STERIL, V90, P1026, DOI 10.1016/j.fertnstert.2007.07.1389; Jarvis CD, 1996, GENE, V169, P203, DOI 10.1016/0378-1119(95)00843-8; Joaquim F, 2016, INT J INVER REP DEV; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jurisicova A, 1998, MOL REPROD DEV, V51, P243, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;243::AID-MRD3&gt;3.0.CO;2-P; KJORSVIK E, 1990, ADV MAR BIOL, V26, P71, DOI 10.1016/S0065-2881(08)60199-6; Le Pennec M, 2003, ICES J MAR SCI, V60, P211, DOI 10.1016/S1054-3139(02)00270-9; Le Pennec M, 1998, J SHELLFISH RES, V17, P97; Lefevre B, 2007, CRIT REV EUKAR GENE, V17, P259, DOI 10.1615/CritRevEukarGeneExpr.v17.i4.10; Liu RZ, 2003, EUR J BIOCHEM, V270, P3223, DOI 10.1046/j.1432-1033.2003.03705.x; Lo TS, 2007, MAR BIOTECHNOL, V9, P459, DOI 10.1007/s10126-007-9006-4; Ma H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1400-0; Ma JY, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103374; MASON J, 1958, J MAR BIOL ASSOC UK, V37, P653, DOI 10.1017/S0025315400005701; Massapina C, 1999, AQUAT LIVING RESOUR, V12, P327, DOI 10.1016/S0990-7440(99)00115-1; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Metcalfe AD, 2004, MOL REPROD DEV, V68, P35, DOI 10.1002/mrd.20055; Migaud H, 2013, REV AQUACULT, V5, pS194, DOI 10.1111/raq.12025; Milan M, 2016, AQUAT TOXICOL, V174, P123, DOI 10.1016/j.aquatox.2016.02.024; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Mommens M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-829; Morvezen R, 2016, HEREDITY, V117, P142, DOI 10.1038/hdy.2016.42; Norman KR, 2002, J CELL BIOL, V157, P665, DOI 10.1083/jcb.200111051; Ohashi Y, 2013, ANIM SCI J, V84, P15, DOI 10.1111/j.1740-0929.2012.01030.x; Osada M, 1998, J EXP ZOOL, V281, P124, DOI 10.1002/(SICI)1097-010X(19980601)281:2&lt;124::AID-JEZ6&gt;3.0.CO;2-Q; OSANAI K, 1985, Bulletin of the Marine Biological Station of Asamushi, V18, P1; Osanai K, 1998, B MAR BIOL STN ASAMU, V182, P45; Patra D, 1998, GENE DEV, V12, P2549, DOI 10.1101/gad.12.16.2549; Pauletto M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113925; Pauletto M, 2014, FISH SHELLFISH IMMUN, V37, P154, DOI 10.1016/j.fsi.2014.01.017; Peretz G, 2009, MECH DEVELOP, V126, P677, DOI 10.1016/j.mod.2009.05.004; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Polinko ES, 2000, CURR BIOL, V10, P1471, DOI 10.1016/S0960-9822(00)00808-3; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; Revel A, 2005, FERTIL STERIL, V83, P580, DOI 10.1016/j.fertnstert.2004.11.008; Robert R, 1999, AQUAT LIVING RESOUR, V12, P121, DOI 10.1016/S0990-7440(99)80021-7; Robson AA, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150679; Salilew-Wondim D, 2010, REPROD FERT DEVELOP, V22, P564, DOI 10.1071/RD09112; Samwer M, 2013, EMBO J, V32, P1886, DOI 10.1038/emboj.2013.108; Sandaa RA, 2003, SYST APPL MICROBIOL, V26, P302, DOI 10.1078/072320203322346164; Shumway SE, 2016, DEV AQUAC FISH SCI, V40, P1; Song JL, 2005, DIFFERENTIATION, V73, P1, DOI 10.1111/j.1432-0436.2005.07301005.x; Song YP, 2009, AQUACULTURE, V287, P311, DOI 10.1016/j.aquaculture.2008.10.018; Spruck CH, 2003, SCIENCE, V300, P647, DOI 10.1126/science.1084149; Stoyanova T, 2009, P NATL ACAD SCI USA, V106, P10690, DOI 10.1073/pnas.0812254106; Sullivan CV, 2015, GEN COMP ENDOCR, V221, P23, DOI 10.1016/j.ygcen.2015.02.012; Sun LQ, 2004, GENE DEV, V18, P1035, DOI 10.1101/gad.1176104; Suquet M, 2012, THERIOGENOLOGY, V78, P462, DOI 10.1016/j.theriogenology.2012.02.014; Suquet M, 2010, THERIOGENOLOGY, V74, P111, DOI 10.1016/j.theriogenology.2010.01.021; Suquet M, 2016, GEN COMP ENDOCR, V229, P127, DOI 10.1016/j.ygcen.2016.02.023; TAKASE K, 1995, TOHOKU J EXP MED, V175, P69, DOI 10.1620/tjem.175.69; Takei K, 2001, TRENDS CELL BIOL, V11, P385, DOI 10.1016/S0962-8924(01)02082-7; Tatone C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/659687; Tatone C, 2014, BIOCHEM SOC T, V42, P433, DOI 10.1042/BST20140023; Thress K, 1999, EMBO J, V18, P5486, DOI 10.1093/emboj/18.20.5486; Ucar H, 2013, J CELL SCI, V126, P5153, DOI 10.1242/jcs.130476; Valdebenito II, 2015, ZYGOTE, V23, P177, DOI 10.1017/S0967199413000506; Von Stetina JR, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005553; Wang Q, 2014, GEN COMP ENDOCR, V204, P71, DOI 10.1016/j.ygcen.2014.05.010; Wang XG, 2014, NEUROENDOCRINOL LETT, V35, P523; Wang ZB, 2013, MOL BIOL CELL, V24, P3832, DOI 10.1091/mbc.E13-03-0123; Wassarman PM, 1996, J CELL SCI, V109, P2001; Widowati I, 1992, ACTES COLL, V13, P47; Wu J, 2000, FERTIL STERIL, V74, P1137, DOI 10.1016/S0015-0282(00)01597-1; Zarnescu DC, 1999, J CELL BIOL, V146, P1075, DOI 10.1083/jcb.146.5.1075; Zhang JJ, 2016, GENE, V575, P680, DOI 10.1016/j.gene.2015.09.043; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132941; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003	106	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172805	10.1371/journal.pone.0172805	http://dx.doi.org/10.1371/journal.pone.0172805			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253290	Green Published, gold, Green Submitted			2022-12-26	WOS:000396011300035
J	Marti, M; de Cola, M; MacDonald, NE; Dumolard, L; Duclos, P				Marti, Melanie; de Cola, Monica; MacDonald, Noni E.; Dumolard, Laure; Duclos, Philippe			Assessments of global drivers of vaccine hesitancy in 2014-Looking beyond safety concerns	PLOS ONE			English	Article								Vaccine hesitancy has become the focus of growing attention and concern globally despite overwhelming evidence of the value of vaccines in preventing disease and saving the lives of millions of individuals every year. Measuring vaccine hesitancy and its determinants worldwide is important in order to understand the scope of the problem and for the development of evidence-based targeted strategies to reduce hesitancy. Two indicators to assess vaccine hesitancy were developed to capture its nature and scope at the national and subnational level to collect data in 2014: 1) The top 3 reasons for not accepting vaccines according to the national schedule in the past year and whether the response was opinion-or assessment-based and 2) Whether an assessment (or measurement) of the level of confidence in vaccination had taken place at national or subnational level in the previous 5 years. The most frequently cited reasons for vaccine hesitancy globally related to (1) the risk-benefit of vaccines, (2) knowledge and awareness issues, (3) religious, cultural, gender or socio-economic factors. Major issues were fear of side effects, distrust in vaccination and lack of information on immunization or immunization services. The analysis revealed that 29% of all countries had done an assessment of the level of confidence in their country, suggesting that vaccine confidence was an issue of importance. Monitoring vaccine hesitancy is critical because of its influence on the success of immunization programs. To our knowledge, the proposed indicators provide the first global snapshot of reasons driving vaccine hesitancy and depicting its widespread nature, as well as the extent of assessments conducted by countries.	[Marti, Melanie; de Cola, Monica; Dumolard, Laure; Duclos, Philippe] WHO, Dept Immunizat Vaccines & Biol, Geneva, Switzerland; [MacDonald, Noni E.] Dalhousie Univ, Dept Paediat, IWK Hlth Ctr, Halifax, NS, Canada; [MacDonald, Noni E.] Canadian Ctr Vaccinol, Halifax, NS, Canada	World Health Organization; Dalhousie University	Marti, M (corresponding author), WHO, Dept Immunizat Vaccines & Biol, Geneva, Switzerland.	MartiM@who.int		Marti, Melanie/0000-0002-6800-760X; de Cola, Monica/0000-0001-9444-8460	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2015, WORLD POP PROSP; Dube E, 2014, VACCINE, V32, P6649, DOI 10.1016/j.vaccine.2014.09.039; Duclos P, 2013, VACCINE, V31, P5314, DOI 10.1016/j.vaccine.2013.08.084; Eskola J, 2015, VACCINE, V33, P4215, DOI 10.1016/j.vaccine.2015.04.043; Grabenstein JD, 2013, VACCINE, V31, P2011, DOI 10.1016/j.vaccine.2013.02.026; Kieny MP, 2014, B WORLD HEALTH ORGAN, V92, P850, DOI 10.2471/BLT.14.149278; Larson HJ, 2015, VACCINE, V33, P4165, DOI 10.1016/j.vaccine.2015.04.037; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Leask J, 2014, HUM VACC IMMUNOTHER, V10, P2600, DOI 10.4161/hv.29725; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Muscat M, 2011, J INFECT DIS, V204, pS353, DOI 10.1093/infdis/jir067	11	91	91	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172310	10.1371/journal.pone.0172310	http://dx.doi.org/10.1371/journal.pone.0172310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249006	gold, Green Published, Green Submitted			2022-12-26	WOS:000395983500036
J	Lin, MC; Lin, JJ; Hsu, CL; Juan, HF; Lou, PJ; Huang, MC				Lin, M-C; Lin, J-J; Hsu, C-L; Juan, H-F; Lou, P-J; Huang, M-C			GATA3 interacts with and stabilizes HIF-1 alpha to enhance cancer cell invasiveness	ONCOGENE			English	Article							INDUCIBLE FACTOR 1-ALPHA; BREAST-CANCER; TRANSCRIPTION FACTORS; HYPOXIA; DIFFERENTIATION; EXPRESSION; DEGRADATION; METASTASIS; PROTEASOME; REPRESSION	GATA binding protein 3 (GATA3) is indispensable in development of human organs. However, the role of GATA3 in cancers remains elusive. Hypoxia inducible factor (HIF)-1 plays an important role in pathogenesis of human cancers. Regulation of HIF-1 alpha degradation is orchestrated through collaboration of its interacting proteins. In this study, we discover that GATA3 is upregulated in head and neck squamous cell carcinoma (HNSCC) and is an independent predictor for poor disease-free survival. GATA3 promotes invasive behaviours of HNSCC and melanoma cells in vitro and in immunodeficient mice. Mechanistically, GATA3 physically associates with HIF-1 alpha under hypoxia to inhibit ubiquitination and proteasomal degradation of HIF-1 alpha, which is independent of HIF-1 alpha prolyl hydroxylation. Chromatin immunoprecipitation assays show that the GATA3/HIF-1 alpha complex binds to and regulates HIF-1 target genes, which is also supported by the microarray analysis. Notably, the GATA3-mediated invasiveness can be significantly reversed by HIF-1 alpha knockdown, suggesting a critical role of HIF-1 alpha in the underlying mechanism of GATA3-mediated effects. Our findings suggest that GATA3 stabilizes HIF-1 alpha to enhance cancer invasiveness under hypoxia and support the GATA3/ HIF-1 alpha axis as a potential therapeutic target for cancer treatment.	[Lin, M-C] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Otolaryngol, Hsinchu, Taiwan; [Lin, M-C; Lou, P-J; Huang, M-C] Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, 1,Sec 1 Jen Ai Rd, Taipei 100, Taiwan; [Lin, J-J] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei, Taiwan; [Hsu, C-L; Juan, H-F] Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan; [Lou, P-J] Natl Taiwan Univ, Hosp & Coll Med, Dept Otolaryngol, 7 Chung Shan South Rd, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Lou, PJ; Huang, MC (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, 1,Sec 1 Jen Ai Rd, Taipei 100, Taiwan.; Lou, PJ (corresponding author), Natl Taiwan Univ, Hosp & Coll Med, Dept Otolaryngol, 7 Chung Shan South Rd, Taipei 100, Taiwan.	pjlou@ntu.edu.tw; mchuang@ntu.edu.tw	Hsu, Chia-Lang/O-1458-2013	Hsu, Chia-Lang/0000-0002-7447-8045; LIN, JING-JER/0000-0001-8250-7398; HUANG, MIN-CHUAN/0000-0002-0704-3447; LOU, PEI-JEN/0000-0002-3383-8593	Excellent Translational Medicine Research Projects of National Taiwan University College of Medicine; National Taiwan University Hospital [106C101-D1]; National Taiwan University Hospital, Hsinchu Branch [HCH104-045, 105-HCH020]; Ministry of Science and Technology, ROC [104-2320-B-002 -068 -MY3, 103-2314-B-002 -082 -MY2, 105-2314-B-002 -203 -MY2]; Academia Sinica, Taiwan Head and Neck Cancer Biosignature	Excellent Translational Medicine Research Projects of National Taiwan University College of Medicine; National Taiwan University Hospital(National Taiwan University); National Taiwan University Hospital, Hsinchu Branch; Ministry of Science and Technology, ROC; Academia Sinica, Taiwan Head and Neck Cancer Biosignature	We thank Drs Mien-Chie Hung and Muh-Hwa Yang for editorial advice, Drs Jean-San Chia, Ming-Shyue Lee, Hsiu-Ni Kung, Wan-Lun Hsu and Hung-Lee Chen for technical supports, and Dr Shu-Yun Tung for performing global gene expression analysis. This study was supported by the Excellent Translational Medicine Research Projects of National Taiwan University College of Medicine, and National Taiwan University Hospital (106C101-D1), the National Taiwan University Hospital, Hsinchu Branch, HCH104-045, 105-HCH020 (MC Lin) and Ministry of Science and Technology, ROC 104-2320-B-002 -068 -MY3 (MC Huang), 103-2314-B-002 -082 -MY2 (PJ Lou), 105-2314-B-002 -203 -MY2 (MC Lin), and the Academia Sinica, Taiwan Head and Neck Cancer Biosignature (PJ Lou).	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Cohen H, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0464-0; Engelsen IB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.043; Hanna SC, 2013, J CLIN INVEST, V123, P2078, DOI 10.1172/JCI66715; Haraguchi T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156524; Higgins JPT, 2007, AM J SURG PATHOL, V31, P673, DOI 10.1097/01.pas.0000213438.01278.5f; Ho IC, 2007, CELL MOL IMMUNOL, V4, P15; Hosoya T, 2010, IMMUNOL REV, V238, P110, DOI 10.1111/j.1600-065X.2010.00954.x; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Joshi S, 2014, J BIOL CHEM, V289, P22785, DOI 10.1074/jbc.M114.587493; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Koh MY, 2010, RECENT RESULTS CANC, V180, P15, DOI 10.1007/978-3-540-78281-0_3; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Krek W, 2000, NAT CELL BIOL, V2, pE121, DOI 10.1038/35017129; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Krug N, 2015, NEW ENGL J MED, V372, P1987, DOI 10.1056/NEJMoa1411776; LABASTIE MC, 1995, KIDNEY INT, V47, P1597, DOI 10.1038/ki.1995.223; Lawoko-Kerali G, 2002, J COMP NEUROL, V442, P378, DOI 10.1002/cne.10088; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Lim KC, 2000, NAT GENET, V25, P209, DOI 10.1038/76080; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Mehra R, 2005, CANCER RES, V65, P11259, DOI 10.1158/0008-5472.CAN-05-2495; Moriguchi T, 2006, DEVELOPMENT, V133, P3871, DOI 10.1242/dev.02553; Peng HW, 2015, MOL MED REP, V11, P881, DOI 10.3892/mmr.2014.2809; Popp V, 2017, GASTROENTEROLOGY, V152, P176, DOI 10.1053/j.gastro.2016.09.005; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shan L, 2014, ONCOGENE, V33, P3205, DOI 10.1038/onc.2013.270; Si WZ, 2015, CANCER CELL, V27, P822, DOI 10.1016/j.ccell.2015.04.011; SIMON MC, 1995, NAT GENET, V11, P9, DOI 10.1038/ng0995-9; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Winter SC, 2006, CANCER-AM CANCER SOC, V107, P757, DOI 10.1002/cncr.21983; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691	37	35	36	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 27	2017	36	30					4243	4252		10.1038/onc.2017.8	http://dx.doi.org/10.1038/onc.2017.8			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FB8AH	28263977	Green Published, hybrid			2022-12-26	WOS:000406360600002
J	Li, Y; Zheng, XM; Yi, XL; Liu, CX; Kong, DX; Zhang, JN; Gong, M				Li, Ying; Zheng, Xuemin; Yi, Xiulin; Liu, Changxiao; Kong, Dexin; Zhang, Jianning; Gong, Min			Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist	FASEB JOURNAL			English	Article						GLP-1 receptor; oral agonist; insulin secretagogue; glucose tolerance test	GLUCAGON-LIKE PEPTIDE-1; DEPENDENT INSULINOTROPIC POLYPEPTIDE; CARDIOVASCULAR-DISEASE; CELL-PROLIFERATION; METABOLIC SYNDROME; RAT ADIPOCYTES; BETA-CELLS; MOLECULE; GLP-1; DIFFERENTIATION	The physiologic properties of glucagon-like peptide 1 (GLP-1) make it a potent candidate drug target in the treatment of type 2 diabetes mellitus (T2DM). GLP-1 is capable of regulating the blood glucose level by insulin secretion after administration of oral glucose. The advantages of GLP-1 for the avoidance of hypoglycemia and the control of body weight are attractive despite its poor stability. The clinical efficacies of long-acting GLP-1 derivatives strongly support discovery pursuits aimed at identifying and developing orally active, small-molecule GLP-1 receptor (GLP-1R) agonists. The purpose of this study was to identify and characterize a novel oral agonist of GLP-1R (i.e., myricetin). The insulinotropic characterization of myricetin was performed in isolated islets and in Wistar rats. Long-termoral administration of myricetin demonstrated glucoregulatory activity. The data in this study suggest that myricetin might be a potential drug candidate for the treatment of T2DM as a GLP-1R agonist. Further structural modifications on myricetin might improve its pharmacology and pharmacokinetics.	[Li, Ying; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Tianjin, Peoples R China; [Kong, Dexin; Gong, Min] Tianjin Med Univ, Dept Pharm, Tianjin 300070, Peoples R China; [Zheng, Xuemin; Yi, Xiulin; Liu, Changxiao] Tianjin Inst Pharmaceut Res, State Key Lab Drug Delivery Technol & Pharmacokin, Tianjin, Peoples R China; [Gong, Min] Univ Oxford, Dept Oncol, Oxford, England	Tianjin Medical University; Tianjin Medical University; University of Oxford	Gong, M (corresponding author), Tianjin Med Univ, Dept Pharm, Tianjin 300070, Peoples R China.; Zhang, JN (corresponding author), Tianjin Med Univ, Tianjin Neurol Inst, Gen Hosp, 22 Qixiangtai Rd, Heping Qu 300070, Peoples R China.	kahongmg@hotmail.com; gongmin@tmu.edu.cn			Ministry of Science and Technology of China [2014ZX09507005-003]; National Natural Science [81400932]; Science and Technology of Tianjin [13RCGFSY19700]; Natural Science Foundation of Tianjin, China [12JCYBJC31500]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science(National Natural Science Foundation of China (NSFC)); Science and Technology of Tianjin; Natural Science Foundation of Tianjin, China(Natural Science Foundation of Tianjin)	This work was supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China (2014ZX09507005-003), the National Natural Science Funding (81400932), Major Project of Science and Technology of Tianjin (13RCGFSY19700), and the Natural Science Foundation of Tianjin, China (12JCYBJC31500). The authors declare no conflicts of interest.	Brubaker PL, 2004, ENDOCRINOLOGY, V145, P2653, DOI 10.1210/en.2004-0015; Chen DS, 2007, P NATL ACAD SCI USA, V104, P943, DOI 10.1073/pnas.0610173104; Devigny C, 2011, J AM CHEM SOC, V133, P8927, DOI 10.1021/ja200160s; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; EISSELE R, 1994, CELL TISSUE RES, V276, P571; ELAHI D, 1994, REGUL PEPTIDES, V51, P63, DOI 10.1016/0167-0115(94)90136-8; Eldor Roy, 2010, J Diabetes Sci Technol, V4, P1516; FRIDOLF T, 1991, PANCREAS, V6, P208, DOI 10.1097/00006676-199103000-00013; GOKE B, 1994, EUR J CLIN INVEST, V24, P25; Guariguata L, 2013, DIABETES RES CLIN PR, V100, P280, DOI 10.1016/j.diabres.2013.02.006; Guariguata L, 2012, DIABETES RES CLIN PR, V98, P524, DOI 10.1016/j.diabres.2012.11.006; Harnly JM, 2006, J AGR FOOD CHEM, V54, P9966, DOI 10.1021/jf061478a; HOLST JJ, 1994, GASTROENTEROLOGY, V107, P1848, DOI 10.1016/0016-5085(94)90831-1; Irwin N, 2010, EUR J PHARMACOL, V628, P268, DOI 10.1016/j.ejphar.2009.11.022; Janghorbani M, 2011, DIABETES METAB SYND, V5, P201, DOI 10.1016/j.dsx.2012.02.010; Jansson SPO, 2016, DIABETIC MED, V33, P324, DOI 10.1111/dme.13019; Kandasamy N, 2014, TOXICOL APPL PHARM, V279, P173, DOI 10.1016/j.taap.2014.05.014; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Kirtland KA, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130300; KREYMANN B, 1987, LANCET, V2, P1300; Kwon O, 2007, FASEB J, V21, P366, DOI 10.1096/fj.06-6620com; Lin CY, 2012, CYTOKINE, V59, P65, DOI 10.1016/j.cyto.2012.04.011; Lin Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162733; Linn T, 1996, ACTA DIABETOL, V33, P19, DOI 10.1007/BF00571935; Linnenkamp U, 2014, DIABETES RES CLIN PR, V103, P186, DOI 10.1016/j.diabres.2013.11.004; Liu IM, 2007, LIFE SCI, V81, P1479, DOI 10.1016/j.lfs.2007.08.045; Manaharan T, 2013, FOOD CHEM, V136, P354, DOI 10.1016/j.foodchem.2012.08.056; Martell-Claros N, 2013, EUR J PREV CARDIOL, V20, P21, DOI 10.1177/1741826711423114; Nauck MA, 1997, EXP CLIN ENDOCR DIAB, V105, P187, DOI 10.1055/s-0029-1211750; Okerson T, 2012, CARDIOVASC THER, V30, pe146, DOI 10.1111/j.1755-5922.2010.00256.x; Ong KC, 1996, BIOCHEM PHARMACOL, V51, P423, DOI 10.1016/0006-2952(95)02195-7; Ong KC, 2000, LIFE SCI, V67, P1695, DOI 10.1016/S0024-3205(00)00758-X; OSHIMA I, 1991, HORM METAB RES, V23, P240, DOI 10.1055/s-2007-1003663; Park HK, 2015, DIABETES METAB J, V39, P478, DOI 10.4093/dmj.2015.39.6.478; ROTH KA, 1992, AM J PHYSIOL, V263, pG174, DOI 10.1152/ajpgi.1992.263.2.G174; RUIZGRANDE C, 1990, CAN J PHYSIOL PHARM, V68, P1568, DOI 10.1139/y90-239; Scott R, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-102; Semwal DK, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020090; SHIMA K, 1988, REGUL PEPTIDES, V22, P245, DOI 10.1016/0167-0115(88)90037-7; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; Song SH, 2016, LANCET DIABETES ENDO, V4, P87, DOI 10.1016/S2213-8587(15)00390-3; Strobel P, 2005, BIOCHEM J, V386, P471, DOI 10.1042/BJ20040703; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Teng M, 2007, BIOORG MED CHEM LETT, V17, P5472, DOI 10.1016/j.bmcl.2007.06.086; Tong Y, 2009, ARCH PHARM RES, V32, P527, DOI 10.1007/s12272-009-1408-6; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wootten D, 2012, MOL PHARMACOL, V82, P281, DOI 10.1124/mol.112.079319	47	42	43	4	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2603	2611		10.1096/fj.201601339R	http://dx.doi.org/10.1096/fj.201601339R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28270518	Green Published, hybrid			2022-12-26	WOS:000401553400031
J	Zhao, JJ; Wu, W; Zhang, W; Lu, YW; Tou, E; Ye, JM; Gao, P; Jourd'heuil, D; Singer, HA; Wu, MF; Long, XC				Zhao, Jinjing; Wu, Wen; Zhang, Wei; Lu, Yao Wei; Tou, Emiley; Ye, Jiemei; Gao, Ping; Jourd'heuil, David; Singer, Harold A.; Wu, Mingfu; Long, Xiaochun			Selective expression of TSPAN2 in vascular smooth muscle is independently regulated by TGF-beta 1/SMAD and myocardin/serum response factor	FASEB JOURNAL			English	Article						differentiation; tetraspanins; phenotypic modulation; arteriovenous fistula	LONG NONCODING RNA; CELL DIFFERENTIATION; NEOINTIMAL HYPERPLASIA; AORTIC-ANEURYSM; GROWTH; GENE; PROTEIN; MICE; ATHEROSCLEROSIS; PHENOTYPE	Tetraspanins (TSPANs) comprise a large family of 4-trans membrane domain proteins. The importance of TSPANs in vascular smooth muscle cells (VSMCs) is unexplored. Given that TGF-beta 1 and myocardin (MYOCD) are potent activators for VSMC differentiation, we screened for TGF-beta 1 and MYOCD/serum response factor (SRF)regulated TSPANs in VSMC by using RNA-seq analyses and RNA-arrays. TSPAN2 was found to be the only TSPAN family gene induced by TGF-beta 1 and MYOCD, and reduced by SRF deficiency in VSMCs. We also found that TSPAN2 is highly expressed in smooth muscle-enriched tissues and down-regulated in in vitro models of VSMC phenotypic modulation. TSPAN2 expressionis attenuated in mouse carotid arteries after ligation injury and infailed human arteriovenous fistula samples after occlusion by dedifferentiated neointimal VSMC. In vitro functional studies showed that TSPAN2 suppresses VSMC proliferation and migration. Luciferase reporter and chromatin immunoprecipitation assays demonstrated that TSPAN2 is regulated by 2 parallel pathways, MYOCD/SRF and TGF-beta 1/SMAD, via distinct binding elements within the proximal promoter. Thus, we identified the first VSMC-enriched and MYOCD/SRFandTGF-beta 1/SMAD-dependentTSPANfamilymember, whose expression is intimately associated with VSMC differentiation and negatively correlated with vascular disease. Our results suggest that TSPAN2 may play important roles in vascular disease.-Zhao, J., Wu, W., Zhang, W., Lu, Y. W., Tou, E., Ye, J., Gao, P., Jourd'heuil, D., Singer, H. A., Wu, M., Long, X. Selective expression of TSPAN2 in vascular smooth muscle is independently regulated by TGF-beta 1/SMAD and myocardin/serum response factor.	[Zhao, Jinjing; Wu, Wen; Zhang, Wei; Lu, Yao Wei; Tou, Emiley; Ye, Jiemei; Gao, Ping; Jourd'heuil, David; Singer, Harold A.; Wu, Mingfu; Long, Xiaochun] Albany Med Coll, Dept Mol & Cellular Physiol, 47 New Scotland Ave, Albany, NY 12208 USA	Albany Medical College	Long, XC (corresponding author), Albany Med Coll, Dept Mol & Cellular Physiol, 47 New Scotland Ave, Albany, NY 12208 USA.	longx@mail.amc.edu	Lu, Yao Wei/AAV-2007-2021; Wu, Wen/V-7065-2017	Lu, Yao Wei/0000-0001-6200-2974; Long, Xiaochun/0000-0001-9714-0023; Tou, Emiley/0000-0003-2992-4269; Jourd'heuil, David/0000-0002-6555-5061	American Heart Association Scientist Development Grant [10SDG3670036, 13SDG16920099]; U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) [R01-HL122686]; Paul Teschan Research Fund [2015_04]; Albany Medical College faculty startup funding; NIH/NHLBI [R01-HL121700, R01-HL49426]; American Heart Association [16GRNT31280002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122686, R01HL121700, R01HL049426] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI); Paul Teschan Research Fund; Albany Medical College faculty startup funding; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Scientist Development Grant 10SDG3670036, U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) Grant R01-HL122686, Paul Teschan Research Fund #2015_04, and Albany Medical College faculty startup funding (to X.L.); American Heart Association Scientist Development Grant 13SDG16920099 and NIH/NHLBI Grant R01-HL121700 (to M.W.); NIH/NHLBI Grant R01-HL49426 (to H.A.S.); and American Heart Association Grant-in-Aid 16GRNT31280002 (to D.J.). The authors declare no conflicts of interest.	Ackers-Johnson M, 2015, ARTERIOSCL THROM VAS, V35, P817, DOI 10.1161/ATVBAHA.114.305218; Albinsson S, 2011, PHYSIOL GENOMICS, V43, P529, DOI 10.1152/physiolgenomics.00146.2010; Alexander MR, 2012, PHYSIOL GENOMICS, V44, P417, DOI 10.1152/physiolgenomics.00160.2011; Bell RD, 2014, ARTERIOSCL THROM VAS, V34, P1249, DOI 10.1161/ATVBAHA.114.303240; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cai YJ, 2015, CIRC RES, V116, P1120, DOI 10.1161/CIRCRESAHA.116.304408; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chen PY, 2016, EMBO MOL MED, V8, P712, DOI 10.15252/emmm.201506181; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; de Monasterio-Schrader P, 2013, GLIA, V61, P1832, DOI 10.1002/glia.22561; Delos Santos RC, 2015, CELL SIGNAL, V27, P1963, DOI 10.1016/j.cellsig.2015.07.004; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Geary RL, 2002, ARTERIOSCL THROM VAS, V22, P2010, DOI 10.1161/01.ATV.0000038147.93527.35; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Herr MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106999; Herring BP, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-21; Hu JH, 2015, ARTERIOSCL THROM VAS, V35, P2647, DOI 10.1161/ATVBAHA.115.306573; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Huang JH, 2015, P NATL ACAD SCI USA, V112, P4447, DOI 10.1073/pnas.1420363112; Hur J, 2016, CELL STEM CELL, V18, P508, DOI 10.1016/j.stem.2016.01.013; Hwang IH, 2016, FASEB J, V30, P3107, DOI 10.1096/fj.201600240RR; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Kiene LS, 2016, ARTERIOSCL THROM VAS, V36, pE9, DOI 10.1161/ATVBAHA.115.306607; Kitchen CM, 2013, GENE, V513, P82, DOI 10.1016/j.gene.2012.10.073; Larsson E, 2008, MOL GENET GENOMICS, V280, P127, DOI 10.1007/s00438-008-0349-y; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Lilly B, 2001, DEV BIOL, V240, P531, DOI 10.1006/dbio.2001.0507; Long XC, 2013, ARTERIOSCL THROM VAS, V33, P378, DOI 10.1161/ATVBAHA.112.300645; Long XC, 2011, J BIOL CHEM, V286, P30119, DOI 10.1074/jbc.M111.258814; Long X, 2009, J BIOL CHEM, V284, P33671, DOI 10.1074/jbc.M109.050419; Mao X, 2012, ARTERIOSCL THROM VAS, V32, P2171, DOI 10.1161/ATVBAHA.112.253872; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Miano JM, 2015, CELL MOL LIFE SCI, V72, P3457, DOI 10.1007/s00018-015-1936-9; Miano JM, 2015, J BIOMED RES, V29, P3, DOI 10.7555/JBR.29.20140151; Otsubo C, 2014, CELL REP, V7, P527, DOI 10.1016/j.celrep.2014.03.027; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; PAULETTO P, 1994, AM J HYPERTENS, V7, P661, DOI 10.1093/ajh/7.7.661; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Rosand J, 2016, LANCET NEUROL, V15, P174, DOI 10.1016/S1474-4422(15)00338-5; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Thyberg J, 1998, HISTOL HISTOPATHOL, V13, P871, DOI 10.14670/HH-13.871; Wang XB, 2011, J BIOL CHEM, V286, P41589, DOI 10.1074/jbc.M111.250878; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wei Q, 2014, CIRCULATION, V130, P1493, DOI 10.1161/CIRCULATIONAHA.114.011096; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Zhang C, 2016, J CLIN INVEST, V126, P1282, DOI 10.1172/JCI82337; Zhang F, 2009, CARDIOVASC RES, V83, P7, DOI 10.1093/cvr/cvp080; Zhang P, 2016, CIRC RES, V118, P388, DOI 10.1161/CIRCRESAHA.115.308040; Zhao JJ, 2016, ARTERIOSCL THROM VAS, V36, P2088, DOI 10.1161/ATVBAHA.116.307879	55	15	17	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2576	2591		10.1096/fj.201601021R	http://dx.doi.org/10.1096/fj.201601021R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28258189	Green Published			2022-12-26	WOS:000401553400029
J	Christensen, EM; Patel, SM; Korasick, DA; Campbell, AC; Krause, KL; Becker, DF; Tanner, JJ				Christensen, Emily M.; Patel, Sagar M.; Korasick, David A.; Campbell, Ashley C.; Krause, Kurt L.; Becker, Donald F.; Tanner, John J.			Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-10-FORMYLTETRAHYDROFOLATE SYNTHETASE; CRYSTAL-STRUCTURES; ELECTRON-DENSITY; PROTEIN CRYSTALLOGRAPHY; GENERAL ACID; TIME PASSES; DEHYDROGENASE; FEATURES; METABOLISM; RESOLUTION	Pyrroline-5-carboxylate reductase (PYCR) is the final enzyme in proline biosynthesis, catalyzing the NAD(P)H-dependent reduction of Delta(1)-pyrroline-5-carboxylate (P5C) to proline. Mutations in the PYCR1 gene alter mitochondrial function and cause the connective tissue disorder cutis laxa. Furthermore, PYCR1 is overexpressed in multiple cancers, and the PYCR1 knock-out suppresses tumorigenic growth, suggesting that PYCR1 is a potential cancer target. However, inhibitor development has been stymied by limited mechanistic details for the enzyme, particularly in light of a previous crystallographic study that placed the cofactor-binding site in the C-terminal domain rather than the anticipated Rossmann fold of the N-terminal domain. To fill this gap, we report crystallographic, sedimentation-velocity, and kinetics data for human PYCR1. Structures of binary complexes of PYCR1 with NADPH or proline determined at 1.9 angstrom resolution provide insight into cofactor and substrate recognition. We see NADPH bound to the Rossmann fold, over 25 angstrom from the previously proposed site. The 1.85 angstrom resolution structure of a ternary complex containing NADPH and a P5C/proline analog provides a model of the Michaelis complex formed during hydride transfer. Sedimentation velocity shows that PYCR1 forms a concentration-dependent decamer in solution, consistent with the pentamer-of-dimers assembly seen crystallographically. Kinetic and mutational analysis confirmed several features seen in the crystal structure, including the importance of a hydrogen bond between Thr-238 and the substrate as well as limited cofactor discrimination.	[Christensen, Emily M.; Tanner, John J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Korasick, David A.; Campbell, Ashley C.; Tanner, John J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Krause, Kurt L.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand; [Patel, Sagar M.; Becker, Donald F.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Patel, Sagar M.; Becker, Donald F.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Otago; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Tanner, JJ (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	tannerjj@missouri.edu	Patel, Sagar M./ABI-1741-2020	Patel, Sagar M./0000-0002-1700-3350; Tanner, John/0000-0001-8314-113X; Korasick, David/0000-0002-6337-2085	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065546] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Jay Nix for help with X-ray diffraction data collection at beamline 4.2.2 of the Advanced Light Source. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; ADAMS MJ, 1970, NATURE, V227, P1098, DOI 10.1038/2271098a0; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bottoms CA, 2002, PROTEIN SCI, V11, P2125, DOI 10.1110/ps.0213502; Branden C., 1991, INTRO PORTEIN STRUCT, pChapter 10; BUEHNER M, 1974, J MOL BIOL, V90, P25, DOI 10.1016/0022-2836(74)90254-X; Celeste L, 2013, PROTEIN SCI, V22, P675, DOI 10.1002/pro.2251; Celeste LR, 2012, PROTEIN SCI, V21, P219, DOI 10.1002/pro.2005; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; De Ingeniis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045190; DeLano W.L., 2015, PYMOL MOL GRAPHICS S; Deller MC, 2015, J COMPUT AID MOL DES, V29, P817, DOI 10.1007/s10822-015-9833-8; Edwards MA, 2017, ENVIRON ENG SCI, V34, P51, DOI 10.1089/ees.2016.0223; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Franklin MC, 2015, PROTEINS, V83, P2124, DOI 10.1002/prot.24841; Hammes-Schiffer S, 2002, CHEMPHYSCHEM, V3, P33, DOI 10.1002/1439-7641(20020118)3:1<33::AID-CPHC33>3.0.CO;2-6; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keenholtz RA, 2013, J BIOL CHEM, V288, P29206, DOI 10.1074/jbc.M113.508028; Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liu D, 2000, BIOCHEMISTRY-US, V39, P11955, DOI 10.1021/bi000790p; Loayza-Puch F, 2016, NATURE, V530, P490, DOI 10.1038/nature16982; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng ZH, 2006, J MOL BIOL, V359, P1364, DOI 10.1016/j.jmb.2006.04.053; Michaelis L, 1913, BIOCHEM Z, V49, P333; Moxley MA, 2014, J BIOL CHEM, V289, P3639, DOI 10.1074/jbc.M113.523704; Muller YA, 2013, ACTA CRYSTALLOGR F, V69, P1071, DOI 10.1107/S1744309113014383; Nakayama T, 2015, AM J HUM GENET, V96, P709, DOI 10.1016/j.ajhg.2015.03.003; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Nocek B, 2005, J MOL BIOL, V354, P91, DOI 10.1016/j.jmb.2005.08.036; Ou RY, 2016, TUMOR BIOL, V37, P6485, DOI 10.1007/s13277-015-3927-8; Pemberton TA, 2012, ACTA CRYSTALLOGR D, V68, P1010, DOI 10.1107/S0907444912019580; Phang JM, 2010, ANNU REV NUTR, V30, P441, DOI 10.1146/annurev.nutr.012809.104638; Phang JM, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00060; PHANG JM, 1985, CURR TOP CELL REGUL, V25, P91; Pozharski E, 2013, ACTA CRYSTALLOGR D, V69, P150, DOI 10.1107/S0907444912044423; Reversade B, 2009, NAT GENET, V41, P1016, DOI 10.1038/ng.413; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Ruszkowski M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00869; Sang P, 2017, J BIOMOL STRUCT DYN, V35, P2441, DOI 10.1080/07391102.2016.1222967; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Singh RK, 2011, J BIOL CHEM, V286, P43144, DOI 10.1074/jbc.M111.292474; Stec B, 2013, PROTEIN SCI, V22, P671, DOI 10.1002/pro.2252; Tanner JJ, 2008, AMINO ACIDS, V35, P719, DOI 10.1007/s00726-008-0062-5; Touw WG, 2016, J MOL BIOL, V428, P1375, DOI 10.1016/j.jmb.2016.02.002; Weichenberger CX, 2013, ACTA CRYSTALLOGR F, V69, P195, DOI 10.1107/S1744309112044387; Weiss MS, 2016, HUM MOL GENET, V25, P4717, DOI 10.1093/hmg/ddw298; WILLIAMS I, 1975, ANAL BIOCHEM, V64, P85, DOI 10.1016/0003-2697(75)90408-X; Wlodawer A, 2013, FEBS J, V280, P5705, DOI 10.1111/febs.12495; Zeng TY, 2017, MED ONCOL, V34, DOI 10.1007/s12032-016-0870-5	53	30	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7233	7243		10.1074/jbc.M117.780288	http://dx.doi.org/10.1074/jbc.M117.780288			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28258219	hybrid, Green Published			2022-12-26	WOS:000400478300033
J	Duque, A; Vinader-Caerols, C; Monleon, S				Duque, Aranzazu; Vinader-Caerols, Concepcion; Monleon, Santiago			Indomethacin counteracts the effects of chronic social defeat stress on emotional but not recognition memory in mice	PLOS ONE			English	Article							PASSIVE-AVOIDANCE TASK; ADULT MALE RATS; ANIMAL-MODELS; OBJECT RECOGNITION; SPATIAL MEMORY; HIPPOCAMPAL NEUROGENESIS; IMMUNE DYSREGULATION; POSTTRAUMATIC STRESS; ALZHEIMERS-DISEASE; BEHAVIORAL-CHANGES	We have previously observed the impairing effects of chronic social defeat stress (CSDS) on emotional memory in mice. Given the relation between stress and inflammatory pro-cesses, we sought to study the effectiveness of the anti-inflammatory indomethacin in reversing the detrimental effects of CSDS on emotional memory in mice. The effects of CSDS and indomethacin on recognition memory were also evaluated. Male CD1 mice were randomly divided into four groups: non-stressed + saline (NS+ SAL); non-stressed + indo-methacin (NS+ IND); stressed + saline (S+ SAL); and stressed + indomethacin (S+ IND). Stressed animals were exposed to a daily 10 min agonistic confrontation (CSDS) for 20 days. All subjects were treated daily with saline or indomethacin (10 mg/kg, i. p.). 24 h after the CSDS period, all the mice were evaluated in a social interaction test to distinguish between those that were resilient or susceptible to social stress. All subjects (n = 10-12 per group) were then evaluated in inhibitory avoidance (IA), novel object recognition (NOR), ele-vated plus maze and hot plate tests. As in control animals (NS+ SAL group), IA learning was observed in the resilient groups, as well as in the susceptible mice treated with indomethacin (S+ IND group). Recognition memory was observed in the non-stressed and the resilient mice, but not in the susceptible animals. Also, stressed mice exhibited higher anxiety levels. No significant differences were observed in locomotor activity or analgesia. In conclusion, CSDS induces anxiety in post-pubertal mice and impairs emotional and recognition memory in the susceptible subjects. The effects of CSDS on emotional memory, but not on recogni-tion memory and anxiety, are reversed by indomethacin. Moreover, memory impairment is not secondary to the effects of CSDS on locomotor activity, emotionality or pain sensitivity.	[Duque, Aranzazu; Vinader-Caerols, Concepcion; Monleon, Santiago] Univ Valencia, Dept Psychobiol, Valencia, Spain	University of Valencia	Monleon, S (corresponding author), Univ Valencia, Dept Psychobiol, Valencia, Spain.	santiago.monleon@uv.es		Monleon, Santiago/0000-0001-8766-5969	Ministerio de Economia y Competitividad [PSI2013-44491-P]; Generalitat Valenciana, Spain [PROMETEOII/2015/020]	Ministerio de Economia y Competitividad(Spanish Government); Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF))	This work was supported by the "Ministerio de Economia y Competitividad" (Grant PSI2013-44491-P) and "Generalitat Valenciana" (Grant PROMETEOII/2015/020), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047218; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Azzinnari D, 2014, NEUROPHARMACOLOGY, V85, P328, DOI 10.1016/j.neuropharm.2014.05.039; Bahi A, 2013, STRESS, V16, P441, DOI 10.3109/10253890.2012.754419; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Blanchard RJ, 2001, PHYSIOL BEHAV, V73, P261, DOI 10.1016/S0031-9384(01)00449-8; Boehme M, 2014, NEUROSCI LETT, V572, P7, DOI 10.1016/j.neulet.2014.04.043; Borniger JC, 2014, PHYSIOL BEHAV, V133, P99, DOI 10.1016/j.physbeh.2014.05.012; Buller KM, 1998, J NEUROENDOCRINOL, V10, P519; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; Campeau S, 2011, STRESS, V14, P503, DOI 10.3109/10253890.2011.596864; Campos AC, 2013, REV BRAS PSIQUIATR, V35, pS101, DOI 10.1590/1516-4446-2013-1139; Castro P, 2009, BIOCHEM PHARMACOL, V77, P1029, DOI 10.1016/j.bcp.2008.12.012; Charney Dennis S, 2004, Sci STKE, V2004, pre5, DOI 10.1126/stke.2252004re5; Cordero MI, 2003, HORM BEHAV, V44, P338, DOI 10.1016/S0018-506X(03)00160-0; Costa-Nunes J, 2014, STRESS, V17, P108, DOI 10.3109/10253890.2013.872619; Craig K.D., 2006, WALL MELLZACKS TXB P, V5th, P231; de Quervain D, 2017, NAT REV NEUROSCI, V18, P7, DOI 10.1038/nrn.2016.155; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Duque A, 2016, ACTA NEUROBIOL EXP, V76, P225, DOI 10.21307/ane-2017-022; Eagle AL, 2013, BEHAV BRAIN RES, V256, P591, DOI 10.1016/j.bbr.2013.09.014; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Fagundes CP, 2013, BRAIN BEHAV IMMUN, V27, P8, DOI 10.1016/j.bbi.2012.06.014; Fan JH, 2017, BEHAV BRAIN RES, V316, P136, DOI 10.1016/j.bbr.2016.09.011; FILE SE, 1978, BRIT J PHARMACOL, V62, P19, DOI 10.1111/j.1476-5381.1978.tb07001.x; Finsterwald C, 2015, J NEUROSCI, V35, P15903, DOI 10.1523/JNEUROSCI.0771-15.2015; Fuertig R, 2016, BRAIN BEHAV IMMUN, V54, P59, DOI 10.1016/j.bbi.2015.12.020; Furtado M, 2015, PSYCHIAT RES, V229, P37, DOI 10.1016/j.psychres.2015.05.036; GOLD PE, 1986, BEHAV NEURAL BIOL, V46, P87, DOI 10.1016/S0163-1047(86)90927-1; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; HEISE GA, 1981, TRENDS PHARMACOL SCI, V2, P158, DOI 10.1016/0165-6147(81)90297-2; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Holder MK, 2014, FRONT NEUROENDOCRIN, V35, P89, DOI 10.1016/j.yfrne.2013.10.004; HOLSCHER C, 1995, EUR J NEUROSCI, V7, P1360, DOI 10.1111/j.1460-9568.1995.tb01127.x; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Huang GB, 2016, PROG NEURO-PSYCHOPH, V66, P73, DOI 10.1016/j.pnpbp.2015.12.002; IBM Corp, 2010, IBM SPSS STAT WIND V; Imbe H, 2006, FRONT BIOSCI-LANDMRK, V11, P2179, DOI 10.2741/1960; Iniguez SD, 2014, STRESS, V17, P247, DOI 10.3109/10253890.2014.910650; Ishida T, 2007, J PSYCHOPHARMACOL, V21, P757, DOI 10.1177/0269881107076369; Izquierdo I, 1997, PSYCHOBIOLOGY, V25, P1; Jaremka LM, 2013, PSYCHONEUROENDOCRINO, V38, P1310, DOI 10.1016/j.psyneuen.2012.11.016; Jung SH, 2015, BRAIN BEHAV IMMUN, V44, P195, DOI 10.1016/j.bbi.2014.09.015; Kanno T, 2012, J CELL PHYSIOL, V227, P919, DOI 10.1002/jcp.22800; Kenney JW, 2011, PSYCHOPHARMACOLOGY, V217, P353, DOI 10.1007/s00213-011-2283-7; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Krishnan V, 2014, EXP NEUROL, V261, P412, DOI 10.1016/j.expneurol.2014.05.012; KUDRYAVTSEVA NN, 1991, PHARMACOL BIOCHEM BE, V38, P315, DOI 10.1016/0091-3057(91)90284-9; Kumar S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5537; Larauche M, 2012, EXP NEUROL, V233, P49, DOI 10.1016/j.expneurol.2011.04.020; Lawlor PA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-11; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lee S, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00129; Lehmann ML, 2013, J NEUROSCI, V33, P2961, DOI 10.1523/JNEUROSCI.3878-12.2013; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Lukas M, 2011, NEUROPSYCHOPHARMACOL, V36, P2159, DOI 10.1038/npp.2011.95; Lupien SJ, 1999, REV NEUROSCIENCE, V10, P117; Martinez M, 1998, AGGRESSIVE BEHAV, V24, P241; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Meduri JD, 2013, BEHAV BRAIN RES, V256, P580, DOI 10.1016/j.bbr.2013.09.009; Mesa-Gresa P, 2016, PHYSIOL BEHAV, V158, P6, DOI 10.1016/j.physbeh.2016.02.027; Mesa-Gresa P, 2013, AGGRESSIVE BEHAV, V39, P269, DOI 10.1002/ab.21481; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monleon S, 2016, BEHAV PROCESS, V124, P23, DOI 10.1016/j.beproc.2015.12.002; Monleon S, 2015, BEHAV PROCESS, V115, P64, DOI 10.1016/j.beproc.2015.03.003; Morrissey MD, 2011, NEUROBIOL LEARN MEM, V95, P46, DOI 10.1016/j.nlm.2010.10.007; Narenji Somayeh Assadian, 2012, Iranian Biomedical Journal, V16, P145, DOI 10.6091/IBJ.1046.2012; Negron-Oyarzo I, 2014, BEHAV BRAIN RES, V259, P342, DOI 10.1016/j.bbr.2013.11.001; Ohl F, 1999, COGNITIVE BRAIN RES, V7, P379, DOI 10.1016/S0926-6410(98)00042-1; Ohl F, 1998, NEUROSCI BIOBEHAV R, V23, P319, DOI 10.1016/S0149-7634(98)00033-5; Okada R, 2015, NEUROSCIENCE, V299, P134, DOI 10.1016/j.neuroscience.2015.04.064; Panksepp J, 2004, BRAIN RES, V1025, P75, DOI 10.1016/j.brainres.2004.07.076; Patki G, 2013, BRAIN RES, V1539, P73, DOI 10.1016/j.brainres.2013.09.033; Perez-Tejada J, 2013, NEUROENDOCRINOLOGY, V98, P73, DOI 10.1159/000353620; Pfau ML, 2016, TRENDS NEUROSCI, V39, P353, DOI 10.1016/j.tins.2016.04.004; Powell ND, 2013, P NATL ACAD SCI USA, V110, P16574, DOI 10.1073/pnas.1310655110; Quan N, 2001, J NEUROIMMUNOL, V115, P36, DOI 10.1016/S0165-5728(01)00273-9; Razzoli M, 2011, PHARMACOL BIOCHEM BE, V97, P566, DOI 10.1016/j.pbb.2010.09.010; Reger ML, 2009, DEV PSYCHOBIOL, V51, P672, DOI 10.1002/dev.20402; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Rothwell NJ, 1999, J PHYSIOL-LONDON, V514, P3, DOI 10.1111/j.1469-7793.1999.003af.x; Sato T, 2007, EUR J PHARMACOL, V560, P36, DOI 10.1016/j.ejphar.2007.01.011; Schroeder A, 2015, BEHAV BRAIN RES, V287, P304, DOI 10.1016/j.bbr.2015.03.063; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Silvers JM, 2007, J NEUROSCI METH, V166, P99, DOI 10.1016/j.jneumeth.2007.06.032; Smith FG, 2011, CLIN EXP PHARMACOL P, V38, P494, DOI 10.1111/j.1440-1681.2011.05536.x; Snedecor GW, 1980, STAT METHODS, V7th; Sorrells SF, 2014, NEUROENDOCRINOLOGY, V100, P129, DOI 10.1159/000367849; Stackman RW, 2003, EXP NEUROL, V184, P510, DOI 10.1016/S0014-4886(03)00399-6; Stankiewicz AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142195; Stephan A, 2003, EUR J NEUROSCI, V17, P1921, DOI 10.1046/j.1460-9568.2003.02610.x; Suleyman H, 2007, PHARMACOL REP, V59, P247; Teather LA, 2002, LEARN MEMORY, V9, P41, DOI 10.1101/lm.43602; Toth I, 2013, CELL TISSUE RES, V354, P107, DOI 10.1007/s00441-013-1636-4; Touyarot K, 2004, PSYCHONEUROENDOCRINO, V29, P290, DOI 10.1016/S0306-4530(03)00031-3; Uchoa ET, 2014, J NEUROENDOCRINOL, V26, P557, DOI 10.1111/jne.12157; Van Kampen M, 2000, PHARMACOL BIOCHEM BE, V65, P539, DOI 10.1016/S0091-3057(99)00190-2; Vinader-Caerols C, 2006, ACTA NEUROBIOL EXP, V66, P23; Vinader-Caerols C, 2012, EFFECTS ANTIDEPRESSA, P23; Wang J.A., 2013, METAL MINE, V10, P8, DOI DOI 10.1371/J0URNAL.P0NE.0064929; Wang XD, 2011, NEUROBIOL DIS, V42, P300, DOI 10.1016/j.nbd.2011.01.020; Watt MJ, 2009, BEHAV NEUROSCI, V123, P564, DOI 10.1037/a0015752; Wolf OT, 2008, ACTA PSYCHOL, V127, P513, DOI 10.1016/j.actpsy.2007.08.002; Yang L, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-015-0181-3; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	107	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173182	10.1371/journal.pone.0173182	http://dx.doi.org/10.1371/journal.pone.0173182			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278165	gold, Green Published, Green Submitted			2022-12-26	WOS:000396087900052
J	Gunnell, GF; Smith, R; Smith, T				Gunnell, Gregg F.; Smith, Richard; Smith, Thierry			33 million year old Myotis (Chiroptera, Vespertilionidae) and the rapid global radiation of modern bats	PLOS ONE			English	Article							MOLECULAR SYSTEMATICS; LOWERMOST OLIGOCENE; LATE PLIOCENE; EARLY EOCENE; MAMMALIA; EVOLUTION; PHYLOGENY; ECHOLOCATION; BIOGEOGRAPHY; ORIGIN	The bat genus Myotis is represented by 120+ living species and 40+ extinct species and is found on every continent except Antarctica. The time of divergence of Myotis has been contentious as has the time and place of origin of its encompassing group the Vespertilionidae, the most diverse (450+ species) and widely distributed extant bat family. Fossil Myotis species are common, especially in Europe, beginning in the Miocene but earlier records are poor. Recent study of new specimens from the Belgian early Oligocene locality of Boutersem reveals the presence of a relatively large vespertilionid. Morphological comparison and phylogenetic analysis confirms that the new, large form can be confidently assigned to the genus Myotis, making this record the earliest known for that taxon and extending the temporal range of this extant genus to over 33 million years. This suggests that previously published molecular divergence dates for crown myotines (Myotis) are too young by at least 7 million years. Additionally, examination of first fossil appearance data of 1,011 extant placental mammal genera indicates that only 13 first occurred in the middle to late Paleogene (48 to 33 million years ago) and of these, six represent bats, including Myotis. Paleogene members of both major suborders of Chiroptera (Yangochiroptera and Yinpterochiroptera) include extant genera indicating early establishment of successful and long-term adaptive strategies as bats underwent an explosive radiation near the beginning of the Early Eocene Climatic Optimum in the Old World. A second bat adaptive radiation in the New World began coincident with the Mid-Miocene Climatic Optimum.	[Gunnell, Gregg F.] Duke Univ, Lemur Ctr, Div Fossil Primates, Durham, NC 27708 USA; [Smith, Richard; Smith, Thierry] Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, Brussels, Belgium	Duke University; Royal Belgian Institute of Natural Sciences	Gunnell, GF (corresponding author), Duke Univ, Lemur Ctr, Div Fossil Primates, Durham, NC 27708 USA.	gregg.gunnell@duke.edu		Gunnell, Gregg F/0000-0003-3504-409X; Smith, Thierry/0000-0002-1795-2564	Federal Science Policy Office of Belgium [BR/121/A3/PALEURAFRICA]	Federal Science Policy Office of Belgium	Field and laboratory research was supported by the Federal Science Policy Office of Belgium under project BR/121/A3/PALEURAFRICA to TS and GFG.r We thank Annelise Folie, Wim Wouters, and Wim Van Neer (Royal Belgian Institute of Natural Sciences, Brussels), for giving access to comparative material, providing casts, and pictures or discussions about fossil bats. We thank Philip Myers and Priscilla Tucker (University of Michigan Museum of Zoology, Ann Arbor), Nancy B. Simmons and Eileen Westwig (American Museum of Natural History, New York) and Gerhard Storch, Irina Ruf and Katrin Krohmann (Senckenberg Forschungsinstitut, Frankfurt am Main) for access to extant bat specimens. SEM pictures were made at RBINS by Julien Cillis and Eric De Bast. Floreal Sole was instrumental in performing the phylogenetic analyses. We also thank two anonymous reviewers who improved the content of this paper. This research was funded by project BR/121/A3/PALEURAFRICA of the Federal Science Policy Office of Belgium. This is Duke Lemur Center Publication 1341.	Aguilar J-P., 1997, MEMOIRES TRAVAUX ECO, V21, P769; Amador L. I., 2016, J MAMMAL EVOL; Butler P.M., 1978, P56; Cirranello A, 2016, ACTA CHIROPTEROL, V18, P39, DOI 10.3161/15081109ACC2016.18.1.002; CZAPLEWSKI N J, 1987, Contributions to Geology University of Wyoming, V25, P133; Czaplewski NJ, 2012, CAM STUD MORPHOL MOL, P162; Czaplewski Nicholas J., 2010, P240; CZAPLEWSKI NJ, 1993, SOUTHWEST NAT, V38, P111, DOI 10.2307/3672062; CZAPLEWSKI NJ, 1991, J MAMMAL, V72, P715, DOI 10.2307/1381832; de Bonis L., 1973, Bulletin Mus natn Hist nat Paris (Sci Terre), VNo. 28, P105; Dumont ER, 2012, P ROY SOC B-BIOL SCI, V279, P1797, DOI 10.1098/rspb.2011.2005; Eick GN, 2005, MOL BIOL EVOL, V22, P1869, DOI 10.1093/molbev/msi180; FINDLEY JS, 1972, SYST ZOOL, V21, P31, DOI 10.2307/2412256; Ghazali M, 2017, J MAMM EVOL, V24, P475, DOI 10.1007/s10914-016-9351-z; GINGERICH PD, 2001, U MICHIGAN PAPERS PA, V33, P1; Gingerich PD, 2006, TRENDS ECOL EVOL, V21, P246, DOI 10.1016/j.tree.2006.03.006; Glibert M., 1952, B I ROYAL SCI NATURE, V28, P1; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Guilday J. E., 1969, Palaeovertebrata, V2, P25; Gunnell GF, 2002, PALAEONTOL ELECT, V5; Gunnell GF, 2008, J VERTEBR PALEONTOL, V28, P1, DOI 10.1671/0272-4634(2008)28[1:NBMCFT]2.0.CO;2; Gunnell GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086712; Gunnell GF, 2012, CAM STUD MORPHOL MOL, P252; Gunnell Gregg F., 2010, P581; Gunnell GF, 2011, NEUES JAHRB GEOL P-A, V260, P55, DOI 10.1127/0077-7749/2011/0128; Habersetzer J., 1987, Courier Forschungsinstitut Senckenberg, V91, P117; HAND S, 1994, J VERTEBR PALEONTOL, V14, P375, DOI 10.1080/02724634.1994.10011565; Hand SJ, 2016, PALAEOVERTEBRATA; Hoofer SR, 2003, ACTA CHIROPTEROL, V5, P1, DOI 10.3161/001.005.s101; HORACEK I, 1976, Lynx (Prague), V18, P35; Horacek I, 2001, B AKIYOSHI DAI MUS N, V32, P123; Horacek Ivan, 2001, Lynx (Prague), V32, P123; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Koopman Karl P., 1993, P137; KOWALSKI KAZIMIERZ, 1962, ACTA ZOOL CRACOVIENSIA, V7, P39; KOWALSKI KAZIMIREZ, 1956, ACTA PALEONTOL POLONICA, V1, P331; Lack JB, 2010, J MAMMAL, V91, P976, DOI 10.1644/09-MAMM-A-192.1; LEGENDRE S, 1984, CR ACAD SCI II, V298, P715; Legendre S., 1988, Journal of Vertebrate Paleontology, V8, P278; Maitre Elodie, 2014, Swiss Journal of Palaeontology, V133, P141, DOI 10.1007/s13358-014-0069-3; MARTIN RA, 1972, AM MIDL NAT, V87, P326, DOI 10.2307/2423565; McKenna MC, 1997, CLASSIFICATION MAMMA; Miller-Butterworth CM, 2007, MOL BIOL EVOL, V24, P1553, DOI 10.1093/molbev/msm076; Morgan GS, 2012, CAM STUD MORPHOL MOL, P105; MORGAN GS, 1985, BRIMLEYANA, P97; Morgan GS, 2002, SM C PALEOB, P15; MORGAN GS, 1991, B AM MUS NAT HIST, P176; Nowak RM, 1994, WALKERS BATS WORLD; OLeary M. A., 2012, MORPHOBANK 3 0 WEB A; Qiu Zhuding, 2000, Senckenbergiana Lethaea, V80, P173; QUINET GE, 1965, B I ROYAL SCI NATURE, V41, P1; Ravel A, 2016, GEODIVERSITAS, V38, P355, DOI 10.5252/g2016n3a3; Ravel A, 2011, NATURWISSENSCHAFTEN, V98, P397, DOI 10.1007/s00114-011-0785-0; Revilliod P., 1922, Abh Schweiz Pal Ges Geneve, V45, P133; Rojas D, 2016, SYST BIOL, V65, P432, DOI 10.1093/sysbio/syw011; Ruedi M, 2001, MOL PHYLOGENET EVOL, V21, P436, DOI 10.1006/mpev.2001.1017; Ruedi M, 2013, MOL PHYLOGENET EVOL, V69, P437, DOI 10.1016/j.ympev.2013.08.011; Samonds KE, 2007, ACTA CHIROPTEROL, V9, P39, DOI 10.3161/1733-5329(2007)9[39:LPBFFA]2.0.CO;2; SEVILLA P, 1990, GEOBIOS-LYON, V23, P173, DOI 10.1016/S0016-6995(06)80050-1; SIGE B, 1988, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V205, P69; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; Simmons Nancy B., 1998, Bulletin of the American Museum of Natural History, V235, P1; Simmons NB, 2005, SCIENCE, V307, P527, DOI 10.1126/science.1108871; Smith R., 2006, Strata Series 1 Communications, V13, P229; Smith R, 2004, NETH J GEOSCI, V83, P187, DOI 10.1017/S0016774600020254; Smith R, 2003, COLOQUIOS PALEONTOLO, V1, P647; Smith R, 2007, BULL INST R SC N B-S, V77, P159; Smith R, 2006, ACTA PALAEONTOL POL, V51, P381; Smith Richard, 2012, Spanish Journal of Palaeontology, V27, P105; Smith T, 2007, NATURWISSENSCHAFTEN, V94, P1003, DOI 10.1007/s00114-007-0280-9; Smith T, 2012, CAM STUD MORPHOL MOL, P23; Spaulding M, 2012, J SYST PALAEONTOL, V10, P653, DOI 10.1080/14772019.2011.630681; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Stadelmann B, 2004, ACTA CHIROPTEROL, V6, P177, DOI 10.3161/001.006.0201; Stadelmann B, 2004, J MAMMAL, V85, P133, DOI 10.1644/1545-1542(2004)085<0133:MSOTFB>2.0.CO;2; Storch Gerhard, 1999, P81; Tate GHH, 1941, B AM MUS NAT HIST, V48, P537; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Vandenberghe N, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P855, DOI 10.1016/B978-0-444-59425-9.00028-7; Ziegler R, 2003, GEOBIOS-LYON, V36, P447, DOI 10.1016/S0016-6995(03)00043-3; Ziegler Reinhard, 1993, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V33, P119; Ziegler Reinhard, 1994, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V26, P97; Ziegler Reinhard, 2000, Senckenbergiana Lethaea, V80, P647	84	12	12	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172621	10.1371/journal.pone.0172621	http://dx.doi.org/10.1371/journal.pone.0172621			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273112	Green Published, Green Submitted, gold			2022-12-26	WOS:000396073700082
J	da Silva, EZM; Freitas, EG; de Souza, DA; DaSilva, LLP; Jamur, MC; Oliver, C				Marcelino da Silva, Elaine Zayas; Freitas-Filho, Edismauro Garcia; de Souza-Junior, Devandir Antonio; Pinto DaSilva, Luis Lamberti; Jamur, Maria Celia; Oliver, Constance			Adaptor protein-3: A key player in RBL-2H3 mast cell mediator release	PLOS ONE			English	Article							HERMANSKY-PUDLAK-SYNDROME; LYSOSOMAL MEMBRANE-PROTEINS; REGULATED SECRETORY PATHWAY; BASOPHILIC LEUKEMIA-CELLS; EICOSANOID MEDIATORS; GOLGI NETWORK; AP-3 ADAPTER; COMPLEX; GRANULES; BIOGENESIS	Mast cell (MC) secretory granules are Lysosome-Related Organelles (LROs) whose biogenesis is associated with the post-Golgi secretory and endocytic pathways in which the sorting of proteins destined for a specific organelle relies on the recognition of sorting signals by adaptor proteins that direct their incorporation into transport vesicles. The adaptor protein 3 (AP-3) complex mediates protein trafficking between the trans-Golgi network (TGN) and late endosomes, lysosomes, and LROs. AP-3 has a recognized role in LROs biogenesis and regulated secretion in several cell types, including many immune cells such as neutrophils, natural killer cells, and cytotoxic T lymphocytes. However, the relevance of AP-3 for these processes in MCs has not been previously investigated. AP-3 was found to be expressed and distributed in a punctate fashion in rat peritoneal mast cells ex vivo. The rat MC line RBL-2H3 was used as a model system to investigate the role of AP-3 in mast cell secretory granule biogenesis and mediator release. By immunofluorescence and immunoelectron microscopy, AP-3 was localized both to the TGN and early endosomes indicating that AP-3 dependent sorting of proteins to MC secretory granules originates in these organ-elles. ShRNA mediated depletion of the AP-3 delta subunit was shown to destabilize the AP-3 complex in RBL-2H3 MCs. AP-3 knockdown significantly affected MC regulated secretion of beta-hexosaminidase without affecting total cellular enzyme levels. Morphometric evaluation of MC secretory granules by electron microscopy revealed that the area of MC secretory granules in AP-3 knockdown MCs was significantly increased, indicating that AP-3 is involved in MC secretory granule biogenesis. Furthermore, AP-3 knockdown had a selective impact on the secretion of newly formed and newly synthesized mediators. These results show for the first time that AP-3 plays a critical role in secretory granule biogenesis and mediator release in MCs.	[Marcelino da Silva, Elaine Zayas; Freitas-Filho, Edismauro Garcia; de Souza-Junior, Devandir Antonio; Pinto DaSilva, Luis Lamberti; Jamur, Maria Celia; Oliver, Constance] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol & Pathogen Bioagents, Sao Paulo, Brazil	Universidade de Sao Paulo	Oliver, C (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol & Pathogen Bioagents, Sao Paulo, Brazil.	coliver@fmrp.usp.br	daSilva, Luis LP/AAD-5657-2019; Da Silva, Elaine Z/O-5535-2015; LP daSilva, Luis/A-9949-2010; Filho, Edismauro G Freitas/F-8219-2012; Oliver, Constance/L-9904-2017	daSilva, Luis LP/0000-0003-3558-0087; Da Silva, Elaine Z/0000-0002-2749-6275; LP daSilva, Luis/0000-0003-3558-0087; Filho, Edismauro G Freitas/0000-0002-1910-1085; Oliver, Constance/0000-0002-8633-4612	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/07363-0, 2013/12861-0, 2009/54013-0, 2014/11396-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [161304/2011-7, 502429/2014-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA)	This work was supported by research grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, www.fapesp.br; EZMS: 2012/07363-0; EGFF: 2013/12861-0; MCJ: 2009/54013-0; CO: 2014/11396-5), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, www.cripq.br; EZMS: 161304/2011-7; DASJ: 502429/2014-3), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes, www.capes.gov.br), and Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA, www.faepa.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Artuc M, 1999, EXP DERMATOL, V8, P1, DOI 10.1111/j.1600-0625.1999.tb00342.x; Asensio CS, 2013, DEV CELL, V27, P425, DOI 10.1016/j.devcel.2013.10.007; Asensio CS, 2010, J CELL BIOL, V191, P1173, DOI 10.1083/jcb.201006131; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Blank U, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00453; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; BONIFACINO JS, 1989, J CELL SCI, V92, P701; Bonifacino JS, 2004, ANN NY ACAD SCI, V1038, P103, DOI 10.1196/annals.1315.018; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Boyce JA, 2005, CHEM IMMUNOL ALLERGY, V87, P59, DOI 10.1159/000087571; Boyce JA, 2007, IMMUNOL REV, V217, P168, DOI 10.1111/j.1600-065X.2007.00512.x; Bozza PT, 2011, PROSTAG LEUKOTR ESS, V85, P205, DOI 10.1016/j.plefa.2011.04.020; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Dragonetti A, 2000, J CELL SCI, V113, P3289; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Enders A, 2006, BLOOD, V108, P81, DOI 10.1182/blood-2005-11-4413; Feng LJ, 2002, BLOOD, V99, P1651, DOI 10.1182/blood.V99.5.1651.h8001651_1651_1658; Fontana S, 2006, BLOOD, V107, P4857, DOI 10.1182/blood-2005-11-4398; Freitas EG, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9160540; Galli SJ, 1999, IMMUNOLOGY, P1137; Grabner CP, 2006, P NATL ACAD SCI USA, V103, P10035, DOI 10.1073/pnas.0509844103; Grimberg E, 2003, J CELL SCI, V116, P145, DOI 10.1242/jcs.00186; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Henz BM, 2008, EXP DERMATOL, V17, P91, DOI 10.1111/j.1600-0625.2007.00658.x; Hiromatsu Y, 2003, MICROSC RES TECHNIQ, V60, P64, DOI 10.1002/jemt.10244; Ihrke G, 2004, TRAFFIC, V5, P946, DOI 10.1111/j.1600-0854.2004.00236.x; Jamur MC, 2005, BLOOD, V105, P4282, DOI 10.1182/blood-2004-02-0756; Jamur MC, 2014, J HISTOCHEM CYTOCHEM; Jedlitschky G, 2002, VITAM HORM, V64, P153, DOI 10.1016/S0083-6729(02)64005-1; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Karnovsky MJ, 1971, 11 ANN M AM SOC CELL; Kent HM, 2012, DEV CELL, V22, P979, DOI 10.1016/j.devcel.2012.01.018; Li J, 2007, J CELL BIOL, V178, P453, DOI 10.1083/jcb.200608033; Luzio JP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016840; Marks MS, 2013, CURR OPIN CELL BIOL, V25, P495, DOI 10.1016/j.ceb.2013.04.008; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Meng RH, 2015, BLOOD, V125, P1623, DOI 10.1182/blood-2014-07-586727; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Moon TC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00569; Nakatsu F, 2003, CELL STRUCT FUNCT, V28, P419, DOI 10.1247/csf.28.419; Newell-Litwa K, 2010, J NEUROSCI, V30, P820, DOI 10.1523/JNEUROSCI.3400-09.2010; NOVAK EK, 1984, BLOOD, V63, P536; OLIVER C, 1992, J CELL BIOL, V116, P635, DOI 10.1083/jcb.116.3.635; Oliver C, 2010, METHODS MOL BIOL, V588, P353, DOI 10.1007/978-1-59745-324-0_37; Olszewski MB, 2006, EUR J IMMUNOL, V36, P997, DOI 10.1002/eji.200535323; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; Reid G, 2003, MOL PHARMACOL, V63, P1094, DOI 10.1124/mol.63.5.1094; Rius M, 2008, J PHARMACOL EXP THER, V324, P86, DOI 10.1124/jpet.107.131342; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shirasaka Y, 2013, J ENDOCRINOL, V217, P265, DOI 10.1530/JOE-12-0339; Souza AMMS, 2008, EXP CELL RES, V314, P2515, DOI 10.1016/j.yexcr.2008.05.014; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; Starcevic M, 2002, SEMIN CELL DEV BIOL, V13, P271, DOI 10.1016/S1084952102000563; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Traub LM, 1997, CURR OPIN CELL BIOL, V9, P527, DOI 10.1016/S0955-0674(97)80029-4; Tsai M, 2011, ADV EXP MED BIOL, V716, P186, DOI 10.1007/978-1-4419-9533-9_11; Woska JR, 2011, SCAND J IMMUNOL, V73, P8, DOI 10.1111/j.1365-3083.2010.02471.x; Woska JR, 2011, J CELL MOL MED	70	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173462	10.1371/journal.pone.0173462	http://dx.doi.org/10.1371/journal.pone.0173462			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273137	Green Submitted, gold, Green Published			2022-12-26	WOS:000396073700004
J	Van Breda, LK; Dhungyel, OP; Ginn, AN; Iredell, JR; Ward, MP				Van Breda, Lechelle K.; Dhungyel, Om P.; Ginn, Andrew N.; Iredell, Jonathan R.; Ward, Michael P.			Pre- and post-weaning scours in southeastern Australia: A survey of 22 commercial pig herds and characterisation of Escherichia coli isolates	PLOS ONE			English	Article							VIRULENCE GENES; HOUSING SYSTEMS; WEANLING PIGS; WEANED PIGS; GUT HEALTH; PERFORMANCE; DIARRHEA; DISEASES; SWINE; ANIMALS	Diarrhoeal diseases in piglets caused by Escherichia coli are responsible for substantial losses each year in the Australian pig industry. A cross-sectional survey was conducted (September 2013-May 2014) across 22 commercial pig herds located in southeastern Australia: NSW (n = 9); VIC (n = 10); and SA (n = 3), to estimate the prevalence of E. coli associated diarrhoea in pre-and post-weaned piglets and to identify key risk factors associated with E. coli disease. A questionnaire on management and husbandry practices was included. Faecal samples (n = 50 from each herd) were tested for the presence of beta-haemolytic E. coli. Species level identification was confirmed by matrix-assisted laser desorption / ionisation time-of-flight mass spectrometry (MALDI-TOF/MS). ETEC virulence and enterotoxin genes (F4, F5, F6, F18, F41, STa, STb and LT) were screened for by multiplex PCR. This study assessed 60 potential risk factors for E. coli disease in post-weaned piglets, with 2 key factors-recent disease events and the presence of bedding, statistically associated with the presence of post-weaning scours. The prevalence of diarrhea in pre-weaned pens was 17% (16/93), compared with 24% (24/102) in post-weaned pens. The most prevalent beta-haemolytic ETEC genes were F18 (32%) and STb (32%) but isolates were more likely to contain F4: STb (11 of 22 herds, 23%), than F18:STb (5 of 22 herds, 6%). These findings indicate that recent disease events that have occurred within the last 12 months, and by the use of bedding or not maintaining fresh bedding can have significant impacts on piglet diarrhoea.	[Van Breda, Lechelle K.; Dhungyel, Om P.; Ward, Michael P.] Univ Sydney, Fac Vet Sci, Camden, NSW, Australia; [Ginn, Andrew N.; Iredell, Jonathan R.] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol, Westmead Millennium Inst Med Res, Westmead, NSW, Australia; [Ginn, Andrew N.] Pathol West, Ctr Infect Dis & Microbiol Lab Serv, Antimicrobial Resistance Reference Lab, Westmead, NSW, Australia	University of Sydney; University of Sydney	Ward, MP (corresponding author), Univ Sydney, Fac Vet Sci, Camden, NSW, Australia.	michael.ward@sydney.edu.au	Dhungyel, Om/AEC-8041-2022; Ward, Michael/C-5758-2009; Ward, Michael Patrick/W-1897-2019; Ward, Michael Patrick/GRX-1851-2022	Ward, Michael/0000-0002-9921-4986; Ward, Michael Patrick/0000-0002-9921-4986	Cooperative Research Centre for High Integrity Pork [A2-106]	Cooperative Research Centre for High Integrity Pork(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was funded by the Cooperative Research Centre for High Integrity Pork (Project A2-106).; This work was funded by the Cooperative Research Centre for High Integrity Pork (Project A2-106). We thank swine veterinaries Dr. Bernie Gleeson, Dr. Peter MacKenzie, Dr. Trish Holyoake and Dr. Ross Cutler; and Chris van Diessel and Tom Weaver for their assistance. Pig producers in southeastern Australia are thanked for participating. Associate Professor Darren Trott, David Wakeham and Justine Gibson provided reference strains. Associate Professor Peter Thomson and Dr. Benjamin McCormick provided statistical assistance, Associate Professor Sally Partridge and Dr. Karen Plain critically reviewed the manuscript and Andrew McPherson and Matthew Cieslak provided technical assistance.	Alali WQ, 2008, APPL ENVIRON MICROB, V74, P3672, DOI 10.1128/AEM.02624-07; Bosi P, 2004, J ANIM SCI, V82, P1764; Buddle JR, 1997, AUST VET J, V75, P274, DOI 10.1111/j.1751-0813.1997.tb10097.x; Chapman TA, 2006, APPL ENVIRON MICROB, V72, P4782, DOI 10.1128/AEM.02885-05; DAF, 2010, PIGL SCOURS GEN INF; Do T, 2005, AUST VET J, V83, P293, DOI 10.1111/j.1751-0813.2005.tb12745.x; Dohoo I., 2009, VET EPIDEMIOLOGIC RE, P335; DRIESEN SJ, 1993, AUST VET J, V70, P259, DOI 10.1111/j.1751-0813.1993.tb08044.x; Fahy V. A., 1987, Manipulating pig production I. Proceedings of the Inaugural Conference of the Australasian Pig Science Association (APSA) Nov 23-25, 1987, Albury, NSW.., P189; Fairbrother JM, 2006, REV SCI TECH OIE, V25, P555, DOI 10.20506/rst.25.2.1682; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Hammerum AM, 2014, J ANTIMICROB CHEMOTH, V69, P2650, DOI 10.1093/jac/dku180; Lalles JP, 2007, P NUTR SOC, V66, P260, DOI 10.1017/S0029665107005484; LIM CH, 1989, J APPL BACTERIOL, V66, P559, DOI 10.1111/j.1365-2672.1989.tb04578.x; MADEC F, 1983, ANN RECH VET, V14, P456; MADEC F, 1994, VET RES, V25, P92; MULLAN BP, 1994, AUST VET J, V71, P151, DOI 10.1111/j.1751-0813.1994.tb03370.x; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; Nagy B, 1999, VET RES, V30, P259; Pedersen KS, 2011, PREV VET MED, V98, P288, DOI 10.1016/j.prevetmed.2010.11.016; Pluske JR, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-1; Pluske JR, 2002, NUTR RES REV, V15, P333, DOI 10.1079/NRR200242; Pluske JR, 1997, LIVEST PROD SCI, V51, P215, DOI 10.1016/S0301-6226(97)00057-2; SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168; Scott K, 2006, LIVEST SCI, V103, P104, DOI 10.1016/j.livsci.2006.01.008; Skirrow SZ, 1997, AUST VET J, V75, P282, DOI 10.1111/j.1751-0813.1997.tb10098.x; Stege H, 2001, PREV VET MED, V50, P153, DOI 10.1016/S0167-5877(01)00194-5; Taylor G. A., 2006, P 2006 IEEE PES GEN, P1; Torrallardona D, 2003, J ANIM SCI, V81, P1220; Tuyttens FAM, 2005, APPL ANIM BEHAV SCI, V92, P261, DOI 10.1016/j.applanim.2005.05.007; van de Weerd HA, 2009, APPL ANIM BEHAV SCI, V116, P1, DOI 10.1016/j.applanim.2008.08.001; Voyles R, 2006, 652 AS IOW STAT U AN; WEINSTEIN DL, 1988, J BACTERIOL, V170, P4223, DOI 10.1128/jb.170.9.4223-4230.1988; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Wu XY, 2007, APPL ENVIRON MICROB, V73, P83, DOI 10.1128/AEM.00990-06; Zhang WP, 2006, INFECT IMMUN, V74, P3107, DOI 10.1128/IAI.01338-05	36	9	9	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172528	10.1371/journal.pone.0172528	http://dx.doi.org/10.1371/journal.pone.0172528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273152	Green Submitted, Green Published, gold			2022-12-26	WOS:000396073700078
J	Song, N; Dai, QQ; Zhu, BT; Wu, YX; Xu, M; Voegele, RT; Gao, XN; Kang, ZS; Huang, LL				Song, Na; Dai, Qingqing; Zhu, Baitao; Wu, Yuxing; Xu, Ming; Voegele, Ralf Thomas; Gao, Xiaoning; Kang, Zhensheng; Huang, Lili			G alpha proteins Gvm2 and Gvm3 regulate vegetative growth, asexual development, and pathogenicityon apple in Valsa mali	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEINS; GENE-EXPRESSION; SIGNALING PATHWAYS; SUBUNIT; CAMP; VIRULENCE; GERMINATION; COLONIZATION; INFECTION; YEAST	In fungi, heterotrimeric guanine-nucleotide binding proteins (G-proteins) are key elements of signal transduction pathways, which control growth, asexual and sexual development, as well as virulence. In this study, we have identified two genes encoding heterotrimeric G protein alpha subunits, named Gvm2 and Gvm3, from Valsa malt, the causal agent of apple Valsa canker. Characterization of Gvm2 and Gvm3 mutants indicates that Gvm3 may be a crucial regulator of vegetative growth. Deletion of the corresponding gene results in a 20% reduction in growth rate. Besides, Gvm2 and Gvm3 seem to be involved in asexual reproduction, and mutants are hypersensitive to oxidative and cell membrane stresses. Interestingly, both G protein alpha subunits were most probably involved in V. mali virulence. In infection assays using Malus domestica cv. 'Fuji' leaves and twigs, the size of lesions caused by deletion mutants Delta Gvm2, or Delta Gvm3 are significantly reduced. Furthermore, many genes encoding hydrolytic enzymes important virulence factors in V. mali are expressed at a lower level in these deletion mutants. Our results suggest that Gvm2 and Gvm3 play an important role in virulence probably by regulation of expression of cell wall degrading enzymes. Delta Gvm2, and Delta Gvm3 mutants were further analyzed with respect to their impact on the transcript levels of genes in the cAMP/PKA pathway. The expression of the genes encoding adenylate cyclase VmAC, protein kinase A (PKA) regulatory subunit VmPKR, and PKA catalytic subunit VmPKA1 are down-regulated in both mutants. Further analyses indicated that intracellular cAMP level and PKA activity are down-regulated in the Delta Gvm3 mutant, but are basically unchanged in the Delta Gvm2 mutant. Overall, our findings indicate that both Gvm2 and Gvm3 play diverse roles in the modulation of vegetative growth, asexual development, and virulence in V. mali.	[Song, Na; Dai, Qingqing; Zhu, Baitao; Wu, Yuxing; Xu, Ming; Gao, Xiaoning; Kang, Zhensheng; Huang, Lili] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China; [Song, Na; Dai, Qingqing; Zhu, Baitao; Wu, Yuxing; Xu, Ming; Gao, Xiaoning; Kang, Zhensheng; Huang, Lili] Northwest A&F Univ, Coll Plant Protect, Yangling, Peoples R China; [Voegele, Ralf Thomas] Univ Hohenheim, Inst Phytomed, Fachgebiet Phytopathol, Stuttgart, Germany	Northwest A&F University - China; Northwest A&F University - China; University Hohenheim	Huang, LL (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China.; Huang, LL (corresponding author), Northwest A&F Univ, Coll Plant Protect, Yangling, Peoples R China.	huanglili@nwsuaf.edu.cn		Kang, Zhensheng/0000-0001-5575-0122	National Natural Science Foundation of China [31471732, 31671982]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (No. 31471732; 31671982).	Abe K, 2007, PLANT BREEDING, V126, P449, DOI 10.1111/j.1439-0523.2007.01379.x; Abe K, 2011, TREE GENET GENOMES, V7, P363, DOI 10.1007/s11295-010-0337-3; Alspaugh JA, 2002, EUKARYOT CELL, V1, P75, DOI 10.1128/EC.1.1.75-84.2002; Alspaugh JA, 1997, GENE DEV, V11, P3206, DOI 10.1101/gad.11.23.3206; Beer SV., 1990, COMPENDIUM APPLE PEA, P61; Bolker M, 1998, FUNGAL GENET BIOL, V25, P143, DOI 10.1006/fgbi.1998.1102; Bruno KS, 2004, EUKARYOT CELL, V3, P1525, DOI 10.1128/EC.3.6.1525-1532.2004; BUSS JE, 1987, P NATL ACAD SCI USA, V84, P7493, DOI 10.1073/pnas.84.21.7493; [曹克强 Cao Keqiang], 2009, [植物保护, Plant Protection], V35, P114; Chang MH, 2004, GENETICS, V167, P1305, DOI 10.1534/genetics.103.025379; Chen C., 1987, ACTA PHYTOPATHOL SIN, V17, P3; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; D'Souza CA, 2001, FEMS MICROBIOL REV, V25, P349, DOI 10.1111/j.1574-6976.2001.tb00582.x; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; Doehlemann G, 2006, MOL MICROBIOL, V59, P821, DOI 10.1111/j.1365-2958.2005.04991.x; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Duan Y., 2013, THESIS, P88; Fang L, 2005, THESIS; Gao Jing, 2011, Weishengwu Xuebao, V51, P1194; Gao SJ, 1996, P NATL ACAD SCI USA, V93, P14122, DOI 10.1073/pnas.93.24.14122; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hallen HE, 2003, MYCOL RES, V107, P969, DOI 10.1017/S0953756203008190; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Jain S, 2005, FEMS MICROBIOL LETT, V243, P165, DOI 10.1016/j.femsle.2004.12.009; Kays AM, 2004, MYCOTA, V3, P175; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; Ke XW, 2014, FUNGAL GENET BIOL, V68, P31, DOI 10.1016/j.fgb.2014.04.004; Ke XW, 2013, AUSTRALAS PLANT PATH, V42, P85, DOI 10.1007/s13313-012-0158-y; Kruger J, 1998, MOL GEN GENET, V260, P193, DOI 10.1007/s004380050885; Krystofova S, 2005, EUKARYOT CELL, V4, P365, DOI 10.1128/EC.4.2.365-378.2005; Kubler E, 1997, J BIOL CHEM, V272, P20321, DOI 10.1074/jbc.272.33.20321; Lafon A, 2005, GENETICS, V171, P71, DOI 10.1534/genetics.105.040584; Lee DH, 2007, PLANT PATHOLOGY J, V23, P37, DOI 10.5423/PPJ.2007.23.2.037; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; Li L, 2007, MOL BIOL CELL, V18, P4201, DOI 10.1091/mbc.E07-02-0136; Liu SH, 1997, MOL PLANT MICROBE IN, V10, P1075, DOI 10.1094/MPMI.1997.10.9.1075; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz MC, 1997, EMBO J, V16, P7008, DOI 10.1093/emboj/16.23.7008; Malbon CC, 2005, NAT REV MOL CELL BIO, V6, P689, DOI 10.1038/nrm1716; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; Regenfelder E, 1997, EMBO J, V16, P1934, DOI 10.1093/emboj/16.8.1934; Schmoll M, 2009, EUKARYOT CELL, V8, P410, DOI 10.1128/EC.00256-08; Seibel C, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-58; Servin JA., 2012, BIOCOMMUNICATION FUN, P21; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Studt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058185; TURNER GE, 1993, J BIOL CHEM, V268, P14805; Wang L., 2005, J NW SCI TECH U AGR, V33, P98, DOI [DOI 10.13207/J.CNKI.JNWAFU.2005.S1.027, 10.13207/j.cnki.jnwafu.2005.s1.027]; WANG P, 1995, P NATL ACAD SCI USA, V92, P11529, DOI 10.1073/pnas.92.25.11529; Wei JieLing, 2010, Acta Phytopathologica Sinica, V40, P14; WEST RE, 1985, J BIOL CHEM, V260, P4428; [许春景 Xu Chunjing], 2016, [中国农业科学, Scientia Agricultura Sinica], V49, P1489; Yin ZY, 2015, NEW PHYTOL, V208, P1202, DOI 10.1111/nph.13544; Yin ZY, 2013, WORLD J MICROB BIOT, V29, P1563, DOI 10.1007/s11274-013-1320-6; You FH, 2007, THESIS; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhou XY, 2011, METHODS MOL BIOL, V722, P199, DOI 10.1007/978-1-61779-040-9_15	59	11	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173141	10.1371/journal.pone.0173141	http://dx.doi.org/10.1371/journal.pone.0173141			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267786	Green Published, Green Submitted, gold			2022-12-26	WOS:000396060600010
J	Abate, KH; Belachew, T				Abate, Kalkidan Hassen; Belachew, Tefera			Women's autonomy and men's involvement in child care and feeding as predictors of infant and young child anthropometric indices in coffee farming households of Jimma Zone, South West of Ethiopia	PLOS ONE			English	Article							NUTRITIONAL-STATUS; MATERNAL AUTONOMY; UNDERNUTRITION; HEALTH; MALNUTRITION; IMPACT	Background Most of child mortality and under nutrition in developing world were attributed to suboptimal childcare and feeding, which needs detailed investigation beyond the proximal factors. This study was conducted with the aim of assessing associations of women's autonomy and men's involvement with child anthropometric indices in cash crop livelihood areas of South West Ethiopia. Methods Multi-stage stratified sampling was used to select 749 farming households living in three coffee producing sub-districts of Jimma zone, Ethiopia. Domains of women's Autonomy were measured by a tool adapted from demographic health survey. A model for determination of paternal involvement in childcare was employed. Caring practices were assessed through the WHO Infant and young child feeding practice core indicators. Length and weight measurements were taken in duplicate using standard techniques. Data were analyzed using SPSS for windows version 21. A multivariable linear regression was used to predict weight for height Z-scores and length for age Z-scores after adjusting for various factors. Results The mean (sd) scores of weight for age (WAZ), height for age (HAZ), weight for height (WHZ) and BMI for age (BAZ) was -0.52(1.26), -0.73(1.43), -0.13(1.34) and -0.1(1.39) respectively. The results of multi variable linear regression analyses showed that WHZ scores of children of mothers who had autonomy of conducting big purchase were higher by 0.42 compared to children's whose mothers had not. In addition, a child whose father was involved in childcare and feeding had higher HAZ score by 0.1. Regarding age, as for every month increase in age of child, a 0.04 point decrease in HAZ score and a 0.01 point decrease in WHZ were noted. Similarly, a child living in food insecure households had lower HAZ score by 0.29 compared to child of food secured households. As family size increased by a person a WHZ score of a child is decreased by 0.08. WHZ and HAZ scores of male child was found lower by 0.25 and 0.38 respectively compared to a female child of same age. Conclusion Women's autonomy and men's involvement appeared in tandem with better child anthropometric outcomes. Nutrition interventions in such setting should integrate enhancing women's autonomy over resource and men's involvement in childcare and feeding, in addition to food security measures.	[Abate, Kalkidan Hassen; Belachew, Tefera] Jimma Univ, Coll Hlth Sci, Dept Populat & Family Hlth, Jimma, Ethiopia	Jimma University	Abate, KH (corresponding author), Jimma Univ, Coll Hlth Sci, Dept Populat & Family Hlth, Jimma, Ethiopia.	kalkidan.hassen@ju.edu.et	Abate, Kalkidan Hassen/ABA-9014-2020; Belachew, Tefera/AAO-5877-2020	Abate, Kalkidan Hassen/0000-0001-9752-5417; 	Jimma University, Jimma, Ethiopia [RPGC/4064/2016]; Jimma University	Jimma University, Jimma, Ethiopia; Jimma University	I (the corresponding author) have received a limited funding from my host institution, Jimma University, Jimma, Ethiopia grant number RPGC/4064/2016. This funding is part of doctoral students support program which covers only travel and data collection expenses. As I am one of the eligible candidate for the support stated, I received the limited funding and my mentor and coauthor Professor Tefera Belachew received none. Details of the funder institution is available here: https://www.ju.edu.et/cphms/node/26. We declare the funding or sources of support we received during this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to present our deepest gratitude to Jimma University for financing this study. We also thank Dr. Yimam Workneh, a lecturer in the department of Foreign Language and Literature, Jimma University, for his support in editing this manuscript. Our appreciation also goes to the data collectors and supervisors. Lastly, our special thanks extend to children's mothers who participated in the study.	Ajao KO, 2010, AFRICAN J REPROD HLT, V14; Allen S., 2007, EFFECTS FATHER INVOL; Amamo A.A., 2014, EUR J BUS MANAGE, V6, P109; Anderman TL, 2014, FOOD SECUR, V6, P541, DOI 10.1007/s12571-014-0360-6; [Anonymous], 2008, SUMM STAT REP 2007 P; Ares Segura Susana, 2016, An Pediatr (Barc), V84, DOI 10.1016/j.anpedi.2015.07.024; BAQUI AH, 1994, EUR J CLIN NUTR, V48, P349; Belachew T, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-55; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Tran BH, 2008, FOOD NUTR BULL, V29, P59, DOI 10.1177/156482650802900107; Bindon JR, 2002, SOC SCI MED, V54, P1299, DOI 10.1016/S0277-9536(01)00097-1; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bronte-Tinkew J, 2004, SOC SCI MED, V58, P499, DOI 10.1016/j.socscimed.2003.09.017; Brunson EK, 2009, AM J HUM BIOL, V21, P55, DOI 10.1002/ajhb.20815; Burchi F, 2012, DEMOGR RES, V27, P681, DOI 10.4054/DemRes.2012.27.23; Carlson GJ, 2015, MATERN CHILD NUTR, V11, P452, DOI 10.1111/mcn.12113; Central Statistical Agency, 2016, DEM HLTH SURV; Central Statistical Agency [Ethiopia] and ICF International, 2011, ETH DEM HLTH SURV; Charmarbagwala R, 2004, DETERMINANTS CHILD H; Clark Gracia, 1985, FIGHTING AFRICAN FOO; Cyril S, 2016, HEALTH PROMOT INT, V31, P809, DOI 10.1093/heapro/dav059; Dancer D, 2009, INDIAN GROWTH DEV RE, V2, P18, DOI 10.1108/17538250910953444; Onis M, 2006, ACTA PAEDIATR, V95, P7, DOI 10.1080/08035320500495407; de Pee S, 2009, FOOD NUTR BULL, V30, pS434, DOI 10.1177/15648265090303S305; Dearden K, 2013, MATERN CHILD NUTR, V9, P143, DOI 10.1111/j.1740-8709.2011.00347.x; DeJong J, 2000, SOC SCI MED, V51, P941, DOI 10.1016/S0277-9536(00)00073-3; FANTA II, 2010, IND ASS INF YOUNG 3; Filmer D, 2009, WORLD BANK ECON REV, V23, P371, DOI 10.1093/wber/lhp009; Gebreyesus S.H., 2015, BMC NUTR, V1, P2, DOI [DOI 10.1186/2055-0928-1-1, 10.1186/2055-0928-1-2]; Headey D., 2014, ANAL TRENDS DETERMIN; Hindin MJ, 2000, SOC SCI MED, V51, P1517, DOI 10.1016/S0277-9536(00)00051-4; Hosegood Victoria, 2010, J Int AIDS Soc, V13 Suppl 2, pS5, DOI 10.1186/1758-2652-13-S2-S5; Kanyamurwa JM, 2013, AFR HEALTH SCI, V13, P829, DOI 10.4314/ahs.v13i3.44; Kassa T, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0675-x; Kiyak Nejat, 2014, ASSESSMENT ANTHROPOM; Lamb M.E., 1987, PARENTING LIFESPAN B, P111, DOI DOI 10.4324/9781315126005-7; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Madhavan S, 2007, SCAND J PUBLIC HEALT, V35, P107, DOI 10.1080/14034950701355700; Malhotra A., 2005, MEASURING EMPOWERMEN, DOI DOI 10.1596/0-8213-6057-4; Mei ZG, 2007, B WORLD HEALTH ORGAN, V85, P441, DOI 10.2471/BLT.06.034421; Milas S, 2004, 4 ETHIOPIAS REGIONAL; Njuki J, 2011, EUR J DEV RES, V23, P426, DOI 10.1057/ejdr.2011.8; Ntoimo LFC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1145; Owusu-Addo E, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0295-4; Paolisso MJ, 2002, ECON DEV CULT CHANGE, V50, P313, DOI 10.1086/322881; Petit N, 2007, J AGRAR CHANGE, V7, P225, DOI 10.1111/j.1471-0366.2007.00145.x; Phiri T., 2014, GRAND CHALLENGES CAN, V2014; Rahman MM, 2015, ASIA-PAC J PUBLIC HE, V27, P509, DOI 10.1177/1010539514568710; Rajaram R, 2016, INT J PUBLIC HEALTH, P1; RAMALINGASWAMI V, 1997, MALNUTRITION S ASIA, P11; Renzaho AMN, 2010, NUTRITION, V26, P1, DOI 10.1016/j.nut.2009.05.001; Ross-Suits H, 2010, 99 GEORG STAT U; Roushdy R, 041011 POP COUNC W A, P306; Sachs JD, 2012, LANCET, V379, P2206, DOI 10.1016/S0140-6736(12)60685-0; Sarah M. Allen, 2007, EFFECTS FATHER INVOL; Shroff M, 2009, MATERN CHILD NUTR, V5, P64, DOI 10.1111/j.1740-8709.2008.00161.x; Smith L., 2003, IFPRI REPORTS; Swindale A, 2007, HOUSEHOLD FOOD INSEC; UNICEF, UNICEF CONC FRAM; *UNICEF, STAT WORLDS CHILDR 2; United Nations Children's Fund (UNICEF), 2013, IMPR CHILD NUTR ACH; Wamani H., 2007, BMC Pediatrics, V7; [World Bank Joint Group WHO UNICEF], 2015, LEV TRENDS CHILD MAN; World Health Organization, 2007, IND ASS INT YOUNG CH; World Health Organization, 2010, IND ASS INF YOUNG CH; Zulfiqar A Bhutta, 2013, LANCET	67	30	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172885	10.1371/journal.pone.0172885	http://dx.doi.org/10.1371/journal.pone.0172885			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5OE	28264008	Green Submitted, Green Published, gold			2022-12-26	WOS:000396054300026
J	Abu-Farha, M; Cherian, P; Al-Khairi, I; Madhu, D; Tiss, A; Warsam, S; Alhubail, A; Sriraman, D; Al-Refaei, F; Abubaker, J				Abu-Farha, Mohamed; Cherian, Preethi; Al-Khairi, Irina; Madhu, Dhanya; Tiss, Ali; Warsam, Samia; Alhubail, Asma; Sriraman, Devarajan; Al-Refaei, Faisal; Abubaker, Jehad			Plasma and adipose tissue level of angiopoietin-like 7 (ANGPTL7) are increased in obesity and reduced after physical exercise	PLOS ONE			English	Article							METABOLIC SYNDROME; OXIDATIVE STRESS; BETATROPHIN/ANGPTL8 LEVEL; TRIGLYCERIDE-METABOLISM; CALORIC RESTRICTION; HEMATOPOIETIC STEM; LIPOPROTEIN-LIPASE; LIPID-METABOLISM; PROTEINS 3; INFLAMMATION	Objective ANGPTL7 is a member of the Angiopoietin- like (ANGPTL) protein family that is composed of eight proteins (1-8). Increasing evidence is associating ANGPTL proteins to obesity and insulin resistance. The biological role of ANGPTL7 is yet to be understood except for a recently proposed role in the pathophysiology of glaucoma. This study was designed to shed light on the function of ANGPTL7 in obesity and its modulation by physical exercise as well as its potential association with lipid profile. Methods A total of 144 subjects were enrolled in this study and finished three months of physical exercise. The participants were classified based on their BMI, 82 subjects were non-obese and 62 obese. ANGPTL7 levels in plasma and adipose tissue were measured by ELISA, RTPCR and immunohistochemistry. Results In this study, we showed that ANGPTL7 level was increased in the plasma of obese subjects (1249.05 +/- 130.39 pg/mL) as compared to non-obese (930.34 +/- 87.27 pg/mL) (p-Value = 0.032). ANGPTL7 Gene and protein expression levels in adipose tissue also showed over two fold increase. Physical exercise reduced circulating level of ANGPTL7 in the obese subjects to 740.98 +/- 127.18 pg/mL, (p-Value = 0.007). ANGPTL7 expression in adipose tissue was also reduced after exercise. Finally, ANGPTL7 circulating level showed significant association with TG level in the obese subjects (R-2 = 0.183, p-Value = 0.03). Conclusion In conclusion, our data shows for the first time that obesity increases the level of ANGPTL7 in both plasma and adipose tissue. Increased expression of ANGPTL7 might play a minor role in the regulation of TG level in obese subjects either directly or through interaction with other ANGPTL protein members. Physical exercise reduced the level of ANGPTL7 highlighting the potential for targeting this protein as a therapeutic target for regulating dyslipidemia.	[Abu-Farha, Mohamed; Cherian, Preethi; Al-Khairi, Irina; Madhu, Dhanya; Tiss, Ali; Warsam, Samia; Abubaker, Jehad] Dasman Diabet Inst, Biochem & Mol Biol Unit, Kuwait, Kuwait; [Alhubail, Asma; Al-Refaei, Faisal] Dasman Diabet Inst, Clin Serv Dept, Kuwait, Kuwait; [Sriraman, Devarajan] Dasman Diabet Inst, Tissue Banking Unit, Kuwait, Kuwait		Abubaker, J (corresponding author), Dasman Diabet Inst, Biochem & Mol Biol Unit, Kuwait, Kuwait.	mohamed.abufarha@dasmaninstitute.org; jehad.abubakr@dasmaninstitute.org	Tiss, Ali/L-6656-2019	Tiss, Ali/0000-0002-3024-5370; Abu-Farha, Mohamed/0000-0001-8357-1252; Abubaker, Jehad/0000-0003-0681-7305	Kuwait Foundation for the Advancement of Sciences (KFAS) [RA-2016-025]	Kuwait Foundation for the Advancement of Sciences (KFAS)(Kuwait Foundation for the Advancement of Sciences (KFAS))	This work was supported by Kuwait Foundation for the Advancement of Sciences (KFAS).; We are grateful to Clinical Laboratory and the Tissue Bank Core Facility at DDI for their contribution in handling samples. We are also indebted to Kuwait Foundation for the Advancement of Sciences (KFAS) for financial support of this research project (RA-2016-025). The funding agency was not involved in data collection, analysis, or interpretation; trial design; patient recruitment; or any aspect pertinent to the study. Special thanks to Dr. Veeramani Marimuthu for his help in accessing journal articles used in this study. The corresponding authors had full access to all the data in the study and had final responsibility for the decision to submit for publication. None of the authors have been paid to write this article by a pharmaceutical company or other agency. Due to institute policy as well as the ethical review board where they restrict sharing such data in a public domain, data are available upon request. This data will be available through direct requisition by contacting Dr. Mohamed Abu-Farha or Dr. Jehad Abubaker. Approval to access data is to be addressed to the Chairman of the Ethical Review Committee Dr. Abdullah Bennakhi, (abdullah.bennakhi@dasmaninstitute.org).	Abu-Farha M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147367; Abu-Farha M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14448; Abu-Farha M, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0277-1; Abu-Farha M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10949; Abu-Farha M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075342; Abubaker J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069217; Ahmadi N, 2011, AM J MED, V124, P978, DOI 10.1016/j.amjmed.2011.02.032; Aldhahi Waleed, 2003, Curr Diab Rep, V3, P293, DOI 10.1007/s11892-003-0020-2; Baturcam E, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/627150; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Carrel AL, 2009, J PEDIATR ENDOCR MET, V22, P409; Chiang J, 2009, EUR J PHARMACOL, V610, P119, DOI 10.1016/j.ejphar.2009.03.035; Comes N, 2011, GENES CELLS, V16, P243, DOI 10.1111/j.1365-2443.2010.01483.x; Essalmani R, 2013, J BIOL CHEM, V288, P26410, DOI 10.1074/jbc.M113.501304; Fu ZY, 2013, BIOCHEM BIOPH RES CO, V430, P1126, DOI 10.1016/j.bbrc.2012.12.025; Goh YY, 2010, J BIOL CHEM, V285, P32999, DOI 10.1074/jbc.M110.108175; Gray SR, 2009, PREV MED, V48, P39, DOI 10.1016/j.ypmed.2008.10.013; Haridas PAN, 2015, J CLIN ENDOCR METAB, V100, pE1299, DOI 10.1210/jc.2015-1254; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Huijgen R, 2012, HUM MUTAT, V33, P448, DOI 10.1002/humu.21660; Jonker JT, 2013, AM J CLIN NUTR, V97, P255, DOI 10.3945/ajcn.112.043687; Kadomatsu T, 2011, FEBS J, V278, P559, DOI 10.1111/j.1742-4658.2010.07979.x; Kersten S, 2014, BBA-MOL CELL BIOL L, V1841, P919, DOI 10.1016/j.bbalip.2014.03.013; Kersten S, 2009, ARTERIOSCL THROM VAS, V29, P969, DOI 10.1161/ATVBAHA.108.182147; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Kuchtey J, 2008, INVEST OPHTH VIS SCI, V49, P3438, DOI 10.1167/iovs.07-1347; Lee EC, 2009, J BIOL CHEM, V284, P13735, DOI 10.1074/jbc.M807899200; Legry V, 2009, J CLIN ENDOCR METAB, V94, P5070, DOI 10.1210/jc.2009-0769; Li C, 2006, CURR OPIN LIPIDOL, V17, P152, DOI 10.1097/01.mol.0000217896.67444.05; Li YC, 2014, J DRUG TARGET, V22, P679, DOI 10.3109/1061186X.2014.928715; Lim SY, 2015, HEPATOLOGY, V62, P521, DOI 10.1002/hep.27838; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Manns PJ, 2005, ARCH PHYS MED REHAB, V86, P1176, DOI 10.1016/j.apmr.2004.11.020; Marcinko K, 2014, EXP PHYSIOL, V99, P1581, DOI 10.1113/expphysiol.2014.082255; Mattijssen F, 2012, BBA-MOL CELL BIOL L, V1821, P782, DOI 10.1016/j.bbalip.2011.10.010; Mehta N, 2014, ARTERIOSCL THROM VAS, V34, P1057, DOI 10.1161/ATVBAHA.113.302802; Montero D, 2012, OBES REV, V13, P441, DOI 10.1111/j.1467-789X.2011.00956.x; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Namkung J, 2011, METABOLISM, V60, P564, DOI 10.1016/j.metabol.2010.05.013; Nehme A, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-58; Oike Y, 2005, TRENDS MOL MED, V11, P473, DOI 10.1016/j.molmed.2005.08.002; Oike Y, 2004, INT J HEMATOL, V80, P21, DOI 10.1532/ijh97.04034; Oike Y, 2009, CIRC J, V73, P2192, DOI 10.1253/circj.CJ-09-0710; Otarod Jila Kaberi, 2004, Curr Atheroscler Rep, V6, P335, DOI 10.1007/s11883-004-0043-4; Puthanveetil P, 2015, CRIT REV CL LAB SCI, V52, P138, DOI 10.3109/10408363.2014.997931; Quagliarini F, 2012, P NATL ACAD SCI USA, V109, P19751, DOI 10.1073/pnas.1217552109; Ren G, 2012, AM J PHYSIOL-ENDOC M, V303, pE334, DOI 10.1152/ajpendo.00084.2012; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Roberts CK, 2006, J APPL PHYSIOL, V100, P1657, DOI 10.1152/japplphysiol.01292.2005; Rozsa FW, 2006, MOL VIS, V12, P125; Santulli G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00004; Schernthaner GH, 2005, SCAND J CLIN LAB INV, V65, P30, DOI 10.1080/00365510500236119; Shan L, 2009, J BIOL CHEM, V284, P1419, DOI 10.1074/jbc.M808477200; Sonnenburg WK, 2009, J LIPID RES, V50, P2421, DOI 10.1194/jlr.M900145-JLR200; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Wang LL, 2015, MOL MED REP, V11, P2789, DOI 10.3892/mmr.2014.3029; Wang Y, 2015, J LIPID RES, V56, P1296, DOI 10.1194/jlr.M054882; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Xiao YR, 2015, HAEMATOLOGICA, V100, P585, DOI 10.3324/haematol.2014.118612; Xiao YR, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-014-0102-4; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Zhang R, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0133-8; Zhang R, 2013, BIOCHEM BIOPH RES CO, V432, P401, DOI 10.1016/j.bbrc.2013.01.129; Zhang R, 2012, BIOCHEM BIOPH RES CO, V424, P786, DOI 10.1016/j.bbrc.2012.07.038	67	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173024	10.1371/journal.pone.0173024	http://dx.doi.org/10.1371/journal.pone.0173024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264047	gold, Green Published, Green Submitted			2022-12-26	WOS:000396054300035
J	Long, XJ; Chen, LF; Jiang, CX; Zhang, LJ				Long, Xiaojing; Chen, Lifang; Jiang, Chunxiang; Zhang, Lijuan		Alzheimer's Dis Neuroimaging	Prediction and classification of Alzheimer disease based on quantification of MRI deformation	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; VOXEL-BASED MORPHOMETRY; SURFACE-BASED ANALYSIS; BRAIN ATROPHY; CEREBROSPINAL-FLUID; CORTICAL THICKNESS; ENTORHINAL CORTEX; EARLY-DIAGNOSIS; MCI PATIENTS; SHAPE	Detecting early morphological changes in the brain and making early diagnosis are important for Alzheimer's disease (AD). High resolution magnetic resonance imaging can be used to help diagnosis and prediction of the disease. In this paper, we proposed a machine learning method to discriminate patients with AD or mild cognitive impairment (MCI) from healthy elderly and to predict the AD conversion in MCI patients by computing and analyzing the regional morphological differences of brain between groups. Distance between each pair of subjects was quantified from a symmetric diffeomorphic registration, followed by an embedding algorithm and a learning approach for classification. The proposed method obtained accuracy of 96.5% in differentiating mild AD from healthy elderly with the whole-brain gray matter or temporal lobe as region of interest (ROI), 91.74% in differentiating progressive MCI from healthy elderly and 88.99% in classifying progressive MCI versus stable MCI with amygdala or hippocampus as ROI. This deformation-based method has made full use of the pair-wise macroscopic shape difference between groups and consequently increased the power for discrimination.	[Long, Xiaojing; Jiang, Chunxiang; Zhang, Lijuan] Chinese Acad Sci, Shenzhen Inst Adv Technol, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Guangdong, Peoples R China; [Chen, Lifang] Shenzhen Univ, Affiliated Hosp 1, Dept Neurol, Shenzhen Peoples Hosp 2, Shenzhen, Guangdong, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Shenzhen University	Zhang, LJ (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Guangdong, Peoples R China.	lj.zhang@siat.ac.cn			National Natural Science Foundation of China [81301285, 81371359]; Scientific Research Program of the Shenzhen Science and Technology Innovation Committee [JCYJ20150521094519463, JCYJ20140415090443270]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Food and Drug Administration; Canadian Institutes of Health Research; National Institutes of Health [P30 AG010129, K01 AG030514]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Program of the Shenzhen Science and Technology Innovation Committee; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Food and Drug Administration(United States Department of Health & Human Services); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was partly supported by the National Natural Science Foundation of China (Grant No. 81301285 and 81371359) and the Scientific Research Program of the Shenzhen Science and Technology Innovation Committee (JCYJ20150521094519463, JCYJ20140415090443270). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, the Food and Drug Administration, and through generous contributions from the following: Abbott; Alzheimers Association; Alzheimers Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimers Disease Cooperative Study at the University of California San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California Los Angeles. This research was also supported by National Institutes of Health grants P30 AG010129 and K01 AG030514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaszewski S, 2013, NEUROBIOL AGING, V34, P2815, DOI 10.1016/j.neurobiolaging.2013.06.015; Aguilar C, 2013, PSYCHIAT RES-NEUROIM, V212, P89, DOI 10.1016/j.pscychresns.2012.11.005; Barnes J, 2004, NEUROIMAGE, V23, P574, DOI 10.1016/j.neuroimage.2004.06.028; Beheshti I, 2016, MAGN RESON IMAGING, V34, P252, DOI 10.1016/j.mri.2015.11.009; Bengio Y., 2004, ADV NEURAL INFORM PR; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bozzali M, 2006, NEUROLOGY, V67, P453, DOI 10.1212/01.wnl.0000228243.56665.c2; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Busatto GF, 2003, NEUROBIOL AGING, V24, P221, DOI 10.1016/S0197-4580(02)00084-2; Casanova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077949; Casanova Ramon, 2011, Front Neuroinform, V5, P22, DOI 10.3389/fninf.2011.00022; Chetelat G, 2005, NEUROIMAGE, V27, P934, DOI 10.1016/j.neuroimage.2005.05.015; Cho H, 2014, J ALZHEIMERS DIS, V40, P285, DOI 10.3233/JAD-132072; Chupin M, 2009, HIPPOCAMPUS, V19, P579, DOI 10.1002/hipo.20626; Colliot O, 2008, RADIOLOGY, V248, P194, DOI 10.1148/radiol.2481070876; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Duchesne S, 2008, IEEE T MED IMAGING, V27, P509, DOI 10.1109/TMI.2007.908685; Eskildsenemail S, 2013, ALZHEIMERS DEMENTI S, V9, P102; Ewers M, 2012, NEUROBIOL AGING, V33, P1203, DOI 10.1016/j.neurobiolaging.2010.10.019; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fletcher PT, 2003, PROC CVPR IEEE, P95; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Fox NC, 1999, NEUROLOGY, V52, P1687, DOI 10.1212/WNL.52.8.1687; Gerardin E, 2009, NEUROIMAGE, V47, P1476, DOI 10.1016/j.neuroimage.2009.05.036; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Gutman B, 2009, HIPPOCAMPUS, V19, P572, DOI 10.1002/hipo.20627; Harvey PD, 2005, ALZ DIS ASSOC DIS, V19, P186, DOI 10.1097/01.wad.0000189034.43203.60; Hirata Y, 2005, NEUROSCI LETT, V382, P269, DOI 10.1016/j.neulet.2005.03.038; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Karas GB, 2004, NEUROIMAGE, V23, P708, DOI 10.1016/j.neuroimage.2004.07.006; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Koikkalainen J, 2011, NEUROIMAGE, V56, P1134, DOI 10.1016/j.neuroimage.2011.03.029; Lao ZQ, 2004, NEUROIMAGE, V21, P46, DOI 10.1016/j.neuroimage.2003.09.027; Lerch JP, 2005, CEREB CORTEX, V15, P995, DOI 10.1093/cercor/bhh200; Lillemark L, 2014, BMC MED IMAGING, V14, DOI 10.1186/1471-2342-14-21; Magnin B, 2009, NEURORADIOLOGY, V51, P73, DOI 10.1007/s00234-008-0463-x; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; Moradi E, 2015, NEUROIMAGE, V104, P398, DOI 10.1016/j.neuroimage.2014.10.002; Musiek ES, 2012, ALZHEIMERS DEMENT, V8, P51, DOI 10.1016/j.jalz.2011.06.003; Nho Kwangsik, 2010, AMIA Annu Symp Proc, V2010, P542; Petrella JR, 2003, RADIOLOGY, V226, P315, DOI 10.1148/radiol.2262011600; Poulin SP, 2011, PSYCHIAT RES-NEUROIM, V194, P7, DOI 10.1016/j.pscychresns.2011.06.014; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; Scahill RI, 2002, P NATL ACAD SCI USA, V99, P4703, DOI 10.1073/pnas.052587399; Shaffer JL, 2013, RADIOLOGY, V266, P583, DOI 10.1148/radiol.12120010; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Spulber G, 2013, J INTERN MED, V273, P396, DOI 10.1111/joim.12028; Tapiola T, 2008, NEUROBIOL AGING, V29, P31, DOI 10.1016/j.neurobiolaging.2006.09.007; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tiraboschi P, 2004, NEUROLOGY, V62, P1984, DOI 10.1212/01.WNL.0000129697.01779.0A; Varol E, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P146, DOI 10.1109/ISBI.2012.6235505; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Vercauteren T, 2008, LECT NOTES COMPUT SC, V5241, P754, DOI 10.1007/978-3-540-85988-8_90; Westman E, 2012, NEUROIMAGE, V62, P229, DOI 10.1016/j.neuroimage.2012.04.056; Willette AA, 2014, PSYCHIAT RES-NEUROIM, V224, P81, DOI 10.1016/j.pscychresns.2014.08.005; Wolz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025446; Xu Y, 2000, NEUROLOGY, V54, P1760, DOI 10.1212/WNL.54.9.1760; Yang WL, 2011, J ALZHEIMERS DIS, V24, P775, DOI 10.3233/JAD-2011-101371; Zhang DQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033182; Zhou Q, 2014, IEEE T BIO-MED ENG, V61, P2245, DOI 10.1109/TBME.2014.2310709	67	60	63	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173372	10.1371/journal.pone.0173372	http://dx.doi.org/10.1371/journal.pone.0173372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264071	Green Published, gold, Green Submitted			2022-12-26	WOS:000396054300057
J	Almand, EA; Moore, MD; Outlaw, J; Jaykus, LA				Almand, Erin A.; Moore, Matthew D.; Outlaw, Janie; Jaykus, Lee-Ann			Human norovirus binding to select bacteria representative of the human gut microbiota	PLOS ONE			English	Article							BLOOD GROUP ANTIGENS; REVERSE TRANSCRIPTION-PCR; TULANE VIRUS RECOGNIZES; ENTERIC BACTERIA; STRUCTURAL BASIS; REPLICATION; DIVERSITY; CALICIVIRUS; INHIBITION; CELLS	Recent reports describe the ability of select bacterial strains to bind human norovirus, although the specificity of such interactions is unknown. The purpose of this work was to determine if a select group of bacterial species representative of human gut microbiota bind to human norovirus, and if so, to characterize the intensity and location of that binding. The bacteria screened included naturally occurring strains isolated from human stool (Klebsiella spp., Citrobacter spp., Bacillus spp., Enterococcus faecium and Hafnia alvei) and select reference strains (Staphylococcus aureus and Enterobacter cloacae). Binding in PBS was evaluated to three human norovirus strains (GII. 4 New Orleans 2009 and Sydney 2012, GI. 6) and two surrogate viruses (Tulane virus and Turnip Crinkle Virus (TCV)) using a suspension assay format linked to RT-qPCR for quantification. The impact of different overnight culture media prior to washing on binding efficiency in PBS was also evaluated, and binding was visualized using transmission electron microscopy. All bacteria tested bound the representative human norovirus strains with high efficiency (< 1 log(10) of input virus remained unbound or < 10% unbound and > 90% binding efficiency) (p> 0.05); there was selective binding for Tulane virus and no binding observed for TCV. Binding efficiency was highest when bacteria were cultured in minimal media (< 1 log(10) of input virus remained unbound, so > 90% bound), but notably decreased when cultured in enriched media (1 - 3 log(10) unbound or 0.01 - < 90% bound)) (p< 0.05). The norovirus-bacteria binding occurred around the outer cell surfaces and pili structures, without apparent localization. The findings reported here further elucidate and inform the dynamics between human noroviruses and enteric bacteria with implications for norovirus pathogenesis.	[Almand, Erin A.; Jaykus, Lee-Ann] North Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC USA; [Moore, Matthew D.; Outlaw, Janie; Jaykus, Lee-Ann] North Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Moore, MD (corresponding author), North Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA.	mdmoore5@ncsu.edu	Moore, Matthew/H-9345-2019	Moore, Matthew/0000-0002-5393-0733	National Institute of Food and Agriculture, U.S. Department of Agriculture under the NoroCORE project [1111-2011-0494, 2011-68003-30395]; US Air Force Institute of Technology Civilian Institute Program Scholarship	National Institute of Food and Agriculture, U.S. Department of Agriculture under the NoroCORE project; US Air Force Institute of Technology Civilian Institute Program Scholarship	This material is based upon work that is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 1111-2011-0494 and 2011-68003-30395, under the NoroCORE project. Support was provided by an US Air Force Institute of Technology Civilian Institute Program Scholarship (EAA). The views expressed in this article are those of the author and do not reflect the official policy or position of the United States Air Force, Department of Defense, or the U.S. Government, https://nifa.usda.gov/grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Amarasiri M, 2016, WATER RES; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211; Farkas T, 2008, J VIROL, V82, P5408, DOI 10.1128/JVI.00070-08; Farkas T, 2010, J VIROL, V84, P8617, DOI 10.1128/JVI.00630-10; Gentry-Shields J, 2015, FOOD RES INT; Han L, 2014, J AM CHEM SOC, V136, P12631, DOI 10.1021/ja505272n; Hansman GS, 2012, J VIROL, V86, P284, DOI 10.1128/JVI.05909-11; Harrington PR, 2004, J VIROL, V78, P3035, DOI 10.1128/JVI.78.6.3035-3045.2004; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Jothikumar N, 2005, APPL ENVIRON MICROB, V71, P1870, DOI 10.1128/AEM.71.4.1870-1875.2005; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Kleerebezem M, 2009, ANNU REV MICROBIOL, V63, P269, DOI 10.1146/annurev.micro.091208.073341; Kolawole AO, 2016, ANTIVIR RES, V132, P46, DOI 10.1016/j.antiviral.2016.05.011; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Li D, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00659; Macfarlane S, 2008, J CLIN GASTROENTEROL, V42, pS142, DOI 10.1097/MCG.0b013e31816207df; Manuel CS, 2015, APPL ENVIRON MICROB, V81, P4940, DOI 10.1128/AEM.00388-15; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; Miura T, 2013, J VIROL, V87, P9441, DOI 10.1128/JVI.01060-13; MOODY MR, 1969, APPL MICROBIOL, V18, P262, DOI 10.1128/AEM.18.2.262-267.1969; PRASAD BVV, 1994, J MOL BIOL, V240, P256, DOI 10.1006/jmbi.1994.1439; Robinson CM, 2014, CELL HOST MICROBE, V15, P36, DOI 10.1016/j.chom.2013.12.004; Rydell GE, 2009, GLYCOBIOLOGY, V19, P309, DOI 10.1093/glycob/cwn139; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scharff RL., 2012, INT ASS FOOD PROTECT, V75, P123, DOI [10.4315/0362-028X.JFP-11-058, DOI 10.4315/0362-028X.JFP-11-058]; Sestak K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037973; SPRINGER GF, 1961, J EXP MED, V113, P1077, DOI 10.1084/jem.113.6.1077; Stevens KA, 2004, J APPL MICROBIOL, V97, P1115, DOI 10.1111/j.1365-2672.2004.02393.x; Tan M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11784; Thorne LG, 2014, J GEN VIROL, V95, P278, DOI 10.1099/vir.0.059634-0; Zhang DS, 2015, J VIROL, V89, P1419, DOI 10.1128/JVI.02595-14	36	65	65	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173124	10.1371/journal.pone.0173124	http://dx.doi.org/10.1371/journal.pone.0173124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257478	Green Published, gold, Green Submitted			2022-12-26	WOS:000396021100060
J	Del Coso, J; Valero, M; Salinero, JJ; Lara, B; Gallo-Salazar, C; Areces, F				Del Coso, Juan; Valero, Marjorie; Jose Salinero, Juan; Lara, Beatriz; Gallo-Salazar, Cesar; Areces, Francisco			Optimum polygenic profile to resist exertional rhabdomyolysis during a marathon	PLOS ONE			English	Article							INDUCED MUSCLE DAMAGE; ACTN3 GENOTYPE; EXERCISE; POLYMORPHISMS; PERFORMANCE; INJURY	Purpose Exertional rhabdomyolysis can occur in individuals performing various types of exercise but it is unclear why some individuals develop this condition while others do not. Previous investigations have determined the role of several single nucleotide polymorphisms (SNPs) to explain inter-individual variability of serum creatine kinase (CK) concentrations after exertional muscle damage. However, there has been no research about the interrelationship among these SNPs. The purpose of this investigation was to analyze seven SNPs that are candidates for explaining individual variations of CK response after a marathon competition (ACE = 287bp Ins/Del, ACTN3 = p. R577X, CKMM = NcoI, IGF2 = C13790G, IL6 = 174G> C, MLCK = C37885A, TNFa = 308G> A). Methods Using Williams and Folland's model, we determined the total genotype score from the accumulated combination of these seven SNPs for marathoners with a low CK response (n = 36; serum CK < 400 U.L-1) vs. marathoners with a high CK response (n = 31; serum CK >= 400 U.L-1). Results At the end of the race, low CK responders had lower serum CK (290 +/- 65 vs. 733 +/- 405 U.L-1; P< 0.01) and myoglobin concentrations (443 +/- 328 vs. 1009 +/- 971 ng.mL(-1), P< 0.01) than high CK responders. Although the groups were similar in age, anthropometric characteristics, running experience and training habits, total genotype score was higher in low CK responders than in high CK responders (5.2 +/- 1.4 vs. 4.4 +/- 1.7 point, P = 0.02). Conclusion Marathoners with a lower CK response after the race had a more favorable polygenic profile than runners with high serum CK concentrations. This might suggest a significant role of genetic polymorphisms in the levels of exertional muscle damage and rhabdomyolysis. Yet other SNPs, in addition to exercise training, might also play a role in the values of CK after damaging exercise.	[Del Coso, Juan; Valero, Marjorie; Jose Salinero, Juan; Lara, Beatriz; Gallo-Salazar, Cesar; Areces, Francisco] Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain	Camilo Jose Cela University	Del Coso, J (corresponding author), Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain.	jdelcoso@ucjc.edu	Areces, Francisco/ABH-3023-2020; Del Coso, Juan/AAC-7117-2020; MARTÍN, JUAN JOSÉ JJ SALINERO/I-4212-2012; Salinero, Juan J./GLT-1243-2022; GALLO, CESAR/O-4823-2019; Lara, Beatriz/AAQ-5269-2021	Areces, Francisco/0000-0003-2996-4156; Del Coso, Juan/0000-0002-5785-984X; MARTÍN, JUAN JOSÉ JJ SALINERO/0000-0003-4153-5100; Salinero, Juan J./0000-0003-4153-5100; GALLO, CESAR/0000-0001-8676-4658; Lara, Beatriz/0000-0001-5516-4852	ViceRectorate of Research and Science at the Camilo Jose Cela University	ViceRectorate of Research and Science at the Camilo Jose Cela University	The study was part of the DAMUS project supported by a Grant-in-aid from the ViceRectorate of Research and Science, at the Camilo Jose Cela University (http://www.ucjc.edu/la-universidad/estructura-academica/vicerrectorados/vicerrectorado-de-innovacion/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Areces F, 2015, J ORTHOP SPORT PHYS, V45, P462, DOI 10.2519/jospt.2015.5863; Baumert P, 2016, EUR J APPL PHYSIOL, V116, P1595, DOI 10.1007/s00421-016-3411-1; Bosch X, 2009, NEW ENGL J MED, V361, P62, DOI 10.1056/NEJMra0801327; Chen YM, 2008, EUR J APPL PHYSIOL, V104, P579, DOI 10.1007/s00421-008-0728-4; Childers MK, 2004, MUSCLE NERVE, V29, P313, DOI 10.1002/mus.10517; Clarkson PM, 2006, MED SCI SPORT EXER, V38, P623, DOI 10.1249/01.mss.0000210192.49210.fc; Clarkson PM, 2005, J APPL PHYSIOL, V99, P564, DOI 10.1152/japplphysiol.00130.2005; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI [10.1097/00002060-200211001-00007, 10.1097/01.PHM.0000029772.45258.43]; Clarkson PM, 2007, SPORTS MED, V37, P361, DOI 10.2165/00007256-200737040-00022; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collins M, 2003, MED SCI SPORT EXER, V35, P1524, DOI 10.1249/01.MSS.0000084522.14168.49; Del Coso J, 2016, SCAND J MED SCI SPOR, V26, P1036, DOI 10.1111/sms.12542; Del Coso J, 2017, EUROPEAN JOURNAL OF; Del Coso J, 2017, EUR J APPL PHYSIOL, V117, P151, DOI 10.1007/s00421-016-3507-7; Del Coso J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160053; Del Coso J, 2013, AMINO ACIDS, V44, P1511, DOI 10.1007/s00726-013-1473-5; Del Coso J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057602; Del Coso J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043280; Deuster PA, 2013, EUR J APPL PHYSIOL, V113, P1997, DOI 10.1007/s00421-013-2622-y; Devaney JM, 2007, J APPL PHYSIOL, V102, P1815, DOI 10.1152/japplphysiol.01165.2006; Duan CM, 2010, GEN COMP ENDOCR, V167, P344, DOI 10.1016/j.ygcen.2010.04.009; Efstratiadis G, 2007, Hippokratia, V11, P129; Head SI, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004862; Heled Y, 1985, J APPL PHYSIOL, V103, P504; Hubal MJ, 2010, J APPL PHYSIOL, V108, P1651, DOI 10.1152/japplphysiol.00361.2009; Landau Mark E, 2012, J Clin Neuromuscul Dis, V13, P122, DOI 10.1097/CND.0b013e31822721ca; Ling PR, 1997, AM J PHYSIOL-ENDOC M, V272, pE333, DOI 10.1152/ajpendo.1997.272.3.E333; Ma F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054685; Mckay BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006027; NEWHAM DJ, 1983, MUSCLE NERVE, V6, P380, DOI 10.1002/mus.880060507; Pimenta EM, 2012, EUR J APPL PHYSIOL, V112, P1495, DOI 10.1007/s00421-011-2109-7; Riedl I, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12314; Ruiz JR, 2009, J PHYSIOL-LONDON, V587, P1527, DOI 10.1113/jphysiol.2008.166645; Santos J Jr, 1999, JAAPA, V12, P46; Santos Jr J ., 1999, JAAPA-J AM ACAD PHYS, V12, P53; Sauret JM, 2002, AM FAM PHYSICIAN, V65, P907; Singh D, 2005, METHOD FIND EXP CLIN, V27, P39, DOI 10.1358/mf.2005.27.1.875435; Stewart CEH, 2004, J CELL PHYSIOL, V198, P237, DOI 10.1002/jcp.10387; Totsuka M, 2002, J APPL PHYSIOL, V93, P1280, DOI 10.1152/japplphysiol.01270.2001; Vincent B, 2010, J APPL PHYSIOL, V109, P564, DOI 10.1152/japplphysiol.01007.2009; Williams AG, 2008, J PHYSIOL-LONDON, V586, P113, DOI 10.1113/jphysiol.2007.141887; Yamin C, 2014, PEDIATR ENDOCR REV P, V11, P400; Yamin C, 2007, J APPL PHYSIOL, V103, P2057, DOI 10.1152/japplphysiol.00867.2007; Yamin C, 2009, EUR J APPL PHYSIOL, V107, P375, DOI 10.1007/s00421-009-1137-z; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002	46	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172965	10.1371/journal.pone.0172965	http://dx.doi.org/10.1371/journal.pone.0172965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257486	gold, Green Published, Green Submitted			2022-12-26	WOS:000396021100047
J	Kawai, E; Nakahara, H; Ueda, SY; Manabe, K; Miyamoto, T				Kawai, Eriko; Nakahara, Hidehiro; Ueda, Shin-ya; Manabe, Kou; Miyamoto, Tadayoshi			A novel approach for evaluating the effects of odor stimulation on dynamic cardiorespiratory functions	PLOS ONE			English	Article							OLFACTORY STIMULATION; GRAPEFRUIT OIL; BLOOD-PRESSURE; INHALATION; HUMANS; SYSTEM; SCENT; RATS	We aimed to develop a novel method to quantitatively evaluate the effects of odor stimulation on cardiorespiratory functions over time, and to examine the potential usefulness of clinical aromatherapy. Eighteen subjects participated. Nine people were assigned to each of the two resting protocols. Protocol 1: After resting for 2 min in a sitting position breathing room air, the subject inhaled either air or air containing sweet marjoram essential oil from the Douglas bag for 6 min, Protocol 2: After resting for 5 min in a supine position, the subject inhaled the essential oil for 10 min, and then recovered for 10 min breathing room air. All subjects inhaled the essential oil through a face mask attached to one-way valve, and beat-to-beat heart rate (HR) and arterial blood pressure (BP) as well as breath-by-breath respiratory variables were continuously recorded. In both protocols, during fragrance inhalation of the essential oil, time-dependent decrease in mean BP and HR were observed (P< 0.05). During post-inhalation recovery, the significant fragrance-induced bradycardic effect lasted at least 5 min (-3.1 +/- 3.9% vs. pre-inhalation baseline value, p< 0.05). The mean BP response at the start of odor stimulation was approximated by a first-order exponential model. However, such fragrance-induced changes were not observed in the respiratory variables. We established a novel approach to quantitatively and accurately evaluate the effects of quantitative odor stimulation on dynamic cardiorespiratory functions, and the duration of the effect. This methodological approach may be useful for scientific evaluation of aromatherapy as an approach to integrated medicine, and the mechanisms of action of physiological effects in fragrance compounds.	[Kawai, Eriko; Nakahara, Hidehiro; Ueda, Shin-ya; Manabe, Kou; Miyamoto, Tadayoshi] Morinomiya Univ Med Sci, Grad Sch Hlth Sci, Osaka, Osaka, Japan		Kawai, E (corresponding author), Morinomiya Univ Med Sci, Grad Sch Hlth Sci, Osaka, Osaka, Japan.	kawai@respiratorycontrol.com		miyamoto, tadayoshi/0000-0001-5504-6119	Research Project for Improving Quality in Healthcare and Collecting Scientific Evidence on Integrative Medicine from Japan Agency for Medical Research and Development, AMED	Research Project for Improving Quality in Healthcare and Collecting Scientific Evidence on Integrative Medicine from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This research was partially supported by the Research Project for Improving Quality in Healthcare and Collecting Scientific Evidence on Integrative Medicine from Japan Agency for Medical Research and Development, AMED.	Asano K, 2009, INFLUENCE ODOR STIMU, V8, P17; Cha JH, 2013, J KOREAN ACAD NURS, V40, P705; Dalton P, 1996, PERCEPT PSYCHOPHYS, V58, P781, DOI 10.3758/BF03213109; Goes TC, 2012, J ALTERN COMPLEM MED, V18, P798, DOI 10.1089/acm.2011.0551; Haze S, 2002, JPN J PHARMACOL, V90, P247, DOI 10.1254/jjp.90.247; Hongratanaworakit T, 2009, NAT PROD COMMUN, V4, P291; Ilmberger J, 2001, CHEM SENSES, V26, P239, DOI 10.1093/chemse/26.3.239; Ito A, 2010, PROMOTION SALIVATION, V14, P134; Niijima A, 2003, EXP BIOL MED, V228, P1190, DOI 10.1177/153537020322801014; Peng SM, 2009, J ALTERN COMPLEM MED, V15, P53, DOI 10.1089/acm.2008.0243; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Sayorwan Winai, 2012, Journal of the Medical Association of Thailand, V95, P598; Shen J, 2005, NEUROSCI LETT, V380, P289, DOI 10.1016/j.neulet.2005.01.058; Shiina Y, 2008, INT J CARDIOL, V129, P193, DOI 10.1016/j.ijcard.2007.06.064; Tanida M, 2006, NEUROSCI LETT, V398, P155, DOI 10.1016/j.neulet.2005.12.076; Umeno K, 2008, BRIT J CLIN PHARMACO, V65, P188, DOI 10.1111/j.1365-2125.2007.02992.x; VieIllard S, 2008, COGNITION EMOTION, V22, P720, DOI 10.1080/02699930701503567; Yamamoto Y., 2003, J JPN SOC PHYSL ANTH, V8, P25	19	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172841	10.1371/journal.pone.0172841	http://dx.doi.org/10.1371/journal.pone.0172841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257441	Green Published, gold, Green Submitted			2022-12-26	WOS:000396021100030
J	Ono, N; Murakami, K; Chan, O; Hall, H; Elford, AR; Yen, P; Calzascia, T; Spencer, DM; Ohashi, PS; Dhanji, S				Ono, Nobuyuki; Murakami, Kiichi; Chan, Olivia; Hall, Hakan; Elford, Alisha R.; Yen, Patty; Calzascia, Thomas; Spencer, David M.; Ohashi, Pamela S.; Dhanji, Salim			Exposure to sequestered self-antigens in vivo is not sufficient for the induction of autoimmune diabetes	PLOS ONE			English	Article							REGULATORY T-CELLS; APOPTOTIC CELLS; DENDRITIC CELLS; CROSS-PRESENTATION; TOLERANCE; BETA; MATURATION; CLEARANCE; DEATH; NECROPTOSIS	Although the role of T cells in autoimmunity has been explored for many years, the mechanisms leading to the initial priming of an autoimmune T cell response remain enigmatic. The `hit and run' model suggests that self-antigens released upon cell death can provide the initial signal for a self-sustaining autoimmune response. Using a novel transgenic mouse model where we could induce the release of self-antigens via caspase-dependent apoptosis. We tracked the fate of CD8+ T cells specific for the self-antigen. Our studies demonstrated that antigens released from apoptotic cells were cross-presented by CD11c+ cells in the draining lymph node. This cross-presentation led to proliferation of self-antigen specific T cells, followed by a transient ability to produce IFN-gamma,but did not lead to the development of autoimmune diabetes. Using this model we examined the consequences on T cell immunity when apoptosis was combined with dendritic cell maturation signals, an autoimmune susceptible genetic background, and the deletion of Tregs. The results of our study demonstrate that autoimmune diabetes cannot be initiated by the presentation of antigens released from apoptotic cells in vivo even in the presence of factors known to promote autoimmunity.	[Ono, Nobuyuki] Saga Univ, Fac Med, Dept Rheumatol, Saga, Japan; [Ono, Nobuyuki; Murakami, Kiichi; Chan, Olivia; Hall, Hakan; Elford, Alisha R.; Yen, Patty; Calzascia, Thomas; Ohashi, Pamela S.; Dhanji, Salim] Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Dept Med Biophys, Toronto, ON, Canada; [Ono, Nobuyuki; Murakami, Kiichi; Chan, Olivia; Hall, Hakan; Elford, Alisha R.; Yen, Patty; Calzascia, Thomas; Ohashi, Pamela S.; Dhanji, Salim] Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Dept Immunol, Toronto, ON, Canada; [Spencer, David M.] Baylor Coll Med, Texas Med Ctr, Dept Pathol & Immunol, Houston, TX 77030 USA; [Spencer, David M.] Bellicum Pharmaceut Inc, Houston, TX USA	Saga University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Ohashi, PS (corresponding author), Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Dept Med Biophys, Toronto, ON, Canada.; Ohashi, PS (corresponding author), Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Dept Immunol, Toronto, ON, Canada.	pohashi@uhnresearch.ca	Ono, Nobuyuki/T-7414-2019	Ohashi, Pamela S./0000-0003-2915-9317; ONO, NOBUYUKI/0000-0003-0709-4858; Calzascia, Thomas/0000-0001-8225-6744	NCIC; Canadian Cancer Society [17506]; CIHR fellowship; Uehara Memorial Foundation; Canada Research Chair in Autoimm unity and Tumor Immunity [950-200562]; NIH Tetramer Core Facility [HHSN272201300006C]; CANVAC Network Centres of Excellence (CANVAC TD1.5)	NCIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Cancer Society(Canadian Cancer Society (CCS)); CIHR fellowship(Canadian Institutes of Health Research (CIHR)); Uehara Memorial Foundation(Uehara Memorial Foundation); Canada Research Chair in Autoimm unity and Tumor Immunity; NIH Tetramer Core Facility(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CANVAC Network Centres of Excellence (CANVAC TD1.5)	This work was supported by the CANVAC Network Centres of Excellence (CANVAC TD1.5: http://www.nce.rce.gc.ca) and the NCIC with funds from the Canadian Cancer Society (17506: http://www.cancer.ca/research). NO is supported by a CIHR fellowship (http://www.cihr-irsc.gc.ca), Uehara Memorial Foundation (http:/www.ueharazaidan.or.jp), SD holds a CIHR fellowship and PSO holds a Canada Research Chair in Autoimm unity and Tumor Immunity (950-200562: http://www.chairs-chaires.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Caiying Guo (UConn Health Center) for generating the transgenic lines. We acknowledge the NIH Tetramer Core Facility (contract HHSN272201300006C) for provision of gp33-41, gp276-286 and np396-404 tetramers.	Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Bachmann MF, 1997, J VIROL, V71, P5764, DOI 10.1128/JVI.71.8.5764-5768.1997; Bluestone JA, 2008, J CLIN IMMUNOL, V28, P677, DOI 10.1007/s10875-008-9242-z; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Coppieters KT, 2012, APMIS, V120, P941, DOI 10.1111/apm.12011; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Ferris ST, 2014, IMMUNITY, V41, P657, DOI 10.1016/j.immuni.2014.09.012; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; George SK, 2004, J AUTOIMMUN, V23, P151, DOI 10.1016/j.jaut.2004.06.006; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Griffith TS, 2007, J IMMUNOL, V178, P2679, DOI 10.4049/jimmunol.178.5.2679; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Hugues S, 2002, IMMUNITY, V16, P169, DOI 10.1016/S1074-7613(02)00273-X; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Mallet VO, 2002, NAT BIOTECHNOL, V20, P1234, DOI 10.1038/nbt762; Melli K, 2009, J IMMUNOL, V182, P2590, DOI 10.4049/jimmunol.0803543; O'Brien BA, 2006, J AUTOIMMUN, V26, P104, DOI 10.1016/j.jaut.2005.11.006; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Parish IA, 2009, BLOOD, V113, P4575, DOI 10.1182/blood-2008-10-185223; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schildknecht A, 2010, P NATL ACAD SCI USA, V107, P199, DOI 10.1073/pnas.0910620107; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Tisch R, 2009, DIABETES, V58, P12, DOI 10.2337/db08-1341; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Trudeau JD, 2000, DIABETES, V49, P1, DOI 10.2337/diabetes.49.1.1; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; Wallet MA, 2008, J EXP MED, V205, P219, DOI 10.1084/jem.20062293; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Zelenay S, 2013, TRENDS IMMUNOL, V34, P329, DOI 10.1016/j.it.2013.03.005	46	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173176	10.1371/journal.pone.0173176	http://dx.doi.org/10.1371/journal.pone.0173176			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257518	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100070
J	Tardy, F; Damour, G; Dorel, M; Moreau, D				Tardy, Florence; Damour, Gaelle; Dorel, Marc; Moreau, Delphine			Trait-based characterisation of soil exploitation strategies of banana, weeds and cover plant species	PLOS ONE			English	Article							PHOSPHORUS ACQUISITION EFFICIENCY; FUNCTIONAL TRAITS; ECONOMICS SPECTRUM; ROOT ARCHITECTURE; CROPPING SYSTEMS; COMPETITION	Cover plants can be introduced in cropping systems to provide agroecosystem services, including weed control via competition for resources. There is currently no consensus on how to identify the best cover plant species, while trait-based approaches are promising for screening plant species due to their agroecosystem service provision potential. This study was carried out to characterize soil exploitation strategies of cover plant species in banana agroecosystems using a trait-based approach, and in turn identify cover plant species with a high weed control potential via competition for soil resources in banana cropping systems. A field experiment was conducted on 17 cover plant species, two weed species and two banana cultivars grown individually. Four functional traits were measured. Two of them (i. e., the size of the zone explored by roots and the root impact density) were used to characterize root system soil exploration patterns. Two other traits (i. e., specific root length and root diameter) were used to characterize resource acquisition within the soil zone explored by the roots. All studied traits exhibited marked variations among species. The findings suggested a trade-off between the abilities of species to develop a limited number of large diameter roots exploring a large soil zone versus many thin roots exploring a smaller soil zone. Three soil-resource exploitation strategies were identified among species: (i) with large diameter roots that explore a large soil zone; (ii) with small diameter roots and a high specific length that explore a smaller soil zone; and (iii) with a high total root-impact density and an intermediate specific root length that explore the uppermost soil layers. Interestingly, in our panel of species, no correlations with regard to belowground and aboveground strategies were noted: species with an acquisitive belowground strategy could display an acquisitive or a conservative aboveground strategy. The findings of this study illustrated that a trait-based approach could be used to identify plant species with potential for competing with weeds, while minimising competition with banana. Six of the 17 studied cover crop species were identified as having this potential. The next step will be to assess them for their weed control performances in banana cropping systems with low reliance on herbicides.	[Tardy, Florence; Damour, Gaelle; Dorel, Marc] CIRAD, UPR GECO, Capesterre Belle Eau, Guadeloupe, France; [Moreau, Delphine] Univ Bourgogne Franche Comte, INRA, AgroSup Dijon, Agroecol, Dijon, France	CIRAD; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Tardy, F; Damour, G (corresponding author), CIRAD, UPR GECO, Capesterre Belle Eau, Guadeloupe, France.; Moreau, D (corresponding author), Univ Bourgogne Franche Comte, INRA, AgroSup Dijon, Agroecol, Dijon, France.	florence.tardyfevrier@gmail.com; gaelle.damour@cirad.fr; delphine.moreau@inra.fr	Moreau, Delphine/C-5968-2014	Moreau, Delphine/0000-0003-2640-9931; DAMOUR, Gaelle/0000-0001-6080-7306	FEDER Guadeloupe Project "Agroecologie des systemes multi-especes pour le developpement d'une agriculture durable en milieu tropical"; CIRAD; INRA	FEDER Guadeloupe Project "Agroecologie des systemes multi-especes pour le developpement d'une agriculture durable en milieu tropical"; CIRAD; INRA	This work was supported by the FEDER Guadeloupe Project "Agroecologie des systemes multi-especes pour le developpement d'une agriculture durable en milieu tropical," lead by the consortium CIRAD/INRA/UA. FT was supported by grants from CIRAD and INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1999, J EXP BOT, V50, P29, DOI 10.1093/jexbot/50.330.29; Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; [Anonymous], 2014, R LANG ENV STAT COMP; BERNTSON GM, 1994, NEW PHYTOL, V127, P483, DOI 10.1111/j.1469-8137.1994.tb03966.x; Chanteloup P, 2013, THESIS; Chapman N, 2012, TRENDS PLANT SCI, V17, P701, DOI 10.1016/j.tplants.2012.08.001; Cornelissen JHC, 1997, OECOLOGIA, V111, P460, DOI 10.1007/s004420050259; Damour G, 2015, ADV AGRON, V134, P81, DOI 10.1016/bs.agron.2015.06.004; de Mendiburu F., 2019, AGRICOLAE STAT PROCE; Dunbabin VM, 2013, PLANT SOIL, V372, P93, DOI 10.1007/s11104-013-1769-y; Ehrmann J, 2014, PLANT SOIL, V376, P1, DOI 10.1007/s11104-013-1921-8; EISSENSTAT DM, 1992, J PLANT NUTR, V15, P763, DOI 10.1080/01904169209364361; Fort F, 2013, J PLANT ECOL, V6, P211, DOI 10.1093/jpe/rts034; Gahoonia TS, 2004, PLANT SOIL, V262, P55, DOI 10.1023/B:PLSO.0000037020.58002.ac; Gardarin A, 2011, ECOL MODEL, V222, P626, DOI 10.1016/j.ecolmodel.2010.10.005; Ge ZY, 2000, PLANT SOIL, V218, P159, DOI 10.1023/A:1014987710937; Hishi T, 2007, J FOREST RES-JPN, V12, P126, DOI 10.1007/s10310-006-0260-5; Hodge A, 1999, PLANT CELL ENVIRON, V22, P811, DOI 10.1046/j.1365-3040.1999.00454.x; Hunt MA, 2006, FOREST ECOL MANAG, V233, P260, DOI 10.1016/j.foreco.2006.05.017; Jungk AO, 2002, DYNAMICS NUTR MOVEME; Koohafkan P, 2012, INT J AGR SUSTAIN, V10, P61, DOI 10.1080/14735903.2011.610206; Lu YC, 2000, FOOD REV INT, V16, P121, DOI 10.1081/FRI-100100285; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Lynch JP, 2001, PLANT SOIL, V237, P225, DOI 10.1023/A:1013324727040; Maire V, 2009, FUNCT ECOL, V23, P668, DOI 10.1111/j.1365-2435.2009.01557.x; Malezieux E, 2009, AGRON SUSTAIN DEV, V29, P43, DOI 10.1051/agro:2007057; Martin AR, 2015, J APPL ECOL, V52, P1425, DOI 10.1111/1365-2664.12526; Mokany K, 2008, J VEG SCI, V19, P119, DOI 10.3170/2007-8-18340; Osone Y, 2005, FUNCT ECOL, V19, P460, DOI 10.1111/j.1365-2435.2005.00970.x; Pages L, 2014, ECOL MODEL, V290, P76, DOI 10.1016/j.ecolmodel.2013.11.014; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Roumet C, 2006, NEW PHYTOL, V170, P357, DOI 10.1111/j.1469-8137.2006.01667.x; Roumet C, 2016, NEW PHYTOL, V210, P815, DOI 10.1111/nph.13828; STEWART AJA, 1982, OECOLOGIA, V52, P269, DOI 10.1007/BF00363848; Tardy F, 2015, EUR J AGRON, V71, P10, DOI 10.1016/j.eja.2015.08.002; Tribouillois H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122156; Vandermeer J.H., 1989, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Wood SA, 2015, TRENDS ECOL EVOL, V30, P531, DOI 10.1016/j.tree.2015.06.013; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zhu JM, 2004, FUNCT PLANT BIOL, V31, P949, DOI 10.1071/FP04046	43	7	7	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173066	10.1371/journal.pone.0173066	http://dx.doi.org/10.1371/journal.pone.0173066			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257454	Green Published, gold, Green Submitted			2022-12-26	WOS:000396021100054
J	Teferi, WM; Desaulniers, MA; Noyce, RS; Shenouda, M; Umer, B; Evans, DH				Teferi, Wondimagegnehu M.; Desaulniers, Megan A.; Noyce, Ryan S.; Shenouda, Mira; Umer, Brittany; Evans, David H.			The vaccinia virus K7 protein promotes histone methylation associated with heterochromatin formation	PLOS ONE			English	Article							CONSTITUTIVE HETEROCHROMATIN; REPRESSIVE CHROMATIN; VIRULENCE FACTOR; IMMUNE-RESPONSE; INFECTED CELLS; MYXOMA VIRUS; BEN-DOMAIN; KAPPA-B; GENE; DNA	It has been well established that many vaccinia virus proteins suppress host antiviral pathways by targeting the transcription of antiviral proteins, thus evading the host innate immune system. However, whether viral proteins have an effect on the host's overall cellular transcription is less understood. In this study we investigated the regulation of heterochromatin during vaccinia virus infection. Heterochromatin is a highly condensed form of chromatin that is less transcriptionally active and characterized by methylation of histone proteins. We examined the change in methylation of two histone proteins, H3 and H4, which are major markers of heterochromatin, during the course of viral infection. Using immunofluorescence microscopy and flow cytometry we were able to track the overall change in the methylated levels of H3K9 and H4K20. Our results suggest that there is significant increase in methylation of H3K9 and H4K20 during Orthopoxviruses infection compared to mock-infected cells. However, this effect was not seen when we infected cells with Leporipoxviruses. We further screened several vaccinia virus single and multi-gene deletion mutant and identified the vaccinia virus gene K7R as a contributor to the increase in cellular histone methylation during infection.	[Teferi, Wondimagegnehu M.; Desaulniers, Megan A.; Noyce, Ryan S.; Shenouda, Mira; Umer, Brittany; Evans, David H.] Univ Alberta, Li Ka Shing Inst Virol, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Teferi, Wondimagegnehu M.] Albert Einstein Coll Med, Jacobi Med Ctr, Dept Med, Bronx, NY 10467 USA	University of Alberta; Jacobi Medical Center; Yeshiva University; Albert Einstein College of Medicine	Evans, DH (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.	devans@ualberta.ca	Evans, David/M-1912-2016	Evans, David/0000-0001-5871-299X	NSERC; CIHR; Canada Foundation for Innovation; Faculty of Medicine AMP; Dentistry Imaging and Flow Cytometry; Alberta Innovates [201600021] Funding Source: researchfish	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Faculty of Medicine AMP; Dentistry Imaging and Flow Cytometry; Alberta Innovates	This work was supported by NSERC and CIHR operating grants to DHE along with infrastructure awards from the Canada Foundation for Innovation.r We thank Dr. Steve Ogg and Dr. Aja Rieger for their advice and the support provided by the Faculty of Medicine & Dentistry Imaging and Flow Cytometry research cores. We also thank Ms. Nicole Favis for excellent technical assistance.	Abhiman S, 2008, BIOINFORMATICS, V24, P458, DOI 10.1093/bioinformatics/btn007; Ayrapetov MK, 2014, P NATL ACAD SCI USA, V111, P9169, DOI 10.1073/pnas.1403565111; Benfield CTO, 2013, J GEN VIROL, V94, P1647, DOI 10.1099/vir.0.052670-0; Benfield CTO, 2011, J BIOL CHEM, V286, P20727, DOI 10.1074/jbc.M111.231381; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Blanie S, 2009, VET RES, V40, DOI 10.1051/vetres:2008049; Broyles SS, 2003, J GEN VIROL, V84, P2293, DOI 10.1099/vir.0.18942-0; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; Ciabrelli F, 2015, J MOL BIOL, V427, P608, DOI 10.1016/j.jmb.2014.09.013; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; Dai Q, 2013, GENE DEV, V27, P602, DOI 10.1101/gad.213314.113; Dambacher S, 2013, CELL CYCLE, V12, P2925, DOI 10.4161/cc.26179; Ember SWJ, 2012, J GEN VIROL, V93, P2098, DOI 10.1099/vir.0.045070-0; ENNIS HL, 1964, SCIENCE, V146, P1474, DOI 10.1126/science.146.3650.1474; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fahy AS, 2008, J GEN VIROL, V89, P2377, DOI 10.1099/vir.0.2008/004895-0; FALKNER FG, 1988, J VIROL, V62, P1849, DOI 10.1128/JVI.62.6.1849-1854.1988; Ferguson BJ, 2013, J GEN VIROL, V94, P2070, DOI 10.1099/vir.0.054114-0; Gammon DB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000984; Gonzalez JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-59; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000128; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guerra S, 2003, J VIROL, V77, P6493, DOI 10.1128/JVI.77.11.6493-6506.2003; Kalverda AP, 2009, J MOL BIOL, V385, P843, DOI 10.1016/j.jmb.2008.09.048; Knipe DM, 2013, VIROLOGY, V435, P141, DOI 10.1016/j.virol.2012.09.023; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kroetz DN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005338; KUFE DW, 1980, J BIOL CHEM, V255, P8997; Liu SW, 2015, CELL HOST MICROBE, V17, P320, DOI 10.1016/j.chom.2015.02.002; Murcia-Nicolas A, 1999, VIRUS RES, V59, P1, DOI 10.1016/S0168-1702(98)00114-2; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Oda S, 2009, STRUCTURE, V17, P1528, DOI 10.1016/j.str.2009.09.005; OPGENORTH A, 1992, J VIROL, V66, P4720, DOI 10.1128/JVI.66.8.4720-4731.1992; Ramsey-Ewing A, 1998, VIROLOGY, V242, P138, DOI 10.1006/viro.1997.8985; Regha K, 2007, MOL CELL, V27, P353, DOI 10.1016/j.molcel.2007.06.024; Rintoul JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024643; Rochester SC, 1998, J VIROL, V72, P2917, DOI 10.1128/JVI.72.4.2917-2926.1998; Rubins KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015615; Saksouk N, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-3; Sathyan KM, 2011, J CELL SCI, V124, P3149, DOI 10.1242/jcs.086603; Schliehe C, 2015, NAT IMMUNOL, V16, P67, DOI 10.1038/ni.3046; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Senkevich TG, 2011, VIROLOGY, V417, P334, DOI 10.1016/j.virol.2011.06.017; Simoes M, 2015, VIRUSES-BASEL, V7, P4978, DOI 10.3390/v7092858; TADDIE JA, 1993, J VIROL, V67, P4323, DOI 10.1128/JVI.67.7.4323-4336.1993; Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247; Wasilenko ST, 2003, P NATL ACAD SCI USA, V100, P14345, DOI 10.1073/pnas.2235583100; Werden SJ, 2009, J VIROL, V83, P12068, DOI 10.1128/JVI.00963-09; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Xiao-Dan Yao, 2004, VACCINIA VIRUS POXVI, pxix; Yang ZL, 2011, J VIROL, V85, P9899, DOI 10.1128/JVI.05446-11; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Yoza BK, 2011, CYTOKINE, V53, P145, DOI 10.1016/j.cyto.2010.10.007; YUWEN H, 1993, VIROLOGY, V195, P732, DOI 10.1006/viro.1993.1424	57	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173056	10.1371/journal.pone.0173056	http://dx.doi.org/10.1371/journal.pone.0173056			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257484	Green Submitted, gold, Green Published			2022-12-26	WOS:000396021100052
J	Weng, CC; Chen, ZA; Chao, KT; Ee, TW; Lin, KJ; Chan, MH; Hsiao, IT; Yen, TC; Kung, MP; Hsu, CH; Wey, SP				Weng, Chi-Chang; Chen, Zi-An; Chao, Ko-Ting; Ee, Ting-Wei; Lin, Kun-Ju; Chan, Ming-Huan; Hsiao, Ing-Tsung; Yen, Tzu-Chen; Kung, Mei-Ping; Hsu, Ching-Han; Wey, Shiaw-Pyng			Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo F-18-9fluoropropyl-(+)-dihydrotetrabenazine PET imaging	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; VESICULAR MONOAMINE TRANSPORTER; DOPAMINE TRANSPORTER; F-18-FP-(+)-DTBZ F-18-AV-133; NEURONS; AUTORADIOGRAPHY; DEGENERATION; DIHYDROTETRABENAZINE; NEURODEGENERATION; DERIVATIVES	F-18-9-Fluoropropyl-(+)-dihydrotetrabenazine [F-18-FP-(+)-DTBZ] positron emission tomography (PET) has been shown to detect dopaminergic neuron loss associated with Parkinson's disease (PD) in human and neurotoxin-induced animal models. A polyphenol compound, magnolol, was recently proposed as having a potentially restorative effect in 1 methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- or 6-hydroxydopamine-treated animal models. In this study, 18F-FP-(+)-DTBZ PET was used to determine the therapeutic efficacy of magnolol in an MPTP PD mouse model that was prepared by giving an intraperitoneally (i.p.) daily dose of 25 mg/kg MPTP to male C57BU6 mice for 5 consecutive days. Twenty minute static 18F-FP-(+)-DTBZ PET scans were performed before MPTP treatment and 5 days after the termination of MPTP treatment to set up the baseline control. Half of the MPTP-treated mice then received a daily dose of magnolol (10 mg/kg dissolved in corn oil, i.p.) for 6 days. 18F-FP-(+)-DTBZ PET imaging was performed the day after the final treatment. All F-18-FP-(+)-DTBZ PET images were analysed and the specific uptake ratio (SUr) was calculated. Ex vivo autoradiography (ARG) and corresponding immunohistochemistry (IHC) studies were conducted to confirm the distribution of dopaminergic terminals in the striatum. The striatal SUr ratios of 18F-FP-(+)-DTBZ PET images for the Sham, the MPTP, and the MPTP + Magnolol-treated groups were 1.25 0.05, 0.75 0.06, and 1.00 0.11, respectively (n = 4 for each group). The ex vivo 18F-FP-(+)-DTBZ ARG and IHC results correlated favourably with the PET imaging results. F-18-FP-(+)-DTBZ PET imaging suggested that magnolol post-treatment may reverse the neuronal damage in the MPTP-lesioned PD mice. In vivo imaging of the striatal vesicular monoamine transporter type 2 (VMAT2) distribution using F-18-FP-(+)-DTBZ animal PET is a useful method to evaluate the efficacy of therapeutic drugs i.e., magnolol, for the management of PD.	[Weng, Chi-Chang; Chen, Zi-An; Ee, Ting-Wei; Hsiao, Ing-Tsung; Wey, Shiaw-Pyng] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan; [Weng, Chi-Chang; Hsu, Ching-Han] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Chao, Ko-Ting; Lin, Kun-Ju; Hsiao, Ing-Tsung; Yen, Tzu-Chen; Wey, Shiaw-Pyng] Chang Gung Mem Hosp, Dept Nucl Med, Ctr Adv Mol Imaging & Translat, Taoyuan, Taiwan; [Lin, Kun-Ju; Hsiao, Ing-Tsung] Chang Gung Mem Hosp, Neurosci Res Ctr, Taoyuan, Taiwan; [Chan, Ming-Huan] Natl Chengchi Univ, Inst Neurosci, Taipei, Taiwan; [Kung, Mei-Ping] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Wey, Shiaw-Pyng] Chang Gung Univ, Inst Radiol Res, Taoyuan, Taiwan; [Wey, Shiaw-Pyng] Chang Gung Mem Hosp, Taoyuan, Taiwan	Chang Gung University; National Tsing Hua University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Chengchi University; University of Pennsylvania; Chang Gung University; Chang Gung Memorial Hospital	Wey, SP (corresponding author), Chang Gung Univ, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan.; Hsu, CH (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.; Wey, SP (corresponding author), Chang Gung Mem Hosp, Dept Nucl Med, Ctr Adv Mol Imaging & Translat, Taoyuan, Taiwan.; Wey, SP (corresponding author), Chang Gung Univ, Inst Radiol Res, Taoyuan, Taiwan.; Wey, SP (corresponding author), Chang Gung Mem Hosp, Taoyuan, Taiwan.	cghsu@mx.nthu.edu.tw; spwey@mail.cgu.edu.tw	; Hsu, Ching-Han/G-6029-2010	Hsiao, Ing-Tsung/0000-0002-5255-7498; Hsu, Ching-Han/0000-0003-2351-2052; CHAN, MING-HUAN/0000-0003-3206-8731	Ministry of Science and Technology, Taiwan [NSC 100-2314-B-182A-092-MY3, 102-2221-E-007-021-MY2, 102-2314-B-182-049-MY3, 1032623-E-182-001-NU]; Research Fund of Chang Gung Memorial Hospital [CMRPG3A0513, CMRPG391514]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Research Fund of Chang Gung Memorial Hospital	This study was carried out with financial support from the Ministry of Science and Technology, Taiwan (Grant NSC 100-2314-B-182A-092-MY3 for KJL, 102-2221-E-007-021-MY2 for CHH, 102-2314-B-182-049-MY3 and 1032623-E-182-001-NU for SPW), and grants from the Research Fund of Chang Gung Memorial Hospital (CMRPG3A0513 and CMRPG391514 for KJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RJE, 2001, LANCET, V358, P1174, DOI 10.1016/S0140-6736(01)06260-2; BARBEAU A, 1969, UNION MED CAN, V98, P183; Bohnen NI, 2006, J CEREBR BLOOD F MET, V26, P1198, DOI 10.1038/sj.jcbfm.9600276; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Chao KT, 2012, SYNAPSE, V66, P823, DOI 10.1002/syn.21572; Chen HH, 2011, NEURODEGENER DIS, V8, P364, DOI 10.1159/000323872; Chen IJ, 2013, THE 11TH INTERNATION; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; Cotzias G C, 1968, Trans Assoc Am Physicians, V81, P171; COTZIAS GC, 1967, NEW ENGL J MED, V276, P374, DOI 10.1056/NEJM196702162760703; COTZIAS GC, 1969, NEW ENGL J MED, V280, P337, DOI 10.1056/NEJM196902132800701; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de la Fuente-Fernandez R, 2011, ANN NEUROL, V69, P803, DOI 10.1002/ana.22284; Fornai F, 2000, BRAIN RES, V887, P110, DOI 10.1016/S0006-8993(00)02999-1; Frey KA, 1996, ANN NEUROL, V40, P873, DOI 10.1002/ana.410400609; Frey KA, 2001, ADV NEUROL, V86, P237; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Goswami R, 2006, NUCL MED BIOL, V33, P685, DOI 10.1016/j.nucmedbio.2006.05.006; HALLMAN H, 1985, J NEUROCHEM, V44, P117, DOI 10.1111/j.1471-4159.1985.tb07120.x; Hsiao IT, 2014, JAMA NEUROL, V71, P758, DOI 10.1001/jamaneurol.2014.290; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Jakowec MW, 2004, J NEUROSCI RES, V76, P539, DOI 10.1002/jnr.20114; Jankovic Joseph, 2008, Neuropsychiatr Dis Treat, V4, P743; Jenner P, 2006, NEUROLOGY, V66, pS24, DOI 10.1212/WNL.66.10_suppl_4.S24; Jenner P, 2008, ANN NEUROL, V64, pS16, DOI 10.1002/ana.21489; JOHNSTON RF, 1990, ELECTROPHORESIS, V11, P355, DOI 10.1002/elps.1150110503; Kilbourn M, 1996, EUR J PHARMACOL, V307, P227, DOI 10.1016/0014-2999(96)00252-X; Kilbourn MR, 2007, NUCL MED BIOL, V34, P233, DOI 10.1016/j.nucmedbio.2007.01.007; Kung MP, 2007, NUCL MED BIOL, V34, P239, DOI 10.1016/j.nucmedbio.2006.12.005; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lee CS, 2004, ARCH NEUROL-CHICAGO, V61, P1920, DOI 10.1001/archneur.61.12.1920; Lin KJ, 2011, NUCL MED BIOL, V38, P1149, DOI 10.1016/j.nucmedbio.2011.05.010; Lin KJ, 2010, J NUCL MED, V51, P1480, DOI 10.2967/jnumed.110.078196; Lin SC, 2014, J NUCL MED, V55, P73, DOI 10.2967/jnumed.113.121897; Lin YR, 2006, EUR J PHARMACOL, V537, P64, DOI 10.1016/j.ejphar.2006.03.035; Liu KY, 2013, NEUROCHEM RES, V38, P201, DOI 10.1007/s11064-012-0909-8; Ma KH, 2009, NEUROIMAGE, V45, P687, DOI 10.1016/j.neuroimage.2008.12.060; Matsui N, 2005, BIOL PHARM BULL, V28, P1762, DOI 10.1248/bpb.28.1762; Matsui N, 2009, BRAIN RES, V1305, P108, DOI 10.1016/j.brainres.2009.09.107; MOTOJI N, 1995, BIOL PHARM BULL, V18, P89; Muroyama A, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/985157; Okamura N, 2010, J NUCL MED, V51, P223, DOI 10.2967/jnumed.109.070094; Schmidt KC, 2005, NUCL MED BIOL, V32, P719, DOI 10.1016/j.nucmedbio.2005.04.020; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Schwarting RKW, 1996, PROG NEUROBIOL, V49, P215, DOI 10.1016/S0301-0082(96)00015-9; Toomey JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039041; Tsao HH, 2010, NUCL MED BIOL, V37, P413, DOI 10.1016/j.nucmedbio.2010.01.002; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; VanderBorght T, 1995, EUR J PHARMACOL, V294, P577; Wilson JM, 1996, J NEUROSCI, V16, P3507; Yahr M D, 1968, Trans Am Neurol Assoc, V93, P56	51	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173503	10.1371/journal.pone.0173503	http://dx.doi.org/10.1371/journal.pone.0173503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257461	gold, Green Published, Green Submitted			2022-12-26	WOS:000396021100094
J	Bellatorre, A; Jackson, SH; Choi, K				Bellatorre, Anna; Jackson, Sharon H.; Choi, Kelvin			Development of the diabetes typology model for discerning Type 2 diabetes mellitus with national survey data	PLOS ONE			English	Article							INSULIN-RESISTANCE; UNITED-STATES; METAANALYSIS; DISEASE; YOUTH; RISK; PREVALENCE; SEARCH; COHORT; WOMEN	Objective To classify individuals with diabetes mellitus (DM) into DM subtypes using population-based studies. Design Population-based survey Setting Individuals participated in 2003-2004, 2005-2006, or 2009-2010 the National Health and Nutrition Examination Survey (NHANES), and 2010 Coronary Artery Risk Development in Young Adults (CARDIA) survey (research materials obtained from the National Heart, Lung, and Blood Institute Biologic Specimen and Data Repository Information Coordinating Center) Participants 3084, 3040 and 3318 US adults from the 2003-2004, 2005-2006 and 2009-2010 NHANES samples respectively, and 5,115 US adults in the CARDIA cohort Primary outcome measures We proposed the Diabetes Typology Model (DTM) through the use of six composite measures based on the Homeostatic Model Assessment (HOMA-IR , HOMA-%beta, high HOMA-%S), insulin and glucose levels, and body mass index and conducted latent class analyses to empirically classify individuals into different classes. Results Three empirical latent classes consistently emerged across studies (entropy = 0.81-0.998). These three classes were likely Type 1 DM, likely Type 2 DM, and atypical DM. The classification has high sensitivity (75.5%), specificity (83.3%), and positive predictive value (97.4%) when validated against C-peptide level. Correlates of Type 2 DM were significantly associated with model-identified Type 2 DM. Compared to regression analysis on known correlates of Type 2 DM using all diabetes cases as outcomes, using DTM to remove likely Type 1 DM and atypical DM cases results in a 2.5-5.3% r-square improvement in the regression analysis, as well as model fits as indicated by significant improvement in -2 log likelihood (p<0.01). Lastly, model-defined likely Type 2 DM was significantly associated with known correlates of Type 2 DM (e.g., age, waist circumference), which provide additional validation of the DTM-defined classes. Conclusions Our Diabetes Typology Model reflects a promising first step toward discerning likely DM types from population-based data. This novel tool will improve how large population-based studies can be used to examine behavioral and environmental factors associated with different types of DM.	[Bellatorre, Anna; Jackson, Sharon H.; Choi, Kelvin] Natl Inst Minor Hlth & Hlth Dispar, Div Intramural Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Minority Health & Health Disparities (NIMHD)	Choi, K (corresponding author), Natl Inst Minor Hlth & Hlth Dispar, Div Intramural Res, Bethesda, MD 20892 USA.	kelvin.choi@nih.gov	Choi, Kelvin/U-1806-2019		Division of Intramural Research, National Institute on Minority Health and Health Disparities, National Institutes of Health; National Institute on Minority Health and Health Disparities [ZIAMD000006] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute on Minority Health and Health Disparities, National Institutes of Health; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work is supported by the Division of Intramural Research, National Institute on Minority Health and Health Disparities, National Institutes of Health.	Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bonora E, 1998, DIABETES, V47, P1643, DOI 10.2337/diabetes.47.10.1643; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Hamman RF, 2014, DIABETES CARE, V37, P3336, DOI 10.2337/dc14-0574; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Johnson JL, 2010, ENDOCR PRACT, V16, P47, DOI 10.4158/EP09031.OR; KATZEFF HL, 1985, DIABETOLOGIA, V28, P264, DOI 10.1007/BF00271682; Lawrence JM, 2014, DIABETES, V63, P3938, DOI 10.2337/db13-1891; Li JKY, 2006, DIABETES-METAB RES, V22, P46, DOI 10.1002/dmrr.577; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Menke A, 2013, EPIDEMIOLOGY, V24, P773, DOI 10.1097/EDE.0b013e31829ef01a; National Institutes of Health, 2014, COR ART RISK DEV YOU; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; Palmer Jerry P., 2004, Diabetes, V53, P250; Pettitt DJ, 2004, CONTROL CLIN TRIALS, V25, P458, DOI 10.1016/j.cct.2004.08.002; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rewers A, 2008, PEDIATRICS, V121, pE1258, DOI 10.1542/peds.2007-1105; Song YQ, 2007, DIABETES CARE, V30, P1747, DOI 10.2337/dc07-0358; Tuomi T, 2014, LANCET, V383, P1084, DOI 10.1016/S0140-6736(13)62219-9; United States Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey, 2015, NAT HLTH NUTR EX SUR; US Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP ES; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Whitsel E.A., 2012, CIRCULATION, V125, DOI [10.1161/circ.125.suppl_10.AP010, DOI 10.1161/CIRC.125.SUPPL_10.AP010]	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173103	10.1371/journal.pone.0173103	http://dx.doi.org/10.1371/journal.pone.0173103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253317	gold, Green Published, Green Submitted			2022-12-26	WOS:000396011300076
J	Cuervo, JJ; Moller, AP				Cuervo, Jose J.; Moller, Anders P.			Colonial, more widely distributed and less abundant bird species undergo wider population fluctuations independent of their population trend	PLOS ONE			English	Article							LIFE-HISTORY VARIATION; TEMPORAL VARIABILITY; DENSITY-DEPENDENCE; FLIGHT DISTANCE; TIME-SERIES; BRAIN SIZE; INFORMATION-CENTERS; SEXUAL SELECTION; BLOOD PARASITES; CLIMATE-CHANGE	Understanding temporal variability in population size is important for conservation biology because wide population fluctuations increase the risk of extinction. Previous studies suggested that certain ecological, demographic, life-history and genetic characteristics of species might be related to the degree of their population fluctuations. We checked whether that was the case in a large sample of 231 European breeding bird species while taking a number of potentially confounding factors such as population trends or similarities among species due to common descent into account. When species-specific characteristics were analysed one by one, the magnitude of population fluctuations was positively related to coloniality, habitat, total breeding range, heterogeneity of breeding distribution and natal dispersal, and negatively related to urbanisation, abundance, relative number of subspecies, parasitism and proportion of polymorphic loci. However, when abundance (population size) was included in the analyses of the other parameters, only coloniality, habitat, total breeding range and abundance remained significantly related to population fluctuations. The analysis including all these predictors simultaneously showed that population size fluctuated more in colonial, less abundant species with larger breeding ranges. Other parameters seemed to be related to population fluctuations only because of their association with abundance or coloniality. The unexpected positive relationship between population fluctuations and total breeding range did not seem to be mediated by abundance. The link between population fluctuations and coloniality suggests a previously unrecognized cost of coloniality. The negative relationship between population size and population fluctuations might be explained by at least three types of non-mutually exclusive stochastic processes: demographic, environmental and genetic stochasticity. Measurement error in population indices, which was unknown, may have contributed to the negative relationship between population size and fluctuations, but apparently only to a minor extent. The association between population size and fluctuations suggests that populations might be stabilized by increasing population size.	[Cuervo, Jose J.] CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, Madrid, Spain; [Moller, Anders P.] Univ Paris Saclay, AgroParisTech, CNRS, Ecol Systemat Evolut,Univ Paris Sud, Orsay, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Cuervo, JJ (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, Madrid, Spain.	jjcuervo@mncn.csic.es	Cuervo, José Javier/K-1646-2014; Moller, Anders/O-6665-2016	Cuervo, José Javier/0000-0001-7943-7835; Moller, Anders/0000-0003-3739-4675	Spanish National Research Council [EST001196]; Spanish Ministry of Science and Innovation; European Regional Development Fund [CGL2008-00137/BOS]; Spanish Ministry of Economy and Competitiveness [CGL2013-48193-C3-3-P]	Spanish National Research Council; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government)	JJC was funded by the Spanish National Research Council (grant EST001196), by the Spanish Ministry of Science and Innovation and the European Regional Development Fund (grant CGL2008-00137/BOS), and by the Spanish Ministry of Economy and Competitiveness (grant CGL2013-48193-C3-3-P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2007, BIOL CONSERV, V137, P271, DOI 10.1016/j.biocon.2007.02.010; Andersson Malte, 1994; [Anonymous], 2014, R LANG ENV STAT COMP; Armenta JK, 2008, J EXP BIOL, V211, P2423, DOI 10.1242/jeb.013094; Belliure J, 2000, J EVOLUTION BIOL, V13, P480; Beninca E, 2015, P NATL ACAD SCI USA, V112, P6389, DOI 10.1073/pnas.1421968112; Bjorkvoll E, 2012, AM NAT, V180, P372, DOI 10.1086/666983; Blackburn TM, 1996, J ANIM ECOL, V65, P52, DOI 10.2307/5699; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; BOHNINGGAESE K, 1994, OIKOS, V70, P121, DOI 10.2307/3545706; BROWN CR, 1988, ECOLOGY, V69, P602, DOI 10.2307/1941009; BROWN JH, 1990, OIKOS, V59, P290, DOI 10.2307/3545139; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; BULMER MG, 1975, BIOMETRICS, V31, P901, DOI 10.2307/2529815; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; CONNELL JH, 1983, AM NAT, V121, P789, DOI 10.1086/284105; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; Cramp S, 1977, HDB BIRDS EUROPE MID, P1; Cuervo JJ, 2001, EVOL ECOL, V15, P53, DOI 10.1023/A:1011913804309; Cuervo JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077654; Curnutt JL, 1996, OIKOS, V76, P131, DOI 10.2307/3545755; Dale J, 2015, NATURE, V527, P367, DOI 10.1038/nature15509; Danchin E, 1997, TRENDS ECOL EVOL, V12, P342, DOI 10.1016/S0169-5347(97)01124-5; Dey S, 2006, SCIENCE, V312, P434, DOI 10.1126/science.1125317; Dhondt AA, 1998, IBIS, V140, P580, DOI 10.1111/j.1474-919X.1998.tb04702.x; Dixon PA, 1999, SCIENCE, V283, P1528, DOI 10.1126/science.283.5407.1528; Dochtermann NA, 2013, OECOLOGIA, V171, P153, DOI 10.1007/s00442-012-2402-0; Dochtermann NA, 2010, J ANIM ECOL, V79, P888, DOI 10.1111/j.1365-2656.2010.01686.x; Eberhard WG, 1998, EVOLUTION, V52, P415, DOI 10.1111/j.1558-5646.1998.tb01642.x; Fagan WF, 2006, ECOL LETT, V9, P51, DOI 10.1111/j.1461-0248.2005.00845.x; Fisher DO, 2001, ECOLOGY, V82, P3531, DOI 10.1890/0012-9658(2001)082[3531:TEBOLH]2.0.CO;2; Foufopoulos J, 1999, AM NAT, V153, P1, DOI 10.1086/303149; Fowler MS, 2009, OIKOS, V118, P604, DOI 10.1111/j.1600-0706.2009.17321.x; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Freckleton RP, 2006, J ANIM ECOL, V75, P837, DOI 10.1111/j.1365-2656.2006.01121.x; Freckleton RP, 2006, AM NAT, V167, P260, DOI 10.1086/498655; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gamelon M, 2014, AM NAT, V184, P673, DOI 10.1086/677929; Garamszegi LZ, 2010, BIOL REV, V85, P797, DOI 10.1111/j.1469-185X.2010.00126.x; Garamszegi LZ, 2007, P ROY SOC B-BIOL SCI, V274, P2003, DOI 10.1098/rspb.2007.0124; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; GASTON KJ, 1994, PHILOS T R SOC B, V345, P335, DOI 10.1098/rstb.1994.0114; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Gilpin M.E., 1986, P19; Glutz von Blotzheim UN, 1966, HDB VOGEL MITTELEURO, V1-15; Greenwood JJD, 1996, PHILOS T R SOC B, V351, P265, DOI 10.1098/rstb.1996.0023; Grell J., 2010, UNTERRICHTSREZEPTE; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; HANSKI I, 1989, ANN ZOOL FENN, V26, P213; Hedrick P, 2005, EVOLUTION, V59, P1596; Heino M, 1997, P ROY SOC B-BIOL SCI, V264, P481, DOI 10.1098/rspb.1997.0069; Hoffmann AA, 1997, EXTREME ENV CHANGE E; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Inchausti P, 2003, J ANIM ECOL, V72, P899, DOI 10.1046/j.1365-2656.2003.00767.x; Inchausti P, 2002, EVOL ECOL RES, V4, P1033; Inger R, 2015, ECOL LETT, V18, P28, DOI 10.1111/ele.12387; Johnson CA, 2009, P R SOC B, V276, P3361, DOI 10.1098/rspb.2008.1958; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; Knape J, 2012, ECOL LETT, V15, P17, DOI 10.1111/j.1461-0248.2011.01702.x; Koelle K, 2004, AM NAT, V163, P901, DOI 10.1086/420798; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Lande R., 2003, OXFORD SERIES ECOLOG; Lande R, 2006, AM NAT, V168, P76, DOI 10.1086/504851; LAWTON JH, 1988, NATURE, V334, P563, DOI 10.1038/334563a0; Lehikoinen E, 2004, ADV ECOL RES, V35, P1, DOI 10.1016/S0065-2504(04)35001-4; Leirs H, 1997, NATURE, V389, P176, DOI 10.1038/38271; Lewellen RH, 1998, ECOL MONOGR, V68, P571, DOI 10.1890/0012-9615(1998)068[0571:TEODDA]2.0.CO;2; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; Lundberg P, 2000, TRENDS ECOL EVOL, V15, P460, DOI 10.1016/S0169-5347(00)01981-9; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Martui R., 2003, ATLAS AVES REPRODUCT; McLaughlin JF, 2002, OECOLOGIA, V132, P538, DOI 10.1007/s00442-002-0997-2; Miller DA, 2011, ECOLOGY, V92, P1658; Moller AP, 2008, BEHAV ECOL, V19, P41, DOI 10.1093/beheco/arm098; Moller AP, 2007, J APPL ECOL, V44, P909, DOI 10.1111/j.1365-2664.2007.01353.x; Moller AP, 2014, J EVOLUTION BIOL, V27, P34, DOI 10.1111/jeb.12272; Moller AP, 2010, ECOLOGY, V91, P2769, DOI 10.1890/09-1300.1; Moller AP, 2011, ETHOLOGY, V117, P529, DOI 10.1111/j.1439-0310.2011.01899.x; Moller AP, 2008, BEHAV ECOL, V19, P1305, DOI 10.1093/beheco/arn074; Moller AP, 2008, BEHAV ECOL, V19, P1095, DOI 10.1093/beheco/arn103; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Moller AP, 2008, BEHAV ECOL SOCIOBIOL, V63, P63, DOI 10.1007/s00265-008-0636-y; Moller AP, 2007, ECOLOGY, V88, P871, DOI 10.1890/06-0747; Moller AP, 2006, BEHAV ECOL SOCIOBIOL, V60, P227, DOI 10.1007/s00265-006-0160-x; Moller AP, 2011, CLIM RES, V49, P201, DOI 10.3354/cr01030; Moller Anders Pape, 2010, Chinese Birds, V1, P97; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Moller AP, 2005, J EVOLUTION BIOL, V18, P223, DOI 10.1111/j.1420-9101.2004.00805.x; Moller AP, 2004, J EVOLUTION BIOL, V17, P603, DOI 10.1111/j.1420-9101.2004.00694.x; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; MOTRO U, 1982, EVOLUTION, V36, P1059, DOI 10.1111/j.1558-5646.1982.tb05474.x; Mullarney T, 2000, COMPLETE GUIDE BIRDS; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PANNEKOEK J, 2005, TRIM 3 MANUAL; Paradis E, 1999, ECOL LETT, V2, P114, DOI 10.1046/j.1461-0248.1999.22060.x; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; PEIRCE MA, 1981, J NAT HIST, V15, P419, DOI 10.1080/00222938100770321; PIMM SL, 1988, NATURE, V334, P613, DOI 10.1038/334613a0; PROMISLOW D, 1994, EVOLUTION, V48, P2045, DOI 10.1111/j.1558-5646.1994.tb02232.x; Reed DH, 2004, ANIM CONSERV, V7, P1, DOI 10.1017/S1367943004003476; Reed DH, 2003, BIOL CONSERV, V113, P23, DOI 10.1016/S0006-3207(02)00346-4; Reif J, 2010, IBIS, V152, P610, DOI 10.1111/j.1474-919X.2010.01036.x; Richner H, 1996, BEHAV ECOL, V7, P115, DOI 10.1093/beheco/7.1.115; RICHNER H, 1995, ADV STUD BEHAV, V24, P1, DOI 10.1016/S0065-3454(08)60391-5; Rolland C, 1998, AM NAT, V151, P514, DOI 10.1086/286137; Rubolini D, 2007, CLIM RES, V35, P135, DOI 10.3354/cr00720; Saether BE, 2005, NATURE, V436, P99, DOI 10.1038/nature03666; Saether BE, 2004, AM NAT, V164, P793, DOI 10.1086/425371; Saether BE, 2002, PHILOS T ROY SOC B, V357, P1185, DOI 10.1098/rstb.2002.1119; Saether BE, 2005, ECOLOGY, V86, P693, DOI 10.1890/04-0878; Saether BE, 2007, J ANIM ECOL, V76, P315, DOI 10.1111/j.1365-2656.2006.01195.x; Saether BE, 2013, AM NAT, V182, P743, DOI 10.1086/673497; Saether BE, 2011, J ANIM ECOL, V80, P215, DOI 10.1111/j.1365-2656.2010.01751.x; Saether BE, 2009, J ANIM ECOL, V78, P1063, DOI 10.1111/j.1365-2656.2009.01565.x; Scheuerlein A, 2004, P ROY SOC B-BIOL SCI, V271, P1363, DOI 10.1098/rspb.2004.2726; Seddon N, 2010, AUK, V127, P283, DOI 10.1525/auk.2009.09070; Seoane J, 2008, GLOBAL ECOL BIOGEOGR, V17, P111, DOI 10.1111/j.1466-8238.2007.00351.x; Shultz S, 2005, P ROY SOC B-BIOL SCI, V272, P2305, DOI 10.1098/rspb.2005.3250; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Sol D, 2007, P ROY SOC B-BIOL SCI, V274, P763, DOI 10.1098/rspb.2006.3765; Spottiswoode C, 2004, P ROY SOC B-BIOL SCI, V271, P267, DOI 10.1098/rspb.2003.2605; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Svensson L, 1984, IDENTIFICATION GUIDE; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x; TAYLOR LR, 1980, J ANIM ECOL, V49, P209, DOI 10.2307/4285; TAYLOR LR, 1982, J ANIM ECOL, V51, P879, DOI 10.2307/4012; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Tucker GM, 1994, BIRDS EUROPE THEIR C, V3; Turchin P, 1996, RES POPUL ECOL, V38, P121, DOI 10.1007/BF02515720; Vucetich JA, 2000, CONSERV BIOL, V14, P1704, DOI 10.1111/j.1523-1739.2000.99359.x; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; WETTON JH, 1987, NATURE, V327, P147, DOI 10.1038/327147a0; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	141	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173220	10.1371/journal.pone.0173220	http://dx.doi.org/10.1371/journal.pone.0173220			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253345	gold, Green Published, Green Submitted			2022-12-26	WOS:000396011300092
J	Liu, S; Wang, XD; Wang, Y; Shi, ZH; Cai, L; Liu, SL; Han, T; Zhou, YY; Wang, XP; Gao, S; Ji, Y				Liu, Shuai; Wang, Xiao-Dan; Wang, Ying; Shi, Zhihong; Cai, Li; Liu, Shuling; Han, Tong; Zhou, Yuying; Wang, Xinping; Gao, Shuo; Ji, Yong			Clinical and neuroimaging characteristics of Chinese dementia with Lewy bodies	PLOS ONE			English	Article							PARKINSON DISEASE DEMENTIA; BODY DEMENTIA; ALZHEIMERS-DISEASE; DIAGNOSIS; IDENTIFICATION; CONSORTIUM; BIOMARKERS; SYMPTOMS; CRITERIA	Dementia with Lewy bodies (DLB) is the second most common subtype of degenerative dementia. To our knowledge, available information about the clinical features of DLB in China remains limited. Our study therefore aimed to address this issue. Thirty-seven Chinese patients with probable DLB were recruited for this study. All subjects underwent neuropsychological assessment by trained neurologists, as well as undergoing MRI, C-11-PIB PET scans for A beta deposition and F-18-FDG PET scans for regional cerebral glucose metabolism. Our results showed that the gender ratio of patients was 16:21 (F:M). The mean age of onset was 69.5 +/- 9.0 years and the mean age at diagnosis was 71.8 +/- 9.1 years. At diagnosis, the prevalence of three core clinical features of DLB was: 64.9% for fluctuating cognition, 73.0% for visual hallucinations and 62.2% for parkinsonism. The result from C-11-PiB PET and F-18-FDG PET scans confirmed A beta deposition in the cortex and demonstrated hypometabolism in the bilateral temporoparietooccipital region, the frontal lobe, the insular lobe, and the posterior cingulate, precuneus and caudate nuclei. Our study elucidated the clinical features of Chinese DLB patients, and will improve the understanding and the early diagnosis of DLB in Chinese patients.	[Liu, Shuai; Wang, Xiao-Dan; Shi, Zhihong; Liu, Shuling; Zhou, Yuying; Wang, Xinping; Ji, Yong] Tianjin Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China; [Liu, Shuai; Wang, Xiao-Dan; Shi, Zhihong; Liu, Shuling; Zhou, Yuying; Wang, Xinping; Ji, Yong] Tianjin Huanhu Hosp, Tianjin Dementia Inst, Tianjin, Peoples R China; [Wang, Ying; Cai, Li; Gao, Shuo] Tianjin Med Univ, Gen Hosp, PET CT Ctr, Tianjin, Peoples R China; [Han, Tong] Tianjin Huanhu Hosp, Dept Radiol, Tianjin, Peoples R China	Tianjin Medical University	Ji, Y (corresponding author), Tianjin Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China.	jiyongusa@126.com	Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022	Wang, Xin/0000-0002-4457-7376; 	National Natural Science Foundation of China [81571057, 81300947]; Tianjin Science and Technology Support Program [12ZCZDSY02900]; Science and Technology Foundation of Tianjin Municipal Health Bureau [2014KR10, 2013KY15]; Key Project of Tianjin Municipal Health Bureau [14KG117]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Science and Technology Support Program; Science and Technology Foundation of Tianjin Municipal Health Bureau; Key Project of Tianjin Municipal Health Bureau	Support was provided by National Natural Science Foundation of China to YJ (funding numbers: 81571057) and X-DW (funding numbers: 81300947) [http://www.nsfc.gov.cn/]; Tianjin Science and Technology Support Program to YJ (funding numbers: 12ZCZDSY02900) [http://www.tstc.gov.cn/]; Science and Technology Foundation of Tianjin Municipal Health Bureau to YJ (funding number: 2014KR10) and X-DW (funding number: 2013KY15) [http://www.tjwsj.gov.cn/html/WSJn/portal/index/index.htm]; Key Project of Tianjin Municipal Health Bureau to YJ (funding number: 14KG117) [http://www.tjwsj.gov.cn/html/WSJn/portal/index/index.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2008, DEMENT GERIATR COGN, V26, P445, DOI 10.1159/000165917; Alladi S, 2011, DEMENT GERIATR COGN, V32, P32, DOI 10.1159/000329862; Auning E, 2011, DEMENT GERIATR COGN, V32, P202, DOI 10.1159/000333072; Ballard C, 2000, DEMENT GERIATR COGN, V11, P219, DOI 10.1159/000017240; Ballard C, 1999, AM J PSYCHIAT, V156, P1039; Ballard C, 2006, NEUROLOGY, V67, P1931, DOI 10.1212/01.wnl.0000249130.63615.cc; CALNE DB, 1992, ANN NEUROL, V32, pS125, DOI 10.1002/ana.410320721; Chiba Y, 2015, INT J GERIATR PSYCH, V30, P316, DOI 10.1002/gps.4144; Chiba Y, 2012, DEMENT GERIATR COGN, V33, P273, DOI 10.1159/000339363; Collerton D, 2003, DEMENT GERIATR COGN, V16, P229, DOI 10.1159/000072807; Dalrymple-Alford J, 2001, J NEUROL NEUROSUR PS, V70, P148, DOI 10.1136/jnnp.70.2.148; Dickson DW, 2009, PARKINSONISM RELAT D, V15, pS1, DOI 10.1016/S1353-8020(09)70769-2; Donaghy P, 2015, AM J GERIAT PSYCHIAT, V23, P23, DOI 10.1016/j.jagp.2013.03.001; Donaghy PC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt274; Edison P, 2008, J NEUROL NEUROSUR PS, V79, P1331, DOI 10.1136/jnnp.2007.127878; Fujishiro H, 2010, NEUROSCI LETT, V486, P19, DOI 10.1016/j.neulet.2010.09.036; Galasko D, 1996, BRAIN COGNITION, V31, P166, DOI 10.1006/brcg.1996.0040; Gnanalingham KK, 1997, J NEUROL NEUROSUR PS, V62, P243, DOI 10.1136/jnnp.62.3.243; Han D, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-1; Jellinger KA, 2008, ACTA NEUROPATHOL, V115, P427, DOI 10.1007/s00401-008-0347-5; Jellinger KA, 2007, NEURODEGENER DIS, V4, P428, DOI 10.1159/000107703; Jones SAV, 2014, PSYCHOL MED, V44, P673, DOI 10.1017/S0033291713000494; Klein JC, 2010, NEUROLOGY, V74, P885, DOI 10.1212/WNL.0b013e3181d55f61; Lobotesis K, 2001, NEUROLOGY, V56, P643, DOI 10.1212/WNL.56.5.643; Lopez OL, 2002, ARCH NEUROL-CHICAGO, V59, P43, DOI 10.1001/archneur.59.1.43; Magierski R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/809503; McKeith I, 2004, LANCET NEUROL, V3, P19, DOI 10.1016/S1474-4422(03)00619-7; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Noe E, 2004, MOVEMENT DISORD, V19, P60, DOI 10.1002/mds.10633; Palmqvist S, 2009, INT J GERIATR PSYCH, V24, P1405, DOI 10.1002/gps.2277; Perneczky R, 2008, DEMENT GERIATR COGN, V25, P531, DOI 10.1159/000132084; PERRY RH, 1990, J NEUROL SCI, V95, P119, DOI 10.1016/0022-510X(90)90236-G; Savica R, 2013, JAMA NEUROL, V70, P1396, DOI 10.1001/jamaneurol.2013.3579; Sinha N, 2012, INT J GERIATR PSYCH, V27, P443, DOI 10.1002/gps.2749; Walker MP, 2000, BRIT J PSYCHIAT, V177, P252, DOI 10.1192/bjp.177.3.252; Wang XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134956; Warr L, 2012, Q J NUCL MED MOL IM, V56, P39; Watson R, 2009, DEMENT GERIATR COGN, V28, P493, DOI 10.1159/000264614; Yoshida H, 2011, PSYCHIAT RES, V185, P211, DOI 10.1016/j.psychres.2009.06.012	40	12	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0171802	10.1371/journal.pone.0171802	http://dx.doi.org/10.1371/journal.pone.0171802			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4XX	28253276	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300007
J	Navet, S; Buresi, A; Baratte, S; Andouche, A; Bonnaud-Ponticelli, L; Bassaglia, Y				Navet, Sandra; Buresi, Auxane; Baratte, Sebastien; Andouche, Aude; Bonnaud-Ponticelli, Laure; Bassaglia, Yann			The Pax gene family: Highlights from cephalopods	PLOS ONE			English	Article							PAIRED BOX GENE; CUTTLEFISH SEPIA-OFFICINALIS; SQUID EUPRYMNA-SCOLOPES; ECO-EVO-DEVO; EYE DEVELOPMENT; EXPRESSION PATTERNS; NERVOUS-SYSTEM; DEVELOPMENTAL EXPRESSION; PHYLOGENETIC ANALYSIS; POX-NEURO	Pax genes play important roles in Metazoan development. Their evolution has been extensively studied but Lophotrochozoa are usually omitted. We addressed the question of Pax paralog diversity in Lophotrochozoa by a thorough review of available databases. The existence of six Pax families (Pax1/9, Pax2/5/8, Pax3/7, Pax4/6, Pax beta, PoxNeuro) was confirmed and the lophotrochozoan Pax beta subfamily was further characterized. Contrary to the pattern reported in chordates, the Pax2/5/8 family is devoid of homeodomain in Lophotrochozoa. Expression patterns of the three main pax classes (pax2/5/8, pax3/7, pax4/6) during Sepia officinalis development showed that Pax roles taken as ancestral and common in metazoans are modified in S. officinalis, most likely due to either the morphological specificities of cephalopods or to their direct development. Some expected expression patterns were missing (e.g. pax6 in the developing retina), and some expressions in unexpected tissues have been found (e.g. pax2/5/8 in dermal tissue and in gills). This study underlines the diversity and functional plasticity of Pax genes and illustrates the difficulty of using probable gene homology as strict indicator of homology between biological structures.	[Navet, Sandra; Buresi, Auxane; Baratte, Sebastien; Andouche, Aude; Bonnaud-Ponticelli, Laure; Bassaglia, Yann] UPMC, Sorbonne Univ, Museum Natl Hist Nat, UCN,UA,UMR BOREA,CNRS7208,IRD207, Paris, France; [Baratte, Sebastien] Univ Paris Sorbonne, Sorbonne Univ, ESPE, Paris, France; [Bassaglia, Yann] Univ Paris Est Creteil Val Marne, Creteil, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Bassaglia, Y (corresponding author), UPMC, Sorbonne Univ, Museum Natl Hist Nat, UCN,UA,UMR BOREA,CNRS7208,IRD207, Paris, France.; Bassaglia, Y (corresponding author), Univ Paris Est Creteil Val Marne, Creteil, France.	yann.bassaglia@mnhn.fr	Bassaglia, Yann/AAN-7502-2020	Bassaglia, Yann/0000-0002-6627-7737	Agence Nationale de la Recherche (ANR) [JC/JC 0043]; Bourse de la Vocation Marcel Bleustein-Blanchet	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Bourse de la Vocation Marcel Bleustein-Blanchet	This work was supported by a grant JC/JC 0043 from Agence Nationale de la Recherche (ANR) and by a "Bourse de la Vocation Marcel Bleustein-Blanchet" to SN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arendt D, 2005, THEOR BIOSCI, V124, P185, DOI 10.1016/j.thbio.2005.08.002; Arendt D, 2003, INT J DEV BIOL, V47, P563; Arendt D, 2002, DEVELOPMENT, V129, P1143; Awasaki T, 2001, DEV GENES EVOL, V211, P20, DOI 10.1007/s004270000119; Bassaglia Y, 2013, J EXP MAR BIOL ECOL, V447, P4, DOI 10.1016/j.jembe.2013.02.006; Bassaglia Y, 2012, GENE, V498, P203, DOI 10.1016/j.gene.2012.01.100; Bassham S, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-35; Blackburn DC, 2008, DEV DYNAM, V237, P2209, DOI 10.1002/dvdy.21634; Blake JA, 2008, DEV DYNAM, V237, P2791, DOI 10.1002/dvdy.21711; Blake JA, 2014, DEVELOPMENT, V141, P737, DOI 10.1242/dev.091785; Boletsky S.v., 1989, Advances in Marine Biology, V25, P85, DOI 10.1016/S0065-2881(08)60188-1; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; Bonnaud-Ponticelli L, 2016, VIE MILIEU, V66, P3; BOYCOTT BB, 1961, PROC R SOC SER B-BIO, V153, P503, DOI 10.1098/rspb.1961.0015; Breitling R, 2000, DEV GENES EVOL, V210, P644, DOI 10.1007/s004270000106; Buckingham M, 2015, SEMIN CELL DEV BIOL, V44, P115, DOI 10.1016/j.semcdb.2015.09.017; Buresi A, 2016, DEV BIOL, V415, P143, DOI 10.1016/j.ydbio.2016.04.027; Buresi A, 2014, J COMP NEUROL, V522, P3004, DOI 10.1002/cne.23562; Buresi A, 2012, GENE EXPR PATTERNS, V12, P109, DOI 10.1016/j.gep.2012.02.001; Callaerts P, 1999, P NATL ACAD SCI USA, V96, P558, DOI 10.1073/pnas.96.2.558; Carbe C, 2013, J BIOL CHEM, V288, P12130, DOI 10.1074/jbc.M112.436865; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Colomb S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002197; Czerny T, 1997, MECH DEVELOP, V67, P179, DOI 10.1016/S0925-4773(97)00119-6; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; Dames P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-39; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Derby CD, 2014, MAR DRUGS, V12, P2700, DOI 10.3390/md12052700; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DumanScheel M, 1997, DEVELOPMENT, V124, P2855; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Fabian P, 2015, FRONT GENET, V6, DOI [10.3382/fgene.2015.00228, 10.3389/fgene.2015.00228]; Favor J, 2001, GENETICS, V159, P1689; Franke FA, 2015, EVOL DEV, V17, P3, DOI 10.1111/ede.12110; Friedrich M, 2015, EVOL DEV, V17, P255, DOI 10.1111/ede.12137; Galliot B, 1999, DEV GENES EVOL, V209, P186, DOI 10.1007/s004270050243; Gehring WJ, 2005, J HERED, V96, P171, DOI 10.1093/jhered/esi027; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Glardon S, 1998, DEVELOPMENT, V125, P2701; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hartmann B, 2003, MECH DEVELOP, V120, P177, DOI 10.1016/S0925-4773(02)00456-2; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; Heller N, 1997, MECH DEVELOP, V69, P83, DOI 10.1016/S0925-4773(97)00158-5; Hill A, 2010, DEV BIOL, V343, P106, DOI 10.1016/j.ydbio.2010.03.010; Holland LZ, 2010, INTEGR COMP BIOL, V50, P22, DOI 10.1093/icb/icq048; Hoshiyama D, 2007, FEBS LETT, V581, P1639, DOI 10.1016/j.febslet.2007.03.027; Hu MY, 2010, CELL TISSUE RES, V339, P571, DOI 10.1007/s00441-009-0921-8; Jiang YR, 2015, DEV BIOL, V397, P162, DOI 10.1016/j.ydbio.2014.10.013; Jiao S, 2015, COMP BIOCHEM PHYS B, V180, P7, DOI 10.1016/j.cbpb.2014.10.002; Jun S, 1998, P NATL ACAD SCI USA, V95, P13720, DOI 10.1073/pnas.95.23.13720; KILCHHERR F, 1986, NATURE, V321, P493, DOI 10.1038/321493a0; Kozmik Z, 1999, DEVELOPMENT, V126, P1295; Kozmik Z, 1997, EMBO J, V16, P6793, DOI 10.1093/emboj/16.22.6793; Kozmik Z, 2005, CURR OPIN GENET DEV, V15, P430, DOI 10.1016/j.gde.2005.05.001; Kozmik Z, 2003, DEV CELL, V5, P773, DOI 10.1016/S1534-5807(03)00325-3; Kumar JP, 2009, BBA-GENE REGUL MECH, V1789, P306, DOI 10.1016/j.bbagrm.2008.10.001; LEMAIRE J, 1970, Bulletin de la Societe Zoologique de France, V95, P773; Loosli F, 1996, P NATL ACAD SCI USA, V93, P2658, DOI 10.1073/pnas.93.7.2658; Matus DQ, 2007, EVOL DEV, V9, P25, DOI 10.1111/j.1525-142X.2006.00135.x; Mayran A, 2015, SEMIN CELL DEV BIOL, V44, P135, DOI 10.1016/j.semcdb.2015.07.007; Minchin JEN, 2008, DEV BIOL, V317, P508, DOI 10.1016/j.ydbio.2008.02.058; Monsoro-Burq AH, 2015, SEMIN CELL DEV BIOL, V44, P87, DOI 10.1016/j.semcdb.2015.09.015; Moreira R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1817-5; Morino Y, 2013, ZOOL SCI, V30, P851, DOI 10.2108/zsj.30.851; Navet S, 2008, DEV DYNAM, V237, P1944, DOI 10.1002/dvdy.21614; Navet S, 2014, J MAR SCI TECH-TAIW, V22, P15, DOI 10.6119/JMST-013-0820-1; Navet S, 2009, GENE EXPR PATTERNS, V9, P461, DOI 10.1016/j.gep.2009.08.001; Nixon M., 2003, BRAINS LIVES CEPHALO; Nodl MT, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0175-8; Nodl MT, 2015, EVODEVO, V6, DOI 10.1186/s13227-015-0012-8; O'Brien EK, 2003, EVOL DEV, V5, P572, DOI 10.1046/j.1525-142X.2003.03062.x; O'Brien EK, 2000, MAR BIOTECHNOL, V2, P545, DOI 10.1007/s101260000039; Paixao-Cortes VR, 2015, SEMIN CELL DEV BIOL, V44, P64, DOI 10.1016/j.semcdb.2015.08.014; Paixao-Cortes VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073560; Passamaneck YJ, 2015, EVODEVO, V6, DOI 10.1186/s13227-015-0004-8; Passamaneck YJ, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-6; Pineda D, 2002, DEVELOPMENT, V129, P1423; Quigley IK, 2007, DEV GENES EVOL, V217, P459, DOI 10.1007/s00427-007-0156-1; Salo E, 2002, GENE, V287, P67, DOI 10.1016/S0378-1119(01)00863-0; Schmerer M, 2009, EVOL DEV, V11, P689, DOI 10.1111/j.1525-142X.2009.00376.x; Schmerer MW, 2013, DEV BIOL, V382, P149, DOI 10.1016/j.ydbio.2013.07.015; Seaver EC, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-8; Shigeno S, 2010, ORIGINS CEPHALPOOD B, P23; Short S, 2008, J MOL EVOL, V66, P605, DOI 10.1007/s00239-008-9113-5; Short S, 2012, J EXP ZOOL PART B, V318B, P555, DOI 10.1002/jez.b.22460; Suga H, 2010, P NATL ACAD SCI USA, V107, P14263, DOI 10.1073/pnas.1008389107; Sun HM, 1997, P NATL ACAD SCI USA, V94, P5156, DOI 10.1073/pnas.94.10.5156; Suzuki T, 2000, DEVELOPMENT, V127, P1531; Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; Thanos S, 2004, J NEUROBIOL, V59, P8, DOI 10.1002/neu.20001; Thompson JA, 2011, PROG NEUROBIOL, V95, P334, DOI 10.1016/j.pneurobio.2011.08.012; Tomarev SI, 1997, P NATL ACAD SCI USA, V94, P2421, DOI 10.1073/pnas.94.6.2421; Underhill DA, 2012, CRIT REV EUKAR GENE, V22, P161, DOI 10.1615/CritRevEukarGeneExpr.v22.i2.70; Vopalensky P, 2009, PHILOS T R SOC B, V364, P2819, DOI 10.1098/rstb.2009.0079; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wollesen T, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0505-z; Woodruff JB, 2007, DEV BIOL, V306, P824, DOI 10.1016/j.ydbio.2007.03.002; Yi BQ, 2009, EVOL DEV, V11, P669, DOI 10.1111/j.1525-142X.2009.00374.x; Yoshida M-A, 2014, SCI REP, V4	101	13	14	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172719	10.1371/journal.pone.0172719	http://dx.doi.org/10.1371/journal.pone.0172719			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253300	Green Submitted, Green Published, gold			2022-12-26	WOS:000396011300030
J	Caberlotto, E; Ruiz, L; Miller, Z; Poletti, M; Tadlock, L				Caberlotto, Elisa; Ruiz, Laetitia; Miller, Zane; Poletti, Mickael; Tadlock, Lauri			Effects of a skin-massaging device on the ex-vivo expression of human dermis proteins and in-vivo facial wrinkles	PLOS ONE			English	Article							GENE-EXPRESSION; VII COLLAGEN; FIBROBLASTS; CULTURE	Mechanical and geometrical cues influence cell behaviour. At the tissue level, almost all organs exhibit immediate mechanical responsiveness, in particular by increasing their stiffness in direct proportion to an applied mechanical stress. It was recently shown in cultured-cell models, in particular with fibroblasts, that the frequency of the applied stress is a fundamental stimulating parameter. However, the influence of the stimulus frequency at the tissue level has remained elusive. Using a device to deliver an oscillating torque that generates cyclic strain at different frequencies, we studied the effect(s) of mild skin massage in an ex vivo model and in vivo. Skin explants were maintained ex vivo for 10 days and massaged twice daily for one minute at various frequencies within the range of 65-85 Hz. Biopsies were analysed at D0, D5 and D10 and processed for immuno-histological staining specific to various dermal proteins. As compared to untreated skin explants, the massaging procedure clearly led to higher rates of expression, in particular for decorin, fibrillin, tropoelastin, and procollagen-1. The mechanical stimulus thus evoked an anti-aging response. Strikingly, the expression was found to depend on the stimulus frequency with maximum expression at 75Hz. We then tested whether this mechanical stimulus had an anti-aging effect in vivo. Twenty Caucasian women (aged 65-75y) applied a commercial anti-aging cream to the face and neck, followed by daily treatments using the anti-aging massage device for 8 weeks. A control group of twenty-two women, with similar ages to the first group, applied the cream alone. At W0, W4 and W8, a blinded evaluator assessed the global facial wrinkles, skin texture, lip area, cheek wrinkles, neck sagging and neck texture using a clinical grading scale. We found that combining the massaging device with a skin anti-aging formulation amplified the beneficial effects of the cream.	[Caberlotto, Elisa] LOreal Res & Innovat, Chevilly Larue, France; [Ruiz, Laetitia] LOreal Res & Innovat, Aulnay Sous Bois, France; [Miller, Zane; Poletti, Mickael; Tadlock, Lauri] LOreal Res & Innovat, Redmond, WA USA	L'Oreal Group; L'Oreal Group; L'Oreal Group	Caberlotto, E (corresponding author), LOreal Res & Innovat, Chevilly Larue, France.	ecaberlotto@rd.loreal.com			L'Oreal Research Innovation	L'Oreal Research Innovation	This work was supported by L'Oreal Research & Innovation. EC, LR, ZM, MP, and LT are employed by L'Oreal. L'Oreal was the sole funder for this study and all research, study design, data collection and analysis, decisions to publish and manuscript preparation was performed by L'Oreal employees or contractors.	Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; Balestrini JL, 2006, J BIOMECH, V39, P2983, DOI 10.1016/j.jbiomech.2005.10.025; Behrens DT, 2012, J BIOL CHEM, V287, P18700, DOI 10.1074/jbc.M111.336073; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; CHEN YQ, 1994, J INVEST DERMATOL, V102, P205, DOI 10.1111/1523-1747.ep12371763; Chiquet M, 1999, MATRIX BIOL, V18, P417, DOI 10.1016/S0945-053X(99)00039-6; Chung HJ, 2010, DERMATOL CLIN, V28, P93, DOI 10.1016/j.det.2009.10.011; Crane JD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002882; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DZAMBA BJ, 1993, J CELL BIOL, V121, P1165, DOI 10.1083/jcb.121.5.1165; Eastwood M, 1998, P I MECH ENG H, V212, P85, DOI 10.1243/0954411981533854; El-Domyati M, 2002, EXP DERMATOL, V11, P398, DOI 10.1034/j.1600-0625.2002.110502.x; Farran AJE, 2013, J TISSUE ENG REGEN M, V7, P213, DOI 10.1002/term.514; Hamed SH, 2012, J COSMET DERMATOL-US, V11, P239, DOI 10.1111/j.1473-2165.2012.00626.x; HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0; HOFFMAN H, 1952, AUST J EXP BIOL MED, V30, P541, DOI 10.1038/icb.1952.52; Huang CY, 2013, TRENDS MOL MED, V19, P555, DOI 10.1016/j.molmed.2013.05.005; Humbert P, 2015, CLIN INTERV AGING, V10, P387, DOI 10.2147/CIA.S69752; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Jiang YY, 2015, PREP BIOCHEM BIOTECH, V45, P476, DOI 10.1080/10826068.2014.923444; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Khan S, 1997, ANNU REV BIOCHEM, V66, P785, DOI 10.1146/annurev.biochem.66.1.785; Kielty CM, 1997, MICROSC RES TECHNIQ, V38, P413, DOI 10.1002/(SICI)1097-0029(19970815)38:4<413::AID-JEMT9>3.0.CO;2-J; Kutty JK, 2010, J TISSUE ENG REGEN M, V4, P62, DOI 10.1002/term.219; Langton A. K., 2010, International Journal of Cosmetic Science, V32, P330, DOI 10.1111/j.1468-2494.2010.00574.x; Lee YH, 2011, YONSEI MED J, V52, P982, DOI 10.3349/ymj.2011.52.6.982; McMahon TA, 1984, MUSCLES REFLEXES AND; Phuong C, 2016, CUTAN OCUL TOXICOL, V35, P153, DOI 10.3109/15569527.2015.1065501; Portillo-Soto A, 2014, J ALTERN COMPLEM MED, V20, P932, DOI 10.1089/acm.2014.0160; Shin MS, 2015, J STRENGTH COND RES, V29, P2255, DOI 10.1519/JSC.0000000000000688; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Sukharev Sergei, 2004, Sci STKE, V2004, pre4, DOI 10.1126/stke.2192004re4; Tong ZX, 2014, TISSUE ENG PT A, V20, P1922, DOI [10.1089/ten.tea.2013.0496, 10.1089/ten.TEA.2013.0496]; Trauer S, 2014, EUR J PHARM BIOPHARM, V86, P301, DOI 10.1016/j.ejpb.2013.11.004; Tunay VB, 2010, J EUR ACAD DERMATOL, V24, P138, DOI 10.1111/j.1468-3083.2009.03355.x; Van Agtmael T, 2010, CELL TISSUE RES, V339, P167, DOI 10.1007/s00441-009-0866-y; Walchli C, 2014, J ALTERN COMPLEM MED, V20, P507, DOI 10.1089/acm.2012.0833; Willand MP, 2016, NEUROREHAB NEURAL RE, V30, P490, DOI 10.1177/1545968315604399; Zerdoum AB, 2014, JOVE-J VIS EXP, DOI 10.3791/51594	44	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172624	10.1371/journal.pone.0172624	http://dx.doi.org/10.1371/journal.pone.0172624			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249037	Green Submitted, Green Published, gold			2022-12-26	WOS:000395983500049
J	Deng, MJ; Lin, XD; Wen, CW; Dong, MJ; Lin, QT; Zhang, SZ; Xu, JP				Deng, Ming-Jie; Lin, Xiao-Dong; Wen, Chao-Wei; Dong, Min-Jian; Lin, Qiu-Ting; Zhang, Shang-Zhi; Xu, Jia-Ping			Metabolic changes in the midgut of Eri silkworm after oral administration of 1-deoxynojirimycin: A H-1-NMR-based metabonomic study	PLOS ONE			English	Article							TRICARBOXYLIC-ACID CYCLE; BOMBYX-MORI; PROTEOMIC ANALYSIS; NMR-SPECTROSCOPY; HIGH GLUCOSE; EX-VIVO; IN-VIVO; RAT; TREHALASE; PROTEIN	1-deoxynojirimycin (DNJ) is a natural D-glucose analogue and has a strong physiological activity in inhibiting a-glucosidase in vivo. The antidiabetic effects of DNJ in mice or other mammals were extensively explored, but the physiological and toxic roles of DNJ in insects was seldom reported. In this study, the biological effects of DNJ were examined in midgut extracts of fourth-instar larvae of Eri silkworm (Samia cynthia ricini, Saturniidae). Based on nuclear magnetic resonance (NMR) metabonomics technology, we analyzed the alterations of glycometabolism, lipids, and energy metabolism pathways in the midgut of S. cynthia ricini caused by DNJ. Pattern recognition analysis (partial least square-discriminant analysis, PLS-DA) showed that four groups of latex, 0.25% DNJ, 0.5% DNJ and the mixture of 0.5% DNJ and latex (1: 1) were distinctly different from the control group. Moreover, several metabolic pathways of DNJ-mediated modulation in the midgut were identified. Compared with the control group, alanine, succinate, glutamate, and fumarate concentrations decreased in three groups of 0.5% DNJ, latex, and the mixture, choline levels increased in two DNJ groups, and trehalose levels increased in all experimental groups. Therefore, these results suggest that DNJ modulated lipid metabolism by limiting the hydrolysis pathways of phospholipids metabolism. Additionally, DNJ has a potent negative effect on energy metabolism by inhibiting the hydrolysis of trehalose, glycolysis and the tricarboxylic acid (TCA) cycle. Overall, DNJ, as a single-ingredient, is an efficient substance for modulating lipid metabolism and inhibiting energy metabolism.	[Deng, Ming-Jie; Lin, Xiao-Dong; Wen, Chao-Wei; Dong, Min-Jian; Lin, Qiu-Ting] Wenzhou Med Univ, Analyt & Testing Ctr, Wenzhou, Peoples R China; [Deng, Ming-Jie; Zhang, Shang-Zhi; Xu, Jia-Ping] Anhui Agr Univ, Sch Life Sci, Hefei, Peoples R China	Wenzhou Medical University; Anhui Agricultural University	Xu, JP (corresponding author), Anhui Agr Univ, Sch Life Sci, Hefei, Peoples R China.	jiapingxu@163.com	Xu, Jiaping/T-4327-2019	Xu, Jiaping/0000-0001-9020-7248	Natural Science Foundation of China [31472148]; Wenzhou Medical University [QTJ16008]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Medical University	This work was supported by the Natural Science Foundation of China (31472148, JPX), (http://www.nsfc.gov.cn/); the Start-up funding from Wenzhou Medical University (QTJ16008, MJD) (http://www.wmu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abian O, 2011, MOL PHARMACEUT, V8, P2390, DOI 10.1021/mp200313e; ANDERSON JM, 1967, J NEUROL NEUROSUR PS, V30, P295, DOI 10.1136/jnnp.30.4.295; Arikawa Y, 1999, J BIOSCI BIOENG, V87, P28, DOI 10.1016/S1389-1723(99)80004-8; BOUNIAS M, 1993, BIOCHEM MOL BIOL INT, V31, P249; Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; BUCKLEY BM, 1977, BIOCHEM J, V166, P539, DOI 10.1042/bj1660539; Bucker R, 2014, J BIOL CHEM, V289, P30114, DOI 10.1074/jbc.M114.581348; Canavoso LE, 2004, INSECT BIOCHEM MOLEC, V34, P845, DOI 10.1016/j.ibmb.2004.05.008; Chikara H, 2008, INSECT BIOCHEM MOLEC, V37, P1348; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Deng MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131696; Diao CF, 2014, MOL BIOSYST, V10, P686, DOI 10.1039/c3mb70609e; Do HJ, 2014, J FUNCT FOODS, V7, P692, DOI 10.1016/j.jff.2013.12.016; Feng F, 2014, J PROTEOMICS, V108, P124, DOI 10.1016/j.jprot.2014.05.015; Gao HC, 2007, NEUROCHEM INT, V50, P386, DOI 10.1016/j.neuint.2006.09.012; Griffin JL, 2008, PHYSIOL GENOMICS, V34, P1, DOI 10.1152/physiolgenomics.00009.2008; Imperiali B, 1999, CURR OPIN CHEM BIOL, V3, P643, DOI 10.1016/S1367-5931(99)00021-6; Kajimoto M, 2014, AM J PHYSIOL-HEART C, V306, pH1164, DOI 10.1152/ajpheart.00964.2013; Kite GC, 1997, J CHEM ECOL, V23, P119, DOI 10.1023/B:JOEC.0000006349.84075.f0; Kong WH, 2008, J AGR FOOD CHEM, V56, P2613, DOI 10.1021/jf073223i; Konno K, 2006, P NATL ACAD SCI USA, V103, P1337, DOI 10.1073/pnas.0506944103; Kwon HJ, 2011, J AGR FOOD CHEM, V59, P3014, DOI 10.1021/jf103463f; Li XH, 2006, J PROTEOME RES, V5, P2809, DOI 10.1021/pr0603093; Li YG, 2013, SCI REP-UK, V3, DOI 10.1038/srep01377; Liu K, 2013, MOL NEUROBIOL, V48, P729, DOI 10.1007/s12035-013-8446-2; Mangia S, 2007, J CEREBR BLOOD F MET, V27, P1055, DOI 10.1038/sj.jcbfm.9600401; Mangia S, 2009, J CEREBR BLOOD F MET, V29, P441, DOI 10.1038/jcbfm.2008.134; Matsumoto Y, 2011, PLOS ONE, V6, P589; Nakagawa K, 2007, J AGR FOOD CHEM, V55, P8928, DOI 10.1021/jf071559m; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Patterson Marc C, 2005, Semin Pediatr Neurol, V12, P144, DOI 10.1016/j.spen.2005.10.002; SCOFIELD AM, 1995, COMP BIOCHEM PHYS A, V112, P187, DOI 10.1016/0300-9629(95)00070-N; Sepuri NBV, 1998, J BIOL CHEM, V273, P1420, DOI 10.1074/jbc.273.3.1420; Shuang E, 2014, EXP GERONTOL, V55, P63, DOI 10.1016/j.exger.2014.03.025; Silva MCP, 2010, INSECT BIOCHEM MOLEC, V40, P733, DOI 10.1016/j.ibmb.2010.07.006; Sowers AD, 2006, COMP BIOCHEM PHYS A, V145, P176, DOI 10.1016/j.cbpa.2006.06.008; Spiga L, 2013, J MATERN-FETAL NEO M, V26, P20, DOI 10.3109/14767058.2013.832062; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Thompson SN, 2003, ADV INSECT PHYSIOL, V31, P205, DOI 10.1016/S0065-2806(03)31004-5; Tyagi R, 2014, CHEM-BIOL INTERACT, V211, P20, DOI 10.1016/j.cbi.2013.12.016; Tyagi R, 2011, J APPL TOXICOL, V31, P663, DOI 10.1002/jat.1617; Tyagi R, 2012, METABOLOMICS, V8, P940, DOI 10.1007/s11306-011-0390-4; van Doorn M, 2007, BRIT J CLIN PHARMACO, V63, P562, DOI 10.1111/j.1365-2125.2006.02816.x; Wasano N, 2009, PHYTOCHEMISTRY, V70, P880, DOI 10.1016/j.phytochem.2009.04.014; Wen CW, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4676505; Westerhuis JA, 2010, METABOLOMICS, V6, P119, DOI 10.1007/s11306-009-0185-z; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xie YF, 2013, FLA ENTOMOL, V96, P1233, DOI 10.1653/024.096.0401; Zhang PB, 2006, PROTEOMICS, V6, P2586, DOI 10.1002/pmic.200500348; Zhao LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108678	51	10	11	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173213	10.1371/journal.pone.0173213	http://dx.doi.org/10.1371/journal.pone.0173213			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249023	Green Published, Green Submitted, gold			2022-12-26	WOS:000395983500082
J	Mesarich, CH; Rees-George, J; Gardner, PP; Ghomi, FA; Gerth, ML; Andersen, MT; Rikkerink, EHA; Fineran, PC; Templeton, MD				Mesarich, Carl H.; Rees-George, Jonathan; Gardner, Paul P.; Ghomi, Fatemeh Ashari; Gerth, Monica L.; Andersen, Mark T.; Rikkerink, Erik H. A.; Fineran, Peter C.; Templeton, Matthew D.			Transposon insertion libraries for the characterization of mutants from the kiwifruit pathogen Pseudomonas syringae pv. actinidiae	PLOS ONE			English	Article							DICKEYA-DADANTII; GENETIC-ANALYSIS; AERUGINOSA; VIRULENCE; IDENTIFICATION; POPULATIONS; GENERATION; RADIATION; MOTILITY; PLATFORM	Pseudomonas syringae pv. actinidiae (Psa), the causal agent of kiwifruit canker, is one of the most devastating plant diseases of recent times. We have generated two mini-Tn5-based random insertion libraries of Psa ICMP 18884. The first, a 'phenotype of interest' (POI) library, consists of 10,368 independent mutants gridded into 96-well plates. By replica plating onto selective media, the POI library was successfully screened for auxotrophic and motility mutants. Lipopolysaccharide (LPS) biosynthesis mutants with 'Fuzzy-Spreader'-like morphologies were also identified through a visual screen. The second, a 'mutant of interest' (MOI) library, comprises around 96,000 independent mutants, also stored in 96-well plates, with approximately 200 individuals per well. The MOI library was sequenced on the Illumina MiSeq platform using Transposon-Directed Insertion site Sequencing (TraDIS) to map insertion sites onto the Psa genome. A grid-based PCR method was developed to recover individual mutants, and using this strategy, the MOI library was successfully screened for a putative LPS mutant not identified in the visual screen. The Psa chromosome and plasmid had 24,031 and 1,236 independent insertion events respectively, giving insertion frequencies of 3.65 and 16.6 per kb respectively. These data suggest that the MOI library is near saturation, with the theoretical probability of finding an insert in any one chromosomal gene estimated to be 97.5%. However, only 47% of chromosomal genes had insertions. This surprisingly low rate cannot be solely explained by the lack of insertions in essential genes, which would be expected to be around 5%. Strikingly, many accessory genes, including most of those encoding type III effectors, lacked insertions. In contrast, 94% of genes on the Psa plasmid had insertions, including for example, the type III effector HopAU1. These results suggest that some chromosomal sites are rendered inaccessible to transposon insertion, either by DNA-binding proteins or by the architecture of the nucleoid.	[Mesarich, Carl H.; Rees-George, Jonathan; Andersen, Mark T.; Rikkerink, Erik H. A.; Templeton, Matthew D.] New Zealand Inst Plant & Food Res Ltd, Bioprotect Portfolio, Auckland, New Zealand; [Mesarich, Carl H.] Massey Univ, Inst Agr & Environm, Lab Mol Plant Pathol, Palmerston North, New Zealand; [Mesarich, Carl H.; Gardner, Paul P.; Ghomi, Fatemeh Ashari; Fineran, Peter C.; Templeton, Matthew D.] Bioprotect Res Ctr, Canterbury, New Zealand; [Gardner, Paul P.; Ghomi, Fatemeh Ashari] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Gerth, Monica L.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Fineran, Peter C.] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand; [Templeton, Matthew D.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand	New Zealand Institute for Plant & Food Research Ltd; Massey University; University of Canterbury; University of Otago; University of Otago; University of Auckland	Mesarich, CH; Templeton, MD (corresponding author), New Zealand Inst Plant & Food Res Ltd, Bioprotect Portfolio, Auckland, New Zealand.; Mesarich, CH (corresponding author), Massey Univ, Inst Agr & Environm, Lab Mol Plant Pathol, Palmerston North, New Zealand.; Mesarich, CH; Templeton, MD (corresponding author), Bioprotect Res Ctr, Canterbury, New Zealand.; Templeton, MD (corresponding author), Univ Auckland, Sch Biol Sci, Auckland, New Zealand.	c.mesarich@massey.ac.nz; matt.templeton@plantandfood.co.nz	Templeton, Matthew D./J-6966-2017; Mesarich, Carl H/E-4304-2015; Rikkerink, Erik H A/B-5752-2011; Gardner, Paul P./B-1978-2009; Fineran, Peter C/A-5766-2012	Templeton, Matthew D./0000-0003-0192-9041; Mesarich, Carl H/0000-0002-5207-4074; Rikkerink, Erik H A/0000-0003-4682-5078; Gardner, Paul P./0000-0002-7808-1213; Fineran, Peter C/0000-0002-4639-6704; Ashari Ghomi, Fatemeh/0000-0001-9786-4558; Gerth, Monica/0000-0002-7959-7852	New Zealand Tertiary Education Commission Centre of Research excellence (CoRE) grant; Rutherford Discovery Fellowships from the Royal Society of New Zealand	New Zealand Tertiary Education Commission Centre of Research excellence (CoRE) grant; Rutherford Discovery Fellowships from the Royal Society of New Zealand	This project was supported by the New Zealand Tertiary Education Commission Centre of Research excellence (CoRE) grant to the Bio-Protection Research Centre (BPRC). PCF and PPG were also supported by Rutherford Discovery Fellowships from the Royal Society of New Zealand.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Molina-Henares MA, 2010, ENVIRON MICROBIOL, V12, P1468, DOI 10.1111/j.1462-2920.2010.02166.x; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Barquist L, 2016, BIOINFORMATICS, V32, P1109, DOI 10.1093/bioinformatics/btw022; Barquist L, 2013, NUCLEIC ACIDS RES, V41, P4549, DOI 10.1093/nar/gkt148; Bouyioukos C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27978; Cagliero C, 2013, NUCLEIC ACIDS RES, V41, P6058, DOI 10.1093/nar/gkt325; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Chapman JR, 2012, PHYTOPATHOLOGY, V102, P1034, DOI 10.1094/PHYTO-03-12-0064-R; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; CHU CP, 1990, J GEN MICROBIOL, V136, P875, DOI 10.1099/00221287-136-5-875; Clemmer KM, 2011, MICROBIOL-SGM, V157, P2534, DOI 10.1099/mic.0.049791-0; de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12; DeJesus MA, 2017, MBIO, V8, DOI 10.1128/mBio.02133-16; Evans TJ, 2010, J APPL MICROBIOL, V109, P505, DOI 10.1111/j.1365-2672.2010.04669.x; Everett KR, 2011, AUSTRALAS PLANT DIS, V6, P67, DOI 10.1007/s13314-011-0023-9; Ferguson GC, 2013, GENETICS, V195, P1319, DOI 10.1534/genetics.113.154948; Fineran PC, 2005, MICROBIOL-SGM, V151, P3833, DOI 10.1099/mic.0.28251-0; FIRTH N, 1992, MOL GEN GENET, V232, P145, DOI 10.1007/BF00299147; Fujikawa T, 2016, SCI REP-UK, V6, DOI 10.1038/srep21399; Guo QY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19141; Guttenplan SB, 2013, FEMS MICROBIOL REV, V37, P849, DOI 10.1111/1574-6976.12018; Hayes F, 2003, ANNU REV GENET, V37, P3, DOI 10.1146/annurev.genet.37.110801.142807; Holeva MC, 2004, MOL PLANT MICROBE IN, V17, P943, DOI 10.1094/MPMI.2004.17.9.943; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kimura S, 2016, MBIO, V7, DOI 10.1128/mBio.01351-16; KING EO, 1954, J LAB CLIN MED, V44, P301; King JD, 2009, INNATE IMMUN-LONDON, V15, P261, DOI 10.1177/1753425909106436; Koh Y., 1994, KOREAN J PLANT PATHO, V10, P68; Kough AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064970; Kroupitski Y, 2009, J APPL MICROBIOL, V106, P1876, DOI 10.1111/j.1365-2672.2009.04152.x; Laia ML, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-12; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Larsen RA, 2002, ARCH MICROBIOL, V178, P193, DOI 10.1007/s00203-002-0442-2; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Manoharan B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137355; Marcelletti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027297; Mazzaglia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036518; McCann HC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003503; Monson R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01442; Monteil CL, 2013, NEW PHYTOL, V199, P800, DOI 10.1111/nph.12316; Patterson AG, 2015, NCUL ACIDS RES; Ponstingl H, 2010, F1000 POSTERS, V1, P313; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rio-Alvarez I, 2015, MOL PLANT PATHOL, V16, P685, DOI 10.1111/mpp.12227; Sambrook J., MOL CLONING LAB MANU; Santiago MF, 2002, CAN J MICROBIOL, V48, P1076, DOI 10.1139/W02-110; Scheurwater EM, 2011, FEMS MICROBIOL LETT, V318, P1, DOI 10.1111/j.1574-6968.2011.02228.x; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; SERIZAWA S, 1989, Annals of the Phytopathological Society of Japan, V55, P427, DOI 10.3186/jjphytopath.55.427; TAKIKAWA Y, 1989, Annals of the Phytopathological Society of Japan, V55, P437, DOI 10.3186/jjphytopath.55.437; Templeton MD, 2015, GENOME ANNOUNCEMENTS, V3; van Opijnen T, 2013, NAT REV MICROBIOL, V11, DOI 10.1038/nrmicro3033; Vanneste JL, 2013, PLANT DIS, V97, P708, DOI 10.1094/PDIS-07-12-0700-RE; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Yan Q, 2012, MOL PLANT MICROBE IN, V25, P69, DOI 10.1094/MPMI-05-11-0121; Yao J, 2006, J BACTERIOL, V188, P3697, DOI 10.1128/JB.188.10.3697-3708.2006; Yoshioka S, 2016, PEERJ, V4, DOI 10.7717/peerj.1543; Young JM, 2010, J PLANT PATHOL, V92, pS5; Zghidi-Abouzid O, 2016, RES MICROBIOL, V167, P247, DOI 10.1016/j.resmic.2016.02.001	63	14	16	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172790	10.1371/journal.pone.0172790	http://dx.doi.org/10.1371/journal.pone.0172790			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249011	Green Submitted, Green Published, gold			2022-12-26	WOS:000395983500058
J	Chen, JL; De Raeymaecker, J; Hovgaard, JB; Smaardijk, S; Vandecaetsbeek, I; Wuytack, F; Moller, JV; Eggermont, J; De Maeyer, M; Christensen, SB; Vangheluwe, P				Chen, Jialin; De Raeymaecker, Joren; Hovgaard, Jannik Brondsted; Smaardijk, Susanne; Vandecaetsbeek, Ilse; Wuytack, Frank; Moller, Jesper Vuust; Eggermont, Jan; De Maeyer, Marc; Christensen, Soren Brogger; Vangheluwe, Peter			Structure/activity relationship of thapsigargin inhibition on the purified Golgi/secretory pathway Ca2+/Mn2+-transport ATPase (SPCA1a)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM CA2+ ATPASE; HAILEY-HAILEY-DISEASE; AMINO-ACID 256; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; CALCIUM-PUMP; BINDING-SITE; CRYSTAL-STRUCTURES; CA2+-ATPASE SPCA1; GENETIC ALGORITHM	The Golgi/secretory pathway Ca2+/Mn2+-transport ATPase (SPCA1a) is implicated in breast cancer and Hailey-Hailey disease. Here, we purified recombinant human SPCA1a from Saccharomyces cerevisiae and measured Ca2+-dependent ATPase activity following reconstitution in proteoliposomes. The purified SPCA1a displays a higher apparent Ca2+ affinity and a lower maximal turnover rate than the purified sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA1a). The lipids cholesteryl hemisuccinate, linoleamide/oleamide, and phosphatidylethanolamine inhibit and phosphatidic acid and sphingomyelin enhance SPCA1a activity. Moreover, SPCA1a is blocked by micromolar concentrations of the commonly used SERCA1a inhibitors thapsigargin (Tg), cyclopiazonic acid, and 2,5-di-tert-butylhydroquinone. Because tissue-specific targeting of SERCA2b by Tg analogues is considered for prostate cancer therapy, the inhibition of SPCA1a by Tg might represent an off-target risk. We assessed the structure-activity relationship (SAR) of Tg for SPCA1a by in silico modeling, site-directed mutagenesis, and measuring the potency of a series of Tg analogues. These indicate that Tg and the analogues are bound via the Tg scaffold but with lower affinity to the same homologous cavity as on the membrane surface of SERCA1a. The lower Tg affinity may depend on a more flexible binding cavity in SPCA1a, with low contributions of the Tg O-3, O-8, and O-10 chains to the binding energy. Conversely, the protein interaction of the Tg O-2 side chain with SPCA1a appears comparable with that of SERCA1a. These differences define a SAR of Tg for SPCA1a distinct from that of SERCA1a, indicating that Tg analogues with a higher specificity for SPCA1a can probably be developed.	[Chen, Jialin; Smaardijk, Susanne; Vandecaetsbeek, Ilse; Wuytack, Frank; Eggermont, Jan; Vangheluwe, Peter] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Cellular Transport Syst, ON1 Campus Gasthuisberg,Herestr 49,Box 802, B-3000 Leuven, Belgium; [De Raeymaecker, Joren; De Maeyer, Marc] Katholieke Univ Leuven, Dept Chem, Biochem Mol & Struct Biol Sect, B-3000 Leuven, Belgium; [Hovgaard, Jannik Brondsted; Christensen, Soren Brogger] Univ Copenhagen, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark; [Moller, Jesper Vuust] Univ Aarhus, Dept Biomed, DK-8000 Aarhus, Denmark	KU Leuven; KU Leuven; University of Copenhagen; Aarhus University	Vangheluwe, P (corresponding author), Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Cellular Transport Syst, ON1 Campus Gasthuisberg,Herestr 49,Box 802, B-3000 Leuven, Belgium.	peter.vangheluwe@kuleuven.be	Christensen, Søren Brøgger/H-4526-2019; Vangheluwe, Peter/P-5476-2017	Christensen, Søren Brøgger/0000-0002-5773-6874; Vangheluwe, Peter/0000-0002-7822-2944; Eggermont, Jan/0000-0002-8497-1159	Flanders Research Foundation FWO [G044212N, G0B1115N]; Inter-University Attraction Poles Program [P7/13]; Danish Council for Strategic Research	Flanders Research Foundation FWO(FWO); Inter-University Attraction Poles Program(Belgian Federal Science Policy Office); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by Flanders Research Foundation FWO Grants G044212N and G0B1115N, the Inter-University Attraction Poles Program P7/13, and by the Danish Council for Strategic Research. The authors declare that they have no conflicts of interest with the contents of this article.	ANDERSEN A, 1994, ACTA CHEM SCAND, V48, P340, DOI 10.3891/acta.chem.scand.48-0340; [Anonymous], 2014, MOL OP ENV MOE VERS; Autzen HE, 2015, MOL MEMBR BIOL, V32, P75, DOI 10.3109/09687688.2015.1073382; Baron S, 2010, BBA-BIOMEMBRANES, V1798, P1512, DOI 10.1016/j.bbamem.2010.03.023; Baron S, 2009, BBA-MOL CELL RES, V1793, P1041, DOI 10.1016/j.bbamcr.2008.11.005; Behne MJ, 2003, J INVEST DERMATOL, V121, P688, DOI 10.1046/j.1523-1747.2003.12528.x; Benaim G, 2016, BIOCHEM BIOPH RES CO, V473, P572, DOI 10.1016/j.bbrc.2016.03.123; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Buettner S, 2013, CELL DEATH DIFFER, V20, P465, DOI 10.1038/cdd.2012.142; BURGE SM, 1992, BRIT J DERMATOL, V126, P275, DOI 10.1111/j.1365-2133.1992.tb00658.x; CHRISTENSEN SB, 1993, FEBS LETT, V335, P345, DOI 10.1016/0014-5793(93)80416-R; Cross BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067348; Denmeade S.R., 2012, SCI TRANSL MED, V4, P140, DOI DOI 10.2174/1871520610909030276; Dode L, 2006, J BIOL CHEM, V281, P3182, DOI 10.1074/jbc.M511547200; Dode L, 2005, J BIOL CHEM, V280, P39124, DOI 10.1074/jbc.M506181200; Dubois C, 2013, FEBS J, V280, P5430, DOI 10.1111/febs.12475; Faddy HM, 2008, BIOCHEM BIOPH RES CO, V369, P977, DOI 10.1016/j.bbrc.2008.03.003; Fairclough RJ, 2003, J BIOL CHEM, V278, P24721, DOI 10.1074/jbc.M300509200; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Grice DM, 2010, J BIOL CHEM, V285, P37458, DOI 10.1074/jbc.M110.163329; Harper C, 2005, J CELL SCI, V118, P1673, DOI 10.1242/jcs.02297; Holemans Tine, 2014, Cold Spring Harb Protoc, V2014, P876, DOI 10.1101/pdb.prot076893; Holemans T, 2015, P NATL ACAD SCI USA, V112, P9040, DOI 10.1073/pnas.1508220112; Jidenko M, 2006, PROTEIN EXPRES PURIF, V48, P32, DOI 10.1016/j.pep.2006.03.001; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KADOWAKI H, 1994, J LIPID RES, V35, P1956; Kaneko M, 2014, NAT GENET, V46, P144, DOI 10.1038/ng.2850; Lai P, 2012, BIOCHEM BIOPH RES CO, V424, P616, DOI 10.1016/j.bbrc.2012.07.004; Lambert O, 1998, BIOPHYS J, V74, P918, DOI 10.1016/S0006-3495(98)74015-9; Law BYK, 2010, MOL CANCER THER, V9, P718, DOI 10.1158/1535-7163.MCT-09-0700; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Micaroni M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.147; Michelangeli F, 2011, BIOCHEM SOC T, V39, P789, DOI 10.1042/BST0390789; Missiaen L, 2004, BIOCHEM BIOPH RES CO, V322, P1204, DOI 10.1016/j.bbrc.2004.07.128; Missiaen L, 2002, J BIOL CHEM, V277, P6898, DOI 10.1074/jbc.M110939200; Mitchell KJ, 2004, DIABETES, V53, P393, DOI 10.2337/diabetes.53.2.393; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Doan NTQ, 2015, CURR PHARM DESIGN, V21, P5501, DOI 10.2174/1381612821666151002112824; Doan NTQ, 2015, STEROIDS, V97, P2, DOI 10.1016/j.steroids.2014.07.009; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Okunade GW, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703029200; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; PlengeTellechea F, 1997, J BIOL CHEM, V272, P2794, DOI 10.1074/jbc.272.5.2794; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; Rigaud JL, 2002, BRAZ J MED BIOL RES, V35, P753, DOI 10.1590/S0100-879X2002000700001; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; SIMMONDS AC, 1982, BIOCHIM BIOPHYS ACTA, V693, P398, DOI 10.1016/0005-2736(82)90447-3; Skytte DM, 2010, BIOORGAN MED CHEM, V18, P5634, DOI 10.1016/j.bmc.2010.06.032; Smaardijk S., 2016, TISSUE CELL, V2016, pS0040; SMITT UW, 1991, PLANTA MED, V57, P196, DOI 10.1055/s-2006-960067; Sohoel H, 2005, J MED CHEM, V48, P7005, DOI 10.1021/jm058036v; Sorin A, 1997, J BIOL CHEM, V272, P9895; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Ton VK, 2002, J BIOL CHEM, V277, P6422, DOI 10.1074/jbc.M110612200; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; Van Baelen K, 2003, BIOCHEM BIOPH RES CO, V306, P430, DOI 10.1016/S0006-291X(03)00977-X; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vandecaetsbeek I, 2011, BBA-MOL CELL RES, V1813, P1118, DOI 10.1016/j.bbamcr.2010.12.020; Vangheluwe P, 2009, CHEM REV, V109, P4733, DOI 10.1021/cr900013m; Vanoevelen J, 2005, J BIOL CHEM, V280, P22800, DOI 10.1074/jbc.M501026200; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Winther AML, 2010, J BIOL CHEM, V285, P28883, DOI 10.1074/jbc.M110.136242; Wootton LL, 2006, J BIOL CHEM, V281, P6970, DOI 10.1074/jbc.M510978200; Wuytack F, 2002, CELL CALCIUM, V32, P279, DOI 10.1016/S0143416002001847; Xiang MH, 2005, J BIOL CHEM, V280, P11608, DOI 10.1074/jbc.M413116200; Xu C, 2004, J BIOL CHEM, V279, P17973, DOI 10.1074/jbc.M313263200; Yamamoto S, 2016, BIOCHEM BIOPH RES CO, V477, P266, DOI 10.1016/j.bbrc.2016.06.055; Young HS, 1997, BIOPHYS J, V72, P2545, DOI 10.1016/S0006-3495(97)78898-2; Yu MH, 1998, J BIOL CHEM, V273, P3542, DOI 10.1074/jbc.273.6.3542; Yu MH, 1999, ARCH BIOCHEM BIOPHYS, V362, P225, DOI 10.1006/abbi.1998.1049	76	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6938	6951		10.1074/jbc.M117.778431	http://dx.doi.org/10.1074/jbc.M117.778431			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28264934	hybrid, Green Published			2022-12-26	WOS:000400478300007
J	Wold, JP; Veiseth-Kent, E; Host, V; Lovland, A				Wold, Jens Petter; Veiseth-Kent, Eva; Host, Vibeke; Lovland, Atle			Rapid on-line detection and grading of wooden breast myopathy in chicken fillets by near-infrared spectroscopy	PLOS ONE			English	Article							IMAGING SPECTROSCOPY; SPECTRA; MUSCLE; WATER	The main objective of this work was to develop a method for rapid and non-destructive detection and grading of wooden breast (WB) syndrome in chicken breast fillets. Near-infrared (NIR) spectroscopy was chosen as detection method, and an industrial NIR scanner was applied and tested for large scale on-line detection of the syndrome. Two approaches were evaluated for discrimination of WB fillets: 1) Linear discriminant analysis based on NIR spectra only, and 2) a regression model for protein was made based on NIR spectra and the estimated concentrations of protein were used for discrimination. A sample set of 197 fillets was used for training and calibration. A test set was recorded under industrial conditions and contained spectra from 79 fillets. The classification methods obtained 99.5-100% correct classification of the calibration set and 100% correct classification of the test set. The NIR scanner was then installed in a commercial chicken processing plant and could detect incidence rates of WB in large batches of fillets. Examples of incidence are shown for three broiler flocks where a high number of fillets (9063, 6330 and 10483) were effectively measured. Prevalence of WB of 0.1%, 6.6% and 8.5% were estimated for these flocks based on the complete sample volumes. Such an on-line system can be used to alleviate the challenges WB represents to the poultry meat industry. It enables automatic quality sorting of chicken fillets to different product categories. Manual laborious grading can be avoided. Incidences of WB from different farms and flocks can be tracked and information can be used to understand and point out main causes for WB in the chicken production. This knowledge can be used to improve the production procedures and reduce today's extensive occurrence of WB.	[Wold, Jens Petter; Veiseth-Kent, Eva; Host, Vibeke] Nofima AS, Norwegian Inst Food & Fisheries Res, Muninbakken 9-13, Tromso, Norway; [Lovland, Atle] Nortura SA, Lorenveien 37, Oslo, Norway	Nofima	Wold, JP (corresponding author), Nofima AS, Norwegian Inst Food & Fisheries Res, Muninbakken 9-13, Tromso, Norway.	jens.petter.wold@nofima.no		Veiseth-Kent, Eva/0000-0002-8432-6010	Norwegian Agricultural Food Research Foundation [225347/F40, 224820/F40]; Norwegian company Nortura SA	Norwegian Agricultural Food Research Foundation; Norwegian company Nortura SA	This work was partially funded by the Norwegian Agricultural Food Research Foundation through the projects Food Imaging (project number 225347/F40) and Impact of protein composition for predictable food quality (224820/F40) and by the Norwegian company Nortura SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially funded by the Norwegian Agricultural Food Research Foundation through the projects Food Imaging (project number 225347/F40) and Impact of protein composition for predictable food quality (224820/F40) and by the Norwegian company Nortura SA. Karen Wahlstrom Sanden and Bjorg Narum are thanked for skilled technical assistance. We are grateful to Dr. Ragni Ofstad, Dr. Ingrid Mage and Dr. Ingunn Berget for valuable discussions.	Abasht B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153750; BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201; Chung SH, 2008, PHYS MED BIOL, V53, P6713, DOI 10.1088/0031-9155/53/23/005; Cozzolino D., 1996, Journal of Near Infrared Spectroscopy, V4, P213; Duda R. O., 1973, PATTERN CLASSIFICATI; Gee K., 2016, WALL STREET J; Kuttappan VA, 2016, POULTRY SCI, V95, P2724, DOI 10.3382/ps/pew216; LIBNAU FO, 1994, VIB SPECTROSC, V7, P243, DOI 10.1016/0924-2031(94)85014-3; MACGREGOR JF, 1995, CONTROL ENG PRACT, V3, P403, DOI 10.1016/0967-0661(95)00014-L; Martens H, 1993, MULIVARIATE CALIBRAT; Porep JU, 2015, TRENDS FOOD SCI TECH, V46, P211, DOI 10.1016/j.tifs.2015.10.002; Segtnan VH, 2009, J NEAR INFRARED SPEC, V17, P247, DOI 10.1255/jnirs.851; Sihvo HK, 2014, VET PATHOL, V51, P619, DOI 10.1177/0300985813497488; Soglia F, 2016, FOOD RES INT, V89, P1071, DOI 10.1016/j.foodres.2016.04.042; Solland GH, 2004, MEAT SCI, V66, P543, DOI [10.1016/50309-1740(03)00157-8, DOI 10.1016/50309-1740(03)00157-8]; Trocino A, 2015, POULTRY SCI, V94, P2996, DOI 10.3382/ps/pev296; Velleman SG, 2015, AVIAN DIS, V59, P410, DOI 10.1637/11097-042015-Reg.1; Wold JP, 2011, MEAT SCI, V89, P317, DOI 10.1016/j.meatsci.2011.05.001; Wold JP, 2010, APPL SPECTROSC, V64, P691, DOI 10.1366/000370210791666273; Wold JP, 2006, J NEAR INFRARED SPEC, V14, P59, DOI 10.1255/jnirs.587; Wold JP., 2016, FLEISCHWIRTSCHAFT, V31, P69	21	53	56	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173384	10.1371/journal.pone.0173384	http://dx.doi.org/10.1371/journal.pone.0173384			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278170	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000396087900083
J	Arenas, A; Roces, F				Arenas, Andres; Roces, Flavio			Avoidance of plants unsuitable for the symbiotic fungus in leaf-cutting ants: Learning can take place entirely at the colony dump	PLOS ONE			English	Article							DIVISION-OF-LABOR; ATTA-SEXDENS-RUBROPILOSA; WASTE MANAGEMENT; MIDDEN WORKERS; ACROMYRMEX; HYMENOPTERA; BEHAVIOR; MEMORY; PERFORMANCE; SELECTION	Plants initially accepted by foraging leaf-cutting ants are later avoided if they prove unsuitable for their symbiotic fungus. Plant avoidance is mediated by the waste produced in the fungus garden soon after the incorporation of the unsuitable leaves, as foragers can learn plant odors and cues from the damaged fungus that are both present in the recently produced waste particles. We asked whether avoidance learning of plants unsuitable for the symbiotic fungus can take place entirely at the colony dump. In order to investigate whether cues available in the waste chamber induce plant avoidance in naive subcolonies, we exchanged the waste produced by subcolonies fed either fungicide-treated privet leaves or untreated leaves and measured the acceptance of untreated privet leaves before and after the exchange of waste. Second, we evaluated whether foragers could perceive the avoidance cues directly at the dump by quantifying the visits of labeled foragers to the waste chamber. Finally, we asked whether foragers learn to specifically avoid untreated leaves of a plant after a confinement over 3 hours in the dump of subcolonies that were previously fed fungicide-treated leaves of that species. After the exchange of the waste chambers, workers from subcolonies that had access to waste from fungicide-treated privet leaves learned to avoid that plant. One-third of the labeled foragers visited the dump. Furthermore, naive foragers learned to avoid a specific, previously unsuitable plant if exposed solely to cues of the dump during confinement. We suggest that cues at the dump enable foragers to predict the unsuitable effects of plants even if they had never been experienced in the fungus garden.	[Arenas, Andres; Roces, Flavio] Univ Wurzburg, Dept Behav Physiol & Sociobiol, Biozentrum, Wurzburg, Germany; [Arenas, Andres] IFIBYNE CONICET, Lab Insectos Sociales, Dept Biodiversidad & Biol Expt, Fac Ciencias Exactas & Nat, Pabellon II,Ciudad Univ, Buenos Aires, DF, Argentina	University of Wurzburg; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Arenas, A (corresponding author), Univ Wurzburg, Dept Behav Physiol & Sociobiol, Biozentrum, Wurzburg, Germany.; Arenas, A (corresponding author), IFIBYNE CONICET, Lab Insectos Sociales, Dept Biodiversidad & Biol Expt, Fac Ciencias Exactas & Nat, Pabellon II,Ciudad Univ, Buenos Aires, DF, Argentina.	aarenas@bg.fcen.uba.ar	Arenas, Andres/ABC-4886-2021	Roces, Flavio/0000-0001-9258-3079	University of Wurzburg [SFB 1047 TP C1]; German Academic Exchange Service (Deutscher Akademischer Austauschdienst, DAAD) [A/11/81698]	University of Wurzburg; German Academic Exchange Service (Deutscher Akademischer Austauschdienst, DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by University of Wurzburg in the funding program Open Access Publishing German Research Foundation (DFG), SFB 1047 TP C1German Academic Exchange Service (Deutscher Akademischer Austauschdienst, DAAD) (ref. no.: A/11/81698).	[Anonymous], 2010, ANT ENCOUNTERS INTER; Arenas A, 2016, J EXP BIOL, V219, P2490, DOI 10.1242/jeb.139568; Arenas A, 2016, ANIM BEHAV, V115, P167, DOI 10.1016/j.anbehav.2016.03.016; Ballari S, 2007, J INSECT BEHAV, V20, P87, DOI 10.1007/s10905-006-9065-9; BASS M, 1995, PHYSIOL ENTOMOL, V20, P1, DOI 10.1111/j.1365-3032.1995.tb00793.x; Bollazzi M, 2012, INSECT SOC, V59, P487, DOI 10.1007/s00040-012-0243-9; Bonetto AA, 1959, HORMIGAS CORTADOERAS, P77; Bot ANM, 2001, ETHOL ECOL EVOL, V13, P225, DOI 10.1080/08927014.2001.9522772; Camargo RS, 2003, SOCIOBIOLOGY, V42, P93; Cherrett J. M., 1989, ECOSYSTEMS WORLD B, P473; Elliot SL, 2010, ECOLOGY, V91, P65, DOI 10.1890/09-0424.1; Falibene A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00084; Farji-Brener AG, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0625; Fowler HG, 1996, BIOL RHYTHM RES, V27, P148, DOI 10.1076/brhm.27.2.148.12944; FOWLER HG, 1985, DEUT ENTOMOL Z, V32, P19, DOI 10.1002/mmnd.19850320105; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Gould J.L., 1984, Life Sciences Research Report, P149; HAINES B, 1983, Tropical Ecology, V24, P85; Hart AG, 2002, BEHAV ECOL, V13, P224, DOI 10.1093/beheco/13.2.224; Hart AG, 2002, NATURWISSENSCHAFTEN, V89, P275, DOI 10.1007/s00114-002-0316-0; Hart AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P387, DOI 10.1007/s002650000312; Herz H, 2008, BEHAV ECOL, V19, P575, DOI 10.1093/beheco/arn016; Herz H, 2007, BIOTROPICA, V39, P476, DOI 10.1111/j.1744-7429.2007.00283.x; Holldobler B., 1990, pi; HUBBELL SP, 1983, OECOLOGIA, V60, P321, DOI 10.1007/BF00376846; Jaffe K., 1982, Social insects in the tropics. Proceedings of the First International Symposium organized by the International Union for the Study of Social Insects and the Sociedad Mexicana de Entomologia. Cocoyoc, Morelos, Mexico, November 1980. Volume 2, P165; Jarau S, 1982, FOOD EXPLOITATION SO; JONKMAN JCM, 1980, Z ANGEW ENTOMOL, V89, P217; JUTSUM AR, 1979, ANIM BEHAV, V27, P839, DOI 10.1016/0003-3472(79)90021-6; KNAPP JJ, 1990, WESTV STUD, P382; Kost C, 2005, J TROP ECOL, V21, P677, DOI 10.1017/S0266467405002592; Kost C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022340; Lacerda FG, 2014, ITAL J ZOOL, V81, P298, DOI 10.1080/11250003.2014.911369; Lacerda FG, 2013, J INSECT BEHAV, V26, P873, DOI 10.1007/s10905-013-9403-7; Langridge EA, 2008, BEHAV ECOL SOCIOBIOL, V62, P447, DOI 10.1007/s00265-007-0472-5; LINDAUER M, 1970, NATURWISSENSCHAFTEN, V57, P463, DOI 10.1007/BF00593072; North RD, 1999, PHYSIOL ENTOMOL, V24, P127, DOI 10.1046/j.1365-3032.1999.00122.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ridley P, 1996, EXPERIENTIA, V52, P631, DOI 10.1007/BF01969745; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROCES F, 1994, OECOLOGIA, V97, P1, DOI 10.1007/BF00317902; ROCES F, 1990, OECOLOGIA, V83, P261, DOI 10.1007/BF00317762; ROCES F, 1994, INSECT SOC, V41, P235, DOI 10.1007/BF01242294; Saverschek N, 2011, ANIM BEHAV, V82, P453, DOI 10.1016/j.anbehav.2011.05.015; Saverschek N, 2010, ANIM BEHAV, V79, P689, DOI 10.1016/j.anbehav.2009.12.021; Saverschek N, 2010, THESIS; Seeley T., 1995, WISDOM HIVE SOCIAL P; Stahel G, 1943, J NEW YORK BOT GARDE, V44, P245; STAHEL GEROLD, 1941, REV ENT [RIO DE JANEIRO], V12, P243; Stahel Gerold, 1939, REV ENT [RIO DE JANEIRO], V10, P27; Thiele T, 2014, J CHEM ECOL, V40, P617, DOI 10.1007/s10886-014-0460-y; Verza SS, 2007, INSECT SOC, V54, P303, DOI 10.1007/s00040-007-0943-8; Waddington SJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P1219, DOI 10.1007/s00265-010-0936-x; Weber N. A., 1972, GARDENING ANTS ATTIN; Wirth R, 2003, HERBIVORY LEAF CUTTI	55	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171388	10.1371/journal.pone.0171388	http://dx.doi.org/10.1371/journal.pone.0171388			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273083	Green Submitted, Green Published, gold			2022-12-26	WOS:000396073700094
J	De Lombaerde, S; Neyt, S; Kersemans, K; Verhoeven, J; Devisscher, L; Van Vlierberghe, H; Vanhove, C; De Vos, F				De Lombaerde, Stef; Neyt, Sara; Kersemans, Ken; Verhoeven, Jeroen; Devisscher, Lindsey; Van Vlierberghe, Hans; Vanhove, Christian; De Vos, Filip			Synthesis, in vitro and in vivo evaluation of 3 beta-[F-18]fluorocholic acid for the detection of drug-induced cholestasis in mice	PLOS ONE			English	Article							WHOLE-BODY DISTRIBUTION; INDUCED LIVER-INJURY; BILE-ACIDS; HEPATOBILIARY TRANSPORTERS; OATP; POLYPEPTIDE; RECEPTOR; BOSENTAN; BIODISTRIBUTION; RADIOSYNTHESIS	Introduction Drug-induced cholestasis is a liver disorder that might be caused by interference of drugs with the hepatobiliary bile acid transporters. It is important to identify this interference early on in drug development. In this work, Positron Emission Tomography (PET)-imaging with a F-18 labeled bile acid analogue was introduced to detect disturbed hepatobiliary transport of bile acids. Methods 3 beta-[F-18]fluorocholic acid ([F-18]FCA) was prepared by nucleophilic substitution of a mesylated precursor with [F-18]fluoride, followed by deprotection with sodium hydroxide. Transport of [F-18]FCA was assessed in vitro using CHO-NTCP, HEK-OATP1B1, HEK-OATP1B3 transfected cells and BSEP & MRP2 membrane vesicles. Investigation of [F-18]FCA metabolites was performed with primary mouse hepatocytes. Hepatobiliary transport of [F-18]FCA was evaluated in vivo in wild-type, rifampicin and bosentan pretreated FVB-mice by dynamic mu PET scanning. Results Radiosynthesis of [F-18] FCA was achieved in a moderate radiochemical yield (8.11-1.94%; non-decay corrected; n = 10) and high radiochemical purity (>99%). FCA was transported by the basolateral bile acid uptake transporters NTCP, OATP1B1 and OATP1B3. For canalicular efflux, BSEP and MRP2 are the relevant bile acid transporters. [F-18]FCA was found to be metabolically stable. In vivo, [F-18]FCA showed fast hepatic uptake (4.5-0.5 min to reach 71.8-1.2% maximum % ID) and subsequent efflux to the gallbladder and intestines (93.3-6.0% ID after 1 hour). Hepatobiliary transport of [F-18]FCA was significantly inhibited by both rifampicin and bosentan. Conclusion A F-18 labeled bile acid analogue, [F-18]FCA, has been developed that shows transport by NTCP, OATP, MRP2 and BSEP. [F-18]FCA can be used as a probe to monitor disturbed hepatobiliary transport in vivo and accumulation of bile acids in blood and liver during drug development.	[De Lombaerde, Stef; Neyt, Sara; Verhoeven, Jeroen; De Vos, Filip] Univ Ghent, Fac Pharmaceut Sci, Lab Radiopharm, Ghent, Belgium; [Kersemans, Ken] Ghent Univ Hosp, Nucl Med, Ghent, Belgium; [Devisscher, Lindsey; Van Vlierberghe, Hans] Ghent Univ Hosp, Gastroenterol & Hepatol, Ghent, Belgium; [Vanhove, Christian] Univ Ghent, IBiTech MEDISIP INFINITY, Ghent, Belgium	Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University	De Lombaerde, S (corresponding author), Univ Ghent, Fac Pharmaceut Sci, Lab Radiopharm, Ghent, Belgium.	stef.delombaerde@ugent.be	Devisscher, Lindsey/AAD-5969-2021; Vanhove, Christian/I-2095-2019	Devisscher, Lindsey/0000-0003-4862-9580; Vanhove, Christian/0000-0002-3988-5980; Van Vlierberghe, Hans/0000-0003-0647-9238; De Lombaerde, Stef/0000-0002-5307-3575; Verhoeven, Jeroen/0000-0002-6641-7760				Baringhaus KH, 1999, J LIPID RES, V40, P2158; Bleibel W, 2007, DIGEST DIS SCI, V52, P2463, DOI 10.1007/s10620-006-9472-y; Chen X, 2009, TOXICOL APPL PHARM, V240, P26, DOI 10.1016/j.taap.2009.06.022; Dong ZQ, 2015, INT J PHARMACEUT, V478, P88, DOI 10.1016/j.ijpharm.2014.11.022; Fattinger K, 2001, CLIN PHARMACOL THER, V69, P223, DOI 10.1067/mcp.2001.114667; Frisch K, 2014, NUCL MED BIOL, V41, P775, DOI 10.1016/j.nucmedbio.2014.07.001; Frisch K, 2012, J NUCL MED, V53, P772, DOI 10.2967/jnumed.111.098731; Ghibellini G, 2008, PHARM RES-DORDR, V25, P1851, DOI 10.1007/s11095-008-9597-0; Gonzalez PM, 2014, MOL PHARMACEUT, V11, P588, DOI 10.1021/mp400575t; Hartman JC, 2010, CAN J PHYSIOL PHARM, V88, P682, DOI 10.1139/Y10-060; He JK, 2014, MOL PHARMACEUT, V11, P2745, DOI 10.1021/mp500027c; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Jia LN, 2014, NUCL MED BIOL, V41, P495, DOI 10.1016/j.nucmedbio.2014.03.016; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Leslie EM, 2007, J PHARMACOL EXP THER, V321, P1170, DOI 10.1124/jpet.106.119073; Moerman L, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-12; Neyt S, 2016, NUCL MED BIOL, V43, P642, DOI 10.1016/j.nucmedbio.2016.07.001; Neyt S, 2013, J NUCL MED, V54, P624, DOI 10.2967/jnumed.112.108233; Padda MS, 2011, HEPATOLOGY, V53, P1377, DOI 10.1002/hep.24229; Pauli-Magnus C, 2006, HEPATOLOGY, V44, P778, DOI 10.1002/hep.21359; Regev A, 2014, SEMIN LIVER DIS, V34, P227, DOI 10.1055/s-0034-1375962; RODA A, 1990, J LIPID RES, V31, P1433; Schacht AC, 2016, J NUCL MED, V57, P628, DOI 10.2967/jnumed.115.161711; Seo JW, 2007, NUCL MED BIOL, V34, P383, DOI 10.1016/j.nucmedbio.2007.01.010; Severgnini M, 2012, CYTOTECHNOLOGY, V64, P187, DOI 10.1007/s10616-011-9407-0; Shimizu K, 2012, NUCL MED BIOL, V39, P847, DOI 10.1016/j.nucmedbio.2012.01.008; Shingaki T, 2013, J PHARMACOL EXP THER, V347, P193, DOI 10.1124/jpet.113.206425; Takashima T, 2012, J NUCL MED, V53, P741, DOI 10.2967/jnumed.111.098681; Testa A, 2015, MOL PHARMACEUT, V12, P2203, DOI 10.1021/acs.molpharmaceut.5b00059; Vieira MDT, 2014, EXPERT OPIN DRUG MET, V10, P581, DOI 10.1517/17425255.2014.884069; Tournier N, 2013, AAPS J, V15, P1082, DOI 10.1208/s12248-013-9514-2; Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002; Vavricka SR, 2002, HEPATOLOGY, V36, P164, DOI 10.1053/jhep.2002.34133	33	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173529	10.1371/journal.pone.0173529	http://dx.doi.org/10.1371/journal.pone.0173529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273180	gold, Green Published, Green Submitted			2022-12-26	WOS:000396073700013
J	Dube, CE; Merciere, A; Vermeij, MJA; Planes, S				Dube, Caroline E.; Merciere, Alexandre; Vermeij, Mark J. A.; Planes, Serge			Population structure of the hydrocoral Millepora platyphylla in habitats experiencing different flow regimes in Moorea, French Polynesia	PLOS ONE			English	Article							CORAL-REEFS; SCLERACTINIAN CORALS; COLONY SIZE; ENVIRONMENTAL GRADIENTS; SPATIAL-DISTRIBUTION; COMMUNITY STRUCTURE; JUVENILE CORALS; CARIBBEAN CORAL; VIRGIN-ISLANDS; ST-JOHN	While the fire coral Millepora platyphylla is an important component of Indo-Pacific reefs, where it thrives in a wide range of environments, the ecological and biological processes driving its distribution and population structure are not well understood. Here, we quantified this species' population structure in five habitats with contrasting hydrodynamic regimes in Moorea, French Polynesia; two in the fore reef: mid and upper slopes, and three in the lagoon: back, fringing and patch reefs. A total of 3651 colonies of fire corals were mapped and measured over 45,000 m(2) of surveyed reef. Due to the species' sensitivity to fragmentation in response to strong water movement, hydrodynamic conditions (e.g. waves, pass and lagoonal circulation) corresponded to marked differences in colony size distributions, morphology and recruitment dynamics among habitats. The size structure varied among reef habitats with higher proportions of larger colonies in calm nearshore reefs (fringing and patch reefs), while populations were dominated by smaller colonies in the exposed fore reefs. The highest densities of fire corals were recorded in fore reef habitats (0.12-0.20 n.m(-2)) where the proportion of recruits and juveniles was higher at mid slope populations (49.3%) than on the upper slope near where waves break (29.0%). In the latter habitat, most colonies grew as vertical sheets on encrusting bases making them more vulnerable to colony fragmentation, whereas fire corals were encrusting or massive in all other habitats. The lowest densities of M. platyphylla occurred in lagoonal habitats (0.02-0.04 n.m(-2)) characterized by a combination of low water movement and other physical and biological stressors. This study reports the first evidence of population structure of fire corals in two common reef environments and illustrates the importance of water flow in driving population dynamic processes of these reef-building species.	[Dube, Caroline E.; Planes, Serge] PSL Res Univ, EPHE, UPVD CNRS, USR CRIOBE 3278, Perpignan, France; [Dube, Caroline E.; Merciere, Alexandre; Planes, Serge] PSL Res Univ, Lab Excellence CORAIL, EPHE, UPVD CNRS,USR CRIOBE 3278, Papetoai, Moorea, France; [Vermeij, Mark J. A.] CARMABI Fdn, Willemstad, Curacao; [Vermeij, Mark J. A.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Aquat Microbiol, Amsterdam, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); University of Amsterdam	Dube, CE (corresponding author), PSL Res Univ, EPHE, UPVD CNRS, USR CRIOBE 3278, Perpignan, France.	caroline.dube.qc@gmail.com	Dubé, Caroline/AAD-9029-2019; Vermeij, Mark/B-2752-2013; PLANES, Serge/ABF-1360-2021; Vermeij, Mark/AAR-6757-2020	Dubé, Caroline/0000-0002-8990-8597; Vermeij, Mark/0000-0001-9612-9527; Vermeij, Mark/0000-0001-9612-9527	Fonds Quebecois de Recherche sur la Nature et les Technologies	Fonds Quebecois de Recherche sur la Nature et les Technologies(FQRNT)	CED is supported by a graduate scholarship from the Fonds Quebecois de Recherche sur la Nature et les Technologies.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adjeroud M, 2007, HYDROBIOLOGIA, V589, P117, DOI 10.1007/s10750-007-0726-2; Adjeroud M, 2015, MAR ENVIRON RES, V112, P131, DOI 10.1016/j.marenvres.2015.10.004; Albright R, 2011, GLOBAL CHANGE BIOL, V17, P2478, DOI 10.1111/j.1365-2486.2011.02404.x; Andrefouet S, 2014, CORAL REEFS, V33, P463, DOI 10.1007/s00338-014-1133-6; Aranceta-Garza F, 2012, CORAL REEFS, V31, P1157, DOI 10.1007/s00338-012-0941-9; Attalla TM, 2011, EGYPT J AQUAT BIOL F, V15, P1; Baird AH, 2000, J EXP MAR BIOL ECOL, V251, P117, DOI 10.1016/S0022-0981(00)00209-4; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; BENDEL RB, 1989, OECOLOGIA, V78, P394, DOI 10.1007/BF00379115; Bivand R. S., 2013, APPL SPATIAL DATA AN, V10, P1, DOI DOI 10.1007/978-0-387-78171-6; Bosserelle P, 2014, GUIDE IDENTIFICATION; Bourmaud CAF, 2013, MAR ECOL-EVOL PERSP, V34, P14, DOI 10.1111/maec.12024; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Brown D, 2013, J EXP MAR BIOL ECOL, V441, P62, DOI 10.1016/j.jembe.2013.01.013; Chiappone M, 1996, B MAR SCI, V58, P555; Chindapol N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002849; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Coma R, 1997, BIOL BULL-US, V193, P20, DOI 10.2307/1542733; Cooper TF, 2007, ESTUAR COAST SHELF S, V74, P458, DOI 10.1016/j.ecss.2007.05.020; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; Denny M., 2014, BIOL MECH WAVE SWEPT; DEWEERDT WH, 1981, BIJDR DIERKD, V51, P1; Dollar S.J., 1982, Coral Reefs, V1, P71, DOI 10.1007/BF00301688; Done T.J., 1982, Coral Reefs, V1, P95, DOI 10.1007/BF00301691; Doropoulos C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128535; Dube CE, 2017, PEERJ, V5, DOI 10.7717/peerj.2936; Dube CE, 2016, MAR BIODIVERS, V46, P329, DOI 10.1007/s12526-015-0392-y; Edmunds PJ, 2010, MAR ECOL PROG SER, V414, P75, DOI 10.3354/meps08728; Edmunds PJ, 1999, CORAL REEFS, V18, P133, DOI 10.1007/s003380050167; Edmunds PJ, 2000, MAR ECOL PROG SER, V202, P113, DOI 10.3354/meps202113; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Ferrario F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4794; Fichez R, 2005, AQUAT LIVING RESOUR, V18, P125, DOI 10.1051/alr:2005015; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Galzin R., 1985, P 5 INT COR REEF C T, V1, P73; Gili JM, 1995, OCEANOGR MAR BIOL, V33, P351; Gilmour J, 1999, MAR BIOL, V135, P451, DOI 10.1007/s002270050645; Gleason DF, 2011, J EXP MAR BIOL ECOL, V408, P42, DOI 10.1016/j.jembe.2011.07.025; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Harris A, 2014, AQUAT CONSERV, V24, P667, DOI 10.1002/aqc.2464; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Hearn CJ, 1999, J GEOPHYS RES-OCEANS, V104, P30007, DOI 10.1029/1999JC900262; Hench JL, 2008, LIMNOL OCEANOGR, V53, P2681, DOI 10.4319/lo.2008.53.6.2681; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; Hoogenboom MO, 2009, ECOLOGY, V90, P767, DOI 10.1890/07-2010.1; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Jackson J.B.C., 1979, Systematics Association Special Volume Series, P499; Kaandorp JA, 1999, MAR BIOL, V134, P295, DOI 10.1007/s002270050547; Kaandorp JA, 2001, J THEOR BIOL, V209, P257, DOI 10.1006/jtbi.2001.2261; Kayal M, 2016, MAR BIODIV, V1-4; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; Koehl MAR, 2004, J MARINE SYST, V49, P75, DOI 10.1016/j.jmarsys.2003.06.003; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Leichter JJ, 2013, OCEANOGRAPHY, V26, P52, DOI 10.5670/oceanog.2013.45; Lenihan HS, 2015, ECOLOGY, V96, P1540, DOI 10.1890/14-1115.1; Lewis JB, 2006, ADV MAR BIOL, V50, P1, DOI 10.1016/S0065-2881(05)50001-4; Madin JS, 2006, NATURE, V444, P477, DOI 10.1038/nature05328; Madin JS, 2006, CORAL REEFS, V25, P635, DOI 10.1007/s00338-006-0137-2; Madin JS, 2014, ECOL LETT, V17, P1008, DOI 10.1111/ele.12306; Madin JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046637; Madin JS, 2012, J EXP BIOL, V215, P968, DOI 10.1242/jeb.061002; Meesters EH, 2001, MAR ECOL PROG SER, V209, P43, DOI 10.3354/meps209043; Monismith SG, 2007, ANNU REV FLUID MECH, V39, P37, DOI 10.1146/annurev.fluid.38.050304.092125; Nagelkerken I, 2004, B MAR SCI, V74, P213; Penin L, 2007, B MAR SCI, V80, P379; Penin L, 2013, MAR ECOL PROG SER, V473, P149, DOI 10.3354/meps10101; Penin L, 2010, MAR ECOL PROG SER, V408, P55, DOI 10.3354/meps08554; Price N, 2010, OECOLOGIA, V163, P747, DOI 10.1007/s00442-010-1578-4; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RICHMOND RH, 1993, AM ZOOL, V33, P524; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Roth MS, 2009, MAR ECOL PROG SER, V376, P133, DOI 10.3354/meps07787; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SOONG K, 1993, CORAL REEFS, V12, P77, DOI 10.1007/BF00302106; Storlazzi C, 2002, OCEAN WAVE MEAS ANAL, P784, DOI DOI 10.1061/40604(273)80; Storlazzi CD, 2005, CORAL REEFS, V24, P43, DOI 10.1007/s00338-004-0430-x; Swierts T, 2016, PEERJ, V4, DOI 10.7717/peerj.1984; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; Tsounis G, 2016, PEERJ, V4, DOI 10.7717/peerj.2544; Urban DL, 2000, SPATIAL ANAL ECOLOGY; Vermeij MJA, 2007, MAR ECOL PROG SER, V351, P91, DOI 10.3354/meps07085; Vermeij MJA, 2008, ECOLOGY, V89, P1994, DOI 10.1890/07-1296.1; Vermeij MJA, 2002, MAR ECOL PROG SER, V233, P105, DOI 10.3354/meps233105; Veron J.E.N., 2000, CORALS WORLD, V1-3; WALLACE CC, 1985, MAR BIOL, V88, P217, DOI 10.1007/BF00392585; Wilkinson C, 2008, STATUS CORAL REEFS W; Williams GJ, 2013, PEERJ, V1, DOI 10.7717/peerj.81; WITMAN JD, 1992, AM ZOOL, V32, P641	92	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173513	10.1371/journal.pone.0173513	http://dx.doi.org/10.1371/journal.pone.0173513			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273119	Green Published, gold, Green Submitted			2022-12-26	WOS:000396073700010
J	Jain, S; Rai, N; Kumar, G; Pruthi, PA; Thangaraj, K; Bajpai, S; Pruthi, V				Jain, Sonal; Rai, Niraj; Kumar, Giriraj; Pruthi, Parul Aggarwal; Thangaraj, Kumarasamy; Bajpai, Sunil; Pruthi, Vikas			Ancient DNA Reveals Late Pleistocene Existence of Ostriches in Indian Sub-Continent	PLOS ONE			English	Article							EGGSHELLS; AFRICA; MATRIX	Ancient DNA (aDNA) analysis of extinct ratite species is of considerable interest as it provides important insights into their origin, evolution, paleogeographical distribution and vicariant speciation in congruence with continental drift theory. In this study, DNA hotspots were detected in fossilized eggshell fragments of ratites (dated >= 25000 years B.P. by radiocarbon dating) using confocal laser scanning microscopy (CLSM). DNA was isolated from five eggshell fragments and a 43 base pair (bp) sequence of a 16S rRNA mitochondrial-conserved region was successfully amplified and sequenced from one of the samples. Phylogenetic analysis of the DNA sequence revealed a 92% identity of the fossil eggshells to Struthio camelus and their position basal to other palaeognaths, consistent with the vicariant speciation model. Our study provides the first molecular evidence for the presence of ostriches in India, complementing the continental drift theory of biogeographical movement of ostriches in India, and opening up a new window into the evolutionary history of ratites.	[Jain, Sonal; Pruthi, Parul Aggarwal; Pruthi, Vikas] Indian Inst Technol, Dept Biotechnol, Roorkee, Uttar Pradesh, India; [Rai, Niraj; Thangaraj, Kumarasamy] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Kumar, Giriraj] Dayalbagh Educ Inst, Agra, Uttar Pradesh, India; [Bajpai, Sunil] Indian Inst Technol, Dept Earth Sci, Roorkee, Uttar Pradesh, India; [Bajpai, Sunil] Birbal Sahni Inst Palaeosci, Lucknow, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Dayalbagh Educational Institute (DEI); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP)	Jain, S (corresponding author), Indian Inst Technol, Dept Biotechnol, Roorkee, Uttar Pradesh, India.	jainsonal20@gmail.com	Rai, Niraj/AAO-7618-2021	Rai, Niraj/0000-0002-1251-9390; Jain, Sonal/0000-0003-0439-6797; Pruthi, Vikas/0000-0002-3666-5552	Council for Scientific and Industrial Research (CSIR); University Grants Commission (UGC), New Delhi	Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC), New Delhi(University Grants Commission, India)	For the financial support, we would like to acknowledge the Council for Scientific and Industrial Research (CSIR) and University Grants Commission (UGC), New Delhi.; We acknowledge the much-needed help received from the All India Institute of Medical Sciences (AIIMS), New Delhi in conducting Confocal Laser Scanning Microscopy imaging. We are thankful to CCMB Director Ch. Mohan Rao, to allow us to perform experiments in his Ancient DNA laboratory. For the financial support, we would like to acknowledge the Council for Scientific and Industrial Research and University Grants Commission (UGC), New Delhi. We would like to thank Mr. Om Prakash Sharma for helping in procuring samples from Bundi site.	Badam G.L., 2005, MAN ENV, V30, P97; BEDNARIK RG, 1994, ANTIQUITY, V68, P68, DOI 10.1017/S0003598X00046202; Bednarik RG, 1993, B INDOPACIFIC PREHIS, V13, P34; Bednarik RG., 1993, MAN ENV, V18, P33; Blinkhom J, 2015, PALAEOGEOGR PALAEOCL, V417, P80, DOI 10.1016/j.palaeo.2014.10.026; Carrino DA, 1996, CONNECT TISSUE RES, V35, P325, DOI 10.3109/03008209609029207; Cooper A, 2000, SCIENCE, V289, P1139; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; Davies W., 1880, GEOL MAG, V7, P18, DOI [10.1017/S0016756800146904, DOI 10.1017/S0016756800146904]; Dawkins R, 2004, NY TIMES BK REV, P688; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng QL, 2001, J CRYST GROWTH, V233, P548, DOI 10.1016/S0022-0248(01)01611-6; Fink D, 2006, SOL ENERG MAT SOL C, V90, P1458, DOI 10.1016/j.solmat.2005.10.022; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Harrison T, 2005, J AFR EARTH SCI, V41, P303, DOI 10.1016/j.jafrearsci.2005.07.001; Hincke MT, 2000, MATRIX BIOL, V19, P443, DOI 10.1016/S0945-053X(00)00095-0; Johnson BJ, 1997, PALAEOGEOGR PALAEOCL, V136, P121, DOI 10.1016/S0031-0182(97)00043-6; Kumar G, 1983, THESIS, P227; Kumar G, 1988, ROCK ART RES, V5, P43; Leakey MG, 2003, LOTHAGAM DAWN HUMANI; Manegold Albrecht, 2013, P135; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; MILLER GH, 1992, PHILOS T ROY SOC B, V337, P149, DOI 10.1098/rstb.1992.0092; Miller GH, 2000, PERSPECTIVES AMINO A, P161; Mitchell KJ, 2014, SCIENCE, V344, P898, DOI 10.1126/science.1251981; MOHABEY DM, 1989, J GEOL SOC INDIA, V33, P477; Mourer-Chauvire C, 2005, 6S INT SOC AV PAL EV, V7, P169; Nys Y, 2004, CR PALEVOL, V3, P549, DOI 10.1016/j.crpv.2004.08.002; Oskam CL, 2012, METHODS MOL BIOL, V840, P65, DOI 10.1007/978-1-61779-516-9_9; Oskam CL, 2010, P ROY SOC LOND B BIO, P277; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Patnaik R, 2009, CURR SCI INDIA, V96, P1485; Pickford M, 2000, GEOLOGY PALAEOBIOLOG; Rai N, 2014, MITOCHONDRION, V14, P1, DOI 10.1016/j.mito.2013.12.002; Roberts P, 2014, P NATL ACAD SCI USA, V111, P5848, DOI 10.1073/pnas.1323465111; Sahn A., 1989, Journal of the Palaeontological Society of India, V34, P91; Sahni A., 1990, MAN ENV, V15, P41; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sauer EG, 1978, PALAEONTOGR ABT A, P1; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; STERN LA, 1994, GEOLOGY, V22, P419, DOI 10.1130/0091-7613(1994)022<0419:CISOEC>2.3.CO;2; Stidham TA, 2004, J HUM EVOL, V46, P489, DOI 10.1016/j.jhevol.2004.02.002; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wellman-Labadie O, 2008, BRIT POULTRY SCI, V49, P133, DOI 10.1080/00071660802001722; Wellman-Labadie O, 2008, FEBS LETT, V582, P699, DOI 10.1016/j.febslet.2008.01.043	46	7	8	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0164823	10.1371/journal.pone.0164823	http://dx.doi.org/10.1371/journal.pone.0164823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273082	gold, Green Submitted, Green Published			2022-12-26	WOS:000396073700088
J	Ramalingam, K; Vuthaluru, S; Srivastava, A; Dinda, AK; Dhar, A				Ramalingam, Kirithiga; Vuthaluru, Seenu; Srivastava, Anurag; Dinda, Amit Kumar; Dhar, Anita			Ultra structural changes occurring in duct ectasia and periductal mastitis and their significance in etiopathogenesis	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; PULMONARY-FIBROSIS	Introduction Duct ectasia (DE) and periductal mastitis (PDM) are the most common benign breast conditions seen in women. The etiopathogenesis of these entities is still not clear and most of the theories regarding the causation are based on the histological features as seen on light microscopy. The ultramicroscopic features associated with these conditions that may give more insight to the etiopathogenesis are unknown. Aim To study the ultrastructural changes occurring in mammary duct cones in patients with DE and PDM using Transmission Electron Microscopic (TEM). Method Major ducts removed by radical duct excision from 21 patients with final histopathological diagnosis of DE and PDM were subjected to TEM study with 2 normal duct samples as controls. Results The TEM features of DE were denudation of the epithelial cells with focal loss of microvilli, widening of the inter-epithelial junctions with focal disruption of the T bars, periductal collagenisation without inflammation, and features suggestive of Epithelial Mesenchymal Transition (EMT). PDM features are intact epithelial lining with proliferative epithelium and periductal collagenisation with inflammation. Conclusions Based on the TEM findings, we suggest that DE and PDM are two different entities. EMT a novel finding observed in DE in this study.	[Ramalingam, Kirithiga; Vuthaluru, Seenu; Srivastava, Anurag; Dhar, Anita] All India Inst Med Sci, Dept Surg Disciplines, New Delhi, India; [Dinda, Amit Kumar] All India Inst Med Sci, Dept Pathol, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Ramalingam, K (corresponding author), All India Inst Med Sci, Dept Surg Disciplines, New Delhi, India.	kirithigaramalingam@gmail.com						Burns WC, 2006, J AM SOC NEPHROL, V17, P2484, DOI 10.1681/ASN.2006050525; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Dudas PL, 2009, NEPHROL DIAL TRANSPL, V24, P1406, DOI 10.1093/ndt/gfn662; HAAGENSEN CD, 1951, CANCER, V4, P749, DOI 10.1002/1097-0142(195107)4:4<749::AID-CNCR2820040413>3.0.CO;2-F; Jenkins RH, 2011, AM J PATHOL, V178, P964, DOI 10.1016/j.ajpath.2010.12.010; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Li F, 2005, MED MOL MORPHOL, V38, P216, DOI [10.1007/s00795-005-0300-9, DOI 10.1007/S00795-005-0300-9]; Mansel R, 2009, MANSEL WEBSTERS BENI; Ozzello L, 1971, PATHOLOGY ANN, V6; Stirling John W., VIRCHOWS ARCH, V373, P119; TSUCHIYA S, 1983, ACTA PATHOL JAPON, V33, P97; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200	13	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173216	10.1371/journal.pone.0173216	http://dx.doi.org/10.1371/journal.pone.0173216			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273122	Green Published, gold, Green Submitted			2022-12-26	WOS:000396073700045
J	Winiewska, M; Bugajska, E; Poznanski, J				Winiewska, Maria; Bugajska, Ewa; Poznanski, Jaroslaw			ITC-derived binding affinity may be biased due to titrant (nano)-aggregation. Binding of halogenated benzotriazoles to the catalytic domain of human protein kinase CK2	PLOS ONE			English	Article							G-QUADRUPLEX DNA; SITE; INHIBITORS; THERMODYNAMICS; AGGREGATION; DERIVATIVES; PARAMETERS; FEATURES	The binding of four bromobenzotriazoles to the catalytic subunit of human protein kinase CK2 was assessed by two complementary methods: Microscale Thermophoresis (MST) and Isothermal Titration Calorimetry (ITC). New algorithm proposed for the global analysis of MST pseudo-titration data enabled reliable determination of binding affinities for two distinct sites, a relatively strong one with the K-d of the order of 100 nM and a substantially weaker one (K-d > 1 mu M). The affinities for the strong binding site determined for the same protein-ligand systems using ITC were in most cases approximately 10-fold underestimated. The discrepancy was assigned directly to the kinetics of ligand nano-aggregates decay occurring upon injection of the concentrated ligand solution to the protein sample. The binding affinities determined in the reverse ITC experiment, in which ligands were titrated with a concentrated protein solution, agreed with the MST-derived data. Our analysis suggests that some ITC-derived Kd values, routinely reported together with PDB structures of protein-ligand complexes, may be biased due to the uncontrolled ligand (nano)-aggregation, which may occur even substantially below the solubility limit.	[Winiewska, Maria; Bugajska, Ewa; Poznanski, Jaroslaw] Polish Acad Sci, Inst Biochem & Biophys, Dept Biophys, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Winiewska, M; Poznanski, J (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Dept Biophys, Warsaw, Poland.	mwin@ibb.waw.pl; jarek@ibb.waw.pl	Winiewska, Maria/ABF-4317-2021; Poznanski, Jaroslaw/F-7705-2014	Poznanski, Jaroslaw/0000-0003-2684-1775; Marzec nee Bugajska, Ewa/0000-0002-2564-4959; Winiewska-Szajewska, Maria/0000-0003-0986-6882	Polish National Science Center [2012/07/B/ST4/01334, 2015/19/B/ST4/02156]; Centre for Preclinical Research and Technology (CePT); European Regional Development Fund and Innovative Economy; National Cohesion Strategy of Poland	Polish National Science Center; Centre for Preclinical Research and Technology (CePT); European Regional Development Fund and Innovative Economy; National Cohesion Strategy of Poland	This work was supported by Polish National Science Center (https://nen.gov.p1/?language=en) grants 2012/07/B/ST4/01334 (JP) and 2015/19/B/ST4/02156 (JP). The equipment used was sponsored in part by the Centre for Preclinical Research and Technology (CePT), a project co-sponsored by European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland (http://ec.europa.eu/regional_policy/en/projects/poland/a-biomedical-research-centre-for-central-europe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu P, 2013, J PHOTOCH PHOTOBIO B, V129, P57, DOI 10.1016/j.jphotobiol.2013.09.011; Battistutta R, 2005, HANDB EXP PHARM, V167, P125; Battistutta R, 2001, PROTEIN SCI, V10, P2200, DOI 10.1110/ps.19601; Battistutta R, 2007, CHEMBIOCHEM, V8, P1804, DOI 10.1002/cbic.200700307; Cozza G, 2013, CURR MED CHEM, V20, P671, DOI 10.2174/092986713804999312; Dam TK, 2002, BIOCHEMISTRY-US, V41, P1359, DOI 10.1021/bi015829k; Desiraju GR, 2013, PURE APPL CHEM, V85, P1711, DOI 10.1351/PAC-REC-12-05-10; Ferguson AD, 2011, FEBS LETT, V585, P104, DOI 10.1016/j.febslet.2010.11.019; FREIRE E, 1990, ANAL CHEM, V62, pA950, DOI 10.1021/ac00217a002; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Goldberg RN, 2002, J PHYS CHEM REF DATA, V31, P231, DOI 10.1063/1.1416902; HEIRWEGH KPM, 1992, BIOCHEM EDUC, V20, P36, DOI 10.1016/0307-4412(92)90018-H; Herrera I, 2016, J PHYS CHEM B, V120, P2077, DOI 10.1021/acs.jpcb.5b09202; Huang RX, 2016, BBA-GEN SUBJECTS, V1860, P945, DOI 10.1016/j.bbagen.2016.01.027; Kinoshita T, 2011, MOL CELL BIOCHEM, V356, P97, DOI 10.1007/s11010-011-0960-9; Kitchens RL, 1998, J IMMUNOL, V160, P1920; Klein T, 2014, ACS MED CHEM LETT, V5, P166, DOI 10.1021/ml4004205; Leavitt S, DIRECT MEASUREMENT P; Maluf NK, 2011, BIOPHYS CHEM, V154, P82, DOI 10.1016/j.bpc.2011.01.004; Mashalidis EH, 2013, NAT PROTOC, V8, P2309, DOI 10.1038/nprot.2013.130; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; McGovern SL, 2003, J MED CHEM, V46, P1478, DOI 10.1021/jm020427b; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Moll D, 2007, BIOL CHEM, V388, P163, DOI 10.1515/BC.2007.018; Nienberg C, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9030036; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Pilch DS, 2008, BIOCHIMIE, V90, P1233, DOI 10.1016/j.biochi.2008.03.011; Poznanski J, 2006, J THERM ANAL CALORIM, V83, P565, DOI 10.1007/s10973-005-7394-0; Raaf J, 2008, CHEM BIOL, V15, P111, DOI 10.1016/j.chembiol.2007.12.012; Reille-Seroussi M, 2015, BIOCHEMISTRY-US, V54, P5147, DOI 10.1021/acs.biochem.5b00722; Rossetti L, 2005, BIOORG MED CHEM LETT, V15, P413, DOI 10.1016/j.bmcl.2004.10.061; Sarno S, 2005, BBA-PROTEINS PROTEOM, V1754, P263, DOI 10.1016/j.bbapap.2005.07.043; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Wasik R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048898; Wasik R, 2012, J PHYS CHEM B, V116, P7259, DOI 10.1021/jp301561x; Wasik R, 2010, J PHYS CHEM B, V114, P10601, DOI 10.1021/jp102848y; Winiewska M, 2015, BBA-PROTEINS PROTEOM, V1854, P1708, DOI 10.1016/j.bbapap.2015.04.004; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zielenkiewicz W., 2002, THEORY CALORIMETRY	42	23	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173260	10.1371/journal.pone.0173260	http://dx.doi.org/10.1371/journal.pone.0173260			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273138	Green Published, Green Submitted, gold			2022-12-26	WOS:000396073700050
J	Rinker, T; Shafer, VL; Kiefer, M; Vidal, N; Yu, YH				Rinker, Tanja; Shafer, Valerie L.; Kiefer, Markus; Vidal, Nancy; Yu, Yan H.			T-complex measures in bilingual Spanish-English and Turkish-German children and monolingual peers	PLOS ONE			English	Article							AUDITORY-EVOKED POTENTIALS; EVENT-RELATED POTENTIALS; SYSTEM ACTIVITY; LANGUAGE; BRAIN; MATURATION; PERCEPTION; DISCRIMINATION; EXPERIENCE; EXPOSURE	Background Lateral temporal neural measures (Na and T-complex Ta and Tb) of the auditory evoked potential (AEP) index maturation of auditory/speech processing. These measures are also sensitive to language experience in adults. This paper examined neural responses to a vowel sound at temporal electrodes in four-to five-year-old Spanish-English bilinguals and English monolinguals and in five- to six-year-old Turkish-German bilinguals and German monolinguals. The goal was to determine whether obligatory AEPs at temporal electrode sites were modulated by language experience. Language experience was defined in terms of monolingual versus bilingual status as well as the amount and quality of the bilingual language experience. Method AEPs were recorded at left and right temporal electrode sites to a 250-ms vowel [epsilon] from 20 monolingual (American)-English and 18 Spanish-English children from New York City, and from 11 Turkish-German and 13 monolingual German children from Ulm, Germany. Language background information and standardized verbal and non-verbal test scores were obtained for the children. Results The results revealed differences in temporal AEPs (Na and Ta of the T-complex) between monolingual and bilingual children. Specifically, bilingual children showed smaller and/or later peak amplitudes than the monolingual groups. Ta-amplitude distinguished monolingual and bilingual children best at right electrode sites for both the German and American groups. Amount of experience and type of experience with the target language (English and German) influenced processing. Conclusions The finding of reduced amplitudes at the Ta latency for bilingual compared to monolingual children indicates that language specific experience, and not simply maturational factors, influences development of the neural processes underlying the Ta AEP, and suggests that lateral temporal cortex has an important role in language- specific speech perception development.	[Rinker, Tanja] Univ Konstanz, Dept Linguist Zukunftskolleg, Constance, Germany; [Shafer, Valerie L.; Vidal, Nancy] CUNY, Grad Ctr, New York, NY USA; [Kiefer, Markus] Univ Ulm, Ulm, Germany; [Yu, Yan H.] St Johns Univ, New York, NY USA	University of Konstanz; City University of New York (CUNY) System; Ulm University; Saint John's University	Rinker, T (corresponding author), Univ Konstanz, Dept Linguist Zukunftskolleg, Constance, Germany.	tanja.rinker@uni-konstanz.de	YU, YAN/Y-8898-2018	YU, YAN/0000-0001-6322-4800; Rinker, Tanja/0000-0002-3107-2598; Shafer, Valerie/0000-0001-8551-1878	NIH [HD46193]; Zukunftskolleg of the University of Konstanz	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zukunftskolleg of the University of Konstanz	Funded by NIH HD46193 to Valerie L. Shafer (www.nichd.nih.gov/Pages/index.aspx). Funding for this research collaboration was also provided by the Zukunftskolleg of the University of Konstanz to Tanja Rinker and Valerie Shafer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1995, CATEGORICAL DATA ANA; Albrecht R, 2000, CLIN NEUROPHYSIOL, V111, P2268, DOI 10.1016/S1388-2457(00)00464-8; Alku P, 1999, CLIN NEUROPHYSIOL, V110, P1329, DOI 10.1016/S1388-2457(99)00088-7; BAKER C, 1998, ENCY BILINGUALISM BI; Baker W, 2002, PROC ANN BUCLD, P36; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bishop DVM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035851; Bishop DVM, 2007, DEVELOPMENTAL SCI, V10, P576, DOI 10.1111/j.1467-7687.2007.00620.x; Bosch L, 2003, LANG SPEECH, V46, P217, DOI 10.1177/00238309030460020801; Bruneau N, 1999, CLIN NEUROPHYSIOL, V110, P1927, DOI 10.1016/S1388-2457(99)00149-2; Ceponiene R, 1998, EVOKED POTENTIAL, V108, P345, DOI 10.1016/S0168-5597(97)00081-6; Cheour M, 2002, NEUROSCI LETT, V325, P187, DOI 10.1016/S0304-3940(02)00269-0; Datta H, 2010, J SPEECH LANG HEAR R, V53, P757, DOI 10.1044/1092-4388(2009/08-0123); Dunn L. M., 1986, TEST VOCABULARIO IM; Dunn L.M., 1981, PEABODY PICTURE VOCA; Dunn MA, 2005, J AUTISM DEV DISORD, V35, P361, DOI 10.1007/s10803-005-3304-3; EULITZ C, 1995, J NEUROSCI, V15, P2748; Flege JE, 1997, J PHONETICS, V25, P437, DOI 10.1006/jpho.1997.0052; Fox J., 2018, R COMPANION APPL REG, VThird; Grimm H, 1991, HEIDELBERGER SPRACHE; Groen MA, 2008, BIOL PSYCHOL, V79, P148, DOI 10.1016/j.biopsycho.2008.04.003; Hisagi M, 2014, ERP INDICES VOWEL PR; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Kuhl PK, 2008, PHILOS T R SOC B, V363, P979, DOI 10.1098/rstb.2007.2154; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Mahajan Y, 2013, INT J DEV NEUROSCI, V31, P1, DOI 10.1016/j.ijdevneu.2012.10.002; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Parra M, 2011, J EXP CHILD PSYCHOL, V108, P113, DOI 10.1016/j.jecp.2010.07.011; Peltola MS, 2005, NEUROSCI LETT, V388, P121, DOI 10.1016/j.neulet.2005.06.037; Ponton C, 2002, CLIN NEUROPHYSIOL, V113, P407, DOI 10.1016/S1388-2457(01)00733-7; R Core Team, 2021, R LANGUAGE ENV STAT; Ramon-Casas M, 2009, COGNITIVE PSYCHOL, V59, P96, DOI 10.1016/j.cogpsych.2009.02.002; Raven JC, 2002, COLOURED PROGR MATRI; Rinker T, 2010, BRAIN LANG, V113, P90, DOI 10.1016/j.bandl.2010.01.007; Sebastian-Galles N, 2006, J COGNITIVE NEUROSCI, V18, P1277, DOI 10.1162/jocn.2006.18.8.1277; Shafer VL, 2015, INT J PSYCHOPHYSIOL, V95, P77, DOI 10.1016/j.ijpsycho.2014.08.1390; Shafer VL, 2012, NEUROSCI LETT, V526, P10, DOI 10.1016/j.neulet.2012.07.064; Shafer VL, 2011, J PHONETICS, V39, P527, DOI 10.1016/j.wocn.2010.11.010; Shafer VL, 2011, CLIN NEUROPHYSIOL, V122, P1137, DOI 10.1016/j.clinph.2010.10.046; Tonnquist-Uhlen I, 2003, CLIN NEUROPHYSIOL, V114, P685, DOI 10.1016/S1388-2457(03)00005-1; TonnquistUhlen I, 1996, ACTA OTO-LARYNGOL, V116, P680, DOI 10.3109/00016489609137907; Tse L., 2001, WHY DONT THEY LEARN; Vidal N., 2015, NEUROPHYSIOLOGICAL C; Videsott G, 2010, BRAIN LANG, V113, P103, DOI [10.1016/j.bandl.2010.01.006, 10.1016/j.band1.2010.01.006]; Wagner M, 2013, BRAIN RES, V1522, P31, DOI 10.1016/j.brainres.2013.04.045; WOLPAW JR, 1975, ELECTROEN CLIN NEURO, V39, P609, DOI 10.1016/0013-4694(75)90073-5; Yeni-Komshian G. H., 2000, BILING-LANG COGN, V3, P131, DOI [10.1017/S1366728900000225, DOI 10.1017/S1366728900000225]; Zimmerman I.L., 2002, PRESCHOOL LANGUAGE S	48	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0171992	10.1371/journal.pone.0171992	http://dx.doi.org/10.1371/journal.pone.0171992			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5QM	28267801	gold, Green Published			2022-12-26	WOS:000396060600054
J	Athanassiou, CG; Kavallieratos, NG; Campbell, JF				Athanassiou, Christos G.; Kavallieratos, Nickolas G.; Campbell, James F.			Competition of three species of Sitophilus on rice and maize	PLOS ONE			English	Article							UNBAITED PROBE TRAPS; ZEAMAIS MOTSCH; GRAIN TRIER; COLEOPTERA; CURCULIONIDAE; INSECTS; WEEVIL; RESISTANCE; MITES	Laboratory tests were carried out in order to examine competition among three congeneric species on rice and maize: the granary weevil, Sitophilus granarius, the rice weevil, Sitophilus oryzae and the maize weevil, Sitophilus zeamais. For this purpose, a total of 30 adults were placed in vials that contained 50 g or either rice or maize: 30 adults of S. granarius, 30 adults of S. oryzae, 30 adults of S. zeamais, 15 adults of S. granarius+ 15 adults of S. oryzae, 15 adults of S. granarius+ 15 adults of S. zeamais, 15 adults of S. oryzae + 15 adults of S. zeamais, and 10 adults of S. granarius+ 10 adults of S. oryzae+ 10 adults of S. zeamais. After 62 days at 30 degrees C and 65% relative humidity the number of individuals of each species were counted. Insect damaged kernels (IDK), weight of frass and grain weight were measured. When each species was alone, S. granarius had the lowest numbers of adults in both grains, which did not exceed 34 adults/vial, and S. oryzae numbers were always higher than other species. For S. oryzae and S. zeamais, the numbers of adults were considerably higher on rice than on maize. On rice, S. oryzae numbers ranged between 281 and 563 adults per vial, while for S. zeamais between 137 and 372 adults per vial. At the same time, for both species on maize, adult numbers did not exceed 54 adults per vial. The number of S. oryzae adults were constantly higher than the other species in all combinations tested. Moreover, for rice, IDK in the vials that contained S. oryzae, either alone or in combination with other species, was higher than all the other combinations. Similarly, grain weight was lower in the vials that contained S. oryzae compared to the other species combinations. In general, for S. oryzae and S. zeamais progeny production was increased with the increase of the number of the initial adults that had been placed inside the vials. At the same time, progeny production of all three species was not affected by the presence of another species inside the vial. Given that the coexistence of congeneric species in the same stored product ecosystem is often reported, our results highlight some of the inferences that are necessary in order to predict the potential outcome of competition patterns. Apart from its ecological significance, the prediction of the superior species in mixed species communities, can guide and time any control measures, on a more species-targeted basis.	[Athanassiou, Christos G.] Univ Thessaly, Dept Agr Crop Prod & Rural Dev, Lab Entomol & Agr Zool, Nea Ionia, Magnissia, Greece; [Athanassiou, Christos G.; Kavallieratos, Nickolas G.; Campbell, James F.] ARS, USDA, CGAHR, Manhattan, KS 66502 USA; [Kavallieratos, Nickolas G.] Univ Agr, Lab Agr Zool & Entomol, Dept Crop Sci, Athens, Attica, Greece	University of Thessaly; United States Department of Agriculture (USDA); Agricultural University of Athens	Kavallieratos, NG (corresponding author), ARS, USDA, CGAHR, Manhattan, KS 66502 USA.; Kavallieratos, NG (corresponding author), Univ Agr, Lab Agr Zool & Entomol, Dept Crop Sci, Athens, Attica, Greece.	nick_kaval@hotmail.com	Kavallieratos, Nickolas G./AAB-7500-2022; Athanassiou, Christos/ABE-8867-2020	Kavallieratos, Nickolas G./0000-0001-5851-5013; Kavallieratos, Nickolas/0000-0003-4342-1289	Fulbright Foundation (Greece)	Fulbright Foundation (Greece)	CGA received support from Fulbright Foundation (Greece) (http://www.fulbright.gr/en/) (Fulbright Visiting Scholar Grant for Research, academic year 2015-2016). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken AD, 1975, USDA TECHNICAL B, V31; Athanassiou C. G., 2001, Annales de l'Institut Phytopathologique Benaki, V19, P140; Athanassiou CG, 2005, J ECON ENTOMOL, V98, P1058, DOI 10.1603/0022-0493-98.3.1058; Athanassiou CG, 2003, APPL ENTOMOL ZOOL, V38, P413, DOI 10.1303/aez.2003.413; Athanassiou CG, 2001, ENTOMOL EXP APPL, V98, P67, DOI 10.1023/A:1018741310337; Athanassiou CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102867; Birch L. C., 1945, Transactions of the Royal Society of South Australia, V69, P140; BIRCH LC, 1945, AUST J EXP BIOL MED, V23, P29, DOI 10.1038/icb.1945.5; BIRCH LC, 1945, AUST J EXP BIOL MED, V23, P141, DOI 10.1038/icb.1945.23; Buchelos CT, 1999, J STORED PROD RES, V35, P397, DOI 10.1016/S0022-474X(99)00024-7; Campbell JF, 2002, J INSECT BEHAV, V15, P429, DOI 10.1023/A:1016225427886; Cordeiro EMG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100990; Correa AS, 2017, B ENTOMOL RES, V107, P9, DOI 10.1017/S0007485316000687; CROMBIE AC, 1945, PROC R SOC SER B-BIO, V132, P362, DOI 10.1098/rspb.1945.0003; Danho M, 2002, J STORED PROD RES, V38, P259, DOI 10.1016/S0022-474X(01)00027-3; DOBIE P, 1974, J STORED PROD RES, V10, P183, DOI 10.1016/0022-474X(74)90006-X; Edde PA, 2012, J STORED PROD RES, V48, P1, DOI 10.1016/j.jspr.2011.08.007; Garcia-Lara S, 2004, CROP SCI, V44, P1546, DOI 10.2135/cropsci2004.1546; GIGA DP, 1993, J STORED PROD RES, V29, P63, DOI 10.1016/0022-474X(93)90023-W; GIGA DP, 1991, J APPL ECOL, V28, P918, DOI 10.2307/2404217; Gokce A, 2004, J AGR FAC GAZIOSMANP, V21, P9; Guedes NMP, 2010, ANIM BEHAV, V79, P281, DOI 10.1016/j.anbehav.2009.10.022; Hill DS., 2003, PESTS STORAGE FOODST; KIRITANI K., 1965, Journal of Stored Products Research, V1, P169, DOI 10.1016/0022-474X(65)90017-2; LONGSTAFF BC, 1981, PROT ECOL, V3, P83; MADRID FJ, 1990, CAN ENTOMOL, V122, P515, DOI 10.4039/Ent122515-5; Mason LJ., 2012, STORED PRODUCT PROTE, P7; Mutters RG., 2009, RICE QUALITY HDB; Nansen C, 2004, ECOL RES, V19, P197, DOI 10.1111/j.1440-1703.2003.00624.x; Nansen C, 2009, J STORED PROD RES, V45, P254, DOI 10.1016/j.jspr.2009.04.005; Nicholson AJ, 1954, AUST J ZOOL, V2, P695; Nwosu LC, 2015, INT J TROP INSECT SC, V35, P185, DOI 10.1017/S1742758415000193; Obata H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014785; RICHARDS OW, 1947, P ZOOL SOC LOND, V117, P1; Robinson W.H., 2005, HDB URBAN INSECTS AR; RYOO MI, 1988, J STORED PROD RES, V24, P79, DOI 10.1016/0022-474X(88)90034-3; SEGROVE F, 1951, J EXP BIOL, V28, P281; SERRATOS A, 1987, J CHEM ECOL, V13, P751, DOI 10.1007/BF01020157; SHARIFI S, 1971, J ECON ENTOMOL, V64, P1114, DOI 10.1093/jee/64.5.1114; SINHA RN, 1995, BOOK SOIL P, P1; Soderstrom E. L., 1966, Journal of the Kansas Entomological Society, V29, P32; SUBRAMANYAM B, 1990, J ECON ENTOMOL, V83, P1102, DOI 10.1093/jee/83.3.1102; THRONE J E, 1989, Journal of Agricultural Entomology, V6, P183; THRONE J E, 1991, Journal of Agricultural Entomology, V8, P93; THRONE JE, 1994, ENVIRON ENTOMOL, V23, P1459, DOI 10.1093/ee/23.6.1459; TIPPING PW, 1988, J KANSAS ENTOMOL SOC, V61, P237; WHITE NDG, 1995, BOOK SOIL P, P123	47	21	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173377	10.1371/journal.pone.0173377	http://dx.doi.org/10.1371/journal.pone.0173377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264050	Green Published, gold, Green Submitted			2022-12-26	WOS:000396054300059
J	Camprasse, ECM; Cherel, Y; Arnould, JPY; Hoskins, AJ; Bost, CA				Camprasse, Elodie C. M.; Cherel, Yves; Arnould, John P. Y.; Hoskins, Andrew J.; Bost, Charles-Andre			Combined bio-logging and stable isotopes reveal individual specialisations in a benthic coastal seabird, the Kerguelen shag	PLOS ONE			English	Article							REARING CROZET SHAGS; FORAGING SPECIALIZATION; BEHAVIOR; DIET; CONSISTENCY; REPEATABILITY; CORMORANTS; PATTERNS; NICHE; FOOD	Individual specialisations, which involve the repetition of specific behaviours or dietary choices over time, have been suggested to benefit animals by avoiding competition with conspecifics and increasing individual foraging efficiency. Among seabirds, resident and benthic species are thought to be good models to study inter-individual variation as they repetitively exploit the same environment. We investigated foraging behaviour, isotopic niche and diet in the Kerguelen shag Phalacrocorax verrucosus during both the incubation and chick-rearing periods for the same individuals to determine the effect of sex, breeding stage, body mass and morphometrics on mean foraging metrics and their consistency. There were large differences between individuals in foraging behaviour and consistency, with strong individual specialisations in dive depths and heading from the colony. Stable isotopes revealed specialisations in feeding strategies, across multiple temporal scales. Specifically, individuals showed medium term specialisations in feeding strategies during the breeding season, as well as long-term consistency. A clustering analysis revealed 4 different foraging strategies displaying significantly different delta N-15 values and body masses. There were no sex or stage biases to clusters and individuals in different clusters did not differ in their morphology. Importantly, the results suggest that the different strategies emphasized were related to individual prey preferences rather than intrinsic characteristics.	[Camprasse, Elodie C. M.; Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood Campus, Geelong, Vic, Australia; [Cherel, Yves; Bost, Charles-Andre] Univ La Rochelle, CNRS, CEBC, UMR 7372, Villiers En Bois, Deux Sevres, France; [Hoskins, Andrew J.] CSIRO Land & Water, Canberra, ACT, Australia	Deakin University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Camprasse, ECM (corresponding author), Deakin Univ, Sch Life & Environm Sci, Burwood Campus, Geelong, Vic, Australia.	elodie.camprasse@gmail.com	Hoskins, Andrew/T-2694-2019; Camprasse, Elodie/X-1832-2019	Hoskins, Andrew/0000-0001-8907-6682; 	French Polar Institute Paul-Emile Victor [394]; Holsworth Wildlife Research Endowment [RM27086]	French Polar Institute Paul-Emile Victor; Holsworth Wildlife Research Endowment	The French Polar Institute Paul-Emile Victor (www.ipev.fr) provided funding (Prog. 394, resp. CAB) used for field expenses. The Holsworth Wildlife Research Endowment (https://equrtytrustees.smartygrants.com au/holmorth, grant #RM27086) provided funding for the purchase data loggers.	Annett CA, 1999, ECOLOGY, V80, P288, DOI 10.1890/0012-9658(1999)080[0288:LTROIW]2.0.CO;2; Baylis AMM, 2015, MAR BIOL, V162, P99, DOI 10.1007/s00227-014-2561-0; Bearhop S, 2006, MAR ECOL PROG SER, V311, P157, DOI 10.3354/meps311157; Beaudoin CP, 1999, OECOLOGIA, V120, P386, DOI 10.1007/s004420050871; Bivand R, 2005, R NEWS, V5; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; BOST CA, 1992, J ZOOL, V226, P135, DOI 10.1111/j.1469-7998.1992.tb06132.x; Bretz F, 2002, R NEWS, V2, P14; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Casaux R, 2006, ANTARCT SCI, V18, P3, DOI 10.1017/S0954102006000010; Ceia FR, 2015, MAR BIOL, V162, P1923, DOI 10.1007/s00227-015-2735-4; Ceia FR, 2012, MAR BIOL, V159, P1581, DOI 10.1007/s00227-012-1946-1; Cherel Y, 2008, MAR ECOL PROG SER, V366, P281, DOI 10.3354/meps07587; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Cherel Y, 2010, LIMNOL OCEANOGR, V55, P324, DOI 10.4319/lo.2010.55.1.0324; Cook TR, 2007, ANTARCT SCI, V19, P55, DOI 10.1017/S0954102007000089; Cook TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056297; Cook TR, 2006, POLAR BIOL, V29, P562, DOI 10.1007/s00300-005-0089-y; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Duhamel G., 2005, POISSONS ILES KERGUE; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Furness RW, 2006, ARDEA, V94, P631; GODIN JGJ, 1995, ANIM BEHAV, V49, P1427, DOI 10.1016/0003-3472(95)90063-2; Laich AG, 2012, J ORNITHOL, V153, P139, DOI 10.1007/s10336-011-0714-1; Green K, 1997, EMU, V97, P76, DOI 10.1071/MU97008; Gremillet D, 2005, BIOL LETTERS, V1, P469, DOI 10.1098/rsbl.2005.0356; Gremillet D, 2003, J APPL ECOL, V40, P266, DOI 10.1046/j.1365-2664.2003.00806.x; Gremillet D, 1998, IBIS, V140, P113, DOI 10.1111/j.1474-919X.1998.tb04547.x; Hamel S, 2009, OECOLOGIA, V161, P421, DOI 10.1007/s00442-009-1377-y; Harris S, 2016, MAR ECOL-EVOL PERSP, V37, P419, DOI 10.1111/maec.12327; Harris S, 2014, IBIS, V156, P523, DOI 10.1111/ibi.12159; Harris S, 2013, MAR BIOL, V160, P1249, DOI 10.1007/s00227-013-2177-9; HECHT T, 1986, S AFR J ZOOL, V21, P294; Jaeger A, 2010, MAR ECOL PROG SER, V401, P269, DOI 10.3354/meps08380; Janzen FJ, 2001, ANIM BEHAV, V62, P73, DOI 10.1006/anbe.2000.1732; Kato A, 2000, AUK, V117, P718, DOI 10.1642/0004-8038(2000)117[0718:VIFAPB]2.0.CO;2; Kaufman L., 2005, FINDING GROUPS DATA; Kernaleguen L, 2016, OECOLOGIA, V180, P657, DOI 10.1007/s00442-015-3407-2; Kernaleguen L, 2015, J ANIM ECOL, V84, P1081, DOI 10.1111/1365-2656.12347; Lack D., 1968, pvii; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Michalik A, 2013, J ORNITHOL, V154, P239, DOI 10.1007/s10336-012-0890-7; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patrick SC, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0630; Patrick SC, 2014, OIKOS, V123, P33, DOI 10.1111/j.1600-0706.2013.00406.x; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; Quillfeldt P, 2011, MAR ECOL PROG SER, V428, P271, DOI 10.3354/meps09058; Quintana F, 2011, OIKOS, V120, P350, DOI 10.1111/j.1600-0706.2010.18387.x; R Core Team, 2013, R LANG ENV STAT COMP; Ratcliffe N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079107; SELANDER RK, 1966, CONDOR, V68, P113, DOI 10.2307/1365712; SIEGELCAUSEY D, 1988, CONDOR, V90, P885, DOI 10.2307/1368846; Stephens D.W., 1986, pi; Sumner MD, 2013, TRIP SPATIAL ANAL AN, P1; Tranquilla LAM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090583; van Tets G.F., 1976, P 16 INT ORN C, P121; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; WANLESS S, 1992, POLAR BIOL, V12, P713; Watanabe YY, 2011, J EXP BIOL, V214, P412, DOI 10.1242/jeb.050161; WATANUKI Y, 1992, CONDOR, V94, P159, DOI 10.2307/1368805; WERNER TK, 1987, P NATL ACAD SCI USA, V84, P5506, DOI 10.1073/pnas.84.15.5506; Williams R., 1990, ANARE RES NOTES, V75, P1; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050; Woo KJ, 2008, J ANIM ECOL, V77, P1082, DOI 10.1111/j.1365-2656.2008.01429.x	67	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172278	10.1371/journal.pone.0172278	http://dx.doi.org/10.1371/journal.pone.0172278			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264057	gold, Green Submitted, Green Published			2022-12-26	WOS:000396054300010
J	Miller, AP; Shah, AS; Aperi, BV; Kurpad, SN; Stemper, BD; Glavaski-Joksimovic, A				Miller, Anna P.; Shah, Alok S.; Aperi, Brandy V.; Kurpad, Shekar N.; Stemper, Brian D.; Glavaski-Joksimovic, Aleksandra			Acute death of astrocytes in blast-exposed rat organotypic hippocampal slice cultures	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; FIBRILLARY ACIDIC PROTEIN; IN-VITRO MODEL; AMYOTROPHIC-LATERAL-SCLEROSIS; AUTOPHAGIC ASTROGLIAL DEATH; GLUTAMATE TRANSPORTER GLT-1; EXCITATORY AMINO-ACIDS; CLOSED-HEAD INJURY; CELL-DEATH	Blast traumatic brain injury (bTBI) affects civilians, soldiers, and veterans worldwide and presents significant health concerns. The mechanisms of neurodegeneration following bTBI remain elusive and current therapies are largely ineffective. It is important to better characterize blast-evoked cellular changes and underlying mechanisms in order to develop more effective therapies. In the present study, our group utilized rat organotypic hippocampal slice cultures (OHCs) as an in vitro system to model bTBI. OHCs were exposed to either 138 +/- 22 kPa (low) or 273 +/- 23 kPa (high) overpressures using an open-ended helium-driven shock tube, or were assigned to sham control group. At 2 hours (h) following injury, we have characterized the astrocytic response to a blast overpressure. Immunostaining against the astrocytic marker glial fibrillary acidic protein (GFAP) revealed acute shearing and morphological changes in astrocytes, including clasmatodendrosis. Moreover, overlap of GFAP immunostaining and propidium iodide (PI) indicated astrocytic death. Quantification of the number of dead astrocytes per counting area in the hippocampal cornu Ammonis 1 region (CA1), demonstrated a significant increase in dead astrocytes in the low- and high-blast, compared to sham control OHCs. However only a small number of GFAP-expressing astrocytes were co-labeled with the apoptotic marker Annexin V, suggesting necrosis as the primary type of cell death in the acute phase following blast exposure. Moreover, western blot analyses revealed calpain mediated breakdown of GFAP. The dextran exclusion additionally indicated membrane disruption as a potential mechanism of acute astrocytic death. Furthermore, although blast exposure did not evoke significant changes in glutamate transporter 1 (GLT-1) expression, loss of GLT-1-expressing astrocytes suggests dysregulation of glutamate uptake following injury. Our data illustrate the profound effect of blast overpressure on astrocytes in OHCs at 2 h following injury and suggest increased calpain activity and membrane disruption as potential underlying mechanisms.	[Miller, Anna P.; Shah, Alok S.; Aperi, Brandy V.; Kurpad, Shekar N.; Stemper, Brian D.; Glavaski-Joksimovic, Aleksandra] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Miller, Anna P.; Kurpad, Shekar N.; Glavaski-Joksimovic, Aleksandra] Med Coll Wisconsin, Dept Cell Biol, Milwaukee, WI 53226 USA; [Miller, Anna P.; Shah, Alok S.; Aperi, Brandy V.; Kurpad, Shekar N.; Stemper, Brian D.; Glavaski-Joksimovic, Aleksandra] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA	Medical College of Wisconsin; Medical College of Wisconsin	Glavaski-Joksimovic, A (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA.	aglavaski@mcw.edu	Kurpad, Shekar/V-2188-2019; Stemper, Brian/AAX-7611-2020	Miller, Anna/0000-0002-6823-0852	Department of Neurosurgery, Medical College of Wisconsin; VA Medical Research	Department of Neurosurgery, Medical College of Wisconsin; VA Medical Research(US Department of Veterans Affairs)	This work was supported by the Department of Neurosurgery, Medical College of Wisconsin and the VA Medical Research.	Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Arun P, 2012, NEUROREPORT, V23, P342, DOI 10.1097/WNR.0b013e328351b58d; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; BAHR BA, 1995, J NEUROSCI RES, V42, P294, DOI 10.1002/jnr.490420303; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Benediktsson AM, 2012, GLIA, V60, P175, DOI 10.1002/glia.21249; Benediktsson AM, 2005, J NEUROSCI METH, V141, P41, DOI 10.1016/j.jneumeth.2004.05.013; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bi Dan, 2015, Yichuan, V37, P140, DOI 10.16288/j.yczz.14-207; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bralic M, 2012, MED HYPOTHESES, V79, P358, DOI 10.1016/j.mehy.2012.05.034; BUCHS PA, 1993, DEV BRAIN RES, V71, P81, DOI 10.1016/0165-3806(93)90108-M; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Burda JE, 2015, EXP NEUROL; Campbell SL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00425; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chechneva O, 2005, NEUROSCIENCE, V136, P343, DOI 10.1016/j.neuroscience.2005.07.058; Chen JL, 2013, CELL BIOCHEM BIOPHYS, V67, P1015, DOI 10.1007/s12013-013-9597-5; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chen Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00117; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cimarosti H, 2009, NEUROPHARMACOLOGY, V56, P1088, DOI 10.1016/j.neuropharm.2009.03.007; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336, DOI 10.1152/physrev.1956.36.3.336; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Collin C, 1997, J NEUROPHYSIOL, V77, P1614, DOI 10.1152/jn.1997.77.3.1614; Coltman BW, 1996, INT J DEV NEUROSCI, V14, P707, DOI 10.1016/S0736-5748(96)00071-8; Conti AC, 1998, J NEUROSCI, V18, P5663; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Cummings Brian S, 2004, Curr Protoc Pharmacol, VChapter 12, DOI 10.1002/0471141755.ph1208s25; Czapiga M, 1999, J NEUROSCI RES, V56, P644, DOI 10.1002/(SICI)1097-4547(19990615)56:6<644::AID-JNR10>3.0.CO;2-9; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Effgen GB, 2016, JOURNAL OF NEUROTRAU; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fahlenkamp AV, 2011, INFLAMM RES, V60, P379, DOI 10.1007/s00011-010-0281-6; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Foraker JE, 2011, J NEUROCHEM, V119, P1052, DOI 10.1111/j.1471-4159.2011.07511.x; Foran E, 2009, ANTIOXID REDOX SIGN, V11, P1587, DOI 10.1089/ars.2009.2444; Furness DN, 2008, NEUROSCIENCE, V157, P80, DOI 10.1016/j.neuroscience.2008.08.043; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Giffard RG, 2005, GLIA, V50, P299, DOI 10.1002/glia.20167; Glavaski-Joksimovic A, 2009, NEUROSCIENCE, V162, P472, DOI 10.1016/j.neuroscience.2009.04.070; Glavaski-Joksimovic A, 2008, CLONING STEM CELLS, V10, P75, DOI 10.1089/clo.2007.0065; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Heales SJR, 2004, NEUROCHEM RES, V29, P513, DOI 10.1023/B:NERE.0000014822.69384.0f; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hlavac Nora, 2015, Biomed Sci Instrum, V51, P439; Hoffer Michael E, 2009, Int Tinnitus J, V15, P115; Huang QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061345; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Hulse RE, 2001, GLIA, V33, P169, DOI 10.1002/1098-1136(200102)33:2<169::AID-GLIA1016>3.0.CO;2-B; Humpel C, 2015, NEUROSCIENCE, V305, P86, DOI 10.1016/j.neuroscience.2015.07.086; Ibolja Cernak FAA, 2010, MEDICAL DATA, V2, P297; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Jeftinija SD, 1996, J NEUROCHEM, V66, P676; Jeremic A, 2001, J NEUROCHEM, V77, P664, DOI 10.1046/j.1471-4159.2001.00272.x; Johnson EA, 2005, EXP BRAIN RES, V167, P17, DOI 10.1007/s00221-005-2362-2; Castejon OJ, 2015, FOLIA NEUROPATHOL, V53, P173, DOI 10.5114/fn.2015.54419; Jurado-Arjona J, 2015, BRAIN RES, V1611, P84, DOI 10.1016/j.brainres.2015.03.016; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kodama T, 1998, ULTRASOUND MED BIOL, V24, P1459, DOI 10.1016/S0301-5629(98)00094-5; Krishnamurthy K, 2016, TRANSLATIONAL RESEAR; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lee JY, 2015, J KOREAN NEUROSURG S, V58, P93, DOI 10.3340/jkns.2015.58.2.93; Lee YB, 2000, BRAIN RES, V864, P220, DOI 10.1016/S0006-8993(00)02180-6; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Levine J, 2015, GLIA; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Lim YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125130; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu D, 1999, MOL BRAIN RES, V68, P29, DOI 10.1016/S0169-328X(99)00063-7; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Macdonald CL, 2014, JOURNAL OF NEUROTRAU; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Mari C, 2004, EUR J NUCL MED MOL I, V31, P733, DOI 10.1007/s00259-004-1473-5; Matute C, 2002, EUR J PHARMACOL, V447, P239, DOI 10.1016/S0014-2999(02)01847-2; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Mennerick S, 1998, J NEUROSCI, V18, P4490; Mewes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045017; Miller AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00020; MILLER LDP, 1994, NEUROSCIENCE, V63, P471, DOI 10.1016/0306-4522(94)90544-4; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Morin-Brureau M, 2011, J NEUROSCI, V31, P10677, DOI 10.1523/JNEUROSCI.5692-10.2011; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Mouser PE, 2006, AM J PATHOL, V168, P936, DOI 10.2353/ajpath.2006.050798; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Ralay R. H., 2011, J NEUROTRAUM, V28, P1757, DOI DOI 10.1089/NEU.2011.1799; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rigg JL, 2011, PM&R, V3, pS380, DOI 10.1016/j.pmrj.2011.08.005; Rossi D, 2008, CELL DEATH DIFFER, V15, P1691, DOI 10.1038/cdd.2008.99; Rossi D, 2005, J BIOL CHEM, V280, P42088, DOI 10.1074/jbc.M504124200; Rossi D, 2009, BRAIN RES BULL, V80, P224, DOI 10.1016/j.brainresbull.2009.07.012; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rytter A, 2003, J CEREBR BLOOD F MET, V23, P23, DOI 10.1097/01.WCB.0000034361.37277.1B; Ryu HJ, 2011, BRAIN RES BULL, V85, P368, DOI 10.1016/j.brainresbull.2011.05.007; Ryu HJ, 2011, CELL MOL NEUROBIOL, V31, P1071, DOI 10.1007/s10571-011-9706-1; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Sakai K, 2013, BRAIN INJURY, V27, P1692, DOI 10.3109/02699052.2013.837198; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Sarnowska A, 2009, EXP NEUROL, V215, P317, DOI 10.1016/j.expneurol.2008.10.023; Sawyer TW, 2016, JOURNAL OF NEUROTRAU; Schousboe Arne, 2013, Front Endocrinol (Lausanne), V4, P102, DOI 10.3389/fendo.2013.00102; Shah AS, 2012, BIOMED SCI INSTRUM, V48, P1; Shah AS, 2011, THE AMERICAN SOCIETY, P17; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Stemper BD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00031; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Su T, 2011, BRAIN RES, V1385, P68, DOI 10.1016/j.brainres.2011.01.115; Suh EC, 2008, NEUROTOXICOLOGY, V29, P691, DOI 10.1016/j.neuro.2008.04.001; SUNESON A, 1989, J TRAUMA, V29, P10, DOI 10.1097/00005373-198901000-00003; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; Tanielian T., 2008, INVISIBLE WOUNDS OF; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tilleux S, 2007, J NEUROSCI RES, V85, P2059, DOI 10.1002/jnr.21325; Valiyaveettil M, 2014, BRAIN RES, V1549, P32, DOI 10.1016/j.brainres.2013.12.031; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; VandeVord PJ, 2008, NEUROSCI LETT, V434, P247, DOI 10.1016/j.neulet.2008.01.056; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang Ke-Wan, 2002, Di Yi Jun Yi Da Xue Xue Bao, V22, P687; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Willoughby KA, 2004, J NEUROCHEM, V91, P1284, DOI 10.1111/j.1471-4159.2004.02812.x; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Yang ZH, 2014, J CEREBR BLOOD F MET, V34, P1444, DOI 10.1038/jcbfm.2014.105; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yi JH, 2005, GLIA, V49, P121, DOI 10.1002/glia.20099; Yong-Ming Z, 2012, AFR HEALTH SCI, V12, P552, DOI 10.4314/ahs.v12i4.24; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhou SD, 2011, BIOTECHNOL J, V6, P513, DOI 10.1002/biot.201000254; Zhu F, 2015, CHIN J TRAUMATOL, V18, P10, DOI 10.1016/j.cjtee.2014.10.001; Zimmer J, 2000, AMINO ACIDS, V19, P7, DOI 10.1007/s007260070029; Zou J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00077; Zuo HY, 2014, INT J MED SCI, V11, P426, DOI 10.7150/ijms.6540	193	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173167	10.1371/journal.pone.0173167	http://dx.doi.org/10.1371/journal.pone.0173167			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5OE	28264063	Green Published, gold, Green Submitted			2022-12-26	WOS:000396054300042
J	Amini, S; Holstege, FCP; Kemmeren, P				Amini, Saman; Holstege, Frank C. P.; Kemmeren, Patrick			Growth condition dependency is the major cause of non-responsiveness upon genetic perturbation	PLOS ONE			English	Article							M(7)GPPPX PYROPHOSPHATASE ACTIVITY; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-ANALYSIS; YEAST; GENOME; NETWORKS; EPISTASIS; ROBUSTNESS; MECHANISMS; EXPRESSION	Investigating the role and interplay between individual proteins in biological processes is often performed by assessing the functional consequences of gene inactivation or removal. Depending on the sensitivity of the assay used for determining phenotype, between 66% (growth) and 53% (gene expression) of Saccharomyces cerevisiae gene deletion strains show no defect when analyzed under a single condition. Although it is well known that this non -responsive behavior is caused by different types of redundancy mechanisms or by growth condition/cell type dependency, it is not known what the relative contribution of these different causes is. Understanding the underlying causes of and their relative contribution to non -responsive behavior upon genetic perturbation is extremely important for designing efficient strategies aimed at elucidating gene function and unraveling complex cellular systems. Here, we provide a systematic classification of the underlying causes of and their relative contribution to non-responsive behavior upon gene deletion. The overall contribution of redundancy to non-responsive behavior is estimated at 29%, of which approximately 17% is due to homology-based redundancy and 12% is due to pathway-based redundancy. The major determinant of non-responsiveness is condition dependency (71%). For approximately 14% of protein complexes, just-in-time assembly can be put forward as a potential mechanistic explanation for how proteins can be regulated in a condition dependent manner. Taken together, the results underscore the large contribution of growth condition requirement to non-responsive behavior, which needs to be taken into account for strategies aimed at determining gene function. The classification provided here, can also be further harnessed in systematic analyses of complex cellular systems.	[Amini, Saman; Holstege, Frank C. P.; Kemmeren, Patrick] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands; [Amini, Saman; Kemmeren, Patrick] Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Kemmeren, P (corresponding author), Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands.; Kemmeren, P (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands.	p.kemmeren@prinsesmaximacentrum.nl	Holstege, Frank/AAM-9944-2021	Kemmeren, Patrick/0000-0003-2237-7354	Dutch Organization for Scientific Research (NWO) [864.11.010]	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Financial support was provided by the Dutch Organization for Scientific Research (NWO), grant 864.11.010 (SA & PK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benschop JJ, 2010, MOL CELL, V38, P916, DOI 10.1016/j.molcel.2010.06.002; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Conant GC, 2002, NUCLEIC ACIDS RES, V30, P3378, DOI 10.1093/nar/gkf449; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Dean EJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000113; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Giaever G, 2014, GENETICS, V197, P451, DOI 10.1534/genetics.114.161620; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Guan YF, 2007, GENETICS, V175, P933, DOI 10.1534/genetics.106.064329; Harrison R, 2007, P NATL ACAD SCI USA, V104, P2307, DOI 10.1073/pnas.0607153104; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hsiao TL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000014; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kemmeren P, 2014, CELL, V157, P740, DOI 10.1016/j.cell.2014.02.054; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Li JJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001187; Liberali P, 2015, NAT REV GENET, V16, P18, DOI 10.1038/nrg3768; Liu HD, 2002, EMBO J, V21, P4699, DOI 10.1093/emboj/cdf448; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Malys N, 2004, NUCLEIC ACIDS RES, V32, P3590, DOI 10.1093/nar/gkh687; Malys N, 2006, J MOL BIOL, V363, P370, DOI 10.1016/j.jmb.2006.08.015; Metallo CM, 2013, MOL CELL, V49, P388, DOI 10.1016/j.molcel.2013.01.018; Musso G, 2008, GENOME RES, V18, P1092, DOI 10.1101/gr.076174.108; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Pitre S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-365; Plata G, 2013, NUCLEIC ACIDS RES; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sameith K, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0222-5; Santt O, 2008, MOL BIOL CELL, V19, P3323, DOI 10.1091/mbc.E08-03-0328; Shen S, 2009, MOL BIOL CELL, V20, P2438, DOI 10.1091/mbc.E08-10-0987; Stillman DJ, 2010, BBA-GENE REGUL MECH, V1799, P175, DOI 10.1016/j.bbagrm.2009.11.010; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Usaj MM, 2016, TRENDS CELL BIOL, V26, P598, DOI 10.1016/j.tcb.2016.03.008; van Wageningen S, 2010, CELL, V143, P991, DOI 10.1016/j.cell.2010.11.021; Vik A, 2001, MOL CELL BIOL, V21, P6395, DOI 10.1128/MCB.21.19.6395-6405.2001; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yao YH, 2010, RNA, V16, P1007, DOI 10.1261/rna.2012310; Zhang JZ, 2012, ADV EXP MED BIOL, V751, P279, DOI 10.1007/978-1-4614-3567-9_13	56	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173432	10.1371/journal.pone.0173432	http://dx.doi.org/10.1371/journal.pone.0173432			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257504	gold, Green Published, Green Submitted			2022-12-26	WOS:000396021100091
J	Hertsenberg, AJ; Shojaati, G; Funderburgh, ML; Mann, MM; Du, YQ; Funderburgh, JL				Hertsenberg, Andrew J.; Shojaati, Golnar; Funderburgh, Martha L.; Mann, Mary M.; Du, Yiqin; Funderburgh, James L.			Corneal stromal stem cells reduce corneal scarring by mediating neutrophil infiltration after wounding	PLOS ONE			English	Article							KERATAN SULFATE PROTEOGLYCAN; TGF-BETA; INFLAMMATORY RESPONSE; PROTEIN TSG-6; IN-VIVO; TISSUE; INJURY; REPAIR; MODEL; DIFFERENTIATION	Corneal scarring limits vision for millions of individuals worldwide. Corneal transplantation (keratoplasty) is the standard of care for corneal opacity; however, it bears the risk of graft rejection and infection and is not universally available. Stem cell therapy holds promise as an alternative to keratoplasty. Stem cells from human corneal stroma (CSSC) induce regen-eration of transparent corneal tissue in a mouse wound-healing model. In this study we investigated the mechanism by which CSSC prevent deposition of fibrotic tissue. Infiltration by CD11b (+)/Ly6G (+) neutrophils and myeloperoxidase expression were increased in corneas 24 hr after corneal wounding but were reduced in CSSC-treated wounds. Secretion of TSG-6, a protein known to regulate neutrophil migration, was up-regulated in CSSC in response to TNFa and as CSSC differentiate to keratocytes. In vivo, wounded mouse corneas treated with CSSC contained human TSG-6. Inhibition of neutrophil infiltration into cornea by CSSC was reversed when TSG-6 expression was knocked down using siRNA. Silencing of TSG-6 expression in CSSC reduced their ability to block scarring and the expression of mRNA for fibrosis-associated proteins collagen III, tenascin C, and smooth muscle actin in wounded corneas. Neutropenic mice exhibited a significant reduction in corneal scarring and fibrotic mRNA expression 2 weeks after wounding. These results support the conclusion that neu-trophil infiltration is an essential event in the fibrotic response to corneal damage and that prevention of scarring by CSSC is mediated by secretion of TSG-6 by these cells.	[Hertsenberg, Andrew J.; Shojaati, Golnar; Funderburgh, Martha L.; Mann, Mary M.; Du, Yiqin; Funderburgh, James L.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Funderburgh, JL (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA.	jlfunder@pitt.edu	DU, YIQIN/AAO-1566-2020; Du, Yiqin/A-7727-2018	DU, YIQIN/0000-0002-4330-0957; Funderburgh, James/0000-0002-6192-6363	National Institutes of Health, National Eye Institute [RO1EY016415, P30 EY008098]; US Department of Defense, U.S. ARMY [W81XWH-14-1-0465]; Eye and Ear Foundation of Pittsburgh; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [R01EY016415] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US Department of Defense, U.S. ARMY(United States Department of Defense); Eye and Ear Foundation of Pittsburgh; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health, National Eye Institute RO1EY016415, JLF PI; US Department of Defense, U.S. ARMY, Grant W81XWH-14-1-0465, JLF PI; National Institutes of Health, National Eye Institute P30 EY008098 Core Grant for Vision Research, Robert L Hendricks PI; Eye and Ear Foundation of Pittsburgh, Unrestricted Grant for Vision Research, JLF; Research to Prevent Blindness, Inc. Unrestricted Grant for Vision Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian OW, 2016, CLIN IMMUNOL, V164, P78, DOI 10.1016/j.clim.2016.02.001; Basu S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009644; Beltran SR, 2015, J PERIODONTOL, V86, P62, DOI 10.1902/jop.2014.140187; Boote C, 2012, INVEST OPHTH VIS SCI, V53, P2786, DOI 10.1167/iovs.11-9305; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Chrysanthopoulou A, 2014, J PATHOL, V233, P294, DOI 10.1002/path.4359; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Du YD, 2005, STEM CELLS, V23, P1266, DOI 10.1634/stemcells.2004-0256; Du YQ, 2007, INVEST OPHTH VIS SCI, V48, P5038, DOI 10.1167/iovs.07-0587; Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91; Dyer DP, 2014, J IMMUNOL, V192, P2177, DOI 10.4049/jimmunol.1300194; Fagerholm P, 2014, INVEST OPHTH VIS SCI, V35, P2420; Forbes SJ, 2014, NAT MED, V20, P857, DOI 10.1038/nm.3653; Glenn Justin D, 2014, World J Stem Cells, V6, P526, DOI 10.4252/wjsc.v6.i5.526; Gregory AD, 2015, J LEUKOCYTE BIOL, V98, P143, DOI 10.1189/jlb.3HI1014-493R; Griffith M, 2009, EYE, V23, P1985, DOI 10.1038/eye.2008.409; Han YM, 1997, J INFECT DIS, V175, P1169, DOI 10.1086/516455; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Hutcheon AEK, 2005, INVEST OPHTH VIS SCI, V46, P2362, DOI 10.1167/iovs.04-0759; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Knight MN, 2013, ADV WOUND CARE, V2, P306, DOI 10.1089/wound.2012.0420; Lee RH, 2014, P NATL ACAD SCI USA, V111, P16766, DOI 10.1073/pnas.1416121111; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Li Fei, 2014, World J Stem Cells, V6, P296, DOI 10.4252/wjsc.v6.i3.296; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P1947, DOI 10.1167/iovs.05-1193; Liu FC, 2014, SHOCK, V41, P491, DOI 10.1097/SHK.0000000000000146; Liu LY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088348, 10.1371/journal.pone.0104748]; Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011; Mariotti SP., GLOBAL DATA VISUAL I; Marrazzo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021180; Matsuba M, 2011, EXP EYE RES, V93, P534, DOI 10.1016/j.exer.2011.06.018; McIlroy DJ, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.07.013; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Norman KE, 2003, BLOOD, V101, P921, DOI 10.1182/blood-2001-12-0190; O'Brien TP, 1998, ARCH OPHTHALMOL-CHIC, V116, P1470, DOI 10.1001/archopht.116.11.1470; Oh JY, 2012, MOL THER, V20, P2143, DOI 10.1038/mt.2012.165; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Petrof G., 2014, COLD SPRING HARB PER, V4; Qi Y, 2014, J INVEST DERMATOL, V134, P526, DOI 10.1038/jid.2013.328; Saika S, 2016, EXP EYE RES, V142, P40, DOI 10.1016/j.exer.2014.12.015; Stramer BM, 2003, INVEST OPHTH VIS SCI, V44, P4237, DOI 10.1167/iovs.02-1188; Swamynathan S, 2012, INVEST OPHTH VIS SCI, V53, P8433, DOI 10.1167/iovs.12-10759; Tasheva ES, 1998, GENE, V218, P63, DOI 10.1016/S0378-1119(98)00390-4; Tate MD, 2012, IMMUNOL CELL BIOL, V90, P197, DOI 10.1038/icb.2011.26; Tateda K, 2001, J IMMUNOL, V166, P3355, DOI 10.4049/jimmunol.166.5.3355; Thompson RW, 2003, OPHTHALMOLOGY, V110, P1396, DOI 10.1016/S0161-6420(03)00463-9; Ul Hassan W, 2014, WOUND REPAIR REGEN, V22, P313, DOI 10.1111/wrr.12173; WAHL SM, 1990, ANN NY ACAD SCI, V593, P188, DOI 10.1111/j.1749-6632.1990.tb16111.x; Wang H, 2015, EUR J PHARMACOL, V751, P42, DOI 10.1016/j.ejphar.2015.01.040; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Wilson SE, 2003, EXP EYE RES, V76, P193, DOI 10.1016/S0014-4835(02)00277-4; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Wu J, 2013, TISSUE ENG PT A, V19, P2063, DOI [10.1089/ten.TEA.2012.0545, 10.1089/ten.tea.2012.0545]; Wu J, 2012, BIOMATERIALS, V33, P1343, DOI 10.1016/j.biomaterials.2011.10.055; Wu J, 2014, ACTA BIOMATER, V10, P751, DOI 10.1016/j.actbio.2013.09.038; Ylostalo JH, 2014, CYTOTHERAPY, V16, P1486, DOI 10.1016/j.jcyt.2014.07.010; Zieske JD, 2001, EXP EYE RES, V72, P33, DOI 10.1006/exer.2000.0926; Zieske JD, 2001, INVEST OPHTH VIS SCI, V42, P1465	58	49	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0171712	10.1371/journal.pone.0171712	http://dx.doi.org/10.1371/journal.pone.0171712			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257425	Green Published, gold, Green Submitted			2022-12-26	WOS:000396021100009
J	Zhao, JS; Salomon, MP; Shibata, D; Curtis, C; Siegmund, K; Marjoram, P				Zhao, Junsong; Salomon, Matthew P.; Shibata, Darryl; Curtis, Christina; Siegmund, Kimberly; Marjoram, Paul			Early mutation bursts in colorectal tumors	PLOS ONE			English	Article							ASYMMETRIC CELL-DIVISION; APPROXIMATE BAYESIAN COMPUTATION; CANCER STEM-CELLS; HUMAN-BREAST; MODEL; STATISTICS; DROSOPHILA; FRAMEWORK	Tumor growth is an evolutionary process involving accumulation of mutations, copy number alterations, and cancer stem cell (CSC) division and differentiation. As direct observation of this process is impossible, inference regarding when mutations occur and how stem cells divide is difficult. However, this ancestral information is encoded within the tumor itself, in the form of intratumoral heterogeneity of the tumor cell genomes. Here we present a framework that allows simulation of these processes and estimation of mutation rates at the various stages of tumor development and CSC division patterns for single-gland sequencing data from colorectal tumors. We parameterize the mutation rate and the CSC division pattern, and successfully retrieve their posterior distributions based on DNA sequence level data. Our approach exploits Approximate Bayesian Computation (ABC), a method that is becoming widely-used for problems of ancestral inference.	[Zhao, Junsong; Marjoram, Paul] Univ Southern Calif, Dept Mol & Computat Biol, Los Angeles, CA 90007 USA; [Salomon, Matthew P.] Providence St Johns Hlth Ctr, John Wayne Canc Inst, Dept Mol Oncol, Santa Monica, CA USA; [Shibata, Darryl] Univ Southern Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA USA; [Curtis, Christina] Stanford Univ, Sch Med, Dept Med Oncol & Genet, Stanford, CA 94305 USA; [Siegmund, Kimberly; Marjoram, Paul] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90007 USA	University of Southern California; John Wayne Cancer Institute; University of Southern California; Stanford University; University of Southern California	Marjoram, P (corresponding author), Univ Southern Calif, Dept Mol & Computat Biol, Los Angeles, CA 90007 USA.	pmarjora@usc.edu			National Human Genome Research Institute [R01 HG006705]; National Cancer Institute [R21 CA185016, R21 CA151139, 5P30 CA014089, P01 CA196569]	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Human Genome Research Institute: grant number R01 HG006705 and National Cancer Institute: grant numbers R21 CA185016, R21 CA151139, 5P30 CA014089 and P01 CA196569. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes CP, 2012, STAT COMPUT, V22, P1181, DOI 10.1007/s11222-012-9335-7; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Blum MGB, 2013, STAT SCI, V28, P189, DOI 10.1214/12-STS406; Bodine DM, 1996, BLOOD, V88, P89; Bozic I, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004731; Caussinus Emmanuel, 2007, Prog Mol Subcell Biol, V45, P205; Chia W, 2008, J CELL BIOL, V180, P267, DOI 10.1083/jcb.200708159; Chiba T, 2016, HEPATOL RES, V46, P50, DOI 10.1111/hepr.12548; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Clevers H, 2005, NAT GENET, V37, P1027, DOI 10.1038/ng1005-1027; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Fearnhead P, 2012, J R STAT SOC B, V74, P419, DOI 10.1111/j.1467-9868.2011.01010.x; Gomez-Lopez S, 2014, CELL MOL LIFE SCI, V71, P575, DOI 10.1007/s00018-013-1386-1; Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077; Hamilton G, 2005, GENETICS, V170, P409, DOI 10.1534/genetics.104.034199; Hearn JP, 2001, REPROD FERT DEVELOP, V13, P517, DOI 10.1071/RD01068; Hong JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069752; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Joyce P, 2008, STAT APPL GENET MOL, V7; Jung H, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1586; Kang H, 2015, J PATHOL, V237, P355, DOI 10.1002/path.4581; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; NORTON L, 1988, CANCER RES, V48, P7067; Nunes MA, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1576; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Sehl ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135797; Shibata D, 2012, SCIENCE, V336, P304, DOI 10.1126/science.1222361; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tanaka S, 2015, J HEPATO-BIL-PAN SCI, V22, P531, DOI 10.1002/jhbp.248; Wegmann D, 2009, GENETICS, V182, P1207, DOI 10.1534/genetics.109.102509; Wodarz A, 2006, CELL, V124, P1121, DOI 10.1016/j.cell.2006.03.004; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhang D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/432652; Zhao J, 2014, J THEOR BIOL, V359, P136, DOI 10.1016/j.jtbi.2014.05.027; Zwaka TP, 2005, STEM CELLS, V23, P146, DOI 10.1634/stemcells.2004-0248	46	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172516	10.1371/journal.pone.0172516	http://dx.doi.org/10.1371/journal.pone.0172516			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257429	gold, Green Published, Green Submitted			2022-12-26	WOS:000396021100018
J	Chang, YL; Miyazawa, Y; Beguer-Pon, M				Chang, Yu-Lin; Miyazawa, Yasumasa; Beguer-Pon, Melanie			The dynamical impact of mesoscale eddies on migration of Japanese eel larvae	PLOS ONE			English	Article							PACIFIC SUBTROPICAL COUNTERCURRENT; ANGUILLA-JAPONICA; FISH LARVAE; TRANSPORT; EDDY; MORTALITY; BEHAVIOR; CURRENTS	In this study, we explore the dynamical role of mesoscale eddies on fish larvae migration using the example of Subtropical Counter Current eddies and the migration of Japanese eel larvae in the western North Pacific Ocean. An idealized experiment is conducted to isolate the effects of eddies, and use a three-dimensional particle-tracking method to simulate virtual eel larvae (v-larvae) migration, including both horizontal and vertical swimming behaviors. The impact of eddies strongly depends on the swimming speed of v-larvae relative to the eddy speed. Eddies accelerate the movement of v-larvae that swim slower than the propagation speed of the eddy, whereas faster-swimming v-larvae are dragged by eddies. A modified stream function that incorporates biological swimming ability explains the non-uniform trapping of v-larvae in mesoscale eddies. A high swimming speed and/or a small eddy rotation speed results in a weak trapping capacity. Simulations of v-larvae migration in realistic cases of eddy fields indicate that the abundance of eddies significantly affects the duration of larval migration, with the effects being largely dependent on the larvae swimming speed. We noted a negative relationship between the observed annual eel recruitment index in Taiwan and the eddy index subtropical countercurrent (STCC) region, which suggests a potentially important role of mesoscale eddies in eel larvae migration.	[Chang, Yu-Lin] Natl Taiwan Normal Univ, Inst Marine Environm Sci & Technol, Taipei, Taiwan; [Miyazawa, Yasumasa] Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Yokohama, Kanagawa, Japan; [Beguer-Pon, Melanie] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada	National Taiwan Normal University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Dalhousie University	Chang, YL (corresponding author), Natl Taiwan Normal Univ, Inst Marine Environm Sci & Technol, Taipei, Taiwan.	ychang@ntnu.edu.tw	Miyazawa, Yasumasa/J-3196-2014	Miyazawa, Yasumasa/0000-0002-0107-6272	Ministry of Science and Technology of Taiwan [102-2611-M-003-003-MY3]; JSPS [26287116]; Canadian Natural Sciences and Engineering Research Council (NSERC) [375118-08]; Canadian Foundation for Innovation (CFI) [13011]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Canadian Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation)	YLC was supported by the Ministry of Science and Technology of Taiwan under grant 102-2611-M-003-003-MY3. YM is supported by JSPS KAKENHI (26287116). MB-P was supported by the Ocean Tracking Network (OTN) through a network project grant (NETGP #375118-08) from the Canadian Natural Sciences and Engineering Research Council (NSERC) with additional support from the Canadian Foundation for Innovation (CFI, Project #13011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey KM, 1997, J FISH BIOL, V51, P135, DOI 10.1111/j.1095-8649.1997.tb06097.x; Beguer-Pon M, 2015, ICEJ MARINE SCI J; Beguer-Pon M, 2016, MAR ECOL PROG SER, V549, P183, DOI 10.3354/meps11706; Black K.P., 1990, ACANTHASTER CORAL RE, P151, DOI [10.1007/978-3-642-46726-4_9, DOI 10.1007/978-3-642-46726-4_9]; Blumberg A.F., 1987, 3 DIMENSIONAL COASTA, P1, DOI [10.1029/co004p0001, DOI 10.1029/CO004P0001]; Brodersen J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002156; CASTONGUAY M, 1987, J PLANKTON RES, V9, P195, DOI 10.1093/plankt/9.1.195; Chang YL, 2014, J PHYS OCEANOGR, V44, P818, DOI 10.1175/JPO-D-13-0162.1; Chang YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150187; Chang YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144423; Chang YL, 2015, J PHYS OCEANOGR, V45, P1651, DOI 10.1175/JPO-D-14-0248.1; Chang YL, 2014, OCEAN DYNAM, V64, P259, DOI 10.1007/s10236-013-0680-7; Chow S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121801; DAVIDSON V. M., 1949, JOUR FISH RES BD CANADA, V7, P432; Fiksen O, 2007, MAR ECOL PROG SER, V347, P195, DOI 10.3354/meps06978; FLIERL GR, 1981, GEOPHYS ASTRO FLUID, V18, P39, DOI 10.1080/03091928108208773; Han YS, 2012, FISH OCEANOGR, V21, P281, DOI 10.1111/j.1365-2419.2012.00624.x; Jacoby D., 2014, IUCN RED LIST THREAT, V2, P2019; Kim H, 2007, ICES J MAR SCI, V64, P1387, DOI 10.1093/icesjms/fsm091; Kobashi F, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001225; LOBEL PS, 1986, DEEP-SEA RES, V33, P483, DOI 10.1016/0198-0149(86)90127-5; Manabe R, 2011, MAR ECOL PROG SER, V437, P229, DOI 10.3354/meps09266; Miyazawa Y, 2009, J OCEANOGR, V65, P737, DOI 10.1007/s10872-009-0063-3; Oey L-Y, 2013, TERR ATMOS OCEANIC S, V24; Ohashi K, 2015, ATMOS OCEAN, P1, DOI [10.1080/07055900.2015.1090390, DOI 10.1080/07055900.2015.1090390]; Press W., 1992, NUMERICAL RECIPES FO; Qiu B, 1999, J PHYS OCEANOGR, V29, P2471, DOI 10.1175/1520-0485(1999)029<2471:SEFMOT>2.0.CO;2; Sanchez-Velasco L, 2013, DEEP-SEA RES PT I, V75, P39, DOI 10.1016/j.dsr.2013.01.009; SHAW PT, 1994, J PHYS OCEANOGR, V24, P573, DOI 10.1175/1520-0485(1994)024<0573:ANSOTE>2.0.CO;2; Shinoda A, 2011, REV FISH BIOL FISHER, V21, P591, DOI 10.1007/s11160-010-9195-1; SMITH DC, 1983, J PHYS OCEANOGR, V13, P1681, DOI 10.1175/1520-0485(1983)013<1681:TIOATL>2.0.CO;2; Uda M., 1969, J OCEANOGRAPHICAL SO, V25, P201, DOI [10.5928/kaiyou1942.25.201, DOI 10.5928/KAIYOU1942.25.201]; Wuenschel MJ, 2008, MAR BIOL, V154, P775, DOI 10.1007/s00227-008-0970-7; Xu FH, 2011, J PHYS OCEANOGR, V41, P1720, DOI 10.1175/2011JPO4589.1; Yamada Y, 2009, MAR ECOL PROG SER, V379, P241, DOI 10.3354/meps07912	35	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172501	10.1371/journal.pone.0172501	http://dx.doi.org/10.1371/journal.pone.0172501			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253293	Green Submitted, gold, Green Published			2022-12-26	WOS:000396011300022
J	Ma, L; Wang, X; Liu, Y; Su, MZ; Huang, GH				Ma, Li; Wang, Xing; Liu, Yan; Su, Ming-Zhu; Huang, Guo-Hua			Temperature effects on development and fecundity of Brachmia macroscopa (Lepidoptera: Gelechiidae)	PLOS ONE			English	Article							APHIS-GOSSYPII HOMOPTERA; 2-SEX LIFE TABLE; AGE-STAGE; SPODOPTERA-EXIGUA; COTTON CULTIVAR; APHIDIDAE; PARAMETERS; NOCTUIDAE; REPRODUCTION; HYMENOPTERA	The current study investigated the impacts of temperature on the development and reproductivity of the sweet potato leaf folder, Brachmia macroscopa (Lepidoptera: Gelechiidae), in sweet potato leaves under laboratory conditions. We determined developmental time of B. macroscopa larval, pupal, and pre-adult stage at different temperatures. Male and female longevity, male and female lifespan, mortality of immature stages, oviposition period of B. macroscopa were also investigated under six constant temperatures (21 degrees C, 24 degrees C, 27 degrees C, 30 degrees C, 33 degrees C, 36 degrees C), based on age-stage, two-sex life tables. The results revealed that eggs in 36 degrees C were unable to hatch. At temperatures between 21 degrees C -33 degrees C, the duration of the pre-adult period, as well as the adult lifespan both for males and females, were shortened by increasing temperatures. The lowest larval mortality rate (15.33%) occurred at 27 degrees C. The age-stage-specific fecundity rates with the greatest number were, in order, 30 degrees C, 27 degrees C, 21 degrees C, 24 degrees C and 33 degrees C. The results show that B. macroscopa population levels could reach highest at the temperature of 27 degrees C.	[Ma, Li; Wang, Xing; Huang, Guo-Hua] Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China; [Ma, Li; Wang, Xing; Liu, Yan; Su, Ming-Zhu; Huang, Guo-Hua] Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China	Hunan Agricultural University	Huang, GH (corresponding author), Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China.; Huang, GH (corresponding author), Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China.	ghhuang@hunau.edu.cn			National Scientific and Technological Supporting Program of China [2012BAD27602]	National Scientific and Technological Supporting Program of China	The present research was supported by a grant from the National Scientific and Technological Supporting Program of China (No. 2012BAD27602). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami S, 2014, ARTHROPOD-PLANT INTE, V8, P475, DOI 10.1007/s11829-014-9330-3; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; Carey JR, 1993, APPL DEMOGRAPHY BIOL, P211; Chi H, 2006, ENVIRON ENTOMOL, V35, P10, DOI 10.1603/0046-225X-35.1.10; CHI H, 1988, ENVIRON ENTOMOL, V17, P26, DOI 10.1093/ee/17.1.26; CHI H, 1988, ENVIRON ENTOMOL, V17, P18, DOI 10.1093/ee/17.1.18; CHI H, 1990, J ECON ENTOMOL, V83, P1143, DOI 10.1093/jee/83.4.1143; CHI H, 1985, Bulletin of the Institute of Zoology Academia Sinica (Taipei), V24, P225; Cividanes Francisco J., 2003, Bragantia, V62, P61, DOI 10.1590/S0006-87052003000100008; DEEVEY ES, 1947, Q REV BIOL, V22, P283, DOI 10.1086/395888; Du L, 2004, J ECON ENTOMOL, V97, P1278, DOI 10.1603/0022-0493-97.4.1278; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fernandes FS, 2013, FLA ENTOMOL, V96, P92, DOI 10.1653/024.096.0112; Gabre RA, 2005, ACTA OECOL, V27, P179, DOI 10.1016/j.actao.2004.12.002; GHULAM-ULLAH CHAUDHRY, 1956, Bulletin of Entomological Research, V16, P869, DOI 10.1017/S0007485300037111; Golizadeh Ali, 2009, Journal of Asia-Pacific Entomology, V12, P207, DOI 10.1016/j.aspen.2009.05.002; GOODMAN D, 1982, AM NAT, V119, P803, DOI 10.1086/283956; Han Lan-Zhi, 2003, Acta Entomologica Sinica, V46, P184; Huang YB, 2013, J APPL ENTOMOL, V137, P327, DOI 10.1111/jen.12002; Jha RK, 2012, ENVIRON ENTOMOL, V41, P30, DOI 10.1603/EN11206; Karimi-Malati A, 2014, J ASIA-PAC ENTOMOL, V17, P349, DOI 10.1016/j.aspen.2014.03.002; Karimi-Malati A, 2014, ENVIRON ENTOMOL, V43, P795, DOI 10.1603/EN11272; Khanamani M, 2013, INT J ACAROL, V39, P638, DOI 10.1080/01647954.2013.861867; Kogan M., 1978, B ENTOMOL SOC AM, V24, P175, DOI [10.1093/besa/24.2.175, DOI 10.1093/BESA/24.2.175]; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Lewis EG, 1942, SANKHYA, V6, P93; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Mehrparvar M, 2007, EUR J ENTOMOL, V104, P631, DOI 10.14411/eje.2007.078; Naseri B, 2014, J AGR SCI TECH-IRAN, V16, P19; Pandey AK, 2008, BIOCONTROL, V53, P461, DOI 10.1007/s10526-007-9083-3; Park HH, 2014, J ASIA-PAC ENTOMOL, V17, P83, DOI 10.1016/j.aspen.2013.11.003; Ponomarenko M.G., 1997, Far Eastern Entomologist, V50, P1; Ramalho FS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122490; Ratte H.T., 1985, P33; Razmjou J, 2006, J ECON ENTOMOL, V99, P1820, DOI 10.1603/0022-0493-99.5.1820; Sarfraz M, 2006, CROP PROT, V25, P625, DOI 10.1016/j.cropro.2005.09.011; Seto-Kuchi O., 1985, Proceedings of the Association for Plant Protection of Kyushu, V31, P143; Southwood TRE., 1978, ECOLOGICAL METHODS P; Tan R. R., 2011, CHANGJIANG VEGET, V4, P75; TANAKA F, 1978, JPN J APPL ENTOMOL Z, V22, P162, DOI 10.1303/jjaez.22.3_162; Vasicek A, 2002, PESQUI AGROPECU BRAS, V37, P407, DOI 10.1590/S0100-204X2002000300023; Yu JZ, 2013, BIOL CONTROL, V64, P1, DOI 10.1016/j.biocontrol.2012.10.002; Yu JZ, 2005, ANN ENTOMOL SOC AM, V98, P475, DOI 10.1603/0013-8746(2005)098[0475:LTAPOL]2.0.CO;2; Yu-Bing H., 2011, J AGR FOOD RES, V60, P337; Zhang P, 2015, PHYTOPARASITICA, V43, P107, DOI 10.1007/s12600-014-0420-7; Zhang ZJ, 2007, J APPL ENTOMOL, V131, P347, DOI 10.1111/j.1439-0418.2007.01186.x; Zhu FL, 2015, AUSTRAL ENTOMOL, V54, P71, DOI 10.1111/aen.12094	47	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173065	10.1371/journal.pone.0173065	http://dx.doi.org/10.1371/journal.pone.0173065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253321	gold, Green Published, Green Submitted			2022-12-26	WOS:000396011300067
J	Quednow, BB; Hulka, LM; Preller, KH; Baumgartner, MR; Eisenegger, C; Vonmoos, M				Quednow, Boris B.; Hulka, Lea M.; Preller, Katrin H.; Baumgartner, Markus R.; Eisenegger, Christoph; Vonmoos, Matthias			Stable self-serving personality traits in recreational and dependent cocaine users	PLOS ONE			English	Article							SOCIAL COGNITION; ASPERGER-SYNDROME; DECISION-MAKING; ADDICTION; DISORDERS; RELIABILITY; IMPULSIVITY; DYSFUNCTION; GUIDELINES; VALIDITY	Chronic cocaine use has been associated with impairments in social cognition, self-serving and antisocial behavior, and socially relevant personality disorders (PD). Despite the apparent relationship between Machiavellianism and stimulant use, no study has explicitly examined this personality concept in cocaine users so far. In the frame of the longitudinal Zurich Cocaine Cognition Study, the Machiavellianism Questionnaire (MACH-IV) was assessed in 68 recreational and 30 dependent cocaine users as well as in 68 psychostimulant-naive controls at baseline. Additionally, three closely related personality dimensions from the Temperament and Character Inventory (TCI)-cooperativeness, (social) reward dependence, and self-directedness-and the screening questionnaire of the Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) were acquired. At the one-year follow-up, 57 cocaine users and 48 controls were reassessed with the MACH-IV. Finally, MACH-IV scores were correlated with measures of social cognition and interaction (cognitive/emotional empathy, Theory-of-Mind, prosocial behavior) and with SCID-II PD scores assessed at baseline. Both recreational and dependent cocaine users showed significantly higher Machiavellianism than controls, while dependent cocaine users additionally displayed significantly lower levels of TCI cooperativeness and self-directedness. During the one-year interval, MACH-IV scores showed high test-retest reliability and also the significant gap between cocaine users and controls remained. Moreover, in cocaine users, higher Machiavellianism correlated significantly with lower levels of cooperativeness and self-directedness, with less prosocial behavior, and with higher cluster B PD scores. However, Machiavellianism was not correlated with measures of cocaine use severity (r<-.15). Both recreational and dependent cocaine users display pronounced and stable Machiavellian personality traits. The lack of correlations with severity of cocaine use and its temporal stability indicates that a Machiavellian personality trait might represent a predisposition for cocaine use that potentially serves as a predictor for stimulant addiction.	[Quednow, Boris B.; Hulka, Lea M.; Preller, Katrin H.; Vonmoos, Matthias] Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Expt & Clin Pharmacopsychol, Zurich, Switzerland; [Baumgartner, Markus R.] Univ Zurich, Zurich Inst Forens Med, Ctr Forens Hair Anal, Zurich, Switzerland; [Eisenegger, Christoph] Univ Vienna, Fac Psychol, Dept Basic Psychol Res & Res Methods, Neuropsychopharmacol & Biopsychol Unit, Vienna, Austria	University of Zurich; University of Zurich; University of Vienna	Vonmoos, M (corresponding author), Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Expt & Clin Pharmacopsychol, Zurich, Switzerland.	matthias.vonmoos@bli.uzh.ch	Preller, Katrin/AAD-8914-2019; Quednow, Boris B./A-1666-2008	Quednow, Boris B./0000-0001-7933-2865	Swiss National Science Foundation (SNSF) [PPOOP1-123516/1, PPOOP1-146326/1]; Olga Mayenfisch Foundation	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Olga Mayenfisch Foundation	The study was supported by grants from the Swiss National Science Foundation (SNSF; grant No. PPOOP1-123516/1 and PPOOP1-146326/1) and the Olga Mayenfisch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Ain S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00454; [Anonymous], 1999, PERLEN PERL MUTT; [Anonymous], 1997, SKID 2 STRUKTURIERTE; APA, 1994, DIAGN STAT MAN MENT; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Bereczkei T, 2014, PERS INDIV DIFFER, V64, P168, DOI 10.1016/j.paid.2014.02.035; Bush DM, 2008, FORENSIC SCI INT, V174, P111, DOI 10.1016/j.forsciint.2007.03.008; Charness G, 2002, Q J ECON, V117, P817, DOI 10.1162/003355302760193904; Christie R., 1970, STUDIES MACHIAVELLIA; Cohen J., 1983, APPL MULTIPLE REGRES; Cooper GAA, 2012, FORENSIC SCI INT, V218, P20, DOI 10.1016/j.forsciint.2011.10.024; Dziobek I, 2008, J AUTISM DEV DISORD, V38, P464, DOI 10.1007/s10803-007-0486-x; Dziobek I, 2006, J AUTISM DEV DISORD, V36, P623, DOI 10.1007/s10803-006-0107-0; Edgington E.S., 2007, RANDOMIZATION TESTS; Engelmann D, 2004, AM ECON REV, V94, P857, DOI 10.1257/0002828042002741; Ersche KD, 2010, BIOL PSYCHIAT, V68, P770, DOI 10.1016/j.biopsych.2010.06.015; Fernandez-Montalvo J, 2007, AN SIST SANIT NAVAR, V30, P225; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Hoelzle C, 2008, FORENSIC SCI INT, V176, P13, DOI 10.1016/j.forsciint.2007.07.020; Hulka LM, 2015, PSYCHOL MED, V45, P3097, DOI 10.1017/S0033291715001063; Hulka LM, 2014, PSYCHOL MED, V44, P1015, DOI 10.1017/S0033291713001839; Hulka Lea M, 2013, Front Psychiatry, V4, P98, DOI 10.3389/fpsyt.2013.00098; Herrero MJ, 2008, SUBST USE MISUSE, V43, P1378, DOI 10.1080/10826080801922652; Jones D.N., 2009, HDB INDIVIDUAL DIFFE, P93; KAESTNER E, 1977, BRIT J ADDICT, V72, P245; KRANZLER HR, 1994, COMPR PSYCHIAT, V35, P335, DOI 10.1016/0010-440X(94)90272-0; Lehrl S., 1999, MEHRFACHWAHL WORTSCH; Linden M, 2007, Z MED PSYCHOL, V16, P135; Lyons M., 2010, J SOCIAL EVOLUTIONAR, V4, P194, DOI [10.1037/h0099290, DOI 10.1037/H0099290]; Maier LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129805; McHoskey JW, 2001, PERS INDIV DIFFER, V31, P791, DOI 10.1016/S0191-8869(00)00187-2; McNamara Patrick, 2007, Cogn Neuropsychiatry, V12, P285; Milivojevic D, 2012, AM J ADDICTION, V21, P462, DOI 10.1111/j.1521-0391.2012.00251.x; Preller KH, 2014, ADDICT BIOL, V19, P452, DOI 10.1111/adb.12070; Preller KH, 2014, P NATL ACAD SCI USA, V111, P2842, DOI 10.1073/pnas.1317090111; Quednow BB, 2004, NEUROPSYCHOPHARMACOL, V29, P982, DOI 10.1038/sj.npp.1300396; Quednow BB, 2017, CURR OPIN BEHAV SCI, V13, P55, DOI 10.1016/j.cobeha.2016.10.001; Stenason L, 2016, PERS INDIV DIFFER, V94, P59, DOI 10.1016/j.paid.2016.01.010; Sussner BD, 2006, DRUG ALCOHOL DEPEN, V83, P233, DOI 10.1016/j.drugalcdep.2005.11.022; Tobler PN, 2016, SOC COGN AFFECT NEUR, V11, P1017, DOI 10.1093/scan/nsw030; Verbeke WJ., 2011, J NEUROSCI PSYCHOL E, V4, P205, DOI DOI 10.1037/A0025802; Verdejo-Garcia A, 2014, P NATL ACAD SCI USA, V111, P2406, DOI 10.1073/pnas.1324287111; Volkow ND, 2011, NEURON, V69, P599, DOI 10.1016/j.neuron.2011.01.027; Vonmoos M, 2014, NEUROPSYCHOPHARMACOL, V39, P2200, DOI 10.1038/npp.2014.71; Vonmoos M, 2013, DRUG ALCOHOL DEPEN, V133, P61, DOI 10.1016/j.drugalcdep.2013.05.032; Vonmoos M, 2013, BRIT J PSYCHIAT, V203, P35, DOI 10.1192/bjp.bp.112.118091; Zizzo DJ, 2010, EXP ECON, V13, P75, DOI 10.1007/s10683-009-9230-z	47	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172853	10.1371/journal.pone.0172853	http://dx.doi.org/10.1371/journal.pone.0172853			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4XX	28253291	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000396011300043
J	Schindler, S; Schreiber, J; Bazin, PL; Trampel, R; Anwander, A; Geyer, S; Schonknecht, P				Schindler, Stephanie; Schreiber, Jan; Bazin, Pierre-Louis; Trampel, Robert; Anwander, Alfred; Geyer, Stefan; Schoenknecht, Peter			Intensity standardisation of 7T MR images for intensity-based segmentation of the human hypothalamus	PLOS ONE			English	Article							MAGNETIC-RESONANCE IMAGES; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; WHITE-MATTER; HUMAN BRAIN; REGISTRATION; SCALE	The high spatial resolution of 7T MRI enables us to identify subtle volume changes in brain structures, providing potential biomarkers of mental disorders. Most volumetric approaches require that similar intensity values represent similar tissue types across different persons. By applying colour-coding to T1-weighted MP2RAGE images, we found that the high measurement accuracy achieved by high-resolution imaging may be compromised by inter-individual variations in the image intensity. To address this issue, we analysed the performance of five intensity standardisation techniques in high-resolution T1-weighted MP2RAGE images. Twenty images with extreme intensities in the GM and WM were standardised to a representative reference image. We performed a multi-level evaluation with a focus on the hypothalamic region-analysing the intensity histograms as well as the actual MR images, and requiring that the correlation between the whole-brain tissue volumes and subject age be preserved during standardisation. The results were compared with T1 maps. Linear standardisation using subcortical ROIs of GM and WM provided good results for all evaluation criteria: it improved the histogram alignment within the ROIs and the average image intensity within the ROIs and the whole-brain GM and WM areas. This method reduced the inter-individual intensity variation of the hypothalamic boundary by more than half, outperforming all other methods, and kept the original correlation between the GM volume and subject age intact. Mixed results were obtained for the other four methods, which sometimes came at the expense of unwarranted changes in the age-related pattern of the GM volume. The mapping of the T1 relaxation time with the MP2RAGE sequence is advertised as being especially robust to bias field inhomogeneity. We found little evidence that substantiated the T1 map's theoretical superiority over the T1-weighted images regarding the inter-individual image intensity homogeneity.	[Schindler, Stephanie; Schoenknecht, Peter] Univ Hosp Leipzig, Dept Psychiat & Psychotherapy, Leipzig, Germany; [Schindler, Stephanie; Bazin, Pierre-Louis; Trampel, Robert; Geyer, Stefan] Max Planck Inst Human Cognit & Brain Sci, Dept Neurophys, Leipzig, Germany; [Schreiber, Jan; Anwander, Alfred] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany; [Bazin, Pierre-Louis] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Schreiber, Jan] Forschungszentrum Julich, Inst Neurosci & Med, Julich, Germany	Leipzig University; Max Planck Society; Max Planck Society; Max Planck Society; Helmholtz Association; Research Center Julich	Schindler, S (corresponding author), Univ Hosp Leipzig, Dept Psychiat & Psychotherapy, Leipzig, Germany.; Schindler, S (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neurophys, Leipzig, Germany.	Stephanie.Schindler@medizin.uni-leipzig.de	Schoenknecht, Peter/GVU-7600-2022; Anwander, Alfred/B-5874-2011	Anwander, Alfred/0000-0002-4861-4808; Schindler, Stephanie/0000-0003-1378-0053				*APA, 1994, DSM 4 DIAGN STAT MAN; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bazin PL, 2007, J NEUROSCI METH, V165, P111, DOI 10.1016/j.jneumeth.2007.05.024; Bazin PL, 2014, NEUROIMAGE, V93, P201, DOI 10.1016/j.neuroimage.2013.03.077; Bedekar D, 2010, MAGN RESON MED, V64, P907, DOI 10.1002/mrm.22445; Belluck P, 2013, NY TIMES; BESSON JAO, 1992, BRIT J PSYCHIAT, V160, P187, DOI 10.1192/bjp.160.2.187; Blu T, 2004, IEEE T IMAGE PROCESS, V13, P710, DOI 10.1109/TIP.2004.826093; Bosc M, 2003, NEUROIMAGE, V20, P643, DOI 10.1016/S1053-8119(03)00406-3; Cataldo R, 2013, J NEUROIMAGING, V23, P473, DOI 10.1111/j.1552-6569.2012.00713.x; Ceritoglu C, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00043; Christensen JD, 2003, MAGN RESON IMAGING, V21, P817, DOI 10.1016/S0730-725X(03)00102-4; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Gonzalez R.C., 2002, DIGIT IMAGE PROCESS, V2, P75; Gouw AA, 2008, BRAIN, V131, P3286, DOI 10.1093/brain/awn265; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hellier P, 2003, IEEE IMAGE PROC, P1109; Hutcheson M. C., 1995, THESIS; IZENMAN AJ, 1991, J AM STAT ASSOC, V86, P205, DOI 10.2307/2289732; Jager F, 2009, IEEE T MED IMAGING, V28, P137, DOI 10.1109/TMI.2008.2004429; Jager F, 2006, VISION MODELING VISU, P269; Jager F., 2007, INFORM AKTUELL, P459; Jiang Z, 2004, SPEC FILE READER; Leung KK, 2010, NEUROIMAGE, V50, P516, DOI 10.1016/j.neuroimage.2009.12.059; Lim JS, 1990, 2 DIMENSIONAL SIGNAL, P453; Lockhart SN, 2014, NEUROPSYCHOL REV, V24, P271, DOI 10.1007/s11065-014-9268-3; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Lundgren J., 2007, SPLINEFIT COMPUTER P; Mai JK, 2007, ATLAS OF THE HUMAN B; Marques JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069294; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; McAuliffe MJ, 2001, COMP MED SY, P381; Meier DS, 2003, NEUROIMAGE, V20, P1193, DOI 10.1016/S1053-8119(03)00354-9; Nyul LG, 1999, MAGNET RESON MED, V42, P1072, DOI 10.1002/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M; Nyul LG, 2000, IEEE T MED IMAGING, V19, P143, DOI 10.1109/42.836373; Robitaille N, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/347120; Schindler S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066394; Silk TJ, 2011, J DEV BEHAV PEDIATR, V32, P158, DOI 10.1097/DBP.0b013e318206d58f; Steen RG, 1997, AM J NEURORADIOL, V18, P819; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Swaab DF, 2003, HUMAN HYPOTHALAMUS B; van der Zwaag W, 2016, NMR BIOMED, V29, P1274, DOI 10.1002/nbm.3275; Vovk U, 2007, IEEE T MED IMAGING, V26, P405, DOI 10.1109/TMI.2006.891486; Wang LQ, 1998, MAGNET RESON MED, V39, P322, DOI 10.1002/mrm.1910390222; Yeatman JD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5932; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	49	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173344	10.1371/journal.pone.0173344	http://dx.doi.org/10.1371/journal.pone.0173344			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4XX	28253330	Green Submitted, gold, Green Published			2022-12-26	WOS:000396011300102
J	Zhang, Y; Ma, LM; Huang, J; Shuang, JQ; Chen, JP; Fan, ZN				Zhang, Yin; Ma, Limei; Huang, Jin; Shuang, Jinquan; Chen, Jianping; Fan, Zhining			The effect of paclitaxel-eluting covered metal stents versus covered metal stents in a rabbit esophageal squamous carcinoma model	PLOS ONE			English	Article							CELL CARCINOMA; INCORPORATED MEMBRANE; CANCER; ADENOCARCINOMA; INTERVENTION; OBSTRUCTION; THERAPY	Background The use of self-expanding metallic stents (SEMSs) is the current treatment of choice for malignant gastrointestinal obstructions. However, these stents can promote only drainage and have no antitumor effect. Some studies have reported that drug-eluting SEMSs may have tumor inhibition potential. The aim of this study was to evaluate the efficiency and safety of paclitaxel-eluting SEMSs (PEMSs) in rabbit esophageal cancer models. Materials and methods A PEMS was covered with a paclitaxel-incorporated membrane, in which the concentration of paclitaxel was 10% (wt/vol). The rabbit models were created endoscopically. Then, a PEMS or SEMS was endoscopically inserted into the rabbit esophagus. Two weeks after stent placement, the rabbits were sacrificed, and we evaluated the tumor volume, area of the wall defect, area of the tumor under endoscopic ultrasound (EUS) before and after stent placement, status of the proximal esophageal obstruction, tumor metastasis food-intake and weight loss. Results A total of 26 rabbits received stent insertion and survived until sacrifice, and migration occurred in 4 cases, 3 in SEMS group and 1 in PEMS group. For the remaining 22 rabbits, at the sacrificed time, the average tumor volume was 7.00 +/- 4.30 cm(3) in the SEMS group and 0.94 +/- 1.51 cm(3) in the PEMS group (P<0.05). The area of the esophageal wall defect was 0.70 +/- 0.63 cm(2) in the SEMS group and 0.17 +/- 0.16 cm(2) in the PEMS group (P<0.05). The tumor area under EUS was 4.40 +/- 1.47 cm(2) in the SEMS group and 1.30 +/- 1.06 cm(2) in the PEMS group (P<0.05). At the time of stent placement, tumor area under EUS was comparable in the two groups. Other indices did not significantly differ between the two groups. Conclusions SEMS and PEMS are both safe and effective to relieve dysphagia in rabbit esophageal cancer models. A PEMS can serve as an alternative tool for advanced esophageal cancer that may inhibit tumor growth by serving as a drug sustained-release platform. Clinical trials of the stent are warranted in the future.	[Zhang, Yin; Chen, Jianping] Soochow Univ, Affiliated Hosp 3, Peoples Hosp Changzhou 1, Dept Digest Dis, Changzhou, Jiangsu, Peoples R China; [Zhang, Yin; Ma, Limei; Huang, Jin; Shuang, Jinquan; Fan, Zhining] Nanjing Med Univ, Affiliated Hosp 1, Dept Digest Endoscopy, Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China	Soochow University - China; Nanjing Medical University	Chen, JP (corresponding author), Soochow Univ, Affiliated Hosp 3, Peoples Hosp Changzhou 1, Dept Digest Dis, Changzhou, Jiangsu, Peoples R China.; Fan, ZN (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Digest Endoscopy, Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China.	chenjianping2016@outlook.com; fanzhining@njmu.edu.cn			National Natural Science Foundation of China [81172266]; Science and Technology Support Program of Jiangsu Province [BE2010719]; Natural Science Foundation of Jiangsu Province [BK2011859]; Jiangsu Innovation of Medical Team and Leading Talents Cultivation [LJ201127]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Support Program of Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Innovation of Medical Team and Leading Talents Cultivation	This work was supported by the National Natural Science Foundation of China (81172266), the Science and Technology Support Program of Jiangsu Province (BE2010719), the Natural Science Foundation of Jiangsu Province (BK2011859), and the Jiangsu Innovation of Medical Team and Leading Talents Cultivation (LJ201127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2012, CANCER DISCOV, V2, P899, DOI 10.1158/2159-8290.CD-12-0189; de Cicco RL, 2004, CLIN CANCER RES, V10, P4480, DOI 10.1158/1078-0432.CCR-03-0670; Fattori R, 2003, LANCET, V361, P247, DOI 10.1016/S0140-6736(03)12275-1; Guo QH, 2007, J CONTROL RELEASE, V118, P318, DOI 10.1016/j.jconrel.2006.12.030; Guo SR, 2010, J PHARM SCI-US, V99, P3009, DOI 10.1002/jps.22066; Huang J, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-40; Huang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085326; Hurst EW, 1933, J EXP MED, V58, P607, DOI 10.1084/jem.58.5.607; Jeon SR, 2009, ENDOSCOPY, V41, P449, DOI 10.1055/s-0029-1214607; Jin CS, 2016, CANCER RES, V76, P5870, DOI 10.1158/0008-5472.CAN-15-3196; KNYRIM K, 1993, NEW ENGL J MED, V329, P1302, DOI 10.1056/NEJM199310283291803; Lagergren J, 2013, CA-CANCER J CLIN, V63, P232, DOI 10.3322/caac.21185; Layke JC, 2006, AM FAM PHYSICIAN, V73, P2187; Lee DK, 2005, GASTROINTEST ENDOSC, V61, P296, DOI 10.1016/S0016-5107(04)02570-2; Lee SS, 2009, GASTROINTEST ENDOSC, V69, P1140, DOI 10.1016/j.gie.2008.08.005; MULLER JM, 1990, BRIT J SURG, V77, P845, DOI 10.1002/bjs.1800770804; Ortner MAEJ, 2004, ENDOSCOPY, V36, P421, DOI 10.1055/s-2004-814327; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; Rozanes I, 2002, EUR J RADIOL, V43, P196, DOI 10.1016/S0720-048X(02)00154-7; Silber Sigmund, 2003, J Interv Cardiol, V16, P485, DOI 10.1046/j.1540-8183.2003.01065.x; Song TJ, 2011, GASTROINTEST ENDOSC, V73, P727, DOI 10.1016/j.gie.2010.11.048; Suk KT, 2007, GASTROINTEST ENDOSC, V66, P798, DOI 10.1016/j.gie.2007.05.037; Talukdar FR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060996; Thomas GR, 2006, INT J CANCER, V118, P2379, DOI 10.1002/ijc.21695; Virmani S, 2008, J VASC INTERV RADIOL, V19, P931, DOI 10.1016/j.jvir.2008.02.019; Wang ZM, 2015, GASTROINTEST ENDOSC, V82, P153, DOI 10.1016/j.gie.2015.02.034; Zhang Y, 2016, EXP THER MED, V12, P2928, DOI 10.3892/etm.2016.3708	27	12	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173262	10.1371/journal.pone.0173262	http://dx.doi.org/10.1371/journal.pone.0173262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253360	Green Submitted, gold, Green Published			2022-12-26	WOS:000396011300097
J	Holubar, M; Stavroulakis, MC; Maldonado, Y; Ioannidis, JPA; Contopoulos-Ioannidis, D				Holubar, Marisa; Stavroulakis, Maria Christina; Maldonado, Yvonne; Ioannidis, John P. A.; Contopoulos-Ioannidis, Despina			Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; ROTAVIRUS VACCINATION; INFLUENZA VACCINATION; ECONOMIC EVALUATIONS; NASOPHARYNGEAL CARRIAGE; MENINGOCOCCAL DISEASE; PUBLIC-HEALTH; 7-VALENT; 13-VALENT; CHILDREN	Background Inclusion of vaccine herd-protection effects in cost-effectiveness analyses (CEAs) can impact the CEAs-conclusions. However, empirical epidemiologic data on the size of herdprotection effects from original studies are limited. Methods We performed a quantitative comparative analysis of the impact of herd-protection effects in CEAs for four childhood vaccinations (pneumococcal, meningococcal, rotavirus and influenza). We considered CEAs reporting incremental-cost-effectiveness-ratios (ICERs) (per quality-adjusted-life-years [QALY] gained; per life-years [LY] gained or per disability-adjusted-life-years [DALY] avoided), both with and without herd protection, while keeping all other model parameters stable. We calculated the size of the ICER-differences without vs with-herd-protection and estimated how often inclusion of herd-protection led to crossing of the cost-effectiveness threshold (of an assumed societal-willingness-to-pay) of $50,000 for more-developed countries or X3GDP/capita (WHO-threshold) for less-developed countries. Results We identified 35 CEA studies (20 pneumococcal, 4 meningococcal, 8 rotavirus and 3 influenza vaccines) with 99 ICER-analyses (55 per-QALY, 27 per-LY and 17 per-DALY). The median ICER-absolute differences per QALY, LY and DALY (without minus with herdprotection) were $15,620 (IQR: $877 to $48,376); $54,871 (IQR: $787 to $115,026) and $49 (IQR: $15 to $1,636) respectively. When the target-vaccination strategy was not cost-saving without herd-protection, inclusion of herd-protection always resulted in more favorable results. In CEAs that had ICERs above the cost-effectiveness threshold without herd-protection, inclusion of herd-protection led to crossing of that threshold in 45% of the cases. This impacted only CEAs for more developed countries, as all but one CEAs for less developed countries had ICERs below the WHO-cost-effectiveness threshold even without herdprotection. In several analyses, recommendation for the adoption of the target vaccination strategy depended on the inclusion of the herd protection effect. Conclusions Inclusion of herd-protection effects in CEAs had a substantial impact in the estimated ICERs and made target-vaccination strategies more attractive options in almost half of the cases where ICERs were above the societal-willingness to pay threshold without herd-protection. More empirical epidemiologic data are needed to determine the size of herd-protection effects across diverse settings and also the size of negative vaccine effects, e.g. from serotype substitution.	[Holubar, Marisa] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Stavroulakis, Maria Christina] Icahn Sch Med Mt Sinai, Elmhurst Hosp Ctr, Dept Pediat, New York, NY 10029 USA; [Maldonado, Yvonne; Contopoulos-Ioannidis, Despina] Stanford Univ, Dept Pediat, Sch Med, Div Pediat Infect Dis,Fac Dev & Divers, Stanford, CA 94305 USA; [Maldonado, Yvonne; Contopoulos-Ioannidis, Despina] Stanford Univ, Fac Dev & Divers, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.; Contopoulos-Ioannidis, Despina] Stanford Univ, Meta Res Innovat Ctr, Stanford METRICS, Stanford, CA 94305 USA	Stanford University; Icahn School of Medicine at Mount Sinai; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Contopoulos-Ioannidis, D (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Div Pediat Infect Dis,Fac Dev & Divers, Stanford, CA 94305 USA.; Contopoulos-Ioannidis, D (corresponding author), Stanford Univ, Fac Dev & Divers, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA.; Contopoulos-Ioannidis, D (corresponding author), Stanford Univ, Meta Res Innovat Ctr, Stanford METRICS, Stanford, CA 94305 USA.	dcontop@stanford.edu	Ioannidis, John P. A./G-9836-2011	Ioannidis, John P./0000-0003-3118-6859	NIAID NIH HHS [T32 AI052073] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052073] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Advisory Committee on Immunization Practices (ACIP), GUID HLTH EC STUD; Gomez JA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1025; [Anonymous], HIST EXCH RAT; Atherly DE, 2012, VACCINE, V30, pA7, DOI 10.1016/j.vaccine.2011.12.096; Atkins KE, 2012, VACCINE, V30, P6766, DOI 10.1016/j.vaccine.2012.09.025; Baker CB, 2003, BRIT J PSYCHIAT, V183, P498, DOI 10.1192/bjp.183.6.498; Bakir M, 2013, VACCINE, V31, P979, DOI 10.1016/j.vaccine.2012.11.071; Bell CM, 2006, BMJ-BRIT MED J, V332, P699, DOI 10.1136/bmj.38737.607558.80; Bergman A, 2008, SCAND J INFECT DIS, V40, P721, DOI 10.1080/00365540802014872; Beutels P, 2007, VACCINE, V25, P1355, DOI 10.1016/j.vaccine.2006.10.034; Bilcke J, 2009, PHARMACOECONOMICS, V27, P281, DOI 10.2165/00019053-200927040-00002; Bilcke J, 2009, MED DECIS MAKING, V29, P33, DOI 10.1177/0272989X08324955; Blank PR, 2012, VACCINE, V30, P4267, DOI 10.1016/j.vaccine.2012.04.028; Boonacker CWB, 2011, PHARMACOECONOMICS, V29, P199, DOI 10.2165/11584930-000000000-00000; Bruijning-Verhagen P, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-112; Bureau of Labor Statistics, CPI CONS PRIC IND IN; Christensen H, 2013, VACCINE, V31, P2638, DOI 10.1016/j.vaccine.2013.03.034; Chuck AW, 2010, VACCINE, V28, P5485, DOI 10.1016/j.vaccine.2010.05.058; Clemens J, 2011, LANCET INFECT DIS, V11, P482, DOI 10.1016/S1473-3099(10)70318-2; Clements KM, 2011, VALUE HEALTH, V14, P800, DOI 10.1016/j.jval.2011.03.005; Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209; Cost Effectiveness Analyses (CEA) Registry, CTR EV VAL RISK HLTH; De Wals P, 2002, VACCINE, V20, P2840, DOI 10.1016/S0264-410X(02)00161-5; Diez-Domingo J, 2011, VACCINE, V29, P9640, DOI 10.1016/j.vaccine.2011.10.038; Earnshaw SR, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-101; Evans Christopher, 2004, Health Care Manag Sci, V7, P43, DOI 10.1023/B:HCMS.0000005397.93173.bb; Garber AM, 1997, J HEALTH ECON, V16, P1, DOI 10.1016/S0167-6296(96)00506-1; Getsios D, 2004, INT J TECHNOL ASSESS, V20, P280, DOI 10.1017/S0266462304001096; Giglio ND, 2010, VACCINE, V28, P2302, DOI 10.1016/j.vaccine.2009.12.070; Goossens LMA, 2008, VACCINE, V26, P1118, DOI 10.1016/j.vaccine.2007.11.070; Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165; Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4; Hepkema H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065036; Hoshi SL, 2012, VACCINE, V30, P3320, DOI 10.1016/j.vaccine.2012.02.033; Hubben GAA, 2007, VACCINE, V25, P3669, DOI 10.1016/j.vaccine.2007.01.088; Isaacman DJ, 2008, CLIN THER, V30, P341, DOI 10.1016/j.clinthera.2008.02.003; Jit M, 2009, VACCINE, V27, P6121, DOI 10.1016/j.vaccine.2009.08.030; Kauf TL, 2010, PHARMACOECONOMICS, V28, P449, DOI 10.2165/11535280-000000000-00000; Kim JJ, 2011, NEW ENGL J MED, V365, P1760, DOI 10.1056/NEJMp1110539; Kim SY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-260; Laxminarayan R., 2006, DIS CONTROL PRIORITI, V2nd ed.; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Loo JD, 2014, PEDIATR INFECT DIS J, V33, pS161, DOI 10.1097/INF.0000000000000084; Lopman BA, 2011, J INFECT DIS, V204, P980, DOI 10.1093/infdis/jir492; Loughlin AM, 2014, PEDIATR INFECT DIS J, V33, P504, DOI 10.1097/INF.0000000000000279; Mangen MJJ, 2010, VACCINE, V28, P2624, DOI 10.1016/j.vaccine.2010.01.014; Manski CF, 2010, P NATL ACAD SCI USA, V107, P3953, DOI 10.1073/pnas.0915009107; Marti Sebastian Garcia, 2013, Cost Eff Resour Alloc, V11, P21, DOI 10.1186/1478-7547-11-21; McIntosh EDG, 2005, VACCINE, V23, P1739, DOI 10.1016/j.vaccine.2004.08.051; Melegaro A, 2004, VACCINE, V22, P4203, DOI 10.1016/j.vaccine.2004.05.003; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Miners AH, 2005, BMJ-BRIT MED J, V330, P65, DOI 10.1136/bmj.38285.482350.82; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; National Institute for Health and Clinical Excellence (NICE), 2008, UPD GUID METH TECHN; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Newall AT, 2013, PHARMACOECONOMICS, V31, P693, DOI 10.1007/s40273-013-0060-7; Newall AT, 2011, VACCINE, V29, P8077, DOI 10.1016/j.vaccine.2011.08.050; Ogilvie I, 2009, VACCINE, V27, P4891, DOI 10.1016/j.vaccine.2009.05.061; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; Payne DC, 2011, CLIN INFECT DIS, V53, P245, DOI 10.1093/cid/cir307; Piedra PA, 2005, VACCINE, V23, P1540, DOI 10.1016/j.vaccine.2004.09.025; Pitman RJ, 2013, VACCINE, V31, P927, DOI 10.1016/j.vaccine.2012.12.010; Postma MJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-84; Ramsay ME, 2003, BRIT MED J, V326, P365, DOI 10.1136/bmj.326.7385.365; Ray G Thomas, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P373, DOI 10.1586/14737167.8.4.373; Ray GT, 2006, PEDIATR INFECT DIS J, V25, P494, DOI 10.1097/01.inf.0000222403.42974.8b; Rozenbaum MH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-462; Rubin JL, 2010, VACCINE, V28, P7634, DOI 10.1016/j.vaccine.2010.09.049; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; Souza CPR, 2009, J BRAS EC SAUDE, V1, P3; Trotter CL, 2006, MED DECIS MAKING, V26, P38, DOI 10.1177/0272989X05284109; Tu HAT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-54; Tyo KR, 2011, VACCINE, V29, P6686, DOI 10.1016/j.vaccine.2011.06.091; Uiuena A, 2011, VACCINE, V29, P4963, DOI [10.1016/j.vaccine.2011.04.111, DOI 10.1016/J.VACCINE.2011.04.111]; Ultsch B, 2016, PHARMACOECONOMICS, V34, P227, DOI 10.1007/s40273-015-0335-2; van de Vooren K, 2014, PHARMACOECONOMICS, V32, P29, DOI 10.1007/s40273-013-0113-y; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; Vespa G, 2009, REV PANAM SALUD PUBL, V26, P518, DOI 10.1590/S1020-49892009001200007; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; Walker DG, 2010, VACCINE, V28, P2356, DOI 10.1016/j.vaccine.2009.06.035; Wisloff T, 2006, VACCINE, V24, P5690, DOI 10.1016/j.vaccine.2006.04.042	82	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172414	10.1371/journal.pone.0172414	http://dx.doi.org/10.1371/journal.pone.0172414			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249046	Green Submitted, Green Published, gold			2022-12-26	WOS:000395983500041
J	Wan, W; Peng, K; Li, M; Qin, L; Tong, Z; Yan, J; Shen, B; Yu, C				Wan, W.; Peng, K.; Li, M.; Qin, L.; Tong, Z.; Yan, J.; Shen, B.; Yu, C.			Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1 alpha	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; GLUCOSE-METABOLISM; GENE-EXPRESSION; JHDM2A; TRANSCRIPTION; COMPLEX	High aerobic glycolysis not only provides energy to cancer cells, but also supports their anabolic growth. JMJD1A, a histone demethylase that specifically demethylates H3K9me1/2, is overexpressed in multiple cancers, including urinary bladder cancer (UBC). It is unclear whether JMJD1A could promote cancer cell growth through enhancing glycolysis. In this study, we found that downregulation of JMJD1A decreased UBC cell proliferation, colony formation and xenograft tumor growth. Knockdown of JMJD1A inhibited glycolysis by decreasing the expression of genes participated in glucose metabolism, including GLUT1, HK2, PGK1, PGM, LDHA and MCT4. Mechanistically, JMJD1A cooperated with hypoxia inducible factor 1 alpha (HIF1 alpha), an important transcription factor for glucose metabolism, to induce the glycolytic gene expression. JMJD1A was recruited to the promoter of glycolytic gene PGK1 to demethylate H3K9me2. However, the JMJD1A (H1120Y) mutant, which loses the demethylase activity, failed to cooperate with HIF1a to induce the glycolytic gene expression, and failed to demethylate H3K9me2 on PGK1 promoter, suggesting that the demethylase activity of JMJD1A is essential for its coactivation function for HIF1a. Inhibition of glycolysis through knocking down HIF1a or PGK1 decelerated JMJD1A-enhanced UBC cell growth. Consistent with these results, a positive correlation between JMJD1A and several key glycolytic genes in human UBC samples was established by analyzing a microarray-based gene expression profile. In conclusion, our study demonstrates that JMJD1A promotes UBC progression by enhancing glycolysis through coactivation of HIF1a, implicating that JMJD1A is a potential molecular target for UBC treatment.	[Wan, W.; Peng, K.; Li, M.; Qin, L.; Tong, Z.; Yu, C.] Xiamen Univ, Innovat Ctr Cell Biol, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361005, Peoples R China; [Li, M.] Xiamen Univ, Chenggong Hosp, Xiamen City Key Lab Biliary Tract Dis, Xiamen, Peoples R China; [Yan, J.] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Yan, J.] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China; [Shen, B.] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Urol, Shanghai, Peoples R China	Xiamen University; Xiamen University; Nanjing University; Nanjing University; Shanghai Jiao Tong University	Yu, C (corresponding author), Xiamen Univ, Innovat Ctr Cell Biol, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361005, Peoples R China.	cdyu@xmu.edu.cn	Tong, Zhangwei/V-2475-2019; Yan, Jun/Q-3031-2017	Yan, Jun/0000-0002-1303-1952	National Basic Research Program of China (973 Program) [2015CB553800]; National Natural Science Foundation of China [81372176, U1405225, 81372168, 81470116]; Shanghai Natural Science Foundation [14ZR1433200]; Wu Jie Ping Medical Foundation [320.6750.16051]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Wu Jie Ping Medical Foundation	This study was supported by grants from National Basic Research Program of China (973 Program, No. 2015CB553800 to CY), the National Natural Science Foundation of China (No. 81372176 to CY, No. U1405225 to CY; No. 81372168 to JY; No. 81470116 to BS), Shanghai Natural Science Foundation (14ZR1433200 to BS) and Wu Jie Ping Medical Foundation (320.6750.16051 to BS).	Bayley JP, 2012, CURR OPIN ONCOL, V24, P62, DOI 10.1097/CCO.0b013e32834deb9e; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cho HS, 2012, INT J CANCER, V131, pE179, DOI 10.1002/ijc.26501; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Fan L, 2016, ONCOGENE, V35, P2441, DOI 10.1038/onc.2015.309; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kobayashi T, 2015, NAT REV CANCER, V15, P42, DOI 10.1038/nrc3858; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Lee HY, 2013, CARCINOGENESIS, V34, P2706, DOI 10.1093/carcin/bgt256; Liu ZL, 2010, J BIOL CHEM, V285, P2758, DOI 10.1074/jbc.M109.066845; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Ma DK, 2008, STEM CELLS, V26, P2131, DOI 10.1634/stemcells.2008-0388; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Mo P, 2015, ONCOGENE, V34, P3935, DOI 10.1038/onc.2014.324; Ohguchi H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10258; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Park SJ, 2013, BIOCHEM BIOPH RES CO, V434, P722, DOI 10.1016/j.bbrc.2013.03.091; Perez-Perri JI, 2016, CELL REP, V16, P37, DOI 10.1016/j.celrep.2016.05.082; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Suikki HE, 2010, PROSTATE, V70, P889, DOI 10.1002/pros.21123; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Thamotharan S, 2013, AM J PHYSIOL-ENDOC M, V304, pE583, DOI 10.1152/ajpendo.00513.2012; Tong ZW, 2015, J BIOL CHEM, V290, P18596, DOI 10.1074/jbc.M115.640490; Wade MA, 2015, NUCLEIC ACIDS RES, V43, P196, DOI 10.1093/nar/gku1298; Wollenick K, 2012, NUCLEIC ACIDS RES, V40, P1928, DOI 10.1093/nar/gkr978; Xu Y, 2010, EURASIP J WIREL COMM, DOI 10.1155/2010/818964; Yamada D, 2012, ANN SURG ONCOL, V19, pS355, DOI 10.1245/s10434-011-1797-x; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zhang CS, 2015, CELL RES, V25, P1025, DOI 10.1038/cr.2015.90; Zhao W, 2014, J BIOL CHEM, V289, P11219, DOI 10.1074/jbc.M113.535989	36	60	64	2	24	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 6	2017	36	27					3868	3877		10.1038/onc.2017.13	http://dx.doi.org/10.1038/onc.2017.13			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EZ6SM	28263974				2022-12-26	WOS:000404848200007
J	Zhou, C; Huang, C; Wang, J; Huang, H; Li, J; Xie, Q; Liu, Y; Zhu, J; Li, Y; Zhang, D; Zhu, Q; Huang, C				Zhou, C.; Huang, C.; Wang, J.; Huang, H.; Li, J.; Xie, Q.; Liu, Y.; Zhu, J.; Li, Y.; Zhang, D.; Zhu, Q.; Huang, C.			LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1 alpha translation	ONCOGENE			English	Article							NONCODING RNA MEG3; DNA METHYLTRANSFERASES; POOR-PROGNOSIS; PROLIFERATION; EXPRESSION; APOPTOSIS; GENE; HYPERMETHYLATION; CARCINOGENESIS; GROWTH	Long noncoding RNAs (lncRNAs) are emerging as key factors in various fundamental cellular biological processes, and many of them are likely to have functional roles in tumorigenesis. Maternally expressed gene 3 (MEG3) is an imprinted gene located at 14q32 that encodes a lncRNA, and the decreased MEG3 expression has been reported in multiple cancer tissues. However, nothing is known about the alteration and role of MEG3 in environmental carcinogen-induced lung tumorigenesis. Our present study, for the first time to the best of our knowledge, discovered that environmental carcinogen nickel exposure led to MEG3 downregulation, consequently initiating c-Jun-mediated PHLPP1 transcriptional inhibition and hypoxia-inducible factor-1 alpha (HIF-1 alpha) protein translation upregulation, in turn resulting in malignant transformation of human bronchial epithelial cells. Mechanistically, MEG3 downregulation was attributed to nickel-induced promoter hypermethylation via elevating DNMT3b expression, whereas PHLPP1 transcriptional inhibition was due to the decreasing interaction of MEG3 with its inhibitory transcription factor c-Jun. Moreover, HIF-1 alpha protein translation was upregulated via activating the Akt/p70S6K/S6 axis resultant from PHLPP1 inhibition in nickel responses. Collectively, we uncover that nickel exposure results in DNMT3b induction and MEG3 promoter hypermethylation and expression inhibition, further reduces its binding to c-Jun and in turn increasing c-Jun inhibition of PHLPP1 transcription, leading to the Akt/p70S6K/S6 axis activation, and HIF-1 alpha protein translation, as well as malignant transformation of human bronchial epithelial cells. Our studies provide a significant insight into understanding the alteration and role of MEG3 in nickel-induced lung tumorigenesis.	[Zhou, C.; Zhu, Q.] Anhui Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China; [Zhou, C.; Huang, H.; Xie, Q.; Huang, C.] Wenzhou Med Univ, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Zhejiang, Peoples R China; [Zhou, C.; Huang, C.; Wang, J.; Li, J.; Zhu, J.; Li, Y.; Zhang, D.; Huang, C.] NYU, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA; [Liu, Y.] Wenzhou Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Wenzhou, Zhejiang, Peoples R China	Anhui Medical University; Wenzhou Medical University; New York University; Wenzhou Medical University	Zhu, Q (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.; Huang, C (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	zqxing@yeah.net; chuanshu.huang@nyumc.org	Zhu, Qixing/AAM-4214-2020; Zhou, Chengfan/AAM-4097-2020		NIH/NCI [CA112557, CA165980, CA177665]; NIH/NIEHS [ES000260]; National Natural Science Foundation of China [81441090, 81229002, 81372946, 81673141, 81371730]; Specialized Research Fund for the Doctoral Program of Higher Education [20133420110001]; Grant for Scientific Research of BSKY from Anhui Medical University [XJ201418]; NATIONAL CANCER INSTITUTE [R01CA177665, R01CA112557, P01CA165980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Grant for Scientific Research of BSKY from Anhui Medical University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We greatly appreciated Dr Shau-Ping Lin (Institute of Biotechnology, National Taiwan University, Taipei, Taiwan) for his generous gifts about shRNA constructs against MEG3 and control vector. This work was supported partially by grants from NIH/NCI CA112557, CA165980 and CA177665, NIH/NIEHS ES000260, National Natural Science Foundation of China (81441090, 81229002, 81372946, 81673141 and 81371730), the Specialized Research Fund for the Doctoral Program of Higher Education (20133420110001), and the Grant for Scientific Research of BSKY (XJ201418) from Anhui Medical University. We also thank Ms Nedda Tichi for her critical reading of the manuscript.	Anwar SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049462; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Benetatos L, 2011, INT J CANCER, V129, P773, DOI 10.1002/ijc.26052; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Field RW, 2012, CLIN CHEST MED, V33, P681, DOI 10.1016/j.ccm.2012.07.001; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Georgescu Maria-Magdalena, 2010, Genes Cancer, V1, P1170, DOI 10.1177/1947601911407325; Hettinger K, 2007, CELL DEATH DIFFER, V14, P218, DOI 10.1038/sj.cdd.4401946; Hou LF, 2012, INT J EPIDEMIOL, V41, P79, DOI 10.1093/ije/dyr154; Huang HS, 2016, AUTOPHAGY, V12, P1687, DOI 10.1080/15548627.2016.1196313; Huang HS, 2015, CLIN CANCER RES, V21, P3783, DOI 10.1158/1078-0432.CCR-14-2829; Jin BL, 2013, ADV EXP MED BIOL, V754, P3, DOI 10.1007/978-1-4419-9967-2_1; Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Lee JW, 2004, EXP MOL MED, V36, P1, DOI 10.1038/emm.2004.1; Li J, 2016, INT J ONCOL, V48, P723, DOI 10.3892/ijo.2015.3285; Li JX, 2004, CANCER RES, V64, P94, DOI 10.1158/0008-5472.CAN-03-0737; Liu LX, 2016, INT J ONCOL, V48, P421, DOI 10.3892/ijo.2015.3248; Lu HT, 2005, MOL CELL BIOCHEM, V279, P45, DOI 10.1007/s11010-005-8215-2; Lu KH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-461; Luo G, 2015, CELL PHYSIOL BIOCHEM, V37, P2209, DOI 10.1159/000438577; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Miyoshi N, 2000, GENES CELLS, V5, P211, DOI 10.1046/j.1365-2443.2000.00320.x; Murphy SK, 2003, HUM MUTAT, V22, P92, DOI 10.1002/humu.10237; Newton AC, 2014, ANNU REV PHARMACOL, V54, P537, DOI 10.1146/annurev-pharmtox-011112-140338; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ouyang WM, 2009, J CELL PHYSIOL, V218, P205, DOI 10.1002/jcp.21590; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Salnikow K, 2004, J BIOL CHEM, V279, P40337, DOI 10.1074/jbc.M403057200; Salnikow K, 2008, CHEM RES TOXICOL, V21, P28, DOI 10.1021/tx700198a; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Subramaniam D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00080; Sun M, 2014, TUMOR BIOL, V35, P1065, DOI 10.1007/s13277-013-1142-z; Wang J, 2005, CANCER RES, V65, P6601, DOI 10.1158/0008-5472.CAN-04-4184; Wang PJ, 2012, J CELL BIOCHEM, V113, P1868, DOI 10.1002/jcb.24055; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; WILLEY JC, 1991, CANCER RES, V51, P5370; Xu Z, 2016, NEURO-ONCOLOGY, V18, P830, DOI 10.1093/neuonc/nov298; Yin DD, 2015, TUMOR BIOL, V36, P4851, DOI 10.1007/s13277-015-3139-2; Ying L, 2013, MOL BIOSYST, V9, P407, DOI 10.1039/c2mb25386k; Yu Y, 2014, ONCOGENE, V33, P996, DOI 10.1038/onc.2013.8; Zhang D, 2012, ACM COMPUT SURV, V44, DOI 10.1145/2071389.2071391; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448; Zhang J, 2016, CANCER BIOL THER, V17, P104, DOI 10.1080/15384047.2015.1108496; Zhao J, 2005, J CLIN ENDOCR METAB, V90, P2179, DOI 10.1210/jc.2004-1848; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	50	78	83	0	25	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 6	2017	36	27					3878	3889		10.1038/onc.2017.14	http://dx.doi.org/10.1038/onc.2017.14			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EZ6SM	28263966	Green Accepted			2022-12-26	WOS:000404848200008
J	Koehler-McNicholas, SR; Nickel, EA; Medvec, J; Barrons, K; Mion, S; Hansen, AH				Koehler-McNicholas, Sara R.; Nickel, Eric A.; Medvec, Joseph; Barrons, Kyle; Mion, Spencer; Hansen, Andrew H.			The influence of a hydraulic prosthetic ankle on residual limb loading during sloped walking	PLOS ONE			English	Article							INCLINED SURFACES; FOOT; GAIT; ALIGNMENT; AMPUTEES; ADAPTATION; KINEMATICS; USERS	In recent years, numerous prosthetic ankle-foot devices have been developed to address the demands of sloped walking for individuals with lower-limb amputation. The goal of this study was to compare the performance of a passive, hydraulic ankle-foot prosthesis to two related, non-hydraulic ankles based on their ability to minimize the socket reaction moments of individuals with transtibial amputation during a range of sloped walking tasks. After a two-week accommodation period, kinematic data were collected on seven subjects with a transtibial amputation walking on an instrumented treadmill set at various slopes. Overall, this study was unable to find significant differences in the torque at the distal end of the prosthetic socket between an ankle-foot prosthesis with a hydraulic range-of-motion and other related ankle-foot prosthesis designs (rigid ankle, multiaxial ankle) during the single-support phase of walking. In addition, socket comfort and perceived exertion were not significantly different for any of the ankle-foot prostheses tested in this study. These results suggest the need for further work to determine if more advanced designs (e.g., those with microprocessor control of hydraulic features, powered ankle-foot designs) can provide more biomimetic function to prosthesis users.	[Koehler-McNicholas, Sara R.; Nickel, Eric A.; Medvec, Joseph; Barrons, Kyle; Mion, Spencer; Hansen, Andrew H.] Minneapolis Dept Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA; [Hansen, Andrew H.] Univ Minnesota, Dept Rehabil Med, Program Rehabil Sci, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Koehler-McNicholas, SR (corresponding author), Minneapolis Dept Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA.	sara.koehler@va.gov		Koehler-McNicholas, Sara/0000-0002-7201-3607	United States Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service [A6568R]	United States Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service	This work was supported by Merit Review Award #A6568R (awarded to AHH) from the United States Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	De Asha AR, 2014, CLIN BIOMECH, V29, P728, DOI 10.1016/j.clinbiomech.2014.06.009; De Asha AR, 2013, CLIN BIOMECH, V28, P218, DOI 10.1016/j.clinbiomech.2012.11.013; Hansen AH, 2004, HUM MOVEMENT SCI, V23, P807, DOI 10.1016/j.humov.2004.08.023; Hansen AH, 2006, PROSTHET ORTHOT INT, V30, P286, DOI 10.1080/03093640600816982; Hanspal RS, 2003, DISABIL REHABIL, V25, P1278, DOI 10.1080/09638280310001603983; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kendrick DB, 2005, AM J EMERG MED, V23, P828, DOI 10.1016/j.ajem.2005.07.009; Klodd E, 2010, J REHABIL RES DEV, V47, P899, DOI 10.1682/JRRD.2009.10.0166; Koehler SR, 2014, J BIOMECH, V47, P1542, DOI 10.1016/j.jbiomech.2014.01.048; Leroux A, 2002, GAIT POSTURE, V15, P64, DOI 10.1016/S0966-6362(01)00181-3; Nickel E, 2014, J REHABIL RES DEV, V51, P803, DOI 10.1682/JRRD.2013.08.0177; Noble JW, 2008, EXP BRAIN RES, V189, P249, DOI 10.1007/s00221-008-1464-z; Owen E, 2010, PROSTHET ORTHOT INT, V34, P254, DOI 10.3109/03093646.2010.485597; Pinzur MS, 1995, J REHABIL RES DEV, V32, P373; Portnoy S, 2012, GAIT POSTURE, V35, P121, DOI 10.1016/j.gaitpost.2011.08.021; Portnoy S, 2010, MED ENG PHYS, V32, P312, DOI 10.1016/j.medengphy.2009.12.006; Ries Andrew L, 2005, COPD, V2, P105; Schmalz T, 2002, GAIT POSTURE, V16, P255, DOI 10.1016/S0966-6362(02)00008-5; Sedki I, 2013, PROSTHET ORTHOT INT, V37, P250, DOI 10.1177/0309364612458448; Seelen HAM, 2003, CLIN REHABIL, V17, P787, DOI 10.1191/0269215503cr678oa; Vrieling AH, 2008, GAIT POSTURE, V28, P235, DOI 10.1016/j.gaitpost.2007.12.006; Wells R P, 1981, Bull Prosthet Res, V10-35, P15	22	10	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173423	10.1371/journal.pone.0173423	http://dx.doi.org/10.1371/journal.pone.0173423			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278172	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900091
J	Stenger, M; Behr-Rasmussen, C; Klein, K; Gronnemose, RB; Andersen, TE; Klitgaard, JK; Kolmos, HJ; Lindholt, JS				Stenger, Michael; Behr-Rasmussen, Carsten; Klein, Kasper; Gronnemose, Rasmus B.; Andersen, Thomas Emil; Klitgaard, Janne K.; Kolmos, Hans Jorn; Lindholt, Jes S.			Systemic thioridazine in combination with dicloxacillin against early aortic graft infections caused by Staphylococcus aureus in a porcine model: In vivo results do not reproduce the in vitro synergistic activity	PLOS ONE			English	Article							EFFLUX PUMP; RESISTANCE; ANTIBIOTICS; ENANTIOMERS; METABOLISM; PREVENTION; MANAGEMENT; POLYESTER; DIAGNOSIS; EFFICACY	Introduction Conservative treatment solutions against aortic prosthetic vascular graft infection (APVGI) for inoperable patients are limited. The combination of antibiotics with antibacterial helper compounds, such as the neuroleptic drug thioridazine (TDZ), should be explored. Aim To investigate the efficacy of conservative systemic treatment with dicloxacillin (DCX) in combination with TDZ (DCX+TDZ), compared to DCX alone, against early APVGI caused by methicillin-sensitive Staphylococcus aureus (MSSA) in a porcine model. Methods The synergism of DCX+TDZ against MSSA was initially assessed in vitro by viability assay. Thereafter, thirty-two pigs had polyester grafts implanted in the infrarenal aorta, followed by inoculation with 10(6) CFU of MSSA, and were randomly administered oral systemic treatment with either 1) DCX or 2) DCX+TDZ. Treatment was initiated one week postoperatively and continued for a further 21 days. Weight, temperature, and blood samples were collected at predefined intervals. By termination, bacterial quantities from the graft surface, graft material, and perigraft tissue were obtained. Results Despite in vitro synergism, the porcine experiment revealed no statistical differences for bacteriological endpoints between the two treatment groups, and none of the treatments eradicated the APVGI. Accordingly, the mixed model analyses of weight, temperature, and blood samples revealed no statistical differences. Conclusion Conservative systemic treatment with DCX+TDZ did not reproduce in vitro results against APVGI caused by MSSA in this porcine model. However, unexpected severe adverse effects related to the planned dose of TDZ required a considerable reduction to the administered dose of TDZ, which may have compromised the results.	[Stenger, Michael; Klein, Kasper; Gronnemose, Rasmus B.; Andersen, Thomas Emil; Klitgaard, Janne K.; Kolmos, Hans Jorn] Univ Southern Denmark, Res Unit Clin Microbiol, Odense, Denmark; [Stenger, Michael; Lindholt, Jes S.] Odense Univ Hosp, Dept Cardiothorac & Vasc Surg, Odense, Denmark; [Behr-Rasmussen, Carsten] Viborg Hosp, Dept Vasc Surg, Viborg, Denmark; [Klitgaard, Janne K.] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Aarhus University; University of Southern Denmark	Stenger, M (corresponding author), Univ Southern Denmark, Res Unit Clin Microbiol, Odense, Denmark.; Stenger, M (corresponding author), Odense Univ Hosp, Dept Cardiothorac & Vasc Surg, Odense, Denmark.	mstenger@health.sdu.dk	Andersen, Thomas/GPT-3151-2022; Klitgaard, Janne Kudsk/F-8952-2010; Lindholt, Jes/J-2907-2014	Andersen, Thomas/0000-0001-9453-1141; Klitgaard, Janne Kudsk/0000-0001-5255-2980; Klein, Kasper/0000-0003-2767-0760; Lindholt, Jes/0000-0001-9536-4488; Gronnemose, Rasmus Birkholm/0000-0001-6411-9981	Research Council at Odense University Hospital; Danish Heart Foundation [14-R97-A5266]	Research Council at Odense University Hospital; Danish Heart Foundation	The study was financially supported by grants form the Research Council at Odense University Hospital received by MS, TEA, JKK, HJK, JSL (no grant number; http://www.ouh.dk/wm379847) and the Danish Heart Foundation (grant number: 14-R97-A5266; https://www.hjerteforeningen.dk) received by MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyk Dennis F, 2002, Semin Vasc Surg, V15, P268, DOI 10.1053/svas.2002.36262; Bonde M, 2011, FEMS MICROBIOL LETT, V318, P168, DOI 10.1111/j.1574-6968.2011.02255.x; Chambers ST, 2005, INTERN MED J, V35, pS72, DOI 10.1111/j.1444-0903.2005.00981.x; Christensen JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057493; Daniel WA, 1999, TOXICOL APPL PHARM, V158, P115, DOI 10.1006/taap.1999.8688; Dasgupta A, 2010, INT J ANTIMICROB AG, V35, P174, DOI 10.1016/j.ijantimicag.2009.09.027; Ejim L, 2011, NAT CHEM BIOL, V7, P348, DOI [10.1038/NCHEMBIO.559, 10.1038/nchembio.559]; Fukumoto A, 2008, J ANTIBIOT, V61, P7, DOI 10.1038/ja.2008.102; Fux CA, 2004, J BACTERIOL, V186, P4486, DOI 10.1128/JB.186.14.4486-4491.2004; Gao H, 2008, EUR J VASC ENDOVASC, V35, P41, DOI 10.1016/j.ejvs.2007.07.005; Gao H, 2012, EUR J VASC ENDOVASC, V43, P582, DOI 10.1016/j.ejvs.2012.02.011; Gao H, 2010, EUR J VASC ENDOVASC, V39, P472, DOI 10.1016/j.ejvs.2009.11.023; Hahn BL, 2014, IN VIVO, V28, P33; Harry DD, 2011, COMP ASSESSMENT PIG, P323; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Jensen AS, 2015, EUR J PHARMACOL, V747, P7, DOI 10.1016/j.ejphar.2014.11.015; JORTANI SA, 1994, FORENSIC SCI INT, V64, P165, DOI 10.1016/0379-0738(94)90227-5; Klitgaard JK, 2008, J ANTIMICROB CHEMOTH, V62, P1215, DOI 10.1093/jac/dkn417; Koyama N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048981; KRISTIANSEN JE, 1988, APMIS, V96, P1079, DOI 10.1111/j.1699-0463.1988.tb00984.x; Kristiansen Malthe M, 2006, In Vivo, V20, P361; Kristiansen MM, 2003, INT J ANTIMICROB AG, V22, P250, DOI 10.1016/S0924-8579(03)00200-0; Kvist M, 2008, APPL ENVIRON MICROB, V74, P7376, DOI 10.1128/AEM.01310-08; Lawrence PF, 2011, SEMIN VASC SURG, V24, P199, DOI 10.1053/j.semvascsurg.2011.10.014; Martins M, 2004, IN VIVO, V18, P787; Martins M, 2007, IN VIVO, V21, P771; Mussa FF, 2007, EXPERT REV ANTI-INFE, V5, P305, DOI 10.1586/14787210.5.2.305; NIEDZWIECKI DM, 1984, J PHARMACOL EXP THER, V228, P636; O'Connor S, 2006, J VASC SURG, V44, P38, DOI 10.1016/j.jvs.2006.02.053; Perera Ganesha B, 2006, Vasc Endovascular Surg, V40, P1, DOI 10.1177/153857440604000101; Pottegard A, 2015, JAMA-J AM MED ASSOC, V314, P296, DOI 10.1001/jama.2015.6669; Poulsen MO, 2013, RES MICROBIOL, V164, P181, DOI 10.1016/j.resmic.2012.10.007; Poulsen MO, 2014, JOURNAL OF MEDICAL M; Robertshaw D., 2004, DUKES PHYSL DOMESTIC; Roy D, 2000, J INFECTION, V40, P184, DOI 10.1016/S0163-4453(00)80014-6; Sabatini S, 2013, J MED CHEM, V56, P4975, DOI 10.1021/jm400262a; Saleem BR, 2010, AM J SURG, V200, P47, DOI 10.1016/j.amjsurg.2009.05.018; Stenger M, 2016, J CONTROL RELEASE, V241, P125, DOI 10.1016/j.jconrel.2016.09.018; Stenger M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135571; Swain Timothy W 3rd, 2004, Vasc Endovascular Surg, V38, P75, DOI 10.1177/153857440403800110; Thorn HA, 2011, EUR J PHARM SCI, V43, P89, DOI 10.1016/j.ejps.2011.03.008; Thorsing M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064518; Wojcikowski J, 2006, DRUG METAB DISPOS, V34, P471, DOI 10.1124/dmd.105.006445; Yasuda K, 2008, DRUG METAB DISPOS, V36, P1689, DOI 10.1124/dmd.108.020701; Yeager R A, 1996, Adv Surg, V29, P33	45	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173362	10.1371/journal.pone.0173362	http://dx.doi.org/10.1371/journal.pone.0173362			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278183	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900077
J	Bryant, J; Winer, ES; Salem, T; Nadorff, MR				Bryant, Jessica; Winer, E. Samuel; Salem, Taban; Nadorff, Michael R.			Struggling toward reward: Recent experience of anhedonia interacts with motivation to predict reward pursuit in the face of a stressful manipulation	PLOS ONE			English	Article							ACTION ORIENTATION; STATE ORIENTATION; SUICIDAL IDEATION; MAJOR DEPRESSION; INDIVIDUALS; MODELS; INFORMATION; VALIDATION; DOPAMINE; DISORDER	Anhedonia, or the loss of interest and/or pleasure, is a core symptom of depression. Individuals experiencing anhedonia have difficulty motivating themselves to pursue rewarding stimuli, which can result in dysfunction. Action orientation is a motivational factor that might interact with anhedonia to potentially buffer against this dysfunction, as action-oriented individuals upregulate positive affect to quickly motivate themselves to complete goals in the face of stress. The Effort-Expenditure for Rewards Task (EEfRT) is a promising new method for examining differences in motivation in individuals experiencing anhedonia. In the EEfRT, participants choose either easier tasks associated with smaller monetary rewards or harder tasks associated with larger monetary rewards. We examined the relationship between action orientation and EEfRT performance following a negative mood induction in a sample with varying levels of anhedonia. There were two competing hypotheses: (1) action orientation would act as a buffer against anhedonia such that action-oriented individuals, regardless of anhedonic symptoms, would be motivated to pursue greater rewards despite stress, or (2) anhedonia would act as a debilitating factor such that individuals with elevated anhedonic symptoms, regardless of action orientation, would not pursue greater rewards. We examined these hypotheses via Generalized Estimating Equations and found an interaction between anhedonia and action orientation. At low levels of anhedonia, action orientation was associated with effort for reward, but this relationship was not present at high levels of anhedonia. Thus, at low levels of anhedonia, action orientation acted as a buffer against stress, but at high levels, anhedonia debilitated action orientation so that it was no longer a promotive factor.	[Bryant, Jessica; Winer, E. Samuel; Salem, Taban; Nadorff, Michael R.] Mississippi State Univ, Dept Psychol, Starkville, MS 39759 USA; [Nadorff, Michael R.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Mississippi State University; Baylor College of Medicine	Bryant, J (corresponding author), Mississippi State Univ, Dept Psychol, Starkville, MS 39759 USA.	jcs579@msstate.edu	Nadorff, Michael/AFL-6299-2022	Nadorff, Michael/0000-0002-8107-7514; Winer, E. Samuel/0000-0002-3817-874X				Admon R, 2015, BIOL PSYCHIAT, V78, P67, DOI 10.1016/j.biopsych.2014.09.019; [Anonymous], 2000, INT J EDUC RES, DOI [10.1016/S0883-0355(00)00045-8, DOI 10.1016/S0883-0355(00)00045-8]; Bartoszek G., 2016, COGNITION EMOTION, V7, P1, DOI DOI 10.1080/02699931.2016.1225004; Bartoszek G, 2015, J BEHAV THER EXP PSY, V46, P1, DOI 10.1016/j.jbtep.2014.07.012; BECKMANN J, 1984, J RES PERS, V18, P224, DOI 10.1016/0092-6566(84)90031-X; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Blunt A, 1998, PERS INDIV DIFFER, V24, P837, DOI 10.1016/S0191-8869(98)00018-X; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; Diefendorff JM, 2000, J APPL PSYCHOL, V85, P250, DOI 10.1037/0021-9010.85.2.250; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Gard DE, 2006, J RES PERS, V40, P1086, DOI 10.1016/j.jrp.2005.11.001; Geaney JT, 2015, TRAIT ANTICIPATORY P, V10, DOI [10.1371/journal.pone.0131357, DOI 10.1371/JOURNAL.PONE.0131357]; Gotlib IH, 1988, COGNITION EMOTION, V2, P185, DOI 10.1080/02699938808410923; Hardin JW, 2012, GEN ESTIMATING EQUAT; Joiner TE, 2003, PSYCHIAT RES, V119, P243, DOI 10.1016/S0165-1781(03)00131-8; Jostmann NB, 2006, PERS SOC PSYCHOL B, V32, P1716, DOI 10.1177/0146167206292595; Kazen M, 2008, J RES PERS, V42, P693, DOI 10.1016/j.jrp.2007.09.005; Koole SL, 2011, COGNITION EMOTION, V25, P440, DOI 10.1080/02699931.2010.544891; Kuhl J., 1994, VOLITION PERSONALITY, P47; Kuhl J., 2004, HDB EXPT EXISTENTIAL, P411; MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037/0033-2909.114.2.376; MENEC VH, 1995, J EXP EDUC, V63, P281, DOI 10.1080/00220973.1995.9943465; Pizzagalli DA, 2005, BIOL PSYCHIAT, V57, P319, DOI 10.1016/j.biopsych.2004.11.026; SALAMONE JD, 1994, PHARMACOL BIOCHEM BE, V49, P25, DOI 10.1016/0091-3057(94)90452-9; Tabachnick B. G.., 2012, USING MULTIVARIATE S; Treadway MT, 2015, SCHIZOPHR RES, V161, P382, DOI 10.1016/j.schres.2014.11.024; Treadway MT, 2013, CURR DIR PSYCHOL SCI, V22, P244, DOI 10.1177/0963721412474460; Treadway MT, 2012, J ABNORM PSYCHOL, V121, P553, DOI 10.1037/a0028813; Treadway MT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006598; Wardle MC, 2011, J NEUROSCI, V31, P16597, DOI 10.1523/JNEUROSCI.4387-11.2011; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Whitton AE, 2015, CURR OPIN PSYCHIATR, V28, P7, DOI 10.1097/YCO.0000000000000122; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Winer ES, 2016, J CLIN PSYCHOL, V72, P947, DOI 10.1002/jclp.22298; Winer ES, 2016, ARCH SUICIDE RES, V20, P265, DOI 10.1080/13811118.2015.1025119; Winer ES, 2016, PSYCHOL BULL, V142, P18, DOI 10.1037/bul0000022; Winer ES, 2014, PSYCHIAT RES, V218, P124, DOI 10.1016/j.psychres.2014.04.016; Winer ES, 2014, J AFFECT DISORDERS, V152, P193, DOI 10.1016/j.jad.2013.09.010; Winer ES, 2011, PERS INDIV DIFFER, V51, P996, DOI 10.1016/j.paid.2011.08.010	41	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173439	10.1371/journal.pone.0173439	http://dx.doi.org/10.1371/journal.pone.0173439			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273126	Green Submitted, Green Published, gold			2022-12-26	WOS:000396073700002
J	Yan, D; Xiang, GX; Chai, XP; Qing, J; Shang, HQ; Zou, B; Mittal, R; Shen, J; Smith, RJH; Fan, YS; Blanton, SH; Tekin, M; Morton, C; Xing, WL; Cheng, J; Liu, XZ				Yan, Denise; Xiang, Guangxin; Chai, Xingping; Qing, Jie; Shang, Haiqiong; Zou, Bing; Mittal, Rahul; Shen, Jun; Smith, Richard J. H.; Fan, Yao-Shan; Blanton, Susan H.; Tekin, Mustafa; Morton, Cynthia; Xing, Wanli; Cheng, Jing; Liu, Xue Zhong			Screening of deafness-causing DNA variants that are common in patients of European ancestry using a microarray-based approach	PLOS ONE			English	Article							VESTIBULAR AQUEDUCT DFNB4; 26 GENE GJB2; HEARING-LOSS; PENDRED-SYNDROME; RECESSIVE DEAFNESS; MUTATION DETECTION; TRANSFER-RNA; CONNEXIN-26; IVS2-2A-GREATER-THAN-G; MULTICENTER	The unparalleled heterogeneity in genetic causes of hearing loss along with remarkable differences in prevalence of causative variants among ethnic groups makes single gene tests technically inefficient. Although hundreds of genes have been reported to be associated with nonsyndromic hearing loss (NSHL), GJB2, GJB6, SLC26A4, and mitochondrial (mt) MT-RNR1 and MTTS are the major contributors. In order to provide a faster, more comprehensive and cost effective assay, we constructed a DNA fluidic array, CapitalBioMiamiOtoArray, for the detection of sequence variants in five genes that are common in most populations of European descent. They consist of c.35delG, p.W44C, p.L90P, c.167delT (GJB2); 309kb deletion (GJB6); p.L236P, p.T416P (SLC26A4); and m.1555A>G, m.7444G>A (mtDNA). We have validated our hearing loss array by analyzing a total of 160 DNAs samples. Our results show 100% concordance between the fluidic array biochip-based approach and the established Sanger sequencing method, thus proving its robustness and reliability at a relatively low cost.	[Yan, Denise; Qing, Jie; Shang, Haiqiong; Zou, Bing; Mittal, Rahul; Blanton, Susan H.; Tekin, Mustafa; Liu, Xue Zhong] Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA; [Xiang, Guangxin; Chai, Xingping; Xing, Wanli; Cheng, Jing] Natl Engn Res Ctr Beijing Biochip Technol, Beijing, Peoples R China; [Chai, Xingping; Xing, Wanli; Cheng, Jing; Liu, Xue Zhong] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Shen, Jun; Morton, Cynthia] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Shen, Jun; Morton, Cynthia] Harvard Med Sch, Boston, MA USA; [Shen, Jun] Partners Personalized Med, Mol Med Lab, Cambridge, MA USA; [Smith, Richard J. H.] Univ Iowa, Carver Coll Med, Dept Otolaryngol Head & Neck Surg, Iowa City, IA USA; [Fan, Yao-Shan; Blanton, Susan H.; Tekin, Mustafa] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Fan, Yao-Shan; Liu, Xue Zhong] Univ Miami, Miller Sch Med, Dr John T Macdonald Dept Human Genet, Miami, FL 33136 USA; [Fan, Yao-Shan; Liu, Xue Zhong] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genet, Miami, FL 33136 USA; [Morton, Cynthia] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, 75 Francis St, Boston, MA 02115 USA; [Morton, Cynthia] Univ Manchester, Div Evolut & Genom Sci, Sch Biol Sci, Manchester Acad Hlth Sci Ctr, Manchester M13 9PL, Lancs, England	University of Miami; Tsinghua University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Iowa; University of Miami; University of Miami; University of Miami; Harvard University; Brigham & Women's Hospital; University of Manchester	Liu, XZ (corresponding author), Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA.; Cheng, J (corresponding author), Natl Engn Res Ctr Beijing Biochip Technol, Beijing, Peoples R China.; Cheng, J; Liu, XZ (corresponding author), Tsinghua Univ, Sch Med, Beijing, Peoples R China.; Liu, XZ (corresponding author), Univ Miami, Miller Sch Med, Dr John T Macdonald Dept Human Genet, Miami, FL 33136 USA.; Liu, XZ (corresponding author), Univ Miami, Miller Sch Med, John P Hussman Inst Human Genet, Miami, FL 33136 USA.	jcheng@tsinghua.edu.cn; xliu@med.miami.edu	Blanton, Susan Halloran/ABF-1323-2021; Tekin, Mustafa/ABG-7627-2020	Smith, Richard/0000-0003-1201-6731; Tekin, Mustafa/0000-0002-3525-7960	National Institutes of Health/National Institute on Deafness and Other Communication Disorders [R01 DC05575, R01 DC01246, R01 DC012115, R01 DC015052]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005575, R01DC009645, R01DC015052, R01DC012115] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	XZL's research is supported by R01 DC05575, R01 DC01246, and R01 DC012115 (National Institutes of Health/National Institute on Deafness and Other Communication Disorders). CCM and JS are supported by R01 DC015052 (National Institutes of Health/National Institute on Deafness and Other Communication Disorders). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; XZL's research is supported by R01 DC05575, R01 DC01246, and R01 DC012115 (National Institutes of Health/National Institute on Deafness and Other Communication Disorders). CCM and JS are supported by R01 DC015052 (National Institutes of Health/National Institute on Deafness and Other Communication Disorders) and acknowledge the support of David and Sharon Neskey. We thank Dr. Andrew Griffith and Parna Chattaraj (National Institute on Deafness and Other Communication Disorders) for providing the control DNA samples with the known GJB2 and SLC26A4 mutations.	Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41; [Anonymous], 2012, PREV BLINDN DEAFN; Arnos KS, 2003, EAR HEARING, V24, P324, DOI 10.1097/01.AUD.0000079800.64741.CF; Martins FTA, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-112; BarskyFirkser L, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.6.e4; Cremers FPM, 2007, J MED GENET, V44, P153, DOI 10.1136/jmg.2006.044784; Cremonesi L, 2007, HEMOGLOBIN, V31, P289, DOI 10.1080/03630260701459366; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; del Castillo I, 2003, AM J HUM GENET, V73, P1452, DOI 10.1086/380205; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Johnson JL, 2005, PEDIATRICS, V116, P663, DOI 10.1542/peds.2004-1688; Kennedy CR, 2006, NEW ENGL J MED, V354, P2131, DOI 10.1056/NEJMoa054915; Kenneson A, 2002, GENET MED, V4, P258, DOI 10.1097/00125817-200207000-00004; Keren R, 2002, PEDIATRICS, V110, P855, DOI 10.1542/peds.110.5.855; Kothiyal P, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-10; Li CX, 2008, HUM MUTAT, V29, P306, DOI 10.1002/humu.20622; Liu XZ, 2002, HUM GENET, V111, P394, DOI 10.1007/s00439-002-0811-6; LONGO MC, 1990, GENE, V93, P125, DOI 10.1016/0378-1119(90)90145-H; Marres HA, 1998, DIS OF THE EAR; Mason JA, 1998, PEDIATRICS, V101, P221, DOI 10.1542/peds.101.2.221; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Pandya A, 2003, GENET MED, V5, P295, DOI 10.1097/01.GIM.0000078026.01140.68; Pandya A, 1999, AM J HUM GENET, V65, P1803, DOI 10.1086/302658; Park HJ, 2000, LARYNGOSCOPE, V110, P1535, DOI 10.1097/00005537-200009000-00023; Parving A, 1999, ACTA PAEDIATR, V88, P69, DOI 10.1080/080352599750029439; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Rodriguez-Paris J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011804; Tang HY, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-30; Tang HY, 2002, GENET MED, V4, P336, DOI 10.1097/00125817-200209000-00004; Teek R, 2009, INT J PEDIATR OTORHI, V73, P103, DOI 10.1016/j.ijporl.2008.10.003; Usami SI, 2008, ACTA OTO-LARYNGOL, V128, P446, DOI 10.1080/00016480701785046; Van Hauwe P, 1998, HUM MOL GENET, V7, P1099, DOI 10.1093/hmg/7.7.1099; Vohr BR, 1998, J PEDIATR-US, V133, P353, DOI 10.1016/S0022-3476(98)70268-9; Waldmuller S, 2008, CLIN CHEM, V54, P682, DOI 10.1373/clinchem.2007.099119; Wu CC, 2010, AUDIOL NEURO-OTOL, V15, P57, DOI 10.1159/000231567; Xing GQ, 2007, CELL RES, V17, P227, DOI 10.1038/sj.cr.7310124; Yan D, 2003, HUM GENET, V114, P44, DOI 10.1007/s00439-003-1018-1; Yang T, 2007, AM J HUM GENET, V80, P1055, DOI 10.1086/518314; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605; Zhang GB, 2011, BIOSENS BIOELECTRON, V26, P4708, DOI 10.1016/j.bios.2011.05.031; Zhu J, 2014, JALA-J LAB AUTOM, V19, P144, DOI 10.1177/2211068213491096	42	18	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0169219	10.1371/journal.pone.0169219	http://dx.doi.org/10.1371/journal.pone.0169219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273078	gold, Green Published, Green Submitted			2022-12-26	WOS:000396073700090
J	Chani, B; Puri, V; Sobti, RC; Jha, V; Puri, S				Chani, Baldeep; Puri, Veena; Sobti, Ranbir C.; Jha, Vivekanand; Puri, Sanjeev			Decellularized scaffold of cryopreserved rat kidney retains its recellularization potential	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MARROW-DERIVED CELLS; MULTIPOTENT STROMAL CELLS; BONE-MARROW; EXTRACELLULAR-MATRIX; INJURED TISSUES; REPAIR; REGENERATION; CONTRIBUTE; HOME	The multi-cellular nature of renal tissue makes it the most challenging organ for regeneration. Therefore, till date whole organ transplantations remain the definitive treatment for the end stage renal disease (ESRD). The shortage of available organs for the transplantation has, thus, remained a major concern as well as an unsolved problem. In this regard generation of whole organ scaffold through decellularization followed by regeneration of the whole organ by recellularization is being viewed as a potential alternative for generating functional tissues. Despite its growing interest, the optimal processing to achieve functional organ still remains unsolved. The biggest challenge remains is the time line for obtaining kidney. Keeping these facts in mind, we have assessed the effects of cryostorage (3 months) on renal tissue architecture and its potential for decellularization and recellularization in comparison to the freshly isolated kidneys. The light microscopy exploiting different microscopic stains as well as immuno-histochemistry and Scanning electron microscopy (SEM) demonstrated that ECM framework is well retained following kidney cryopreservation. The strength of these structures was reinforced by calculating mechanical stress which confirmed the similarity between the freshly isolated and cryopreserved tissue. The recellularization of these bio-scaffolds, with mesenchymal stem cells quickly repopulated the decellularized structures irrespective of the kidneys status, i.e. freshly isolated or the cryopreserved. The growth pattern employing mesenchymal stem cells demonstrated their equivalent recellularization potential. Based on these observations, it may be concluded that cryopreserved kidneys can be exploited as scaffolds for future development of functional organ.	[Chani, Baldeep; Puri, Sanjeev] Panjab Univ, Ctr Stem Cell Tissue Engn & Biomed Excellence, Chandigarh, India; [Puri, Veena] Panjab Univ, Ctr Syst Biol & Bioinformat, Chandigarh, India; [Sobti, Ranbir C.] Panjab Univ, Dept Biotechnol, Chandigarh, India; [Jha, Vivekanand] George Inst Global Hlth India, Dept Nephrol, New Delhi, India; [Jha, Vivekanand] Univ Oxford, New Delhi, India; [Puri, Sanjeev] Panjab Univ, Univ Inst Engn & Technol, Biotechnol Branch, Chandigarh, India	Panjab University; Panjab University; Panjab University; University of Oxford; Panjab University	Puri, S (corresponding author), Panjab Univ, Ctr Stem Cell Tissue Engn & Biomed Excellence, Chandigarh, India.; Puri, S (corresponding author), Panjab Univ, Univ Inst Engn & Technol, Biotechnol Branch, Chandigarh, India.	spuri_1111@yahoo.com	sobti, ranbir/AAX-8037-2021; puri, veena/AAH-7207-2021	Puri, Sanjeev/0000-0002-4314-9871; puri, veena/0000-0002-0639-5897; Puri, Sanjeev/0000-0002-3967-987X; Jha, Vivekanand/0000-0002-8015-9470	Council of Scientific and Industrial Research (CSIR), New Delhi, India [09/135(0681)/2012-EMR-I]; PURSE Grant from Department of Science and Technology, New Delhi [136-137/RPC/3/6/2016- 38/RPC/29/4/2016]	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); PURSE Grant from Department of Science and Technology, New Delhi	This work is funded by Council of Scientific and Industrial Research (CSIR), New Delhi, India (BC, Fellowship award no. 09/135(0681)/2012-EMR-I), and PURSE Grant from Department of Science and Technology, New Delhi, to Center for Stem Cell and Tissue Engineering, Panjab University Chandigarh, India (vide letters no.136-137/RPC/3/6/2016- 38/RPC/29/4/2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AH, 2010, LAB INVEST, V90, P985, DOI 10.1038/labinvest.2010.86; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067; Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Bonandrini B, 2014, TISSUE ENG PT A, V20, P1486, DOI [10.1089/ten.tea.2013.0269, 10.1089/ten.TEA.2013.0269]; Burgkart R, 2014, TISSUE ENG PART C-ME, V20, P553, DOI [10.1089/ten.tec.2013.0270, 10.1089/ten.TEC.2013.0270]; Chapel A, 2003, J GENE MED, V5, P1028, DOI 10.1002/jgm.452; Choi S, 2009, STEM CELLS DEV, V18, P521, DOI 10.1089/scd.2008.0097; Cortiella J, 2010, TISSUE ENG PT A, V16, P2565, DOI 10.1089/ten.tea.2009.0730; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; El-Ansary M, 2012, NEPHROLOGY, V17, P650, DOI 10.1111/j.1440-1797.2012.01622.x; Ezquer FE, 2008, BIOL BLOOD MARROW TR, V14, P631, DOI 10.1016/j.bbmt.2008.01.006; Franquesa M, 2012, STEM CELLS DEV, V21, P3125, DOI 10.1089/scd.2012.0096; Freytes DO, 2008, J BIOMED MATER RES B, V84B, P408, DOI 10.1002/jbm.b.30885; Gratzer PF, 2006, TISSUE ENG, V12, P2975, DOI 10.1089/ten.2006.12.2975; Hayakawa M, 2005, PEDIATR RES, V58, P323, DOI 10.1203/01.PDR.0000169997.45684.05; Humphreys BD, 2008, ANNU REV MED, V59, P311, DOI 10.1146/annurev.med.59.061506.154239; Ikarashi K, 2005, KIDNEY INT, V67, P1925, DOI 10.1111/j.1523-1755.2005.00291.x; Imasawa T, 2001, J AM SOC NEPHROL, V12, P1401, DOI 10.1681/ASN.V1271401; Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di; Ito T, 2001, J AM SOC NEPHROL, V12, P2625, DOI 10.1681/ASN.V12122625; Ito T, 2001, EXP NEPHROL, V9, P444; Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Miner JH, 1999, KIDNEY INT, V56, P2016, DOI 10.1046/j.1523-1755.1999.00785.x; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Mouiseddine M, 2007, BRIT J RADIOL, V80, pS49, DOI 10.1259/bjr/25927054; Nakamura K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054036, 10.1371/journal.pone.0074720, 10.1371/journal.pone.0064134]; Nakayama KH, 2010, TISSUE ENG PT A, V16, P2207, DOI [10.1089/ten.tea.2009.0602, 10.1089/ten.TEA.2009.0602]; Nasef A, 2009, INT J LAB HEMATOL, V31, P9, DOI 10.1111/j.1751-553X.2007.00997.x; Nasef A, 2007, TRANSPLANTATION, V84, P231, DOI 10.1097/01.tp.0000267918.07906.08; Nasef A, 2007, GENE EXPRESSION, V13, P217; O'Neill JD, 2013, BIOMATERIALS, V34, P9830, DOI 10.1016/j.biomaterials.2013.09.022; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Poulsom R, 2001, J PATHOL, V195, P229, DOI 10.1002/path.976; Prodromidi EI, 2006, STEM CELLS, V24, P2448, DOI 10.1634/stemcells.2006-0201; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; Rookmaaker MB, 2003, AM J PATHOL, V163, P553, DOI 10.1016/S0002-9440(10)63683-8; Ross EA, 2009, J AM SOC NEPHROL, V20, P2338, DOI 10.1681/ASN.2008111196; Sambanis A, 2000, Diabetes Technol Ther, V2, P81, DOI 10.1089/152091599316784; Semedo P, 2009, STEM CELLS, V27, P3063, DOI 10.1002/stem.214; Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717; Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P7321, DOI 10.1073/pnas.0601436103; Sullivan DC, 2012, BIOMATERIALS, V33, P7756, DOI 10.1016/j.biomaterials.2012.07.023; Tang HL, 2012, ULTRASOUND MED BIOL, V38, P661, DOI 10.1016/j.ultrasmedbio.2012.01.003; Totonelli G, 2012, BIOMATERIALS, V33, P3401, DOI 10.1016/j.biomaterials.2012.01.012; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Volarevic V, 2011, STEM CELLS, V29, P5, DOI 10.1002/stem.556; Wang Y, 2005, HEPATOLOGY, V53, P293; Wise AF, 2012, NEPHROLOGY, V17, P1, DOI 10.1111/j.1440-1797.2011.01501.x; Yen TH, 2007, CELL PROLIFERAT, V40, P143, DOI 10.1111/j.1365-2184.2007.00423.x	54	25	29	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173040	10.1371/journal.pone.0173040	http://dx.doi.org/10.1371/journal.pone.0173040			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267813	Green Published, Green Submitted, gold			2022-12-26	WOS:000396060600009
J	Chen, Q; Li, N; Wang, X; Ma, L; Huang, JB; Huang, GH				Chen, Qi; Li, Ni; Wang, Xing; Ma, Li; Huang, Jian-Bin; Huang, Guo-Hua			Age-stage, two-sex life table of Parapoynx crisonalis (Lepidoptera: Pyralidae) at different temperatures	PLOS ONE			English	Article							DIFFERENT BEAN CULTIVARS; CONSTANT TEMPERATURES; SPODOPTERA-EXIGUA; APHIDIDAE; PARAMETERS; NOCTUIDAE; HYMENOPTERA; POPULATION; HOMOPTERA; HEMIPTERA	Parapoynx crisonalis is an important pest of many aquatic vegetables including water chestnuts. Understanding the relationship between temperature variations and the population growth rates of P. crisonalis is essential to predicting its population dynamics in water chestnuts ponds. These relationships were examined in this study based on the age-stage, two-sex life table of P. crisonalis developed in the laboratory at 21, 24, 27, 30, 33 and 36 degrees C. The results showed that the values of S-xj (age-stage-specific survival rate), f(xj) (age-stage-specific fecundity), l(x) (age specific survival rate) and m(x) (age-specific fecundity) increased as the temperature rose from 21 to 27 degrees C, then decreased from 30 to 36 degrees C. Temperature also had a significant effect on the net reproductive rate (R-0), gross reproductive rate (GRR), intrinsic rate of increase (r) and finite rate of increase (gimel.). The value of these parameters were at low levels at 21, 33, and 36 degrees C. Further, the r value decreased as the temperature rose from 24 to 30 degrees C, while the GRR reached its highest level at 27 degrees C. The results indicated that optimal growth and development of P. crisonalis occurred at temperatures between 24 degrees C to 30 degrees C when compared to the lowest temperature (21 degrees C) and higher temperatures of 33 degrees C and 36 degrees C.	[Chen, Qi; Li, Ni; Wang, Xing; Ma, Li; Huang, Guo-Hua] Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China; [Chen, Qi; Li, Ni; Wang, Xing; Ma, Li; Huang, Jian-Bin; Huang, Guo-Hua] Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China	Hunan Agricultural University	Huang, GH (corresponding author), Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China.; Huang, GH (corresponding author), Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China.	ghhuang@hunau.edu.cn			National Scientific and Technological Supporting Program of China [2012BAD27602]	National Scientific and Technological Supporting Program of China	The present research was supported by a grant from the National Scientific and Technological Supporting Program of China (No. 2012BAD27602). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami S, 2014, ARTHROPOD-PLANT INTE, V8, P475, DOI 10.1007/s11829-014-9330-3; Bennett C.A., 1999, P 10 INT S BIOL CONT, P307; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; Carey JR, 1993, APPL DEMOGRAPHY BIOL, P211; Chen FQ, 2006, AQUAT INSECT, V28, P291, DOI 10.1080/01650420601099204; Chi H, 2006, ENVIRON ENTOMOL, V35, P10, DOI 10.1603/0046-225X-35.1.10; CHI H, 1988, ENVIRON ENTOMOL, V17, P26, DOI 10.1093/ee/17.1.26; CHI H, 1988, ENVIRON ENTOMOL, V17, P18, DOI 10.1093/ee/17.1.18; CHI H, 1990, J ECON ENTOMOL, V83, P1143, DOI 10.1093/jee/83.4.1143; CHI H, 1985, Bulletin of the Institute of Zoology Academia Sinica (Taipei), V24, P225; Cividanes Francisco J., 2003, Bragantia, V62, P61, DOI 10.1590/S0006-87052003000100008; Davis T., 2012, REV STATUS MICROLEPI; DEEVEY ES, 1947, Q REV BIOL, V22, P283, DOI 10.1086/395888; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fernandes FS, 2013, FLA ENTOMOL, V96, P92, DOI 10.1653/024.096.0112; Golizadeh Ali, 2009, Journal of Asia-Pacific Entomology, V12, P207, DOI 10.1016/j.aspen.2009.05.002; GOODMAN D, 1982, AM NAT, V119, P803, DOI 10.1086/283956; Habeck DH, 2005, AUST J ENTOMOL, V44, P354, DOI 10.1111/j.1440-6055.2005.00503.x; Huang G. H., 2013, COLOR HDB INSECT PES, P109; Huang YB, 2013, J APPL ENTOMOL, V137, P327, DOI 10.1111/jen.12002; Huang Yu-Bing, 2012, Insect Science, V19, P263, DOI 10.1111/j.1744-7917.2011.01424.x; Jha K. R., 2012, ENVIRON ENTOMOL, V41, P30; Karimi-Malati A, 2014, J ASIA-PAC ENTOMOL, V17, P349, DOI 10.1016/j.aspen.2014.03.002; Karimi-Malati A, 2014, ENVIRON ENTOMOL, V43, P795, DOI 10.1603/EN11272; Khanamani M, 2013, INT J ACAROL, V39, P638, DOI 10.1080/01647954.2013.861867; Marchioro CA, 2011, NEOTROP ENTOMOL, V40, P533, DOI 10.1590/S1519-566X2011000500003; Mehrparvar M, 2007, EUR J ENTOMOL, V104, P631, DOI 10.14411/eje.2007.078; Naseri B, 2014, J AGR SCI TECH-IRAN, V16, P19; Park HH, 2014, J ASIA-PAC ENTOMOL, V17, P83, DOI 10.1016/j.aspen.2013.11.003; Ramalho FS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122490; Ratte H.T., 1985, P33; Razmjou J, 2006, J ECON ENTOMOL, V99, P1820, DOI 10.1603/0022-0493-99.5.1820; Southwood TRE, 2000, ECOLOGICAL METHODS; Southwood TRE., 1978, ECOLOGICAL METHODS P; Speidel Wolfgang, 1999, Tijdschrift voor Entomologie, V142, P125; Tanaka F, 1978, JAPANESE J APPL ENTO; Vasicek A, 2002, PESQUI AGROPECU BRAS, V37, P407, DOI 10.1590/S0100-204X2002000300023; Yen Shen-Horn, 2004, P545; Yu JZ, 2013, BIOL CONTROL, V64, P1, DOI 10.1016/j.biocontrol.2012.10.002; Yu-Bing H., 2011, J AGR FOOD RES, V60, P337; Zhang P, 2015, PHYTOPARASITICA, V43, P107, DOI 10.1007/s12600-014-0420-7; Zhang ZJ, 2007, J APPL ENTOMOL, V131, P347, DOI 10.1111/j.1439-0418.2007.01186.x; Zhu FL, 2015, AUSTRAL ENTOMOL, V54, P71, DOI 10.1111/aen.12094	43	35	38	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173380	10.1371/journal.pone.0173380	http://dx.doi.org/10.1371/journal.pone.0173380			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264022	Green Published, Green Submitted, gold			2022-12-26	WOS:000396054300061
J	Takahashi, M; Nishida, S; Nakamura, M; Kobayashi, M; Matsui, K; Ito, E; Usui, A; Inoue, Y				Takahashi, Masayoshi; Nishida, Shingo; Nakamura, Masaki; Kobayashi, Mina; Matsui, Kentaro; Ito, Eiki; Usui, Akira; Inoue, Yuichi			Restless legs syndrome augmentation among Japanese patients receiving pramipexole therapy: Rate and risk factors in a retrospective study	PLOS ONE			English	Article							SYNDROME RLS; RATING-SCALE; MANAGEMENT; ASSOCIATION; DIAGNOSIS; CONSENSUS; LEVODOPA; FERRITIN	To investigate the rate of and risk factors for restless legs syndrome (RLS) augmentation in Japanese patients receiving pramipexole (PPX) treatment. Records of 231 consecutive patients with idiopathic RLS who received PPX therapy for more than one month in a single sleep disorder center were analyzed retrospectively. Augmentation was diagnosed based on the Max Planck Institute criteria; associated factors were identified by logistic regression analysis. Mean age at PPX initiation was 60.6 +/- 14.9 years and mean treatment duration was 48.5 +/- 26.4 months. Augmentation was diagnosed in 21 patients (9.1%). Daily PPX dose and treatment duration were significantly associated with augmentation. By analyzing the receiver operating characteristic curve, a PPX dose of 0.375 mg/day was found to be the optimal cut-off value for predicting augmentation. After stratifying patients according to PPX treatment duration, at median treatment duration of 46 months, optimal cut-off values for daily doses were 0.375 and 0.500 mg/day for <46 months and >= 46 months of treatment, respectively. The RLS augmentation with PPX treatment in Japanese patients was occurred at rate of 9.1%, being quite compatible with previously reported rates in Caucasian patients. The symptom could appear within a relatively short period after starting the treatment in possibly vulnerable cases even with a smaller drug dose. Our results support the importance of keeping doses of PPX low throughout the RLS treatment course to prevent augmentation.	[Takahashi, Masayoshi; Nakamura, Masaki; Ito, Eiki; Inoue, Yuichi] Tokyo Med Univ, Dept Somnol, Tokyo, Japan; [Nishida, Shingo; Nakamura, Masaki; Kobayashi, Mina; Matsui, Kentaro; Ito, Eiki; Usui, Akira; Inoue, Yuichi] Neuropsychiat Res Inst, Japan Somnol Ctr, Tokyo, Japan; [Nishida, Shingo] Maezawa Hosp, Ashikaga, Tochigi, Japan; [Matsui, Kentaro] Tokyo Womens Med Univ, Dept Psychiat, Tokyo, Japan	Tokyo Medical University; Tokyo Women's Medical University	Inoue, Y (corresponding author), Tokyo Med Univ, Dept Somnol, Tokyo, Japan.; Inoue, Y (corresponding author), Neuropsychiat Res Inst, Japan Somnol Ctr, Tokyo, Japan.	inoue@somnology.com		Matsui, Kentaro/0000-0003-4538-5381	JSPS KAKENHI Grant [24621011]; Health and Labour Sciences Research Grants for Comprehensive Research on Persons with Disabilities from the Japan Agency for Medical Research and Development	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health and Labour Sciences Research Grants for Comprehensive Research on Persons with Disabilities from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported by JSPS KAKENHI Grant Number 24621011 and the Health and Labour Sciences Research Grants for Comprehensive Research on Persons with Disabilities from the Japan Agency for Medical Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RP, 2011, SLEEP MED, V12, P431, DOI 10.1016/j.sleep.2011.03.003; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Ferini-Strambi L, 2002, SLEEP MED, V3, pS23, DOI 10.1016/S1389-9457(02)00144-2; Frauscher B, 2009, SLEEP MED, V10, P611, DOI 10.1016/j.sleep.2008.09.007; Garcia-Borreguero D, 2007, SLEEP MED, V8, P520, DOI 10.1016/j.sleep.2007.03.022; Garci-Borreguero D, 2007, SLEEP MED, V8, P455, DOI 10.1016/j.sleep.2007.03.023; Garcia-Borreguero D, 2013, SLEEP MED, V14, P675, DOI 10.1016/j.sleep.2013.05.016; Garcia-Borreguero D, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-28; Garcia-Borreguero D, 2010, SLEEP MED REV, V14, P339, DOI 10.1016/j.smrv.2009.11.006; Hening WA, 2009, SLEEP MED, V10, P976, DOI 10.1016/j.sleep.2008.09.015; Hogl B, 2011, SLEEP MED, V12, P351, DOI 10.1016/j.sleep.2010.12.007; Inoue Y, 2013, PSYCHIAT CLIN NEUROS, V67, P412, DOI 10.1111/pcn.12074; Jeon JY, 2015, SLEEP BREATH, V19, P523, DOI 10.1007/s11325-014-1041-6; Lipford MC, 2012, SLEEP MED, V13, P1280, DOI 10.1016/j.sleep.2012.08.004; Silber MH, 2003, SLEEP, V26, P819, DOI 10.1093/sleep/26.7.819; Silver N, 2011, SLEEP MED, V12, P440, DOI 10.1016/j.sleep.2010.11.002; Trenkwalder C, 2008, SLEEP MED, V9, P572, DOI 10.1016/j.sleep.2007.07.020; Trenkwalder C, 2015, NAT REV NEUROL, V11, P434, DOI 10.1038/nrneurol.2015.122; Winkelman JW, 2004, SLEEP MED, V5, P9, DOI 10.1016/j.sleep.2003.07.005	19	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173535	10.1371/journal.pone.0173535	http://dx.doi.org/10.1371/journal.pone.0173535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264052	Green Published, Green Submitted, gold			2022-12-26	WOS:000396054300069
J	Berdugo-Cely, J; Valbuena, RI; Sanchez-Betancourt, E; Barrero, LS; Yockteng, R				Berdugo-Cely, Jhon; Ivan Valbuena, Raul; Sanchez-Betancourt, Erika; Stella Barrero, Luz; Yockteng, Roxana			Genetic diversity and association mapping in the Colombian Central Collection of Solanum tuberosum L. Andigenum group using SNPs markers	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; AGRONOMICAL TRAITS; POTATO GERMPLASM; LATE BLIGHT; R-PACKAGE; SSR; RESISTANCE; SOFTWARE	The potato (Solanum tuberosum L.) is the fourth most important crop food in the world and Colombia has one of the most important collections of potato germplasm in the world (the Colombian Central Collection-CCC). Little is known about its potential as a source of genetic diversity for molecular breeding programs. In this study, we analyzed 809 Andigenum group accessions from the CCC using 5968 SNPs to determine: 1) the genetic diversity and population structure of the Andigenum germplasm and 2) the usefulness of this collection to map qualitative traits across the potato genome. The genetic structure analysis based on principal components, cluster analyses, and Bayesian inference revealed that the CCC can be subdivided into two main groups associated with their ploidy level: Phureja (diploid) and Andigena (tetraploid). The Andigena population was more genetically diverse but less genetically substructured than the Phureja population (three vs. five subpopulations, respectively). The association mapping analysis of qualitative morphological data using 4666 SNPs showed 23 markers significantly associated with nine morphological traits. The present study showed that the CCC is a highly diverse germplasm collection genetically and phenotypically, useful to implement association mapping in order to identify genes related to traits of interest and to assist future potato genetic breeding programs.	[Berdugo-Cely, Jhon; Ivan Valbuena, Raul; Sanchez-Betancourt, Erika; Stella Barrero, Luz; Yockteng, Roxana] Colombian Agr Res Corp CORPOICA Mosquera, Cundinamarca, Colombia; [Yockteng, Roxana] Museum Natl Hist Nat, CNRS, UMR 7205, Paris, France	Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Yockteng, R (corresponding author), Colombian Agr Res Corp CORPOICA Mosquera, Cundinamarca, Colombia.; Yockteng, R (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7205, Paris, France.	ryockteng@corpoica.org.co		Sanchez-Betancourt, Erika/0000-0002-3024-3180; Yockteng, Roxana/0000-0003-2133-6139; Berdugo-Cely, Jhon A./0000-0002-2675-0462	Colombian Ministry of Agriculture (Ministerio de Agricultura y Desarrollo Rural de Colombia); Colombian Ministry of Agriculture	Colombian Ministry of Agriculture (Ministerio de Agricultura y Desarrollo Rural de Colombia); Colombian Ministry of Agriculture	Support was provided by the Colombian Ministry of Agriculture (Ministerio de Agricultura y Desarrollo Rural de Colombia).; We thank the Potato Germplasm Bank of CORPOICA for providing the germplasm material and associated information of the CCC used in this study. The authors thank Ivania Ceron for assistance in revising the final version of the manuscript. This study was funded by the Colombian Ministry of Agriculture.	Abouzied HM, 2013, BRIT BIOTECHNOL J, P390, DOI DOI 10.9734/BBJ/2013/4340; Adetunji I, 2014, THEOR APPL GENET, V127, P559, DOI 10.1007/s00122-013-2239-x; Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Akkale C, 2010, TURK J FIELD CROPS, V15, P73; Alvarez M., 2014, THESIS; Ammar MH, 2015, SAUDI J BIOL SCI, V22, P340, DOI 10.1016/j.sjbs.2015.02.005; Arslanoglu F, 2008, TURK J FIELD CROPS, V13, P70; Arslanoglu F, 2011, AFR J BIOTECHNOL, V10, P922; Azizi A, 2012, CHEM BIODIVERS, V9, P2784, DOI 10.1002/cbdv.201200125; Bernal Ángela María, 2006, Agron. colomb., V24, P226; Bornet B, 2002, GENOME, V45, P481, DOI 10.1139/G02-002; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bradshaw JE., 2006, POTATO RES, V49, P49, DOI [10.1007/s11540-006-9002-5, DOI 10.1007/S11540-006-9002-5]; Brown CR, 2003, AM J POTATO RES, V80, P241, DOI 10.1007/BF02855360; Burlingame B, 2009, J FOOD COMPOS ANAL, V22, P494, DOI 10.1016/j.jfca.2009.09.001; Carputo D, 2003, GENETICS, V163, P287; Carputo D, 2013, PLANT GENET RESOUR-C, V11, P131, DOI 10.1017/S1479262112000500; Chen HD, 2014, MOL PLANT, V7, P541, DOI 10.1093/mp/sst135; CIPAR M. S., 1964, AMER POTATO J, V41, P155, DOI 10.1007/BF02855317; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Das AB, 2010, CROP BREED APPL BIOT, V10, P238, DOI 10.1590/S1984-70332010000300009; del Rio AH, 2002, AM J POTATO RES, V79, P335, DOI 10.1007/BF02870170; Dhoop BB, THEOR APPL; Di Rienzo J. A., 2014, INFOSTAT VERSION 201; Duarte-Delgado D, 2015, THESIS; Ducreux LJM, 2008, J EXP BOT, V59, P4219, DOI 10.1093/jxb/ern264; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eichhorn S, 2005, FOOD RES INT, V38, P943, DOI 10.1016/j.foodres.2005.03.011; Endelman JB, 2016, THEOR APPL GENET, V129, P935, DOI 10.1007/s00122-016-2673-7; Esfahani ST, 2009, CROP BREED APPL BIOT, V9, P75, DOI 10.12702/1984-7033.v09n01a11; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felcher KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036347; Felsenstein J., 2013, PHYLIP PHYLOGENY INF; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Fu YB, 2009, AM J POTATO RES, V86, P38, DOI 10.1007/s12230-008-9059-6; Galani YJH, 2015, J PLANT SCI, V3, P191; Gebhardt C, 2004, MOL BREEDING, V13, P93, DOI 10.1023/B:MOLB.0000012878.89855.df; Ghebreslassie B. M., 2015, American Journal of Plant Sciences, V6, P2122, DOI 10.4236/ajps.2015.613213; Ghislain M, 2006, THEOR APPL GENET, V113, P1515, DOI 10.1007/s00122-006-0399-7; Ghislain M, 2004, THEOR APPL GENET, V108, P881, DOI 10.1007/s00122-003-1494-7; Gomez R., 2006, MANUAL CARACTERIZACI, P26; Guevara, 2011, THESIS; Hackett CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063939; Hamilton JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-302; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hanneman R. E. Jr., 1994, Biosafety for sustainable agriculture: sharing biotechnology regulatory experiences of the Western Hemisphere., P47; Hao DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142585; Hardigan MA, 2014, PLANT GENOME, V8, P1; HAWKES JG, 1990, POTATO EVOLUTION BIO; Hirsch CN, 2013, G3-GENES GENOM GENET, V3, P1003, DOI 10.1534/g3.113.005595; Hoque M. E., 2013, SAARC Journal of Agriculture, V11, P95; Human Z, 2002, AM J BOT, V89, P947, DOI 10.3732/ajb.89.6.947; Jansky SH, 2015, AM J BOT, V102, P1213, DOI 10.3732/ajb.1500203; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Juyo D, 2015, CROP SCI, V55, P760, DOI 10.2135/cropsci2014.07.0524; Karuri HW, 2010, INT J AGRIC BIOL, V12, P33; Keilwagen J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05231; Kujal Sheetal, 2005, Potato Journal (Shimla), V32, P17; Li JQ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-484; Liao H, 2014, ACTA BIOL CRACOV BOT, V56, P16, DOI 10.2478/abcsb-2014-0003; Lindqvist-Kreuze H, 2014, PHYTOPATHOLOGY, V104, P624, DOI 10.1094/PHYTO-10-13-0270-R; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu NJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S26; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Madronero I. C., 2013, Revista Temas Agrarios, V18, P50; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; MANTEL N, 1967, CANCER RES, V27, P209; Massa AN, 2015, G3-GENES GENOM GENET, V5, P2357, DOI 10.1534/g3.115.019646; Mattila P, 2007, J FOOD COMPOS ANAL, V20, P152, DOI 10.1016/j.jfca.2006.05.007; McGregor CE, 2000, EUPHYTICA, V113, P135, DOI 10.1023/A:1003925620546; McGregor CE, 2002, THEOR APPL GENET, V104, P146, DOI 10.1007/s001220200018; Milbourne D, 2007, GENOME MAPPING MOL B, V3, P206; Moreno J, 2006, REV CORPOICA CIENC T, V4, P1; Morris WL, 2008, AM J POTATO RES, V85, P286, DOI 10.1007/s12230-008-9031-5; Mosquera T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156254; Navarro C, 2010, REV CIENC AGRIC, V27, P27; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nunziata A., 2010, American Journal of Plant Sciences, V1, P95, DOI 10.4236/ajps.2010.12012; Obidiegwu JE, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0195-y; Onamu Rose, 2014, Rev. Mex. Cienc. Agríc, V5, P561; Pal BP, 1942, NATURE, V149, P246, DOI 10.1038/149246a0; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Patwardhan A., 2014, J PHYLOGENETICS EVOL, DOI [10.4172/2329-9002.1000131, DOI 10.4172/2329-9002.1000131]; Pavek JJ, 2001, AM J POTATO RES, V78, P433, DOI 10.1007/BF02896375; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pembleton LW, 2013, MOL ECOL RESOUR, V13, P946, DOI 10.1111/1755-0998.12129; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Reid A, 2011, EUPHYTICA, V182, P239, DOI 10.1007/s10681-011-0462-6; Rosyara UR, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.08.0073; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruggieri V, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0337-9; de Galarreta JIR, 2011, GENET RESOUR CROP EV, V58, P383, DOI 10.1007/s10722-010-9583-3; Sakiroglu M, 2012, THEOR APPL GENET, V125, P577, DOI 10.1007/s00122-012-1854-2; Sehgal D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132112; Sharma SK, 2013, G3-GENES GENOM GENET, V3, P2031, DOI 10.1534/g3.113.007153; Sharma V, 2014, MOL PHYLOGENET EVOL, V73, P10, DOI 10.1016/j.ympev.2014.01.003; Sim SC, 2011, HEREDITY, V106, P927, DOI 10.1038/hdy.2010.139; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Simko I, 2006, GENETICS, V173, P2237, DOI 10.1534/genetics.106.060905; Solano J, 2013, ELECTRON J BIOTECHN, V16, DOI 10.2225/vol16-issue6-fulltext-15; Solano-Solis J, 2007, ELECT J BIOTECHNOL, V10; Spooner DM, 2008, CROP SCI, V48, pS27, DOI 10.2135/cropsci2007.09.0504tpg; Spooner DM, 2007, P NATL ACAD SCI USA, V104, P19398, DOI 10.1073/pnas.0709796104; Spooner DM, 2010, AM J BOT, V97, P2049, DOI 10.3732/ajb.1000277; Spooner DM, 2005, P NATL ACAD SCI USA, V102, P14694, DOI 10.1073/pnas.0507400102; Spooner DM, 1996, THEOR APPL GENET, V92, P532, DOI 10.1007/BF00224555; Stich B, 2013, PLANT BREEDING, V132, P718, DOI 10.1111/pbr.12102; Sukhotu T, 2006, GENOME, V49, P636, DOI 10.1139/G06-014; Urbany C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-7; Uribe F, 2011, THESIS; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; Vieira EA, 2007, GENET MOL BIOL, V30, P392, DOI 10.1590/S1415-47572007000300016; Vos PG, 2017, THEOR APPL GENET, V130, P123, DOI 10.1007/s00122-016-2798-8; Vos PG, 2015, THEOR APPL GENET, V128, P2387, DOI 10.1007/s00122-015-2593-y; Wang XM, 2012, INT J MOL SCI, V13, P3900, DOI 10.3390/ijms13033900; Wurschum T, 2013, THEOR APPL GENET, V126, P1477, DOI 10.1007/s00122-013-2065-1; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Zhao YL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086308, 10.1371/journal.pone.0099704]	123	39	40	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173039	10.1371/journal.pone.0173039	http://dx.doi.org/10.1371/journal.pone.0173039			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257509	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100051
J	Lindqvist, A; Ekelund, M; Garcia-Vaz, E; Stahlman, M; Pierzynowski, S; Gomez, MF; Rehfeld, JF; Groop, L; Hedenbro, J; Wierup, N; Spegel, P				Lindqvist, Andreas; Ekelund, Mikael; Garcia-Vaz, Eliana; Stahlman, Marcus; Pierzynowski, Stefan; Gomez, Maria F.; Rehfeld, Jens F.; Groop, Leif; Hedenbro, Jan; Wierup, Nils; Spegel, Peter			The impact of Roux-en-Y gastric bypass surgery on normal metabolism in a porcine	PLOS ONE			English	Article							BETA-CELL FUNCTION; LOW-CALORIE DIET; BARIATRIC SURGERY; WEIGHT-LOSS; BILE-ACIDS; INSULIN SENSITIVITY; LIPOPROTEINS; MAINTENANCE; SECRETION; MASS	Background A growing body of literature on Roux-en-Y gastric bypass surgery (RYGB) has generated inconclusive results on the mechanism underlying the beneficial effects on weight loss and glycaemia, partially due to the problems of designing clinical studies with the appropriate controls. Moreover, RYGB is only performed in obese individuals, in whom metabolism is perturbed and not completely understood. Methods In an attempt to isolate the effects of RYGB and its effects on normal metabolism, we investigated the effect of RYGB in lean pigs, using sham-operated pair-fed pigs as controls. Two weeks post-surgery, pigs were subjected to an intravenous glucose tolerance test (IVGTT) and circulating metabolites, hormones and lipids measured. Bile acid composition was profiled after extraction from blood, faeces and the gallbladder. Results A similar weight development in both groups of pigs validated our experimental model. Despite similar changes in fasting insulin, RYGB-pigs had lower fasting glucose levels. During an IVGTT RYGB-pigs had higher insulin and lower glucose levels. VLDL and IDL were lower in RYGB-than in sham-pigs. RYGB-pigs had increased levels of most amino acids, including branched-chain amino acids, but these were more efficiently suppressed by glucose. Levels of bile acids in the gallbladder were higher, whereas plasma and faecal bile acid levels were lower in RYGB-than in sham-pigs. Conclusion In a lean model RYGB caused lower plasma lipid and bile acid levels, which were compensated for by increased plasma amino acids, suggesting a switch from lipid to protein metabolism during fasting in the immediate postoperative period.	[Lindqvist, Andreas; Hedenbro, Jan; Wierup, Nils] Lund Univ, Ctr Diabet, Dept Clin Sci Malmo, Neuroendocrine Cell Biol, Malmo, Sweden; [Ekelund, Mikael] Lund Univ, Dept Clin Sci Malmo, Dept Surg, Lund, Sweden; [Garcia-Vaz, Eliana; Gomez, Maria F.] Lund Univ, Ctr Diabet, Dept Clin Sci Malmo, Vasc ET Coupling, Malmo, Sweden; [Stahlman, Marcus] Univ Gothenburg, Dept Mol & Clin Med, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden; [Stahlman, Marcus] Univ Gothenburg, Wallenberg Lab, Gothenburg, Sweden; [Pierzynowski, Stefan] Lund Univ, Dept Cell & Organism Biol, Lund, Sweden; [Pierzynowski, Stefan] Innovat Ctr STB, Tczew, Poland; [Rehfeld, Jens F.] Univ Copenhagen, Rigshosp, Dept Clin Biochem, Copenhagen, Denmark; [Groop, Leif] Lund Univ, Ctr Diabet, Dept Clin Sci Malmo, Diabet & Endocrinol, Malmo, Sweden; [Hedenbro, Jan] Lund Univ, Dept Clin Sci Lund, Surg, Lund, Sweden; [Spegel, Peter] Lund Univ, Ctr Diabet, Dept Clin Sci Malmo, Mol Metab, Malmo, Sweden; [Spegel, Peter] Lund Univ, Dept Chem, Ctr Anal & Synth, Lund, Sweden	Lund University; Lund University; Lund University; University of Gothenburg; University of Gothenburg; Lund University; Rigshospitalet; University of Copenhagen; Lund University; Lund University; Lund University; Lund University	Spegel, P (corresponding author), Lund Univ, Ctr Diabet, Dept Clin Sci Malmo, Mol Metab, Malmo, Sweden.; Spegel, P (corresponding author), Lund Univ, Dept Chem, Ctr Anal & Synth, Lund, Sweden.	peter.spegel@chem.lu.se	Spégel, Peter/G-9947-2018; Gomez, Maria F/D-3696-2014; StÃhlman, Marcus/M-4597-2019	Spégel, Peter/0000-0002-6092-2387; Gomez, Maria F/0000-0001-6210-3142; Henricsson, Marcus/0000-0002-4202-0339; Pierzynowski, Stefan Grzegorz/0000-0002-0308-3214	Swedish Diabetes Foundation; Royal Physiographic Society; Diabetes Wellness; Novo Nordisk Foundation; PahIsson; Crafoord Foundations; Swedish Research Council [521-2007-4037, 20084216, 2011-3900, 2009-1039, 349-2008-6589]; European Research Council [GA 269045]; Wallenberg foundation [KAW 20090243]; Lundberg foundation [359]; EU grant ENGAGE; Novo Nordisk Fonden [NNF15OC0016154] Funding Source: researchfish	Swedish Diabetes Foundation; Royal Physiographic Society; Diabetes Wellness; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); PahIsson; Crafoord Foundations; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Wallenberg foundation(European Commission); Lundberg foundation(European Commission); EU grant ENGAGE; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Swedish Diabetes Foundation (PS, NW), the Royal Physiographic Society (PS), The Diabetes Wellness (NW), the Novo Nordisk Foundation (PS), PahIsson (PS, NW), and Crafoord Foundations (PS), the Swedish Research Council incl. project grant (LG: Dnr. 521-2007-4037, NW: Dnr. 20084216, MG: Dnr. 2011-3900), strategic research area grant (EXODIAB: Dnr. 2009-1039) and Linnaeus grant (LUDC: Dnr. 349-2008-6589), an Advanced Research Grant from the European Research Council for (LG: GA 269045) as well as equipment grants from Wallenberg (KAW 20090243) and Lundberg foundation (grant nr. 359). In addition, the project was funded by the EU grant ENGAGE. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aguiar EJ, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-2; [Anonymous], DIABETES; Bojsen-Moller KN, 2013, J CLIN ENDOCR METAB, V98, pE1066, DOI 10.1210/jc.2013-1286; Breen DM, 2012, NAT MED, V18, P950, DOI 10.1038/nm.2745; Carmena R, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000131511.50734.44; Dirksen C, 2012, DIABETOLOGIA, V55, P1890, DOI 10.1007/s00125-012-2556-7; Dixon JB, 2011, NAT REV GASTRO HEPAT, V8, P429, DOI 10.1038/nrgastro.2011.112; Gloy VL, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5934; Gustavsson C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012699; Hodis HN, 1997, CIRCULATION, V95, P2022, DOI 10.1161/01.CIR.95.8.2022; Jackness C, 2013, DIABETES, V62, P3027, DOI 10.2337/db12-1762; Jacobsen SH, 2012, OBES SURG, V22, P1084, DOI 10.1007/s11695-012-0621-4; Johansson K, 2014, AM J CLIN NUTR, V99, P14, DOI 10.3945/ajcn.113.070052; Jorgensen NB, 2013, DIABETES, V62, P3044, DOI 10.2337/db13-0022; Kashyap SR, 2013, DIABETES CARE, V36, P2175, DOI 10.2337/dc12-1596; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Kumar R, 2011, SURGERY, V149, P654, DOI 10.1016/j.surg.2010.11.015; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; Lien LF, 2009, OMICS, V13, P21, DOI 10.1089/omi.2008.0035; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Lindqvist A, 2014, DIABETES, V63, P1665, DOI 10.2337/db13-0969; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; Litten-Brown JC, 2010, ANIMAL, V4, P899, DOI 10.1017/S1751731110000200; MANN JI, 1980, DIABETOLOGIA, V18, P89, DOI 10.1007/BF00290483; Mutch DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007905; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Odstrcil EA, 2010, AM J CLIN NUTR, V92, P704, DOI 10.3945/ajcn.2010.29870; Peterli R, 2012, OBES SURG, V22, P740, DOI 10.1007/s11695-012-0622-3; Pihlajamaki J, 2010, METABOLISM, V59, P866, DOI 10.1016/j.metabol.2009.10.004; Pournaras DJ, 2012, ENDOCRINOLOGY, V153, P3613, DOI 10.1210/en.2011-2145; RAPP JH, 1994, ARTERIOSCLER THROMB, V14, P1767, DOI 10.1161/01.ATV.14.11.1767; Rehfeld JF, 1998, CLIN CHEM, V44, P991; Ryan KK, 2014, NATURE, V509, P183, DOI 10.1038/nature13135; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Sham JG, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/526972; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Smushkin G, 2012, DIABETES, V61, P1082, DOI [10.2337/db11-1732, 10.2337/db12-0923]; Spegel P, 2013, DIABETES, V62, P653, DOI 10.2337/db12-0827; Steinert RE, 2013, OBESITY, V21, pE660, DOI 10.1002/oby.20522; Tremaroli V, 2015, CELL METAB, V22, P228, DOI 10.1016/j.cmet.2015.07.009; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Tura A, 2010, DIABETOLOGIA, V53, P144, DOI 10.1007/s00125-009-1547-9; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510	45	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173137	10.1371/journal.pone.013137	http://dx.doi.org/10.1371/journal.pone.013137			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257455				2022-12-26	WOS:000396021100064
J	Montanari, SR; Hobbs, JPA; Pratchett, MS; Bay, LK; van Herwerden, L				Montanari, Stefano R.; Hobbs, Jean-Paul A.; Pratchett, Morgan S.; Bay, Line K.; van Herwerden, Lynne			Naturally occurring hybrids of coral reef butterflyfishes have similar fitness compared to parental species	PLOS ONE			English	Article							STICKLEBACK GASTEROSTEUS-ACULEATUS; EVOLUTIONARY HISTORY; FEEDING FISHES; INDIAN-OCEAN; HYBRIDIZATION; CONSERVATION; SPECIATION; ZONE; CHAETODONTIDAE; INTROGRESSION	Hybridisation can produce evolutionary novelty by increasing fitness and adaptive capacity. Heterosis, or hybrid vigour, has been documented in many plant and animal taxa, and is a notable consequence of hybridisation that has been exploited for decades in agriculture and aquaculture. On the contrary, loss of fitness in naturally occurring hybrid taxa has been observed in many cases. This can have negative consequences for the parental species involved (wasted reproductive effort), and has raised concerns for species conservation. This study evaluates the relative fitness of previously documented butterflyfish hybrids of the genus Chaetodon from the Indo-Pacific suture zone at Christmas Island. Histological examination confirmed the reproductive viability of Chaetodon hybrids. Examination of liver lipid content showed that hybrid body condition was not significantly different from parent species body condition. Lastly, size at age data revealed no difference in growth rates and asymptotic length between hybrids and parent species. Based on the traits measured in this study, naturally occurring hybrids of Chaetodon butterflyfishes have similar fitness to their parental species, and are unlikely to supplant parental species under current environmental conditions at the suture zone. However, given sufficient fitness and ongoing genetic exchange between the respective parental species, hybrids are likely to persist within the suture zone.	[Montanari, Stefano R.] James Cook Univ North Queensland, Coll Sci & Engn, Australian Inst Marine Sci, AIMS JCU, Townsville, Qld, Australia; [Hobbs, Jean-Paul A.] Curtin Univ, Dept Environm & Agr, Bentley, WA, Australia; [Pratchett, Morgan S.] James Cook Univ North Queensland, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Bay, Line K.] Australian Inst Marine Sci, Townsville, Qld, Australia; [van Herwerden, Lynne] James Cook Univ North Queensland, Coll Sci & Engn, Townsville, Qld, Australia; [van Herwerden, Lynne] James Cook Univ North Queensland, Ctr Comparat Genom, Townsville, Qld, Australia	Australian Institute of Marine Science; James Cook University; Curtin University; James Cook University; Australian Institute of Marine Science; James Cook University; James Cook University	Montanari, SR (corresponding author), James Cook Univ North Queensland, Coll Sci & Engn, Australian Inst Marine Sci, AIMS JCU, Townsville, Qld, Australia.	stefanomontanari@gmail.com	Pratchett, Morgan/AAW-5179-2020; van Herwerden, Lynne/I-1087-2012	Pratchett, Morgan/0000-0002-1862-8459; van Herwerden, Lynne/0000-0001-6717-8995; Bay, Line/0000-0002-9760-2977	Australian Institute of Marine Science (AIMS@JCU)	Australian Institute of Marine Science (AIMS@JCU)	This work was supported by Australian Institute of Marine Science (AIMS@JCU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Allen G.R., 1998, GUIDE ANGELFISHES BU; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; [Anonymous], 1963, ANIMAL SPECIES EVOLU; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Arnold ML, 2010, TRENDS ECOL EVOL, V25, P530, DOI 10.1016/j.tree.2010.06.005; ARNOLD ML, 1993, J HERED, V84, P13, DOI 10.1093/oxfordjournals.jhered.a111269; Barber Bruce J., 2006, Developments in Aquaculture and Fisheries Science, V35, P357; Bartley DM, 2000, REV FISH BIOL FISHER, V10, P325, DOI 10.1023/A:1016691725361; Bellwood DR, 2010, J EVOLUTION BIOL, V23, P335, DOI 10.1111/j.1420-9101.2009.01904.x; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Cancela ML, 2010, INTRODUCTION TO MARINE GENOMICS, P213, DOI 10.1007/978-90-481-8639-6_7; CARNEY SE, 1994, AM J BOT, V81, P1169, DOI 10.2307/2445479; Chen ZJ, 2013, NAT REV GENET, V14, P471, DOI 10.1038/nrg3503; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; CRUZAN MB, 1993, EVOLUTION, V47, P1432, DOI 10.1111/j.1558-5646.1993.tb02165.x; DiBattista J.D., 2015, J BIOGEOGRAPHY; DiBattista JD, 2013, J BIOGEOGR, V40, P1170, DOI 10.1111/jbi.12068; DiBattista JD, 2012, CORAL REEFS, V31, P839, DOI 10.1007/s00338-012-0907-y; Gardner J, 1997, ADV MAR BIOL, V31, P78; Hobbs J-PA, 2013, BIOL BUTTERFLYFISHES; Hobbs JPA, 2014, RAFFLES B ZOOL, P220; Hobbs JPA, 2014, RAFFLES B ZOOL, P184; Hobbs JPA, 2009, BIOL LETTERS, V5, P258, DOI 10.1098/rsbl.2008.0561; Hobbs JPA, 2014, MAR POLICY, V44, P149, DOI 10.1016/j.marpol.2013.08.020; Hoey J, 2007, CORAL REEFS, V26, P603, DOI 10.1007/s00338-007-0246-6; Hoffmeister TS, 2005, ECOSYSTEMS, V8, P657, DOI 10.1007/s10021-003-0138-8; Huff D. D., 2010, EXAMINING GENETIC DI; Huff DD, 2011, MOL ECOL, V20, P4246, DOI 10.1111/j.1365-294X.2011.05271.x; Johansen JL, 2011, GLOBAL CHANGE BIOL, V17, P2971, DOI 10.1111/j.1365-2486.2011.02436.x; Lavretsky P, 2016, MOL ECOL, V25, P661, DOI 10.1111/mec.13487; MacCallum CJ, 1998, EVOLUTION, V52, P227, DOI 10.1111/j.1558-5646.1998.tb05156.x; Mallet J, 2001, J EVOLUTION BIOL, V14, P887, DOI 10.1046/j.1420-9101.2001.00342.x; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Messmer V, 2016, GLOBAL CHANGE BIOL; Montanari SR, 2016, REV FISH BIOL FISHER, P1; Montanari SR, 2014, MOL ECOL, V23, P2757, DOI 10.1111/mec.12762; Montanari SR, 2012, ECOL EVOL, V2, P310, DOI 10.1002/ece3.83; Payet SD, 2016, CORAL REEFS, V35, P1157, DOI 10.1007/s00338-016-1482-4; Pratchett M.S., 2007, RAFFLES B ZOOL, V14, P155; Pratchett MS, 2006, CORAL REEFS, V25, P85, DOI 10.1007/s00338-005-0081-6; Pratchett MS, 2005, MAR BIOL, V148, P373, DOI 10.1007/s00227-005-0084-4; Pratchett MS, 2001, CORAL REEFS, V20, P13, DOI 10.1007/s003380000113; PYLE RL, 1994, ENVIRON BIOL FISH, V41, P127; REMINGTON C L, 1968, Evolutionary Biology (New York), P321; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Richards ZT, 2015, CURR ZOOL, V61, P132, DOI 10.1093/czoolo/61.1.132; Riginos C, 2007, MOL ECOL, V16, P3971, DOI 10.1111/j.1365-294X.2007.03505.x; Rosenfield JA, 2004, CONSERV BIOL, V18, P1589, DOI 10.1111/j.1523-1739.2004.00356.x; Schilthuizen M, 2011, HEREDITY, V107, P95, DOI 10.1038/hdy.2010.170; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Secor DH, 1990, MANUAL OTOLITH REMOV; Seehausen O, 2006, CURR BIOL, V16, pR334, DOI 10.1016/j.cub.2006.03.080; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2003, P ROY SOC B-BIOL SCI, V270, P129, DOI 10.1098/rspb.2002.2153; SHULL GH, 1948, GENETICS, V33, P439; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; Taylor EB, 2012, EVOLUTION, V66, P240, DOI 10.1111/j.1558-5646.2011.01439.x; THEILACKER GH, 1978, FISH B-NOAA, V76, P403; Thompson WL, 2004, SAMPLING RARE ELUSIV; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Woods A, 1994, LAB HISTOPATHOLOGY C; Yaakub SM, 2006, MOL PHYLOGENET EVOL, V40, P84, DOI 10.1016/j.ympev.2006.02.012; Yabuta S, 2014, BIOLOGY OF BUTTERFLYFISHES, P200	68	6	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173212	10.1371/journal.pone.0173212	http://dx.doi.org/10.1371/journal.pone.0173212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257492	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000396021100078
J	Chung, SD; Kao, LT; Lin, HC; Xirasagar, S; Huang, CC; Lee, HC				Chung, Shiu-Dong; Kao, Li-Ting; Lin, Herng-Ching; Xirasagar, Sudha; Huang, Chung-Chien; Lee, Hsin-Chien			Patients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorder	PLOS ONE			English	Article							LOW TESTOSTERONE LEVELS; CORONARY-HEART-DISEASE; OLDER MEN; BIOAVAILABLE TESTOSTERONE; DIAGNOSIS; ILLNESS; IMPACT; AGE	Androgen deprivation therapy (ADT) results in testosterone suppression, a hypothesized mechanism linking ADT to depressive symptoms. This study investigated the relationship between ADT and the risk of subsequently being diagnosed with depressive disorder (DD) during a 3-year follow-up period. The patient sample for this population-based, retrospective cohort study was retrieved from the Taiwan Longitudinal Health Insurance Database 2005. We included all 1714 patients aged over 40 years with a first-time diagnosis of prostate cancer (PC) during 2001 to 2010 who did not have an orchiectomy. Among them, we defined 868 patients who received ADT during the 3-year follow-up period as the study group, and 846 patients who did not receive ADT as the comparison group. The incidence rates of DD per 1000 person-years were 13.9 (95% confidence interval (CI): 9.5 similar to 19.6) and 6.7 (95% CI: 3.7 similar to 11.0), respectively. Cox proportional hazard regressions showed that the adjusted hazard ratio for DD for ADT recipients was 1.93 (95% CI: 1.03 similar to 3.62) relative to the comparison group. This study presents epidemiological evidence of an association between ADT and a subsequent DD diagnosis.	[Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, Taipei, Taiwan; [Chung, Shiu-Dong] Yuan Ze Univ, Coll Informat, Grad Program Biomed Informat, Chungli, Taiwan; [Chung, Shiu-Dong; Kao, Li-Ting; Lin, Herng-Ching; Lee, Hsin-Chien] Taipei Med Univ, Coll Med, Res Ctr Sleep Med, Taipei, Taiwan; [Kao, Li-Ting] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lin, Herng-Ching; Huang, Chung-Chien] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Xirasagar, Sudha] Univ South Carolina, Arnold Sch Publ Hlth, Dept Hlth Serv Policy & Management, Columbia, SC USA; [Lee, Hsin-Chien] Taipei Med Univ, Shuang Ho Hosp, Dept Psychiat, Taipei, Taiwan; [Lee, Hsin-Chien] Taipei Med Univ, Coll Med, Sch Med, Dept Psychiat, Taipei, Taiwan	Far Eastern Memorial Hospital; Yuan Ze University; Taipei Medical University; National Defense Medical Center; Taipei Medical University; University of South Carolina System; University of South Carolina Columbia; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University	Lee, HC (corresponding author), Taipei Med Univ, Coll Med, Res Ctr Sleep Med, Taipei, Taiwan.; Lee, HC (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Psychiat, Taipei, Taiwan.; Lee, HC (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Psychiat, Taipei, Taiwan.	ellalee@tmu.edu.tw	Xirasagar, Sudha/AAA-2350-2022; Huang, CC/AAX-5872-2021; Kao, Li-Ting/W-9287-2018	Huang, CC/0000-0003-0818-7175; Kao, Li-Ting/0000-0003-0692-7408; lee, hsin-chien/0000-0002-7557-8259				Aragon-Ching JB, 2007, FRONT BIOSCI-LANDMRK, V12, P4957, DOI 10.2741/2441; Barrett-Connor E, 1999, J CLIN ENDOCR METAB, V84, P573, DOI 10.1210/jc.84.2.573; Casey RG, 2012, ASIAN J ANDROL, V14, P226, DOI 10.1038/aja.2011.108; Chen Allen C, 2004, Curr Oncol Rep, V6, P209, DOI 10.1007/s11912-004-0051-0; Chen HM, 2014, NEUROUROL URODYNAM, V33, P511, DOI 10.1002/nau.22444; Chipperfield K, 2013, PSYCHO-ONCOLOGY, V22, P2169, DOI 10.1002/pon.3269; Chung SD, 2015, ACTA OPHTHALMOL, V93, pE176, DOI 10.1111/aos.12478; Cooperberg MR, 2004, J UROLOGY, V171, P1393, DOI 10.1097/01.ju.0000107247.81471.06; Dinh KT, 2016, J CLIN ONCOL, V34, P1905, DOI 10.1200/JCO.2015.64.1969; Donovan KA, 2015, CANCER-AM CANCER SOC, V121, P4286, DOI 10.1002/cncr.29672; Gray RE, 2000, PSYCHO-ONCOLOGY, V9, P273, DOI 10.1002/1099-1611(200007/08)9:4<273::AID-PON463>3.0.CO;2-F; Hervouet S, 2013, HEALTH PSYCHOL, V32, P675, DOI 10.1037/a0031639; Howlader N., 2016, SEER CANC STAT REV 1; Huang CY, 2011, J AFFECT DISORDERS, V135, P395, DOI 10.1016/j.jad.2011.07.001; Jin C, 2016, PROSTATE CANCER P D, V19, P333, DOI 10.1038/pcan.2016.35; Labrie F, 2004, J ANDROL, V25, P305; Lee M, 2015, PSYCHO-ONCOLOGY, V24, P472, DOI 10.1002/pon.3608; McIntyre RS, 2006, PSYCHONEUROENDOCRINO, V31, P1029, DOI 10.1016/j.psyneuen.2006.06.005; Morgia G, 2016, UROLOGY, V96, P165, DOI 10.1016/j.urology.2016.06.024; Nguyen PL, 2015, EUR UROL, V67, P825, DOI 10.1016/j.eururo.2014.07.010; Pirl WF, 2002, PSYCHO-ONCOLOGY, V11, P518, DOI 10.1002/pon.592; Seidman SN, 2002, AM J PSYCHIAT, V159, P456, DOI 10.1176/appi.ajp.159.3.456; Seidman SN, 1999, AM J GERIAT PSYCHIAT, V7, P18; Shahinian VB, 2006, ARCH INTERN MED, V166, P465; Shores MM, 2005, J CLIN PSYCHIAT, V66, P7, DOI 10.4088/JCP.v66n0102; Shores MM, 2004, ARCH GEN PSYCHIAT, V61, P162, DOI 10.1001/archpsyc.61.2.162; Taylor LG, 2009, CANCER-AM CANCER SOC, V115, P2388, DOI 10.1002/cncr.24283; Timilshina N, 2012, CANCER-AM CANCER SOC, V118, P1940, DOI 10.1002/cncr.26477; Tsai MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129962; Vedhara K., 2005, HUMAN PSYCHONEUROIMM; Wang LH, 2016, ANDROLOGY-US, V4, P128, DOI 10.1111/andr.12141	31	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173266	10.1371/journal.pone.0173266	http://dx.doi.org/10.1371/journal.pone.0173266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4XX	28253340	gold, Green Submitted, Green Published			2022-12-26	WOS:000396011300098
J	Janem, WF; Scannapieco, FA; Sabharwal, A; Tsompana, M; Berman, HA; Haase, EM; Miecznikowski, JC; Mastrandrea, LD				Janem, Waleed F.; Scannapieco, Frank A.; Sabharwal, Amarpeet; Tsompana, Maria; Berman, Harvey A.; Haase, Elaine M.; Miecznikowski, Jeffrey C.; Mastrandrea, Lucy D.			Salivary inflammatory markers and microbiome in normoglycemic lean and obese children compared to obese children with type 2 diabetes	PLOS ONE			English	Article							NITRIC-OXIDE LEVELS; PERIODONTAL-DISEASE; GLYCEMIC CONTROL; SUBGINGIVAL PLAQUE; METABOLIC SYNDROME; PEDIATRIC OBESITY; CLINICAL-TRIAL; MELLITUS; ASSOCIATION; PREVALENCE	Background There is emerging evidence linking diabetes with periodontal disease. Diabetes is a well recognized risk factor for periodontal disease. Conversely, pro-inflammatory molecules released by periodontally-diseased tissues may enter the circulation to induce insulin resistance. While this association has been demonstrated in adults, there is little information regarding periodontal status in obese children with and without type 2 diabetes (T2D). We hypothesized that children with T2D have higher rates of gingivitis, elevated salivary inflammatory markers, and an altered salivary microbiome compared to children without T2D. Methods Three pediatric cohorts ages 10-19 years were studied: lean (normal weight-C), obese (Ob), and obese with T2D (T2D). Each subject completed an oral health survey, received a clinical oral examination, and provided unstimulated saliva for measurement of inflammatory markers and microbiome analysis. Results The diabetes group was less likely to have had a dental visit within the last six months. Body mass index (BMI) Z-scores and waist circumference/height ratios were similar between Ob and T2D cohorts. The number of carious lesions and fillings were similar for all three groups. The gingival index was greater in the T2D group compared to the Ob and C groups. Although salivary microbial diversity was minimal between groups, a few differences in bacterial genus composition were noted. Conclusions Obese children with T2D show a trend toward poorer oral health compared to normal weight and obese children without T2D. This study characterizes the salivary microbiome of children with and without obesity and T2D. This study supports a modest link between T2D and periodontal inflammation in the pediatric population.	[Janem, Waleed F.; Mastrandrea, Lucy D.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Pediat, Buffalo, NY 14228 USA; [Scannapieco, Frank A.; Sabharwal, Amarpeet; Haase, Elaine M.] Univ Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY USA; [Tsompana, Maria] Univ Buffalo, Sch Publ Hlth & Hlth Profess, Dept Epidemiol & Environm Hlth, Buffalo, NY USA; [Berman, Harvey A.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Pharmacol & Toxicol, Buffalo, NY USA; [Miecznikowski, Jeffrey C.] Univ Buffalo, Sch Publ Hlth & Hlth Profess, Dept Biostat, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Mastrandrea, LD (corresponding author), Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Pediat, Buffalo, NY 14228 USA.	ldm@buffalo.edu	Scannapieco, Frank A./AAE-1584-2020; Haase, Elaine/G-8634-2016	Scannapieco, Frank A./0000-0002-8804-6593; Haase, Elaine/0000-0002-8169-0319; Tsompana, Maria/0000-0001-7546-3198	Endocrine Fellows Foundation; Colgate-Palmolive	Endocrine Fellows Foundation; Colgate-Palmolive	This work was supported by: Endocrine Fellows Foundation http://www.endocrinefellows.org/ (WFJ). This funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. And by Colgate-Palmolive http://www.colgateprofessional.com/research (FAS, LDM). This funder had no role in the study design, data collection and analysis, or preparation of the manuscript. They did review the manuscript prior to submission for publication but made no revisions to the manuscript.	[Anonymous], 2014, PEDIATRICS, V134, P1224, DOI 10.1542/peds.2014-2984; [Anonymous], 2016, MIS REP GEN FASTQ WO; [Anonymous], 2016, COMPLEX200 V6 DSP PR; [Anonymous], HOMD 16S RRNA GENE S; Barnes VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105181; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Califano Joseph V, 2005, Pediatr Dent, V27, P189; Casarin RCV, 2013, J PERIODONTAL RES, V48, P30, DOI 10.1111/j.1600-0765.2012.01498.x; Chaffee BW, 2010, J PERIODONTOL, V81, P1708, DOI 10.1902/jop.2010.100321; Chee B, 2013, INT J EVID-BASED HEA, V11, P317, DOI 10.1111/1744-1609.12038; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Chukkapalli SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143291; Crocker MK, 2011, PEDIATR CLIN N AM, V58, P1217, DOI 10.1016/j.pcl.2011.07.004; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Demmer RT, 2015, J DENT RES, V94, p201S, DOI 10.1177/0022034515590369; Edblad E, 2001, SWED DENT J, V25, P53; Engebretson SP, 2013, JAMA-J AM MED ASSOC, V310, P2523, DOI 10.1001/jama.2013.282431; Franchini R, 2011, J CLIN PERIODONTOL, V38, P1021, DOI 10.1111/j.1600-051X.2011.01770.x; Ge XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065520; Giustarini D, 2008, METHOD ENZYMOL, V440, P361, DOI 10.1016/S0076-6879(07)00823-3; Goodson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098799; Gursoy UK, 2015, J DIABETES, V7, P681, DOI 10.1111/1753-0407.12228; Illumina, 16S MET SEQ LIB PREP; Javed F, 2014, J INVESTIG CLIN DENT, V5, P1, DOI 10.1111/jicd.12066; Jorth P, 2014, MBIO, V5, DOI 10.1128/mBio.01012-14; Katagiri S, 2012, J DIABETES INVEST, V3, P402, DOI 10.1111/j.2040-1124.2012.00209.x; Katz J, 2011, QUINTESSENCE INT, V42, P595; Khorsavi Samani M, 2012, Minerva Stomatol, V61, P443; Kim EK, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-64; Knight ET, 2016, PERIODONTOL 2000, V71, P22, DOI 10.1111/prd.12110; Kuczmarski RJ, 2000, VITAL HLTH STAT, V11, P1; Kumar PS, 2003, J DENT RES, V82, P338, DOI 10.1177/154405910308200503; Lal S, 2007, PEDIATR DENT, V29, P426; Liese AD, 2006, PEDIATRICS, V118, P1510, DOI 10.1542/peds.2006-0690; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; LOE H, 1967, J PERIODONTOL, V38, P610, DOI 10.1902/jop.1967.38.6.610; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Miller CS, 2010, BIOMARK MED, V4, P171, DOI 10.2217/BMM.09.68; Miller CS, 2006, J AM DENT ASSOC, V137, P322, DOI 10.14219/jada.archive.2006.0181; Nascimento GG, 2015, J CLIN PERIODONTOL; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ouellet-Morin I, 2011, BRAIN BEHAV IMMUN, V25, P640, DOI 10.1016/j.bbi.2010.12.020; Parwani SR, 2012, INT J DENT HYG, V10, P67, DOI 10.1111/j.1601-5037.2011.00508.x; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Rai K, 2011, J CLIN PEDIATR DENT, V36, P181, DOI 10.17796/jcpd.36.2.x436ln878221g364; RAMS TE, 1993, J CLIN PERIODONTOL, V20, P147, DOI 10.1111/j.1600-051X.1993.tb00330.x; RCore Team, 2020, R LANG ENV STAT COMP; Riis JL, 2014, DEV PSYCHOBIOL, V56, P797, DOI 10.1002/dev.21149; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shojaee M, 2013, INT J MOL CELL MED, V2, P151; Singh S, 2008, INT J DIABETES DEV C, V28, P38, DOI 10.4103/0973-3930.43097; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Spooner R, 2016, SCI REP-UK, V6, DOI 10.1038/srep33638; Stewart JE, 2001, J CLIN PERIODONTOL, V28, P306, DOI 10.1034/j.1600-051x.2001.028004306.x; Sundar NM, 2013, J CLIN DIAGN RES, V7, P1223, DOI 10.7860/JCDR/2013/5386.3068; Suvan J, 2011, OBES REV, V12, pe381, DOI 10.1111/j.1467-789X.2010.00808.x; Tanner ACR, 2011, J DENT RES, V90, P1298, DOI 10.1177/0022034511421201; Taylor G W, 2001, Ann Periodontol, V6, P99, DOI 10.1902/annals.2001.6.1.99; Teles R, 2013, PERIODONTOL 2000, V62, P95, DOI 10.1111/prd.12010; Tremblay M, 2011, J CAN DENT ASSOC, V77, P1; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yoon AJ, 2012, J CLIN PERIODONTOL, V39, P434, DOI 10.1111/j.1600-051X.2012.01866.x; Zhou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061516	65	38	39	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172647	10.1371/journal.pone.0172647	http://dx.doi.org/10.1371/journal.pone.0172647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253297	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300025
J	Kadhel, P; Costet, N; Toto, T; Janky, E; Multigner, L				Kadhel, Philippe; Costet, Nathalie; Toto, Teddy; Janky, Eustase; Multigner, Luc			The annual carnival in Guadeloupe (French West Indies) is associated with an increase in the number of conceptions and subsequent births nine months later: 2000-2011	PLOS ONE			English	Article							SEASONAL-VARIATION; REPRODUCTIVE HEALTH; YOUNG-ADULTS; TIME-SERIES; PATTERNS; RATIO; WOMEN	The seasonal patterns of conceptions and births differ between geographic areas. Several potential determinants of this variation have been identified, including biological, environmental and behavioral elements, but festive events are rarely mentioned. We investigated the possible association between the carnival and seasonal fertility variations in the French West Indies. We ran a retrospective registry-based study. The data were extracted from the registry of all births on Guadeloupe between 2000 and 2011 (n = 74,412), and from the Maternity Birth Register of the University Hospital, for all pregnancies of at least 14 completed weeks of gestation (observable conceptions) with an outcome recorded between 2007 and 2010 (n = 8,425). We compared data during and outside the carnival period for each year, including 2009, when there was no carnival due to a 44-day general strike. In all years other than 2009, the weekly number of births was higher for pregnancies initiated during the carnival period than for pregnancies initiated at other times, and the weekly number of observable conceptions was higher during the carnival period than at other times. Our findings support the hypothesis that carnivals in the French West Indies are associated with an increase in the number of conceptions and subsequent births.	[Kadhel, Philippe; Toto, Teddy; Janky, Eustase] Ctr Hosp, Pointe A Pitre, Guadeloupe, France; [Kadhel, Philippe; Toto, Teddy; Janky, Eustase] Univ Pointe A Pitre Abymes, Pole Parent Enfant, Serv Gynecol & Obstet, Pointe A Pitre, Guadeloupe, France; [Kadhel, Philippe] Univ Antilles, Campus Fouillole, Pointe A Pitre, Guadeloupe, France; [Kadhel, Philippe; Costet, Nathalie; Multigner, Luc] INSERM, U1085, IRSET, Rennes, France; [Costet, Nathalie; Multigner, Luc] Univ Rennes 1, Rennes, France	CHU Guadeloupe; Universite des Antilles; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Kadhel, P (corresponding author), Ctr Hosp, Pointe A Pitre, Guadeloupe, France.; Kadhel, P (corresponding author), Univ Pointe A Pitre Abymes, Pole Parent Enfant, Serv Gynecol & Obstet, Pointe A Pitre, Guadeloupe, France.; Kadhel, P (corresponding author), Univ Antilles, Campus Fouillole, Pointe A Pitre, Guadeloupe, France.; Kadhel, P (corresponding author), INSERM, U1085, IRSET, Rennes, France.	philippe.kadhel@orange.fr	Multigner, Luc/I-2926-2015; Multigner, Luc/AAA-6214-2020	Multigner, Luc/0000-0003-3205-8568; Multigner, Luc/0000-0003-3205-8568; Costet, Nathalie/0000-0002-3706-4812; Kadhel, Philippe/0000-0001-8759-6895				BECKER S, 1991, ADV EXP MED BIOL, V286, P59; Bobak M, 2001, HUM REPROD, V16, P1512, DOI 10.1093/humrep/16.7.1512; BRONSON FH, 1995, Q REV BIOL, V70, P141, DOI 10.1086/418980; Cheng C, 2013, PSYCHIAT CLIN NEUROS, V67, P426, DOI 10.1111/pcn.12076; Cohan CL, 2002, J FAM PSYCHOL, V16, P14, DOI 10.1037//0893-3200.16.1.14; Davis DL, 1998, JAMA-J AM MED ASSOC, V279, P1018, DOI 10.1001/jama.279.13.1018; Doblhammer G, 2001, P NATL ACAD SCI USA, V98, P2934, DOI 10.1073/pnas.041431898; Dorelien AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075806; Ellison PT, 2005, CAM S BIO EVOL ANTHR, V44, P379, DOI 10.1017/CBO9780511542343.014; Friger M, 2009, HUM REPROD, V24, P1492, DOI 10.1093/humrep/dep040; Fukuda M, 1998, HUM REPROD, V13, P2321, DOI 10.1093/humrep/13.8.2321; Fukuda M, 1996, HUM REPROD, V11, P1244; Hawe E, 2015, HLTH STAT Q, V9, P5; Jasienska G, 2004, AM J HUM BIOL, V16, P563, DOI 10.1002/ajhb.20063; Lam DA, 1996, DEMOGRAPHY, V33, P291, DOI 10.2307/2061762; LAM DA, 1994, ANN NY ACAD SCI, V709, P9, DOI 10.1111/j.1749-6632.1994.tb30385.x; Passos MRL, 2010, REV ASSOC MED BRAS, V56, P420, DOI 10.1590/S0104-42302010000400014; Leridon H., 1986, POPULATION, V41, P559; Levine RJ, 1999, SCAND J WORK ENV HEA, V25, P34; Liu SJ, 2010, INT J GYNECOL OBSTET, V108, P161, DOI 10.1016/j.ijgo.2009.08.030; Luteijn JM, 2014, BIRTH DEFECTS RES A, V100, P260, DOI 10.1002/bdra.23231; Masukume G, 2016, EARLY HUM DEV, V97, P11, DOI 10.1016/j.earlhumdev.2015.12.002; Patel RR, 2004, INT J EPIDEMIOL, V33, P107, DOI 10.1093/ije/dyg238; Regnier-Loilier A, 2011, POPUL SOC, V474, P1; Rodgers JL, 2005, DEMOGRAPHY, V42, P675, DOI 10.1353/dem.2005.0034; ROJANSKY N, 1992, HUM REPROD, V7, P735, DOI 10.1093/oxfordjournals.humrep.a137729; Saastamoinen KP, 2012, MULT SCLER J, V18, P563, DOI 10.1177/1352458511426814; Sharma R, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-66; THOMPSON RW, 1973, AM ANTHROPOL, V75, P676, DOI 10.1525/aa.1973.75.3.02a00030; Tong V, 2011, MATERN CHILD HLTH J, V15, P281, DOI 10.1007/s10995-010-0576-9; Torrey EF, 2000, NEUROEPIDEMIOLOGY, V19, P177, DOI 10.1159/000026253; UDRY JR, 1970, DEMOGRAPHY, V7, P325, DOI 10.2307/2060151; Vaiserman AM, 2007, DIABETOLOGIA, V50, P32, DOI 10.1007/s00125-006-0456-4; van Laar M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-365; World Health Organization, 2004, ICD1O WHO	35	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173102	10.1371/journal.pone.0173102	http://dx.doi.org/10.1371/journal.pone.0173102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4XX	28253323	gold, Green Submitted, Green Published			2022-12-26	WOS:000396011300075
J	Ottman, N; Reunanen, J; Meijerink, M; Pietila, TE; Kainulainen, V; Klievink, J; Huuskonen, L; Aalvink, S; Skurnik, M; Boeren, S; Satokari, R; Mercenier, A; Palva, A; Smidt, H; de Vos, WM; Belzer, C				Ottman, Noora; Reunanen, Justus; Meijerink, Marjolein; Pietila, Taija E.; Kainulainen, Veera; Klievink, Judith; Huuskonen, Laura; Aalvink, Steven; Skurnik, Mikael; Boeren, Sjef; Satokari, Reetta; Mercenier, Annick; Palva, Airi; Smidt, Hauke; de Vos, Willem M.; Belzer, Clara			Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function	PLOS ONE			English	Article							INTESTINAL EPITHELIUM; BACTEROIDES-FRAGILIS; ULCERATIVE-COLITIS; GEN. NOV.; MUCIN; MICROBIOTA; BACTERIA; ENTEROCYTES; INFECTION; ADHERES	Gut barrier function is key in maintaining a balanced response between the host and its microbiome. The microbiota can modulate changes in gut barrier as well as metabolic and inflammatory responses. This highly complex system involves numerous microbiota-derived factors. The gut symbiont Akkermansia muciniphila is positively correlated with a lean phenotype, reduced body weight gain, amelioration of metabolic responses and restoration of gut barrier function by modulation of mucus layer thickness. However, the molecular mechanisms behind its metabolic and immunological regulatory properties are unexplored. Herein, we identify a highly abundant outer membrane pili-like protein of A. muciniphila MucT that is directly involved in immune regulation and enhancement of trans-epithelial resistance. The purified Amuc_1100 protein and enrichments containing all its associated proteins induced production of specific cytokines through activation of Toll-like receptor (TLR) 2 and TLR4. This mainly leads to high levels of IL-10 similar to those induced by the other beneficial immune suppressive microorganisms such as Faecalibacterium prausnitzii A2-165 and Lactobacillus plantarum WCFS1. Together these results indicate that outer membrane protein composition and particularly the newly identified highly abundant pili-like protein Amuc_1100 of A. muciniphila are involved in host immunological homeostasis at the gut mucosa, and improvement of gut barrier function.	[Ottman, Noora; Aalvink, Steven; de Vos, Willem M.; Belzer, Clara] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Ottman, Noora] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Ottman, Noora] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Reunanen, Justus] Bioctr Oulu, Canc & Translat Med Res Unit, Oulu, Finland; [Reunanen, Justus] Univ Oulu, Fac Med, Oulu, Finland; [Meijerink, Marjolein; Mercenier, Annick] Wageningen Univ, Anim Sci, Host Microbe Interact, Wageningen, Netherlands; [Meijerink, Marjolein] TNO, Dept Risk Anal Prod Dev, Zeist, Netherlands; [Pietila, Taija E.; Huuskonen, Laura; Palva, Airi; de Vos, Willem M.] Univ Helsinki, Dept Vet Biosci, Fac Vet Med, Helsinki, Finland; [Kainulainen, Veera] Univ Helsinki, Pharmacol, Fac Med, Helsinki, Finland; [Klievink, Judith; Skurnik, Mikael; Satokari, Reetta; de Vos, Willem M.] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland; [Klievink, Judith; Skurnik, Mikael; Satokari, Reetta; de Vos, Willem M.] Univ Helsinki, Res Programs Unit, Immunobiol, Helsinki, Finland; [Klievink, Judith] Univ Helsinki, Hematol Res Unit Helsinki, Helsinki, Finland; [Klievink, Judith] Helsinki Univ Hosp, Dept Hematol, Ctr Comprehens Canc, Helsinki, Finland; [Skurnik, Mikael] Helsinki Univ Cent Hosp, Diagnost Lab, Helsinki, Finland; [Boeren, Sjef] Wageningen Univ, Biochem Lab, Wageningen, Netherlands	Wageningen University & Research; University of Helsinki; Karolinska Institutet; University of Oulu; University of Oulu; Wageningen University & Research; Netherlands Organization Applied Science Research; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Wageningen University & Research	Belzer, C (corresponding author), Wageningen Univ, Microbiol Lab, Wageningen, Netherlands.	clara.belzer@wur.nl	Belzer, Clara/P-6500-2018; Smidt, Hauke/D-7054-2014; Skurnik, Mikael/I-8477-2019; Kainulainen, Veera/P-6166-2018; Ottman, Noora/C-2225-2018	Belzer, Clara/0000-0001-6922-836X; Smidt, Hauke/0000-0002-6138-5026; Skurnik, Mikael/0000-0001-8791-9260; Kainulainen, Veera/0000-0002-4557-9605; Aalvink, Steven/0000-0001-7554-1723; Satokari, Reetta/0000-0002-4258-3414; Huuskonen, Laura/0000-0001-6914-0712; Ottman, Noora/0000-0001-5011-9294	European Research Council [250172]; Netherlands Organization for Scientific Research (NWO); European Community [215553-2]; Finland Academy of Sciences [138902, 258439, 252803, 141130]	European Research Council(European Research Council (ERC)European Commission); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission); Finland Academy of Sciences	This work was supported by Advanced Research Grant 250172 (MicrobesInside) of the European Research Council (https://erc.europa.eu/) to WMdV, the Gravity (SIAM) and Spinoza grants of the Netherlands Organization for Scientific Research (NWO, http://www.nwo.nl/en) to WMdV, the European Community's Seventh Framework Programme (FP7/2007-2013, https://ec.europa.eu/research/fp7/) under grant agreement no215553-2 to NO, and the Finland Academy of Sciences (http://www.aka.fi/en) (138902 & 258439 to RS, 252803 to JR, 141130 to WMdV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhawi M, 2009, J MED MICROBIOL, V58, P1015, DOI 10.1099/jmm.0.009936-0; Belzer C, 2011, EUR J MICROBIOL IMMU, V1, P311, DOI 10.1556/EuJMI.1.2011.4.7; Berry D, 2012, ISME J, V6, P2091, DOI 10.1038/ismej.2012.39; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Coats SR, 2011, INFECT IMMUN, V79, P203, DOI 10.1128/IAI.00937-10; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Derrien M, 2016, MICROBIAL PATHOGENES; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Derrien M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00166; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Ganesh BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074963; Geens MM, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/469583; Hakansson A, 2015, CLIN EXP MED, V15, P107, DOI 10.1007/s10238-013-0270-5; Hartmann P, 2013, HEPATOLOGY, V58, P108, DOI 10.1002/hep.26321; James SL, 2015, GUT, V64, P562, DOI 10.1136/gutjnl-2014-307198; Kainulainen V, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-014-0337-9; Kainulainen V, 2013, APPL ENVIRON MICROB, V79, P6989, DOI 10.1128/AEM.01993-13; Kainulainen V, 2012, J BACTERIOL, V194, P2509, DOI 10.1128/JB.06704-11; Kang CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076520; Kant R, 2014, J MED MICROBIOL, V63, P293, DOI 10.1099/jmm.0.064220-0; Karlsson CLJ, 2012, OBESITY, V20, P2257, DOI 10.1038/oby.2012.110; Kuhn KA, 2013, SEMIN IMMUNOL, V25, P364, DOI 10.1016/j.smim.2013.10.002; Lu J, 2011, J PROTEOMICS, V75, P34, DOI 10.1016/j.jprot.2011.07.031; Lukovac S, 2014, MBIO, V5, DOI 10.1128/mBio.01438-14; Ottman N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01157; Peran L, 2005, WORLD J GASTROENTERO, V11, P5185; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Rajilic-Stojanovic M, 2013, INFLAMM BOWEL DIS, V19, P481, DOI 10.1097/MIB.0b013e31827fec6d; Rescigno M, 2013, BEST PRACT RES CL GA, V27, P17, DOI 10.1016/j.bpg.2013.03.004; Reunanen J, 2015, APPL ENVIRON MICROB, V81, P3655, DOI 10.1128/AEM.04050-14; Rupakula A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0325; Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Strugnell RA, 2010, NAT REV MICROBIOL, V8, P656, DOI 10.1038/nrmicro2384; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; van Passel MWJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016876; Vigsnaes LK, 2012, BENEF MICROBES, V3, P287, DOI 10.3920/BM2012.0018; ZHANG LJ, 1994, J BACTERIOL, V176, P1756, DOI 10.1128/jb.176.6.1756-1760.1994; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108	44	201	218	13	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173004	10.1371/journal.pone.0173004	http://dx.doi.org/10.1371/journal.pone.0173004			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249045	Green Published, Green Submitted, gold			2022-12-26	WOS:000395983500069
J	Hardbower, DM; Coburn, LA; Asim, M; Singh, K; Sierra, JC; Barry, DP; Gobert, AP; Piazuelo, MB; Washington, MK; Wilson, KT				Hardbower, D. M.; Coburn, L. A.; Asim, M.; Singh, K.; Sierra, J. C.; Barry, D. P.; Gobert, A. P.; Piazuelo, M. B.; Washington, M. K.; Wilson, K. T.			EGFR-mediated macrophage activation promotes colitis-associated tumorigenesis	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; CANCER CELL-LINES; EPITHELIAL-CELLS; PROLIFERATION; INFLAMMATION; POLARIZATION; EXPRESSION; ANGIOGENESIS; PHENOTYPE; MODEL	Epidermal growth factor receptor (EGFR) signaling is a known mediator of colorectal carcinogenesis. Studies have focused on the role of EGFR signaling in epithelial cells, although the exact nature of the role of EGFR in colorectal carcinogenesis remains a topic of debate. Here, we present evidence that EGFR signaling in myeloid cells, specifically macrophages, is critical for colon tumorigenesis in the azoxymethane-dextran sodium sulfate (AOM-DSS) model of colitis-associated carcinogenesis (CAC). In a human tissue microarray, colonic macrophages demonstrated robust EGFR activation in the pre-cancerous stages of colitis and dysplasia. Utilizing the AOM-DSS model, mice with a myeloid-specific deletion of Egfr had significantly decreased tumor multiplicity and burden, protection from high-grade dysplasia and significantly reduced colitis. Intriguingly, mice with gastrointestinal epithelial cell-specific Egfr deletion demonstrated no differences in tumorigenesis in the AOM-DSS model. The alterations in tumorigenesis in myeloid-specific Egfr knockout mice were accompanied by decreased macrophage, neutrophil and T-cell infiltration. Pro-tumorigenic M2 macrophage activation was diminished in myeloid-specific Egfr-deficient mice, as marked by decreased Arg1 and Il10 mRNA expression and decreased interleukin (IL)-4, IL10 and IL-13 protein levels. Surprisingly, diminished M1 macrophage activation was also detectable, as marked by significantly reduced Nos2 and Il1b mRNA levels and decreased interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha and IL-1 beta protein levels. The alterations in M1 and M2 macrophage activation were confirmed in bone marrow-derived macrophages from mice with the myeloid-specific Egfr knockout. The combined effect of restrained M1 and M2 macrophage activation resulted in decreased production of pro-angiogenic factors, CXCL1 and vascular endothelial growth factor (VEGF), and reduced CD31(+) blood vessels, which likely contributed to protection from tumorigenesis. These data reveal that EGFR signaling in macrophages, but not in colonic epithelial cells, has a significant role in CAC. EGFR signaling in macrophages may prove to be an effective biomarker of CAC or target for chemoprevention in patients with inflammatory bowel disease.	[Hardbower, D. M.; Washington, M. K.; Wilson, K. T.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Hardbower, D. M.; Coburn, L. A.; Asim, M.; Singh, K.; Sierra, J. C.; Barry, D. P.; Gobert, A. P.; Piazuelo, M. B.; Wilson, K. T.] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA; [Coburn, L. A.; Gobert, A. P.; Piazuelo, M. B.; Wilson, K. T.] Vanderbilt Univ, Med Ctr, Ctr Mucosal Inflammat & Canc, Nashville, TN 37232 USA; [Coburn, L. A.; Wilson, K. T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA; [Wilson, K. T.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Wilson, K. T.] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University	Wilson, KT (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Med Gastroenterol Hepatol & Nutr, 1030C Med Res Bldg 4,2215 Garland Ave, Nashville, TN 37232 USA.	keith.wilson@vanderbilt.edu	Barry, Daniel P/B-5647-2008	Barry, Daniel P/0000-0002-3972-3914; Coburn, Lori/0000-0003-3249-9806	NIH [P30CA068485, U24DK059637, R01DK053620, R01AT004821, R01CA190612, P01CA116087, P01CA028842, P50CA095103, P30DK058404]; DMH [T32GM008554, F31DK10715]; Veterans Affairs Career Development [1IK2BX002126]; Veterans Affairs Merit Review [I01BX001453]; Vanderbilt Center for Mucosal Inflammation and Cancer; Vanderbilt Mouse Metabolic Phenotyping Center; Thomas F Frist Sr Endowment; NATIONAL CANCER INSTITUTE [P01CA028842, P01CA116087, P30CA068485, R01CA190612] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053620, F31DK107159, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002126, I01BX001453] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DMH; Veterans Affairs Career Development(US Department of Veterans Affairs); Veterans Affairs Merit Review(US Department of Veterans Affairs); Vanderbilt Center for Mucosal Inflammation and Cancer; Vanderbilt Mouse Metabolic Phenotyping Center; Thomas F Frist Sr Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	CD3, CD45R and CD31 staining was performed by the Vanderbilt University Medical Center Translational Pathology Shared Resource supported by NIH grant P30CA068485 and the Vanderbilt Mouse Metabolic Phenotyping Center, supported by NIH grant U24DK059637. Slide imaging and quantification was performed in the Digital Histology Shared Resource (www.mc.vanderbilt.edu/dhsr). This work was funded by NIH grants R01DK053620, R01AT004821, R01CA190612, P01CA116087 and P01CA028842 (KTW), Veterans Affairs Merit Review grant I01BX001453 (KTW), the Thomas F Frist Sr Endowment (KTW) and the Vanderbilt Center for Mucosal Inflammation and Cancer (KTW). The human TMA was supported by NIH grant P50CA095103 and the DDRC Tissue Morphology Subcore (NIH grant P30DK058404). DMH was supported by T32GM008554 and F31DK10715. LAC was supported by Veterans Affairs Career Development Award 1IK2BX002126.	Anderson CF, 2002, J LEUKOCYTE BIOL, V72, P101; Angelo LS, 2007, CLIN CANCER RES, V13, P2825, DOI 10.1158/1078-0432.CCR-06-2416; Barrett CW, 2011, CANCER RES, V71, P1302, DOI 10.1158/0008-5472.CAN-10-3317; Brower V, 2005, J NATL CANCER I, V97, P251, DOI 10.1093/jnci/97.4.251; Chandrasekar B, 2013, J INFECT DIS, V207, P1556, DOI 10.1093/infdis/jit067; Chaturvedi R, 2014, GASTROENTEROLOGY, V146, P1739, DOI 10.1053/j.gastro.2014.02.005; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; De Simone V, 2015, ONCOGENE, V34, P3493, DOI 10.1038/onc.2014.286; Dube PE, 2012, J CLIN INVEST, V122, P2780, DOI 10.1172/JCI62888; Engstrom A, 2014, INT J ONCOL, V44, P385, DOI 10.3892/ijo.2013.2203; Erreni M, 2011, CANCER MICROENVIRON, V4, P141, DOI 10.1007/s12307-010-0052-5; Feagins LA, 2009, NAT REV GASTRO HEPAT, V6, P297, DOI 10.1038/nrgastro.2009.44; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Georgoudaki AM, 2016, CELL REP, V15, P2000, DOI 10.1016/j.celrep.2016.04.084; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hardbower DM, 2016, AMINO ACIDS, V48, P2375, DOI 10.1007/s00726-016-2231-2; Hardbower DM, 2016, J CLIN INVEST, V126, P3296, DOI 10.1172/JCI83585; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; Hiemisch H, 1997, EMBO J, V16, P3995, DOI 10.1093/emboj/16.13.3995; Hol J, 2010, J LEUKOCYTE BIOL, V87, P501, DOI 10.1189/jlb.0809532; Holmfeldt P, 2016, J EXP MED, V213, P433, DOI 10.1084/jem.20150806; Huaux F, 2015, J PATHOL, V235, P698, DOI 10.1002/path.4487; Isidro RA, 2016, AM J PHYSIOL-GASTR L, V311, pG59, DOI 10.1152/ajpgi.00123.2016; Kanneganti M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/342637; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Krasinskas A. M., 2011, PATHOLOG RES INT, V2011, P6, DOI DOI 10.4061/2011/932932; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Markman B, 2010, ADV CLIN CHEM, V51, P71, DOI 10.1016/S0065-2423(10)51004-7; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Mousa Luay, 2015, Biomark Cancer, V7, P13, DOI 10.4137/BIC.S25250; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Norton SE, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.21; Parang B, 2016, GUT, P1; Parang B, 2016, METHODS MOL BIOL, V1422, P297, DOI 10.1007/978-1-4939-3603-8_26; Payne CM, 1999, ANTIOXID REDOX SIGN, V1, P449, DOI 10.1089/ars.1999.1.4-449; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Rmali KA, 2007, COLORECTAL DIS, V9, P3, DOI 10.1111/j.1463-1318.2006.01089.x; Sakamoto K, 2009, CLIN CANCER RES, V15, P2248, DOI 10.1158/1078-0432.CCR-08-1383; Sasaki T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/546318; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Shibata W, 2010, GASTROENTEROLOGY, V138, P1022, DOI 10.1053/j.gastro.2009.11.054; Singh K, 2008, J BIOL CHEM, V283, P16752, DOI 10.1074/jbc.M710530200; Spano JP, 2005, ANN ONCOL, V16, P102, DOI 10.1093/annonc/mdi006; Sweet MJ, 2003, ARCH IMMUNOL THER EX, V51, P169; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026; Valbuena G, 2003, AM J PATHOL, V163, P1357, DOI 10.1016/S0002-9440(10)63494-3; Van Overmeire E, 2016, CANCER RES, V76, P35, DOI 10.1158/0008-5472.CAN-15-0869; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; West NR, 2015, NAT REV IMMUNOL, V15, P615, DOI 10.1038/nri3896; Wu WK, 2010, IMMUNOBIOLOGY, V215, P796, DOI 10.1016/j.imbio.2010.05.025; Xie WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058639; Yang JL, 2004, GUT, V53, P123, DOI 10.1136/gut.53.1.123; Yu HY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6218; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yue Xuetian, 2015, Cancer Cell Microenviron, V2	61	45	48	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 6	2017	36	27					3807	3819		10.1038/onc.2017.23	http://dx.doi.org/10.1038/onc.2017.23			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EZ6SM	28263971	Green Accepted			2022-12-26	WOS:000404848200002
J	Zhang, W; Hong, R; Xue, L; Ou, Y; Liu, X; Zhao, Z; Xiao, W; Dong, D; Dong, L; Fu, M; Ma, L; Lu, N; Chen, H; Song, Y; Zhan, Q				Zhang, W.; Hong, R.; Xue, L.; Ou, Y.; Liu, X.; Zhao, Z.; Xiao, W.; Dong, D.; Dong, L.; Fu, M.; Ma, L.; Lu, N.; Chen, H.; Song, Y.; Zhan, Q.			Piccolo mediates EGFR signaling and acts as a prognostic biomarker in esophageal squamous cell carcinoma	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; PRESYNAPTIC ACTIVE ZONES; NEUROTRANSMITTER RELEASE; EPITHELIAL-CELLS; CANCER GENOMICS; PROTEIN; BASSOON; OVEREXPRESSION; MUTATIONS; SYNAPSE	The presynaptic cytomatrix protein Piccolo, encoded by PCLO, is frequently mutated and amplified in esophageal squamous cell carcinoma (ESCC), but its exact roles in ESCC remain unclear. Here we report that Piccolo expression correlates significantly with clinical stage, patient survival and tumor embolus. Functional studies demonstrate that PCLO knockdown remarkably attenuates ESCC malignancy in vitro and in vivo, and ectopic EGFR expression partially compensates for Piccolo loss. PCLO knockdown promotes ubiquitination and degradation of EGFR, which is associated with the negative regulatory effect of Piccolo on E3 ligase Siah1. An anti-Piccolo monoclonal antibody inhibited tumor proliferation in a mouse model of ESCC. These results demonstrate that Piccolo contributes to tumor aggressiveness in ESCC, likely by stabilizing EGFR and promoting EGFR-dependent signaling. Our results further suggest that Piccolo may represent a novel prognostic biomarker and therapeutic target for patients with ESCC.	[Zhang, W.; Ou, Y.; Liu, X.; Zhao, Z.; Xiao, W.; Dong, D.; Dong, L.; Fu, M.; Ma, L.; Song, Y.; Zhan, Q.] Chinese Acad Med Sci, Canc Inst & Canc Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Zhang, W.; Liu, X.; Zhao, Z.; Xiao, W.; Dong, D.; Dong, L.; Fu, M.; Ma, L.; Song, Y.; Zhan, Q.] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, W.; Zhan, Q.] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Sichuan, Peoples R China; [Zhang, W.; Chen, H.] Guangdong Koheala Precis Med Inst, Guangzhou, Guangdong, Peoples R China; [Hong, R.] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Xue, L.; Lu, N.] Peking Union Med Coll, Canc Inst & Canc Hosp, Dept Pathol, Beijing, Peoples R China; [Xue, L.; Lu, N.] Chinese Acad Med Sci, Beijing, Peoples R China; [Ou, Y.] Capital Med Univ, Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Liu, X.] Dalian Med Univ, Canc Ctr, Inst Canc Stem Cell, Dalian, Peoples R China; [Zhan, Q.] Peking Univ Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Sichuan University; State Key Lab Oncology South China; Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Capital Medical University; Dalian Medical University; Peking University	Zhan, Q (corresponding author), Chinese Acad Med Sci, Canc Inst & Canc Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.; Zhan, Q (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.	zhanqimin@bjmu.edu.cn	Dong, Dezuo/EUE-3308-2022		National 973 Program [2015CB553904]; National Natural Fund of China [81230047, 81321091]	National 973 Program(National Basic Research Program of China); National Natural Fund of China	We appreciated Jie Chen and Tian Lan for revising this manuscript and offering constructive advices. This work is supported by the National 973 Program (2015CB553904) and National Natural Fund of China (81230047 and 81321091).	Abedi-Ardekani B, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-602; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Cao HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106007; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cremona O, 2001, J CELL SCI, V114, P1041; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Fujimoto A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7120; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao ZH, 2014, ONCOL LETT, V7, P1118, DOI 10.3892/ol.2014.1881; Garcia J, 2004, NAT STRUCT MOL BIOL, V11, P45, DOI 10.1038/nsmb707; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Gerber SH, 2001, EMBO J, V20, P1605, DOI 10.1093/emboj/20.7.1605; Hanawa M, 2006, INT J CANCER, V118, P1173, DOI 10.1002/ijc.21454; Kalabis J, 2012, NAT PROTOC, V7, P235, DOI 10.1038/nprot.2011.437; Lehman HL, 2015, AM J PATHOL, V185, P240, DOI 10.1016/j.ajpath.2014.09.008; Limbach C, 2011, P NATL ACAD SCI USA, V108, pE392, DOI 10.1073/pnas.1101707108; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Navarini D, 2012, GASTROENT RES PRACT, V2012; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111045; Shen ZY, 2002, WORLD J GASTROENTERO, V8, P357; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; SORKIN A, 1993, BIOESSAYS, V15, P375, DOI 10.1002/bies.950150603; Sunpaweravong P, 2005, J CANCER RES CLIN, V131, P111, DOI 10.1007/s00432-004-0610-7; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Waites CL, 2013, EMBO J, V32, P954, DOI 10.1038/emboj.2013.27; Wang QF, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-278; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Xue LY, 2012, MODERN PATHOL, V25, P1364, DOI 10.1038/modpathol.2012.89; Yang F, 2013, J BIOL CHEM, V288, P6552, DOI 10.1074/jbc.M112.418335; Yang YL, 2012, CHINESE MED J-PEKING, V125, P450, DOI 10.3760/cma.j.issn.0366-6999.2012.03.009; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhang H, 2006, CANCER GENET CYTOGEN, V165, P25, DOI 10.1016/j.cancergencyto.2005.07.016; Zhang YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100854	39	20	20	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 6	2017	36	27					3890	3902		10.1038/onc.2017.15	http://dx.doi.org/10.1038/onc.2017.15			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EZ6SM	28263981				2022-12-26	WOS:000404848200009
J	Mookerjee, SA; Gerencser, AA; Nicholls, DG; Brand, MD				Mookerjee, Shona A.; Gerencser, Akos A.; Nicholls, David G.; Brand, Martin D.			Quantifying intracellular rates of glycolytic and oxidative ATP production and consumption using extracellular flux measurements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPARE RESPIRATORY CAPACITY; AEROBIC GLYCOLYSIS; ADENOSINE-TRIPHOSPHATE; MITOCHONDRIAL; INHIBITION; METABOLISM; STRESS; DEMAND; SODIUM; INDEX	Partitioning of ATP generation between glycolysis and oxidative phosphorylation is central to cellular bioenergetics but cumbersome to measure. We describe here how rates of ATP generation by each pathway can be calculated from simultaneous measurements of extracellular acidification and oxygen consumption. We update theoretical maximum ATP yields by mitochondria and cells catabolizing different substrates. Mitochondrial P/O ratios (mol of ATP generated per mol of [O] consumed) are 2.73 for oxidation of pyruvate plus malate and 1.64 for oxidation of succinate. Complete oxidation of glucose by cells yields up to 33.45 ATP/glucose with a maximum P/O of 2.79. We introduce novel indices to quantify bioenergetic phenotypes. The glycolytic index reports the proportion of ATP production from glycolysis and identifies cells as primarily glycolytic (glycolytic index > 50%) or primarily oxidative. The Warburg effect is a chronic increase in glycolytic index, quantified by the Warburg index. Additional indices quantify the acute flexibility of ATP supply. The Crabtree index and Pasteur index quantify the responses of oxidative and glycolytic ATP production to alterations in glycolysis and oxidative reactions, respectively; the supply flexibility index quantifies overall flexibility of ATP supply; and the bioenergetic capacity quantifies the maximum rate of total ATP production. We illustrate the determination of these indices using C2C12 myoblasts. Measurement of ATP use revealed no significant preference for glycolytic or oxidative ATP by specific ATP consumers. Overall, we demonstrate how extracellular fluxes quantitatively reflect intracellular ATP turnover and cellular bioenergetics. We provide a simple spreadsheet to calculate glycolytic and oxidative ATP production rates from raw extracellular acidification and respiration data.	[Mookerjee, Shona A.; Brand, Martin D.] Touro Univ Calif, Coll Pharm, Vallejo, CA 94592 USA; [Mookerjee, Shona A.; Gerencser, Akos A.; Nicholls, David G.; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA	Touro University California; Buck Institute for Research on Aging	Mookerjee, SA (corresponding author), Touro Univ Calif, Coll Pharm, Vallejo, CA 94592 USA.; Mookerjee, SA (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	shona.mookerjee@tu.edu	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153				Affourtit C, 2009, METHOD ENZYMOL, V457, P405, DOI 10.1016/S0076-6879(09)05023-X; Arora R, 2015, ONCOTARGET, V6, P662, DOI 10.18632/oncotarget.2689; Barnett JA, 2005, YEAST, V22, P835, DOI 10.1002/yea.1249; BEUTLER E, 1978, P NATL ACAD SCI USA, V75, P2825, DOI 10.1073/pnas.75.6.2825; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brand MD, 1996, J THEOR BIOL, V182, P351, DOI 10.1006/jtbi.1996.0174; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; BRAND MD, 1984, BIOCHEM J, V224, P1027, DOI 10.1042/bj2241027; BUTTGEREIT F, 1992, BIOSCIENCE REP, V12, P381, DOI 10.1007/BF01121501; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Chacko BK, 2016, REDOX BIOL, V8, P43, DOI 10.1016/j.redox.2015.12.008; Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; Epstein T, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-7; FELBER SM, 1983, BIOCHEM J, V210, P893, DOI 10.1042/bj2100893; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; IBSEN KH, 1961, CANCER RES, V21, P829; James AD, 2015, J BIOL CHEM, V290, P24760, DOI 10.1074/jbc.M115.668707; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Mangnall David, 1993, Biochemical Society Transactions, V21, p438S; MERCER RW, 1981, J GEN PHYSIOL, V78, P547, DOI 10.1085/jgp.78.5.547; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Mookerjee SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152016; Mookerjee SA, 2015, JOVE-J VIS EXP, DOI 10.3791/53464; Mookerjee SA, 2015, BBA-BIOENERGETICS, V1847, P171, DOI 10.1016/j.bbabio.2014.10.005; Mouradian M, 2015, MOL CARCINOGEN, V54, P810, DOI 10.1002/mc.22151; Nedachi T, 2006, AM J PHYSIOL-ENDOC M, V291, pE817, DOI 10.1152/ajpendo.00194.2006; Nicholls D. G., 2010, JOVE-J VIS EXP, DOI 10.3791/2511; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; NICHOLLS DG, 1979, BIOCHIM BIOPHYS ACTA, V549, P1, DOI 10.1016/0304-4173(79)90016-8; PAUL RJ, 1979, SCIENCE, V206, P1414, DOI 10.1126/science.505014; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; STICKLAND LH, 1956, BIOCHEM J, V64, P503, DOI 10.1042/bj0640503; THOMPSON J, 1984, J BACTERIOL, V158, P791, DOI 10.1128/JB.158.3.791-800.1984; Tourmente M, 2015, J BIOL CHEM, V290, P20613, DOI 10.1074/jbc.M115.664813; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Vayalil PK, 2015, ONCOTARGET, V6, P43065, DOI 10.18632/oncotarget.5487; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007	44	183	185	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7189	7207		10.1074/jbc.M116.774471	http://dx.doi.org/10.1074/jbc.M116.774471			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28270511	hybrid, Green Published			2022-12-26	WOS:000400478300030
J	Fujiki, R; Hijikata, A; Shirai, T; Okada, S; Kobayashi, M; Ohara, O				Fujiki, Ryoji; Hijikata, Atsushi; Shirai, Tsuyoshi; Okada, Satoshi; Kobayashi, Masao; Ohara, Osamu			Molecular mechanism and structural basis of gain-of-function of STAT1 caused by pathogenic R274Q mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INBORN-ERRORS; ACTIVATION	Gain-of-function (GOF) mutations in the STAT1 gene are critical for the onset of chronic mucocutaneous candidiasis (CMC) disease. However, the molecular basis for the gain of STAT1 function remains largely unclear. Here, we investigated the structural features of STAT1 GOF residues to better understand the impact of these pathogenic mutations. We constructed STAT1 alanine mutants of the alpha 3 helix residues of the coiled-coil domain, which are frequently found in CMC pathogenic mutations, and measured their transcriptional activities. Most of the identified GOF residues were located inside the coiled-coil domain stem structure or at the protein surface of the anti-parallel dimer interface. Unlike those, Arg-274 was adjacent to the DNA-binding domain. In addition, Arg-274 was found to functionally interact with Gln-441 in the DNA-binding domain. Because Gln-441 is located at the anti-parallel dimer contact site, Gln-441 reorientation by Arg-274 mutation probably impedes formation of the dimer. Further, the statistical analysis of RNA-seq data with STAT1-deficient epithelial cells and primary T cells from a CMC patient revealed that the R274Q mutation affected gene expression levels of 66 and 76 non-overlapping RefSeq genes, respectively. Because their transcription levels were only slightly modulated by wild-type STAT1, we concluded that the R274Q mutation increased transcriptional activity but did not change dramatically the repertoire of STAT1 targets. Hence, we provide a novel mechanism of STAT1 GOF triggered by a CMC pathogenic mutation.	[Fujiki, Ryoji; Ohara, Osamu] Kazusa DNA Res Inst, Dev Technol Dept, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 2920818, Japan; [Hijikata, Atsushi; Shirai, Tsuyoshi] Nagahama Inst Biosci & Technol, 1266 Tamura, Nagahama, Shiga 5260829, Japan; [Okada, Satoshi; Kobayashi, Masao] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima 7348551, Japan	Kazusa DNA Research Institute; Hiroshima University	Fujiki, R (corresponding author), Kazusa DNA Res Inst, Dev Technol Dept, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 2920818, Japan.	fujiki@kazusa.or.jp	Okada, Satoshi/B-8901-2011; Ohara, Osamu/G-5448-2015	Okada, Satoshi/0000-0002-4622-5657; Ohara, Osamu/0000-0002-3328-9571; Hijikata, Atsushi/0000-0003-4297-8368	Platform for Drug Design, Informatics, and Structural Lifescience (PDIS); Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Scientific Research [15K00411] Funding Source: KAKEN	Platform for Drug Design, Informatics, and Structural Lifescience (PDIS); Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by research grants from the Platform for Drug Design, Informatics, and Structural Lifescience (PDIS) and by the Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED). The authors declare that they have no conflicts of interest with the contents of this article.	Boisson-Dupuis S, 2012, CURR OPIN IMMUNOL, V24, P364, DOI 10.1016/j.coi.2012.04.011; Bonjardim CA, 1998, BRAZ J MED BIOL RES, V31, P1389, DOI 10.1590/S0100-879X1998001100004; Casanova JL, 2012, IMMUNITY, V36, P515, DOI 10.1016/j.immuni.2012.03.016; Chapgier A, 2006, PLOS GENET, V2, P1193, DOI 10.1371/journal.pgen.0020131; Chen XM, 2003, PROTEIN SCI, V12, P361, DOI 10.1110/ps.0218903; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Hartman SE, 2005, GENE DEV, V19, P2953, DOI 10.1101/gad.1371305; Hoey T, 1998, CURR OPIN GENET DEV, V8, P582, DOI 10.1016/S0959-437X(98)80015-4; Horvath CM, 1996, MOL CELL BIOL, V16, P6957; Liu LD, 2011, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2011-2; Mao X, 2005, ACTA CRYSTALLOGR F, V61, P666, DOI 10.1107/S1744309105017392; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Toubiana J, 2016, BLOOD, V127, P3154, DOI 10.1182/blood-2015-11-679902; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102	21	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6240	6254		10.1074/jbc.M116.753848	http://dx.doi.org/10.1074/jbc.M116.753848			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28258222	Green Published, hybrid			2022-12-26	WOS:000399538700019
J	Moutkine, I; Quentin, E; Guiard, BP; Maroteaux, L; Doly, S				Moutkine, Imane; Quentin, Emily; Guiard, Bruno P.; Maroteaux, Luc; Doly, Stephane			Heterodimers of serotonin receptor subtypes 2 are driven by 5-HT2C protomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIAL PREFRONTAL CORTEX; DORSAL RAPHE NUCLEUS; G-PROTEIN; RAT-BRAIN; NOREPINEPHRINE NEURONS; FUNCTIONAL SELECTIVITY; DEPENDENT MECHANISM; FIRING ACTIVITY; MESSENGER-RNAS; 5-HYDROXYTRYPTAMINE	The serotonin receptor subtypes 2 comprise 5-HT2A,5-HT2B, and 5-HT2C, which are G alpha(q)-coupled receptors and display distinct pharmacological properties. Although co-expressed in some brain regions and involved in various neurological disorders, their functional interactions have not yet been studied. We report that 5-HT2 receptors can form homo-and heterodimers when expressed alone or co-expressed in transfected cells. Co-immunoprecipitation and bioluminescence resonance energy transfer studies confirmed that 5-HT2C receptors interact with either 5-HT2A or 5-HT2B receptors. Although heterodimerization with 5-HT2C receptors does not alter 5-HT2C G alpha(q)-dependent inositol phosphate signaling, 5-HT2A or 5-HT2B receptor-mediated signaling was totally blunted. This feature can be explained by a dominance of 5-HT2C on 5-HT2A and 5-HT2B receptor binding; in 5-HT2C-containing heterodimers, ligands bind and activate the 5-HT2C protomer exclusively. This dominant effect on the associated protomer was also observed in neurons, supporting the physiological relevance of 5-HT2 receptor heterodimerization in vivo. Accordingly, exogenous expression of an inactive form of the 5-HT2C receptor in the locus ceruleus is associated with decreased 5-HT2A-dependent noradrenergic transmission. These data demonstrate that 5-HT2 receptors can form functionally asymmetric heterodimers in vitro and in vivo that must be considered when analyzing the physiological or pathophysiological roles of serotonin in tissues where 5-HT2 receptors are co-expressed.	[Moutkine, Imane; Quentin, Emily; Maroteaux, Luc] INSERM, UMR S839, F-75005 Paris, France; [Moutkine, Imane; Quentin, Emily; Maroteaux, Luc] Univ Paris 06, F-75005 Paris, France; [Moutkine, Imane; Quentin, Emily; Maroteaux, Luc] Inst Fer Moulin, F-75005 Paris, France; [Doly, Stephane] Inst Cochin, CNRS UMR8104, INSERM U1016, F-75014 Paris, France; [Doly, Stephane] Univ Paris 05, Sorbonne Paris Cite, F-75014 Paris, France; [Doly, Stephane] Univ Clermont Auvergne, INSERM, NEURO DOL, F-63000 Clermont Ferrand, France; [Guiard, Bruno P.] Univ Paul Sabatier, Res Ctr Anim Cognit, Ctr Integrat Biol, CNRS UMR5169, 118 Route Narbonne, F-31062 Toulouse 9, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Maroteaux, L (corresponding author), INSERM, UMR S839, F-75005 Paris, France.; Maroteaux, L (corresponding author), Univ Paris 06, F-75005 Paris, France.; Maroteaux, L (corresponding author), Inst Fer Moulin, F-75005 Paris, France.; Doly, S (corresponding author), Univ Clermont Auvergne, INSERM, NEURO DOL, F-63000 Clermont Ferrand, France.	Luc.maroteaux@upmc.fr; stephane.doly@inserm.fr	doly, stephane/Y-2318-2019; Maroteaux, Luc/H-4585-2019; Core, Vector/CAF-4832-2022; Guiard, Bruno/A-3955-2016	doly, stephane/0000-0002-3517-8605; Maroteaux, Luc/0000-0002-9499-8603; 	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Universite Pierre et Marie Curie; Universite Paris Descartes; Fondation de France; Fondation pour la Recherche Medicale "Equipe" [FRM DEQ2014039529]; French Ministry of Research [ANR-12-BSV1-0015-01]; Investissements d'Avenir Programme [ANR-11-IDEX-0004-02]; French state funds; ANR within the Investissements d'Avenir programme [ANR-11-IDEX-0004-02]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie; Universite Paris Descartes; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale "Equipe"(Fondation pour la Recherche Medicale); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Investissements d'Avenir Programme(French National Research Agency (ANR)); French state funds; ANR within the Investissements d'Avenir programme(French National Research Agency (ANR))	This work was supported by funds from the Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, the Universite Pierre et Marie Curie, the Universite Paris Descartes, grants from the Fondation de France, Fondation pour la Recherche Medicale "Equipe FRM DEQ2014039529," and the French Ministry of Research (Agence Nationale pour la Recherche Grant ANR-12-BSV1-0015-01 and the Investissements d'Avenir Programme Grant ANR-11-IDEX-0004-02). The L.M. team is part of the Ecole des Neurosciences de Paris Ile-de-France network and the Bio-Psy Labex, and as such this work was supported by French state funds managed by the ANR within the Investissements d'Avenir programme under Reference ANR-11-IDEX-0004-02. The authors declare that they have no conflicts of interest with the contents of this article.	AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; Achour L, 2011, METHODS MOL BIOL, V756, P183, DOI 10.1007/978-1-61779-160-4_9; AGHAJANIAN GK, 1982, J HISTOCHEM CYTOCHEM, V30, P813, DOI 10.1177/30.8.6749973; Albizu L, 2011, NEUROPHARMACOLOGY, V61, P770, DOI 10.1016/j.neuropharm.2011.05.023; Anastasio NC, 2015, ACS CHEM NEUROSCI, V6, P1248, DOI 10.1021/acschemneuro.5b00094; Banas SM, 2011, NEUROPSYCHOPHARMACOL, V36, P423, DOI 10.1038/npp.2010.173; Beique JC, 2004, J PHYSIOL-LONDON, V556, P739, DOI 10.1113/jphysiol.2003.051284; Beique JC, 2004, J NEUROSCI, V24, P4807, DOI 10.1523/JNEUROSCI.5113-03.2004; Berthouze M, 2005, FEBS LETT, V579, P2973, DOI 10.1016/j.febslet.2005.04.040; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bohn LM, 2010, CRIT REV BIOCHEM MOL, V45, P555, DOI 10.3109/10409238.2010.516741; Bombardi C, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00068; BONHAUS DW, 1995, BRIT J PHARMACOL, V115, P622, DOI 10.1111/j.1476-5381.1995.tb14977.x; Boothman LJ, 2005, NEUROREPORT, V16, P891, DOI 10.1097/00001756-200506210-00004; Bortolozzi A, 2003, NEUROPSYCHOPHARMACOL, V28, P421, DOI 10.1038/sj.npp.1300061; Brea J, 2009, MOL PHARMACOL, V75, P1380, DOI 10.1124/mol.108.054395; Bubar MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020508; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Carr DB, 2002, J NEUROSCI, V22, P6846; Cornea-Hebert V, 1999, J COMP NEUROL, V409, P187, DOI 10.1002/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P; Cussac D, 2012, CELL SIGNAL, V24, P1648, DOI 10.1016/j.cellsig.2012.04.010; Deraet M, 2005, MOL PHARMACOL, V67, P983, DOI 10.1124/mol.104.008268; Diaz SL, 2012, MOL PSYCHIATR, V17, P154, DOI 10.1038/mp.2011.159; Doly S, 2016, MOL PSYCHIATR, V21, P480, DOI 10.1038/mp.2015.72; Doly S, 2004, J COMP NEUROL, V472, P496, DOI 10.1002/cne.20082; Du YZ, 2006, GENE, V382, P39, DOI 10.1016/j.gene.2006.06.007; Esposito E, 2006, CURR DRUG TARGETS, V7, P177, DOI 10.2174/138945006775515455; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200; Herrick-Davis K, 2015, MOL PHARMACOL, V87, P660, DOI 10.1124/mol.114.096636; Herrick-Davis K, 2013, EXP BRAIN RES, V230, P375, DOI 10.1007/s00221-013-3622-1; Herrick-Davis K, 2012, J BIOL CHEM, V287, P23604, DOI 10.1074/jbc.M112.350249; Jaffre F, 2009, CIRC RES, V104, P113, DOI 10.1161/CIRCRESAHA.108.180976; Janoshazi A, 2007, MOL PHARMACOL, V71, P1463, DOI 10.1124/mol.106.032656; Jastrzebska B, 2013, AMINO ACIDS, V45, P1303, DOI 10.1007/s00726-013-1593-y; Kamal M, 2015, J BIOL CHEM, V290, P11537, DOI 10.1074/jbc.M114.559542; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; Li QH, 2004, J COMP NEUROL, V469, P128, DOI 10.1002/cne.11004; Lukasiewicz S, 2007, PHARMACOL REP, V59, P379; Maeshima T, 1998, NEUROSCI LETT, V252, P72, DOI 10.1016/S0304-3940(98)00546-1; Mancia F, 2008, EMBO REP, V9, P363, DOI 10.1038/embor.2008.27; Maurice P, 2011, TRENDS PHARMACOL SCI, V32, P514, DOI 10.1016/j.tips.2011.05.006; Millan MJ, 2008, TRENDS PHARMACOL SCI, V29, P454, DOI 10.1016/j.tips.2008.06.007; Moreno JL, 2012, J BIOL CHEM, V287, P44301, DOI 10.1074/jbc.M112.413161; Nocjar C, 2015, NEUROSCIENCE, V297, P22, DOI 10.1016/j.neuroscience.2015.03.050; PAZOS A, 1985, BRAIN RES, V346, P231, DOI 10.1016/0006-8993(85)90857-1; Pellissier LP, 2011, J BIOL CHEM, V286, P9985, DOI 10.1074/jbc.M110.201939; POMPEIANO M, 1994, MOL BRAIN RES, V23, P163, DOI 10.1016/0169-328X(94)90223-2; Quesseveur G, 2013, EXP BRAIN RES, V226, P285, DOI 10.1007/s00221-013-3434-3; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; Renner U, 2012, J CELL SCI, V125, P2486, DOI 10.1242/jcs.101337; Roth BL, 2011, NEUROPHARMACOLOGY, V61, P348, DOI 10.1016/j.neuropharm.2011.01.012; Schellekens H, 2013, J BIOL CHEM, V288, P181, DOI 10.1074/jbc.M112.382473; Siddiquee K, 2013, BRIT J PHARMACOL, V168, P1104, DOI 10.1111/j.1476-5381.2012.02192.x; Smith C, 2011, MOL PHARMACOL, V79, P318, DOI 10.1124/mol.110.069278; Szabo ST, 2002, J PHARMACOL EXP THER, V302, P983, DOI 10.1124/jpet.102.033282; Szabo ST, 2001, BRAIN RES, V922, P9, DOI 10.1016/S0006-8993(01)03121-3; Vinals X, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002194; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Ward RP, 1996, J COMP NEUROL, V370, P405, DOI 10.1002/(SICI)1096-9861(19960701)370:3<405::AID-CNE10>3.0.CO;2-R; WRIGHT DE, 1995, J COMP NEUROL, V351, P357, DOI 10.1002/cne.903510304; Xie XD, 1999, FEBS LETT, V456, P63, DOI 10.1016/S0014-5793(99)00918-7; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051	67	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6352	6368		10.1074/jbc.M117.779041	http://dx.doi.org/10.1074/jbc.M117.779041			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28258217	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000399538700028
J	Tam, LE; Kim, N; De Souza, GM				Tam, Laura E.; Kim, Namhee; De Souza, Grace M.			Effect of tooth whitening strips on fatigue resistance and flexural strength of bovine dentin in vitro	PLOS ONE			English	Article							CARBAMIDE PEROXIDE; FRACTURE-TOUGHNESS; BLEACHING AGENTS; COMPOSITE RESIN; PREVALENCE; ENAMEL; EFFICACY; MICROHARDNESS; 10-PERCENT; EXPOSURE	Objective To determine the effects of whitening strips on bovine dentin fatigue resistance and flexural strength in vitro. Materials and methods A total of eighty bovine dentin specimens (2x2x17mm) were treated with either: control glycerine gel on plastic film wrap or whitening strips containing 9.5% hydrogen peroxide. Treatment was applied for 30 minutes, twice a day, for 1- or 4-weeks. After the last treatment, ten specimens per group were randomly selected to undergo fatigue testing (10 6 cycles, 3Hz, 20N) while the other ten were subjected to flexural strength testing after ten days of storage in artificial saliva. Kaplan-Meier method with a log rank test, Wilcoxon test and Cox regression were used to assess fatigue test results (p<0.05). One-way ANOVA and Tukey's tests were used to compare the flexural strength results (p<0.05). Results There were significant differences in survival during the fatigue test among the groups (p<0.001). Treatment (control or bleach) was a significant factor for specimen survival (p<0.001, Exp(B) = 33.45). There were significant differences in mean flexural strength (p<0.001). No significant difference was found between "1-wk control" and "4-wk control". The mean flexural strength and fatigue resistance of the "4-wk bleach" were significantly lower than all the other groups. Conclusions The use of whitening strips reduced the fatigue resistance and flexural strength of bovine dentin in vitro. Until the effect of whitening strips on mechanical properties of human dentin is fully elucidated, it remains prudent to advise patients to avoid excessive direct use of whitening strips on dentin.	[Tam, Laura E.; Kim, Namhee; De Souza, Grace M.] Univ Toronto, Dept Clin Sci, Restorat Dent, Fac Dent, Toronto, ON, Canada	University of Toronto	Tam, LE (corresponding author), Univ Toronto, Dept Clin Sci, Restorat Dent, Fac Dent, Toronto, ON, Canada.	laura.tam@dentistry.utoronto.ca	de Souza, Grace M/H-2213-2018	de Souza, Grace M/0000-0002-7521-9723	Canadian Institute of Health Research Health Professional Summer Research Award	Canadian Institute of Health Research Health Professional Summer Research Award(Canadian Institutes of Health Research (CIHR))	The study was supported by a Canadian Institute of Health Research Health Professional Summer Research Award, 2014/2015 (NK). The whitening strips were provided by Proctor & Gamble Incorporated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablal MA, 2009, J DENT, V37, P835, DOI 10.1016/j.jdent.2009.06.016; ADIBFAR A, 1992, J ENDODONT, V18, P488, DOI 10.1016/S0099-2399(06)81348-8; Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; American Dental Association Council on Scientific Affairs, 2015, RES IMP PRACT DENT; Auschill TM, 2005, OPER DENT, V30, P156; Berger SB, 2012, ACTA ODONTOL SCAND, V70, P56, DOI 10.3109/00016357.2011.575176; BOWLES WH, 1987, J ENDODONT, V13, P375, DOI 10.1016/S0099-2399(87)80196-6; Cavalli V, 2009, INT ENDOD J, V42, P568, DOI 10.1111/j.1365-2591.2009.01543.x; Chng HK, 2004, J ORAL REHABIL, V31, P811, DOI 10.1111/j.1365-2842.2004.01298.x; Cvikl B, 2016, OPER DENT, V41, pE39, DOI 10.2341/15-010-L; Dietschi D, 2006, QUINTESSENCE INT, V37, P515; Eimar H, 2012, J DENT, V40, pE25, DOI 10.1016/j.jdent.2012.08.008; Forner L, 2009, J ENDODONT, V35, P1384, DOI 10.1016/j.joen.2009.06.023; Goldberg M, 2010, CLIN ORAL INVEST, V14, P1, DOI 10.1007/s00784-009-0302-4; Hasson H, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006202; Hosoya N, 2003, J DENT, V31, P543, DOI 10.1016/S0300-5712(03)00109-X; Joiner A, 2004, J DENT, V32, P3, DOI 10.1016/j.jdent.2003.10.013; Joiner A, 2006, J DENT, V34, P412, DOI 10.1016/j.jdent.2006.02.002; KHOCHT A, 1993, J PERIODONTOL, V64, P900, DOI 10.1902/jop.1993.64.9.900; Khoroushi M, 2011, OPER DENT, V36, P372, DOI 10.2341/10-280-L; Kinney JH, 2003, CRIT REV ORAL BIOL M, V14, P13, DOI 10.1177/154411130301400103; Kuga MC, 2012, DENT TRAUMATOL, V28, P238, DOI 10.1111/j.1600-9657.2011.01077.x; Kwon SR, 2013, AM J DENT, V26, P356; Leonard R H Jr, 1998, Compend Contin Educ Dent, V19, P766; Li Y, 2013, BRIT DENT J, V215, P29, DOI 10.1038/sj.bdj.2013.629; LOE H, 1992, J PERIODONTOL, V63, P489; Pegoraro LF, 2005, J AM DENT ASSOC, V136, P1694, DOI 10.14219/jada.archive.2005.0113; Price R B, 2000, J Can Dent Assoc, V66, P421; Rodrigues JA, 2001, AM J DENT, V14, P67; SANO H, 1994, J DENT RES, V73, P1205, DOI 10.1177/00220345940730061201; Sato C, 2013, J DENT RES, V92, P187, DOI 10.1177/0022034512470831; Smith BGN, 1997, J PROSTHET DENT, V78, P367, DOI 10.1016/S0022-3913(97)70043-X; Soares FZM, 2016, DENT MATER, V32, P1385, DOI 10.1016/j.dental.2016.09.019; Tam LE, 2007, J DENT RES, V86, P1193, DOI 10.1177/154405910708601210; Tam LE, 2013, OPER DENT, V38, P142, DOI 10.2341/12-127-C; Tam LE, 2007, J ESTHET RESTOR DENT, V19, P100, DOI 10.1111/j.1708-8240.2007.00075.x; Tam LE, 2015, J ESTHET RESTOR DENT, V27, P374, DOI 10.1111/jerd.12157; Teixeira EC, 2007, J MATER SCI-MATER M, V18, P1219, DOI 10.1007/s10856-007-0131-4; Thitinanthapan W, 1999, J Esthet Dent, V11, P259, DOI 10.1111/j.1708-8240.1999.tb00407.x; Titley KC, 1998, ARCH ORAL BIOL, V43, P305, DOI 10.1016/S0003-9969(97)00112-X; Toledano M, 2011, J ENDODONT, V37, P1668, DOI 10.1016/j.joen.2011.08.003; Tonami K, 1996, Dent Mater J, V15, P205; TORNECK CD, 1990, J ENDODONT, V16, P123, DOI 10.1016/S0099-2399(06)81588-8; Van't Spijker A, 2009, INT J PROSTHODONT, V22, P35; Wise R., 2004, J BUS STRAT, V25, P26, DOI [10.1108/02756660410558915, DOI 10.1108/02756660410558915]; Yassen Ghaeth H, 2011, J Oral Sci, V53, P273; Zantner C, 2007, DENT MATER, V23, P243, DOI 10.1016/j.dental.2006.06.044	47	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173480	10.1371/journal.pone.0173480	http://dx.doi.org/10.1371/journal.pone.0173480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278191	Green Published, gold, Green Submitted			2022-12-26	WOS:000396087900101
J	Yan, CR; Zhao, X; Zhang, QL; Huang, YF				Yan, Cairong; Zhao, Xue; Zhang, Qinglong; Huang, Yongfeng			Efficient string similarity join in multi-core and distributed systems	PLOS ONE			English	Article								In big data area a significant challenge about string similarity join is to find all similar pairs more efficiently. In this paper, we propose a parallel processing framework for efficient string similarity join. First, the input is split into some disjoint small subsets according to the joint frequency distribution and the interval distribution of strings. Then the filter-verification strategy is adopted in the computation of string similarity for each subset so that the number of candidate pairs is reduced before an effective pruning strategy is used to improve the performance. Finally, the operation of string join is executed in parallel. Para-Join algorithm based on the multi-threading technique is proposed to implement the framework in a multi-core system while Pada-Join algorithm based on Spark platform is proposed to implement the framework in a cluster system. We prove that Para-Join and Pada-Join cannot only avoid reduplicate computation but also ensure the completeness of the result. Experimental results show that Para-Join can achieve high efficiency and significantly outperform than state-of-the-art approaches, meanwhile, Pada-Join can work on large datasets.	[Yan, Cairong; Zhao, Xue; Zhang, Qinglong; Huang, Yongfeng] Donghua Univ, Sch Comp Sci & Technol, Shanghai, Peoples R China	Donghua University	Yan, CR (corresponding author), Donghua Univ, Sch Comp Sci & Technol, Shanghai, Peoples R China.	cryan@dhu.edu.cn			 [61402100]		This work was supported by grant No. 61402100 (2014). https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list.	Afrati FN, 2012, PROC INT CONF DATA, P498, DOI 10.1109/ICDE.2012.66; Alba A, 2012, IEEE ENG MED BIO, P6309, DOI 10.1109/EMBC.2012.6347436; Bayardo R.J., 2007, P 16 INT C WORLD WID, DOI DOI 10.1145/1242572.1242591; Chen Yi-Cheng, 2014, Application Research of Computers, V31, P3002, DOI 10.3969/j.issn.1001-3695.2014.10.028; Deng D, 2014, PROC INT CONF DATA, P340, DOI 10.1109/ICDE.2014.6816663; Jestes J., 2010, SIGMOD, P327; Jiang Y., 2013, P JOINT EDBTICDT 201, P341, DOI [10.1145/2457317.2457382, DOI 10.1145/2457317.2457382]; Jiang Y, 2014, PROC VLDB ENDOW, V7, P625, DOI 10.14778/2732296.2732299; Kim Y, 2012, PROC INT CONF DATA, P510, DOI 10.1109/ICDE.2012.87; Lu J., 2013, P 2013 ACM SIGMOD IN, P373, DOI [10.1145/2463676.2465313, DOI 10.1145/2463676.2465313]; Metwally A, 2012, PROC VLDB ENDOW, V5, P704, DOI 10.14778/2212351.2212353; Vernica R., 2010, P 2010 ACM SIGMOD IN, DOI DOI 10.1145/1807167.1807222; Wang J., 2012, ACM SIGMOD, P85; Wang JN, 2014, ACM T DATABASE SYST, V39, DOI 10.1145/2535628; Wang JN, 2010, PROC VLDB ENDOW, V3, P1219, DOI 10.14778/1920841.1920992; Wang JN, 2011, PROC INT CONF DATA, P458, DOI 10.1109/ICDE.2011.5767865; Wang W, 2009, ACM SIGMOD/PODS 2009 CONFERENCE, P759; Xiao C, 2011, ACM T DATABASE S AUG, V8, P1; Xu KF, 2013, PROCEDIA COMPUT SCI, V17, P523, DOI 10.1016/j.procs.2013.05.067; Yuan XP, 2012, J CENT SOUTH UNIV, V19, P2231, DOI 10.1007/s11771-012-1267-z; Zhang Z., 2010, SIGMOD, P915, DOI DOI 10.1145/1807167.1807266	21	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172526	10.1371/journal.pone.0172526	http://dx.doi.org/10.1371/journal.pone.0172526			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278177	Green Published, gold, Green Submitted			2022-12-26	WOS:000396087900121
J	Borlee, F; Yzermans, CJ; Krop, E; Aalders, B; Rooijackers, J; Zock, JP; van Dijk, CE; Maassen, CBM; Schellevis, F; Heederik, D; Smit, LAM				Borlee, Floor; Yzermans, C. Joris; Krop, Esmeralda; Aalders, Bernadette; Rooijackers, Jos; Zock, Jan-Paul; van Dijk, Christel E.; Maassen, Catharina B. M.; Schellevis, Francois; Heederik, Dick; Smit, Lidwien A. M.			Spirometry, questionnaire and electronic medical record based COPD in a population survey: Comparing prevalence, level of agreement and associations with potential risk factors	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; IDENTIFY PATIENTS; DEFINITIONS; ASTHMA; EPIDEMIOLOGY; VALIDITY; HISTORY; COHORT; ADULTS	Background COPD-diagnosis is confirmed by post-bronchodilator (BD) spirometry. However, epidemiological studies often rely on pre-BD spirometry, self-reports, or medical records. This population-based study aims to determine COPD-prevalence based on four different operational definitions and their level of agreement, and to compare associations between COPD-definitions and risk factors. Methods COPD-prevalence in 1,793 adults from the general Dutch population (aged 18-70 years) was assessed based on self-reported data, Electronic Medical Records (EMR), and post-BD spirometry: using the FEV1/FVC below the lower limit of normal (LLN) and GOLD fixed cut-off (FEV1/FVC <0.70). Using spirometry as a reference, sensitivity was calculated for self-reported and EMR-based COPD. Associations between COPD and known risk factors were assessed with logistic regression. Data were collected as part of the cross-sectional VGO study (Livestock Farming and Neighboring Residents' Health Study). Results The highest prevalence was found based on spirometry (GOLD: 10.9%, LLN: 5.9%), followed by self-report (4.6%) and EMR (2.9%). Self-reported or EMR-based COPD identified less than 30% of all COPD-cases based on spirometry. The direction of association between known risk factors and COPD was similar across the four definitions, however, magnitude and significance varied. Especially indicators of allergy were more strongly associated with self-reported COPD compared to the other definitions. Conclusions COPD-prevalence varied depending on the used definition. A substantial number of subjects with spirometry-based COPD cannot be identified with questionnaires or medical records which can cause underestimation of COPD-prevalence. The influence of the different COPD-definitions on associations with known risk factors was limited.	[Borlee, Floor; Krop, Esmeralda; Heederik, Dick; Smit, Lidwien A. M.] Univ Utrecht, IRAS, Utrecht, Netherlands; [Borlee, Floor; Yzermans, C. Joris; Zock, Jan-Paul; van Dijk, Christel E.; Schellevis, Francois] NIVEL, Inst Hlth Serv Res, Utrecht, Netherlands; [Aalders, Bernadette; Rooijackers, Jos] Netherlands Expertise Ctr Occupat Resp Disorders, Utrecht, Netherlands; [Maassen, Catharina B. M.] Ctr Infect Dis Control, Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Schellevis, Francois] Vrije Univ Amsterdam, Dept Gen Practice & Elderly Care Med, EMGO Inst Hlth & Care Res, Med Ctr, Amsterdam, Netherlands	Utrecht University; Netherlands Institute for Health Services Research; Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam	Smit, LAM (corresponding author), Univ Utrecht, IRAS, Utrecht, Netherlands.	L.A.Smit@uu.nl	Zock, Jan-Paul/P-5034-2018; Smit, Lidwien AM/AFC-8689-2022	Zock, Jan-Paul/0000-0002-2941-6259; Smit, Lidwien AM/0000-0003-0292-0946; Krop, Esmeralda/0000-0002-6009-1181; Heederik, Dick/0000-0002-4550-1437	Ministry of Health, Welfare and Sports; Ministry of Economic Affairs of The Netherlands; Lung Foundation Netherlands [3.2.11.022]	Ministry of Health, Welfare and Sports; Ministry of Economic Affairs of The Netherlands(Ministry of Economic Affairs, Netherlands); Lung Foundation Netherlands	The Livestock Farming and Neighbouring Residents' Health (VGO) study was funded by the Ministry of Health, Welfare and Sports and the Ministry of Economic Affairs of The Netherlands. LAMS received also a grant from the Lung Foundation Netherlands (Grant number: 3.2.11.022) (www.longfonds.nl/) to support this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos EC, 2015, INT J CHRONIC OBSTR, V10, P2665, DOI 10.2147/COPD.S91392; Armstrong BG, 1998, OCCUP ENVIRON MED, V55, P651, DOI 10.1136/oem.55.10.651; Borlee F, 2015, EUR RESPIR J, V46, P1605, DOI 10.1183/13993003.00265-2015; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Burney P, 2015, LUNG FUNCTION PROTOC; Celli BR, 2003, EUR RESPIR J, V22, P268, DOI 10.1183/09031936.03.00075102; Cooke CR, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-37; de Marco R, 2015, EUR RESPIR J, V46, P671, DOI 10.1183/09031936.00008615; de Marco R, 2011, AM J RESP CRIT CARE, V183, P891, DOI 10.1164/rccm.201007-1125OC; Dirven JAM, 2010, COPD, V7, P352, DOI 10.3109/15412555.2010.510547; Doekes G, 1996, OCCUP ENVIRON MED, V53, P63, DOI 10.1136/oem.53.1.63; Gupta RP, 2014, INT J TUBERC LUNG D, V18, P998, DOI 10.5588/ijtld.13.0910; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Jarvis D, 2013, EUR RESP J S57, V42, P1809; Kjeldgaard P, 2015, INT J CHRONIC OBSTR, V10, P407, DOI 10.2147/COPD.S76047; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leffondre K, 2002, AM J EPIDEMIOL, V156, P813, DOI 10.1093/aje/kwf122; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mohangoo AD, 2006, EUR J PUBLIC HEALTH, V16, P101, DOI 10.1093/eurpub/cki043; Murgia N, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-49; Peat JK, 2001, THORAX, V56, P406, DOI 10.1136/thorax.56.5.406; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Prieto-Centurion V, 2014, AM J RESP CRIT CARE, V190, P989, DOI 10.1164/rccm.201406-1166OC; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Romanelli AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149302; Schermer TRJ, 2008, EUR RESPIR J, V32, P945, DOI 10.1183/09031936.00170307; Shirtcliffe P, 2007, EUR RESPIR J, V30, P232, DOI 10.1183/09031936.00157906; van der Molen Thys, 2003, Health Qual Life Outcomes, V1, P13, DOI 10.1186/1477-7525-1-13; van Dijk CE, 2016, ENV POLLUT; van Dijk W, 2015, ANN FAM MED, V13, P41, DOI 10.1370/afm.1714; Verheij R.A., 2014, NIVEL ZORGREGISTRATI; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Viegi G, 2007, EUR RESPIR J, V30, P993, DOI 10.1183/09031936.00082507	34	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171494	10.1371/journal.pone.0171494	http://dx.doi.org/10.1371/journal.pone.0171494			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273094	gold, Green Published, Green Submitted			2022-12-26	WOS:000396073700095
J	Clark-Knowles, KV; He, XH; Jardine, K; Coulombe, J; Dewar-Darch, D; Caron, AZ; Gray, DA; McBurney, MW				Clark-Knowles, Katherine V.; He, Xiaohong; Jardine, Karen; Coulombe, Josee; Dewar-Darch, Danielle; Caron, Annabelle Z.; Gray, Douglas A.; McBurney, Michael W.			Reversible modulation of SIRT1 activity in a mouse strain	PLOS ONE			English	Article							TAMOXIFEN-INDUCIBLE FORM; EMBRYONIC STEM-CELLS; DEACETYLASE ACTIVITY; MAMMALIAN MICRORNAS; SIR2-ALPHA PROTEIN; CHIMERIC PROTEINS; ESTROGEN-RECEPTOR; BINDING DOMAIN; MICE DEVELOP; SIRTUINS	The SIRT1 protein deacetylase is reported to have a remarkably wide spectrum of biological functions affecting such varied processes as aging, cancer, metabolism, neurodegeneration and immunity. However, the SIRT1 literature is also full of contradictions. To help establish the role(s) of SIRT1 in these and other biological processes, we set out to create a mouse in which the SIRT1 activity could be toggled between on and off states by fusing the estrogen receptor ligand-binding domain (ER) to the C terminus of the SIRT1 protein. We found that the catalytic activity of the SIRT1-ER fusion protein increased 4-5 fold in cells treated with its ligand, 4-hydroxy-tamoxifen (4OHT). The 4OHT-induced activation of SIRT1-ER was due in large part to a 2 to 4-fold increase in abundance of the SIRT1-ER protein in cells in culture and in tissues in vivo. This increase is reversible and is a consequence of 4OHTinduced stabilization of the SIRT1-ER protein. Since changes in SIRT1 level or activity of 2-4 fold are frequently reported to be sufficient to affect its biological functions, this mouse should be helpful in establishing the causal relationships between SIRT1 and the diseases and processes it affects.	[Clark-Knowles, Katherine V.; He, Xiaohong; Jardine, Karen; Coulombe, Josee; Dewar-Darch, Danielle; Caron, Annabelle Z.; Gray, Douglas A.; McBurney, Michael W.] Ottawa Hosp Res Inst, Program Canc Therapeut, Ottawa, ON, Canada; [Gray, Douglas A.; McBurney, Michael W.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [McBurney, Michael W.] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	McBurney, MW (corresponding author), Ottawa Hosp Res Inst, Program Canc Therapeut, Ottawa, ON, Canada.	mmcburney@ohri.ca	/U-3554-2018	/0000-0002-8634-4984	Canadian Institute for Health Research [MOP-130575]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute for Health Research, MOP-130575. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Boily G, 2009, ONCOGENE, V28, P2882, DOI 10.1038/onc.2009.147; Boutant M, 2016, CELL REP, V14, P2068, DOI 10.1016/j.celrep.2016.02.007; Buelow B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003264; Campagna M, 2011, CELL DEATH DIFFER, V18, P72, DOI 10.1038/cdd.2010.77; Caron AZ, 2014, FASEB J, V28, P1306, DOI 10.1096/fj.13-243568; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Choi SE, 2013, MOL CELLS, V36, P385, DOI 10.1007/s10059-013-0297-1; Chu YY, 2008, GENESIS, V46, P530, DOI 10.1002/dvg.20426; Chuprin A, 2015, NAT IMMUNOL, V16, P737, DOI 10.1038/ni.3194; Clark-Knowles KV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082106; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DANIELIAN PS, 1993, MOL ENDOCRINOL, V7, P232, DOI 10.1210/me.7.2.232; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; Garcia D, 2011, GENE DEV, V25, P1746, DOI 10.1101/gad.16722111; Ghosh HS, 2007, BIOCHEM J, V408, P105, DOI 10.1042/BJ20070817; Greulich H, 1998, J BIOL CHEM, V273, P13280, DOI 10.1074/jbc.273.21.13280; Guarente L, 2000, GENE DEV, V14, P1021; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Jones ME, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-51; Kiga K, 2014, RNA BIOL, V11, P1347, DOI 10.4161/rna.32093; Kong SY, 2012, IMMUNOL CELL BIOL, V90, P6, DOI 10.1038/icb.2011.102; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Lin Zhenghong, 2013, Genes Cancer, V4, P97, DOI 10.1177/1947601912475079; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.553; Liu YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013533; Malaterre J, 2016, ONCOGENE, V35, P2475, DOI 10.1038/onc.2015.305; McBurney Michael W, 2013, Genes Cancer, V4, P125, DOI 10.1177/1947601912474893; McBurney MW, 2003, MOL CANCER RES, V1, P402; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Mercken EM, 2014, AGING CELL, V13, P193, DOI 10.1111/acel.12151; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Naia L, 2015, BBA-MOL BASIS DIS, V1852, P2183, DOI 10.1016/j.bbadis.2015.07.003; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Picard D, 2000, METHOD ENZYMOL, V327, P385, DOI 10.1016/S0076-6879(00)27291-1; Picard Didier, 1994, Current Opinion in Biotechnology, V5, P511, DOI 10.1016/0958-1669(94)90066-3; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; SCHERRER LC, 1993, BIOCHEMISTRY-US, V32, P5381, DOI 10.1021/bi00071a013; Seifert EL, 2012, FASEB J, V26, P555, DOI 10.1096/fj.11-193979; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Wang H, 2016, AGING CELL; Whitfield Jonathan, 2015, Cold Spring Harb Protoc, V2015, P227, DOI 10.1101/pdb.top069815; Wierenga ATJ, 2008, MOL CELL BIOL, V28, P6668, DOI 10.1128/MCB.01025-08; Wilson CH, 2014, ONCOGENE, V33, P4877, DOI 10.1038/onc.2014.78; Yamakuchi M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00068; Yuan HF, 2013, ONCOTARGETS THER, V6, P1399, DOI 10.2147/OTT.S37750; Zhang DY, 2009, J BIOL CHEM, V284, P20917, DOI 10.1074/jbc.M109.020073	59	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173002	10.1371/journal.pone.0173002	http://dx.doi.org/10.1371/journal.pone.0173002			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273169	Green Published, gold, Green Submitted			2022-12-26	WOS:000396073700034
J	Hu, L; Yang, Z; Pan, XJ; Zhao, N; Peng, JH; Wan, CY				Hu, Lian; Yang, Zhi; Pan, Xiaojie; Zhao, Na; Peng, Jianhua; Wan, Chengyan			Use offish species from different trophic levels to control algae and water quality: An enclosure experiment in eutrophic area of Xiaojiang River	PLOS ONE			English	Article							3 GORGES RESERVOIR; FISH SILVER CARP; BIGHEAD CARP; ENVIRONMENTAL-FACTORS; BIOMANIPULATION; LAKE; PHYTOPLANKTON; IMPOUNDMENT; CHINA; PHOSPHORUS	The effects of stocking both filter-feeding fish and piscivorous fish were compared to the effects of stocking only filter-feeding fish for suppressing algal blooms and improving water quality in the impoundment area of Xiaojiang River where catfish were dominant. Using only filter-feeding fish for algal suppression and water quality control was more effective in the short-term, but use of both filter-feeding fish and piscivorous fish was better in the long-term. Obvious suppression of phytoplankton biomass (PB) only occurred during the first 14 days regardless of the fish stocked. Adding fish to the enclosure clearly alters phytoplankton community structure and introducing piscivorous fish to an enclosure stocked with filter-feeding fish changed the relative densities of dominant algae species. While stocking filter-feeding fish decreased total nitrogen concentration by removing phytoplankton, it did not effectively decrease total phosphorus and Chlorophyll a concentrations. Introducing piscivorous fish to the enclosure weakened the relationship between nutrients and phytoplankton. Results indicate that stocking only filter-feeding fish to improve water quality and suppress phytoplankton in an impoundment area is insufficient and other technologies and means should be applied simultaneously.	[Hu, Lian; Yang, Zhi; Pan, Xiaojie; Zhao, Na; Peng, Jianhua; Wan, Chengyan] Minist Water Resources, Key Lab, Minist Water Resources Ecol Impacts Hydraul Proje, Inst Hydroecol, Wuhan, Peoples R China; [Hu, Lian; Yang, Zhi; Pan, Xiaojie; Zhao, Na; Peng, Jianhua; Wan, Chengyan] Chinese Acad Sci, Wuhan, Peoples R China; [Hu, Lian; Yang, Zhi; Pan, Xiaojie; Zhao, Na; Peng, Jianhua; Wan, Chengyan] Hubei Prov Collaborat Innovat Ctr Water Resources, Wuhan, Peoples R China	Chinese Academy of Sciences; Ministry of Water Resources; Chinese Academy of Sciences	Wan, CY (corresponding author), Minist Water Resources, Key Lab, Minist Water Resources Ecol Impacts Hydraul Proje, Inst Hydroecol, Wuhan, Peoples R China.; Wan, CY (corresponding author), Chinese Acad Sci, Wuhan, Peoples R China.; Wan, CY (corresponding author), Hubei Prov Collaborat Innovat Ctr Water Resources, Wuhan, Peoples R China.	chywan@mail.ihe.ac.cn			Science and Technology Program for Water Pollution Control and Treatment [2013ZX07104-004]	Science and Technology Program for Water Pollution Control and Treatment	This work was supported by Science and Technology Program for Water Pollution Control and Treatment (2013ZX07104-004).	[Anonymous], 1980, FRESHWATER ALGAE CHI; [Anonymous], 2014, CURR WORLD ENVIRON, DOI 10.12944/CWE.9.1.15; Burns CW, 2014, NEW ZEAL J MAR FRESH, V48, P127, DOI 10.1080/00288330.2013.838589; Chen XJ, 2012, J HYDROECOL, V33, P1; CREMER MC, 1980, AQUACULTURE, V20, P57, DOI 10.1016/0044-8486(80)90061-7; Ding R., 1994, FISHES SICHUAN; Domaizon Isabelle, 1999, Annee Biologique, V38, P91; Dorantes-Aranda JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133549; Ekvall MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112956; Fukushima M, 1999, FRESHWATER BIOL, V42, P719, DOI 10.1046/j.1365-2427.1999.00507.x; Gehrke PC, 2002, RIVER RES APPL, V18, P265, DOI 10.1002/rra.669; Gibson John A.E., 1997, Proceedings of the NIPR Symposium on Polar Biology, V10, P77; Guo Jing-song, 2011, Huanjing Kexue, V32, P976; Ha JY, 2013, LIMNOLOGY, V14, P19, DOI 10.1007/s10201-012-0381-9; Hallett CS, 2016, HYDROBIOLOGIA, V763, P267, DOI 10.1007/s10750-015-2383-1; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Hu L, 2013, BIOMED RES INT, V2013, P1; Imteaz MA, 2009, WATER SCI TECHNOL, V60, P2599, DOI 10.2166/wst.2009.632; Jeong YH, 2014, J COASTAL RES, V30, P1278, DOI 10.2112/JCOASTRES-D-13-00081.1; Klug JL, 2015, NORTHEAST NAT, V22, P273, DOI 10.1656/045.022.0204; [李斌 Li Bin], 2013, [生态学报, Acta Ecologica Sinica], V33, P6704; Lian JJ, 2014, WATER-SUI, V6, P3200, DOI 10.3390/w6103200; Lieberman DM, 1996, J FRESHWATER ECOL, V11, P391, DOI 10.1080/02705060.1996.9664466; Ma H, 2010, J ENVIRON SCI, V22, P161, DOI 10.1016/S1001-0742(09)60088-7; Margolis BE, 2001, CAN J FISH AQUAT SCI, V58, P2271, DOI 10.1139/cjfas-58-11-2271; MEPPRC(Ministry of Environmental Protection of the People's Republic China), 2005, ENV EC MON B 3 GORG; Mims MC, 2013, FRESHWATER BIOL, V58, P50, DOI 10.1111/fwb.12037; Norusis, 2008, SPSS 16 0 GUIDE DATA; Patino R, 2014, HARMFUL ALGAE, V33, P1, DOI 10.1016/j.hal.2013.12.006; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Radke RJ, 2002, FRESHWATER BIOL, V47, P2337, DOI 10.1046/j.1365-2427.2002.00993.x; Rangel LM, 2012, HYDROBIOLOGIA, V693, P13, DOI 10.1007/s10750-012-1083-3; Sieben K, 2011, J EXP MAR BIOL ECOL, V397, P79, DOI 10.1016/j.jembe.2010.11.020; Skov C, 2002, FRESHWATER BIOL, V47, P2388, DOI 10.1046/j.1365-2427.2002.01012.x; Tuzun I, 1996, HYDROBIOLOGIA, V331, P79, DOI 10.1007/BF00025410; Van der Merwe D, 2015, TOXINS, V7, P1065, DOI 10.3390/toxins7041065; Vasek M, 2013, ECOL ENG, V52, P104, DOI 10.1016/j.ecoleng.2012.12.100; Vriesman ACVB, 2002, EUROPEAN RADIOLOGY, V37, P87; Waajen GWAM, 2016, ECOL ENG, V90, P141, DOI 10.1016/j.ecoleng.2016.01.036; Wang HJ, 2008, FRESHWATER BIOL, V53, P935, DOI 10.1111/j.1365-2427.2007.01950.x; Wang Liping, 2012, Hupo Kexue, V24, P232; Withers PJA, 2007, SOIL USE MANAGE, V23, P1, DOI 10.1111/j.1475-2743.2007.00116.x; Xie P., 2003, SILVER CARP BIGHEAD; Xu XB, 2013, EARTH-SCI REV, V124, P115, DOI 10.1016/j.earscirev.2013.05.007; Yang ZJ, 2010, SCI CHINA TECHNOL SC, V53, P1114, DOI 10.1007/s11431-009-0387-7; Yi CL, 2016, ECOL ENG, V89, P7, DOI 10.1016/j.ecoleng.2016.01.022; Zanden MJV, 2008, ECOLOGY, V83, P2152; Zhang X, 2006, AQUACULTURE, V257, P173, DOI 10.1016/j.aquaculture.2006.03.018; Zhang X, 2008, THESCIENTIFICWORLDJO, V8, P1184, DOI 10.1100/tsw.2008.144; Zhang ZY, 2013, ENVIRON SCI POLLUT R, V20, P7080, DOI 10.1007/s11356-013-1702-1; Zhao HJ, 2015, ECOL INDIC, V58, P113, DOI 10.1016/j.ecolind.2015.03.033; Zhu TS, 2016, ECOL ENG, V86, P113, DOI 10.1016/j.ecoleng.2015.10.031	52	7	7	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171953	10.1371/journal.pone.0171953	http://dx.doi.org/10.1371/journal.pone.0171953			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273091	Green Published, gold, Green Submitted			2022-12-26	WOS:000396073700064
J	Murison, DA; Ollivierre, JN; Huang, QY; Budil, DE; Beuning, PJ				Murison, David A.; Ollivierre, Jaylene N.; Huang, Qiuying; Budil, David E.; Beuning, Penny J.			Altering the N-terminal arms of the polymerase manager protein UmuD modulates protein interactions	PLOS ONE			English	Article							REPLICATIVE DNA-POLYMERASE; BETA-PROCESSIVITY CLAMP; ESCHERICHIA-COLI; SOS MUTAGENESIS; TRANSLESION SYNTHESIS; CLPXP PROTEASE; INTACT UMUD; RECA; CLEAVAGE; COMPLEX	Escherichia coli cells that are exposed to DNA damaging agents invoke the SOS response that involves expression of the umuD gene products, along with more than 50 other genes. Full-length UmuD is expressed as a 139-amino-acid protein, which eventually cleaves its Nterminal 24 amino acids to form UmuD '. The N-terminal arms of UmuD are dynamic and contain recognition sites for multiple partner proteins. Cleavage of UmuD to UmuD ' dramatically affects the function of the protein and activates UmuC for translesion synthesis ( TLS) by forming DNA Polymerase V. To probe the roles of the N-terminal arms in the cellular functions of the umuD gene products, we constructed additional N- terminal truncated versions of UmuD: UmuD 8 ( UmuD Delta 1-7) and UmuD 18 ( UmuD Delta 1-17). We found that the loss of just the N- terminal seven ( 7) amino acids of UmuD results in changes in conformation of the N- terminal arms, as determined by electron paramagnetic resonance spectroscopy with site-directed spin labeling. UmuD 8 is cleaved as efficiently as full-length UmuD in vitro and in vivo, but expression of a plasmid-borne non-cleavable variant of UmuD 8 causes hypersensitivity to UV irradiation, which we determined is the result of a copy-number effect. UmuD 18 does not cleave to form UmuD A, but confers resistance to UV radiation. Moreover, removal of the N- terminal seven residues of UmuD maintained its interactions with the alpha polymerase subunit of DNA polymerase III as well as its ability to disrupt interactions between alpha and the beta processivity clamp, whereas deletion of the N- terminal 17 residues resulted in decreases in binding to alpha and in the ability to disrupt the alpha-beta interaction. We find that UmuD 8 mimics full-length UmuD in many respects, whereas UmuD 18 lacks a number of functions characteristic of UmuD.	[Murison, David A.; Ollivierre, Jaylene N.; Huang, Qiuying; Budil, David E.; Beuning, Penny J.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA	Northeastern University	Beuning, PJ (corresponding author), Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA.	beuning@neu.edu	Budil, David E/B-3631-2018	Budil, David E/0000-0003-2384-7928; Beuning, Penny/0000-0002-7770-022X	National Science Foundation [MCB-0845033]; American Cancer Society [RSG-12-161-01-DMC]; Northeastern University Office of the Provost	National Science Foundation(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); Northeastern University Office of the Provost	This work was supported by generous financial support from the National Science Foundation [CAREER Award, MCB-0845033 to P.J. B.]; the American Cancer Society [Research Scholar Grant RSG-12-161-01-DMC to P.J.B.]; and the Northeastern University Office of the Provost (Undergraduate Research Grant to Q.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bailey S, 2006, CELL, V126, P893, DOI 10.1016/j.cell.2006.07.027; BATTISTA JR, 1990, P NATL ACAD SCI USA, V87, P7190, DOI 10.1073/pnas.87.18.7190; Becherel OJ, 1999, J MOL BIOL, V294, P299, DOI 10.1006/jmbi.1999.3272; Beuning PJ, 2006, METHOD ENZYMOL, V408, P318, DOI 10.1016/S0076-6879(06)08020-7; Beuning PJ, 2009, J BACTERIOL, V191, P5910, DOI 10.1128/JB.00292-09; Beuning PJ, 2006, J BIOL CHEM, V281, P9633, DOI 10.1074/jbc.M511101200; Boudsocq F, 1997, J MOL BIOL, V270, P201, DOI 10.1006/jmbi.1997.1098; BURCKHARDT SE, 1988, P NATL ACAD SCI USA, V85, P1811, DOI 10.1073/pnas.85.6.1811; Chaurasiya KR, 2013, NUCLEIC ACIDS RES, V41, P8959, DOI 10.1093/nar/gkt648; CHURCHWARD G, 1984, GENE, V31, P165, DOI 10.1016/0378-1119(84)90207-5; Courcelle CT, 2006, P NATL ACAD SCI USA, V103, P9154, DOI 10.1073/pnas.0600785103; Duzen JIM, 2004, DNA REPAIR, V3, P301, DOI 10.1016/j.dnarep.2003.11.008; Fang J, 2010, J MOL BIOL, V398, P40, DOI 10.1016/j.jmb.2010.02.040; Ferentz AE, 2001, EMBO J, V20, P4287, DOI 10.1093/emboj/20.15.4287; Frank EG, 1996, P NATL ACAD SCI USA, V93, P10291, DOI 10.1073/pnas.93.19.10291; Freidberg E. C., 2005, DNA REPAIR MUTAGENES; Godoy VG, 2007, MOL CELL, V28, P1058, DOI 10.1016/j.molcel.2007.10.025; Gonzalez M, 2000, EMBO J, V19, P5251, DOI 10.1093/emboj/19.19.5251; Gonzalez M, 2002, BIOESSAYS, V24, P141, DOI 10.1002/bies.10040; Guzzo A, 1996, J BACTERIOL, V178, P7295, DOI 10.1128/jb.178.24.7295-7303.1996; Han ES, 2006, NUCLEIC ACIDS RES, V34, P1084, DOI 10.1093/nar/gkj503; Hawver LA, 2011, J BACTERIOL, V193, P5400, DOI 10.1128/JB.05301-11; KATO T, 1977, MOL GEN GENET, V156, P121, DOI 10.1007/BF00283484; Kuban W, 2012, DNA REPAIR, V11, P726, DOI 10.1016/j.dnarep.2012.06.005; Lamers MH, 2006, CELL, V126, P881, DOI 10.1016/j.cell.2006.07.028; Lapenta F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152915; Lee MH, 1996, J BACTERIOL, V178, P7285, DOI 10.1128/jb.178.24.7285-7294.1996; LEE MH, 1994, J BACTERIOL, V176, P4825, DOI 10.1128/jb.176.16.4825-4837.1994; MARSH L, 1985, J BACTERIOL, V162, P155, DOI 10.1128/JB.162.1.155-161.1985; McDonald JP, 1998, P NATL ACAD SCI USA, V95, P1478, DOI 10.1073/pnas.95.4.1478; Neher SB, 2003, P NATL ACAD SCI USA, V100, P13219, DOI 10.1073/pnas.2235804100; NOHMI T, 1988, P NATL ACAD SCI USA, V85, P1816, DOI 10.1073/pnas.85.6.1816; Ollivierre JN, 2013, BBA-PROTEINS PROTEOM, V1834, P611, DOI 10.1016/j.bbapap.2012.11.008; Ollivierre JN, 2011, MOL BIOSYST, V7, P3183, DOI 10.1039/c1mb05334e; Ollivierre JN, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/947680; Ollivierre JN, 2011, J BIOL CHEM, V286, P3607, DOI 10.1074/jbc.M110.167254; Opperman T, 1999, P NATL ACAD SCI USA, V96, P9218, DOI 10.1073/pnas.96.16.9218; Peat TS, 1996, NATURE, V380, P727, DOI 10.1038/380727a0; Rehrauer WM, 1998, J BIOL CHEM, V273, P32384, DOI 10.1074/jbc.273.49.32384; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; Shen X, 2003, J BIOL CHEM, V278, P52546, DOI 10.1074/jbc.M310127200; SHINAGAWA H, 1988, P NATL ACAD SCI USA, V85, P1806, DOI 10.1073/pnas.85.6.1806; Silva MC, 2012, NUCLEIC ACIDS RES, V40, P5511, DOI 10.1093/nar/gks229; Simmons LA, 2008, ECOSAL PLUS, V3; SOMMER S, 1993, MOL GEN GENET, V239, P137, DOI 10.1007/BF00281612; Sommer S, 1998, MOL MICROBIOL, V28, P281, DOI 10.1046/j.1365-2958.1998.00803.x; SOMMER S, 1993, MOL MICROBIOL, V10, P963, DOI 10.1111/j.1365-2958.1993.tb00968.x; Sommer S, 2000, MOL MICROBIOL, V35, P1443, DOI 10.1046/j.1365-2958.2000.01809.x; Sutton MD, 1999, P NATL ACAD SCI USA, V96, P12373, DOI 10.1073/pnas.96.22.12373; Sutton MD, 2002, DNA REPAIR, V1, P77, DOI 10.1016/S1568-7864(01)00006-4; Sutton MD, 2002, P NATL ACAD SCI USA, V99, P5307, DOI 10.1073/pnas.082322099; Sutton MD, 2001, J BACTERIOL, V183, P1215, DOI 10.1128/JB.183.4.1215-1224.2001; Sutton MD, 2001, J BACTERIOL, V183, P347, DOI 10.1128/JB.183.1.347-357.2001; Szpilewska H, 1995, BIOCHIMIE, V77, P848, DOI 10.1016/0300-9084(95)90002-0; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919	57	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173388	10.1371/journal.pone.0173388	http://dx.doi.org/10.1371/journal.pone.0173388			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273172	Green Submitted, Green Published, gold			2022-12-26	WOS:000396073700057
J	Gott, C; Gates, T; Dermody, N; Brew, BJ; Cysique, LA				Gott, Chloe; Gates, Thomas; Dermody, Nadene; Brew, Bruce J.; Cysique, Lucette A.			Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity	PLOS ONE			English	Article							NEUROCOGNITIVE DISORDERS; NEUROPSYCHOLOGICAL FUNCTION; DEFICIT SCORES; CHRONICITY; IMPAIRMENT; MEMORY; COHORT; ADULTS; ERA; AGE	Background The longitudinal rate and profile of cognitive decline in persons with stable, treated, and virally suppressed HIV infection is not established. To address this question, the current study quantifies the rate of cognitive decline in a cohort of virally suppressed HIV+ persons using clinically relevant definitions of decline, and determine cognitive trajectories taking into account historical and baseline HAND status. Methods Ninety-six HIV+ (clinically stable and virally undetectable) and 44 demographically comparable HIV-participants underwent standard neuropsychological testing at baseline and 18-months follow-up. We described clinically relevant cognitive trajectories based on standard definitions of historical and baseline HAND status and cognitive decline. Historical, moderate to severe HAND was formally diagnosed at the start of the cART era in 15/96 participants based on clinical neurological and neuropsychological assessment. The same standard of care has been applied to all participants at St. Vincent's Hospital Infectious Disease Department for the duration of their HIV infection (median of 20 years). Results Relative to HIV-controls (4.5%), 14% of HIV+ participants declined (p = .11), they also scored significantly lower on the global change score (p = .03), processing speed (p = .02), and mental flexibility/inhibition (p = .02) domains. Having HAND at baseline significantly predicted cognitive decline at follow up (p = .005). We determined seven clinically relevant cognitive trajectories taking into account whether participant has a history of HAND prior to study entry (yes/no); their results on the baseline assessment (baseline impairment: yes/no) and their results on the 18-month follow up (decline or stable) which in order of prevalence were: 1) No HAND history, no baseline impairment, 18-month follow-up stable (39%), 2) No HAND history, baseline impairment, 18-month follow-up stable (35%), 3) History of HAND; baseline impairment, 18-month follow-up stable (9%) 4) No history of HAND, baseline impairment, 18-month follow-up decline (7%), 5) History of HAND, no baseline impairment, 18-month follow-up stable (3%), 6) No HAND history, no baseline impairment, 18-month follow- up decline (3%) 7) History of HAND, baseline impairment, 18-month follow-up decline (3%). There was no relationship between cognitive decline (taking into account historical and baseline HAND) and traditional HIV disease biomarkers. Conclusions Despite long-term viral suppression, we found mostly subclinical levels of decline in psychomotor speed and executive functioning (mental flexibility and cognitive inhibition); well-established markers of HAND progression. Moreover, 57% of our cohort is undergoing slow evolution of their disease, challenging the notion of prevalent neurocognitive stability in virally suppressed HIV infection.	[Gott, Chloe; Dermody, Nadene] Macquarie Univ, Dept Psychol, Sydney, NSW, Australia; [Gott, Chloe; Dermody, Nadene; Brew, Bruce J.; Cysique, Lucette A.] Univ New South Wales, Fac Med, Sydney, NSW, Australia; [Gates, Thomas; Brew, Bruce J.; Cysique, Lucette A.] St Vincents Hosp, Dept HIV, Darlinghurst, NSW, Australia; [Gates, Thomas; Brew, Bruce J.; Cysique, Lucette A.] St Vincents Hosp, Dept Neurol, Darlinghurst, NSW, Australia; [Gates, Thomas; Brew, Bruce J.; Cysique, Lucette A.] St Vincents Ctr, Appl Med Res Ctr, Peter Duncan Neurosci Unit, Darlinghurst, NSW, Australia; [Cysique, Lucette A.] Neurosci Res Australia NeuRA, Sydney, NSW, Australia	Macquarie University; University of New South Wales Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; Neuroscience Research Australia	Cysique, LA (corresponding author), Univ New South Wales, Fac Med, Sydney, NSW, Australia.; Cysique, LA (corresponding author), St Vincents Hosp, Dept HIV, Darlinghurst, NSW, Australia.; Cysique, LA (corresponding author), St Vincents Hosp, Dept Neurol, Darlinghurst, NSW, Australia.; Cysique, LA (corresponding author), St Vincents Ctr, Appl Med Res Ctr, Peter Duncan Neurosci Unit, Darlinghurst, NSW, Australia.	lcysique@unsw.edu.au	Cysique, Lucette A./U-1357-2017; Gates, Thomas/AAB-5623-2022	Cysique, Lucette A./0000-0002-7711-6373; Gates, Thomas/0000-0003-0113-8282; brew, bruce/0000-0003-0622-1392	NHMRC project grant [APP568746]; NHMRC Career Development Fellowship [APP1045400]; Peter Duncan Neuroscience Unit at St. Vincent's Hospital Applied Medical Research Centre	NHMRC project grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Peter Duncan Neuroscience Unit at St. Vincent's Hospital Applied Medical Research Centre	The study was funded by the NHMRC project grant (APP568746; CIA/PI Cysique) and NHMRC Career Development Fellowship (APP1045400; CIA/PI Cysique), and the support of the Peter Duncan Neuroscience Unit at St. Vincent's Hospital Applied Medical Research Centre (Director: Prof. Brew).	Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Bischof GN, 2016, AMYLOID DEPOSITION Y; Blackstone K, 2012, CLIN NEUROPSYCHOL, V26, P894, DOI 10.1080/13854046.2012.694479; Brew BJ, 2009, J NEUROIMMUNE PHARM, V4, P163, DOI 10.1007/s11481-008-9143-1; Brouillette M-J, 2016, PLOS ONE IN PRESS, P1; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Chelune G. J., 1986, ADV CLIN NEUROPSYCHO, V3, P15, DOI DOI 10.1007/978-1-4613-2211-5_4; Cole MA, 2007, NEUROLOGY, V69, P2213, DOI 10.1212/01.WNL.0000277520.94788.82; Cysique L, 2012, NEUROBEHAV HIV MED, P63; Cysique LA, 2015, APOE ABNORMAL CSF AB, P4; Cysique LAJ, 2006, NEUROLOGY, V66, P1447, DOI 10.1212/01.wnl.0000210477.63851.d3; Cysique LA, 2016, J NEUROVIROL, V22, P56, DOI 10.1007/s13365-015-0368-5; Cysique LA, 2014, J NEUROVIROL, V20, P258, DOI 10.1007/s13365-014-0242-x; Cysique LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061738; Cysique LA, 2011, J CLIN EXP NEUROPSYC, V33, P505, DOI 10.1080/13803395.2010.535504; Cysique LA, 2010, AIDS, V24, P983, DOI 10.1097/QAD.0b013e32833336c8; Dore GJ, 2010, MARKED IMPROVEMENT S; Fellows RP, 2014, J CLIN EXP NEUROPSYC, V36, P806, DOI 10.1080/13803395.2014.943696; Gates TM, 2016, CNS DRUGS, V30, P53, DOI 10.1007/s40263-015-0302-7; Grant I, 2008, INT REV PSYCHIATR, V20, P33, DOI 10.1080/09540260701877894; Harezlak J, 2014, J NEUROVIROL, V20, P294, DOI 10.1007/s13365-014-0246-6; Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton R.K., 2004, REVISED COMPREHENSIV; Heaton RK, 2015, CLIN INFECT DIS, V60, P473, DOI 10.1093/cid/ciu862; JANSSEN RS, 1991, NEUROLOGY, V41, P778; Lane TA, 2012, NEUROPSYCHOLOGY, V26, P713, DOI 10.1037/a0029964; Reger M, 2002, J INT NEUROPSYCH SOC, V8, P410, DOI 10.1017/S1355617702813212; Sacktor N, 2016, NEUROLOGY, V86, P334, DOI 10.1212/WNL.0000000000002277; Seider TR, 2014, J CLIN EXP NEUROPSYC, V36, P356, DOI 10.1080/13803395.2014.892061; Sheppard DP, 2015, CLIN NEUROPSYCHOL, V29, P656, DOI 10.1080/13854046.2015.1077995; The Kirby Institute, 2015, ANN SURV REP 2015; Wendelken LA, 2012, J NEUROVIROL, V18, P256, DOI 10.1007/s13365-012-0094-1; Woods SP, 2009, NEUROPSYCHOL REV, V19, P152, DOI 10.1007/s11065-009-9102-5	34	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0171887	10.1371/journal.pone.0171887	http://dx.doi.org/10.1371/journal.pone.0171887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5OE	28264037	Green Published, Green Submitted, gold			2022-12-26	WOS:000396054300005
J	Nishijima, R; Okamoto, Y; Hatano, H; Takumi, S				Nishijima, Ryo; Okamoto, Yuki; Hatano, Hitoshi; Takumi, Shigeo			Quantitative trait locus analysis for spikelet shape-related traits in wild wheat progenitor Aegilops tauschii: Implications for intraspecific diversification and subspecies differentiation	PLOS ONE			English	Article							HEXAPLOID WHEAT; D-GENOME; COMMON WHEAT; GENETIC-VARIATION; KERNEL SIZE; GRAIN-SIZE; COSS; EVOLUTION; IDENTIFICATION; POPULATIONS	Wild diploid wheat Aegilops tauschii, the D-genome progenitor of common wheat, carries large genetic variation in spikelet and grain morphology. Two differentiated subspecies of Ae. tauschii, subspecies tauschii and strangulata, have been traditionally defined based on differences in spikelet morphology. Here, we first assessed six spikelet shape-related traits among 199 Ae. tauschii accessions, and found that the accessions belonging to TauL1major lineage produced significantly longer spikes, higher spikelet density, and shorter, narrower spikelets than another major lineage, TauL2, in which the strangulata accessions are included. Next, we performed quantitative trait locus (QTL) analysis of the spikelet and grain shape using three mapping populations derived from interlineage crosses between TauL1 and TauL2 to identify the genetic loci for the morphological variations of the spikelet and grain shape in Ae. tauschii. Three major QTL regions for the examined traits were detected on chromosomes 3D, 4D and 7D. The 3D and 4D QTL regions for several spikelet shape-related traits were conserved in the three mapping populations, which indicated that the 3D and 4D QTLs contribute to divergence of the two major lineages. The 7D QTLs were found only in a mapping population from a cross of the two subspecies, suggesting that these 7D QTLs may be closely related to subspecies differentiation in Ae. tauschii. Thus, QTL analysis for spikelet and grain morphology may provide useful information to elucidate the evolutionary processes of intraspecific differentiation.	[Nishijima, Ryo; Okamoto, Yuki; Hatano, Hitoshi; Takumi, Shigeo] Kobe Univ, Grad Sch Agr Sci, Lab Plant Genet, Nada Ku, Kobe, Hyogo, Japan	Kobe University	Takumi, S (corresponding author), Kobe Univ, Grad Sch Agr Sci, Lab Plant Genet, Nada Ku, Kobe, Hyogo, Japan.	takumi@kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [21380005, 16H04862]; Japan Society for the Promotion of Science for Young Scientists	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (Grant-in-Aid for Scientific Research (B) Nos. 21380005 and 16H04862) to ST, and by a Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists to RN.	[Anonymous], 2021, LANG ENV STAT COMP; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Breseghello F, 2007, FIELD CROP RES, V101, P172, DOI 10.1016/j.fcr.2006.11.008; Dudnikov AJ, 1998, HEREDITY, V80, P248, DOI 10.1038/sj.hdy.6882810; Dudnikov AJ, 2006, GENET RESOUR CROP EV, V53, P579, DOI 10.1007/s10722-004-2681-3; Dvorak J, 1998, THEOR APPL GENET, V97, P657, DOI 10.1007/s001220050942; EIG A, 1929, REPERT SPEC NOV RE S, V55, P1; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; HAMMER K, 1980, Kulturpflanze, V28, P33; Hirao K, 2015, GENES GENET SYST, V90, P283, DOI 10.1266/ggs.15-00035; Huang L, 2012, GENET RESOUR CROP EV, V59, P1027, DOI 10.1007/s10722-011-9741-2; Ishikawa G, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-135; Jafarzadeh J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162860; Jones H, 2013, THEOR APPL GENET, V126, P1793, DOI 10.1007/s00122-013-2093-x; Masaru IJC, 2012, DNA RES, V19, P487, DOI 10.1093/dnares/dss028; KIHARA H., 1949, Hereditas, P307; Kippes N, 2016, THEOR APPL GENET, V129, P1417, DOI 10.1007/s00122-016-2713-3; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Matsuoka Y, 2004, THEOR APPL GENET, V109, P1710, DOI 10.1007/s00122-004-1806-6; Matsuoka Y, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0496-9; Matsuoka Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068310; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Matsuoka Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003138; Matsuoka Y, 2009, PLANT SYST EVOL, V279, P233, DOI 10.1007/s00606-009-0159-7; Mizuno N, 2010, MOL ECOL, V19, P999, DOI 10.1111/j.1365-294X.2010.04537.x; MujeebKazi A, 1996, GENET RESOUR CROP EV, V43, P129, DOI 10.1007/BF00126756; Nakano H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121583; Nishijima R, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0246-y; Okamoto Y, 2013, BREEDING SCI, V63, P423, DOI 10.1270/jsbbs.63.423; Okamoto Y, 2013, EUPHYTICA, V194, P207, DOI 10.1007/s10681-013-0916-0; Okamoto Y, 2012, GENES GENET SYST, V87, P299, DOI 10.1266/ggs.87.299; Pestsova E, 2000, THEOR APPL GENET, V101, P100, DOI 10.1007/s001220051456; Rstudio Team, 2015, RSTUDIO INT DEV R; Saeidi H, 2006, GENET RESOUR CROP EV, V53, P1477, DOI 10.1007/s10722-005-7110-8; Saisho D, 2016, SCI REP-UK, V6, DOI 10.1038/srep38554; Shahinnia F, 2012, THEOR APPL GENET, V124, P373, DOI 10.1007/s00122-011-1712-7; Sun XY, 2009, EUPHYTICA, V165, P615, DOI 10.1007/s10681-008-9794-2; Takumi S, 2011, GENES GENET SYST, V86, P183, DOI 10.1266/ggs.86.183; Takumi S, 2009, BREEDING SCI, V59, P579, DOI 10.1270/jsbbs.59.579; TSUNEWAKI K, 1979, EUPHYTICA, V28, P579, DOI 10.1007/BF00038924; TSUNEWAKI K, 1966, JPN J BOT, V19, P175; VANSLAGEREN MW, 1994, WILD WHEATS MONOGRAP, P326; Wang JR, 2013, NEW PHYTOL, V198, P925, DOI 10.1111/nph.12164; Wang S., 2011, WINDOWS QTL CARTOGRA; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; ZOHARY D, 1969, EUPHYTICA, V18, P58	48	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173210	10.1371/journal.pone.0173210	http://dx.doi.org/10.1371/journal.pone.0173210			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264068	Green Submitted, Green Published, gold			2022-12-26	WOS:000396054300046
J	Schwab-Reese, LM; Parker, EA; Peek-Asa, C				Schwab-Reese, Laura M.; Parker, Edith A.; Peek-Asa, Corinne			Interactions of adolescent social experiences and dopamine genes to predict physical intimate partner violence perpetration	PLOS ONE			English	Article							TRANSPORTER GENE; RISK-FACTORS; ENVIRONMENT; DISADVANTAGE; EXPOSURE; PROGRAMS; DAT1; MAPS	Objectives We examined the interactions between three dopamine gene alleles (DAT1, DRD2, DRD4) previously associated with violent behavior and two components of the adolescent environment (exposure to violence, school social environment) to predict adulthood physical intimate partner violence (IPV) perpetration among white men and women. Methods We used data from Wave IV of the National Longitudinal Study of Adolescent to Adult Health, a cohort study following individuals from adolescence to adulthood. Based on the prior literature, we categorized participants as at risk for each of the three dopamine genes using this coding scheme: two 10-R alleles for DAT1; at least one A-1 allele for DRD2; at least one 7-R or 8-R allele for DRD4. Adolescent exposure to violence and school social environment was measured in 1994 and 1995 when participants were in high school or middle school. Intimate partner violence perpetration was measured in 2008 when participants were 24 to 32 years old. We used simple and multivariable logistic regression models, including interactions of genes and the adolescent environments for the analysis. Results Presence of risk alleles was not independently associated with IPV perpetration but increasing exposure to violence and disconnection from the school social environment was associated with physical IPV perpetration. The effects of these adolescent experiences on physical IPV perpetration varied by dopamine risk allele status. Among individuals with non-risk dopamine alleles, increased exposure to violence during adolescence and perception of disconnection from the school environment were significantly associated with increased odds of physical IPV perpetration, but individuals with high risk alleles, overall, did not experience the same increase. Conclusion Our results suggested the effects of adolescent environment on adulthood physical IPV perpetration varied by genetic factors. This analysis did not find a direct link between risk alleles and violence, but contributes to growing research indicating that if genetic factors contribute to perpetration, this relationship is likely complicated and the result of interactions with other factors.	[Schwab-Reese, Laura M.; Parker, Edith A.] Univ Iowa, Coll Publ Hlth, Dept Community & Behav Hlth, Iowa City, IA 52242 USA; [Peek-Asa, Corinne] Univ Iowa, Coll Publ Hlth, Dept Occupat & Environm, Iowa City, IA USA; [Schwab-Reese, Laura M.] Univ Colorado, Sch Med, Dept Pediat, Kempe Ctr Prevent & Treatment Child Abuse & Negle, Anschutz Med Campus, Aurora, CO 80045 USA	University of Iowa; University of Iowa; University of Colorado System; University of Colorado Anschutz Medical Campus	Schwab-Reese, LM (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Community & Behav Hlth, Iowa City, IA 52242 USA.; Schwab-Reese, LM (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Kempe Ctr Prevent & Treatment Child Abuse & Negle, Anschutz Med Campus, Aurora, CO 80045 USA.	laura.m.schwab@gmail.com		Schwab-Reese, Laura/0000-0002-9174-1730	University of Iowa Injury Prevention Research Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [T42OH008491] Funding Source: NIH RePORTER	University of Iowa Injury Prevention Research Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	LMSR, EAP, and CPA received pilot funding from the University of Iowa Injury Prevention Research Center for this project. This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Special acknowledgment is due Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Information on how to obtain the Add Health data files is available on the Add Health website (http://www.cpc.unc.edu/addhealth). No direct support was received from grant P01-HD31921 for this analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Bakermans-Kranenburg MJ, 2011, DEV PSYCHOPATHOL, V23, P39, DOI 10.1017/S0954579410000635; Barnes JC, 2013, J PSYCHIATR RES, V47, P371, DOI 10.1016/j.jpsychires.2012.10.016; Barnes JC, 2013, J INTERPERS VIOLENCE, V28, P92, DOI 10.1177/0886260512448847; Beaver KM, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-30; Beaver KM, 2012, YOUTH VIOLENCE JUV J, V10, P25, DOI 10.1177/1541204011422085; Bell KM, 2008, CLIN PSYCHOL REV, V28, P1096, DOI 10.1016/j.cpr.2008.03.003; Black M.C., 2011, NATL INTIMATE PARTNE; Brookmeyer KA, 2006, J CLIN CHILD ADOLESC, V35, P504, DOI 10.1207/s15374424jccp3504_2; Capaldi DM, 2012, PARTN ABUSE, V3, P231, DOI 10.1891/1946-6560.3.2.231; Casey EA, 2010, J YOUTH ADOLESCENCE, V39, P620, DOI 10.1007/s10964-009-9423-y; Costa BM, 2015, AGGRESS VIOLENT BEH, V24, P261, DOI 10.1016/j.avb.2015.06.001; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Eckhardt CI, 2006, PUBLIC HEALTH REP, V121, P369, DOI 10.1177/003335490612100405; Falb KL, 2011, ARCH PEDIAT ADOL MED, V165, P890, DOI 10.1001/archpediatrics.2011.91; Ferguson CJ, 2008, CRIM JUSTICE BEHAV, V35, P311, DOI 10.1177/0093854807311719; Fuke S., 2001, Pharmacogenomics Journal, V1, P152; GELERNTER J, 1992, GENOMICS, V13, P208, DOI 10.1016/0888-7543(92)90222-E; Guo G, 2007, HUM GENET, V121, P125, DOI 10.1007/s00439-006-0244-8; Harris KM, 2009, NATL LONGITUDINAL ST; Hines Denise A, 2004, Violence Vict, V19, P701, DOI 10.1891/088667004780927729; Johnson SL, 2009, J SCHOOL HEALTH, V79, P451, DOI 10.1111/j.1746-1561.2009.00435.x; McNeely CA, 2002, J SCHOOL HEALTH, V72, P138, DOI 10.1111/j.1746-1561.2002.tb06533.x; Menard S, 2014, CHILD ABUSE NEGLECT, V38, P627, DOI 10.1016/j.chiabu.2014.02.001; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; National Library of Medicine, 2015, POLYM; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Raghavan C, 2006, VIOLENCE AGAINST WOM, V12, P1132, DOI 10.1177/1077801206294115; Raiford JL, 2013, J URBAN HEALTH, V90, P784, DOI 10.1007/s11524-012-9717-3; Ramirez M, 2012, J ADOLESCENT HEALTH, V51, P503, DOI 10.1016/j.jadohealth.2012.02.016; Renner LM, 2015, J FAM VIOLENCE, V30, P1069, DOI 10.1007/s10896-015-9737-3; Shorey RC, 2008, AGGRESS VIOLENT BEH, V13, P185, DOI 10.1016/j.avb.2008.03.003; Smolen A., 2013, ADD HLTH WAVE 4 DOCU; Stuart GL, 2014, VIOLENCE AGAINST WOM, V20, P385, DOI 10.1177/1077801214528587; Ttofi MM, 2011, J EXP CRIMINOL, V7, P27, DOI 10.1007/s11292-010-9109-1; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; Wang CX, 2013, THEOR PRACT, V52, P296, DOI 10.1080/00405841.2013.829735; Whitaker DJ, 2013, PARTN ABUSE, V4, P175, DOI 10.1891/1946-6560.4.2.175; Yoshihama M, 2005, SOC WORK RES, V29, P151, DOI 10.1093/swr/29.3.151	40	5	5	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172840	10.1371/journal.pone.0172840	http://dx.doi.org/10.1371/journal.pone.0172840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264032	gold, Green Published			2022-12-26	WOS:000396054300021
J	de Montalembert, M; Ribeil, JA; Brousse, V; Guerci-Bresler, A; Stamatoullas, A; Vannier, JP; Dumesnil, C; Lahary, A; Touati, M; Bouabdallah, K; Cavazzana, M; Chauzit, E; Baptiste, A; Lefebvre, T; Puy, H; Elie, C; Karim, Z; Ernst, O; Rose, C				de Montalembert, Mariane; Ribeil, Jean-Antoine; Brousse, Valentine; Guerci-Bresler, Agnes; Stamatoullas, Aspasia; Vannier, Jean-Pierre; Dumesnil, Cecile; Lahary, Agnes; Touati, Mohamed; Bouabdallah, Krimo; Cavazzana, Marina; Chauzit, Emmanuelle; Baptiste, Amandine; Lefebvre, Thibaud; Puy, Herve; Elie, Caroline; Karim, Zoubida; Ernst, Olivier; Rose, Christian			Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome	PLOS ONE			English	Article							BETA-THALASSEMIA; DEPENDENT PATIENTS; CHELATION; DISEASE; RESONANCE; ACCUMULATION; MORBIDITY; MORTALITY; CHILDREN; SURVIVAL	The risk and clinical significance of cardiac iron overload due to chronic transfusion varies with the underlying disease. Cardiac iron overload shortens the life expectancy of patients with thalassemia, whereas its effect is unclear in those with myelodysplastic syndromes (MDS). In patients with sickle cell anemia (SCA), iron does not seem to deposit quickly in the heart. Our primary objective was to assess through a multicentric study the prevalence of cardiac iron overload, defined as a cardiovascular magnetic resonance T2*<20 ms, in patients with thalassemia, SCA, or MDS. Patient inclusion criteria were an accurate record of erythrocyte concentrates (ECs) received, a transfusion history >8 ECs in the past year, and age older than 6 years. We included from 9 centers 20 patients with thalassemia, 41 with SCA, and 25 with MDS in 2012-2014. Erythrocytapharesis did not consistently prevent iron overload in patients with SCA. Cardiac iron overload was found in 3 (15%) patients with thalassemia, none with SCA, and 4 (16%) with MDS. The liver iron content (LIC) ranged from 10.4 to 15.2 mg/g dry weight, with no significant differences across groups (P = 0.29). Abnormal T2* was not significantly associated with any of the measures of transfusion or chelation. Ferritin levels showed a strong association with LIC. Non-transferrin-bound iron was high in the thalassemia and MDS groups but low in the SCA group (P<0.001). Hepcidin was low in thalassemia, normal in SCA, and markedly elevated in MDS ( P<0.001). Two mechanisms may explain that iron deposition largely spares the heart in SCA: the high level of erythropoiesis recycles the iron and the chronic inflammation retains iron within the macrophages. Thalassemia, in contrast, is characterized by inefficient erythropoiesis, unable to handle free iron. Iron accumulation varies widely in MDS syndromes due to the competing influences of abnormal erythropoiesis, excess iron supply, and inflammation.	[de Montalembert, Mariane; Brousse, Valentine] Necker Childrens Hosp, AP HP, Dept Pediat, Paris, France; [de Montalembert, Mariane; Brousse, Valentine; Lefebvre, Thibaud; Puy, Herve; Karim, Zoubida] Lab Excellence GR Ex, Paris, France; [Ribeil, Jean-Antoine; Cavazzana, Marina] Necker Childrens Hosp, AP HP, Biotherapy Dept, Paris, France; [Ribeil, Jean-Antoine; Cavazzana, Marina] Grp Hosp Univ Ouest, AP HP, Biotherapy Clin Investigat Ctr, INSERM, Paris, France; [Guerci-Bresler, Agnes] Hop Adultes Brabois, Dept Hematol, Vandoeuvre Les Nancy, France; [Stamatoullas, Aspasia] Ctr Henri Becquerel, Rouen, France; [Vannier, Jean-Pierre; Dumesnil, Cecile] Hop Charles Nicolle, Pediat Oncol & Hematol Unit, Rouen, France; [Lahary, Agnes] Hop Charles Nicolle, Dept Biochem, Rouen, France; [Touati, Mohamed] CHU, Serv Hematol Clin & Therapie Cellulaire, Limoges, France; [Bouabdallah, Krimo] Hop Haut Leveque, Serv Malad Sang, Pessac, France; [Cavazzana, Marina] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, Paris, France; [Cavazzana, Marina] INSERM, UMR 1163, Lab Human Lymphopoiesis, Paris, France; [Chauzit, Emmanuelle] CHU, Dept Pharmacol Clin & Toxicol, Bordeaux, France; [Baptiste, Amandine; Elie, Caroline] Necker Childrens Hosp, AP HP, Paris Descartes Clin Res Unit, Paris, France; [Lefebvre, Thibaud; Puy, Herve; Karim, Zoubida] Ctr Rech Inflammat, INSERM UMR 1149, ERL CNRS 8252, Paris, France; [Lefebvre, Thibaud; Puy, Herve] Louis Mourier Hosp, AP HP, French Ctr Porphyria, Colombes, France; [Ernst, Olivier] CHRU Lille, Hop Huriez, Dept Radiol, Lille, France; [Rose, Christian] Univ Catholique Lille, Hop St Vincent Paul, Hematol Clin, Lille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Nancy; UNICANCER; Centre Henri Becquerel; CHU de Rouen; CHU de Rouen; CHU Limoges; CHU Bordeaux; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite Catholique de Lille	de Montalembert, M (corresponding author), Necker Childrens Hosp, AP HP, Dept Pediat, Paris, France.	mariane.demontal@aphp.fr	PUY, HERVE/O-1785-2017; Ribeil, Jean-Antoine/F-7896-2017; Ribeil, Jean-Antoine/AAK-7979-2020	PUY, HERVE/0000-0003-3362-2634; Ribeil, Jean-Antoine/0000-0002-5733-9123; Ribeil, Jean-Antoine/0000-0002-4549-4783; KARIM, Zoubida/0000-0002-3724-5592; Cavazzana, Marina/0000-0002-0264-0891; Lefebvre, Thibaud/0000-0003-1398-6473	Novartis	Novartis(Novartis)	The authors received funding from Novartis for collecting the data. Novartis had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822; Ballas SK, 2001, SEMIN HEMATOL, V38, P30, DOI 10.1053/shem.2001.20142; Borgna-Pignatti C, 2005, ANN NY ACAD SCI, V1054, P40, DOI 10.1196/annals.1345.006; Camaschella C, 2016, BR J HAEMATOL; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; Chauzit E, 2010, THER DRUG MONIT, V32, P476, DOI 10.1097/FTD.0b013e3181d8b37f; Darbari DS, 2006, AM J HEMATOL, V81, P858, DOI 10.1002/ajh.20685; Di Tucci AA, 2008, HAEMATOL-HEMATOL J, V93, P1385, DOI 10.3324/haematol.12759; Drasar E, 2011, BRIT J HAEMATOL, V152, P766, DOI 10.1111/j.1365-2141.2010.08451.x; Ernst O, 2013, Diagn Interv Imaging, V94, P601, DOI 10.1016/j.diii.2013.03.005; Fasano RM, 2016, TRANSFUSION, V56, P1707, DOI 10.1111/trf.13558; Fenaux P, 2009, BLOOD REV, V23, pS15, DOI 10.1016/S0268-960X(09)70005-0; Fung EB, 2008, TRANSFUSION, V48, P1971, DOI 10.1111/j.1537-2995.2008.01775.x; Fung EB, 2007, AM J HEMATOL, V82, P255, DOI 10.1002/ajh.20809; Fung EB, 2006, BRIT J HAEMATOL, V135, P574, DOI 10.1111/j.1365-2141.2006.06332.x; Gandon Y, 2004, LANCET, V363, P357, DOI 10.1016/S0140-6736(04)15436-6; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Hilliard LM, 1998, AM J HEMATOL, V59, P28, DOI 10.1002/(SICI)1096-8652(199809)59:1<28::AID-AJH6>3.0.CO;2-1; Karafin MS, 2015, BLOOD CELL MOL DIS, V55, P304, DOI 10.1016/j.bcmd.2015.07.010; Kaushik N, 2012, PEDIATR HEMAT ONCOL, V29, P254, DOI 10.3109/08880018.2011.630774; KIM HC, 1994, BLOOD, V83, P1136; Kremastinos DT, 2011, CIRCULATION, V124, P2253, DOI 10.1161/CIRCULATIONAHA.111.050773; Lucania G, 2011, BRIT J HAEMATOL, V154, P545, DOI 10.1111/j.1365-2141.2011.08769.x; Meloni A, 2014, AM J HEMATOL, V89, P678, DOI 10.1002/ajh.23721; Modell B, 2000, LANCET, V355, P2051, DOI 10.1016/S0140-6736(00)02357-6; Nemeth E, 2013, BLOOD, V122, P3, DOI 10.1182/blood-2013-05-502617; Noetzli LJ, 2008, BLOOD, V112, P2973, DOI 10.1182/blood-2008-04-148767; Pascal L, 2013, BRIT J HAEMATOL, V162, P413, DOI 10.1111/bjh.12368; Pinto V, 2015, CLIN CASE REP, V3, P952, DOI 10.1002/ccr3.407; Porter J, 2013, HEMATOL-AM SOC HEMAT, P447, DOI 10.1182/asheducation-2013.1.447; Porter JB, 2014, BRIT J HAEMATOL, V167, P692, DOI 10.1111/bjh.13081; Rose C, 2011, LEUKEMIA RES, V34, P864; Roy NBA, 2011, BRIT J HAEMATOL, V154, P521, DOI 10.1111/j.1365-2141.2011.08749.x; Santini V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023109; Shenoy N, 2014, BLOOD, V124, P873, DOI 10.1182/blood-2014-03-563221; Vichinsky E, 2005, AM J HEMATOL, V80, P70, DOI 10.1002/ajh.20402; Walter PB, 2006, BRIT J HAEMATOL, V135, P254, DOI 10.1111/j.1365-2141.2006.06277.x; Wood JC, 2004, BLOOD, V103, P1934, DOI 10.1182/blood-2003-06-1919; Wood JC, 2016, BRIT J HAEMATOL, V172, P122, DOI 10.1111/bjh.13791	40	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172147	10.1371/journal.pone.0172147	http://dx.doi.org/10.1371/journal.pone.0172147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257476	gold, Green Published, Green Submitted			2022-12-26	WOS:000396021100013
J	Hammer, A; Steiner, A; Kerry, G; Ranaie, G; Baer, I; Hammer, CM; Kunze, S; Steiner, HH				Hammer, Alexander; Steiner, Anahi; Kerry, Ghassan; Ranaie, Gholamreza; Baer, Ingrid; Hammer, Christian M.; Kunze, Stefan; Steiner, Hans-Herbert			Treatment of ruptured intracranial aneurysms yesterday and now	PLOS ONE			English	Article							LENGTH-OF-STAY; ENDOVASCULAR TREATMENT; SUBARACHNOID HEMORRHAGE; CEREBRAL ANEURYSMS; SINGLE-CENTER; COILING; TRIAL; OCCLUSION; SURVIVAL	Objective This prospective study is designed to detect changes in the treatment of ruptured intracranial aneurysms over a period of 17 years. Methods We compared 361 treated cases of aneurysm occlusion after subarachnoid hemorrhage from 1997 to 2003 with 281 cases from 2006 to 2014. Specialists of neuroradiology and vascular neurosurgery decided over the modality assignment. We established a prospective data acquisition in both groups to detect significant differences within a follow-up time of one year. With this setting we evaluated the treatment methods over time and compared endovascular with microsurgical treatment. Results When compared to the earlier group, microsurgical treatment was less frequently chosen in the more recent collective because of neck-configuration. Endovascular treatment was chosen more frequently over time (31.9% versus 48.8%). Occurrence of initial symptomatic ischemic stroke was significantly lower in the clipping group compared to the endovascular group and remained stable over time. The number of reinterventions due to refilled treated aneurysms significantly decreased in the endovascular group at one-year follow-up, but the significantly better occlusion-and reintervention-rate of the microsurgical group persisted. The rebleeding rate in the endovascular group at one year follow-up decreased from 6.1% to 2.2% and showed no statistically significant difference to the microsurgical group, anymore (endovascular 2.2% versus microsurgical 0.0%, p = 0.11). Conclusion Microsurgical clipping still has some advantages, however endovascular treatment is improving rapidly.	[Hammer, Alexander; Steiner, Anahi; Kerry, Ghassan; Ranaie, Gholamreza; Steiner, Hans-Herbert] Paracelsus Med Univ, Dept Neurosurg, Nurnberg, Bavaria, Germany; [Baer, Ingrid] Klinikum Nuremberg, Inst Radiol & Neuroradiol, Nurnberg, Bavaria, Germany; [Hammer, Christian M.] Univ Erlangen Nurnberg, Dept Anat 2, Univ Str 19, Erlangen, Bavaria, Germany; [Kunze, Stefan] Heidelberg Univ, Dept Neurosurg, Heidelberg, Baden Wuerttemb, Germany	Klinikum Nurnberg Nord; University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg	Hammer, A (corresponding author), Paracelsus Med Univ, Dept Neurosurg, Nurnberg, Bavaria, Germany.	alexander.hammer@klinikum-nuernberg.de						Ambrosi PB, 2015, INTERV NEURORADIOL, V21, P462, DOI 10.1177/1591019915590083; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; de Vries J, 2014, ACTA NEUROCHIR WIEN, V156, P66; de Vries J, 2014, ACTA NEUROCHIR, V156, P1259, DOI 10.1007/s00701-014-2101-1; Fleming JB, 2011, J NEUROSURG, V114, P1778, DOI 10.3171/2011.1.JNS101232; Hammer A, 2016, WORLD NEUROSURG; Hoh BL, 2004, ACTA NEUROCHIR, V146, P1177, DOI 10.1007/s00701-004-0349-6; Hoh BL, 2010, STROKE, V41, P337, DOI 10.1161/STROKEAHA.109.569269; Hoh BL, 2009, NEUROSURGERY, V64, P614, DOI 10.1227/01.NEU.0000340784.75352.A4; Johnston SC, 2008, STROKE, V39, P120, DOI 10.1161/STROKEAHA.107.495747; Krisht AF, 2006, NEUROSURGERY, V58, P207, DOI 10.1227/01.NEU.0000194638.61073.FC; Lucas CD, 2008, NEUROSURGERY, V62, P414, DOI 10.1227/01.NEU.0000297078.05799.FF; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Molyneux Andrew, 2002, J Stroke Cerebrovasc Dis, V11, P304, DOI 10.1053/jscd.2002.130390; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; O'Kelly CJ, 2010, J NEUROSURG, V113, P795, DOI 10.3171/2009.9.JNS081645; Park HK, 2005, AM J NEURORADIOL, V26, P506; Pierot L, 2015, J NEUROSURG, V18, P1; Piotin M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00041; Piotin M, 2010, STROKE, V41, P110, DOI 10.1161/STROKEAHA.109.558114; Raabe A, 2005, J NEUROSURG, V103, P982, DOI 10.3171/jns.2005.103.6.0982; Ryttlefors M, 2008, STROKE, V39, P2720, DOI 10.1161/STROKEAHA.107.506030; Sedat J, 2009, NEURORADIOLOGY, V51, P401, DOI 10.1007/s00234-009-0502-2; Spetzler RF, 2015, J NEUROSURG, V123, P609, DOI 10.3171/2014.9.JNS141749; Spetzler RF, 2013, J NEUROSURG, V119, P146, DOI 10.3171/2013.3.JNS12683; Sprengers ME, 2008, AM J NEURORADIOL, V29, P1768, DOI 10.3174/ajnr.A1181; Steiner T, 2013, CEREBROVASC DIS, V35, P93, DOI 10.1159/000346087; van Rooij WJ, 2009, AM J NEURORADIOL, V30, P1646, DOI 10.3174/ajnr.A1673; Van Rooij WJ, 2014, INTERV NEURORADIOL, V20, P428, DOI 10.15274/NRJ-2014-10047; Zheng Y, 2015, J NEUROINTERV SURG	31	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172837	10.1371/journal.pone.0172837	http://dx.doi.org/10.1371/journal.pone.0172837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257502	Green Submitted, Green Published, gold			2022-12-26	WOS:000396021100029
J	Yasuike, M; Nishiki, I; Iwasaki, Y; Nakamura, Y; Fujiwara, A; Shimahara, Y; Kamaishi, T; Yoshida, T; Nagai, S; Kobayashi, T; Katoh, M				Yasuike, Motoshige; Nishiki, Issei; Iwasaki, Yuki; Nakamura, Yoji; Fujiwara, Atushi; Shimahara, Yoshiko; Kamaishi, Takashi; Yoshida, Terutoyo; Nagai, Satoshi; Kobayashi, Takanori; Katoh, Masaya			Analysis of the complete genome sequence of Nocardia seriolae UTF1, the causative agent of fish nocardiosis: The first reference genome sequence of the fish pathogenic Nocardia species	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IN-VITRO; RESISTANCE; PROTEIN; ANNOTATION; QUINQUERADIATA; DEGRADATION; TRANSPORTER; VIRULENCE; INSIGHTS	Nocardiosis caused by Nocardia seriolae is one of the major threats in the aquaculture of Seriola species (yellowtail; S. quinqueradiata, amberjack; S. dumerili and kingfish; S. lalandi) in Japan. Here, we report the complete nucleotide genome sequence of N. seriolae UTF1, isolated from a cultured yellowtail. The genome is a circular chromosome of 8,121,733 bp with a G+C content of 68.1% that encodes 7,697 predicted proteins. In the N. seriolae UTF1 predicted genes, we found orthologs of virulence factors of pathogenic mycobacteria and human clinical Nocardia isolates involved in host cell invasion, modulation of phagocyte function and survival inside the macrophages. The virulence factor candidates provide an essential basis for understanding their pathogenic mechanisms at the molecular level by the fish nocardiosis research community in future studies. We also found many potential antibiotic resistance genes on the N. seriolae UTF1 chromosome. Comparative analysis with the four existing complete genomes, N. farcinica IFM 10152, N. brasiliensis HUJEG-1 and N. cyriacigeorgica GUH-2 and N. nova SH22a, revealed that 2,745 orthologous genes were present in all five Nocardia genomes (core genes) and 1,982 genes were unique to N. seriolae UTF1. In particular, the N. seriolae UTF1 genome contains a greater number of mobile elements and genes of unknown function that comprise the differences in structure and gene content from the other Nocardia genomes. In addition, a lot of the N. seriolae UTF1-specific genes were assigned to the ABC transport system. Because of limited resources in ocean environments, these N. seriolae UTF1 specific ABC transporters might facilitate adaptation strategies essential for marine environment survival. Thus, the availability of the complete N. seriolae UTF1 genome sequence will provide a valuable resource for comparative genomic studies of N. seriolae isolates, as well as provide new insights into the ecological and functional diversity of the genus Nocardia.	[Yasuike, Motoshige; Nishiki, Issei; Iwasaki, Yuki; Nakamura, Yoji; Fujiwara, Atushi; Nagai, Satoshi; Katoh, Masaya] Japan Fisheries Res & Educ Agcy, Natl Res Inst Fisheries Sci, Res Ctr Bioinformat & Biosci, Yokohama, Kanagawa, Japan; [Shimahara, Yoshiko] Japan Fisheries Res & Educ Agcy, Natl Res Inst Aquaculture, Res Ctr Fish Dis, Saiki, Oita, Japan; [Kamaishi, Takashi] Minist Agr Forestry & Fisheries, Fisheries Agcy, Chiyoda Ku, Tokyo, Japan; [Yoshida, Terutoyo] Miyazaki Univ, Fac Agr, Miyazaki, Japan; [Kobayashi, Takanori] Japan Fisheries Res & Educ Agcy, Headquarters, Yokohama, Kanagawa, Japan; [Iwasaki, Yuki] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka, Japan	Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Ministry of Agriculture Forestry & Fisheries - Japan; University of Miyazaki; Japan Fisheries Research & Education Agency (FRA); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Yasuike, M; Fujiwara, A (corresponding author), Japan Fisheries Res & Educ Agcy, Natl Res Inst Fisheries Sci, Res Ctr Bioinformat & Biosci, Yokohama, Kanagawa, Japan.	yasuike@affrc.go.jp; jiwara@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This study was supported by a Grant-in-Aid (Marine Metagenomics for Monitoring the Coastal Microbiota) from the Ministry of Agriculture, Forestry and Fisheries of Japan (There are no grant number and the URLs.). (MK, T. Kobayashi, AF, SN, YS, T. Kamaishi, YN and MY received the funding).	Akhtar S, 2013, J BACTERIOL, V195, P4592, DOI 10.1128/JB.00698-13; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; BEAMAN BL, 1985, INFECT IMMUN, V47, P135, DOI 10.1128/IAI.47.1.135-141.1985; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Casali N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-60; Chen LH, 2016, NUCLEIC ACIDS RES, V44, pD694, DOI 10.1093/nar/gkv1239; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DeJongh M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-139; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; Fraser CM, 2002, J BACTERIOL, V184, P6403, DOI 10.1128/JB.184.23.6403-6405.2002; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; Gonzalez-Carrillo C, 2016, INFECT IMMUN, V84, P2595, DOI 10.1128/IAI.00329-16; Hahn JS, 2002, J BACTERIOL, V184, P5214, DOI 10.1128/JB.184.19.5214-5222.2002; Hashemi-Shahraki A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17862; Imajoh M, 2016, GENOME ANNOUNC, V4; Imajoh M, 2015, GENOME ANNOUNC, V3; Ishikawa J, 2004, P NATL ACAD SCI USA, V101, P14925, DOI 10.1073/pnas.0406410101; Ismail TF, 2012, FISHERIES SCI, V78, P351, DOI 10.1007/s12562-011-0450-8; Ismail TF, 2011, FISH PATHOL, V46, P62, DOI 10.3147/jsfp.46.62; Ismail TF, 2011, FISHERIES SCI, V77, P113, DOI 10.1007/s12562-010-0302-y; Itano T, 2006, FISH PATHOL, V41, P135, DOI 10.3147/jsfp.41.135; Kandi V, 2015, CUREUS, V7, DOI 10.7759/cureus.304; Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006; Kariya T., 1968, FISH PATHOL, V3, P16, DOI [10.3147/jsfp.3.16, DOI 10.3147/JSFP.3.16]; Khan A, 2012, MICROBIOL-SGM, V158, P301, DOI 10.1099/mic.0.054759-0; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Koshkin A, 2004, ARCH BIOCHEM BIOPHYS, V427, P41, DOI 10.1016/j.abb.2004.04.017; Koshkin A, 2003, J BIOL CHEM, V278, P29502, DOI 10.1074/jbc.M303747200; Kristensen DM, 2010, BIOINFORMATICS, V26, P1481, DOI 10.1093/bioinformatics/btq229; KUDO T, 1988, INT J SYST BACTERIOL, V38, P173, DOI 10.1099/00207713-38-2-173; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; KUSUDA R, 1989, NIPPON SUISAN GAKK, V55, P1183; Labrie L., 2008, DIS ASIAN AQUACULTUR, P297; Lerner PI, 1996, CLIN INFECT DIS, V22, P891, DOI 10.1093/clinids/22.6.891; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Liu H, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00013; Luo Q, 2014, APPL ENVIRON MICROB, V80, P3895, DOI 10.1128/AEM.00473-14; Luo Q, 2014, ENVIRON MICROBIOL, V16, P29, DOI 10.1111/1462-2920.12221; Martino MC, 2001, INFECT IMMUN, V69, P1697, DOI 10.1128/IAI.69.3.1697-1703.2001; Miyamoto M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-699; Nakamura Y, 2016, GENE, V576, P676, DOI 10.1016/j.gene.2015.10.029; Nayak SK, 2014, FISH SHELLFISH IMMUN, V39, P354, DOI 10.1016/j.fsi.2014.05.015; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rahman A, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-35; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Rodriguez RL, MICROBE MAGAZINE; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Seo KS, 2012, INFECT IMMUN, V80, P3559, DOI 10.1128/IAI.00294-12; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Shimahara Y, 2008, J FISH DIS, V31, P481, DOI 10.1111/j.1365-2761.2008.00920.x; Shimahara Y, 2009, AQUACULTURE, V294, P165, DOI 10.1016/j.aquaculture.2009.06.017; Shin SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068824; Stadermann KB, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0726-6; Strauss EJ, 1997, SCIENCE, V276, P707, DOI 10.1126/science.276.5313.707; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Tamura T, 2012, ANTON LEEUW INT J G, V102, P481, DOI 10.1007/s10482-012-9780-5; Tang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041204; Tikhonova EB, 2007, MOL MICROBIOL, V63, P895, DOI 10.1111/j.1365-2958.2006.05549.x; Tillier ERM, 2000, NAT GENET, V26, P195, DOI 10.1038/79918; Varaldo PE, 2009, ANTIMICROB AGENTS CH, V53, P343, DOI 10.1128/AAC.00781-08; Vera-Cabrera L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065425; Verma H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1014; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992; Xia L, 2015, GENOME ANNOUNC, V3; Zhang F, 2011, MOL CELL BIOCHEM, V352, P1, DOI 10.1007/s11010-011-0733-5; Zhou B, 2010, P NATL ACAD SCI USA, V107, P4573, DOI 10.1073/pnas.0909133107; Zimmerli S, 1996, J CELL BIOL, V132, P49, DOI 10.1083/jcb.132.1.49; Zoropogui A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-286	77	26	29	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173198	10.1371/journal.pone.0173198	http://dx.doi.org/10.1371/journal.pone.0173198			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257489	Green Submitted, gold, Green Published			2022-12-26	WOS:000396021100074
J	Ogama, N; Sakurai, T; Nakai, T; Niida, S; Saji, N; Toba, K; Umegaki, H; Kuzuya, M				Ogama, Noriko; Sakurai, Takashi; Nakai, Toshiharu; Niida, Shumpei; Saji, Naoki; Toba, Kenji; Umegaki, Hiroyuki; Kuzuya, Masafumi			Impact of frontal white matter hyperintensity on instrumental activities of daily living in elderly women with Alzheimer disease and amnestic mild cognitive impairment	PLOS ONE			English	Article							GLOBAL FUNCTIONAL DECLINE; DWELLING OLDER-ADULTS; SUBCORTICAL HYPERINTENSITIES; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; DEPRESSIVE SYMPTOMS; LADIS LEUKOARAIOSIS; SUNNYBROOK DEMENTIA; NATIONAL INSTITUTE; EXECUTIVE FUNCTION	Background Instrumental activities of daily living (IADL) start to decline during the progression of amnestic mild cognitive impairment (aMCI) to Alzheimer disease (AD). Cognitive and physical decline are involved in the loss of functional independence. However, little is known about AD-related neural change that leads to IADL impairment. The purpose of this study was to clarify the effects of regional white matter hyperintensity (WMH) on IADL impairment in persons with AD and aMCI. Methods The participants were 347 female subjects aged 65-85 years diagnosed with AD (n = 227), aMCI (n = 44) or normal cognition (n = 76). IADL was assessed by the Lawton Index. Cognition, mood and mobility function were evaluated by comprehensive geriatric assessment batteries. WMH and brain atrophy were analyzed with brain magnetic resonance imaging, using an automatic segmentation program. Regional WMH was measured in the frontal, temporal, occipital and parietal lobes. Results Ability to carry out IADL of shopping, food preparation, mode of transportation, responsibility for own medication, and ability to handle finances was obviously impaired in the early stage of AD. Frontal WMH was specifically associated with disability to do shopping and food preparation even after adjusting for several confounders including brain atrophy. Conclusions IADL subcategories were differentially impaired along with cognitive status in persons with AD and aMCI. Frontal WMH was an important predictor of impaired ability to do shopping and food preparation. A preventive strategy for WMH might lead to suppression of IADL disability and slow the progression of AD.	[Ogama, Noriko; Sakurai, Takashi; Saji, Naoki; Toba, Kenji] Natl Ctr Geriatr & Gerontol, Ctr Comprehens Care & Res Memory Disorders, Obu, Japan; [Ogama, Noriko; Umegaki, Hiroyuki; Kuzuya, Masafumi] Nagoya Univ, Grad Sch Med, Dept Community Healthcare & Geriatr, Nagoya, Aichi, Japan; [Nakai, Toshiharu] Natl Ctr Geriatr & Gerontol, NeuroImaging & Informat, Obu, Japan; [Niida, Shumpei] Natl Ctr Geriatr & Gerontol, Med Genome Ctr, Obu, Japan	National Center for Geriatrics & Gerontology; Nagoya University; National Center for Geriatrics & Gerontology; National Center for Geriatrics & Gerontology	Sakurai, T (corresponding author), Natl Ctr Geriatr & Gerontol, Ctr Comprehens Care & Res Memory Disorders, Obu, Japan.	tsakurai@ncgg.go.jp			National Center for Geriatrics and Gerontology [25-6, 27-21, 28-15]; Japanese Society for the Promotion of Science [26870765]	National Center for Geriatrics and Gerontology; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	T.S discloses a research grant from Research Funding of Longevity Sciences (25-6, 27-21) from National Center for Geriatrics and Gerontology (http://www.ncgg.go.jp/ncgg-kenkyu/index.html). N.S discloses a research grant from Research Funding of Longevity Sciences (28-15) from the National Center for Geriatrics and Gerontology (http://www.ncgg.go.jp/ncgg-kenkyu/index.html), and Grants-in-Aid for Scientific Research (B) (No. 26870765) from the Japanese Society for the Promotion of Science (https://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admiraal-Behloul F, 2005, NEUROIMAGE, V28, P607, DOI 10.1016/j.neuroimage.2005.06.061; Akisaki T, 2006, DIABETES-METAB RES, V22, P376, DOI 10.1002/dmrr.632; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Albert SM, 2015, J GERONTOL A-BIOL, V70, P71, DOI 10.1093/gerona/glu088; Artaud F, 2015, J AM GERIATR SOC, V63, P1129, DOI 10.1111/jgs.13442; Behl P, 2007, ARCH NEUROL-CHICAGO, V64, P266, DOI 10.1001/archneur.64.2.266; Brown PJ, 2011, ARCH GEN PSYCHIAT, V68, P617, DOI 10.1001/archgenpsychiatry.2011.57; Burton CL, 2006, CLIN NEUROPSYCHOL, V20, P432, DOI 10.1080/13854040590967063; Cahn-Weiner DA, 2007, J INT NEUROPSYCH SOC, V13, P747, DOI 10.1017/S1355617707070853; DeCarli C, 2005, STROKE, V36, P50, DOI 10.1161/01.STR.0000150668.58689.f2; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gao FQ, 2011, J ALZHEIMERS DIS, V26, P379, DOI 10.3233/JAD-2011-0058; Gobbens Robbert J J, 2014, Curr Gerontol Geriatr Res, V2014, P358137, DOI 10.1155/2014/358137; Gobbens RJJ, 2012, GERONTOLOGIST, V52, P619, DOI 10.1093/geront/gnr135; Hanyu H, 1999, EUR J NEUROL, V6, P195, DOI 10.1111/j.1468-1331.1999.tb00013.x; Honda Y, 2015, GERIATR GERONTOL INT, V15, P43, DOI 10.1111/ggi.12672; Hybels CF, 2009, PSYCHOL MED, V39, P1677, DOI 10.1017/S0033291709005650; Inzitari D, 2007, ARCH INTERN MED, V167, P81, DOI 10.1001/archinte.167.1.81; Inzitari D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2477; Kamiya M, 2014, GERIATR GERONTOL INT, V14, P45, DOI 10.1111/ggi.12260; Kim HJ, 2013, J ALZHEIMERS DIS, V35, P129, DOI 10.3233/JAD-122320; Kondo N, 2008, PREV MED, V46, P457, DOI 10.1016/j.ypmed.2007.12.007; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee JJ, 2015, PSYCHIAT INVEST, V12, P516, DOI 10.4306/pi.2015.12.4.516; MAHONEY F I, 1965, Md State Med J, V14, P61; Marshall GA, 2011, ALZHEIMERS DEMENT, V7, P300, DOI 10.1016/j.jalz.2010.04.005; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; McNeely AA, 2015, J ALZHEIMERS DIS, V43, P785, DOI 10.3233/JAD-140588; Moon SY, 2011, EUR NEUROL, V65, P223, DOI 10.1159/000318161; Nyunt MSZ, 2012, INT PSYCHOGERIATR, V24, P1633, DOI 10.1017/S1041610212000890; Ogama N, 2016, GERIATR GERONTOL INT, V16, P167, DOI 10.1111/ggi.12447; Ogama N, 2015, GERIATR GERONTOL INT, V15, P83, DOI 10.1111/ggi.12664; Ogama N, 2014, J AM MED DIR ASSOC, V15, P36, DOI 10.1016/j.jamda.2013.11.004; Okochi J., 2006, Geriatrics and Gerontology International, V6, P223, DOI 10.1111/j.1447-0594.2006.00352.x; Otsuka Y, 2012, AM J NEURORADIOL, V33, P726, DOI 10.3174/ajnr.A2853; Pantoni L, 2006, J AM GERIATR SOC, V54, P1095, DOI 10.1111/j.1532-5415.2006.00798.x; Ramirez J, 2016, FRONT AGING NEUROSCI, V8, DOI [10.3389/fnagi.2010.00062, 10.3389/fnagi.2016.00062]; Ramirez J, 2016, ALZHEIMERS DEMENT, V12, P203, DOI 10.1016/j.jalz.2015.06.1886; Roy K, 2014, J ALZHEIMERS DIS, V42, P291, DOI 10.3233/JAD-131796; Royall DR, 2007, J NEUROPSYCH CLIN N, V19, P249, DOI 10.1176/appi.neuropsych.19.3.249; Sahin A, 2015, TURK J MED SCI, V45, P1353, DOI 10.3906/sag-1406-132; Saji N, 2015, GERIATR GERONTOL INT, V15, P17, DOI 10.1111/ggi.12673; Sakurai T, 2015, GERIATR GERONTOL INT, V15, P1, DOI 10.1111/ggi.12714; Schmidt R, 2011, ACTA NEUROPATHOL, V122, P171, DOI 10.1007/s00401-011-0851-x; Seidel D, 2011, AGE AGEING, V40, P463, DOI 10.1093/ageing/afr054; Song HJ, 2014, J NUTR HEALTH AGING, V18, P765, DOI 10.1007/s12603-014-0452-1; Sugimoto T, 2016, CURR ALZHEIMER RES, V13, P718, DOI 10.2174/1567205013666160211124828; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tomaszewski S, 2009, CLIN NEUROPSYCHOL, V23, P446, DOI 10.1080/13854040802360558; Tomimoto H, 2015, GERIATR GERONTOL INT, V15, P3, DOI 10.1111/ggi.12661; Vidoni ED, 2010, J ALZHEIMERS DIS, V19, P517, DOI 10.3233/JAD-2010-1245; Yoon B, 2014, J STROKE CEREBROVASC, V23, pE365, DOI 10.1016/j.jstrokecerebrovasdis.2013.12.040; Yoon B, 2013, NEUROL SCI, V34, P715, DOI 10.1007/s10072-012-1120-z; Yoshita M, 2006, NEUROLOGY, V67, P2192, DOI 10.1212/01.wnl.0000249119.95747.1f	55	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172484	10.1371/journal.pone.0172484	http://dx.doi.org/10.1371/journal.pone.0172484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4XX	28253275	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300021
J	Dumanian, ZP; Tollemar, V; Ye, JX; Lu, MP; Zhu, YX; Liao, JY; Ameer, GA; He, TC; Reid, RR				Dumanian, Zari P.; Tollemar, Viktor; Ye, Jixing; Lu, Minpeng; Zhu, Yunxiao; Liao, Junyi; Ameer, Guillermo A.; He, Tong-Chuan; Reid, Russell R.			Repair of critical sized cranial defects with BMP9-transduced calvarial cells delivered in a thermoresponsive scaffold	PLOS ONE			English	Article							BMP-9-INDUCED OSTEOGENIC DIFFERENTIATION; BONE MORPHOGENETIC PROTEIN-2; HYDROGELS; DRUG; RECONSTRUCTION; POLYMER; BMP9	Large skeletal defects caused by trauma, congenital malformations, and post-oncologic resections of the calvarium present major challenges to the reconstructive surgeon. We previously identified BMP-9 as the most osteogenic BMP in vitro and in vivo. Here we sought to investigate the bone regenerative capacity of murine-derived calvarial mesenchymal progenitor cells (iCALs) transduced by BMP-9 in the context of healing critical-sized calvarial defects. To accomplish this, the transduced cells were delivered to the defect site within a thermoresponsive biodegradable scaffold consisting of poly(polyethylene glycol citrate-co-N-isopropylacrylamide mixed with gelatin (PPCN-g). A total of three treatment arms were evaluated: PPCN-g alone, PPCN-g seeded with iCALs expressing GFP, and PPCN-g seeded with iCALs expressing BMP-9. Defects treated only with PPCN-g scaffold did not statistically change in size when evaluated at eight weeks postoperatively (p = 0.72). Conversely, both animal groups treated with iCALs showed significant reductions in defect size after 12 weeks of follow-up (BMP9-treated: p = 0.0025; GFP-treated: p = 0.0042). However, H&E and trichrome staining revealed more complete osseointegration and mature bone formation only in the BMP9-treated group. These results suggest that BMP9-transduced iCALs seeded in a PPCN-g thermoresponsive scaffold is capable of inducing bone formation in vivo and is an effective means of creating tissue engineered bone for critical sized defects.	[Dumanian, Zari P.; Tollemar, Viktor; Reid, Russell R.] Univ Chicago, Med Ctr, Dept Surg, Sect Plast Surg, Chicago, IL 60637 USA; [Tollemar, Viktor; Ye, Jixing; Lu, Minpeng; He, Tong-Chuan] Univ Chicago, Med Ctr, Dept Orthoped Surg & Rehabil Med, Mol Oncol Lab, Chicago, IL 60637 USA; [Zhu, Yunxiao; Liao, Junyi; Ameer, Guillermo A.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Zhu, Yunxiao; Liao, Junyi; Ameer, Guillermo A.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA	University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago Medical Center; Northwestern University; Northwestern University; Feinberg School of Medicine	Reid, RR (corresponding author), Univ Chicago, Med Ctr, Dept Surg, Sect Plast Surg, Chicago, IL 60637 USA.	rreid@surgery.bsd.uchicago.edu	Junyi, Liao/AAP-9076-2020; Ameer, Guillermo/B-6765-2009		China Scholarship Council; National Institute of Dental and Craniofacial Research [DE020140]; Chicago Community Trust; National Center for Advancing Translational Sciences [UL1 TR000430]	China Scholarship Council(China Scholarship Council); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Chicago Community Trust; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by the pre-doctoral fellowship from the China Scholarship Council (JY), National Institute of Dental and Craniofacial Research, DE020140, Chicago Community Trust, and the National Center for Advancing Translational Sciences, UL1 TR000430 granted to Dr. Russell Reid. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akbay E, 2014, AURIS NASUS LARYNX, V41, P56, DOI 10.1016/j.anl.2013.07.002; Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282; Alonso N, 2010, TISSUE ENG PART C-ME, V16, P1183, DOI [10.1089/ten.tec.2009.0824, 10.1089/ten.TEC.2009.0824]; BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012; Beederman Maureen, 2013, J Biomed Sci Eng, V6, P32; Brun-Graeppi AKAS, 2011, J CONTROL RELEASE, V149, P209, DOI 10.1016/j.jconrel.2010.09.023; Calori GM, 2009, INJURY, V40, P67; Cellesi F, 2012, THER DELIV, V3, P1395, DOI [10.4155/tde.12.114, 10.4155/TDE.12.114]; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Chung EJ, 2011, ACTA BIOMATER, V7, P4057, DOI 10.1016/j.actbio.2011.07.001; Fujioka-Kobayashi M, J PERIODONTOL, V87, pe101, DOI [10.1902/jop.2016.150561, DOI 10.1902/J0P.2016.150561]; Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017; He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Huang EY, 2012, J BONE MINER RES, V27, P1566, DOI 10.1002/jbmr.1622; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kavanagh CA, 2004, PHARMACOL THERAPEUT, V102, P1, DOI 10.1016/j.pharmthera.2003.01.001; Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025; Kunert-Keil C, 2015, ANN ANAT, V199, P79, DOI 10.1016/j.aanat.2013.12.001; Lamplot JD, 2013, AM J STEM CELLS, V2, P1; Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338; Lu S, 2016, AM J TRANSL IN PRESS; Luther G, 2011, CURR GENE THER, V11, P229; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Mangano FG, 2015, CASE REP DENT, V2015, DOI 10.1155/2015/941265; Misch CM, 2010, IMPLANT DENT, V19, P361, DOI 10.1097/ID.0b013e3181f8115b; Nakamura T, 2016, CLIN ORAL INVEST; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0; Shenaq DS, 2015, J CRANIOFAC SURG, V26, P1207, DOI 10.1097/SCS.0000000000001717; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Teven CM, 2015, GENES DIS, V2, P268, DOI 10.1016/j.gendis.2015.06.003; van Lith R, 2014, BIOMATERIALS, V35, P8113, DOI 10.1016/j.biomaterials.2014.06.004; Yang J, 2014, BIOMACROMOLECULES, V15, P3942, DOI 10.1021/bm5010004; Ye JX, 2016, BIOMED MATER, V11, DOI 10.1088/1748-6041/11/2/025021; Zaky SH, 2009, J DENT RES, V88, P1077, DOI 10.1177/0022034509349926; Zhao C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092908	38	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172327	10.1371/journal.pone.0172327	http://dx.doi.org/10.1371/journal.pone.0172327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249039	gold, Green Published, Green Submitted			2022-12-26	WOS:000395983500037
J	Moraes-Souza, RQ; Reinaque, AP; Soares, TS; Silva, ALT; Giunchetti, RC; Takano, MAS; Akamatsu, MA; Kubrusly, FS; Lucio-Macarini, F; Raw, I; Iourtov, D; Ho, PL; Bueno, LL; Fujiwara, RT; Volpato, GT				Moraes-Souza, Rafaianne Q.; Reinaque, Ana Paula; Soares, Thaigra S.; Silva, Ana Luiza T.; Giunchetti, Rodolfo C.; Takano, Maria A. S.; Akamatsu, Milena A.; Kubrusly, Flavia S.; Lucio-Macarini, Fernanda; Raw, Isaias; Iourtov, Dmitri; Ho, Paulo Lee; Bueno, Lilian L.; Fujiwara, Ricardo T.; Volpato, Gustavo T.			Safety evaluation of a vaccine: Effect in maternal reproductive outcome and fetal anomaly frequency in rats using a leishmanial vaccine as a model	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; PREGNANCY; IMMUNIZATION; EMBRYOPATHY; PREVENTION; CHAGASI; EXTENT; MICE	While the immunogenic potential of the vaccination against infectious diseases was extensively shown, data on the safety assessment of recombinant proteins in vaccine formulations administered during pregnancy are still scarce. In the current study, the antigenicity of a vaccine against leishmaniasis (based on Leishmania braziliensis recombinant protein peroxidoxin) during pregnancy and possible maternal reproductive outcomes and fetal anomalies after immunization with a leishmanial vaccine or adjuvant alone (Bordetella pertussis derived MPLA adjuvant) were assessed. Rats were mated and allocated in three groups: Control D rats received saline; Adjuvant D rats received the adjuvant MPLA, and Vaccine D rats received the combination of MPLA and peroxidoxin. The administration was subcutaneously at the dorsal region, three times (days 0, 7, 14 of pregnancy). On day 21 of pregnancy, all rats were bled for biochemical and immunological measurements. The gravid uterus was weighed with its contents, and the fetuses were analyzed. The immunization with peroxidoxin induced a significant production of circulating IgG levels compared to other groups but caused a significant in post-implantation loss (14.7%) when compared to Control (5.0%) and Adjuvant (4.4%) groups. Furthermore, a significantly high rate of fetal visceral anomalies, such as hydronephrosis and convoluted ureter, was also observed in animals that received vaccine when compared to Control or Adjuvant groups. These data indicate the importance of safety evaluation of vaccines during pregnancy and the limited use of peroxidoxin administration during pregnancy. More importantly, the safety monitoring of immunization with MPLA derived from Bordetella pertussis demonstrated no reproductive outcomes associated with adjuvant administration, suggesting its safe use during pregnancy.	[Moraes-Souza, Rafaianne Q.; Soares, Thaigra S.; Volpato, Gustavo T.] Fed Univ Mato Grosso UFMT, Inst Biol & Hlth Sci, Lab Syst Physiol & Reprod Toxicol, Barra Do Garcas, MG, Brazil; [Reinaque, Ana Paula; Silva, Ana Luiza T.; Bueno, Lilian L.; Fujiwara, Ricardo T.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Lab Immunol & Genom Parasites, Belo Horizonte, MG, Brazil; [Giunchetti, Rodolfo C.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Lab Cell Cell Interact, Belo Horizonte, MG, Brazil; [Takano, Maria A. S.; Akamatsu, Milena A.; Kubrusly, Flavia S.; Lucio-Macarini, Fernanda; Raw, Isaias; Iourtov, Dmitri; Ho, Paulo Lee] Butantan Inst, Div Technol Dev & Prod DDTP, Sao Paulo, Brazil	Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Instituto Butantan	Volpato, GT (corresponding author), Fed Univ Mato Grosso UFMT, Inst Biol & Hlth Sci, Lab Syst Physiol & Reprod Toxicol, Barra Do Garcas, MG, Brazil.	gtvolpato@yahoo.com	SAKAUCHI, MARIA APARECIDA/D-8728-2015; S macarini, fernanda/V-8252-2017; Ho, Paulo/P-8267-2015; Fujiwara, Ricardo Toshio/J-7579-2012; Akamatsu, Milena Apetito/V-8084-2017; Volpato, Gustavo Tadeu/A-5350-2013; Bueno, Lilian/AAQ-1939-2020; Volpato, Gustavo Tadeu/ABC-4863-2020	Ho, Paulo/0000-0003-3652-241X; Fujiwara, Ricardo Toshio/0000-0002-4713-575X; Akamatsu, Milena Apetito/0000-0002-8193-3448; Volpato, Gustavo Tadeu/0000-0002-4753-3264; Bueno, Lilian/0000-0003-3510-4590; Volpato, Gustavo Tadeu/0000-0002-4753-3264; Cordeiro Giunchetti, Rodolfo/0000-0003-4181-7546; Teixeira Silva, Ana Luiza/0000-0002-1152-9255; Sousa Soares, Thaigra/0000-0003-4402-0241; Moraes-Souza, Rafaianne/0000-0002-3639-5740; Kubrusly, Flavia/0000-0003-0646-583X	FAPEMIG; FAPESP; CAPES; CNPq; Fundacao Butantan, Brazil; CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); Fundacao Butantan; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Butantan, Brazil; CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Butantan; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was financially supported by FAPEMIG, FAPESP, CAPES, CNPq and Fundacao Butantan, Brazil. RTF, RCG and PLH are research fellows (Bolsa de Produtividade em Pesquisa) from CNPq.; This work was supported by: Rafaianne Q. Moraes-Souza received CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior) scholarship; Ana Paula Reinaque received CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior) - DINTER allowance; part of this study was supported by grants from FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); part of this study was supported by grants from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); part of this study was supported by grants from Fundacao Butantan; Ricardo T. Fujiwara, Rodolfo C. Giunchetti, and Paulo L. Ho received support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	ALIVERTI V, 1979, TERATOLOGY, V20, P237, DOI 10.1002/tera.1420200208; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Baran CP, 2004, CURR PHARM DESIGN, V10, P855, DOI 10.2174/1381612043452866; Barr SD, 2003, J BIOL CHEM, V278, P10816, DOI 10.1074/jbc.M212990200; Barr SD, 2001, J BIOL CHEM, V276, P34279, DOI 10.1074/jbc.M104406200; Bayih AG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003391; Boehme CC, 2006, EMERG INFECT DIS, V12, P359, DOI 10.3201/eid1202.050449d; Caldas AJM, 2003, ACTA TROP, V88, P39, DOI 10.1016/S0001-706X(03)00160-8; Chahoud I, 2005, BRAZ J MED BIOL RES, V38, P565, DOI 10.1590/S0100-879X2005000400010; Chahoud I, 1999, REPROD TOXICOL, V13, P375, DOI 10.1016/S0890-6238(99)00035-0; Daifalla NS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/348401; Damasceno DC, 2002, PHYTOMEDICINE, V9, P667, DOI 10.1078/094471102321616508; Damasceno DC, 2002, ANIM REPROD SCI, V72, P235, DOI 10.1016/S0378-4320(02)00094-5; Damasceno DC, 2008, ANOMALIAS CONGENITAS; Desale M, 2016, BEST PRACT RES CLIN, V16, P1; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; El Safi SH, 2007, NATURE REV MICROBIOL, V5, pS30, DOI DOI 10.1038/NRMICRO1766; ERIKSSON UJ, 1986, DIABETES, V35, P1356, DOI 10.2337/diabetes.35.12.1356; Eriksson UJ, 2009, SEMIN FETAL NEONAT M, V14, P85, DOI 10.1016/j.siny.2008.11.001; Figueiro EA, 2008, ARCH GYNECOL OBSTET, V278, P13, DOI 10.1007/s00404-007-0532-0; Figueiro-Filho Ernesto Antonio, 2004, Infect Dis Obstet Gynecol, V12, P31, DOI 10.1080/1064744042000210384; Fowden AL, 2009, HORM RES, V72, P257, DOI 10.1159/000245927; GOLDMAN AS, 1991, ISRAEL J MED SCI, V27, P469; HAGAY ZJ, 1995, AM J OBSTET GYNECOL, V173, P1036, DOI 10.1016/0002-9378(95)91323-8; HOD M, 1990, ISRAEL J MED SCI, V26, P541; Jimenez-Marco T, 2016, TRANSFUSION, V56, pS45, DOI 10.1111/trf.13344; Keller-Stanislawski B, 2014, VACCINE, V32, P7057, DOI 10.1016/j.vaccine.2014.09.052; KNOPFHOLZ J, 2014, CHOLESTEROL, V2014, P1; LIN H, 1993, J IMMUNOL, V151, P4562; Linnet K, 2012, CLIN CHEM, V58, P1292, DOI 10.1373/clinchem.2012.182543; Manson JN, 1994, PRINCIPLES METHODS T, P989; Menezes-Souza D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099216; Merkert S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071000; MICHELON T., 2006, REV AMRIGS, V50, P145; Miyaki C, 2010, VACCINE, V28, P2505, DOI 10.1016/j.vaccine.2010.01.044; Mueller M, 2006, J ANTIMICROB CHEMOTH, V58, P811, DOI 10.1093/jac/dkl342; Nascimento IP, 2012, BRAZ J MED BIOL RES, V45, P1102, DOI 10.1590/S0100-879X2012007500142; Neubert D., 1992, RISK ASSESSMENT PREN; PINTER E, 1986, TERATOLOGY, V33, P73, DOI 10.1002/tera.1420330110; Quintilio W, 2009, VACCINE, V27, P4219, DOI 10.1016/j.vaccine.2009.04.047; Rudge MVC, 2000, OBSTET BASICA, P42; SALEWSKI E, 1964, N-S ARCH PHARMACOL, P247; Santos TMM, 2015, CELL STRESS CHAPERON, V20, P595, DOI 10.1007/s12192-015-0581-4; Sarafana Sofia, 2007, Acta Med Port, V20, P355; Soares TD, 2015, BIRTH DEFECTS RES B, V104, P190, DOI 10.1002/bdrb.21152; Solecki Roland, 2003, Reproductive Toxicology, V17, P625, DOI 10.1016/S0890-6238(03)00092-3; Solecki R, 2013, REPROD TOXICOL, V35, P48, DOI 10.1016/j.reprotox.2012.06.006; STAPLES RE, 1964, STAIN TECHNOL, V39, P61; Sundar S, 2014, EXPERT REV VACCINES, V13, P489, DOI 10.1586/14760584.2014.894467; Tavares Mariana Vide, 2011, Acta Med Port, V24 Suppl 4, P1063; United States Environmental Protection Agency, 1996, OPPTS HARM TEST GUID; Vicentin EC, 2014, INFECT IMMUN, V82, P1296, DOI 10.1128/IAI.01169-13; Volpato GT, 2015, AN ACAD BRAS CIENC, V87, P407, DOI 10.1590/0001-3765201520140354; Wilson JG, TERATOLOGY PRINCIPLE, P262	55	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172525	10.1371/journal.pone.0172525	http://dx.doi.org/10.1371/journal.pone.0172525			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249007	gold, Green Published, Green Submitted			2022-12-26	WOS:000395983500045
J	Yang, H; Kircher, DA; Kim, KH; Grossmann, AH; VanBrocklin, MW; Holmen, SL; Robinson, JP				Yang, H.; Kircher, D. A.; Kim, K. H.; Grossmann, A. H.; VanBrocklin, M. W.; Holmen, S. L.; Robinson, J. P.			Activated MEK cooperates with Cdkn2a and Pten loss to promote the development and maintenance of melanoma	ONCOGENE			English	Article							BRAF V600E MUTATION; ACQUIRED-RESISTANCE; METASTATIC MELANOMA; RAF INHIBITION; INK4A/ARF LOSS; OPEN-LABEL; B-RAF; VEMURAFENIB; BRAF(V600E); MULTICENTER	The development of targeted inhibitors, vemurafenib and dabrafenib, has led to improved clinical outcome for melanoma patients with BRAF(V600E) mutations. Although the initial response to these inhibitors can be dramatic, sometimes causing complete tumor regression, the majority of melanomas eventually become resistant. Mitogen-activated protein kinase kinase (MEK) mutations are found in primary melanomas and frequently reported in BRAF melanomas that develop resistance to targeted therapy; however, melanoma is a molecularly heterogeneous cancer, and which mutations are drivers and which are passengers remains to be determined. In this study, we demonstrate that in BRAFV600E melanoma cell lines, activating MEK mutations drive resistance and contribute to suboptimal growth of melanoma cells following the withdrawal of BRAF inhibition. In this manner, the cells are drug-addicted, suggesting that melanoma cells evolve a 'just right' level of mitogen-activated protein kinase signaling and the additive effects of MEK and BRAF mutations are counterproductive. We also used a novel mouse model of melanoma to demonstrate that several of these MEK mutants promote the development, growth and maintenance of melanoma in vivo in the context of Cdkn2a and Pten loss. By utilizing a genetic approach to control mutant MEK expression in vivo, we were able to induce tumor regression and significantly increase survival; however, after a long latency, all tumors subsequently became resistant. These data suggest that resistance to BRAF or MEK inhibitors is probably inevitable, and novel therapeutic approaches are needed to target dormant tumors.	[Yang, H.; Kim, K. H.; Robinson, J. P.] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Kircher, D. A.; VanBrocklin, M. W.; Holmen, S. L.] Univ Utah, Hlth Sci Ctr, Huntsman Canc Inst, Salt Lake City, UT USA; [Kircher, D. A.; Holmen, S. L.] Univ Utah, Hlth Sci Ctr, Dept Oncol Sci, Salt Lake City, UT USA; [Grossmann, A. H.] Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84132 USA; [Grossmann, A. H.] ARUP Labs, Salt Lake City, UT USA; [VanBrocklin, M. W.; Holmen, S. L.] Univ Utah, Hlth Sci Ctr, Dept Surg, Salt Lake City, UT USA	University of Minnesota System; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah	Robinson, JP (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	jrobinson@hi.umn.edu		YANG, HANA/0000-0002-7008-6837; Kircher, David/0000-0003-4122-0336; KIM, KWAN HYUN/0000-0003-4975-2839; Robinson, James/0000-0002-6585-0116	Hormel Institute; National Cancer Institute [R01 CA121118]; NATIONAL CANCER INSTITUTE [R01CA121118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073870, R01NS075155] Funding Source: NIH RePORTER	Hormel Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the members of the Holmen labs as well as W. Pavan, M. McMahon, M. Bosenberg, R. DePinho and L. Chin for providing mouse strains, reagents and advice. This work was largely supported by The Hormel Institute. We thank our lab technicians Selena Hataye and Anne Holtz for their assistance with our experiments and in preparing reagents. We also thank the Huntsman Cancer Institute and Hormel Vivarium staff for assistance. This work was also supported by Award Number R01 CA121118 from the National Cancer Institute (to SLH).	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Bromberg-White JL, 2004, J VIROL, V78, P4914, DOI 10.1128/JVI.78.9.4914-4916.2004; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cho JH, 2015, CELL REP, V13, P898, DOI 10.1016/j.celrep.2015.09.057; Corcoran RB, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001148; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies MA, 2008, BRIT J CANCER, V99, P1265, DOI 10.1038/sj.bjc.6604637; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Ferguson B, 2010, PIGM CELL MELANOMA R, V23, P771, DOI 10.1111/j.1755-148X.2010.00752.x; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Gowrishankar K, 2012, J INVEST DERMATOL, V132, P1850, DOI 10.1038/jid.2012.63; Greger JG, 2012, MOL CANCER THER, V11, P909, DOI 10.1158/1535-7163.MCT-11-0989; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Huang TG, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-30; Jang S, 2013, LANCET ONCOL, V14, pE60, DOI 10.1016/S1470-2045(12)70539-9; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Johnson DB, 2015, EUR J CANCER, V51, P2792, DOI 10.1016/j.ejca.2015.08.022; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Kemper K, 2015, EMBO MOL MED, V7, P1104, DOI 10.15252/emmm.201404914; Kunz M, 2013, EXP DERMATOL, V22, P10, DOI 10.1111/exd.12054; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Livingstone E, 2014, CHIN CLIN ONCOL, V3, DOI 10.3978/j.issn.2304-3865.2014.03.03; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; McArthur GA, 2014, LANCET ONCOL, V15, P323, DOI 10.1016/S1470-2045(14)70012-9; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Narita Y, 2014, MOL CANCER THER, V13, P823, DOI 10.1158/1535-7163.MCT-13-0667; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Robinson JP, 2011, ONCOGENE, V30, P1341, DOI 10.1038/onc.2010.513; Robinson JP, 2010, ONCOGENE, V29, P335, DOI 10.1038/onc.2009.333; Shin Clifford H, 2015, Genes Cancer, V6, P9; Shull AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043369; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Trunzer K, 2013, J CLIN ONCOL, V31, P1767, DOI 10.1200/JCO.2012.44.7888; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; VanBrocklin MW, 2012, NEURO-ONCOLOGY, V14, P34, DOI 10.1093/neuonc/nor184; VanBrocklin MW, 2010, PIGM CELL MELANOMA R, V23, P531, DOI 10.1111/j.1755-148X.2010.00717.x; VanBrocklin MW, 2009, CANCER RES, V69, P1985, DOI 10.1158/0008-5472.CAN-08-3934; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2014, CANCER DISCOV, V4, P61, DOI 10.1158/2159-8290.CD-13-0631; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Young MR, 2006, GENE, V379, P1, DOI 10.1016/j.gene.2006.05.001	46	11	11	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 6	2017	36	27					3842	3851		10.1038/onc.2016.526	http://dx.doi.org/10.1038/onc.2016.526			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EZ6SM	28263969	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000404848200005
J	Maki, K; Shibata, T; Kawabata, SI				Maki, Kouki; Shibata, Toshio; Kawabata, Shun-Ichiro			Transglutaminase-catalyzed incorporation of polyamines masks the DNA-binding region of the transcription factor Relish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSE; TISSUE TRANSGLUTAMINASE; NUCLEAR-LOCALIZATION; NEGATIVE REGULATION; PROTEINS DORSAL; GUT-MICROBIOTA; DROSOPHILA; GENE; CELLS; HOMEOSTASIS	In Drosophila, the final immune deficiency (IMD) pathway-dependent signal is transmitted through proteolytic conversion of the nuclear factor-kappa B (NF-kappa B)-like transcription factor Relish to the active N-terminal fragment Relish-N. Relish-N is then translocated from the cytosol into the nucleus for the expression of IMD- controlled genes. We previously demonstrated that transglutaminase (TG) suppresses the IMD pathway by polymerizing Relish-N to inhibit its nuclear translocation. Conversely, we also demonstrated that orally ingested synthetic amines, such as monodansylcadaverine (DCA) and biotin-labeled pentylamine, are TG-dependently incorporated into Relish-N, causing the nuclear translocation of modified Relish-N in gut epithelial cells. It remains unclear, however, whether polyamine- containing Relish-N retains transcriptional activity. Here, we used mass spectrometry analysis of a recombinant Relish- N modified with DCA by TG activity after proteolytic digestion and show that the DCA-modified Gln residues are located in the DNA-binding region of Relish-N. TG-catalyzed DCA incorporation inhibited binding of Relish-N to the Rel-responsive element in the NF-kappa B-binding DNA sequence. Subcellular fractionation of TG-expressing Drosophila S2 cells indicated that TG was localized in both the cytosol and nucleus. Of note, natural polyamines, including spermidine and spermine, competitively inhibited TG-dependent DCA incorporation into Relish- N. Moreover, in vivo experiments demonstrated that Relish-N was modified by spermine and that this modification reduced transcription of IMD pathway-controlled cecropin A1 and diptericin genes. These findings suggest that intracellular TG regulates Relish-N-mediated transcriptional activity by incorporating polyamines into Relish- N and via protein-protein cross-linking.	[Maki, Kouki; Kawabata, Shun-Ichiro] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8190395, Japan; [Shibata, Toshio] Kyushu Univ, Inst Adv Study, Fukuoka 8190395, Japan; [Shibata, Toshio; Kawabata, Shun-Ichiro] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8190395, Japan	Kyushu University; Kyushu University; Kyushu University	Kawabata, SI (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	skawascb@kyudai.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development Fund Grant [26701];  [15H04353];  [26860333];  [16J02938]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyushu University Interdisciplinary Programs in Education and Projects in Research Development Fund Grant; ; ; 	This work was supported in part by Grants-in-aid for Scientific Research (B) 15H04353 (to S.K.), for Young Scientists (B) 26860333 (toT.S.), and for Japan Society for the Promotion of Science Fellows 16J02938 (to K.M.) and the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Kyushu University Interdisciplinary Programs in Education and Projects in Research Development Fund Grant 26701 (Tenure track type; to T.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Aparicio R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062052; Basbous N, 2011, EMBO REP, V12, P327, DOI 10.1038/embor.2011.19; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Bond D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000655; Bonnay F, 2013, P NATL ACAD SCI USA, V110, P2957, DOI 10.1073/pnas.1221910110; Cao Y, 2013, P NATL ACAD SCI USA, V110, pE1752, DOI 10.1073/pnas.1306220110; Dickneite G, 2015, THROMB HAEMOSTASIS, V113, P686, DOI 10.1160/TH14-07-0625; Djouhri-Bouktab Lamia, 2014, Anti-Infective Agents, V12, P95; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; Eckert RL, 2014, PHYSIOL REV, V94, P383, DOI 10.1152/physrev.00019.2013; Ferrandon D, 2013, CURR OPIN IMMUNOL, V25, P59, DOI 10.1016/j.coi.2012.11.008; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; FOLK JE, 1980, J BIOL CHEM, V255, P3695; Gao JH, 2013, J PHYSIOL PHARMACOL, V64, P681; Gross I, 1996, NUCLEIC ACIDS RES, V24, P1238, DOI 10.1093/nar/24.7.1238; Hetru C, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000232; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Kawabata S., 2015, TRANSGLUTAMINASES MU, P117; Kim M, 2006, P NATL ACAD SCI USA, V103, P16358, DOI 10.1073/pnas.0603238103; Kim SH, 2014, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00116; Kiraly R, 2011, FEBS J, V278, P4717, DOI 10.1111/j.1742-4658.2011.08345.x; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Kuraishi T, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00375; Lee KZ, 2011, EMBO J, V30, P988, DOI 10.1038/emboj.2011.47; Lee KA, 2013, CELL, V153, P797, DOI 10.1016/j.cell.2013.04.009; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lesort M, 1998, J BIOL CHEM, V273, P11991, DOI 10.1074/jbc.273.20.11991; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Lindgren M, 2008, J INSECT PHYSIOL, V54, P586, DOI 10.1016/j.jinsphys.2007.12.008; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; Matsuda Y, 2007, J BIOL CHEM, V282, P37316, DOI 10.1074/jbc.M705731200; Paredes JC, 2011, IMMUNITY, V35, P770, DOI 10.1016/j.immuni.2011.09.018; Park SS, 2006, J BIOL CHEM, V281, P34965, DOI 10.1074/jbc.M604150200; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Peng XJ, 1999, FEBS LETT, V446, P35, DOI 10.1016/S0014-5793(99)00018-6; PETERSEN UM, 1995, EMBO J, V14, P3146, DOI 10.1002/j.1460-2075.1995.tb07317.x; Piredda L, 1999, FASEB J, V13, P355, DOI 10.1096/fasebj.13.2.355; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sekihara S, 2016, J BIOL CHEM, V291, P25077, DOI 10.1074/jbc.M116.761791; Shibata T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005244; Shibata T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003970; Shibata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013477; Shrestha R, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.339; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Takeuchi Y, 1998, Z NATURFORSCH C, V53, P352; Tatsukawa H., 2009, GASTROENTEROLOGY, V136; Wang R, 2001, FISH SHELLFISH IMMUN, V11, P623, DOI 10.1006/fsim.2001.0341; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; WATANABE S, 1991, J BIOL CHEM, V266, P20803; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	53	10	12	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6369	6380		10.1074/jbc.M117.779579	http://dx.doi.org/10.1074/jbc.M117.779579			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28258224	Green Published, hybrid			2022-12-26	WOS:000399538700029
J	Cheng, JJ; Romantsov, T; Engel, K; Doxey, AC; Rose, DR; Neufeld, JD; Charles, TC				Cheng, Jiujun; Romantsov, Tatyana; Engel, Katja; Doxey, Andrew C.; Rose, David R.; Neufeld, Josh D.; Charles, Trevor C.			Functional metagenomics reveals novel beta-galactosidases not predictable from gene sequences	PLOS ONE			English	Article							HOST-RANGE CLONING; ESCHERICHIA-COLI; LACTOSE HYDROLYSIS; DEFINED DELETIONS; PROTEIN FAMILIES; IDENTIFICATION; EXPRESSION; LIBRARIES; ENZYME; CONSTRUCTION	The techniques of metagenomics have allowed researchers to access the genomic potential of uncultivated microbes, but there remain significant barriers to determination of gene function based on DNA sequence alone. Functional metagenomics, in which DNA is cloned and expressed in surrogate hosts, can overcome these barriers, and make important contributions to the discovery of novel enzymes. In this study, a soil metagenomic library carried in an IncP cosmid was used for functional complementation for beta-galactosidase activity in both Sinorhizobium meliloti (alpha-Proteobacteria) and Escherichia coli (gamma-Proteobacteria) backgrounds. One a-galactosidase, encoded by six overlapping clones that were selected in both hosts, was identified as a member of glycoside hydrolase family 2. We could not identify ORFs obviously encoding possible beta-galactosidases in 19 other sequenced clones that were only able to complement S. meliloti. Based on low sequence identity to other known glycoside hydrolases, yet not beta-galactosidases, three of these ORFs were examined further. Biochemical analysis confirmed that all three encoded a-galactosidase activity. Lac36-W_ORF11 and Lac161_ORF7 had conserved domains, but lacked similarities to known glycoside hydrolases. Lac161_ORF10 had neither conserved domains nor similarity to known glycoside hydrolases. Bioinformatic and structural modeling implied that Lac161_ORF10 protein represented a novel enzyme family with a five-bladed propeller glycoside hydrolase domain. By discovering founding members of three novel a-galactosidase families, we have reinforced the value of functional metagenomics for isolating novel genes that could not have been predicted from DNA sequence analysis alone.	[Cheng, Jiujun; Romantsov, Tatyana; Engel, Katja; Doxey, Andrew C.; Rose, David R.; Neufeld, Josh D.; Charles, Trevor C.] Univ Waterloo, Dept Biol, Waterloo, ON, Canada	University of Waterloo	Charles, TC (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON, Canada.	trevor.charles@uwaterloo.ca	Cheng, Jiujun/AAG-8193-2019; Charles, Trevor C./A-5014-2010	Charles, Trevor C./0000-0002-0344-5932	Natural Sciences and Engineering Research Council of Canada [STPGP 381646 - 2009]; Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada Strategic Projects Grant STPGP 381646 - 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Julia Hanchard and Shirley Wong for technical assistance. This work was financially supported by a Strategic Projects grant and Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (NSERC).	Aakvik T, 2009, FEMS MICROBIOL LETT, V296, P149, DOI 10.1111/j.1574-6968.2009.01639.x; Anantharaman V, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-34; Andre I, 2014, CURR OPIN CHEM BIOL, V19, P17, DOI 10.1016/j.cbpa.2013.11.014; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beloqui A, 2010, APPL ENVIRON MICROB, V76, P5934, DOI 10.1128/AEM.00902-10; Biver S, 2013, J MICROBIOL BIOTECHN, V23, P850, DOI 10.4014/jmb.1212.12008; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHARLES TC, 1991, GENETICS, V127, P5; Cheng JJ, 2007, MICROBIOL-SGM, V153, P375, DOI 10.1099/mic.0.2006/001362-0; Cheng JJ, 2014, J MICROBIOL METH, V99, P27, DOI 10.1016/j.mimet.2014.01.015; Cowie A, 2006, APPL ENVIRON MICROB, V72, P7156, DOI 10.1128/AEM.01397-06; Craig JW, 2010, APPL ENVIRON MICROB, V76, P1633, DOI 10.1128/AEM.02169-09; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Doxey AC, 2015, ISME J, V9, P461, DOI 10.1038/ismej.2014.142; Erich S, 2015, J BIOTECHNOL, V210, P27, DOI 10.1016/j.jbiotec.2015.06.411; Ferrer M, 2009, J MOL MICROB BIOTECH, V16, P109, DOI 10.1159/000142898; Ferrer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038134; FINAN TM, 1984, J BACTERIOL, V159, P120, DOI 10.1128/JB.159.1.120-124.1984; Gabor EM, 2004, ENVIRON MICROBIOL, V6, P879, DOI 10.1111/j.1462-2920.2004.00640.x; Gosling A, 2010, FOOD CHEM, V121, P307, DOI 10.1016/j.foodchem.2009.12.063; Guimaraes PMR, 2010, BIOTECHNOL ADV, V28, P375, DOI 10.1016/j.biotechadv.2010.02.002; Gupta R, 2012, APPL BIOCHEM BIOTECH, V168, P1681, DOI 10.1007/s12010-012-9889-z; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hao YA, 2010, ENVIRON MICROBIOL, V12, P105, DOI 10.1111/j.1462-2920.2009.02049.x; Harju M, 2012, INT DAIRY J, V22, P104, DOI 10.1016/j.idairyj.2011.09.011; Iqbal HA, 2012, CURR OPIN CHEM BIOL, V16, P109, DOI 10.1016/j.cbpa.2012.02.015; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khan SR, 2008, APPL ENVIRON MICROB, V74, P5053, DOI 10.1128/AEM.01098-08; Lam KN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098968; Lammens W, 2009, J EXP BOT, V60, P727, DOI 10.1093/jxb/ern333; Li YC, 2015, BIORESOURCE TECHNOL, V198, P464, DOI 10.1016/j.biortech.2015.09.032; Li YG, 2005, ENVIRON MICROBIOL, V7, P1927, DOI 10.1111/j.1462-2920.2005.00853.x; LISSER S, 1993, NUCLEIC ACIDS RES, V21, P1507, DOI 10.1093/nar/21.7.1507; MacLellan SR, 2006, MICROBIOL-SGM, V152, P1751, DOI 10.1099/mic.0.28743-0; Ly MA, 2011, J MICROBIOL METH, V86, P320, DOI 10.1016/j.mimet.2011.06.005; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marrakchi M, 2008, MAT SCI ENG C-BIO S, V28, P872, DOI 10.1016/j.msec.2007.10.046; Martinez A, 2004, APPL ENVIRON MICROB, V70, P2452, DOI 10.1128/AEM.70.4.2452-2463.2004; Maruthamuthu M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2404-0; Matsuzawa T, 2017, APPL MICROBIOL BIOT, V101, P633, DOI 10.1007/s00253-016-7803-2; MEADE HM, 1982, J BACTERIOL, V149, P114, DOI 10.1128/JB.149.1.114-122.1982; MESELSON M, 1968, NATURE, V217, P1110, DOI 10.1038/2171110a0; Naumoff DG, 2001, PROTEINS, V42, P66, DOI 10.1002/1097-0134(20010101)42:1<66::AID-PROT70>3.0.CO;2-4; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Patil KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038581; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrenko P, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0195-4; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ramirez-Escudero M, 2016, J BIOL CHEM, V291, P24200, DOI 10.1074/jbc.M116.747527; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shade A, 2012, ENVIRON MICROBIOL, V14, P2247, DOI 10.1111/j.1462-2920.2012.02817.x; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Taupp M, 2011, CURR OPIN BIOTECH, V22, P465, DOI 10.1016/j.copbio.2011.02.010; Ufarte L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00563; Vester JK, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-72; WALLENFELS K, 1961, ADV CARBOHYD CHEM, V16, P239; Wang CX, 2006, APPL ENVIRON MICROB, V72, P384, DOI 10.1128/AEM.72.1.384-391.2006; Wang K, 2010, APPL MICROBIOL BIOT, V88, P155, DOI 10.1007/s00253-010-2744-7; Wang SD, 2014, ENZYME MICROB TECH, V57, P26, DOI 10.1016/j.enzmictec.2014.01.007; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Wexler M, 2010, METHODS MOL BIOL, V668, P77, DOI 10.1007/978-1-60761-823-2_5; Wierzbicka-Wos A, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-22; Zhang X, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-237; Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275	67	24	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172545	10.1371/journal.pone.0172545	http://dx.doi.org/10.1371/journal.pone.0172545			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273103	Green Submitted, Green Published, gold			2022-12-26	WOS:000396073700079
J	Morton, CM				Morton, Cynthia M.			Phylogenetic relationships of Vepris (Rutaceae) inferred from chloroplast, nuclear, and morphological data	PLOS ONE			English	Article							CLADISTIC-ANALYSIS; NONCODING REGIONS; SUBFAMILIES; CONGRUENCE	The tribe Toddalieae Hook. F. (Rutaceae) has been controversial since its inception by Bentham and Hooker. The nine taxa examined, Acronychia J.R. & G. Foster, Diphasia Pierre, Diphasiopsis Mendonca, Fagaropsis Mildbr. ex. Siebenl., Oricia Pierre, Teclea Delile, Toddaliopsis Engl., Toddalia Juss. and Vepris Comm. ex. A. Juss, have been recognized under the tribe Toddalieae or Tribes Acronychia, Phellodendron and Toddalia. More recently Araliopsis Engl., Diphasia, Diphasiopsis, Oricia, Teclea, and Toddaliopsis have been incorporated into the genus Vepris, while Toddalia and Fagaropsis have continued to be recognized as closely related. For this study, sequence data of one non-coding chloroplast region (trnL-F) and one nuclear region (ITS) and various morphological characters, based on Mziray's taxonomic studies were examined to try to elucidate these relationships. This study found that the taxa Diphasia, Diphasiopsis, Oricia, Teclea, Toddaliopsis, Vepris, Toddalia eugeniifolia Engl. and Toddalia glomerata F. Hoffm. form a monophyletic group. Due to the amount of intrageneric and intraspecific variation, species delimitations were difficult to determine; however, these genera should be united into Vepris. The analyses also confirmed that Toddalia asiatica (L.) Lam., Zanthoxylon sp. and Fagaropsis angolensis (Engl.) H.M. Gardner are the closest relatives to this group.	[Morton, Cynthia M.] Pittsburgh Pk Conservancy, Pittsburgh, PA 15203 USA		Morton, CM (corresponding author), Pittsburgh Pk Conservancy, Pittsburgh, PA 15203 USA.	mortoncm100@gmail.com			National Geographic society [7638-04]	National Geographic society(National Geographic Society)	This work was supported by the National Geographic society 7638-04 to Cynthia Morton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelhans MS, 2011, ANN BOT-LONDON, V107, P1259, DOI 10.1093/aob/mcr076; Bayer RJ, 2009, AM J BOT, V96, P668, DOI 10.3732/ajb.0800341; Bazinet AL, 2014, SYST BIOL, V63, P812, DOI 10.1093/sysbio/syu031; Bentham G., 1867, GENERA PLANTARUM, V1, DOI 10.5962/bhl.title.747; Buerki S, 2009, MOL PHYLOGENET EVOL, V51, P238, DOI 10.1016/j.ympev.2009.01.012; Chase MW, 1999, AM J BOT, V86, P1191, DOI 10.2307/2656983; Compton JA, 1998, TAXON, V47, P593, DOI 10.2307/1223580; DA SILVA MFGF, 1988, PLANT SYST EVOL, V161, P97; Engler A., 1896, NATURLICHEN PFLANZEN, P95; Engler A, 1917, BOT JB, V54, P305; Engler H.G.A., 1931, NATURLICHEN PFLANZEN, P187; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Groppo M, 2008, AM J BOT, V95, P985, DOI 10.3732/ajb.2007313; Hall JB, 1979, P AETFAT, VIX, P105; HARTLEY TG, 1975, J ARNOLD ARBORETUM, V56, P164; Johnson LA, 1999, PLANT SYST EVOL, V214, P65, DOI 10.1007/BF00985732; Kokwaro OJ, 1982, FLORA TROPICAL E AFR; Maddison WP., 2000, MACCLADE ANAL PHYLOG; Manos PS, 1997, AM J BOT, V84, P1137, DOI 10.2307/2446156; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; Miller M.A., 2010, CIPRES PORTALS; Morton CM, 2003, AM J BOT, V90, P1463, DOI 10.3732/ajb.90.10.1463; Morton CM, 2014, MISSOURI BOT GARDENS, V94, P620, DOI [10.3417/2010034, DOI 10.3417/2010034]; Mziray W., 1992, ACTA U PUSALIENSES S, V30, P67; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Perrier H, 1948, MEM ACAD SCI PARIS 2, VLXVII, P15; Poon WS, 2007, SYST BOT, V32, P837, DOI 10.1600/036364407783390692; Ronquist F, 2005, MRBAYES; Salvo G, 2008, MOL PHYLOGENET EVOL, V49, P736, DOI 10.1016/j.ympev.2008.09.004; Salvo G, 2010, SYST BIOL, V59, P705, DOI 10.1093/sysbio/syq046; Scott KD, 2000, PLANT SYST EVOL, V223, P15, DOI 10.1007/BF00985324; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Verdoorn, 1926, KEW B, V9, P389; Wells JA, PLOS ONE UNPUB; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yingzhi L, 2007, J AM SOC HORTIC SCI, V132, P796, DOI 10.21273/JASHS.132.6.796	37	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172708	10.1371/journal.pone.0172708	http://dx.doi.org/10.1371/journal.pone.0172708			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273098	Green Published, gold, Green Submitted			2022-12-26	WOS:000396073700086
J	Son, SH; Choi, KH; Kim, SW				Son, Seok Hyun; Choi, Kyu Hye; Kim, Shin-Wook			Dosimetric comparison of simultaneous integrated boost with whole-breast irradiation for early breast cancer	PLOS ONE			English	Article							TUMOR BED; LOCAL-CONTROL; RADIOTHERAPY; SURVIVAL; ELECTRON; THERAPY	Purpose The purpose of this study was to identify a more suitable boost plan for simultaneously integrated boost scheme in patients with breast cancer by comparing among 3 types of whole-breast irradiation plus tumor bed boost plans. Methods Twenty patients who received radiotherapy following breast-conserving surgery for early breast cancer were enrolled in this study. We performed 1 type of electron plan (E1P plan) and 2 types of 3-dimensional conformal plans using a photon (P3P and P5P plans). The dosimetric parameters for the heart, total lung and the target volume between the 3 treatment types were compared. Results For the tumor bed, the difference in the mean dose between the 3 plans was maximally 0.1 Gy. For normal breast parenchyma, the difference in the mean dose between the 3 plans was maximally 1.1 Gy. In the dose range over the prescribed dose of 51 Gy, V-55 and V-60 in the E1P plan were lower than those in the P3P and P5P plans, which indicated that the E1P plan was more suitable than the P3P and P5P plans. In case of the heart and total lung, the values of clinically important parameters were slightly higher in the E1P plan than in the P3P and P5P plans. However, these differences were less than 2%. Conclusion We observed that a simple electron plan for tumor bed boost is preferable over multi-field photon plans in terms of the target volume coverage and normal tissue sparing.	[Son, Seok Hyun; Choi, Kyu Hye; Kim, Shin-Wook] Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Radiat Oncol, Seoul, South Korea	Catholic University of Korea	Son, SH (corresponding author), Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Radiat Oncol, Seoul, South Korea.	sonshyun@catholic.ac.kr		Son, Seok Hyun/0000-0002-2577-1915				Abe O, 2005, LANCET, V366, P2087; Aly MMOM, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0452-2; Bartelink H, 2007, J CLIN ONCOL, V25, P3259, DOI 10.1200/JCO.2007.11.4991; Chen GP, 2015, MED DOSIM, V40, P21, DOI 10.1016/j.meddos.2014.06.007; Chen XJ, 2014, INT J RADIAT ONCOL, V90, P1208, DOI 10.1016/j.ijrobp.2014.08.342; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Gagliardi G, 2010, INT J RADIAT ONCOL, V76, pS77, DOI 10.1016/j.ijrobp.2009.04.093; Ghoncheh Mahshid, 2016, Asian Pac J Cancer Prev, V17, P43; Guerrero M, 2004, INT J RADIAT ONCOL, V59, P1513, DOI 10.1016/j.ijrobp.2004.04.007; Marks LB, 2010, INT J RADIAT ONCOL, V76, pS70, DOI 10.1016/j.ijrobp.2009.06.091; Offersen BV, 2016, RADIOTHER ONCOL, V118, P205, DOI 10.1016/j.radonc.2015.12.027; Park K, 2015, RADIAT ONCOL J, V33, P242, DOI 10.3857/roj.2015.33.3.242; Park SH, 2013, J BREAST CANCER, V16, P300, DOI 10.4048/jbc.2013.16.3.300; Sautter-Bihl ML, 2006, STRAHLENTHER ONKOL, V182, P199, DOI 10.1007/s00066-006-6701-4; Toscas JI, 2010, RADIOTHER ONCOL, V96, P192, DOI 10.1016/j.radonc.2010.05.007; Van Parijs H, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-36; Wong P, 2011, INT J RADIAT ONCOL, V79, P39, DOI 10.1016/j.ijrobp.2009.10.023; Wu SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120811	18	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173552	10.1371/journal.pone.0173552	http://dx.doi.org/10.1371/journal.pone.0173552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273157	gold, Green Published, Green Submitted			2022-12-26	WOS:000396073700017
J	Santoro, M; D'Alessio, N; Cerrone, A; Lucibelli, MG; Borriello, G; Aloise, G; Auriemma, C; Riccone, N; Galiero, G				Santoro, Mario; D'Alessio, Nicola; Cerrone, Anna; Lucibelli, Maria Gabriella; Borriello, Giorgia; Aloise, Gaetano; Auriemma, Clementina; Riccone, Nunzia; Galiero, Giorgio			The Eurasian otter (Lutra lutra) as a potential host for rickettsial pathogens in southern Italy	PLOS ONE			English	Article							REAL-TIME PCR; VECTOR-BORNE PATHOGENS; FOXES VULPES-VULPES; EHRLICHIA-CANIS; ORDER CHLAMYDIALES; MOLECULAR EVIDENCE; DNA; INFECTION; TICKS; DOGS	Canine monocytic ehrlichiosis and rickettsiosis are zoonotic tick-borne diseases of canids caused by the intracellular obligate bacteria Ehrlichia canis and Rickettsia species respectively. In this study, we investigated using standard and real-time PCR and sequencing, the occurrence and molecular characterization of E. canis and Rickettsia species in the Eurasian otter (Lutra lutra) from the southern Italian population. Samples were screened by using molecular assays also for Neospora caninum, Toxoplasma gondii, Clamydophyla spp., Coxiella burnetii, Leishmania spp., Cryptosporidium spp., and Giardia spp. detection, and helminths were studied by traditional methods. Out of six carcasses tested, three were positive for E. canis and co-infection with Rickettsia sp. occurred in one of those. Sequences of the 16S rRNA E. canis gene were identical to each other but differed from most of those previously found in red foxes (Vulpes vulpes) and wolves (Canis lupus) from southern Italy. Helminths included just cystacanths of Sphaerirostris spp. from the intestine of two Eurasian otters and the nematode Angiostrongylus vasorum from the lungs of a single Eurasian otter. None of the samples was positive for the other investigated selected pathogens. This study is the first report on the evidence of infection by rickettsial pathogens in the Eurasian otter. The present result prompts some inquiries into the pathogenic role of those bacteria for the isolated sub-populations of the endangered Eurasian otter in southern Italy.	[Santoro, Mario; D'Alessio, Nicola; Cerrone, Anna; Lucibelli, Maria Gabriella; Borriello, Giorgia; Auriemma, Clementina; Riccone, Nunzia; Galiero, Giorgio] Ist Zooprofilatt Sperimentale Mezzogiorno, Naples, Italy; [Aloise, Gaetano] Univ Calabria, Museo Storia Nat Calabria, Cosenza, Italy; [Aloise, Gaetano] Univ Calabria, Orto Bot, Cosenza, Italy	IZS del Mezzogiorno; University of Calabria; University of Calabria	Santoro, M (corresponding author), Ist Zooprofilatt Sperimentale Mezzogiorno, Naples, Italy.	marisant@libero.it	Borriello, Giorgia/Z-5759-2019; Santoro, Mario/K-3251-2019	Santoro, Mario/0000-0002-6483-3103	Istituto Zooprofilattico del Mezzogiorno	Istituto Zooprofilattico del Mezzogiorno	The Italian Ministry of Health systematically support the Istituto Zooprofilattico del Mezzogiorno on surveys of infectious diseases of wildlife.	Cardoso L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0756-y; Carrasco SE, 2014, VET MICROBIOL, V170, P325, DOI 10.1016/j.vetmic.2014.02.021; Chinnadurai SK, 2010, J WILDLIFE DIS, V46, P947, DOI 10.7589/0090-3558-46.3.947; Christian Axel, 2012, Soil Organisms, V84, P481; Dantas-Torres F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-26; Dimitrova ZM, 1997, FOLIA PARASIT, V44, P224; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; Everett KDE, 1999, J CLIN MICROBIOL, V37, P575, DOI 10.1128/JCM.37.3.575-580.1999; Guy RA, 2003, APPL ENVIRON MICROB, V69, P5178, DOI 10.1128/AEM.69.9.5178-5185.2003; Haque R, 2007, AM J TROP MED HYG, V76, P713, DOI 10.4269/ajtmh.2007.76.713; Harrus S, 1998, J CLIN MICROBIOL, V36, P73, DOI 10.1128/JCM.36.1.73-76.1998; HARVEY JW, 1979, J AM VET MED ASSOC, V175, P901; Hodzic A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0692-x; Hornok S, 2013, ACTA VET HUNG, V61, P42, DOI 10.1556/AVet.2012.050; Hughes JM, 2008, EXP PARASITOL, V120, P255, DOI 10.1016/j.exppara.2008.07.011; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Loy A, 2010, HYSTRIX, V21, P19; Malatesta D, 2014, VET ITAL, V50, P199, DOI 10.12834/VetIt.40.1916.8; Mancini F, ANN 1 SUPER SANITA, V51, P284, DOI [10.4415/ANN_15_04_07, DOI 10.4415/AHINI150407]; Millan J, 2016, TICKS TICK-BORNE DIS, V7, P284, DOI 10.1016/j.ttbdis.2015.11.003; Mortarino M, 2014, PARASSITOLOGIA, V46, P163; Noeckler K., 2007, FAOWHOOIE GUIDELINES, P69; Ossewaarde JM, 1999, MICROBIOL-SGM, V145, P411, DOI 10.1099/13500872-145-2-411; Otranto D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-328; Perez M, 2006, ANN NY ACAD SCI, V1078, P110, DOI 10.1196/annals.1374.016; Prina E, 2007, MICROBES INFECT, V9, P1307, DOI 10.1016/j.micinf.2007.06.005; Rene-Martellet M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0613-4; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roulichova J, 2007, FOLIA ZOOL, V56, P440; Rovery C, 2008, EMERG INFECT DIS, V14, P1360, DOI 10.3201/eid1409.071133; Santoro M, 2016, PARASITOL RES, V115, P4427, DOI 10.1007/s00436-016-5213-0; Santoro M, 2015, ACTA PARASITOL, V60, P356, DOI 10.1515/ap-2015-0050; Santoro M, 2012, J PARASITOL, V98, P22, DOI 10.1645/GE-2924.1; Schex S, 2011, VECTOR-BORNE ZOONOT, V11, P493, DOI 10.1089/vbz.2010.0060; Schneeberger Peter M, 2010, Clin Vaccine Immunol, V17, P286, DOI 10.1128/CVI.00454-09; Sherrard-Smith E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047131; Solano-Gallego L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0824-3; Stich RW, 2008, VET PARASITOL, V158, P256, DOI 10.1016/j.vetpar.2008.09.013; Telford SR, 2008, TICKS: BIOLOGY, DISEASE AND CONTROL, P344, DOI 10.1017/CBO9780511551802.017; Tilburg JJHC, 2010, J CLIN MICROBIOL, V48, P3923, DOI 10.1128/JCM.01006-10; Torina A, 2013, TRANSBOUND EMERG DIS, V60, P125, DOI 10.1111/tbed.12137; TZIANABOS T, 1989, J CLIN MICROBIOL, V27, P2866, DOI 10.1128/JCM.27.12.2866-2868.1989; Waner T, 2014, VET J, V202, P618, DOI 10.1016/j.tvjl.2014.10.004; Zivkovic Z, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-7	44	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173556	10.1371/journal.pone.0173556	http://dx.doi.org/10.1371/journal.pone.0173556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267780	Green Published, gold, Green Submitted			2022-12-26	WOS:000396060600043
J	Kuwata, H; Okamura, S; Hayashino, Y; Tsujii, S; Ishii, H				Kuwata, Hirohito; Okamura, Shintaro; Hayashino, Yasuaki; Tsujii, Satoru; Ishii, Hitoshi		Diabet Distress Care Registry T	Higher levels of physical activity are independently associated with a lower incidence of diabetic retinopathy in Japanese patients with type 2 diabetes: A prospective cohort study, Diabetes Distress and Care Registry at Tenri (DDCRT15)	PLOS ONE			English	Article							GLYCEMIC CONTROL; PROLIFERATIVE RETINOPATHY; HIGH PREVALENCE; RISK-FACTORS; COMPLICATIONS; MORTALITY; MELLITUS; EPIDEMIOLOGY; NEPHROPATHY; PROGRESSION	We assessed the prospective association between baseline levels of physical activity (PA) and the incidence of newly developed diabetic retinopathy (DR) in patients with type 2 diabetes. Data from 1,814 patients with type 2 diabetes without DR were obtained from a Japanese diabetes registry at Tenri Hospital, Nara, Japan. To assess the independent correlations between baseline PA levels and newly developed DR, the participants were divided into five categories based on their PA levels. A Cox proportional hazards model with time-varying exposure information was used and adjusted for potential confounders to assess the independent correlations. At baseline, the mean age, BMI, and hemoglobin A1c levels of the patients were 65.5 years, 24.5 kg/m(2), and 7.2% (54 mmol/mol), respectively. After 2 years, newly developed DR was confirmed in 184 patients (10.1%). Patients with newly developed DR had longer duration of type 2 diabetes (14.7 versus 11.0 years, p < 0.0001), higher systolic blood pressure (139.2 versus 135.1 mmHg, p = 0.0012), lower estimated glomerular filtration rate (74.0 versus 77.1 mL/min/1.73 m(2), p = 0.0382), greater urinary albumin - creatinine ratio (4.00 versus 2.45 mg/mmol, p < 0.0039), and higher HbA1c levels (7.5 versus 7.2%, p = 0.0006) than those without newly developed DR. The multivariable-adjusted hazard ratios for DR development were 0.87 (95% CI, 0.53 - 1.40; p = 0.557), 0.83 (95% CI, 0.52 - 1.31; p = 0.421), 0.58 (95% CI, 0.35 - 0.94; p = 0.027), and 0.63 (95% CI, 0.42 - 0.94; p = 0.025) for the second, third, fourth, and fifth PA categories, respectively, compared with the reference category of patients with a mean PA of 0 metabolic equivalent of task-hours/week). Higher PA levels are independently associated with a lower incidence of DR in Japanese patients with type 2 diabetes.	[Kuwata, Hirohito; Ishii, Hitoshi] Nara Med Univ, Dept Diabetol, Kashihara, Nara, Japan; [Okamura, Shintaro; Hayashino, Yasuaki; Tsujii, Satoru] Tenriyorozu Hosp, Dept Endocrinol, Tenri, Nara, Japan	Nara Medical University	Ishii, H (corresponding author), Nara Med Univ, Dept Diabetol, Kashihara, Nara, Japan.	hit3910@gmail.com	Hayashino, Yasuaki/AAA-8637-2022	Hayashino, Yasuaki/0000-0002-2932-8478; Tsujii, Satoru/0000-0002-1834-6515; Okamura, Shintaro/0000-0002-1205-6883	Manpei Suzuki Diabetes Foundation; Takeda Pharmaceutical Company Limited; JSPS KAKENHI [25460641]; Grants-in-Aid for Scientific Research [16K08897] Funding Source: KAKEN	Manpei Suzuki Diabetes Foundation; Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by the Manpei Suzuki Diabetes Foundation, the grants and endowment from Takeda Pharmaceutical Company Limited, and JSPS KAKENHI (Grant Number 25460641); however, they played no role in the design, conduct, data collection, analysis, or interpretation of the study, or in the preparation, review, or approval of the manuscript.	American Diabetes Association, 2015, Diabetes Care, V38 Suppl, pS20, DOI 10.2337/dc15-S007; Blomster JI, 2013, DIABETES OBES METAB, V15, P1008, DOI 10.1111/dom.12122; Boule NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218; Buch H, 2004, OPHTHALMOLOGY, V111, P53, DOI 10.1016/j.ophtha.2003.05.010; Coker RH, 2009, J CLIN ENDOCR METAB, V94, P4258, DOI 10.1210/jc.2008-2033; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; CRUICKSHANKS KJ, 1992, DIABETES CARE, V15, P1267, DOI 10.2337/diacare.15.10.1267; CRUICKSHANKS KJ, 1995, OPHTHALMOLOGY, V102, P1177, DOI 10.1016/S0161-6420(95)30893-7; Davis MD, 1998, INVEST OPHTH VIS SCI, V39, P233; Fenwick E, 2012, CLIN EXP OPHTHALMOL, V40, P27, DOI 10.1111/j.1442-9071.2011.02599.x; FUKUDA M, 1983, Tohoku Journal of Experimental Medicine, V141, P331; Hayashino Y, 2013, EXP CLIN ENDOCR DIAB, V121, P628, DOI 10.1055/s-0033-1355424; Hayashino Y, 2014, DIABETES CARE, V37, P2459, DOI 10.2337/dc13-2312; Hayashino Y, 2012, DIABETES RES CLIN PR, V97, P405, DOI 10.1016/j.diabres.2012.04.005; Ito D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138037; Kamada M, 2014, J EPIDEMIOL, V24, P474, DOI 10.2188/jea.JE20140025; Kawasaki R, 2011, DIABETOLOGIA, V54, P2288, DOI 10.1007/s00125-011-2199-0; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010; KRISKA AM, 1991, J CLIN EPIDEMIOL, V44, P1207, DOI 10.1016/0895-4356(91)90153-Z; Kuwata H, 2016, DIABETOL INT; LAPORTE RE, 1986, PEDIATRICS, V78, P1027; LEHMANN R, 1995, DIABETOLOGIA, V38, P1313; Lu B, 2007, DIABETES RES CLIN PR, V75, P184, DOI 10.1016/j.diabres.2006.06.024; Mashitani T, 2015, ACTA DIABETOL, V52, P639, DOI 10.1007/s00592-015-0725-0; Mashitani T, 2014, DIABETES CARE, V37, P252, DOI 10.2337/dc13-0407; Mashitani T, 2013, DIABETES RES CLIN PR, V100, P189, DOI 10.1016/j.diabres.2013.03.006; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Murase N, 2002, J HLTH WELF STAT, V49, P1; Pradeepa R, 2010, DIABETES TECHNOL THE, V12, P755, DOI 10.1089/dia.2010.0069; Sclavo M, 2001, Ital Heart J Suppl, V2, P563; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Stehouwer CDA, 2002, DIABETES, V51, P1157, DOI 10.2337/diabetes.51.4.1157; Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x; Waden J, 2008, DIABETES CARE, V31, P230, DOI 10.2337/dc07-1238; Waden J, 2015, DIABETOLOGIA, V58, P929, DOI 10.1007/s00125-015-3499-6; Wei M, 2000, ANN INTERN MED, V132, P605, DOI 10.7326/0003-4819-132-8-200004180-00002; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Yasuaki Hayashino, 2016, ACTA DIABETOL; Zethelius B, 2014, EUR J PREV CARDIOL, V21, P244, DOI 10.1177/2047487313510893	39	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172890	10.1371/journal.pone.0172890	http://dx.doi.org/10.1371/journal.pone.0172890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257419	Green Published, gold, Green Submitted			2022-12-26	WOS:000396021100037
J	Zapiola, ML; Mallory-Smith, CA				Zapiola, Maria Luz; Mallory-Smith, Carol Ann			Pollen-mediated gene flow from transgenic perennial creeping bentgrass and hybridization at the landscape level	PLOS ONE			English	Article							AGROSTIS-STOLONIFERA; ESTABLISHMENT; ESCAPE	The planting of 162 ha of transgenic glyphosate-resistant creeping bentgrass (Agrostis stolonifera) near Madras, OR, USA, allowed a unique opportunity to study gene flow over time from a perennial outcrossing species at the landscape level. While conducting a four year in situ survey, we collected panicles and leaf tissue samples from creeping bentgrass and its sexually compatible species. Seeds from the panicles were planted, and seedlings were tested in the greenhouse for expression of the transgene. Gene flow via pollen was found in all four years, at frequencies of 0.004 to 2.805%. Chloroplast markers, in combination with internal transcribed spacer nuclear sequence analysis, were used to aid in identification of transgenic interspecific and intergeneric hybrid seedlings found during the testing and of established plants that could not be positively identified in the field. Interspecific transgenic hybrids produced on redtop (Agrostis gigantea) plants in situ were identified three of the four years and one intergeneric transgenic creeping bentgrass x rabbitfoot grass (Polypogon monspeliensis) hybrid was identified in 2005. In addition, we confirmed a non-transgenic creeping bentgrass x redtop hybrid in situ, demonstrating that interspecific hybrids have established in the environment outside production fields. Results of this study should be considered for deregulation of transgenic events, studies of population dynamics, and prediction of gene flow in the environment.	[Zapiola, Maria Luz; Mallory-Smith, Carol Ann] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA; [Zapiola, Maria Luz] Pontificia Univ Catolica Argentina, Fac Ciencias Agr, Buenos Aires, DF, Argentina	Oregon State University; Pontifical Catholic University of Argentina	Zapiola, ML (corresponding author), Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA.; Zapiola, ML (corresponding author), Pontificia Univ Catolica Argentina, Fac Ciencias Agr, Buenos Aires, DF, Argentina.	malu.zapiola@gmail.com			US Department of Agriculture (USDA), Biotechnology Risk Assessment [2004-02875]; special grants from USDA-Animal and Plant Health Inspection Service (APHIS); Scotts Company	US Department of Agriculture (USDA), Biotechnology Risk Assessment(United States Department of Agriculture (USDA)); special grants from USDA-Animal and Plant Health Inspection Service (APHIS); Scotts Company	This study was funded in part by the US Department of Agriculture (USDA), Biotechnology Risk Assessment Grant number 2004-02875. Support also was received from special grants from USDA-Animal and Plant Health Inspection Service (APHIS) and The Scotts Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong TT, 2005, MOL ECOL, V14, P2111, DOI 10.1111/j.1365-294X.2005.02572.x; Belanger FC, 2003, CROP SCI, V43, P240, DOI 10.2135/cropsci2003.0240; EDGAR E, 1991, NEW ZEAL J BOT, V29, P139, DOI 10.1080/0028825X.1991.10416717; Ellstrand N. C., 2003, DANGEROUS LIAISONS C; Ellstrand NC, 2014, AM J BOT, V101, P737, DOI 10.3732/ajb.1400024; Fei S, 2004, IN VITRO CELL DEV-PL, V40, P266, DOI 10.1079/IVP2003522; Fei S, 2003, CROP SCI, V43, P2177, DOI 10.2135/cropsci2003.2177; Gardner DS, 2004, WEED TECHNOL, V18, P773, DOI 10.1614/WT-03-184R1; Hubbard CE Grasses, 1992, GUIDE THEIR STRUCTUR; Huelsenbeck JP, 2007, GENETICS, V175, P1787, DOI 10.1534/genetics.106.061317; Lee D, 2006, TRENDS BIOTECHNOL, V24, P109, DOI 10.1016/j.tibtech.2006.01.006; Zapiola ML, 2010, WEED SCI, V58, P223, DOI 10.1614/WS-D-09-00076.1; Mallory-Smith C, 2015, WEED SCI, V63, P12, DOI 10.1614/WS-D-13-00064.1; Mallory-Smith CA, 2011, J AGR FOOD CHEM, V59, P5813, DOI 10.1021/jf103389v; Marvier M, 2005, FRONT ECOL ENVIRON, V3, P99, DOI 10.2307/3868516; Messeguer J, 2003, PLANT CELL TISS ORG, V73, P201, DOI 10.1023/A:1023007606621; Nap JP, 2003, PLANT J, V33, P1, DOI 10.1046/j.0960-7412.2003.01602.x; Pfender W, 2007, CROP SCI, V47, P2529, DOI 10.2135/cropsci2007.01.0030; Reichman JR, 2006, MOL ECOL, V15, P4243, DOI 10.1111/j.1365-294X.2006.03072.x; Rieger MA, 1999, AUST J AGR RES, V50, P115, DOI 10.1071/A97138; Rozen S, 2000, Methods Mol Biol, V132, P365; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Wang ZY, 2012, ANN BOT-LONDON, V110, P1317, DOI 10.1093/aob/mcs027; Warnke S., 2003, TURFGRASS BIOL GENET, P175; Watrud LS, 2004, P NATL ACAD SCI USA, V101, P14533, DOI 10.1073/pnas.0405154101; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wipff J. K., 2001, International Turfgrass Society Research Journal, V9, P224; Zapiola ML, 2008, J APPL ECOL, V45, P486, DOI 10.1111/j.1365-2664.2007.01430.x; Zapiola ML, 2010, MOL ECOL RESOUR, V10, P738, DOI 10.1111/j.1755-0998.2009.02828.x; Zapiola ML, 2012, MOL ECOL, V21, P4663, DOI [10.1111/j.1365-294X.2012.05695.x, DOI 10.1111/J.1365-294X.2012.05695.X]	30	9	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173308	10.1371/journal.pone.0173308	http://dx.doi.org/10.1371/journal.pone.0173308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257488	Green Submitted, Green Published, gold			2022-12-26	WOS:000396021100085
J	Whelan, FJ; Heirali, AA; Rossi, L; Rabin, HR; Parkins, MD; Surette, MG				Whelan, Fiona J.; Heirali, Alya A.; Rossi, Laura; Rabin, Harvey R.; Parkins, Michael D.; Surette, Michael G.			Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis	PLOS ONE			English	Article							PULMONARY EXACERBATIONS; RESPIRATORY-TRACT; GENE; COMMUNITIES; DISEASE; SPUTUM; EPIDEMIOLOGY; STABILITY; SEQUENCES; DYNAMICS	Cystic fibrosis (CF) manifests in the lungs resulting in chronic microbial infection. Most morbidity and mortality in CF is due to cycles of pulmonary exacerbations-episodes of acute inflammation in response to the lung microbiome-which are difficult to prevent and treat because their cause is not well understood. We hypothesized that longitudinal analyses of the bacterial component of the CF lung microbiome may elucidate causative agents within this community for pulmonary exacerbations. In this study, 6 participants were sampled thrice-weekly for up to one year. During sampling, sputum, and data (antibiotic usage, spirometry, and symptom scores) were collected. Time points were categorized based on relation to exacerbation as Stable, Intermediate, and Treatment. Retrospectively, a subset of were interrogated via 16S rRNA gene sequencing. When samples were examined categorically, a significant difference between the lung microbiota in Stable, Intermediate, and Treatment samples was observed in a subset of participants. However, when samples were examined longitudinally, no correlations between microbial composition and collected data (antibiotic usage, spirometry, and symptom scores) were observed upon exacerbation onset. In this study, we identified no universal indicator within the lung microbiome of exacerbation onset but instead showed that changes to the CF lung microbiome occur outside of acute pulmonary episodes and are patient-specific.	[Whelan, Fiona J.; Rossi, Laura; Surette, Michael G.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Heirali, Alya A.; Rabin, Harvey R.; Parkins, Michael D.; Surette, Michael G.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Rabin, Harvey R.; Parkins, Michael D.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Surette, Michael G.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; University of Calgary; University of Calgary; McMaster University	Surette, MG (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.; Surette, MG (corresponding author), Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada.; Surette, MG (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	surette@mcmaster.ca	Surette, Michael G/AAE-8825-2020; Whelan, Fiona/AAE-9386-2020	Whelan, Fiona/0000-0001-9165-4859	Cystic Fibrosis Canada; Cystic Fibrosis Canada Doctoral Studentship; Canadian Institutes of Health Research (CIHR) Fredrick Banting and Charles Best Canadian Graduate Scholarship; Canada Research Chair in Interdisciplinary Microbiome Research	Cystic Fibrosis Canada; Cystic Fibrosis Canada Doctoral Studentship; Canadian Institutes of Health Research (CIHR) Fredrick Banting and Charles Best Canadian Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Interdisciplinary Microbiome Research	This work was supported by grants from Cystic Fibrosis Canada to MGS and MDP. FJW is supported by a Cystic Fibrosis Canada Doctoral Studentship and a Canadian Institutes of Health Research (CIHR) Fredrick Banting and Charles Best Canadian Graduate Scholarship. MGS is supported as a Canada Research Chair in Interdisciplinary Microbiome Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2004, AM J RESP CRIT CARE, V169, P811, DOI 10.1164/rccm.200309-1306OC; Andersen DH, 1938, AM J DIS CHILD, V56, P344, DOI 10.1001/archpedi.1938.01980140114013; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carmody LA, 2013, CHANGES CYSTIC FIBRO; Carmody LA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0074-9; Coburn B, 2015, SCI REP-UK, V5, DOI 10.1038/srep10241; Corey M, 1997, J PEDIATR-US, V131, P809, DOI 10.1016/S0022-3476(97)70025-8; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Cuthbertson L, 2016, ISME J, V10, P1081, DOI 10.1038/ismej.2015.198; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doring G, 2012, J CYST FIBROS, V11, P461, DOI 10.1016/j.jcf.2012.10.004; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elborn J. S., 2016, LANCET; Ferkol T, 2006, J PEDIATR-US, V148, P259, DOI 10.1016/j.jpeds.2005.10.019; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Flume PA, 2009, AM J RESP CRIT CARE, V180, P802, DOI 10.1164/rccm.200812-1845PP; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045001; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Goss CH, 2007, THORAX, V62, P360, DOI 10.1136/thx.2006.060889; He Y, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0081-x; Hiatt PW, 1999, PEDIATRICS, V103, P619, DOI 10.1542/peds.103.3.619; Jarad NA, 2012, QJM-INT J MED, V105, P137, DOI 10.1093/qjmed/hcr149; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kramer R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117436; Lam JC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0856-5; Levesque C, 2003, ORAL MICROBIOL IMMUN, V18, P333, DOI 10.1034/j.1399-302X.2003.00085.x; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Lynch S V., 2013, COLD SPRING HARB PER, V3; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Muzanye G, 2009, AFR HEALTH SCI, V9, P200; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Sakamoto H, 1998, Bull Tokyo Dent Coll, V39, P103; Sanders DB, 2011, PEDIATR PULM, V46, P393, DOI 10.1002/ppul.21374; Sawicki GS, 2009, J CYST FIBROS, V8, P91, DOI 10.1016/j.jcf.2008.09.007; Sibley CD, 2010, J MED MICROBIOL, V59, P534, DOI 10.1099/jmm.0.016592-0; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Smith DJ, 2014, EUR RESPIR J, V44, P922, DOI 10.1183/09031936.00203013; Surette MG, 2014, CYSTIC FIBROSIS LUNG; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Westcott SL, 2015, PEERJ, V3, DOI 10.7717/peerj.1487; Whelan FJ, 2015, ANN AM THORAC SOC, V12, pS207, DOI 10.1513/AnnalsATS.201506-353AW; Whelan Fiona J, 2014, Ann Am Thorac Soc, V11, P513, DOI 10.1513/AnnalsATS.201310-351OC; Xia LC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S15; Ye Y, 2011, P IEEE INT C BIOINFO, V2010, P153, DOI DOI 10.1109/BIBM.2010.5706555; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	50	47	47	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172811	10.1371/journal.pone.0172811	http://dx.doi.org/10.1371/journal.pone.0172811			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253277	Green Published, gold, Green Submitted			2022-12-26	WOS:000396011300038
J	Ramke, J; Gilbert, CE; Lee, AC; Ackland, P; Limburg, H; Foster, A				Ramke, Jacqueline; Gilbert, Clare E.; Lee, Arier C.; Ackland, Peter; Limburg, Hans; Foster, Allen			Effective cataract surgical coverage: An indicator for measuring quality-of-care in the context of Universal Health Coverage	PLOS ONE			English	Article							VISUAL-IMPAIRMENT; SURGERY; BLINDNESS; PREVALENCE; OUTCOMES; KENYA; PEEK	Objective To define and demonstrate effective cataract surgical coverage (eCSC), a candidate UHC indicator that combines a coverage measure (cataract surgical coverage, CSC) with quality (post-operative visual outcome). Methods All Rapid Assessment of Avoidable Blindness (RAAB) surveys with datasets on the online RAAB Repository on April 1 2016 were downloaded. The most recent study from each country was included. By country, cataract surgical outcome (CSOGood, 6/18 or better; CSOPoor, worse than 6/60), CSC (operated cataract as a proportion of operable plus operated cataract) and eCSC (operated cataract and a good outcome as a proportion of operable plus operated cataract) were calculated. The association between CSC and CSO was assessed by linear regression. Gender inequality in CSC and eCSC was calculated. Findings Datasets from 20 countries were included (2005-2013; 67,337 participants; 5,474 cataract surgeries). Median CSC was 53.7% (inter-quartile range[IQR] 46.1-66.6%), CSOGood was 58.9% (IQR 53.7-67.6%) and CSOPoor was 17.7% (IQR 11.3-21.1%). Coverage and quality of cataract surgery were moderately associated-every 1% CSC increase was associated with a 0.46% CSOGood increase and 0.28% CSOPoor decrease. Median eCSC was 36.7% (IQR 30.2-50.6%), approximately one-third lower than the median CSC. Women tended to fare worse than men, and gender inequality was slightly higher for eCSC (4.6% IQR 0.5-7.1%) than for CSC (median 2.3% IQR -1.5-11.6%). Conclusion eCSC allows monitoring of quality in conjunction with coverage of cataract surgery. In the surveys analysed, on average 36.7% of people who could benefit from cataract surgery had undergone surgery and obtained a good visual outcome.	[Ramke, Jacqueline] Univ New South Wales, Sch Social Sci, Fac Arts & Social Sci, Sydney, NSW, Australia; [Ramke, Jacqueline; Lee, Arier C.] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand; [Gilbert, Clare E.; Foster, Allen] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London, England; [Ackland, Peter] Int Agcy Prevent Blindness, London, England; [Limburg, Hans] Hlth Informat Serv, Nijenburg 32, Grootebroek, Netherlands	University of New South Wales Sydney; University of Auckland; University of London; London School of Hygiene & Tropical Medicine	Ramke, J (corresponding author), Univ New South Wales, Sch Social Sci, Fac Arts & Social Sci, Sydney, NSW, Australia.; Ramke, J (corresponding author), Univ Auckland, Sch Populat Hlth, Auckland, New Zealand.	jramke@gmail.com	Ramke, Jacqueline/I-8844-2019	Ramke, Jacqueline/0000-0002-5764-1306; Foster, Allen/0000-0003-2368-4436				Ahmad K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131774; Bastawrous A, 2015, JAMA OPHTHALMOL, V133, P930, DOI 10.1001/jamaophthalmol.2015.1468; Boerma T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001728; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Bryce J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001423; Campbell J, 2013, B WORLD HEALTH ORGAN, V91, P853, DOI 10.2471/BLT.13.118729; Cockburn N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030718; Congdon N, 2016, LANCET GLOB HEALTH, V4, pE96, DOI 10.1016/S2214-109X(15)00267-3; Danquah L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094140; Dineen B, 2006, OPHTHAL EPIDEMIOL, V13, P31, DOI 10.1080/09286580500473787; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; DONABEDIAN A, 1990, ARCH PATHOL LAB MED, V114, P1115; Duerksen R, 2013, OPHTHAL EPIDEMIOL, V20, P301, DOI 10.3109/09286586.2013.821497; Essue BM, 2014, OPHTHALMOLOGY, V121, P2138, DOI 10.1016/j.ophtha.2014.05.014; Finger RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044268; Grimes CE, 2014, WORLD J SURG, V38, P252, DOI 10.1007/s00268-013-2243-y; He W., 2016, AN AGING WORLD 2015; Health Information Services, RAAB REPOSITORY 2014; Henry JA, 2015, WORLD J SURG, V39, P822, DOI 10.1007/s00268-014-2937-9; Hodgins S, 2014, GLOB HEALTH-SCI PRAC, V2, P173, DOI 10.9745/GHSP-D-13-00176; Hogan D, 2016, DEV INDEX COVERAGE E; Hosseinpoor AR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001727; Kuper Hannah, 2006, Community Eye Health, V19, P68; Lewallen S, 2009, BRIT J OPHTHALMOL, V93, P295, DOI 10.1136/bjo.2008.140301; Limburg H, 1998, Community Eye Health, V11, P3; Limburg H, 2005, BRIT J OPHTHALMOL, V89, P50, DOI 10.1136/bjo.2004.045369; Limburg H, 2005, BRIT J OPHTHALMOL, V89, P45, DOI 10.1136/bjo.2004.045351; Lodhia V, 2016, JMIR MHEALTH UHEALTH, V4, P72, DOI 10.2196/mhealth.4746; Mathenge W, 2012, OPHTHALMOLOGY, V119, P2033, DOI 10.1016/j.ophtha.2012.04.019; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Mock CN, 2015, LANCET, V385, P2209, DOI 10.1016/S0140-6736(15)60091-5; Ng M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001730; Riaz Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001323.pub2; World Health Organization, 2015, TRACK UN HLTH COV 1; World Health Organization, 2016, WHAT IS UN COV; World Health Organization, 2014, FINAL REPORT OF THE; World Health Organization, 2001, BACKGR PAP TECHN CON; World Health Organization, 1988, GUID HLTH HOUS; World Health Organization, 2013, UN EYE HLTH GLOB ACT; World Health Organization & World Bank, 2013, MON PROGR UN HLTH CO; Yorston D, 2002, BRIT J OPHTHALMOL, V86, P543, DOI 10.1136/bjo.86.5.543	41	52	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172342	10.1371/journal.pone.0172342	http://dx.doi.org/10.1371/journal.pone.0172342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249047	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000395983500038
J	Hu, HY; Yan, HJ; Liu, XY; Xu, XQ; Xu, JS; Qiu, T; Shi, LE; Fu, GF; Huan, XP; McFarland, W; Wei, CY				Hu, Haiyang; Yan, Hongjing; Liu, Xiaoyan; Xu, Xiaoqin; Xu, Jinshui; Qiu, Tao; Shi, Ling-en; Fu, Gengfeng; Huan, Xiping; McFarland, Willi; Wei, Chongyi			Trends in late HIV diagnosis among men who have sex with men in Jiangsu province, China: Results from four consecutive community-based surveys, 2011-2014	PLOS ONE			English	Article							PREVALENCE; INFECTION; SYPHILIS; PREVENTION; SAMPLES; ONLINE; MSM	Objectives To examine trends in HIV testing, late HIV diagnosis and associated factors among men who have sex with men (MSM) in Jiangsu province, China. Methods Four consecutive community-based cross-sectional surveys were conducted among MSM from 2011 to 2014 in eight cities in the province. Participants were recruited from MSM venues and via the internet. HIV bio-behavioral surveys were conducted to collect demographic and behavioral data and measure HIV infection. HIV-infected participants with CD4 counts less than 350 cells/uL were defined as having a late HIV diagnosis. Chi-square trend tests were used to compare temporal changes over the years and multivariable logistic regression analyses were used to identify factors associated with late diagnosis. Results A total of 2,441, 2,677, 2,591 and 2,610 participants were enrolled in 2011, 2012, 2013 and 2014, respectively. Testing for HIV in the last 12 months decreased over the time period, from 59.9% to 52.5% (p< 0.001). Late HIV diagnosis remained high and steady, ranging from 33.3% to 44.2% over the years with no significant change over time (p = 0.418). MSM who were older than 24 years (aOR = 1.748, p = 0.020 for 25-39 years old; aOR = 3.148, p< 0.001 for 40 years old or older), were recruited via internet (aOR = 1.596, p = 0.024), and did not have an HIV test in the past 12 months (aOR = 3.385, p< 0.001) were more likely to be late diagnosed. Conclusions Our study showed a plateau in HIV testing among MSM in China, in parallel to high levels of late diagnosis. Emerging and innovative strategies such as HIV self-testing and reaching more MSM by internet, both highly acceptable to MSM in China, may reduce late diagnosis.	[Hu, Haiyang; Yan, Hongjing; Liu, Xiaoyan; Xu, Xiaoqin; Xu, Jinshui; Qiu, Tao; Shi, Ling-en; Fu, Gengfeng; Huan, Xiping] Jiangsu Prov Ctr Dis Control & Prevent, Inst HIV AIDS STI Prevent & Control, Nanjing, Jiangsu, Peoples R China; [McFarland, Willi; Wei, Chongyi] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [McFarland, Willi; Wei, Chongyi] Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA; [McFarland, Willi] San Francisco Dept Publ Hlth, San Francisco, CA USA	Jiangsu Provincial Center for Disease Control & Prevention; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco Department of Public Health	Wei, CY (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.; Wei, CY (corresponding author), Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA.	Chongyi.Wei@ucsf.edu			Preventive Medicine Program of Jiangsu Provincial Health Department [Y2013051]; Jiangsu Department of Health [H201330]; National Natural Science Foundation of China [81373125]; University of California, San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS) - U.S. NIMH [R25MH064712]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH064712, P30MH062246] Funding Source: NIH RePORTER	Preventive Medicine Program of Jiangsu Provincial Health Department; Jiangsu Department of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of California, San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS) - U.S. NIMH; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Preventive Medicine Program of Jiangsu Provincial Health Department (Grant No. Y2013051), Jiangsu Department of Health (Grant No. H201330), and the National Natural Science Foundation of China (Grant No. 81373125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to acknowledge the support from the University of California, San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS) funded by a grant from the U.S. NIMH (grant number: R25MH064712).	Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Chinese Center for Disease Control and Prevention, 2011, OP MAN NAT AIDS SENT; Choi KH, 2006, AIDS EDUC PREV, V18, P33, DOI 10.1521/aeap.2006.18.1.33; Chow EPF, 2012, HIV MED, V13, P255, DOI 10.1111/j.1468-1293.2011.00974.x; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dai SY, 2015, J MED VIROL, V87, P970, DOI 10.1002/jmv.24066; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Han L, 2014, JAIDS-J ACQ IMM DEF, V67, P216, DOI 10.1097/QAI.0000000000000278; Jiang HB, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001511; Lorente N, 2012, AIDS CARE, V24, P1039, DOI 10.1080/09540121.2012.668171; Mao YR, 2010, INT J EPIDEMIOL, V39, pII79, DOI 10.1093/ije/dyq213; Ministry of Health in People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2011, 2011 EST HIV AIDS EP; Ministry of Health of the People's Republic of China, 2012, 2012 CHIN AIDS RESP; Rou KM, 2010, INT J EPIDEMIOL, V39, pII38, DOI 10.1093/ije/dyq211; Shi LE, 2016, LGBT HEALTH, V3, P238, DOI 10.1089/lgbt.2014.0129; Tang HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096098; Wang KL, 2012, INT J EPIDEMIOL, V41, P423, DOI 10.1093/ije/dyr182; Wang Xue-Qing, 2008, BMC Biochemistry, V9, P30, DOI 10.1186/1471-2091-9-30; Wei CY, 2014, AIDS CARE, V26, P372, DOI 10.1080/09540121.2013.824538; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Yan HJ, 2015, AIDS BEHAV, V19, P485, DOI 10.1007/s10461-014-0968-8; Yang HT, 2014, CLIN INFECT DIS, V58, P1753, DOI 10.1093/cid/ciu175; Zeng G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/602719; Zhang DP, 2008, AIDS CARE, V20, P1128, DOI 10.1080/09540120701842829; Zou HC, 2012, AIDS BEHAV, V16, P1717, DOI 10.1007/s10461-012-0225-y	25	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172664	10.1371/journal.pone.0172664	http://dx.doi.org/10.1371/journal.pone.0172664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278195	gold, Green Published			2022-12-26	WOS:000396087900126
J	Eberlein, T; Wohlrab, S; Rost, B; John, U; Bach, LT; Riebesell, U; van de Waal, DB				Eberlein, Tim; Wohlrab, Sylke; Rost, Bjoern; John, Uwe; Bach, Lennart T.; Riebesell, Ulf; Van de Waal, Dedmer B.			Effects of ocean acidification on primary production in a coastal North Sea phytoplankton community	PLOS ONE			English	Article							INORGANIC CARBON ACQUISITION; CONCENTRATING MECHANISMS; MARINE-PHYTOPLANKTON; CO2 CONCENTRATION; TECHNICAL NOTE; USE EFFICIENCY; ELEVATED CO2; DIATOM; GROWTH; BLOOM	We studied the effect of ocean acidification (OA) on a coastal North Sea plankton community in a long-term mesocosm CO2-enrichment experiment (BIOACID II long-term mesocosm study). From March to July 2013, 10 mesocosms of 19 m length with a volume of 47.5 to 55.9 m(-3) were deployed in the Gullmar Fjord, Sweden. CO2 concentrations were enriched in five mesocosms to reach average CO2 partial pressures (pCO(2)) of 760 mu atm. The remaining five mesocosms were used as control at ambient pCO(2) of 380 mu atm. Our paper is part of a PLOS collection on this long-term mesocosm experiment. Here, we here tested the effect of OA on total primary production (PPT) by performing C-14-based bottle incubations for 24 h. Furthermore, photoacclimation was assessed by conducting C-14-based hotosynthesis-irradiance response (P/I) curves. Changes in chlorophyll a concentrations over time were reflected in the development of PPT, and showed higher phytoplankton biomass build-up under OA. We observed two subsequent phytoplankton blooms in all mesocosms, with peaks in PPT around day 33 and day 56. OA had no significant effect on PPT, except for a marginal increase during the second phytoplankton bloom when inorganic nutrients were already depleted. Maximum light use efficiencies and light saturation indices calculated from the P/I curves changed simultaneously in all mesocosms, and suggest that OA did not alter phytoplankton photoacclimation. Despite large variability in time-integrated productivity estimates among replicates, our overall results indicate that coastal phytoplankton communities can be affected by OA at certain times of the seasonal succession with potential consequences for ecosystem functioning.	[Eberlein, Tim; Wohlrab, Sylke; Rost, Bjoern; John, Uwe; Van de Waal, Dedmer B.] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Handelshafen 12, Bremerhaven, Germany; [John, Uwe] Helmholtz Inst Funct Marine Biodivers Oldenburg H, Carl von Ossietzky Str, Oldenburg, Germany; [Bach, Lennart T.; Riebesell, Ulf] GEOMAR Helmholtz Ctr Ocean Res Kiel, Dusternbrooker Weg 20, Kiel, Germany; [Van de Waal, Dedmer B.] NIOO KNAW, Netherlands Inst Ecol, Wageningen, Netherlands	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Eberlein, T (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Handelshafen 12, Bremerhaven, Germany.	tim.eberlein@rub.de	Riebesell, Ulf/AAC-9717-2020; Rost, Bjoern/B-4447-2015; Van de Waal, Dedmer B/B-8002-2012; KNAW, NIOO-KNAW/A-4320-2012	Rost, Bjoern/0000-0001-5452-5505; Van de Waal, Dedmer B/0000-0001-8803-1247; KNAW, NIOO-KNAW/0000-0002-3835-159X; Bach, Lennart/0000-0003-0202-3671; Wohlrab, Sylke/0000-0003-3190-0880; Riebesell, Ulf/0000-0002-9442-452X	German Federal Ministry of Science and Education (BMBF) [FKZ 03F0655A]; EU [227799]; Royal Swedish Academy of Sciences	German Federal Ministry of Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Royal Swedish Academy of Sciences	This project was funded by the German Federal Ministry of Science and Education (BMBF) in the framework of the BIOACID II project (grant no. FKZ 03F0655A). SW, TE and DBvdW received support from the EU FP7 research infrastructure initiative 'Association of European Marine Biological Laboratories' (ASSEMBLE (grant no. 227799), and SW from the Royal Swedish Academy of Sciences.r We thank the Sven Loven Centre for Marine Sciences, Kristineberg, for their hospitality and help during the field work. We thank Amy Forsberg-Grivogiannis for her great help during the field work. We also gratefully acknowledge the captain and crew of RV ALKOR for their work transporting, deploying and recovering the mesocosms during cruises AL406 and AL420. This project was funded by the German Federal Ministry of Science and Education (BMBF) in the framework of the BIOACID II project (grant no. FKZ 03F0655A). SW, TE and DBvdW received support from the EU FP7 research infrastructure initiative 'Association of European Marine Biological Laboratories' (ASSEMBLE (grant no. 227799), and SW from the Royal Swedish Academy of Sciences.	Bach LT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159068; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; BENDER M, 1987, LIMNOL OCEANOGR, V32, P1085, DOI 10.4319/lo.1987.32.5.1085; Boxhammer T, 2016, BIOGEOSCIENCES, V13, P2849, DOI 10.5194/bg-13-2849-2016; Brading P, 2013, NEW PHYTOL, V200, P432, DOI 10.1111/nph.12379; Burkhardt S, 1999, LIMNOL OCEANOGR, V44, P683, DOI 10.4319/lo.1999.44.3.0683; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Eberlein T, 2016, MAR ECOL PROG SER, V543, P127, DOI 10.3354/meps11568; Egge JK, 2009, BIOGEOSCIENCES, V6, P877, DOI 10.5194/bg-6-877-2009; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Engel A, 2013, BIOGEOSCIENCES, V10, P1291, DOI 10.5194/bg-10-1291-2013; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Hopkinson BM, 2010, LIMNOL OCEANOGR, V55, P2011, DOI 10.4319/lo.2010.55.5.2011; Hoppe CJM, 2015, NEW PHYTOL, V207, P159, DOI 10.1111/nph.13334; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; Kranz SA, 2009, LIMNOL OCEANOGR, V54, P548, DOI 10.4319/lo.2009.54.2.0548; Lindahl O, 1998, ICES J MAR SCI, V55, P723, DOI 10.1006/jmsc.1998.0379; Lindahl O, 1995, ECOLOGY OF FJORDS AND COASTAL WATERS, P105; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Paul AJ, 2015, BIOGEOSCIENCES, V12, P6181, DOI 10.5194/bg-12-6181-2015; RAVEN JA, 1991, PLANT CELL ENVIRON, V14, P779, DOI 10.1111/j.1365-3040.1991.tb01442.x; Raven JA, 1997, ADV BOT RES, V27, P85; Raven JA, 2014, PHOTOSYNTH RES, V121, P111, DOI 10.1007/s11120-013-9962-7; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Riebesell U, 2013, BIOGEOSCIENCES, V10, P1835, DOI 10.5194/bg-10-1835-2013; Riebesell U., 2011, OCEAN ACIDIFICATION, P99, DOI [10.1093/oso/9780199591091.003.0011, DOI 10.1093/OSO/9780199591091.003.0011]; Rost B, 2008, MAR ECOL PROG SER, V373, P227, DOI 10.3354/meps07776; Roy T, 2011, J CLIMATE, V24, P2300, DOI 10.1175/2010JCLI3787.1; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sala MM, 2016, ICES J MAR SCI, V73, P670, DOI 10.1093/icesjms/fsv130; Schaum E, 2013, NAT CLIM CHANGE, V3, P298, DOI 10.1038/NCLIMATE1774; Steemann-Nielsen E, 1952, J CONS CONS PERM INT, V18, P117, DOI DOI 10.1093/ICESJMS/18.2.117; Stocker T F, 2013, CLIM CHANG 2013 PHYS; Tiselius P, 1996, J PLANKTON RES, V18, P133, DOI 10.1093/plankt/18.2.133; Trimborn S, 2008, PHYSIOL PLANTARUM, V133, P92, DOI 10.1111/j.1399-3054.2007.01038.x; Waite AM, 2006, MAR ECOL PROG SER, V326, P77, DOI 10.3354/meps326077; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Wu Y, 2010, BIOGEOSCIENCES, V7, P2915, DOI 10.5194/bg-7-2915-2010; Young JN, 2016, J EXP BOT	40	22	22	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172594	10.1371/journal.pone.0172594	http://dx.doi.org/10.1371/journal.pone.0172594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273107	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000396073700080
J	Liu, JJW; Vickers, K; Reed, M; Hadad, M				Liu, Jenny J. W.; Vickers, Kristin; Reed, Maureen; Hadad, Marilyn			Re-conceptualizing stress: Shifting views on the consequences of stress and its effects on stress reactivity	PLOS ONE			English	Article							35-PERCENT CARBON-DIOXIDE; PHYSIOLOGICAL-RESPONSES; REAPPRAISING AROUSAL; ASSOCIATION; INTEGRATION; MATTER	Background The consequences of stress are typically regarded from a deficit-oriented approach, conceptualizing stress to be entirely negative in its outcomes. This approach is unbalanced, and may further hinder individuals from engaging in adaptive coping. In the current study, we explored whether negative views and beliefs regarding stress interacted with a stress framing manipulation (positive, neutral and negative) on measures of stress reactivity for both psychosocial and physiological stressors. Method Ninety participants were randomized into one of three framing conditions that conceptualized the experience of stress in balanced, unbalanced-negative or unbalanced-positive ways. After watching a video on stress, participants underwent a psychosocial (Trier Social Stress Test), or a physiological (CO2 challenge) method of stress-induction. Subjective and objective markers of stress were assessed. Results Most of the sampled population regarded stress as negative prior to framing. Further, subjective and objective reactivity were greater to the TSST compared to the CO2 challenge. Additionally, significant cubic trends were observed in the interactions of stress framing and stress-induction methodologies on heart rate and blood pressure. Balanced framing conditions in the TSST group had a significantly larger decrease in heart rate and diastolic blood pressure following stress compared to the positive and negative framing conditions. Conclusion Findings confirmed a deficit-orientation of stress within the sampled population. In addition, results highlighted the relative efficacy of the TSST compared to CO2 as a method of stress provocation. Finally, individuals in framing conditions that posited stress outcomes in unbalanced manners responded to stressors less efficiently. This suggests that unbalanced framing of stress may have set forth unrealistic expectations regarding stress that later hindered individuals from adaptive responses to stress. Potential benefits of alternative conceptualizations of stress on stress reactivity are discussed, and suggestions for future research are made.	[Liu, Jenny J. W.; Vickers, Kristin; Reed, Maureen; Hadad, Marilyn] Ryerson Univ, Dept Psychol, Toronto, ON, Canada	Toronto Metropolitan University	Vickers, K (corresponding author), Ryerson Univ, Dept Psychol, Toronto, ON, Canada.	kvickers@psych.ryerson.ca			Joseph-Armand Bombardier Canada Graduate Scholarships Program Master's Scholarships from Social Sciences and Humanities Research Council of Canada	Joseph-Armand Bombardier Canada Graduate Scholarships Program Master's Scholarships from Social Sciences and Humanities Research Council of Canada	This research was supported by the Joseph-Armand Bombardier Canada Graduate Scholarships Program Master's Scholarships from Social Sciences and Humanities Research Council of Canada ($17500 - http.//www.sshrc-crsh.gc.ca/funding-firiancement/programs-programmes/fellottishipstcgs_masters-besc_maitrisetenlaspx).	Beltzer ML, 2014, EMOTION, V14, P761, DOI 10.1037/a0036326; Cohen GL, 2006, SCIENCE, V313, P1307, DOI 10.1126/science.1128317; Cohen J.E., 1988, STAT POWER ANAL BEHA; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Gruber J, 2011, CURR DIR PSYCHOL SCI, V20, P217, DOI 10.1177/0963721411414632; Harrington R., 2013, STRESS HLTH WELL BEI; Jamieson JP, 2013, CLIN PSYCHOL SCI, V1, P363, DOI 10.1177/2167702613482119; Jamieson JP, 2012, J EXP PSYCHOL GEN, V141, P417, DOI 10.1037/a0025719; Jamieson JP, 2010, J EXP SOC PSYCHOL, V46, P208, DOI 10.1016/j.jesp.2009.08.015; Kaye J, 2004, J NEUROENDOCRINOL, V16, P256, DOI 10.1111/j.0953-8194.2004.01158.x; Keller A, 2012, HEALTH PSYCHOL, V31, P677, DOI 10.1037/a0026743; Kelly MM, 2008, J BEHAV THER EXP PSY, V39, P87, DOI 10.1016/j.jbtep.2007.02.003; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Lazarus R. S., 1984, STRESS APPRAISAL COP; Liu JJW, 2015, ADV PSYCHOL RES, P125; Lupien S., 2012, WELL STRESSED MANAGE; Michie S, 2002, OCCUP ENVIRON MED, V59, P67, DOI 10.1136/oem.59.1.67; Nelson DL, 2004, BEHAV RES METH INS C, V36, P402, DOI 10.3758/BF03195588; Schmidt NB, 2007, J ANXIETY DISORD, V21, P302, DOI 10.1016/j.janxdis.2006.06.002; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; Skoluda N, 2015, PSYCHONEUROENDOCRINO, V51, P227, DOI 10.1016/j.psyneuen.2014.10.002; Stratakis CA, 1995, ANN NY ACAD SCI, V771, P1, DOI 10.1111/j.1749-6632.1995.tb44666.x; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Telch MJ, 2011, J ANXIETY DISORD, V25, P645, DOI 10.1016/j.janxdis.2011.02.005; van Duinen MA, 2005, J PSYCHOPHARMACOL, V19, P243, DOI 10.1177/0269881105051527; Vickers K, 2012, CLIN PSYCHOL REV, V32, P153, DOI 10.1016/j.cpr.2011.12.004; Wetherell MA, 2006, PSYCHONEUROENDOCRINO, V31, P736, DOI 10.1016/j.psyneuen.2006.02.005; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405; Wolkowitz O. M., 2003, PSYCHONEUROENDOCRINO; Woznica A, 2015, PSYCHIAT RES, V228, P571, DOI 10.1016/j.psychres.2015.05.050	31	18	18	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173188	10.1371/journal.pone.0173188	http://dx.doi.org/10.1371/journal.pone.0173188			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273132	Green Published, Green Submitted, gold			2022-12-26	WOS:000396073700044
J	Wade, MJ; Oakley, J; Harbisher, S; Parker, NG; Dolfing, J				Wade, Matthew J.; Oakley, Jordan; Harbisher, Sophie; Parker, Nicholas G.; Dolfing, Jan			MI-Sim: A MATLAB package for the numerical analysis of microbial ecological interactions	PLOS ONE			English	Article							ANAEROBIC-DIGESTION; MATHEMATICAL-MODEL; CHEMOSTAT; BIFURCATION; STABILITY	Food-webs and other classes of ecological network motifs, are a means of describing feeding relationships between consumers and producers in an ecosystem. They have application across scales where they differ only in the underlying characteristics of the organisms and substrates describing the system. Mathematical modelling, using mechanistic approaches to describe the dynamic behaviour and properties of the system through sets of ordinary differential equations, has been used extensively in ecology. Models allow simulation of the dynamics of the various motifs and their numerical analysis provides a greater understanding of the interplay between the system components and their intrinsic properties. We have developed the MI-Sim software for use with MATLAB to allow a rigorous and rapid numerical analysis of several common ecological motifs. MI-Sim contains a series of the most commonly used motifs such as cooperation, competition and predation. It does not require detailed knowledge of mathematical analytical techniques and is offered as a single graphical user interface containing all input and output options. The tools available in the current version of MI-Sim include model simulation, steady-state existence and stability analysis, and basin of attraction analysis. The software includes seven ecological interaction motifs and seven growth function models. Unlike other system analysis tools, MI-Sim is designed as a simple and user-friendly tool specific to ecological population type models, allowing for rapid assessment of their dynamical and behavioural properties.	[Wade, Matthew J.; Dolfing, Jan] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Oakley, Jordan; Harbisher, Sophie; Parker, Nicholas G.] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Wade, MJ (corresponding author), Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	matthew.wade@ncl.ac.uk	Parker, Nicholas G/E-4753-2011; Dolfing, Jan/B-8641-2015; Wade, Matthew John/Q-3951-2018	Parker, Nicholas G/0000-0002-7238-8492; Dolfing, Jan/0000-0002-7220-530X; Wade, Matthew John/0000-0001-9824-7121	Biotechnology and Biological Sciences Research Council UK [BB/K003240/2]; Institute of Sustainability, Newcastle University; Biotechnology and Biological Sciences Research Council [BB/K003240/2] Funding Source: researchfish; BBSRC [BB/K003240/2] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute of Sustainability, Newcastle University; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MJW and JD acknowledge the Biotechnology and Biological Sciences Research Council UK (BB/K003240/2 Engineering synthetic microbial communities for biomethane production) for funding the project (www.bbsrc.ac.uk/). MJW, JO and SH developed the software with funding provided by the Institute of Sustainability, Newcastle University (http//www.ncl.ac.uk/sustainabily/).; This work was funded by the Biotechnology and Biological Sciences Research Council UK (BB/K003240/2 Engineering synthetic microbial communities for biomethane production) and by the Institute of Sustainability, Newcastle University. The authors would like to thank George Stagg at Newcastle University for his help in setting-up the github repository.	Amend JP, 2001, FEMS MICROBIOL REV, V25, P175, DOI 10.1016/S0168-6445(00)00062-0; ARIS R, 1977, BIOTECHNOL BIOENG, V19, P1375, DOI 10.1002/bit.260190910; Arnalcios M, 2015, WATER RES, V70, P458, DOI 10.1016/j.watres.2014.11.046; Bascompte J, 2005, ECOLOGY, V86, P2868, DOI 10.1890/05-0101; Batstone DJ, 2002, WATER SCI TECHNOL, V45, P65; Bungay H R 3rd, 1968, Adv Appl Microbiol, V10, P269, DOI 10.1016/S0065-2164(08)70194-1; BUTLER GJ, 1983, J MATH BIOL, V17, P133, DOI 10.1007/BF00305755; Clewley R H, 2007, PYDSTOOL SOFTWARE EN; Dhooge A, 2003, ACM T MATH SOFTWARE, V29, P141, DOI 10.1145/779359.779362; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Escalante AE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00143; Fassoni AC, 2014, ECOL COMPLEX, V18, P39, DOI 10.1016/j.ecocom.2013.12.004; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Flamholz A, 2013, P NATL ACAD SCI USA, V110, P10039, DOI 10.1073/pnas.1215283110; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; GILPIN ME, 1972, SCIENCE, V177, P902, DOI 10.1126/science.177.4052.902; Gonzalez-Cabaleiro R, 2013, ENERG ENVIRON SCI, V6, P3780, DOI 10.1039/c3ee42754d; Govorukhin VN, 2004, MATLAB BASED VERSION; Grosskopf T, 2016, ISME J, V10, P2725, DOI 10.1038/ismej.2016.49; Grosskopf T, 2014, CURR OPIN MICROBIOL, V18, P72, DOI 10.1016/j.mib.2014.02.002; Harry Dankowicz., 2013, RECIPES CONTINUATION, DOI 10.1137/1.9781611972573; Hellweger FL, 2016, NAT REV MICROBIOL, V14, P461, DOI 10.1038/nrmicro.2016.62; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; KREIKENBOHM R, 1986, FEMS MICROBIOL ECOL, V38, P131, DOI 10.1016/0378-1097(86)90044-3; LAUWERIER H A, 1986, IMA Journal of Mathematics Applied in Medicine and Biology, V3, P191; Levy R, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0588-y; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Rodriguez J, 2008, TRENDS BIOTECHNOL, V26, P366, DOI 10.1016/j.tibtech.2008.04.003; Sivaprakash B, 2011, INT J COMP APPL, V3, P15; Song HS, 2014, PROCESSES, V2, P711, DOI 10.3390/pr2040711; Van Nes E, 2017, GRIND FOR MATLAB; Wade MJ, 2016, J THEOR BIOL, V389, P171, DOI 10.1016/j.jtbi.2015.10.032; Weedermann M, 2013, J BIOL DYNAM, V7, P59, DOI 10.1080/17513758.2012.755573; Xu AP, 2011, J THEOR BIOL, V276, P35, DOI 10.1016/j.jtbi.2011.01.026; Zomorrodi AR, 2016, J MOL BIOL, V428, P837, DOI 10.1016/j.jmb.2015.10.019	35	3	3	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173249	10.1371/journal.pone.0173249	http://dx.doi.org/10.1371/journal.pone.0173249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273164	Green Published, Green Submitted, gold			2022-12-26	WOS:000396073700048
J	Hu, ZZ; Zhu, FM; Zhang, N; Zhang, CX; Pei, GC; Wang, PG; Yang, J; Guo, YJ; Wang, M; Wang, YX; Yang, Q; Zhu, H; Liao, WH; Zhang, ZG; Yao, Y; Zeng, R; Xu, G				Hu, Zhizhi; Zhu, Fengmin; Zhang, Nan; Zhang, Chunxiu; Pei, Guangchang; Wang, Pengge; Yang, Juan; Guo, Yujiao; Wang, Meng; Wang, Yuxi; Yang, Qian; Zhu, Han; Liao, Wenhui; Zhang, Zhiguo; Yao, Ying; Zeng, Rui; Xu, Gang			Impact of arteriovenous fistula blood flow on serum il-6, cardiovascular events and death: An ambispective cohort analysis of 64 Chinese hemodialysis patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INTERLEUKIN-6 LEVELS; MICROINFLAMMATORY STATE; VASCULAR ACCESS; RENAL-DISEASE; MORTALITY; MALNUTRITION; PREDICTOR; INFLAMMATION; ALBUMIN	Flows (Qa) of arteriovenous fistula (AVF) impact the dialysis adequacy in hemodialysis (HD) patients. However, data for different access flow levels on outcomes related to long-term dialysis patients, especially in Chinese patients, are limited. Herein, we performed an ambispective, mono-centric cohort study investigating the association between the AVF flows and inflammation, cardiovascular events and deaths in Chinese hemodialysis patients bearing a radio-cephalic fistula (AVF) from 2009 to 2015. Twenty-three patients (35.9%) developed at least one episode of cardiovascular disease (CVD) in two years after AVF creation. AVF Qa, IL-6 and hsCRP were significantly higher in patients with CVD than in patients without CVD. Multi-factorial binary logistic regression analysis found that the independent and strongest risk factor for CVD in HD patients was serum IL-6, which showed a positive association with AVF Qa levels in patients. Therefore, the linkage between AVF Qa tertiles and adverse clinical outcomes (cardiovascular events and mortality) was examined over a median follow-up of five years. IL-6 was significantly increased in the high AVF Qa (>1027.13 ml/min) group. Patients with median AVF Qa showed the lowest morbidity and mortality of CVD according to the AVF Qa tertiles, whereas higher Qa was associated with a higher risk of CVD, and lower AVF Qa (600 ml/min <= AVF Qa <821.12 ml/min) had a higher risk of non-CVD death. Therefore, keeping the AVF Qa at an optimal level (821.12 to 1027.13 ml/min) would benefit HD patients, improve long-term clinical outcomes and lower AVF-induced inflammation.	[Hu, Zhizhi; Zhu, Fengmin; Zhang, Nan; Zhang, Chunxiu; Pei, Guangchang; Wang, Pengge; Yang, Juan; Guo, Yujiao; Wang, Meng; Wang, Yuxi; Yang, Qian; Zhu, Han; Yao, Ying; Zeng, Rui; Xu, Gang] Huazhong Univ Sci & Technol, Tongji Hosp, Div Nephrol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Zhang, Nan] Jining Med Univ, Affiliated Hosp, Dept Nephrol, Jining, Shandong, Peoples R China; [Liao, Wenhui] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Geriatr, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Zhang, Zhiguo] Huazhong Univ Sci & Technol, Sch Med & Hlth Management, Tongji Med Coll, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Jining Medical University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zeng, R; Xu, G (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Div Nephrol, Tongji Med Coll, Wuhan, Hubei, Peoples R China.	zengrui@tjh.tjmu.edu.cn; xugang@tjh.tjmu.edu.cn	Zeng, RUI/AAF-7238-2019; Yang, Juan/ABF-4433-2021; Zeng, Rui/GRY-0646-2022	Zeng, Rui/0000-0003-1188-3198	National Natural Science Foundation of China [81270770, 81470948, 81270771, 81370798, 81170686]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grants 81270770, 81470948, 81270771, 81370798 and 81170686).	[Anonymous], 2001, AMERICAN JOURNAL OF, V37, pS137; Basile C, 2008, NEPHROL DIAL TRANSPL, V23, P282, DOI 10.1093/ndt/gfm549; BATAILLE R, 1992, ARTHRITIS RHEUM-US, V35, P982, DOI 10.1002/art.1780350824; Begin V, 2002, AM J KIDNEY DIS, V40, P1277, DOI 10.1053/ajkd.2002.36898; Bode AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034491; BRESCIA MJ, 1966, NEW ENGL J MED, V275, P1089, DOI 10.1056/NEJM196611172752002; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Honda H, 2006, AM J KIDNEY DIS, V47, P139, DOI 10.1053/j.ajkd.2005.09.014; Hoshi T, 2005, STROKE, V36, P768, DOI 10.1161/01.STR.0000158915.28329.51; Hua Jincheng, 2015, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V27, P354, DOI 10.3760/cma.j.issn.2095-4352.2015.05.007; Kaizu Y, 1998, AM J KIDNEY DIS, V31, P93, DOI 10.1053/ajkd.1998.v31.pm9428458; Kaysen GA, 2001, J AM SOC NEPHROL, V12, P1549, DOI 10.1681/ASN.V1271549; Kobayashi S, 2003, BIOCHEM BIOPH RES CO, V308, P306, DOI 10.1016/S0006-291X(03)01362-7; Korsheed S, 2009, HEMODIAL INT, V13, P505, DOI 10.1111/j.1542-4758.2009.00384.x; Lameire N, 2012, NEPHROL DIAL TRANSPL, V27, P3758, DOI 10.1093/ndt/gfs275; Langer S, 2011, MAGN RESON IMAGING, V29, P57, DOI 10.1016/j.mri.2010.07.010; Memoli B, 2002, AM J KIDNEY DIS, V39, P266, DOI 10.1053/ajkd.2002.30545; Neyra NR, 1998, KIDNEY INT, V54, P1714, DOI 10.1046/j.1523-1755.1998.00145.x; Owen WF, 1998, KIDNEY INT, V54, P627, DOI 10.1046/j.1523-1755.1998.00032.x; Panichi V, 2004, NEPHROL DIAL TRANSPL, V19, P1154, DOI 10.1093/ndt/gfh052; Pecoits-Filho R, 2002, NEPHROL DIAL TRANSPL, V17, P1684, DOI 10.1093/ndt/17.9.1684; Qureshi AR, 2002, J AM SOC NEPHROL, V13, pS28; Rao M, 2005, AM J KIDNEY DIS, V45, P324, DOI 10.1053/j.ajkd.2004.09.018; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Schomig M, 2000, BLOOD PURIFICAT, V18, P327, DOI 10.1159/000014457; Stenvinkel P, 2002, AM J KIDNEY DIS, V39, P274, DOI 10.1053/ajkd.2002.30546; Wollert K C, 2001, Heart Fail Rev, V6, P95; Yao Q, 2004, ASAIO J, V50, pLII, DOI 10.1097/01.MAT.0000147958.87989.EB; Yun KA, 2004, SCAND J CLIN LAB INV, V64, P223, DOI 10.1080/00365510410005749	29	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0172490	10.1371/journal.pone.0172490	http://dx.doi.org/10.1371/journal.pone.0172490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267753	gold, Green Published, Green Submitted			2022-12-26	WOS:000396060600052
J	Paolin, A; Trojan, D; Petit, P; Coato, P; Rigoli, R				Paolin, Adolfo; Trojan, Diletta; Petit, Pieter; Coato, Paola; Rigoli, Roberto			Evaluation of allograft contamination and decontamination at the Treviso Tissue Bank Foundation: A retrospective study of 11,129 tissues	PLOS ONE			English	Article							HEART-VALVE; BONE; INFECTION; CULTURES; DONORS; STERILIZATION; PROCUREMENT; FROZEN	Microbiological contamination of retrieved tissues has become a very important topic and a critical aspect in the safety of allografts. We have analysed contamination in 11,129 tissues with a longitudinal contamination profile for each individual tissue. More specifically, 10,035 musculoskeletal tissues and 1,094 cardiovascular tissues were retrieved from a total of 763 multi-tissue donors, of whom 105 were heart-beating donors as well as organ donors, while the remaining 658 were non-heart beating donors and tissue donors only. All tissues were decontaminated twice, the first time immediately after retrieval and the second time after processing. Each tissue was submitted to microbiological culture three times, i.e., upon retrieval (Time 1), after the first decontamination (Time 2) and after the second decontamination (Time 3). The contamination rate for musculoskeletal tissues was 52%, 16.2% and 0.5% at Time 1, 2 and 3, respectively. The contamination rate for cardiovascular tissues was 84%, 42% and 6%. More than one strain was simultaneously present in 10.8% of musculoskeletal tissues and 44.6% of cardiovascular tissues. Out of 8,560 non-heart-beating donor musculoskeletal tissues, 4,689 (54.8%), 1,383 (16.2%) and 42 (0.5%) were contaminated at Time 1, Time 2 and Time 3, respectively. Out of 1,475 heart-beating donor musculoskeletal tissues, 522 (35.4%) 113 (7.7%) and 2 (0.1%) tissues were found to be contaminated at Time 1, 2 and 3, respectively. Out of 984 non-heart beating donor cardiovascular tissues, 869 (88.3%), 449 (45.6%) and 69 (7%) proved positive at Time 1, 2 and 3 respectively, while 50 (45.5%) and 10 (9.1%) heart-beating donor cardiovascular tissues were contaminated at Time 1 and 2. No tissue was contaminated at Time 3. Based on our methods, the two-step decontamination approach is mandatory in order to drastically reduce the number of tissues found to be positive at the end of the process.	[Paolin, Adolfo; Trojan, Diletta] Treviso Tissue Bank Fdn, Treviso, Italy; [Petit, Pieter] Fdn European Tissue Banks, Berlin, Germany; [Coato, Paola; Rigoli, Roberto] Reg Hosp, Dept Clin Pathol, Treviso, Italy		Paolin, A (corresponding author), Treviso Tissue Bank Fdn, Treviso, Italy.	apaolin@fbtv-treviso.org						BROCKBANK KGM, 1993, CRYOBIOLOGY, V30, P19, DOI 10.1006/cryo.1993.1003; Buzzi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112679; de By TMMH, 2012, HEART LUNG VESSEL, V4, P251; Deijkers RLM, 1997, J BONE JOINT SURG BR, V79B, P161, DOI 10.1302/0301-620X.79B1.7137; Eastlund T., 2004, ADV TISSUE BANKING, V7, P51, DOI DOI 10.1142/9789812796646_0003; Eastlund Ted, 2006, Cell and Tissue Banking, V7, P147, DOI 10.1007/s10561-006-0003-z; Fan YD, 2012, CELL TISSUE BANK, V13, P297, DOI 10.1007/s10561-011-9255-3; GALL K, 1995, J THORAC CARDIOV SUR, V110, P680, DOI 10.1016/S0022-5223(95)70099-4; Gatto C, 2013, CELL TISSUE BANK, V14, P107, DOI 10.1007/s10561-012-9305-5; Germain M, 2010, CELL TISSUE BANK, V11, P197, DOI 10.1007/s10561-009-9155-y; GOTTESDIENER KM, 1989, ANN INTERN MED, V110, P1001, DOI 10.7326/0003-4819-110-12-1001; Hamer AJ, 1996, J BONE JOINT SURG BR, V78B, P363, DOI 10.1302/0301-620X.78B3.0780363; Heng WL, 2013, J TRANSPLANT, V2013, DOI 10.1155/2013/163150; Ibrahim T, 2004, INT ORTHOP, V28, P315, DOI 10.1007/s00264-004-0579-5; Ireland Lyn, 2005, Cell and Tissue Banking, V6, P181, DOI 10.1007/s10561-005-7365-5; Jashari R., 2007, Cell and Tissue Banking, V8, P247, DOI 10.1007/s10561-007-9040-5; Johnson DL, 1998, ANN THORAC SURG, V66, pS221, DOI 10.1016/S0003-4975(98)01033-9; Lannau B, 2015, CELL TISSUE BANK, V16, P65, DOI 10.1007/s10561-014-9439-8; MARTINEZ OV, 1985, DIAGN MICR INFEC DIS, V3, P193, DOI 10.1016/0732-8893(85)90031-8; MUNTING E, 1988, ACTA ORTHOP SCAND, V59, P34, DOI 10.3109/17453678809149340; Steffen V, 2016, J THORAC CARDIOV SUR, V151, P1251, DOI 10.1016/j.jtcvs.2015.11.029; Tabaku M., 2004, Cell and Tissue Banking, V5, P261, DOI 10.1007/s10561-004-1440-1; TOMFORD WW, 1990, J BONE JOINT SURG AM, V72A, P1137, DOI 10.2106/00004623-199072080-00003; van Kats JP, 2010, EUR J CARDIO-THORAC, V37, P163, DOI 10.1016/j.ejcts.2009.07.011; VEEN MR, 1994, CLIN ORTHOP RELAT R, P259; Vehmeyer S, 2002, ACTA ORTHOP SCAND, V73, P678, DOI 10.3109/17453670209178036	26	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173154	10.1371/journal.pone.0173154	http://dx.doi.org/10.1371/journal.pone.0173154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267776	gold, Green Submitted, Green Published			2022-12-26	WOS:000396060600011
J	Gebhardt, MJ; Jacobson, RK; Shuman, HA				Gebhardt, Michael J.; Jacobson, Rachael K.; Shuman, Howard A.			Seeing red; the development of pON. mCherry, a broad-host range constitutive expression plasmid for Gram-negative bacteria	PLOS ONE			English	Article							INTRACELLULAR MULTIPLICATION; LEGIONELLA-PNEUMOPHILA; ESCHERICHIA-COLI; LAC REPRESSOR; VECTORS; PROMOTERS; TRAITS; SYSTEM; GROWTH	The development of plasmid-mediated gene expression control in bacteria revolutionized the field of bacteriology. Many of these expression control systems rely on the addition of small molecules, generally metabolites or non-metabolized analogs thereof, to the growth medium to induce expression of the genes of interest. The paradigmatic example of an expression control system is the lac system from Escherichia coli, which typically relies on the Ptac promoter and the Lac repressor, LacI. In many cases, however, constitutive gene expression is desired, and other experimental approaches require the coordinated control of multiple genes. While multiple systems have been developed for use in E. coli and its close relatives, the utility and/or functionality of these tools does not always translate to other species. For example, for the Gram-negative pathogen, Legionella pneumophila, a causative agent of Legionnaires' Disease, the aforementioned Ptac system represents the only well-established expression control system. In order to enhance the tools available to study bacterial gene expression in L. pneumophila, we developed a plasmid, pON. mCherry, which confers constitutive gene expression from a mutagenized LacI binding site. We demonstrate that pON. mCherry neither interferes with other plasmids harboring an intact LacI-Ptac expression system nor alters the growth of Legionella species during intracellular growth. Furthermore, the broad-host range plasmid backbone of pON. mCherry allows constitutive gene expression in a wide variety of Gram-negative bacterial species, making pON. mCherry a useful tool for the greater research community.	[Gebhardt, Michael J.; Jacobson, Rachael K.; Shuman, Howard A.] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University of Chicago	Gebhardt, MJ (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.	mgebhardt@uchicago.edu	Gebhardt, Michael/HHN-0863-2022	Gebhardt, Michael/0000-0002-1213-8408				Alli OAT, 2003, MICROBIOL-SGM, V149, P631, DOI 10.1099/mic.0.25980-0; Amaro F, 2015, ISME J, V9, P1607, DOI 10.1038/ismej.2014.248; BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; Bertram R, 2008, MICROB BIOTECHNOL, V1, P2, DOI 10.1111/j.1751-7915.2007.00001.x; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hervet E, 2011, INFECT IMMUN, V79, P1936, DOI 10.1128/IAI.00805-10; Hovel-Miner G, 2009, J BACTERIOL, V191, P2461, DOI 10.1128/JB.01578-08; Isenman HL, 2016, RESPIROLOGY, V21, P1292, DOI 10.1111/resp.12808; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kalodimos CG, 2002, EMBO J, V21, P2866, DOI 10.1093/emboj/cdf318; Khan SR, 2008, APPL ENVIRON MICROB, V74, P5053, DOI 10.1128/AEM.01098-08; Khodr A, 2016, INFECT GENET EVOL, V43, P108, DOI 10.1016/j.meegid.2016.04.033; Lessard JC, 2013, METHOD ENZYMOL, V533, P181, DOI 10.1016/B978-0-12-420067-8.00011-8; Lewis M, 2005, CR BIOL, V328, P521, DOI 10.1016/j.crvi.2005.04.004; Neumeister B, 2004, METH MOL B, V268, P141; PFAHL M, 1976, J BACTERIOL, V128, P257, DOI 10.1128/JB.128.1.257-263.1976; Shuman HA, 2003, NAT REV GENET, V4, P419, DOI 10.1038/nrg1087; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; Tiaden A, 2007, CELL MICROBIOL, V9, P2903, DOI 10.1111/j.1462-5822.2007.01005.x; Whiley H, 2011, EMERG INFECT DIS, V17, P579, DOI 10.3201/eid1704.100446	21	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173116	10.1371/journal.pone.0173116	http://dx.doi.org/10.1371/journal.pone.0173116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257493	gold, Green Submitted, Green Published			2022-12-26	WOS:000396021100058
J	Lavi, H; Assayag, M; Schwartz, A; Arish, N; Fridlender, ZG; Berkman, N				Lavi, Hadas; Assayag, Miri; Schwartz, Assaf; Arish, Nissim; Fridlender, Zvi G.; Berkman, Neville			The association between osteopontin gene polymorphisms, osteopontin expression and sarcoidosis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MULTIPLE-SCLEROSIS; RHEUMATOID-ARTHRITIS; SERUM OSTEOPONTIN; DISEASE; SUSCEPTIBILITY; RISK; PROGRESSION; POPULATION; GRANULOMAS	Background Sarcoidosis is a systemic inflammatory disease of unknown etiology. Osteopontin (SPP1, OPN) is an extra cellular matrix glycoprotein and cytokine with a known role in granuloma formation and in autoimmune and inflammatory diseases. Objective To determine whether plasma OPN levels are elevated in patients with sarcoidosis and compare the frequency of four single nucleotide polymorphism (SNPs) variants in the OPN gene in sarcoidosis patients compared to healthy controls. Methods Demographic and clinical information, radiological studies and pulmonary function tests were evaluated in 113 patients with sarcoidosis and in 79 healthy controls. Blood samples were analyzed for SNPs of the OPN gene and for plasma OPN and CRP levels. Association between clinical features of disease and OPN levels as well as SNP frequencies was determined. Results Plasma OPN levels were higher in sarcoidosis patients than in healthy subjects, (median: 217 vs 122ng/ml, p<0.001). Area under the curve for receiver operator curves (ROC) was 0.798 (0.686-0.909 95% CI.) No differences were observed between sarcoidosis patients and controls in the frequency of any of the SNPs evaluated. Presence of lung parenchymal involvement was associated with SNP distribution at rs1126772 (p = 0.02). We found no correlation between SNPs distribution and plasma OPN levels. Conclusions Osteopontin protein levels are elevated in sarcoidosis. We found no evidence for an association between SNPs on the osteopontin gene and plasma OPN levels or the presence of sarcoidosis, however, an association between genotype and several phenotypic clinical parameters of disease was observed.	[Lavi, Hadas; Assayag, Miri; Schwartz, Assaf; Arish, Nissim; Fridlender, Zvi G.; Berkman, Neville] Hebrew Univ Jerusalem, Inst Pulm Med, Hadassah Med Ctr, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Berkman, N (corresponding author), Hebrew Univ Jerusalem, Inst Pulm Med, Hadassah Med Ctr, Jerusalem, Israel.	Neville@hadassah.org.il						Akahoshi M, 2004, HUM GENET, V114, P503, DOI 10.1007/s00439-004-1099-5; Arjomandi M, 2011, PEDIAT ALLER IMM PUL, V24, P207, DOI 10.1089/ped.2011.0095; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Bandopadhyay M, 2014, EXPERT OPIN THER TAR, V18, P883, DOI 10.1517/14728222.2014.925447; Bargagli E, 2013, J CLIN IMMUNOL, V33, P264, DOI 10.1007/s10875-012-9754-4; Bons JA, 2007, RESP MED, V101, P1687, DOI 10.1016/j.rmed.2007.03.002; Carlson I, 1997, LAB INVEST, V77, P103; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chiocchetti A, 2005, J NEUROIMMUNOL, V163, P172, DOI 10.1016/j.jneuroim.2005.02.020; Chu ML, 2011, INVEST OPHTH VIS SCI, V52, P7084, DOI 10.1167/iovs.11-7539; Chu ML, 2011, HUM IMMUNOL, V72, P525, DOI 10.1016/j.humimm.2011.03.016; Comabella M, 2005, J NEUROIMMUNOL, V158, P231, DOI 10.1016/j.jneuroim.2004.09.004; CROSBY AH, 1995, GENOMICS, V27, P155, DOI 10.1006/geno.1995.1018; D'Alfonso S, 2005, ARTHRITIS RHEUM, V52, P539, DOI 10.1002/art.20808; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Dubaniewicz A, 2005, EUR J HUM GENET, V13, P829, DOI 10.1038/sj.ejhg.5201370; Feng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080150; Floe A, 2014, DAN MED J, V61; Fridlender ZG, 2010, RESP MED, V104, P1336, DOI 10.1016/j.rmed.2010.03.029; Glas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029309; Grunewald J, 2004, AM J RESP CRIT CARE, V169, P696, DOI 10.1164/rccm.200303-459OC; Hofmann S, 2008, NAT GENET, V40, P1103, DOI 10.1038/ng.198; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Karamizadeh Z, 2013, J ENDOCRINOL INVEST, V36, P1090, DOI 10.3275/9098; Kariuki SN, 2009, GENES IMMUN, V10, P487, DOI 10.1038/gene.2009.15; Koechl Silvano, 2005, V297, P13; Maeda K, 2001, LUNG, V179, P279, DOI 10.1007/s004080000068; Maver A, 2009, DIS MARKERS, V27, P295, DOI [10.1155/2009/864313, 10.3233/DMA-2009-0675]; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mishima R, 2007, J CLIN GASTROENTEROL, V41, P167, DOI 10.1097/MCG.0b013e31802d6268; Nau GJ, 1997, P NATL ACAD SCI USA, V94, P6414, DOI 10.1073/pnas.94.12.6414; NOWACK D, 1987, ARCH INTERN MED, V147, P481, DOI 10.1001/archinte.147.3.481; Ogbureke KUE, 2007, J HISTOCHEM CYTOCHEM, V55, P403, DOI 10.1369/jhc.6A7075.2007; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Petrow PK, 2000, ARTHRITIS RHEUM, V43, P1597, DOI 10.1002/1529-0131(200007)43:7<1597::AID-ANR25>3.0.CO;2-0; Rossman MD, 2003, AM J HUM GENET, V73, P720, DOI 10.1086/378097; Sato T, 2005, GUT, V54, P1254, DOI 10.1136/gut.2004.048298; Schurmann Manfred, 2003, Am J Pharmacogenomics, V3, P233; Spagnolo P, 2007, INVEST OPHTH VIS SCI, V48, P3019, DOI 10.1167/iovs.06-1485; Steinman L, 2009, NAT REV IMMUNOL, V9, P440, DOI 10.1038/nri2548; Su R, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-121; Typiak M, 2016, ADV EXP MED BIOL, V905, P57, DOI 10.1007/5584_2015_193; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Valeyre D, 2014, LANCET, V383, P1155, DOI 10.1016/S0140-6736(13)60680-7; Vogt MHJ, 2003, ANN NEUROL, V53, P819, DOI 10.1002/ana.10606; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Wong CK, 2005, RHEUMATOLOGY, V44, P602, DOI 10.1093/rheumatology/keh558; Yamamoto N, 2003, J CLIN INVEST, V112, P181, DOI 10.1172/JCI200317778; Yigla M, 2006, RESPIROLOGY, V11, P586, DOI 10.1111/j.1440-1843.2006.00891.x	51	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0171945	10.1371/journal.pone.0171945	http://dx.doi.org/10.1371/journal.pone.0171945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253271	gold, Green Published, Green Submitted			2022-12-26	WOS:000396011300009
J	Liu, Q; Ma, YH; Wang, JL; Zhu, XF; Yang, YJ; Mei, YF				Liu, Qian; Ma, Yanhong; Wang, Junlan; Zhu, Xuefang; Yang, Yanjing; Mei, Yufeng			Demineralized bone matrix used for direct pulp capping in rats	PLOS ONE			English	Article							MINERAL TRIOXIDE AGGREGATE; CALCIUM HYDROXIDE; MORPHOGENETIC PROTEIN-2; DENTAL-PULP; STEM-CELLS; DIFFERENTIATION; HYDROXYAPATITE; TISSUE	Objectives To evaluate the wound healing process following direct pulp capping with demineralized bone matrix (DBM) and calcium hydroxide (Ca(OH)(2)). Methods Fifty 8-weeks-old SPF Wistar male rats were divided into two groups: one was the DBM treated group, and the other was the Ca(OH)(2) treated group. Pulpotomy was performed on the maxillary first molar of one side of each rat, and the another side was left as the blank control. Rats were sacrificed after each observation period (1, 3, 7, 14 and 28 days) and specimen slices were made. Hematoxylin-Eosin (HE) staining was used for observing the changes of pulp tissue, and immunohistochemical staining was used for observing the expression of reparative dentinogenesis-related factors runt transcription factor 2 (Runx2), type I collagen (COL I), osteocalcin (OCN) and dentin sialoprotein (DSP). Results Inflammatory cell infiltration (ICI) and pulp tissue disorganization (PTD) could be observed in both the DBM and Ca(OH)(2) groups at all observation periods. The DBM group showed slighter ICI on 1 and 28 days and milder PTD on 28 days, with a significant difference (P<0.05). Reparative dentin formation (RDF) could initially be observed on 14 days postoperatively, and the DBM group showed more regular and thinner RDF with significant differences on 14 and 28 days compared with the Ca(OH)2 group (P<0.05). In both groups, the expression of Runx2, COL I, DSP and OCN were positive. Generally, the expression of these four factors in the DBM group was stronger than the Ca(OH)(2) group on the same observation periods. Conclusions DBM had the ability of inducing odontoblast differentiation and promoting dentinogenesis. DBM could initiate physiologic wound healing in pulp and had the ability to promote reparative dentin formation. Consequently, DBM may be an acceptable alternative for direct pulp capping.	[Liu, Qian; Wang, Junlan; Yang, Yanjing; Mei, Yufeng] Nanjing Med Univ, Key Lab Oral Dis Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Liu, Qian; Wang, Junlan; Yang, Yanjing; Mei, Yufeng] Nanjing Med Univ, Stomatol Sch, Nanjing, Jiangsu, Peoples R China; [Liu, Qian; Wang, Junlan; Yang, Yanjing; Mei, Yufeng] Nanjing Med Univ, Affiliated Stomatol Hosp, Dept Pediat & Prevent Dent, Nanjing, Jiangsu, Peoples R China; [Ma, Yanhong] Xuzhou Cent Hosp, Dept Stomatol, Xuzhou, Jiangsu, Peoples R China; [Zhu, Xuefang] Nanchang Univ, Affiliated Stomatol Hosp, Key Lab Oral Biomed, Nanchang, Jiangxi, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanchang University	Mei, YF (corresponding author), Nanjing Med Univ, Key Lab Oral Dis Jiangsu Prov, Nanjing, Jiangsu, Peoples R China.; Mei, YF (corresponding author), Nanjing Med Univ, Stomatol Sch, Nanjing, Jiangsu, Peoples R China.; Mei, YF (corresponding author), Nanjing Med Univ, Affiliated Stomatol Hosp, Dept Pediat & Prevent Dent, Nanjing, Jiangsu, Peoples R China.	yfmei@njmu.edu.cn	MA, YAN/HHN-2912-2022					BAUME LJ, 1981, INT DENT J, V31, P251; Bhatia M, 2007, ANN NY ACAD SCI, V1106, P219, DOI 10.1196/annals.1392.007; BOUVIER M, 1990, ARCH ORAL BIOL, V35, P301, DOI 10.1016/0003-9969(90)90047-E; Briso André Luiz Fraga, 2006, Braz. oral res., V20, P219, DOI 10.1590/S1806-83242006000300007; Camilleri S, 2006, EUR J ORAL SCI, V114, P361, DOI 10.1111/j.1600-0722.2006.00399.x; Chen B, 2007, J BIOMED MATER RES A, V80A, P428, DOI 10.1002/jbm.a.30900; Chen PY, 2010, NUTR RES, V30, P191, DOI 10.1016/j.nutres.2010.03.004; Costa CAD, 2001, DENT MATER, V17, P230; FOREMAN PC, 1990, INT ENDOD J, V23, P283, DOI 10.1111/j.1365-2591.1990.tb00108.x; Fransson H, 2011, INT ENDOD J, V44, P259, DOI 10.1111/j.1365-2591.2010.01824.x; Gaikwad J S, 2001, Adv Dent Res, V15, P19; Han NN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088890; Hilton TJ, 2009, OPER DENT, V34, P615, DOI 10.2341/09-132-0; Islam I, 2006, J ENDODONT, V32, P193, DOI 10.1016/j.joen.2005.10.043; Ito S, 2004, J BIOMED MATER RES A, V69A, P11, DOI 10.1002/jbm.a.20066; Iwata H, 2002, CLIN ORTHOP RELAT R, P99; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Liu X, 2001, Zhonghua Kou Qiang Yi Xue Za Zhi, V36, P448; Mondalek FG, 2008, BIOMATERIALS, V29, P1159, DOI 10.1016/j.biomaterials.2007.11.020; OWEN TA, 1990, P NATL ACAD SCI USA, V87, P9990, DOI 10.1073/pnas.87.24.9990; Pabaney AH, 2015, CLIN NEUROL NEUROSUR, V136, P66, DOI 10.1016/j.clineuro.2015.05.034; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Parirokh M, 2010, J ENDODONT, V36, P400, DOI 10.1016/j.joen.2009.09.009; Rabie ABM, 1997, CONNECT TISSUE RES, V36, P337, DOI 10.3109/03008209709160232; Raedel M, 2015, OUTCOMES OF DIRECT P; Saito T, 2004, J ENDODONT, V30, P205, DOI 10.1097/00004770-200404000-00005; Suzuki M, 2016, J DENT, V44, P27, DOI 10.1016/j.jdent.2015.11.005; Swarup SJ, 2014, J CLIN PEDIATR DENT, V38, P201, DOI 10.17796/jcpd.38.3.83121661121g6773; TORNECK CD, 1983, J ENDODONT, V9, P131, DOI 10.1016/S0099-2399(83)80031-4; Yamamoto R, 2015, J DENT RES, V94, P1120, DOI 10.1177/0022034515585715; Yang X, 2009, J DENT RES, V88, P1020, DOI 10.1177/0022034509346258; Zhang M, 1999, HISTOCHEM CELL BIOL, V112, P325, DOI 10.1007/s004180050413; Zimmermann G, 2011, INJURY, V42, pS16, DOI 10.1016/j.injury.2011.06.199	33	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172693	10.1371/journal.pone.0172693	http://dx.doi.org/10.1371/journal.pone.0172693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253279	gold, Green Published, Green Submitted			2022-12-26	WOS:000396011300027
J	Peterson, CL; Bednar, MS; Bryden, AM; Keith, MW; Perreault, EJ; Murray, WM				Peterson, Carrie L.; Bednar, Michael S.; Bryden, Anne M.; Keith, Michael W.; Perreault, Eric J.; Murray, Wendy M.			Voluntary activation of biceps-to-triceps and deltoid-to-triceps transfers in quadriplegia	PLOS ONE			English	Article							SPINAL-CORD-INJURY; UPPER-LIMB SURGERY; ELBOW EXTENSION; INTERPOLATED TWITCH; TETRAPLEGIC PATIENTS; SURGICAL RESTORATION; ISOMETRIC ELBOW; TENDON TRANSFER; VALID MEASURE; MUSCLE	The biceps or the posterior deltoid can be transferred to improve elbow extension function for many individuals with C5 or C6 quadriplegia. Maximum strength after elbow reconstruction is variable; the patient's ability to voluntarily activate the transferred muscle to extend the elbow may contribute to the variability. We compared voluntary activation during maximum isometric elbow extension following biceps transfer (n = 5) and deltoid transfer (n = 6) in three functional postures. Voluntary activation was computed as the elbow extension moment generated during maximum voluntary effort divided by the moment generated with full activation, which was estimated via electrical stimulation. Voluntary activation was on average 96% after biceps transfer and not affected by posture. Individuals with deltoid transfer demonstrated deficits in voluntary activation, which differed by posture (80% in horizontal plane, 69% in overhead reach, and 70% in weight-relief), suggesting inadequate motor re-education after deltoid transfer. Overall, individuals with a biceps transfer better activated their transferred muscle than those with a deltoid transfer. This difference in neural control augmented the greater force-generating capacity of the biceps leading to increased elbow extension strength after biceps transfer (average 9.37 N-m across postures) relative to deltoid transfer (average 2.76 N-m across postures) in our study cohort.	[Peterson, Carrie L.; Bednar, Michael S.; Murray, Wendy M.] Edward Hines Jr VA Hosp, Hines, IL 60141 USA; [Peterson, Carrie L.; Perreault, Eric J.; Murray, Wendy M.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Peterson, Carrie L.; Perreault, Eric J.; Murray, Wendy M.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Bednar, Michael S.] Loyola Univ, Stritch Sch Med, Dept Orthopaed Surg & Rehabil, 2160 S 1st Ave, Maywood, IL 60153 USA; [Bryden, Anne M.; Keith, Michael W.] MetroHealth, Cleveland FES Ctr, Cleveland, OH USA; [Bryden, Anne M.; Keith, Michael W.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Keith, Michael W.] Case Western Reserve Univ, Sch Med, Dept Orthopaed, Cleveland, OH USA; [Perreault, Eric J.; Murray, Wendy M.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Peterson, Carrie L.] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23284 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Shirley Ryan AbilityLab; Northwestern University; Feinberg School of Medicine; Loyola University Chicago; MetroHealth System; Case Western Reserve University; Case Western Reserve University; Northwestern University; Virginia Commonwealth University	Peterson, CL (corresponding author), Edward Hines Jr VA Hosp, Hines, IL 60141 USA.; Peterson, CL (corresponding author), Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA.; Peterson, CL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.; Peterson, CL (corresponding author), Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23284 USA.	clpeterson@vcu.edu	Perreault, Eric/B-7632-2009; Murray, Wendy/B-7629-2009; Murray, Wendy/AAD-6257-2022; Murray, Wendy M./D-1520-2009; Peterson, Carrie/C-6007-2016	Murray, Wendy/0000-0002-7547-621X; Murray, Wendy M./0000-0002-7547-621X; Peterson, Carrie/0000-0002-7169-2089; Bryden, Anne/0000-0003-4381-1156; Perreault, Eric/0000-0002-9860-6427	Rehabilitation Research and Development Services of the Department of Veterans Affairs [B7515R]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000377] Funding Source: NIH RePORTER	Rehabilitation Research and Development Services of the Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Veterans Affairs(US Department of Veterans Affairs)	This work was funded by the Rehabilitation Research and Development Services of the Department of Veterans Affairs (Merit Review Award B7515R to WMM) http://www.research.va.gov/services/rrd.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beekhuizen KS, 2008, ARCH PHYS MED REHAB, V89, P602, DOI 10.1016/j.apmr.2007.11.021; Behm DG, 1996, J APPL PHYSIOL, V81, P2267, DOI 10.1152/jappl.1996.81.5.2267; Bonds Cale W, 2009, Tech Hand Up Extrem Surg, V13, P94, DOI 10.1097/BTH.0b013e318196c92d; Council MR., 1943, MED RES COUNCIL AIDS; Creasey Graham H, 2004, J Spinal Cord Med, V27, P365; de Haan A, 2009, J APPL PHYSIOL, V107, P355, DOI 10.1152/japplphysiol.91220.2008a; DOWLING JJ, 1994, NEUROSCI LETT, V179, P25, DOI 10.1016/0304-3940(94)90926-1; Dunn JA, 2014, J HAND SURG-AM, V39, P317, DOI 10.1016/j.jhsa.2013.11.037; Frazer A, 2016, ANODAL TRANSCRANIAL; Friden J, 2012, PHYS MED REH CLIN N, V23, P33, DOI 10.1016/j.pmr.2011.11.002; FRIEDENBERG ZB, 1954, J BONE JOINT SURG AM, V36-A, P656, DOI 10.2106/00004623-195436030-00019; Gagnon D, 2008, J REHABIL RES DEV, V45, P863, DOI 10.1682/JRRD.2007.11.0189; Gerasimenko YP, 2015, J NEUROTRAUM, V32, P1968, DOI 10.1089/neu.2015.4008; Hamou C, 2009, J HAND SURG-AM, V34A, P692, DOI 10.1016/j.jhsa.2008.12.002; Horstman AM, 2009, J APPL PHYSIOL, V107, P359, DOI 10.1152/japplphysiol.00362.2009; Hutchinson D, 2008, J HAND SURG-AM, V33A, P1331, DOI 10.1016/j.jhsa.2008.04.022; Johanson ME, 2006, J HAND SURG-AM, V31A, P747, DOI 10.1016/j.jhsa.2006.01.006; Johanson ME, 2011, J HAND SURG-AM, V36A, P480, DOI 10.1016/j.jhsa.2010.11.006; Kim HE, 2015, J NEUROPHYSIOL, V114, P427, DOI 10.1152/jn.01074.2014; Kirsch R F, 1996, IEEE Trans Rehabil Eng, V4, P403, DOI 10.1109/86.547942; Klein CS, 2001, J APPL PHYSIOL, V91, P1341, DOI 10.1152/jappl.2001.91.3.1341; Kozin SH, 2010, J HAND SURG-AM, V35A, P968, DOI 10.1016/j.jhsa.2010.03.011; Kuz JE, 1999, J HAND SURG-AM, V24A, P161; Langenderfer J, 2004, CLIN BIOMECH, V19, P664, DOI 10.1016/j.clinbiomech.2004.04.009; Leclercq C, 2008, HAND CLIN, V24, P185, DOI 10.1016/j.hcl.2008.02.003; Lieber RL, 2003, J HAND SURG-AM, V28A, P288, DOI 10.1053/jhsu.2003.50057; Martinez M, 2009, EUR J NEUROSCI, V30, P2356, DOI 10.1111/j.1460-9568.2009.07019.x; Memberg WD, 2003, J REHABIL RES DEV, V40, P477, DOI 10.1682/JRRD.2003.11.0477; Memberg WD, 2001, CLIN BIOMECH, V16, P918, DOI 10.1016/S0268-0033(01)00071-7; MOBERG E, 1975, J BONE JOINT SURG AM, VA 57, P196, DOI 10.2106/00004623-197557020-00012; Mulcahey MJ, 2003, J HAND SURG-AM, V28A, P964, DOI 10.1016/S0363-5023(03)00485-4; Murray WM, 2000, J BIOMECH, V33, P943, DOI 10.1016/S0021-9290(00)00051-8; RABISCHONG E, 1993, PARAPLEGIA, V31, P33, DOI 10.1038/sc.1993.6; Revol M, 1999, J HAND SURG-BRIT EUR, V24B, P235, DOI 10.1054/jhsb.1998.0184; Ridding MC, 2003, CLIN NEUROPHYSIOL, V114, P1437, DOI 10.1016/S1388-2457(03)00115-9; Song WG, 2016, EXP NEUROL, V277, P46, DOI 10.1016/j.expneurol.2015.12.008; Squitieri L, 2008, HAND CLIN, V24, P169, DOI 10.1016/j.hcl.2008.01.001; Taylor JL, 2009, J APPL PHYSIOL, V107, P354, DOI 10.1152/japplphysiol.91220.2008; Trombly C., 1989, OCCUPATIONAL THERAPY; Tsiampa VA, 2012, J PLAST SURG HAND SU, V46, P262, DOI 10.3109/2000656X.2012.684097; Turcsanyi I, 2010, J PLAST SURG HAND SU, V44, P156, DOI 10.3109/02844311.2010.488886; van Drongelen S, 2005, ARCH PHYS MED REHAB, V86, P1214, DOI 10.1016/j.apmr.2004.09.023; Vastamaki M, 2006, J HAND SURG-AM, V31A, P1490, DOI 10.1016/j.jhsa.2006.06.001; Wangdell J, 2012, J HAND SURG-AM, V37A, P1003, DOI 10.1016/j.jhsa.2012.01.026; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042	45	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0171141	10.1371/journal.pone.0171141	http://dx.doi.org/10.1371/journal.pone.0171141			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253262	gold, Green Submitted, Green Published			2022-12-26	WOS:000396011300004
J	Maruoka, M; Kedashiro, S; Ueda, Y; Mizutani, K; Takai, Y				Maruoka, Masahiro; Kedashiro, Shin; Ueda, Yuki; Mizutani, Kiyohito; Takai, Yoshimi			Nectin-4 co-stimulates the prolactin receptor by interacting with SOCS1 and inhibiting its activity on the JAK2-STAT5a signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-GLAND DEVELOPMENT; GROWTH-FACTOR RECEPTORS; CELL-CELL JUNCTIONS; MOVING NIH3T3 CELLS; INTEGRIN ALPHA(6)BETA(4); ACTIVATION LOOP; BREAST-CANCER; PROTEIN; CYTOKINE; ADHESION	Cell-surface cytokine receptors are regulated by their cis-interacting stimulatory and inhibitory co-receptors. We previously showed that the Ig-like cell-adhesion molecule nectin-4 cis-interacts with the prolactin receptor through the extracellular region and stimulates prolactin-induced prolactin receptor activation and signaling, resulting in alveolar development in the mouse mammary gland. However, it remains unknown how this interaction stimulates these effects. We show here that the cis-interaction of the extracellular region of nectin-4 with the prolactin receptor was not sufficient for eliciting these effects and that the cytoplasmic region of nectin-4 was also required for this interaction. The cytoplasmic region of nectin-4 directly interacted with suppressor of cytokine signaling 1 (SOCS1), but not SOCS3, JAK2, or STAT5a, and inhibited the interaction of SOCS1 with JAK2, eventually resulting in the increased phosphorylation of STAT5a. The juxtamembrane region of nectin-4 interacted with the Src homology 2 domain of SOCS1. Both the interaction of nectin-4 with the extracellular region of the prolactin receptor and the interaction of SOCS1 with the cytoplasmic region of nectin-4 were required for the stimulatory effect of nectin-4 on the prolactin-induced prolactin receptor activation. The third Ig-like domain of nectin-4 and the second fibronectin type III domain of the prolactin receptor were involved in this cis-interaction, and both the extracellular and transmembrane regions of nectin-4 and the prolactin receptor were required for this direct interaction. These results indicate that nectin-4 serves as a stimulatory co-receptor for the prolactin receptor by regulating the feedback inhibition of SOCS1 in the JAK2-STAT5a signaling pathway.	[Maruoka, Masahiro; Kedashiro, Shin; Ueda, Yuki; Mizutani, Kiyohito; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Pathogenet Signaling,Chuo Ku, 1-5-6 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan; [Maruoka, Masahiro] RIKEN Compass Hlth Life Res Complex Program, Hlth Metr Dev Team, Chuo Ku, 6-7-1 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan; [Takai, Yoshimi] RIKEN Ctr Life Sci Technol, Pathophysiol & Hlth Sci Team, Chuo Ku, 6-7-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan	Kobe University; RIKEN; RIKEN	Mizutani, K; Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Pathogenet Signaling,Chuo Ku, 1-5-6 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.; Takai, Y (corresponding author), RIKEN Ctr Life Sci Technol, Pathophysiol & Hlth Sci Team, Chuo Ku, 6-7-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	mizutani@med.kobe-u.ac.jp; ytakai@med.kobe-u.ac.jp	Mizutani, Kiyohito/L-8474-2019	Maruoka, Masahiro/0000-0003-4625-8544	Japan Society for the Promotion of Science [26251013, 26860190, 16K19035]; Ministry of Education, Culture, Sports, Science, and Technology [26114007]; P-CREATE from the Japan Agency for Medical Research and Development (AMED); Japan Foundation for Applied Enzymology; Research Complex Promotion Program of the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [26114007] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); P-CREATE from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Foundation for Applied Enzymology; Research Complex Promotion Program of the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research 26251013 (to Y. T.), 26860190 (to K. M.), and 16K19035 (to M. M.) from the Japan Society for the Promotion of Science; Grant-in-Aid for Scientific Research on Innovative Areas 26114007 (to Y. T.) from the Ministry of Education, Culture, Sports, Science, and Technology; P-CREATE from the Japan Agency for Medical Research and Development (AMED) (to Y. T.); and the Japan Foundation for Applied Enzymology (to Y. T.). This work was also supported in part by the Research Complex Promotion Program of the Japan Science and Technology Agency. The authors declare that they have no conflicts of interest with the contents of this article.	Amano H, 2008, GENES CELLS, V13, P269, DOI 10.1111/j.1365-2443.2008.01167.x; Bernard V, 2015, NAT REV ENDOCRINOL, V11, P265, DOI 10.1038/nrendo.2015.36; Bezbradica JS, 2009, NAT IMMUNOL, V10, P333, DOI 10.1038/ni.1713; Bojesen KB, 2012, J BIOL CHEM, V287, P37420, DOI 10.1074/jbc.M112.345215; Chen CY, 2003, GENE CHROMOSOME CANC, V37, P300, DOI 10.1002/gcc.10222; Das D, 2015, CANCER CHEMOTH PHARM, V76, P471, DOI 10.1007/s00280-015-2794-8; DaSilva L, 1996, MOL CELL ENDOCRINOL, V117, P131, DOI 10.1016/0303-7207(95)03738-1; De Sepulveda P, 2000, J BIOL CHEM, V275, P14005, DOI 10.1074/jbc.C000106200; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Fabre-Lafay S, 2005, J BIOL CHEM, V280, P19543, DOI 10.1074/jbc.M410943200; Fabre-Lafay S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-73; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Galm O, 2003, BLOOD, V101, P2784, DOI 10.1182/blood-2002-06-1735; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Ishiuchi T, 2012, GENES CELLS, V17, P387, DOI 10.1111/j.1365-2443.2012.01593.x; Kamio M, 2004, ONCOGENE, V23, P3107, DOI 10.1038/sj.onc.1207453; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kanzaki N, 2008, J CELL SCI, V121, P2008, DOI 10.1242/jcs.024620; Kawano S, 2010, GENES CELLS, V15, P995, DOI 10.1111/j.1365-2443.2010.01438.x; Kawano S, 2009, J BIOL CHEM, V284, P23793, DOI 10.1074/jbc.M109.025155; Kinugasa M, 2012, CIRC RES, V110, P716, DOI 10.1161/CIRCRESAHA.111.256834; Kirkbride KC, 2005, TRENDS BIOCHEM SCI, V30, P611, DOI 10.1016/j.tibs.2005.09.003; Kitayama M, 2016, J BIOL CHEM, V291, P5817, DOI 10.1074/jbc.M115.685917; Komazaki T, 2004, JPN J CLIN ONCOL, V34, P191, DOI 10.1093/jjco/hyh035; Liu XW, 1996, MOL ENDOCRINOL, V10, P1496, DOI 10.1210/me.10.12.1496; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Mandai K, 2015, CURR TOP DEV BIOL, V112, P197, DOI 10.1016/bs.ctdb.2014.11.019; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Minami A, 2010, GENES CELLS, V15, P1123, DOI 10.1111/j.1365-2443.2010.01450.x; Minami Y, 2007, J BIOL CHEM, V282, P18481, DOI 10.1074/jbc.M611330200; Miyata M, 2009, J CELL SCI, V122, P4319, DOI 10.1242/jcs.048439; Mizutani K, 2011, J BIOL CHEM, V286, P36667, DOI 10.1074/jbc.M110.200535; Msaouel P, 2013, EXPERT OPIN BIOL TH, V13, P483, DOI 10.1517/14712598.2013.749851; Muschler J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003202; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; Pavlova NN, 2013, ELIFE, V2, DOI 10.7554/eLife.00358; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; Pezet A, 1999, J BIOL CHEM, V274, P24497, DOI 10.1074/jbc.274.35.24497; Sakamoto Y, 2008, J BIOL CHEM, V283, P496, DOI 10.1074/jbc.M704195200; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; Strebovsky J, 2011, FASEB J, V25, P863, DOI 10.1096/fj.10-170597; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Sugiyama H, 2013, GENES CELLS, V18, P519, DOI 10.1111/gtc.12056; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tomic S, 1999, MOL CELL ENDOCRINOL, V158, P45, DOI 10.1016/S0303-7207(99)00180-X; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Xu R, 2009, J CELL BIOL, V184, P57, DOI 10.1083/jcb.200807021; Yamada A, 2013, MOL CELL NEUROSCI, V56, P234, DOI 10.1016/j.mcn.2013.06.003; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309	56	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6895	6909		10.1074/jbc.M116.769091	http://dx.doi.org/10.1074/jbc.M116.769091			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28258213	hybrid, Green Published			2022-12-26	WOS:000400478300004
J	Amdahl, H; Haapasalo, K; Tan, L; Meri, T; Kuusela, PI; van Strijp, JA; Rooijakkers, S; Jokiranta, TS				Amdahl, Hanne; Haapasalo, Karita; Tan, Lydia; Meri, Taru; Kuusela, Pentti I.; van Strijp, Jos A.; Rooijakkers, Suzan; Jokiranta, T. Sakari			Staphylococcal protein Ecb impairs complement receptor-1 mediated recognition of opsonized bacteria	PLOS ONE			English	Article							FIBRINOGEN-BINDING PROTEIN; HEMOLYTIC-UREMIC SYNDROME; INHIBITOR FACTOR-H; HUMAN-NEUTROPHILS; IMMUNE EVASION; AUREUS; INNATE; C-3; C3B; REGULATORS	Staphyloccus aureus is a major human pathogen leading frequently to sepsis and soft tissue infections with abscesses. Multiple virulence factors including several immune modulating molecules contribute to its survival in the host. When S. aureus invades the human body, one of the first line defenses is the complement system, which opsonizes the bacteria with C3b and attract neutrophils by release of chemotactic peptides. Neutrophils express Complement receptor-1 [CR1, CD35) that interacts with the C3b-opsonized particles and thereby plays an important role in pathogen recognition by phagocytic cells. In this study we observed that a fraction of S. aureus culture supernatant prevented binding of C3b to neutrophils. This fraction consisted of S. aureus leukocidins and Efb. The C-terminus of Efb is known to bind C3b and shares significant sequence homology to the extracellular complement binding protein [Ecb). Here we show that S. aureus Ecb displays various mechanisms to block bacterial recognition by neutrophils. The presence of Ecb blocked direct interaction between soluble CR1 and C3b and reduced the cofactor activity of CR1 in proteolytic inactivation of C3b. Furthermore, Ecb could dose-dependently prevent recognition of C3b by cell-bound CR1 that lead to impaired phagocytosis of NHS-opsonized S. aureus. Phagocytosis was furthermore reduced in the presence of soluble CR1 [sCR1). These data indicate that the staphylococcal protein Ecb prevents recognition of C3b opsonized bacteria by neutrophil CR1 leading to impaired killing by phagocytosis and thereby contribute to immune evasion of S. aureus.	[Amdahl, Hanne; Haapasalo, Karita; Kuusela, Pentti I.; Jokiranta, T. Sakari] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, Helsinki, Finland; [Amdahl, Hanne; Haapasalo, Karita; Jokiranta, T. Sakari] Univ Helsinki, Res Programs Unit, Immunobiol, Helsinki, Finland; [Tan, Lydia; van Strijp, Jos A.; Rooijakkers, Suzan] Univ Med Ctr Utrecht, Med Microbiol, Utrecht, Netherlands; [Meri, Taru] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Kuusela, Pentti I.] Univ Helsinki, Div Clin Microbiol, Cent Hosp Lab, Helsinki, Finland	University of Helsinki; University of Helsinki; Utrecht University; Utrecht University Medical Center; University of Helsinki; University of Helsinki	Jokiranta, TS (corresponding author), Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, Helsinki, Finland.; Jokiranta, TS (corresponding author), Univ Helsinki, Res Programs Unit, Immunobiol, Helsinki, Finland.; Rooijakkers, S (corresponding author), Univ Med Ctr Utrecht, Med Microbiol, Utrecht, Netherlands.	S.H.M.Rooijakkers@umcutrecht.nl; sakari.jokiranta@helsinki.fi	van Strijp, Jos A.G./J-9549-2014	van Strijp, Jos A.G./0000-0001-6253-0830; Haapasalo, Karita/0000-0002-9619-625X	Finnish Cultural Foundation [00131060, 00142390]; Academy of Finland [128646, 259793]; Sigrid Juselius Foundation	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was financially supported by The Finnish Cultural Foundation (grants 00131060 and 00142390), https://skr.fi, The Academy of Finland (grants 128646 and 259793), www.aka.fi, and The Sigrid Juselius Foundation, www..sigridjuselius.fi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge help from the technicians at the Haartman Institute and the Research Programs Unit, Immunobiology. This work was financially supported by The Finnish Cultural Foundation (grants 00131060 and 00142390), the Academy of Finland (grants 128646 and 259793) and the Sigrid Juselius Foundation.	Amdahl H, 2013, J IMMUNOL, V191, P1775, DOI 10.4049/jimmunol.1300638; Amdahl H, 2011, MOL IMMUNOL, V48, P697, DOI 10.1016/j.molimm.2010.11.015; Austen K F, 1979, Adv Exp Med Biol, V120B, P3; Benoit LA, 2005, J IMMUNOL, V175, P3542, DOI 10.4049/jimmunol.175.6.3542; Berends ETM, 2015, MOL IMMUNOL, V65, P328, DOI 10.1016/j.molimm.2015.01.020; BERGER M, 1984, J CLIN INVEST, V74, P1566, DOI 10.1172/JCI111572; Bexborn F, 2009, J BIOMED MATER RES A, V89A, P951, DOI 10.1002/jbm.a.32034; Blanc C, 2012, J IMMUNOL, V189, P3528, DOI 10.4049/jimmunol.1200679; BODEN MK, 1994, MOL MICROBIOL, V12, P599, DOI 10.1111/j.1365-2958.1994.tb01046.x; Burman JD, 2008, J BIOL CHEM, V283, P17579, DOI 10.1074/jbc.M800265200; Cunnion KM, 2004, J LAB CLIN MED, V143, P358, DOI 10.1016/j.lab.2004.03.005; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; EASMON CSF, 1976, INFECT IMMUN, V13, P399, DOI 10.1128/IAI.13.2.399-406.1976; FEARON DT, 1979, P NATL ACAD SCI USA, V76, P5867, DOI 10.1073/pnas.76.11.5867; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; FEARON DT, 1977, J EXP MED, V146, P22, DOI 10.1084/jem.146.1.22; Friberg N, 2008, J IMMUNOL, V181, P8624, DOI 10.4049/jimmunol.181.12.8624; GORDON DL, 1988, J INFECT DIS, V157, P697, DOI 10.1093/infdis/157.4.697; Haapasalo K, 2008, MOL MICROBIOL, V70, P583, DOI 10.1111/j.1365-2958.2008.06347.x; Hadders MA, 2012, CELL REP, V1, P200, DOI 10.1016/j.celrep.2012.02.003; Hallstrom T, 2008, J IMMUNOL, V181, P537, DOI 10.4049/jimmunol.181.1.537; Hammel M, 2007, PROTEIN SCI, V16, P2605, DOI 10.1110/ps.073170807; Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Jongerius I, 2012, J INNATE IMMUN, V4, P301, DOI 10.1159/000334604; Jongerius I, 2010, J BIOL CHEM, V285, P14973, DOI 10.1074/jbc.M109.091975; Jongerius I, 2010, J IMMUNOL, V184, P420, DOI 10.4049/jimmunol.0902865; Ko YP, 2011, J BIOL CHEM, V286, P9865, DOI 10.1074/jbc.M110.199687; Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476; KOISTINEN V, 1989, COMPLEMENT INFLAMMAT, V6, P270, DOI 10.1159/000463102; Lee LYL, 2004, J BIOL CHEM, V279, P50710, DOI 10.1074/jbc.M408570200; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; McCarthy AJ, 2013, INFECT GENET EVOL, V19, P7, DOI 10.1016/j.meegid.2013.06.012; Meri T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003308; Meri T, 2002, INFECT IMMUN, V70, P5185, DOI 10.1128/IAI.70.9.5185-5192.2002; Mollnes TE, 2002, BLOOD, V100, P1869; Mullaly SC, 2006, J IMMUNOL, V177, P8154, DOI 10.4049/jimmunol.177.11.8154; NEWMAN SL, 1985, J EXP MED, V161, P1414, DOI 10.1084/jem.161.6.1414; Nuutila J, 2013, HUM IMMUNOL, V74, P522, DOI [10.1016/j.humimm.2013.01.011, 10.]; PANGBURN MK, 1986, J IMMUNOL, V136, P2216; Ricklin D, 2008, J IMMUNOL, V181, P7463, DOI 10.4049/jimmunol.181.11.7463; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; ROSS GD, 1978, J EXP MED, V147, P730, DOI 10.1084/jem.147.3.730; SCHIFFERLI JA, 1986, NEW ENGL J MED, V315, P488; SCHREIBER RD, 1979, J EXP MED, V149, P870, DOI 10.1084/jem.149.4.870; SENGELOV H, 1994, J IMMUNOL, V153, P804; Serruto D, 2010, NAT REV MICROBIOL, V8, P393, DOI 10.1038/nrmicro2366; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Todd RF, 1996, J CLIN INVEST, V98, P1, DOI 10.1172/JCI118752; Troelstra A, 1997, J LEUKOCYTE BIOL, V61, P173, DOI 10.1002/jlb.61.2.173; VERBRUGH HA, 1982, J IMMUNOL, V129, P1681; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755	54	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172675	10.1371/journal.pone.0172675	http://dx.doi.org/10.1371/journal.pone.0172675			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273167	gold, Green Published			2022-12-26	WOS:000396073700085
J	Leng, F; Xu, C; Xia, XY; Pan, XM				Leng, Fei; Xu, Chao; Xia, Xia-Yu; Pan, Xian-Ming			Establishing knowledge on the sequence arrangement pattern of nucleated protein folding	PLOS ONE			English	Article							THERMOPHILIC PROTEINS; MESOPHILIC ORGANISMS; SALT BRIDGES; SIDE-CHAIN; STABILITY; THERMOSTABILITY; ENZYMES; MECHANISM; RESIDUES; PACKING	The heat-tolerance mechanisms of (hyper)thermophilic proteins provide a unique opportunity to investigate the unsolved protein folding problem. In an attempt to determine whether the interval between residues in sequence might play a role in determining thermostability, we constructed a sequence interval-dependent value function to calculate the residue pair frequency. Additionally, we identified a new sequence arrangement pattern, where like-charged residues tend to be adjacently assembled, while unlike-charged residues are distributed over longer intervals, using statistical analysis of a large sequence database. This finding indicated that increasing the intervals between unlike-charged residues can increase protein thermostability, with the arrangement patterns of these charged residues serving as thermodynamically favorable nucleation points for protein folding. Additionally, we identified that the residue pairs K-E, R-E, L-V and V-V involving long sequence intervals play important roles involving increased protein thermostability. This work demonstrated a novel approach for considering sequence intervals as keys to understanding protein folding. Our findings of novel relationships between residue arrangement and protein thermostability can be used in industry and academia to aid the design of thermostable proteins.	[Leng, Fei; Xu, Chao; Xia, Xia-Yu; Pan, Xian-Ming] Tsinghua Univ, Sch Life Sci, Key Lab Bioinformat, Minist Educ, Beijing, Peoples R China	Tsinghua University	Pan, XM (corresponding author), Tsinghua Univ, Sch Life Sci, Key Lab Bioinformat, Minist Educ, Beijing, Peoples R China.	pan-xm@mail.tsinghua.edu.cn			National Natural Science Foundation of China [20143000221, 20141301071]; Ministry of Science and Technology of China [20151860049]; International Development Research Center, Ottawa, Canada [104519-010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); International Development Research Center, Ottawa, Canada	This work was supported in part by grants 20143000221 and 20141301071 from the National Natural Science Foundation of China, 20151860049 from the Ministry of Science and Technology of China and 104519-010 from the International Development Research Center, Ottawa, Canada.	ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bauer MW, 1998, BIOCHEMISTRY-US, V37, P17170, DOI 10.1021/bi9814944; Berezovsky IN, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035002; Chakravarty S, 2002, BIOCHEMISTRY-US, V41, P8152, DOI 10.1021/bi025523t; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Daniel RM, 2010, TRENDS BIOCHEM SCI, V35, P584, DOI 10.1016/j.tibs.2010.05.001; Das Rajdeep, 2000, Functional and Integrative Genomics, V1, P76, DOI 10.1007/s101420050009; de Carvalho CCCR, 2011, BIOTECHNOL ADV, V29, P75, DOI 10.1016/j.biotechadv.2010.09.001; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Galzitskaya Oxana V., 2008, Journal of Bioinformatics and Computational Biology, V6, P667, DOI 10.1142/S0219720008003618; Ge M, 2008, J BIOL CHEM, V283, P31690, DOI 10.1074/jbc.M805750200; Glyakina AV, 2007, BIOINFORMATICS, V23, P2231, DOI 10.1093/bioinformatics/btm345; Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; Hamelryck T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013714; Haney P, 1997, PROTEINS, V28, P117, DOI 10.1002/(SICI)1097-0134(199705)28:1<117::AID-PROT12>3.0.CO;2-M; Hong H, 2006, NAT CHEM BIOL, V2, P627, DOI 10.1038/nchembio827; Karshikoff A, 1998, PROTEIN ENG, V11, P867, DOI 10.1093/protein/11.10.867; Katava M, 2016, J PHYS CHEM B, V120, P2721, DOI 10.1021/acs.jpcb.6b00306; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; Lassila KS, 2002, PROTEIN SCI, V11, P688, DOI 10.1110/ps.23502; Lee CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112751; Li PY, 2015, J BIOL CHEM, V290, P11188, DOI 10.1074/jbc.M115.646182; Li YQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-62; Luisi DL, 2003, BIOCHEMISTRY-US, V42, P7050, DOI 10.1021/bi027202n; Ma BG, 2010, STRUCTURE, V18, P819, DOI 10.1016/j.str.2010.04.004; Mamonova TB, 2013, BBA-PROTEINS PROTEOM, V1834, P854, DOI 10.1016/j.bbapap.2013.02.011; Pack SP, 2013, APPL BIOCHEM BIOTECH, V171, P1212, DOI 10.1007/s12010-013-0195-1; Panja AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131495; Porter JL, 2015, ACS CHEM BIOL, V10, P611, DOI 10.1021/cb500809f; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Sammond DW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145848; Sippl MJ, 1996, FOLD DES, V1, P289, DOI 10.1016/S1359-0278(96)00042-9; Tompa DR, 2016, J MOL GRAPH MODEL, V64, P85, DOI 10.1016/j.jmgm.2016.01.001; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; VIEILLE C, 1995, APPL ENVIRON MICROB, V61, P1867, DOI 10.1128/AEM.61.5.1867-1875.1995	39	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173583	10.1371/journal.pone.0173583	http://dx.doi.org/10.1371/journal.pone.0173583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273143	Green Published, gold, Green Submitted			2022-12-26	WOS:000396073700019
J	Pollack, TM; Duong, HT; Pham, TT; Do, CD; Colby, D				Pollack, Todd M.; Duong, Hao T.; Pham, Thuy T.; Do, Cuong D.; Colby, Donn			Cigarette smoking is associated with high HIV viral load among adults presenting for antiretroviral therapy in Vietnam	PLOS ONE			English	Article							DISEASE PROGRESSION; ALCOHOL-CONSUMPTION; INFECTED PATIENTS; HEPATITIS-B; VIRUS LOAD; CELL COUNT; SET-POINT; IMPACT; COHORT; TUBERCULOSIS	High HIV viral load (VL >100,000 cp/ml) is associated with increased HIV transmission risk, faster progression to AIDS, and reduced response to some antiretroviral regimens. To better understand factors associated with high VL, we examined characteristics of patients presenting for treatment in Hanoi, Vietnam. We examined baseline data from the Viral Load Monitoring in Vietnam Study, a randomized controlled trial of routine VL monitoring in a population starting antiretroviral therapy (ART) at a clinic in Hanoi. Patients with prior treatment failure or ART resistance were excluded. Characteristics examined included demographics, clinical and laboratory data, and substance use. Logistic regression was used to calculate crude and adjusted odds ratios (aOR) and 95% confidence intervals (95% CI). Out of 636 patients, 62.7% were male, 72.9% were >= 30 years old, and 28.3% had a history of drug injection. Median CD4 was 132 cells/mm3, and 34.9% were clinical stage IV. Active cigarette smoking was reported by 36.3% with 14.0% smoking >10 cigarettes per day. Alcohol consumption was reported by 20.1% with 6.1% having >= 5 drinks per event. Overall 53.0% had a VL >100,000 cp/ml. Male gender, low body weight, low CD4 count, prior TB, and cigarette smoking were associated with high VL. Those who smoked 1-10 cigarettes per day were more likely to have high VL (aOR = 1.99, 95% CI = 1.15-3.45), while the smaller number of patients who smoked >10 cigarettes per day had a non-significant trend toward higher VL (aOR = 1.41, 95% CI = 0.75-2.66). Alcohol consumption was not significantly associated with high VL. Tobacco use is increasingly recognized as a contributor to premature morbidity and mortality among HIV-infected patients. In our study, cigarette smoking in the last 30 days was associated with a 1.5 to 2-fold higher odds of having an HIV VL >100,000 cp/ml among patients presenting for ART. These findings provide further evidence of the negative effects of tobacco use among HIV-infected patients.	[Pollack, Todd M.; Duong, Hao T.; Pham, Thuy T.] Partnership Hlth Adv Vietnam HAIVN, Hanoi, Vietnam; [Pollack, Todd M.] Harvard Med Sch, BIDMC, Boston, MA 02115 USA; [Pham, Thuy T.; Do, Cuong D.] BMH, Dept Infect Dis, Hanoi, Vietnam; [Colby, Donn] HCMC, Ctr Appl Res Men & Community Hlth CARMAH, Hanoi, Vietnam; [Colby, Donn] Thai Red Cross AIDS Res Ctr, SEARCH, Bangkok, Thailand	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Thai Red Cross Society	Pollack, TM (corresponding author), Partnership Hlth Adv Vietnam HAIVN, Hanoi, Vietnam.; Pollack, TM (corresponding author), Harvard Med Sch, BIDMC, Boston, MA 02115 USA.	todd@haivn.org		colby, donn j./0000-0003-3931-5926	Roche Molecular Systems, Inc. (RMS);  [L974]	Roche Molecular Systems, Inc. (RMS); 	This study was funded by a research grant from Roche Molecular Systems, Inc. (RMS); contract No. L974. RMS developed the COBAS (R) AmpliPrep/COBAS (R) TaqMan (R) HIV-1 Test which was used in the study for measuring plasma HIV viral load. RMS has had no role in the study design; collection, analysis, and interpretation of data, writing of the paper, and/or decision to submit for publication.	Akhtar-Khaleel WZ, 2016, AIDS BEHAV, V20, P622, DOI 10.1007/s10461-015-1099-6; Ande A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122402; [Anonymous], 2015, NAT AD TOB QUEST 201; Ansari-Moghaddam A, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.6618; Badri M, 2001, INT J TUBERC LUNG D, V5, P225; Baum MK, 2010, AIDS RES HUM RETROV, V26, P511, DOI 10.1089/aid.2009.0211; Buchacz K, 2004, SYPHILIS INCREASES H, P2075; Chakravarti Anita, 2005, Trop Gastroenterol, V26, P183; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Conen A, 2013, JAIDS-J ACQ IMM DEF, V64, P472, DOI 10.1097/QAI.0b013e3182a61ea9; Cuong DD, 2012, SCAND J INFECT DIS, V44, P201, DOI 10.3109/00365548.2011.631937; Donnelly CA, 2005, HIV MED, V6, P170, DOI 10.1111/j.1468-1293.2005.00285.x; Donovan RM, 1996, J INFECT DIS, V174, P401, DOI 10.1093/infdis/174.2.401; Duffus WA, 2005, INT J STD AIDS, V16, P733, DOI 10.1258/095646205774763298; Feldman DN, 2009, AIDS EDUC PREV, V21, P81, DOI 10.1521/aeap.2009.21.3_supp.81; Feldman JG, 2006, AM J PUBLIC HEALTH, V96, P1060, DOI 10.2105/AJPH.2005.062745; Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104; French AL, 2007, J INFECT DIS, V195, P1437, DOI 10.1086/515578; Gandhi M, 2002, CLIN INFECT DIS, V35, P313, DOI 10.1086/341249; Goletti D, 1996, J IMMUNOL, V157, P1271; Gray RH, 2004, J INFECT DIS, V189, P1209, DOI 10.1086/382750; Kabali C, 2011, AIDS CARE, V23, P947, DOI 10.1080/09540121.2010.542128; Kalichman SC, 2014, INT J BEHAV MED, V21, P811, DOI 10.1007/s12529-013-9353-7; Kato M, 2014, CURR HIV-AIDS REP, V11, P487, DOI 10.1007/s11904-014-0235-7; McLean RC, 2011, J CARDIOVASC SURG, V52, P877; Mdodo R, 2015, ANN INTERN MED, V162, P335, DOI 10.7326/M14-0954; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Miguez-Burbano MJ, 2003, ADDICT BIOL, V8, P39, DOI 10.1080/1355621031000069864; Miller V, 2002, J INFECT DIS, V186, P189, DOI 10.1086/341466; MOH, 2015, GUID HIV AIDS DIAGN; MOH, 2011, GUID HIV AIDS DIGAN; Molina PE, 2014, ALCOHOL CLIN EXP RES, V38, P2335, DOI 10.1111/acer.12507; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Nakagawa F, 2014, AIDS, V28, P1351, DOI 10.1097/QAD.0000000000000224; National Cancer Institute, TOB US 2015; National Committee for AIDS Drug and Prostitution Prevention and Control, 2014, DRUG PROS PREV CONTR; National Institute on Alcohol Abuse and Alcoholism, ALC FACTS STAT 2016; Novitsky V, 2003, J VIROL, V77, P882, DOI 10.1128/JVI.77.2.882-890.2003; Phillips AN, 2001, JAMA-J AM MED ASSOC, V286, P2560; Rangarajan S, 2014, RISK FACTORS DELAYED, P9; Rangarajan S, 2016, J VIRUS ERAD, V2, P36; Samet JH, 2007, JAIDS-J ACQ IMM DEF, V46, P194, DOI 10.1097/QAI.0b013e318142aabb; Sax PE, 2009, NEW ENGL J MED, V361, P2230, DOI 10.1056/NEJMoa0906768; Sobell LC, ALCOHOL CONSUMPTION, P75; Substance Abuse and Mental Health Services Administration (SAMHSA), BING DRINK TERM PATT; Toossi Z, 2001, CLIN EXP IMMUNOL, V123, P233, DOI 10.1046/j.1365-2249.2001.01401.x; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Williams BG, 2011, CURR HIV RES, V9, P367, DOI 10.2174/157016211798038533; Zarski JP, 1998, J HEPATOL, V28, P27, DOI 10.1016/S0168-8278(98)80198-0; Zhang X, 2013, CLIN VACCINE IMMUNOL, V20, P1048, DOI 10.1128/CVI.00015-13	51	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173534	10.1371/journal.pone.0173534	http://dx.doi.org/10.1371/journal.pone.0173534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5QM	28267790	Green Published, gold, Green Submitted			2022-12-26	WOS:000396060600042
J	Barbieri, NL; Nielsen, DW; Wannemuehler, Y; Cavender, T; Hussein, A; Yan, SG; Nolan, LK; Logue, CM				Barbieri, Nicolle Lima; Nielsen, Daniel W.; Wannemuehler, Yvonne; Cavender, Tia; Hussein, Ashraf; Yan, Shi-gan; Nolan, Lisa K.; Logue, Catherine M.			mcr-1 identified in Avian Pathogenic Escherichia coli (APEC)	PLOS ONE			English	Article							RESISTANCE GENE MCR-1; SPECTRUM BETA-LACTAMASE; FOOD ANIMALS; SALMONELLA-ENTERICA; HUMAN-ORIGIN; PLASMID; EMERGENCE; VIRULENCE; STRAINS; EGYPT	Antimicrobial resistance associated with colistin has emerged as a significant concern worldwide threatening the use of one of the most important antimicrobials for treating human disease. Here, we examined a collection (n = 980) of Avian Pathogenic Escherichia coli (APEC) isolated from poultry with colibacillosis from the US and internationally for the presence of mcr-1 and mcr-2, genes known to encode colistin resistance. Included in the analysis was an additional set of avian fecal E. coli (AFEC) (n = 220) isolates from healthy birds for comparative analysis. The mcr-1 gene was detected in a total of 12 isolates recovered from diseased production birds from China and Egypt. No mcr genes were detected in the healthy fecal isolates. The full mcr-1 gene from positive isolates was sequenced using specifically designed primers and were compared with sequences currently described in NCBI. mcr-1 positive isolates were also assessed for phenotypic colistin resistance and extended spectrum beta lactam phenotypes and genotypes. This study has identified mcr-1 in APEC isolates dating back to at least 2010 and suggests that animal husbandry practices could result in a potential source of resistance to the human food chain in countries where application of colistin in animal health is practiced.	[Barbieri, Nicolle Lima; Nielsen, Daniel W.; Wannemuehler, Yvonne; Cavender, Tia; Nolan, Lisa K.; Logue, Catherine M.] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, 1802 Univ Blvd,VMRI 5 Ames, Ames, IA 50011 USA; [Hussein, Ashraf] Zagazig Univ, Dept Avian & Rabbit Med, Fac Vet Med, Zagazig, Egypt; [Yan, Shi-gan] Qilu Univ Technol, Sch Bioengn, Jinan, Shandong, Peoples R China	Iowa State University; Egyptian Knowledge Bank (EKB); Zagazig University; Qilu University of Technology	Logue, CM (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, 1802 Univ Blvd,VMRI 5 Ames, Ames, IA 50011 USA.	cmlogue@iastate.edu	hussein, ashraf/AAA-6212-2021; Barbieri, Nicolle Lima/L-6477-2013; Barbieri, Nicolle/AAB-3223-2020	Barbieri, Nicolle Lima/0000-0002-8223-6580; Nielsen, Daniel/0000-0002-6642-1399; Logue, Catherine/0000-0002-6098-2662	College of Veterinary Medicine; Iowa State University	College of Veterinary Medicine; Iowa State University	Funding for this project was provided by the Dean's Office, College of Veterinary Medicine and the Vice President for Research Office, Iowa State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072322; Barbieri NL, 2015, FOODBORNE PATHOG DIS, V12, P74, DOI 10.1089/fpd.2014.1815; Brinas L, 2002, ANTIMICROB AGENTS CH, V46, P3156, DOI 10.1128/AAC.46.10.3156-3163.2002; Campos J., 2016, EURO SURVEILL, V21; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Castanheira M, 2016, ANTIMICROB AGENTS CH, V60, P5623, DOI 10.1128/AAC.01267-16; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Coetzee I, 2016, SAMJ S AFR MED J, V106, P35, DOI [10.7196/SAMJ.2016.v106i5.10710, 10.7196/samj.2016.v106i5.10710]; Di Pilato V, 2016, ANTIMICROBIAL AGENTS; Doumith M, 2016, J ANTIMICROB CHEMOTH, V71, P2300, DOI 10.1093/jac/dkw093; El Garch F, 2016, CLIN MICROBIOLOGY IN; Elnahriry SS, 2016, ANTIMICROB AGENTS CH, V60, P3249, DOI 10.1128/AAC.00269-16; Ewers C, 2016, GENOME ANNOUNC, V4; Falgenhauer L, 2016, EMERG INFECT DIS, V22, P1689, DOI 10.3201/eid2209.160692; Fernandes MR, 2016, ANTIMICROBIAL AGENTS; Grami R, 2016, EURO SURVEILL, V21; Grobner S, 2009, J MED MICROBIOL, V58, P912, DOI 10.1099/jmm.0.005850-0; Haenni M, 2016, ANTIMICROBIAL AGENTS; Haenni M, 2016, LANCET INFECT DIS, V16, P281, DOI 10.1016/S1473-3099(16)00007-4; Hasman H, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES.2015.20.49.30085; Hussein AHM, 2013, AVIAN DIS, V57, P602, DOI 10.1637/10503-012513-Reg.1; Irrgang A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159863; Johnson TJ, 2012, PLASMID, V68, P43, DOI 10.1016/j.plasmid.2012.03.001; Johnson TJ, 2009, METHODS MOL BIOL, V551, P27, DOI 10.1007/978-1-60327-999-4_3; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Khalifa HO, 2016, INT J ANTIMICROB AG, V47, P413, DOI 10.1016/j.ijantimicag.2016.02.011; Li A, 2016, ANTIMICROBIAL AGENTS; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Lo WU, 2014, J MED MICROBIOL, V63, P835, DOI 10.1099/jmm.0.074021-0; Logue CM, 2012, APPL ENVIRON MICROB, V78, P5824, DOI 10.1128/AEM.07869-11; Maluta RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105016; Maynard C, 2004, J CLIN MICROBIOL, V42, P5444, DOI 10.1128/JCM.42.12.5444-5452.2004; McGann P, 2016, ANTIMICROBIAL AGENTS; Meinersmann RJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02244-16; Meinersmann RJ, 2016, GENOME ANNOUNCEMENTS, V4; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V45, P3366, DOI 10.1128/JCM.00037-07; Nolan LK, 2013, COLIBACILLOSIS; Nordmann P, 2016, EUROPEAN J CLIN MICR; Perreten V, 2016, ANTIMICROBIAL AGENTS; Perreten V, 2016, ANTIMICROB AGENTS CH, V60, P4414, DOI 10.1128/AAC.00548-16; Perrin-Guyomard A, 2016, EURO SURVEILL, V21; Rodriguez-Siek KE, 2005, VET RES, V36, P241, DOI 10.1051/vetres:2004057; Schwarz S, 2016, J ANTIMICROB CHEMOTH, V71, P2066, DOI 10.1093/jac/dkw274; Sellera FP, 2016, J ANTIMICROB CHEMOTH; Shen ZQ, 2016, LANCET INFECT DIS, V16, P293, DOI 10.1016/S1473-3099(16)00061-X; Singer RS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00028; Skyberg JA, 2006, INFECT IMMUN, V74, P6287, DOI 10.1128/IAI.00363-06; Teo JQ, 2016, ANTIMICROBIAL AGENTS; Tivendale KA, 2004, INFECT IMMUN, V72, P6554, DOI 10.1128/IAI.72.11.6554-6560.2004; Tivendale KA, 2010, INFECT IMMUN, V78, P3412, DOI 10.1128/IAI.00347-10; Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P979, DOI 10.15585/mmwr.mm6536e3; Veldman K, 2016, J ANTIMICROB CHEMOTH, V71, P2340, DOI 10.1093/jac/dkw181; Wang Y, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.260; Xavier B. B., 2016, EURO SURVEILL, V21; Yang R, 2016, PROCEEDINGS OF THE 2016 12TH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION (WCICA), P1, DOI 10.1109/WCICA.2016.7578286; Yang YQ, 2016, J ANTIMICROB CHEMOTH, V71, P2336, DOI 10.1093/jac/dkw243; Zhao FF, 2016, ANTIMICROB AGENTS CH, V60, P7498, DOI 10.1128/AAC.01165-16; Zhao SH, 2001, ANTIMICROB AGENTS CH, V45, P3647, DOI 10.1128/AAC.45.12.3647-3650.2001; Zhi CP, 2016, LANCET INFECT DIS, V16, P292, DOI 10.1016/S1473-3099(16)00063-3; Zurfluh K, 2016, GENOME ANNOUNCEMENTS, V4	61	55	56	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							E0172997	10.1371/journal.pone.0172997	http://dx.doi.org/10.1371/journal.pone.0172997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264015	Green Submitted, gold, Green Published			2022-12-26	WOS:000396054300031
J	Imanishi, Y; Fukuma, S; Karaboyas, A; Robinson, BM; Pisoni, RL; Nomura, T; Akiba, T; Akizawa, T; Kurokawa, K; Saito, A; Fukuhara, S; Inaba, M				Imanishi, Yasuo; Fukuma, Shingo; Karaboyas, Angelo; Robinson, Bruce M.; Pisoni, Ronald L.; Nomura, Takanobu; Akiba, Takashi; Akizawa, Tadao; Kurokawa, Kiyoshi; Saito, Akira; Fukuhara, Shunichi; Inaba, Masaaki			Associations of employment status and educational levels with mortality and hospitalization in the dialysis outcomes and practice patterns study in Japan	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SOCIAL ADAPTABILITY INDEX; SOCIOECONOMIC-STATUS; HEMODIALYSIS-PATIENTS; INTERNATIONAL HEMODIALYSIS; MULTILEVEL ANALYSIS; ELDERLY POPULATION; INCOME INEQUALITY; HEALTH; DOPPS	Background Socioeconomic status (SES) factors such as employment, educational attainment, income, and marital status can affect the health and well-being of the general population and have been associated with the prevalence of chronic kidney disease (CKD). However, no studies to date in Japan have reported on the prognosis of patients with CKD with respect to SES. This study aimed to investigate the influences of employment and education level on mortality and hospitalization among maintenance hemodialysis (HD) patients in Japan. Methods Data on 7974 HD patients enrolled in Dialysis Outcomes and Practice Patterns Study phases 1-4 (1999-2011) in Japan were analysed. Employment status, education level, demographic data, and comorbidities were abstracted at entry into DOPPS from patient records. Mortality and hospitalization events were collected during follow-up. Patients on dialysis < 120 days at study entry were excluded from the analyses. Cox regression modelled the association between employment and both mortality and hospitalization among patients < 60 years old. The association between education and outcomes was also assessed. The association between patient characteristics and employment among patients < 60 years old was assessed using logistic regression. Results During a median follow-up of 24.9 months (interquartile range, 18.4-32.0), 10% of patients died and 43% of patients had an inpatient hospitalization. Unemployment was associated with mortality (hazard ratio [HR] = 1.57; 95% confidence interval [CI]: 1.05-2.36) and hospitalization (HR = 1.25; 95% CI: 1.08-1.44). Compared to patients who graduated from university, patients with less than a high school (HS) education and patients who graduated HS with some college tended to have elevated mortality (HR = 1.41; 95% CI, 1.04-1.92 and HR = 1.36; 95% CI: 1.02-1.82, respectively) but were not at risk for increased hospitalizations. Factors associated with unemployment included lower level of education, older age, female gender, longer vintage, and several comorbidities. Conclusions Employment and education status were inversely associated with mortality in patients on maintenance HD in Japan. Employment but not education was also inversely associated with hospitalizations. After adjustment for comorbidities, the associations with clinical outcomes tended to be stronger for employment than education status.	[Imanishi, Yasuo; Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka, Japan; [Fukuma, Shingo; Fukuhara, Shunichi] Kyoto Univ, Dept Healthcare Epidemiol, Sch Publ Hlth, Grad Sch Med, Kyoto, Japan; [Karaboyas, Angelo; Robinson, Bruce M.; Pisoni, Ronald L.] Arbor Res Collaborat Hlth, Ann Arbor, MI USA; [Robinson, Bruce M.] Univ Michigan, Ann Arbor, MI 48109 USA; [Nomura, Takanobu] Kyowa Hakko Kirin Co Ltd, Med Affairs, Kyowa, Tokyo, Japan; [Akiba, Takashi] Tokyo Womens Med Univ, Dept Blood Purificat & Internal Med, Kidney Ctr, Tokyo, Japan; [Akizawa, Tadao] Showa Univ, Sch Med, Div Nephrol, Dept Med, Tokyo, Japan; [Kurokawa, Kiyoshi] Natl Grad Inst Policy Studies, Tokyo, Japan; [Saito, Akira] Shonantobu Gen Hosp, Div Nephrol, Kanagawa, Japan; [Saito, Akira] Shonantobu Gen Hosp, Dialysis Ctr, Kanagawa, Japan; [Fukuhara, Shunichi] Fukushima Med Univ, Ctr Innovat Res Communities & Clin Excellence, Fukushima, Japan	Osaka Metropolitan University; Kyoto University; Arbor Research Collaborative for Health; University of Michigan System; University of Michigan; Kyowa Kirin Ltd; Tokyo Women's Medical University; Showa University; National Graduate Institute for Policy Studies; Fukushima Medical University	Imanishi, Y (corresponding author), Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka, Japan.	imanishi@med.osaka-cu.ac.jp			Amgen; Kyowa Hakko Kirin; AbbVie; Sanofi Renal; Baxter Healthcare; Vifor Fresenius Medical Care Renal Pharma; Keryx Biopharmaceuticals; Merck Sharp Dohme; Proteon Therapeutics; Relypsa; F. Hoffmann-LaRoche; BHC Medical; Janssen; Takeda; Hexal; DGfN; Shire; WiNe Institute; Japanese Society for Peritoneal Dialysis (JSPD); Kyowa Hakko Kirin, Co.Ltd.	Amgen(Amgen); Kyowa Hakko Kirin(Kyowa Kirin Ltd); AbbVie(AbbVie); Sanofi Renal; Baxter Healthcare; Vifor Fresenius Medical Care Renal Pharma; Keryx Biopharmaceuticals; Merck Sharp Dohme(Merck & Company); Proteon Therapeutics; Relypsa; F. Hoffmann-LaRoche(Hoffmann-La Roche); BHC Medical; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Takeda(Takeda Pharmaceutical Company Ltd); Hexal; DGfN; Shire; WiNe Institute; Japanese Society for Peritoneal Dialysis (JSPD); Kyowa Hakko Kirin, Co.Ltd.(Kyowa Kirin Ltd)	The DOPPS Program is supported by Amgen, Kyowa Hakko Kirin, AbbVie, Sanofi Renal, Baxter Healthcare, and Vifor Fresenius Medical Care Renal Pharma. Additional support for specific projects and countries is provided by Keryx Biopharmaceuticals, Merck Sharp & Dohme, Proteon Therapeutics, Relypsa, and F. Hoffmann-LaRoche; in Canada by Amgen, BHC Medical, Janssen, Takeda, and the Kidney Foundation of Canada (for logistics support); in Germany by Hexal, DGfN, Shire, and the WiNe Institute; and for PDOPPS in Japan by the Japanese Society for Peritoneal Dialysis (JSPD). All support is provided without restrictions on publications. Kyowa Hakko Kirin, Co.Ltd. provided support in the form of salaries for authors T.N., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Drey N, 2003, AM J KIDNEY DIS, V42, P677, DOI 10.1016/S0272-6386(03)00916-8; Edwards M, 2009, PATIENT EDUC COUNS, V75, P37, DOI 10.1016/j.pec.2008.09.025; Fedewa SA, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-136; Fored CM, 2003, NEPHROL DIAL TRANSPL, V18, P82, DOI 10.1093/ndt/18.1.82; Fujino Y, 2005, PREV MED, V40, P444, DOI 10.1016/j.ypmed.2004.07.002; Fukuda Y, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-53; Fukuda Y, 2004, SOC SCI MED, V59, P2435, DOI 10.1016/j.socscimed.2004.04.012; Giskes K, 2002, PUBLIC HEALTH NUTR, V5, P663, DOI 10.1079/PHN2002339; Goldfarb-Rumyantzev AS, 2010, NEPHROL DIAL TRANSPL, V25, P3672, DOI 10.1093/ndt/gfq177; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; Gray L, 2009, PUBLIC HEALTH NUTR, V12, P1351, DOI 10.1017/S1368980008004047; Ishikawa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040664; Kagamimori S, 2009, SOC SCI MED, V68, P2152, DOI 10.1016/j.socscimed.2009.03.030; Keita AD, 2009, J AM DIET ASSOC, V109, P1612, DOI 10.1016/j.jada.2009.06.373; Lopes AA, 2007, NEPHROL DIAL TRANSPL, V22, P3538, DOI 10.1093/ndt/gfm453; Lopes AA, 2010, J RENAL NUTR, V20, P224, DOI 10.1053/j.jrn.2009.10.002; Marinovich S, 2012, NEFROLOGIA, V32, P79, DOI 10.3265/Nefrologia.pre2011.Nov.11110; Marmot M, 2001, NEW ENGL J MED, V345, P134, DOI 10.1056/NEJM200107123450210; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; McClellan WM, 2010, AM J NEPHROL, V32, P38, DOI 10.1159/000313883; Merkin SS, 2007, SOC SCI MED, V65, P809, DOI 10.1016/j.socscimed.2007.04.011; Merkin SS, 2005, AM J KIDNEY DIS, V46, P203, DOI 10.1053/j.ajkd.2005.04.033; Pickett KE, 2015, PEDIATRICS, V135, pS39, DOI 10.1542/peds.2014-3549E; Pifer TB, 2002, KIDNEY INT, V62, P2238, DOI 10.1046/j.1523-1755.2002.00658.x; Pisoni RL, 2004, AM J KIDNEY DIS, V44, pS7, DOI 10.1053/j.ajkd.2004.08.005; Robinson BM, 2014, KIDNEY INT, V85, P158, DOI 10.1038/ki.2013.252; Robinson BM, 2009, CLIN J AM SOC NEPHRO, V4, pS12, DOI 10.2215/CJN.04720709; Sandhu GS, 2011, NEPHROL DIAL TRANSPL, V26, P2667, DOI 10.1093/ndt/gfq789; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; Young EW, 2000, KIDNEY INT, V57, pS74, DOI 10.1046/j.1523-1755.2000.07413.x	30	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0170731	10.1371/journal.pone.0170731	http://dx.doi.org/10.1371/journal.pone.0170731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5OE	28264035	gold, Green Published, Green Submitted			2022-12-26	WOS:000396054300003
J	Bayat, M; Denis, M; Gregory, A; Mehrmohammadi, M; Kumar, V; Meixner, D; Fazzio, RT; Fatemi, M; Alizad, A				Bayat, Mahdi; Denis, Max; Gregory, Adriana; Mehrmohammadi, Mohammad; Kumar, Viksit; Meixner, Duane; Fazzio, Robert T.; Fatemi, Mostafa; Alizad, Azra			Diagnostic features of quantitative combpush shear elastography for breast lesion differentiation	PLOS ONE			English	Article							WAVE ELASTOGRAPHY; ULTRASOUND; US; MAMMOGRAPHY; BENIGN; MASSES	Background Lesion stiffness measured by shear wave elastography has shown to effectively separate benign from malignant breast masses. The aim of this study was to evaluate different aspects of Comb-push Ultrasound Shear Elastography (CUSE) performance in differentiating breast masses. Methods With written signed informed consent, this HIPAA-compliant, IRB approved prospective study included patients from April 2014 through August 2016 with breast masses identified on conventional imaging. Data from 223 patients (19 - 85 years, mean 59.93 +/- 14.96 years) with 227 suspicious breast masses identifiable by ultrasound (mean size 1.83 +/- 2.45cm) were analyzed. CUSE was performed on all patients. Three regions of interest (ROI), 3 mm in diameter each, were selected inside the lesion on the B-mode ultrasound which also appeared in the corresponding shear wave map. Lesion elasticity values were measured in terms of the Young's modulus. In correlation to pathology results, statistical analyses were performed. Results Pathology revealed 108 lesions as malignant and 115 lesions as benign. Additionally, 4 lesions (BI-RADS 2 and 3) were considered benign and were not biopsied. Average lesion stiffness measured by CUSE resulted in 84.26% sensitivity (91 of 108), 89.92% specificity (107 of 119), 85.6% positive predictive value, 89% negative predictive value and 0.91 area under the curve (P< 0.0001). Stiffness maps showed spatial continuity such that maximum and average elasticity did not have significantly different results (P > 0.21). Conclusion CUSE was able to distinguish between benign and malignant breast masses with high sensitivity and specificity. Continuity of stiffness maps allowed for choosing multiple quantification ROIs which covered large areas of lesions and resulted in similar diagnostic performance based on average and maximum elasticity. The overall results of this study, highlights the clinical value of CUSE in differentiation of breast masses based on their stiffness.	[Bayat, Mahdi; Gregory, Adriana; Mehrmohammadi, Mohammad; Kumar, Viksit; Fatemi, Mostafa; Alizad, Azra] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Denis, Max; Meixner, Duane; Fazzio, Robert T.; Alizad, Azra] Mayo Clin, Coll Med, Dept Radiol, Rochester, MN 55905 USA; [Alizad, Azra] Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA; [Mehrmohammadi, Mohammad] Wayne State Univ, Dept Biomed Engn, 42 W Warren Ave, Detroit, MI USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Wayne State University	Alizad, A (corresponding author), Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.; Alizad, A (corresponding author), Mayo Clin, Coll Med, Dept Radiol, Rochester, MN 55905 USA.; Alizad, A (corresponding author), Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA.	aza@mayo.edu		Fatemi, Mostafa/0000-0002-6603-9077; Alizad, Azra/0000-0002-7658-1572; Mehrmohammadi, Mohammad/0000-0002-9264-9354; Bayat, Mahdi/0000-0001-9069-0823	NIH-National Cancer Institute [R01CA148994, R01CA148994-S1, R01CA168575, R01EB017213, R01CA174723]; National Institute of Biomedical Imaging and Bioengineering [R01EB017213]; NATIONAL CANCER INSTITUTE [R01CA148994] Funding Source: NIH RePORTER	NIH-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by grants R01CA148994, R01CA148994-S1, R01CA168575, R01EB017213 and R01CA174723 from the NIH-National Cancer Institute and R01EB017213 from the National Institute of Biomedical Imaging and Bioengineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Institute of Ultrasound in Medicine, 2009, J Ultrasound Med, V28, P105; Athanasiou A, 2010, RADIOLOGY, V256, P297, DOI 10.1148/radiol.10090385; Barr RG, 2014, RADIOLOGY; Barr RG, 2012, J ULTRAS MED, V31, P347, DOI 10.7863/jum.2012.31.3.347; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Burnside ES, 2007, RADIOLOGY, V245, P401, DOI 10.1148/radiol.2452061805; Cosgrove DO, 2012, EUR RADIOL, V22, P1023, DOI 10.1007/s00330-011-2340-y; Denis M, 2015, PLOS ONE, V10; Denis M, 2015, IEEE T ULTRASON FERR, V62, P1644, DOI 10.1109/TUFFC.2015.007043; Evans A, 2012, BRIT J CANCER, V107, P224, DOI 10.1038/bjc.2012.253; Evans A, 2012, BR J CANC; Evans A, 2012, RADIOLOGY, V263, P673, DOI 10.1148/radiol.12111317; Evans A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2787; Gregory A, 2015, ENG MED BIOL SOC EMB; Gregory A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137898; Kolb TM, 2002, RADIOLOGY, V225, P165, DOI 10.1148/radiol.2251011667; Li G., 2013, PLOS ONE, V8; Mehrmohammadi M, 2015, COMB PUSH ULTRASOUND; Neetu G, 2010, CASE REP ONCOL, V3, P245, DOI 10.1159/000318641; Nightingale K, 2002, P 2002 IEEE INT S; Nothacker M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-335; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Schaefer FKW, 2011, EUR J RADIOL, V77, P450, DOI 10.1016/j.ejrad.2009.08.026; SEWELL CW, 1995, RADIOL CLIN N AM, V33, P1067; Song PF, 2015, IEEE T ULTRASON FERR, V62, P290, DOI 10.1109/TUFFC.2014.006628; Song PF, 2012, IEEE T MED IMAGING, V31, P1821, DOI 10.1109/TMI.2012.2205586; Tang L, 2015, INT J CLIN EXP MED, V8, P10920; Yao MH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/142504; Zhou JQ, 2014, RADIOLOGY, V272, P63, DOI 10.1148/radiol.14130818	32	26	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172801	10.1371/journal.pone.0172801	http://dx.doi.org/10.1371/journal.pone.0172801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257467	gold, Green Published, Green Submitted			2022-12-26	WOS:000396021100028
J	Tsai, AYL; Chan, K; Ho, CY; Canam, T; Capron, R; Master, ER; Brautigam, K				Tsai, Alex Yi-Lin; Chan, Kin; Ho, Chi-Yip; Canam, Thomas; Capron, Resmi; Master, Emma R.; Brautigam, Katharina			Transgenic expression of fungal accessory hemicellulases in Arabidopsis thaliana triggers transcriptional patterns related to biotic stress and defense response	PLOS ONE			English	Article							PLANT-CELL WALL; RECEPTOR-LIKE KINASE; ETHYLENE BIOSYNTHESIS; BOTRYTIS-CINEREA; BINDING-PROTEINS; INCREASED RESISTANCE; NICOTIANA-TABACUM; SALICYLIC-ACID; POWDERY MILDEW; GENES	The plant cell wall is an abundant and renewable resource for lignocellulosic applications such as the production of biofuel. Due to structural and compositional complexities, the plant cell wall is, however, recalcitrant to hydrolysis and extraction of platform sugars. A cell wall engineering strategy to reduce this recalcitrance makes use of microbial cell wall modifying enzymes that are expressed directly in plants themselves. Previously, we constructed transgenic Arabidopsis thaliana constitutively expressing the fungal hemicellulases: Phanerochaete carnosa glucurnoyl esterase (PcGCE) and Aspergillus nidulans alpha-arabinofuranosidase (AnAF54). While the PcGCE lines demonstrated improved xylan extractability, they also displayed chlorotic leaves leading to the hypothesis that expression of such enzymes in planta resulted in plant stress. The objective of this study is to investigate the impact of transgenic expression of the aforementioned microbial hemicellulases in planta on the host arabidopsis. More specifically, we investigated transcriptome profiles by short read high throughput sequencing (RNAseq) from developmentally distinct parts of the plant stem. When compared to non-transformed wild-type plants, a subset of genes was identified that showed differential transcript abundance in all transgenic lines and tissues investigated. Intriguingly, this core set of genes was significantly enriched for those involved in plant defense and biotic stress responses. While stress and defense-related genes showed increased transcript abundance in the transgenic plants regardless of tissue or genotype, genes involved in photosynthesis ( light harvesting) were decreased in their transcript abundance potentially reflecting wide-spread effects of heterologous microbial transgene expression and the maintenance of plant homeostasis. Additionally, an increase in transcript abundance for genes involved in salicylic acid signaling further substantiates our finding that transgenic expression of microbial cell wall modifying enzymes induces transcriptome responses similar to those observed in defense responses.	[Tsai, Alex Yi-Lin; Brautigam, Katharina] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Tsai, Alex Yi-Lin] Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Berkeley, CA USA; [Chan, Kin; Ho, Chi-Yip] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Canam, Thomas] Eastern Illinois Univ, Dept Biol Sci, Charleston, IL 61920 USA; [Capron, Resmi; Master, Emma R.] Univ Toronto, Dept Chem Engn Appl Chem, Toronto, ON, Canada; [Brautigam, Katharina] Univ Toronto, Dept Biol, Mississauga, ON, Canada	University of Toronto; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Lawrence Berkeley National Laboratory; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Eastern Illinois University; University of Toronto; University of Toronto; University Toronto Mississauga	Brautigam, K (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.; Brautigam, K (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON, Canada.	katharina.braeutigam@utoronto.ca	Master, Emma/O-3554-2014	Master, Emma/0000-0002-6837-9817; Canam, Thomas/0000-0002-7674-5653; Braeutigam, Katharina/0000-0001-5655-7156	Government of Ontario [ORF-RE-05-005]; Natural Sciences and Engineering Research Council of Canada; University of Toronto; DOE Joint BioEnergy Institute by U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Lawrence Berkeley National Laboratory; U. S. Department of Energy	Government of Ontario; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Toronto(University of Toronto); DOE Joint BioEnergy Institute by U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); U. S. Department of Energy(United States Department of Energy (DOE))	Funding for this research was provided by the Government of Ontario for the project Forest FAB: Applied Genomics for Functionalized Fiber and Biochemicals (ORF-RE-05-005), the Natural Sciences and Engineering Research Council of Canada. This work was also partly funded through the University of Toronto and the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U. S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Alves MS, 2014, PROTEOMES, V2, DOI 10.3390/proteomes2010085; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; AVNI A, 1994, PLANT PHYSIOL, V106, P1049, DOI 10.1104/pp.106.3.1049; BAILEY BA, 1990, PLANT PHYSIOL, V94, P1849, DOI 10.1104/pp.94.4.1849; Bellincampi D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00228; Berardini TZ, 2004, PLANT PHYSIOL, V135, P745, DOI 10.1104/pp.104.040071; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Bethke G, 2014, PLANT PHYSIOL, V164, P1093, DOI 10.1104/pp.113.227637; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Buanafina MMD, 2015, PLANTA, V242, P97, DOI 10.1007/s00425-015-2288-2; Chou HL, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-58; COTE F, 1994, PLANT MOL BIOL, V26, P1379, DOI 10.1007/BF00016481; Ehlting J, 2005, PLANT J, V42, P618, DOI 10.1111/j.1365-313X.2005.02403.x; Ellinger D, 2013, PLANT PHYSIOL, V161, P1433, DOI 10.1104/pp.112.211011; Enkerli J, 1999, PLANT PHYSIOL, V121, P391, DOI 10.1104/pp.121.2.391; Ferrari S, 2008, PLANT PHYSIOL, V146, P669, DOI 10.1104/pp.107.109686; FRY SC, 1993, PLANT PHYSIOL, V103, P1, DOI 10.1104/pp.103.1.1; Gandla ML, 2015, PHYTOCHEMISTRY, V112, P210, DOI 10.1016/j.phytochem.2014.06.002; Hall H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-14; Hamann T, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00077; Hortensteiner S, 2011, BBA-BIOENERGETICS, V1807, P977, DOI 10.1016/j.bbabio.2010.12.007; ISHII T, 1992, PLANT CELL PHYSIOL, V33, P321, DOI 10.1093/oxfordjournals.pcp.a078257; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kim KC, 2008, PLANT CELL, V20, P2357, DOI 10.1105/tpc.107.055566; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; Klose H, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0443-3; Klose H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-53; Lai ZB, 2011, PLANT CELL, V23, P3824, DOI 10.1105/tpc.111.090571; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2006, PLANT J, V46, P477, DOI 10.1111/j.1365-313X.2006.02712.x; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Liu R, 2013, J EXP BOT, V64, P5443, DOI 10.1093/jxb/ert307; Liu SA, 2015, ELIFE, V4, DOI 10.7554/eLife.07295; Llorente F, 2005, PLANT J, V43, P165, DOI 10.1111/j.1365-313X.2005.02440.x; Malinovsky FG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00178; Manabe Y, 2011, PLANT PHYSIOL, V155, P1068, DOI 10.1104/pp.110.168989; Minic Z, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-6; Narusaka M, 2008, J GEN PLANT PATHOL, V74, P345, DOI 10.1007/s10327-008-0117-1; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pogorelko G, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25435; Pogorelko G, 2013, PLANT PHYSIOL, V162, P9, DOI 10.1104/pp.113.214460; Pogorelko G, 2011, PLANT MOL BIOL, V77, P433, DOI 10.1007/s11103-011-9822-9; Raiola A, 2011, MOL PLANT MICROBE IN, V24, P432, DOI 10.1094/MPMI-07-10-0157; Ramonell K, 2005, PLANT PHYSIOL, V138, P1027, DOI 10.1104/pp.105.060947; Reem NT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00630; Rennie EA, 2014, CURR OPIN BIOTECH, V26, P100, DOI 10.1016/j.copbio.2013.11.013; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanchez-Rodriguez C, 2009, MOL PLANT MICROBE IN, V22, P953, DOI 10.1094/MPMI-22-8-0953; SHARON A, 1993, PLANT PHYSIOL, V102, P1325, DOI 10.1104/pp.102.4.1325; Sindhu R, 2016, BIORESOURCE TECHNOL, V199, P76, DOI 10.1016/j.biortech.2015.08.030; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai AYL, 2012, PLANT BIOTECHNOL J, V10, P1077, DOI 10.1111/j.1467-7652.2012.00735.x; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Yano A, 1998, MOL PLANT MICROBE IN, V11, P115, DOI 10.1094/MPMI.1998.11.2.115; Yi X, 2013, NUCLEIC ACIDS RES, V41, pW98, DOI 10.1093/nar/gkt281; Yu DQ, 2001, PLANT CELL, V13, P1527, DOI 10.1105/tpc.13.7.1527; Zhang D, 2011, BIOENERG RES, V4, P276, DOI 10.1007/s12155-011-9138-2; Zhong RQ, 2015, PLANT CELL PHYSIOL, V56, P195, DOI 10.1093/pcp/pcu140	64	2	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173094	10.1371/journal.pone.0173094	http://dx.doi.org/10.1371/journal.pone.0173094			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253318	Green Published, gold, Green Submitted			2022-12-26	WOS:000396011300072
J	Yu, L; Di, Y; Xin, L; Ren, Y; Liu, X; Sun, X; Zhang, W; Yao, Z; Yang, J				Yu, L.; Di, Y.; Xin, L.; Ren, Y.; Liu, X.; Sun, X.; Zhang, W.; Yao, Z.; Yang, J.			SND1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGF beta 1 response and breast cancer metastasis	ONCOGENE			English	Article							GROWTH-FACTOR-BETA; NUCLEASE TUDOR-SN; TGF-BETA; TUMOR-SUPPRESSOR; ACETYLTRANSFERASE ACTIVITY; COACTIVATOR; ENHANCE; PROTEIN; REGULATOR; CARCINOMA	As an AEG-1/MTDH/LYRIC-binding protein, Staphylococcal nuclease domain-containing 1 (SND1) is upregulated in numerous human cancers where it has been assigned multiple functional roles. In this study, we discovered that SND1 was upregulated in breast cancer tissues, particularly the tissues from patients with distant metastases. The underlying molecular mechanisms demonstrated a novel role of SND1 in regulating the activity of transforming growth factor beta 1 (TGF beta 1) signaling pathway, which promotes metastasis in breast cancer. We illustrated that SND1 physically associated with and recruited the histone acetylase GCN5 to the promoter regions of Smad2/3/4, and consequently enhanced the gene transcriptional activation of Smad2/3/4, which are essential downstream regulators in the TGF beta 1 pathway. An electrophoretic mobility shift assay experiment further verified that SND1 could recognize the conserved domains (motifs 1 and 2) in the promoter regions of the Smad genes. Glutathione S-transferase (GST) pulldown assays indicated that the tudor domain of SND1 was responsible for the recruitment of GCN5, which increased histone H3K9 acetylation. Consistent with these results, a loss-of-function of SND1 reduced the protein level of Smads and the phosphorylation of R-Smads, thereby attenuating the R-Smad/Co-Smad depended transcription and, as a result, inhibited TGF beta signaling activation.	[Yu, L.; Di, Y.; Xin, L.; Ren, Y.; Liu, X.; Sun, X.; Zhang, W.; Yang, J.] Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin, Peoples R China; [Yu, L.; Di, Y.; Xin, L.; Ren, Y.; Liu, X.; Sun, X.; Zhang, W.; Yao, Z.; Yang, J.] Tianjin Med Univ, Sch Basic Med Sci, Dept Immunol, Tianjin, Peoples R China; [Yu, L.; Di, Y.; Xin, L.; Ren, Y.; Liu, X.; Sun, X.; Zhang, W.; Yao, Z.; Yang, J.] Tianjin Med Univ, Res Ctr Basic Med Sci, Lab Mol Immunol, Tianjin, Peoples R China; [Yu, L.; Di, Y.; Xin, L.; Ren, Y.; Liu, X.; Sun, X.; Zhang, W.; Yao, Z.; Yang, J.] Tianjin Med Univ, Educ Minist China, Key Lab, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China; [Yu, L.; Di, Y.; Xin, L.; Ren, Y.; Liu, X.; Sun, X.; Zhang, W.; Yao, Z.; Yang, J.] Tianjin Med Univ, Tianjin Key Lab Cellular & Mol Immunol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Yu, L; Yao, Z; Yang, J (corresponding author), Tianjin Med Univ, Educ Minist China, Key Lab, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.; Yu, L; Yao, Z; Yang, J (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol,Res Ctr Basic Med Sci, Dept Immunol,Lab Mol Immunol,Tianjin Key Lab Cell, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.	onoblivion@tmu.edu.cn; yaozhi@tijmu.edu.cn; yangj@tijmu.edu.cn	Yu, Lin/AAH-1131-2019	Yu, Lin/0000-0002-9972-3799	National Science Foundation for Distinguished Young Scholars of China [31125012]; National Natural Science Foundation of China [81202102, 81672592, 31370749, 31670759, 81572882]; Project for Innovative Research Team of Ministry of Education [IRT13085]; Project of Applicative Basic Research and Advanced Technology of Tianjin Municipal Science and Technology Commission [13JCQNJC12100]; Specialized Research Fund for the Doctoral Program of Higher Education [20121202120018]	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project for Innovative Research Team of Ministry of Education; Project of Applicative Basic Research and Advanced Technology of Tianjin Municipal Science and Technology Commission; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grant from the National Science Foundation for Distinguished Young Scholars of China (31125012 to JY), grants from the National Natural Science Foundation of China (81202102 and 81672592 to LY, 31370749 and 31670759 to JY and 81572882 to ZY), grant from Project for Innovative Research Team of Ministry of Education (IRT13085 to JY), grants from Project of Applicative Basic Research and Advanced Technology of Tianjin Municipal Science and Technology Commission (13JCQNJC12100 to LY) and grant from Specialized Research Fund for the Doctoral Program of Higher Education (20121202120018 to LY).	Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Bai X, 2016, ANGEW CHEM INT EDIT, V55, P7993, DOI 10.1002/anie.201602558; Borcherding N, 2015, CANCER RES, V75, P1972, DOI 10.1158/0008-5472.CAN-14-2761; Callebaut I, 1997, BIOCHEM J, V321, P125, DOI 10.1042/bj3210125; Cappellari M, 2014, ONCOGENE, V33, P3794, DOI 10.1038/onc.2013.360; Cerami Ethan G, 2011, Nucleic Acids Res, V39, pD685, DOI 10.1093/nar/gkq1039; Do TV, 2008, MOL CANCER RES, V6, P695, DOI 10.1158/1541-7786.MCR-07-0294; Drabsch Y, 2012, CANCER METAST REV, V31, P553, DOI 10.1007/s10555-012-9375-7; Gao XJ, 2012, J BIOL CHEM, V287, P18130, DOI 10.1074/jbc.M111.311852; He YB, 2014, NAT NEUROSCI, V17, P943, DOI 10.1038/nn.3732; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang L, 2007, J BIOL CHEM, V282, P27923, DOI 10.1074/jbc.M704194200; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kannan N, 2014, CELL STEM CELL, V15, P118, DOI 10.1016/j.stem.2014.07.010; Kuruma H, 2009, AM J PATHOL, V174, P2044, DOI 10.2353/ajpath.2009.080776; Lee IH, 2014, ONCOGENE, V33, P4675, DOI 10.1038/onc.2014.69; Lee SG, 2013, ADV CANCER RES, V120, P1, DOI 10.1016/B978-0-12-401676-7.00001-2; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; Li CL, 2008, NUCLEIC ACIDS RES, V36, P3579, DOI 10.1093/nar/gkn236; Liu L, 2015, NUCLEIC ACIDS RES, V43, P3873, DOI 10.1093/nar/gkv255; Liu X, 2011, CELL MOL IMMUNOL, V8, P88, DOI 10.1038/cmi.2010.47; Murphy SJ, 2016, CANCER RES, V76, P749, DOI 10.1158/0008-5472.CAN-15-2198; Nam JS, 2006, CANCER RES, V66, P6327, DOI 10.1158/0008-5472.CAN-06-0068; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Quintana AM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-30; Riss A, 2015, J BIOL CHEM, V290, P28997, DOI 10.1074/jbc.M115.668533; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Shaw N, 2007, NAT STRUCT MOL BIOL, V14, P779, DOI 10.1038/nsmb1269; Su C, 2015, J BIOL CHEM, V290, P7208, DOI 10.1074/jbc.M114.625046; Valineva T, 2005, J BIOL CHEM, V280, P14989, DOI 10.1074/jbc.M410465200; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wang G, 2015, ONCOGENE, V35, P4388; Wang N, 2012, MOL BIOL REP, V39, P10497, DOI 10.1007/s11033-012-1933-0; [王旭 WANG Xu], 2010, [高分子通报, Polymer Bulletin], P1; Xie W, 2002, CANCER RES, V62, P497; Xu J, 2015, CANCER CELL, V27, P177, DOI 10.1016/j.ccell.2014.11.025; Yan XH, 2016, J BIOL CHEM, V291, P382, DOI 10.1074/jbc.M115.694281; Yang L, 2010, CANCER METAST REV, V29, P263, DOI 10.1007/s10555-010-9226-3; Yin J, 2013, ANAT REC, V296, P1568, DOI 10.1002/ar.22737; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Yu L, 2015, CANCER RES, V75, P1275, DOI 10.1158/0008-5472.CAN-14-2387	41	28	30	4	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 6	2017	36	27					3903	3914		10.1038/onc.2017.30	http://dx.doi.org/10.1038/onc.2017.30			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EZ6SM	28263968				2022-12-26	WOS:000404848200010
J	Xu, J; McPherson, PS				Xu, Jie; McPherson, Peter S.			Regulation of DENND3, the exchange factor for the small GTPase Rab12 through an intramolecular interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXANUCLEOTIDE REPEAT; STRUCTURAL BASIS; N-WASP; PHOSPHORYLATION; C9ORF72; AUTOINHIBITION; ACTIVATION; AUTOPHAGY; PROTEIN; DOMAIN	The Rab family of small GTPases functions in multiple aspects of cellular membrane trafficking. Proteins bearing a differentially expressed in normal and neoplastic cells (DENN) domain have emerged as the largest family of Rab-activating guanine nucleotide exchange factors (GEFs). Rab12 functions in the initiation of starvation-induced autophagy, and our previous work revealed that its activator, DENN domain-containing protein 3 (DENND3), is phosphorylated and activated upon starvation. However, how the GEF activity of DENND3 toward Rab12 is regulated at the molecular level is still not understood. Here, we combine size-exclusion chromatography, Forster resonance energy transfer, pulldown, and in vitro GEF assays to demonstrate that regulation of GEF activity is achieved through an intramolecular interaction that is controlled by a key residue in DENND3, tyrosine 940. Our study sheds light on the regulation of Rab12 activation and lays the groundwork for characterizing the regulation of other DENN domain-containing proteins.	[Xu, Jie; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, 3801 Univ, Montreal, PQ H3A 2B4, Canada	McGill University	Xu, J; McPherson, PS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, 3801 Univ, Montreal, PQ H3A 2B4, Canada.	jie.xu3@mail.mcgill.ca; peter.mcpherson@mcgill.ca			Canadian Institutes of Health Research [MOP-62684]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-62684 (to P. S. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Amick J, 2016, MOL BIOL CELL, V27, P3040, DOI 10.1091/mbc.E16-01-0003; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Fisslthaler B, 2008, CIRC RES, V102, P1520, DOI 10.1161/CIRCRESAHA.108.172072; Han CS, 2016, AM J HUM GENET, V99, P1359, DOI 10.1016/j.ajhg.2016.10.006; He XJ, 2013, STRUCTURE, V21, P355, DOI 10.1016/j.str.2013.01.001; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Levine TP, 2013, BIOINFORMATICS, V29, P499, DOI 10.1093/bioinformatics/bts725; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Matsui T, 2011, TRAFFIC, V12, P1432, DOI 10.1111/j.1600-0854.2011.01240.x; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Sellier C, 2016, EMBO J, V35, P1276, DOI 10.15252/embj.201593350; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Xu J, 2015, CELL CYCLE, V14, P2717, DOI 10.1080/15384101.2015.1071136; Xu J, 2015, EMBO REP, V16, P709, DOI 10.15252/embr.201440006; Yang CW, 2016, CELL, V164, P141, DOI 10.1016/j.cell.2015.11.052; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Zhang Dapeng, 2012, Frontiers in Genetics, V3, P283, DOI 10.3389/fgene.2012.00283; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717; Zhang Z, 2014, ELIFE, V3, DOI 10.7554/eLife.02687; Zimnicka AM, 2016, MOL BIOL CELL, V27, P2090, DOI 10.1091/mbc.E15-11-0756	33	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7274	7282		10.1074/jbc.M116.772434	http://dx.doi.org/10.1074/jbc.M116.772434			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28249939	Green Published, hybrid			2022-12-26	WOS:000400478300036
J	Chowdhury, R; Taneja, S; Bhandari, N; Sinha, B; Upadhyay, RP; Bhan, MK; Strand, TA				Chowdhury, Ranadip; Taneja, Sunita; Bhandari, Nita; Sinha, Bireshwar; Upadhyay, Ravi Prakash; Bhan, Maharaj Kishan; Strand, Tor A.			Vitamin-D deficiency predicts infections in young north Indian children: A secondary data analysis	PLOS ONE			English	Article							LOWER RESPIRATORY-INFECTION; ZINC SUPPLEMENTATION; CHILDHOOD DIARRHEA; PNEUMONIA; MALNUTRITION; NUTRITION; RECEPTOR; DISEASE; RISK	Background Recent studies have demonstrated a relationship between poor vitamin D status and respiratory infections and diarrhea among young children. Acute lower respiratory infections (ALRI) and diarrhea are among the two most important causes of death in under-5 children. In this paper, we examined the extent to which vitamin-D deficiency (<10 ng/ml) predicts ALRI, clinical pneumonia and diarrhea among 6 to 30 months old children. Methods We used data from a randomized controlled trial (RCT) of daily folic acid and/or vitamin B12 supplementation for six months in 6 to 30 months old children conducted in Delhi, India. Generalized estimating equations (GEE) were used to examine the associations between vitamin-D deficiency and episodes of ALRI, clinical pneumonia and diarrhea. Results Of the 960 subjects who had vitamin-D concentrations measured, 331(34.5%) were vitamin-D deficient. We found, after controlling for relevant potential confounders (age, sex, breastfeeding status, wasting, stunting, underweight, anemia status and season), that the risk of ALRI was significantly higher among vitamin-D deficient (OR 1.26; 95% CI: 1.03 to 1.55) compared to vitamin-D-replete children in the six months follow-up period. Vitamin-D status was not associated with episodes of diarrhea or clinical pneumonia. Conclusion Vitamin-D deficiency is common in young children in New Delhi and is associated with a higher risk of ALRI. The role of vitamin D in Indian children needs to be elucidated in further studies.	[Chowdhury, Ranadip; Taneja, Sunita; Bhandari, Nita; Sinha, Bireshwar; Upadhyay, Ravi Prakash] Soc Appl Studies, Ctr Hlth Res & Dev, New Delhi, India; [Bhan, Maharaj Kishan] Indian Inst Technol Delhi, New Delhi, India; [Bhan, Maharaj Kishan] BIRAC, Knowledge Integrat & Translat Platform KnIT, New Delhi, India; [Strand, Tor A.] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth, Ctr Int Hlth, Bergen, Norway; [Strand, Tor A.] Innlandet Hosp Trust, Dept Res, Brumunddal, Norway	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Biotechnology Industry Research Assistance Council (BIRAC); University of Bergen; Innlandet Hospital Trust	Chowdhury, R (corresponding author), Soc Appl Studies, Ctr Hlth Res & Dev, New Delhi, India.	ranadip.chowdhury@sas.org.in	Strand, Tor/D-9836-2016; Chowdhury, Ranadip/P-2416-2019	Strand, Tor/0000-0002-4038-151X; Chowdhury, Ranadip/0000-0002-0055-6653	Centre for Intervention Science in Maternal and Child Health (CISMAC GRANTS) [250216, 223269]; Research Council of Norway through its Centres of Excellence scheme; University of Bergen (UiB), Norway; South-Eastern Norway Regional Health Authority [2012090]; Thrasher Research Fund [9144]; Centre for Intervention Science in Maternal and Child Health (RCN Project) [223269]; Centre for International Health, University of Bergen (Norway); Knowledge Integration and Technology Platform (KnIT); Grand Challenges Initiative of the Department of Biotechnology and Biotechnology Industry Research Assistance Council (BIRAC) of Government of India; Bill & Melinda Gates Foundation (USA); Centre for Intervention Science in Maternal and Child Health (CISMAC) [223269]	Centre for Intervention Science in Maternal and Child Health (CISMAC GRANTS); Research Council of Norway through its Centres of Excellence scheme; University of Bergen (UiB), Norway; South-Eastern Norway Regional Health Authority; Thrasher Research Fund; Centre for Intervention Science in Maternal and Child Health (RCN Project); Centre for International Health, University of Bergen (Norway); Knowledge Integration and Technology Platform (KnIT); Grand Challenges Initiative of the Department of Biotechnology and Biotechnology Industry Research Assistance Council (BIRAC) of Government of India; Bill & Melinda Gates Foundation (USA)(Bill & Melinda Gates Foundation); Centre for Intervention Science in Maternal and Child Health (CISMAC)	The study was supported by grants from the Centre for Intervention Science in Maternal and Child Health (CISMAC GRANTS 250216) (CISMAC; project number 223269), which is funded by the Research Council of Norway through its Centres of Excellence scheme and the University of Bergen (UiB), Norway. The implementation of the main trial was supported by grants from the South-Eastern Norway Regional Health Authority (grant no. 2012090) and Thrasher Research Fund (grant no. 9144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the input from Ratnasamy Selvakumar, Department of Biochemistry from Christian Medical College, Vellore, India for biochemical analysis. The Society for Applied Studies acknowledges the core support provided by the Department of Maternal, Newborn, Child and Adolescent Health, World Health Organisation, Geneva (WHO Collaborating Centre IND-096) and the Centre for Intervention Science in Maternal and Child Health (RCN Project No. 223269), Centre for International Health, University of Bergen (Norway). We also acknowledge the support extended by the Knowledge Integration and Technology Platform (KnIT), a Grand Challenges Initiative of the Department of Biotechnology and Biotechnology Industry Research Assistance Council (BIRAC) of Government of India and Bill & Melinda Gates Foundation (USA). We also acknowledge Centre for Intervention Science in Maternal and Child Health (CISMAC; project number 223269), which is funded by the Research Council of Norway through its Centres of Excellence scheme and the University of Bergen (UiB), Norway. The implementation of the main trial was supported by grants from the South-Eastern Norway Regional Health Authority (grant no. 2012090) and Thrasher Research Fund (grant no. 9144).	Abba K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-88; Ahmed AMS, 2016, EUR J CLIN NUTR, V70, P620, DOI 10.1038/ejcn.2016.7; Aluisio AR, 2013, PEDIATRICS, V132, pE832, DOI 10.1542/peds.2012-3986; Bhandari N, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e86; Bhandari N, 2002, BRIT MED J, V324, P1358, DOI 10.1136/bmj.324.7350.1358; Bhutta ZA, 2013, PEDIATRICS, V131, P634, DOI 10.1542/peds.2012-3737; Bikle DD, 2008, CURR OPIN NEPHROL HY, V17, P348, DOI 10.1097/MNH.0b013e3282ff64a3; Cantorna MT, 2000, P SOC EXP BIOL MED, V223, P230, DOI 10.1046/j.1525-1373.2000.22333.x; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Costelloe SJ, 2009, ANN CLIN BIOCHEM, V46, P86, DOI 10.1258/acb.2008.008157; Craig TA, 2001, RAPID COMMUN MASS SP, V15, P1011, DOI 10.1002/rcm.332; El Sakka AS, 2014, EGYPT PEDIATR ASSO, V62, P1, DOI 10.1016/j.epag.2013.12.001; Esposito S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1196-1; Fischer Walker Christa L, 2012, BMC Public Health, V12, P220, DOI 10.1186/1471-2458-12-220; Gopalan C, 1996, NUTR VALUE INDIAN FO, P45; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; Harinarayan C V, 2009, J Assoc Physicians India, V57, P40; Harinarayan CV, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.23873; Holick MF, 2010, ENDOCRIN METAB CLIN, V39, P381, DOI [10.1016/j.rdc.2012.03.013, 10.1016/j.ecl.2010.02.016]; Hollis BW, 2015, PEDIATRICS, V136, P625, DOI 10.1542/peds.2015-1669; Hollis BW, 2004, J CLIN ENDOCR METAB, V89, P3149, DOI 10.1210/jc.2004-0682; Hughes DA, 2009, CLIN EXP IMMUNOL, V158, P20, DOI 10.1111/j.1365-2249.2009.04001.x; Kamen DL, 2010, J MOL MED BERL, V88, P50; Karatekin G, 2009, EUR J CLIN NUTR, V63, P473, DOI 10.1038/sj.ejcn.1602960; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Lamberg-Allardt C, 2006, PROG BIOPHYS MOL BIO, V92, P33, DOI 10.1016/j.pbiomolbio.2006.02.017; Lassi ZS, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005978.pub3; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mayo-Wilson E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009384.pub2; Mayo-Wilson E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5094; Muhe L, 1997, LANCET, V349, P1801, DOI 10.1016/S0140-6736(96)12098-5; Norris JM, 2001, LANCET, V358, P1476, DOI 10.1016/S0140-6736(01)06570-9; Pichler J, 2002, PEDIATR RES, V52, P12, DOI 10.1203/01.PDR.0000017267.23950.48; Puri S, 2008, BRIT J NUTR, V99, P876, DOI 10.1017/S0007114507831758; Quraishi SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081120; Ren Jing, 2013, Zhongguo Dang Dai Er Ke Za Zhi, V15, P519; Ritu G, 2014, NUTRIENTS, V6, P729, DOI 10.3390/nu6020729; Rodriguez L, 2011, INT J ENV RES PUB HE, V8, P1174, DOI 10.3390/ijerph8041174; Roth DE, 2010, ACTA PAEDIATR, V99, P389, DOI 10.1111/j.1651-2227.2009.01594.x; Roth DE, 2009, EUR J CLIN NUTR, V63, P297, DOI 10.1038/sj.ejcn.1602946; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Spiro A, 2014, NUTR BULL, V39, P322, DOI 10.1111/nbu.12108; Sun J, 2010, CURR OPIN GASTROEN, V26, P591, DOI 10.1097/MOG.0b013e32833d4b9f; Taneja S, 2013, AM J CLIN NUTR, V98, P731, DOI 10.3945/ajcn.113.059592; Thornton KA, 2013, PEDIATR INFECT DIS J, V32, P585, DOI 10.1097/INF.0b013e3182868989; Ulak M, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030149; Wayse V, 2004, EUR J CLIN NUTR, V58, P563, DOI 10.1038/sj.ejcn.1601845; Wei R, 2015, NUTRIENTS, V7, P8251, DOI 10.3390/nu7105392; Wood SN, 2000, J ROY STAT SOC B, V62, P413, DOI 10.1111/1467-9868.00240; World Health Organization, 2003, INT MAN CHILDH ILLN; Yakoob MY, 2016, COCHRANE DB SYST REV, V11, DOI [10.1002/14651858.CD008824.pub2, DOI 10.1002/14651858.CD008824.PUB2]	52	14	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0170509	10.1371/journal.pone.0170509	http://dx.doi.org/10.1371/journal.pone.0170509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273084	gold, Green Submitted, Green Published			2022-12-26	WOS:000396073700091
J	Yang, SB; Li, XF; Wu, C; He, X; Zhong, Y				Yang, Shaobo; Li, Xingfei; Wu, Chao; He, Xin; Zhong, Ying			Application of the PJ and NPS evaporation duct models over the South China Sea (SCS) in winter	PLOS ONE			English	Article								The detection of duct height has a significant effect on marine radar or wireless apparatus applications. The paper presents two models to verify the adaptation of evaporation duct models in the SCS in winter. A meteorological gradient instrument used to measure evaporation ducts was fabricated using hydrological and meteorological sensors at different heights. An experiment on the adaptive characteristics of evaporation duct models was carried out over the SCS. The heights of the evaporation ducts were measured by means of log-linear fit, Paulus-Jeske (PJ) and Naval Postgraduate School (NPS) models. The results showed that NPS model offered significant advantages in stability compared with the PJ model. According the collected data computed by the NPS model, the mean deviation (MD) was -1.7 m, and the Standard Deviation (STD) of the MD was 0.8 m compared with the true value. The NPS model may be more suitable for estimating the evaporation duct height in the SCS in winter due to its simpler system characteristics compared with meteorological gradient instruments.	[Yang, Shaobo; Li, Xingfei; Wu, Chao; He, Xin; Zhong, Ying] Tianjin Univ, State Key Lab Precis Measuring Technol & Instrume, Tianjin, Peoples R China	Tianjin University	Li, XF (corresponding author), Tianjin Univ, State Key Lab Precis Measuring Technol & Instrume, Tianjin, Peoples R China.	lixftju@sina.com						Babin SM, 1997, J APPL METEOROL, V36, P193, DOI 10.1175/1520-0450(1997)036<0193:ANMOTO>2.0.CO;2; Babin SM, 2002, J APPL METEOROL, V41, P434, DOI 10.1175/1520-0450(2002)041<0434:LBEDMC>2.0.CO;2; Cheng YH, 2013, CHINESE J RADIO SCI, V28, P797; Cheng YH, 2016, CHIN J OCEANOL LIMN, V34, P619, DOI 10.1007/s00343-016-4275-2; Cheng YH, 2015, ACTA OCEANOL SIN, V34, P63, DOI 10.1007/s13131-015-0749-x; [成印河 Cheng Yinhe], 2013, [地球科学进展, Advance in Earth Sciences], V28, P318; Ding J L, 2008, MARIN SCI B, V28, P86; Edson JB, 2013, J PHYS OCEANOGR, V43, P1589, DOI 10.1175/JPO-D-12-0173.1; Jeske H, 1971, STATE RADAR RANGE 2; Jobson Harvey E., 1984, METEOROLOGY, V33, P267; Lowry AR, 2002, RADIO SCI, V37, DOI 10.1029/2000RS002565; Patterson WL, 2002, IEEE RAD C, P891; Rogers LT, 1997, RADIO SCI, V32, P79, DOI 10.1029/96RS02904; Tian B, 2009, SHIP SCI TECHNOLOGY, V31, P96; Yang C, 2014, RADIOENGINEERING, V2, P96; Yang KD, 2009, ACTA PHYS SIN-CH ED, V58, P7339, DOI 10.7498/aps.58.7339; Yang SB, 2016, MICROCHIM ACTA, P1; Yardim C, 2007, STAT ESTIMATION TRAC; Yardim C, 2009, RADIO SCI, V44, DOI 10.1029/2008RS003897; Zhang J., 2012, PESTICIDE SCI ADM, V12, P20; Zhang L, 2010, WIREL NETW MOB COMMU, P1; Zhao XF, 2013, CHINESE SCI BULL, V58, P2794, DOI 10.1007/s11434-013-5942-8; Zhao XF, 2012, IEEE T ANTENN PROPAG, V60, P1020, DOI 10.1109/TAP.2011.2173115; Zhu MY, 2012, PHYSCS PROC, V33, P1670, DOI 10.1016/j.phpro.2012.05.269	24	12	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172284	10.1371/journal.pone.0172284	http://dx.doi.org/10.1371/journal.pone.0172284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273113	Green Published, Green Submitted, gold			2022-12-26	WOS:000396073700072
J	Aslam, M; Arif, OH; Jun, CH				Aslam, Muhammad; Arif, Osama H.; Jun, Chi-Hyuck			An attribute control chart for a Weibull distribution under accelerated hybrid censoring	PLOS ONE			English	Article							EXACT LIKELIHOOD INFERENCE; STEP-STRESS MODEL; EXPONENTIAL-DISTRIBUTION	In this article, an attribute control chart has been proposed using the accelerated hybrid censoring logic for the monitoring of defective items whose life follows a Weibull distribution. The product can be tested by introducing the acceleration factor based on different pressurized conditions such as stress, load, strain, temperature, etc. The control limits are derived based on the binomial distribution, but the fraction defective is expressed only through the shape parameter, the acceleration factor and the test duration constant. Tables of the average run lengths have been generated for different process parameters to assess the performance of the proposed control chart. Simulation studies have been performed for the practical use, where the proposed chart is compared with the Shewhart np chart for demonstration of the detection power of a process shift.	[Aslam, Muhammad; Arif, Osama H.] King Abdulaziz Univ, Dept Stat, Fac Sci, Jeddah, Saudi Arabia; [Jun, Chi-Hyuck] POSTECH, Dept Ind & Management Engn, Pohang, South Korea	King Abdulaziz University; Pohang University of Science & Technology (POSTECH)	Aslam, M (corresponding author), King Abdulaziz Univ, Dept Stat, Fac Sci, Jeddah, Saudi Arabia.	aslam_ravian@hotmail.com	Jun, Chi-Hyuck/AAE-1695-2019; Aslam, Muhammad/GRS-8220-2022; Aslam, Muhammad/E-6354-2015; Arif, Osama/L-7302-2015	Aslam, Muhammad/0000-0002-6071-5468; Aslam, Muhammad/0000-0003-0644-1950; Arif, Osama/0000-0001-5798-0706	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia [D1435-1006-130]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia; DSR	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia, under grant No. (D1435-1006-130). The authors, therefore, acknowledge with thanks DSR technical and financial support.	Ahmad L, 2014, T I MEAS CONTROL, V36, P367, DOI 10.1177/0142331213502070; Aslam M., 2016, QUALITY RELIABILITY; Aslam M, 2015, P I MECH ENG O-J RIS, V229, P193, DOI 10.1177/1748006X15572499; Bagdonaviius V., 2001, ACCELERATED LIFE MOD, DOI 10.1201/9781420035872; Balakrishnan N, 2008, J STAT COMPUT SIM, V78, P475, DOI 10.1080/00949650601158336; Balakrishnan N, 2007, J STAT PLAN INFER, V137, P2543, DOI 10.1016/j.jspi.2006.04.017; Balakrishnan N, 2007, J STAT PLAN INFER, V137, P3268, DOI 10.1016/j.jspi.2007.03.011; Balakrishnan N, 2013, COMPUT STAT DATA AN, V57, P166, DOI 10.1016/j.csda.2012.03.025; Bao L., 2011, SPIE LASE; Carson PK, 2008, IND ENG CHEM RES, V47, P405, DOI 10.1021/ie070589b; Chandrasekar B, 2004, NAV RES LOG, V51, P994, DOI 10.1002/nav.20038; Childs A, 2003, ANN I STAT MATH, V55, P319, DOI 10.1023/A:1026326020003; EPSTEIN B, 1954, ANN MATH STAT, V25, P555, DOI 10.1214/aoms/1177728723; FAIRBANKS K, 1982, J AM STAT ASSOC, V77, P137, DOI 10.2307/2287779; Gupta RD, 1998, COMMUN STAT-THEOR M, V27, P3065, DOI 10.1080/03610929808832273; Knoth S., 2007, SEQUENTIAL ANAL, V26, P251, DOI [10.1080/07474940701404823, DOI 10.1080/07474940701404823]; Li ZH, 2014, J STAT COMPUT SIM, V84, P1779, DOI 10.1080/00949655.2013.766737; Loughmiller D., 2011, QUALITY RELIABILITY; Meeker WQ., 2013, STAT METHODS RELIABI; Montgomery D.C., 2011, INTRO STAT QUALITY C, V6th; Nelson WB, 1990, ACCELERATED LIFE TES; Vigrass W., 2010, CALCULATIONS SEMICON; Yen FY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065440	23	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173406	10.1371/journal.pone.0173406	http://dx.doi.org/10.1371/journal.pone.0173406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257479	Green Published, gold, Green Submitted			2022-12-26	WOS:000396021100089
J	Chen, XW; Wang, J; Qian, L; Gaughan, S; Xiang, W; Ai, T; Fan, ZM; Wang, CH				Chen, Xiaowen; Wang, Jun; Qian, Long; Gaughan, Sarah; Xiang, Wei; Ai, Tao; Fan, Zhenming; Wang, Chenghui			Domestication drive the changes of immune and digestive system of Eurasian perch (Perca fluviatilis)	PLOS ONE			English	Article							RNA-SEQ DATA; WILD; GROWTH; ADAPTATION; ANNOTATION; ALIGNMENT; GENETICS; GENOMICS; ANIMALS; BIOLOGY	Domestication has altered a variety of traits within the Eurasian perch (Perca fluviatilis), including phenotypic, physiological and behavioral traits of Eurasian perch (Perca fluviatilis). Little is known, however, about the genetic changes between domesticated and wild Eurasian perch. In this study, we assembled a high-quality de novo reference transcriptome and identified differentially expressed genes between wild and domesticated Eurasian perch. A total of 113,709 transcripts were assembled, and 58,380 transcripts were annotated. Transcriptomic comparison revealed 630 differentially expressed genes between domesticated and wild Eurasian perch. Within domesticated Eurasian perch there were 412 genes that were up-regulated including MHCI, MHCII, chia, ighm within immune system development. There were 218 genes including try1, ctrl, ctrb, cela3b, cpa1 and cpb1, which were down-regulated that were associated with digestive processes. Our results indicated domestication drives the changes of immune and digestive system of Eurasian perch. Our study not only provide valuable genetic resources for further studies in Eurasian perch, but also provide novel insights into the genetic basis of physiological changes in Eurasian perch during domestication process.	[Chen, Xiaowen; Wang, Jun; Wang, Chenghui] Shanghai Ocean Univ, Key Lab Freshwater Fisheries Germplasm Resources, Minist Agr, Shanghai, Peoples R China; [Qian, Long; Xiang, Wei; Ai, Tao; Fan, Zhenming] Xinjiang Prod & Construct Corps, Fisheries Technol Extens Stn, Urumqi, Xinjiang, Peoples R China; [Gaughan, Sarah] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; University of Nebraska System	Wang, CH (corresponding author), Shanghai Ocean Univ, Key Lab Freshwater Fisheries Germplasm Resources, Minist Agr, Shanghai, Peoples R China.; Fan, ZM (corresponding author), Xinjiang Prod & Construct Corps, Fisheries Technol Extens Stn, Urumqi, Xinjiang, Peoples R China.	btscf@sina.com; wangch@shou.edu.cn		wang, jun/0000-0002-6591-3316	National Key Technology Support Program [2012BAD25B10-03]; Shanghai collaborative Innovation Center for Aquatic Animal Genetics and Breeding Project [ZF1206]; Shanghai Ocean University [A2- 0203-00-100220]; National Science Foundation East Asia and Pacific Summer Institutes for U.S. Graduate Students [1613917]	National Key Technology Support Program(National Key Technology R&D Program); Shanghai collaborative Innovation Center for Aquatic Animal Genetics and Breeding Project; Shanghai Ocean University; National Science Foundation East Asia and Pacific Summer Institutes for U.S. Graduate Students	This work was supported by the National Key Technology Support Program (Grant No.2012BAD25B10-03), the Shanghai collaborative Innovation Center for Aquatic Animal Genetics and Breeding Project (ZF1206), Shanghai Ocean University funding (Grant no A2- 0203-00-100220), and National Science Foundation East Asia and Pacific Summer Institutes for U.S. Graduate Students (1613917).	[Anonymous], 2010, IMMUNE REDISTRIBUTIO; [Anonymous], 2004, FOOD COMPETITION AND, P329; Ao JQ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005118; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Belteky J, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160033; Ben Khadher S, 2016, AQUACULT REP, V3, P136, DOI 10.1016/j.aqrep.2015.12.003; Bolger AM, 2014, BIOINFORMATICS; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cuvier-Peres A, 2001, FISH PHYSIOL BIOCHEM, V24, P279, DOI 10.1023/A:1015033300526; Devlin RH, 2013, J ANIM SCI, V91, P5247, DOI 10.2527/jas.2013-6612; Dong YH, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/903186; Douxfils J, 2011, FISH SHELLFISH IMMUN, V31, P1113, DOI 10.1016/j.fsi.2011.10.001; Douxfils J, 2011, COMP BIOCHEM PHYS A, V159, P92, DOI 10.1016/j.cbpa.2011.01.021; Douxfils J, 2015, DOMESTICATION RESPON, P743; Douxfils J, 2012, FISH SHELLFISH IMMUN, V33, P1112, DOI 10.1016/j.fsi.2012.08.013; FAO, 2016, CONTRIBUTING FOOD SE; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Huang SX, 2005, J BIOL CHEM, V280, P21183, DOI 10.1074/jbc.M501087200; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Jankowska B, 2007, CZECH J ANIM SCI, V52, P260, DOI 10.17221/2279-CJAS; Jankowska B, 2010, FOOD CHEM, V118, P764, DOI 10.1016/j.foodchem.2009.05.055; Jentoft S, 2005, COMP BIOCHEM PHYS A, V141, P353, DOI 10.1016/j.cbpb.2005.06.006; Krist'an J, 2012, TURK J FISH AQUAT SC, V12, P191, DOI 10.4194/1303-2712-v12_2_01; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larson G, 2014, P NATL ACAD SCI USA, V111, P6139, DOI 10.1073/pnas.1323964111; Larson G, 2013, TRENDS GENET, V29, P197, DOI 10.1016/j.tig.2013.01.003; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li QH, 2012, GENOMICS, V100, P314, DOI 10.1016/j.ygeno.2012.07.008; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzen K, 2012, BIOL REV, V87, P639, DOI 10.1111/j.1469-185X.2011.00215.x; Luczynska J, 2016, TURKISH J FISHERIES, V16; Mairesse G, 2005, AQUACULTURE, V246, P295, DOI 10.1016/j.aquaculture.2004.09.023; Malmstrom M, 2016, NAT GENET; Mandiki S.N.M., 2011, P298; Mirkena T, 2010, LIVEST SCI, V132, P1, DOI 10.1016/j.livsci.2010.05.003; Montague MJ, 2014, P NATL ACAD SCI USA, V111, P17230, DOI 10.1073/pnas.1410083111; Nguyen NH, 2016, FISH FISH, V17, P483, DOI 10.1111/faf.12122; Pimakhin A, 2015, J APPL ICHTHYOL, V31, P56, DOI 10.1111/jai.12901; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Ren M L Y G, 2002, FISHERIES RESOURCES, P139; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rougeot C, 2007, AQUACULTURE, V272, pS306, DOI 10.1016/j.aquaculture.2007.07.175; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Sullivan KM, 2016, FOOD CULT SOC, V19, P625, DOI 10.1080/15528014.2016.1209290; Teletchea, 2016, NATURAL RESOURCES, V7, P399, DOI [10.4236/nr.2016.76034, DOI 10.4236/nr.2016.76034, DOI 10.4236/NR.2016.76034]; Teletchea F, 2014, FISH FISH, V15, P181, DOI 10.1111/faf.12006; TISCH R, 1988, P NATL ACAD SCI USA, V85, P6914, DOI 10.1073/pnas.85.18.6914; Toth AL, 2007, TRENDS GENET, V23, P334, DOI 10.1016/j.tig.2007.05.001; Tymchuk W, 2009, GEN COMP ENDOCR, V164, P175, DOI 10.1016/j.ygcen.2009.05.015; Wang FH, 2010, FISH SHELLFISH IMMUN, V29, P32, DOI 10.1016/j.fsi.2010.01.006; Wang FH, 2011, FISH SHELLFISH IMMUN, V30, P1095, DOI 10.1016/j.fsi.2011.02.004; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Whiteley AR, 2008, GENETICS, V180, P147, DOI 10.1534/genetics.108.089938; Yan Jiang YT, 2007, J AQUACULTURE, V28; Zeder MA, 2012, J ANTHROPOL RES, V68, P161, DOI 10.3998/jar.0521004.0068.201	59	18	18	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172903	10.1371/journal.pone.0172903	http://dx.doi.org/10.1371/journal.pone.0172903			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257494	gold, Green Published, Green Submitted			2022-12-26	WOS:000396021100040
J	Claassens, MM; van Schalkwyk, C; Floyd, S; Ayles, H; Beyers, N				Claassens, M. M.; van Schalkwyk, C.; Floyd, S.; Ayles, H.; Beyers, N.			Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys	PLOS ONE			English	Article							RANDOMIZED TRIAL; INTERVENTIONS; COMMUNITIES; HIV	Background High tuberculosis (TB) burden countries should consider systematic screening among adults in the general population. We identified symptom screening rules to be used in addition to cough >= 2 weeks, in a context where X-ray screening is not feasible, aiming to increase the sensitivity of screening while achieving a specificity of similar to 85%. Methods We used 2010 Zambia South Africa Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) survey data: a South African (SA) training dataset, a SA testing dataset for internal validation and a Zambian dataset for external validation. Regression analyses investigated relationships between symptoms or combinations of symptoms and active disease. Sensitivity and specificity were calculated for candidate rules. Results Among all participants, the sensitivity of using only cough >= 2 weeks as a screening rule was less than 25% in both SA and Zambia. The addition of any three of six TB symptoms (cough < 2 weeks, night sweats, weight loss, fever, chest pain, shortness of breath), or 2 or more of cough < 2 weeks, night sweats, and weight loss, increased the sensitivity to similar to 38%, while reducing specificity from similar to 95% to similar to 85% in SA and similar to 97% to similar to 92% in Zambia. Among HIV-negative adults, findings were similar in SA, whereas in Zambia the increase in sensitivity was relatively small (15% to 22%). Conclusion High TB burden countries should investigate cost-effective strategies for systematic screening: one such strategy could be to use our rule in addition to cough >= 2 weeks.	[Claassens, M. M.; Beyers, N.] Univ Stellenbosch, Desmond Tutu TB Ctr, Dept Pediat & Child Hlth, Cape Town, South Africa; [van Schalkwyk, C.] Univ Stellenbosch, Ctr Excellence Epidemiol Modelling & Anal, Natl Res Fdn, South African Dept Sci & Technol, Stellenbosch, South Africa; [Floyd, S.; Ayles, H.] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [Ayles, H.] Univ Zambia, Zambia AIDS Related TB Project, Ridgeway Campus, Lusaka, Zambia	Stellenbosch University; National Research Foundation - South Africa; Stellenbosch University; University of London; London School of Hygiene & Tropical Medicine; University of Zambia	Claassens, MM (corresponding author), Univ Stellenbosch, Desmond Tutu TB Ctr, Dept Pediat & Child Hlth, Cape Town, South Africa.	mcla@sun.ac.za	Claassens, Mareli/Y-3544-2019	Claassens, Mareli/0000-0002-5927-284X; van Schalkwyk, Cari/0000-0001-5154-1390; Ayles, Helen/0000-0003-4108-2842	Johns Hopkins University; Bill and Melinda Gates Foundation [19790.01]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Johns Hopkins University(Johns Hopkins University); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by a subcontract from Johns Hopkins University with funds provided by grant number 19790.01 from the Bill and Melinda Gates Foundation. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P217; Claassens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058689; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Corbett EL, 2010, B WORLD HEALTH ORGAN, V88, P13, DOI 10.2471/BLT.08.055467; Cori A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084511; den Boon S, 2007, EMERG INFECT DIS, V13, P1189, DOI 10.3201/eid1308.051327; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Langendam MW, 2013, SYSTEMATIC REV SENSI; Lewis JJ, 2009, AM J RESP CRIT CARE, V180, P1271, DOI 10.1164/rccm.200806-846OC; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Marais BJ, 2010, AM J RESP CRIT CARE, V181, P195, DOI 10.1164/ajrccm.181.2.195a; Samandari T, 2011, AM J RESP CRIT CARE, V183, P1103, DOI 10.1164/rccm.201004-0620OC; TB CARE I, 2014, INT STAND TUB CAR; van't Hoog AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038691; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2013, SYST SCREEN ACT TUB	19	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172881	10.1371/journal.pone.0172881	http://dx.doi.org/10.1371/journal.pone.0172881			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257424	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000396021100035
J	E, MJ; Gong, Y; Yu, JP; Zhang, SY; Fan, QX; Jiang, YL; Wang, HT				E, Mingju; Gong, Ye; Yu, Jiangping; Zhang, Siyu; Fan, Qianxi; Jiang, Yunlei; Wang, Haitao			Low level of extra-pair paternity between nearest neighbors results from female preference for high-quality males in the yellow-rumped flycatcher (Ficedula zanthopygia)	PLOS ONE			English	Article							SEXUAL SELECTION; FREQUENT COPULATIONS; INBREEDING AVOIDANCE; BREEDING DENSITY; GENETIC QUALITY; PIED FLYCATCHER; MATE CHOICE; BIRDS; HETEROZYGOSITY; OPPORTUNITY	Extra-pair copulation is considered to be a means by which females can modify their initial mate choice, and females might obtain indirect benefits to offspring fitness by engaging in this behavior. Here, we examined the patterns of extra-pair paternity and female preferences in the yellow-rumped flycatcher (Ficedula zanthopygia). We found that female yellow-rumped flycatchers are more likely to choose larger and relatively highly heterozygous males than their social mates as extra-pair mates, that the genetic similarity of pairs that produced mixed-paternity offspring did not differ from the similarity of pairs producing only within-pair offspring, and that extra-pair offspring were more heterozygous than their half-siblings. These findings support the good genes hypothesis but do not exclude the compatibility hypothesis. Most female yellow-rumped flycatchers attained extra-pair paternity with distant males rather than their nearest accessible neighboring males, and no differences in genetic and phenotypic characteristics were detected between cuckolded males and their nearest neighbors. There was no evidence that extra-pair mating by female flycatchers reduced inbreeding. Moreover, breeding density, breeding synchrony and their interaction did not affect the occurrence of extra-pair paternity in this species. Our results suggest that the variation in extra-pair paternity distribution between nearest neighbors in some passerine species might result from female preference for highly heterozygous males.	[E, Mingju; Gong, Ye; Yu, Jiangping; Wang, Haitao] Northeast Normal Univ, Sch Life Sci, Jilin Prov Engn Lab Avian Ecol & Conservat Genet, Changchun, Peoples R China; [Zhang, Siyu] Northeast Normal Univ, Jilin Key Lab Anim Resource Conservat & Utilizat, Changchun, Peoples R China; [Fan, Qianxi] Northeast Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Peoples R China; [Jiang, Yunlei] Jilin Agr Univ, Anim Sci & Technol Inst, Changchun, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Northeast Normal University - China; Jilin Agricultural University	Wang, HT (corresponding author), Northeast Normal Univ, Sch Life Sci, Jilin Prov Engn Lab Avian Ecol & Conservat Genet, Changchun, Peoples R China.	wanght402@nenu.edu.cn			National Natural Science Foundation of China [31470458, 31270471]; Fundamental Research Funds for the Central Universities; Northeast Normal University [11SSXT151]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Northeast Normal University	This research was supported by the National Natural Science Foundation of China (31470458 H.T.W.; 31270471 Y.L.J), the Fundamental Research Funds for the Central Universities and the Doctorial Innovation Fund of Northeast Normal University (grant 11SSXT151 M.J.E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht T, 2007, BEHAV ECOL, V18, P477, DOI 10.1093/beheco/arm001; Andersson Malte, 1994; Annavi G, 2014, ECOL EVOL, V4, P2594, DOI 10.1002/ece3.1112; Arct A, 2015, BEHAV ECOL, V26, P959, DOI 10.1093/beheco/arv004; Arnqvist G, 2005, AM NAT, V165, pS26, DOI 10.1086/429350; BAKER MC, 1987, ORNIS SCAND, V18, P186, DOI 10.2307/3676765; Balenger S, 2009, BEHAV ECOL SOCIOBIOL, V63, P403, DOI 10.1007/s00265-008-0674-5; Berzins A, 2010, BEHAV ECOL, V21, P1054, DOI 10.1093/beheco/arq104; BIRKHEAD TR, 1992, BIOL J LINN SOC, V45, P363, DOI 10.1111/j.1095-8312.1992.tb00649.x; BOLLINGER EK, 1991, BEHAV ECOL SOCIOBIOL, V29, P1, DOI 10.1007/BF00164288; Both C., 2004, ACTA ORN, V27, P131; Bouwman KM, 2005, BEHAVIOUR, V142, P1449, DOI 10.1163/156853905774831819; Brouwer L, 2011, MOL ECOL, V20, P4796, DOI 10.1111/j.1365-294X.2011.05325.x; Brown JL, 1997, BEHAV ECOL, V8, P60, DOI 10.1093/beheco/8.1.60; Canal D, 2012, BEHAV ECOL SOCIOBIOL, V66, P67, DOI 10.1007/s00265-011-1253-8; Charmantier A, 2004, J AVIAN BIOL, V35, P524, DOI 10.1111/j.0908-8857.2004.03296.x; Cohas A, 2009, MOL ECOL, V18, P1491, DOI 10.1111/j.1365-294X.2009.04116.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Crowe SA, 2009, ANIM BEHAV, V77, P183, DOI 10.1016/j.anbehav.2008.09.024; Ditchkoff SS, 2001, EVOLUTION, V55, P616, DOI 10.1554/0014-3820(2001)055[0616:MHCAVI]2.0.CO;2; DIXON A, 1994, NATURE, V371, P698, DOI 10.1038/371698a0; DUNN PO, 1994, BEHAV ECOL, V5, P123, DOI 10.1093/beheco/5.2.123; Edme A, 2016, J AVIAN BIOL, V47, P552, DOI 10.1111/jav.00839; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; Formica VA, 2004, ECOLOGY, V85, P1125, DOI 10.1890/03-0029; Forstmeier W, 2002, J ANIM ECOL, V71, P1, DOI 10.1046/j.0021-8790.2001.00569.x; Freeman-Gallant CR, 2005, EVOLUTION, V59, P422, DOI 10.1111/j.0014-3820.2005.tb01000.x; Friedl TWP, 2005, AUK, V122, P57, DOI 10.1642/0004-8038(2005)122[0057:EFIRBE]2.0.CO;2; GAUNT AS, 1999, GUIDELINES USE WILD; Gowaty PA., PARTNERSHIPS BIRDS, P21; Gray EM, 1996, BEHAV ECOL SOCIOBIOL, V38, P267, DOI 10.1007/s002650050242; Gray EM, 1997, ANIM BEHAV, V53, P625, DOI 10.1006/anbe.1996.0336; Greene E, 2000, NATURE, V407, P1000, DOI 10.1038/35039500; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griffith SC, 2015, BEHAV ECOL, V26, P970, DOI 10.1093/beheco/arv031; HAMILTON WD, 1990, AM ZOOL, V30, P341; Hasselquist D, 1998, ECOLOGY, V79, P2376, DOI 10.2307/176829; Hill CE, 2011, BEHAV ECOL, V22, P73, DOI 10.1093/beheco/arq171; HOUTMAN AM, 1992, P ROY SOC B-BIOL SCI, V249, P3, DOI 10.1098/rspb.1992.0075; Hyman J, 2006, ANIM BEHAV, V72, P209, DOI 10.1016/j.anbehav.2006.01.007; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Johansson J, 2012, AM NAT, V179, P463, DOI 10.1086/664624; Johnsen A, 2000, NATURE, V406, P296, DOI 10.1038/35018556; Johnsen A, 2003, OECOLOGIA, V136, P476, DOI 10.1007/s00442-003-1286-4; Jones MGW, 2012, BEHAV ECOL SOCIOBIOL, V66, P1213, DOI 10.1007/s00265-012-1374-8; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kempenaers B, 1997, BEHAV ECOL, V8, P481, DOI 10.1093/beheco/8.5.481; Kempenaers B., 1993, ORNIS SCAND, P24; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; Kim CH, 1998, KOREAN J ORNITHOL, V5, P17; Kokko H, 2005, BEHAV ECOL, V16, P724, DOI 10.1093/beheco/ari050; Komdeur J, 2001, P ROY SOC B-BIOL SCI, V268, P2103, DOI 10.1098/rspb.2001.1750; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Leder EH, 2008, MOL ECOL RESOUR, V8, P874, DOI 10.1111/j.1755-0998.2008.02096.x; Li JQ, 2016, BEHAV ECOL SOCIOBIOL, V70, P963, DOI 10.1007/s00265-016-2119-x; LIFJELD JT, 1992, BEHAV ECOL SOCIOBIOL, V31, P89, DOI 10.1007/BF00166341; Lindstedt ER, 2007, J AVIAN BIOL, V38, P214, DOI 10.1111/j.2007.0908-8857.03889.x; Lovlie H, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1296; Mays HL, 2008, GENETICA, V134, P147, DOI 10.1007/s10709-007-9219-5; Mays HL, 2004, TRENDS ECOL EVOL, V19, P554, DOI 10.1016/j.tree.2004.07.018; MEEK SB, 1994, AUK, V111, P739; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; MOLLER AP, 1992, AM NAT, V139, P1089, DOI 10.1086/285374; MOLLER AP, 1991, BEHAVIOUR, V118, P170, DOI 10.1163/156853991X00274; O'Loghlen AL, 1999, ANIM BEHAV, V58, P13, DOI 10.1006/anbe.1999.1125; OLoghlen AL, 1997, ANIM BEHAV, V53, P835, DOI 10.1006/anbe.1996.0348; Perlut NG, 2012, NORTHEAST NAT, V19, P335, DOI 10.1656/045.019.0214; Perreault S, 1997, BEHAV ECOL, V8, P612, DOI 10.1093/beheco/8.6.612; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; R Development Core Team, 2014, R LANG ENV STAT COMP; Reid JM, 2015, EVOLUTION, V69, P59, DOI 10.1111/evo.12557; Richardson DS, 2001, ANIM BEHAV, V62, P519, DOI 10.1006/anbe.2001.1778; Rosengrave P, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0001; Russell E, 2000, AUST J ZOOL, V48, P161, DOI 10.1071/ZO99066; Segelbacher G, 2005, J ORNITHOL, V146, P99, DOI 10.1007/s10336-004-0062-5; Song X., 2013, PATTERNS INFLUENCING; Stewart IRK, 2006, CONDOR, V108, P399, DOI 10.1650/0010-5422(2006)108[399:TOEPAG]2.0.CO;2; Stewart SLM, 2010, BEHAV ECOL SOCIOBIOL, V64, P463, DOI 10.1007/s00265-009-0862-y; Stutchbury Bridget J.M., 1998, Ornithological Monographs, V49, P103; Szulkin M, 2013, TRENDS ECOL EVOL, V28, P205, DOI 10.1016/j.tree.2012.10.016; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Vaclav R, 2007, J ORNITHOL, V148, P395, DOI 10.1007/s10336-007-0143-3; Valera F, 2003, BEHAV ECOL, V14, P403, DOI 10.1093/beheco/14.3.403; WAGNER RH, 1992, BEHAV ECOL SOCIOBIOL, V29, P455; Wang R, 1998, J TONGHUA TEACHERS C; Webster MS, 2001, BEHAV ECOL, V12, P439, DOI 10.1093/beheco/12.4.439; Wei Zhongmin, 2012, Journal of Northeast Forestry University, V40, P141; Westneat D.F., 1990, Current Ornithology, V7, P331; Westneat D F, 1992, TRENDS ECOL EVOL, V7, P423; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Whiteman NK, 2006, P ROY SOC B-BIOL SCI, V273, P797, DOI 10.1098/rspb.2005.3396; YEZERINAC SM, 1995, BEHAV ECOL SOCIOBIOL, V37, P179, DOI 10.1007/BF00176715; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010; Zeh JA, 2003, ETHOLOGY, V109, P929, DOI 10.1046/j.1439-0310.2003.00945.x	94	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172713	10.1371/journal.pone.0172713	http://dx.doi.org/10.1371/journal.pone.0172713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257431	Green Published, gold, Green Submitted			2022-12-26	WOS:000396021100024
J	Grabarczyk, DB; Berks, BC				Grabarczyk, Daniel B.; Berks, Ben C.			Intermediates in the Sox sulfur oxidation pathway are bound to a sulfane conjugate of the carrier protein SoxYZ	PLOS ONE			English	Article							PARACOCCUS-PANTOTROPHUS GB17; MULTI-ENZYME SYSTEM; THIOSULFATE OXIDATION; THIOBACILLUS-VERSUTUS; STRUCTURAL BASIS; CYCLE; MECHANISM; SITE; A2	The Sox pathway found in many sulfur bacteria oxidizes thiosulfate to sulfate. Pathway intermediates are covalently bound to a cysteine residue in the carrier protein SoxYZ. We have used biochemical complementation by SoxYZ-conjugates to probe the identity of the intermediates in the Sox pathway. We find that unconjugated SoxYZ and SoxYZ-S-sulfonate are unlikely to be intermediates during normal turnover in disagreement with current models. By contrast, conjugates with multiple sulfane atoms are readily metabolised by the Sox pathway. The most parsimonious interpretation of these data is that the true carrier species in the Sox pathway is a SoxYZ-S-sulfane adduct.	[Grabarczyk, Daniel B.; Berks, Ben C.] Univ Oxford, Dept Biochem, Oxford, England; [Grabarczyk, Daniel B.] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2,Haus D15, Wurzburg, Germany	University of Oxford; University of Wurzburg	Grabarczyk, DB; Berks, BC (corresponding author), Univ Oxford, Dept Biochem, Oxford, England.; Grabarczyk, DB (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2,Haus D15, Wurzburg, Germany.	daniel.grabarczyk@virchow.uni-wuerzburg.de; ben.berks@bioch.ox.ac.uk		Grabarczyk, Daniel/0000-0003-0216-7085	Biotechnology and Biological Research Council	Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Research Council (GB) through a studentship to DBG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Friedrich CG, 2000, J BACTERIOL, V182, P4677, DOI 10.1128/JB.182.17.4677-4687.2000; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; Grabarczyk DB, 2015, P NATL ACAD SCI USA, V112, pE7166, DOI 10.1073/pnas.1506386112; Grabarczyk DB, 2015, J BIOL CHEM, V290, P9209, DOI 10.1074/jbc.M114.618025; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Knofel T, 1999, NAT STRUCT BIOL, V6, P448; Kurth JM, 2016, J BIOL CHEM; LU WP, 1984, J GEN MICROBIOL, V130, P1683; LU WP, 1985, BIOCHIM BIOPHYS ACTA, V828, P116, DOI 10.1016/0167-4838(85)90046-9; LU WP, 1983, J GEN MICROBIOL, V129, P3549; Ogawa T, 2010, BIOSCI BIOTECH BIOCH, V74, P771, DOI 10.1271/bbb.90815; Quentmeier A, 2001, FEBS LETT, V503, P168, DOI 10.1016/S0014-5793(01)02727-2; Quentmeier A, 2008, FEBS LETT, V582, P3701, DOI 10.1016/j.febslet.2008.09.043; Quentmeier A, 2007, BIOCHEMISTRY-US, V46, P10990, DOI 10.1021/bi700378k; Rawlings DE, 2007, MICROBIOL-SGM, V153, P315, DOI 10.1099/mic.0.2006/001206-0; Rossi G, 2014, ADV BIOCHEM ENG BIOT, V142, P147, DOI 10.1007/10_2013_178; Sauve V, 2007, J BIOL CHEM, V282, P23194, DOI 10.1074/jbc.M701602200; Sauve V, 2009, J BIOL CHEM, V284, P21707, DOI 10.1074/jbc.M109.002709; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; VISHNIAC W, 1957, BACTERIOL REV, V21, P195, DOI 10.1128/MMBR.21.3.195-213.1957; Zander U, 2011, J BIOL CHEM, V286, P8349, DOI 10.1074/jbc.M110.193631	23	25	27	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173395	10.1371/journal.pone.0173395	http://dx.doi.org/10.1371/journal.pone.0173395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257465	Green Published, gold, Green Submitted			2022-12-26	WOS:000396021100088
J	Janssen, T; Karssen, G; Topalovic, O; Coyne, D; Bert, W				Janssen, Toon; Karssen, Gerrit; Topalovic, Olivera; Coyne, Danny; Bert, Wim			Integrative taxonomy of root-knot nematodes reveals multiple independent origins of mitotic parthenogenesis	PLOS ONE			English	Article							GENUS MELOIDOGYNE; SPECIES IDENTIFICATION; FEMALE GONODUCT; RIBOSOMAL-RNA; EVOLUTION; COFFEE; DNA; DIVERSITY; DIAGNOSIS; GENES	During sampling of several Coffea arabica plantations in Tanzania severe root galling, caused by a root-knot nematode was observed. From pure cultures, morphology and morphometrics of juveniles and females matched perfectly with Meloidogyne africana, whereas morphology of the males matched identically with those of Meloidogyne decalineata. Based on their Cox1 sequence, however, the recovered juveniles, females and males were confirmed to belong to the same species, creating a taxonomic conundrum. Adding further to this puzzle, re-examination of M. oteifae type material showed insufficient morphological evidence to maintain its status as a separate species. Consequently, M. decalineata and M. oteifae are synonymized with M. africana, which is herewith redescribed based on results of light and scanning electron microscopy, ribosomal and mitochondrial DNA sequences, isozyme electrophoresis, along with bionomic and cytogenetic features. Multi-gene phylogenetic analysis placed M. africana outside of the three major clades, together with M. coffeicola, M. ichinohei andM. camelliae. This phylogenetic position was confirmed by several morphological features, including cellular structure of the spermatheca, egg mass position, perineal pattern and head shape. Moreover, M. africana was found to be a polyphagous species, demonstrating that "early-branching" Meloidogyne spp. are not as oligophagous as had previously been assumed. Cytogenetic information indicates M. africana (2n = 21) and M. ardenensis (2n = 51-54) to be a triploid mitotic parthenogenetic species, revealing at least four independent origins of mitotic parthenogenesis within the genus Meloidogyne. Furthermore, M. mali (n = 12) was found to reproduce by amphimixis, indicating that amphimictic species with a limited number of chromosomes are widespread in the genus, potentially reflecting the ancestral state of the genus. The wide variation in chromosome numbers and associated changes in reproduction modes indicate that cytogenetic evolution played a crucial role in the speciation of root-knot nematodes and plant-parasitic nematodes in general.	[Janssen, Toon; Karssen, Gerrit; Topalovic, Olivera; Bert, Wim] Univ Ghent, Dept Biol, Nematol Res Unit, Ghent, Belgium; [Janssen, Toon] Vrije Univ Brussel, UZ Brussel, Ctr Med Genet Reprod & Genet Reprod Genet & Regen, Brussels, Belgium; [Karssen, Gerrit; Topalovic, Olivera] HC Wageningen, Wageningen Nematode Collect, Natl Plant Protect Org, Wageningen, Netherlands; [Coyne, Danny] ICIPE, Int Inst Trop Agr, Nairobi, Kenya	Ghent University; University Hospital Brussels; Vrije Universiteit Brussel; International Centre of Insect Physiology & Ecology (ICIPE)	Janssen, T (corresponding author), Univ Ghent, Dept Biol, Nematol Res Unit, KL Ledeganckstr, Ghent, Belgium.	toon.janssen88@gmail.com	Topalović, Olivera/AAM-2208-2020; Bert, Wim/D-4511-2013	Bert, Wim/0000-0002-5864-412X; Janssen, Toon/0000-0001-9914-3906; van Tienoven, Theun Pieter/0000-0003-1532-254X; Topalovic, Olivera/0000-0003-3839-1839	special research fund from Ghent University [01N02312]	special research fund from Ghent University	This work was supported by a special research fund from Ghent University 01N02312.; The authors would like to thank Myrtle Verhaeven and the nematology lab of IITA for assistance during sampling in Tanzania, Dr. Hans Helder for kindly sharing DNA extraction of Meloidogyne sp. MHMH-2008, Prof. Wilfrida Decraemer for well-appreciated taxonomic advice, Prof. Jonathan D. Eisenback for contributing preliminary molecular results of Meloidogyne kikuyensis and Marjolein Couvreur for SEM analysis. We are especially grateful to the nematology lab from the National Plant Protection Organization Wageningen for technical support and the maintenance of the greenhouse cultures. This work was supported by a special research fund UGent 01N02312.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Ahmed M, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.362.6352; Araki M., 1992, JAP J NEMATOL, P11; Bert W, 2002, NEMATOLOGY, V4, P953, DOI 10.1163/156854102321122575; Bert W, 2003, NEMATOLOGY, V5, P293, DOI 10.1163/156854103767139761; Bert W, 2008, MOL PHYLOGENET EVOL, V48, P728, DOI 10.1016/j.ympev.2008.04.011; Blok Vivian C., 2009, P98, DOI 10.1079/9781845934927.0098; BOWLES J, 1992, MOL BIOCHEM PARASIT, V54, P165, DOI 10.1016/0166-6851(92)90109-W; BRIDGE J., 1984, COFFEE NEMATODE SURV; Brito JA, 2016, DISEASE NOTES, V100, P1246; Campos V.P., 1990, P387; Campos Vicente Paulo, 2005, P529, DOI 10.1079/9780851997278.0529; Carneiro Regina M. D. G., 2008, P87, DOI 10.1007/978-1-4020-8720-2_6; Carneiro RMDG, 2000, NEMATOLOGY, V2, P645, DOI 10.1163/156854100509510; Castagnone-Sereno P, 2006, HEREDITY, V96, P282, DOI 10.1038/sj.hdy.6800794; Castagnone-Sereno P, 2013, ANNU REV PHYTOPATHOL, V51, P203, DOI 10.1146/annurev-phyto-082712-102300; CASTAGNONESERENO P, 1993, HEREDITY, V70, P195, DOI 10.1038/hdy.1993.29; CHITWOOD BG, 1960, PHYTOPATHOLOGY, V50, P631; Chitwood DJ, 2010, ROOT-KNOT NEMATODES, P182, DOI 10.1079/9781845934927.0182; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Correa VR, 2013, EUR J PLANT PATHOL, V137, P305, DOI 10.1007/s10658-013-0242-3; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Almeida AMSF, 2002, J NEMATOL, V34, P140; De Giorgi C, 2002, MOL BIOCHEM PARASIT, V124, P91, DOI 10.1016/S0166-6851(02)00161-5; De Grisse A., 1960, Nematologica, V5, P303; De Ley IT, 2002, J NEMATOL, V34, P319; De Ley P, 1999, NEMATOLOGY, V1, P591, DOI 10.1163/156854199508559; DeGiorgi C, 1996, GENE, V170, P261, DOI 10.1016/0378-1119(95)00894-2; Derycke S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013716; Eisenback JD, 1988, J NEMATOL; Eisenback Jonathan D., 2009, P18, DOI 10.1079/9781845934927.0018; Eisenback Jonathan D., 1991, P191; Elling AA, 2013, PHYTOPATHOLOGY, V103, P1092, DOI 10.1094/PHYTO-01-13-0019-RVW; ELMILIGY IA, 1968, NEMATOLOGICA, V14, P577, DOI 10.1163/187529268X00282; Eyualem A, 2003, J NEMATOL, V35, P119; Geraert E., 1983, Systematics Association Special Volume Series, P73; GOLDEN AM, 1979, J NEMATOL, V11, P175; Holterman M, 2009, PHYTOPATHOLOGY, V99, P227, DOI 10.1094/PHYTO-99-3-0227; Hooper D. J., 1986, Laboratory methods for work with plant and soil nematodes., P5; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hugall A, 1999, MOL BIOL EVOL, V16, P157, DOI 10.1093/oxfordjournals.molbev.a026098; Humphreys-Pereira DA, 2014, NEMATOLOGY, V16, P643, DOI 10.1163/15685411-00002794; Hunt David J., 2009, P55, DOI 10.1079/9781845934927.0055; International Coffee Organization (ICO), 2014, WORLD COFF TRAD 1963; International Coffee Organization (ICO), 2015, SUST COFF SECT AFR, P1; Janssen T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22591; Jepson S.B., 1987, IDENTIFICATION ROOT; Jorge AS, 2016, PLANT DIS, V100, P2173, DOI 10.1094/PDIS-03-16-0294-PDN; KARSSEN G, 1995, ELECTROPHORESIS, V16, P105, DOI 10.1002/elps.1150160119; Karssen G., 2002, PLANT PARASIT NEMAT, P93; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kiewnick S, 2014, EUR J PLANT PATHOL, V140, P97, DOI 10.1007/s10658-014-0446-1; Lordello LGE, 1960, REV BRAS BIOL, P375; Lordello R. R. A., 1980, Revista de Agricultura, Piracicaba, Brazil, V55, P238; Lukhtanov VA, 2005, NATURE, V436, P385, DOI 10.1038/nature03704; Maddison WP, 2016, MESQUITE A MODULAR S; Maleita CM, 2016, PLANT DIS, V100, P1725, DOI 10.1094/PDIS-01-16-0112-RE; Maleita CM, 2012, PLANT DIS, V96, P865, DOI 10.1094/PDIS-09-11-0769-RE; MARAIS M, 1991, Phytophylactica, V23, P265; Melters DP, 2012, CHROMOSOME RES, V20, P579, DOI 10.1007/s10577-012-9292-1; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Onkendi EM, 2014, PLANT PATHOL, V63, P727, DOI 10.1111/ppa.12202; PAPADOPOULOU J, 1982, J NEMATOL, V14, P549; PARLEVLIET J E, 1971, Acta Horticulturae (Wageningen), V21, P201; Plantard O, 2007, J NEMATOL, V39, P127; Randig O, 2002, GENOME, V45, P862, DOI [10.1139/g02-054, 10.1139/G02-054]; ROMAN J, 1969, J NEMATOL, V1, P357; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHRADER F, 1956, CHROMOSOMA, V7, P469; SEINHORST J. W., 1962, NEMATOLOGICA, V8, P29; SOHLENIUS B, 1987, BIOL FERT SOILS, V3, P19, DOI 10.1007/BF00260574; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Subbotin SA, 2008, MOL PHYLOGENET EVOL, V48, P491, DOI 10.1016/j.ympev.2008.04.028; Tang CQ, 2012, P NATL ACAD SCI USA, V109, P16208, DOI 10.1073/pnas.1209160109; Tomalova I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038656; TRIANTAPHYLLOU A C, 1990, Revue de Nematologie, V13, P175; Triantaphyllou A. C., 1985, An advanced treatise on Meloidogyne.Volume II: Methodology., P107; Triantaphyllou A. C., 1962, Nematologica, V7, P105; Triantaphyllou A.C., 1983, Systematics Association Special Volume Series, P55; TRIANTAPHYLLOU A C, 1984, Revue de Nematologie, V7, P65; Triantaphyllou A.C., 1985, ADV TREATISE MELOIDO, VI, P113; TRIANTAPHYLLOU AC, 1963, J MORPHOL, V113, P489, DOI 10.1002/jmor.1051130309; TRIANTAPHYLLOU AC, 1966, J MORPHOL, V118, P403, DOI 10.1002/jmor.1051180308; TRIANTAPHYLLOU AC, 1980, ANNU REV PHYTOPATHOL, V18, P333, DOI 10.1146/annurev.py.18.090180.002001; TRIANTAPHYLLOU AC, 1973, ANNU REV PHYTOPATHOL, V11, P441, DOI 10.1146/annurev.py.11.090173.002301; Triantaphyllou AC, 1997, FUND APPL NEMATOL, V20, P385; TRIANTAPHYLLOU AC, 1987, J NEMATOL, V19, P1; Trisciuzzi N, 2014, EUR J PLANT PATHOL, V138, P231, DOI 10.1007/s10658-013-0337-x; van Bezooijen J., 2006, METHODS TECHNIQUES N; Van der Beek JG, 1998, FUND APPL NEMATOL, V21, P393; Vega FE, 2003, NATURE, V425, P343, DOI 10.1038/425343a; WHITEHEAD A G, 1968, Transactions of the Zoological Society of London, V31, P263; Whitehead A. G, 1959, NEMATOLOGICA, V4, P272; WHITEHEAD AG, 1969, NEMATOLOGICA, V15, P315, DOI 10.1163/187529269X00362; YASSIN A.M., 1982, P 3 RES PLANN C ROOT, P131; Ye WM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143556; Yoder M, 2006, NEMATOLOGY, V8, P367, DOI 10.1163/156854106778493448	97	24	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172190	10.1371/journal.pone.0172190	http://dx.doi.org/10.1371/journal.pone.0172190			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257464	Green Published, gold, Green Submitted			2022-12-26	WOS:000396021100014
J	Muhr, LSA; Hortlund, M; Bzhalava, Z; Kleppe, SN; Bzhalava, D; Hultin, E; Dillner, J				Muhr, Laila Sara Arroyo; Hortlund, Maria; Bzhalava, Zurab; Kleppe, Sara Nordqvist; Bzhalava, Davit; Hultin, Emilie; Dillner, Joakim			Viruses in case series of tumors: Consistent presence in different cancers in the same subject	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS-DNA; ORGAN TRANSPLANT RECIPIENTS; NONMELANOMA SKIN-CANCER; BETAPAPILLOMAVIRUSES; DIVERSITY; VIREMIA; RISK; CELL	Studies investigating presence of viruses in cancer often analyze case series of cancers, resulting in detection of many viruses that are not etiologically linked to the tumors where they are found. The incidence of virus-associated cancers is greatly increased in immuno-compromised individuals. Non-melanoma skin cancer (NMSC) is also greatly increased and a variety of viruses have been detected in NMSC. As immunosuppressed patients often develop multiple independent NMSCs, we reasoned that viruses consistently present in independent tumors might be more likely to be involved in tumorigenesis. We sequenced 8 different NMSCs from 1 patient in comparison to 8 different NMSCs from 8 different patients. Among the latter, 12 different virus sequences were detected, but none in more than 1 tumor each. In contrast, the patient with multiple NMSCs had human papillomavirus type 15 and type 38 present in 6 out of 8 NMSCs.	[Muhr, Laila Sara Arroyo; Hortlund, Maria; Bzhalava, Zurab; Kleppe, Sara Nordqvist; Bzhalava, Davit; Hultin, Emilie; Dillner, Joakim] Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden	Karolinska Institutet	Dillner, J (corresponding author), Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden.	joakim.dillner@ki.se	Hortlund, Maria/AAA-1613-2020	Hortlund, Maria/0000-0002-2627-4451; Arroyo Muhr, Laila Sara/0000-0003-2498-5206; Hultin, Emilie/0000-0003-2169-0840; Nordqvist Kleppe, Sara/0000-0002-8892-7497	Swedish Research Council [K2015-57X-21044-07-3]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council, grant number K2015-57X-21044-07-3 (www.vr.se). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgari MM, 2008, J INVEST DERMATOL, V128, P1409, DOI 10.1038/sj.jid.5701227; Berg D, 2002, J AM ACAD DERMATOL, V47, P1, DOI 10.1067/mjd.2002.125579; Bhatia K, 2012, CURR OPIN ONCOL, V24, P537, DOI 10.1097/CCO.0b013e328355e115; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; Bzhalava D, 2013, PLOS ONE, V8; Bzhalava D, 2016, INT J CANCER, V138, P2212, DOI 10.1002/ijc.29666; Bzhalava D, 2012, VIROLOGY, V432, P427, DOI 10.1016/j.virol.2012.06.022; Bzhalava Z, 2016, SCI REPORTS; Collett D, 2010, AM J TRANSPLANT, V10, P1889, DOI 10.1111/j.1600-6143.2010.03181.x; de Koning MNC, 2007, J GEN VIROL, V88, P1489, DOI 10.1099/vir.0.82732-0; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Dichosa AEK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037387; Ekstrom J, 2013, VIROLOGY, V447, P300, DOI 10.1016/j.virol.2013.09.010; Engels EA, 2011, JAMA-J AM MED ASSOC, V306, P1891, DOI 10.1001/jama.2011.1592; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Forslund O, 2004, J INVEST DERMATOL, V123, P388, DOI 10.1111/j.0022-202X.2004.23205.x; Forslund O, 2003, J CUTAN PATHOL, V30, P423, DOI 10.1034/j.1600-0560.2003.00092.x; Forslund O, 2007, J GEN VIROL, V88, P2662, DOI 10.1099/vir.0.82911-0; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hazard K, 2006, INT J CANCER, V119, P1073, DOI 10.1002/ijc.21920; Johansson H, 2013, VIROLOGY, V440, P1, DOI 10.1016/j.virol.2013.01.023; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Mackintosh LJ, 2009, BRIT J DERMATOL, V161, P56, DOI 10.1111/j.1365-2133.2009.09146.x; Meiring TL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-164; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Muhr LSA, 2015, INT J CANCER, V136, P2546, DOI 10.1002/ijc.29325; Muhr LSA, 2015, VIROLOGY, V485, P283, DOI 10.1016/j.virol.2015.07.023; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Saiki R. K., 1992, BIOTECHNOLOGY, V24, P476; Skewes-Cox P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105067; Smelov V, 2016, SCI REP-UK, V6, DOI 10.1038/srep25235; van Leeuwen MT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c570; Vasiljevic N, 2008, J GEN VIROL, V89, P2467, DOI 10.1099/vir.0.2008/001925-0; Vasiljevic N, 2007, J GEN VIROL, V88, P1479, DOI 10.1099/vir.0.82679-0; Wang J, 2011, APPL ENVIRON MICROB, V77, P4241, DOI 10.1128/AEM.01834-10; Weissenborn SJ, 2005, J INVEST DERMATOL, V125, P93, DOI 10.1111/j.0022-202X.2005.23733.x; World Health Organization and International Agency for Research on Cancer, 2007, IARC MONOGRAPHS EVAL, V90, P348; Yilmaz S, 2010, NAT METHODS, V7, P943, DOI 10.1038/nmeth1210-943	41	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172308	10.1371/journal.pone.0172308	http://dx.doi.org/10.1371/journal.pone.0172308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257474	Green Published, gold, Green Submitted			2022-12-26	WOS:000396021100015
J	Hou, PF; Zhu, LJ; Chen, XY; Qiu, ZQ				Hou, Pan-Fei; Zhu, Li-Jing; Chen, Xiao-Ying; Qiu, Zhu-Qiang			Age-related changes in CD4(+)CD25(+)FOXP3(+) regulatory T cells and their relationship with lung cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; CARCINOMA; COPD; EXPRESSION; DIAGNOSIS	Objectives CD4(+)CD25(+)FOXP3(+) regulatory T cells (Treg) inhibit the anti-tumour immune response and reduce the effect of cancer immunotherapy. Although studies have demonstrated that the number and suppressive activity of Treg increase with age, it is not clear whether these changes correlate with a higher incidence of tumours in the elderly. This study was designed to explore the relationship between increase in CD4(+)CD25(+)FOXP3(+) Treg and the higher risk of lung cancer in the elderly. Methods Seventy lung cancer patients and 60 sex-and age-matched controls were recruited. Both groups were divided into three subgroups based on their age (young, middle-aged, or elderly). The proportion of CD4(+)CD25(+)FOXP3(+)/CD4(+) T cells was detected using flow cytometry, and the level of FOXP3 mRNA in the peripheral blood was examined with realtime RT-PCR. Results The levels of CD4(+)CD25(+)FOXP3(+)/CD4(+) T cells and FOXP3 mRNA were significantly higher in lung cancer patients than in healthy controls (t = 7.16, P < 0.01 and t = 3.65, P < 0.01, respectively). Within the healthy groups, the elderly group had larger proportion of CD4(+)CD25(+)FOXP3(+) Treg (F = 32.54, P < 0.01) and higher FOXP3 mRNA expression (F = 4.76, P < 0.01) than their younger counterparts. Among the six subgroups, the elderly lung cancer patients exhibited the highest levels of both CD4(+)CD25(+)FOXP3(+) Treg (11.81 +/- 2.40%) and FOXP3 mRNA (3.14 +/- 1.30). Conclusions The accumulation of CD4(+)CD25(+)FOXP3(+) Treg with age correlates well with the increasing incidence of lung cancer in the elderly.	[Hou, Pan-Fei; Qiu, Zhu-Qiang] Binzhou Med Univ, Rushan Hosp, Dept Clin Lab, Binzhou, Shandong, Peoples R China; [Zhu, Li-Jing] Binzhou Med Univ, Rushan Hosp, Dept Respirat, Binzhou, Shandong, Peoples R China; [Chen, Xiao-Ying] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Lab Med, Shanghai, Peoples R China	Binzhou Medical University; Binzhou Medical University; Shanghai Jiao Tong University	Zhu, LJ (corresponding author), Binzhou Med Univ, Rushan Hosp, Dept Respirat, Binzhou, Shandong, Peoples R China.	zhulijing830710@126.com	Hou, Panfei/W-2383-2019		Shandong Province Natural Science Foundation [ZR2014HP061]; projects of medical and health technology development program in Shandong province [2013WS0066]	Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); projects of medical and health technology development program in Shandong province	Support was provided by Shandong Province Natural Science Foundation, grant ZR2014HP061 [http://www.sdnsf.gov.cn/portal/] to Pan-Fei Hou and the projects of medical and health technology development program in Shandong province, grant 2013WS0066 [http://www.sdwskj.cn/] to Li-Jing Zhu. The funders played a role in data collection and analysis.	Anisimov VN, 2009, MECH AGEING DEV, V130, P105, DOI 10.1016/j.mad.2008.02.004; Burkle Alexander, 2007, Immun Ageing, V4, P4, DOI 10.1186/1742-4933-4-4; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chen Wanqing, 2010, Zhongguo Fei Ai Za Zhi, V13, P488, DOI 10.3779/j.issn.1009-3419.2010.05.20; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Domagala-Kulawik J, 2011, SCAND J IMMUNOL, V73, P59, DOI 10.1111/j.1365-3083.2010.02474.x; Groome PA, 2007, J THORAC ONCOL, V2, P694, DOI 10.1097/JTO.0b013e31812d05d5; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Lee KM, 2014, EUR J IMMUNOL, V44, P1728, DOI 10.1002/eji.201344062; Li F, 2014, CLIN CHEM LAB MED, V52, P1357, DOI 10.1515/cclm-2013-0878; Li JF, 2010, MOL MED REP, V3, P959, DOI 10.3892/mmr.2010.374; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; Peterson RA, 2012, TOXICOL PATHOL, V40, P186, DOI 10.1177/0192623311430693; Rosenkranz D, 2007, J NEUROIMMUNOL, V188, P117, DOI 10.1016/j.jneuroim.2007.05.011; Shen XH, 2010, J CANCER RES CLIN, V136, P1745, DOI 10.1007/s00432-010-0833-8; Tan DBA, 2014, IMMUNOBIOLOGY, V219, P975, DOI 10.1016/j.imbio.2014.07.005; The Ministry of Health of the People's Republic of China, 2008, 3 NATL RETROSPECT SP, V2, P344; Walecki M, 2015, MOL BIOL CELL, V26, P2845, DOI 10.1091/mbc.E14-08-1323; Wei TF, 2015, AM J CANCER RES, V5, P2190; Zhang XH, 2015, J GASTROINTEST ONCOL, V6, P307, DOI 10.3978/j.issn.2078-6891.2015.017; Zhi XY, 2012, J THORAC DIS, V4, P88, DOI 10.3978/j.issn.2072-1439.2010.08.01; Zhu LJ, 2012, INT J GERONTOL, V6, P187, DOI 10.1016/j.ijge.2012.01.013	24	24	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173048	10.1371/journal.pone.0173048	http://dx.doi.org/10.1371/journal.pone.0173048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253320	gold, Green Published, Green Submitted			2022-12-26	WOS:000396011300066
J	Mansor, MS; Ramli, R				Mansor, Mohammad Saiful; Ramli, Rosli			Foraging niche segregation in Malaysian babblers (Family: Timaliidae)	PLOS ONE			English	Article							TREE-SPECIES PREFERENCES; INSECTIVOROUS BIRDS; PENINSULAR MALAYSIA; TEMPERATE FOREST; TROPICAL FOREST; PASSERINE BIRDS; RESOURCE USE; RAIN-FOREST; ECOLOGY; DIVERSITY	Tropical rainforests are considered as hotspots for bird diversity, yet little is known about the system that upholds the coexistence of species. Differences in body size that are associated with foraging strategies and spatial distribution are believed to promote the coexistence of closely related species by reducing competition. However, the fact that many babbler species do not differ significantly in their morphology has challenged this view. We studied the foraging ecology of nine sympatric babbler species (i.e., Pellorneum capistratum, P. bicolor, P. malaccense, Malacopteron cinereum, M. magnum, Stachyris nigriceps, S. nigricollis, S. maculata, and Cyanoderma erythropterum) in the Krau Wildlife Reserve in Peninsular Malaysia. We investigated; i) how these babblers forage in the wild and use vegetation to obtain food, and ii) how these trophically similar species differ in spatial distribution and foraging tactics. Results indicated that most babblers foraged predominantly on aerial leaf litter and used gleaning manoeuvre in intermediate-density foliage but exhibited wide ranges of vertical strata usage, thus reducing interspecific competition. The principal component analysis indicated that two components, i.e., foraging height and substrate are important as mechanisms to allow the coexistence of sympatric babblers. The present findings revealed that these bird species have unique foraging niches that are distinct from each other, and this may apply to other insectivorous birds inhabiting tropical forests. This suggests that niche separation does occur among coexisting birds, thus following Gause' law of competitive exclusion, which states two species occupying the same niche will not stably coexist.	[Mansor, Mohammad Saiful; Ramli, Rosli] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Mansor, Mohammad Saiful] Univ Kebangsaan Malaysia, Sch Environm & Nat Resource Sci, Fac Sci & Technol, Bangi, Selangor, Malaysia	Universiti Malaya; Universiti Kebangsaan Malaysia	Mansor, MS; Ramli, R (corresponding author), Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia.; Mansor, MS (corresponding author), Univ Kebangsaan Malaysia, Sch Environm & Nat Resource Sci, Fac Sci & Technol, Bangi, Selangor, Malaysia.	msaifulmansor@gmail.com; rosliramli@um.edu.my	Ramli, Rosli/A-8498-2010; Mansor, Mohammad Saiful/AFT-4431-2022	Ramli, Rosli/0000-0003-0410-9604; Mansor, Mohammad Saiful/0000-0002-8472-780X	University of Malaya [PG019-2013B]	University of Malaya(Universiti Malaya)	We are grateful to University of Malaya Research Fund (PG019-2013B) that provides financial support for this wildlife research.	Adamik P, 2004, ORNIS FENNICA, V81, P13; ALATALO RV, 1979, OIKOS, V33, P46, DOI 10.2307/3544510; Allen R.B., 1993, PERMANENT PLOT METHO; ALLEN RB, 1983, FRI B, V48; [Anonymous], 2001, PALEONTOLOGICAL STAT; Barbaro L, 2014, DIVERS DISTRIB, V20, P149, DOI 10.1111/ddi.12132; Black J.T, 1992, MULTIVARIATE DATA AN; Bohm SM, 2009, J ORNITHOL, V150, P799, DOI 10.1007/s10336-009-0401-7; BOWES GG, 1994, CAN J PLANT SCI, V74, P383, DOI 10.4141/cjps94-073; Braun-Blanquet J., 1932, STUDY PLANT COMMUNIT; Canaday C, 1996, BIOL CONSERV, V77, P63, DOI 10.1016/0006-3207(95)00115-8; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chen Chao-Chieh, 2008, Taiwan Journal of Forest Science, V23, P233; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clark DB, 1996, J TROP ECOL, V12, P735, DOI 10.1017/S0266467400009937; Cloyed CS, 2014, COEVOLUTION, V2, P26, DOI DOI 10.1080/; DeWalt SJ, 2006, PLANT ECOL, V186, P203, DOI 10.1007/s11258-006-9123-6; Dinesen L, 1995, AFR J ECOL, V33, P420, DOI 10.1111/j.1365-2028.1995.tb01051.x; Vargas LE, 2011, J TROP ECOL, V27, P65, DOI 10.1017/S026646741000060X; Evans KL, 2005, P ROY SOC B-BIOL SCI, V272, P2155, DOI 10.1098/rspb.2005.3209; Farine DR, 2013, BEHAV ECOL SOCIOBIOL, V67, P321, DOI 10.1007/s00265-012-1452-y; Ford HA, 2001, BIOL CONSERV, V97, P71, DOI 10.1016/S0006-3207(00)00101-4; Freeman B, 2014, J FIELD ORNITHOL, V85, P23, DOI 10.1111/jofo.12046; Gabbe AP, 2002, CONSERV BIOL, V16, P462, DOI 10.1046/j.1523-1739.2002.00460.x; Gokula V., 2000, Tropical Ecology, V41, P195; GRADWOHL J, 1982, ECOLOGY, V63, P581, DOI 10.2307/1938974; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Greenberg R, 2010, ECOLOGY, V91, P2428, DOI 10.1890/09-1136.1; Hamer KC, 2015, BIOL CONSERV, V188, P82, DOI 10.1016/j.biocon.2014.09.026; HOLMES RT, 1981, OECOLOGIA, V48, P31, DOI 10.1007/BF00346985; HOLMES RT, 1988, WILSON BULL, V100, P377; Hsieh FS, 2011, J ORNITHOL, V152, P955, DOI 10.1007/s10336-011-0678-1; Hurst JM., 2007, PERMANENT PLOT METHO; KARR JR, 1983, ECOLOGY, V64, P1481, DOI 10.2307/1937503; Keddy P.A., 1989, COMPETITION; Kiszka J, 2011, MAR ECOL PROG SER, V433, P273, DOI 10.3354/meps09165; Kovach WL., 2007, MVSP A MULTIVARIATE; Lara C, 2015, ZOOL STUD, V54, DOI 10.1186/s40555-015-0106-y; Lara C, 2011, CURR ZOOL, V57, P56, DOI 10.1093/czoolo/57.1.56; Luther D, 2011, AUK, V128, P201, DOI 10.1525/auk.2011.10262; MAC NALLY R, 1994, J ANIM ECOL, V63, P988; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; Mansor MS, 2012, ACTA ORNITHOL, V47, P27, DOI 10.3161/000164512X653890; Mansor MS, 2015, SAINS MALAYS, V44, P687, DOI 10.17576/jsm-2015-4405-07; MILES DB, 1984, ECOLOGY, V65, P1629, DOI 10.2307/1939141; Mohd-Azlan J, 2012, EMU, V112, P287, DOI 10.1071/MU12018; Moradi HV, 2010, J TROP FOR SCI, V22, P36; MORRISON ML, 1987, AUK, V104, P225, DOI 10.1093/auk/104.2.225; MORRISON ML, 1984, CONDOR, V86, P146, DOI 10.2307/1367029; Moyle RG, 2012, SYST BIOL, V61, P631, DOI 10.1093/sysbio/sys027; Myers S., 2009, FIELD GUIDE BIRDS BO; Paiva VH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151340; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; Radford AN, 2003, J ANIM ECOL, V72, P258, DOI 10.1046/j.1365-2656.2003.00697.x; Remsen J.V. Jr, 1990, Studies in Avian Biology, P144; Robertson OJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065299; ROBINSON SK, 1982, ECOLOGY, V63, P1918, DOI 10.2307/1940130; ROLANDO A, 1985, B ZOOL, V52, P281, DOI 10.1080/11250008509440530; Roswag A, 2015, POPUL ECOL, V57, P601, DOI 10.1007/s10144-015-0508-z; Sekercioglu CH, 2002, P NATL ACAD SCI USA, V99, P263, DOI 10.1073/pnas.012616199; SPSS Inc. Released, 2008, SPSS STAT WIND VERS; Styring AR, 2016, CURR ZOOL, V62, P345, DOI 10.1093/cz/zow022; Styring AR, 2004, J TROP ECOL, V20, P487, DOI 10.1017/S0266467404001579; Svanback R, 2003, OIKOS, V102, P273, DOI 10.1034/j.1600-0706.2003.12657.x; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Terraube J, 2011, OIKOS, V120, P234, DOI 10.1111/j.1600-0706.2010.18554.x; Wagner JL, 2010, ECOLOGY, V62, P973; Watson DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142992; Weimerskirch H, 2009, MAR ECOL PROG SER, V391, P267, DOI 10.3354/meps07981; Wellborn GA, 2007, OECOLOGIA, V154, P175, DOI 10.1007/s00442-007-0816-x; Wereszczuk A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139852; Whelan CJ, 2001, ECOLOGY, V82, P219, DOI 10.1890/0012-9658(2001)082[0219:FSIFOI]2.0.CO;2; Yong DL, 2011, J TROP ECOL, V27, P1, DOI 10.1017/S0266467410000520; Yusof E, 2000, J WILDL PARKS, V18, P3; Zakria Nurulhuda, 2014, Check List, V10, P335; Zou FS, 2011, IBIS, V153, P269, DOI 10.1111/j.1474-919X.2011.01105.x	77	14	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172836	10.1371/journal.pone.0172836	http://dx.doi.org/10.1371/journal.pone.0172836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253284	Green Submitted, Green Published, gold			2022-12-26	WOS:000396011300041
J	Tarade, D; Ma, D; Pignanelli, C; Mansour, F; Simard, D; van den Berg, S; Gauld, J; McNulty, J; Pandey, S				Tarade, Daniel; Ma, Dennis; Pignanelli, Christopher; Mansour, Fadi; Simard, Daniel; van den Berg, Sean; Gauld, James; McNulty, James; Pandey, Siyaram			Structurally simplified biphenyl combretastatin A4 derivatives retain in vitro anti-cancer activity dependent on mitotic arrest	PLOS ONE			English	Article							SPINDLE CHECKPOINT; A-4 ANALOGS; TUBULIN POLYMERIZATION; ANTINEOPLASTIC AGENTS; CYTOTOXIC EVALUATION; ANTITUMOR-ACTIVITY; APOPTOSIS; PHOSPHATE; DESIGN; POTENT	The cis-stilbene, combretastatin A4 (CA4), is a potent microtubule targeting and vascular damaging agent. Despite promising results at the pre-clinical level and extensive clinical evaluation, CA4 has yet to be approved for therapeutic use. One impediment to the development of CA4 is an inherent conformational instability about the ethylene linker, which joins two aromatic rings. We have previously published preliminary data regarding structurally simplified biphenyl derivatives of CA4, lacking an ethylene linker, which retain anti-proliferative and pro-apoptotic activity, albeit at higher doses. Our current study provides a more comprehensive evaluation regarding the anti-proliferative and pro-apoptotic properties of biphenyl CA4 derivatives in both 2D and 3D cancerous and non-cancerous cell models. Computational analysis has revealed that cytotoxicity of CA4 and biphenyl analogues correlates with predicted tubulin affinity. Additional mechanistic evaluation of the biphenyl derivatives found that their anti-cancer activity is dependent on prolonged mitotic arrest, in a similar manner to CA4. Lastly, we have shown that cancer cells deficient in the extrinsic pathway of apoptosis experience delayed cell death following treatment with CA4 or analogues. Biphenyl derivatives of CA4 represent structurally simplified analogues of CA4, which retain a similar mechanism of action. The biphenyl analogues warrant in vivo examination to evaluate their potential as vascular damaging agents.	[Tarade, Daniel; Ma, Dennis; Pignanelli, Christopher; Mansour, Fadi; Simard, Daniel; Gauld, James; Pandey, Siyaram] Univ Windsor, Dept Chem & Biochem, Windsor, ON, Canada; [van den Berg, Sean; McNulty, James] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada	University of Windsor; McMaster University	Pandey, S (corresponding author), Univ Windsor, Dept Chem & Biochem, Windsor, ON, Canada.	spandey@uwindsor.ca	Pignanelli, Christopher/N-7183-2019; McNulty, James/E-7871-2011; Pandey, Siyaram/AAI-5491-2020	Tarade, Daniel/0000-0001-7029-9640; Pignanelli, Christopher/0000-0001-7120-4818	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	We acknowledge Sasha Dowhayko for supplying peripheral blood mononuclear cells for our study. We acknowledge funding from NSERC to JM and SP. We gratefully acknowledge from Windsor Mold, the Couvillion family and Pajama Angels for their generous donations.	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Alvarez C, 2008, BIOORGAN MED CHEM, V16, P5952, DOI 10.1016/j.bmc.2008.04.054; Assadieskandar A, 2013, BIOORGAN MED CHEM, V21, P2703, DOI 10.1016/j.bmc.2013.03.011; Beale TM, 2012, ACS MED CHEM LETT, V3, P177, DOI 10.1021/ml200149g; Bellina F, 2006, BIOORG MED CHEM LETT, V16, P5757, DOI 10.1016/j.bmcl.2006.08.087; Chaplin DJ, 1999, ANTICANCER RES, V19, P189; Chen H, 2013, J MED CHEM, V56, P685, DOI 10.1021/jm301864s; Cooney M, 2006, ASCO ANN M P; Dark GG, 1997, CANCER RES, V57, P1829; Dowlati A, 2002, CANCER RES, V62, P3408; Ferlini C, 2009, CANCER RES, V69, P6906, DOI 10.1158/0008-5472.CAN-09-0540; GETAHUN Z, 1992, J MED CHEM, V35, P1058, DOI 10.1021/jm00084a011; Griggs J, 2001, LANCET ONCOL, V2, P82, DOI 10.1016/S1470-2045(00)00224-2; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Kanthou C, 2004, AM J PATHOL, V165, P1401, DOI 10.1016/S0002-9440(10)63398-6; Kanthou C, 2002, BLOOD, V99, P2060, DOI 10.1182/blood.V99.6.2060; Kim KH, 2009, J NAT PROD, V72, P2061, DOI 10.1021/np900460j; Lu Y, 2012, PHARM RES-DORDR, V29, P2943, DOI 10.1007/s11095-012-0828-z; Lunt SJ, 2011, INT J CANCER, V129, P1979, DOI 10.1002/ijc.25848; Mahal K, 2015, INVEST NEW DRUG, V33, P541, DOI 10.1007/s10637-015-0215-9; Mendez-Callejas GM, 2014, CELL BIOL INT, V38, P296, DOI 10.1002/cbin.10199; Masuda A, 2003, AM J PATHOL, V163, P1109, DOI 10.1016/S0002-9440(10)63470-0; McNulty J, 2015, BIOORG MED CHEM LETT, V25, P117, DOI 10.1016/j.bmcl.2014.10.090; Mendez G, 2011, APOPTOSIS, V16, P940, DOI 10.1007/s10495-011-0619-8; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Nabha SM, 2002, CLIN CANCER RES, V8, P2735; Odlo K, 2008, BIOORGAN MED CHEM, V16, P4829, DOI 10.1016/j.bmc.2008.03.049; Petit I, 2008, BLOOD, V111, P1951, DOI 10.1182/blood-2007-05-089219; Pettit GR, 2005, J MED CHEM, V48, P4087, DOI 10.1021/jm0205797; PETTIT GR, 1989, EXPERIENTIA, V45, P209, DOI 10.1007/BF01954881; Rajak H, 2013, CURR PHARM DESIGN, V19, P1923, DOI 10.2174/1381612811319100013; Rustin GJ, 2010, BRIT J CANCER, V102, P1355, DOI 10.1038/sj.bjc.6605650; Rustin GJS, 2003, J CLIN ONCOL, V21, P2815, DOI 10.1200/JCO.2003.05.185; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schobert R, 2010, J MED CHEM, V53, P6595, DOI 10.1021/jm100345r; Siemann DW, 2009, REV UPDATE CURRENT S; Simoni D, 2005, J MED CHEM, V48, P723, DOI 10.1021/jm049622b; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sun J, 2015, CHEM BIOL DRUG DES, V86, P1541, DOI 10.1111/cbdd.12617; Tarade D, 2016, MINIREVIEWS MED CHEM; Theeramunkong S, 2011, J MED CHEM, V54, P4977, DOI 10.1021/jm200555r; Tron GC, 2006, J MED CHEM, V49, P3033, DOI 10.1021/jm0512903; Tron GC, 2005, J MED CHEM, V48, P3260, DOI 10.1021/jm049096o; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Vitale I, 2007, APOPTOSIS, V12, P155, DOI 10.1007/s10495-006-0491-0; Wang L, 2002, J MED CHEM, V45, P1697, DOI 10.1021/jm010523x; Young SL, 2004, EXPERT OPIN INV DRUG, V13, P1171, DOI 10.1517/13543784.13.9.1171; Zhang GH, 1997, BIOTECHNIQUES, V23, P525, DOI 10.2144/97233pf01; Zheng SL, 2014, J MED CHEM, V57, P3369, DOI 10.1021/jm500002k; Zuo DY, 2015, CHEM-BIOL INTERACT, V227, P7, DOI 10.1016/j.cbi.2014.12.016	50	25	25	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0171806	10.1371/journal.pone.0171806	http://dx.doi.org/10.1371/journal.pone.0171806			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253265	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300008
J	Wu, CH; Chen, YJ; Wang, MH; Chiou, LL; Tseng, WYI; Lee, HS				Wu, Cheng-Han; Chen, Yu-Jen; Wang, Mu-Hui; Chiou, Ling-Ling; Tseng, Wen-Yih Isaac; Lee, Hsuan-Shu			Diffusion tensor tractography reveals muscle reconnection during axolotl limb regeneration	PLOS ONE			English	Article							MOUSE SKELETAL-MUSCLE; VIVO MR TRACTOGRAPHY; FIBER TRACKING; ANISOTROPY; INJURY; ECHO	Axolotls have amazing ability to regenerate their lost limbs. Our previous works showed that after amputation the remnant muscle ends remained at their original location whilst sending satellite cells into the regenerating parts to develop into early muscle fibers in the late differentiation stage. The parental and the newly formed muscle fibers were not connected until very late stage. The present study used non-invasive diffusion tensor imaging (DTI) to monitor weekly axolotl upper arm muscles after amputation of their upper arms. DTI tractography showed that the regenerating muscle fibers became visible at 9-wpa (weeks post amputation), but a gap was observed between the regenerating and parental muscles. The gap was filled at 10-wpa, indicating reconnection of the fibers of both muscles. This was confirmed by histology. The DTI results indicate that 23% of the muscle fibers were reconnected at 10wpa. In conclusion, DTI can be used to visualize axolotls' skeletal muscles and the results of muscle reconnection were in accordance with our previous findings. This non-invasive technique will allow researchers to identify the timeframe in which muscle fiber reconnection takes place and thus enable the study of the mechanisms underlying this reconnection.	[Wu, Cheng-Han; Wang, Mu-Hui; Lee, Hsuan-Shu] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan; [Chen, Yu-Jen; Tseng, Wen-Yih Isaac] Natl Taiwan Univ, Coll Med, Inst Med Device & Imaging, Taipei, Taiwan; [Chiou, Ling-Ling] Liver Dis Prevent & Treatment Res Fdn, Taipei, Taiwan; [Lee, Hsuan-Shu] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Lee, Hsuan-Shu] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Lee, Hsuan-Shu] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Academia Sinica - Taiwan	Lee, HS (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan.; Tseng, WYI (corresponding author), Natl Taiwan Univ, Coll Med, Inst Med Device & Imaging, Taipei, Taiwan.; Lee, HS (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Lee, HS (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.; Lee, HS (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan.	wytseng@ntu.edu.tw; benlee@ntu.edu.tw		LEE, HSUAN-SHU/0000-0002-8017-0434; Tseng, Wen-Yih Isaac/0000-0002-2314-6868	Ministry of Science and Technology, Taiwan [MOST 102-2314-B- 002 -127 -MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant to HSL from Ministry of Science and Technology (MOST 102-2314-B- 002 -127 -MY3), Taiwan (http://www.most.gov.tw/mp.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bammer R, 2003, EUR J RADIOL, V45, P223, DOI 10.1016/S0720-048X(02)00311-X; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Budzik JF, 2007, EUR RADIOL, V17, P3079, DOI 10.1007/s00330-007-0713-z; CLEVELAND GG, 1976, BIOPHYS J, V16, P1043, DOI 10.1016/S0006-3495(76)85754-2; Conturo TE, 1996, MAGNET RESON MED, V35, P399, DOI 10.1002/mrm.1910350319; Damon BM, 2002, MAGN RESON MED, V48, P97, DOI 10.1002/mrm.10198; Diogo R, 2012, J ANAT, V221, P622, DOI 10.1111/j.1469-7580.2012.01567.x; Heemskerk AM, 2005, MAGNET RESON MED, V53, P1333, DOI 10.1002/mrm.20476; Heemskerk AM, 2006, MAGN RESON MED, V56, P272, DOI 10.1002/mrm.20953; HENKELMAN RM, 1994, MAGNET RESON MED, V32, P592, DOI 10.1002/mrm.1910320508; Hsu EW, 1998, AM J PHYSIOL-HEART C, V274, pH1627, DOI 10.1152/ajpheart.1998.274.5.H1627; Kragl M, 2008, COLD SH Q B, V73, P583, DOI 10.1101/sqb.2008.73.034; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; Mattiello J, 1997, MAGNET RESON MED, V37, P292, DOI 10.1002/mrm.1910370226; McCusker C, 2011, GERONTOLOGY, V57, P565, DOI 10.1159/000323761; Schwartz ED, 2005, J NEUROTRAUM, V22, P1388, DOI 10.1089/neu.2005.22.1388; Van Donkelaar CC, 1999, J ANAT, V194, P79, DOI 10.1046/j.1469-7580.1999.19410079.x; VanDoorn A, 1996, EUR J MORPHOL, V34, P5, DOI 10.1076/ejom.34.1.5.13156; Wu CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116068; Zaraiskaya T, 2006, J MAGN RESON IMAGING, V24, P402, DOI 10.1002/jmri.20651; Zeng Hui, 2006, Chinese Medical Sciences Journal, V21, P276	21	1	1	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173425	10.1371/journal.pone.0173425	http://dx.doi.org/10.1371/journal.pone.0173425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253344	Green Published, gold, Green Submitted			2022-12-26	WOS:000396011300104
J	Gaube, P; Barcelo, C; McGillicuddy, DJ; Domingo, A; Miller, P; Giffoni, B; Marcovaldi, N; Swimmer, Y				Gaube, Peter; Barcelo, Caren; McGillicuddy, Dennis J., Jr.; Domingo, Andres; Miller, Philip; Giffoni, Bruno; Marcovaldi, Neca; Swimmer, Yonat			The use of mesoscale eddies by juvenile loggerhead sea turtles (Caretta caretta) in the southwestern Atlantic	PLOS ONE			English	Article							CENTRAL NORTH PACIFIC; DYNAMIC OCEAN; BEHAVIOR; CURRENTS; HABITAT; BRAZIL	Marine animals, such as turtles, seabirds and pelagic fishes, are observed to travel and congregate around eddies in the open ocean. Mesoscale eddies, large swirling ocean vortices with radius scales of approximately 50-100 km, provide environmental variability that can structure these populations. In this study, we investigate the use of mesoscale eddies by 24 individual juvenile loggerhead sea turtles (Caretta caretta) in the Brazil-Malvinas Confluence region. The influence of eddies on turtles is assessed by collocating the turtle trajectories to the tracks of mesoscale eddies identified in maps of sea level anomaly. Juvenile loggerhead sea turtles are significantly more likely to be located in the interiors of anticyclones in this region. The distribution of surface drifters in eddy interiors reveals no significant association with the interiors of cyclones or anticyclones, suggesting higher prevalence of turtles in anticyclones is a result of their behavior. In the southern portion of the Brazil-Malvinas Confluence region, turtle swimming speed is significantly slower in the interiors of anticyclones, when compared to the periphery, suggesting that these turtles are possibly feeding on prey items associated with anomalously low near-surface chlorophyll concentrations observed in those features.	[Gaube, Peter; McGillicuddy, Dennis J., Jr.] Woods Hole Oceanog Inst, Dept Appl Ocean Phys & Engn, Woods Hole, MA 02543 USA; [Barcelo, Caren] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Domingo, Andres] Direcc Nacl Recursos Acuat, Montevideo, Uruguay; [Miller, Philip] Ctr Invest & Conservac Marina CICMAR, El Pinar, Canelones, Uruguay; [Giffoni, Bruno; Marcovaldi, Neca] Fundacao Pro Tamar ICMBio, Projecto TAMAR, Salvador, BA, Brazil; [Swimmer, Yonat] NOAA Fisheries, Long Beach, CA USA; [Gaube, Peter] Univ Washington, Appl Phys Lab, Air Sea Interact & Remote Sensing Dept, Seattle, WA 98105 USA	Woods Hole Oceanographic Institution; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle	Gaube, P (corresponding author), Woods Hole Oceanog Inst, Dept Appl Ocean Phys & Engn, Woods Hole, MA 02543 USA.; Gaube, P (corresponding author), Univ Washington, Appl Phys Lab, Air Sea Interact & Remote Sensing Dept, Seattle, WA 98105 USA.	pgaube@apl.washington.edu	de Barros Giffoni, Bruno/AAT-7020-2020	McGillicuddy, Dennis/0000-0002-1437-2425; Gaube, Peter/0000-0002-3282-5803; Miller, Philip/0000-0003-4908-2716	Woods Hole Oceanographic Institution; National Aeronautics and Space Administration [NNX13AE47G]; National Science Foundation [1314109]; NOAA National Marine Fisheries Service, Pacific Island Fisheries Science Center; NASA [NNX13AE47G]; NOAA; NSF-GRFP [1314109]; NSF	Woods Hole Oceanographic Institution; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF)); NOAA National Marine Fisheries Service, Pacific Island Fisheries Science Center; NASA(National Aeronautics & Space Administration (NASA)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); NSF-GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF))	Support was provided by: Woods Hole Oceanographic Institution [www.whoi.edu] to PG; National Aeronautics and Space Administration [www.nasa.gov] NNX13AE47G to PG and DJM; and National Science Foundation [www.nsf.gov] 1314109 to CB.; Thanks to Uruguay's and Brazil's scientific observers for deploying satellite transmitters and providing accompanying information on the bycatch turtles, as well as the skippers and crew of fishing vessels where turtles were captured and equipped with transmitters. Funding for satellite transmitters and ARGOS satellite time was made available for this project by NOAA National Marine Fisheries Service, Pacific Island Fisheries Science Center. We thank Dr. Francesco d'Ovidio for helpful comments and discussion on an earlier version of the manuscript and three anonymous reviewers for constructive feedback. We acknowledge Collecte Localis Satellites, AVISO (http://www.aviso.oceanobs.com) for the SLA observations, NOAA's Atlantic Oceanographic and Meteorological Laboratory AOML (http://www.aoml.noaa.gov/phod/index.php) for the drifter observations, NASA MEaSUREs Ocean Color Product Evaluation Project (ftp://ftp.oceancolor.ucsb.edu) for the CHL observations, NOAA National Climatic Data Center for the SST observations (data available at ftp://eclipse.ncdc.noaa.gov/pub/OI-daily-v2/NetCDF), and NOAA National Geophysical Data Center NGDC (http://www.ngdc.noaa.gov/mgg/fliers/06mgg01.html) for the global bathymetric data. A Woods Hole Postdoctoral Fellowship awarded to PG and NASA grant NNX13AE47G funded this work. CB is grateful for support from NOAA and the NSF-GRFP (Grant No. 1314109). DJM gratefully acknowledges support from NASA and NSF.	Barcelo C, 2013, MAR ECOL PROG SER, V479, P235, DOI 10.3354/meps10222; Benitez-Nelson CR, 2007, SCIENCE, V316, P1017, DOI 10.1126/science.1136221; Bjorndal Karen A., 1997, P199; BOWEN BW, 1995, P NATL ACAD SCI USA, V92, P3731, DOI 10.1073/pnas.92.9.3731; Chelton DB, 2011, SCIENCE, V334, P328, DOI 10.1126/science.1208897; Chelton DB, 2011, PROG OCEANOGR, V91, P167, DOI 10.1016/j.pocean.2011.01.002; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Doyle Thomas K., 2008, Endangered Species Research, V4, P23, DOI 10.3354/esr00076; FALKOWSKI PG, 1991, NATURE, V352, P55, DOI 10.1038/352055a0; Foley AM, 2013, ENDANGER SPECIES RES, V21, P129, DOI 10.3354/esr00512; Fossette S, 2012, MAR ECOL PROG SER, V457, P285, DOI 10.3354/meps09581; Frick Michael G., 2010, Endangered Species Research, V9, P91, DOI 10.3354/esr00227; Fu LL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026245; Garver SA, 1997, J GEOPHYS RES-OCEANS, V102, P18607, DOI 10.1029/96JC03243; Gaspar P, 2006, P ROY SOC B-BIOL SCI, V273, P2697, DOI 10.1098/rspb.2006.3623; Gaube P, 2013, J GEOPHYS RES-OCEANS, V118, P6349, DOI 10.1002/2013JC009027; Gaube P, 2014, J GEOPHYS RES-OCEANS, V119, P8195, DOI 10.1002/2014JC010111; Gaube P, 2015, J PHYS OCEANOGR, V45, P104, DOI 10.1175/JPO-D-14-0032.1; Godo OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030161; Hansen DV, 1996, J ATMOS OCEAN TECH, V13, P900, DOI 10.1175/1520-0426(1996)013<0900:QCAIOW>2.0.CO;2; Hobday AJ, 2014, OCEANOGRAPHY, V27, P134, DOI 10.5670/oceanog.2014.92; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; Kobayashi DR, 2011, ICES J MAR SCI, V68, P707, DOI 10.1093/icesjms/fsq185; Lumpkin R, 2007, LAGRANGIAN ANALYSIS AND PREDICTION OF COASTAL AND OCEAN DYNAMICS, P39, DOI 10.1017/CBO9780511535901.003; Luschi P, 2006, S AFR J SCI, V102, P51; Luschi P, 2003, P ROY SOC B-BIOL SCI, V270, pS129, DOI 10.1098/rsbl.2003.0036; Lutz PL, 2002, BIOL SEA TURTLES, VII; Mansfield KL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3039; Mansfield KL, 2009, MAR BIOL, V156, P2555, DOI 10.1007/s00227-009-1279-x; Marcovaldi MA, 1999, BIOL CONSERV, V91, P35, DOI 10.1016/S0006-3207(99)00043-9; Maritorena S, 2002, APPL OPTICS, V41, P2705, DOI 10.1364/AO.41.002705; Matano RP, 2010, OCEAN SCI, V6, P983, DOI 10.5194/os-6-983-2010; Maxwell SM, 2015, MAR POLICY, V58, P42, DOI 10.1016/j.marpol.2015.03.014; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; McGillicuddy DJ, 2016, ANNU REV MAR SCI, V8, P125, DOI 10.1146/annurev-marine-010814-015606; Mora O., 2006, COLLECTIVE VOLUME SC, V59, P608; Oliveira LR, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004900; Palma ED, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004720; Parker DM, 2005, FISH B-NOAA, V103, P142; Polovina J, 2006, DEEP-SEA RES PT II, V53, P326, DOI 10.1016/j.dsr2.2006.01.006; Polovina JJ, 2000, FISH OCEANOGR, V9, P71, DOI 10.1046/j.1365-2419.2000.00123.x; Polovina JJ, 2004, FISH OCEANOGR, V13, P36, DOI 10.1046/j.1365-2419.2003.00270.x; Putman NF, 2015, CURR BIOL, V25, P1221, DOI 10.1016/j.cub.2015.03.014; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; SALMON M, 1987, J EXP MAR BIOL ECOL, V109, P137, DOI 10.1016/0022-0981(87)90012-8; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Siegel DA, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000965; Thompson PA, 2007, DEEP-SEA RES PT II, V54, P1003, DOI 10.1016/j.dsr2.2006.12.009; Wyneken J, 2008, MAR BIOL, V156, P171, DOI 10.1007/s00227-008-1074-0	51	24	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172839	10.1371/journal.pone.0172839	http://dx.doi.org/10.1371/journal.pone.0172839			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249020	Green Published, Green Submitted, gold			2022-12-26	WOS:000395983500060
J	Motta, V; Trevisi, P; Bertolini, F; Ribani, A; Schiavo, G; Fontanesi, L; Bosi, P				Motta, Vincenzo; Trevisi, Paolo; Bertolini, Francesca; Ribani, Anisa; Schiavo, Giuseppina; Fontanesi, Luca; Bosi, Paolo			Exploring gastric bacterial community in young pigs	PLOS ONE			English	Article							STREPTOCOCCUS-SUIS; SP-NOV; STOMACH; MICROBIOME; EPITHELIUM; PIGLETS	Microbiota plays an important role in the homeostasis of the gastrointestinal tract. Understanding the variations of the commensal microbiota composition is crucial for a more efficient control of enteric infectious diseases and for the reduction of the use of antibiotics in animal production, which are the main points of interest for improved animal healthcare and welfare and for consumer health protection. Even though the intestinal microbiota has been extensively studied, little is known about the gastric microbiota. This pilot study was aimed at a descriptive analysis of the gastric microbiota in healthy pigs and at the identification of any differences among four potentially distinct microbial niches in the stomach. Gastric mucosal samples from the oxyntic area, the pylorus and the gastric groove, and a sample of gastric contents were collected from four healthy weaned pigs. Bacterial DNA was isolated and extracted from each sample and amplicons from the V6 region of the 16S rRNA gene were sequenced using Ion Torrent PGM. The data were analysed by an "unsupervised" and a "supervised" approach in the Ribosomal Database Project (RDP) pipeline. Proteobacteria was the dominant phylum in all the samples. Differences in bacterial community composition were found between mucosal and content samples (one-way ANOSIM pairwise post hoc test, p < 0.05); instead, the different mucosal regions did not show differences between them. The mucosal samples were characterised by Herbiconiux and Brevundimonas, two genera which include cellulolytic and xylanolytic strains. Nevertheless, additional larger trials are needed to support the data presented in this pilot study and to increase the knowledge regarding the resident microbiota of the stomach.	[Motta, Vincenzo; Trevisi, Paolo; Bertolini, Francesca; Ribani, Anisa; Schiavo, Giuseppina; Fontanesi, Luca; Bosi, Paolo] Univ Bologna, Dept Agr & Food Sci DISTAL, Bologna, Italy	University of Bologna	Bosi, P (corresponding author), Univ Bologna, Dept Agr & Food Sci DISTAL, Bologna, Italy.	paolo.bosi@unibo.it	Fontanesi, Luca/L-1770-2014; bertolini, francesca/AAX-3836-2021	Fontanesi, Luca/0000-0001-7050-3760; Bertolini, Francesca/0000-0003-4181-3895; MOTTA, VINCENZO/0000-0002-1443-1309				Behrendt U, 2011, INT J SYST EVOL MICR, V61, P1039, DOI 10.1099/ijs.0.021352-0; Bhat MK, 2000, BIOTECHNOL ADV, V18, P355, DOI 10.1016/S0734-9750(00)00041-0; Buczolits S, 2001, SYST APPL MICROBIOL, V24, P368, DOI 10.1078/0723-2020-00052; Choi E, 2014, GUT, P1; Chu SJ, 2012, CURR OPIN GASTROEN, V28, P587, DOI 10.1097/MOG.0b013e328358e5cc; Cole JR, 2014, NUCLEIC ACIDS RES, V42, P1; Colombo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111447; Hamada M, 2012, INT J SYST EVOL MICR, V62, P795, DOI 10.1099/ijs.0.031260-0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hu X, 2014, FORESTS, V5, P455, DOI 10.3390/f5030455; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Karlsson NG, 1997, BIOCHEM J, V326, P911, DOI 10.1042/bj3260911; Kernaghan Shaun, 2012, Animal Health Research Reviews, V13, P110, DOI 10.1017/S1466252312000102; Kim BC, 2012, INT J SYST EVOL MICR, V62, P90, DOI 10.1099/ijs.0.028357-0; Li XF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008334; Lopetuso LR, 2014, BEST PRACT RES CL GA, V28, P995, DOI 10.1016/j.bpg.2014.10.004; MacInnes JI, 2008, CAN J VET RES, V72, P242; Malmuthuge N, 2014, APPL ENVIRON MICROB, V80, P2021, DOI 10.1128/AEM.03864-13; Mann E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086950; Mazzoni M, 2011, J ANAT, V219, P611, DOI 10.1111/j.1469-7580.2011.01415.x; Nordman H, 1998, BIOCHEM J, V331, P687, DOI 10.1042/bj3310687; Pedersen NR, 2012, J ANIM SCI, V90, P149, DOI 10.2527/jas.53832; Perkins GA, 2012, APPL ENVIRON MICROB, V78, P2522, DOI 10.1128/AEM.06252-11; Priori D, 2014, J ANIM PHYSL ANIM NU; Sheh A, 2013, LANDES BIOSCIENCE, P505; Su Y, 2008, FEMS MICROBIOL ECOL, V66, P546, DOI 10.1111/j.1574-6941.2008.00529.x; Sul WJ, 2011, P NATL ACAD SCI USA, V108, P14637, DOI 10.1073/pnas.1111435108; Trevisi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081473; VANGYLSWYK NO, 1987, INT J SYST BACTERIOL, V37, P102, DOI 10.1099/00207713-37-2-102; Varloud M, 2007, J ANIM SCI, V85, P2508, DOI 10.2527/jas.2006-182; Walker MM, 2014, ALIMENT PHARM THER, V39, P767, DOI 10.1111/apt.12666; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Yang I, 2013, FEMS MICROBIOL REV, V37, P736, DOI 10.1111/1574-6976.12027; Yuki N, 2000, APPL ENVIRON MICROB, V66, P5030, DOI 10.1128/AEM.66.11.5030-5034.2000; Zoetendal Erwin G, 2004, Curr Issues Intest Microbiol, V5, P31	37	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173029	10.1371/journal.pone.0173029	http://dx.doi.org/10.1371/journal.pone.0173029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249050	gold, Green Published, Green Submitted			2022-12-26	WOS:000395983500070
J	Jiang, JY; Creasy, KT; Purnell, J; Peterson, ML; Spear, BT				Jiang, Jieyun; Creasy, Kate Townsend; Purnell, Justin; Peterson, Martha L.; Spear, Brett T.			Zhx2 (zinc fingers and homeoboxes 2) regulates major urinary protein gene expression in the mouse liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-FETOPROTEIN SYNTHESIS; INTIMA-MEDIA THICKNESS; AGGRESSIVE-BEHAVIOR; MICE; FAMILY; ASSOCIATION; BALB/CJ; IDENTIFICATION; REPRESSION; MEMBER	The mouse major urinary proteins (Mups) are encoded by a large family of highly related genes clustered on chromosome 4. Mups, synthesized primarily and abundantly in the liver and secreted through the kidneys, exhibit male-biased expression. Mups bind a variety of volatile ligands; these ligands, and Mup proteins themselves, influence numerous behavioral traits. Although urinary Mup protein levels vary between inbred mouse strains, this difference is most pronounced in BALB/cJ mice, which have dramatically low urinary Mup levels; this BALB/cJ trait had been mapped to a locus on chromosome 15. We previously identified Zhx2 (zinc fingers and homeoboxes 2) as a regulator of numerous liver-enriched genes. Zhx2 is located on chromosome 15, and a natural hypomorphic mutation in the BALB/cJ Zhx2 allele dramatically reduces Zhx2 expression. Based on these data, we hypothesized that reduced Zhx2 levels are responsible for lower Mup expression in BALB/cJ mice. Using both transgenic and knock-out mice along with in vitro assays, our data show that Zhx2 binds Mup promoters and is required for high levels of Mup expression in the adult liver. In contrast to previously identified Zhx2 targets that appear to be repressed by Zhx2, Mup genes are positively regulated by Zhx2. These data identify Zhx2 as a novel regulator of Mup expression and indicate that Zhx2 activates as well as represses expression of target genes.	[Jiang, Jieyun; Purnell, Justin; Peterson, Martha L.; Spear, Brett T.] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, 800 Rose St, Lexington, KY 40536 USA; [Creasy, Kate Townsend; Spear, Brett T.] Univ Kentucky, Coll Med, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA; [Peterson, Martha L.; Spear, Brett T.] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY 40536 USA; [Creasy, Kate Townsend] Univ Calif San Francisco, Cardiovasc Res Inst, 555 Mission Bay Blvd S,Rm 282T, San Francisco, CA 94158 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of California System; University of California San Francisco	Jiang, JY; Spear, BT (corresponding author), Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, 800 Rose St, Lexington, KY 40536 USA.	jieyun.jiang2@uky.edu; bspear@uky.edu	Creasy, Kate Townsend/GMW-8097-2022	Creasy, Kate Townsend/0000-0003-1870-4586; Peterson, Martha/0000-0002-7214-421X	Public Health Service [R01DK074816, P20RR021954, T32DK007778]; National Science Foundation [MCB-1158234]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074816, T32DK007778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by Public Health Service Grants R01DK074816 (to B. T. S.), P20RR021954 (to B. T. S.), and T32DK007778 (to K. T. C.) and National Science Foundation Grant MCB-1158234 (to M. L. P.). The authors declare that they have no conflicts of interest with the contents of this article.	ABELEV GI, 1963, TRANSPLANTATION, V1, P174, DOI 10.1097/00007890-196301020-00004; BELAYEW A, 1982, MOL CELL BIOL, V2, P1427, DOI 10.1128/MCB.2.11.1427; Beynon RJ, 2003, BIOCHEM SOC T, V31, P142, DOI 10.1042/bst0310142; Bis JC, 2011, NAT GENET, V43, P940, DOI 10.1038/ng.920; BISHOP JO, 1982, EMBO J, V1, P615, DOI 10.1002/j.1460-2075.1982.tb01217.x; BLANKENHORN EP, 1988, GENETICS, V119, P687; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Cheetham SA, 2009, PHYSIOL BEHAV, V96, P253, DOI 10.1016/j.physbeh.2008.10.005; CIARANELLO RD, 1974, P NATL ACAD SCI USA, V71, P3006, DOI 10.1073/pnas.71.8.3006; CIARANELLO RD, 1974, J BIOL CHEM, V249, P4528; Creasy Kate Townsend, 2016, Gene Expression, V17, P7, DOI 10.3727/105221616X691712; Dow HC, 2011, GENES BRAIN BEHAV, V10, P57, DOI 10.1111/j.1601-183X.2010.00640.x; DRAGANI TA, 1989, MOL CARCINOGEN, V2, P355, DOI 10.1002/mc.2940020610; DUNCAN R, 1988, MOL CELL BIOL, V8, P2705, DOI 10.1128/MCB.8.7.2705; FINLAYSON JS, 1965, SCIENCE, V149, P981, DOI 10.1126/science.149.3687.981; Ganfornina MD, 2000, MOL BIOL EVOL, V17, P114, DOI 10.1093/oxfordjournals.molbev.a026224; Gargalovic PS, 2010, CIRC-CARDIOVASC GENE, V3, P60, DOI 10.1161/CIRCGENETICS.109.902320; Gomez-Baena G, 2014, BIOCHEM SOC T, V42, P886, DOI 10.1042/BST20140083; HASTIE ND, 1979, CELL, V17, P449, DOI 10.1016/0092-8674(79)90171-5; Holloway MG, 2006, MOL ENDOCRINOL, V20, P647, DOI 10.1210/me.2005-0328; Kaur AW, 2014, CELL, V157, P676, DOI 10.1016/j.cell.2014.02.025; Kawata H, 2003, BIOCHEM J, V373, P747, DOI 10.1042/BJ20030171; Kawata H, 2003, GENE, V323, P133, DOI 10.1016/j.gene.2003.09.013; KNOPF JL, 1983, MOL CELL BIOL, V3, P2232, DOI 10.1128/MCB.3.12.2232; Kwak J, 2012, PHYSIOL BEHAV, V107, P112, DOI 10.1016/j.physbeh.2012.06.008; Li CW, 2015, GENE, V562, P226, DOI 10.1016/j.gene.2015.02.078; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Morford LA, 2007, HEPATOLOGY, V46, P1541, DOI 10.1002/hep.21825; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; O'Geen H, 2011, METHODS MOL BIOL, V791, P265, DOI 10.1007/978-1-61779-316-5_20; OLSSON M, 1977, J EXP MED, V145, P819, DOI 10.1084/jem.145.4.819; PACHNIS V, 1984, P NATL ACAD SCI-BIOL, V81, P5523, DOI 10.1073/pnas.81.17.5523; Perincheri S, 2005, P NATL ACAD SCI USA, V102, P396, DOI 10.1073/pnas.0408555102; Perincheri S, 2008, MAMM GENOME, V19, P26, DOI 10.1007/s00335-007-9077-6; Peyton DK, 2000, GENOMICS, V63, P173, DOI 10.1006/geno.1999.6073; SHAW PH, 1983, CELL, V32, P755, DOI 10.1016/0092-8674(83)90061-2; Shen H, 2008, J CELL MOL MED, V12, P2772, DOI 10.1111/j.1582-4934.2008.00233.x; Spear BT, 2006, CELL MOL LIFE SCI, V63, P2922, DOI 10.1007/s00018-006-6258-5; SZOKA PR, 1978, GENETICS, V90, P597; Waxman S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-243; Yamada K, 2003, BIOCHEM J, V373, P167, DOI 10.1042/BJ20021866; YAN C, 1990, EMBO J, V9, P869, DOI 10.1002/j.1460-2075.1990.tb08184.x; Yue XT, 2012, GASTROENTEROLOGY, V142, P1559, DOI 10.1053/j.gastro.2012.02.049; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	46	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6765	6774		10.1074/jbc.M116.768275	http://dx.doi.org/10.1074/jbc.M116.768275			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28258223	Green Published, hybrid			2022-12-26	WOS:000399813400027
J	Li, A; Ziehr, JL; Johnson, KA				Li, An; Ziehr, Jessica L.; Johnson, Kenneth A.			A new general method for simultaneous fitting of temperature and concentration dependence of reaction rates yields kinetic and thermodynamic parameters for HIV reverse transcriptase specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-LEVEL RESISTANCE; DNA-POLYMERASE; MECHANISM; AZT; DISCRIMINATION; POLYMERIZATION; INTERMEDIATE; SELECTIVITY; ZIDOVUDINE; MUTATIONS	Recent studies have demonstrated the dominant role of induced fit in enzyme specificity of HIV reverse transcriptase and many other enzymes. However, relevant thermodynamic parameters are lacking, and equilibrium thermodynamic methods are of no avail because the key parameters can only be determined by kinetic measurement. By modifying KinTek Explorer software, we present a new general method for globally fitting data collected over a range of substrate concentrations and temperatures and apply it to HIV reverse transcriptase. Fluorescence stopped-flow methods were used to record the kinetics of enzyme conformational changes that monitor nucleotide binding and incorporation. The nucleotide concentration dependence was measured at temperatures ranging from 5 to 37 degrees C, and the raw data were fit globally to derive a single set of rate constants at 37 degrees C and a set of activation enthalpy terms to account for the kinetics at all other temperatures. This comprehensive analysis afforded thermodynamic parameters for nucleotide binding (K-d, Delta G, Delta H, and Delta S at 37 degrees C) and kinetic parameters for enzyme conformational changes and chemistry (rate constants and activation enthalpy). Comparisons between wildtype enzyme and a mutant resistant to nucleoside analogs used to treat HIV infections reveal that the ground state binding is weaker and the activation enthalpy for the conformational change step is significantly larger for the mutant. Further studies to explore the structural underpinnings of the observed thermodynamics and kinetics of the conformational change step may help to design better analogs to treat HIV infections and other diseases. Our new method is generally applicable to enzyme and chemical kinetics.	[Li, An; Ziehr, Jessica L.; Johnson, Kenneth A.] Univ Texas Austin, Inst Cell & Mol Biol, Mol Biosci Dept, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Johnson, KA (corresponding author), 2500 Speedway,MBB3 122, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu			Welch Foundation [F-1604]; National Institutes of Health [R01 GM084741]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084741] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Welch Foundation Grant F-1604 and National Institutes of Health Grant R01 GM084741. K. A. J. is the President of KinTek Corp., which provided the AutoSF-120 stopped flow instrument and KinTek Explorer software used in this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Bec G, 2013, J AM CHEM SOC, V135, P9743, DOI 10.1021/ja4018418; Bilsel O, 1999, BIOCHEMISTRY-US, V38, P1018, DOI 10.1021/bi982365q; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Das K, 2016, ACS CHEM BIOL, V11, P3226, DOI 10.1021/acschembio.6b00798; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; JOHNSON KA, 1978, BIOCHEMISTRY-US, V17, P3432, DOI 10.1021/bi00610a002; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KELLAM P, 1992, P NATL ACAD SCI USA, V89, P1934, DOI 10.1073/pnas.89.5.1934; Kellinger MW, 2011, BIOCHEMISTRY-US, V50, P5008, DOI 10.1021/bi200204m; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Kerr SG, 1997, BIOCHEMISTRY-US, V36, P14064, DOI 10.1021/bi9713862; Kirmizialtin S, 2015, J PHYS CHEM B, V119, P11513, DOI 10.1021/acs.jpcb.5b05467; Kirmizialtin S, 2012, STRUCTURE, V20, P618, DOI 10.1016/j.str.2012.02.018; Kuznetsov NA, 2012, NUCLEIC ACIDS RES, V40, P7384, DOI 10.1093/nar/gks423; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; Lee HR, 2009, BIOCHEMISTRY-US, V48, P2087, DOI 10.1021/bi8016284; Li A, 2016, J BIOL CHEM, V291, P26554, DOI 10.1074/jbc.M116.753152; Meyer PR, 2004, J BIOL CHEM, V279, P45389, DOI 10.1074/jbc.M405072200; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Prasad BR, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-012-1288-6; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Shafer RW, 2008, AIDS REV, V10, P67; Stull F, 2016, NAT STRUCT MOL BIOL, V23, P53, DOI 10.1038/nsmb.3133; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Zhu W, 2016, BIOCHEMISTRY-US, V55, P2163, DOI 10.1021/acs.biochem.6b00043	28	6	6	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6695	6702		10.1074/jbc.M116.760827	http://dx.doi.org/10.1074/jbc.M116.760827			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28255091	Green Published, hybrid			2022-12-26	WOS:000399813400021
J	Schonauer, S; Koorschen, HG; Penno, A; Rennhack, A; Breiden, B; Sandhoff, K; Gutbrod, K; Dormann, P; Raju, DN; Haberkant, P; Gerl, MJ; Brugger, B; Zigdon, H; Vardi, A; Futerman, AH; Thiele, C; Wachten, D				Schonauer, Sophie; Koerschen, Heinz G.; Penno, Anke; Rennhack, Andreas; Breiden, Bernadette; Sandhoff, Konrad; Gutbrod, Katharina; Dormann, Peter; Raju, Diana N.; Haberkant, Per; Gerl, Mathias J.; Bruegger, Britta; Zigdon, Hila; Vardi, Ayelet; Futerman, Anthony H.; Thiele, Christoph; Wachten, Dagmar			Identification of a feedback loop involving beta-glucosidase 2 and its product sphingosine sheds light on the molecular mechanisms in Gaucher disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSYLCERAMIDE ACCUMULATION; MULTIPLE-SCLEROSIS; FINGOLIMOD FTY720; B EPOXIDE; GLUCOSYLSPHINGOSINE; DEFICIENCY; MODEL; MICE; MUTATION; TYPE-3	The lysosomal acid beta-glucosidase GBA1 and the non-lysosomal beta-glucosidase GBA2 degrade glucosylceramide (GlcCer) to glucose and ceramide in different cellular compartments. Loss of GBA2 activity and the resulting accumulation of GlcCer results in male infertility, whereas mutations in the GBA1 gene and loss of GBA1 activity cause the lipid-storage disorder Gaucher disease. However, the role of GBA2 in Gaucher disease pathology and its relationship to GBA1 is not well understood. Here, we report a GBA1-dependent down-regulation of GBA2 activity in patients with Gaucher disease. Using an experimental approach combining cell biology, biochemistry, and mass spectrometry, we show that sphingosine, the cytotoxic metabolite accumulating in Gaucher cells through the action of GBA2, directly binds to GBA2 and inhibits its activity. We propose a negative feedback loop, in which sphingosine inhibits GBA2 activity in Gaucher cells, preventing further sphingosine accumulation and, thereby, cytotoxicity. Our findings add a new chapter to the understanding of the complex molecular mechanism underlying Gaucher disease and the regulation of beta-glucosidase activity in general.	[Schonauer, Sophie; Raju, Diana N.; Wachten, Dagmar] Ctr Adv European Studies & Res Caesar, Minerva Max Planck Res Grp, Mol Physiol, D-53175 Bonn, Germany; [Koerschen, Heinz G.; Rennhack, Andreas] Ctr Adv European Studies & Res Caesar, Dept Mol Sensory Syst, D-53175 Bonn, Germany; [Thiele, Christoph] Univ Bonn, Dept Cell Biol Lipids, LIMES Inst, Bonn, Germany; [Breiden, Bernadette; Sandhoff, Konrad] Univ Bonn, LIMES Inst, Kekule Inst, D-53115 Bonn, Germany; [Gutbrod, Katharina; Dormann, Peter] Univ Bonn, Inst Mol Physiol & Biotechnol Plants, D-53115 Bonn, Germany; [Haberkant, Per] EMBL Heidelberg, Prote Core Facil, D-69117 Heidelberg, Germany; [Gerl, Mathias J.; Bruegger, Britta] Heidelberg Univ, Biochem Zentrum BZH, D-69120 Heidelberg, Germany; [Zigdon, Hila; Vardi, Ayelet; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel; [Wachten, Dagmar] Univ Bonn, Inst Innate Immun, Univ Hosp, D-53127 Bonn, Germany; [Gerl, Mathias J.] Lipotype GmbH, Tatzberg 47, D-01307 Dresden, Germany; [Futerman, Anthony H.] Weizmann Inst Sci, Biochem, Rehovot, Israel	Center of Advanced European Studies & Research (CAESAR); Center of Advanced European Studies & Research (CAESAR); University of Bonn; University of Bonn; University of Bonn; European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Weizmann Institute of Science; University of Bonn; Weizmann Institute of Science	Wachten, D (corresponding author), Ctr Adv European Studies & Res Caesar, Ludwig Erhard Allee 2, D-53175 Bonn, Germany.	dagmar.wachten@caesar.de	Breiden, Bernadette/S-3005-2019; Breiden, Bernadette/F-2422-2014	Breiden, Bernadette/0000-0002-4838-4109; Breiden, Bernadette/0000-0002-4838-4109; Haberkant, Per/0000-0002-5608-9062; Futerman, Anthony/0000-0003-0013-0115; Gerl, Mathias/0000-0002-8074-7221	Fritz Thyssen Foundation; Deutsche Forschungsgemeinschaft [SFB645, TRR83]; Excellence Cluster ImmunoSensation, Bonn	Fritz Thyssen Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster ImmunoSensation, Bonn	The work was supported in part by a grant from the Fritz Thyssen Foundation and by the Deutsche Forschungsgemeinschaft Grants SFB645 (to D. W., C. T., and P. D.) and TRR83 (to C. T., B. B., and K. S.), and a grant from the Excellence Cluster ImmunoSensation, Bonn (to D. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Aureli M, 2012, J INHERIT METAB DIS, V35, P1081, DOI 10.1007/s10545-012-9478-x; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Burke DG, 2013, J INHERIT METAB DIS, V36, P869, DOI 10.1007/s10545-012-9561-3; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Contreras FX, 2006, BIOPHYS J, V90, P4085, DOI 10.1529/biophysj.105.076471; Dekker N, 2011, BLOOD, V118, pE118, DOI 10.1182/blood-2011-05-352971; Elleder M, 2006, J INHERIT METAB DIS, V29, P707, DOI 10.1007/s10545-006-0411-z; ERICKSON JS, 1973, J LIPID RES, V14, P133; Farfel-Becker T, 2011, DIS MODEL MECH, V4, P746, DOI 10.1242/dmm.008185; Ferraz MJ, 2016, MOL GENET METAB, V117, P186, DOI 10.1016/j.ymgme.2015.12.006; Filocamo M, 2014, OPEN J BIORESOURCES, V1, pe2, DOI [DOI 10.5334/0JB.AB, 10.5334/ojb.ab, DOI 10.5334/OJB.AB]; Fuller M, 2008, MOL GENET METAB, V93, P437, DOI 10.1016/j.ymgme.2007.11.011; Futerman A.H., 2006, GAUCHER DIS; Ginkel C, 2012, J BIOL CHEM, V287, P41888, DOI 10.1074/jbc.M112.413500; Goni FM, 1996, FEBS LETT, V390, P1, DOI 10.1016/0014-5793(96)00603-5; GRABOWSKI GA, 1985, AM J HUM GENET, V37, P499; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Korschen HG, 2013, J BIOL CHEM, V288, P3381, DOI 10.1074/jbc.M112.414714; Korkotian E, 1999, J BIOL CHEM, V274, P21673, DOI 10.1074/jbc.274.31.21673; LEGLER G, 1988, ARCH BIOCHEM BIOPHYS, V260, P437, DOI 10.1016/0003-9861(88)90467-5; MEIVARLEVY I, 1994, BIOCHEM J, V303, P377, DOI 10.1042/bj3030377; Mistry PK, 2014, P NATL ACAD SCI USA, V111, P4934, DOI 10.1073/pnas.1400768111; NILSSON O, 1982, J NEUROCHEM, V39, P709, DOI 10.1111/j.1471-4159.1982.tb07950.x; Orvisky E, 2002, MOL GENET METAB, V76, P262, DOI 10.1016/S1096-7192(02)00117-8; Pastores GM, 1997, BAILLIERE CLIN HAEM, V10, P739, DOI 10.1016/S0950-3536(97)80037-6; Raju D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005063; Ridley CM, 2013, J BIOL CHEM, V288, P26052, DOI 10.1074/jbc.M113.463562; SARMIENTOS F, 1986, EUR J BIOCHEM, V160, P527, DOI 10.1111/j.1432-1033.1986.tb10071.x; Sasaki H, 2009, BIOPHYS J, V96, P2727, DOI 10.1016/j.bpj.2008.12.3926; Scherer M, 2010, J LIPID RES, V51, P2001, DOI 10.1194/jlr.D005322; Schueler UH, 2003, NEUROBIOL DIS, V14, P595, DOI 10.1016/j.nbd.2003.08.016; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sun Y, 2010, HUM MOL GENET, V19, P1088, DOI 10.1093/hmg/ddp580; Vardi A, 2016, J PATHOL, V239, P496, DOI 10.1002/path.4751; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224	37	15	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6177	6189		10.1074/jbc.M116.762831	http://dx.doi.org/10.1074/jbc.M116.762831			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28258214	hybrid, Green Published			2022-12-26	WOS:000399538700014
J	Cho, HY; Jung, I; Kwon, JY; Kim, SJ; Park, YW; Kim, YH				Cho, Hee Young; Jung, Inkyung; Kwon, Ja-Young; Kim, So Jung; Park, Yong Won; Kim, Young-Han			The Delta Neutrophil Index as a predictive marker of histological chorioamnionitis in patients with preterm premature rupture of membranes: A retrospective study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INTRAAMNIOTIC INFECTION; INTRAUTERINE INFECTION; WOMEN; GRANULOCYTE; PERFORMANCE; FUNISITIS; COUNT; LABOR; AGE	Background Histological chorioamnionitis (HCA) is related to perinatal morbidity. However, there is no definite diagnostic method for detecting chorioamnionitis before delivery. Methods We evaluated whether the delta neutrophil index (DNI) was an effective early marker of HCA in patients with preterm premature rupture of membranes (PPROM). We retrospectively evaluated 149 women diagnosed with PPROM (gestational age, 20(+0) to 36(+6) weeks) at Severance Hospital from January 2013 to December 2014. The women were categorized into the following two groups: (a) PPROM without HCA and (b) PPROM with HCA. The maternal white blood cell (WBC) count, neutrophil-to-lymphocyte ratio (NLR), C-reactive protein (CRP) level, and DNI were measured at admission. The DNI has been reported to reflect the fraction of circulating immature granulocytes associated with infection. Results Of the 149 patients, 87 were included in the PPROM without HCA group and 62 were included in the PPROM with HCA group. The interval between admission and delivery was significantly shorter in the PPROM with HCA group than in the PPROM without HCA group. There was no significant difference in the maternal WBC count. The serum CRP level, NLR, and DNI were significantly lower in the PPROM without HCA group than in the PPROM with HCA group, while the lymphocyte count was significantly lower in the PPROM with HCA group than in the PPROM without HCA group. A predictive equation was generated by combining the DNI, lymphocyte count, and CRP level, and the sensitivity and specificity for predicting a placental inflammatory response were 69.1% and 70.5%, respectively. Conclusions The DNI could be a predictive marker for HCA in patients with PPROM. Our predictive equation involving the DNI, lymphocyte count, and CRP level may be helpful for predicting the placental inflammatory response in patients with PPROM.	[Cho, Hee Young; Kwon, Ja-Young; Park, Yong Won; Kim, Young-Han] Yonsei Univ, Yonsei Univ Hlth Syst, Coll Med, Dept Obstet & Gynecol,Inst Womens Life Med Sci, Seoul, South Korea; [Cho, Hee Young] CHA Univ, CHA Bundang Med Ctr, Dept Obstet & Gynecol, Seongnam, South Korea; [Jung, Inkyung] Yonsei Univ, Coll Med, Dept Biostat & Med Informat, Seoul, South Korea; [Kim, So Jung] Yonsei Univ, Coll Med, Dept Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, YH (corresponding author), Yonsei Univ, Yonsei Univ Hlth Syst, Coll Med, Dept Obstet & Gynecol,Inst Womens Life Med Sci, Seoul, South Korea.	yhkim522@yuhs.ac		Kwon, Ja-Young/0000-0003-3009-6325; Cho, Hee Young/0000-0001-7064-5056; Jung, Inkyung/0000-0003-3780-3213; Kim, Young-Han/0000-0003-0645-6028				Ansari-Lari MA, 2003, AM J CLIN PATHOL, V120, P795, DOI 10.1309/LT30BV9UJJV9CFHQ; Beazley D, 1996, SEMIN PERINATOL, V20, P409, DOI 10.1016/S0146-0005(96)80008-5; Berger A, 2009, J PERINAT MED, V37, P72, DOI 10.1515/JPM.2009.016; Cecic I, 2002, CANCER LETT, V183, P43, DOI 10.1016/S0304-3835(02)00092-7; Croci DO, 2007, CANCER IMMUNOL IMMUN, V56, P1687, DOI 10.1007/s00262-007-0343-y; Denison FC, 1997, BRIT J OBSTET GYNAEC, V104, P851, DOI 10.1111/j.1471-0528.1997.tb12035.x; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Harris Neil, 2005, Lab Hematol, V11, P47, DOI 10.1532/LH96.04075; Henderson J.J., 2012, J MATERN-FETAL NEO M, V25, P642; HyunNahm C, 2008, ANN CLIN LAB SCI, V38, P241; Kadanali S, 1997, INT J GYNECOL OBSTET, V58, P269, DOI 10.1016/S0020-7292(97)00085-4; Kemp K, 2002, INFECT IMMUN, V70, P5019, DOI 10.1128/IAI.70.9.5019-5025.2002; Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS29, DOI 10.1016/j.ajog.2015.08.040; Kim H, 2014, CLIN LAB, V60, P2015, DOI 10.7754/Clin.Lab.2014.140528; Kim MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107880; Kim MA, 2011, EUR J CLIN INVEST, V41, P773, DOI 10.1111/j.1365-2362.2011.02469.x; Kim OH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148799; KURKI T, 1990, ARCH GYNECOL OBSTET, V247, P31, DOI 10.1007/BF02390652; Lee SY, 2012, J KOREAN MED SCI, V27, P674, DOI 10.3346/jkms.2012.27.6.674; Lim TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086884; MAZOR M, 1993, J REPROD MED, V38, P799; Nigro KG, 2005, AM J CLIN PATHOL, V123, P618, DOI 10.1309/73H7K7UBW816PBJJ; Nunez J, 2008, AM J CARDIOL, V101, P747, DOI 10.1016/j.amjcard.2007.11.004; POTKUL RK, 1985, AM J OBSTET GYNECOL, V153, P642, DOI 10.1016/S0002-9378(85)80249-0; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Roberts DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031819; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; ROMERO R, 1993, AM J OBSTET GYNECOL, V169, P839, DOI 10.1016/0002-9378(93)90014-A; Romero R, 2007, NUTR REV, V65, pS194, DOI 10.1301/nr.2007.dec.S194-S202; Romero R, 2015, J PERINAT MED, V43, P19, DOI 10.1515/jpm-2014-0249; Romero R, 2014, AM J REPROD IMMUNOL, V71, P330, DOI 10.1111/aji.12189; Ryu A, 2013, ACTA OBSTET GYN SCAN, V92, P517, DOI 10.1111/aogs.12073; Seok Y, 2012, SHOCK, V37, P242, DOI 10.1097/SHK.0b013e3182454acf; Suliman MARM, 2010, ARCH MED RES, V41, P618, DOI 10.1016/j.arcmed.2010.11.006; Vaisbuch E, 2002, J PERINAT MED, V30, P287, DOI 10.1515/JPM.2002.041; WATTS DH, 1993, OBSTET GYNECOL, V82, P509; Yune HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120677	37	9	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173382	10.1371/journal.pone.0173382	http://dx.doi.org/10.1371/journal.pone.0173382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278168	gold, Green Published, Green Submitted			2022-12-26	WOS:000396087900082
J	Lima, PDA; Chen, ZL; Tayab, A; Murphy, MSQ; Pudwell, J; Smith, GN; Croy, BA				Lima, Patricia D. A.; Chen, Zhilin; Tayab, Aysha; Murphy, Malia S. Q.; Pudwell, Jessica; Smith, Graeme N.; Croy, B. Anne			Circulating progenitor and angiogenic cell frequencies are abnormally static over pregnancy in women with preconception diabetes: A pilot study	PLOS ONE			English	Article							COMPLICATIONS; PREECLAMPSIA; EPC	Type 1 and 2 diabetes decrease the frequencies and functional capacities of circulating angiogenic cells (CAC). Diabetes also elevates gestational complications. These observations may be interrelated. We undertook pilot studies to address the hypothesis that preconception diabetes deviates known gestational increases in CACs. Cross-sectional study of type 1 diabetic, type 2 diabetic and normoglycemic pregnant women was conducted at 1st, 2nd, and 3rd trimester and compared to a 6mo postpartum surrogate baseline. Circulating progenitor cells (CPC; CD34+CD45dimSSlow) and CACs (CD34+CD45dimSSlow expressing CD133 without or with KDR) were quantified by flow cytometry and by colony assay (CFU-Hill). In pregnant normoglycemic women, CD34+CD45dimSSlow cell frequency was greater in 1st and 3rd trimester than postpartum but frequency of these cells was static over type 1 or 2 diabetic pregnancies. Type 1 and type 2 diabetic women showed CACs variance versus normal controls. Type 1 diabetic women had more total CD34+KDR+ CACs in 1st trimester and a higher ratio of CD133+KDR+ to total CD133+ cells in 1st and 2nd trimesters than control women, demonstrating an unbalance in CD133+KDR+ CACs. Type 2 diabetic women had more CD133+KDR+ CACs in 1st trimester and fewer CD133+KDR- CACs at mid-late pregnancy than normal pregnant women. Thus, pregnancy stage-specific physiological fluctuation in CPCs (CD34+) and CACs (CD133+KDR+ and CD133+KDR-) did not occur in type 1 and type 2 diabetic women. Early outgrowth colonies were stable across normal and diabetic pregnancies. Therefore, preconception diabetes blocks the normal dynamic pattern of CAC frequencies across gestation but does not alter colony growth. The differences between diabetic and typical women were seen at specific gestational stages that may be critical for initiation of the uterine vascular pathologies characterizing diabetic gestations.	[Lima, Patricia D. A.; Chen, Zhilin; Tayab, Aysha; Croy, B. Anne] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Murphy, Malia S. Q.; Pudwell, Jessica; Smith, Graeme N.] Queens Univ, Dept Obstet & Gynecol, Kingston, ON, Canada; [Lima, Patricia D. A.] Ottawa Hosp, Res Inst, Dept Obstet & Gynecol, Ottawa, ON, Canada	Queens University - Canada; Queens University - Canada; University of Ottawa; Ottawa Hospital Research Institute	Lima, PDA (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.; Lima, PDA (corresponding author), Ottawa Hosp, Res Inst, Dept Obstet & Gynecol, Ottawa, ON, Canada.	limapda@gmail.com	Smith, Graeme Neil/ABB-6863-2021	Smith, Graeme Neil/0000-0002-3128-4523; Pudwell, Jessica/0000-0002-7000-2605; Murphy, Malia/0000-0002-4566-4957; Lima, Patricia/0000-0002-6456-2470				Acosta JC, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.10.913; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Briguori C, 2010, FASEB J, V24, P1981, DOI 10.1096/fj.09-138198; Buemi M, 2007, AM J OBSTET GYNECOL, V196, P68, DOI 10.1016/j.ajog.2006.08.032; Bulut D, 2007, CLIN RES CARDIOL, V96, P258, DOI 10.1007/s00392-007-0494-z; Chapman AB, 1998, KIDNEY INT, V54, P2056, DOI 10.1046/j.1523-1755.1998.00217.x; Churdchomjan W, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-5; DiPersio JF, 2011, NEW ENGL J MED, V365, P2536, DOI 10.1056/NEJMcibr1112347; Evers IN, 2004, BMJ-BRIT MED J, V328, P915, DOI 10.1136/bmj.38043.583160.EE; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fadini GP, 2014, STEM CELL TRANSL MED, V3, P949, DOI 10.5966/sctm.2014-0052; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Fadini GP, 2006, DIABETES CARE, V29, P714, DOI 10.2337/diacare.29.03.06.dc05-1834; Flo K, 2016, ACTA OBSTET GYN SCAN, V95, P225, DOI 10.1111/aogs.12802; Hernandez SL, 2014, DIABETES CARE, V37, P2193, DOI 10.2337/dc13-2547; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Holmes VA, 2013, DIABETES CARE, V36, P3671, DOI 10.2337/dc13-0944; Howangyin KY, 2014, ARTERIOSCL THROM VAS, V34, P1126, DOI 10.1161/ATVBAHA.114.303090; Hubel CA, 2011, PREGNANCY HYPERTENS, V1, P48, DOI 10.1016/j.preghy.2010.11.001; Jo DY, 2000, J CLIN INVEST, V105, P101, DOI 10.1172/JCI7954; Karumanchi SA, 2016, HYPERTENSION, V67, P238, DOI 10.1161/HYPERTENSIONAHA.115.05024; Lash GE, 2016, J LEUKOCYTE BIOL, V100, P315, DOI 10.1189/jlb.1A0815-351R; Lash GE, 2006, J LEUKOCYTE BIOL, V80, P572, DOI 10.1189/jlb.0406250; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Liguori A, 2008, EUR J HAEMATOL, V80, P258, DOI 10.1111/j.1600-0609.2007.01007.x; Lima PDA, 2014, CELL MOL IMMUNOL, V11, P522, DOI 10.1038/cmi.2014.63; Luppi P, 2010, REPROD SCI, V17, P643, DOI 10.1177/1933719110366164; Maiorino MI, 2015, ENDOCRINE, V48, P342, DOI 10.1007/s12020-014-0277-z; Martinez-Varea A, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/128616; Osol G, 2009, PHYSIOLOGY, V24, P58, DOI 10.1152/physiol.00033.2008; Parsanezhad ME, 2015, J CHIN MED ASSOC, V78, P345, DOI 10.1016/j.jcma.2015.03.013; Perricone R, 2003, AM J REPROD IMMUNOL, V50, P232, DOI 10.1034/j.1600-0897.2003.00083.x; Petersen OFaye, 2006, HDB PLACENTAL PATHOL; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; PIJNENBORG R, 1983, PLACENTA, V4, P397, DOI 10.1016/S0143-4004(83)80043-5; Rigato M, 2015, J CLIN ENDOCR METAB, V100, P2666, DOI 10.1210/jc.2015-1687; Sanghavi M, 2014, CIRCULATION, V130, P1003, DOI 10.1161/CIRCULATIONAHA.114.009029; Scarpellini F, 2009, HUM REPROD, V24, P2703, DOI 10.1093/humrep/dep240; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Sorrentino SA, 2007, CIRCULATION, V116, P163, DOI 10.1161/CIRCULATIONAHA.106.684381; Taylor R, 2007, BMJ-BRIT MED J, V334, P742, DOI 10.1136/bmj.39154.700417.BE; Valgimigli M, 2004, CIRCULATION, V110, P1209, DOI 10.1161/01.CIR.0000136813.89036.21; Wu X, 2005, J IMMUNOL, V175, P61, DOI 10.4049/jimmunol.175.1.61	43	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172988	10.1371/journal.pone.0172988	http://dx.doi.org/10.1371/journal.pone.0172988			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278173	gold, Green Published, Green Submitted			2022-12-26	WOS:000396087900132
J	Hundsdoerfer, AK; Kitching, IJ				Hundsdoerfer, Anna K.; Kitching, Ian J.			Historic DNA for taxonomy and conservation: A case-study of a century-old Hawaiian hawkmoth type (Lepidoptera: Sphingidae)	PLOS ONE			English	Article							GENUS HYLES LEPIDOPTERA; MOLECULAR PHYLOGENY; MITOCHONDRIAL; PLIOCENE; SEA	Analysing historic DNA from museum specimens offers the unique opportunity to study the molecular systematics and phylogenetics of rare and possibly extinct taxa. In the Hawaiian fauna, the hawkmoth, Hyles calida calida, occurs on several of the main islands and is quite frequent, whereas Hyles c. hawaiiensis is restricted to the Island of Hawaii where it appears to be very rare. Analysis of mitochondrial DNA sequences shows that Hyles c. hawaiiensis differs from the nominotypical subspecies by an average p-distance of 2.8%, which is of a similar order of magnitude to that found between other species of Hyles, suggesting that Hyles c. hawaiiensis should perhaps be awarded species status, although more data are required for a formal taxonomic revision. Given the rarity of this taxon, these analyses should be undertaken urgently so that conservation measures can be implemented before it becomes extinct.	[Hundsdoerfer, Anna K.] Senckenberg Nat Hist Collect Dresden, Dresden, Germany; [Kitching, Ian J.] Nat Hist Museum, Dept Life Sci, London, England	Senckenberg Gesellschaft fur Naturforschung (SGN); Natural History Museum London	Hundsdoerfer, AK (corresponding author), Senckenberg Nat Hist Collect Dresden, Dresden, Germany.	anna.hundsdoerfer@senckenberg.de		Hundsdoerfer, Anna/0000-0001-5594-4154	DFG [HU 1561/1-1, HU 1561/1-2]; EU's Improving Human Potential program SYNTHESYS [GB-TAF-3410, GB-TAF-5177]; Open Access Fund of the Leibniz Association, AKH's Senckenberg research budget [923042]; NHMUK Department of Life Sciences Funds	DFG(German Research Foundation (DFG)); EU's Improving Human Potential program SYNTHESYS; Open Access Fund of the Leibniz Association, AKH's Senckenberg research budget; NHMUK Department of Life Sciences Funds	This work was supported by the DFG [grant numbers HU 1561/1-1 and 1-2 awarded to AKH]; and the EU's Improving Human Potential program SYNTHESYS [grant numbers GB-TAF-3410, GB-TAF-5177 awarded to AKH and IJK]. The publication of this article was funded by the Open Access Fund of the Leibniz Association, AKH's Senckenberg research budget [number 923042] and the NHMUK Department of Life Sciences Funds.	Butler AG, 1881, ANN MAGAZINE NATURAL, V7, p[317, 92]; DABRERA B, 1986, SPHINGIDAE MUNDI HAW; DANNER F, 1998, HERBIPOLIANA, V4, P1; Dwyer GS, 2009, PHILOS T R SOC A, V367, P157, DOI 10.1098/rsta.2008.0222; Hundsdoerfer AK, 2005, MOL PHYLOGENET EVOL, V35, P442, DOI 10.1016/j.ympev.2005.02.004; Hundsdoerfer AK, ZOOLOGICA S IN PRESS; Hundsdoerfer AK, 2011, ZOOL SCR, V40, P403, DOI 10.1111/j.1463-6409.2011.00477.x; Hundsdoerfer AK, 2010, ARTHROPOD SYST PHYLO, V68, P151; Hundsdoerfer AK, 2009, MOL PHYLOGENET EVOL, V52, P852, DOI 10.1016/j.ympev.2009.05.023; Kitching I. J., 2000, HAWKMOTHS WORLD ANNO; Kitching I. J., 2016, SPHINGIDAE TAXONOMIC; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Mende MB, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-83; Meyrick E., 1899, FAUNA HAWAIIENSIS, VI, P123; Nishida G.M, 1992, HAWAIIAN TERRESTRIAL; Rothschild LW, 1895, NOVITATES ZOOLOGICAE, V2; Rothschild LW, 1915, SOME NEW SPHINGIDAE, V22, P291; Sharp D., 1899, FAUNA HAWAIIENSIS ZO; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stroynowski Z, 2015, PALEOCEANOGRAPHY, V30, P1641, DOI 10.1002/2015PA002866; Stuckas H, 2011, J ZOOL SYST EVOL RES, V49, P335, DOI 10.1111/j.1439-0469.2011.00632.x; Swezey OH., 1944, P HAWAIIAN ENTOMOLOG, V12, P22; Swezey OH., 1954, FOREST ENTOMOLOGY HA, V44, P1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WILSON JT, 1963, CAN J PHYS, V41, P863, DOI 10.1139/p63-094; Zimmermann EC, 1958, INSECTS HAWAII, V7, P1; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	32	5	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173255	10.1371/journal.pone.0173255	http://dx.doi.org/10.1371/journal.pone.0173255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273123	Green Published, gold, Green Submitted			2022-12-26	WOS:000396073700049
J	Jeong, SR; Yang, HY; Hwang, HY				Jeong, Seri; Yang, Heeyoung; Hwang, Hyunyong			Evaluation of an automated connective tissue disease screening assay in Korean patients with systemic rheumatic diseases	PLOS ONE			English	Article							ANTINUCLEAR ANTIBODY; LUPUS-ERYTHEMATOSUS; CLASSIFICATION CRITERIA; AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; GENERAL-POPULATION; NUCLEAR ANTIGENS; IMMUNOFLUORESCENCE; AUTOANTIBODIES; GUIDELINES	This study aimed to evaluate the diagnostic utilities of the automated connective tissues disease screening assay, CTD screen, in patients with systemic rheumatic diseases. A total of 1093 serum samples were assayed using CTD screen and indirect immunofluorescent (IIF) methods. Among them, 162 were diagnosed with systemic rheumatic disease, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and mixed connective tissue disease (MCT). The remaining 931 with non-systemic rheumatic disease were assigned to the control group. The median ratios of CTD screen tests were significantly higher in the systemic rheumatic disease group than in the control group. The positive likelihood ratios of the CTD screen were higher than those of IIF in patients with total rheumatic diseases (4.1 vs. 1.6), including SLE (24.3 vs. 10.7). The areas under the receiver operating characteristic curves (ROC-AUCs) of the CTD screen for discriminating total rheumatic diseases, RA, SLE, and MCT from controls were 0.68, 0.56, 0.92 and 0.80, respectively. The ROC-AUCs of the combinations with IIF were significantly higher in patients with total rheumatic diseases (0.72) and MCT (0.85) than in those of the CTD screen alone. Multivariate analysis indicated that both the CTD screen and IIF were independent variables for predicting systemic rheumatic disease. CTD screen alone and in combination with IIF were a valuable diagnostic tool for predicting systemic rheumatic diseases, particularly for SLE.	[Jeong, Seri; Hwang, Hyunyong] Kosin Univ, Coll Med, Dept Lab Med, Busan, South Korea; [Yang, Heeyoung] Paju Hosp, Gyeonggi Prov Med Ctr, Dept Lab Med, Gyeonggi, South Korea		Hwang, HY (corresponding author), Kosin Univ, Coll Med, Dept Lab Med, Busan, South Korea.	terminom@gmail.com	Hwang, Hyunyong/AAH-1041-2020; Hwang, Hyunyong/AAC-7027-2022	Hwang, Hyunyong/0000-0003-0662-3041	College of Medicine, Kosin University [2016]	College of Medicine, Kosin University	The funding source was College of Medicine, Kosin University (Award number: 2016) and the grant recipient was Seri Jeong, M.D., Ph.D., who had roles in study validation, formal analysis, investigation, data curation, original draft preparation, and visualization. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALARCONSEGOVIA D, 1989, J RHEUMATOL, V16, P328; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Benito-Garcia E, 2004, ARTHRIT RHEUM-ARTHR, V51, P1030, DOI 10.1002/art.20836; Bernardini S, 2004, CLIN CHEM LAB MED, V42, P1155, DOI 10.1515/CCLM.2004.235; Bizzaro N, 2004, CLIN EXP RHEUMATOL, V22, P349; Bonilla E, 2007, CLIN IMMUNOL, V124, P18, DOI 10.1016/j.clim.2007.04.010; Bossuyt X, 2005, CLIN CHEM, V51, P2426, DOI 10.1373/clinchem.2005.058552; Bossuyt X, 2009, AUTOIMMUN REV, V8, P543, DOI 10.1016/j.autrev.2009.01.013; CHELLINGWORTH MC, 1984, RHEUMATOL INT, V4, P23, DOI 10.1007/BF00683880; Colglazier CL, 2005, SOUTH MED J, V98, P185, DOI 10.1097/01.SMJ.0000153572.22346.E9; Doria A, 2010, AUTOIMMUN REV, V10, P55, DOI 10.1016/j.autrev.2010.08.014; Fenger M, 2004, CLIN CHEM, V50, P2141, DOI 10.1373/clinchem.2004.038422; Gonzalez C, 2005, CLIN CHIM ACTA, V359, P109, DOI 10.1016/j.cccn.2005.03.042; GRANT KD, 1981, J RHEUMATOL, V8, P587; Guo Ya-Ping, 2014, Curr Ther Res Clin Exp, V76, P116, DOI 10.1016/j.curtheres.2014.06.004; Hanly JG, 2010, J IMMUNOL METHODS, V352, P147, DOI 10.1016/j.jim.2009.10.003; Hayashi N, 2008, MOD RHEUMATOL, V18, P153, DOI 10.1007/s10165-008-0028-1; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Jeong S, 2012, CLIN CHIM ACTA, V414, P93, DOI 10.1016/j.cca.2012.08.018; Kavanaugh A, 2000, ARCH PATHOL LAB MED, V124, P71; Kavanaugh AF, 2002, ARTHRIT RHEUM-ARTHR, V47, P546, DOI 10.1002/art.10558; Kroshinsky D, 2009, NEW ENGL J MED, V360, P711, DOI 10.1056/NEJMcpc0807822; Lee JW, 2016, LUPUS; Linden A, 2006, J EVAL CLIN PRACT, V12, P132, DOI 10.1111/j.1365-2753.2005.00598.x; Meroni PL, 2010, ANN RHEUM DIS, V69, P1420, DOI 10.1136/ard.2009.127100; Op De Beeck K, 2011, AUTOIMMUN REV, V10, P801, DOI 10.1016/j.autrev.2011.06.005; Parker JC, 2011, J CLIN PATHOL, V64, P631, DOI 10.1136/jcp.2010.084756; Peene I, 2001, ANN RHEUM DIS, V60, P1131, DOI 10.1136/ard.60.12.1131; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Simmons SC, 2015, AM J NEPHROL, V42, P451, DOI 10.1159/000443747; Solomon DH, 2002, ARTHRIT RHEUM-ARTHR, V47, P434, DOI 10.1002/art.10561; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	37	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173597	10.1371/journal.pone.0173597	http://dx.doi.org/10.1371/journal.pone.0173597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273146	gold, Green Submitted, Green Published			2022-12-26	WOS:000396073700020
J	Marcus, AF; Illescas, AH; Hohl, BC; Llanos, AAM				Marcus, Andrea Fleisch; Illescas, Alex H.; Hohl, Bernadette C.; Llanos, Adana A. M.			Relationships between social isolation, neighborhood poverty, and cancer mortality in a population-based study of US adults	PLOS ONE			English	Article							BREAST-CANCER; SOCIOECONOMIC-STATUS; NETWORKS; DISPARITIES; SUPPORT; HEALTH; RISK; INTEGRATION; ASSOCIATIONS; INEQUALITIES	Background Social isolation is an important determinant of all-cause mortality, with evidence suggesting an association with cancer-specific mortality as well. In this study, we examined the associations between social isolation and neighborhood poverty ( independently and jointly) on cancer mortality in a population-based sample of US adults. Methods Using data from the Third National Health and Nutrition Examination Survey ( NHANES III; 1988-1994), NHANES III Linked Mortality File ( through 2011) and 1990 Census, we estimated the relationship between social isolation and high neighborhood poverty and time-tocancer death using multivariable-adjusted Cox proportional hazards models. We examined the associations of each factor independently and explored the multiplicative and additive interaction effects on cancer mortality risk and also analyzed these associations by sex. Results Among 16 044 US adults with 17-23 years of follow-up, there were 1133 cancer deaths. Social isolation ( HR 1.25, 95% CI: 1.01-1.54) and high neighborhood poverty ( HR 1.31, 95% CI: 1.08-1.60) were associated with increased risk of cancer mortality adjusting for age, sex, and race/ethnicity; in sex-specific estimates this increase in risk was evident among females only ( HR 1.39, 95% CI: 1.04-1.86). These associations were attenuated upon further adjustment for socioeconomic status. There was no evidence of joint effects of social isolation and high neighborhood poverty on cancer mortality overall or in the sex-stratified models. Conclusions These findings suggest that social isolation and higher neighborhood poverty are independently associated with increased risk of cancer mortality, although there is no evidence to support our a priori hypothesis of a joint	[Marcus, Andrea Fleisch; Illescas, Alex H.] Rutgers Sch Hlth Profess, Dept Nutr Sci, Newark, NJ 07107 USA; [Marcus, Andrea Fleisch; Hohl, Bernadette C.; Llanos, Adana A. M.] Rutgers Sch Publ Hlth, Dept Epidemiol, Piscataway, NJ 08854 USA; [Hohl, Bernadette C.] Rutgers Sch Criminal Justice, Newark, NJ USA; [Llanos, Adana A. M.] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Marcus, AF (corresponding author), Rutgers Sch Hlth Profess, Dept Nutr Sci, Newark, NJ 07107 USA.; Marcus, AF (corresponding author), Rutgers Sch Publ Hlth, Dept Epidemiol, Piscataway, NJ 08854 USA.	andreafleischmarcus@gmail.com	Llanos, Adana A.M./J-8695-2019	Llanos, Adana A.M./0000-0001-9954-9121; Fleisch Marcus, Andrea/0000-0001-6557-3748	Rutgers SHP Faculty Development; Cancer Center Support Grant [P30 CA072720]; Rutgers SHRP Faculty Development	Rutgers SHP Faculty Development; Cancer Center Support Grant; Rutgers SHRP Faculty Development	This study was supported by Rutgers SHP Faculty Development funding and by and Cancer Center Support Grant P30 CA072720 (Rutgers Cancer Institute of New Jersey). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially supported by Rutgers SHRP Faculty Development funding and by the Cancer Center Support Grant P30 CA072720 (Rutgers Cancer Institute of New Jersey). We sincerely thank Jing Tian, PhD at the National Center for Health Statistics Research Data Center for preparation of the data. The findings and conclusions in this paper are those of the authors and do not necessarily represent the views of the Research Data Center, the National Center for Health Statistics, or the Centers for Disease Control and Prevention.	Beasley JM, 2010, J CANCER SURVIV, V4, P372, DOI 10.1007/s11764-010-0139-5; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Bradley CJ, 2002, J NATL CANCER I, V94, P490; Ertel KA, 2008, AM J PUBLIC HEALTH, V98, P1215, DOI 10.2105/AJPH.2007.113654; Ford ES, 2006, ANN EPIDEMIOL, V16, P78, DOI 10.1016/j.annepidem.2005.08.005; Galea S, 2011, AM J PUBLIC HEALTH, V101, P1456, DOI 10.2105/AJPH.2010.300086; Ginsburg O., 2016, LANCET; Gomez SL, 2015, CANCER-AM CANCER SOC, V121, P2314, DOI 10.1002/cncr.29345; Hinzey A, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0700-x; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Ikeda A, 2013, CANCER CAUSE CONTROL, V24, P847, DOI 10.1007/s10552-013-0147-7; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kawachi I, 1996, J EPIDEMIOL COMMUN H, V50, P245, DOI 10.1136/jech.50.3.245; Kish Jonathan K., 2014, Journal of the National Cancer Institute Monographs, P236, DOI 10.1093/jncimonographs/lgu020; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Krieger N, 2003, AM J PUBLIC HEALTH, V93, P1655, DOI 10.2105/AJPH.93.10.1655; Krieger N, 2005, AM J PUBLIC HEALTH, V95, P312, DOI 10.2105/AJPH.2003.032482; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Krieger N, 2012, AM J PUBLIC HEALTH, V102, P936, DOI 10.2105/AJPH.2011.300544; Kroenke CH, 2013, BREAST CANCER RES TR, V139, P515, DOI 10.1007/s10549-013-2477-2; Kroenke CH, 2013, BREAST CANCER RES TR, V137, P261, DOI 10.1007/s10549-012-2253-8; Kroenke CH, 2006, J CLIN ONCOL, V24, P1105, DOI 10.1200/JCO.2005.04.2846; Lutgendorf SK, 2012, J CLIN ONCOL, V30, P2885, DOI 10.1200/JCO.2011.39.4411; Marcus AF, 2016, ANN EPIDEMIOL, V26, P261, DOI 10.1016/j.annepidem.2016.02.006; Marcus AF, 2015, AM J COMMUN PSYCHOL, V56, P134, DOI 10.1007/s10464-015-9732-0; Markossian TW, 2013, HEALTH SERV RES; Nagayoshi M, 2014, STROKE, V45, P2868, DOI 10.1161/STROKEAHA.114.005815; National Center for Health Statistics, 1996, 3 NAT HLTH NUTR EX S; National Center for Health Statistics, 2013, 3 NAT HLTH EX SURV N; [National Center for Health Statistics US Department of Health and Human Services], 2009, NAT HLTH NUTR EX SUR; O'Campo P, 2015, HEALTH PLACE, V31, P65, DOI 10.1016/j.healthplace.2014.11.001; O'Campo P, 2009, HEALTH PLACE, V15, P56, DOI 10.1016/j.healthplace.2008.02.004; Pantell M, 2013, AM J PUBLIC HEALTH, V103, P2056, DOI 10.2105/AJPH.2013.301261; Pinquart M, 2010, CRIT REV ONCOL HEMAT, V75, P122, DOI 10.1016/j.critrevonc.2009.06.003; Plickert G, 2007, SOC NETWORKS, V29, P405, DOI 10.1016/j.socnet.2007.01.007; Roux AVD, 2008, J EPIDEMIOL COMMUN H, V62, P957, DOI 10.1136/jech.2007.064311; Samuel LJ, 2015, PREV MED, V71, P61, DOI 10.1016/j.ypmed.2014.12.008; Schulz AJ, 2013, HEALTH PLACE, V24, P147, DOI 10.1016/j.healthplace.2013.09.005; Schulz AJ, 2012, AM J PUBLIC HEALTH, V102, P1706, DOI 10.2105/AJPH.2011.300412; SEEMAN TE, 1987, AM J EPIDEMIOL, V126, P714, DOI 10.1093/oxfordjournals.aje.a114711; Sposto R, 2016, CANCER EPIDEM BIOMAR, V25, P1064, DOI 10.1158/1055-9965.EPI-15-1326; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Stringhini S, 2012, AM J EPIDEMIOL, V175, P1275, DOI 10.1093/aje/kwr461; Subramanian SV, 2005, AM J PUBLIC HEALTH, V95, P260, DOI 10.2105/AJPH.2003.034132; The Public Health Disparities Geocoding Project, 2004, PUBL HLTH DISP GEOC; Tian N, 2012, WOMEN HEALTH ISS, V22, pE267, DOI 10.1016/j.whi.2011.11.007; Turesky RJ, 2003, CHEM RES TOXICOL, V16, P1162, DOI 10.1021/tx030029r; Warner ET, 2015, J CLIN ONCOL, V33, P2254, DOI 10.1200/JCO.2014.57.1349; Whitman S, 2012, CANCER EPIDEMIOL, V36, pE147, DOI 10.1016/j.canep.2011.10.012	51	46	46	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173370	10.1371/journal.pone.0173370	http://dx.doi.org/10.1371/journal.pone.0173370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273125	Green Published, gold, Green Submitted			2022-12-26	WOS:000396073700056
J	Pfeiffer, W; Braun, J; Burchell, J; Witte, CL; Rideout, BA				Pfeiffer, Wayne; Braun, Josephine; Burchell, Jennifer; Witte, Carmel L.; Rideout, Bruce A.			Whole-genome analysis of mycobacteria from birds at the San Diego Zoo	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; AVIUM SUBSP-AVIUM; TUBERCULOSIS TRANSMISSION; DIVERSITY; IDENTIFICATION; INFECTIONS; STRAINS; LEVEL	Methods Mycobacteria isolated from more than 100 birds diagnosed with avian mycobacteriosis at the San Diego Zoo and its Safari Park were cultured postmortem and had their whole genomes sequenced. Computational workflows were developed and applied to identify the mycobacterial species in each DNA sample, to find single-nucleotide polymorphisms (SNPs) between samples of the same species, to further differentiate SNPs between as many as three different genotypes within a single sample, and to identify which samples are closely clustered genomically. Results Nine species of mycobacteria were found in 123 samples from 105 birds. The most common species were Mycobacterium avium and Mycobacterium genavense, which were in 49 and 48 birds, respectively. Most birds contained only a single mycobacterial species, but two birds contained a mixture of two species. The M. avium samples represent diverse strains of M. avium avium and M. avium hominissuis, with many pairs of samples differing by hundreds or thousands of SNPs across their common genome. By contrast, the M. genavense samples are much closer genomically; samples from 46 of 48 birds differ from each other by less than 110 SNPs. Some birds contained two, three, or even four genotypes of the same bacterial species. Such infections were found in 4 of 49 birds (8%) with M. avium and in 11 of 48 birds (23%) with M. genavense. Most were mixed infections, in which the bird was infected by multiple mycobacterial strains, but three infections with two genotypes differing by <= 10 SNPs were likely the result of within-host evolution. The samples from 31 birds with M. avium can be grouped into nine clusters within which any sample is <= 12 SNPs from at least one other sample in the cluster. Similarly, the samples from 40 birds with M. genavense can be grouped into ten such clusters. Information about these genomic clusters is being used in an ongoing, companion study of mycobacterial transmission to help inform management of bird collections.	[Pfeiffer, Wayne] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Braun, Josephine; Burchell, Jennifer; Witte, Carmel L.; Rideout, Bruce A.] San Diego Zoo Global, Wildlife Dis Labs, San Diego, CA USA	University of California System; University of California San Diego	Pfeiffer, W (corresponding author), Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA.	pfeiffer@sdsc.edu	DeHovitz Braun, Joan/D-8690-2018	DeHovitz Braun, Joan/0000-0001-9975-7959	Ellen Browning Scripps Foundation; McBeth Foundation; National Science Foundation	Ellen Browning Scripps Foundation; McBeth Foundation; National Science Foundation(National Science Foundation (NSF))	This study was funded in large part by the Ellen Browning Scripps Foundation. Additional funds were provided by the McBeth Foundation. The funders had no role in study design data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Rachael Keeler for assistance with data tracking and organization as well as all other Wildlife Disease Laboratories personnel that helped identify cases and handle samples. In addition, WP gratefully acknowledges helpful discussions with Steven Head regarding whole-genome sequencing, Zamin Iqbal and Madhusudan Gujral regarding variant calling, and Mark Miller regarding interpretation of the results. All computer analyses, except for the FastQC and FigTree processing, were run on the Gordon supercomputer at the San Diego Supercomputer Center, which is supported by the National Science Foundation.	Ahlstrom C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1387-6; ARBEIT RD, 1993, J INFECT DIS, V167, P1384, DOI 10.1093/infdis/167.6.1384; BODDINGHAUS B, 1990, J CLIN MICROBIOL, V28, P1751; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Cohen T, 2012, CLIN MICROBIOL REV, V25, P708, DOI 10.1128/CMR.00021-12; Dvorska L, 2007, VET MICROBIOL, V119, P366, DOI 10.1016/j.vetmic.2006.09.010; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Hanekom M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070178; Hatherell HA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0566-x; Hoop RK, 1996, J CLIN MICROBIOL, V34, P991, DOI 10.1128/JCM.34.4.991-992.1996; Kauppinen J, 2001, VET MICROBIOL, V81, P41, DOI 10.1016/S0378-1135(01)00330-3; Kay GL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7717; Lieberman TD, 2016, NAT MED, V22, P1470, DOI 10.1038/nm.4205; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Pankhurst LJ, 2016, LANCET RESP MED, V4, P49, DOI 10.1016/S2213-2600(15)00466-X; Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Schrenzel M, 2008, VET MICROBIOL, V126, P122, DOI 10.1016/j.vetmic.2007.06.016; Shamputa IC, 2004, J CLIN MICROBIOL, V42, P5528, DOI 10.1128/JCM.42.12.5528-5536.2004; Shamputa IC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-99; Shitaye JE, 2008, VET MICROBIOL, V127, P155, DOI 10.1016/j.vetmic.2007.07.026; TAKEWAKI S, 1993, J CLIN MICROBIOL, V31, P446, DOI 10.1128/JCM.31.2.446-450.1993; TELENTI A, 1993, J CLIN MICROBIOL, V31, P175, DOI 10.1128/JCM.31.2.175-178.1993; Tell LA, 2001, REV SCI TECH OIE, V20, P180, DOI 10.20506/rst.20.1.1273; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; Witte CL, 2008, J VET DIAGN INVEST, V20, P186, DOI 10.1177/104063870802000207; Worby CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003549	28	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173464	10.1371/journal.pone.0173464	http://dx.doi.org/10.1371/journal.pone.0173464			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267758	Green Published, gold, Green Submitted			2022-12-26	WOS:000396060600034
J	Kang, ZH; Zhang, X; Ding, SM; Tang, CF; Wang, YY; de Jong, H; Cameron, SL; Wang, MQ; Yang, D				Kang, Zehui; Zhang, Xiao; Ding, Shuangmei; Tang, Chufei; Wang, Yuyu; de Jong, Herman; Cameron, Stephen L.; Wang, Mengqing; Yang, Ding			Transcriptomes of three species of Tipuloidea (Diptera, Tipulomorpha) and implications for phylogeny of Tipulomorpha	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; GENE ONTOLOGY; GENOME; EVOLUTION; NEMATOCERA; INSIGHTS; DATABASE; INSECTA; MAFFT; TREE	Tipulomorpha has long been a problematic taxon in terms of familial composition, phylogenetic relationships among families and position relative to other `lower' Diptera. Whole-transcriptome shotgun sequencing provides a powerful basis for phylogenetic studies. We performed de novo transcriptome sequencing to produce the first transcriptome datasets representing the families Pediciidae, Limoniidae and Cylindrotomidae using high-throughput sequencing technologies. We assembled cDNA libraries for Pedicia vetusta (Alexander) (Pediciidae), Rhipidia sejuga Zhang, Li and Yang (Limoniidae) and Liogma simplicicornis Alexander (Cylindrotomidae). Using the Illumina RNA-Seq method, we obtained 28,252, 44,152 and 44,281 unigenes, from the three respective species. Based on sequence similarity searches, 12,475 (44.16%), 20,334 (46.05%) and 17,478 (39.47%) genes were identified. Analysis of genes highly conserved at the amino acid sequence level revealed there were 1,709 single-copy orthologs genes across the analyzed species. Phylogenetic trees constructed using maximum likelihood (ML) based on the 1,709 single-copy orthologs genes indicated that the relationship between the four major infraorders of lower Diptera was: Culicomorpha + (Tipulomorpha + (Psychodomorpha + (Bibionomorpha + Brachycera))). Trichoceridae belongs within Tipulomorpha as the sister-group of Tipuloidea. Highly supported relationships within the Tipuloidea are Pediciidae + (Limoniidae + (Cylindrotomidae + Tipulidae)). Four-cluster likelihood mapping was used to study potential incongruent signals supporting other topologies, however, results were congruent with the ML tree.	[Kang, Zehui; Zhang, Xiao; Ding, Shuangmei; Tang, Chufei; Wang, Yuyu; Wang, Mengqing; Yang, Ding] China Agr Univ, Dept Entomol, Beijing, Peoples R China; [de Jong, Herman] Darwinweg, Nat Biodivers Ctr, Cr Leiden, Netherlands; [Cameron, Stephen L.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Wang, Mengqing] Chinese Acad Agr Sci, Inst Plant Protect, Beijing, Peoples R China	China Agricultural University; Naturalis Biodiversity Center; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wang, MQ; Yang, D (corresponding author), China Agr Univ, Dept Entomol, Beijing, Peoples R China.; Wang, MQ (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Beijing, Peoples R China.	mengqingsw@163.com; dyangcau@126.com	Wang, Yuyu/J-3117-2019; Zhang, Xiao/AAD-7627-2020; Cameron, Stephen L/A-3742-2008	Cameron, Stephen L/0000-0002-6694-4130; Kang, Zehui/0000-0003-1961-9578; Tang, Chufei/0000-0001-6266-4900; Zhang, Xiao/0000-0002-8054-0968	National Natural Science Foundation of China [31320103902, 31272354]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31320103902 and 31272354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CP., 1919, MEMOIRS CORNELL U AG, V25, P767; Alexander CP., 1920, MEMOIRS CORNELL U AG, V38, P691; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beckenbach AT, 2012, GENOME BIOL EVOL, V4, P89, DOI 10.1093/gbe/evr131; Bertone MA, 2008, SYST ENTOMOL, V33, P668, DOI 10.1111/j.1365-3113.2008.00437.x; Blagoderov V., 2007, AM MUSEUM NOVITATES, V3572; Brodo F., 1984, THESIS; Ribeiro GC, 2008, INVERTEBR SYST, V22, P627, DOI 10.1071/IS08017; DAHL C, 1980, ZOOL SCR, V9, P165, DOI 10.1111/j.1463-6409.1980.tb00662.x; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Friedrich M, 1997, MOL BIOL EVOL, V14, P644, DOI 10.1093/oxfordjournals.molbev.a025804; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths GCD, 1990, QUAEST ENTOMOL, V26, P117; Hennig W., 1954, Beitraege zur Entomologie Berlin, V4, P245; Hennig W., 1973, Handbuch der Zoologie, V4(2), P1; Hennig W., 1981, INSECT PHYLOGENY; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jong HD, 2007, HYDROBIOLOGIA, V595, P457; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; KRZEMINSKI W, 1992, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V65, P39; Lambkin CL, 2013, SYST ENTOMOL, V38, P164, DOI 10.1111/j.1365-3113.2012.00652.x; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Michelsen V, 1996, ZOOL J LINN SOC-LOND, V117, P71; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; OOSTERBROEK P, 1991, Tijdschrift voor Entomologie, V134, P211; OOSTERBROEK P, 1995, ZOOL J LINN SOC-LOND, V115, P267, DOI 10.1111/j.1096-3642.1995.tb02462.x; Oosterbroek P., CATALOGUE CRANEFLIES; Peters RS, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-52; Petersen MJ, 2010, SYST ENTOMOL, V35, P526, DOI 10.1111/j.1365-3113.2010.00524.x; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Savchenko E.N., 1979, Tijdschrift voor Entomologie, V122, P91; Savchenko EN., 1966, TIPULIDAE FAUNA UKRA, V14, P1; Savchenko EN, 1983, FAUNA USSR DIPTERA, V127, P1; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; STARY J, 1992, Acta Zoologica Cracoviensia, V35, P11; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Wood D.M, 1989, MANUAL NEARCTIC DIPT, V3, P1333; Yeates DK, 2005, EVOLUTIONARY BIOL FL; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	45	12	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173207	10.1371/journal.pone.0173207	http://dx.doi.org/10.1371/journal.pone.0173207			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264066	Green Published, Green Submitted, gold			2022-12-26	WOS:000396054300045
J	Otterpohl, KL; Gould, KA				Otterpohl, Karla L.; Gould, Karen A.			Evaluation of Rint1 as a modifier of intestinal tumorigenesis and cancer risk	PLOS ONE			English	Article							GOLGI-ER RETROGRADE; RAD50-INTERACTING PROTEIN; COMPLEX; ZW10; LOCALIZATION; TRAFFICKING; BREAST; LOCUS; MOM5	The Rad50 Interacting Protein 1 (Rint1) influences cellular homeostasis through maintenance of endoplasmic reticulum, Golgi and centrosome integrity and regulation of vesicle transport, autophagy and the G(2)/M checkpoint. Rint1 has been postulated to function as a tumor suppressor as well as an oncogene, with its role depending perhaps upon the precise cellular and/or experimental context. In humans, heterozygosity for germline missense variants in RINT1 have, in some studies, been associated with increased risk of both breast and Lynch syndrome type cancers. However, it is not known if these germline variants represent loss of function alleles or gain of function alleles. Based upon these findings, as well as our initial consideration of Rint1 as a potential candidate for Mom5, a genetic modifier of intestinal tumorigenesis in Apc(Min/+) mice, we sought to explicitly examine the impact of Rint1 on tumorigenesis in Apc(Min/+) mice. However, heterozygosity for a knockout of Rint1 had no impact on tumorigenesis in Rint1(+/-); Apc(Min/+) mice. Likewise, we found no evidence to suggest that the remaining Rint1 allele was lost somatically in intestinal tumors in Apc(Min/+) mice. Interestingly, in contrast to what has been observed in Rint1(+/-) mice on a mixed genetic background, Rint1(+/-) mice on a pure C57BL/6J background did not show spontaneous tumor development. We also evaluated colorectal cancer data available in the COSMIC and ONCOMINE databases and found that RINT1 overexpression, as well as the presence of somatic missense mutations in RINT1 were associated with colorectal cancer development. In vitro evaluation of two missense variants in RINT1 suggested that such variants do have the potential to impact RINT1 function.	[Otterpohl, Karla L.; Gould, Karen A.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Otterpohl, Karla L.] Sanford Res, Childrens Hlth Res Ctr, Sioux Falls, SD USA	University of Nebraska System; University of Nebraska Medical Center; Sanford Health	Gould, KA (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.	kagould@unmc.edu			NCRR [5P20RR016469, RR018788]; National Institute for General Medical Science (NIGMS) [8P20GM103427, P20GM103471]	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute for General Medical Science (NIGMS)	The University of Nebraska DNA Sequencing Core receives partial support from the NCRR (5P20RR016469, RR018788) and the National Institute for General Medical Science (NIGMS) (8P20GM103427, P20GM103471). The author(s) received no other specific funding for this work.	Arasaki K, 2007, BIOCHEM BIOPH RES CO, V359, P811, DOI 10.1016/j.bbrc.2007.05.188; Arasaki K, 2006, MOL BIOL CELL, V17, P2780, DOI 10.1091/mbc.E05-10-0973; Arasaki K, 2013, MOL BIOL CELL, V24, P2907, DOI 10.1091/mbc.E13-01-0014; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Grigaravicius P, 2016, CELL DEATH DIFFER, V23, P454, DOI 10.1038/cdd.2015.113; Haines DC, 2001, TOXICOL PATHOL, V29, P653, DOI 10.1080/019262301753385988; He SS, 2014, AUTOPHAGY, V10, P180, DOI 10.4161/auto.26917; He SS, 2013, NAT CELL BIOL, V15, P1206, DOI 10.1038/ncb2848; Hirose H, 2004, EMBO J, V23, P1267, DOI 10.1038/sj.emboj.7600135; Kong LJ, 2006, MOL CELL, V22, P63, DOI 10.1016/j.molcel.2006.02.016; Li N, 2016, BREAST CANCER RES TR, V159, P385, DOI 10.1007/s10549-016-3944-3; Lin XQ, 2007, MOL CELL BIOL, V27, P4905, DOI 10.1128/MCB.02396-06; Oikarinen SI, 2009, CARCINOGENESIS, V30, P1591, DOI 10.1093/carcin/bgp159; Otterpohl KL, 2015, MAMM GENOME, V26, P235, DOI 10.1007/s00335-015-9567-x; Park DJ, 2014, CANCER DISCOV, V4, P804, DOI 10.1158/2159-8290.CD-14-0212; Quayle SN, 2012, NEURO-ONCOLOGY, V14, P1325, DOI 10.1093/neuonc/nos246; Xiao J, 2001, J BIOL CHEM, V276, P6105, DOI 10.1074/jbc.M008893200	17	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172247	10.1371/journal.pone.0172247	http://dx.doi.org/10.1371/journal.pone.0172247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264000	Green Submitted, gold, Green Published			2022-12-26	WOS:000396054300009
J	Liu, CQ; Hu, KD; Li, TT; Yang, Y; Yang, F; Li, YH; Liu, HP; Chen, XY; Zhang, H				Liu, Cheng-Qian; Hu, Kang-Di; Li, Ting-Ting; Yang, Ying; Yang, Feng; Li, Yan-Hong; Liu, He-Ping; Chen, Xiao-Yan; Zhang, Hua			Polygalacturonase gene pgxB in Aspergillus niger is a virulence factor in apple fruit	PLOS ONE			English	Article							ENDOPOLYGALACTURONASE; ENZYMES; FAMILY; FLAVUS; LYASE; PATHOGENICITY; DEGRADATION; DISRUPTION; EXPRESSION; HOST	Aspergillus niger, a saprophytic fungus, is widely distributed in soil, air and cereals, and can cause postharvest diseases in fruit. Polygalacturonase (PG) is one of the main enzymes in fungal pathogens to degrade plant cell wall. To evaluate whether the deletion of an exopolygalacturonase gene pgxB would influence fungal pathogenicity to fruit, pgxB gene was deleted in Aspergillus niger MA 70.15 (wild type) via homologous recombination. The Delta pgx13 mutant showed similar growth behavior compared with the wild type. Pectin medium induced significant higher expression of all pectinase genes in both wild type and Delta pgx13 in comparison to potato dextrose agar medium. However, the Delta pgxB mutant was less virulent on apple fruits as the necrosis diameter caused by Delta pgxB mutant was significantly smaller than that of wild type. Results of quantitive-PCR showed that, in the process of infection in apple fruit, gene expressions of polygalacturonase genes pgal, pgall, pgaA, pgaC, pgaD and pgaE were enhanced in Delta pgxB mutant in comparison to wild type. These results prove that, despite the increased gene expression of other polygalacturonase genes in Delta pgxB mutant, the lack of pgxB gene significantly reduced the virulence of A. niger on apple fruit, suggesting that pgxB plays an important role in the infection process on the apple fruit.	[Liu, Cheng-Qian; Hu, Kang-Di; Li, Ting-Ting; Li, Yan-Hong; Chen, Xiao-Yan; Zhang, Hua] Hefei Univ Technol, Sch Food Sci & Engn, Hefei, Peoples R China; [Yang, Ying] Anhui Jianzhu Univ, Coll Environm & Energy Engn, Hefei, Peoples R China; [Yang, Feng] Xuhuai Dist Jiangsu Prov, Xuzhou Inst Agr Sci, Xuzhou, Peoples R China; [Li, Yan-Hong; Liu, He-Ping] Anhui Siping Food Dev Co Ltd, Tongling, Peoples R China	Hefei University of Technology; Anhui Jianzhu University; Jiangsu Academy of Agricultural Sciences	Zhang, H (corresponding author), Hefei Univ Technol, Sch Food Sci & Engn, Hefei, Peoples R China.	hzhanglab@hfut.edu.cn	chen, xi/GXH-3653-2022; chen, xia/GXM-5435-2022; chen, xia/GYR-3948-2022		National Natural Science Foundation of China; Anhui Provincial Science and Technology Major Project; Anhui Provincial Education Department; Anhui Siping Food Development Co. Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Science and Technology Major Project; Anhui Provincial Education Department; Anhui Siping Food Development Co. Ltd.	The funders National Natural Science Foundation of China, Anhui Provincial Science and Technology Major Project, and Anhui Provincial Education Department had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Anhui Siping Food Development Co. Ltd. provided support in the form of salaries for authors YHL and HPL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baltz RH, 2010, MANUAL OF INDUSTRIAL MICROBIOLOGY AND BIOTECHNOLOGY, THIRD EDITION, P1; Barras F, 2003, ANNU REV PHYTOPATHOL, V32, P201; Benen JAE, 1999, EUR J BIOCHEM, V259, P577, DOI 10.1046/j.1432-1327.1999.00080.x; BUSSINK HJD, 1992, EUR J BIOCHEM, V208, P83, DOI 10.1111/j.1432-1033.1992.tb17161.x; Collmer A, 2003, ANNU REV PHYTOPATHOL, V24, P383; COTTY PJ, 1990, APPL ENVIRON MICROB, V56, P3885, DOI 10.1128/AEM.56.12.3885-3887.1990; De Lorenzo G, 2002, CURR OPIN PLANT BIOL, V5, P295, DOI 10.1016/S1369-5266(02)00271-6; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; Delmas S, 2014, APPL ENVIRON MICROB, V80, P3484, DOI 10.1128/AEM.00625-14; Di Pietro A, 2003, MOL PLANT PATHOL, V4, P315, DOI [10.1046/j.1364-3703.2003.00180.x, 10.1046/J.1364-3703.2003.00180.X]; Garcia-Maceira FI, 2000, MOL PLANT MICROBE IN, V13, P359, DOI 10.1094/MPMI.2000.13.4.359; GYSLER C, 1990, GENE, V89, P101, DOI 10.1016/0378-1119(90)90211-9; HARMSEN JAM, 1990, CURR GENET, V18, P161, DOI 10.1007/BF00312604; Have AT, 2002, CONTRIBUTION CELL WA, P341; Herron SR, 2000, P NATL ACAD SCI USA, V97, P8762, DOI 10.1073/pnas.97.16.8762; Isshiki A, 2001, MOL PLANT MICROBE IN, V14, P749, DOI 10.1094/MPMI.2001.14.6.749; Jayani RS, 2005, PROCESS BIOCHEM, V40, P2931, DOI 10.1016/j.procbio.2005.03.026; Kars I, 2005, PLANT J, V43, P213, DOI 10.1111/j.1365-313X.2005.02436.x; Kars I., 2007, BOTRYTIS BIOL PATHOL, P99; KUSTERSVANSOMEREN M, 1992, MOL GEN GENET, V234, P113, DOI 10.1007/BF00272352; Liu N, 2015, PLOS ONE, V11; Maldonado MC, 1989, SCI ALIMENTS; Martens-Uzunova ES, 2006, BIOCHEM J, V400, P43, DOI 10.1042/BJ20060703; Meyer V, 2007, J BIOTECHNOL, V128, P770, DOI 10.1016/j.jbiotec.2006.12.021; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Oeser B, 2002, FUNGAL GENET BIOL, V36, P176, DOI 10.1016/S1087-1845(02)00020-8; Parenicova L, 2000, BIOCHEM J, V345, P637, DOI 10.1042/0264-6021:3450637; Parenicova L, 1998, EUR J BIOCHEM, V251, P72, DOI 10.1046/j.1432-1327.1998.2510072.x; Parenicova L, 2000, FEBS LETT, V467, P333, DOI 10.1016/S0014-5793(00)01173-X; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Ramesh MV, 1996, J BACTERIOL, V178, P3899, DOI 10.1128/jb.178.13.3899-3907.1996; Reignault P, 2008, EUR J PLANT PATHOL, V120, P1, DOI 10.1007/s10658-007-9184-y; Rogers LM, 2000, P NATL ACAD SCI USA, V97, P9813, DOI 10.1073/pnas.160271497; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Schuster E, 2002, APPL MICROBIOL BIOT, V59, P426, DOI 10.1007/s00253-002-1032-6; SCOTTCRAIG JS, 1990, PLANT CELL, V2, P1191, DOI 10.1105/tpc.2.12.1191; Shieh MT, 1997, APPL ENVIRON MICROB, V63, P3548, DOI 10.1128/AEM.63.9.3548-3552.1997; Solis-Pereira S, 1990, APPL MICROBIOL BIOT, V39, P36; Strauss MLA, 2001, J APPL MICROBIOL, V91, P182, DOI 10.1046/j.1365-2672.2001.01379.x; Sun WX, 2009, GENESIS, V47, P535, DOI 10.1002/dvg.20530; ten Have A, 1998, MOL PLANT MICROBE IN, V11, P1009, DOI 10.1094/MPMI.1998.11.10.1009; Valette-Collet O, 2003, MOL PLANT MICROBE IN, V16, P360, DOI 10.1094/MPMI.2003.16.4.360; Yakoby N, 2001, MOL PLANT MICROBE IN, V14, P988, DOI 10.1094/MPMI.2001.14.8.988	43	19	20	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173277	10.1371/journal.pone.0173277	http://dx.doi.org/10.1371/journal.pone.0173277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257463	Green Submitted, gold, Green Published			2022-12-26	WOS:000396021100081
J	Matthews, H; Deakin, J; Rajab, M; Idris-Usman, M; Nirmalan, NJ				Matthews, Holly; Deakin, Jon; Rajab, May; Idris-Usman, Maryam; Nirmalan, Niroshini J.			Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations	PLOS ONE			English	Article							FALCIPARUM IN-VITRO; PLASMODIUM-FALCIPARUM; COMBINATION; ATOVAQUONE; RESISTANT; ANTAGONISM; PROGUANIL; MECHANISM; DIHYDROARTEMISININ; AMODIAQUINE	The widespread introduction of artemisinin-based combination therapy has contributed to recent reductions in malaria mortality. Combination therapies have a range of advantages, including synergism, toxicity reduction, and delaying the onset of resistance acquisition. Unfortunately, antimalarial combination therapy is limited by the depleting repertoire of effective drugs with distinct target pathways. To fast-track antimalarial drug discovery, we have previously employed drug-repositioning to identify the anti-amoebic drug, emetine dihydrochloride hydrate, as a potential candidate for repositioned use against malaria. Despite its 1000-fold increase in in vitro antimalarial potency (ED50 47 nM) compared with its anti-amoebic potency (ED50 26-32 uM), practical use of the compound has been limited by dose-dependent toxicity (emesis and cardiotoxicity). Identification of a synergistic partner drug would present an opportunity for dose-reduction, thus increasing the therapeutic window. The lack of reliable and standardised methodology to enable the in vitro definition of synergistic potential for antimalarials is a major drawback. Here we use isobologram and combination-index data generated by CalcuSyn software analyses (Biosoft v2.1) to define drug interactivity in an objective, automated manner. The method, based on the median effect principle proposed by Chou and Talalay, was initially validated for antimalarial application using the known synergistic combination (atovaquone-proguanil). The combination was used to further understand the relationship between SYBR Green viability and cytocidal versus cytostatic effects of drugs at higher levels of inhibition. We report here the use of the optimised Chou Talalay method to define synergistic antimalarial drug interactivity between emetine dihydrochloride hydrate and atovaquone. The novel findings present a potential route to harness the nanomolar antimalarial efficacy of this affordable natural product.	[Matthews, Holly; Deakin, Jon; Rajab, May; Idris-Usman, Maryam; Nirmalan, Niroshini J.] Univ Salford, Environm & Life Sci, Manchester, England; [Matthews, Holly] Imperial Coll, Dept Life Sci, Fac Nat Sci, London, England	University of Salford; Imperial College London	Nirmalan, NJ (corresponding author), Univ Salford, Environm & Life Sci, Manchester, England.	n.j.nirmalan@salford.ac.uk	Idris-Usman, Maryam/AAD-8484-2022		University of Salford	University of Salford	The authors received no specific funding for the project except for the PhD studentship awarded by the University of Salford for HM.	Akinboye E. S., 2011, Open Natural Products Journal, V4, P8, DOI 10.2174/1874848101104010008; Akinboye ES, 2012, J MED CHEM, V55, P7450, DOI 10.1021/jm300426q; Andrews KT, 2014, INT J PARASITOL-DRUG, V4, P95, DOI 10.1016/j.ijpddr.2014.02.002; Bansal Devendra, 2004, Ann Clin Microbiol Antimicrob, V3, P27, DOI 10.1186/1476-0711-3-27; Bell A, 2005, FEMS MICROBIOL LETT, V253, P171, DOI 10.1016/j.femsle.2005.09.035; Bhattacharya A, 2009, EUR J MED CHEM, V44, P3388, DOI 10.1016/j.ejmech.2009.02.008; CANFIELD CJ, 1995, EXP PARASITOL, V80, P373, DOI 10.1006/expr.1995.1049; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Co EMA, 2009, ANTIMICROB AGENTS CH, V53, P2557, DOI 10.1128/AAC.01370-08; Corral MJ, 2014, ANTIMICROB AGENTS CH, V58, P1596, DOI 10.1128/AAC.00710-13; Feng JY, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-44; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; Fivelman QL, 2007, ANTIMICROB AGENTS CH, V51, P2265, DOI 10.1128/AAC.01479-06; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Goodman CD, 2016, SCIENCE, V352, P349, DOI 10.1126/science.aad9279; Gorka AP, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-332; GROLLMAN AP, 1966, P NATL ACAD SCI USA, V56, P1867, DOI 10.1073/pnas.56.6.1867; Harasym TO, 2010, METHODS MOL BIOL, V596, P291, DOI 10.1007/978-1-60761-416-6_13; Hu Y, 2010, P NATL ACAD SCI USA, V107, P5955, DOI 10.1073/pnas.0912327107; Keiser J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-292; Keiser J, 2011, J ANTIMICROB CHEMOTH, V66, P1791, DOI 10.1093/jac/dkr178; Khositnithikul R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-23; Kremsner PG, 2004, LANCET, V364, P285, DOI 10.1016/S0140-6736(04)16680-4; Lucumi E, 2010, ANTIMICROB AGENTS CH, V54, P3597, DOI 10.1128/AAC.00431-10; Mariga ST, 2005, ACTA TROP, V93, P221, DOI 10.1016/j.actatropica.2005.01.007; Matthews H, 2013, DRUG REPOSITIONING R; Mott BT, 2015, SCI REP-UK, V5, DOI 10.1038/srep13891; Painter HJ, 2010, ANTIMICROB AGENTS CH, V54, P5281, DOI 10.1128/AAC.00937-10; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Radloff PD, 1996, LANCET, V347, P1511, DOI 10.1016/S0140-6736(96)90671-6; Read M, 1993, Methods Mol Biol, V21, P43; Reynolds CP, 2005, METH MOLEC MED, V110, P173; Sanz LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030949; Srivastava IK, 1999, ANTIMICROB AGENTS CH, V43, P1334, DOI 10.1128/AAC.43.6.1334; Vivas L, 2007, J ANTIMICROB CHEMOTH, V59, P658, DOI 10.1093/jac/dkl563; Wein S, 2010, J CLIN MICROBIOL, V48, P1651, DOI 10.1128/JCM.02250-09; Wong W, 2014, ELIFE, V3, DOI 10.7554/eLife.03080; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	40	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173303	10.1371/journal.pone.0173303	http://dx.doi.org/10.1371/journal.pone.0173303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257497	Green Published, gold, Green Submitted			2022-12-26	WOS:000396021100084
J	Liu, B; Wang, CG; Liu, DX; He, N; Deng, X				Liu, Bing; Wang, Chaogang; Liu, Danxia; He, Ning; Deng, Xu			Hg tolerance and biouptake of an isolated pigmentation yeast Rhodotorula mucilaginosa	PLOS ONE			English	Article							BACTERIA HIGHLY RESISTANT; SACCHAROMYCES-CEREVISIAE; METAL TOLERANCE; MERCURY; BIOSORPTION; COPPER; BIOACCUMULATION; WATER; BIOREMEDIATION; REMOVAL	A pigmented yeast R1 with strong tolerance to Hg2+ was isolated. Phylogenetic identification based on the analysis of 26S rDNA and ITS revealed R1 is a Rhodotorula mucilaginosa species. R1 was able to grow in the presence of 80 mg/L Hg2+, but the lag phase was much prolonged compared to its growth in the absence of Hg2+. The maximum Hg2+ binding capacity of R1 was 69.9 mg/g, and dead cells could bind 15% more Hg2+ than living cells. Presence of organic substances drastically reduced bioavailability of Hg2+ and subsequently decreased Hg2+ removal ratio from aqueous solution, but this adverse effect could be remarkably alleviated by the simultaneous process of cell propagation and Hg2+ biouptake with actively growing R1. Furthermore, among the functional groups involved in Hg2+ binding, carboxyl group contributed the most, followed by amino & hydroxyl group and phosphate group. XPS analysis disclosed the mercury species bound on yeast cells was HgCl2 rather than HgO or Hg-0.	[Liu, Bing; Wang, Chaogang; Liu, Danxia; Deng, Xu] Shenzhen Univ, Coll Life Sci & Oceanog, Shenzhen Key Lab Marine Bioresources & Ecol, Shenzhen, Peoples R China; [He, Ning] Xiamen Univ, Dept Chem Biochem Engn, Xiamen, Peoples R China; [Liu, Bing] Shenzhen Inst Informat Technol, Shenzhen, Peoples R China	Shenzhen University; Xiamen University; Shenzhen Institute of Information Technology	Deng, X (corresponding author), Shenzhen Univ, Coll Life Sci & Oceanog, Shenzhen Key Lab Marine Bioresources & Ecol, Shenzhen, Peoples R China.; He, N (corresponding author), Xiamen Univ, Dept Chem Biochem Engn, Xiamen, Peoples R China.	hening@xmu.edu.cn; dengxu@szu.edu.cn		Wang, Chaogang/0000-0002-2207-3732	National Natural Science Foundation of China [51578339]; Shenzhen R$D Fund [JCYJ20140418193546101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen R$D Fund	This work was supported by the National Natural Science Foundation of China (No. 51578339) (https://www.nsfc.gov.on/) to XD; Shenzhen R$D Fund (JCYJ20140418193546101), (http://www.szsti.gov.cn/) to XD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aatif A, 2016, J BASIC MICROBIOL; Abdulaziz A, 2016, J BASIC MICROB, V56, P845, DOI 10.1002/jobm.201500693; Balsalobre L, 2003, J BASIC MICROB, V43, P185, DOI 10.1002/jobm.200390021; Bilal M, 2013, J HAZARD MATER, V263, P322, DOI 10.1016/j.jhazmat.2013.07.071; Chojnacka K, 2005, CHEMOSPHERE, V59, P75, DOI 10.1016/j.chemosphere.2004.10.005; Dash HR, 2014, ENVIRON SCI POLLUT R, V21, P2642, DOI 10.1007/s11356-013-2206-8; De J, 2007, ECOL INDIC, V7, P511, DOI 10.1016/j.ecolind.2006.05.002; Debelius B, 2009, ECOTOX ENVIRON SAFE, V72, P1503, DOI 10.1016/j.ecoenv.2009.04.006; Deng X, 2013, BIORESOURCE TECHNOL, V130, P69, DOI 10.1016/j.biortech.2012.11.133; Deng X, 2012, BIORESOURCE TECHNOL, V121, P342, DOI 10.1016/j.biortech.2012.07.017; Dengis PB, 1996, J MICROBIOL METH, V26, P171, DOI 10.1016/0167-7012(96)00909-8; Diffels JF, 2006, BIOCHIMIE, V88, P1639, DOI 10.1016/j.biochi.2006.08.008; Ghosh SK, 2004, B ENVIRON CONTAM TOX, V72, P21, DOI 10.1007/s00128-003-0236-5; Hai RT, 2013, ASIAN J CHEM, V25, P6528, DOI 10.14233/ajchem.2013.14339; Hesham AEL, 2012, ENVIRON SCI POLLUT R, V19, P3568, DOI 10.1007/s11356-012-0919-8; Hutson ND, 2007, ENVIRON SCI TECHNOL, V41, P1747, DOI 10.1021/es062121q; HYLAND MM, 1990, GEOCHIM COSMOCHIM AC, V54, P1957, DOI 10.1016/0016-7037(90)90264-L; Irazusta V, 2013, PROCESS BIOCHEM, V48, P803, DOI 10.1016/j.procbio.2013.04.006; Irazusta V, 2012, BIOMETALS, V25, P517, DOI 10.1007/s10534-012-9531-0; Jarboui R, 2012, ENVIRON TECHNOL, V33, P951, DOI 10.1080/09593330.2011.603753; Kapoor A, 1997, BIORESOURCE TECHNOL, V61, P221, DOI 10.1016/S0960-8524(97)00055-2; Kefala MI, 1999, ENVIRON POLLUT, V104, P283, DOI 10.1016/S0269-7491(98)00178-X; Li CS, 2013, BIORESOURCE TECHNOL, V143, P46, DOI 10.1016/j.biortech.2013.05.114; Nascimento Andrea M A, 2003, Genet Mol Res, V2, P92; Nimick DA, 2013, SCI TOTAL ENVIRON, V443, P40, DOI 10.1016/j.scitotenv.2012.10.080; Okino S, 2002, B ENVIRON CONTAM TOX, V68, P712, DOI 10.1007/s001280312; Oyetibo GO, 2015, APPL MICROBIOL BIOT, V99, P3651, DOI 10.1007/s00253-014-6279-1; Rajpert L, 2013, CHEMOSPHERE, V91, P1257, DOI 10.1016/j.chemosphere.2013.02.022; Saksinchai S, 2012, FUNGAL DIVERS, V52, P123, DOI 10.1007/s13225-011-0115-z; Tristezza M, 2009, J MICROBIOL METH, V78, P286, DOI 10.1016/j.mimet.2009.06.012; Vieira RS, 2011, COLLOID SURFACE A, V374, P108, DOI 10.1016/j.colsurfa.2010.11.022; Villegas LB., 2009, J BASIC MICROB, V49, P1; VOLESKY B, 1994, FEMS MICROBIOL REV, V14, P291, DOI 10.1111/j.1574-6976.1994.tb00102.x; Volesky B, 2007, WATER RES, V41, P4017, DOI 10.1016/j.watres.2007.05.062; Williams GP, 2013, INDIAN J GEO-MAR SCI, V42, P402; Xu GC, 2015, J S CHINA NORMAL U, V47, P101; Zhang HM, 2015, CHIN J HOSP STAT, V1, P1, DOI DOI 10.1016/J.JNS.2015.02.038	37	7	8	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172984	10.1371/journal.pone.0172984	http://dx.doi.org/10.1371/journal.pone.0172984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253367	Green Published, gold, Green Submitted			2022-12-26	WOS:000396011300055
J	Liu, K; Mao, J; Song, LP; Fan, AR; Zhang, S; Wang, JY; Fan, NN; Liu, N; Ye, XY; Fu, HF; Zhou, ZC; Wang, Y; Wei, H; Liu, ZH; Li, ZY; Lai, LX; Wang, XM; Liu, L				Liu, Kai; Mao, Jian; Song, Lipu; Fan, Anran; Zhang, Sheng; Wang, Jianyu; Fan, Nana; Liu, Na; Ye, Xiaoying; Fu, Haifeng; Zhou, Zhongcheng; Wang, Yong; Wei, Hong; Liu, Zhonghua; Li, Ziyi; Lai, Liangxue; Wang, Xumin; Liu, Lin			DNA repair and replication links to pluripotency and differentiation capacity of pig iPS cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR TRANSFER; TELOMERE LENGTH; DEFINED FACTORS; SOMATIC-CELLS; MINIATURE PIG; GENERATION; INDUCTION; FIBROBLASTS; GENES	Pigs are proposed to be suitable large animal models for test of the efficacy and safety of induced pluripotent stem cells (iPSCs) for stem cell therapy, but authentic pig ES/iPS cell lines with germline competence are rarely produced. The pathways or signaling underlying the defective competent pig iPSCs remain poorly understood. By improving induction conditions using various small chemicals, we generated pig iPSCs that exhibited high pluripotency and differentiation capacity that can contribute to chimeras. However, their potency was reduced with increasing passages by teratoma formation test, and correlated with declined expression levels of Rex1, an important marker for naive state. By RNA-sequencing analysis, genes related to WNT signaling were upregulated and MAPK signaling and TGF beta pathways downregulated in pig iPSCs compared to fibroblasts, but they were abnormally expressed during passages. Notably, pathways involving in DNA repair and replication were upregulated at early passage, but downregulated in iPSCs during prolonged passage in cluster with fibroblasts. Our data suggests that reduced DNA repair and replication capacity links to the instability of pig iPSCs. Targeting these pathways may facilitate generation of truly pluripotent pig iPSCs, with implication in translational studies.	[Liu, Kai] Capital Med Univ, Beijing Friendship Hosp, Expt & Translat Res Ctr, Beijing, Peoples R China; [Liu, Kai; Mao, Jian; Liu, Na; Ye, Xiaoying; Fu, Haifeng; Zhou, Zhongcheng; Liu, Lin] Nankai Univ, Collaborat Innovat Ctr Biotherapy 2011, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin, Peoples R China; [Song, Lipu; Wang, Xumin] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Fan, Anran; Zhang, Sheng; Li, Ziyi] Jilin Univ, Hosp 1, Changchun, Peoples R China; [Wang, Jianyu; Liu, Zhonghua] Northeast Agr Univ, Coll Life Sci, Harbin, Peoples R China; [Fan, Nana; Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Wang, Yong; Wei, Hong] Third Mil Med Univ, Coll Basic Med Sci, Chongqing, Peoples R China	Capital Medical University; Nankai University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Jilin University; Northeast Agricultural University - China; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Army Medical University	Liu, L (corresponding author), Nankai Univ, Collaborat Innovat Ctr Biotherapy 2011, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin, Peoples R China.; Wang, XM (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China.	wangxm@big.ac.cn; liulin@nankai.edu.cn	wang, xumin/HII-8627-2022; Liu, Na/E-5674-2012	Liu, Na/0000-0003-3832-5591	China MOST National Major Basic Research Program [2011CBA01002, 2012CB911202]; National Natural Science Foundation of China [31271587]; PCSIRT [IRT13023]	China MOST National Major Basic Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by China MOST National Major Basic Research Program (2011CBA01002, 2012CB911202), National Natural Science Foundation of China (31271587), and PCSIRT (No. IRT13023). We thank Jianyong Han and Qiuyan Li for kindly providing Nong Da Small Xiang pig embryonic fibroblasts.	Adam SJ, 2008, METHOD ENZYMOL, V439, P39, DOI 10.1016/S0076-6879(07)00404-1; Cao SY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-4; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Cheng D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051778; Cozzi E, 2009, ORGANOGENESIS, V5, P288; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Dan JM, 2015, J CELL PHYSIOL, V230, P2337, DOI 10.1002/jcp.24980; Dan JM, 2014, DEV CELL, V29, P7, DOI 10.1016/j.devcel.2014.03.004; Du XG, 2015, STEM CELLS, V33, P3228, DOI 10.1002/stem.2089; Esteban MA, 2010, IUBMB LIFE, V62, P277, DOI 10.1002/iub.307; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fan NN, 2013, CELL RES, V23, P162, DOI 10.1038/cr.2012.176; Fang RG, 2014, CELL STEM CELL, V15, P488, DOI 10.1016/j.stem.2014.09.004; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gao Y, 2014, DNA CELL BIOL, V33, P1, DOI 10.1089/dna.2013.2095; Giraud S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/532127; Hall VJ, 2012, CELL REPROGRAM, V14, P204, DOI 10.1089/cell.2011.0089; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Huang JJ, 2008, STEM CELLS, V26, P1883, DOI 10.1634/stemcells.2008-0164; Huang JJ, 2011, CELL RES, V21, P779, DOI 10.1038/cr.2011.16; Huang YY, 2011, CELL REPROGRAM, V13, P513, DOI 10.1089/cell.2011.0032; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jeon BG, 2008, REPRODUCTION, V135, P815, DOI 10.1530/REP-07-0442; Ji GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074202; Ji GZ, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-36; Jiang J, 2013, CELL RES, V23, P92, DOI 10.1038/cr.2012.157; Kues WA, 2013, STEM CELLS DEV, V22, P124, DOI 10.1089/scd.2012.0382; Kwon DJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/140639; Li XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066688; Liang GY, 2010, J BIOL CHEM, V285, P25516, DOI 10.1074/jbc.M110.142059; Liu K, 2012, CELL REPROGRAM, V14, P505, DOI 10.1089/cell.2012.0047; Liu SC, 2015, DEV DYNAM, V244, P619, DOI 10.1002/dvdy.24248; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Medvedev SP, 2011, STEM CELLS DEV, V20, P1099, DOI 10.1089/scd.2010.0249; Montserrat N, 2012, CELL TRANSPLANT, V21, P815, DOI 10.3727/096368911X601019; Montserrat N, 2011, J CARDIOVASC TRANSL, V4, P121, DOI 10.1007/s12265-010-9233-3; Muro Y, 2015, CLIN CHIM ACTA, V442, P102, DOI 10.1016/j.cca.2015.01.014; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Okada M, 2010, BBA-GEN SUBJECTS, V1800, P956, DOI 10.1016/j.bbagen.2010.04.004; Petkov S, 2014, CELL REPROGRAM, V16, P235, DOI 10.1089/cell.2014.0010; Roberts RM, 2009, CELL CYCLE, V8, P3078, DOI 10.4161/cc.8.19.9589; Rodriguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049079; Ruan WM, 2011, SCI CHINA LIFE SCI, V54, P553, DOI 10.1007/s11427-011-4179-5; Samstein B, 2001, J AM SOC NEPHROL, V12, P182, DOI 10.1681/ASN.V121182; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Telugu BPVL, 2010, INT J DEV BIOL, V54, P1703, DOI 10.1387/ijdb.103200bt; Thomson AJ, 2012, CELL REPROGRAM, V14, P112, DOI 10.1089/cell.2011.0078; Valamehr B, 2014, STEM CELL REP, V2, P366, DOI 10.1016/j.stemcr.2014.01.014; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Weissbein U, 2014, J CELL BIOL, V204, P153, DOI 10.1083/jcb.201310135; West F, 2011, ANN NY ACAD SCI, V1245, P21, DOI 10.1111/j.1749-6632.2011.06337.x; West FD, 2011, STEM CELLS, V29, P1640, DOI 10.1002/stem.713; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; Whyte JJ, 2011, MOL REPROD DEV, V78, P879, DOI 10.1002/mrd.21333; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Zhang SQ, 2015, STEM CELL REV REP, V11, P24, DOI 10.1007/s12015-014-9552-x; Zhang YG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109159, 10.1371/journal.pone.0105725, 10.1371/journal.pone.0093458, 10.1371/journal.pone.0088491]; Zhang ZH, 2013, STEM CELLS DEV, V22, P2268, DOI 10.1089/scd.2012.0650; Zhao XY, 2010, CELL RES, V20, P383, DOI 10.1038/cr.2010.26; Zhou L, 2011, STEM CELLS, V29, P972, DOI 10.1002/stem.637; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	68	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173047	10.1371/journal.pone.0173047	http://dx.doi.org/10.1371/journal.pone.0173047			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253351	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300065
J	Wu, SM; Yu, CW; Zhang, WT; Yin, SL; Chen, Y; Feng, Y; Ma, WT				Wu, Sanmao; Yu, Chunwu; Zhang, Wentao; Yin, Shaolin; Chen, Yong; Feng, Yu; Ma, Wentao			Tag mechanism as a strategy for the RNA replicase to resist parasites in the RNA world	PLOS ONE			English	Article							POLYMERASE RIBOZYME; PREBIOTIC EVOLUTION; ORIGIN; LIFE; 1ST; SIMULATION; CHEMISTRY; SELECTION; DYNAMICS; MODELS	The idea that life may have started with an "RNA world" is attractive. Wherein, a crucial event (perhaps at the very beginning of the scenario) should have been the emergence of a ribozyme that catalyzes its own replication, i.e., an RNA replicase. Although now there is experimental evidence supporting the chemical feasibility of such a ribozyme, the evolutionary dynamics of how the replicase could overcome the "parasite" problem (because other RNAs may also exploit this ribozyme) and thrive, as described in the scenario, remains unclear. It has been suggested that spatial limitation may have been important for the replicase to confront parasites. However, more studies showed that such a mechanism is not sufficient when this ribozyme's altruistic trait is taken into full consideration. "Tag mechanism", which means labeling the replicase with a short subsequence for recognition in replication, may be a further mechanism supporting the thriving of the replicase. However, because parasites may also "equip" themselves with the tag, it is far from clear whether the tag mechanism could take effect. Here, we conducted a computer simulation using a Monte-Carlo model to study the evolutionary dynamics surrounding the development of a tag-driven (polymerase-type) RNA replicase in the RNA world. We concluded that (1) with the tag mechanism the replicase could resist the parasites and become prosperous, (2) the main underlying reason should be that the parasitic molecules, especially those strong parasites, are more difficult to appear in the tag-driven system, and (3) the tag mechanism has a synergic effect with the spatial limitation mechanism-while the former provides "time" for the replicase to escape from parasites, the latter provides "space" for the replicase to escape. Notably, tags may readily serve as "control handles", and once the tag mechanism was exploited, the evolution towards complex life may have been much easier.	[Wu, Sanmao; Yin, Shaolin; Chen, Yong; Feng, Yu; Ma, Wentao] Wuhan Univ, Coll Life Sci, Wuhan, Peoples R China; [Yu, Chunwu; Zhang, Wentao] Wuhan Univ, Coll Comp Sci, Wuhan, Peoples R China	Wuhan University; Wuhan University	Ma, WT (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan, Peoples R China.	mwt@whu.edu.cn			National Natural Science Foundation of China [31571367, 31170958]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 31571367, 31170958). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwater J, 2013, NAT CHEM, V5, P1011, DOI [10.1038/nchem.1781, 10.1038/NCHEM.1781]; Attwater J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1076; Bartel D.P, 1999, RNA WORLD 2 NAT MOD, V37, P143; Bernhardt HS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-23; BOERLIJST MC, 1991, PHYSICA D, V48, P17, DOI 10.1016/0167-2789(91)90049-F; CECH TR, 1989, NATURE, V339, P507, DOI 10.1038/339507a0; Cheng LKL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002204; Colizzi ES, 2014, GENOME BIOL EVOL, V6, P1990, DOI 10.1093/gbe/evu150; Coveney PV, 2012, CHEM SOC REV, V41, P5430, DOI 10.1039/c2cs35018a; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Higgs PG, 2015, NAT REV GENET, V16, P7, DOI 10.1038/nrg3841; Hogeweg P, 2003, ORIGINS LIFE EVOL B, V33, P375, DOI 10.1023/A:1025754907141; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Joyce G. F., 2006, THE RNA WORLD, P23; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; LOVETT ST, 1993, GENETICS, V135, P631; Ma W, 2007, RNA, V13, P2012, DOI 10.1261/rna.658507; Ma WT, 2007, BIOSYSTEMS, V90, P28, DOI 10.1016/j.biosystems.2006.06.005; Ma WT, 2006, ORIGINS LIFE EVOL B, V36, P413, DOI 10.1007/s11084-005-9006-1; Ma WT, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0150-5; Ma WT, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0548-1; Ma WT, 2014, CHEM BIODIVERS, V11, P1998, DOI 10.1002/cbdv.201400188; Ma WT, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-21; Ma WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035454; Ma WT, 2010, ASTROBIOLOGY, V10, P437, DOI 10.1089/ast.2009.0385; Ma WT, 2010, BIOSYSTEMS, V99, P201, DOI 10.1016/j.biosystems.2009.11.003; McCaskill JS, 2001, BIOL CHEM, V382, P1343, DOI 10.1515/BC.2001.167; Mutschler H, 2015, NAT CHEM, V7, P502, DOI [10.1038/NCHEM.2251, 10.1038/nchem.2251]; Pressman A, 2015, CURR BIOL, V25, pR953, DOI 10.1016/j.cub.2015.06.016; Robertson M.P., 2012, COLD SPRING HARB PER, V4, P4, DOI DOI 10.1101/CSHPERSPECT.A003608; Scheuring I, 2003, ORIGINS LIFE EVOL B, V33, P319, DOI 10.1023/A:1025742505324; Szabo P, 2002, NATURE, V420, P340, DOI 10.1038/nature01187; Szathmary E, 2003, ORIGINS LIFE EVOL B, V33, P313, DOI 10.1023/A:1025704003507; Szathmary E, 2006, PHILOS T R SOC B, V361, P1761, DOI 10.1098/rstb.2006.1912; Szilagyi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003193; Takeuchi N, 2007, J MOL EVOL, V65, P668, DOI 10.1007/s00239-007-9044-6; Takeuchi N, 2012, PHYS LIFE REV, V9, P219, DOI 10.1016/j.plrev.2012.06.001; Takeuchi N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002024; Takeuchi N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000542; Takeuchi N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-11; Viguera E, 2001, EMBO J, V20, P2587, DOI 10.1093/emboj/20.10.2587; WEINER AM, 1987, P NATL ACAD SCI USA, V84, P7383, DOI 10.1073/pnas.84.21.7383; Wochner A, 2011, SCIENCE, V332, P209, DOI 10.1126/science.1200752; Zaher HS, 2007, RNA, V13, P1017, DOI 10.1261/rna.548807	44	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172702	10.1371/journal.pone.0172702	http://dx.doi.org/10.1371/journal.pone.0172702			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253281	Green Published, gold, Green Submitted			2022-12-26	WOS:000396011300028
J	Jablonski, RP; Kim, SJ; Cheresh, P; Williams, DB; Morales-Nebreda, L; Cheng, Y; Yeldandi, A; Bhorade, S; Pardo, A; Selman, M; Ridge, K; Gius, D; Budinger, GRS; Kamp, DW				Jablonski, Renea P.; Kim, Seok-Jo; Cheresh, Paul; Williams, David B.; Morales-Nebreda, Luisa; Cheng, Yuan; Yeldandi, Anjana; Bhorade, Sangeeta; Pardo, Annie; Selman, Moises; Ridge, Karen; Gius, David; Budinger, G. R. Scott; Kamp, David W.			SIRT3 deficiency promotes lung fibrosis by augmenting alveolar epithelial cell mitochondrial DNA damage and apoptosis	FASEB JOURNAL			English	Article						sirtuin 3; oxidative stress; pulmonary fibrosis	MANGANESE SUPEROXIDE-DISMUTASE; IDIOPATHIC PULMONARY-FIBROSIS; TUMOR-SUPPRESSOR; OXIDATIVE DAMAGE; INJURY; MICE; DEACETYLATION; BLOCKS; DEATH; SUSCEPTIBILITY	Alveolar epithelial cell (AEC) mitochondrial dysfunction and apoptosis are important in idiopathic pulmonary fibrosis and asbestosis. Sirtuin 3 (SIRT3) detoxifies mitochondrial reactive oxygen species, in part, by deacetylatingmanganese superoxide dismutase (MnSOD) andmitochondrial 8-oxoguanine DNA glycosylase. We reasoned that SIRT3 deficiency occurs in fibrotic lungs and thereby augments AEC mtDNA damage and apoptosis. Human lungswere assessed by using immunohistochemistry for SIRT3 activity via acetylated MnSODK68. Murine AEC SIRT3 and cleaved caspase-9 (CC-9) expression were assayed by immunoblotting with or without SIRT3 enforced expression or silencing. mtDNA damage was measured by using quantitative PCR and apoptosis via ELISA. Pulmonary fibrosis after asbestos or bleomycin exposure was evaluated in 129SJ/wild-type and SIRT3-knockout mice (Sirt3(-/-)) by using fibrosis scoring and lung collagen levels. Idiopathic pulmonary fibrosis lung alveolar type II cells have increased MnSODK68 acetylation compared with controls. Asbestos andH(2)O(2) diminished AEC SIRT3 protein expression and increased mitochondrial protein acetylation, including MnSODK68. SIRT3 enforced expression reduced oxidant-induced AEC OGG1(K338/341) acetylation, mtDNA damage, and apoptosis, whereas SIRT3 silencing promoted these effects. Asbestos-or bleomycin-induced lung fibrosis, AEC mtDNA damage, and apoptosis in wild-type mice were amplified in Sirt3(-/-) animals. These data suggest a novel role for SIRT3 deficiency in mediating AEC mtDNA damage, apoptosis, and lung fibrosis.-Jablonski, R. P., Kim, S.-J., Cheresh, P., Williams, D. B., Morales-Nebreda, L., Cheng, Y., Yeldandi, A., Bhorade, S., Pardo, A., Selman, M., Ridge, K., Gius, D., Budinger, G. R. S., Kamp, D. W. SIRT3deficiencypromotes lungfibrosisbyaugmentingalveolar epithelial cell mitochondrial DNA damage and apoptosis.	[Jablonski, Renea P.; Kim, Seok-Jo; Cheresh, Paul; Williams, David B.; Morales-Nebreda, Luisa; Cheng, Yuan; Ridge, Karen; Budinger, G. R. Scott; Kamp, David W.] Jesse Brown Vet Affairs Med Ctr, Div Pulm & Crit Care Med, Dept Med, Chicago, IL USA; [Jablonski, Renea P.; Kim, Seok-Jo; Cheresh, Paul; Williams, David B.; Morales-Nebreda, Luisa; Cheng, Yuan; Bhorade, Sangeeta; Ridge, Karen; Budinger, G. R. Scott; Kamp, David W.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Yeldandi, Anjana] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Gius, David] Northwestern Univ, Dept Radiat Biol, Feinberg Sch Med, Chicago, IL 60611 USA; [Pardo, Annie] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City, DF, Mexico; [Selman, Moises] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico	US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Universidad Nacional Autonoma de Mexico	Kamp, DW (corresponding author), Northwestern Univ, Pulm & Crit Care Med, Feinberg Sch Med, McGaw M-330,240 E Huron St, Chicago, IL 60611 USA.	d-kamp@northwestern.edu		Morales-Nebreda, Luisa/0000-0002-7126-0518	U.S. Veteran's Administration Merit Grant [2I01BX000786-05A2]; U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences [R01-ES020357]; NIH National Heart, Lung, and Blood Institute Training Grant [2T32HL076139-11A1]; NIH [2R01CA152601-A1, 1R01CA152799-01A1, 1R01CA168292-01A1, 1R01CA214025-01]; Avon Foundation for Breast Cancer Research; Lynn Sage Cancer Research Foundation; Zell Family Foundation; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL CANCER INSTITUTE [R01CA152799, R01CA152601, R01CA168292, R01CA214025] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL134222, T32HL076139, P01HL071643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020357] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000201, I01BX000786] Funding Source: NIH RePORTER	U.S. Veteran's Administration Merit Grant; U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences; NIH National Heart, Lung, and Blood Institute Training Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Avon Foundation for Breast Cancer Research; Lynn Sage Cancer Research Foundation; Zell Family Foundation; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by U.S. Veteran's Administration Merit Grant 2I01BX000786-05A2 (to D.W.K.), U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences Grant R01-ES020357 (to D.W.K.), and NIH National Heart, Lung, and Blood Institute Training Grant 2T32HL076139-11A1 (to R.P.J.). D.G. was supported by NIH grants 2R01CA152601-A1, 1R01CA152799-01A1, 1R01CA168292-01A1, and 1R01CA214025-01; the Avon Foundation for Breast Cancer Research; the Lynn Sage Cancer Research Foundation; the Zell Family Foundation; and the Chicago Biomedical Consortium; as well as support from the Searle Funds at The Chicago Community Trust.	Akamata K, 2016, ONCOTARGET, V7, P69321, DOI 10.18632/oncotarget.12504; Beck JM, 2009, INFECT IMMUN, V77, P1053, DOI 10.1128/IAI.00967-08; Bindu S, 2017, AM J PHYSIOL-LUNG C, V312, pL68, DOI 10.1152/ajplung.00188.2016; Bohr VA, 2002, GENE, V286, P127, DOI 10.1016/S0378-1119(01)00813-7; Brar SS, 2012, AM J PHYSIOL-LUNG C, V303, pL413, DOI 10.1152/ajplung.00343.2011; BRODY AR, 1989, AM J PATHOL, V134, P133; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; CHANG LY, 1988, AM J PATHOL, V131, P156; Chen Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.14; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Chen YW, 2013, ECON POLIT STUD-EPS, V1, P3, DOI 10.1080/20954816.2013.11673857; Cheresh P, 2015, AM J RESP CELL MOL, V52, P25, DOI 10.1165/rcmb.2014-0038OC; Coleman MC, 2014, ANTIOXID REDOX SIGN, V20, P1423, DOI 10.1089/ars.2012.5091; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; de Souza-Pinto NC, 2002, INT REV NEUROBIOL, V53, P519; Fattman CL, 2006, FREE RADICAL BIO MED, V40, P601, DOI 10.1016/j.freeradbiomed.2005.09.030; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Haigis MC, 2012, CANCER RES, V72, P2468, DOI 10.1158/0008-5472.CAN-11-3633; Hebert SL, 2015, J GERONTOL A-BIOL, V70, P1409, DOI 10.1093/gerona/glv086; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Huang SXL, 2011, J TOXICOL ENV HEAL B, V14, P179, DOI 10.1080/10937404.2011.556051; Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x; Kawamura Y, 2010, J CLIN INVEST, V120, P2817, DOI 10.1172/JCI42020; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim SJ, 2016, FREE RADICAL BIO MED, V101, P482, DOI 10.1016/j.freeradbiomed.2016.11.007; Kim SJ, 2014, J BIOL CHEM, V289, P6165, DOI 10.1074/jbc.M113.515130; Kincaid B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00048; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Kuwano K, 1996, AM J RESP CRIT CARE, V154, P477, DOI 10.1164/ajrccm.154.2.8756825; Lam AP, 2014, AM J RESP CRIT CARE, V190, P185, DOI 10.1164/rccm.201401-0079OC; Li SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010486; Liu G, 2013, ANNU REV PATHOL-MECH, V8, P161, DOI 10.1146/annurev-pathol-020712-163942; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu JQ, 2015, FREE RADICAL BIO MED, V85, P114, DOI 10.1016/j.freeradbiomed.2015.04.011; Mahjabeen I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146948; McGlynn LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131344; Mercer PF, 2009, AM J RESP CRIT CARE, V179, P414, DOI 10.1164/rccm.200712-1827OC; Minagawa S, 2011, AM J PHYSIOL-LUNG C, V300, pL391, DOI 10.1152/ajplung.00097.2010; Morigi M, 2015, J CLIN INVEST, V125, P715, DOI 10.1172/JCI77632; Mossman BT, 2011, J TOXICOL ENV HEAL B, V14, P76, DOI 10.1080/10937404.2011.556047; Murthy S, 2009, AM J PHYSIOL-LUNG C, V297, pL846, DOI 10.1152/ajplung.90590.2008; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Ozden O, 2014, FREE RADICAL BIO MED, V76, P163, DOI 10.1016/j.freeradbiomed.2014.08.001; Panduri V, 2003, AM J RESP CELL MOL, V28, P241, DOI 10.1165/rcmb.4903; Panduri V, 2009, FREE RADICAL BIO MED, V47, P750, DOI 10.1016/j.freeradbiomed.2009.06.010; Patel AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121246; Pillai VB, 2016, AM J PHYSIOL-HEART C, V310, pH962, DOI 10.1152/ajpheart.00832.2015; Pillai VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7656; Porter GA, 2014, AM J PHYSIOL-HEART C, V306, pH1602, DOI 10.1152/ajpheart.00027.2014; Raghu G, 2015, AM J RESP CRIT CARE, V192, pE3, DOI 10.1164/rccm.201506-1063ST; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rato L, 2014, BBA-BIOENERGETICS, V1837, P335, DOI 10.1016/j.bbabio.2013.12.008; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Santos Janine H, 2002, Methods Mol Biol, V197, P159, DOI 10.1385/1-59259-284-8:159; Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200; Selman M, 2014, AM J RESP CRIT CARE, V189, P1161, DOI 10.1164/rccm.201312-2221PP; Shulga N, 2010, J CELL SCI, V123, P4117, DOI 10.1242/jcs.073502; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Sosulski M. L., 2016, J GERONTOL A; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sundaresan NR, 2016, MOL CELL BIOL, V36, P678, DOI 10.1128/MCB.00586-15; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tao RD, 2014, ANTIOXID REDOX SIGN, V20, P1646, DOI 10.1089/ars.2013.5482; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Thannickal VJ, 2015, AM J RESP CRIT CARE, V191, P261, DOI 10.1164/rccm.201410-1876PP; Uhal BD, 2013, AM J PHYSIOL-LUNG C, V305, pL906, DOI 10.1152/ajplung.00246.2013; Urich D, 2009, FASEB J, V23, P2055, DOI 10.1096/fj.08-114546; Yan SM, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0103-8; Yang B, 2014, BIOCHEM BIOPH RES CO, V443, P156, DOI 10.1016/j.bbrc.2013.11.068; Zhang CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051703	72	77	79	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2520	2532		10.1096/fj.201601077R	http://dx.doi.org/10.1096/fj.201601077R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28258190	Green Published			2022-12-26	WOS:000401553400025
J	Lim, CS; Alkon, DL; Stephenson, FA				Lim, Chol Seung; Alkon, Daniel L.; Stephenson, F. Anne			Inhibition of coactivator-associated arginine methyltransferase 1 modulates dendritic arborization and spine maturation of cultured hippocampal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SYNAPTIC PLASTICITY; POSTSYNAPTIC DENSITY; ALZHEIMERS-DISEASE; MASS-SPECTROMETRY; MEMORY; PKC; METHYLATION; STABILITY; PHOSPHORYLATION	An improved understanding of the molecular mechanisms in synapse formation provides insight into both learning and memory and the etiology of neurodegenerative disorders. Coactivator-associated arginine methyltransferase 1 (CARM1) is a protein methyltransferase that negatively regulates synaptic gene expression and inhibits neuronal differentiation. Despite its regulatory function in neurons, little is known about the CARM1 cellular location and its role in dendritic maturation and synapse formation. Here, we examined the effects of CARM1 inhibition on dendritic spine and synapse morphology in the rat hippocampus. CARM1 was localized in hippocampal post-synapses, with immunocytochemistry and electron microscopy revealing co-localization of CARM1 with post-synaptic density (PSD)-95 protein, a post-synaptic marker. Specific siRNA-mediated suppression of CARM1 expression resulted in precocious dendritic maturation, with increased spine width and density at sites along dendrites and induction of mushroom-type spines. These changes were accompanied by a striking increase in the cluster size and number of key synaptic proteins, including N-methyl-D-aspartate receptor subunit 2B (NR2B) and PSD-95. Similarly, pharmacological inhibition of CARM1 activity with the CARM1-specific inhibitor AMI-1 significantly increased spine width and mushroom-type spines and also increased the cluster size and number of NR2B and cluster size of PSD-95. These results suggest that CARM1 is a postsynaptic protein that plays roles in dendritic maturation and synaptic formation and that spatiotemporal regulation of CARM1 activity modulates neuronal connectivity and improves synaptic dysfunction.	[Lim, Chol Seung; Alkon, Daniel L.; Stephenson, F. Anne] West Virginia Univ, Blanchette Rockefeller Neurosci Inst, 8 Med Ctr Dr, Morgantown, WV 26505 USA	West Virginia University	Lim, CS (corresponding author), West Virginia Univ, Blanchette Rockefeller Neurosci Inst, 8 Med Ctr Dr, Morgantown, WV 26505 USA.	clim@hsc.wvu.edu						Amtul Z, 2015, REV NEUROSCIENCE, V26, P253, DOI 10.1515/revneuro-2014-0075; Basso M, 2015, EXP NEUROL, V271, P77, DOI 10.1016/j.expneurol.2015.05.003; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Colombrita C, 2013, MOL CELL NEUROSCI, V56, P447, DOI 10.1016/j.mcn.2013.02.003; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Feng Q, 2009, J BIOL CHEM, V284, P36167, DOI 10.1074/jbc.M109.065524; Fujiwara T, 2006, MOL CELL BIOL, V26, P2273, DOI 10.1128/MCB.26.6.2273-2285.2006; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Harris KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005587; Higashimoto K, 2007, P NATL ACAD SCI USA, V104, P12318, DOI 10.1073/pnas.0610792104; Hongpaisan J, 2007, P NATL ACAD SCI USA, V104, P19571, DOI 10.1073/pnas.0709311104; Hongpaisan J, 2011, J NEUROSCI, V31, P630, DOI 10.1523/JNEUROSCI.5209-10.2011; Hu H, 2016, EXPERT OPIN INV DRUG, V25, P335, DOI 10.1517/13543784.2016.1144747; Hunt DL, 2012, CURR OPIN NEUROBIOL, V22, P496, DOI 10.1016/j.conb.2012.01.007; Kandel ER, 2014, CELL, V157, P163, DOI 10.1016/j.cell.2014.03.001; Kastellakis G, 2015, PROG NEUROBIOL, V126, P19, DOI 10.1016/j.pneurobio.2014.12.002; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Koleske AJ, 2013, NAT REV NEUROSCI, V14, P536, DOI 10.1038/nrn3486; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Lim CS, 2008, CELL SIGNAL, V20, P825, DOI 10.1016/j.cellsig.2007.12.013; Lim CS, 2012, HIPPOCAMPUS, V22, P2303, DOI 10.1002/hipo.22048; Matsuoka Y, 1998, J CELL BIOL, V142, P485, DOI 10.1083/jcb.142.2.485; McBride AE, 2006, ENZYMES, V24, P51, DOI 10.1016/S1874-6047(06)80005-3; Morales Y, 2016, ARCH BIOCHEM BIOPHYS, V590, P138, DOI 10.1016/j.abb.2015.11.030; Nagura H, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-43; Nelson TJ, 2008, EUR J PHARMACOL, V585, P76, DOI 10.1016/j.ejphar.2008.01.051; Newpher TM, 2009, TRENDS CELL BIOL, V19, P218, DOI 10.1016/j.tcb.2009.02.004; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Pascale A, 2005, P NATL ACAD SCI USA, V102, P12065, DOI 10.1073/pnas.0504702102; Pontrello Crystal G, 2009, Open Neurosci J, V3, P67; Rochefort NL, 2012, EMBO REP, V13, P699, DOI 10.1038/embor.2012.102; Routtenberg A, 2005, TRENDS NEUROSCI, V28, P12, DOI 10.1016/j.tins.2004.11.006; Sala C, 2014, PHYSIOL REV, V94, P141, DOI 10.1152/physrev.00012.2013; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; Schubert V, 2007, J CELL SCI, V120, P205, DOI 10.1242/jcs.03337; Shen K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001842; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Sun MK, 2010, PHARMACOL THERAPEUT, V127, P66, DOI 10.1016/j.pharmthera.2010.03.001; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Wondolowski J, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00223; Woolfrey KM, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/3025948; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhu JW, 2016, NAT REV NEUROSCI, V17, P209, DOI 10.1038/nrn.2016.18	51	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6402	6413		10.1074/jbc.M117.775619	http://dx.doi.org/10.1074/jbc.M117.775619			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28264928	hybrid, Green Published			2022-12-26	WOS:000399538700032
J	Pozo, FM; Tang, JS; Bonk, KW; Keri, RA; Yao, XS; Zhang, YW				Pozo, Franklin Mayca; Tang, Jinshan; Bonk, Kristen W.; Keri, Ruth A.; Yao, Xinsheng; Zhang, Youwei			Regulatory cross-talk determines the cellular levels of 53BP1 protein, a critical factor in DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; checkpoint control; DNA damage; DNA damage response; DNA repair; degradation	DOUBLE-STRAND BREAKS; CHECKPOINT KINASE 1; 5' END RESECTION; A-TYPE LAMINS; HOMOLOGOUS RECOMBINATION; BRCA1 DEFICIENCY; PATHWAY CHOICE; CATHEPSIN-L; DSB REPAIR; DAMAGE	DNA double strand breaks (DSBs) severely disrupt DNA integrity. 53BP1 plays critical roles in determining DSB repair. Whereas the recruitment of 53BP1 to the DSB site is key for its function, recent evidence suggests that 53BP1's abundance also plays an important role in DSB repair because recruitment to damage sites will be influenced by protein availability. Initial evidence has pointed to three proteins, the ubiquitin-conjugating enzyme UbcH7, the cysteine protease cathepsin L (CTSL), and the nuclear structure protein lamin A/C, that may impact 53BP1 levels, but the roles of each protein and any interplay between them were unclear. Here we report that UbcH7-dependent degradation plays a major role in controlling 53BP1 levels both under normal growth conditions and during DNA damage. CTSL influenced 53BP1 degradation during DNA damage while having little effect under normal growth conditions. Interestingly, both the protein and the mRNA levels of CTSL were reduced in UbcH7-depleted cells. Lamin A/C interacted with 53BP1 under normal conditions. DNA damage disrupted the lamin A/C-53BP1 interaction, which preceded the degradation of 53BP1 in soluble, but not chromatin-enriched, cellular fractions. Inhibition of 53BP1 degradation by a proteasome inhibitor or by UbcH7 depletion restored the 53BP1-lamin A/C interaction. Depletion of lamin A/C, but not CTSL, caused a similar enhancement in cell sensitivity to DNA damage as UbcH7 depletion. These data suggest that multiple pathways collectively fine-tune the cellular levels of 53BP1 protein to ensure proper DSB repair and cell survival.	[Pozo, Franklin Mayca; Tang, Jinshan; Bonk, Kristen W.; Keri, Ruth A.; Zhang, Youwei] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Tang, Jinshan; Yao, Xinsheng] Jinan Univ, Inst Tradit Chinese Med & Nat Prod, Coll Pharm, Guangzhou 510632, Guangdong, Peoples R China	Case Western Reserve University; Jinan University	Zhang, YW (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Case Comprehens Canc Ctr, 2109 Adelbert Rd,Wood Bldg W343A, Cleveland, OH 44106 USA.	yxz169@case.edu	Keri, Ruth/ABF-2209-2021	Keri, Ruth/0000-0002-1640-3088	National Institutes of Health [CA163214]; Clinical and Translational Science Collaborative of Cleveland [UL1TR000439]; Case Cancer Center [CA043703, CA126710]; American Cancer Society [ACS RSG-15-042 DMC]; United States Department of Defense [W81XWH-14-1-0354]; National 111 Project of China [B13038]; NATIONAL CANCER INSTITUTE [R01CA163214, P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Collaborative of Cleveland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Case Cancer Center; American Cancer Society(American Cancer Society); United States Department of Defense(United States Department of Defense); National 111 Project of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA163214 (NCI; to Y. Z.), the Clinical and Translational Science Collaborative of Cleveland Grant UL1TR000439 (National Center for National Center for Translational Sciences (NCATS) (to Y. Z.), Case Cancer Center P30 Grant CA043703 (to Y. Z.), and Grant CA126710 (NCI; to R. A. K.). This work was also supported by American Cancer Society Grant ACS RSG-15-042 DMC (to Y. Z.) and United States Department of Defense Grant W81XWH-14-1-0354) (to R. A. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National 111 Project of China (B13038).	Boersma V, 2015, NATURE, V521, P537, DOI 10.1038/nature14216; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Burden RE, 2012, BIOCHIMIE, V94, P487, DOI 10.1016/j.biochi.2011.08.017; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Daley JM, 2014, MOL CELL BIOL, V34, P1380, DOI 10.1128/MCB.01639-13; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gibbs-Seymour I, 2015, AGING CELL, V14, P162, DOI 10.1111/acel.12258; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Gonzalez-Suarez I, 2011, EMBO J, V30, P3383, DOI 10.1038/emboj.2011.225; Gonzalez-Suarez I, 2009, EMBO J, V28, P2414, DOI 10.1038/emboj.2009.196; Goodarzi AA, 2013, ADV GENET, V82, P1, DOI 10.1016/B978-0-12-407676-1.00001-9; Grotsky DA, 2013, J CELL BIOL, V200, P187, DOI 10.1083/jcb.201204053; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Han XZ, 2014, P NATL ACAD SCI USA, V111, P17456, DOI 10.1073/pnas.1408538111; He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200; Jacot W, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-523; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Jullien D, 2002, J CELL SCI, V115, P71; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Moudry P, 2012, CELL DEATH DIFFER, V19, P798, DOI 10.1038/cdd.2011.150; Neboori HJR, 2012, INT J RADIAT ONCOL, V83, pE677, DOI 10.1016/j.ijrobp.2012.01.089; Pennington KP, 2013, GYNECOL ONCOL, V128, P493, DOI 10.1016/j.ygyno.2012.12.007; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287; Wang JD, 2014, GENE DEV, V28, P2693, DOI 10.1101/gad.252478.114; Wang JN, 2012, CANCER RES, V72, P3786, DOI 10.1158/0008-5472.CAN-12-0523; Wang JN, 2012, J BIOL CHEM, V287, P25501, DOI 10.1074/jbc.M112.350397; Whitcomb EA, 2009, MOL BIOL CELL, V20, P1, DOI 10.1091/mbc.E08-01-0036; Xu GT, 2015, NATURE, V521, P541, DOI 10.1038/nature14328; Zhang HX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10201; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573; Zong DL, 2015, NUCLEIC ACIDS RES, V43, P4950, DOI 10.1093/nar/gkv336	43	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5992	6003		10.1074/jbc.M116.760645	http://dx.doi.org/10.1074/jbc.M116.760645			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28255090	Green Published, hybrid			2022-12-26	WOS:000398813200032
J	Sharpe, SA; White, AD; Sibley, L; Gleeson, F; Hall, GA; Basaraba, RJ; McIntyre, A; Clark, SO; Gooch, K; Marsh, PD; Williams, A; Dennis, MJ				Sharpe, S. A.; White, A. D.; Sibley, L.; Gleeson, F.; Hall, G. A.; Basaraba, R. J.; McIntyre, A.; Clark, S. O.; Gooch, K.; Marsh, P. D.; Williams, A.; Dennis, M. J.			An aerosol challenge model of tuberculosis in Mauritian cynomolgus macaques	PLOS ONE			English	Article							MONKEYS MACACA-FASCICULARIS; MHC CLASS-I; MYCOBACTERIUM-TUBERCULOSIS; RHESUS MACAQUES; BCG VACCINATION; INFECTION; HAPLOTYPES; METAANALYSIS; ORIGIN	Background New interventions for tuberculosis are urgently needed. Non-human primate (NHP) models provide the most relevant pre-clinical models of human disease and play a critical role in vaccine development. Models utilising Asian cynomolgus macaque populations are well established but the restricted genetic diversity of the Mauritian cynomolgus macaques may be of added value. Methods Mauritian cynomolgus macaques were exposed to a range of doses of M. tuberculosis delivered by aerosol, and the outcome was assessed using clinical, imaging and pathology based measures. Results All macaques developed characteristic clinical signs and disease features of tuberculosis (TB). Disease burden and the ability to control disease were dependent on exposure dose. Mauritian cynomolgus macaques showed less variation in pulmonary disease burden and total gross pathology scores within exposure dose groups than either Indian rhesus macaques or Chinese cynomolgus macaques Conclusions The genetic homogeneity of Mauritian cynomolgus macaques makes them a potentially useful model of human tuberculosis.	[Sharpe, S. A.; White, A. D.; Sibley, L.; Hall, G. A.; Clark, S. O.; Gooch, K.; Marsh, P. D.; Williams, A.; Dennis, M. J.] Publ Hlth England, Natl Infect Serv, Salisbury SP4 0JG, Wilts, England; [Gleeson, F.; McIntyre, A.] Churchill Hosp, Oxford, England; [Basaraba, R. J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Coll Vet Med & Biomed Sci, Ft Collins, CO 80523 USA	Public Health England; University of Oxford; Colorado State University	Sharpe, SA (corresponding author), Publ Hlth England, Natl Infect Serv, Salisbury SP4 0JG, Wilts, England.	sally.sharpe@phe.gov.uk		Sibley, Laura/0000-0002-4188-3423; McIntyre, Anthony/0000-0001-9868-6183; Gleeson, Fergus/0000-0002-5121-3917; White, Andrew/0000-0001-9481-0079; clark, simon/0000-0003-1923-6120	Department of Health, UK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106733, R21AI107254] Funding Source: NIH RePORTER	Department of Health, UK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Department of Health, UK.	Basaraba RJ, 2008, TUBERCULOSIS, V88, pS35, DOI 10.1016/S1472-9792(08)70035-0; Borsetti A, 2012, TISSUE ANTIGENS, V80, P36, DOI 10.1111/j.1399-0039.2012.01875.x; Borsetti A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093235; Bourges-Abella N, 2014, J MED PRIMATOL, V43, P1, DOI 10.1111/jmp.12077; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Clark SO, 2011, J APPL MICROBIOL, V111, P350, DOI 10.1111/j.1365-2672.2011.05069.x; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Drevon-Gaillot E, 2006, EXP TOXICOL PATHOL, V58, P77, DOI 10.1016/j.etp.2006.07.003; DRUETT HA, 1969, J HYG-CAMB, V67, P437, DOI 10.1017/S0022172400041851; Florese RH, 2008, VACCINE, V26, P3312, DOI 10.1016/j.vaccine.2008.03.100; Greene JM, 2010, J VIROL, V84, P3362, DOI 10.1128/JVI.02028-09; Greene JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002384; HARPER GJ, 1953, J HYG-CAMBRIDGE, V51, P372, DOI 10.1017/S0022172400015801; Kanthaswamy S, 2013, J MED PRIMATOL, V42, P120, DOI 10.1111/jmp.12043; Kaushal D, 2012, J MED PRIMATOL, V41, P191, DOI 10.1111/j.1600-0684.2012.00536.x; Krebs KC, 2005, J IMMUNOL, V175, P5230, DOI 10.4049/jimmunol.175.8.5230; Langermans JAM, 2001, P NATL ACAD SCI USA, V98, P11497, DOI 10.1073/pnas.201404898; LAWLER SH, 1995, AM J PHYS ANTHROPOL, V96, P133, DOI 10.1002/ajpa.1330960203; Lin PL, 2006, INFECT IMMUN, V74, P3790, DOI 10.1128/IAI.00064-06; Luetjens CM, 2012, REGUL TOXICOL PHARM, V63, P391, DOI 10.1016/j.yrtph.2012.05.003; Mee ET, 2010, TISSUE ANTIGENS, V76, P223, DOI 10.1111/j.1399-0039.2010.01500.x; Mee ET, 2009, IMMUNOGENETICS, V61, P327, DOI 10.1007/s00251-009-0369-8; Mee ET, 2009, J MED PRIMATOL, V38, P1, DOI 10.1111/j.1600-0684.2008.00299.x; O'Connor SL, 2007, IMMUNOGENETICS, V59, P449, DOI 10.1007/s00251-007-0209-7; O'Connor SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000524; Pena JC, 2015, INFECT IMMUN, V83, P852, DOI 10.1128/IAI.02850-14; Reed SG, 2009, P NATL ACAD SCI USA, V106, P2301, DOI 10.1073/pnas.0712077106; Scanga CA, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018564; Seekatz AM, 2013, PLOS ONE, V8; Sharpe SA, 2010, CLIN VACCINE IMMUNOL, V17, P1170, DOI 10.1128/CVI.00079-10; Sharpe SA, 2009, TUBERCULOSIS, V89, P405, DOI 10.1016/j.tube.2009.09.002; Sharpe S, 2016, TUBERCULOSIS, V96, P1, DOI 10.1016/j.tube.2015.10.004; Sibley L, 2016, TUBERCULOSIS, V96, P141, DOI 10.1016/j.tube.2015.11.004; Sugawara I, 2007, TUBERCULOSIS, V87, P518, DOI 10.1016/j.tube.2007.06.002; Sui Yongjun, 2013, Curr Protoc Immunol, V102, DOI 10.1002/0471142735.im1214s102; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Walsh GP, 1996, NAT MED, V2, P430, DOI 10.1038/nm0496-430; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4	39	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171906	10.1371/journal.pone.0171906	http://dx.doi.org/10.1371/journal.pone.0171906			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273087	Green Published, gold			2022-12-26	WOS:000396073700061
J	He, S; Wang, H; Liu, R; He, MN; Che, TD; Jin, L; Deng, LM; Tian, SL; Li, Y; Lu, HF; Li, XW; Jiang, Z; Li, DY; Li, MZ				He, Shen; Wang, Hong; Liu, Rui; He, Mengnan; Che, Tiandong; Jin, Long; Deng, Lamei; Tian, Shilin; Li, Yan; Lu, Hongfeng; Li, Xuewei; Jiang, Zhi; Li, Diyan; Li, Mingzhou			mRNA N-6-methyladenosine methylation of postnatal liver development in pig	PLOS ONE			English	Article							EXPRESSION; M(6)A; CELLS; AMIDINOTRANSFERASE; ENRICHMENT; PROTEINS; HOMOLOG; MOUSE; EDEM2; FATE	N-6-methyladenosine (m(6)A) is a ubiquitous reversible epigenetic RNA modification that plays an important role in the regulation of post-transcriptional protein coding gene expression. Liver is a vital organ and plays a major role in metabolism with numerous functions. Information concerning the dynamic patterns of mRNA m(6)A methylation during postnatal development of liver has been long overdue and elucidation of this information will benefit for further deciphering a multitude of functional outcomes of mRNA m(6)A methylation. Here, we profile transcriptome-wide m(6)A in porcine liver at three developmental stages: newborn (0 day), suckling (21 days) and adult (2 years). About 33% of transcribed genes were modified by m(6)A, with 1.33 to 1.42 m(6)A peaks per modified gene. m(6)A was distributed predominantly around stop codons. The consensus motif sequence RRm(6)ACH was observed in 78.90% of m(6)A peaks. A negative correlation (average Pearson's r = -0.45, P < 10(-16)) was found between levels of m(6)A methylation and gene expression. Functional enrichment analysis of genes consistently modified by m(6)A methylation at all three stages showed genes relevant to important functions, including regulation of growth and development, regulation of metabolic processes and protein catabolic processes. Genes with higher m(6)A methylation and lower expression levels at any particular stage were associated with the biological processes required for or unique to that stage. We suggest that differential m(6)A methylation may be important for the regulation of nutrient metabolism in porcine liver.	[He, Shen; Liu, Rui; He, Mengnan; Che, Tiandong; Jin, Long; Tian, Shilin; Li, Xuewei; Li, Diyan; Li, Mingzhou] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Chengdu, Sichuan, Peoples R China; [Wang, Hong; Deng, Lamei; Tian, Shilin; Li, Yan; Lu, Hongfeng; Jiang, Zhi] Novogene Bioinformat Inst, Beijing, Peoples R China	Sichuan Agricultural University	Li, DY; Li, MZ (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Chengdu, Sichuan, Peoples R China.; Jiang, Z (corresponding author), Novogene Bioinformat Inst, Beijing, Peoples R China.	jiangzhi@novogene.com; diyanli@sicau.edu.cn; mingzhou.li@sicau.edu.cn	Tian, Shilin/AAP-9998-2020	Li, Mingzhou/0000-0001-8681-7684; Tian, Shilin/0000-0001-8958-1806; Li, Diyan/0000-0001-7490-3550	National High Technology Research and Development Program of China (863 Program) [2013AA102502]; Sichuan Provincial Department of Science and Technology Program [2015JQ0023]; National Natural Science Foundation of China [31530073, 31522055, 31472081, 31401073]; National Program for Support of Top-notch Young Professionals; Program for Innovative Research Team of Sichuan Province [2015TD0012]; Fund of Fok Ying-Tung Education Foundation [141117]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Sichuan Provincial Department of Science and Technology Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for Support of Top-notch Young Professionals; Program for Innovative Research Team of Sichuan Province; Fund of Fok Ying-Tung Education Foundation	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program) (2013AA102502), Sichuan Provincial Department of Science and Technology Program (2015JQ0023), the National Natural Science Foundation of China (31530073, 31522055, 31472081 and 31401073), the National Program for Support of Top-notch Young Professionals, the Program for Innovative Research Team of Sichuan Province (2015TD0012), and the Fund of Fok Ying-Tung Education Foundation (141117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abshagen K., 2015, PANVASCULAR MED, P3607; AHERNE FX, 1992, VET CLIN N AM-FOOD A, V8, P589, DOI 10.1016/S0749-0720(15)30706-4; Anders S., 2013, DIFFERENTIAL EXPRESS; Andrada A.D., 2004, SPAN J AGRIC RES, P333, DOI [10.5424/sjar/2004023-102, DOI 10.5424/SJAR/2004023-102]; Antony AC, 2004, J CLIN INVEST, V113, P285, DOI 10.1172/JCI200411548; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Bailey TL, 2012, NUCLEIC ACIDS RES, V40, P610; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bodi Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132090; Boschi-Muller S, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1392, DOI 10.1134/S0006297913130026; Council N, 2012, NUTR REQ SWIN; CSEPANY T, 1990, J BIOL CHEM, V265, P20117; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dourmad JY, 2002, J ANIM SCI, V80, P2144; Faust GG, 2014, BIOINFORMATICS, V30, P2503, DOI 10.1093/bioinformatics/btu314; Feranchak AP, 2004, GASTROENTEROLOGY, V127, P903, DOI 10.1053/j.gastro.2004.06.047; Fontana RJ, 1999, GASTROENTEROLOGY, V117, P89, DOI 10.1016/S0016-5085(99)70554-8; Gilbert WV, 2016, SCIENCE, V352, P1408, DOI 10.1126/science.aad8711; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Humm A, 1997, EMBO J, V16, P3373, DOI 10.1093/emboj/16.12.3373; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; LEE SL, 1978, ARTHRITIS RHEUM, V21, P958, DOI 10.1002/art.1780210813; LEONG SR, 1992, MOL ENDOCRINOL, V6, P870, DOI 10.1210/me.6.6.870; LEVIS R, 1978, J MOL BIOL, V120, P487, DOI 10.1016/0022-2836(78)90350-9; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lima J P, 1980, Arq Gastroenterol, V17, P149; Liu N, 2016, NAT STRUCT MOL BIOL, V23, P98, DOI 10.1038/nsmb.3162; Luo GZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6630; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Maity A, 2015, FEBS J; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Merregaert J, 2010, J BIOL CHEM, V285, P37823, DOI 10.1074/jbc.M110.136408; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Ninagawa S, 2014, J CELL BIOL, V206, P347, DOI 10.1083/jcb.201404075; Niu Yamei, 2013, Genomics Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002; Pemberton TA, 2014, BIOCHEMISTRY-US, V53, P1350, DOI 10.1021/bi500048b; Phillips DH, 1999, MUTAT RES-GEN TOX EN, V443, P139, DOI 10.1016/S1383-5742(99)00016-2; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Reinke H, 2016, GASTROENTEROLOGY, V150, P574, DOI 10.1053/j.gastro.2015.11.043; Riedel TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026021; SENO M, 1995, BBA-GENE STRUCT EXPR, V1261, P424, DOI 10.1016/0167-4781(95)00040-N; Shimada T, 2006, DRUG METAB PHARMACOK, V21, P257, DOI 10.2133/dmpk.21.257; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Toki T, 1997, ONCOGENE, V14, P1901, DOI 10.1038/sj.onc.1201024; Urban A, 2009, J BIOL CHEM, V284, P5845, DOI 10.1074/jbc.M807986200; Vakharia DD, 2001, TOXICOL APPL PHARM, V170, P93, DOI 10.1006/taap.2000.9087; Wahl B, 2010, J BIOL CHEM, V285, P37847, DOI 10.1074/jbc.M110.169532; Wan YZ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0839-2; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Wang YC, 2011, J NUTR, V141, P777, DOI 10.3945/jn.110.135954; WEI CM, 1976, BIOCHEMISTRY-US, V15, P397, DOI 10.1021/bi00647a024; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zahid H, 2016, BIOCHEM J, V473, P43, DOI 10.1042/BJ20150836; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao BS, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0609-1; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883; Zhu YF, 2001, MOL CELL BIOCHEM, V221, P139, DOI 10.1023/A:1010946414017	60	35	37	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173421	10.1371/journal.pone.0173421	http://dx.doi.org/10.1371/journal.pone.0173421			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267806	gold, Green Published, Green Submitted			2022-12-26	WOS:000396060600031
J	Liang, C; Pauly, D				Liang, Cui; Pauly, Daniel			Fisheries impacts on China's coastal ecosystems: Unmasking a pervasive 'fishing down' effect	PLOS ONE			English	Article							TROPHIC-LEVEL; MARINE; EXPANSION; CATCH	Intensive fishing can strongly impact marine ecosystems; among other things, it usually causes the mean trophic level of the catches to decline, an indicator of the occurrence of the `fishing down' (FD) phenomenon. Although FD occurs throughout the world oceans, it can easily be masked by diverse factors, which has misled authors as to its generality. In this contribution, which uses the East China Sea as an example, we explore the masking effect on FD of the taxonomic coarseness of catch data, of assuming that individual sizes remain constant after intensive fishing, and the geographic expansion of fisheries. The result showed that all of these masking factors occur in the East China Sea, where only a few species are reported separately and the bulk of the catch is pooled into non-informative 'mixed fishes'. Also, the small mesh sizes and intensive fishing have reduced the sizes of fish and their trophic levels, while the fisheries have expanded offshore. Overall, taking the masking factors into account, the fishing down effect, i.e., the decline of the mean trophic level of the catch between 1979 and 2014 is in the order of 0.15 TL per decade, i.e., one of the highest estimates of FD in the world. Some ecological implications are presented.	[Liang, Cui] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Fujian Province, Peoples R China; [Pauly, Daniel] Univ British Columbia, Sea Us, Inst Ocean & Fisheries, Vancouver, BC, Canada	Xiamen University; University of British Columbia	Liang, C (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Fujian Province, Peoples R China.	cui-liang@hotmail.com	Pauly, Daniel Marc/AAY-2316-2021; Hsieh, Chih-hao/B-3797-2008	Pauly, Daniel/0000-0003-3756-4793; Hsieh, Chih-hao/0000-0001-5935-7272	Paul G. Allen Family Foundation; China Scholarship Council [201506310099]	Paul G. Allen Family Foundation; China Scholarship Council(China Scholarship Council)	This work was supported by Paul G. Allen Family Foundation (DP), URL: http://www.pgafamilyfoundation.org/, and China Scholarship Council (CL), Grant number: 201506310099, URL: http://en.csc.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], UNEP LARGE MARINE EC; Banobi JA, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00142.1; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Beverton R.J.H., 1957, FISHERY INVESTIGAT 2, VXIX; Bhathal B, 2008, FISH RES, V91, P26, DOI 10.1016/j.fishres.2007.10.022; Branch TA, 2016, FISH FISH, V17, P1094, DOI 10.1111/faf.12160; Branch TA, 2010, NATURE, V468, P431, DOI 10.1038/nature09528; Caddy J.F., 1998, SCIENCE, V282, p1383a, DOI 10.1126/science.282.5393.1383a; Cao L, 2015, SCIENCE, V347, P133, DOI 10.1126/science.1260149; Chassot E, 2008, J FISH BIOL, V73, P763, DOI 10.1111/j.1095-8649.2008.01938.x; Chinese State Council, 1979, STAT COUNC STAT APPR; Du Jianguo, 2014, Biodiversity Science, V22, P532, DOI 10.3724/SP.J.1003.2014.13200; FAO, 2014, YB 2012 FISH AQ STAT; Fisheries and Fishery Administration of the Ministry of Agriculture, 1979, CHINA FISHERY STAT Y; Garibaldi L, 2012, MAR POLICY, V36, P760, DOI 10.1016/j.marpol.2011.10.024; Gascuel D, 2016, FISH FISH, V17, P31, DOI 10.1111/faf.12090; GAUSE G. F., 1934, SCIENCE, V79, P16, DOI 10.1126/science.79.2036.16-a; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Huang Y., 1990, MODERN FISHERIES INF, V5, P13; Kleisner K, 2014, MAR ECOL PROG SER, V512, P185, DOI 10.3354/meps10949; Liang C, 2017, J APPL ICHTHYOLOGY; Lin Long-shan, 2008, Marine Fisheries, V30, P126; Milessi AC, 2005, FISH RES, V74, P223, DOI 10.1016/j.fishres.2005.02.002; Pang L., 2001, FISHERIES CTR RES RE, V9, P1; Parsons Timothy R., 1996, P352; Pauly D, 2005, B MAR SCI, V76, P197; Pauly D, 2005, PHILOS T ROY SOC B, V360, P415, DOI 10.1098/rstb.2004.1597; Pauly D, 2001, CAN J FISH AQUAT SCI, V58, P51, DOI 10.1139/cjfas-58-1-51; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2000, AM SCI, V88, P46; PAULY D, 1980, J CONSEIL, V39, P175; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pauly D, 1998, SCI AAAS WEEKLY PAPE, V282, P1516; Pauly D., 1986, 1 ASIAN FISHERIES FO, P491; Pauly D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10244; Pauly D, 2014, FISH FISH, V15, P474, DOI 10.1111/faf.12032; Stergiou K, 2000, FISHING MEDITERRANEA, V26, P30; Stergiou KI, 2001, REV FISH BIOL FISHER, V11, P217, DOI 10.1023/A:1020556722822; Stergiou KI, 2011, MAR ECOL PROG SER, V441, P295, DOI 10.3354/meps09377; Swartz W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015143; Valtysson Hthorn, 2003, COMPETITIVENESS GLOB, P12; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Watson RA, 2013, FISH RES, V140, P63, DOI 10.1016/j.fishres.2012.12.004; Wei Chen, 2006, FOSHAN CERAMICS, V16, P7; Zeller D, 2016, MAR POLICY, V70, P145, DOI 10.1016/j.marpol.2016.04.046	46	32	34	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173296	10.1371/journal.pone.0173296	http://dx.doi.org/10.1371/journal.pone.0173296			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267755	Green Published, gold, Green Submitted			2022-12-26	WOS:000396060600020
J	Mattei, G; Magliaro, C; Giusti, S; Ramachandran, SD; Heinz, S; Braspenning, J; Ahluwalia, A				Mattei, Giorgio; Magliaro, Chiara; Giusti, Serena; Ramachandran, Sarada Devi; Heinz, Stefan; Braspenning, Joris; Ahluwalia, Arti			On the adhesion-cohesion balance and oxygen consumption characteristics of liver organoids	PLOS ONE			English	Article							VISCOELASTIC CHARACTERIZATION; MECHANICAL-PROPERTIES; CELL-CULTURE; IN-VITRO; HEPATOCYTES; BIOREACTOR; SCAFFOLDS; SOFT	Liver organoids (LOs) are of interest in tissue replacement, hepatotoxicity and pathophysiological studies. However, it is still unclear what triggers LO self-assembly and what the optimal environment is for their culture. Hypothesizing that LO formation occurs as a result of a fine balance between cell-substrate adhesion and cell-cell cohesion, we used 3 cell types (hepatocytes, liver sinusoidal endothelial cells and mesenchymal stem cells) to investigate LO self-assembly on different substrates keeping the culture parameters (e.g. culture media, cell types/number) and substrate stiffness constant. As cellular spheroids may suffer from oxygen depletion in the core, we also sought to identify the optimal culture conditions for LOs in order to guarantee an adequate supply of oxygen during proliferation and differentiation. The oxygen consumption characteristics of LOs were measured using an O-2 sensor and used to model the O-2 concentration gradient in the organoids. We show that no LO formation occurs on highly adhesive hepatic extra-cellular matrix-based substrates, suggesting that cellular aggregation requires an optimal trade-off between the adhesiveness of a substrate and the cohesive forces between cells and that this balance is modulated by substrate mechanics. Thus, in addition to substrate stiffness, physicochemical properties, which are also critical for cell adhesion, play a role in LO self-assembly.	[Mattei, Giorgio; Magliaro, Chiara; Giusti, Serena; Ahluwalia, Arti] Univ Pisa, Res Ctr E Piaggio, Pisa, Italy; [Ramachandran, Sarada Devi; Heinz, Stefan] Medicyte GmbH, Heidelberg, Germany; [Braspenning, Joris] Univ Hosp Wuerzburg, Tissue Engn & Regenerat Med, Roentgering, Wuerzburg, Germany	University of Pisa; University of Wurzburg	Ahluwalia, A (corresponding author), Univ Pisa, Res Ctr E Piaggio, Pisa, Italy.	arti.ahluwalia@centropiaggio.unipi.it	Kostjuka, Milana/ABA-6395-2021	Mattei, Giorgio/0000-0003-0441-9653; Ahluwalia, Arti/0000-0001-5370-6750	European Union [304961]	European Union(European Commission)	The work leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement 304961 (ReLiver, http://cordis.europa.eu/project/rcn/104054_en.html). The funder provided support in the form of salaries for authors SDR, SH, JB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen JW, 2003, BIOTECHNOL BIOENG, V82, P253, DOI 10.1002/bit.10569; Burkard A, 2012, XENOBIOTICA, V42, P939, DOI 10.3109/00498254.2012.675093; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; FOY BD, 1994, CELL TRANSPLANT, V3, P515, DOI 10.1177/096368979400300609; FRISANCHO AR, 1975, SCIENCE, V187, P313, DOI 10.1126/science.1089311; Gentile P, 2012, J BIOMED MATER RES A, V100A, P2654, DOI 10.1002/jbm.a.34205; Giulitti S, 2013, LAB CHIP, V13, P4430, DOI 10.1039/c3lc50643f; Gonzalez R.C., 2010, DIGITAL IMAGE PROCES, V3rd ed.; Jelen C, 2013, MAT SCI ENG C-MATER, V33, P28, DOI 10.1016/j.msec.2012.07.046; Kane RJ, 2012, J MECH BEHAV BIOMED, V7, P41, DOI 10.1016/j.jmbbm.2011.09.010; Kutty MN, 1987, SITE SELECTION FOR A; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee JS, 2014, BIOMACROMOLECULES, V15, P206, DOI 10.1021/bm4015039; Lee MY, 2006, AM J PHYSIOL-GASTR L, V291, pG744, DOI 10.1152/ajpgi.00551.2005; Leturque A, 2005, J PHYSIOL BIOCHEM, V61, P529, DOI 10.1007/BF03168378; Lu YH, 2012, BIOTECHNOL BIOENG, V109, P595, DOI 10.1002/bit.23349; Maes M, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00405; Mattei G, 2015, J MECH BEHAV BIOMED, V50, P150, DOI 10.1016/j.jmbbm.2015.06.015; Mattei G, 2014, J BIOMECH, V47, P2641, DOI 10.1016/j.jbiomech.2014.05.017; Mattei G, 2014, ACTA BIOMATER, V10, P875, DOI 10.1016/j.actbio.2013.10.023; Mattei G, 2016, ACTA BIOMATER, V45, P60, DOI 10.1016/j.actbio.2016.08.055; Mattei G, 2014, PROCESSES, V2, P548, DOI 10.3390/pr2030548; Mattei G, 2015, SCI REP-UK, V5, DOI 10.1038/srep10778; Mazzei D, 2010, BIOTECHNOL BIOENG, V106, P127, DOI 10.1002/bit.22671; Normand V, 2000, BIOMACROMOLECULES, V1, P730, DOI 10.1021/bm005583j; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pinkse GGM, 2004, LIVER INT, V24, P218, DOI 10.1111/j.1478-3231.2004.0914.x; Ramachandran SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139345; Regehr KJ, 2009, LAB CHIP, V9, P2132, DOI 10.1039/b903043c; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Smith I, 2015, NEUROSCI LETT, V609, P198, DOI 10.1016/j.neulet.2015.10.044; Smith MK, 2007, J BIOMED MATER RES A, V80A, P520, DOI 10.1002/jbm.a.30930; Soares CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038147; Speicher T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4862; Takebe T, 2015, CELL STEM CELL, V16, P556, DOI 10.1016/j.stem.2015.03.004; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Tan GDS, 2013, BIOTECHNOL BIOENG, V110, P1663, DOI 10.1002/bit.24822; Tirella A, 2014, J BIOMED MATER RES A, V102, P3352, DOI 10.1002/jbm.a.34914; Wen YA, 2009, TOXICOL IN VITRO, V23, P744, DOI 10.1016/j.tiv.2009.02.009; Zawada RJX, 2009, BIOCHEM CELL BIOL, V87, P541, DOI [10.1139/O09-011, 10.1139/o09-011]	40	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173206	10.1371/journal.pone.0173206	http://dx.doi.org/10.1371/journal.pone.0173206			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267799	Green Published, Green Submitted, gold			2022-12-26	WOS:000396060600014
J	Trudell, AS; Tuuli, MG; Colditz, GA; Macones, GA; Odibo, AO				Trudell, Amanda S.; Tuuli, Methodius G.; Colditz, Graham A.; Macones, George A.; Odibo, Anthony O.			A stillbirth calculator: Development and internal validation of a clinical prediction model to quantify stillbirth risk	PLOS ONE			English	Article							UTERINE ARTERY DOPPLER; BREAST-CANCER; INFANT-DEATH; PREGNANCY; INDEX; AGE	Objective To generate a clinical prediction tool for stillbirth that combines maternal risk factors to provide an evidence based approach for the identification of women who will benefit most from antenatal testing for stillbirth prevention. Design Retrospective cohort study Setting Midwestern United States quaternary referral center Population Singleton pregnancies undergoing second trimester anatomic survey from 1999-2009. Pregnancies with incomplete follow-up were excluded. Methods Candidate predictors were identified from the literature and univariate analysis. Backward stepwise logistic regression with statistical comparison of model discrimination, calibration and clinical performance was used to generate final models for the prediction of stillbirth. Internal validation was performed using bootstrapping with 1,000 repetitions. A stillbirth risk calculator and stillbirth risk score were developed for the prediction of stillbirth at or beyond 32 weeks excluding fetal anomalies and aneuploidy. Statistical and clinical cut-points were identified and the tools compared using the Integrated Discrimination Improvement. Main outcome measures Antepartum stillbirth Results 64,173 women met inclusion criteria. The final stillbirth risk calculator and score included maternal age, black race, nulliparity, body mass index, smoking, chronic hypertension and pre-gestational diabetes. The stillbirth calculator and simple risk score demonstrated modest discrimination but clinically significant performance with no difference in overall performance between the tools [(AUC 0.66 95% CI 0.60-0.72) and (AUC 0.64 95% CI 0.58-0.70), (p = 0.25)]. Conclusion A stillbirth risk score was developed incorporating maternal risk factors easily ascertained during prenatal care to determine an individual woman's risk for stillbirth and provide an evidenced based approach to the initiation of antenatal testing for the prediction and prevention of stillbirth.	[Trudell, Amanda S.] Mercy Hosp St Louis, Dept Obstet & Gynecol, Midwest Maternal Fetal Med, St Louis, MO USA; [Tuuli, Methodius G.; Macones, George A.] Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, St Louis, MO 63110 USA; [Colditz, Graham A.] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth, St Louis, MO 63110 USA; [Odibo, Anthony O.] Univ S Florida, Moorsani Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Tampa, FL USA	Saint Johns Mercy Medical Center; Washington University (WUSTL); Washington University (WUSTL); State University System of Florida; University of South Florida	Trudell, AS (corresponding author), Mercy Hosp St Louis, Dept Obstet & Gynecol, Midwest Maternal Fetal Med, St Louis, MO USA.	dr.atrudell@gmail.com	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NIH [2T32HD055172-06]; Washington University Institute of Clinical and Translational Sciences Grant [UL1TR000448]; Foundation from Barnes-Jewish Hospital, St Louis	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Institute of Clinical and Translational Sciences Grant; Foundation from Barnes-Jewish Hospital, St Louis	At the time of this work Dr. Trudell was supported by NIH T32 Grant #2T32HD055172-06 (PI G. Macones) and by Washington University Institute of Clinical and Translational Sciences Grant #UL1TR000448 (PI B. Evanoff). G Colditz is supported by the Foundation from Barnes-Jewish Hospital, St Louis.	Akolekar R, 2016, ULTRASOUND OBSTET GY; [Anonymous], 2014, Obstet Gynecol, V124, P182, DOI 10.1097/01.AOG.0000451759.90082.7b; Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; FREEMAN RK, 1982, AM J OBSTET GYNECOL, V143, P771, DOI 10.1016/0002-9378(82)90008-4; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Goldenberg RL, 2011, LANCET, V377, P1798, DOI 10.1016/S0140-6736(10)62235-0; Liu XH, 2012, STAT MED, V31, P2676, DOI 10.1002/sim.4509; Odibo AO, 2011, J MATERN-FETAL NEO M, V24, P411, DOI 10.3109/14767058.2010.506566; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Poon LCY, 2013, FETAL DIAGN THER, V33, P28, DOI 10.1159/000342109; Reddy UM, 2006, AM J OBSTET GYNECOL, V195, P764, DOI 10.1016/j.ajog.2006.06.019; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; Rosenstein MG, 2012, OBSTET GYNECOL, V120, P76, DOI 10.1097/AOG.0b013e31825bd286; Singh T, 2012, OBSTET GYNECOL, V119, P256, DOI 10.1097/AOG.0b013e318242ad81; Smith GCS, 2007, OBSTET GYNECOL, V109, P144, DOI 10.1097/01.AOG.0000248536.94919.e3; Trudell AS, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.04.021; Yao RF, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.044; Yerlikaya G, 2016, ULTRASOUND OBST GYN, V48, P607, DOI 10.1002/uog.17290; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	26	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173461	10.1371/journal.pone.0173461	http://dx.doi.org/10.1371/journal.pone.0173461			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267756	gold, Green Published, Green Submitted			2022-12-26	WOS:000396060600033
J	Chicote, JU; DeSalle, R; Garcia-Espana, A				Chicote, Javier U.; DeSalle, Rob; Garcia-Espana, Antonio			Phosphotyrosine phosphatase R3 receptors: Origin, evolution and structural diversification	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; DOMAIN; IDENTIFICATION; REGULATORS; GENES; PTPRQ	Subtype R3 phosphotyrosine phosphatase receptors (R3 RPTPs) are single-spanning membrane proteins characterized by a unique modular composition of extracellular fibronectin repeats and a single cytoplasmatic protein tyrosine phosphatase (PTP) domain. Vertebrate R3 RPTPs consist of five members: PTPRB, PTPRJ, PTPRH and PTPRO, which dephosphorylate tyrosine residues, and PTPRQ, which dephosphorylates phophoinositides. R3 RPTPs are considered novel therapeutic targets in several pathologies such as ear diseases, nephrotic syndromes and cancer. R3 RPTP vertebrate receptors, as well as their known invertebrate counterparts from animal models: PTP52F, PTP10D and PTP4e from the fruitfly Drosophila melanogaster and F44G4.8/DEP-1 from the nematode Caenorhabditis elegans, participate in the regulation of cellular activities including cell growth and differentiation. Despite sharing structural and functional properties, the evolutionary relationships between vertebrate and invertebrate R3 RPTPs are not fully understood. Here we gathered R3 RPTPs from organisms covering a broad evolutionary distance, annotated their structure and analyzed their phylogenetic relationships. We show that R3 RPTPs (i) have probably originated in the common ancestor of animals (metazoans), (ii) are variants of a single ancestral gene in protostomes (arthropods, annelids and nematodes); (iii) a likely duplication of this ancestral gene in invertebrate deuterostomes (echinodermes, hemichordates and tunicates) generated the precursors of PTPRQ and PTPRB genes, and (iv) R3 RPTP groups are monophyletic in vertebrates and have specific conserved structural characteristics. These findings could have implications for the interpretation of past studies and provide a framework for future studies and functional analysis of this important family of proteins.	[Chicote, Javier U.; Garcia-Espana, Antonio] Univ Rovira & Virgili, Hosp Univ Tarragona Joan 23, Inst Invest Saniaria Pere Virgili, Tarragona, Spain; [DeSalle, Rob] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA	Universitat Rovira i Virgili; American Museum of Natural History (AMNH)	Garcia-Espana, A (corresponding author), Univ Rovira & Virgili, Hosp Univ Tarragona Joan 23, Inst Invest Saniaria Pere Virgili, Tarragona, Spain.	antonio.garciaespana@urv.cat	garcia-espana, antonio/I-4756-2015	garcia-espana, antonio/0000-0002-9957-3161; UGARTE CHICOTE, JAVIER/0000-0001-6771-8584	Spanish MINECO; European Regional Development Fund (ERDF) grant CONSOLIDER INGENIO [CSD00065]; Sackler Institute for Comparative Genomics; Korein Foundation; Lewis and Dorothy Cullman Program in Molecular Systematics	Spanish MINECO(Spanish Government); European Regional Development Fund (ERDF) grant CONSOLIDER INGENIO; Sackler Institute for Comparative Genomics; Korein Foundation; Lewis and Dorothy Cullman Program in Molecular Systematics	This work was supported by Spanish MINECO and the European Regional Development Fund (ERDF) grant CONSOLIDER INGENIO 2010 CSD00065 (A.G.E), and the Sackler Institute for Comparative Genomics, the Korein Foundation and the Lewis and Dorothy Cullman Program in Molecular Systematics (R.D.).	Agosti D, 1996, CLADISTICS, V12, P65; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2005, METHODS, V35, P90, DOI 10.1016/j.ymeth.2004.07.012; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Behjati S, 2014, NAT GENET, V46, P376, DOI 10.1038/ng.2921; Berset TA, 2005, GENE DEV, V19, P1328, DOI 10.1101/gad.333505; Bohmer F, 2013, FEBS J, V280, P413, DOI 10.1111/j.1742-4658.2012.08655.x; BRADYKALNAY SM, 1995, CURR OPIN CELL BIOL, V7, P650, DOI 10.1016/0955-0674(95)80106-5; Byrum CA, 2006, DEV BIOL, V300, P194, DOI 10.1016/j.ydbio.2006.08.050; Camp E, 2009, STEM CELLS, V27, P2081, DOI 10.1002/stem.133; Chicote J U, 2017, PLOS ONE FORTHCOMING; DeSalle R., 2015, J PHYLOGENET EVOL BI, V3, pE116; DeSalle R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-13; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; Garcia-Espana A, 2006, MOL PHYLOGENET EVOL, V41, P355, DOI 10.1016/j.ympev.2006.04.023; Garcia-Espana A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004680; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Hedges BS, 2009, TIMETREE LIFE; Hendriks WJAJ, 2013, BBA-MOL BASIS DIS, V1832, P1673, DOI 10.1016/j.bbadis.2013.05.022; Hendriks WJAJ, 2013, FEBS J, V280, P708, DOI 10.1111/febs.12000; HUELSENBECK J, 2005, MRBAYES VERSION 3 1; Jeon M, 2015, SEMIN CELL DEV BIOL, V37, P119, DOI 10.1016/j.semcdb.2014.09.005; Jeon M, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-3; Jin J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000546; Kaessmann H, 2002, GENOME RES, V12, P1642, DOI 10.1101/gr.520702; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Logsdon JM, 2004, P NATL ACAD SCI USA, V101, P11195, DOI 10.1073/pnas.0404148101; Manning G, 2008, P NATL ACAD SCI USA, V105, P9674, DOI 10.1073/pnas.0801314105; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Matozaki T, 2010, CELL SIGNAL, V22, P1811, DOI 10.1016/j.cellsig.2010.07.001; Moorhead GBG, 2009, BIOCHEM J, V417, P401, DOI 10.1042/BJ20081986; Ono K, 1999, J MOL EVOL, V48, P654, DOI 10.1007/PL00006509; Ono-Koyanagi K, 2000, J MOL EVOL, V50, P302, DOI 10.1007/s002399910035; Pincus D, 2008, P NATL ACAD SCI USA, V105, P9680, DOI 10.1073/pnas.0803161105; Pulido R, 2013, HUM MOL GENET, V22, pR66, DOI 10.1093/hmg/ddt347; Santhanam A, 2013, FEBS J, V280, P476, DOI 10.1111/j.1742-4658.2012.08696.x; Seifert RA, 2003, EXP CELL RES, V287, P374, DOI 10.1016/S0014-4827(03)00121-6; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Suga H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3325; Swofford D.L., 1989, PAUP PHYLOGENETIC AN; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; van Eekelen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012573; Wheeler WC, 1995, MOL PHYLOGENET EVOL, V4, P1, DOI 10.1006/mpev.1995.1001; Yu KR, 2013, ACTA CRYSTALLOGR D, V69, P1522, DOI 10.1107/S0907444913010457	47	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172887	10.1371/journal.pone.0172887	http://dx.doi.org/10.1371/journal.pone.0172887			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257417	Green Published, gold, Green Submitted			2022-12-26	WOS:000396021100036
J	Hequet, D; Rouzier, R				Hequet, Delphine; Rouzier, Roman			Determinants of geographic inequalities in HPV vaccination in the most populated region of France	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; YOUNG-ADULT WOMEN; UNITED-STATES; LOW-INCOME; CERVICAL ABNORMALITIES; GENERAL-PRACTITIONERS; ADOLESCENT GIRLS; NATIONAL-HEALTH; CARE PROVIDERS; REDUCTION	Background In France, there are recommendations and reimbursements for human papillomavirus (HPV) vaccination but no HPV vaccination programs. Therefore, vaccination is largely determined by parents' initiative, which can lead to inequalities. The objective of this study was to determine the factors associated with poorer vaccination coverage rates in the most populated region of France. Methods The data of this study were obtained from the National Health Insurance between 2011 and 2013. Correlations between vaccination initiation rate (at least 1 dose reimbursed) and socio-demographic/cultural factors were assessed using Pearson's product-moment correlation coefficient. Multivariate analyses were performed using logistic regression. Results In total, 121,636 girls received at least one HPV vaccine dose. The vaccination rate for girls born from 1996 to 1999 was 18.7%. Disparities in vaccination coverage rates were observed between the 8 departments of the region, ranging from 12.9% to 22.6%. At the department level, unemployment, proportion of immigrants and foreigners, and coverage by CMU health insurance ("Couverture Maladie Universelle", a health insurance plan for those who are not otherwise covered through business or employment and who have a low income) were significantly inversely correlated with vaccination rates, whereas urban residence, medical density, income and use of medical services were not related to coverage. In the multivariate model, only the percentage of foreigners remained independently associated with lower vaccination coverage. At the individual level, the use of medical services was a strong driver of HPV vaccination initiation. Conclusion We observed geographic disparities in HPV vaccination initiation coverage. Even if no clear factor was identified as a vaccination determinant, we observed a failure of vaccination only based on parents' initiative. Therefore, an organized policy on HPV vaccination, such as school-based programs, can help improve coverage rates.	[Hequet, Delphine; Rouzier, Roman] Inst Curie Rene Huguenin, Dept Surg, 35 Rue Dailly, St Cloud, France; [Hequet, Delphine; Rouzier, Roman] Univ Versailles St Quentin, Equipe Accueil Risk & Safety Clin Med Women & Per, 2 Ave Source Bievre, Montigny Le Bretonneux, France	Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Saclay	Hequet, D (corresponding author), Inst Curie Rene Huguenin, Dept Surg, 35 Rue Dailly, St Cloud, France.; Hequet, D (corresponding author), Univ Versailles St Quentin, Equipe Accueil Risk & Safety Clin Med Women & Per, 2 Ave Source Bievre, Montigny Le Bretonneux, France.	delphine.hequet@gmail.com	; Rouzier, Roman/G-2953-2018	Hequet, Delphine/0000-0001-8926-5651; Rouzier, Roman/0000-0002-8167-6808	Institut National Du Cancer: PAIR_GYNECOLOGIE	Institut National Du Cancer: PAIR_GYNECOLOGIE	This work was funded by Institut National Du Cancer: PAIR_2012 GYNECOLOGIE to Roman Rouzier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSM, 2015, VACC ANT HPV RISQ MA; Bagcchi S, 2015, LANCET ONCOL, V16, pE111, DOI 10.1016/S1470-2045(15)70068-9; Blake KD, 2015, AM J PREV MED, V48, P402, DOI 10.1016/j.amepre.2014.10.024; Bruno DM, 2014, VACCINE, V32, P4149, DOI 10.1016/j.vaccine.2014.05.058; Bynum SA, 2014, J ADOLESCENT HEALTH, V54, P190, DOI 10.1016/j.jadohealth.2013.08.006; Collange F, 2016, VACCINE, V34, P762, DOI 10.1016/j.vaccine.2015.12.054; Conseil National de lOrdre des Me A decins, DEM MED REG IL DE FR; Crowe E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1458; Cummings T, 2012, VACCINE, V30, P5496, DOI 10.1016/j.vaccine.2012.06.057; Fisher H, 2013, INT J EPIDEMIOL, V42, P896, DOI 10.1093/ije/dyt049; Fowler B, 2016, J COMMUN HEALTH, V41, P825, DOI 10.1007/s10900-016-0160-3; Gelman A, 2013, J ADOLESCENT HEALTH, V53, P756, DOI 10.1016/j.jadohealth.2013.07.002; Gertig DM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-227; Haut Conseil de la sante publique, 2014, AV REL UT VACC INF P; Henry KA, 2016, CANCER EPIDEM BIOMAR, V25, P309, DOI 10.1158/1055-9965.EPI-15-0658; Institut de Veille Sanitaire, DOSS THEM VACC HPV 2; Institut National de la Statistique et des Etudes Economiques (INSEE), REV SAL NET ANN MOYE; Institut National de la Statistique et des Etudes Economiques (INSEE), POP IMM SEL PRINC PA; Institut National de la Statistique et des Etudes Economiques (INSEE), POP PRINC NAT 2013 C; Institut National de la Statistique et des Etudes Economiques (INSEE), TAUX CHOM LOC COMP R; Joseph NP, 2014, J PEDIATR ADOL GYNEC, V27, P83, DOI 10.1016/j.jpag.2013.08.011; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Lefevere E, 2015, VACCINE, V33, P5188, DOI 10.1016/j.vaccine.2015.07.088; Markowitz LE, 2013, J INFECT DIS, V208, P385, DOI 10.1093/infdis/jit192; Mesher D, 2013, VACCINE, V32, P26, DOI 10.1016/j.vaccine.2013.10.085; Musto R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-640; Poole T, 2012, VACCINE, V31, P84, DOI 10.1016/j.vaccine.2012.10.099; R Core Team, 2012, R LANG ENV STAT COMP; Schmidt S, 2014, AM J PUBLIC HEALTH, V104, P946, DOI 10.2105/AJPH.2013.301828; Schreiber SMS, 2015, J ADOLESCENT HEALTH, V56, P402, DOI 10.1016/j.jadohealth.2014.12.008; Smith PJ, 2016, VACCINE, V34, P1604, DOI 10.1016/j.vaccine.2016.01.061; Tanday S, 2015, LANCET ONCOL, V16, pE57, DOI 10.1016/S1470-2045(14)71194-5; Verger P, 2015, EBIOMEDICINE, V2, P891, DOI 10.1016/j.ebiom.2015.06.018; Wang W, 2015, VACCINE, V33, P2570, DOI 10.1016/j.vaccine.2015.04.010; Wei FF, 2013, AM J PREV MED, V44, P154, DOI 10.1016/j.amepre.2012.09.061	35	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172906	10.1371/journal.pone.0172906	http://dx.doi.org/10.1371/journal.pone.0172906			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257434	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100041
J	Corleis, B; Lisanti, AC; Korner, C; Schiff, AE; Rosenberg, ES; Allen, TM; Altfeld, M; Kwon, DS				Corleis, Bjorn; Lisanti, Antonella C.; Koerner, Christian; Schiff, Abigail E.; Rosenberg, Eric S.; Allen, Todd M.; Altfeld, Marcus; Kwon, Douglas S.			Early type I Interferon response induces upregulation of human beta-defensin 1 during acute HIV-1 infection	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; TOLL-LIKE RECEPTOR-3; ANTIMICROBIAL PEPTIDES; INNATE IMMUNITY; EPITHELIAL-CELLS; HUMAN BETA-DEFENSIN-3; HOST-DEFENSE; INHIBIT HIV; T-CELLS; EXPRESSION	HIV-1 is able to evade innate antiviral responses during acute infection to establish a chronic systemic infection which, in the absence of antiretroviral therapy (ART), typically progresses to severe immunodeficiency. Understanding these early innate immune responses against HIV-1 and their mechanisms of failure is relevant to the development of interventions to better prevent HIV-1 transmission. Human beta defensins (HBDs) are antibacterial peptides but have recently also been associated with control of viral replication. HBD1 and 2 are expressed in PBMCs as well as intestinal tissue, but their expression in vivo during HIV-1 infection has not been characterized. We demonstrate that during acute HIV-1 infection, HBD1 but not HBD2 is highly upregulated in circulating monocytes but returns to baseline levels during chronic infection. HBD1 expression in monocytes can be induced by HIV-1 in vitro, although direct infection may not entirely account for the increase in HBD1 during acute infection. We provide evidence that HIV-1 triggers antiviral IFN-alpha responses, which act as a potent inducer of HBD1. Our results show the first characterization of induction of an HBD during acute and chronic viral infection in humans. HBD1 has been reported to have low activity against HIV-1 compared to other defensins, suggesting that in vivo induced defensins may not significantly contribute to the robust early antiviral response against HIV1. These data provide important insight into the in vivo kinetics of HBD expression, the mechanism of HBD1 induction by HIV-1, and the role of HBDs in the early innate response to HIV-1 during acute infection.	[Corleis, Bjorn; Lisanti, Antonella C.; Koerner, Christian; Schiff, Abigail E.; Allen, Todd M.; Altfeld, Marcus; Kwon, Douglas S.] Harvard Med Sch, Massachusetts Gen Hosp, Ragon Inst MGH MIT & Harvard, Boston, MA 02115 USA; [Rosenberg, Eric S.; Kwon, Douglas S.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Koerner, Christian] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts General Hospital; Heinrich Pette Institute	Kwon, DS (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ragon Inst MGH MIT & Harvard, Boston, MA 02115 USA.; Kwon, DS (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	dkwon@mgh.harvard.edu	Körner, Christian/ABB-8335-2020; Altfeld, Marcus/AAE-7306-2019; Allen, Todd/F-5473-2011	Körner, Christian/0000-0002-3431-7319; Altfeld, Marcus/0000-0001-5972-2997; Allen, Todd/0000-0002-6609-1318	National Institute of Allergy and Infectious Disease [P01 AI074415, R01DK101354]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part with federal funds from the National Institute of Allergy and Infectious Disease through P01 AI074415 (TMA and MA) and R01DK101354 (DSK). DSK is funded by an award from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alp S, 2005, EUR J MED RES, V10, P1; Annicotte JS, 2005, ONCOGENE, V24, P8167, DOI 10.1038/sj.onc.1208950; Berg RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029291; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Book M, 2007, CRIT CARE, V11, DOI 10.1186/cc5694; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Braida L, 2004, AIDS, V18, P1598, DOI 10.1097/01.aids.0000131363.82951.fb; Brenchley JM, 2008, CURR OPIN HIV AIDS, V3, P356, DOI 10.1097/COH.0b013e3282f9ae9c; Caballero S, 2015, ANNU REV IMMUNOL, V33, P227, DOI 10.1146/annurev-immunol-032713-120238; Campbell JH., 2014, AIDS; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Cederlund A, 2011, FEBS J, V278, P3942, DOI 10.1111/j.1742-4658.2011.08302.x; David RYS, 2016, ELIFE, V5, DOI 10.7554/eLife.11275; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Drewes JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094375; Duits LA, 2002, IMMUNOLOGY, V106, P517, DOI 10.1046/j.1365-2567.2002.01430.x; Estrada-Aguirre JA, 2014, CURR HIV RES, V12, P220, DOI 10.2174/1570162X12666140708102722; Fang XM, 2003, EUR J CLIN INVEST, V33, P82, DOI 10.1046/j.1365-2362.2003.01076.x; Feng Z, 2006, J IMMUNOL, V177, P782, DOI 10.4049/jimmunol.177.2.782; Feng ZM, 2013, FEBS J, V280, P3365, DOI 10.1111/febs.12328; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Ganz T, 2003, INTEGR COMP BIOL, V43, P300, DOI 10.1093/icb/43.2.300; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Garraud Olivier, 2010, Inflammation & Allergy Drug Targets, V9, P322; Gomez AM, 2015, J IMMUNOL, V194, P2300, DOI 10.4049/jimmunol.1402147; Gootenberg DB, 2017, CURR OPIN INFECT DIS, V30, P31, DOI 10.1097/QCO.0000000000000341; Gordon SN, 2010, J IMMUNOL, V185, P5169, DOI 10.4049/jimmunol.1001801; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Hazlett L, 2011, CELL TISSUE RES, V343, P175, DOI 10.1007/s00441-010-1022-4; Iwasaki A, 2012, ANNU REV MICROBIOL, V66, P177, DOI 10.1146/annurev-micro-092611-150203; Jarczak J, 2013, HUM IMMUNOL, V74, P1069, DOI 10.1016/j.humimm.2013.05.008; Kelly CJ, 2013, MUCOSAL IMMUNOL, V6, P1110, DOI 10.1038/mi.2013.6; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Kraemer BF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002355; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lafferty MK, 2010, BLOOD, V115, P1564, DOI 10.1182/blood-2009-06-226423; Lehner T, 2011, Adv Dent Res, V23, P19, DOI 10.1177/0022034511399081; Mangan NE, 2012, IMMUNOL CELL BIOL, V90, P510, DOI 10.1038/icb.2012.13; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Meisch JP, 2013, INFLAMM BOWEL DIS, V19, P942, DOI 10.1097/MIB.0b013e318280b11a; Milanese M, 2006, AIDS, V20, P1673, DOI 10.1097/01.aids.0000238417.05819.40; Mukherjee S, 2015, IMMUNITY, V42, P28, DOI 10.1016/j.immuni.2014.12.028; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; NAKASHIMA H, 1993, AIDS, V7, P1129, DOI 10.1097/00002030-199308000-00019; Nakatsuji T, 2012, J INVEST DERMATOL, V132, P887, DOI 10.1038/jid.2011.387; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Reinwald S, 2008, J IMMUNOL, V180, P5890, DOI 10.4049/jimmunol.180.9.5890; Ricci E, 2009, JAIDS-J ACQ IMM DEF, V51, P13, DOI 10.1097/QAI.0b013e31819df249; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Ryan LK, 2011, J LEUKOCYTE BIOL, V90, P343, DOI 10.1189/jlb.0209079; Scagnolari C, 2016, IMMUNOBIOLOGY, V221, P282, DOI 10.1016/j.imbio.2015.10.007; Seidel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009737; Sherman H, 2008, MOL IMMUNOL, V45, P3163, DOI 10.1016/j.molimm.2008.03.004; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Sun LL, 2005, J VIROL, V79, P14318, DOI 10.1128/JVI.79.22.14318-14329.2005; Tomescu C, 2007, J IMMUNOL, V179, P2097, DOI 10.4049/jimmunol.179.4.2097; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Wang YZ, 2013, J LEUKOCYTE BIOL, V94, P337, DOI 10.1189/jlb.0313158; Weinberg A, 2006, Adv Dent Res, V19, P42; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Wilson SS, 2013, J MOL BIOL, V425, P4965, DOI 10.1016/j.jmb.2013.09.038; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Zahoor MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106418; Zhou Y, 2010, IMMUNOLOGY, V131, P40, DOI 10.1111/j.1365-2567.2010.03270.x; Zilbauer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015389	72	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173161	10.1371/journal.pone.0173161	http://dx.doi.org/10.1371/journal.pone.0173161			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253319	Green Published, gold, Green Submitted			2022-12-26	WOS:000396011300085
J	Kather, JN; Zollner, FG; Schad, LR; Melchers, SM; Sinn, HP; Marx, A; Gaiser, T; Weis, CA				Kather, Jakob Nikolas; Zoellner, Frank Gerrit; Schad, Lothar R.; Melchers, Susanne Maria; Sinn, Hans-Peter; Marx, Alexander; Gaiser, Timo; Weis, Cleo-Aron			Identification of a characteristic vascular belt zone in human colorectal cancer	PLOS ONE			English	Article							INTRATUMOR HETEROGENEITY; TUMOR MICROENVIRONMENT; MICROVESSEL DENSITY; MAGNETIC-RESONANCE; SOLID TUMORS; ANGIOGENESIS; MODEL; QUANTIFICATION; METAANALYSIS; INTERFACE	Blood vessels in cancer Intra-tumoral blood vessels are of supreme importance for tumor growth, metastasis and therapy. Yet, little is known about spatial distribution patterns of these vessels. Most experimental or theoretical tumor models implicitly assume that blood vessels are equally abundant in different parts of the tumor, which has far-reaching implications for chemotherapy and tumor metabolism. In contrast, based on histological observations, we hypothesized that blood vessels follow specific spatial distribution patterns in colorectal cancer tissue. We developed and applied a novel computational approach to identify spatial patterns of angiogenesis in histological whole-slide images of human colorectal cancer. A characteristic spatial pattern of blood vessels in colorectal cancer In 33 of 34 (97%) colorectal cancer primary tumors blood vessels were significantly aggregated in a sharply limited belt-like zone at the interface of tumor tissue to the intestinal lumen. In contrast, in 11 of 11 (100%) colorectal cancer liver metastases, a similar hypervascularized zone could be found at the boundary to surrounding liver tissue. Also, in an independent validation cohort, we found this vascular belt zone: 22 of 23 (96%) samples of primary tumors and 15 of 16 (94%) samples of liver metastases exhibited the above-mentioned spatial distribution. Summary and implications We report consistent spatial patterns of tumor vascularization that may have far-reaching implications for models of drug distribution, tumor metabolism and tumor growth: luminal hypervascularization in colorectal cancer primary tumors is a previously overlooked feature of cancer tissue. In colorectal cancer liver metastases, we describe a corresponding pattern at the invasive margin. These findings add another puzzle piece to the complex concept of tumor heterogeneity.	[Kather, Jakob Nikolas] Heidelberg Univ, Univ Heidelberg Hosp, Dept Med Oncol & Internal Med 6, Natl Ctr Tumor Dis, Heidelberg, Germany; [Kather, Jakob Nikolas; Marx, Alexander; Gaiser, Timo; Weis, Cleo-Aron] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, Mannheim, Germany; [Kather, Jakob Nikolas; Zoellner, Frank Gerrit; Schad, Lothar R.] Heidelberg Univ, Med Fac Mannheim, Inst Comp Assisted Clin Med, Mannheim, Germany; [Melchers, Susanne Maria] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, Mannheim, Germany; [Sinn, Hans-Peter] Heidelberg Univ, Univ Heidelberg Hosp, Dept Pathol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Kather, JN (corresponding author), Heidelberg Univ, Univ Heidelberg Hosp, Dept Med Oncol & Internal Med 6, Natl Ctr Tumor Dis, Heidelberg, Germany.; Kather, JN (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, Mannheim, Germany.; Kather, JN (corresponding author), Heidelberg Univ, Med Fac Mannheim, Inst Comp Assisted Clin Med, Mannheim, Germany.	jakob.kather@nct-heidelberg.de	Weis, Cleo-Aron/GVT-8400-2022; Sinn, Hans-Peter/C-5661-2008; Zöllner, Frank G/A-2725-2012; Kather, Jakob Nikolas/D-4279-2015	Sinn, Hans-Peter/0000-0003-2836-6699; Zöllner, Frank G/0000-0003-3405-1394; Kather, Jakob Nikolas/0000-0002-3730-5348	Studienstiftung des Deutschen Volkes	Studienstiftung des Deutschen Volkes	JNK received financial support from Studienstiftung des Deutschen Volkes (no grant number, http://www.studienstiftung.de/en/). The other authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsat C, 2011, ISRN Obstet Gynecol, V2011, P354861, DOI 10.5402/2011/354861; Bender JL, 2013, J MED INTERNET RES, V15; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Botev ZI, 2010, ANN STAT, V38, P2916, DOI 10.1214/10-AOS799; Brannon-Peppas L, 2012, ADV DRUG DELIVER REV, V64, P206, DOI 10.1016/j.addr.2012.09.033; Burns MB, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0177-8; Caie PD, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-156; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Des Guetz G, 2006, BRIT J CANCER, V94, P1823, DOI 10.1038/sj.bjc.6603176; Domsch S, 2014, Z MED PHYS, V24, P231, DOI 10.1016/j.zemedi.2014.03.009; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Ekdawi SN, 2015, J CONTROL RELEASE, V207, P101, DOI 10.1016/j.jconrel.2015.04.006; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ghaznavi F, 2013, ANNU REV PATHOL-MECH, V8, P331, DOI 10.1146/annurev-pathol-011811-120902; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; Halama N, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24116; Halama N, 2011, CANCER RES, V71, P5670, DOI 10.1158/0008-5472.CAN-11-0268; Heindl A, 2015, LAB INVEST, V95, P377, DOI 10.1038/labinvest.2014.155; Jayasinghe C, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1013-7; Kachlik D, 2010, J ANAT, V216, P335, DOI 10.1111/j.1469-7580.2009.01199.x; Kather JN, 2015, ONCOTARGET, V6, P19163, DOI 10.18632/oncotarget.4383; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Nguyen L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-522; Muralidharan Vijayaragavan, 2014, HPB Surg, V2014, P954604, DOI 10.1155/2014/954604; Ostergaard L, 2013, CANCER RES, V73, P5618, DOI 10.1158/0008-5472.CAN-13-0964; Peddareddigari VG, 2010, CANCER MICROENVIRON, V3, P149, DOI 10.1007/s12307-010-0038-3; Pina Y, 2009, OPHTHALMIC RES, V41, P160, DOI 10.1159/000209670; Primeau AJ, 2005, CLIN CANCER RES, V11, P8782, DOI 10.1158/1078-0432.CCR-05-1664; Raman V, 2006, CANCER RES, V66, P9929, DOI 10.1158/0008-5472.CAN-06-0886; Righi A, 2015, HISTOPATHOLOGY, V66, P982, DOI 10.1111/his.12602; Rijken PFJW, 2000, INT J RADIAT ONCOL, V48, P571, DOI 10.1016/S0360-3016(00)00686-6; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; SCHAD LR, 1993, MAGN RESON IMAGING, V11, P889, DOI 10.1016/0730-725X(93)90206-S; Stahl PR, 2015, PATHOL ONCOL RES; Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819; Tozer GM, 2003, BRIT J RADIOL, V76, pS23, DOI 10.1259/bjr/30165281; Vermeulen PB, 2002, EUR J CANCER, V38, P1564, DOI 10.1016/S0959-8049(02)00094-1; Waclaw B, 2015, NATURE, V525, P261, DOI 10.1038/nature14971; Wainwright J, 2005, ENV MODELLING FINDIN; Welsch U, 2010, ROMEIS MIKROSKOPISCH; YEN JC, 1995, IEEE T IMAGE PROCESS, V4, P370, DOI 10.1109/83.366472; Yuan Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005298; Zlobec I, 2009, WORLD J GASTROENTERO, V15, P5898, DOI 10.3748/wjg.15.5898	45	9	9	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0171378	10.1371/journal.pone.0171378	http://dx.doi.org/10.1371/journal.pone.0171378			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253263	gold, Green Published			2022-12-26	WOS:000396011300005
J	Caminer, MA; Mila, B; Jansen, M; Fouquet, A; Venegas, PJ; Chavez, G; Lougheed, SC; Ron, SR				Caminer, Marcel A.; Mila, Borja; Jansen, Martin; Fouquet, Antoine; Venegas, Pablo J.; Chavez, German; Lougheed, Stephen C.; Ron, Santiago R.			Systematics of the Dendropsophus leucophyllatus species complex (Anura: Hylidae): Cryptic diversity and the description of two new species	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENY; FROGS; BIODIVERSITY; AMPHIBIA; TREEFROG; COMMUNITIES	Genetic data in studies of systematics of Amazonian amphibians frequently reveal that purportedly widespread single species in reality comprise species complexes. This means that real species richness may be significantly higher than current estimates. Here we combine genetic, morphological, and bioacoustic data to assess the phylogenetic relationships and species boundaries of two Amazonian species of the Dendropsophus leucophyllatus species group: D. leucophyllatus and D. triangulum. Our results uncovered the existence of five confirmed and four unconfirmed candidate species. Among the confirmed candidate species, three have available names: Dendropsophus leucophyllatus, Dendropsophus triangulum, and Dendropsophus reticulatus, this last being removed from the synonymy of D. triangulum. A neotype of D. leucophyllatus is designated. We describe the remaining two confirmed candidate species, one from Bolivia and another from Peru. All confirmed candidate species are morphologically distinct and have much smaller geographic ranges than those previously reported for D. leucophyllatus and D. triangulum sensu lato. Dendropsophus leucophyllatus sensu stricto occurs in the Guianan region. Dendropsophus reticulatus comb. nov. corresponds to populations in the Amazon basin of Brazil, Ecuador, and Peru previously referred to as D. triangulum. Dendropsophus triangulum sensu stricto is the most widely distributed species; it occurs in Amazonian Ecuador, Peru and Brazil, reaching the state of Para A. We provide accounts for all described species including an assessment of their conservation status.	[Caminer, Marcel A.; Venegas, Pablo J.; Ron, Santiago R.] Pontificia Univ Catolica Ecuador, Escuela Biol, Museo Zool, Quito, Ecuador; [Caminer, Marcel A.; Mila, Borja] CSIC, Natl Museum Nat Sci, Natl Museum Nat Sci, Madrid, Spain; [Jansen, Martin] Senckenberg Gesell Nat Forsch, Frankfurt, Germany; [Fouquet, Antoine] Ctr Rech Montabo, CNRS Guyane USR LEEISA, Cayenne, French Guiana; [Venegas, Pablo J.; Chavez, German] Urb Huertos De San Antonio, CORBIDI, Ctr Ornitol & Biodiversidad, Div Herpetol, Lima, Peru; [Lougheed, Stephen C.] Queens Univ, Dept Biol, Kingston, ON, Canada	Pontificia Universidad Catolica del Ecuador; Consejo Superior de Investigaciones Cientificas (CSIC); Senckenberg Gesellschaft fur Naturforschung (SGN); Ifremer; Queens University - Canada	Ron, SR (corresponding author), Pontificia Univ Catolica Ecuador, Escuela Biol, Museo Zool, Quito, Ecuador.	santiago.r.ron@gmail.com	Ron, Santiago/J-4203-2019; Rodríguez, Marcel Adrián Caminer/I-1687-2019	Ron, Santiago/0000-0001-6300-9350; Rodríguez, Marcel Adrián Caminer/0000-0002-5827-7462; Chavez, German/0000-0002-9291-156X; Jansen, Martin/0000-0002-2631-4601; venegas, pablo/0000-0002-6501-4492	BIOPAT; Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador SENESCYT (Arca de Noe initiative); Pontificia Universidad Catolica del Ecuador of the Direccion General Academica (DGA)	BIOPAT; Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador SENESCYT (Arca de Noe initiative); Pontificia Universidad Catolica del Ecuador of the Direccion General Academica (DGA)	This work was supported by BIOPAT. Field and laboratory work were funded by grants from the Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador SENESCYT (Arca de Noe initiative; SRR principal investigator), and a grant from Pontificia Universidad Catolica del Ecuador of the Direccion General Academica (DGA) department for SRR. AFs contribution to this work has benefited from an Investissement dAvenir grant managed by Agence Nationale de la Recherche (CEBA, ref.ANR-10-LABX-25-01), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], US GUID; Beireis GC, 1783, SCHRIFTEN BERLIN GES, V4, P178; BLAIR WF, 1958, AM NAT, V92, P27, DOI 10.1086/282007; Bohme W., 1981, Bonner Zoologische Beitraege, V32, P283; Brook BW, 2006, BIOTROPICA, V38, P302, DOI 10.1111/j.1744-7429.2006.00141.x; Caminer MA, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.370.6291; Charif RA, 2010, RAVEN PRO 1 4 USERS; Chek AA, 2001, MOL PHYLOGENET EVOL, V18, P370, DOI 10.1006/mpev.2000.0889; Cochran D.M., 1970, B US NATL MUSEUM, V288, P1, DOI DOI 10.5962/BHL.PART.6346; Coloma LA, 2012, ZOOTAXA, P1; CONDIT JOHN M., 1964, J OHIO HERPETOLOGICAL SOC, V4, P85, DOI 10.2307/1562641; Darst CR, 2004, MOL PHYLOGENET EVOL, V31, P462, DOI 10.1016/j.ympev.2003.09.003; Daudin FM, 1802, HIST NATURELLE RAINE; De La Riva Ignacio, 1997, Amphibia-Reptilia, V18, P433, DOI 10.1163/156853897X00486; De la Riva Ignacio, 2000, Revista Espanola de Herpetologia, V14, P19; Duellman W.E., 1970, Monograph Mus nat Hist Univ Kans, V1, P1; Duellman W.E., 1974, Occasional Papers Mus Nat Hist Univ Kans, VNo. 27, P1; Duellman W. E., 1977, TIERREICH, V95, P1, DOI DOI 10.2307/1443200; Duellman W.E., 2005, CUSCO AMAZONICO THE; DUELLMAN WE, 1983, COPEIA, P639, DOI 10.2307/1444328; DUELLMAN WE, 1978, MISCELLANEOUS PUBLIC, V65, P1; ESRI, 2010, ARCMAP 10 0; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Ferreira RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142893; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2015, ZOOTAXA, V4052, P39, DOI 10.11646/zootaxa.4052.1.2; Fouquet A, 2011, ZOOTAXA, P59, DOI 10.11646/zootaxa.3035.1.3; Frank N., 1995, COMPLETE GUIDE SCI C; Frost D. R., 2016, AMPHIBIANS SPECIES W; Fund W, 2014, ECOREGION; Gehara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103958; Goin CJ, 1957, J WASHINGTON ACAD SC, V47, P60; Gunther A.C.L.G., 1869, P ZOOL SOC LOND, V1868, P478; Hewitt GM, 2011, GENETICA, V139, P617, DOI 10.1007/s10709-011-9547-3; Int Commission Zoological Nomencla, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.219.3944; Jansen M, 2011, ZOOL SCR, V40, P567, DOI 10.1111/j.1463-6409.2011.00498.x; Jansen Martin, 2009, Salamandra, V45, P233; Jansen Martin, 2008, Herpetological Review, V39, P459; Jungfer KH, 2010, SALAMANDRA, V46, P204; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lougheed SC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-23; Maddison WP., 2021, MESQUITE MODULAR SYS; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; MARQUEZ R, 1993, BIOTROPICA, V25, P426, DOI 10.2307/2388866; Marquez R, 2002, GUIA SONORA RANAS SA; McDiarmid R. W., 1994, MEASURING MONITORING; Moravec J, 2004, HERPETOZOA, V17, P90; Moravec Jiri, 2000, Casopis Narodniho Muzea Rada Prirodovedna, V169, P1; Motta AP, 2012, ZOOTAXA, P18, DOI 10.11646/zootaxa.3249.1.2; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rambaut A., 2007, TRACE 1 4; Rivera-Correa M, 2013, ZOOTAXA, V3686, P447, DOI 10.11646/zootaxa.3686.4.3; Rodriguez L. O., 1994, GUIDE FROGS IQUITOS, V22; Ron SR, 2016, AMPHIBIAWEBECUADOR V; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Salducci MD, 2005, CR BIOL, V328, P1009, DOI 10.1016/j.crvi.2005.07.005; Salducci MD, 2002, CR BIOL, V325, P141, DOI 10.1016/S1631-0691(02)01423-3; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schulze A, 2015, ZOOTAXA, V4016, P1, DOI 10.11646/zootaxa.4016.1.1; Schulze Arne, 2009, Salamandra, V45, P75; Sierra R., 1999, MAPA VEGETACION ECUA; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TITUS TA, 1989, HERPETOLOGICA, V45, P17; Toledo LF, 2014, ACTA ETHOLOGICA; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wiens JJ, 2006, AM NAT, V168, P579, DOI 10.1086/507882; Wiens JJ, 2010, MOL PHYLOGENET EVOL, V55, P871, DOI 10.1016/j.ympev.2010.03.013; Zwickl DJ., 2006, GENETIC ALGORITHM AP	68	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0171785	10.1371/journal.pone.0171785	http://dx.doi.org/10.1371/journal.pone.0171785			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248998	Green Published, Green Submitted, gold			2022-12-26	WOS:000395983500018
J	Findlay, KP; Seakamela, SM; Meyer, MA; Kirkman, SP; Barendse, J; Cade, DE; Hurwitz, D; Kennedy, AS; Kotze, PGH; McCue, SA; Thornton, M; Vargas-Fonseca, OA; Wilke, CG				Findlay, Ken P.; Seakamela, S. Mduduzi; Meyer, Michael A.; Kirkman, Stephen P.; Barendse, Jaco; Cade, David E.; Hurwitz, David; Kennedy, Amy S.; Kotze, Pieter G. H.; McCue, Steven A.; Thornton, Meredith; Vargas-Fonseca, O. Alejandra; Wilke, Christopher G.			Humpback whale "super-groups" - A novel low-latitude feeding behaviour of Southern Hemisphere humpback whales (Megaptera novaeangliae) in the Benguela Upwelling System	PLOS ONE			English	Article							WEST-COAST; CETACEAN DISTRIBUTION; POPULATION-STRUCTURE; BALEEN WHALES; MOVEMENTS; MIGRATION; ABUNDANCE; WATERS; DESTINATIONS; AUSTRALIA	Southern Hemisphere humpback whales (Megaptera novaeangliae) generally undertake annual migrations from polar summer feeding grounds to winter calving and nursery grounds in subtropical and tropical coastal waters. Evidence for such migrations arises from seasonality of historic whaling catches by latitude, Discovery and natural mark returns, and results of satellite tagging studies. Feeding is generally believed to be limited to the southern polar region, where Antarctic krill (Euphausia superba) has been identified as the primary prey item. Non-migrations and / or suspended migrations to the polar feeding grounds have previously been reported from a summer presence of whales in the Benguela System, where feeding on euphausiids (E. lucens), hyperiid amphipods (Themisto gaudichaudii), mantis shrimp (Pterygosquilla armata capensis) and clupeid fish has been described. Three recent research cruises (in October/November 2011, October/November 2014 and October/November 2015) identified large tightly-spaced groups (20 to 200 individuals) of feeding humpback whales aggregated over at least a one-month period across a 220 nautical mile region of the southern Benguela System. Feeding behaviour was identified by lunges, strong milling and repetitive and consecutive diving behaviours, associated bird and seal feeding, defecations and the pungent "fishy" smell of whale blows. Although no dedicated prey sampling could be carried out within the tightly spaced feeding aggregations, observations of E. lucens in the region of groups and the full stomach contents of mantis shrimp from both a co-occurring predatory fish species (Thyrsites atun) and one entangled humpback whale mortality suggest these may be the primary prey items of at least some of the feeding aggregations. Reasons for this recent novel behaviour pattern remain speculative, but may relate to increasing summer humpback whale abundance in the region. These novel, predictable, inter-annual, low latitude feeding events provide considerable potential for further investigation of Southern Hemisphere humpback feeding behaviours in these relatively accessible low-latitude waters.	[Findlay, Ken P.; Barendse, Jaco; Thornton, Meredith] Univ Pretoria, Mammal Res Inst, Whale Unit, ZA-0001 Pretoria, Wynberg, South Africa; [Findlay, Ken P.] Cape Peninsula Univ Technol, Res Chair Oceans Econ, Cape Town, South Africa; [Seakamela, S. Mduduzi; Meyer, Michael A.; Kirkman, Stephen P.; Kotze, Pieter G. H.; McCue, Steven A.] Dept Environm Affairs, Branch Oceans & Coasts, Cape Town, South Africa; [Barendse, Jaco] 16 Ebor Rd, Wynberg, South Africa; [Barendse, Jaco] Marine Stewardship Council, 1 Snow Hill, London, England; [Cade, David E.] Stanford Univ, Hopkins Marine Stn, Dept Biol, 120 Ocean View Blvd, Pacific Grove, CA 93950 USA; [Hurwitz, David] 12 Victory Way, Cape Town, South Africa; [Kennedy, Amy S.] Alaska Fisheries Sci Ctr, Marine Mammal Lab, 7600 Sand Point Way NE, Seattle, WA USA; [Vargas-Fonseca, O. Alejandra] ConserBio Fdn, Heredia, Costa Rica; [Wilke, Christopher G.] Dept Agr Forestry & Fisheries, Branch Fisheries Management, Foretrust Bldg, Cape Town, South Africa	University of Pretoria; Cape Peninsula University of Technology; Department of Environment, Forestry & Fisheries; Stanford University; National Oceanic Atmospheric Admin (NOAA) - USA	Findlay, KP (corresponding author), Univ Pretoria, Mammal Res Inst, Whale Unit, ZA-0001 Pretoria, Wynberg, South Africa.; Findlay, KP (corresponding author), Cape Peninsula Univ Technol, Res Chair Oceans Econ, Cape Town, South Africa.	findlayk@cput.ac.za	Barendse, Jaco/F-7064-2012; Seakamela, S Mduduzi/HGA-6807-2022; Kennedy, Amy/O-9947-2017; Kirkman, Stephen/AAA-9139-2021; Findlay, Ken P/A-5766-2019	Barendse, Jaco/0000-0003-2859-4501; Kennedy, Amy/0000-0002-5282-9676; Kirkman, Stephen/0000-0001-5428-7375; Findlay, Ken P/0000-0001-7154-8805; Vargas Fonseca, Olga Alejandra/0000-0002-9131-4624	Simon's Town Boat Company	Simon's Town Boat Company	David Hurwitz is employed by The Simon's Town Boat Company. The Simon's Town Boat Company provided support in the form of salary for author DH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Acevedo J, 2007, MAR MAMMAL SCI, V23, P453, DOI 10.1111/j.1748-7692.2007.00116.x; Acevedo J, 2014, MAR MAMMAL SCI, V30, P433, DOI 10.1111/mms.12048; Acevedo J, 2011, REV BIOL MAR OCEANOG, V46, P483, DOI 10.4067/S0718-19572011000300018; Bannister J. L., 1967, Norsk Hvalfangsttidende Sandefjord, V56, P78; BARAFF LS, 1991, MAR MAMMAL SCI, V7, P197, DOI 10.1111/j.1748-7692.1991.tb00567.x; Barendse J, 2011, AFR J MAR SCI, V33, P353, DOI 10.2989/1814232X.2011.637343; Barendse J, 2010, AFR J MAR SCI, V32, P1, DOI 10.2989/18142321003714203; Barendse J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081238; Best P.B., 1979, FISH B S AFR, V12, P1; BEST PB, 1995, MAR ECOL PROG SER, V118, P1, DOI 10.3354/meps118001; Bortolotto GA, 2016, MARINE BIODIVERSITY, V9; Branch T. A., 2011, Journal of Cetacean Research and Management, P53; Brown SG, 1977, VOYAGE DISCOVERY, P569; Carvalho I, 2014, MAR BIOL, V161, P805, DOI 10.1007/s00227-013-2379-1; CHITTLEBOROUGH R. G., 1965, AUSTRALIAN J MAR FRESHWATER RES, V16, P33; Corkeron PJ, 1999, MAR MAMMAL SCI, V15, P1228, DOI 10.1111/j.1748-7692.1999.tb00887.x; Dalla Rosa L, 2008, POLAR BIOL, V31, P771, DOI 10.1007/s00300-008-0415-2; Danielwicz Daniel, 2009, JMBA2 Biodiversity Records, V6348, P1; Dawbin W.H., 1966, SEASONAL MIGRATORY C, P145; Dawbin WH, 1956, MIGRATIONS HUMPBACK, P147; Alves LCPD, 2009, MAR MAMMAL SCI, V25, P416, DOI 10.1111/j.1748-7692.2008.00249.x; Felix F, 2014, AQUAT MAMM, V40, P329, DOI 10.1578/AM.40.4.2014.329; Findlay K. P., 2002, Memoirs of the Queensland Museum, V47, P411; Findlay Ken, 2011, Journal of Cetacean Research and Management, P163; Findlay KP, 1996, MAR MAMMAL SCI, V12, P354, DOI 10.1111/j.1748-7692.1996.tb00589.x; FINDLAY KP, 1995, S AFR J MARINE SCI, V15, P279; Findlay KP, 2011, AFRICAN J MARINE SCI, P33; Friedlaender AS, 2006, MAR ECOL PROG SER, V317, P297, DOI 10.3354/meps317297; Garrigue C, 2015, ROYAL SOC OPEN SCI, V2, DOI [10.1098/rsos.150489, DOI 10.1098/RS0S.150489]; Garrigue C, 2010, J MAMMAL, V91, P109, DOI 10.1644/09-MAMM-A-033R.1; GENDRON D, 1993, MAR MAMMAL SCI, V9, P76, DOI 10.1111/j.1748-7692.1993.tb00428.x; Gill Peter C., 1998, Records of the Queen Victoria Museum, V107, P1; GRIFFITHS CL, 1988, S AFR J MARINE SCI, V7, P45, DOI 10.2989/025776188784379008; Harmer S.F., 1931, P LINN SOC LOND, V142, P85, DOI [10.1111/j.1095-8312.1931.tb01464.x, DOI 10.1111/J.1095-8312.1931.TB01464.X]; Harmer SF, 1927, P LINN SOC LONDON, V1928, P51; Hauser N, 2010, MAR MAMMAL SCI, V26, P679, DOI 10.1111/j.1748-7692.2009.00363.x; Hazen EL, 2009, MAR ECOL PROG SER, V395, P75, DOI 10.3354/meps08108; Hinton MAC, REPORT PAPERS LEFT L; Hucke-Gaete R, 2013, AQUAT CONSERV, V23, P858, DOI 10.1002/aqc.2343; Huggett J, 2009, PROG OCEANOGR, V83, P197, DOI 10.1016/j.pocean.2009.07.048; Hutchings L, 2009, PROG OCEANOGR, V83, P15, DOI 10.1016/j.pocean.2009.07.046; IWC (International Whaling Commission), 1998, ANN G REP SUBC COMPR; IWC (International Whaling Commission), 2016, ANN H REP SUBC OTH S; Kasamatsu F, 2000, POLAR BIOL, V23, P466, DOI 10.1007/s003009900107; KELLOGG REMINGTON, 1929, SMITHSONIAN INST ANN REPT BOARD OF REGENTS, V1928, P467; Laws R.M., 1977, ADAPTATIONS ANTARCTI, P411; LAWS RM, 1985, AM SCI, V73, P26; Lockyer C.H., 1981, Society for Experimental Biology Seminar Series, P105; Lockyer C, 2007, J MAR BIOL ASSOC UK, V87, P1035, DOI 10.1017/S0025315407054720; Mackintosh NA, 1942, SO STOCKS WHALEBONE, P197; Matthews LH, 1938, DISCOVERY REP, V17, P7; Minton Gianna, 2010, Journal of Cetacean Research and Management, V11, P301; Moore SE, 2002, PROG OCEANOGR, V55, P249, DOI 10.1016/S0079-6611(02)00082-4; Morch JA, 1911, P ZOOL SOC LOND, V1911, P661; Murase H, 2002, POLAR BIOL, V25, P135, DOI 10.1007/s003000100321; NEMOTO T, 1980, Scientific Reports of the Whales Research Institute Tokyo, P97; Norris K. S., 1967, P101; Nowacek D.P., 2011, PLOS ONE, V6; Olsen O, 1914, BERGENS MUSEUM ARBOK, V5, P1; Omura H., 1973, Scientific Rep Whales Res Inst Tokyo, VNo. 25, P105; Owen K, 2015, MAR ECOL PROG SER, V541, P231, DOI 10.3354/meps11551; Pitman RL, 2015, MAR MAMMAL SCI, V31, P629, DOI 10.1111/mms.12182; Rasmussen K, 2007, BIOLOGY LETT, V3, P302, DOI 10.1098/rsbl.2007.0067; Rayner G. W., 1940, Discovery Reports Cambridge, V19, P245; Risting S., 1912, KNOLHVALEN NORSK FIS, V11, P437; Rock J., 2006, Journal of Cetacean Research and Management, V8, P301; Rosenbaum HC, 2014, CONSERV BIOL, V28, P604, DOI 10.1111/cobi.12225; SHANNON LV, 1985, OCEANOGR MAR BIOL, V23, P105; Stamation Kasey A., 2007, Aquatic Mammals, V33, P165, DOI 10.1578/AM.33.2.2007.165; Stockin Karen A., 2005, Aquatic Mammals, V31, P120, DOI 10.1578/AM.31.1.2005.120; STONE GS, 1990, NATURE, V346, P705, DOI 10.1038/346705a0; TOWNSEND CHARLES HASKINS, 1935, ZOOLOGICA [NEW YORK], V19, P1; TYACK P, 1983, BEHAVIOUR, V83, P132, DOI 10.1163/156853982X00067; Tynan CT, 1998, NATURE, V392, P708, DOI 10.1038/33675; Verheye HM, 2015, ENV DEV; WHITEHEAD H, 1988, CAN J ZOOL, V66, P217, DOI 10.1139/z88-031; WHITEHEAD H, 1983, CAN J ZOOL, V61, P1391, DOI 10.1139/z83-186; Zerbini AN, 2006, MAR ECOL PROG SER, V313, P295, DOI 10.3354/meps313295; Zerbini Alexandre N., 2011, Journal of Cetacean Research and Management, P113	79	44	44	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172002	10.1371/journal.pone.0172002	http://dx.doi.org/10.1371/journal.pone.0172002			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249036	Green Published, Green Submitted, gold			2022-12-26	WOS:000395983500025
J	Garcia-Alvarez, M; Alcoceba, M; Lopez-Parra, M; Puig, N; Anton, A; Balanzategui, A; Prieto-Conde, I; Jimenez, C; Sarasquete, ME; Chillon, MC; Gutierrez, ML; Corral, R; Alonso, JM; Queizan, JA; Vidan, J; Pardal, E; Penarrubia, MJ; Bastida, JM; Garcia-Sanz, R; Marin, L; Gonzalez, M				Garcia-Alvarez, Maria; Alcoceba, Miguel; Lopez-Parra, Miriam; Puig, Noemi; Anton, Alicia; Balanzategui, Ana; Prieto-Conde, Isabel; Jimenez, Cristina; Sarasquete, Maria E.; Carmen Chillon, M.; Laura Gutierrez, Maria; Corral, Rocio; Maria Alonso, Jose; Antonio Queizan, Jose; Vidan, Julia; Pardal, Emilia; Jesus Penarrubia, Maria; Bastida, Jose M.; Garcia-Sanz, Ramon; Marin, Luis; Gonzalez, Marcos			HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMAS; NATURAL-HISTORY; CELIAC-DISEASE; CLASS-I; LEUKEMIA; RISK; POPULATION; DIFFERENTIATION; IMMUNOGLOBULIN; ABNORMALITIES	Introduction Molecular alterations leading progression of asymptomatic CLL-like high-count monoclonal B lymphocytosis (hiMBL) to chronic lymphocytic leukemia (CLL) remain poorly understood. Recently, genome-wide association studies have found 6p21.3, where the human leukocyte antigen (HLA) system is coded, to be a susceptibility risk region for CLL. Previous studies have produced discrepant results regarding the association between HLA and CLL development and outcome, but no studies have been performed on hiMBL. Aims We evaluated the role of HLA class I (-A, -B and -C) and class II (-DRB1 and -DQB1) in hiMBL/CLL susceptibility, hiMBL progression to CLL, and treatment requirement in a large series of 263 patients diagnosed in our center with hiMBL (n = 156) or Binet A CLL (n = 107). Results No consistent association between HLA specificities and hiMBL or CLL susceptibility was found. With a median follow-up of 7.7 years, 48/156 hiMBLs (33%) evolved to asymptomatic CLLs, while 16 hiMBLs (10%) and 44 CLLs (41%) required treatment. No HLA specificities were found to be significantly associated with hiMBL progression or treatment in the whole cohort. However, within antigen-experienced immunoglobulin heavy-chain (IGHV)-mutated hiMBLs, which represents the highest proportion of hiMBL cases (81%), the presence of HLA-DQB1*03 showed a trend to a higher risk of progression to CLL (60% vs. 26%, P = 0.062). Moreover, HLA-DQB1*02 specificity was associated with a lesser requirement for 15-year treatment (10% vs. 36%, P = 0.012). Conclusion In conclusion, our results suggest a role for HLA in IGHV-mutated hiMBL prognosis, and are consistent with the growing evidence of the influence of 6p21 on predisposition to CLL. Larger non-biased series are required to enable definitive conclusions to be drawn.	[Garcia-Alvarez, Maria; Alcoceba, Miguel; Lopez-Parra, Miriam; Puig, Noemi; Anton, Alicia; Balanzategui, Ana; Prieto-Conde, Isabel; Jimenez, Cristina; Sarasquete, Maria E.; Carmen Chillon, M.; Corral, Rocio; Bastida, Jose M.; Garcia-Sanz, Ramon; Marin, Luis; Gonzalez, Marcos] Univ Hosp Salamanca HUS IBSAL, Dept Hematol, Salamanca, Spain; [Alcoceba, Miguel; Maria Alonso, Jose; Antonio Queizan, Jose; Vidan, Julia; Pardal, Emilia; Jesus Penarrubia, Maria; Garcia-Sanz, Ramon; Gonzalez, Marcos] Soc Hematol & Hemotherapy SCLHH, Cooperat Working Grp Lymphomas & Lymphoproliferat, Castilla Leon, Spain; [Alcoceba, Miguel; Carmen Chillon, M.; Marin, Luis; Gonzalez, Marcos] CIBERONC, Madrid, Spain; [Laura Gutierrez, Maria] Canc Res Ctr IBMCC CSIC USAL, Dept Med, Cytometry Serv NUCLEUS, Salamanca, Spain; [Laura Gutierrez, Maria] IBSAL Univ Salamanca, Salamanca, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC)	Garcia-Sanz, R (corresponding author), Univ Hosp Salamanca HUS IBSAL, Dept Hematol, Salamanca, Spain.; Garcia-Sanz, R (corresponding author), Soc Hematol & Hemotherapy SCLHH, Cooperat Working Grp Lymphomas & Lymphoproliferat, Castilla Leon, Spain.	rgarcias@usal.es	Chillón, M. Carmen/E-1339-2018; Gutiérrez, María Laura ML/J-4313-2016; sarasquete, Maria E/U-8063-2018; Jiménez, Cristina/A-1532-2019; Alcoceba, Miguel/AAH-2784-2020; Bastida, Jose Maria/F-5726-2016; Gutiérrez, María Laura/AAY-9195-2020; Alcoceba, Miguel/B-7873-2017; Garcia-Sanz, Ramon/B-7986-2017; Alcoceba, Miguel/GXH-4002-2022	Chillón, M. Carmen/0000-0003-1624-6059; Gutiérrez, María Laura ML/0000-0003-2997-6317; sarasquete, Maria E/0000-0001-7335-3657; Jiménez, Cristina/0000-0002-5543-5154; Bastida, Jose Maria/0000-0002-8007-3909; Gutiérrez, María Laura/0000-0003-2997-6317; Alcoceba, Miguel/0000-0002-3819-4846; Garcia-Sanz, Ramon/0000-0003-4120-2787; Alcoceba, Miguel/0000-0002-3819-4846; Marin Rubio, Luis Alberto/0000-0002-9882-0036; Pardal, Emilia/0000-0001-7712-7876	Hematology and Hemotherapy Society of Castilla-Leon [1 FUCALHH-2010]; Instituto de Salud Carlos III (ISCIII) [RTICC-RD12/0036/0069, CIBERONC CB16/12/00233, CEI-2010-1-0010]; European Union FEDER program	Hematology and Hemotherapy Society of Castilla-Leon; Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); European Union FEDER program(European Commission)	This work was supported in part by Grants from the Hematology and Hemotherapy Society of Castilla-Leon (#1 FUCALHH-2010), and the Instituto de Salud Carlos III (ISCIII), award numbers (#2) RTICC-RD12/0036/0069, (#3) CIBERONC CB16/12/00233, and (#4) Innocampus; CEI-2010-1-0010. All ISCIII funding was co-sponsored by the European Union FEDER program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcoceba M, 2008, TISSUE ANTIGENS, V71, P548, DOI 10.1111/j.1399-0039.2008.01048.x; Alcoceba M, 2011, TISSUE ANTIGENS, V78, P249, DOI 10.1111/j.1399-0039.2011.01766.x; Alcoceba M, 2013, BLOOD, V122, P1448, DOI 10.1182/blood-2013-02-483420; Berndt SI, 2013, NAT GENET, V45, P868, DOI 10.1038/ng.2652; Borgerding A, 2010, EXP HEMATOL, V38, P213, DOI 10.1016/j.exphem.2009.12.007; Caporaso NE, 2010, CYTOM PART B-CLIN CY, V78B, pS115, DOI 10.1002/cyto.b.20555; Casabonne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052808; Chaperot L, 1999, EXP HEMATOL, V27, P1185, DOI 10.1016/S0301-472X(99)00057-0; Chiorazzi N, 2011, BLOOD, V117, P1781, DOI 10.1182/blood-2010-07-155663; Drenou B, 2004, BRIT J HAEMATOL, V127, P40, DOI 10.1111/j.1365-2141.2004.05151.x; Drenou B, 2002, BRIT J HAEMATOL, V119, P417, DOI 10.1046/j.1365-2141.2002.03814.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ghia P, 2007, LEUKEMIA, V21, P1, DOI 10.1038/sj.leu.2404457; Ghodke Y, 2005, EUR J EPIDEMIOL, V20, P475, DOI 10.1007/s10654-005-5081-x; Gonzalez M, 1999, HAEMATOLOGICA, V84, P779; Marin IGGY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/257517; Gragert L, 2014, BLOOD, V124, P2657, DOI 10.1182/blood-2014-02-558767; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Kern W, 2012, BRIT J HAEMATOL, V157, P86, DOI 10.1111/j.1365-2141.2011.09010.x; Landgren O, 2007, BLOOD, V109, P2198, DOI 10.1182/blood-2006-08-044008; Lech-Maranda E, 2007, HAEMATOL-HEMATOL J, V92, P710, DOI 10.3324/haematol.10910; Liu Y, 2015, INT J CLIN EXP MED, V8, P11490; Machulla HKG, 2001, INT J CANCER, V92, P203, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1167>3.0.CO;2-A; Marti GE, 2005, BRIT J HAEMATOL, V130, P325, DOI 10.1111/j.1365-2141.2005.05550.x; Megiorni F, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-88; Molica S, 2011, HAEMATOL-HEMATOL J, V96, P277, DOI 10.3324/haematol.2010.030189; Montes-Ares O, 2006, BRIT J HAEMATOL, V135, P517, DOI 10.1111/j.1365-2141.2006.06334.x; Morabito F, 2013, CLIN CANCER RES, V19, P5890, DOI 10.1158/1078-0432.CCR-13-0622; Parikh SA, 2014, HAEMATOLOGICA, V99, P140, DOI 10.3324/haematol.2013.086066; Plot L, 2009, AUTOIMMUN REV, V8, P316, DOI 10.1016/j.autrev.2008.10.001; Rawstron AC, 2008, NEW ENGL J MED, V359, P575, DOI 10.1056/NEJMoa075290; Rossi D, 2009, BRIT J HAEMATOL, V146, P64, DOI 10.1111/j.1365-2141.2009.07711.x; Sebastian E, 2012, AM J PATHOL, V181, P1879, DOI 10.1016/j.ajpath.2012.07.028; Seliger B, 2006, INT J CANCER, V118, P129, DOI 10.1002/ijc.21312; Shah N, 2011, LEUKEMIA, V25, P1036, DOI 10.1038/leu.2011.30; Shanafelt TD, 2009, J CLIN ONCOL, V27, P3959, DOI 10.1200/JCO.2008.21.2704; Shanafelt TD, 2009, BLOOD, V113, P4188, DOI 10.1182/blood-2008-09-176149; Slager SL, 2013, SEMIN HEMATOL, V50, P296, DOI 10.1053/j.seminhematol.2013.09.007; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Speedy HE, 2014, NAT GENET, V46, P56, DOI 10.1038/ng.2843; Strati P, 2015, BLOOD, V126, P454, DOI 10.1182/blood-2015-02-585059; Swerdlow SH, 2008, WHO CLASSIFICATION T; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Vardi A, 2013, BLOOD, V121, P4521, DOI 10.1182/blood-2012-12-471698; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wang SS, 2010, BLOOD, V115, P4820, DOI 10.1182/blood-2010-01-266775; Wilkinson ST, 2012, BLOOD, V119, P1459, DOI 10.1182/blood-2011-07-363820	49	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172978	10.1371/journal.pone.0172978	http://dx.doi.org/10.1371/journal.pone.0172978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249016	gold, Green Submitted, Green Published			2022-12-26	WOS:000395983500068
J	Vorrink, SU; Ullah, S; Schmidt, SF; Nandania, JT; Velagapudi, V; Beck, O; Ingelman-Sundberg, M; Lauschke, VM				Vorrink, Sabine U.; Ullah, Shahid; Schmidt, Staffan; Nandania, Jatin; Velagapudi, Vidya; Beck, Olof; Ingelman-Sundberg, Magnus; Lauschke, Volker M.			Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics	FASEB JOURNAL			English	Article						3D cell culture; hepatic metabolism; drug metabolism; cytochrome P450 enzymes; mass spectrometry	CONSTITUTIVE ANDROSTANE RECEPTOR; INDUCED LIVER-INJURY; SPECTROMETRY-BASED METABOLOMICS; ORBITRAP MASS-SPECTROMETRY; PREGNANE-X-RECEPTOR; DRUG-METABOLISM; HEPARG CELLS; IN-VITRO; DEXTROMETHORPHAN METABOLISM; GLUCOCORTICOID-RECEPTOR	Adverse reactions or lack of response to medications are important concerns for drug development programs. However, faithful predictions of drug metabolism and toxicity are difficult because animal models show only limited translatability to humans. Furthermore, current in vitro systems, such as hepatic cell lines or primary human hepatocyte (PHH) 2-dimensional (2D) monolayer cultures, can be used only for acute toxicity tests because of their immature phenotypes and inherent instability. Therefore, the migration to novel phenotypically stable models is of prime importance for the pharmaceutical industry. Novel 3-dimensional (3D) culture systems have been shown to accurately mimic in vivo hepatic phenotypes on transcriptomic and proteomic level, but information about their metabolic stability is lacking. Using a combination of targeted and untargeted high-resolution mass spectrometry, we found that PHHs in 3D spheroid cultures remained metabolically stable for multiple weeks, whereas metabolic patterns of PHHs from the same donors cultured as conventional 2D monolayers rapidly deteriorated. Furthermore, pharmacokinetic differences between donors were maintained in 3D spheroid cultures, enabling studies of interindividual variability in drug metabolism and toxicity. We conclude that the 3D spheroid system is metabolically stable and constitutes a suitable model for in vitro studies of long-term drug metabolism and pharmacokinetics.	[Vorrink, Sabine U.; Ingelman-Sundberg, Magnus; Lauschke, Volker M.] Karolinska Inst, Dept Physiol & Pharmacol, Sect Pharmacogenet, SE-17177 Stockholm, Sweden; [Ullah, Shahid; Schmidt, Staffan; Beck, Olof] Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden; [Nandania, Jatin; Velagapudi, Vidya] Univ Helsinki, Inst Mol Med Finland FIMM, Metabol Unit, Helsinki, Finland	Karolinska Institutet; Karolinska Institutet; University of Helsinki	Lauschke, VM (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Sect Pharmacogenet, SE-17177 Stockholm, Sweden.	volker.lauschke@ki.se	Lauschke, Volker/O-3014-2017; Velagapudi, Vidya/L-7278-2015; Ullah, Shahid/AAC-3054-2020; Ingelman-Sundberg, Magnus/ABD-9302-2021	Lauschke, Volker/0000-0002-1140-6204; Velagapudi, Vidya/0000-0002-8261-7164; 	Karolinska Institutet Early Verification Program; Innovative Medicine Initiative [115336]; Swedish Research Council [2016-01153, 2016-01154]	Karolinska Institutet Early Verification Program; Innovative Medicine Initiative; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by the Karolinska Institutet Early Verification Program (to V.M.L.), Innovative Medicine Initiative Project MIP-DILI Grant 115336 (to M.I.-S.), and by Swedish Research Council Grants 2016-01153 and 2016-01154 (both to V.M.L.). V.M.L. and M.I.-S. are cofounders and owners of HepaPredict AB.	Antherieu S, 2010, DRUG METAB DISPOS, V38, P516, DOI 10.1124/dmd.109.030197; Azimifar SB, 2014, CELL METAB, V20, P1076, DOI 10.1016/j.cmet.2014.11.002; Baxter M, 2015, J HEPATOL, V62, P581, DOI 10.1016/j.jhep.2014.10.016; Bell C., 2017, DRUG METAB DISPOS; Bell CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25187; Bjornsson E, 2005, HEPATOLOGY, V42, P481, DOI 10.1002/hep.20800; Bjornsson ES, 2013, GASTROENTEROLOGY, V144, P1419, DOI 10.1053/j.gastro.2013.02.006; BOWSHER RR, 1994, ANTIMICROB AGENTS CH, V38, P2134, DOI 10.1128/AAC.38.9.2134; Brown MV, 2013, OBESITY, V21, pE561, DOI 10.1002/oby.20440; Cajka T, 2016, ANAL CHEM, V88, P524, DOI 10.1021/acs.analchem.5b04491; Garcia-Canaveras JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27239; Chapman KL, 2013, REGUL TOXICOL PHARM, V66, P88, DOI 10.1016/j.yrtph.2013.03.001; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; Eliuk S, 2015, ANNU REV ANAL CHEM, V8, P61, DOI 10.1146/annurev-anchem-071114-040325; Ferguson SS, 2005, MOL PHARMACOL, V68, P747, DOI 10.1124/mol.105.013169; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Gpmez-Lechon M. J., 2014, EXPERT OPIN DRUG MET, V10, P1553; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Haberle J, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-32; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; HAYES KC, 1981, ANNU REV NUTR, V1, P401, DOI 10.1146/annurev.nu.01.070181.002153; Henry H, 2012, RAPID COMMUN MASS SP, V26, P499, DOI 10.1002/rcm.6121; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Ihunnah CA, 2011, BBA-MOL BASIS DIS, V1812, P956, DOI 10.1016/j.bbadis.2011.01.014; Inoue Y, 2006, J LIPID RES, V47, P215, DOI 10.1194/jlr.M500430-JLR200; Jeon SM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.81; Jones DR, 1996, CLIN PHARMACOL THER, V60, P374, DOI 10.1016/S0009-9236(96)90194-0; Kanebratt KP, 2008, DRUG METAB DISPOS, V36, P1444, DOI 10.1124/dmd.107.020016; Kim SR, 2014, J TOXICOL SCI, V39, P717, DOI 10.2131/jts.39.717; Kir S, 2012, J BIOL CHEM, V287, P41334, DOI 10.1074/jbc.M112.421834; Krauss RM, 2013, CLIN PHARMACOL THER, V94, P562, DOI 10.1038/clpt.2013.164; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; Lauschke VM, 2016, CHEM RES TOXICOL, V29, P1936, DOI 10.1021/acs.chemrestox.6b00150; Lauschke VM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101714; Lauschke VM, 2016, HEPATOLOGY, V64, P1743, DOI 10.1002/hep.28780; Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200; Manning FJ, 1995, REV FIALURIDINE FIAU; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Marudanayagam R, 2009, HPB, V11, P429, DOI 10.1111/j.1477-2574.2009.00086.x; Maurel P, 1996, ADV DRUG DELIVER REV, V22, P105, DOI 10.1016/S0169-409X(96)00417-6; MCKENZIE R, 1995, NEW ENGL J MED, V333, P1099, DOI 10.1056/NEJM199510263331702; Meissen JK, 2015, METABOLOMICS, V11, P707, DOI 10.1007/s11306-014-0729-8; Najdekr L, 2016, ANAL CHEM, V88, P11429, DOI 10.1021/acs.analchem.6b02319; Olson H, 2000, REGUL TOXICOL PHARM, V32, P56, DOI 10.1006/rtph.2000.1399; Oshiro C, 2010, PHARMACOGENET GENOM, V20, P211, DOI 10.1097/FPC.0b013e328333b99c; Ranninger C, 2016, ANAL CHIM ACTA, V930, P13, DOI 10.1016/j.aca.2016.05.017; Renwick AB, 2000, DRUG METAB DISPOS, V28, P1202; Reuben A, 2010, HEPATOLOGY, V52, P2065, DOI 10.1002/hep.23937; Roe B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023641; Roman-Garcia P, 2014, J CLIN INVEST, V124, P2988, DOI 10.1172/JCI72606; Rowe C, 2013, HEPATOLOGY, V58, P799, DOI 10.1002/hep.26414; Sahi J, 2009, J BIOCHEM MOL TOXIC, V23, P43, DOI 10.1002/jbt.20264; SCHMID B, 1985, CLIN PHARMACOL THER, V38, P618, DOI 10.1038/clpt.1985.235; Sgro C, 2002, HEPATOLOGY, V36, P451, DOI 10.1053/jhep.2002.34857; Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270; Sison-Young RL, 2017, ARCH TOXICOL, V91, P1385, DOI 10.1007/s00204-016-1745-4; Spaggiari D, 2014, J PHARMACEUT BIOMED, V101, P221, DOI 10.1016/j.jpba.2014.03.018; Sugatani J, 2005, MOL PHARMACOL, V67, P845, DOI 10.1124/mol.104.007161; Tiziani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004251; Tostoes RM, 2012, HEPATOLOGY, V55, P1227, DOI 10.1002/hep.24760; Tufts Center for the Study of Drug Development, 2014, TUFTS CTR STUD DRUG; Van den Eede N, 2015, TOXICOL IN VITRO, V29, P2045, DOI 10.1016/j.tiv.2015.08.012; Venkatakrishnan K, 2005, DRUG METAB DISPOS, V33, P845, DOI 10.1124/dmd.105.004077; Vrzal R, 2009, CHEM-BIOL INTERACT, V179, P288, DOI 10.1016/j.cbi.2008.10.035; Wang Y, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-8; Ware BR, 2017, TRENDS BIOTECHNOL, V35, P172, DOI 10.1016/j.tibtech.2016.08.001; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; Yoshinari K, 2010, BIOCHEM PHARMACOL, V79, P261, DOI 10.1016/j.bcp.2009.08.008; Yu AM, 2001, DRUG METAB DISPOS, V29, P1514; Zhou JT, 2016, ANALYST, V141, P6362, DOI 10.1039/c6an01753c	70	85	86	1	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2696	2708		10.1096/fj.201601375R	http://dx.doi.org/10.1096/fj.201601375R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28264975	Green Published, hybrid			2022-12-26	WOS:000401553400039
J	Go, SJ; Go, S; Veillon, L; Ciampa, MG; Mauri, L; Sato, C; Kitajima, K; Prinetti, A; Sonnino, S; Inokuchi, J				Go, Shinji; Go, Shiori; Veillon, Lucas; Ciampa, Maria Grazia; Mauri, Laura; Sato, Chihiro; Kitajima, Ken; Prinetti, Alessandro; Sonnino, Sandro; Inokuchi, Jin-ichi			Altered expression of ganglioside GM3 molecular species and a potential regulatory role during myoblast differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-GLYCOLYLNEURAMINIC ACID; NONHUMAN SIALIC-ACID; CERAMIDE SYNTHASES; ACETYLNEURAMINIC ACID; POLYSIALIC ACID; NEU3 SIALIDASE; CELL; FUSION; CHOLESTEROL; ACTIVATION	Gangliosides (sialic acid-containing glycosphingolipids) help regulate many important biological processes, including cell proliferation, signal transduction, and differentiation, via formation of functional microdomains in plasma membranes. The structural diversity of gangliosides arises from both the ceramide moiety and glycan portion. Recently, differing molecular species of a given ganglioside are suggested to have distinct biological properties and regulate specific and distinct biological events. Elucidation of the function of each molecular species is important and will provide new insights into ganglioside biology. Gangliosides are also suggested to be involved in skeletal muscle differentiation; however, the differential roles of ganglioside molecular species remain unclear. Here we describe striking changes in quantity and quality of gangliosides (particularly GM3) during differentiation of mouse C2C12 myoblast cells and key roles played by distinct GM3 molecular species at each step of the process.	[Go, Shinji; Go, Shiori; Veillon, Lucas; Inokuchi, Jin-ichi] Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Glycopathol, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan; [Go, Shiori; Sato, Chihiro; Kitajima, Ken] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Ciampa, Maria Grazia; Mauri, Laura; Prinetti, Alessandro; Sonnino, Sandro] Univ Milan, Dept Med Biotechnol & Translat Med, I-20090 Segrate, Italy	Tohoku Medical & Pharmaceutical University; Nagoya University; University of Milan	Inokuchi, J (corresponding author), Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Glycopathol, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jin@tohoku-mpu.ac.jp	Naganawa, Shinji/I-1572-2012; Prinetti, Alessandro/R-4206-2017; Inokuchi, Jin-ichi/AAW-9964-2020; SATO, Chihiro/B-7396-2014; Sonnino, Sandro/R-4154-2017; mauri, laura/GPS-4868-2022; MAURI, LAURA/H-5076-2017	Naganawa, Shinji/0000-0002-0214-613X; Prinetti, Alessandro/0000-0003-0252-2593; Inokuchi, Jin-ichi/0000-0002-0703-5746; Sonnino, Sandro/0000-0001-8180-5908; MAURI, LAURA/0000-0002-4194-4804	MEXT, Japan [23110002]; MEXT	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research (B) (to J.-i.I.) and for Scientific Research on Innovative Areas (23110002, Deciphering sugar chain-based signals regulating integrative neuronal functions) from MEXT, Japan and by MEXT-Supported Program for the Strategic Research Foundation at Private Universities. The authors declare that they have no conflicts of interest with the contents of this article.	Anastasia L, 2008, J BIOL CHEM, V283, P36265, DOI 10.1074/jbc.M805755200; ANDO S, 1978, ANAL BIOCHEM, V89, P437, DOI 10.1016/0003-2697(78)90373-1; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Chandrasekharan K, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000692; Charrin S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2675; Chisada S, 2009, J BIOL CHEM, V284, P30534, DOI 10.1074/jbc.M109.016188; CORNELL RB, 1980, J CELL BIOL, V86, P820, DOI 10.1083/jcb.86.3.820; Go S, 2007, BIOCHEM BIOPH RES CO, V357, P537, DOI 10.1016/j.bbrc.2007.03.181; Hayashi N, 2013, CANCER SCI, V104, P43, DOI 10.1111/cas.12027; Hindi SM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003832; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; Inokuchi J, 2014, GLYCOCONJUGATE J, V31, P193, DOI 10.1007/s10719-013-9516-4; Inokuchi J, 2011, P JPN ACAD B-PHYS, V87, P179, DOI 10.2183/pjab.87.179; Inokuchi J, 2010, FEBS LETT, V584, P1864, DOI 10.1016/j.febslet.2009.10.012; Jennemann R, 2013, PROG LIPID RES, V52, P231, DOI 10.1016/j.plipres.2013.02.001; Kabayama K, 2005, GLYCOBIOLOGY, V15, P21, DOI 10.1093/glycob/cwh135; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; Krauss RS, 2005, J CELL SCI, V118, P2355, DOI 10.1242/jcs.02397; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin PT, 2013, GLYCOBIOLOGY, V23, P833, DOI 10.1093/glycob/cwt020; Mermelstein CS, 2005, CELL TISSUE RES, V319, P289, DOI 10.1007/s00441-004-1004-5; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Mukai A, 2008, EXP CELL RES, V314, P387, DOI 10.1016/j.yexcr.2007.10.006; Mukai A, 2009, EXP CELL RES, V315, P3052, DOI 10.1016/j.yexcr.2009.07.010; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Naito-Matsui Y, 2014, J BIOL CHEM, V289, P1564, DOI 10.1074/jbc.M113.523753; Ong E, 2002, J BIOL CHEM, V277, P18182, DOI 10.1074/jbc.M201312200; OZAWA H, 1992, ARCH BIOCHEM BIOPHYS, V294, P427, DOI 10.1016/0003-9861(92)90707-4; PALESTINI P, 1995, BBA-BIOMEMBRANES, V1235, P221, DOI 10.1016/0005-2736(95)80008-4; Papini N, 2012, J CELL BIOCHEM, V113, P2967, DOI 10.1002/jcb.24174; Park JW, 2014, BBA-MOL CELL BIOL L, V1841, P671, DOI 10.1016/j.bbalip.2013.08.019; Samraj AN, 2015, P NATL ACAD SCI USA, V112, P542, DOI 10.1073/pnas.1417508112; Samraj AN, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00033; Scaringi R, 2013, J BIOL CHEM, V288, P3153, DOI 10.1074/jbc.M112.404327; Schlenzka W, 1996, FEBS LETT, V385, P197, DOI 10.1016/0014-5793(96)00384-5; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Schwarzmann G, 2001, SEMIN CELL DEV BIOL, V12, P163, DOI 10.1006/scdb.2000.0233; SEKIYA T, 1984, CELL STRUCT FUNCT, V9, P143, DOI 10.1247/csf.9.143; Singhal N, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-014-0028-0; Suzuki M, 2003, J BIOL CHEM, V278, P49459, DOI 10.1074/jbc.M308316200; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Valiente O, 2001, J LIPID RES, V42, P1318; Varki A, 2001, BIOCHIMIE, V83, P615, DOI 10.1016/S0300-9084(01)01309-8; Veillon L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129645; Casadesus AV, 2013, GLYCOCONJUGATE J, V30, P687, DOI 10.1007/s10719-013-9473-y; Yin J, 2006, CANCER RES, V66, P2937, DOI 10.1158/0008-5472.CAN-05-2615; YU RK, 1972, J LIPID RES, V13, P680	52	13	14	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7040	7051		10.1074/jbc.M116.771253	http://dx.doi.org/10.1074/jbc.M116.771253			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28275055	Green Published, hybrid			2022-12-26	WOS:000400478300015
J	Jansen, S; Melkova, K; Trosanova, Z; Hanakova, K; Zachrdla, M; Novacek, J; Zupa, E; Zdrahal, Z; Hritz, J; Zidek, L				Jansen, Severine; Melkova, Katerina; Trosanova, Zuzana; Hanakova, Katerina; Zachrdla, Milan; Novacek, Jiri; Zupa, Erikz; Zdrahal, Zbynek; Hritz, Jozef; Zidek, Lukas			Quantitative mapping of microtubule-associated protein 2c (MAP2c) phosphorylation and regulatory protein 14-3-3 zeta-binding sites reveals key differences between MAP2c and its homolog Tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; PAIRED HELICAL FILAMENTS; TUBULIN POLYMERIZATION; MULTIDIMENSIONAL NMR; NEURONAL DEVELOPMENT; DISORDERED PROTEINS; SYNAPTIC PLASTICITY; BETA-STRUCTURE; KINASE-A; BINDING	Microtubule-associated protein 2c (MAP2c) is involved in neuronal development and is less characterized than its homolog Tau, which has various roles in neurodegeneration. Using NMR methods providing single-residue resolution and quantitative comparison, we investigated molecular interactions important for the regulatory roles of MAP2c in microtubule dynamics. We found that MAP2c and Tau significantly differ in the position and kinetics of sites that are phosphorylated by cAMP-dependent protein kinase (PKA), even in highly homologous regions. Wedetermined the binding sites of unphosphorylated and phosphorylated MAP2c responsible for interactions with the regulatory protein 14-3-3 zeta. Differences in phosphorylation and in charge distribution between MAP2c and Tau suggested that both MAP2c and Tau respond to the same signal (phosphorylation by PKA) but have different downstream effects, indicating a signaling branch point for controlling microtubule stability. Although the interactions of phosphorylated Tau with 14-3-3 zeta are supposed to be a major factor in microtubule destabilization, the binding of 14-3-3 zeta to MAP2c enhanced by PKA-mediated phosphorylation is likely to influence microtubule-MAP2c binding much less, in agreement with the results of our tubulin co-sedimentation measurements. The specific location of the major MAP2c phosphorylation site in a region homologous to the muscarinic receptor-binding site of Tau suggests that MAP2c also may regulate processes other than microtubule dynamics.	[Jansen, Severine; Melkova, Katerina; Trosanova, Zuzana; Zachrdla, Milan; Zupa, Erikz; Hritz, Jozef; Zidek, Lukas] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Kamenice 5, CZ-62500 Brno, Czech Republic; [Jansen, Severine; Melkova, Katerina; Trosanova, Zuzana; Hanakova, Katerina; Zachrdla, Milan; Novacek, Jiri; Zupa, Erikz; Hritz, Jozef; Zidek, Lukas] Masaryk Univ, Cent European Inst Technol, Kamenice 5, CZ-62500 Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno	Hritz, J; Zidek, L (corresponding author), Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Kamenice 5, CZ-62500 Brno, Czech Republic.; Hritz, J (corresponding author), Masaryk Univ, Cent European Inst Technol, Kamenice 5, CZ-62500 Brno, Czech Republic.	jozef.hritz@ceitec.muni.cz; lzidek@chemi.muni.cz	Zidek, Lukas/D-7112-2012; Zidek, Lukas/AAB-6109-2020; Novacek, Jiri/AAQ-4739-2021; Hritz, Jozef/J-6887-2015; Jansen, Severine/Q-6364-2019; Zdrahal, Zbynek/D-9491-2012; Novacek, Jiri/D-8551-2012	Zidek, Lukas/0000-0002-8013-0336; Zidek, Lukas/0000-0002-8013-0336; Novacek, Jiri/0000-0003-4013-3898; Hritz, Jozef/0000-0002-4512-9241; Novacek, Jiri/0000-0003-4013-3898; Zdrahal, Zbynek/0000-0003-3044-5548; Hanakova, Katerina/0000-0001-9575-8866; Trosanova, Zuzana/0000-0002-0247-4168	Ministry of Education, Youth and Sports of the Czech Republic (MEYS CR) [LM2015043]	Ministry of Education, Youth and Sports of the Czech Republic (MEYS CR)	CIISB research infrastructure project LM2015043, funded by Ministry of Education, Youth and Sports of the Czech Republic (MEYS CR), is gratefully acknowledged for partial financial support of the measurements at the Josef Dadok National NMR Centre, Biomolecular Interactions and Crystallization and Proteomics Core Facilities, Central European Institute of Technology (CEITEC), Masaryk University. We thank Tanvir Shaikh for language corrections and Arnost Mladek and Irmgard Fischer for technical help.	Ackmann M, 2000, J BIOL CHEM, V275, P30335, DOI 10.1074/jbc.M002590200; AINSZTEIN AM, 1994, J BIOL CHEM, V269, P28465; AITKEN A, 1992, TRENDS BIOCHEM SCI, V17, P498, DOI 10.1016/0968-0004(92)90339-B; Alexa A, 2002, BIOCHEMISTRY-US, V41, P12427, DOI 10.1021/bi025916s; Ambrosini A, 2000, MOL BRAIN RES, V75, P54, DOI 10.1016/S0169-328X(99)00294-6; AVILA J, 1994, INT J DEV BIOL, V38, P13; Bermel W, 2009, J AM CHEM SOC, V131, P15339, DOI 10.1021/ja9058525; Blanco-Aparicio C, 1999, J CELL BIOL, V147, P1129, DOI 10.1083/jcb.147.6.1129; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BRANDT R, 1994, J BIOL CHEM, V269, P11776; BURNS RG, 1984, EUR J BIOCHEM, V141, P609, DOI 10.1111/j.1432-1033.1984.tb08236.x; Busceti CL, 2015, PHARMACOL RES, V99, P258, DOI 10.1016/j.phrs.2015.06.017; Dehmelt L, 2005, GENOME BIOL, V6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Drewes G, 1998, TRENDS BIOCHEM SCI, V23, P307, DOI 10.1016/S0968-0004(98)01245-6; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Elie A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09964; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Gamblin TC, 1996, BIOCHEMISTRY-US, V35, P12576, DOI 10.1021/bi961135d; Gardiner J, 2011, SYNAPSE, V65, P249, DOI 10.1002/syn.20841; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; HOSHI M, 1988, EUR J BIOCHEM, V174, P225, DOI 10.1111/j.1432-1033.1988.tb14086.x; Hritz J, 2014, BIOPHYS J, V107, P2185, DOI 10.1016/j.bpj.2014.08.039; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Itoh TJ, 1997, BIOCHEMISTRY-US, V36, P12574, DOI 10.1021/bi962606z; Jalava NS, 2007, INT J DEV NEUROSCI, V25, P121, DOI 10.1016/j.ijdevneu.2006.12.001; Joo Y, 2015, FASEB J, V29, P4133, DOI 10.1096/fj.14-265009; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; Kazimierczuk K, 2008, J MAGN RESON, V192, P123, DOI 10.1016/j.jmr.2008.02.003; Kazimierczuk K, 2009, J MAGN RESON, V197, P219, DOI 10.1016/j.jmr.2009.01.003; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kim HA, 1997, J NEUROSCI RES, V49, P236; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Lousa P, 2017, BIOPHYS CHEM, V223, P25, DOI 10.1016/j.bpc.2017.01.003; Madeira F, 2015, BIOINFORMATICS, V31, P2276, DOI 10.1093/bioinformatics/btv133; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Mohan R, 2015, IUBMB LIFE, V67, P395, DOI 10.1002/iub.1384; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Novacek J, 2013, J BIOMOL NMR, V56, P291, DOI 10.1007/s10858-013-9761-7; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ovsepian SV, 2016, NEUROSCIENTIST, V22, P238, DOI 10.1177/1073858415588264; Ozer RS, 2000, MOL BIOL CELL, V11, P3573, DOI 10.1091/mbc.11.10.3573; Sadik G, 2009, J NEUROCHEM, V108, P33, DOI 10.1111/j.1471-4159.2008.05716.x; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Sillen A, 2007, BIOCHEMISTRY-US, V46, P3055, DOI 10.1021/bi061920i; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Skoulakis EMC, 1998, MOL NEUROBIOL, V16, P269, DOI 10.1007/BF02741386; Sluchanko NN, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1528, DOI 10.1134/S0006297910130031; Sluchanko NN, 2011, J ALZHEIMERS DIS, V27, P467, DOI 10.3233/JAD-2011-110692; Sluchanko NN, 2009, FEBS LETT, V583, P2739, DOI 10.1016/j.febslet.2009.07.043; Sluchanko NN, 2009, BIOCHEM BIOPH RES CO, V379, P990, DOI 10.1016/j.bbrc.2008.12.164; Stanek J, 2010, J BIOMOL NMR, V47, P65, DOI 10.1007/s10858-010-9411-2; Sundermann F, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2590-9; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Valencia RG, 2013, MOL BIOL CELL, V24, P768, DOI 10.1091/mbc.E12-06-0488; VALLEE R, 1980, P NATL ACAD SCI-BIOL, V77, P3206, DOI 10.1073/pnas.77.6.3206; VIERECK C, 1989, J NEUROSCI, V9, P3547; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang HB, 2012, REV NEUROSCIENCE, V23, P67, DOI 10.1515/revneuro-2011-0063; Wisniewski JR, 2011, J PROTEOME RES, V10, P3040, DOI 10.1021/pr200019m; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Xie C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089796; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; YAMAUCHI T, 1983, BIOCHEM BIOPH RES CO, V110, P287, DOI 10.1016/0006-291X(83)91293-7; Yoshida H, 2006, J NEUROCHEM, V99, P154, DOI 10.1111/j.1471-4159.2006.04052.x	76	13	13	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6715	6727		10.1074/jbc.M116.771097	http://dx.doi.org/10.1074/jbc.M116.771097			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28258221	hybrid, Green Published			2022-12-26	WOS:000399813400023
J	Kamariah, N; Eisenhaber, B; Eisenhaber, F; Gruber, G				Kamariah, Neelagandan; Eisenhaber, Birgit; Eisenhaber, Frank; Gruber, Gerhard			Essential role of the flexible linker on the conformational equilibrium of bacterial peroxiredoxin reductase for effective regeneration of peroxiredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKYL-HYDROPEROXIDE REDUCTASE; SMALL-ANGLE SCATTERING; XYLANUS NADH OXIDASE; ESCHERICHIA-COLI; ALKYLHYDROPEROXIDE REDUCTASE; SALMONELLA-TYPHIMURIUM; BIOLOGICAL MACROMOLECULES; THIOREDOXIN REDUCTASE; HYDROGEN-PEROXIDE; ELECTRON-TRANSFER	Reactive oxygen species (ROS) can damage DNA, proteins, and lipids, so cells have antioxidant systems that regulate ROS. In many bacteria, a dedicated peroxiredoxin reductase, alkyl hydroperoxide reductase subunit F (AhpF), catalyzes the rapid reduction of the redox-active disulfide center of the antioxidant protein peroxiredoxin (AhpC) to detoxifyROSsuch as hydrogen peroxide, organic hydroperoxide, and peroxynitrite. AhpF is a flexible multidomain protein that enables a series of electron transfers among the redox centers by accepting reducing equivalents from NADH. A flexible linker connecting the N-terminal domain (NTD) and C-terminal domain (CTD) of AhpF suggests that the enzyme adopts a large-scale domain motion that alternates between the closed and open states to shuttle electrons from the CTD via the NTD to AhpC. Here, we conducted comprehensive mutational, biochemical, and biophysical analyses to gain insights into the role of the flexible linker and the residues critical for the domain motions of Escherichia coli AhpF (EcAhpF) during electron transfer. Small-angle X-ray scattering studies of linker mutants revealed that a group of charged residues, 200EKR202, is crucial for the swiveling motion of the NTD. Moreover, NADH binding significantly affected EcAhpF flexibility and the movement of the NTD relative to the CTD. The mutants also exhibited a decrease in H2O2 reduction by the AhpF-AhpC ensemble. We propose that a concerted movement involving the NTD, C-terminal NADH, and FAD domains, and the flexible linker between them is essential for optimal intradomain cross-talk and for efficient electron transfer to the redox partner AhpC required for peroxidation.	[Kamariah, Neelagandan; Eisenhaber, Birgit; Eisenhaber, Frank; Gruber, Gerhard] ASTAR, Bioinformat Inst, Singapore 138671, Singapore; [Gruber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Eisenhaber, Frank] Nanyang Technol Univ, Sch Comp Engn, Singapore 637553, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Gruber, G (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	ggrueber@ntu.edu.sg			NTU-fund (Nanyang Technological University) [M4080811.080]; Genome Informatics Grant [IAF311010]	NTU-fund (Nanyang Technological University)(Nanyang Technological University); Genome Informatics Grant	This work was supported in part by NTU-fund (Nanyang Technological University) Grant M4080811.080 (to G. G.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Genome Informatics Grant IAF311010.	Balakrishna AM, 2015, J BIOL CHEM, V290, P3183, DOI 10.1074/jbc.M114.622688; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dip PV, 2014, BBA-BIOENERGETICS, V1837, P1932, DOI 10.1016/j.bbabio.2014.08.007; Dip PV, 2014, ACTA CRYSTALLOGR D, V70, P2848, DOI 10.1107/S1399004714019233; Dreiss CA, 2006, J APPL CRYSTALLOGR, V39, P32, DOI 10.1107/S0021889805033091; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gokhale RS, 2000, CURR OPIN CHEM BIOL, V4, P22, DOI 10.1016/S1367-5931(99)00046-0; Gruber G, 2002, BIOCHEM BIOPH RES CO, V298, P383, DOI 10.1016/S0006-291X(02)02468-3; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; JACOBSON FS, 1989, J BIOL CHEM, V264, P1488; Kamariah N, 2016, SCI REP-UK, V6, DOI 10.1038/srep37610; Kamariah N, 2016, J STRUCT BIOL, V193, P13, DOI 10.1016/j.jsb.2015.11.004; Kamariah N, 2015, BBA-BIOENERGETICS, V1847, P1139, DOI 10.1016/j.bbabio.2015.06.011; Kikhney AG, 2015, FEBS LETT, V589, P2570, DOI 10.1016/j.febslet.2015.08.027; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leys D, 2004, CURR OPIN STRUC BIOL, V14, P642, DOI 10.1016/j.sbi.2004.10.002; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Nartey W, 2015, FEBS J, V282, P4620, DOI 10.1111/febs.13522; Niimura Y, 1996, J BIOL CHEM, V271, P30459, DOI 10.1074/jbc.271.48.30459; NIIMURA Y, 1995, J BIOL CHEM, V270, P25645, DOI 10.1074/jbc.270.43.25645; Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623; Parsonage D, 2008, P NATL ACAD SCI USA, V105, P8209, DOI 10.1073/pnas.0708308105; Parsonage D, 2015, BIOCHEMISTRY-US, V54, P1567, DOI 10.1021/bi501515w; Poole LB, 2000, BIOCHEMISTRY-US, V39, P6602, DOI 10.1021/bi000405w; Poole LB, 2000, EUR J BIOCHEM, V267, P6126, DOI 10.1046/j.1432-1327.2000.01704.x; Poole LB, 1996, BIOCHEMISTRY-US, V35, P56, DOI 10.1021/bi951887s; Poole LB, 2000, FREE RADICAL BIO MED, V28, P108, DOI 10.1016/S0891-5849(99)00218-X; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Saw WG, 2015, ACTA CRYSTALLOGR D, V71, P2309, DOI 10.1107/S1399004715017721; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Wood ZA, 2001, BIOCHEMISTRY-US, V40, P3900, DOI 10.1021/bi002765p	44	5	5	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6667	6679		10.1074/jbc.M117.775858	http://dx.doi.org/10.1074/jbc.M117.775858			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28270505	hybrid, Green Published			2022-12-26	WOS:000399813400019
J	Choo, B; Zhu, M; Qu, QM; Yu, XB; Jia, LT; Zhao, WJ				Choo, Brian; Zhu, Min; Qu, Qingming; Yu, Xiaobo; Jia, Liantao; Zhao, Wenjin			A new osteichthyan from the late Silurian of Yunnan, China	PLOS ONE			English	Article							RAY-FINNED FISHES; SCALE MORPHOLOGY; SHEDS LIGHT; BONY FISHES; ORIGIN; GNATHOSTOME; ANDREOLEPIS; PLACODERM; VERTEBRATES; CHARACTERS	Our understanding of early gnathostome evolution has been hampered by a generally scant fossil record beyond the Devonian. Recent discoveries from the late Silurian Xiaoxiang Fauna of Yunnan, China, have yielded significant new information, including the earliest articulated osteichthyan fossils from the Ludlow-aged Kuanti Formation. Here we describe the partial postcranium of a new primitive bony fish from the Kuanti Formation that represents the second known taxon of pre-Devonian osteichthyan revealing articulated remains. The new form, Sparalepis tingi gen. et sp. nov., displays similarities with Guiyu and Psarolepis, including a spine-bearing pectoral girdle and a placoderm-like dermal pelvic girdle, a structure only recently identified in early osteichthyans. The squamation with particularly thick rhombic scales shares an overall morphological similarity to that of Psarolepis. However, the anterior flank scales of Sparalepis possess an unusual interlocking system of ventral bulges embraced by dorsal concavities on the outer surfaces. A phylogenetic analysis resolves Sparalepis within a previously recovered cluster of stem-sarcopterygians including Guiyu, Psarolepis and Achoania. The high diversity of osteichthyans from the Ludlow of Yunnan strongly contrasts with other Silurian vertebrate assemblages, suggesting that the South China block may have been an early center of diversification for early gnathostomes, well before the advent of the Devonian "Age of Fishes".	[Choo, Brian; Zhu, Min; Yu, Xiaobo; Jia, Liantao; Zhao, Wenjin] Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origins, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China; [Choo, Brian] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA, Australia; [Zhu, Min; Zhao, Wenjin] Univ Chinese Acad Sci, Coll Earth Sci, Beijing, Peoples R China; [Qu, Qingming] Uppsala Univ, Dept Physiol & Dev Biol, Subdept Evolutionary Organismal Biol, Uppsala, Sweden; [Qu, Qingming] Univ Ottawa, Ctr Adv Res Environm Genom, Ottawa, ON, Canada; [Yu, Xiaobo] Kean Univ, Dept Biol Sci, Union, NJ USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Flinders University South Australia; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Uppsala University; University of Ottawa	Choo, B; Zhu, M (corresponding author), Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origins, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China.; Choo, B (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA, Australia.; Zhu, M (corresponding author), Univ Chinese Acad Sci, Coll Earth Sci, Beijing, Peoples R China.	brian.choo@flinders.edu.au; zhumin@ivpp.ac.cn	Yu, Xiaobo/G-7160-2011; min, zhu/AAL-6712-2021; Zhu, Min/E-8728-2012	Yu, Xiaobo/0000-0001-9600-7888; Zhu, Min/0000-0002-4786-0898; Choo, Brian/0000-0002-9983-0762; Zhao, Wenjin/0000-0002-9649-2171	National Nature Science Foundation of China [41530102]; Chinese Academy of Sciences [QYZDJ-SSW-DQC002]; Australian Research Council [DE160100247]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Australian Research Council(Australian Research Council)	Funding was provided by the National Nature Science Foundation of China (41530102), Chinese Academy of Sciences (QYZDJ-SSW-DQC002; Funds for Paleontology Fieldwork and Fossil Preparation), and Australian Research Council (Discovery Project DE160100247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basden AM, 2000, NATURE, V403, P185, DOI 10.1038/35003183; BLIECK A, 1991, SPEC PAP PALAEONTOL, V44, P345; Blieck Alain, 2000, Courier Forschungsinstitut Senckenberg, V223, P223; Botella H, 2007, NATURE, V448, P583, DOI 10.1038/nature05989; Brazeau MD, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2210; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Burrow Carole J., 1999, Records of the Western Australian Museum Supplement, V57, P1; Burrow Carole J., 1995, Geobios Memoire Special (Villeurbanne), V19, P327; Chang M.M., 1984, Proceedings of the Linnean Society of New South Wales, V107, P171; Chang Meemann, 1993, Memoir of the Association of Australasian Palaeontologists, V15, P183; Chen DL, 2016, NATURE, V539, P237, DOI 10.1038/nature19812; Chen DL, 2012, HIST BIOL, V24, P411, DOI 10.1080/08912963.2012.668187; Choo B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05242; Choo B, 2011, EARTH ENV SCI T R SO, V102, P77, DOI 10.1017/S1755691011011029; Choo B, 2009, ACTA ZOOL-STOCKHOLM, V90, P194, DOI 10.1111/j.1463-6395.2008.00370.x; Coates MI, 2009, NATURE, V458, P413, DOI 10.1038/458413a; Cunningham JA, 2012, BIOL LETTERS, V8, P833, DOI 10.1098/rsbl.2012.0357; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; Esi D.N.., 1990, PALEONTOL J+, V1990, P90; Fang R.S., 1985, MIDDLE SILURIAN EARL; Friedman M, 2010, J VERTEBR PALEONTOL, V30, P36, DOI 10.1080/02724630903409071; Friedman M, 2006, J PALEONTOL, V80, P1186, DOI 10.1666/0022-3360(2006)80[1186:ANAFTF]2.0.CO;2; Giles S, 2015, PALAEONTOLOGY, V58, P849, DOI 10.1111/pala.12182; Giles S, 2015, NATURE, V520, P82, DOI 10.1038/nature14065; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Janvier P., 1996, EARLY VERTEBRATES; Johanson Z, 2005, BIOL REV, V80, P303, DOI 10.1017/S1464793104006682; Karatajute-Talimaa Valentina, 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P39; Long J.A., 1988, Memoir of the Association of Australasian Palaeontologists, V7, P1; Long JA, 2015, NATURE, V517, P196, DOI 10.1038/nature13825; Lu J, 2016, CURRENT BIOL; Lu J, 2016, CURR BIOL, V26, P1602, DOI 10.1016/j.cub.2016.04.045; Lu J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2170; Maddison WP., 2021, MESQUITE MODULAR SYS; Marss Tiiu, 2001, Proceedings of the Estonian Academy of Sciences Geology, V50, P174; Pan J., 1986, PROFESSIONAL PAPERS, P67; Qiao T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163157; Qu Qing-Ming, 2010, Palaeoworld, V19, P146, DOI 10.1016/j.palwor.2009.11.003; Qu QM, 2015, NATURE, V526, P108, DOI 10.1038/nature15259; Qu QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061485; RICHTER M, 1995, ZOOL J LINN SOC-LOND, V114, P173, DOI 10.1006/zjls.1995.0023; Sansom IJ, 1996, NATURE, V379, P628, DOI 10.1038/379628a0; Schultze HP, 2001, SYST ASSOC SPEC VOL, V61, P315; Ting V. K., 1937, Bulletin of the Geological Society of China, V16, P1; Trinajstic K, 1999, ALCHERINGA, V23, P9, DOI 10.1080/03115519908619335; Turner S, 2004, CRIT MOM PERSP EARTH, P327; Zhang Guo-Rui, 2010, Palaeoworld, V19, P129, DOI 10.1016/j.palwor.2009.11.006; Zhao Wen-Jin, 2010, Palaeoworld, V19, P4, DOI 10.1016/j.palwor.2009.11.007; Zhu M, 2004, NATURE, V432, P94, DOI 10.1038/nature02843; Zhu M, 2001, SYST ASSOC SPEC VOL, V61, P289; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2006, NATURE, V441, P77, DOI 10.1038/nature04563; Zhu M, 2001, NATURE, V410, P81, DOI 10.1038/35065078; Zhu M., 2009, RENDICONTI SOC PALEO, V3, P357; Zhu M, 2016, SCIENCE, V354, P334, DOI 10.1126/science.aah3764; Zhu M, 2014, NATL SCI REV, V1, P490, DOI 10.1093/nsr/nwu062; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; Zhu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035103; Zhu M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1764; Zhu M, 2009, BIOL LETTERS, V5, P372, DOI 10.1098/rsbl.2008.0784; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855; [No title captured]	63	20	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0170929	10.1371/journal.pone.0170929	http://dx.doi.org/10.1371/journal.pone.0170929			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273081	gold, Green Published, Green Submitted			2022-12-26	WOS:000396073700092
J	Kohanoff, J; Artacho, E				Kohanoff, Jorge; Artacho, Emilio			Water radiolysis by low-energy carbon projectiles from first-principles molecular dynamics	PLOS ONE			English	Article							LIQUID WATER; IONS; DISSOCIATION; IONIZATION; AMMONIA; ICE	Water radiolysis by low-energy carbon projectiles is studied by first-principles molecular dynamics. Carbon projectiles of kinetic energies between 175 eV and 2.8 keV are shot across liquid water. Apart from translational, rotational and vibrational excitation, they produce water dissociation. The most abundant products are H and OH fragments. We find that the maximum spatial production of radiolysis products, not only occurs at low velocities, but also well below the maximum of energy deposition, reaching one H every 5 angstrom at the lowest speed studied (1 Bohr/fs), dissociative collisions being more significant at low velocity while the amount of energy required to dissociate water is constant and much smaller than the projectile's energy. A substantial fraction of the energy transferred to fragments, especially for high velocity projectiles, is in the form of kinetic energy, such fragments becoming secondary projectiles themselves. High velocity projectiles give rise to well-defined binary collisions, which should be amenable to binary approximations. This is not the case for lower velocities, where multiple collision events are observed. H secondary projectiles tend to move as radicals at high velocity, as cations when slower. We observe the generation of new species such as hydrogen peroxide and formic acid. The former occurs when an O radical created in the collision process attacks a water molecule at the O site. The latter when the C projectile is completely stopped and reacts with two water molecules.	[Kohanoff, Jorge; Artacho, Emilio] Queens Univ Belfast, Atomist Simulat Ctr, Belfast BT7 1NN, Antrim, North Ireland; [Kohanoff, Jorge] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Artacho, Emilio] Univ Cambridge, Cavendish Lab, Theory Condensed Matter, Cambridge CB3 0HE, England; [Artacho, Emilio] CIC Nanogune, Tolosa Hiribidea 76, San Sebastian 20018, Spain; [Artacho, Emilio] DIPC, Tolosa Hiribidea 76, San Sebastian 20018, Spain; [Artacho, Emilio] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain	Queens University Belfast; University of Cambridge; University of Cambridge; Basque Foundation for Science	Kohanoff, J (corresponding author), Queens Univ Belfast, Atomist Simulat Ctr, Belfast BT7 1NN, Antrim, North Ireland.; Kohanoff, J (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	j.kohanoff@qub.ac.uk	Artacho, Emilio/G-2616-2015; Kohanoff, Jorge/H-9874-2015	Artacho, Emilio/0000-0001-9357-1547; Kohanoff, Jorge/0000-0002-8237-7543	Wellcome Trust [084069/Z/07/Z]; Electron-Stopping, European Commission, Marie-Curie CIG [333813]; Spanish Ministry of Science [FIS2012-37549-C05]; Programa Red Guipuzcoana de Ciencia, Tecnologia e Innovacion, Diputacion Foral de Gipuzkoa [97/14]; UKCP [EP/F037325/1]; EPSRC [EP/F037325/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F037325/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Electron-Stopping, European Commission, Marie-Curie CIG; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Programa Red Guipuzcoana de Ciencia, Tecnologia e Innovacion, Diputacion Foral de Gipuzkoa; UKCP; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Wellcome Trust: flexible travel award 084069/Z/07/Z, https://wellcome.ac.uk/; Electron-Stopping 333813, European Commission, Marie-Curie CIG, http://ec.europa.eu/research/mariecurieactions/; FIS2012-37549-C05, Spanish Ministry of Science, http://www.idi.mineco.gob.es/stfls/MICINN/Ayudas/; Exp. 97/14 (Wet Nanoscopy) from the Programa Red Guipuzcoana de Ciencia, Tecnologia e Innovacion, Diputacion Foral de Gipuzkoa, http://www.gipuzkoa.eus/subvenciones/; and UKCP consortium EP/F037325/1, http://www.ukcp.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artacho E, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/27/275211; Baldacchino G, 2008, RAD CHEM BASICS APPL, P53; Blanksby SJ, 2003, ACCOUNTS CHEM RES, V36, P255, DOI 10.1021/ar020230d; Cavazzoni C, 1999, SCIENCE, V283, P44, DOI 10.1126/science.283.5398.44; Cobut V, 1998, RADIAT PHYS CHEM, V51, P85, DOI [10.1016/S0969-806X(97)00060-1, DOI 10.1016/S0969-806X(97)00060-1]; Deng ZW, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.243203; Emfietzoglou D, 2007, NUCL INSTRUM METH B, V257, P609, DOI 10.1016/j.nimb.2007.01.049; Fernandez-Serra MV, 2004, J CHEM PHYS, V121, P11136, DOI 10.1063/1.1813431; Gaigeot MP, 2007, J PHYS B-AT MOL OPT, V40, P1, DOI 10.1088/0953-4075/40/1/001; Grimes C.A., 2008, LIGHT WATER HYDROGEN, DOI [10.1007/978-0-387-68238-9, DOI 10.1007/978-0-387-68238-9]; HOLZAPFEL WB, 1969, J CHEM PHYS, V50, P4424, DOI 10.1063/1.1670914; Hunniford CA, 2007, PHYS MED BIOL, V52, P3729, DOI 10.1088/0031-9155/52/13/005; Kohanoff J, 2008, AIP CONF PROC, V1080, P78, DOI 10.1063/1.3058991; Markin SN, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.113201; McBride EJ, 2014, J PHYS CHEM A, V118, P6991, DOI 10.1021/jp502738x; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Pruneda JM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.235501; Pruneda JM, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.035106; Soler JM, 2002, J PHYS-CONDENS MAT, V14, P2745, DOI 10.1088/0953-8984/14/11/302; Solov'yov AV, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.011909; Von Sonntag C, 1987, CHEM BASIS RAD BIOL; WILSON WE, 1984, J CHEM PHYS, V80, P5631, DOI 10.1063/1.446628; Ziegler J. F., 1985, STOPPING RANGE IONS, V1	23	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0171820	10.1371/journal.pone.0171820	http://dx.doi.org/10.1371/journal.pone.0171820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267804	Green Submitted, Green Published, gold			2022-12-26	WOS:000396060600056
J	Liu, JM; Tong, WL; Chen, XY; Zhou, Y; Chen, WZ; Huang, SH; Liu, ZL				Liu, Jia-Ming; Tong, Wei-Lai; Chen, Xuan-Yin; Zhou, Yang; Chen, Wen-Zhao; Huang, Shan-Hu; Liu, Zhi-Li			The incidences and risk factors related to early dysphagia after anterior cervical spine surgery: A prospective study	PLOS ONE			English	Article							OROPHARYNGEAL DYSPHAGIA; OUTCOMES TOOL; SWAL-QOL; DISKECTOMY; FUSION; ADULTS	Dysphagia is a common complication following anterior cervical spine surgery (ACSS). The incidences of dysphagia were variable and controversial. The purpose of this study was to determine the incidence of early dysphagia after ACSS with a new scoring system, and to identify the risk factors of it. A prospective study was carried out and patients who underwent ACSS from March 2014 to August 2014 in our hospital were included in this study. A self-designed dysphagia questionnaire was delivered to all of the patients from the first day to the fifth day after ACSS. Perioperative characteristics of patients were recorded, and incidences and risk factors of dysphagia were analyzed. A total of 104 patients who underwent ACSS were included and incidences of dysphagia from the first to the fifth day after ACSS was 87.5%, 79.81%, 62.14%, 50% and 44.23%, respectively. There was a good correlation between the new dysphagia scoring system and Bazaz scoring system (P < 0.001). Operative time and body mass index (BMI) were the risk factors for dysphagia during the first to the second day postoperatively. However, the dC2-C7angle was the main risk factor for dysphagia from the third to the fifth day after surgery. There were comparatively high incidences of early dysphagia after ACSS, which may be ascribed to operative time, BMI and the dC2-C7 angle.	[Liu, Jia-Ming; Tong, Wei-Lai; Chen, Xuan-Yin; Zhou, Yang; Chen, Wen-Zhao; Huang, Shan-Hu; Liu, Zhi-Li] Nanchang Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Nanchang, Jiangxi, Peoples R China	Nanchang University	Liu, ZL (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Nanchang, Jiangxi, Peoples R China.	liuzhiliyfy@163.com			National Natural Science Foundation of China [81560435]; Department of Science and Technology Program Funds of Jiangxi Province, China [20123BBG70245, 20121BBG70037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology Program Funds of Jiangxi Province, China	Funded by National Natural Science Foundation of China 81560435 (Jia-Ming Liu) and Department of Science and Technology Program Funds of Jiangxi Province, China 20123BBG70245, 20121BBG70037 (Dr. Zhili Liu).	Baron EM, 2003, ANN OTO RHINOL LARYN, V112, P921, DOI 10.1177/000348940311201102; Bazaz R, 2002, SPINE, V27, P2453, DOI 10.1097/00007632-200211150-00007; Buttermann GR, 2008, SPINE J, V8, P426, DOI 10.1016/j.spinee.2006.12.006; Campbell PG, 2010, WORLD NEUROSURG, V74, P363, DOI 10.1016/j.wneu.2010.05.034; Cho SK, 2013, BONE JOINT J, V95B, P868, DOI 10.1302/0301-620X.95B7.31029; Edwards CC, 2004, J BONE JOINT SURG AM, V86A, P251, DOI 10.2106/00004623-200402000-00006; Fehlings MG, 2012, J NEUROSURG-SPINE, V16, P425, DOI 10.3171/2012.1.SPINE11467; Joaquim AF, 2014, SPINE J, V14, P2246, DOI 10.1016/j.spinee.2014.03.030; Kalb S, 2012, WORLD NEUROSURG, V77, P183, DOI 10.1016/j.wneu.2011.07.004; Kepler CK, 2012, SPINE J, V12, P639, DOI 10.1016/j.spinee.2012.03.024; Lee MJ, 2007, SPINE J, V7, P141, DOI 10.1016/j.spinee.2006.02.024; McAfee PC, 2010, J SPINAL DISORD TECH, V23, P1, DOI 10.1097/BSD.0b013e31819e2ab8; McHorney CA, 2000, DYSPHAGIA, V15, P122, DOI 10.1007/s004550010013; McHorney CA, 2002, DYSPHAGIA, V17, P97, DOI 10.1007/s00455-001-0109-1; Olsson EC, 2015, ORTHOPEDICS, V38, pE319, DOI 10.3928/01477447-20150402-61; Rihn JA, 2011, CLIN ORTHOP RELAT R, V469, P658, DOI 10.1007/s11999-010-1731-8; Skeppholm M, 2012, SPINE, V37, P996, DOI 10.1097/BRS.0b013e31823a7a5b; Tian W, 2013, DYSPHAGIA, V28, P131, DOI 10.1007/s00455-012-9421-1; Winslow CP, 2001, ARCH OTOLARYNGOL, V127, P51, DOI 10.1001/archotol.127.1.51	19	14	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173364	10.1371/journal.pone.0173364	http://dx.doi.org/10.1371/journal.pone.0173364			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267777	Green Published, gold, Green Submitted			2022-12-26	WOS:000396060600026
J	Uchida, R; Nakata, K; Kawano, F; Yonetani, Y; Ogasawara, I; Nakai, N; Mae, T; Matsuo, T; Tachibana, Y; Yokoi, H; Yoshikawa, H				Uchida, Ryohei; Nakata, Ken; Kawano, Fuminori; Yonetani, Yasukazu; Ogasawara, Issei; Nakai, Naoya; Mae, Tatsuo; Matsuo, Tomohiko; Tachibana, Yuta; Yokoi, Hiroyuki; Yoshikawa, Hideki			Vibration acceleration promotes bone formation in rodent models	PLOS ONE			English	Article							FREQUENCY MECHANICAL STIMULI; LOW-MAGNITUDE; TRABECULAR BONE; LOW-LEVEL; MORPHOGENETIC PROTEIN; WEIGHT-BEARING; LOW-INTENSITY; ENHANCE; RATS; STRENGTH	All living tissues and cells on Earth are subject to gravitational acceleration, but no reports have verified whether acceleration mode influences bone formation and healing. Therefore, this study was to compare the effects of two acceleration modes, vibration and constant (centrifugal) accelerations, on bone formation and healing in the trunk using BMP 2-induced ectopic bone formation (EBF) mouse model and a rib fracture healing (RFH) rat model. Additionally, we tried to verify the difference in mechanism of effect on bone formation by accelerations between these two models. Three groups (low-and high-magnitude vibration and control-VA groups) were evaluated in the vibration acceleration study, and two groups (centrifuge acceleration and control-CA groups) were used in the constant acceleration study. In each model, the intervention was applied for ten minutes per day from three days after surgery for eleven days (EBF model) or nine days (RFH model). All animals were sacrificed the day after the intervention ended. In the EBF model, ectopic bone was evaluated by macroscopic and histological observations, wet weight, radiography and microfocus computed tomography (micro-CT). In the RFH model, whole fracture-repaired ribs were excised with removal of soft tissue, and evaluated radiologically and histologically. Ectopic bones in the low-magnitude group (EBF model) had significantly greater wet weight and were significantly larger (macroscopically and radiographically) than those in the other two groups, whereas the size and wet weight of ectopic bones in the centrifuge acceleration group showed no significant difference compared those in control-CA group. All ectopic bones showed calcified trabeculae and maturated bone marrow. Micro-CT showed that bone volume (BV) in the low-magnitude group of EBF model was significantly higher than those in the other two groups (3.1 1.2mm(3) v.s. 1.8 1.2mm(3) in high-magnitude group and 1.3 0.9mm(3) in control-VA group), but BV in the centrifuge acceleration group had no significant difference compared those in control-CA group. Union rate and BV in the low-magnitude group of RFH model were also significantly higher than those in the other groups (Union rate: 60% v.s. 0% in the high-magnitude group and 10% in the control-VA group, BV: 0.69 0.30mm(3) v.s. 0.15 0.09mm(3) in high-magnitude group and 0.22 0.17mm(3) in control-VA group). BV/TV in the low-magnitude group of RFH model was significantly higher than that in control-VA group (59.4 14.9% v.s. 35.8 13.5%). On the other hand, radiographic union rate (10% in centrifuge acceleration group v.s. 20% in control-CA group) and micro-CT parameters in RFH model were not significantly different between two groups in the constant acceleration studies. Radiographic images of non-union rib fractures showed cartilage at the fracture site and poor new bone formation, whereas union samples showed only new bone. In conclusion, low-magnitude vibration acceleration promoted bone formation at the trunk in both BMP-induced ectopic bone formation and rib fracture healing models. However, the micro-CT parameters were not similar between two models, which suggested that there might be difference in the mechanism of effect by vibration between two models.	[Uchida, Ryohei; Yonetani, Yasukazu; Mae, Tatsuo; Matsuo, Tomohiko; Tachibana, Yuta; Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Dept Orthoped Surg, Osaka, Japan; [Uchida, Ryohei] Seifu Hosp, Dept Sports Med, Osaka, Japan; [Uchida, Ryohei; Nakata, Ken; Kawano, Fuminori; Ogasawara, Issei; Nakai, Naoya; Yokoi, Hiroyuki] Osaka Univ, Grad Sch Med, Dept Med Sports & Performing Arts, Osaka, Japan	Osaka University; Osaka University	Nakata, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Med Sports & Performing Arts, Osaka, Japan.	ken.nakata7@gmail.com	米谷, 泰一/AAO-2767-2021; Uchida, Ryohei/AAW-7733-2021		PROTEA JAPAN Company, Limited [J167701901]; Department of Medicine for Sports and Performing Arts, Osaka University Graduate School of Medicine; Grants-in-Aid for Scientific Research [26293336] Funding Source: KAKEN	PROTEA JAPAN Company, Limited; Department of Medicine for Sports and Performing Arts, Osaka University Graduate School of Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support was provided by PROTEA JAPAN Company, Limited [http://www.protea.co.jp], grant number J167701901. The initial of author who received the funding is K.N (Department of Medicine for Sports and Performing Arts, Osaka University Graduate School of Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Flieger J, 1998, CALCIFIED TISSUE INT, V63, P510, DOI 10.1007/s002239900566; Garman R, 2007, J ORTHOP RES, V25, P732, DOI 10.1002/jor.20354; Gilsanz V, 2006, J BONE MINER RES, V21, P1464, DOI 10.1359/JBMR.060612; Goodship AE, 2009, J ORTHOP RES, V27, P922, DOI 10.1002/jor.20824; Harrison A, 2016, ULTRASONICS, V70, P45, DOI 10.1016/j.ultras.2016.03.016; HASHIMOTO J, 1989, BONE, V10, P453, DOI 10.1016/8756-3282(89)90078-1; Hsieh YF, 2001, J BONE MINER RES, V16, P918, DOI 10.1359/jbmr.2001.16.5.918; MAHY PR, 1988, CLIN ORTHOP RELAT R, P236; Martin-Badosa E, 2003, COMPUT MED IMAG GRAP, V27, P447, DOI 10.1016/S0895-6111(03)00031-4; Martinez DA, 1998, AVIAT SPACE ENVIR MD, V69, pA17; Oxlund BS, 2003, BONE, V32, P69, DOI 10.1016/S8756-3282(02)00916-X; Ozcivici E, 2007, J BIOMECH, V40, P3404, DOI 10.1016/j.jbiomech.2007.05.015; Rubin C, 2002, J BONE MINER RES, V17, P349, DOI 10.1359/jbmr.2002.17.2.349; Rubin C, 2001, FASEB J, V15, P2225, DOI 10.1096/fj.01-0166com; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Rubin CT, 2001, DRUG DISCOV TODAY, V6, P848, DOI 10.1016/S1359-6446(01)01872-4; TAKAOKA K, 1988, CLIN ORTHOP RELAT R, P250; Torvinen S., 2003, EFFECT OF WHOLE BODY; Verschueren SMP, 2004, J BONE MINER RES, V19, P352, DOI 10.1359/JBMR.0301245; Vico L, 1999, EUR J APPL PHYSIOL, V80, P360, DOI 10.1007/s004210050604; von Stengel S, 2011, MED SCI SPORT EXER, V43, P1071, DOI 10.1249/MSS.0b013e318202f3d3; Ward K, 2004, J BONE MINER RES, V19, P360, DOI 10.1359/JBMR.040129; WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8; Wenger KH, 2010, BONE, V47, P746, DOI 10.1016/j.bone.2010.07.014; Xie LQ, 2006, BONE, V39, P1059, DOI 10.1016/j.bone.2006.05.012; Yoshikawa H, 2009, CLIN ORTHOP RELAT R, V467, P3087, DOI 10.1007/s11999-009-0976-6	27	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172614	10.1371/journal.pone.0172614	http://dx.doi.org/10.1371/journal.pone.0172614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264058	Green Published, Green Submitted, gold			2022-12-26	WOS:000396054300013
J	Carr, JS; King, S; Dekaney, CM				Carr, Jacquelyn S.; King, Stephanie; Dekaney, Christopher M.			Depletion of enteric bacteria diminishes leukocyte infiltration following doxorubicin-induced small intestinal damage in mice	PLOS ONE			English	Article							STREPTOCOCCUS-THERMOPHILUS TH-4; CYTO-TOXIC DRUGS; REPERFUSION INJURY; GUT MICROBIOTA; CELLS; APOPTOSIS; MUCOSITIS; RESPONSES; ACTIVATION; MECHANISMS	Background & aims While enteric bacteria have been shown to play a critical role in other forms of intestinal damage, their role in mediating the response to the chemotherapeutic drug Doxorubicin (Doxo) is unclear. In this study, we used a mouse model of intestinal bacterial depletion to evaluate the role enteric bacteria play in mediating Doxo-induced small intestinal damage and, more specifically, in mediating chemokine expression and leukocyte infiltration following Doxo treatment. An understanding of this pathway may allow for development of intervention strategies to reduce chemotherapy-induced small intestinal damage. Methods Mice were treated with (Abx) or without (NoAbx) oral antibiotics in drinking water for four weeks and then with Doxo. Jejunal tissues were collected at various time points following Doxo treatment and stained and analyzed for apoptosis, crypt damage and restitution, and macrophage and neutrophil number. In addition, RNA expression of inflammatory markers (TNF alpha, IL1-beta, IL-10) and cytokines (CCL2, CC7, KC) was assessed by qRT-PCR. Results In NoAbx mice Doxo-induced damage was associated with rapid induction of apoptosis in jejunal crypt epithelium and an increase weight loss and crypt loss. In addition, we observed an increase in immune-modulating chemokines CCL2, CCL7 and KC and infiltration of macrophages and neutrophils. In contrast, while still positive for induction of apoptosis following Doxo treatment, Abx mice showed neither the overall weight loss nor crypt loss seen in NoAbx mice nor the increased chemokine expression and leukocyte infiltration. Conclusion Enteric bacteria play a critical role in Doxo-induced small intestinal damage and are associated with an increase in immune-modulating chemokines and cells. Manipulation of enteric bacteria or the damage pathway may allow for prevention or treatment of chemotherapy induced small intestinal damage.	[Carr, Jacquelyn S.; Dekaney, Christopher M.] Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA; [King, Stephanie; Dekaney, Christopher M.] NC State Univ, Dept Mol Biomed Sci, Raleigh, NC 27695 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	Dekaney, CM (corresponding author), Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA.; Dekaney, CM (corresponding author), NC State Univ, Dept Mol Biomed Sci, Raleigh, NC 27695 USA.	chris_dekaney@ncsu.edu	, Histology Research Core Facility/ABF-6317-2021	Dekaney, Christopher/0000-0002-3252-1199	National Institutes of Health [DK100508, DK007737]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007737, R01DK100508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health, Grant #DK100508 to CMD and Grant #DK007737 to JSC (nitabov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhinder G, 2014, INFECT IMMUN, V82, P3753, DOI 10.1128/IAI.02045-14; BJARNASON I, 1991, GUT, V32, P275, DOI 10.1136/gut.32.3.275; Bojarski C, 2000, ANN NY ACAD SCI, V915, P270; BORDEN EC, 1987, J CLIN ONCOL, V5, P840, DOI 10.1200/JCO.1987.5.6.840; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Chen LW, 2008, SHOCK, V30, P563, DOI 10.1097/SHK.0b013e31816a3458; Coiffier B, 2010, BLOOD, V116, P2040, DOI 10.1182/blood-2010-03-276246; Dekaney CM, 2009, AM J PHYSIOL-GASTR L, V297, pG461, DOI 10.1152/ajpgi.90446.2008; Frantz AL, 2012, MUCOSAL IMMUNOL, V5, P501, DOI 10.1038/mi.2012.23; Goto S, 1996, ANTICANCER RES, V16, P2507; Hans W, 2000, EUR J GASTROEN HEPAT, V12, P267, DOI 10.1097/00042737-200012030-00002; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; IJIRI K, 1983, BRIT J CANCER, V47, P175, DOI 10.1038/bjc.1983.25; Kaczmarek A, 2012, J PATHOL, V226, P598, DOI 10.1002/path.3009; King SL, 2013, AM J PHYSIOL-GASTR L, V305, pG151, DOI 10.1152/ajpgi.00441.2012; Konaka A, 1999, PHARMACOL RES, V40, P517, DOI 10.1006/phrs.1999.0550; Marshman E, 2001, J PATHOL, V195, P285; Mizutani H, 2005, LIFE SCI, V76, P1439, DOI 10.1016/j.lfs.2004.05.040; MOORE JV, 1985, CANCER CHEMOTH PHARM, V15, P11; MOWAT AM, 1989, IMMUNOLOGY, V68, P18; Muhlbauer M, 2013, INFLAMM BOWEL DIS, V19, P2857, DOI 10.1097/01.MIB.0000435445.96933.37; Nakao T, 2012, J SURG RES, V173, P341, DOI 10.1016/j.jss.2010.10.003; Nigro G, 2014, CELL HOST MICROBE, V15, P792, DOI 10.1016/j.chom.2014.05.003; Nishikawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108494; Norris B, 2000, J CLIN ONCOL, V18, P2385, DOI 10.1200/JCO.2000.18.12.2385; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Rigby RJ, 2016, GUT MICROBES, V7, P414, DOI 10.1080/19490976.2016.1215806; Roulis M, 2015, MUCOSAL IMMUNOL; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Seiler KM, 2015, CELL TISSUE RES, V361, P427, DOI 10.1007/s00441-015-2111-1; SISLEY AC, 1994, J SURG RES, V57, P192, DOI 10.1006/jsre.1994.1130; Sun Z, 1998, SCAND J GASTROENTERO, V33, P415; Touchefeu Y, 2014, ALIMENT PHARM THER, V40, P409, DOI 10.1111/apt.12878; Wang HR, 2013, SCAND J GASTROENTERO, V48, P959, DOI 10.3109/00365521.2013.812142; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Watanabe T, 2008, GUT, V57, P181, DOI 10.1136/gut.2007.125963; Watanabe T, 2012, AM J PHYSIOL-GASTR L, V303, pG324, DOI 10.1152/ajpgi.00075.2012; Whitford EJ, 2009, CANCER BIOL THER, V8, P505, DOI 10.4161/cbt.8.6.7594; Xu Y, 2002, ANN ONCOL, V13, P1841, DOI 10.1093/annonc/mdf337; Xuan WJ, 2015, J LEUKOCYTE BIOL, V97, P61, DOI 10.1189/jlb.1A0314-170R; YAMADA T, 1993, INFLAMMATION, V17, P641, DOI 10.1007/BF00920471; Yeung CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138746; ZIMMERMAN BJ, 1992, SURG CLIN N AM, V72, P65	46	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173429	10.1371/journal.pone.0173429	http://dx.doi.org/10.1371/journal.pone.0173429			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257503	gold, Green Published, Green Submitted			2022-12-26	WOS:000396021100090
J	Eldridge, MDB; Miller, EJ; Neaves, LE; Zenger, KR; Herbert, CA				Eldridge, Mark D. B.; Miller, Emily J.; Neaves, Linda E.; Zenger, Kyall R.; Herbert, Catherine A.			Extensive genetic differentiation detected within a model marsupial, the tammar wallaby (Notamacropus eugenii)	PLOS ONE			English	Article							SOUTH-EASTERN AUSTRALIA; MACROPUS-EUGENII; ISLAND POPULATIONS; LINKAGE MAP; NEW-ZEALAND; NORTHERN AUSTRALIA; GREY KANGAROOS; FULIGINOSUS; DIVERSITY; GIGANTEUS	The tammar wallaby (Notamacropus eugenii) is one of the most intensively studied of all macropodids and was the first Australasian marsupial to have its genome sequenced. However, comparatively little is known about genetic diversity and differentiation amongst the morphologically distinct allopatric populations of tammar wallabies found in Western (WA) and South Australia (SA). Here we compare autosomal and Y-linked microsatellite genotypes, as well as sequence data (similar to 600 bp) from the mitochondrial DNA (mtDNA) control region (CR) in tammar wallabies from across its distribution. Levels of diversity at autosomal microsatellite loci were typically high in the WA mainland and Kangaroo Island (SA) populations (A = 8.9 - 10.6; He = 0.77 - 0.78) but significantly reduced in other endemic island populations (A = 3.8 - 4.1; He = 0.41 - 0.48). Autosomal and Y-linked microsatellite loci revealed a pattern of significant differentiation amongst populations, especially between SA and WA. The Kangaroo Island and introduced New Zealand population showed limited differentiation. Multiple divergent mtDNA CR haplotypes were identified within both SA and WA populations. The CR haplotypes of tammar wallabies from SA and WA show reciprocal monophyly and are highly divergent (14.5%), with levels of sequence divergence more typical of different species. Within WA tammar wallabies, island populations each have unique clusters of highly related CR haplotypes and each is most closely related to different WA mainland haplotypes. Y-linked microsatellite haplotypes show a similar pattern of divergence although levels of diversity are lower. In light of these differences, we suggest that two subspecies of tammar wallaby be recognized; Notamacropus eugenii eugenii in SA and N. eugenii derbianus in WA. The extensive neutral genetic diversity and inter-population differentiation identified within tammar wallabies should further increase the species value and usefulness as a model organism.	[Eldridge, Mark D. B.; Neaves, Linda E.] Australian Museum Res Inst, Sydney, NSW, Australia; [Eldridge, Mark D. B.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Miller, Emily J.; Herbert, Catherine A.] Univ New South Wales, Sch Biol Earth & Environm Sci, Kensington, NSW, Australia; [Neaves, Linda E.] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Zenger, Kyall R.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Zenger, Kyall R.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia; [Miller, Emily J.] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia; [Herbert, Catherine A.] Univ Sydney, Fac Vet Sci, Camperdown, NSW, Australia	Australian Museum; Macquarie University; University of New South Wales Sydney; James Cook University; James Cook University; University of Sydney; University of Sydney	Eldridge, MDB (corresponding author), Australian Museum Res Inst, Sydney, NSW, Australia.; Eldridge, MDB (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	mark.eldridge@austmus.gov.au	Neaves, Linda/AAY-6886-2020; Zenger, Kyall R/ABD-2101-2020; Herbert, Cathy/AAB-6609-2019	Neaves, Linda/0000-0002-5626-1029; Zenger, Kyall R/0000-0001-6817-8786; Herbert, Cathy/0000-0003-0174-0898; Eldridge, Mark/0000-0002-7109-0600	Australian Research Council Fellowship Scheme [F19905373]	Australian Research Council Fellowship Scheme(Australian Research Council)	This work was supported by the Australian Research Council Fellowship Scheme. Grant F19905373 (ME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott Ian, 1995, CALMScience, V1, P259; Alsemgeest J, 2013, VET IMMUNOL IMMUNOP, V155, P139, DOI 10.1016/j.vetimm.2013.06.009; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Aplin KP, 2015, ZOOTAXA, V4055, P1, DOI 10.11646/zootaxa.4055.1.1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Browning TL, 2001, CONSERV GENET, V2, P145, DOI 10.1023/A:1011850201944; Calaby J.H., 1988, Zoological Catalogue of Australia, V5, P60; COOPER DW, 1994, MAMM GENOME, V5, P531, DOI 10.1007/BF00354925; Coulson, 2010, MACROPODS BIOL KANGA; Crowther MS, 2002, AUST J ZOOL, V50, P627, DOI 10.1071/ZO02030; Deakin JE, 2010, MARSUPIAL GENETICS AND GENOMICS, P1, DOI 10.1007/978-90-481-9023-2; DEH, 2004, REINTR MAINL SA TAMM; Donnellan SC, 2009, EMU, V109, P143, DOI 10.1071/MU07011; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eldridge M.D.B., 2015, HDB MAMMALS WORLD, P630; Eldridge MDB, 2010, MARSUPIAL GENETICS AND GENOMICS, P461, DOI 10.1007/978-90-481-9023-2_22; Eldridge MDB, 2004, CONSERV GENET, V5, P325, DOI 10.1023/B:COGE.0000031148.59923.aa; Eldridge MDB, 2001, AUST J ZOOL, V49, P323, DOI 10.1071/ZO00082; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FORD J, 1987, EMU, V87, P158, DOI 10.1071/MU9870158; Frankham R, 2017, GENETIC MANAGEMENT OF FRAGMENTED ANIMAL AND PLANT POPULATIONS, P1, DOI 10.1093/oso/9780198783398.001.0001; Frankham R, 2012, HEREDITY, V108, P167, DOI 10.1038/hdy.2011.66; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Frankham R, 2012, BIOL CONSERV, V153, P25, DOI 10.1016/j.biocon.2012.04.034; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Fumagalli L, 1997, MOL ECOL, V6, P1199, DOI 10.1046/j.1365-294X.1997.00298.x; Gamat M, 2015, SEX DEV, V9, P216, DOI 10.1159/000439499; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Graves JAM, 2013, ANNU REV GENOM HUM G, V14, P393, DOI 10.1146/annurev-genom-091212-153452; Hadley C, 2009, AUST J ZOOL, V57, P337, DOI 10.1071/ZO08098; Haio A. B., 1961, Journal of the Royal Society of Western Australia, V44, P84; Hetz JA, 2016, MOL CELL ENDOCRINOL, V428, P148, DOI 10.1016/j.mce.2016.03.030; Hickford D, 2009, TAMMAR WALLABY MACRO, P449; HINDS LA, 1990, AUST J ZOOL, V37, P223; HINDS LA, 2008, MAMMALS AUSTR, P330; How RA, 2009, J ZOOL, V278, P206, DOI 10.1111/j.1469-7998.2009.00569.x; Jackson S. M, 2015, TAXONOMY AUSTR MAMMA; KEAST ALLEN, 1961, BULL MUS COMP ZOOL HARVARD UNIV, V123, P303; Keogh JS, 2005, EVOLUTION, V59, P226; King CM., 2005, HDB NZ MAMMALS; Kinnear JE, 2002, BIOL CONSERV, V108, P335, DOI 10.1016/S0006-3207(02)00116-7; KIRSCH J A W, 1972, Australian Journal of Zoology, V20, P315, DOI 10.1071/ZO9720315; Le Page SL, 2000, MOL ECOL, V9, P753, DOI 10.1046/j.1365-294x.2000.00922.x; MacDonald AJ, 2014, HEREDITY, V112, P333, DOI 10.1038/hdy.2013.109; MacDonald AJ, 2006, MOL ECOL NOTES, V6, P1202, DOI 10.1111/j.1471-8286.2006.01491.x; Macqueen P, 2009, MOL ECOL, V18, P3291, DOI 10.1111/j.1365-294X.2009.04262.x; Maxwell S., 1996, 1996 ACTION PLAN AUS; McKenzie LM, 1997, J HERED, V88, P398, DOI 10.1093/oxfordjournals.jhered.a023125; MCKENZIE LM, 1993, CYTOGENET CELL GENET, V64, P264, DOI 10.1159/000133590; McKenzie LM, 1995, ANZCCART NEWS, V8, P1; Menkhorst P.W., 2011, FIELD GUIDE MAMMALS, V3rd; Miller EJ, 2010, MACROPODS: THE BIOLOGY OF KANGAROOS, WALLABIES AND RAT-KANGAROOS, P77; Miller EJ, 2011, CONSERV GENET, V12, P1619, DOI 10.1007/s10592-011-0265-2; Miller EJ, 2010, REPROD FERT DEVELOP, V22, P539, DOI 10.1071/RD09061; Modepalli V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1012; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Neaves LE, 2010, HEREDITY, V104, P502, DOI 10.1038/hdy.2009.137; Neaves LE, 2013, AUST J ZOOL, V61, P58, DOI 10.1071/ZO12087; Neaves LE, 2012, J BIOGEOGR, V39, P1545, DOI 10.1111/j.1365-2699.2012.02702.x; Neaves LE, 2009, MOL ECOL, V18, P3363, DOI 10.1111/j.1365-294X.2009.04293.x; OLIVER AJ, 1979, AUST J ZOOL, V27, P363, DOI 10.1071/ZO9790363; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; POOLE WE, 1974, AUST J ZOOL, V22, P277, DOI 10.1071/ZO9740277; POOLE WE, 1991, WILDLIFE RES, V18, P625, DOI 10.1071/WR9910625; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Renfree MB, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r81; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robinson A., 1996, S AUSTR OFFSHORE ISL; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Salinas M, 2009, AUST J ZOOL, V57, P41, DOI 10.1071/ZO08097; Schodde R, 1999, DIRECTORY AUSTR BIRD; Spencer PBS, 2001, AUST J ZOOL, V49, P369, DOI 10.1071/ZO00080; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Sunnucks P, 2000, MOL ECOL, V9, P1699, DOI 10.1046/j.1365-294x.2000.01084.x; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Taylor AC, 1999, ANIM CONSERV, V2, P195, DOI 10.1111/j.1469-1795.1999.tb00065.x; Taylor AC, 1999, ANIM CONSERV, V2, P41, DOI 10.1111/j.1469-1795.1999.tb00047.x; Taylor AC, 1998, MOL ECOL, V7, P925; Telfer WR, 2010, AUST J ZOOL, V58, P104, DOI 10.1071/ZO09119; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toon A, 2010, MOL ECOL, V19, P2980, DOI 10.1111/j.1365-294X.2010.04730.x; Toon A, 2007, MOL ECOL, V16, P2525, DOI 10.1111/j.1365-294X.2007.03289.x; Tyndale-Biscoe CH, 1988, DEV MARSUPIAL MODELS; Tyndale-Biscoe CH., 1987, REPROD PHYSL MARSUPI; TyndaleBiscoe H, 2005, LIFE OF MARSUPIALS, P1; Wang CW, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-72; Wang CW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-422; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wright M, 1999, KANGAROO ISLAND TAMM; Zenger KR, 2005, CONSERV GENET, V6, P193, DOI 10.1007/s10592-004-7828-4; Zenger KR, 2001, MOL ECOL NOTES, V1, P98, DOI 10.1046/j.1471-8278.2001.00044.x; Zenger KR, 2001, ANIM GENET, V32, P166, DOI 10.1046/j.1365-2052.2001.0723d.x; Zenger KR, 2002, GENETICS, V162, P321	100	7	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172777	10.1371/journal.pone.0172777	http://dx.doi.org/10.1371/journal.pone.0172777			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257440	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000396021100027
J	Pascacio-Villafan, C; Birke, A; Williams, T; Aluja, M				Pascacio-Villafan, Carlos; Birke, Andrea; Williams, Trevor; Aluja, Martin			Modeling the cost-effectiveness of insect rearing on artificial diets: A test with a tephritid fly used in the sterile insect technique	PLOS ONE			English	Article							ABBREVIATUS COLEOPTERA-CURCULIONIDAE; DIPTERA-TEPHRITIDAE; LARVAL DIET; PERFORMANCE; PROTEIN; GROWTH; ENERGY; FEASIBILITY; PROGRAMS; FEEDS	We modeled the cost-effectiveness of rearing Anastrepha ludens, a major fruit fly pest currently mass reared for sterilization and release in pest control programs implementing the sterile insect technique (SIT). An optimization model was generated by combining response surface models of artificial diet cost savings with models of A. ludens pupation, pupal weight, larval development time and adult emergence as a function of mixtures of yeast, a costly ingredient, with corn flour and corncob fractions in the diet. Our model revealed several yeast-reduced mixtures that could be used to prepare diets that were considerably cheaper than a standard diet used for mass rearing. Models predicted a similar production of insects (pupation and adult emergence), with statistically similar pupal weights and larval development times between yeast-reduced diets and the standard mass rearing diet formulation. Annual savings from using the modified diets could be up to 5.9% of the annual cost of yeast, corn flour and corncob fractions used in the standard diet, representing a potential saving of US $27.45 per ton of diet (US $47,496 in the case of the mean annual production of 1,730.29 tons of artificial diet in the Moscafrut mass rearing facility at Metapa, Chiapas, Mexico). Implementation of the yeast-reduced diet on an experimental scale at mass rearing facilities is still required to confirm the suitability of new mixtures of artificial diet for rearing A. ludens for use in SIT. This should include the examination of critical quality control parameters of flies such as adult flight ability, starvation resistance and male sexual competitiveness across various generations. The method used here could be useful for improving the cost-effectiveness of invertebrate or vertebrate mass rearing diets worldwide.	[Pascacio-Villafan, Carlos; Birke, Andrea; Williams, Trevor; Aluja, Martin] Inst Ecol AC, Cluster Cient & Tecnol BioMim, Red Manejo Biorrac Plagas & Vectores, Xalapa, Veracruz, Mexico	Instituto de Ecologia - Mexico	Pascacio-Villafan, C; Aluja, M (corresponding author), Inst Ecol AC, Cluster Cient & Tecnol BioMim, Red Manejo Biorrac Plagas & Vectores, Xalapa, Veracruz, Mexico.	cpascacio@hotmail.com; martin.aluja@inecol.mx	Biewendt, Andrea Barbara Birke/Q-6287-2018; Pascacio-Villafán, Carlos/Q-6202-2018; Williams, Trevor/F-1447-2011; Williams, Trevor/ABG-3961-2020; Aluja, Martín/Q-6810-2018	Biewendt, Andrea Barbara Birke/0000-0001-5870-3153; Pascacio-Villafán, Carlos/0000-0002-1431-9667; Williams, Trevor/0000-0003-3414-3440; Aluja, Martín/0000-0002-2936-3011	Asociacion de Productores, Empacadores y Exportadores de Aguacate de Mexico, A.C. (APEAM); Campana Nacional contra Moscas de la Fruta SAGARPA-IICA-INECOL; Campana Nacional contra Moscas de la Fruta SAGARPA-CONACOFI-INECOL; Institute de Ecologia, A.C. (INECOL); Mexican Consejo Nacional de Ciencia y Tecnologia (CONACyT	Asociacion de Productores, Empacadores y Exportadores de Aguacate de Mexico, A.C. (APEAM); Campana Nacional contra Moscas de la Fruta SAGARPA-IICA-INECOL; Campana Nacional contra Moscas de la Fruta SAGARPA-CONACOFI-INECOL; Institute de Ecologia, A.C. (INECOL); Mexican Consejo Nacional de Ciencia y Tecnologia (CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding was provided by the Asociacion de Productores, Empacadores y Exportadores de Aguacate de Mexico, A.C. (APEAM), the Campana Nacional contra Moscas de la Fruta SAGARPA-IICA-INECOL and SAGARPA-CONACOFI-INECOL and the Institute de Ecologia, A.C. (INECOL). CP-V gratefully acknowledges a student scholarship from the Mexican Consejo Nacional de Ciencia y Tecnologia (CONACyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluja M, 2009, BIOCONTROL SCI TECHN, V19, P49, DOI 10.1080/09583150802377373; Anderson M.J., 2016, RSM SIMPLIFIED OPTIM; Anderson-Cook C.M., 2016, RESPONSE SURFACE MET; Basurco V, 2015, J APPL POULTRY RES, V24, P304, DOI 10.3382/japr/pfv030; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Catacutan MR, 2002, AQUACULTURE, V208, P113, DOI 10.1016/S0044-8486(01)00709-8; Chaudhury MF, 2007, J ECON ENTOMOL, V100, P241, DOI 10.1603/0022-0493(2007)100[241:ACFDFS]2.0.CO;2; Cohen AC, 2004, INSECT DIETS SCI TEC; Cohen Allen Carson, 2001, American Entomologist, V47, P198; Cook R. D., 1982, RESIDUALS AND INFLUE; Cornell J.A., 2011, PRIMER EXPT MIXTURES; De Santis C, 2015, AQUACULTURE, V444, P70, DOI 10.1016/j.aquaculture.2015.03.024; Direccion General de Sanidad Vegetal-Direccion de Moscas de la Fruta (DGSV-DMF), 2009, CRIA MAS AN LUD; Dominguez J., 2010, MOSCAS FRUTA FUNDAME, P259; Ekesi S, 2007, ANN ENTOMOL SOC AM, V100, P562, DOI 10.1603/0013-8746(2007)100[562:ATASRO]2.0.CO;2; Enkerlin WR, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P651, DOI 10.1007/1-4020-4051-2_25; Estes AM, 2012, J APPL ENTOMOL, V136, P1, DOI 10.1111/j.1439-0418.2011.01620.x; FAO/IAEA/USDA, 2014, MAN PROD QUAL CONTR; Forster IP, 2010, AQUACULTURE, V298, P260, DOI 10.1016/j.aquaculture.2009.10.023; Garcia S, 2011, AQUACULT NUTR, V17, pE174, DOI 10.1111/j.1365-2095.2009.00746.x; Gutierrez J. M., 2013, PROGRAMAS MOSCAS FRU; Hernandez E, 2014, INT J TROP INSECT SC, V34, pS13, DOI 10.1017/S1742758414000046; Hernandez E, 2010, FLA ENTOMOL, V93, P167, DOI 10.1653/024.093.0204; Jeffs A, 2000, J WORLD AQUACULT SOC, V31, P30, DOI 10.1111/j.1749-7345.2000.tb00695.x; Lapointe SL, 2008, J INSECT PHYSIOL, V54, P1157, DOI 10.1016/j.jinsphys.2008.04.020; Lapointe SL, 2010, ENVIRON ENTOMOL, V39, P670, DOI 10.1603/EN09304; Lapointe SL, 2010, FLA ENTOMOL, V93, P56, DOI 10.1653/024.093.0108; Liu SY, 2015, 26 ANN AUSTR POULTR, P52; Moadeli T, 2016, J PEST SCI; Myers R., 1990, CLASSICAL MODERN REG; Pascacio-Villafan C, 2015, J ECON ENTOMOL, V108, P53, DOI 10.1093/jee/tou033; Pascacio-Villafan C, 2016, SCI REP-UK, V6, DOI 10.1038/srep29413; RIVERA J. Pedro, 2012, Acta Zool. Mex, V28, P102; PIEPEL GF, 1994, J QUAL TECHNOL, V26, P177, DOI 10.1080/00224065.1994.11979525; PINSON E, 1993, FRUIT FLIES, P285; Pinson E, 1990, PROGRAMA Y RESUMENES, P147; Ramirez F, 2016, 9 M WORK GROUP FRUIT; Rempoulakis P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157679; Rull J, 2012, ENTOMOL EXP APPL, V142, P78, DOI 10.1111/j.1570-7458.2011.01196.x; Ruohonen K, 2004, AQUACULT NUTR, V10, P145, DOI 10.1111/j.1365-2095.2004.00277.x; Ruohonen K, 2003, AQUACULTURE, V225, P27, DOI 10.1016/S0044-8486(03)00275-8; Sartori D, 2016, AQUACULT NUTR, V22, P1214, DOI 10.1111/anu.12326; TANAKA N, 1972, J ECON ENTOMOL, V65, P866, DOI 10.1093/jee/65.3.866; Weisberg S., 1985, APPL LINEAR REGRESSI; Welsch R, 1980, REGRESSION DIAGNOSTI; Woyengo TA, 2014, J ANIM SCI, V92, P1293, DOI 10.2527/jas.2013-7169; Zar J.H, 2010, BIOSTATICAL ANAL	47	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173205	10.1371/journal.pone.0173205	http://dx.doi.org/10.1371/journal.pone.0173205			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257496	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100077
J	Li, Z; Duan, XG; Chen, S; Wu, J				Li, Zhu; Duan, Xuguo; Chen, Sheng; Wu, Jing			Improving the reversibility of thermal denaturation and catalytic efficiency of Bacillus licheniformis alpha-amylase through stabilizing a long loop in domain B	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; THERMOSTABILITY; DETERMINANTS; RESIDUES; SITE	The reversibility of thermal denaturation and catalytic efficiency of Bacillus licheniformis aamylase were improved through site-directed mutagenesis. By using multiple sequence alignment and PoPMuSiC algorithm, Ser187 and Asn188, which located within a long loop in Domain B of Bacillus licheniformis alpha-amylase, were selected for mutation. In addition, Ala269, which is adjacent to Ser187 and Asn188, was also investigated. Seven mutants carrying the mutations S187D, N188T, N188S, A269K, A269K/S187D, S187D/N188T, and A269K/S187D/N188T were generated and characterized. The most thermostable mutant, A269K/S187D/N188T, exhibited a 9-fold improvement in half-life at 95 degrees C and pH 5.5, compared with that of the wild-type enzyme. Mutant A269K/S187D/N188T also exhibited improved catalytic efficiency. The catalytic efficiency of mutant A269K/S187D/N188T reached 5.87x10(3)+/- 0.17 g.L-(1).s-(1) at pH 5.5, which is 1.84-fold larger than the corresponding value determined for the wild-type enzyme. Furthermore, the structure analysis showed that immobilization of the loop containing Ser187 and Asn188 plays a significant role in developing the properties of Bacillus licheniformis a-amylase.	[Li, Zhu; Duan, Xuguo; Chen, Sheng; Wu, Jing] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Li, Zhu; Duan, Xuguo; Chen, Sheng; Wu, Jing] Jiangnan Univ, Minist Educ, Sch Biotechnol, Wuxi, Peoples R China; [Li, Zhu; Duan, Xuguo; Chen, Sheng; Wu, Jing] Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China; [Duan, Xuguo] Nanjing Forestry Univ, Coll Light Ind Sci & Engn, Dept Food Sci & Engn, Nanjing, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University; Nanjing Forestry University	Wu, J (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.; Wu, J (corresponding author), Jiangnan Univ, Minist Educ, Sch Biotechnol, Wuxi, Peoples R China.; Wu, J (corresponding author), Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China.	jingwu@jiangnan.edu.cn	Wu, Jing/GZK-5063-2022	Duan, Xuguo/0000-0002-2136-0449	National Natural Science Foundation of China [31571776]; National Science Fund for Distinguished Young Scholars [31425020]; Project of Outstanding Science and Technological Innovation Group of Jiangsu Province; Production and Research Prospective Joint Research Project of Jiangsu Province [BY2015019-32]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Project of Outstanding Science and Technological Innovation Group of Jiangsu Province; Production and Research Prospective Joint Research Project of Jiangsu Province	This work was supported by grants from the National Natural Science Foundation of China (31571776), the National Science Fund for Distinguished Young Scholars (31425020), the Project of Outstanding Science and Technological Innovation Group of Jiangsu Province (Jing Wu), and the Production and Research Prospective Joint Research Project of Jiangsu Province (BY2015019-32).	Ali Mamdouh Ben, 2001, Enzyme and Microbial Technology, V28, P537, DOI 10.1016/S0141-0229(01)00294-0; Alikhajeh J, 2010, ACTA CRYSTALLOGR F, V66, P121, DOI 10.1107/S1744309109051938; [Anonymous], 2014, APPL MICROBIOL BIOT, V98, P8937; Ben Ali M, 2006, BIOCHEM J, V394, P51, DOI 10.1042/BJ20050726; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzozowski AM, 2000, BIOCHEMISTRY-US, V39, P9099, DOI 10.1021/bi0000317; Declerck N, 2002, BIOLOGIA, V57, P203; Declerck N, 2003, PROTEIN ENG, V16, P287, DOI 10.1093/proeng/gzg032; Declerck N, 2000, J MOL BIOL, V301, P1041, DOI 10.1006/jmbi.2000.4025; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta R, 2003, PROCESS BIOCHEM, V38, P1599, DOI 10.1016/S0032-9592(03)00053-0; Igarashi K, 1998, BIOCHEM BIOPH RES CO, V248, P372, DOI 10.1006/bbrc.1998.8970; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li ZF, 2010, APPL MICROBIOL BIOT, V85, P553, DOI 10.1007/s00253-009-2157-7; Li Z, 2016, J BIOTECHNOL, V222, P65, DOI 10.1016/j.jbiotec.2016.02.013; Liu YH, 2008, APPL MICROBIOL BIOT, V80, P795, DOI 10.1007/s00253-008-1580-5; MACHIUS M, 1995, J MOL BIOL, V246, P545, DOI 10.1006/jmbi.1994.0106; Machius M, 2003, J BIOL CHEM, V278, P11546, DOI 10.1074/jbc.M212618200; Machius M, 1998, STRUCTURE, V6, P281, DOI 10.1016/S0969-2126(98)00032-X; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nielsen JE, 2001, PROTEIN ENG, V14, P505, DOI 10.1093/protein/14.7.505; Nielsen JE, 2000, BBA-PROTEIN STRUCT M, V1543, P253, DOI 10.1016/S0167-4838(00)00240-5; Nielsen JE, 1999, EUR J BIOCHEM, V264, P816, DOI 10.1046/j.1432-1327.1999.00664.x; Offen WA, 2015, ACTA CRYSTALLOGR F, V71, P66, DOI 10.1107/S2053230X14026508; Sharma A, 2013, PROCESS BIOCHEM, V48, P201, DOI 10.1016/j.procbio.2012.12.018; Shaw A, 1999, CURR OPIN BIOTECH, V10, P349, DOI 10.1016/S0958-1669(99)80063-9; Suvd D, 2001, J BIOCHEM, V129, P461, DOI 10.1093/oxfordjournals.jbchem.a002878; SUZUKI Y, 1989, J BIOL CHEM, V264, P18933; SVENSSON B, 1994, PLANT MOL BIOL, V25, P141, DOI 10.1007/BF00023233; TOMAZIC SJ, 1988, J BIOL CHEM, V263, P3092; VIHINEN M, 1989, CRIT REV BIOCHEM MOL, V24, P329, DOI 10.3109/10409238909082556	33	8	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173187	10.1371/journal.pone.0173187	http://dx.doi.org/10.1371/journal.pone.0173187			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253342	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300089
J	Toi, CS; Webb, CE; Haniotis, J; Clancy, J; Doggett, SL				Toi, Cheryl S.; Webb, Cameron E.; Haniotis, John; Clancy, John; Doggett, Stephen L.			Seasonal activity, vector relationships and genetic analysis of mosquito-borne Stratford virus	PLOS ONE			English	Article							ROSS-RIVER-VIRUS; AEDES-NOTOSCRIPTUS DIPTERA; BARMAH FOREST VIRUS; ARBOVIRUS EVOLUTION; NORTHERN-TERRITORY; VIGILAX DIPTERA; MAROOCHY SHIRE; CULICIDAE; TRANSMISSION; AUSTRALIA	There are many gaps to be filled in our understanding of mosquito-borne viruses, their relationships with vectors and reservoir hosts, and the environmental drivers of seasonal activity. Stratford virus (STRV) belongs to the genus Flavivirus and has been isolated from mosquitoes and infected humans in Australia but little is known of its vector and reservoir host associations. A total of 43 isolates of STRV from mosquitoes collected in New South Wales between 1995 and 2013 was examined to determine the genetic diversity between virus isolates and their relationship with mosquito species. The virus was isolated from six mosquito species; Aedes aculeatus, Aedes alternans, Aedes notoscriptus, Aedes procax, Aedes vigilax, and Anopheles annulipes. While there were distinct differences in temporal and spatial activity of STRV, with peaks of activity in 2006, 2010 and 2013, a sequence homology of 95.9%-98.4% was found between isolates and the 1961 STRV prototype with 96.2%-100% identified among isolates. Temporal differences but no apparent nucleotide divergence by mosquito species or geographic location was evident. The result suggests the virus is geographically widespread in NSW (albeit only from coastal regions) and increased local STRV activity is likely to be driven by reservoir host factors and local environmental conditions influencing vector abundance. While STRV may not currently be associated with major outbreaks of human disease, with the potential for urbanisation and climate change to increase mosquito-borne disease risks, and the possibility of genomic changes which could produce pathogenic strains, understanding the drivers of STRV activity may assist the development of strategic response to public health risks posed by zoonotic flaviviruses in Australia.	[Toi, Cheryl S.; Webb, Cameron E.; Haniotis, John; Clancy, John; Doggett, Stephen L.] Westmead Hosp, NSW Hlth Pathol, Ctr Infect Dis & Microbiol Lab Serv, Dept Med Entomol, Westmead, NSW, Australia; [Webb, Cameron E.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Toi, CS (corresponding author), Westmead Hosp, NSW Hlth Pathol, Ctr Infect Dis & Microbiol Lab Serv, Dept Med Entomol, Westmead, NSW, Australia.	cheryl.toi@health.nsw.gov.au		Webb, Cameron/0000-0003-1029-5140	NSW Ministry of Health; Centre for Infectious Diseases and Microbiology-Public Health and Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney	NSW Ministry of Health; Centre for Infectious Diseases and Microbiology-Public Health and Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney	All STRV isolates were part of the New South Wales Arbovirus and Mosquito Monitoring Program, which is funded by the NSW Ministry of Health. Additional funding for analysis and manuscript preparation was provided by Centre for Infectious Diseases and Microbiology-Public Health and Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUGHTON CR, 1986, MED J AUSTRALIA, V145, P90, DOI 10.5694/j.1326-5377.1986.tb101087.x; Boyd AM, 1999, J MED ENTOMOL, V36, P186, DOI 10.1093/jmedent/36.2.186; Broom AK, 1998, PATHOLOGY, V30, P286, DOI 10.1080/00313029800169456; Ciota AT, 2010, VIRUSES-BASEL, V2, P2594, DOI 10.3390/v2122594; Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Doggett SL., 2009, ARBOVIRUS RES AUSTR, V10, P28; Doggett Stephen L., 1997, Arbovirus Research in Australia, V7, P79; DOHERTY RL, 1963, AUST J EXP BIOL MED, V41, P17, DOI 10.1038/icb.1963.2; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Endersby NM, 2013, INFECT GENET EVOL, V18, P191, DOI 10.1016/j.meegid.2013.04.035; Flies EJ, 2015, VECTOR-BORNE ZOONOT, V15, P397, DOI 10.1089/vbz.2014.1759; Hardy CM, 2015, MITOCHONDR DNA, P1; Hardy CM, 2014, MITOCHONDR DNA, P1; Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001; HAWKES RA, 1985, MED J AUSTRALIA, V143, P555, DOI 10.5694/j.1326-5377.1985.tb119949.x; Hemmerter S, 2009, MOL PHYLOGENET EVOL, V50, P317, DOI 10.1016/j.ympev.2008.11.016; Hu W, 2010, ENVIRON ENTOMOL, V39, P88, DOI 10.1603/EN07037; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7; Jacups SP, 2009, J VECTOR ECOL, V34, P311, DOI [10.1111/j.1948-7134.2009.00039.x, 10.3376/038.034.0217]; Jacups SP, 2008, TROP MED INT HEALTH, V13, P943, DOI 10.1111/j.1365-3156.2008.02095.x; Jacups SP, 2011, J MED ENTOMOL, V48, P453, DOI 10.1603/ME10193; Jansen CC, 2009, AM J TROP MED HYG, V81, P849, DOI 10.4269/ajtmh.2009.09-0008; Jansen CC, 2009, J AM MOSQUITO CONTR, V25, P272, DOI 10.2987/09-5908.1; Johansen Cheryl A., 2005, Arbovirus Research in Australia, V9, P164; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kay BH, 2008, AUST J ENTOMOL, V47, P142, DOI 10.1111/j.1440-6055.2008.00641.x; Kay BH, 2007, AM J TROP MED HYG, V76, P417, DOI 10.4269/ajtmh.2007.76.417; Kent RJ, 2005, AM J TROP MED HYG, V73, P336, DOI 10.4269/ajtmh.2005.73.336; Knox J, 2012, MED J AUSTRALIA, V196, P322, DOI 10.5694/mja11.11026; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; LINDSAY MDA, 1993, J VIROL, V67, P3576, DOI 10.1128/JVI.67.6.3576-3585.1993; MACKENZIE JS, 1994, ARCH VIROL, V136, P447, DOI 10.1007/BF01321074; Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16; May FJ, 2013, J GEN VIROL, V94, P1462, DOI 10.1099/vir.0.049940-0; Nisbet DJ, 2005, J GEN VIROL, V86, P121, DOI 10.1099/vir.0.80381-0; Poidinger M, 1997, AM J TROP MED HYG, V57, P230, DOI 10.4269/ajtmh.1997.57.230; Poidinger M, 2000, VIRUS RES, V68, P7, DOI 10.1016/S0168-1702(00)00143-X; Potter A, 2014, VECTOR-BORNE ZOONOT, V14, P740, DOI 10.1089/vbz.2014.1617; Puslednik L, 2012, J BIOGEOGR, V39, P1333, DOI 10.1111/j.1365-2699.2012.02683.x; Roche SE, 2013, AUST VET J, V91, P5, DOI 10.1111/avj.12018; Rohe D.L., 1979, Bulletin of the Society of Vector Ecologists, V4, P24; Russell R. C., 1995, Review of Medical and Veterinary Entomology, V83, P141; Russell R. C., 1993, MOSQUITOES MOSQUITO; Russell RC, 2004, AUST J ENTOMOL, V43, P271, DOI 10.1111/j.1326-6756.2004.00436.x; Russell RC, 2009, AUST J ENTOMOL, V48, P1, DOI 10.1111/j.1440-6055.2008.00677.x; Ryan PA, 1999, J MED ENTOMOL, V36, P856, DOI 10.1093/jmedent/36.6.856; Ryan PA, 2000, AUST J ENTOMOL, V39, P212, DOI 10.1046/j.1440-6055.2000.00169.x; Ryan PA, 1997, AM J TROP MED HYG, V57, P476, DOI 10.4269/ajtmh.1997.57.476; Sammels LM, 1999, J GEN VIROL, V80, P739, DOI 10.1099/0022-1317-80-3-739; Stapleford KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004402; Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van den Hurk AF, 2009, AM J TROP MED HYG, V81, P457, DOI 10.4269/ajtmh.2009.81.457; Warrilow D, 2014, GENOME ANNOUNC, V2; Watson TM, 2000, J MED ENTOMOL, V37, P380, DOI 10.1603/0022-2585(2000)037[0380:ANDCSA]2.0.CO;2; Watson TM, 1999, J MED ENTOMOL, V36, P508, DOI 10.1093/jmedent/36.4.508; Watson TM, 1998, J MED ENTOMOL, V35, P104, DOI 10.1093/jmedent/35.2.104; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Webb CE, 1999, J AM MOSQUITO CONTR, V15, P242; Yang GJ, 2008, ECOL APPL, V18, P2028, DOI 10.1890/07-1209.1	62	7	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173105	10.1371/journal.pone.0173105	http://dx.doi.org/10.1371/journal.pone.0173105			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253306	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300078
J	Cannito, S; Morello, E; Bocca, C; Foglia, B; Benetti, E; Novo, E; Chiazza, F; Rogazzo, M; Fantozzi, R; Povero, D; Sutti, S; Bugianesi, E; Feldstein, AE; Albano, E; Collino, M; Parola, M				Cannito, Stefania; Morello, Elisabetta; Bocca, Claudia; Foglia, Beatrice; Benetti, Elisa; Novo, Erica; Chiazza, Fausto; Rogazzo, Mara; Fantozzi, Roberto; Povero, Davide; Sutti, Salvatore; Bugianesi, Elisabetta; Feldstein, Ariel E.; Albano, Emanuele; Collino, Massimo; Parola, Maurizio			Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; LIVER-DISEASE; EXTRACELLULAR VESICLES; ENDOTHELIAL-CELLS; NATURAL-HISTORY; CANCER-CELLS; MICROPARTICLES; HEPATOCYTES; MECHANISMS; FIBROSIS	Non-Alcoholic Fatty Liver Disease (NAFLD) is a major form of chronic liver disease in the general population in relation to its high prevalence among overweight/obese individuals and patients with diabetes type II or metabolic syndrome. NAFLD can progress to steatohepatitis (NASH), fibrosis and cirrhosis and end-stage of liver disease but mechanisms involved are still incompletely characterized. Within the mechanisms proposed to mediate the progression of NAFLD, lipotoxicity is believed to play a major role. In the present study we provide data suggesting that microvesicles (MVs) released by fat-laden cells undergoing lipotoxicity can activate NLRP3 inflammasome following internalization by either cells of hepatocellular origin or macrophages. Inflammasome activation involves NF-kB-mediated up-regulation of NLRP3, pro-caspase-1 and pro-Interleukin-1, then inflammasome complex formation and Caspase-1 activation leading finally to an increased release of IL-1 beta. Since the release of MVs from lipotoxic cells and the activation of NLRP3 inflammasome have been reported to occur in vivo in either clinical or experimental NASH, these data suggest a novel rational link between lipotoxicity and increased inflammatory response.	[Cannito, Stefania; Morello, Elisabetta; Bocca, Claudia; Foglia, Beatrice; Novo, Erica; Parola, Maurizio] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Benetti, Elisa; Chiazza, Fausto; Rogazzo, Mara; Fantozzi, Roberto; Collino, Massimo] Univ Turin, Dept Drug Sci & Technol, Turin, Italy; [Povero, Davide; Feldstein, Ariel E.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Sutti, Salvatore; Albano, Emanuele] Univ Amedeo Avogadro East Piedmont, Dept Hlth Sci, Novara, Italy; [Sutti, Salvatore; Albano, Emanuele] Univ Amedeo Avogadro East Piedmont, Interdisciplinary Res Ctr Autoimmune Dis, Novara, Italy; [Bugianesi, Elisabetta] Univ Turin, Dept Med Sci, Div Gastroenterol, Turin, Italy	University of Turin; University of Turin; University of California System; University of California San Diego; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; University of Turin	Parola, M (corresponding author), Univ Turin, Dept Clin & Biol Sci, Turin, Italy.	maurizio.parola@unito.it	Foglia, Beatrice/AAF-4279-2020; Chiazza, Fausto/I-5559-2015; Foglia, Beatrice/E-5592-2017; Collino, Massimo/AAK-8532-2020; Sutti, Salvatore/X-5716-2019	Foglia, Beatrice/0000-0001-7973-9681; Foglia, Beatrice/0000-0001-7973-9681; Collino, Massimo/0000-0001-8782-3496; Sutti, Salvatore/0000-0002-0192-8199; Cannito, Stefania/0000-0001-9883-6882; novo, erica/0000-0003-2586-4246; Chiazza, Fausto/0000-0001-7273-0051	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano, Italy) [15274]; University of Torino (Fondo di Ateneo)	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano, Italy)(Fondazione AIRC per la ricerca sul cancro); University of Torino (Fondo di Ateneo)	This study has been funded by: i) Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano, Italy), IG-2014 grant, project code 15274, (to MP); ii) the University of Torino (Fondo di Ateneo ex 60%, to EN and MP).	Alkhouri Naim, 2009, Expert Rev Gastroenterol Hepatol, V3, P445, DOI 10.1586/egh.09.32; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bhala N, 2011, HEPATOLOGY, V54, P1208, DOI 10.1002/hep.24491; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Cannito S, 2015, ONCOTARGET, V6, P2206, DOI 10.18632/oncotarget.2943; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Csak T, 2014, LIVER INT, V34, P1402, DOI 10.1111/liv.12537; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; Diehl P, 2012, CARDIOVASC RES, V93, P633, DOI 10.1093/cvr/cvs007; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Ertunc M. E., 2016, J LIPID RES IN PRESS; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Feldstein AE, 2009, GUT, V58, P1538, DOI 10.1136/gut.2008.171280; Galastri S, 2012, CLIN SCI, V123, P459, DOI 10.1042/CS20110515; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Henao-Mejia J, 2014, ANNU REV PHYSIOL, V76, P57, DOI 10.1146/annurev-physiol-021113-170324; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hirsova P, 2016, GASTROENTEROLOGY, V150, P956, DOI 10.1053/j.gastro.2015.12.037; Hirsova P, 2015, CELL MOL GASTROENTER, V1, P17, DOI 10.1016/j.jcmgh.2014.11.005; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Kornek M, 2012, GASTROENTEROLOGY, V143, P448, DOI 10.1053/j.gastro.2012.04.031; Kornek M, 2011, HEPATOLOGY, V53, P230, DOI 10.1002/hep.23999; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Locatelli I, 2014, HEPATOLOGY, V60, P531, DOI 10.1002/hep.27141; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Morel O, 2011, SEMIN IMMUNOPATHOL, V33, P469, DOI 10.1007/s00281-010-0239-3; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Novo E, 2012, J PATHOL, V226, P588, DOI 10.1002/path.3005; Pan QW, 2012, GUT, V61, P1330, DOI 10.1136/gutjnl-2011-300449; Povero D, 2015, CELL MOL GASTROENTER, V1, P646, DOI 10.1016/j.jcmgh.2015.07.007; Povero D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113651; Povero D, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004512; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Roberts Eve A, 2007, Clin Liver Dis, V11, P155, DOI 10.1016/j.cld.2007.02.008; Schattenberg JM, 2016, GASTROENTEROLOGY, V150, P815, DOI 10.1053/j.gastro.2016.02.064; Schattenberg JM, 2011, CURR OPIN LIPIDOL, V22, P479, DOI 10.1097/MOL.0b013e32834c7cfc; Szabo G, 2015, NAT REV GASTRO HEPAT, V12, P387, DOI 10.1038/nrgastro.2015.94; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Vivoli E, 2016, CLIN SCI, V130, P1793, DOI 10.1042/CS20160400; Witek RP, 2009, GASTROENTEROLOGY, V136, P320, DOI 10.1053/j.gastro.2008.09.066; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Wree A, 2014, HEPATOLOGY, V59, P898, DOI 10.1002/hep.26592; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722	54	38	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172575	10.1371/journal.pone.0172575	http://dx.doi.org/10.1371/journal.pone.0172575			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249038	Green Published, Green Submitted, gold			2022-12-26	WOS:000395983500048
J	Palmu, AA; Rinta-Kokko, H; Nohynek, H; Nuorti, JP; Kilpi, TM; Jokinen, J				Palmu, Arto A.; Rinta-Kokko, Hanna; Nohynek, Hanna; Nuorti, J. Pekka; Kilpi, Terhi M.; Jokinen, Jukka			Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study	PLOS ONE			English	Article							PLACEBO-CONTROLLED-TRIAL; CHILDHOOD PNEUMONIA; DOUBLE-BLIND; HOSPITALIZATIONS; AGE; PREVENTION; ADMISSIONS; EFFICACY; YOUNGER; DISEASE	Background The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into the Finnish National Vaccination Program (NVP) in September 2010 using a 2+1 schedule (3, 5, 12 months). We estimated the direct and indirect effects of PCV10 on pneumonia among children to evaluate the public health impact of the vaccine. Methods We conducted a nation-wide population-based, observational study comparing rates of pneumonia in children before and after the NVP introduction. For the total (direct and indirect) effect, the cohort of vaccine-eligible children (born June 1, 2010 or later) was followed until the end of 2013 (age range 3-42 months). For the indirect effect, a cohort of older children (age range 7-71 months) not eligible for the PCV vaccination was followed from 2011 to 2013. Both cohorts were compared with two season-and age-matched reference cohorts before NVP introduction. Hospitals' in-and outpatient discharge notifications with ICD-10 diagnoses compatible with pneumonia (J10.0, J11.0, J12-J18, J85.1 or J86) as set by the hospital pediatricians were collected from the national Care Register. The main outcome was hospital-treated primary pneumonia (HTPP), defined as primary diagnosis of pneumonia after in-patient hospitalization. We compared rates of pneumonia in the NVP target and reference cohorts by using Poisson regression models. Results The rate of HTPP episodes was 5.3/1000 person-years in the combined reference cohorts and 4.1/1000 person-years in the target cohort vaccine-eligible children. Compared with the reference cohort, the relative rate reduction in target cohort was 23% (95% CI 18-28) and the absolute reduction 1.3/1000 person-years. In the indirect effect evaluation, we observed continued increase in HTPP incidence until 2011 with a subsequent reduction of 18% (95% CI 10-25) during years 2012 to 2013. Number of empyema diagnoses remained low. Conclusions A substantial decrease in pneumonia rates was observed both among vaccine-eligible children and among older, unvaccinated children after PCV10 introduction.	[Palmu, Arto A.] Natl Inst Hlth & Welf, Dept Publ Hlth Solut, Tampere, Finland; [Rinta-Kokko, Hanna; Kilpi, Terhi M.; Jokinen, Jukka] Natl Inst Hlth & Welf, Dept Publ Hlth Solut, Helsinki, Finland; [Nohynek, Hanna; Nuorti, J. Pekka] Natl Inst Hlth & Welf, Dept Hlth Secur, Helsinki, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare	Palmu, AA (corresponding author), Natl Inst Hlth & Welf, Dept Publ Hlth Solut, Tampere, Finland.	arto.palmu@thl.fi		Palmu, Arto A./0000-0001-8071-8896	National Institute for Health and Welfare; GlaxoSmithKline	National Institute for Health and Welfare; GlaxoSmithKline(GlaxoSmithKline)	The current study was funded by the National Institute for Health and Welfare (THL). The authors are employees of the National Institute for Health and Welfare, which has received research funding from GlaxoSmithKline for a Nationwide effectiveness trial of the ten-valent pneumococcal conjugate vaccine. AAP, HRK, TMK, and JJ are coinvestigators in the trial. GlaxoSmithKline had no role in the funding or conduct of the current study.	Afonso ET, 2013, EMERG INFECT DIS, V19, P589, DOI 10.3201/eid1904.121198; AGRESTI A, 2004, CATEGORICAL DATA ANA; Berglund A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112211; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; Pirez MC, 2014, PEDIATR INFECT DIS J, V33, P753, DOI 10.1097/INF.0000000000000294; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; De Wals P, 2008, PEDIATR INFECT DIS J, V27, P963, DOI 10.1097/INF.0b013e31817cf76f; Diaz J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153141; Fernandez JP, 2015, REV CHIL PEDIATR-CHI, V86, P168, DOI 10.1016/j.rchipe.2015.04.026; Grant LR, 2012, CLIN INFECT DIS, V54, pS140, DOI [10.1093/cid/cir1069, 10.1093/cid/cir1073]; Greenberg D, 2015, VACCINE, V33, P4623, DOI 10.1016/j.vaccine.2015.06.062; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; Jardine A, 2010, PEDIATR INFECT DIS J, V29, P607, DOI 10.1097/INF.0b013e3181d7d09c; Jokinen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120290; Kilpi T., 2014, ICAAC 2014; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Lindstrand A, 2014, PEDIATRICS, V134, pE1528, DOI 10.1542/peds.2013-4177; Lucero MG, 2009, PEDIATR INFECT DIS J, V28, P455, DOI 10.1097/INF.0b013e31819637af; McCullagh P, 1989, GEN LINEAR MODELS; Palmu AA, 2013, LANCET, V381, P214, DOI 10.1016/S0140-6736(12)61854-6; Rodrigo C, 2015, EUR RESPIR J, V45, P1632, DOI 10.1183/09031936.00183614; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Saxena S, 2015, J INFECTION, V71, P428, DOI 10.1016/j.jinf.2015.06.011; Scotta MC, 2014, VACCINE, V32, P4495, DOI 10.1016/j.vaccine.2014.06.042; Sgambatti S, 2016, VACCINE, V34, P663, DOI 10.1016/j.vaccine.2015.12.007; Tregnaghi MW, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001657	29	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172690	10.1371/journal.pone.0172690	http://dx.doi.org/10.1371/journal.pone.0172690			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249015	Green Published, gold			2022-12-26	WOS:000395983500050
J	Chatel, B; Bendahan, D; Hourde, C; Pellerin, L; Lengacher, S; Magistretti, P; Le Fur, Y; Vilmen, C; Bernard, M; Messonnier, LA				Chatel, Benjamin; Bendahan, David; Hourde, Christophe; Pellerin, Luc; Lengacher, Sylvain; Magistretti, Pierre; Le Fur, Yann; Vilmen, Christophe; Bernard, Monique; Messonnier, Laurent A.			Role of MCT1 and CAII in skeletal muscle pH homeostasis, energetics, and function: in vivo insights from MCT1 haploinsufficient mice	FASEB JOURNAL			English	Article						magnetic resonance spectroscopy; monocarboxylate transporters; carbonic anhydrases	PHOSPHOCREATINE RECOVERY KINETICS; LACTATE-PROTON COTRANSPORT; LOW CELL PH; MONOCARBOXYLATE TRANSPORTERS; INTRACELLULAR PH; LACTIC-ACID; MECHANICAL PERFORMANCE; SUPRAMAXIMAL EXERCISE; INORGANIC-PHOSPHATE; EXPRESSION	The purpose of this study was to investigate the effects of a partial suppression of monocarboxylate transporter (MCT)-1 on skeletalmuscle pH, energetics, and function (MCT1(+/-) mice). Twenty-fourMCT1(+/-) and 13 wild-type (WT) mice were subjected to a rest-exercise-recovery protocol, allowing assessment of muscle energetics (bymagnetic resonance spectroscopy) and function. The study included analysis of enzyme activities and content of protein involved in pH regulation. Skeletalmuscle ofMCT1(+/-) mice had lower MCT1 (-61%; P < 0.05) and carbonic anhydrase (CA)-II (254%; P < 0.05) contents. Although intramuscular pH was higher in MCT1(+/-) mice at rest (P < 0.001), the mice showed higher acidosis during the first minute of exercise (P < 0.01). Then, the pH time course was similar among groups until exercise completion. MCT1(+/-) mice had higher specific peak (P < 0.05) and maximumtetanic (P < 0.01) forces and lower fatigability (P < 0.001) when compared to WT mice. We conclude that both MCT1 and CAII are involved in the homeostatic control of pH in skeletal muscle, both at rest and at the onset of exercise. The improved muscle function and resistance to fatigue in MCT1(+/-) mice remain unexplained.-Chatel, B., Bendahan, D., Hourd e, C., Pellerin, L., Lengacher, S., Magistretti, P., Fur, Y. L., Vilmen, C., Bernard, M., Messonnier, L. A. Role of MCT1 and CAII in skeletal muscle pH homeostasis, energetics, and function: in vivo insights from MCT1 haploinsufficient mice.	[Chatel, Benjamin; Bendahan, David; Le Fur, Yann; Vilmen, Christophe; Bernard, Monique; Messonnier, Laurent A.] Aix Marseille Univ, Ctr Resonance Magnet Biol & Med, CNRS, Marseille, France; [Hourde, Christophe; Messonnier, Laurent A.] Univ Savoie Mt Blanc, Lab Interuniv Biol Motricit, Chambery, France; [Pellerin, Luc; Lengacher, Sylvain] Univ Lausanne, Dept Physiol, Lausanne, Switzerland; [Lengacher, Sylvain; Magistretti, Pierre] Ecole Polytech Fed Lausanne, Lab Neuroenerget & Cellular Dynam, Brain & Mind Inst, Lausanne, Switzerland; [Magistretti, Pierre] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; King Abdullah University of Science & Technology	Chatel, B (corresponding author), Aix Marseille Univ, Fac Med, Ctr Resonance Magnet Biol & Med, 27 Blvd Jean Moulin, F-13385 Marseille 05, France.	benjamin.chatel@live.fr	Bernard, Monique/Q-7254-2017; Hourdé, Christophe/H-3844-2011; Lengacher, Sylvain/C-2591-2009; CHATEL, Benjamin/AAE-2000-2019; Bendahan, David/AAU-1420-2020; Pellerin, Luc/A-8912-2017	Bernard, Monique/0000-0002-3179-8698; Hourdé, Christophe/0000-0001-5209-2590; Lengacher, Sylvain/0000-0003-2190-9654; CHATEL, Benjamin/0000-0002-8197-1903; Pellerin, Luc/0000-0002-1016-1970; Magistretti, Pierre Julius/0000-0002-6678-320X	Centre National de la Recherche Scientifique Unite Mixte de Recherche [7339]; Societe Francaise de Myologie; Genzyme;  [ANR-11-INBS-0006]	Centre National de la Recherche Scientifique Unite Mixte de Recherche(Centre National de la Recherche Scientifique (CNRS)); Societe Francaise de Myologie; Genzyme(Sanofi-AventisGenzyme Corporation); 	The authors thank Cendrine Repond (University of Lausanne) for technical assistance. This study was supported by the Centre National de la Recherche Scientifique Unite Mixte de Recherche 7339, and a grant from the Societe Francaise de Myologie and Genzyme. This work was performed by a laboratory member of France Life Imaging Network, funded by Grant ANR-11-INBS-0006. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Abe H, 2000, BIOCHEMISTRY-MOSCOW+, V65, P757; AICKIN CC, 1977, J PHYSIOL-LONDON, V273, P295, DOI 10.1113/jphysiol.1977.sp012095; Andrews MAW, 1996, J APPL PHYSIOL, V80, P2060, DOI 10.1152/jappl.1996.80.6.2060; ARNOLD DL, 1984, MAGNET RESON MED, V1, P307, DOI 10.1002/mrm.1910010303; Baker SK, 1998, J APPL PHYSIOL, V84, P987, DOI 10.1152/jappl.1998.84.3.987; Bandschapp O, 2012, AM J PHYSIOL-CELL PH, V302, pC1019, DOI 10.1152/ajpcell.00279.2011; Bechir N, 2016, FASEB J, V30, P3551, DOI 10.1096/fj.201600271RR; Becker HM, 2005, J BIOL CHEM, V280, P39882, DOI 10.1074/jbc.M503081200; Becker HM, 2008, J BIOL CHEM, V283, P21655, DOI 10.1074/jbc.M802134200; Becker HM, 2011, P NATL ACAD SCI USA, V108, P3071, DOI 10.1073/pnas.1014293108; Benton CR, 2008, PHYSIOL GENOMICS, V35, P45, DOI 10.1152/physiolgenomics.90217.2008; Bonen A, 2001, EUR J APPL PHYSIOL, V86, P6, DOI 10.1007/s004210100516; Bonen A, 2006, APPL PHYSIOL NUTR ME, V31, P31, DOI 10.1139/H05-002; Brooks GA, 2002, J PHYSIOL-LONDON, V541, P333, DOI 10.1113/jphysiol.2002.023705; Brooks GA, 2000, MED SCI SPORT EXER, V32, P790, DOI 10.1097/00005768-200004000-00011; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; CHASIOTIS D, 1983, J PHYSIOL-LONDON, V335, P197, DOI 10.1113/jphysiol.1983.sp014528; Debold EP, 2012, MED SCI SPORT EXER, V44, P1440, DOI 10.1249/MSS.0b013e31824cfd26; Debold EP, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00151; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Dubouchaud H, 2000, AM J PHYSIOL-ENDOC M, V278, pE571, DOI 10.1152/ajpendo.2000.278.4.E571; Emhoff CAW, 2013, J APPL PHYSIOL, V115, P829, DOI 10.1152/japplphysiol.00538.2013; Favero TG, 1997, J APPL PHYSIOL, V82, P447, DOI 10.1152/jappl.1997.82.2.447; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; Fitts RH, 2008, J APPL PHYSIOL, V104, P551, DOI 10.1152/japplphysiol.01200.2007; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; GARCIA CK, 1995, J BIOL CHEM, V270, P1843, DOI 10.1074/jbc.270.4.1843; Giannesini B, 2013, AM J PHYSIOL-ENDOC M, V305, pE33, DOI 10.1152/ajpendo.00651.2012; Giannesini B, 2010, MAGN RESON MED, V64, P262, DOI 10.1002/mrm.22386; Gineste C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072294; Gineste C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061517; Gore CJ, 2001, ACTA PHYSIOL SCAND, V173, P275, DOI 10.1046/j.1365-201X.2001.00906.x; Guthrie B M, 1996, Can J Appl Physiol, V21, P251; Halestrap AP, 2013, COMPR PHYSIOL, V3, P1611, DOI 10.1002/cphy.c130008; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Halestrap AP, 2012, IUBMB LIFE, V64, P1, DOI 10.1002/iub.573; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hashimoto T, 2005, J PHYSIOL-LONDON, V567, P121, DOI 10.1113/jphysiol.2005.087411; Hashimoto T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1237, DOI 10.1152/ajpendo.00594.2005; HOGAN MC, 1995, MED SCI SPORT EXER, V27, P371; Hollidge-Horvat MG, 1999, AM J PHYSIOL-ENDOC M, V277, pE647, DOI 10.1152/ajpendo.1999.277.4.E647; Jackson VN, 1997, BIOCHEM J, V324, P447, DOI 10.1042/bj3240447; Jubrias SA, 2003, J PHYSIOL-LONDON, V553, P589, DOI 10.1113/jphysiol.2003.045872; Juel C, 2008, ACTA PHYSIOL, V193, P17, DOI 10.1111/j.1748-1716.2008.01840.x; Juel C, 1996, ACTA PHYSIOL SCAND, V156, P369, DOI 10.1046/j.1365-201X.1996.206000.x; Juel C, 2001, EUR J APPL PHYSIOL, V86, P12, DOI 10.1007/s004210100517; Juel C, 1998, PFLUG ARCH EUR J PHY, V436, P560, DOI 10.1007/s004240050672; Juel C, 1999, J PHYSIOL-LONDON, V517, P633, DOI 10.1111/j.1469-7793.1999.0633s.x; Juel C, 1997, PHYSIOL REV, V77, P321, DOI 10.1152/physrev.1997.77.2.321; Knuth ST, 2006, J PHYSIOL-LONDON, V575, P887, DOI 10.1113/jphysiol.2006.106732; Kobayashi Masaki, 2004, Drug Metab Pharmacokinet, V19, P363, DOI 10.2133/dmpk.19.363; Layec G, 2013, NMR BIOMED, V26, P1403, DOI 10.1002/nbm.2966; Le Fur Y, 2010, MAGN RESON MATER PHY, V23, P23, DOI 10.1007/s10334-009-0186-y; Leite TC, 2007, BIOCHEM J, V408, P123, DOI 10.1042/BJ20070687; Lengacher S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082505; Lindinger MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084451; MAINWOOD GW, 1985, CAN J PHYSIOL PHARM, V63, P403, DOI 10.1139/y85-072; MANNION AF, 1993, J APPL PHYSIOL, V75, P1412, DOI 10.1152/jappl.1993.75.3.1412; Marcinek DJ, 2010, J APPL PHYSIOL, V108, P1479, DOI 10.1152/japplphysiol.01189.2009; Marqueste T., 2008, J APPL PHYSIOL, V105, P299; McCullagh KJA, 1997, AM J PHYSIOL-ENDOC M, V273, pE239, DOI 10.1152/ajpendo.1997.273.2.E239; McCullagh KJA, 1996, AM J PHYSIOL-ENDOC M, V271, pE143, DOI 10.1152/ajpendo.1996.271.1.E143; Messonnier L, 2007, J APPL PHYSIOL, V102, P1936, DOI 10.1152/japplphysiol.00691.2006; Messonnier LA, 2013, J APPL PHYSIOL, V114, P1593, DOI 10.1152/japplphysiol.00043.2013; METZGER JM, 1987, J APPL PHYSIOL, V62, P1392, DOI 10.1152/jappl.1987.62.4.1392; MOON RB, 1973, J BIOL CHEM, V248, P7276; Nelson CR, 2014, AM J PHYSIOL-CELL PH, V306, pC670, DOI 10.1152/ajpcell.00347.2013; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; Pedersen TH, 2004, SCIENCE, V305, P1144, DOI 10.1126/science.1101141; Pellerin L, 2005, J NEUROSCI RES, V79, P55, DOI 10.1002/jnr.20307; Pilegaard H, 1999, AM J PHYSIOL-ENDOC M, V276, pE843, DOI 10.1152/ajpendo.1999.276.5.E843; PILEGAARD H, 1994, J APPL PHYSIOL, V77, P1858, DOI 10.1152/jappl.1994.77.4.1858; Polanski R, 2014, CLIN CANCER RES, V20, P926, DOI 10.1158/1078-0432.CCR-13-2270; Renaud JM, 2006, J APPL PHYSIOL, V101, P367, DOI 10.1152/japplphysiol.00181.2006; Rivero-Gutierrez B, 2014, ANAL BIOCHEM, V467, P1, DOI 10.1016/j.ab.2014.08.027; Roussel M, 2000, BBA-BIOENERGETICS, V1457, P18, DOI 10.1016/S0005-2728(99)00111-5; Roussel M, 2003, J APPL PHYSIOL, V94, P1145, DOI 10.1152/japplphysiol.01024.2000; Sahlin K., 2006, J APPL PHYSIOL, V101, P369; Saxena S, 2016, HIGH ALT MED BIOL, V17, P32, DOI 10.1089/ham.2015.0048; Semenza GL, 2008, J CLIN INVEST, V118, P3835, DOI 10.1172/JCI37373; Stridh MH, 2012, J PHYSIOL-LONDON, V590, P2333, DOI 10.1113/jphysiol.2011.220152; SUTTON JR, 1981, CLIN SCI, V61, P331, DOI 10.1042/cs0610331; Thomas C, 2005, J APPL PHYSIOL, V98, P804, DOI 10.1152/japplphysiol.01057.2004; TRIVEDI B, 1966, J BIOL CHEM, V241, P4110; Westerblad H, 2002, NEWS PHYSIOL SCI, V17, P17; Wilson MC, 1998, J BIOL CHEM, V273, P15920, DOI 10.1074/jbc.273.26.15920; Yoshida Y, 2004, J APPL PHYSIOL, V97, P527, DOI 10.1152/japplphysiol.01347.2003; Zaccagnini G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142111	89	15	15	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2562	2575		10.1096/fj.201601259R	http://dx.doi.org/10.1096/fj.201601259R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28254758				2022-12-26	WOS:000401553400028
J	Menning, S; de Ruiter, MB; Veltman, DJ; Boogerd, W; Oldenburg, HSA; Reneman, L; Schagen, SB				Menning, Sanne; de Ruiter, Michiel B.; Veltman, Dick J.; Boogerd, Willem; Oldenburg, Hester S. A.; Reneman, Liesbeth; Schagen, Sanne B.			Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type	PLOS ONE			English	Article							CHEMOTHERAPY; IMPAIRMENT; TASK; SURVIVORS; THERAPY; SYSTEM; MRI	Background Cognitive problems in breast cancer patients are common after systemic treatment, particularly chemotherapy. An increasing number of fMRI studies show altered brain activation in breast cancer patients after treatment, suggestive of neurotoxicity. Previous prospective fMRI studies administered a single cognitive task. The current study employed two task paradigms to evaluate whether treatment-induced changes depend on the probed cognitive domain. Methods Participants were breast cancer patients scheduled to receive systemic treatment (anthracycline-based chemotherapy +/- endocrine treatment, n = 28), or no systemic treatment (n = 24) and no-cancer controls (n = 31). Assessment took place before adjuvant treatment and six months after chemotherapy, or at similar intervals. Blood oxygen level dependent (BOLD) activation and performance were measured during an executive functioning task and an episodic memory task. Group-by-time interactions were analyzed using a flexible factorial design. Results Task performance did not differ between patient groups and did not change over time. Breast cancer patients who received systemic treatment, however, showed increased parietal activation compared to baseline with increasing executive functioning task load compared to breast cancer patients who did not receive systemic treatment. This hyperactivation was accompanied by worse physical functioning, higher levels of fatigue and more cognitive complaints. In contrast, in breast cancer patients who did not receive systemic treatment, parietal activation normalized over time compared to the other two groups. Conclusions Parietal hyperactivation after systemic treatment in the context of stable levels of executive task performance is compatible with a compensatory processing account of hyperactivation or maintain adequate performance levels. This over-recruitment of brain regions depends on the probed cognitive domain and may represent a response to decreased neural integrity after systemic treatment. Overall these results suggest different neurobehavioral trajectories in breast cancer patients depending on treatment type.	[Menning, Sanne; de Ruiter, Michiel B.; Schagen, Sanne B.] Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands; [Menning, Sanne; de Ruiter, Michiel B.; Reneman, Liesbeth] Univ Amsterdam, Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Veltman, Dick J.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Boogerd, Willem] Netherlands Canc Inst, Dept Neurooncol, Amsterdam, Netherlands; [Oldenburg, Hester S. A.] Netherlands Canc Inst, Dept Surg Oncol, Amsterdam, Netherlands	Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Netherlands Cancer Institute; Netherlands Cancer Institute	Schagen, SB (corresponding author), Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands.	s.schagen@nki.nl		Reneman, Liesbeth/0000-0002-5912-9971	Dutch Cancer Society [KWF 2009-4284]	Dutch Cancer Society(KWF Kankerbestrijding)	This work as supported by a grant from the Dutch Cancer Society (www.kwf.nl), grant number (KWF 2009-4284) to SBS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Berman MG, 2014, HEALTH PSYCHOL, V33, P222, DOI 10.1037/a0033425; Cheung YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081234; Cimprich B, 2010, J CLIN EXP NEUROPSYC, V32, P324, DOI 10.1080/13803390903032537; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; de Ruiter MB, 2013, BRAIN IMAGING BEHAV, V7, P388, DOI 10.1007/s11682-013-9249-9; de Ruiter MB, 2011, HUM BRAIN MAPP, V32, P1206, DOI 10.1002/hbm.21102; Dekkers AMM, 2010, COMMUNITY MENT HLT J, V46, P20, DOI 10.1007/s10597-009-9195-6; Deprez S, 2014, J CLIN ONCOL, V32, P2031, DOI 10.1200/JCO.2013.53.6219; Ferguson RJ, 2007, J CLIN ONCOL, V25, P3866, DOI 10.1200/JCO.2007.10.8639; Flandin G, 2016, ANAL FAMILY WISE ERR, P1; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Hermelink K, 2015, JNCI-J NATL CANCER I, V107; HESBACHER PT, 1980, J CLIN PSYCHIAT, V41, P6; Jager G, 2007, EUR NEUROPSYCHOPHARM, V17, P289, DOI 10.1016/j.euroneuro.2006.10.003; Joly F, 2015, J PAIN SYMPTOM MANAG, V50, P830, DOI 10.1016/j.jpainsymman.2015.06.019; Kesler S. R., 2015, JAMA ONCOL, V2, P1, DOI DOI 10.1001/JAMAONCOL.2015.4333; Mazaika P, 2009, HUM BRAIN MAPP; McDonald BC, 2012, J CLIN ONCOL, V30, P2500, DOI 10.1200/JCO.2011.38.5674; Menning S, 2016, J PAIN SYMPTOM MANAG, V52, P560, DOI 10.1016/j.jpainsymman.2016.04.012; Menning S, 2015, NEUROIMAGE-CLIN, V7, P547, DOI 10.1016/j.nicl.2015.02.005; Schagen S B, 2014, EJC Suppl, V12, P29, DOI 10.1016/j.ejcsup.2014.03.003; Schilder CMT, 2010, CRIT REV ONCOL HEMAT, V76, P133, DOI 10.1016/j.critrevonc.2009.11.001; Schilder CM, 2010, J CLIN ONCOL, V28, P1294, DOI 10.1200/JCO.2008.21.3553; Schmand B., 1992, NEDERLANDSE LEESTEST; Seigers R, 2013, BRAIN IMAGING BEHAV, V7, P453, DOI 10.1007/s11682-013-9250-3; Silverman DHS, 2007, BREAST CANCER RES TR, V103, P303, DOI 10.1007/s10549-006-9380-z; Stewart A.L., 1992, MEASURING FUNCTIONIN; Stouten-Kemperman MM, 2015, J INT NEUROPSYCH SOC, V21, P50, DOI 10.1017/S1355617714001015; van den Heuvel OA, 2003, NEUROIMAGE, V18, P367, DOI 10.1016/S1053-8119(02)00010-1; Wald FDM., 1990, NEDERLANDS TIJDSCHRI, V45, P86; Wefel JS, 2015, CA-CANCER J CLIN, V65, P123, DOI 10.3322/caac.21258; Wefel JS, 2011, LANCET ONCOL, V12, P703, DOI 10.1016/S1470-2045(10)70294-1; Weiss D.S., 1997, ASSESSING PSYCHOL TR, P399, DOI DOI 10.1037/T12199-000; Zunini RAL, 2013, BRAIN IMAGING BEHAV, V7, P460, DOI 10.1007/s11682-012-9213-0; Zwart W, 2015, NAT REV CLIN ONCOL, V12, P597, DOI 10.1038/nrclinonc.2015.124	36	33	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0171724	10.1371/journal.pone.0171724	http://dx.doi.org/10.1371/journal.pone.0171724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5QM	28267750	Green Submitted, Green Published, gold			2022-12-26	WOS:000396060600057
J	Shields, RK; Anand, R; Clarke, LG; Paronish, JA; Weirich, M; Perone, H; Kieserman, J; Freedy, H; Andrzejewski, C; Bonilla, H				Shields, Ryan K.; Anand, Rohit; Clarke, Lloyd G.; Paronish, Julie A.; Weirich, Matthew; Perone, Hanna; Kieserman, Jake; Freedy, Henry; Andrzejewski, Christina; Bonilla, Hector			Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; INTRAVENOUS COLISTIN; PROSPECTIVE COHORT; INDUCED NEPHROTOXICITY; RENAL DYSFUNCTION; SERUM CREATININE; POLYMYXIN-B; RAT MODEL; METHANESULFONATE; CARE	Background Acute kidney injury (AKI) remains a treatment-limiting toxicity of colistin. Recently developed clinical practice guidelines from the Kidney Disease: Improving Global Outcomes (KDIGO) group have harmonized definitions of AKI, but have not been widely applied to patients receiving colistin. Methods We retrospectively defined AKI by KDIGO definitions among adult patients receiving intravenous colistin for >= 3 days. Risk factors for AKI within 48 hours and 7 days of initiating colistin were determined by multivariable logistic regression. Results Among 249 patients treated with colistin, rates of AKI were 12% and 29% at 48 hours and 7 days, respectively. At 48 hours, patients in the intensive care unit were at increased risk for AKI. Within 7 days, colistin daily doses >5mg/kg, chronic liver disease, and concomitant vancomycin were independent predictors. Seven percent of patients required renal replacement therapy at a median of 5 days (range: 3-7) following colistin initiation. Conclusion Safe use of colistin is promoted by early detection of AKI with KDIGO criteria, avoiding nephrotoxins, and limiting duration of therapy.	[Shields, Ryan K.; Anand, Rohit; Clarke, Lloyd G.; Paronish, Julie A.; Weirich, Matthew; Perone, Hanna; Kieserman, Jake; Bonilla, Hector] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Freedy, Henry; Andrzejewski, Christina; Bonilla, Hector] UPMC Mercy Hosp, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shields, RK (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.	shieldsrk@upmc.edu	Perone, Hanna/AAR-1847-2021	Perone, Hanna/0000-0002-1572-8657; Bonilla, Hector/0000-0002-0513-8733	National Institutes of Health (NIH) [K08AI114883]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI114883] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by funding provided by the National Institutes of Health (NIH) under award number K08AI114883 awarded to R. K. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Collins JM, 2013, PHARMACOTHERAPY, V33, P812, DOI 10.1002/phar.1271; Dalfino L, 2015, CLIN INFECT DIS, V61, P1771, DOI 10.1093/cid/civ717; DeRyke CA, 2010, ANTIMICROB AGENTS CH, V54, P4503, DOI 10.1128/AAC.01707-09; Doshi NM, 2011, PHARMACOTHERAPY, V31, P1257, DOI 10.1592/phco.31.12.1257; Elefritz JL, 2016, J INTENSIVE CARE MED; Elyasi S, 2012, EUR J CLIN PHARMACOL, V68, P1243, DOI 10.1007/s00228-012-1259-9; Fiaccadori E, 2016, AM J KIDNEY DIS, V68, P296, DOI 10.1053/j.ajkd.2016.03.421; Garcia-Tsao G, 2008, HEPATOLOGY, V48, P2064, DOI 10.1002/hep.22605; Garonzik SM, 2011, ANTIMICROB AGENTS CH, V55, P3284, DOI 10.1128/AAC.01733-10; Ghlissi Z, 2014, ENVIRON TOXICOL PHAR, V37, P960, DOI 10.1016/j.etap.2014.03.004; Hartzell JD, 2009, CLIN INFECT DIS, V48, P1724, DOI 10.1086/599225; Javan AO, 2015, EUR J CLIN PHARMACOL, V71, P801, DOI 10.1007/s00228-015-1865-4; Kellum JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11454; Ko HJ, 2011, NEPHRON CLIN PRACT, V117, pC284, DOI 10.1159/000320746; Kwon JA, 2010, INT J ANTIMICROB AG, V35, P473, DOI 10.1016/j.ijantimicag.2009.12.002; Luo XY, 2014, CRIT CARE, V18, DOI 10.1186/cc13977; Nation RL, 2016, DOSING GUIDANCE INTR; Nation RL, 2015, UPDATED US EUROPEAN; Nation RL, 2016, CLIN INFECT DIS, V62, P552, DOI 10.1093/cid/civ964; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Binh NG, 2015, INT J INFECT DIS, V35, P18, DOI 10.1016/j.ijid.2015.03.020; O'Hara JA, 2013, ANTIMICROB AGENTS CH, V57, P2103, DOI 10.1128/AAC.02501-12; Omrani AS, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0062-8; Ozkan G, 2012, KIDNEY BLOOD PRESS R, V35, P445, DOI 10.1159/000337926; Palevsky PM, 2013, AM J KIDNEY DIS, V61, P649, DOI 10.1053/j.ajkd.2013.02.349; Phe K, 2014, ANTIMICROB AGENTS CH, V58, P6946, DOI 10.1128/AAC.03776-14; Pogue JM, 2011, CLIN INFECT DIS, V53, P879, DOI 10.1093/cid/cir611; Rigatto MH, 2016, ANTIMICROB AGENTS CH, V60, P2443, DOI 10.1128/AAC.02634-15; Rocco M, 2013, CRIT CARE, V17, DOI 10.1186/cc12853; Samra Manpreet, 2012, Perm J, V16, P51; Slack A, 2010, CRIT CARE, V14, DOI 10.1186/cc8855; Tanita Marcos Toshyiuki, 2013, Rev. bras. ter. intensiva, V25, P297, DOI 10.5935/0103-507X.20130051; Tuon FF, 2014, INT J ANTIMICROB AG, V43, P349, DOI 10.1016/j.ijantimicag.2013.12.002; Yousef JM, 2011, ANTIMICROB AGENTS CH, V55, P4044, DOI 10.1128/AAC.00328-11	36	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173286	10.1371/journal.pone.0173286	http://dx.doi.org/10.1371/journal.pone.0173286			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267779	Green Published, gold, Green Submitted			2022-12-26	WOS:000396060600019
J	North, BJ; Almeciga-Pinto, I; Tamang, D; Yang, M; Jones, SS; Quayle, SN				North, Brian J.; Almeciga-Pinto, Ingrid; Tamang, David; Yang, Min; Jones, Simon S.; Quayle, Steven N.			Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitor	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; REFRACTORY MULTIPLE-MYELOMA; C-MYC; IMMUNOMODULATORY DRUGS; DOWN-REGULATION; CANCER CELLS; LENALIDOMIDE; EXPRESSION; SURVIVIN; DEGRADATION	Thalidomide-based Immunomodulatory Drugs (IMiDs((R))), including lenalidomide and pomalidomide, are effective therapeutics for multiple myeloma. These agents have been approved with, or are under clinical development with, other targeted therapies including proteasome inhibitors, alpha CD38 monoclonal antibodies, as well as histone deacetylase (HDAC) inhibitors for combination therapy. HDAC inhibitors broadly targeting Class I and IIb HDACs have shown potent preclinical efficacy but have frequently demonstrated an undesirable safety profile in combination therapy approaches in clinical studies. Therefore, development of more selective HDAC inhibitors could provide enhanced efficacy with reduced side effects in combination with IMiDs((R)) for the treatment of B-cell malignancies, including multiple myeloma. Here, the second generation selective HDAC6 inhibitor citarinostat (ACY-241), with a more favorable safety profile than non-selective pan-HDAC inhibitors, is shown to synergize with pomalidomide in in vitro assays through promoting greater apoptosis and cell cycle arrest. Furthermore, utilizing a multiple myeloma in vivo murine xenograft model, combination treatment with pomalidomide and ACY-241 leads to increased tumor growth inhibition. At the molecular level, combination treatment with ACY-241 and pomalidomide leads to greater suppression of the pro-survival factors survivin, Myc, and IRF4. The results presented here demonstrate synergy between pomalidomide and ACY-241 in both in vitro and in vivo preclinical models, providing further impetus for clinical development of ACY-241 for use in combination with IMiDs for patients with multiple myeloma and potentially other B-cell malignancies.	[North, Brian J.; Almeciga-Pinto, Ingrid; Tamang, David; Yang, Min; Jones, Simon S.; Quayle, Steven N.] Acetylon Pharmaceut, Boston, MA 02210 USA		Jones, SS (corresponding author), Acetylon Pharmaceut, Boston, MA 02210 USA.	sjones@acetylon.com			Acetylon Pharmaceuticals	Acetylon Pharmaceuticals	Funding was provided by Acetylon Pharmaceuticals (http://www.acetylon.com). The funder provided support in the form of research materials and salaries for BJN, IAP, DT, MY, SSJ, and SNQ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andhavarapu S, 2013, EXPERT REV HEMATOL, V6, P69, DOI [10.1586/EHM.12.62, 10.1586/ehm.12.62]; Bjorklund CC, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.66; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Campbell RA, 2010, EUR J HAEMATOL, V84, P201, DOI 10.1111/j.1600-0609.2009.01384.x; Canella A, 2015, ONCOTARGET, V6, P31134, DOI 10.18632/oncotarget.5290; Chen Hong Ping, 2015, Critical Reviews in Oncogenesis, V20, P35; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Garg H, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0326-1; Harada T, 2016, INT J HEMATOL, V104, P300, DOI 10.1007/s12185-016-2008-0; Hideshima T, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.38; Holien T, 2012, BLOOD, V120, P2450, DOI 10.1182/blood-2011-08-371567; Hsu YF, 2012, BBA-GEN SUBJECTS, V1820, P104, DOI 10.1016/j.bbagen.2011.11.011; Huang PY, 2017, ONCOTARGET, V8, P2694, DOI 10.18632/oncotarget.13738; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kaufman JL, 2013, CL LYMPH MYELOM LEUK, V13, P370, DOI 10.1016/j.clml.2013.03.016; Kim SH, 2016, ENDOCRINE, V51, P274, DOI 10.1007/s12020-015-0706-7; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lee HC, 2016, CURR HEMATOL MALIG R, V11, P148, DOI 10.1007/s11899-016-0312-7; Lee JH, 2010, EPIGENOMICS-UK, V2, P723, DOI [10.2217/epi.10.59, 10.2217/EPI.10.59]; Li H, 2004, BIOCHEM BIOPH RES CO, V324, P860, DOI 10.1016/j.bbrc.2004.09.130; Li Y., 2016, COLD SPRING HARB PER, V6; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lopez-Girona A, 2011, BRIT J HAEMATOL, V154, P325, DOI 10.1111/j.1365-2141.2011.08689.x; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Mahalingam D, 2010, CLIN CANCER RES, V16, P141, DOI 10.1158/1078-0432.CCR-09-1385; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Romagnoli M, 2007, LEUKEMIA, V21, P1070, DOI 10.1038/sj.leu.2404602; Santo L, 2012, BLOOD, V119, P2579, DOI 10.1182/blood-2011-10-387365; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Shabason JE, 2010, ONCOLOGY-NY, V24, P180; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shin DY, 2015, CANCER LETT, V364, P89, DOI 10.1016/j.canlet.2015.03.016; Subramanian S, 2010, PHARMACEUTICALS, V3, P2751, DOI 10.3390/ph3092751; Wang SL, 2016, ONCOTARGET, V7, P37693, DOI 10.18632/oncotarget.9264; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Xu YX, 2005, INT J MOL MED, V15, P169; Yee AJ, 2016, LANCET ONCOL, V17, P1569, DOI 10.1016/S1470-2045(16)30375-8; Zhang H, 2016, HEPATOL RES; Zhang P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136193	41	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173507	10.1371/journal.pone.0173507	http://dx.doi.org/10.1371/journal.pone.0173507			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264055	gold, Green Published, Green Submitted			2022-12-26	WOS:000396054300067
J	Helenius, LK; Saiz, E				Helenius, Laura K.; Saiz, Enric			Feeding behaviour of the nauplii of the marine calanoid copepod Paracartia grani Sars: Functional response, prey size spectrum, and effects of the presence of alternative prey	PLOS ONE			English	Article							ACARTIA-TONSA; FOOD SELECTION; PLANKTONIC COPEPODS; ADULT FEMALES; FRESH-WATER; RATES; DISCRIMINATION; CAPABILITIES; BACTERIVORY; PARTICLES	Laboratory feeding experiments were conducted to study the functional response and prey size spectrum of the young naupliar stages of the calanoid copepod Paracartia grani Sars. Experiments were conducted on a range of microalgal prey of varying sizes and motility patterns. Significant feeding was found in all prey of a size range of 4.5-19.8 mu m, with Holling type III functional responses observed for most prey types. The highest clearance rates occurred when nauplii fed on the dinoflagellate Heterocapsa sp. and the diatom Thalassiosira weissflogii (respectively, 0.61 and 0.70 mL ind(-1) d(-1)), suggesting an optimal prey: predator ratio of 0.09. Additional experiments were conducted to examine the effects of the presence of alternative prey (either Heterocapsa sp. or Gymnodinium litoralis) on the functional response to the haptophyte Isochrysis galbana. In the bialgal mixtures, clearance and ingestion rates of I. galbana along the range of the functional response were significantly reduced as a result of selectivity towards the larger, alternative prey. Paradoxically, relatively large prey trigger a perception response in the nauplii, but most likely such prey cannot be completely ingested and a certain degree of sloppy feeding may occur. Our results are further evidence of the complex prey-specific feeding interactions that are likely to occur in natural assemblages with several available prey types.	[Helenius, Laura K.] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Helenius, Laura K.] Univ Helsinki, Tvarminne Zool Stn, Hango, Finland; [Saiz, Enric] CSIC, Inst Ciencias Mar, Barcelona, Catalunya, Spain	University of Helsinki; University of Helsinki; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Helenius, LK (corresponding author), Univ Helsinki, Dept Environm Sci, Helsinki, Finland.; Helenius, LK (corresponding author), Univ Helsinki, Tvarminne Zool Stn, Hango, Finland.	laura.helenius@alumni.helsinki.fi	Saiz, Enric/K-4263-2014	Saiz, Enric/0000-0003-2611-0067	Walter and Andree de Nottbeck Foundation; University of Helsinki; Ministerio de Economia, Industria y Competitividad [CTM2011-23480, CGL2014-59227-R]; FEDER, EU	Walter and Andree de Nottbeck Foundation; University of Helsinki; Ministerio de Economia, Industria y Competitividad(Spanish Government); FEDER, EU(European Commission)	LH was funded by the Walter and Andree de Nottbeck Foundation (http://www.nottbeck.org/en) and University of Helsinki (https://www.heisinki.fi/en). ES was funded by projects CTM2011-23480 and CGL2014-59227-R of the Ministerio de Economia, Industria y Competitividad (http://www.mineco.gob.es/portal/site/mineco/) (cofinanced with FEDER funds, EU) (http://ec.europa.eu/regional_policy/es/funding/erdf/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN JD, 1977, MAR BIOL, V43, P317, DOI 10.1007/BF00396926; Almeda R, 2010, J EXP MAR BIOL ECOL, V387, P24, DOI 10.1016/j.jembe.2010.03.002; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; BERGGREEN U, 1988, MAR BIOL, V99, P341, DOI 10.1007/BF02112126; Borg CMA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047486; Bruno E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047906; Calbet A, 2001, J PLANKTON RES, V23, P319, DOI 10.1093/plankt/23.3.319; COWLES TJ, 1988, MAR BIOL, V100, P41, DOI 10.1007/BF00392953; Cyr H, 1998, CAN J FISH AQUAT SCI, V55, P414, DOI 10.1139/cjfas-55-2-414; DEMOTT WR, 1986, OECOLOGIA, V69, P334, DOI 10.1007/BF00377053; DEMOTT WR, 1989, LIMNOL OCEANOGR, V34, P140, DOI 10.4319/lo.1989.34.1.0140; DEMOTT WR, 1988, LIMNOL OCEANOGR, V33, P397, DOI 10.4319/lo.1988.33.3.0397; DONAGHAY PL, 1979, MAR BIOL, V52, P137, DOI 10.1007/BF00390421; FANTA E S, 1976, Boletim de Zoologia, V1, P205; FANTA E S, 1972, Crustaceana (Leiden), V23, P165, DOI 10.1163/156854072X00345; FERNANDEZ F, 1979, MAR BIOL, V53, P131, DOI 10.1007/BF00389185; FERNANDEZ F, 1979, Journal of Plankton Research, V1, P313, DOI 10.1093/plankt/1.4.313; Finlay K, 2004, ICES J MAR SCI, V61, P552, DOI 10.1016/j.icesjms.2004.03.010; Moller EF, 2007, LIMNOL OCEANOGR, V52, P79, DOI 10.4319/lo.2007.52.1.0079; FROST BW, 1977, LIMNOL OCEANOGR, V22, P472, DOI 10.4319/lo.1977.22.3.0472; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Garrido S, 2015, MAR ECOL PROG SER, V539, P271, DOI 10.3354/meps11506; Garrido S, 2013, J PLANKTON RES, V35, P843, DOI 10.1093/plankt/fbt037; Gentleman W, 2003, DEEP-SEA RES PT II, V50, P2847, DOI 10.1016/J.DSR2.2003.07.001; Gentleman WC, 2008, J PLANKTON RES, V30, P1215, DOI 10.1093/plankt/fbn078; GILL CW, 1988, MAR ECOL PROG SER, V43, P269, DOI 10.3354/meps043269; Gismervik I, 1997, MAR ECOL PROG SER, V157, P247, DOI 10.3354/meps157247; Goncalves RJ, 2015, LIMNOL OCEANOGR, V60, P1286, DOI 10.1002/lno.10102; Goncalves RJ, 2014, MAR ECOL PROG SER, V517, P61, DOI 10.3354/meps11039; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; Henriksen CI, 2007, MAR ECOL PROG SER, V331, P119, DOI 10.3354/meps331119; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; HOLLING C. S., 1966, Memoirs of the Entomology Society of Canada; Isari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084742; Isari S, 2011, J PLANKTON RES, V33, P715, DOI 10.1093/plankt/fbq149; Kiorboe T, 1996, MAR ECOL PROG SER, V143, P65, DOI 10.3354/meps143065; KIORBOE T, 1985, MAR ECOL PROG SER, V26, P85, DOI 10.3354/meps026085; Kiorboe T, 1998, HYDROBIOLOGIA, V363, P13, DOI 10.1023/A:1003173721751; Kiorboe T, 2016, LIMNOL OCEANOGR, V61, P1169, DOI 10.1002/lno.10293; LANDRY MR, 1981, MAR BIOL, V65, P77, DOI 10.1007/BF00397070; Meyer B, 2002, HELGOLAND MAR RES, V56, P169, DOI 10.1007/s10152-002-0105-3; Morozov A, 2012, PROG OCEANOGR, V103, P80, DOI 10.1016/j.pocean.2012.04.001; MULLIN MM, 1963, LIMNOL OCEANOGR, V8, P239, DOI 10.4319/lo.1963.8.2.0239; Mullin MM, 1988, THEORY BIOL PHYSICAL, P297; PAFFENHOFER GA, 1989, MAR ECOL PROG SER, V57, P129, DOI 10.3354/meps057129; PAFFENHOFER GA, 1978, MAR BIOL, V48, P143, DOI 10.1007/BF00395014; PAFFENHOFER GA, 1988, MAR ECOL PROG SER, V42, P33, DOI 10.3354/meps042033; POULET SA, 1977, J FISH RES BOARD CAN, V34, P2381, DOI 10.1139/f77-319; POULET SA, 1974, MAR BIOL, V25, P109, DOI 10.1007/BF00389260; Price H.J., 1985, Advances in Limnology, V21, P115; PRICE HJ, 1983, LIMNOL OCEANOGR, V28, P116, DOI 10.4319/lo.1983.28.1.0116; ROFF JC, 1995, AQUAT MICROB ECOL, V9, P165, DOI 10.3354/ame009165; Romera-Castillo C, 2010, LIMNOL OCEANOGR, V55, P446, DOI 10.4319/lo.2010.55.1.0446; Sabates A, 2000, MAR ECOL PROG SER, V201, P261, DOI 10.3354/meps201261; SAIZ E, 1994, LIMNOL OCEANOGR, V39, P1566, DOI 10.4319/lo.1994.39.7.1566; SAIZ E, 1995, MAR ECOL PROG SER, V122, P147, DOI 10.3354/meps122147; Saiz E, 2003, LIMNOL OCEANOGR, V48, P1304, DOI 10.4319/lo.2003.48.3.1304; Saiz E, 2007, LIMNOL OCEANOGR, V52, P668, DOI 10.4319/lo.2007.52.2.0668; Saiz E, 2014, LIMNOL OCEANOGR, V59, P2077, DOI 10.4319/lo.2014.59.6.2077; Saiz E, 2011, HYDROBIOLOGIA, V666, P181, DOI 10.1007/s10750-010-0421-6; Sarnelle O, 2008, ECOLOGY, V89, P1723, DOI 10.1890/07-0935.1; Smith JK, 2008, J PLANKTON RES, V30, P937, DOI 10.1093/plankt/fbn050; Tiselius P, 2013, LIMNOL OCEANOGR, V58, P1657, DOI 10.4319/lo.2013.58.5.1657; Titelman J, 2003, MAR ECOL PROG SER, V247, P123, DOI 10.3354/meps247123; Turner JT, 2015, PROG OCEANOGR, V130, P205, DOI 10.1016/j.pocean.2014.08.005; TURNER JT, 1992, J EXP MAR BIOL ECOL, V160, P149, DOI 10.1016/0022-0981(92)90235-3; Turner JT, 2004, ZOOL STUD, V43, P255; VANDERPLOEG HA, 1988, B MAR SCI, V43, P377; VANDERPLOEG HA, 1984, J PLANKTON RES, V6, P919, DOI 10.1093/plankt/6.6.919; Vanderploeg Henry A., 1994, P205; Vilela MH, 1972, NOTAS ESTUDOS I BIOL, V40; WILSON DS, 1973, ECOLOGY, V54, P909, DOI 10.2307/1935688	72	16	16	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172902	10.1371/journal.pone.0172902	http://dx.doi.org/10.1371/journal.pone.0172902			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257517	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100039
J	Liu, SL; Metcalfe, A; Leon, JA; Sauve, R; Kramer, MS; Joseph, KS				Liu, Shiliang; Metcalfe, Amy; Leon, Juan Andres; Sauve, Reg; Kramer, Michael S.; Joseph, K. S.		Canadian Perinatal Surveillance	Evaluation of the INTERGROWTH-21st project newborn standard for use in Canada	PLOS ONE			English	Article							FETAL-GROWTH; BIRTH-WEIGHT; INTERNATIONAL STANDARDS; GESTATIONAL-AGE; MORTALITY; PREGNANCY; MORBIDITY; INFANTS; RISK	Objective To evaluate the performance of the INTERGROWTH-21 st Project newborn standard vis-avis the current Canadian birth weight-for-gestational age reference. Methods All hospital-based singleton live births in Canada (excluding Quebec) between 2002 and 2012 with a gestational age between 33 and 42 weeks were included using information obtained from the Canadian Institute for Health Information. Small-and large-for gestational age centile categories of the INTERGROWTH standard and Canadian reference were contrasted in terms of frequency distributions and rates of composite neonatal morbidity/mortality. Results Among 2,753,817 singleton live births, 0.87% and 9.63% were < 3 rd centile and > 97 th centile, respectively, of the INTERGROWTH standard, while 2.27% and 3.55% were < 3 rd centile and > 97 th centile, respectively, of the Canadian reference. Infants < 3 rd centile and > 97 th centile had a composite neonatal morbidity/mortality rate of 46.4 and 12.9 per 1,000 live births, respectively, under the INTERGROWTH standard and 30.9 and 16.6 per 1,000 live births, respectively, under the Canadian reference. The INTERGROWTH standard < 3 rd centile and > 97 th centile categories had detection rates of 3.14% and 9.74%, respectively, for composite neonatal morbidity/mortality compared with 5.48% and 4.60%, respectively for the Canadian reference. Similar patterns were evident in high-and low-risk subpopulations. Conclusions The centile distribution of the INTERGROWTH newborn standard is left shifted compared with the Canadian reference, and this shift alters the frequencies and neonatal morbidity/mortality rates associated with specific centile categories. Further outcome-based research is required for defining abnormal growth categories before the INTERGROWTH newborn standard can be used.	[Liu, Shiliang; Leon, Juan Andres] Publ Hlth Agcy Canada, Maternal Child & Youth Hlth, Surveillance & Epidemiol Div, Ctr Chron Dis Prevent, Ottawa, ON, Canada; [Metcalfe, Amy] Univ Calgary, Dept Obstet & Gynecol, Calgary, AB, Canada; [Metcalfe, Amy; Sauve, Reg] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Sauve, Reg] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Kramer, Michael S.] McGill Univ, Dept Pediat, Montreal, PQ, Canada; [Kramer, Michael S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Joseph, K. S.] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada; [Joseph, K. S.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Joseph, K. S.] Womens & Childrens Hosp, Vancouver, BC, Canada; [Joseph, K. S.] Hlth Ctr British Columbia, Vancouver, BC, Canada	Public Health Agency of Canada; University of Calgary; University of Calgary; University of Calgary; McGill University; McGill University; University of British Columbia; University of British Columbia	Liu, SL (corresponding author), Publ Hlth Agcy Canada, Maternal Child & Youth Hlth, Surveillance & Epidemiol Div, Ctr Chron Dis Prevent, Ottawa, ON, Canada.	kjoseph@cw.bc.ca		Joseph, K.S./0000-0003-2317-5607	BC Children's Hospital Research Institute; Canadian Institutes of Health Research [APR-126338]; Public Health Agency of Canada	BC Children's Hospital Research Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada	K.S. Joseph's work is supported by the Investigator Grant Awards Program of the BC Children's Hospital Research Institute and a Chair Award from the Canadian Institutes of Health Research (APR-126338). Funding for Open access publication was provided by the Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PS, 2014, LANCET DIABETES ENDO, V2, P773, DOI 10.1016/S2213-8587(14)70186-X; Bernstein IM, 2000, AM J OBSTET GYNECOL, V182, P198, DOI 10.1016/S0002-9378(00)70513-8; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Copel JA, 2014, OBSTET GYNECOL, V123, P1057, DOI 10.1097/AOG.0000000000000232; Evans N, 2007, ARCH DIS CHILD-FETAL, V92, pF34, DOI 10.1136/adc.2006.094169; Francis JH, 2014, AUST NZ J OBSTET GYN, V54, P354, DOI 10.1111/ajo.12205; Gardosi J, 2014, LANCET DIABETES ENDO, V2, P773, DOI 10.1016/S2213-8587(14)70188-3; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Joseph KS, 2011, BJOG-INT J OBSTET GY, V118, P1617, DOI 10.1111/j.1471-0528.2011.03128.x; Joseph KS, 2009, CHRONIC DIS CAN, V29, P96; Joseph KS, 2009, AM J EPIDEMIOL, V169, P616, DOI 10.1093/aje/kwn374; Kramer M, 2015, B NUTR FDN INDIA, V36, P1; Kramer MS, 1998, EUR J CLIN NUTR, V52, pS29; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Mortensen LH, 2009, J EPIDEMIOL COMMUN H, V63, P281, DOI 10.1136/jech.2008.076364; Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2; Piper JM, 1996, OBSTET GYNECOL, V87, P169, DOI 10.1016/0029-7844(95)00400-9; Seeds JW, 1998, AM J OBSTET GYNECOL, V178, P658, DOI 10.1016/S0002-9378(98)70475-2; Seravalli V, 2015, OBSTET GYN CLIN N AM, V42, P275, DOI 10.1016/j.ogc.2015.01.005; Steer PJ, 2014, LANCET DIABETES ENDO, V2, P766, DOI 10.1016/S2213-8587(14)70157-3; TYSON JE, 1995, PEDIATRICS, V95, P534; Unterscheider J, 2013, AM J OBSTET GYNECOL, V208, DOI [10. 1016/j. ajog. 2013. 02. 007, DOI 10.1016/J.AJ0G.2013.02.007]; Vasak B, 2015, ULTRASOUND OBST GYN, V45, P162, DOI 10.1002/uog.14644; Villar J, 2014, LANCET DIABETES ENDO, V2, P781, DOI 10.1016/S2213-8587(14)70121-4; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; Wen S W, 1997, Chronic Dis Can, V18, P113; WHO, 2009, WHO CHILD GROWTH STA; YOON JJ, 1980, PEDIATRICS, V65, P735	28	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172910	10.1371/journal.pone.0172910	http://dx.doi.org/10.1371/journal.pone.0172910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257473	Green Submitted, gold, Green Published			2022-12-26	WOS:000396021100042
J	Juga, AJC; Hens, N; Osman, N; Aerts, M				Juga, Adelino J. C.; Hens, Niel; Osman, Nafissa; Aerts, Marc			A flexible method to model HIV serodiscordance among couples in Mozambique	PLOS ONE			English	Article								Whereas the number of people newly infected by HIV is continuing to decline globally, the epidemic continues to expand in many parts of the world. As the HIV/AIDS epidemic has matured in many countries, it is believed that the proportion of new infections occurring within couples has risen. Across countries, including Mozambique, a sizeable proportion of couples with HIV infection are discordant. A serodiscordant couple is a couple in which one partner has tested positive for HIV and the other has not. To describe the HIV serodiscordance among couples, a variety of association measures can be used. In this paper, we propose the serodiscordance measure (SDM) as a new alternative measure. Focus is on the specification of flexible marginal and random effects models for multivariate correlated binary data together with a full-likelihood estimation method, to adequately and directly describe the measure of interest. Fitting joint models allows examining the effects of different risk factors and other covariates on the probability to be HIV positive for each member within a couple, and estimating common effects for both probabilities more efficiently, while accounting for the association between their infection status. Moreover, the interpretation of the proposed association parameter SDM is more direct and relevant and effects of covariates can be studied as well. Results show that the HIV prevalence for the province where a couple was located as well as the union number for the woman within a couple are factors associated with HIV serodiscordance. These findings are important for the Mozambican public health policy makers to design national prevention plans, which include policies to stimulate regular HIV testing for couples as well as adolescents and young adults, prior to getting married or living together as a couple.	[Juga, Adelino J. C.] Eduardo Mondlane Univ, Dept Math & Informat, Fac Sci, Maputo, Mozambique; [Juga, Adelino J. C.; Hens, Niel; Aerts, Marc] Hasselt Univ, BioStat I, Diepenbeek, Belgium; [Hens, Niel] Univ Antwerp, Vaccine & Infect Dis Inst VAXINFECTIO, Ctr Hlth Econ Res & Modelling Infect Dis, Antwerp, Belgium; [Hens, Niel] Univ Antwerp, Epidemiol & Social Med ESOC, Fac Med & Hlth Sci, Antwerp, Belgium; [Osman, Nafissa] Maputo Cent Hosp, Dept Obstet & Gynaecol, Maputo, Mozambique; [Osman, Nafissa] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique	Eduardo Mondlane University; Hasselt University; University of Antwerp; University of Antwerp; Eduardo Mondlane University	Juga, AJC (corresponding author), Eduardo Mondlane Univ, Dept Math & Informat, Fac Sci, Maputo, Mozambique.; Juga, AJC (corresponding author), Hasselt Univ, BioStat I, Diepenbeek, Belgium.	adelino.juga@gmail.com	Hens, Niel/M-4445-2017	Hens, Niel/0000-0003-1881-0637	Flemish Interuniversity Council (VLIR-UOS); Eduardo Mondlane University (UEM) through the DESAFIO Program	Flemish Interuniversity Council (VLIR-UOS); Eduardo Mondlane University (UEM) through the DESAFIO Program	Flemish Interuniversity Council (VLIR-UOS) in collaboration with Eduardo Mondlane University (UEM) through the DESAFIO Program provided financial support.; This study was only possible thanks to the financial support of the Flemish Interuniversity Council (VLIR-UOS) in collaboration with Eduardo Mondlane University (UEM) through the DESAFIO Program. The authors would also like to acknowledge the support given by the Mozambican Health Ministry (MISAU) and Demography Health Survey (DHS) Program for providing the INSIDA survey data. The authors would also like to thank the editors and the reviewers for their interesting and helpful comments and suggestions.	Agresti A, 2013, CATEGORICAL DATA ANA; Akaike H, 1973, REPRODUCED BREAKTHRO, V1, P267; [Anonymous], 2014, PSYCHOLOGY; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; CAREY V, 1993, BIOMETRIKA, V80, P517, DOI 10.2307/2337173; DALE JR, 1986, BIOMETRICS, V42, P909, DOI 10.2307/2530704; Dokubo EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106760; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Ewayo O, 2010, LANCET INFECT DIS, V10, P770, DOI [10.1016/S1473-3099(10)70189-4, DOI 10.1016/S1473-3099(10)70189-4]; Faes C, 2008, J AM STAT ASSOC, V103, P149, DOI 10.1198/016214507000000419; Fishel JD, 2011, HIV COUPLES MOZAMBIQ; Glynn JR, 2003, JAIDS-J ACQ IMM DEF, V33, P526, DOI 10.1097/00126334-200308010-00015; Instituto Nacional de Saude (INS) Instituto Nacional de Estatistica (INE), 2010, INQ NAC PREV RISC CO, P333; Kaiser R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017842; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lovasi Gina S, 2012, Open Epidemiol J, V5, P13; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Thomas SL, 2001, RES HIGH EDUC, V42, P517, DOI 10.1023/A:1011098109834	18	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172959	10.1371/journal.pone.0172959	http://dx.doi.org/10.1371/journal.pone.0172959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253283	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300053
J	Lu, J; Li, XH; Wang, QY; Pei, G				Lu, Jing; Li, Xiaohang; Wang, Qinying; Pei, Gang			Dopamine D-2 receptor and beta-arrestin 2 mediate Amyloid-beta elevation induced by antiparkinson's disease drugs, levodopa and piribedil, in neuronal cells	PLOS ONE			English	Article							GAMMA-SECRETASE ACTIVITY; DOPA-INDUCED DYSKINESIA; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; ALPHA-SYNUCLEIN; STEM-CELLS; FOLLOW-UP; G-PROTEIN; IN-VIVO	Although levodopa is the first-line medication for the treatment of Parkinson's disease (PD) showing unsurpassable efficiency, its chronic use causes dyskinesia. Accordingly, dopamine agonists are increasingly employed as monotherapy or in combination with levodopa to reduce the risk of motor complications. It is well recognized that patients with PD often exhibit cognitive deficits. However, clinical and animal studies assessing the effects of dopaminergic medications on cognition are controversial. Amyloid-beta (A beta) is one of the major hallmarks of Alzheimer's disease (AD), leading to progressive memory loss and cognitive deficit. Interestingly, the abnormal accumulation of A beta is also detected in PD patients with cognitive deficits. Evidence indicated that levodopa induced a mild increase of A beta plaque number and size in the brain of AD mouse. However, the underlying mechanism is unclear. Here we present that both levodopa and piribedil enhance the generation of A beta and the activity gamma-secretase in human neuronal cells and primary neurons isolated from AD mouse. This effect was reduced by either the antagonism or the knockdown of dopamine D-2 receptor (D2R). We further showed that in the cells expressing beta-arrestin 2-biased D2R mutant, piribedil promoted cellular A beta production to the extent comparable to the wild-type D2R whereas this activity was absent in those with G protein-biased D2R mutant. Moreover, the knockdown of beta-arrestin 2 attenuated the increases of A beta generation gamma-secretase activity mediated by levodopa or piribedil. Thus, our study suggests that targeting-mediated beta-arrestin function may have potential risk in the modulation of A beta pathology.	[Lu, Jing; Li, Xiaohang; Wang, Qinying; Pei, Gang] Chinese Acad Sci, Univ Chinese Acad Sci, State Key Lab Cell Biol, Ctr Excellence Mol Cell Sci,Shanghai Inst Biochem, Shanghai, Peoples R China; [Pei, Gang] Tongji Univ, Collaborat Innovat Ctr Brain Sci, Sch Life Sci & Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Tongji University	Pei, G (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, State Key Lab Cell Biol, Ctr Excellence Mol Cell Sci,Shanghai Inst Biochem, Shanghai, Peoples R China.; Pei, G (corresponding author), Tongji Univ, Collaborat Innovat Ctr Brain Sci, Sch Life Sci & Technol, Shanghai, Peoples R China.	gpei@sibs.ac.cn		Li, Xiaohang/0000-0002-7316-2196	Ministry of Science and Technology of China [2015CB964502, 2014CB964802]; National Natural Science Foundation of China [31371419]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Ministry of Science and Technology of China (2015CB964502, 2014CB964802) and the National Natural Science Foundation of China (31371419). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambree O, 2009, NEUROBIOL AGING, V30, P1192, DOI 10.1016/j.neurobiolaging.2007.11.010; Backman L, 2010, NEUROSCI BIOBEHAV R, V34, P670, DOI 10.1016/j.neubiorev.2009.12.008; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Beaulieu JM, 2007, J NEUROSCI, V27, P881, DOI 10.1523/JNEUROSCI.5074-06.2007; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Clayton CC, 2014, J BIOL CHEM, V289, P33663, DOI 10.1074/jbc.M114.605378; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Cote SR, 2015, NEUROSCI LETT, V585, P33, DOI 10.1016/j.neulet.2014.11.023; Eckart C, 2014, NEUROIMAGE, V94, P185, DOI 10.1016/j.neuroimage.2014.03.011; Hernandez VS, 2014, NEUROPHARMACOLOGY, V82, P88, DOI 10.1016/j.neuropharm.2013.11.013; Himeno E, 2011, ANN NEUROL, V69, P248, DOI 10.1002/ana.22319; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Itoh A, 1996, J NEUROCHEM, V66, P1113; Joyce JN, 1998, NEUROPSYCHOPHARMACOL, V19, P472, DOI 10.1016/S0893-133X(98)00044-X; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kotzbauer PT, 2012, ARCH NEUROL-CHICAGO, V69, P1326, DOI 10.1001/archneurol.2012.1608; Kulisevsky J, 1996, BRAIN, V119, P2121, DOI 10.1093/brain/119.6.2121; Kulisevsky J, 2000, MOVEMENT DISORD, V15, P613, DOI 10.1002/1531-8257(200007)15:4<613::AID-MDS1005>3.0.CO;2-F; Liu XS, 2013, CELL RES, V23, P351, DOI 10.1038/cr.2012.167; Lu J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166415; Mytilineou C, 2003, J PHARMACOL EXP THER, V304, P792, DOI 10.1124/jpet.102.042267; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Peritore CS, 2012, NEUROREPORT, V23, P989, DOI 10.1097/WNR.0b013e32835a4ea4; Peterson SM, 2015, P NATL ACAD SCI USA, V112, P7097, DOI 10.1073/pnas.1502742112; Pizzolato G, 1996, NEUROLOGY, V47, P1065, DOI 10.1212/WNL.47.4.1065; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Solis O, 2017, CEREB CORTEX, V27, P435, DOI 10.1093/cercor/bhv231; Thathiah A, 2013, NAT MED, V19, P43, DOI 10.1038/nm.3023; Thathiah A, 2011, NAT REV NEUROSCI, V12, P73, DOI 10.1038/nrn2977; Urs NM, 2015, P NATL ACAD SCI USA, V112, pE2517, DOI 10.1073/pnas.1502740112; Vo A, 2016, PSYCHOPHARMACOLOGY, V233, P2753, DOI 10.1007/s00213-016-4322-x; Volkow ND, 1996, PSYCHIAT RES-NEUROIM, V67, P11, DOI 10.1016/0925-4927(96)02809-0; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; Yin YI, 2007, J BIOL CHEM, V282, P23639, DOI 10.1074/jbc.M704601200; Zhang XQ, 2010, METHODS MOL BIOL, V584, P355, DOI 10.1007/978-1-60761-369-5_19	38	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173240	10.1371/journal.pone.0173240	http://dx.doi.org/10.1371/journal.pone.0173240			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253352	Green Published, Green Submitted, gold			2022-12-26	WOS:000396011300094
J	Wang, ZW; Xiao, XY; Ge, RB; Li, JJ; Johnson, CW; Rassoulian, C; Olumi, AF				Wang, Zongwei; Xiao, Xingyuan; Ge, Rongbin; Li, Jijun; Johnson, Cameron W.; Rassoulian, Cyrus; Olumi, Aria F.			Metformin inhibits the proliferation of benign prostatic epithelial cells	PLOS ONE			English	Article							GROWTH-FACTOR-I; SIGNALING PATHWAY; CYCLE PROGRESSION; CANCER-CELLS; HYPERPLASIA; INSULIN; EXPRESSION; RISK; RECEPTOR; D1	Objective Benign prostatic hyperplasia (BPH) is the most common proliferative abnormality of the prostate affecting elderly men throughout the world. Epidemiologic studies have shown that diabetes significantly increases the risk of developing BPH, although whether anti-diabetic medications preventing the development of BPH remains to be defined. We have previously found that stromally expressed insulin-like growth factor 1 (IGF-1) promotes benign prostatic epithelial cell proliferation through paracrine mechanisms. Here, we seek to understand if metformin, a first line medication for the treatment of type 2 diabetes, inhibits the proliferation of benign prostatic epithelial cells through reducing the expression of IGF-1 receptor (IGF-1R) and regulating cell cycle. Methods BPE cell lines BPH-1 and P69, murine fibroblasts3T3 and primary human prostatic fibroblasts were cultured and tested in this study. Cell proliferation and the cell cycle were analyzed by MTS assay and flow cytometry, respectively. The expression of IGF-1R was determined by western-blot and immunocytochemistry. The level of IGF-1 secretion in culture medium was measured by ELISA. Results Metformin (0.5-10mM, 6-48h) significantly inhibited the proliferation of BPH-1 and P69 cells in a dose-dependent and time-dependent manner. Treatment with metformin for 24 hours lowered the G(2)/M cell population by 43.24% in P69 cells and 24.22% in BPH-1 cells. On the other hand, IGF-1 (100ng/mL, 24h) stimulated the cell proliferation (increased by 28.81% in P69 cells and 20.95% in BPH-1 cells) and significantly enhanced the expression of IGF-1R in benign prostatic epithelial cells. Metformin (5mM) abrogated the proliferation of benign prostatic epithelial cells induced by IGF-1. In 3T3 cells, the secretion of IGF-1 was significantly inhibited by metformin from 574.31pg/ml to 197.61pg/ml. The conditioned media of 3T3 cells and human prostatic fibroblasts promoted the proliferation of epithelial cells and the expression of IGF-1R in epithelial cells. Metformin abrogated the proliferation of benign prostatic epithelial cells promoted by 3T3 conditioned medium. Conclusions Our study demonstrates that metformin inhibits the proliferation of benign prostatic epithelial cells by suppressing the expression of IGF-1R and IGF-1 secretion in stromal cells. Metformin lowers the G2/M cell population and simultaneously increases the G0/G1 population. Findings here might have significant clinical implications in management of BPH patients treated with metformin.	[Wang, Zongwei; Xiao, Xingyuan; Johnson, Cameron W.; Rassoulian, Cyrus; Olumi, Aria F.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Urol, Boston, MA 02115 USA; [Xiao, Xingyuan] Huazhong Univ Sci & Technol, Wuhan Union Hosp, Dept Urol, Wuhan, Peoples R China; [Ge, Rongbin] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Li, Jijun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai, Peoples R China	Harvard University; Harvard Medical School; Massachusetts General Hospital; Huazhong University of Science & Technology; University of Massachusetts System; University of Massachusetts Worcester; Shanghai Jiao Tong University	Wang, ZW (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Urol, Boston, MA 02115 USA.	zwang0@mgh.harvard.edu	wang, zongwei/HIA-0279-2022		NIH/National Institute for Diabetes and Digestive and Kidney Diseases [NIH/R01 DK091353]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091353] Funding Source: NIH RePORTER	NIH/National Institute for Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH/National Institute for Diabetes and Digestive and Kidney Diseases (NIH/R01 DK091353) to AFO.	Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Borowiec AS, 2011, BBA-MOL CELL RES, V1813, P723, DOI 10.1016/j.bbamcr.2011.01.025; Bourke J B, 1966, Br J Urol, V38, P18, DOI 10.1111/j.1464-410X.1966.tb09675.x; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Chen Z, 2015, INT J CLIN EXP MED, V8, P11289; Clemmons DR, 2005, MOL ENDOCRINOL, V19, P1, DOI 10.1210/me.2004-0376; COHEN P, 1991, J CLIN ENDOCR METAB, V73, P401, DOI 10.1210/jcem-73-2-401; Dahle SE, 2002, J UROLOGY, V168, P599, DOI 10.1016/S0022-5347(05)64687-3; Dekanty A, 2006, J BIOL CHEM, V281, P6136, DOI 10.1074/jbc.M505839200; Dong GY, 1997, J CLIN ENDOCR METAB, V82, P2198, DOI 10.1210/jc.82.7.2198; Dowling RJO, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-33; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Ge RB, 2015, ONCOTARGET, V6, P28973, DOI 10.18632/oncotarget.5023; Gong EM, 2004, AM J CHINESE MED, V32, P331, DOI 10.1142/S0192415X04001989; Hammarsten J, 1999, BLOOD PRESSURE, V8, P29, DOI 10.1080/080370599438365; Hammarsten J, 2001, EUR UROL, V39, P151, DOI 10.1159/000052430; Hammarsten J, 2009, PROSTATE CANCER P D, V12, P160, DOI 10.1038/pcan.2008.50; Jiang Y, 2006, J CELL BIOCHEM, V98, P208, DOI 10.1002/jcb.20771; Kaplan-Lefko PJ, 2008, ONCOGENE, V27, P2868, DOI 10.1038/sj.onc.1210943; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Li WH, 2007, AM J PATHOL, V171, P1189, DOI 10.2353/ajpath.2007.070285; MacCorkle RA, 2005, CELL BIOCHEM BIOPHYS, V43, P451, DOI 10.1385/CBB:43:3:451; Marderosian M, 2006, ONCOGENE, V25, P6277, DOI 10.1038/sj.onc.1209645; MCNEAL JE, 1978, INVEST UROL, V15, P340; Nandeesha H, 2006, CLIN CHIM ACTA, V370, P89, DOI 10.1016/j.cca.2006.01.019; Papatsoris AG, 2001, TRENDS MOL MED, V7, P288, DOI 10.1016/S1471-4914(01)02015-9; Patel AK, 2006, BRIT MED J, V333, P535, DOI 10.1136/bmj.38946.616551.BE1; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Ren M, 2009, ACTA PHARMACOL SIN, V30, P113, DOI 10.1038/aps.2008.8; Ruan WF, 1999, ENDOCRINOLOGY, V140, P1984, DOI 10.1210/en.140.5.1984; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Starborg M, 1996, J CELL SCI, V109, P143; Vignozzi L, 2016, NAT REV UROL, V13, P108, DOI 10.1038/nrurol.2015.301; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang ZW, 2012, DIABETES, V61, P2134, DOI 10.2337/db11-1763; Wang ZW, 2011, DIFFERENTIATION, V82, P261, DOI 10.1016/j.diff.2011.04.004; Yu CR, 2003, CANCER RES, V63, P1822; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zhang DL, 2004, J BIOL CHEM, V279, P19683, DOI 10.1074/jbc.M313145200	39	17	17	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173335	10.1371/journal.pone.0173335	http://dx.doi.org/10.1371/journal.pone.0173335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253329	gold, Green Published, Green Submitted			2022-12-26	WOS:000396011300101
J	Hermosilla, S; You, P; Aifah, A; Abildayev, T; Akilzhanova, A; Kozhamkulov, U; Muminov, T; Darisheva, M; Zhussupov, B; Terlikbayeva, A; El-Bassel, N; Schluger, N				Hermosilla, Sabrina; You, Paul; Aifah, Angela; Abildayev, Tleukhan; Akilzhanova, Ainur; Kozhamkulov, Ulan; Muminov, Talgat; Darisheva, Meruert; Zhussupov, Baurzhan; Terlikbayeva, Assel; El-Bassel, Nabila; Schluger, Neil			Identifying risk factors associated with smear positivity of pulmonary tuberculosis in Kazakhstan	PLOS ONE			English	Article							C VIRUS-INFECTION; HIV; DIAGNOSIS; DETERMINANTS; TRANSMISSION; BACILLI; DISEASE; GENDER; HEALTH; LUNG	Background Sputum smear-positive tuberculosis (TB) patients have a high risk of transmission and are of great epidemiological and infection control significance. Little is known about the smear-positive populations in high TB burden regions, such as Kazakhstan. The objective of this study is to characterize the smear-positive population in Kazakhstan and identify associated modifiable risk factors. Methods Data on incident TB cases' (identified between April 2012 and March 2014) socio-demographic, risk behavior, and comorbidity characteristics were collected in four regions of Kazakhstan through structured survey and medical record review. We used multivariable logistic regression to determine factors associated with smear positivity. Results Of the total sample, 193 (34.3%) of the 562 study participants tested smear-positive. In the final adjusted multivariable logistic regression model, sex (adjusted odds ratio (aOR) = 2.0, 95% CI:1.3-3.1, p < 0.01), incarceration (aOR = 3.6, 95% CI: 1.2-11.1, p = 0.03), alcohol dependence (aOR = 2.6, 95% CI: 1.2-5.7, p = 0.02), diabetes (aOR = 5.0, 95% CI: 2.4-10.7, p < 0.01), and physician access (aOR = 2.7, 95% CI: 1.3-5.5p < 0.01) were associated with smear-positivity. Conclusions Incarceration, alcohol dependence, diabetes, and physician access are associated with smear positivity among incident TB cases in Kazakhstan. To stem the TB epidemic, screening, treatment and prevention policies should address these factors.	[Hermosilla, Sabrina; You, Paul; Schluger, Neil] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Aifah, Angela; El-Bassel, Nabila] Columbia Univ, Sch Social Work, 1255 Amsterdam Ave, New York, NY USA; [Abildayev, Tleukhan] Natl Ctr TB Problems, Alma Ata, Kazakhstan; [Akilzhanova, Ainur; Kozhamkulov, Ulan] Nazarbayev Univ, Ctr Life Sci, 53 Kabanbay Batyr Ave, Astana, Kazakhstan; [Muminov, Talgat] Natl Assoc TB Specialists, Alma Ata, Kazakhstan; [Darisheva, Meruert; Zhussupov, Baurzhan; Terlikbayeva, Assel] Columbia Univ, Global Hlth Res Ctr Cent Asia, Alma Ata, Kazakhstan	Columbia University; Columbia University; Nazarbayev University	Hermosilla, S (corresponding author), Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA.	sh2405@columbia.edu	Zhussupov, Baurzhan/AAR-8305-2021; Kozhamkulov, Ulan/H-6805-2016; Schluger, Neil/ABA-1793-2021; Hermosilla, Sabrina/D-6599-2017; Akilzhanova, Ainur R/N-6931-2015	Kozhamkulov, Ulan/0000-0002-9782-7631; Hermosilla, Sabrina/0000-0002-4166-815X; Akilzhanova, Ainur R/0000-0001-6161-8355; Aifah, Angela/0000-0002-2811-8487; Terlikbayeva, Assel/0000-0002-4067-1998	Kazakhstan Ministry of Education and Science; National Institute of Mental Health (NIMH) [T32MH096724]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH096724] Funding Source: NIH RePORTER	Kazakhstan Ministry of Education and Science(Government of the Republic of Kazakhstan); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The primary recipient of this grant was the Center for Life Sciences of Nazarbayev University (http://cls.nu.edu.kz/cls/about/) which received funding from the Kazakhstan Ministry of Education and Science (http://edu.gov.kz/ru/). The Global Health Research Center of Central Asia (GHRCCA) had a subcontract with the Nazarbayev University Center for Life Sciences to develop methodologies, implement the field data collection, and analyze the study results. Dr. Hermosilla received additional funding from the National Institute of Mental Health (NIMH https://www.nimh.nih.gov/index.shtml) T32MH096724.	Andrews JR, 2015, INT J TUBERC LUNG D, V19, P375, DOI 10.5588/ijtld.14.0423; [Anonymous], 2015, KAZAKHSTAN AOSOTRO; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boum Y, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0638-5; Bumburidi Ekaterina, 2006, MMWR Suppl, V55, P11; Chien JY, 2010, INT J TUBERC LUNG D, V14, P616; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT, V18; Doherty AM, 2013, GEN HOSP PSYCHIAT, V35, P398, DOI 10.1016/j.genhosppsych.2013.03.018; El-Bassel N, 2013, AIDS BEHAV, V17, P2490, DOI 10.1007/s10461-013-0484-2; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Grenfell P, 2013, DRUG ALCOHOL DEPEN, V129, P180, DOI 10.1016/j.drugalcdep.2012.11.013; Hermosilla S, 2014, PUBLIC HLTH; Hudelson P, 1996, TUBERCLE LUNG DIS, V77, P391, DOI 10.1016/S0962-8479(96)90110-0; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kapustina V, 2014, EUROPEAN RESP J, V44, pP3574, DOI [10.1183/09031936.0000381424, DOI 10.1183/09031936.0000381424]; KITCHENS JM, 1994, JAMA-J AM MED ASSOC, V272, P1782, DOI 10.1001/jama.272.22.1782; Kocurek EG, 2016, OBSTET GYN CLIN N AM, V43, P307, DOI 10.1016/j.ogc.2016.01.003; Kuznetsov VN, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/693963; Lamprecht B, 2013, EUR RESPIR J, V42, P858, DOI 10.1183/09031936.00047613; Lombardi G, 2014, TREND MICROBIOLOGICA, P14; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Maric-Bilkan C, 2016, HYPERTENSION, V67, P802, DOI 10.1161/HYPERTENSIONAHA.115.06967; Ministry of Health National Center of T, 2008, GUID TUB CONTR REP K; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Reis NRS, 2011, INT J TUBERC LUNG D, V15, P1397, DOI 10.5588/ijtld.10.0636; ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2; Sakundarno Mateus, 2009, BMC Pulm Med, V9, P16, DOI 10.1186/1471-2466-9-16; Steingart KR, 2006, SPUTUM PROCESSING ME, V6; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Terlikbayeva A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-262; Thorson A, 2001, Curr Opin Pulm Med, V7, P165, DOI 10.1097/00063198-200105000-00009; (UNICEF) UNCsF, STAT KAZ UNICEF; van den Hof S, 2013, INT J TUBERC LUNG D, V17, P526, DOI 10.5588/ijtld.12.0703; Volkmann T, 2015, INT J TUBERC LUNG D, V19, P111, DOI 10.5588/ijtld.14.0516; Wan TTH, 2007, INT J PUBLIC POLICY, V2, P217; WHO, 2014, GLOB TUB REP 2014; World Health Organization, 2011, TUB COUNTR WORK SUMM; Yohanes A, 2011, SMEAR POSITIVE PULMO, P325	41	15	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172942	10.1371/journal.pone.0172942	http://dx.doi.org/10.1371/journal.pone.0172942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249005	Green Published, Green Submitted, gold			2022-12-26	WOS:000395983500065
J	Smeets, MWJ; Bierings, R; Meems, H; Mul, FPJ; Geerts, D; Vlaar, APJ; Voorberg, J; Hordijk, PL				Smeets, Michel W. J.; Bierings, Ruben; Meems, Henriet; Mul, Frederik P. J.; Geerts, Dirk; Vlaar, Alexander P. J.; Voorberg, Jan; Hordijk, Peter L.			Platelet- independent adhesion of calcium-loaded erythrocytes to von Willebrand factor	PLOS ONE			English	Article							HUMAN-ENDOTHELIAL-CELLS; VONWILLEBRAND-FACTOR; SICKLE ERYTHROCYTES; VASCULAR ENDOTHELIUM; ADHERENCE; BLOOD; THROMBOSIS; RELEASE; DISEASE; FLOW	Adhesion of erythrocytes to endothelial cells lining the vascular wall can cause vaso-occlusive events that impair blood flow which in turn may result in ischemia and tissue damage. Adhesion of erythrocytes to vascular endothelial cells has been described in multiple hemolytic disorders, especially in sickle cell disease, but the adhesion of normal erythrocytes to endothelial cells has hardly been described. It was shown that calcium-loaded erythrocytes can adhere to endothelial cells. Because sickle erythrocyte adhesion to ECs can be enhanced by ultra-large von Willebrand factor multimers, we investigated whether calcium loading of erythrocytes could promote binding to endothelial cells via ultra-large von Willebrand factor multimers. We used (immunofluorescent) live-cell imaging of washed erythrocytes perfused over primary endothelial cells at venular flow rate. Using this approach, we show that calcium-loaded erythrocytes strongly adhere to histamine-stimulated primary human endothelial cells. This adhesion is mediated by ultra-large von Willebrand factor multimers. Von Willebrand factor knockdown or ADAMTS13 cleavage abolished the binding of erythrocytes to activated endothelial cells under flow. Platelet depletion did not interfere with erythrocyte binding to von Willebrand factor. Our results reveal platelet-independent adhesion of calcium-loaded erythrocytes to endothelium-derived von Willebrand factor. Erythrocyte adhesion to von Willebrand factor may be particularly relevant for venous thrombosis, which is characterized by the formation of erythrocyte-rich thrombi.	[Smeets, Michel W. J.; Mul, Frederik P. J.; Hordijk, Peter L.] Acad Med Ctr, Sanquin, Landsteiner Lab, Dept Mol Cell Biol, Amsterdam, Netherlands; [Bierings, Ruben; Meems, Henriet; Voorberg, Jan] Acad Med Ctr, Sanquin, Landsteiner Lab, Dept Plasma Prot, Amsterdam, Netherlands; [Geerts, Dirk] Erasmus Univ, Dept Pediat Oncol Hematol, Med Ctr, Rotterdam, Netherlands; [Vlaar, Alexander P. J.] Amsterdam Med Ctr, Dept Intens Care Med, Amsterdam, Netherlands; [Hordijk, Peter L.] Vrije Univ Amsterdam, Dept Physiol, Med Ctr, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Hordijk, PL (corresponding author), Acad Med Ctr, Sanquin, Landsteiner Lab, Dept Mol Cell Biol, Amsterdam, Netherlands.; Hordijk, PL (corresponding author), Vrije Univ Amsterdam, Dept Physiol, Med Ctr, Amsterdam, Netherlands.	p.hordijk@vumc.nl	Bierings, Ruben/AAQ-8854-2020; Geerts, Dirk/K-8260-2015	Bierings, Ruben/0000-0002-1205-9689; Geerts, Dirk/0000-0002-6386-8187; Hordijk, Peter/0000-0002-3348-078X; Vlaar, Alexander/0000-0002-3453-7186; Voorberg, Jan/0000-0003-4585-2621				ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Andre P, 2000, BLOOD, V96, P3322, DOI 10.1182/blood.V96.10.3322.h8003322_3322_3328; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Bogdanova A, 2013, INT J MOL SCI, V14, P9848, DOI 10.3390/ijms14059848; BOOKCHIN RM, 1980, NATURE, V284, P561, DOI 10.1038/284561a0; Brill A, 2011, BLOOD, V117, P1400, DOI 10.1182/blood-2010-05-287623; Cavallaro U, 2011, NAT REV MOL CELL BIO, V12, P189, DOI 10.1038/nrm3068; Chen JM, 2011, BLOOD, V117, P3680, DOI 10.1182/blood-2010-08-302539; Chiou E, 2015, INT J BIOCHEM CELL B, V65, P40, DOI 10.1016/j.biocel.2015.05.013; De Ceunynck K, 2013, BLOOD, V121, P270, DOI 10.1182/blood-2012-07-442285; Du VX, 2014, SEMIN THROMB HEMOST, V40, P72, DOI 10.1055/s-0033-1363470; Gallagher PG, 2003, BLOOD, V101, P4625, DOI 10.1182/blood-2001-12-0329; HAMILTON KK, 1987, J CLIN INVEST, V79, P600, DOI 10.1172/JCI112853; HEBBEL RP, 1980, J CLIN INVEST, V65, P154, DOI 10.1172/JCI109646; HEBBEL RP, 1980, NEW ENGL J MED, V302, P992, DOI 10.1056/NEJM198005013021803; Hermand P, 2003, J BIOL CHEM, V278, P4892, DOI 10.1074/jbc.M211282200; Hovav T, 1999, BRIT J HAEMATOL, V106, P178; Jiang Aixiang, 2007, J Bioinform Comput Biol, V5, P875, DOI 10.1142/S0219720007002989; Kaestner L, 2012, BIOELECTROCHEMISTRY, V87, P89, DOI 10.1016/j.bioelechem.2011.08.004; KAUL DK, 1989, P NATL ACAD SCI USA, V86, P3356, DOI 10.1073/pnas.86.9.3356; KAUL DK, 1993, BLOOD, V81, P2429; Knipe L, 2010, BLOOD, V116, P2183, DOI 10.1182/blood-2010-03-276170; Kroll MH, 1996, BLOOD, V88, P1525; LEVINE JD, 1982, BLOOD, V60, P531; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Mackman N, 2012, J CLIN INVEST, V122, P2331, DOI 10.1172/JCI60229; Makhro A, 2013, AM J PHYSIOL-CELL PH, V305, pC1123, DOI 10.1152/ajpcell.00031.2013; Makhro A, 2010, AM J PHYSIOL-CELL PH, V298, pC1315, DOI 10.1152/ajpcell.00407.2009; Martin-Ramirez J, 2012, NAT PROTOC, V7, P1709, DOI 10.1038/nprot.2012.093; Matsui NM, 2001, BLOOD, V98, P1955, DOI 10.1182/blood.V98.6.1955; Pos W, 2010, BLOOD, V115, P1640, DOI 10.1182/blood-2009-06-229203; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Shahani T, 2010, BLOOD, V115, P4902, DOI 10.1182/blood-2009-07-232546; Smith BD, 1997, BLOOD, V89, P3451, DOI 10.1182/blood.V89.9.3451; STEL HV, 1984, BLOOD, V63, P1408; Stuart MJ, 2004, LANCET, V364, P1343, DOI 10.1016/S0140-6736(04)17192-4; SUGIHARA K, 1992, BLOOD, V80, P2634; Tokarev AA, 2011, BIOPHYS J, V100, P799, DOI 10.1016/j.bpj.2010.12.3740; TSAI HM, 1990, BLOOD, V75, P261; VANSCHRAVENDIJK MR, 1992, BLOOD, V80, P2105; Wautier MP, 2007, BLOOD, V110, P894, DOI 10.1182/blood-2006-10-048298; WICK TM, 1993, AM J HEMATOL, V42, P284, DOI 10.1002/ajh.2830420308; WICK TM, 1987, J CLIN INVEST, V80, P905, DOI 10.1172/JCI113151; WILEY JS, 1982, BLOOD, V60, P92; Yang L, 2000, BLOOD, V95, P2420, DOI 10.1182/blood.V95.7.2420.007k12_2420_2425	46	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173077	10.1371/journal.pone.0173077	http://dx.doi.org/10.1371/journal.pone.0173077			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249049	gold, Green Published, Green Submitted			2022-12-26	WOS:000395983500073
J	Reznick, DN; Furness, AI; Meredith, RW; Springer, MS				Reznick, David N.; Furness, Andrew I.; Meredith, Robert W.; Springer, Mark S.			The origin and biogeographic diversification of fishes in the family Poeciliidae	PLOS ONE			English	Article							MOLECULAR PHYLOGENETIC-RELATIONSHIPS; HISTORICAL BIOGEOGRAPHY; PERCIFORMES CICHLIDAE; TELEOSTEI; EVOLUTION; EOCENE; GENUS; CYPRINODONTIFORMES; ACTINOPTERYGII; SUPERFETATION	The fish subfamily Poeciliinae(sensu Parenti, 1981) is widely distributed across the Western Hemisphere and a dominant component of the fish communities of Central America. Poeciliids have figured prominently in previous studies on the roles of dispersal and vicariance in shaping current geographic distributions. Most recently, Hrbek et al. combined a DNA- based phylogeny of the family with geological models to provide a biogeographic perspective that emphasized the role of both vicariance and dispersal. Here we expand on that effort with a database enlarged in the quantity of sequence represented per species, in the number of species included, and in an enlarged and more balanced representation of the order Cyprinodontiformes. We combine a robust timetree based upon multiple fossil calibrations with enhanced biogeographic analyses that include ancestral area reconstructions to provide a detailed biogeographic history of this clade. Key features of our results are that the family originated in South America, but its major diversification dates to a later colonization of Central America. We also resolve additional colonizations among South, Central and North America and the Caribbean and consider how this reconstruction contributes to our understanding of the mechanisms of dispersal.	[Reznick, David N.; Springer, Mark S.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Furness, Andrew I.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Meredith, Robert W.] Montclair State Univ, Dept Biol & Mol Biol, Montclair, NJ USA	University of California System; University of California Riverside; University of California System; University of California Irvine; Montclair State University	Reznick, DN (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	david.reznick@ucr.edu		Furness, Andrew/0000-0001-7596-9623; reznick, david/0000-0002-1144-0568	Environmental Biology Division of the National Science Foundation (US) [DEB-0416085];  [DBI-1523666]; Direct For Biological Sciences [1523666] Funding Source: National Science Foundation	Environmental Biology Division of the National Science Foundation (US); ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Our project was funded by the Environmental Biology Division of the National Science Foundation (US) (https://www.nsf.gov/div/index.jsp?div=DEB) primarily with DEB-0416085 to DR (PI) and MS (co-PI). AF is currently supported by DBI-1523666.	Agorreta A, 2013, MOL PHYLOGENET EVOL, V66, P80, DOI 10.1016/j.ympev.2012.09.010; Alda F, 2013, MOL PHYLOGENET EVOL, V66, P1011, DOI 10.1016/j.ympev.2012.12.012; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Alvarado-Ortega J, 2008, J VERTEBR PALEONTOL, V28, P53, DOI 10.1671/0272-4634(2008)28[53:TASNTE]2.0.CO;2; Alvarez J, 1972, B SOC CIENCIAS NATUR, V6, P6; Arcila D, 2015, MOL PHYLOGENET EVOL, V82, P131, DOI 10.1016/j.ympev.2014.10.011; Arratia G., 1999, MESOZOIC FISHES; Arratia G., 1997, PALAEOICHTHYOLOGICA, V7, P1; Arratia Gloria, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P9; Arratia Gloria, 1999, P265; Arratia Gloria, 2000, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V3, P137; Bannikov AF, 2006, GEODIVERSITAS, V28, P249; Bell MA, 2009, COPEIA, P256, DOI 10.1643/CG-08-059; Benton MJ, 2015, PALAEONTOL ELECTRON, V18; Benton Michael J., 2009, P35; Bertini Reinaldo J., 1993, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V188, P71; Betancur R, 2013, SYST BIOL, V62, P763, DOI 10.1093/sysbio/syt039; Candeiro CRA, 2009, B GEOSCI, V84, P573, DOI 10.3140/bull.geosci.1101; Carnevale G, 2009, GEOBIOS VILLEURBANNE, V43, P283; Carnevale G, 2011, GEOL MAG, V148, P461, DOI 10.1017/S0016756810000907; Carnevale G, 2010, GEOBIOS-LYON, V43, P283, DOI 10.1016/j.geobios.2009.10.005; Chang MM, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)404<0001:ROEBAD>2.0.CO;2; Cione AL, 2002, J PALEONTOL, V76, P190, DOI 10.1666/0022-3360(2002)076<0190:TOKCTS>2.0.CO;2; Crowell J.C., 2003, EVOLUTION RIDGE BASI, V367, P157, DOI DOI 10.1130/0-8137-2367-1.157; Diogo R, 2009, INT J MORPHOL, V27, P333, DOI 10.4067/S0717-95022009000200008; Doadrio I, 2009, MOL PHYLOGENET EVOL, V50, P16, DOI 10.1016/j.ympev.2008.09.014; EVANS J.P., 2011, ECOLOGY EVOLUTION PO; Fara E, 2010, SER TELEOST FISH BIO, P173, DOI 10.1201/b10194-7; Filleul A, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)455<0001:ROSDOC>2.0.CO;2; Friedman M, 2009, P NATL ACAD SCI USA, V106, P5218, DOI 10.1073/pnas.0808468106; Furness AI, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2189; Gayet M., 1998, PHYLOGENY CLASSIFICA, P85; GRANDE L, 1985, B AM MUS NAT HIST, V181, P235; Ho ALFC, 2016, MOL PHYLOGENET EVOL, V101, P32, DOI 10.1016/j.ympev.2016.04.032; Hrbek T, 2007, MOL PHYLOGENET EVOL, V43, P986, DOI 10.1016/j.ympev.2006.06.009; Ingley SJ, 2015, MOL PHYLOGENET EVOL, V89, P104, DOI 10.1016/j.ympev.2015.04.013; Kriwet J, 2008, NATURWISSENSCHAFTEN, V95, P899, DOI 10.1007/s00114-008-0409-5; Lee DS, 1983, N CAROLINA BIOL SURV, V1983, P1; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Lucinda P.H.F., 2003, CHECK LIST FRESHWATE, P555; LYDEARD C, 1995, SYST BIOL, V44, P221, DOI 10.1093/sysbio/44.2.221; Maddison W.P., MESQUITE MODULAR SYS; Malabarba MC, 2010, J VERTEBR PALEONTOL, V30, P341, DOI 10.1080/02724631003618348; Malbarba Maria Claudia, 2010, P317; Mateos M, 2005, J BIOGEOGR, V32, P775, DOI 10.1111/j.1365-2699.2005.01236.x; Mateos M, 2002, EVOLUTION, V56, P972; Matzke N.J., 2012, FRONTIERS BIOGEOGRAP, V4, P210; Matzke N.J., 2013, FRONT BIOGEOGR, V5, P242, DOI [DOI 10.21425/F5FBG19694, 10.21425/F5FBG19694]; Matzke N.J., 2013, PACKAGE BIOGEOBEARS; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Meredith RW, 2011, MOL PHYLOGENET EVOL, V59, P148, DOI 10.1016/j.ympev.2011.01.014; Meredith RW, 2010, MOL PHYLOGENET EVOL, V55, P631, DOI 10.1016/j.ympev.2009.11.006; MEYER A, 1993, P ROY SOC B-BIOL SCI, V254, P153, DOI 10.1098/rspb.1993.0140; Miller R.R., 1986, P487; MILLER R R, 1974, Transactions of the San Diego Society of Natural History, V17, P235; Miya M, 2010, BMC EVOLUTIONARY BIO, V10; Morlo Michael, 2004, Courier Forschungsinstitut Senckenberg, V252, P95; Nolf D., 1990, Mississippi Geology, V10, P1; Nolf Dirk, 2003, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V73, P155; Nolf Dirk, 1996, P433; Palacios M, 2016, MOL PHYLOGENET EVOL, V103, P230, DOI 10.1016/j.ympev.2016.07.025; Parenti LR, 1981, B AM MUS NAT HIST, V168, P335, DOI DOI 10.1080/00222930210135631; Parenti Lynne R., 2005, P13; Perez PA, 2010, NEOTROP ICHTHYOL, V8, P631, DOI 10.1590/S1679-62252010000300008; Pires MN, 2011, FUNCT ECOL, V25, P757, DOI 10.1111/j.1365-2435.2011.01842.x; Pires MN, 2010, BIOL J LINN SOC, V99, P784, DOI 10.1111/j.1095-8312.2010.01391.x; Poeser FN., 2003, IBED IFBAED; Pollux BJA, 2009, ANNU REV ECOL EVOL S, V40, P271, DOI 10.1146/annurev.ecolsys.110308.120209; Pollux BJA, 2014, NATURE, P1; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Rauchenberger M, 1989, AM MUS NOVIT, V2951, P1; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Reznick DN, 2002, SCIENCE, V298, P1018, DOI 10.1126/science.1076018; Rosen D. E., 1963, Bulletin of the American Museum of Natural History, V126, P1; ROSEN DE, 1985, ANN MO BOT GARD, V72, P636, DOI 10.2307/2399218; ROSEN DE, 1975, SYST ZOOL, V24, P431, DOI 10.2307/2412905; Santini F, 2004, INTEGR COMP BIOL, V44, P349, DOI 10.1093/icb/44.5.349; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Schartl M, 2014, DIS MODEL MECH, V7, P181, DOI 10.1242/dmm.012245; Schwarzhans Werner, 2003, Geological Survey of Denmark and Greenland Bulletin, V2, P1; Silva HMA, 2011, AN ACAD BRAS CIENC, V83, P483, DOI 10.1590/S0001-37652011000200010; Smith ML., 1980, EVOLUTIONARY ECOLOGI; Smith WL, 2008, CLADISTICS, V24, P625, DOI 10.1111/j.1096-0031.2008.00210.x; Springer MS, 2011, PHILOS T R SOC B, V366, P2478, DOI 10.1098/rstb.2011.0023; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Taverne L., 1981, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V51, P43; Tyler James C., 2006, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V30, P49; Uyeno T., 1962, Copeia, V1962, P520, DOI 10.2307/1441173; Van Der Laan R, 2014, ZOOTAXA, V3882, P1, DOI 10.11646/zootaxa.3882.1.1; Weaver PF, 2016, J BIOGEOGRAPHY; Webb SA, 2004, MOL PHYLOGENET EVOL, V30, P527, DOI 10.1016/S1055-7903(03)00257-4; Whitlock JA, 2010, J VERTEBR PALEONTOL, V30, P1037, DOI 10.1080/02724634.2010.483534; Wilson Mark V.H., 2010, P379; WILSON MVH, 1992, J PALEONTOL, V66, P839, DOI 10.1017/S0022336000020849; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	95	54	55	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172546	10.1371/journal.pone.0172546	http://dx.doi.org/10.1371/journal.pone.0172546			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278162	gold, Green Submitted, Green Published			2022-12-26	WOS:000396087900123
J	Ogihara, T; Mita, T; Osonoi, Y; Osonoi, T; Saito, M; Tamasawa, A; Nakayama, S; Someya, Y; Ishida, H; Gosho, M; Kanazawa, A; Watada, H				Ogihara, Takeshi; Mita, Tomoya; Osonoi, Yusuke; Osonoi, Takeshi; Saito, Miyoko; Tamasawa, Atsuko; Nakayama, Shiho; Someya, Yuki; Ishida, Hidenori; Gosho, Masahiko; Kanazawa, Akio; Watada, Hirotaka			Relationships between lifestyle patterns and cardio-renal-metabolic parameters in patients with type 2 diabetes mellitus: A cross-sectional study	PLOS ONE			English	Article							MORNINGNESS-EVENINGNESS QUESTIONNAIRE; CORONARY-HEART-DISEASE; SLEEP DURATION; ALCOHOL-CONSUMPTION; ARTERIAL STIFFNESS; PHYSICAL-ACTIVITY; GLYCEMIC CONTROL; RISK-FACTOR; DEPRESSION; SCORE	Introduction While individuals tend to show accumulation of certain lifestyle patterns, the effect of such patterns in real daily life on cardio-renal-metabolic parameters remains largely unknown. This study aimed to assess clustering of lifestyle patterns and investigate the relationships between such patterns and cardio-renal-metabolic parameters. Participants and methods The study participants were 726 Japanese type 2 diabetes mellitus (T2DM) outpatients free of history of cardiovascular diseases. The relationship between lifestyle patterns and cardiorenal-metabolic parameters was investigated by linear and logistic regression analyses. Results Factor analysis identified three lifestyle patterns. Subjects characterized by evening type, poor sleep quality and depressive status (type 1 pattern) had high levels of HbA1c, alanine aminotransferase and albuminuria. Subjects characterized by high consumption of food, alcohol and cigarettes (type 2 pattern) had high levels of gamma-glutamyl transpeptidase, triglycerides, HDL-cholesterol, blood pressure, and brachial-ankle pulse wave velocity. Subjects characterized by high physical activity (type 3 pattern) had low uric acid and mild elevation of alanine aminotransferase and aspartate aminotransferase. In multivariate regression analysis adjusted by age, gender and BMI, type 1 pattern was associated with higher HbA1c levels, systolic BP and brachial-ankle pulse wave velocity. Type 2 pattern was associated with higher HDL-cholesterol levels, triglycerides, aspartate aminotransferase, gamma-glutamyl transpeptidase levels, and diastolic BP. Conclusions The study identified three lifestyle patterns that were associated with distinct cardio-metabolic-renal parameters in T2DM patients.	[Ogihara, Takeshi; Mita, Tomoya; Osonoi, Yusuke; Nakayama, Shiho; Someya, Yuki; Kanazawa, Akio; Watada, Hirotaka] Dept Endocrinol & Metab, Tokyo, Japan; [Mita, Tomoya; Kanazawa, Akio; Watada, Hirotaka] Ctr Therapeut Innovat Diabet, Tokyo, Japan; [Osonoi, Takeshi; Saito, Miyoko; Tamasawa, Atsuko; Ishida, Hidenori] Naka Mem Clin, Naka, Ibaraki, Japan; [Gosho, Masahiko] Univ Tsukuba, Fac Med, Dept Clin Trial & Clin Epidemiol, Tsukuba, Ibaraki, Japan; [Watada, Hirotaka] Ctr Mol Diabetol, Tokyo, Japan; [Watada, Hirotaka] Juntendo Univ, Sportol Ctr, Grad Sch Med, Tokyo, Japan	University of Tsukuba; Juntendo University	Mita, T (corresponding author), Dept Endocrinol & Metab, Tokyo, Japan.	tom-m@juntendo.ac.jp		Mita, Tomoya/0000-0002-4401-2965; Watada, Hirotaka/0000-0001-5961-1816	Manpei Suzuki Diabetes Foundation [26-76]	Manpei Suzuki Diabetes Foundation	This study was supported by research grand from Manpei Suzuki Diabetes Foundation (to T.M., Number 26-76). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAN A, 1994, ADDICTION, V89, P455, DOI 10.1111/j.1360-0443.1994.tb00926.x; Agency SaT, 2005, STAND TABL FOOD COMP, V5th; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Balkau B, 2004, DIABETOLOGIA, V47, P2118, DOI 10.1007/s00125-004-1574-5; Beck A. T, 1996, CORPORATION; Broms U, 2011, ADDICTION, V106, P170, DOI 10.1111/j.1360-0443.2010.03112.x; Buysse D J, 1989, Psychiatry Res, V28, P193; Chaput JP, 2012, APPETITE, V59, P650, DOI 10.1016/j.appet.2012.07.012; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Hu G, 2005, DIABETES CARE, V28, P799, DOI 10.2337/diacare.28.4.799; Iwasaki M, 2013, J DIABETES INVEST, V4, P376, DOI 10.1111/jdi.12047; Jin Z, 2013, ANN RHEUM DIS; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Lee JH, 2014, CHRONOBIOL INT, V31, P479, DOI 10.3109/07420528.2013.867864; Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Mahmood WAW, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/341506; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Musselman DL, 2003, BIOL PSYCHIAT, V54, P317, DOI 10.1016/S0006-3223(03)00569-9; Nakamura M, 2010, HYPERTENS RES, V33, P1018, DOI 10.1038/hr.2010.126; Ohkuma T, 2013, DIABETES CARE, V36, P611, DOI 10.2337/dc12-0904; Osonoi Y, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0132-6; Osonoi Y, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0026-1; Osonoi Y, 2014, CHRONOBIOL INT, V31, P1017, DOI 10.3109/07420528.2014.943843; OSTBERG O, 1973, ERGONOMICS, V16, P203, DOI 10.1080/00140137308924497; Reutrakul S, 2013, DIABETES CARE, V36, P2523, DOI 10.2337/dc12-2697; Roeser K, 2012, PHYSIOL BEHAV, V106, P151, DOI 10.1016/j.physbeh.2012.01.023; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Seike N, 2008, ASIA PAC J CLIN NUTR, V17, P545; Sone H, 2010, DIABETOLOGIA, V53, P419, DOI 10.1007/s00125-009-1622-2; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Takeno K, 2012, AM J HYPERTENS, V25, P165, DOI 10.1038/ajh.2011.158; Trento M, 2008, ACTA DIABETOL, V45, P225, DOI 10.1007/s00592-008-0047-6; Tsuchida Y, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-9; Vgontzas AN, 1999, CLIN ENDOCRINOL, V51, P205, DOI 10.1046/j.1365-2265.1999.00763.x; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Williams CJ, 2007, DIABETES CARE, V30, P1233, DOI 10.2337/dc06-2107; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879	43	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173540	10.1371/journal.pone.0173540	http://dx.doi.org/10.1371/journal.pone.0173540			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273173	Green Published, gold, Green Submitted			2022-12-26	WOS:000396073700015
J	Sheehan, DF; Criss, SD; Gazelle, GS; Pandharipande, PV; Kong, CY				Sheehan, Deirdre F.; Criss, Steven D.; Gazelle, G. Scott; Pandharipande, Pari V.; Kong, Chung Yin			Evaluating lung cancer screening in China: Implications for eligibility criteria design from a microsimulation modeling approach	PLOS ONE			English	Article							COST-EFFECTIVENESS; TOBACCO CONTROL; AIR-POLLUTION; RISK; MORTALITY; SMOKING; BENEFITS; PROGRAM; TRENDS	More than half of males in China are current smokers and evidence from western countries tells us that an unprecedented number of smoking-attributable deaths will occur as the Chinese population ages. We used the China Lung Cancer Policy Model (LCPM) to simulate effects of computed tomography (CT)-based lung cancer screening in China, comparing the impact of a screening guideline published in 2015 by a Chinese expert group to a version developed for the United States by the U.S. Centers for Medicare & Medicaid Services (CMS). The China LCPM, built using an existing lung cancer microsimulation model, can project population outcomes associated with interventions for smoking-related diseases. After calibrating the model to published Chinese smoking prevalence and lung cancer mortality rates, we simulated screening from 2016 to 2050 based on eligibility criteria from the CMS and Chinese guidelines, which differ by age to begin and end screening, pack-years smoked, and years since quitting. Outcomes included number of screens, mortality reduction, and life-years saved for each strategy. We projected that in the absence of screening, 14.98 million lung cancer deaths would occur between 2016 and 2050. Screening with the CMS guideline would prevent 0.72 million deaths and 5.8 million life-years lost, resulting in 6.58% and 1.97% mortality reduction in males and females, respectively. Screening with the Chinese guideline would prevent 0.74 million deaths and 6.6 million life-years lost, resulting in 6.30% and 2.79% mortality reduction in males and females, respectively. Through 2050, 1.43 billion screens would be required using the Chinese screening strategy, compared to 988 million screens using the CMS guideline. In conclusion, CT-based lung cancer screening implemented in 2016 and based on the Chinese screening guideline would prevent about 20,000 (2.9%) more lung cancer deaths through 2050, but would require about 445 million (44.7%) more screens than the CMS guideline.	[Sheehan, Deirdre F.; Criss, Steven D.; Gazelle, G. Scott; Pandharipande, Pari V.; Kong, Chung Yin] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [Gazelle, G. Scott; Pandharipande, Pari V.; Kong, Chung Yin] Harvard Med Sch, Boston, MA 02115 USA; [Gazelle, G. Scott] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Kong, CY (corresponding author), Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA.; Kong, CY (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	joey@mgh-ita.org		Criss, Steven/0000-0002-9394-1381; Kong, Chung Yin/0000-0001-6431-7830	National Institutes of Health [U01CA199284]; NATIONAL CANCER INSTITUTE [U01CA199284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health, Grant number: U01CA199284, https://www.nih.gov/.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; [Anonymous], 2013, LARG STUD NEV SMOK S; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Cassidy A, 2008, BRIT J CANCER, V98, P270, DOI 10.1038/sj.bjc.6604158; Centers for Medicare & Medicaid Services (CMS), 2015, DEC MEM SCREEN LUNG; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chen ZM, 2015, LANCET, V386, P1447, DOI 10.1016/S0140-6736(15)00340-2; CHNS, 2015, CHIN HLTH NUTR SURV; de Koning HJ, 2014, ANN INTERN MED, V160, P311, DOI 10.7326/M13-2316; de Koning HJ, 2013, ANN INTERN MED; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; Institute for Health Metrics and Evaluation, 2015, GLOB BURD DIS DAT; International Agency for Research on Cancer, 2015, LUNG CANC EST INC MO; Knudsen AB, 2010, JNCI-J NATL CANCER I, V102, P1238, DOI 10.1093/jnci/djq242; Kong JY, 2014, RESPIROLOGY, V19, P1222, DOI 10.1111/resp.12373; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Levy David, 2014, BMJ, V348, pg1134, DOI 10.1136/bmj.g1134; Li KR, 2015, CANCER PREV RES, V8, P777, DOI 10.1158/1940-6207.CAPR-14-0424; Li Q, 2011, NEW ENGL J MED, V364, P2469, DOI 10.1056/NEJMc1102459; Loomis D, 2014, CHIN J CANCER, V33, P189, DOI 10.5732/cjc.014.10028; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; McMahon PM, 2008, RADIOLOGY, V248, P278, DOI 10.1148/radiol.2481071446; McMahon PM, 2012, RISK ANAL, V32, pS117, DOI 10.1111/j.1539-6924.2011.01652.x; McMahon PM, 2011, J THORAC ONCOL, V6, P1841, DOI 10.1097/JTO.0b013e31822e59b3; McMahon PM, 2008, CANCER-AM CANCER SOC, V113, P3440, DOI 10.1002/cncr.23962; Moolgavkar SH, 2012, JNCI-J NATL CANCER I, V104, P541, DOI 10.1093/jnci/djs136; Mu LN, 2013, CANCER CAUSE CONTROL, V24, P439, DOI 10.1007/s10552-012-0130-8; Qian JC, 2010, B WORLD HEALTH ORGAN, V88, P769, DOI 10.2471/BLT.09.064709; Rutter CM, 2011, MED DECIS MAKING, V31, P10, DOI 10.1177/0272989X10369005; Sone S, 1998, LANCET, V351, P1242, DOI 10.1016/S0140-6736(97)08229-9; Sone S, 2007, LUNG CANCER, V58, P329, DOI 10.1016/j.lungcan.2007.06.022; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; ten Haaf K, 2015, J THORAC ONCOL, V10, P1285, DOI 10.1097/JTO.0000000000000593; United States Census Bureau, 2015, INT DAT BAS; Wang Y, 2012, SHANDONG AGR SCI, V5, P9; Zhao SJ, 2015, THORAC CANCER, V6, P385, DOI 10.1111/1759-7714.12253; Zhou QH, 2015, THORAC CANCER, V6, P812, DOI 10.1111/1759-7714.12287; Zhou QH, 2014, THORAC CANCER, V5, P197, DOI 10.1111/1759-7714.12078	39	9	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173119	10.1371/journal.pone.0173119	http://dx.doi.org/10.1371/journal.pone.0173119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273181	Green Submitted, Green Published, gold			2022-12-26	WOS:000396073700040
J	Suld, K; Saarma, U; Valdmann, H				Suld, Karmen; Saarma, Urmas; Valdmann, Harri			Home ranges of raccoon dogs in managed and natural areas	PLOS ONE			English	Article							MEDIUM-SIZED CARNIVORES; NYCTEREUTES-PROCYONOIDES; SOUTHERN FINLAND; HABITAT USE; ECHINOCOCCUS-MULTILOCULARIS; BODY-TEMPERATURE; RABIES SPREAD; WINTER SLEEP; EUROPE; ESTONIA	Knowledge of space use is central to understand animals' role in ecosystems. The raccoon dog Nyctereutes procyonoides is considered as one of the most influential alien mesopredator species in Europe, having the potential to cause loss of local biodiversity and act as a vector for zoonotic diseases. We collared 12 animals to study their home range and habitat use in two areas with different management regimes in Estonia: in a protected natural area and in an intensively managed area. From May to October raccoon dogs inhabiting the natural area had considerably smaller home ranges compared to the managed area, 193.3ha +/- 37.3SD and 391.9ha +/- 292.9SD, respectively. This result contradicts somewhat earlier findings in other European raccoon dog populations, where the home range sizes in natural areas in summer and autumn period have usually been larger compared to managed areas. In both study areas raccoon dogs preferred watersides, where amphibians and other semiaquatic prey are abundant, to other habitats available in their home ranges. We also studied movements of a raccoon dog pair in the managed study area in winter period. Due to mild weather conditions during the study period, raccoon dogs changed their resting sites quite often, covering a relatively large 599 ha area from November 2012 to January 2013, indicating the absence of usual winter lethargy during the mild winters.	[Suld, Karmen; Saarma, Urmas; Valdmann, Harri] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Tartu, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Valdmann, H (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Tartu, Estonia.	harri.valdmann@ut.ee	Saarma, Urmas/AAC-9813-2019	Saarma, Urmas/0000-0002-3222-571X	Estonian Environmental Investment Centre [3-3/53]	Estonian Environmental Investment Centre	This work was supported by Estonian Environmental Investment Centre, Contract nr 3-3/53; Recipient Karmen SON.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Aul Juhan, 1957, EESTI NSV IMETAJAD; Drygala F, 2008, MAMM BIOL, V73, P371, DOI 10.1016/j.mambio.2007.09.005; Drygala F, 2013, EUR J WILDLIFE RES, V59, P683, DOI 10.1007/s10344-013-0722-y; Drygala F, 2008, WILDLIFE BIOL, V14, P457, DOI 10.2981/0909-6396-14.4.457; Genovesi Piero, 2009, V3, P119; Heptner VG, 1998, MAMMALS SOVIET UN 1A; Holmala K, 2009, ANN ZOOL FENN, V46, P233, DOI 10.5735/086.046.0401; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; JEDRZEJEWSKA B, 1998, ECOLOGICAL STUDIES, V135; Kauhala K, 2006, ACTA THERIOL, V51, P1, DOI 10.1007/BF03192650; Kauhala K, 1996, Z SAUGETIERKD, V61, P269; KAUHALA K, 1993, J ZOOL, V231, P95, DOI 10.1111/j.1469-7998.1993.tb05355.x; Kauhala K, 2001, ECOGRAPHY, V24, P151, DOI 10.1034/j.1600-0587.2001.240205.x; Kauhala K, 2008, ACTA THERIOL, V53, P333, DOI 10.1007/BF03195194; Kauhala K, 2007, MAMM BIOL, V72, P342, DOI 10.1016/j.mambio.2006.10.006; Kauhala K, 2011, CURR ZOOL, V57, P584, DOI 10.1093/czoolo/57.5.584; Kauhala K, 2010, ACTA THERIOL, V55, P371, DOI 10.4098/j.at.0001-7051.063.2009; Kauhala K, 2010, ACTA THERIOL, V55, P231, DOI 10.4098/j.at.0001-7051.040.2009; Keller Reuben P., 2011, Environmental Sciences Europe, V23, P23, DOI 10.1186/2190-4715-23-23; Laurimaa L, 2016, VET PARASITOL, V219, P24, DOI 10.1016/j.vetpar.2016.01.020; Laurimaa L, 2015, VET PARASITOL, V212, P200, DOI 10.1016/j.vetpar.2015.06.004; Laurimaa L, 2015, EMERG INFECT DIS, V21, P163, DOI 10.3201/eid2101.140136; Moks E, 2005, EMERG INFECT DIS, V11, P1973, DOI 10.3201/eid1112.050339; Mustonen AM, 2007, CHRONOBIOL INT, V24, P1095, DOI 10.1080/07420520701797999; Mustonen AM, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-27; Naaber J., 1971, EESTI LODUS, V14, P449; Neronov VM, 2008, INTEGR ZOOL, V3, P83, DOI 10.1111/j.1749-4877.2008.00084.x; Oja R., 2010, METSSEA SUS SCROFA L; Partel A, 2013, B OIE, V3, P58; Pavlov M. P., 1974, ACCLIMATIZATION GA 2; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Suld K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096358; Sutor A, 2012, EUR J WILDLIFE RES, V58, P85, DOI 10.1007/s10344-011-0546-6; Veeroja R., 2015, STATUS GAME POPULATI; Vila M, 2008, HDB ALIEN SPECIES EU, P265	36	6	6	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171805	10.1371/journal.pone.0171805	http://dx.doi.org/10.1371/journal.pone.0171805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273085	Green Published, Green Submitted, gold			2022-12-26	WOS:000396073700060
J	Hjelmen, CE; Johnston, JS				Hjelmen, Carl E.; Johnston, J. Spencer			The mode and tempo of genome size evolution in the subgenus Sophophora	PLOS ONE			English	Article							NUCLEAR-DNA CONTENT; DETERMINANT; DROSOPHILA; INFERENCE; DURATION; MRBAYES; BIAS	Genome size varies widely across organisms, with no apparent tie to organismal complexity. While genome size is inherited, there is no established evolutionary model for this trait. Hypotheses have been postulated for the observed variation in genome sizes across species, most notably the effective population size hypothesis, the mutational equilibrium hypothesis, and the adaptive hypothesis. While much data has been collected on genome size, the above hypotheses have largely ignored impacts from phylogenetic relationships. In order to test these competing hypotheses, genome sizes of 87 Sophophora species were analyzed in a comparative phylogenetic approach using Pagel's parameters of evolution, Blomberg's K, Abouheif's C-mean and Moran's I. In addition to testing the mode and rate of genome size evolution in Sophophora species, the effect of number of taxa on detection of phylogenetic signal was analyzed for each of these comparative phylogenetic methods. Sophophora genome size was found to be dependent on the phylogeny, indicating that evolutionary time was important for predicting the variation among species. Genome size was found to evolve gradually on branches of the tree, with a rapid burst of change early in the phylogeny. These results suggest that Sophophora genome size has experienced gradual changes, which support the largely theoretical mutational equilibrium hypothesis. While some methods (Abouheif's C-mean and Moran's I) were found to be affected by increasing taxa numbers, more commonly used methods (lambda and Blomberg's K) were found to have increasing reliability with increasing taxa number, with significantly more support with fifteen or more taxa. Our results suggest that these comparative phylogenetic methods, with adequate taxon sampling, can be a powerful way to uncover the enigma that is genome size variation through incorporation of phylogenetic relationships.	[Hjelmen, Carl E.; Johnston, J. Spencer] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Hjelmen, CE (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	cehjelmen09@tamu.edu	Hjelmen, Carl/AAO-8084-2020	Hjelmen, Carl/0000-0003-3061-6458				Abouheif E, 1999, EVOL ECOL RES, V1, P895; BENNETT M D, 1971, Proceedings of the Royal Society of London Series B Biological Sciences, V178, P277; BENNETT MD, 1972, PROC R SOC SER B-BIO, V181, P109, DOI 10.1098/rspb.1972.0042; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; CAVALIERSMITH T, 1982, ANNU REV BIOPHYS BIO, V11, P273, DOI 10.1146/annurev.bb.11.060182.001421; Da Lage JL, 2007, J ZOOL SYST EVOL RES, V45, P47, DOI 10.1111/j.1439-0469.2006.00389.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drosophila 12 Genomes Consortium, 2007, NATURE, V450, P203; Gregory TR, 2008, HEREDITY, V101, P228, DOI 10.1038/hdy.2008.49; Gregory T. R., ANIMAL GENOME SIZE D; Gregory T. Ryan, 2005, P3; Gregory TR, 2004, GENE, V324, P15, DOI 10.1016/j.gene.2003.09.030; Gregory TR, 2005, ANN BOT-LONDON, V95, P133, DOI 10.1093/aob/mci009; Gregory TR, 2003, TRENDS GENET, V19, P485, DOI 10.1016/S0168-9525(03)00192-6; Gregory TR, 1999, GENOME RES, V9, P317; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; GROSSET L, 1975, CELL TISSUE KINET, V8, P91, DOI 10.1111/j.1365-2184.1975.tb01210.x; Hare EE, 2011, METHODS MOL BIOL, V772, P3, DOI 10.1007/978-1-61779-228-1_1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUELSENBECK JP, 2001, BIOMETRICS, V17, P754, DOI [DOI 10.1093/BIOINFORMATICS/17.8.754, DOI 10.1093/BI0INF0RMATICS/17.8.754]; Jombart T., 2008, ADEPHYLO EXPLORATORY; Kapusta A, 2017, P NATL ACAD SCI USA, V114, pE1460, DOI 10.1073/pnas.1616702114; Kellermann V, 2012, EVOLUTION, V66, P3377, DOI 10.1111/j.1558-5646.2012.01685.x; Kelly VE, 2012, PARKINSONS DIS-US, V2012, DOI [10.1155/2012/918719, 10.1073/pnas.1207553109]; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kidwell MG, 2002, GENETICA, V115, P49, DOI 10.1023/A:1016072014259; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2007, ORIGINS GENOME ARCHI; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Oliver MJ, 2007, GENOME RES, V17, P594, DOI 10.1101/gr.6096207; Orme D., 2013, CAPER PACKAGE COMP A, V5, P1; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Palazzo AF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004351; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Petrov DA, 2002, THEOR POPUL BIOL, V61, P531, DOI 10.1006/tpbi.2002.1605; Petrov DA, 2001, TRENDS GENET, V17, P23, DOI 10.1016/S0168-9525(00)02157-0; Petrov DA, 2000, SCIENCE, V287, P1060, DOI 10.1126/science.287.5455.1060; Petrov DA, 2002, GENETICA, V115, P81, DOI 10.1023/A:1016076215168; Powell J. R., 1997, PROGR PROSPECTS EVOL; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Sessegolo C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0407; van der Linde K, 2010, GENET RES, V92, P25, DOI 10.1017/S001667231000008X; VANTHOF J, 1963, P NATL ACAD SCI USA, V49, P897, DOI 10.1073/pnas.49.6.897; Vinogradov AE, 2004, CURR OPIN GENET DEV, V14, P620, DOI 10.1016/j.gde.2004.09.007; Whitney KD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001080	46	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173505	10.1371/journal.pone.0173505	http://dx.doi.org/10.1371/journal.pone.0173505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267812	Green Submitted, gold, Green Published			2022-12-26	WOS:000396060600039
J	Hojman, DA; Duarte, F; Ruiz-Tagle, J; Budnich, M; Delgado, C; Slachevsky, A				Hojman, Daniel A.; Duarte, Fabian; Ruiz-Tagle, Jaime; Budnich, Marilu; Delgado, Carolina; Slachevsky, Andrea			The cost of dementia in an unequal country: The case of Chile	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; INFORMAL CARE; SOCIOECONOMIC INEQUALITIES; COGNITIVE DECLINE; ECONOMIC-IMPACT; RUD INSTRUMENT; UNITED-STATES; PEOPLE; DETERMINANTS; UNDERDIAGNOSIS	We study the economic cost of dementia in Chile, and its variation according to socioeconomic status (SES). We use primary data from a survey of 330 informal primary caregivers who completed both a RUD-Lite and a socio-demographic questionnaire to evaluate the severity of dementia and caregiver's burden. The costs of dementia are broken into three components: direct medical costs (medical care, drugs, tests); direct social costs (social service, daycare); and indirect costs (mostly associated to informal care). The average monthly cost per patient is estimated at US$ 1,463. Direct medical costs account for 20 per cent, direct social costs for 5 per cent and indirect costs for 75 per cent of the total cost. The mean monthly cost is found to be inversely related to SES, a pattern largely driven by indirect costs. The monthly cost for high SES is US$ 1,083 and US$ 1,588 for low SES. A multivariate regression analysis suggests that severity of dementia and caregiver's burden account for between 49 and 70 per cent of the difference in the indirect cost across SES. However, between one-third and one-half of the variation across SES is not due to gradient in severity of dementia. Direct medical costs increase in higher SES, reflecting differences in purchasing power, while indirect costs are inversely related to SES and more than compensate differences in medical costs. Moreover, in lower SES groups, female caregivers, typically family members who are inactive in the labor market, mostly provide informal care. The average annual cost of dementia in Chile (US$ 17,559) is lower in comparison to high-income countries (US$ 39,595) and the proportion of cost related to informal cost is higher (74 per cent compared to 40 per cent). SES is a key determinant in the cost of dementia. In the absence of universal access to treatment, part of the social cost of dementia potentially preserves or increases income and gender inequality.	[Hojman, Daniel A.; Duarte, Fabian; Ruiz-Tagle, Jaime] Univ Chile, Fac Econ & Business, Dept Econ, Santiago, Chile; [Hojman, Daniel A.; Duarte, Fabian] Ctr Social Conflict & Cohes Studies, Santiago, Chile; [Budnich, Marilu] Ctr KINTUN, Serv Salud Metropolitano Oriente, Santiago, Chile; [Delgado, Carolina] Hosp Clin Univ Chile, Neurol & Neurosurg Dept, Santiago, Chile; [Delgado, Carolina] Clin Santa Maria, Neurol & Neurosurg Dept, Santiago, Chile; [Slachevsky, Andrea] Univ Chile, Fac Med, ICBM, Physiopathol Dept, Santiago, Chile; [Slachevsky, Andrea] Univ Chile, Fac Med, East Neurosci Dept, Santiago, Chile; [Slachevsky, Andrea] Gerosci Ctr Brain Hlth & Metab GERO, Santiago, Chile; [Slachevsky, Andrea] Hosp Salvador, Dept Neurol, Cognit Neurol & Dementia, Santiago, Chile; [Slachevsky, Andrea] Clin Alemana Univ Desarrollo, Dept Med, Neurol Serv, Santiago, Chile; [Slachevsky, Andrea] Ctr Adv Res Educ, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad del Desarrollo	Hojman, DA (corresponding author), Univ Chile, Fac Econ & Business, Dept Econ, Santiago, Chile.; Hojman, DA (corresponding author), Ctr Social Conflict & Cohes Studies, Santiago, Chile.; Slachevsky, A (corresponding author), Univ Chile, Fac Med, ICBM, Physiopathol Dept, Santiago, Chile.; Slachevsky, A (corresponding author), Univ Chile, Fac Med, East Neurosci Dept, Santiago, Chile.; Slachevsky, A (corresponding author), Gerosci Ctr Brain Hlth & Metab GERO, Santiago, Chile.; Slachevsky, A (corresponding author), Hosp Salvador, Dept Neurol, Cognit Neurol & Dementia, Santiago, Chile.; Slachevsky, A (corresponding author), Clin Alemana Univ Desarrollo, Dept Med, Neurol Serv, Santiago, Chile.; Slachevsky, A (corresponding author), Ctr Adv Res Educ, Santiago, Chile.	dhojman@fen.uchile.cl; andrea.slachevsky@uchile.cl	Hojman, Daniel A/N-4178-2015; delgado, carolina/AAS-2383-2021; Slachevsky, Andrea/P-4039-2014	Hojman, Daniel A/0000-0001-7768-0065; delgado, carolina/0000-0001-5551-0065; Slachevsky, Andrea/0000-0001-6285-3189	CONICYT/FONDECYT Regular [1140423]; Project IV concurso de Investigacion SSMO Santiago-Chile; CONICYT /Associative Research Program / Grant Basal Funds for Centers of Excellence [FB 0003]; Centre for Social Conflict and Cohesion Studies [CONICYT/FONDAP/15130009];  [CONICYT/FONDAP/15150012]	CONICYT/FONDECYT Regular(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Project IV concurso de Investigacion SSMO Santiago-Chile; CONICYT /Associative Research Program / Grant Basal Funds for Centers of Excellence; Centre for Social Conflict and Cohesion Studies; 	The study was funded by CONICYT/FONDECYT Regular/1140423 (AS and CD; CONICYT/FONDAP/15150012 (AS); Project IV concurso de Investigacion SSMO Santiago-Chile (AS and MLB); CONICYT /Associative Research Program / Grant Basal Funds for Centers of Excellence FB 0003 (AS) and Centre for Social Conflict and Cohesion Studies (grant number CONICYT/FONDAP/15130009 (DH and FD). The funder had no role in study design, data collection, analysis, data interpretation, manuscript writing, or decision to submit for publication. All authors had responsibility for the decision to submit for publication.	Adimark, 2000, NIV SOC EC ES MAN AP; Allegri RF, 2007, INT PSYCHOGERIATR, V19, P705, DOI 10.1017/S1041610206003784; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; [Anonymous], 2015, LANCET NEUROL, V14, P1143, DOI 10.1016/S1474-4422(15)00307-5; ARAYA R, 1992, SOC PSYCH PSYCH EPID, V27, P168, DOI 10.1007/BF00789001; Atun R, 2015, LANCET, V385, P1230, DOI 10.1016/S0140-6736(14)61646-9; Bossert TJ, 2016, NEW ENGL J MED, V374, P1, DOI 10.1056/NEJMp1514202; Breinbauer H, 2009, REV MED CHILE, V137, P657, DOI /S0034-98872009000500009; Casey David A, 2010, P T, V35, P208; Cavallo MC, 1997, ALZ DIS ASSOC DIS, V11, P184; Chiatti C, 2015, INT PSYCHOGERIATR, V27, P1563, DOI 10.1017/S104161021500040X; Coduras A, 2010, J ALZHEIMERS DIS, V19, P601, DOI 10.3233/JAD-2010-1258; Connolly A, 2011, AGING MENT HEALTH, V15, P978, DOI 10.1080/13607863.2011.596805; Cotlear D, 2015, LANCET, V385, P1248, DOI 10.1016/S0140-6736(14)61647-0; Custodio N, 2014, DEMENT NEUROPSYCHOL, V9, P32; Cutler DM, 2011, HDB HLTH EC; Darba J, 2014, EUROPEAN J HLTH EC H; Dartigues JF, 2009, LANCET NEUROL, V8, P1082, DOI 10.1016/S1474-4422(09)70298-4; [Data Processing Co. Ltd Frekans Research Field], 2004, SOC CLAS; Dodel R, 2015, ALZHEIMERS DEMENT, V11, P933, DOI 10.1016/j.jalz.2015.02.005; Frenz P, 2014, HEALTH POLICY PLANN, V29, P717, DOI 10.1093/heapol/czt054; Fuentes Patricio, 2014, Dement. neuropsychol., V8, P317, DOI 10.1590/S1980-57642014DN84000003; Fuentes-Garcia A, 2013, GAC SANIT, V27, P226, DOI 10.1016/j.gaceta.2012.11.005; Fukami M., 1998, MONETARY VALUATION U; GONZALEZ F, 2009, ESTUDIO NACL DEPENDE; Gustavsson A, 2011, ALZHEIMERS DEMENT, V7, P466, DOI 10.1016/j.jalz.2010.06.002; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Jonsson B, 2000, DEMENTIA WPA SERIES, P335; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Kang IO, 2007, INT J GERIATR PSYCH, V22, P675, DOI 10.1002/gps.1729; Karlsson G, 1998, HLTH EC DEMENTIA, P161; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233; Koopmanschap M, 1998, HLTH EC DEMENTIA, P245; Kotagal V, 2015, NEUROLOGY, V84, P64, DOI 10.1212/WNL.0000000000001096; Lanska DJ, 2002, NEUROLOGY, V58, P1718, DOI 10.1212/WNL.58.12.1718; Liu Z, 2013, THESIS; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Martin BC, 2000, ALZ DIS ASSOC DIS, V14, P151, DOI 10.1097/00002093-200007000-00006; McDaid D, 2001, INT J GERIATR PSYCH, V16, P400, DOI 10.1002/gps.353; Munoz-Neira C, 2012, DEMENT GERIATR COGN, V33, P361, DOI 10.1159/000338606; Nakamura AE, 2015, LANCET, V385, P418, DOI 10.1016/S0140-6736(15)60153-2; Pickett K., 2011, SPIRIT LEVEL WHY GRE; Prince M, 2015, WORLD ALZHEIMERS REP; Scarmeas N, 2006, J NEUROL NEUROSUR PS, V77, P308, DOI 10.1136/jnnp.2005.072306; Slachevsky A, 2013, J ALZHEIMERS DIS, V35, P297, DOI 10.3233/JAD-122086; Turro-Garriga O, 2015, ARCH GERONTOL GERIAT, V60, P448, DOI 10.1016/j.archger.2015.01.020; van den Berg B, 2006, SOC SCI MED, V62, P835, DOI 10.1016/j.socscimed.2005.06.046; van den Berg Bernard, 2004, Eur J Health Econ, V5, P36, DOI 10.1007/s10198-003-0189-y; Veras RP, 2008, PSYCHOGERIATRICS, V8, P88, DOI 10.1111/j.1479-8301.2008.00237.x; Wimo A, 2010, J NUTR HEALTH AGING, V14, P685, DOI 10.1007/s12603-010-0316-2; Wimo A, 2000, INT J GERIATR PSYCH, V15, P969, DOI 10.1002/1099-1166(200010)15:10<969::AID-GPS272>3.0.CO;2-9; Wimo A, 2010, GLOBALL EC IMPACT DE; Wimo A, 2013, ALZHEIMERS DEMENT, V9; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; Wimo A, 2010, ALZHEIMERS DEMENT, V6, P98, DOI 10.1016/j.jalz.2010.01.010; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR	57	35	38	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0172204	10.1371/journal.pone.0172204	http://dx.doi.org/10.1371/journal.pone.0172204			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5QM	28267795	Green Published, gold, Green Submitted			2022-12-26	WOS:000396060600055
J	Penberthy, KK; Buckley, MW; Arandjelovic, S; Ravichandran, K				Penberthy, Kristen Kelley; Buckley, Monica Weaver; Arandjelovic, Sanja; Ravichandran, Kodi			Ex vivo modulation of the Foxo1 phosphorylation state does not lead to dysfunction of T regulatory cells	PLOS ONE			English	Article							FOXP3 EXPRESSION; PHOSPHATASE PP2A; ASTHMA; IL-10; DIFFERENTIATION; INDUCTION; PROTEINS; TREGS; GAMMA	Peripheral regulatory CD4(+) T cells (Treg cells) prevent maladaptive inflammatory responses to innocuous foreign antigens. Treg cell dysfunction has been linked to many inflammatory diseases, including allergic airway inflammation. Glucocorticoids that are used to treat allergic airway inflammation and asthma are thought to work in part by promoting Treg cell differentiation; patients who are refractory to these drugs have defective induction of anti-inflammatory Treg cells. Previous observations suggest that Treg cells deficient in the transcription factor FoxO1 are pro-inflammatory, and that FoxO1 activity is regulated by its phosphorylation status and nuclear localization. Here, we asked whether altering the phosphorylation state of FoxO1 through modulation of a regulatory phosphatase might affect Treg cell function. In a mouse model of house dust mite-induced allergic airway inflammation, we observed robust recruitment of Treg cells to the lungs and lymph nodes of diseased mice, without an apparent increase in the Treg cytokine interleukin-10 in the airways. Intriguingly, expression of PP2A, a serine/threonine phosphatase linked to the regulation of FoxO1 phosphorylation, was decreased in the mediastinal lymph nodes of HDM-treated mice, mirroring the decreased PP2A expression seen in peripheral blood monocytes of glucocorticoid-resistant asthmatic patients. When we asked whether modulation of PP2A activity alters Treg cell function via treatment with the PP2A inhibitor okadaic acid, we observed increased phosphorylation of FoxO1 and decreased nuclear localization. However, dysregulation of FoxO1 did not impair Treg cell differentiation ex vivo or cause Treg cells to adopt a pro-inflammatory phenotype. Moreover, inhibition of PP2A activity did not affect the suppressive function of Treg cells ex vivo. Collectively, these data suggest that modulation of the phosphorylation state of FoxO1 via PP2A inhibition does not modify Treg cell function ex vivo. Our data also highlight the caveat in using ex vivo assays of Treg cell differentiation and function, in that while these assays are useful, they may not fully recapitulate Treg cell phenotypes that are observed in vivo.	[Penberthy, Kristen Kelley; Buckley, Monica Weaver; Arandjelovic, Sanja; Ravichandran, Kodi] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA; [Penberthy, Kristen Kelley; Buckley, Monica Weaver; Arandjelovic, Sanja; Ravichandran, Kodi] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22903 USA; [Penberthy, Kristen Kelley; Buckley, Monica Weaver; Arandjelovic, Sanja; Ravichandran, Kodi] Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia; University of Virginia	Ravichandran, K (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA.; Ravichandran, K (corresponding author), Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22903 USA.; Ravichandran, K (corresponding author), Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22903 USA.	Ravi@virginia.edu		Ravichandran, Kodi/0000-0001-9049-1410	National Institute of General Medical Sciences [GM064709]; National Heart, Lung and Blood Institute [P01HL120840, F30 HL126385]; Center for Cell Clearance/University of Virginia School of Medicine; National Institute of Allergy and Infectious Disease NIH [T32 A1007496]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL126385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Center for Cell Clearance/University of Virginia School of Medicine; National Institute of Allergy and Infectious Disease NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by grants to K.S. R. from National Institute of General Medical Sciences (GM064709), National Heart, Lung and Blood Institute (P01HL120840), and the Center for Cell Clearance/University of Virginia School of Medicine. K.K.P. is supported by an National Heart, Lung and Blood Institute F30 award (F30 HL126385) and previously by the National Institute of Allergy and Infectious Disease NIH T32 Immunology Training Grant (T32 A1007496). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolidis SA, 2016, NAT IMMUNOL, V17, P556, DOI 10.1038/ni.3390; Bengtsson L, 2009, J CELL SCI, V122, P1248, DOI 10.1242/jcs.039552; Bohm L, 2015, J IMMUNOL, V194, P887, DOI 10.4049/jimmunol.1401612; Borish L, 1996, J ALLERGY CLIN IMMUN, V97, P1288, DOI 10.1016/S0091-6749(96)70197-5; Chang X, 2005, J EXP MED, V202, P1141, DOI 10.1084/jem.20050157; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Du XR, 2014, J IMMUNOL, V192, P1525, DOI 10.4049/jimmunol.1301060; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsu P, 2015, J IMMUNOL, V195, P3665, DOI 10.4049/jimmunol.1402898; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Karagiannidis C, 2004, J ALLERGY CLIN IMMUN, V114, P1425, DOI 10.1016/j.jaci.2004.07.014; Kennedy JL, 2012, CLIN EXP ALLERGY, V42, P659, DOI 10.1111/j.1365-2222.2011.03944.x; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kobayashi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027627; Kumar Rakesh K., 2006, Inflammation & Allergy Drug Targets, V5, P253, DOI 10.2174/187152806779010909; Kurimchak A, 2012, GENE, V499, P1, DOI 10.1016/j.gene.2012.02.015; Kwak JH, 2008, J BIOL CHEM, V283, P19816, DOI 10.1074/jbc.M802285200; Lambrecht BN, 2013, EUR J IMMUNOL, V43, P3125, DOI 10.1002/eji.201343730; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Lin YL, 2008, ALLERGY, V63, P67, DOI 10.1111/j.1398-9995.2007.01526.x; Lu J, 2009, P NATL ACAD SCI USA, V106, P11697, DOI 10.1073/pnas.0905930106; Luo CT, 2016, NATURE, V529, P532, DOI 10.1038/nature16486; Mamessier E, 2008, ALLERGY, V63, P1202, DOI 10.1111/j.1398-9995.2008.01687.x; Martelli AM, 2012, BBA-MOL CELL RES, V1823, P2168, DOI 10.1016/j.bbamcr.2012.08.017; Mays LE, 2013, J CLIN INVEST, V123, P1216, DOI 10.1172/JCI65351; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nadeau K, 2010, J ALLERGY CLIN IMMUN, V126, P845, DOI 10.1016/j.jaci.2010.08.008; Nguyen Khoa D, 2010, Allergy Asthma Clin Immunol, V6, P4, DOI 10.1186/1710-1492-6-4; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Provoost S, 2009, ALLERGY, V64, P1539, DOI 10.1111/j.1398-9995.2009.02056.x; Puthanveetil P, 2013, CARDIOVASC RES, V97, P393, DOI 10.1093/cvr/cvs426; Raundhal M, 2015, J CLIN INVEST, V125, P3037, DOI 10.1172/JCI80911; Robinson DS, 2004, J CLIN INVEST, V114, P1389, DOI 10.1172/JCI200423595; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Swingle Mark, 2007, V365, P23; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Van Hoof C, 2004, CANCER CELL, V5, P105, DOI 10.1016/S1535-6108(04)00027-3; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	49	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173386	10.1371/journal.pone.0173386	http://dx.doi.org/10.1371/journal.pone.0173386			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267764	Green Published, Green Submitted, gold			2022-12-26	WOS:000396060600028
J	Zhou, T; Souzeau, E; Sharma, S; Landers, J; Mills, R; Goldberg, I; Healey, PR; Graham, S; Hewitt, AW; Mackey, DA; Galanopoulos, A; Casson, RJ; Ruddle, JB; Ellis, J; Leo, P; Brown, MA; MacGregor, S; Lynn, DJ; Burdon, KP; Craig, JE				Zhou, Tiger; Souzeau, Emmanuelle; Sharma, Shiwani; Landers, John; Mills, Richard; Goldberg, Ivan; Healey, Paul R.; Graham, Stuart; Hewitt, Alex W.; Mackey, David A.; Galanopoulos, Anna; Casson, Robert J.; Ruddle, Jonathan B.; Ellis, Jonathan; Leo, Paul; Brown, Matthew A.; MacGregor, Stuart; Lynn, David J.; Burdon, Kathryn P.; Craig, Jamie E.			Whole exome sequencing implicates eye development, the unfolded protein response and plasma membrane homeostasis in primary open-angle glaucoma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ENDOPLASMIC-RETICULUM STRESS; COPY NUMBER VARIATIONS; CHEMICAL CHAPERONE; MOUSE MODEL; CELL-DEATH; WILD-TYPE; MYOCILIN; MUTATIONS; LOCI	Purpose To identify biological processes associated with POAG and its subtypes, high-tension (HTG) and normal -tension glaucoma (NTG), by analyzing rare potentially damaging genetic variants. Methods A total of 122 and 65 unrelated HTG and NTG participants, respectively, with early onset advanced POAG, 103 non -glaucoma controls and 993 unscreened ethnicity-matched controls were included in this study. Study participants without myocilin disease-causing variants and non -glaucoma controls were subjected to whole exome sequencing on an Illumina HiSeq2000. Exomes of participants were sequenced on an Illumina HiSeq2000. Qualifying variants were rare in the general population (MAF < 0.001) and potentially functionally damaging (nonsense, frameshift, splice or predicted pathogenic using SIFT or Polyphen2 software). Genes showing enrichment of qualifying variants in cases were selected for pathway and network analysis using InnateDB. Results POAG cases showed enrichment of rare variants in camera -type eye development genes (p = 1.40x10-7, corrected p = 3.28x10-4). Implicated eye development genes were related to neuronal or retinal development. HTG cases were significantly enriched for key regulators in the unfolded protein response (UPR) (p = 7.72x10-5, corrected p = 0.013). The UPR is known to be involved in myocilin-related glaucoma; our results suggest the UPR has a role in non-myocilin causes of HTG. NTG cases showed enrichment in ion channel transport processes (p = 1.05x10-4, corrected p = 0.027) including calcium, chloride and phospholipid transporters involved in plasma membrane homeostasis. Network analysis also revealed enrichment of the MHC Class I antigen presentation pathway in HTG, and the EGFR1 and cell-cycle pathways in both HTG and NTG. Conclusion This study suggests that mutations in eye development genes are enriched in POAG. HTG can result from aberrant responses to protein misfolding which may be amenable to molecular chaperone therapy. NTG is associated with impaired plasma membrane homeostasis increasing susceptibility to apoptosis.	[Zhou, Tiger; Souzeau, Emmanuelle; Sharma, Shiwani; Landers, John; Mills, Richard; Burdon, Kathryn P.; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Bedford Pk, SA, Australia; [Goldberg, Ivan; Healey, Paul R.; Graham, Stuart] Univ Sydney, Discipline Ophthalmol, Sydney, NSW, Australia; [Goldberg, Ivan] Sydney Eye Hosp, Glaucoma Unit, Sydney, NSW, Australia; [Healey, Paul R.] Univ Sydney, Westmead Inst Med Res, Ctr Vis Res, Sydney, NSW, Australia; [Hewitt, Alex W.; Burdon, Kathryn P.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Mackey, David A.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA, Australia; [Galanopoulos, Anna; Casson, Robert J.] Univ Adelaide, Discipline Ophthalmol & Visual Sci, Adelaide, SA, Australia; [Ruddle, Jonathan B.] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Ellis, Jonathan; Leo, Paul; Brown, Matthew A.] Univ Queensland, Diamantina Inst, Translat Res Inst, Princess Alexandra Hosp, Woolloongabba, Qld, Australia; [MacGregor, Stuart] Royal Brisbane Hosp, QIMR Berghofer Med Res Inst, Stat Genet, Brisbane, Qld, Australia; [Lynn, David J.] South Australian Med & Hlth Res Inst, Infect & Immun Theme, EMBL Australia Grp, Adelaide, SA, Australia; [Lynn, David J.] Flinders Univ S Australia, Sch Med, Adelaide, SA, Australia	Flinders University South Australia; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Tasmania; Menzies Institute for Medical Research; Lions Eye Institute; University of Western Australia; University of Adelaide; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Queensland; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Flinders University South Australia	Zhou, T (corresponding author), Flinders Univ S Australia, Dept Ophthalmol, Bedford Pk, SA, Australia.	tiger.zhou@sa.gov.au	Mackey, David A/H-5340-2014; Burdon, Kathryn/A-5026-2009; Burdon, Kathryn/AAD-2334-2022; Brown, Matthew A/E-5749-2010; Souzeau, Emmanuelle/AAB-5608-2022; Leo, Paul/R-4464-2019; Macgregor, Stuart/C-6442-2009; Ellis, Jonathan J/F-2920-2010	Mackey, David A/0000-0001-7914-4709; Burdon, Kathryn/0000-0001-8217-1249; Burdon, Kathryn/0000-0001-8217-1249; Brown, Matthew A/0000-0003-0538-8211; Souzeau, Emmanuelle/0000-0002-2015-6577; Macgregor, Stuart/0000-0001-6731-8142; Ellis, Jonathan J/0000-0003-0410-5064; Hewitt, Alex/0000-0002-5123-5999; Mills, Richard/0000-0002-7386-2571; Craig, Jamie/0000-0001-9955-9696; Sharma, Shiwani/0000-0002-0828-025X; Lynn, David/0000-0003-4664-1404; Graham, Stuart/0000-0001-7519-969X; Ellis, Jonathan/0000-0003-0218-546X	National Health and Medical Research Council (NHMRC) [APP1023911, APP1107098]; Australian Research Council Future Fellowship; EMBL Australia Group Leader award; NHMRC Practitioner Fellowship [APP1065433]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council); EMBL Australia Group Leader award; NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This project is supported by The National Health and Medical Research Council (NHMRC) Centres of Research Excellence scheme (APP1023911) and project grant (APP1107098). SM is supported by an Australian Research Council Future Fellowship. DJL is supported by an EMBL Australia Group Leader award. JEC is supported by an NHMRC Practitioner Fellowship (APP1065433). The funding organizations had no role in the design or conduct of this research.	Abu-Amero KK, 2013, OPHTHALMIC GENETICS; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anholt RRH, 2013, TRENDS MOL MED, V19, P586, DOI 10.1016/j.molmed.2013.06.005; Awadalla MS, 2015, AM J OPHTHALMOL, V159, P124, DOI 10.1016/j.ajo.2014.09.044; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Carbone MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020649; Carbone MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004216; Charitou T, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0205-1; Charlesworth J, 2010, INVEST OPHTH VIS SCI, V51, P3509, DOI 10.1167/iovs.09-4786; Cirulli ET, 2015, SCIENCE NEW YORK NY; Coleman JA, 2014, J CELL SCI, V127, P1138, DOI 10.1242/jcs.145052; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Fingert JH, 2011, HUM MOL GENET, V20, P2482, DOI 10.1093/hmg/ddr123; Fromm JA, 2008, MOL CELL BIOL, V28, P6483, DOI 10.1128/MCB.00288-08; Gemenetzi M, 2012, EYE, V26, P355, DOI 10.1038/eye.2011.309; Gharahkhani P, 2014, NAT GENET, V46, P1120, DOI 10.1038/ng.3079; Gobeil S, 2004, INVEST OPHTH VIS SCI, V45, P3560, DOI 10.1167/iovs.04-0300; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Hu SS, 2010, MOL VIS, V16, P1585; Hu T, 2015, BIOCOMPUT-PAC SYM, P207; Huang XB, 2015, INT J MOL MED, V36, P1111, DOI 10.3892/ijmm.2015.2325; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Jakobs TC, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a020636; Jia LY, 2009, INVEST OPHTH VIS SCI, V50, P3743, DOI 10.1167/iovs.08-3151; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lu Y, 2013, NAT GENET, V45, P155, DOI 10.1038/ng.2506; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Mackey DA, 2014, CURR OPIN OPHTHALMOL, V25, P386, DOI 10.1097/ICU.0000000000000090; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Rieck J, 2013, INVEST OPHTH VIS SCI, V54, P2393, DOI 10.1167/iovs.12-9781; Ruggiero L, 2012, P NATL ACAD SCI USA, V109, P8145, DOI 10.1073/pnas.1121101109; Sacca SC, 2015, J CELL PHYSIOL, V230, P510, DOI 10.1002/jcp.24826; Sakamoto K, 2014, EUR J PHARMACOL, V733, P13, DOI 10.1016/j.ejphar.2014.03.035; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Souzeau E, 2015, JAMA OPHTHALMOL, V133, P826, DOI 10.1001/jamaophthalmol.2015.0980; Souzeau E, 2012, CLIN EXP OPHTHALMOL, V40, P569, DOI 10.1111/j.1442-9071.2011.02742.x; Springelkamp H, 2015, GENET EPIDEMIOL, V39, P207, DOI 10.1002/gepi.21886; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Su CC, 2012, EYE, V26, P1369, DOI 10.1038/eye.2012.159; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ward NJ, 2014, J NEUROSCI, V34, P3161, DOI 10.1523/JNEUROSCI.4089-13.2014; Wolfs RCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1640, DOI 10.1001/archopht.116.12.1640; Xia CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052894; Yam GHT, 2007, INVEST OPHTH VIS SCI, V48, P1683, DOI 10.1167/iovs.06-0943; Yam GHF, 2007, AM J PATHOL, V170, P100, DOI 10.2353/ajpath.2007.060806; Zode GS, 2012, INVEST OPHTH VIS SCI, V53, P1557, DOI 10.1167/iovs.11-8837; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	61	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172427	10.1371/journal.pone.0172427	http://dx.doi.org/10.1371/journal.pone.0172427			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264060	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000396054300012
J	Comte, A; Grafenhan, T; Links, MG; Hemmingsen, SM; Dumonceaux, TJ				Comte, Alexia; Grafenhan, Tom; Links, Matthew G.; Hemmingsen, Sean M.; Dumonceaux, Tim J.			Quantitative molecular diagnostic assays of grain washes for Claviceps purpurea are correlated with visual determinations of ergot contamination	PLOS ONE			English	Article							ALKALOIDS; REGION; WHEAT; DNA	We examined the epiphytic microbiome of cereal grain using the universal barcode chaperonin-60 (cpn60). Microbial community profiling of seed washes containing DNA extracts prepared from field-grown cereal grain detected sequences from a fungus identified only to Class Sordariomycetes. To identify the fungal sequence and to improve the reference database, we determined cpn60 sequences from field -collected and reference strains of the ergot fungus, Claviceps purpurea. These data allowed us to identify this fungal sequence as deriving from C. purpurea, and suggested that C. purpurea DNA is readily detectable on agricultural commodities, including those for which ergot was not identified as a grading factor. To get a sense of the prevalence and level of C. purpurea DNA in cereal grains, we developed a quantitative PCR assay based on the fungal internal transcribed spacer (ITS) and applied it to 137 samples from the 2014 crop year. The amount of Claviceps DNA quantified correlated strongly with the proportion of ergot sclerotia identified in each grain lot, although there was evidence that non -target organisms were responsible for some false positives with the ITS -based assay. We therefore developed a cpn60-targeted loop -mediated isothermal amplification assay and applied it to the same grain wash samples. The time to positive displayed a significant, inverse correlation to ergot levels determined by visual ratings. These results indicate that both laboratory -based and field -adaptable molecular diagnostic assays can be used to detect and quantify pathogen load in bulk commodities using cereal grain washes.	[Comte, Alexia; Links, Matthew G.; Dumonceaux, Tim J.] Agr & Agri Food Canada, Saskatoon Res & Dev Ctr, Saskatoon, SK, Canada; [Grafenhan, Tom] Canadian Grain Commiss, Grain Res Lab, Winnipeg, MB, Canada; [Links, Matthew G.] Univ Saskatchewan, Dept Comp Sci, Saskatoon, SK, Canada; [Hemmingsen, Sean M.] Natl Res Council Canada, Saskatoon, SK, Canada; [Hemmingsen, Sean M.] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada; [Dumonceaux, Tim J.] Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK, Canada	Agriculture & Agri Food Canada; University of Saskatchewan; National Research Council Canada; University of Saskatchewan; University of Saskatchewan	Dumonceaux, TJ (corresponding author), Agr & Agri Food Canada, Saskatoon Res & Dev Ctr, Saskatoon, SK, Canada.; Dumonceaux, TJ (corresponding author), Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK, Canada.	tim.dumonceaux@agr.gc.ca	Dumonceaux, Tim/H-4751-2019; Links, Matthew G./P-4949-2019	Dumonceaux, Tim/0000-0001-5165-0343; Links, Matthew G./0000-0003-1917-6789	Canadian Safety and Security Program (CSSP) [CRTI 09-462RD/CSSP 30w01]; Genomics Research and Development Initiative (GRDI) Quarantine and Invasive Species (QIS) project	Canadian Safety and Security Program (CSSP); Genomics Research and Development Initiative (GRDI) Quarantine and Invasive Species (QIS) project	This work was funded by the Canadian Safety and Security Program (CSSP) funded project CRTI 09-462RD/CSSP 30w01, and by the Genomics Research and Development Initiative (GRDI) Quarantine and Invasive Species (QIS) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman SC, 2015, PLANT DIS, V99, P1410, DOI 10.1094/PDIS-09-14-0978-RE; Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmico1523, 10.1038/nrmicro1523]; Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09; Comte A, 2016, DATA BRIEF UNPUB; Dahan ME, 2016, REUTERS; Flieger M, 1997, FOLIA MICROBIOL, V42, P3, DOI 10.1007/BF02898641; Guo QZ, 2016, J AGR FOOD CHEM, V64, P7033, DOI 10.1021/acs.jafc.6b02484; Hill JE, 2005, APPL ENVIRON MICROB, V71, P867, DOI 10.1128/AEM.71.2.867-875.2005; Hill JE, 2004, GENOME RES, V14, P1669, DOI 10.1101/gr.2649204; KENDRICK B, 1992, 5 KINGDOM; Levesque C, 2015, CRTI 09 462RD NEXT G; Links MG, 2014, NEW PHYTOL, V202, P542, DOI 10.1111/nph.12693; Links MG, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-23; Links MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049755; Magnuson BA, 2014, FOOD CHEM TOXICOL, V63, P91, DOI 10.1016/j.fct.2013.10.041; Oellig C, 2016, J CHROMATOGR A, V1441, P126, DOI 10.1016/j.chroma.2016.02.075; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POINAR G, 2015, PALAEODIVERSITY, P13; Schardl CL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003323; Schellenberg J, 2011, METHODS MOL BIOL, V733, P143, DOI 10.1007/978-1-61779-089-8_10; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165995; Tittlemier SA, 2015, J AGR FOOD CHEM, V63, P6644, DOI 10.1021/acs.jafc.5b02977; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57	27	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173495	10.1371/journal.pone.0173495	http://dx.doi.org/10.1371/journal.pone.0173495			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257512	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100093
J	Otgonjargala, B; Becker, K; Batbaatar, G; Tsogtsaikhan, S; Enkhtsetseg, J; Enkhjargal, A; Pfeffer, K; Adams, O; Battogtokh, C; Henrich, B				Otgonjargala, Byambaa; Becker, Kathrin; Batbaatar, Gunchin; Tsogtsaikhan, Sandag; Enkhtsetseg, Jamsranjav; Enkhjargal, Altangerel; Pfeffer, Klaus; Adams, Ortwin; Battogtokh, Chimeddorj; Henrich, Birgit			Effect of Mycoplasma hominis and cytomegalovirus infection on pregnancy outcome: A prospective study of 200 Mongolian women and their newborns	PLOS ONE			English	Article							UREAPLASMA-UREALYTICUM; BACTERIAL VAGINOSIS; CHLAMYDIA-TRACHOMATIS; GENITAL MYCOPLASMA; PRETERM LABOR; PREVALENCE; TRACT; BIRTH; COLONIZATION; ASSOCIATION	In Mongolia, diagnostic tests for the detection of the sexually transmitted mycoplasmas, ureaplasmas, Herpes simplex virus (HSV), and cytomegalovirus (CMV) are currently not routinely used in clinical settings and the frequency of these STIs are enigmatic. The prevalence of these STI pathogens were prospectively evaluated among 200 Mongolian pregnant women and their newborns and correlated with pregnancy outcome. TaqMan PCRs were used to detect bacterial and viral STI pathogens in pre-birth vaginal swabs of the pregnant women and in oral swabs of their newborns. A standardized questionnaire concerning former and present pregnancies was developed and linear regression analysis was used to correlate pathogen detection with pregnancy outcome. Ureaplasmas were the most prevalent of the tested pathogens (positive in 90.5% positive women and 47.5% newborns), followed by mycoplasmas (32.5% and 7.5%), chlamydia (14.5% and 7.5%), trichomonas (8.5% and 4.0%) and gonococcus (0.5% and 0%). CMV was found in 46.5% of the pregnant women and in 10.5% of their newborns, whereas HSV-2 was detected in only two mothers. Multiple regression analyses indicate that colonization of the mothers with U. urealyticum, M. hominis, T. vaginalis or CMV is associated with transmission to newborns and that transmission of M. hominis or CMV from Mongolian pregnant women to offspring is associated with reduced neonatal length and gestational age. Thus, diagnostic tests for their detection should be implemented in the clinical settings in Mongolia.	[Otgonjargala, Byambaa; Batbaatar, Gunchin; Tsogtsaikhan, Sandag] Mongolian Natl Univ Med Sci, Sch Pharm & Biomed, Dept Microbiol & Immunol, Ulaanbaatar, Mongolia; [Becker, Kathrin] Univ Clin, Dept Orthodont, Dusseldorf, Germany; [Enkhtsetseg, Jamsranjav] Mongolian Natl Univ Med Sci, Sch Med, Dept Obstet & Gynecol, Ulaanbaatar, Mongolia; [Enkhjargal, Altangerel; Battogtokh, Chimeddorj] Inst Publ Hlth, Ctr Environm Hlth & Toxicol, Ulaanbaatar, Mongolia; [Pfeffer, Klaus; Henrich, Birgit] Heinrich Heine Univ, Inst Med Microbiol & Hosp Hyg, Dusseldorf, Germany; [Adams, Ortwin] Heinrich Heine Univ, Inst Virol, Dusseldorf, Germany	Mongolian National University of Medical Sciences; Mongolian National University of Medical Sciences; Mongolian National University of Medical Sciences; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Henrich, B (corresponding author), Heinrich Heine Univ, Inst Med Microbiol & Hosp Hyg, Dusseldorf, Germany.	Birgit.henrich@hhu.de	Becker, Kathrin/GPS-8383-2022; Becker, Kathrin/H-7656-2019; San, Tsogt/AAX-6434-2020	Becker, Kathrin/0000-0003-1936-4683; San, Tsogt/0000-0003-4916-5108; Batbaatar, Gunchin/0000-0002-6678-7569	German Foreign Exchange Service (DAAD) PAGEL project [54448058]	German Foreign Exchange Service (DAAD) PAGEL project(Deutscher Akademischer Austausch Dienst (DAAD))	This study had been supported by the German Foreign Exchange Service (DAAD) PAGEL project # 54448058. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists, 2015, OBSTET GYNECOL, V125, P1510, DOI DOI 10.1097/01.AOG.0000466430.19823.53; Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203; Capoccia R, 2013, CURR OPIN INFECT DIS, V26, P231, DOI 10.1097/QCO.0b013e328360db58; Choi SJ, 2012, ANN LAB MED, V32, P194, DOI 10.3343/alm.2012.32.3.194; DaSilva O, 1997, PEDIATR INFECT DIS J, V16, P364, DOI 10.1097/00006454-199704000-00006; Dingens AS, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1073-y; Donders GGG, 2000, AM J OBSTET GYNECOL, V183, P431, DOI 10.1067/mob.2000.105738; El-Khier N. T. A., 2014, African Journal of Microbiology Research, V8, P2631; Foxman B, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.003; Garland S M, 2001, Infect Dis Obstet Gynecol, V9, P143, DOI 10.1155/S1064744901000254; Geisler WM, 2004, SEX TRANSM INFECT, V80, P401, DOI 10.1136/sti.2003.009134; Giakoumelou S, 2016, HUM REPROD UPDATE, V22, P116, DOI 10.1093/humupd/dmv041; Glaser K, 2015, EXPERT REV ANTI-INFE, V13, P233, DOI 10.1586/14787210.2015.999670; Kafetzis DA, 2004, CLIN INFECT DIS, V39, P1113, DOI 10.1086/424505; Kwak DW, 2014, J MATERN-FETAL NEO M, V27, P333, DOI 10.3109/14767058.2013.818124; Li LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116699; Ljubojevic S, 2010, ACTA DERMATOVENER CR, V18, P305; McDonagh S, 2004, J INFECT DIS, V190, P826, DOI 10.1086/422330; Megli C, 2016, AM J OBSTET GYNECOL, V214, pS271, DOI 10.1016/j.ajog.2015.10.540; Mobius N, 2012, METHODS MOL BIOL, V903, P235, DOI 10.1007/978-1-61779-937-2_15; Mussi-Pinhata MM, 2009, CLIN INFECT DIS, V49, P522, DOI 10.1086/600882; Naing ZW, 2016, AUST NZ J OBSTET GYN, V56, P9, DOI 10.1111/ajo.12408; Olomu IN, 2009, PEDIATRICS, V123, P1329, DOI 10.1542/peds.2008-1113; Onderdonk AB, 2016, CLIN MICROBIOL REV, V29, P223, DOI 10.1128/CMR.00075-15; Onderdonk AB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.068; Patel KK, 2011, RESPIROLOGY, V16, P1081, DOI 10.1111/j.1440-1843.2011.02016.x; Ross SA, 2005, J INFECT DIS, V192, P1727, DOI 10.1086/497150; RStudio, 2015, RSTUDIO INT DEV R; Schirm J, 2007, J MICROBIOL METH, V68, P243, DOI 10.1016/j.mimet.2006.08.002; Schonberger S, 2010, BIOL BLOOD MARROW TR, V16, P1428, DOI 10.1016/j.bbmt.2010.04.008; Seifoleslami M, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.16823; Silveira MF, 2009, INT J STD AIDS, V20, P465, DOI 10.1258/ijsa.2008.008388; Song D, 2014, CHINESE MED J-PEKING, V127, P3171, DOI 10.3760/cma.j.issn.0366-6999.20133072; Vouga M, 2014, CLIN MICROBIOL INFEC, V20, P1074, DOI 10.1111/1469-0691.12686	34	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173283	10.1371/journal.pone.0173283	http://dx.doi.org/10.1371/journal.pone.0173283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257513	Green Published, Green Submitted, gold			2022-12-26	WOS:000396021100083
J	Liberton, M; Chrisler, WB; Nicora, CD; Moore, RJ; Smith, RD; Koppenaal, DW; Pakrasi, HB; Jacobs, JM				Liberton, Michelle; Chrisler, William B.; Nicora, Carrie D.; Moore, Ronald J.; Smith, Richard D.; Koppenaal, David W.; Pakrasi, Himadri B.; Jacobs, Jon M.			Phycobilisome truncation causes widespread proteome changes in Synechocystis sp PCC 6803	PLOS ONE			English	Article							MASS-SPECTROMETRY; PHOTOSYSTEM-I; ENERGY-DISSIPATION; NEUTRON-SCATTERING; ANTENNA SIZE; CYANOBACTERIA; MUTANTS; PRODUCTIVITY; CONSEQUENCES; PCC-6803	In cyanobacteria such as Synechocystis sp. PCC 6803, large antenna complexes called phycobilisomes (PBS) harvest light and transfer the energy to the photosynthetic reaction centers. Modification of the light harvesting machinery in cyanobacteria has widespread consequences, causing changes in cell morphology and physiology. In the current study, we investigated the effects of PBS truncation on the proteomes of three Synechocystis 6803 PBS antenna mutants. These range from the progressive truncation of phycocyanin rods in the CB and CK strains, to full removal of PBS in the PAL mutant. Comparative quantitative protein results revealed surprising changes in protein abundances in the mutant strains. Our results showed that PBS truncation in Synechocystis 6803 broadly impacted core cellular mechanisms beyond light harvesting and photosynthesis. Specifically, we observed dramatic alterations in membrane transport mechanisms, where the most severe PBS truncation in the PAL strain appeared to suppress the cellular utilization and regulation of bicarbonate and iron. These changes point to the role of PBS as a component critical to cell function, and demonstrate the continuing need to assess systems-wide protein based abundances to understand potential indirect phenotypic effects.	[Liberton, Michelle; Pakrasi, Himadri B.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Chrisler, William B.; Koppenaal, David W.] Pacific Northwest Natl Lab, Environm Mol Sci Lab, Richland, WA USA; [Nicora, Carrie D.; Moore, Ronald J.; Smith, Richard D.; Jacobs, Jon M.] Pacific Northwest Natl Lab, Div Biol Sci, Richland, WA 99354 USA	Washington University (WUSTL); United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Jacobs, JM (corresponding author), Pacific Northwest Natl Lab, Div Biol Sci, Richland, WA 99354 USA.	Jon.Jacobs@pnnl.gov	Smith, Richard D/J-3664-2012	Smith, Richard D/0000-0002-2381-2349	Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center - the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC 0001035]; U.S. Department of Energy [DE-AC05-76RLO 1830]; National Science Foundation [DGE-1143954]	Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center - the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This work was supported as part of the Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Award Number DE-SC 0001035. Work was performed in the Environmental Molecular Sciences Laboratory, a U. S. Department of Energy Office of Biological and Environmental Research national scientific user facility located at Pacific Northwest National Laboratory in Richland, Washington. Pacific Northwest National Laboratory is operated by Battelle for the U.S. Department of Energy under Contract No. DE-AC05-76RLO 1830. AYN has been partially supported by the National Science Foundation Graduate Research Fellowship Program (DGE-1143954).	Adir N, 2005, PHOTOSYNTHESIS RES; AJLANI G, 1995, BBA-BIOENERGETICS, V1231, P189, DOI 10.1016/0005-2728(95)00086-X; Ajlani G, 1998, PLANT MOL BIOL, V37, P577, DOI 10.1023/A:1005924730298; ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Arteni AA, 2009, BBA-BIOENERGETICS, V1787, P272, DOI 10.1016/j.bbabio.2009.01.009; Baier A, 2014, J BIOL CHEM, V289, P11755, DOI 10.1074/jbc.M113.520601; Berera R, 2009, BIOPHYS J, V96, P2261, DOI 10.1016/j.bpj.2008.12.3905; Bernat G, 2009, PHOTOSYNTH RES, V99, P205, DOI 10.1007/s11120-008-9398-7; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; CHITNIS VP, 1993, FEBS LETT, V336, P330, DOI 10.1016/0014-5793(93)80831-E; COLLIER JL, 1992, J BACTERIOL, V174, P4718, DOI 10.1128/JB.174.14.4718-4726.1992; Collins AM, 2012, PLANT PHYSIOL, V158, P1600, DOI 10.1104/pp.111.192849; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Grossman AR, 1993, MICROBIOLOGY MOL BIO; Herrero A, 2001, J BACTERIOL, V183, P411, DOI 10.1128/JB.183.2.411-425.2001; Katoh H, 2001, J BACTERIOL, V183, P2779, DOI 10.1128/JB.183.9.2779-2784.2001; Kelly RT, 2006, ANAL CHEM, V78, P7796, DOI 10.1021/ac061133r; Keren N, 2004, PLANT PHYSIOL, V135, P1666, DOI 10.1104/pp.104.042770; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Kirst H, 2014, BBA-BIOENERGETICS, V1837, P1653, DOI 10.1016/j.bbabio.2014.07.009; Kirst H, 2012, PLANT PHYSIOL, V160, P2251, DOI 10.1104/pp.112.206672; Klotz A, 2016, CURR BIOL, V26, P2862, DOI 10.1016/j.cub.2016.08.054; Kwon JH, 2013, ALGAL RES, V2, P188, DOI 10.1016/j.algal.2013.04.008; Lea-Smith DJ, 2014, PLANT PHYSIOL, V165, P705, DOI 10.1104/pp.114.237206; Liberton M, 2013, PHOTOSYNTH RES, V118, P17, DOI 10.1007/s11120-013-9940-0; Liberton M, 2013, J BIOL CHEM, V288, P3632, DOI 10.1074/jbc.M112.416933; Maiolica A, 2005, PROTEOMICS, V5, P3847, DOI 10.1002/pmic.200402010; May AP, 1999, TRENDS BIOCHEM SCI, V24, P12, DOI 10.1016/S0968-0004(98)01310-3; Melis A, 2009, PLANT SCI, V177, P272, DOI 10.1016/j.plantsci.2009.06.005; Nagarajan Aparna, 2014, Life-Basel, V4, P903, DOI 10.3390/life4040903; Nagy G, 2011, BIOCHEM J, V436, P225, DOI 10.1042/BJ20110180; Nguyen AY, 2017, PHOTOSYNTH RES; Olive J, 1997, BBA-BIOENERGETICS, V1319, P275, DOI 10.1016/S0005-2728(96)00168-5; Page LE, 2012, APPL ENVIRON MICROB, V78, P6349, DOI 10.1128/AEM.00499-12; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Singh AK, 2007, PHOTOSYNTH RES, V93, P17, DOI 10.1007/s11120-007-9151-7; Stadnichuk IN, 2009, PHOTOSYNTH RES, V99, P227, DOI 10.1007/s11120-009-9402-x; Thomas JC, 2006, P NATL ACAD SCI USA, V103, P18368, DOI 10.1073/pnas.0607718103; Trautner C, 2013, J BACTERIOL, V195, P5370, DOI 10.1128/JB.00615-13; Ughy B, 2004, MICROBIOL-SGM, V150, P4147, DOI 10.1099/mic.0.27498-0; Vermaas W. F., 2001, ENCY LIFE SCI, P1, DOI DOI 10.1002/9780470015902.A0021539; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wegener KM, 2010, MOL CELL PROTEOMICS, V9, DOI 10.1074/mcp.M110.000109; Wilson A, 2007, PLANT CELL, V19, P656, DOI 10.1105/tpc.106.045351; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zhang PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105952	48	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173251	10.1371/journal.pone.0173251	http://dx.doi.org/10.1371/journal.pone.0173251			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253354	gold, Green Published, Green Submitted			2022-12-26	WOS:000396011300095
J	Marshall, A; Celentano, A; Cirillo, N; McCullough, M; Porter, S				Marshall, Alison; Celentano, Antonio; Cirillo, Nicola; McCullough, Michael; Porter, Stephen			Tissue-specific regulation of CXCL9/10/11 chemokines in keratinocytes: Implications for oral inflammatory disease	PLOS ONE			English	Article							CELL ALPHA CHEMOATTRACTANT; CD8(+) T-CELLS; IFN-GAMMA; CXC-CHEMOKINE; I-TAC; INTERFERON-GAMMA; LICHEN-PLANUS; ATTRACTANT CHEMOKINE; PERIODONTAL-DISEASE; INDUCED EXPRESSION	The IFN-gamma-inducible chemokines CXCL9, CXCL10, and CXCL11 play a key role in many inflammatory conditions, particularly those mediated by T cells. Therefore, the production of these chemokines in peripheral tissues could be instrumental in the pathophysiology of tissue-specific immunological diseases such as oral lichen planus (OLP). In the present study, we assessed the production of keratinocyte-derived CXCL9/10/11 under basal and inflammatory conditions and investigated whether these chemokines were involved in the pathogenesis of OLP. We used semi-quantitative PCR, ELISA, chemotaxis assays, and fluorescence-activated cell sorting (FACS) to assess the expression and functional role of CXCL9/10/11 in oral keratinocytes (three strains of normal human oral keratinocytes (NHOK), and the H357 oral cancer cell line) in the presence or absence of IFN-gamma. CXCL9/10/11 were also assessed in tissues from normal patients and those with oral lichen planus (OLP). The time course study in oral keratinocytes treated with IFN-gamma showed that expression of CXCL9/10/11 chemokines was significantly enhanced by IFN-gamma in a time-dependent manner. In particular, CXCL10, a prominent chemokine that was overexpressed by IFN-gamma-stimulated NHOK, was able to effectively recruit CD4 lymphocytes, mainly CD4+CD45RA- cells. Significantly higher levels of CXCL9/10/11 were found in tissues from patients with OLP compared to normal oral mucosa. Taken together, the results demonstrate that normal oral keratinocytes produce chemotactic molecules that mediate T cell recruitment. This study furthers understanding of chemokine production in oral keratinocytes and their role in the pathophysiology of oral mucosa, with particular relevance to OLP.	[Marshall, Alison; Porter, Stephen] UCL, UCL Eastman Dent Inst, London, England; [Celentano, Antonio] Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Naples, Italy; [Celentano, Antonio; Cirillo, Nicola; McCullough, Michael] Univ Melbourne, Melbourne Dent Sch, Melbourne, Vic 3010, Australia; [Celentano, Antonio; Cirillo, Nicola; McCullough, Michael] Univ Melbourne, Oral Hlth CRC, Melbourne, Vic 3010, Australia	University of London; University College London; University of Naples Federico II; University of Melbourne; University of Melbourne	Celentano, A (corresponding author), Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Naples, Italy.; Celentano, A (corresponding author), Univ Melbourne, Melbourne Dent Sch, Melbourne, Vic 3010, Australia.; Celentano, A (corresponding author), Univ Melbourne, Oral Hlth CRC, Melbourne, Vic 3010, Australia.	antony.celentano@gmail.com	Celentano, Antonio/AAZ-7647-2020	Celentano, Antonio/0000-0003-4293-2511; McCullough, Michael/0000-0001-7829-4684; Cirillo, NIcola/0000-0003-1429-1323; Porter, Stephen/0000-0002-3328-2759				Albanesi C, 2000, J IMMUNOL, V165, P1395, DOI 10.4049/jimmunol.165.3.1395; Albanesi C, 2001, J LEUKOCYTE BIOL, V70, P617; Altenburg A, 1999, J IMMUNOL, V162, P4140; Antonelli A, 2014, AUTOIMMUN REV, V13, P272, DOI 10.1016/j.autrev.2013.10.010; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boorsma DM, 1998, ARCH DERMATOL RES, V290, P335, DOI 10.1007/s004030050314; CLARKLEWIS I, 1993, P NATL ACAD SCI USA, V90, P3574, DOI 10.1073/pnas.90.8.3574; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Cox MA, 2001, MOL PHARMACOL, V59, P707, DOI 10.1124/mol.59.4.707; Danielsson K, 2013, J EUR ACAD DERMATOL, V27, P1410, DOI 10.1111/jdv.12027; Dwinell MB, 2001, GASTROENTEROLOGY, V120, P49, DOI 10.1053/gast.2001.20914; Engelhardt E, 1998, AM J PATHOL, V153, P1849, DOI 10.1016/S0002-9440(10)65699-4; Flier J, 2001, J PATHOL, V194, P398, DOI 10.1002/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S; Fukui A, 2013, MICROBIOL IMMUNOL, V57, P198, DOI 10.1111/1348-0421.12022; Gasperini S, 1999, J IMMUNOL, V162, P4928; Gemmell E, 2001, CLIN EXP IMMUNOL, V125, P134, DOI 10.1046/j.1365-2249.2001.01511.x; Goebeler M, 2001, AM J PATHOL, V158, P431, DOI 10.1016/S0002-9440(10)63986-7; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hiroi M, 2003, BIOCHEM J, V376, P393, DOI 10.1042/BJ20030842; Ichimura M, 2006, J ORAL PATHOL MED, V35, P167, DOI 10.1111/j.1600-0714.2006.00402.x; Kabashima H, 2002, CYTOKINE, V20, P70, DOI 10.1006/cyto.2002.1985; Kanda N, 2007, EUR J IMMUNOL, V37, P338, DOI 10.1002/eji.200636420; Kawaguchi S, 2009, IMMUNOL LETT, V123, P9, DOI 10.1016/j.imlet.2009.01.008; Kearney S, 2013, IMMUNOL RES, V55, P187, DOI 10.1007/s12026-012-8362-y; Khan A, 2003, J ORAL PATHOL MED, V32, P77, DOI 10.1034/j.1600-0714.2003.00077.x; Loetscher M, 1998, EUR J IMMUNOL, V28, P3696, DOI 10.1002/(SICI)1521-4141(199811)28:11<3696::AID-IMMU3696>3.0.CO;2-W; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Mazanet MM, 2000, J IMMUNOL, V164, P5383, DOI 10.4049/jimmunol.164.10.5383; Medoff BD, 2002, J IMMUNOL, V168, P5278, DOI 10.4049/jimmunol.168.10.5278; Meyer M, 2001, EUR J IMMUNOL, V31, P2521, DOI 10.1002/1521-4141(200108)31:8<2521::AID-IMMU2521>3.0.CO;2-Q; Miura M, 2001, J IMMUNOL, V167, P3494, DOI 10.4049/jimmunol.167.6.3494; Ohta K, 2008, J DENT RES, V87, P1160, DOI 10.1177/154405910808701211; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; PRIME SS, 1990, J PATHOL, V160, P259, DOI 10.1002/path.1711600313; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; Rabin RL, 1999, J IMMUNOL, V162, P3840; Redondo P, 1998, EXP DERMATOL, V7, P175, DOI 10.1111/j.1600-0625.1998.tb00320.x; Romagnani P, 2002, AM J PATHOL, V161, P195, DOI 10.1016/S0002-9440(10)64171-5; Romagnani P, 2012, CLIN CHIM ACTA, V413, P1364, DOI 10.1016/j.cca.2012.02.009; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Sauty A, 1999, J IMMUNOL, V162, P3549; Schroepf S, 2010, INFLAMM BOWEL DIS, V16, P1882, DOI 10.1002/ibd.21312; Scully C, 1998, CRIT REV ORAL BIOL M, V9, P86, DOI 10.1177/10454411980090010501; Sebastiani S, 2002, J INVEST DERMATOL, V118, P1052, DOI 10.1046/j.1523-1747.2002.01771.x; Spandau U, 1998, J INVEST DERMATOL, V111, P1003, DOI 10.1046/j.1523-1747.1998.00426.x; Taubman MA, 2001, CRIT REV ORAL BIOL M, V12, P125, DOI 10.1177/10454411010120020301; Tensen CP, 1999, J INVEST DERMATOL, V112, P716, DOI 10.1046/j.1523-1747.1999.00581.x; Thornhill MH, 2001, ACTA ODONTOL SCAND, V59, P174, DOI 10.1080/000163501750266774; Tokuriki A, 2002, J DERMATOL SCI, V28, P234, DOI 10.1016/S0923-1811(01)00172-4; Tornwall J, 1999, LAB INVEST, V79, P1719; Van den Brule FA, 2000, CELL ADHES COMMUN, V7, P321; Van Raemdonck K, 2014, CYTOKINE GROWTH FACT, V22; Wenzel J, 2008, J INVEST DERMATOL, V128, P2392, DOI 10.1038/jid.2008.96; Wenzel J, 2006, J CUTAN PATHOL, V33, P672, DOI 10.1111/j.1600-0560.2006.00527.x; Wu CL, 2009, J ETHNOPHARMACOL, V122, P48, DOI 10.1016/j.jep.2008.11.024; Yoshie O, 2001, ADV IMMUNOL, V78, P57, DOI 10.1016/S0065-2776(01)78002-9	57	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172821	10.1371/journal.pone.0172821	http://dx.doi.org/10.1371/journal.pone.0172821			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253295	Green Published, gold, Green Submitted			2022-12-26	WOS:000396011300039
J	Martin, B; Tamanai-Shacoori, Z; Bronsard, J; Ginguene, F; Meuric, V; Mahe, F; Bonnaure-Mallet, M				Martin, Benedicte; Tamanai-Shacoori, Zohreh; Bronsard, Julie; Ginguene, Franck; Meuric, Vincent; Mahe, Fabrice; Bonnaure-Mallet, Martine			A new mathematical model of bacterial interactions in two-species oral biofilms	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; STREPTOCOCCUS-GORDONII; CARBOHYDRATE-METABOLISM; PROTEOMICS; VIRULENCE; PROFILES; DISTINCT; DISEASE	Periodontitis are bacterial inflammatory diseases, where the bacterial biofilms present on the tooth-supporting tissues switch from a healthy state towards a pathogenic state. Among bacterial species involved in the disease, Porphyromonas gingivalis has been shown to induce dysbiosis, and to induce virulence of otherwise healthy bacteria like Streptococcus gordonii. During biofilm development, primary colonizers such as S. gordonii first attach to the surface and allow the subsequent adhesion of periodontal pathogens such as P. gingivalis. Interactions between those two bacteria have been extensively studied during the adhesion step of the biofilm. The aim of the study was to understand interactions of both species during the growing phase of the biofilm, for which little knowledge is available, using a mathematical model. This two-species biofilm model was based on a substrate-dependent growth, implemented with damage parameters, and validated thanks to data obtained on experimental biofilms. Three different hypothesis of interactions were proposed and assayed using this model: independence, competition between both bacteria species, or induction of toxicity by one species for the other species. Adequacy between experimental and simulated biofilms were found with the last hypothetic mathematical model. This new mathematical model of two species bacteria biofilms, dependent on different substrates for growing, can be applied to any bacteria species, environmental conditions, or steps of biofilm development. It will be of great interest for exploring bacterial interactions in biofilm conditions.	[Martin, Benedicte; Tamanai-Shacoori, Zohreh; Bronsard, Julie; Meuric, Vincent; Bonnaure-Mallet, Martine] Univ Europeenne Bretagne, Univ Rennes 1, EA Microbiol Risques Infect 1254, Rennes, France; [Ginguene, Franck; Mahe, Fabrice] Univ Europeenne Bretagne, Univ Rennes 1, CNRS, Inst Rech Math Rennes, Rennes, France; [Meuric, Vincent; Bonnaure-Mallet, Martine] Ctr Hosp Univ, Rennes, France	Universite de Bretagne Occidentale; Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); Universite de Bretagne Occidentale; Universite de Rennes; CHU Rennes	Martin, B (corresponding author), Univ Europeenne Bretagne, Univ Rennes 1, EA Microbiol Risques Infect 1254, Rennes, France.	benedicte.martin@univ-rennes1.fr	Bronsard, Julie/AAL-7406-2020; Meuric, Vincent/AAW-7709-2020; Bronsard, Julie/AAL-7399-2020	Bronsard, Julie/0000-0002-4714-0241; Meuric, Vincent/0000-0001-5411-4001; MARTIN, Benedicte/0000-0003-0897-5884; Bonnaure-Mallet, martine/0000-0001-5214-7803; TAMANAI-SHACOORI, Zohreh/0000-0003-2287-3438	Conseil Regional de Bretagne, France [F3/48 CPER]; Fondation "Sourire Quand Meme," France; Biosit, France (AAP); Fondation "Sourire Quand Meme"; Research Federative Structure Biosit (Rennes)	Conseil Regional de Bretagne, France(Region Bretagne); Fondation "Sourire Quand Meme," France; Biosit, France (AAP); Fondation "Sourire Quand Meme"; Research Federative Structure Biosit (Rennes)	This work was supported by the Conseil Regional de Bretagne, France (F3/48 CPER): MBM; the Fondation "Sourire Quand Meme," France (www.gueules-cassees.asso.fr): MBM BM; and Biosit, France (AAP2015) (www.biosit.univ-rennes1.fr): BM FM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Conseil Regional de Bretagne, France (F3/48 CPER), the Fondation "Sourire Quand Meme" and the Research Federative Structure Biosit (Rennes). We also thank all people of the Microscopy Rennes Imaging Center (Biosit) for technical assistance for microscopy experiments.	Barnard JP, 1999, INFECT IMMUN, V67, P6558; Cao B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153616; Chawla A, 2010, MOL MICROBIOL, V78, P1510, DOI 10.1111/j.1365-2958.2010.07420.x; Cook GS, 1998, J PERIODONTAL RES, V33, P323, DOI 10.1111/j.1600-0765.1998.tb02206.x; Cugini C, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.19804; Daep CA, 2011, INFECT IMMUN, V79, P67, DOI 10.1128/IAI.00361-10; Diaz PI, 2006, J BACTERIOL, V188, P2454, DOI 10.1128/JB.188.7.2454-2462.2006; Duran-Pinedo AE, 2014, ISME J, V8, P1659, DOI 10.1038/ismej.2014.23; Elias S, 2012, FEMS MICROBIOL REV, V36, P990, DOI 10.1111/j.1574-6976.2012.00325.x; Fagerlind MG, 2012, J THEOR BIOL, V295, P23, DOI 10.1016/j.jtbi.2011.10.007; Flemming HC, 2010, THE BIOFILM MATRIX; Frias-Lopez J, 2012, J BACTERIOL, V194, P2082, DOI 10.1128/JB.06328-11; Grenier D, 1996, MICROBIOL-UK, V142, P955, DOI 10.1099/00221287-142-4-955; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hendrickson EL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-211; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Ilie O, 2012, J THEOR BIOL, V309, P159, DOI 10.1016/j.jtbi.2012.05.024; Klapper I, 2010, SIAM REV, V52, P221, DOI 10.1137/080739720; Kreft JU, 1998, MICROBIOL-UK, V144, P3275, DOI 10.1099/00221287-144-12-3275; Kreft JU, 2001, MICROBIOL-SGM, V147, P2897, DOI 10.1099/00221287-147-11-2897; Kuboniwa M, 2006, MOL MICROBIOL, V60, P121, DOI 10.1111/j.1365-2958.2006.05099.x; Kuboniwa M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-98; MARSH PD, 1985, J GEN MICROBIOL, V131, P2505; Masuda K, 2001, ANAEROBE, V7, P209, DOI 10.1006/anae.2001.0383; McNab R, 2003, J BACTERIOL, V185, P274, DOI 10.1128/JB.185.1.274-284.2003; Meuric V, 2013, MOL ORAL MICROBIOL, V28, P40, DOI 10.1111/omi.12004; Meuric V, 2010, FUTURE MICROBIOL, V5, P717, DOI 10.2217/FMB.10.32; Picioreanu C, 1998, BIOTECHNOL BIOENG, V58, P101, DOI 10.1002/(SICI)1097-0290(19980405)58:1<101::AID-BIT11>3.0.CO;2-M; Picioreanu C, 1999, THESIS; Pollanen MT, 2013, INT J MOL SCI, V14, P17221, DOI 10.3390/ijms140817221; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; SHAH HN, 1993, CLIN INFECT DIS, V16, pS404, DOI 10.1093/clinids/16.Supplement_4.S404; SHAH HN, 1993, FEMS IMMUNOL MED MIC, V6, P165; Shao HJ, 2010, PERIODONTOL 2000, V52, P53, DOI 10.1111/j.1600-0757.2009.00318.x; Shen Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27537; Simionato MR, 2006, INFECT IMMUN, V74, P6419, DOI 10.1128/IAI.00639-06; SLOTS J, 1978, INFECT IMMUN, V19, P254, DOI 10.1128/IAI.19.1.254-264.1978; Tan KH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003955; Wanner O, 1996, BIOTECHNOL BIOENG, V49, P172; Wright CJ, 2014, MICROBIOLOGYOPEN, V3, P383, DOI 10.1002/mbo3.177; Yost S, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0153-3; Zhang ZS, 2011, ANTIMICROB AGENTS CH, V55, P1075, DOI 10.1128/AAC.01329-10	44	16	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							E0173153	10.1371/journal.pone.0173153	http://dx.doi.org/10.1371/journal.pone.0173153			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253369	Green Submitted, Green Published, gold			2022-12-26	WOS:000396011300082
J	Watanabe, S; Ogasawara, T; Tamura, Y; Saito, T; Ikeda, T; Suzuki, N; Shimosawa, T; Shibata, S; Chung, UI; Nangaku, M; Uchida, S				Watanabe, Sumiyo; Ogasawara, Toru; Tamura, Yoshifuru; Saito, Taku; Ikeda, Toshiyuki; Suzuki, Nobuchika; Shimosawa, Tatsuo; Shibata, Shigeru; Chung, Ung-il; Nangaku, Masaomi; Uchida, Shunya			Targeting gene expression to specific cells of kidney tubules in vivo, using adenoviral promoter fragments	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; COTRANSPORTER; DISEASE; RAT; PERSPECTIVES; TRAFFICKING; GLOMERULI; MUTATION; VECTORS; THERAPY	Although techniques for cell-specific gene expression via viral transfer have advanced, many challenges (e.g., viral vector design, transduction of genes into specific target cells) still remain. We investigated a novel, simple methodology for using adenovirus transfer to target specific cells of the kidney tubules for the expression of exogenous proteins. We selected genes encoding sodium-dependent phosphate transporter type 2a (NPT2a) in the proximal tubule, sodium-potassium-2-chloride cotransporter (NKCC2) in the thick ascending limb of Henle (TALH), and aquaporin 2 (AQP2) in the collecting duct. The promoters of the three genes were linked to a GFP-coding fragment, the final constructs were then incorporated into an adenovirus vector, and this was then used to generate gene-manipulated viruses. After flushing circulating blood, viruses were directly injected into the renal arteries of rats and were allowed to site-specifically expression in tubule cells, and rats were then euthanized to obtain kidney tissues for immunohistochemistry. Double staining with adenovirus-derived EGFP and endogenous proteins were examined to verify orthotopic expression, i.e. "adenovirus driven NPT2a-EGFP and endogenous NHE3 protein", "adenovirus driven NKCC2-EGFP and endogenous NKCC2 protein" and "\adenovirus driven AQP2-EGFP and endogenous AQP2 protein". Owing to a lack of finding good working anti-NPT2a antibody, an antibody against a different protein (sodium-hydrogen exchanger 3 or NHE3) that is also specifically expressed in the proximal tubule was used. Kidney structures were well-preserved, and other organ tissues did not show EGFP staining. Our gene transfer method is easier than using genetically engineered animals, and it confers the advantage of allowing the manipulation of gene transfer after birth. This is the first method to successfully target gene expression to specific cells in the kidney tubules. This study may serve as the first step for safe and effective gene therapy in the kidney tubule diseases.	[Watanabe, Sumiyo; Chung, Ung-il] Univ Tokyo, Ctr Dis Biol & Integrat Med, Fac Med, Bunkyo Ku, Tokyo, Japan; [Watanabe, Sumiyo; Shimosawa, Tatsuo; Nangaku, Masaomi] Univ Tokyo, Grad Sch Med, Div Nephrol & Endocrinol, Bunkyo Ku, Tokyo, Japan; [Watanabe, Sumiyo; Tamura, Yoshifuru; Shibata, Shigeru; Uchida, Shunya] Teikyo Univ, Dept Internal Med, Sch Med, Itabashi Ku, Tokyo, Japan; [Ogasawara, Toru] Univ Tokyo, Dept Oral & Maxillofacial Surg, Fac Med, Bunkyo Ku, Tokyo, Japan; [Saito, Taku] Univ Tokyo, Dept Orthopaed Surg, Fac Med, Tokyo, Japan; [Ikeda, Toshiyuki] Univ Tokyo, Dept Blood Transfus, Fac Med, Tokyo, Japan; [Suzuki, Nobuchika] Nippon Med Sch, Dept Bioregulat, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; Teikyo University; University of Tokyo; University of Tokyo; University of Tokyo; Nippon Medical School	Watanabe, S (corresponding author), Univ Tokyo, Ctr Dis Biol & Integrat Med, Fac Med, Bunkyo Ku, Tokyo, Japan.; Watanabe, S (corresponding author), Univ Tokyo, Grad Sch Med, Div Nephrol & Endocrinol, Bunkyo Ku, Tokyo, Japan.; Watanabe, S (corresponding author), Teikyo Univ, Dept Internal Med, Sch Med, Itabashi Ku, Tokyo, Japan.	swatanabe@bmw.t.u-tokyo.ac.jp	Ogasawara, Toru/I-1629-2014; Ikeda, Toshiyuki/GVS-5588-2022	Ogasawara, Toru/0000-0002-2996-081X; Shibata, Shigeru/0000-0002-6868-0626	Ministry of Education, Culture, Sports, Science and Technology of Japan [19590936, 22890196]; Japan Society for the Promotion of Science (JSPS KAKENHI) [25670846]; Grants-in-Aid for Scientific Research [15H05788] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grant-in-aid scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (19590936, 22890196) and by the Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number 25670846). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armando I, 2015, TRANSL RES, V165, P505, DOI 10.1016/j.trsl.2014.07.006; Capasso C, 2014, VIRUSES-BASEL, V6, P832, DOI 10.3390/v6020832; Chikatsu N, 2003, ENDOCR J, V50, P91, DOI 10.1507/endocrj.50.91; Choi YK, 2003, GENE THER, V10, P559, DOI 10.1038/sj.gt.3301926; Curran J, 2015, ANNU REV PHYSIOL, V77, P505, DOI 10.1146/annurev-physiol-021014-071838; Devuyst O, 2014, LANCET, V383, P1844, DOI 10.1016/S0140-6736(14)60659-0; Edvardsson VO, 2013, PEDIATR NEPHROL, V28, P1923, DOI 10.1007/s00467-012-2329-z; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Heikkila P, 1996, GENE THER, V3, P21; Hildebrandt F, 2010, LANCET, V375, P1287, DOI 10.1016/S0140-6736(10)60236-X; Igarashi P, 1996, J BIOL CHEM, V271, P9666, DOI 10.1074/jbc.271.16.9666; Isaka Yoshitaka, 2006, Clin Exp Nephrol, V10, P229, DOI 10.1007/s10157-006-0442-7; JAFFE HA, 1992, NAT GENET, V1, P372, DOI 10.1038/ng0892-372; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; MASTRANGELI A, 1993, J CLIN INVEST, V91, P225, DOI 10.1172/JCI116175; MOULLIER P, 1994, KIDNEY INT, V45, P1220, DOI 10.1038/ki.1994.162; Obermuller N, 1996, J CLIN INVEST, V98, P635, DOI 10.1172/JCI118834; Siggaard C, 1999, J CLIN ENDOCR METAB, V84, P2933, DOI 10.1210/jc.84.8.2933; Watanabe S, 2002, LANCET, V360, P692, DOI 10.1016/S0140-6736(02)09842-2; Weinman EJ, 2005, J PHYSIOL-LONDON, V567, P27, DOI 10.1113/jphysiol.2005.086777; Yao XL, 2011, CURR CANCER DRUG TAR, V11, P810, DOI 10.2174/156800911796798896; Zhu GM, 1997, KIDNEY INT, V52, P992, DOI 10.1038/ki.1997.421	24	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0168638	10.1371/journal.pone.0168638	http://dx.doi.org/10.1371/journal.pone.0168638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253301	gold, Green Published, Green Submitted			2022-12-26	WOS:000396011300001
J	Tashiro, M; Iwata, A; Yamauchi, M; Shimizu, K; Okada, A; Ishiguro, N; Inoshima, Y				Tashiro, Manami; Iwata, Ami; Yamauchi, Marika; Shimizu, Kaori; Okada, Ayaka; Ishiguro, Naotaka; Inoshima, Yasuo			The N-terminal region of serum amyloid A3 protein activates NF-kappa B and up-regulates MUC2 mucin mRNA expression in mouse colonic epithelial cells	PLOS ONE			English	Article							INFLAMMATORY RESPONSES; GENE-EXPRESSION; IN-VITRO; BACTERIA; ALPHA; MICE; DEXAMETHASONE; MICROBIOTA; CYTOKINES; PATHWAY	Serum amyloid A (SAA) is the major acute-phase protein and a precursor of amyloid A (AA) in AA amyloidosis in humans and animals. SAA isoforms have been identified in a wide variety of animals, such as SAA1, SAA2, SAA3, and SAA4 in mouse. Although the biological functions of SAA isoforms are not completely understood, recent studies have suggested that SAA3 plays a role in host defense. Expression of SAA3 is increased on the mouse colon surface in the presence of microbiota in vivo, and it increases mRNA expression of mucin 2 (MUC2) in murine colonic epithelial cells in vitro, which constitutes a protective mucus barrier in the intestinal tract. In this study, to identify responsible regions in SAA3 for MUC2 expression, recombinant murine SAA1 (rSAA1), rSAA3, and rSAA1/3, a chimera protein constructed with mature SAA1 (amino acids 1-36) and SAA3 (amino acids 37-103), and vice versa for rSAA3/1, were added to murine colonic epithelial CMT-93 cells, and the mRNA expressions of MUC2 and cytokines were measured. Inhibition assays with NF-kappa B inhibitor or TLR4/MD2 inhibitor were also performed. Up-regulation of MUC2 mRNA expression was strongly stimulated by rSAA3 and rSAA3/1, but not by rSAA1 or rSAA1/3. Moreover, NF-kappa B and TLR4/MD2 inhibitors suppressed the increase of MUC2 mRNA expression. These results suggest that the major responsible region for MUC2 expression exists in amino acids 1-36 of SAA3, and that up-regulations of MUC2 expression by SAA3 and SAA3/1 are involved with activation of NF-kappa B via the TLR4/MD2 complex.	[Tashiro, Manami; Iwata, Ami; Yamauchi, Marika; Shimizu, Kaori; Okada, Ayaka; Ishiguro, Naotaka; Inoshima, Yasuo] Gifu Univ, Fac Appl Biol Sci, Cooperat Dept Vet Med, Lab Food & Environm Hyg, Gifu, Japan; [Ishiguro, Naotaka; Inoshima, Yasuo] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan; [Inoshima, Yasuo] Gifu Univ GeFAH, Educ & Res Ctr Food Anim Hlth, Gifu, Gifu, Japan	Gifu University; Gifu University	Inoshima, Y (corresponding author), Gifu Univ, Fac Appl Biol Sci, Cooperat Dept Vet Med, Lab Food & Environm Hyg, Gifu, Japan.; Inoshima, Y (corresponding author), Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan.; Inoshima, Y (corresponding author), Gifu Univ GeFAH, Educ & Res Ctr Food Anim Hlth, Gifu, Gifu, Japan.	inoshima@gifu-u.ac.jp		Moriyama, Masafumi/0000-0003-2911-2244	Research Center for Zoonosis Control, Hokkaido University; Ministry of Education, Culture, Sports, Science and Technology, Japan; Ito Foundation, Japan;  [25292171];  [16H05027]	Research Center for Zoonosis Control, Hokkaido University; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ito Foundation, Japan; ; 	This study was partly supported by a Grant-in-Aid for Scientific Research (No. 25292171 and 16H05027) and the Grant for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University, from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This study was also supported in part by the Ito Foundation, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly supported by Grant-in-Aid for Scientific Research (No. 25292171 and 16H05027) and the Grant for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University, from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This study was also supported in part by the Ito Foundation, Japan.	Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bottero Virginie, 2003, Mol Diagn, V7, P187, DOI 10.2165/00066982-200307030-00008; Cadera EJ, 2009, J EXP MED, V206, P1803, DOI 10.1084/jem.20082815; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; Clarke LL, 2004, AM J PHYSIOL-GASTR L, V286, pG1050, DOI 10.1152/ajpgi.00393.2003; DEBEER MC, 1995, J LIPID RES, V36, P526; Deguchi A, 2013, J IMMUNOL, V191, P1856, DOI 10.4049/jimmunol.1201996; Dilly AK, 2015, TRANSL RES, V166, P344, DOI 10.1016/j.trsl.2015.03.004; Eckhardt ERM, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-133; Enss ML, 2000, INFLAMM RES, V49, P162, DOI 10.1007/s000110050576; Fasshauer M, 2004, J ENDOCRINOL, V183, P561, DOI 10.1677/joe.1.05699; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Iwashita J, 2003, IMMUNOL CELL BIOL, V81, P275, DOI 10.1046/j.1440-1711.2003.t01-1-01163.x; Kasahara DI, 2014, AM J PHYSIOL-LUNG C, V306, pL508, DOI 10.1152/ajplung.00235.2013; Loonen LMP, 2014, MUCOSAL IMMUNOL, V7, P939, DOI 10.1038/mi.2013.109; Mack DR, 2003, PEDIATR RES, V53, P137, DOI 10.1203/01.PDR.0000041517.15440.F3; MEEK RL, 1986, J EXP MED, V164, P2006, DOI 10.1084/jem.164.6.2006; Mejias-Luque R, 2008, BBA-MOL CELL RES, V1783, P1728, DOI 10.1016/j.bbamcr.2008.05.020; Obici L, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13580; Rahman A, 2011, CLIN EXP IMMUNOL, V163, P123, DOI 10.1111/j.1365-2249.2010.04282.x; Reigstad CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005842; Shah C, 2006, BLOOD, V108, P1751, DOI 10.1182/blood-2005-11-011932; Shigemura H, 2014, J VET MED SCI, V76, P985, DOI 10.1292/jvms.14-0007; SHIMIZU H, 1994, GENE, V149, P305; Son DS, 2004, ENDOCRINOLOGY, V145, P2245, DOI 10.1210/en.2003-1261; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Yang YH, 2004, ARTHRITIS RHEUM-US, V50, P976, DOI 10.1002/art.20201; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	30	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181796	10.1371/journal.pone.0181796	http://dx.doi.org/10.1371/journal.pone.0181796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738073	gold, Green Published, Green Submitted			2022-12-26	WOS:000406362700072
